<SEC-DOCUMENT>0001193125-16-505366.txt : 20160315
<SEC-HEADER>0001193125-16-505366.hdr.sgml : 20160315
<ACCEPTANCE-DATETIME>20160315171740
ACCESSION NUMBER:		0001193125-16-505366
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		106
CONFORMED PERIOD OF REPORT:	20151231
FILED AS OF DATE:		20160315
DATE AS OF CHANGE:		20160315

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANNKIND CORP
		CENTRAL INDEX KEY:			0000899460
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133607736
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50865
		FILM NUMBER:		161507878

	BUSINESS ADDRESS:	
		STREET 1:		25134 RYE CANYON LOOP
		STREET 2:		SUITE 300
		CITY:			VALENCIA
		STATE:			CA
		ZIP:			91355
		BUSINESS PHONE:		6617755300

	MAIL ADDRESS:	
		STREET 1:		25134 RYE CANYON LOOP
		STREET 2:		SUITE 300
		CITY:			VALENCIA
		STATE:			CA
		ZIP:			91355
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>d107849d10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 10-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:2px;margin-top:0px;margin-bottom:0px;border-bottom:2pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>UNITED STATES SECURITIES AND
EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>Form 10-K </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT><B></B><B></B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </B></FONT></TD></TR></TABLE>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>For the fiscal year ended December&nbsp;31, 2015 </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>or </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>For the transition period from
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Commission file number: 000-50865 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="6"><B>MannKind Corporation </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>(Exact name of registrant as specified in its
charter) </I></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13-3607736</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>(State or other jurisdiction of</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>incorporation or organization)</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>(I.R.S. Employer</I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><I>Identification No.)</I></FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>25134 Rye Canyon Loop Suite 300</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Valencia, California</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>91355</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>(Address of principal executive offices)</I></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>(Zip Code)</I></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(661) 775-5300 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Securities registered pursuant to Section&nbsp;12(b) of the Act: </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:44pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Title of Class</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:156pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name of Each Exchange on Which Registered</B></FONT></P></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Common Stock, par value $0.01 per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">The NASDAQ Global Market</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Securities registered pursuant to Section&nbsp;12(g) of the Act: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>None </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>(Title of Class) </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is not required to file reports pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Act.
&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing requirements for the past
90&nbsp;days.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation&nbsp;S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such
files).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if disclosure of delinquent filers pursuant to Item&nbsp;405 of Regulation S-K is not contained herein, and will
not be contained, to the best of registrant&#146;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form&nbsp;10-K.&nbsp;&nbsp;&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in
<FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> of the Exchange Act. (Check one): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD></TR>


<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Large&nbsp;accelerated&nbsp;filer&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accelerated&nbsp;filer&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-accelerated&nbsp;filer&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Smaller&nbsp;reporting&nbsp;company&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(Do&nbsp;not&nbsp;check&nbsp;if&nbsp;a&nbsp;smaller&nbsp;reporting&nbsp;company)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of June&nbsp;30, 2015, the aggregate market value of the voting stock held by non-affiliates of the registrant, computed by reference
to the last sale price of such stock as of such date on the NASDAQ Global Market, was approximately $1,461,620,053. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of
February&nbsp;22, 2016, there were 428,850,858 shares of the registrant&#146;s Common Stock outstanding. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DOCUMENTS
INCORPORATED BY REFERENCE </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Portions of the registrant&#146;s definitive Proxy Statement (the &#147;Proxy Statement&#148;)
for the 2016 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Form 10-K, are incorporated by reference in Part
III of this Annual Report on Form 10-K. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:2pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Annual Report on Form 10-K </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>For the Fiscal Year Ended December&nbsp;31, 2015 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE
OF CONTENTS </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Page</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A HREF="#toc107849_1">PART I</A></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item&nbsp;1.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_2">Business</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item&nbsp;1A.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_3">Risk Factors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 1B.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_4">Unresolved Staff Comments</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 2.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_5">Properties</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 3.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_6">Legal Proceedings</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 4.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_7">Mine Safety Disclosures</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A HREF="#toc107849_8">PART II</A></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 5.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_9">Market for the Registrant&#146;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</A></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 6.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_10">Selected Financial Data</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 7.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_11">Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item&nbsp;7A.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_12">Quantitative and Qualitative Disclosures About Market Risk</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 8.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_13">Financial Statements and Supplementary Data</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_14">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_15">CONSOLIDATED BALANCE SHEETS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_16">CONSOLIDATED STATEMENTS OF OPERATIONS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_17">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_18">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#146; DEFICIT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_19">CONSOLIDATED STATEMENTS OF CASH FLOWS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_20">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">81</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 9.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_21">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 9A.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_22">Controls and Procedures</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item&nbsp;9B.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_23">Other Information</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A HREF="#toc107849_24">PART III</A></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 10.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_25">Directors, Executive Officers and Corporate Governance</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 11.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_26">Executive Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 12.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_27">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</A></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 13.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_28">Certain Relationships and Related Transactions, and Director Independence</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 14.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_29">Principal Accounting Fees and Services</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A HREF="#toc107849_30">PART IV</A></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Item 15.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_31">Exhibits. Financial Statement Schedules</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc107849_32">Signatures</A></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Forward-Looking Statements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Statements in this report that are not strictly historical in nature are &#147;forward-looking statements&#148; within the meaning of the federal securities laws made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148;
&#147;goal,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would,&#148; and similar expressions intended to identify
forward-looking statements, though not all forward-looking statements contain these identifying words. These statements may include, but are not limited to, statements regarding: our ability to successfully market, commercialize and achieve market
acceptance for AFREZZA or any other product candidates or therapies that we may develop; our ability to manufacture sufficient quantities of AFREZZA and obtain insulin supply as needed; our ability to successfully commercialize our Technosphere drug
delivery platform; our estimates for future performance; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; the timing and amount of our future recognition of deferred
product sales from collaboration, product costs from collaboration and income from collaboration; the progress or success of our research, development and clinical programs, including the application for and receipt of regulatory clearances and
approvals; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; and scientific studies and the conclusions we draw from them. These statements are only
predictions or conclusions based on current information and expectations and involve a number of risks and uncertainties. The underlying information and expectations are likely to change over time. Actual events or results may differ materially from
those projected in the forward-looking statements due to various factors, including, but not limited to, those set forth under the caption &#147;Risk Factors&#148; and elsewhere in this report. Except as required by law, we undertake no obligation
to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">AFREZZA<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>,
MedTone<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, Dreamboat<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> and Technosphere<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> are our
trademarks in the United States. We have also applied for or have registered company trademarks in other jurisdictions, including Europe and Japan. This document also contains trademarks and service marks of other companies that are the property of
their respective owners. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_1"></A>PART I </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_2"></A>Item&nbsp;1. </B><B><I>Business </I></B><B> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless the context requires otherwise, the words &#147;MannKind,&#148; &#147;we,&#148; &#147;company,&#148; &#147;us&#148; and
&#147;our&#148; refer to MannKind Corporation and its subsidiaries. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">MannKind Corporation is a biopharmaceutical company
focused on the discovery and development of therapeutic products for diseases such as diabetes. Our only approved product, AFREZZA, is a rapid-acting inhaled insulin that was approved by the U.S. Food and Drug Administration (the &#147;FDA&#148;) on
June&nbsp;27, 2014 to improve glycemic control in adult patients with diabetes. AFREZZA became available by prescription in United States retail pharmacies in February 2015. According to the Centers for Disease Control and Prevention, in the United
States in 2012, approximately 29.1&nbsp;million people had diabetes. Globally, the International Diabetes Federation has estimated that approximately 415.0&nbsp;million people had diabetes in 2015 and approximately 642.0&nbsp;million people will
have diabetes by 2040. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">AFREZZA is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and
type 2 diabetes. The product consists of a dry formulation of human insulin delivered from a small and portable inhaler. Administered at the beginning of a meal, AFREZZA dissolves rapidly upon inhalation to the lung and delivers insulin quickly to
the bloodstream. Peak insulin levels are achieved within 12&#150;15 minutes of administration. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;11, 2014, we
entered into a license and collaboration agreement (the &#147;Sanofi License Agreement&#148;) with Sanofi-Aventis Deutschland GmbH (which subsequently assigned its rights and obligations under the agreement to Sanofi-Aventis U.S. LLC
(&#147;Sanofi&#148;)), pursuant to which Sanofi became responsible for global commercial, regulatory and development activities for AFREZZA. For the year ended December&nbsp;31, 2015, Sanofi reported a total of &#128;7.0&nbsp;million in annual sales
of AFREZZA. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;4, 2016, we received written notice from Sanofi of its election to terminate
in its entirety the Sanofi License Agreement. Sanofi&#146;s notice indicated that the termination was pursuant to Sanofi&#146;s right to terminate the agreement upon Sanofi&#146;s good faith determination that the commercialization of AFREZZA is no
longer economically viable in the United States, in which case the effective date of termination (the &#147;Termination Date&#148;) would be April&nbsp;4, 2016. In the alternative, Sanofi indicated that the termination was also pursuant to its right
to terminate the agreement for any reason, in which case the Termination Date would be July&nbsp;4, 2016. We believe that Sanofi lacks a good faith basis for determining that commercialization of AFREZZA is no longer economically viable in the
United States. Nonetheless, in the interest of an expedient transition, we are currently working with Sanofi to transfer and wind down the agreement activities by April&nbsp;4, 2016, or as soon as practicable thereafter. As required by the Sanofi
License Agreement, we and Sanofi are currently using diligent efforts to facilitate the smooth and orderly transition of development and commercialization activities related to AFREZZA, and are negotiating in good faith a written transition
agreement for this purpose. As a result of the foregoing termination, effective on the Termination Date and thereafter during any period which Sanofi is required to perform any wind-down activities pursuant to the terms of the Sanofi License
Agreement, the rights granted to Sanofi under the Sanofi License Agreement to develop and commercialize AFREZZA will become non-exclusive and we will have the right to engage one or more other distributors and/or licensees of AFREZZA. Sanofi will
continue to distribute AFREZZA during the wind-down period as required by the agreement until such time that we or our designee takes over responsibility for distribution. All profits and losses from AFREZZA product sales by Sanofi or its affiliates
after the Termination Date, if any, will continue to be shared 65% by Sanofi and 35% by us pursuant to the terms of the Sanofi License Agreement. We and Sanofi are also parties to a supply agreement, dated August&nbsp;11, 2014 (the &#147;Sanofi
Supply Agreement&#148;), pursuant to which we are required to supply Sanofi or its affiliates or its sublicensees such quantities of AFREZZA as requested by Sanofi to cover its commercial requirements. As a result of the termination of the Sanofi
License Agreement, the Sanofi Supply Agreement will terminate by its terms on the Termination Date. In addition to the foregoing agreements, we and Aventisub LLC, an affiliate of Sanofi, are parties to a Senior Secured Revolving Promissory Note,
dated September&nbsp;23, 2014 (the &#147;Sanofi Loan Facility&#148;) and a Guaranty and Security Agreement (the &#147;Security Agreement&#148;). Both the Sanofi Loan Facility and the Security Agreement remain in effect. Pursuant to the Sanofi Loan
Facility, we may borrow up to an aggregate of $175.0 million to fund our share of net losses from AFREZZA product sales by Sanofi or its affiliates. The original maturity date of September&nbsp;23, 2024 for repayment of the outstanding principal
amount of the loans under the Sanofi Loan Facility is not affected by the termination of the Sanofi License Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As part
of the approval of AFREZZA, the FDA required us to conduct the following post-marketing studies: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A dose-ranging pharmacokinetic (PK)-pharmacodynamic (PD) glucose-clamp trial to characterize the dose-response of AFREZZA relative to subcutaneous
insulin in patients with type 1 diabetes, which Sanofi completed in 2015; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A PK-PD glucose-clamp trial to characterize within-subject variability, which Sanofi completed in 2015; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An open-label PK and multiple-dose safety and tolerability dose-titration trial of AFREZZA in pediatric patients ages 4 to 17 years with type 1
diabetes, for which Sanofi is in the process of enrolling subjects, followed by a prospective, open-label, randomized, controlled trial comparing the efficacy and safety of prandial AFREZZA to prandial subcutaneous insulin as part used in
combination with subcutaneous basal insulin in pediatric patients 4 to 17 years old with type 1 or type 2 diabetes; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A five-year, randomized, controlled trial in 8,000-10,000 patients with type 2 diabetes to assess the potential serious risk of pulmonary malignancy
with AFREZZA use. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the Sanofi License Agreement, we transferred the approved new drug application
(&#147;NDA&#148;) for AFREZZA to Sanofi following the closing of the transaction. Sanofi has completed the two PK-PD studies and is in the process of enrolling subjects in the first part of the pediatric study. The obligation to complete the
pediatric study and to conduct the five-year pulmonary safety study will revert to us when the NDA for AFREZZA is transferred back to us in connection with the termination of the Sanofi License Agreement. At that time, we will become responsible for
the NDA and its maintenance. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Manufacturing and Supply </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We manufacture AFREZZA in our Danbury, Connecticut facility, where we formulate the AFREZZA inhalation powder, fill it into plastic cartridges and then blister package the cartridges and seal the blister
cards inside a foil overwrap. These overwraps are then packaged into cartons along with inhalers and printed material by a third-party packager. The cartridges and inhalers are manufactured for us by a third-party plastic-molding company; the
cartridges are delivered to our Connecticut facility whereas the inhalers are shipped directly to the packaging contractor. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The quality management systems of our Connecticut facility were certified to be in conformance with the ISO 13485 and ISO 9001 standards.
Our facility has been inspected twice by the FDA, once for a pre-approval inspection in the fall of 2009 and once for a regular inspection in May 2013. The FDA is expected to conduct additional inspections of our facility. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that our Connecticut facility has enough capacity to satisfy the current commercial demand for AFREZZA. We currently have three
operational filling lines with the capacity to process 300-360&nbsp;million cartridges per year. In addition, the facility includes expansion space to accommodate additional filling lines and other equipment, allowing production capacity to be
increased based on the demand for AFREZZA over the next several years. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, the only approved source of insulin for
AFREZZA is manufactured by Amphastar France Pharmaceuticals S.A.S. (&#147;Amphastar&#148;). In April 2014, Amphastar acquired a manufacturing facility from N.V. Organon, a subsidiary of Merck&nbsp;&amp; Co., Inc., where we had previously obtained
the insulin that we use to make AFREZZA. On July&nbsp;31, 2014, we entered into a supply agreement with Amphastar (the &#147;Insulin Supply Agreement&#148;), pursuant to which we agreed to purchase certain annual minimum quantities of insulin for
calendar years 2015 through 2019 for an aggregate total purchase price of approximately &#128;120.1&nbsp;million, of which &#128;98.5&nbsp;million is remaining at December&nbsp;31, 2015. We have contracted for the purchase of &#128;28.8&nbsp;million
in 2016 and the remaining annual minimum quantities will be &#128;23.3&nbsp;million for the years ending December&nbsp;31, 2017 through 2019. We also may purchase additional quantities of insulin over such annual minimum quantities at our option.
Unless earlier terminated, the term of the Insulin Supply Agreement expires on December&nbsp;31, 2019 and can be renewed for additional, successive two year terms upon 12 months written notice given prior to the end of the initial term or any
additional two year term. We and Amphastar each have normal and customary termination rights, including termination for material breach that is not cured within a specific time frame or in the event of liquidation, bankruptcy or insolvency of the
other party. In addition, we may terminate the Insulin Supply Agreement upon two years&#146; prior written notice to Amphastar without cause or upon 30 days prior written notice to Amphastar if a controlling regulatory authority withdraws approval
for AFREZZA, provided, however, in the event of a termination pursuant to either of the latter two scenarios, the provisions of the Insulin Supply Agreement require us to pay the full amount of all unpaid purchase commitments due over the initial
term within 60 calendar days of the effective date of such termination. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also own a quantity of bulk insulin that we
acquired in June 2009 from Pfizer Manufacturing Frankfurt GmbH, a subsidiary of Pfizer Inc., as well as an option to purchase from Pfizer additional insulin inventory, in whole or in part, at a specified price, to the extent it remains available.
The purchase price for this insulin was fully expensed at the time of the purchase. To date, none of this insulin has been qualified as a source of insulin for AFREZZA. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Currently, we purchase the raw material from which we produce Technosphere particles (fumaryl diketopiperazine (&#147;FDKP&#148;)) from a major chemical manufacturer with facilities in Europe and North
America. We also have the capability of manufacturing this chemical ourselves in our Danbury facility. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have a three-year
supply agreement with the contract manufacturer that produces our inhaler and the corresponding cartridges. We expect to be able to qualify an additional vendor of plastic-molding contract manufacturing services, if warranted by demand. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also have a three-year agreement with the contractor that performs the final packaging of AFREZZA overwraps, inhalers and printed
material into patient kits. We expect to be able to qualify an additional vendor of packaging services, if warranted by demand. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our third-party suppliers are subject to extensive governmental regulation. We rely on our
suppliers to comply with relevant regulatory requirements, including compliance with Quality System Regulations (&#147;QSRs&#148;). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Technosphere Formulation Technology </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">AFREZZA utilizes our proprietary Technosphere formulation technology; however, the application of this technology is not limited to insulin delivery. We believe it represents a versatile drug delivery
platform that may allow the oral inhalation of a wide range of therapeutics. We have successfully prepared Technosphere formulations of anionic and cationic drugs, hydrophobic and hydrophilic drugs, proteins, peptides, and small molecules.
Technosphere powders are based on our proprietary excipient, FDKP, which is a pH-sensitive organic molecule that self-assembles into small particles under acidic conditions. Certain drugs, such as insulin, can be loaded onto these particles by
combining a solution of the drug with a suspension of Technosphere material, which is then dried to powder form. The resulting powder has a consistent and narrow range of particle sizes with good aerodynamic properties that enable them to fly
efficiently deep into the lungs. Technosphere powders dissolve extremely fast after inhalation when the particles contact the moist lung surface with its neutral pH, releasing the drug molecules to diffuse across a thin layer of cells into the
arterial circulation, bypassing the liver to provide excellent systemic exposure. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have also created an innovative line of
breath-powered, dry powder inhalers. Our inhalers are easy to use, cost-effective and can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format. Both the reusable and single use inhaler formats use the same
internal air-flow design. Being breath-powered, our inhalers require only the patient&#146;s inhalation effort to deliver the powder. Patients are not required to activate the inhaler prior to use and no activation step with inhalation is required.
To administer the inhalation powder, a patient loads a cartridge into our inhaler and inhales through the mouthpiece. Upon inhalation, the dry powder is lifted out of the cartridge and broken (or de-agglomerated) into small particles. The inhalers
are engineered to produce an aggressive airstream to de-agglomerate the powder while keeping the powder moving slowly. This slow-moving powder effectively navigates the patient&#146;s airways for delivery into the lung with minimal deposition at the
back of the throat. Our inhalers show very little change in performance over a wide range of inhalation efforts and produce high bioavailability. In a handling study, pediatric subjects as young as four years old were readily able to use the
inhaler. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To aid in the development of our oral inhalation products, we have created a number of innovative development tools
and techniques. For example, our BluHale technology is a novel inhalation profiling tool that uses miniature acoustic sensors to assess the drug delivery process at the level of an individual inhaler. This tool provides real-time insight into
patient usage, device system performance and pharmacokinetic effects. We can combine this tool with other development tools, such as patient inhalation simulators and anatomically correct airway models, in order to integrate inhaler performance with
formulation development right from the beginning of the development program. The result is a powder/inhaler combination product customized to the target patient population from the first clinical study. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2016, we entered into a collaboration and license agreement with a newly formed entity, Receptor Life Sciences, Inc., pursuant
to which Receptor is evaluating the feasibility of developing multiple inhaled therapeutic products using our technology to explore their potential to treat conditions such as chronic pain, neurologic diseases and inflammatory disorders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Strategy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
following are the key elements of our strategy: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Commercialization and development of AFREZZA. </I>As soon as practicable
following the Termination Date of the Sanofi License Agreement, our intention is to assume the responsibility for commercializing and developing AFREZZA in the United States. In order to commercially market AFREZZA, we will need to develop an
internal sales team and expand our marketing infrastructure, collaborate with third parties who have greater sales and marketing capabilities, purchase services from a contract commercial organization, or utilize some combination of one or more of
the above. We also intend to seek regional partnerships for the development and commercialization of AFREZZA in foreign jurisdictions where there are appropriate commercial opportunities. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Capitalize on our proprietary Technosphere and inhaler technology for the delivery of
active pharmaceutical ingredients. </I>We believe that Technosphere formulations of active pharmaceutical ingredients have the potential to demonstrate clinical advantages over existing therapeutic options in a variety of therapeutic areas. In
addition to our collaboration with Receptor, we are actively exploring other opportunities to out-license our proprietary Technosphere formulation and device technologies. We are also evaluating several product opportunities that we would consider
developing as internally funded efforts. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Sales and Marketing </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To date, we have relied on Sanofi to conduct all sales and marketing activities related to AFREZZA. As soon as practicable following the Termination Date of the Sanofi License Agreement, our intention is
to assume the responsibility for these activities. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to commercially market AFREZZA, we will need to develop an
internal sales team and expand our marketing infrastructure, collaborate with third parties who have greater sales and marketing capabilities, purchase services from a contract commercial organization, or utilize some combination of these
approaches. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Intellectual Property </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our success will depend in large measure on our ability to obtain and enforce our intellectual property rights, effectively maintain our trade secrets and avoid infringing the proprietary rights of third
parties. Our policy is to file patent applications on what we deem to be important technological developments that might relate to our product candidates or methods of using our product candidates and to seek intellectual property protection in the
United States, Europe, Japan and selected other jurisdictions for all significant inventions. We have obtained, are seeking, and will continue to seek patent protection on the compositions of matter, methods and devices flowing from our research and
development efforts. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Technosphere drug delivery platform, including AFREZZA, enjoys patent protection relating to the
particles, their manufacture, and their use for pulmonary delivery of drugs. We have additional patent coverage relating to the treatment of diabetes using AFREZZA. We have been granted patent coverage for the commercial version of our inhaler and
cartridges. We have additional pending patent applications, and expect to file further applications, relating to the drug delivery platform, methods of manufacture, the AFREZZA product and its use, and other Technosphere-based products, inhalers and
inhaler cartridges. Overall, AFREZZA is protected by over 330 issued patents in the United States and selected jurisdictions around the world and we also have over 350 applications pending that may provide additional protection if and when they are
allowed. These include composition and inhaler and cartridge patents providing protection for AFREZZA with various expiration dates, the longer-lived of which will not expire until 2032. In addition, we have certain method of treatment claims that
have terms extending into 2026 and 2029. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The field of pulmonary drug delivery is crowded and a substantial number of patents
have been issued in these fields. In addition, because patent positions can be highly uncertain and frequently involve complex legal and factual questions, the breadth of claims obtained in any application or the enforceability of issued patents
cannot be confidently predicted. Further, there can be substantial delays in commercializing pharmaceutical products, which can partially consume the statutory period of exclusivity through patents. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, the coverage claimed in a patent application can be significantly reduced before a patent is issued, either in the United
States or abroad. Statutory differences in patentable subject matter may limit the protection we can obtain on some of our inventions outside of the United States. For example, methods of treating humans are not patentable in many countries outside
of the United States. These and other issues may limit the patent protection we are able to secure internationally. Consequently, we do not know whether any of our pending or future patent applications will result in the issuance of patents or, to
the extent patents have been issued or will be issued, whether these patents will be subjected to further proceedings limiting their scope, will provide significant proprietary protection or competitive advantage, or will be circumvented or
invalidated. Furthermore, patents already issued to us or our pending applications may become subject to disputes that could be resolved against us. In addition, in certain countries, including the United States, applications are generally published
18 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
months after the application&#146;s priority date. In any event, because publication of discoveries in scientific or patent literature often trails behind actual discoveries, we cannot be certain
that we were the first inventor of the subject matter covered by our pending patent applications or that we were the first to file patent applications on such inventions. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Although we own a number of domestic and foreign patents and patent applications relating to AFREZZA and our oral inhalation technologies, we have identified certain third-party patents having claims that
may trigger an allegation of infringement by virtue of the commercial manufacture and sale of AFREZZA. We believe that AFREZZA does not infringe any valid claims of any patent owned by a third party. However, if a court were to determine that the
manufacture or sale of AFREZZA were infringing any of these patent rights, we would have to establish with the court that these patents were invalid in order to avoid legal liability for infringement of these patents. Proving patent invalidity can
be difficult because issued patents are presumed valid. Therefore, in the event that we are unable to prevail in an infringement or invalidity action we will either have to acquire the third-party patents outright or seek a royalty-bearing license.
Royalty-bearing licenses effectively increase costs and therefore may materially affect product profitability. Furthermore, if the patent holder refuses to either assign or license us the infringed patents, it may be necessary to cease manufacturing
the product entirely and/or design around the patents. In either event, our business would be harmed and our profitability could be materially adversely impacted. If third parties file patent applications, or are issued patents claiming technology
also claimed by us in pending applications, we may be required to participate in interference proceedings in the United States Patent and Trademark Office (&#147;USPTO&#148;) to determine priority of invention. We may also be required to participate
in interference proceedings involving our issued patents. We also rely on trade secrets and know-how, which are not protected by patents, to maintain our competitive position. We require our officers, employees, consultants and advisors to execute
proprietary information and invention and assignment agreements upon commencement of their relationships with us. These agreements provide that all confidential information developed or made known to the individual during the course of our
relationship must be kept confidential, except in specified circumstances. These agreements also provide that all inventions developed by the individual on behalf of us must be assigned to us and that the individual will cooperate with us in
connection with securing patent protection on the invention if we wish to pursue such protection. There can be no assurance, however, that these agreements will provide meaningful protection for our inventions, trade secrets or other proprietary
information in the event of unauthorized use or disclosure of such information. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also execute confidentiality agreements
with outside collaborators. However, disputes may arise as to the ownership of proprietary rights to the extent that outside collaborators apply technological information to our projects that are developed independently by them or others, or apply
our technology to outside projects, and there can be no assurance that any such disputes would be resolved in our favor. In addition, any of these parties may breach the agreements and disclose our confidential information or our competitors might
learn of the information in some other way. If any trade secret, know-how or other technology not protected by a patent were to be disclosed to or independently developed by a competitor, our business, results of operations and financial condition
could be adversely affected. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Competition </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The pharmaceutical and biotechnology industries are highly competitive and characterized by rapidly evolving technology and intense research and development efforts. We compete with companies, including
major global pharmaceutical companies, and other institutions that have substantially greater financial, research and development, marketing and sales capabilities and have substantially greater experience in undertaking preclinical and clinical
testing of products, obtaining regulatory approvals and marketing and selling biopharmaceutical products. We face competition based on, among other things, product efficacy and safety, the timing and scope of regulatory approvals, product ease of
use and price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Diabetes Treatments </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We believe that AFREZZA has important competitive advantages in the delivery of insulin when compared with currently known alternatives. However, new drugs or further developments in alternative drug
delivery </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
methods may provide greater therapeutic benefits, or comparable benefits at lower cost, than AFREZZA. There can be no assurance that existing or new competitors will not introduce products or
processes competitive with or superior to our product candidates. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have set forth below more detailed information about
certain of our competitors. The following is based on information currently available to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Rapid-acting (Injected) Insulin
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, there is no approved insulin product that is absorbed into the bloodstream as rapidly as AFREZZA, i.e.,
reaching peak levels within 12 to 15 minutes after administration. There are several formulations of &#147;rapid-acting&#148; insulin analogs that reach peak insulin levels within 45 to 90 minutes after injection. The principal products in this
category are insulin lispro, which is marketed by Eli Lilly&nbsp;&amp; Company, or Lilly; insulin aspart, which is marketed by Novo Nordisk A/S, or Novo Nordisk; and insulin glulisine, which is marketed by Sanofi. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Several insulin products in development are reported to have a time-action profile that is more rapid than that of the currently available
injected rapid-acting insulin analogs. For example, Novo Nordisk is developing NN1218, an insulin analog that is intended to provide faster onset of action than aspart. NN1218 is currently undergoing regulatory review in the United States and
Europe. In addition, Biodel, Inc. has conducted a Phase 2 clinical trial of BIOD-123, a formulation of human insulin with certain excipients that increase the rate of absorption following injection. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Inhaled Insulin Delivery Systems </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">In January 2006, Exubera<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, developed by Pfizer in collaboration
with Nektar Therapeutics, Inc., was approved for the treatment of adults with type 1 and type 2 diabetes.
Exubera<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> was slow to gain market acceptance and, in October 2007, Pfizer announced that it was discontinuing the
product. In September 2008, we announced a collaboration agreement with Pfizer pursuant to which certain patients with a continuing medical need for inhaled insulin were transitioned to AFREZZA on a compassionate use basis. Pfizer subsequently
withdrew the NDA for Exubera from the FDA. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2008, Novo Nordisk announced that it was halting development of its
inhaled insulin product, having reached the conclusion that the product did not have adequate commercial potential. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">In March 2008, Lilly announced that it was terminating the development of its
AIR<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> inhaled insulin system. Lilly stated that this decision resulted from increasing uncertainties in the
regulatory environment and after a thorough evaluation of the evolving commercial and clinical potential of its product compared to existing medical therapies. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dance Biopharm, Inc. has completed Phase 2 clinical studies of an inhaled insulin product that utilizes a liquid formulation of human insulin, dispensed through a handheld electronic aerosol device, and
is preparing to commence pivotal studies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Non-insulin Medications </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">AFREZZA also competes with currently available non-insulin medication products for type 2 diabetes. These products include the following:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">GLP-1 agonists, such as exenatide or liraglutide, which mimic a naturally occurring hormone that stimulates the pancreas to secrete insulin when blood
glucose levels are high. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inhibitors of dipeptidyl peptidase IV, such as sitagliptin or saxagliptin, are a class of drugs that work by blocking the enzyme that normally degrades
GLP-1. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sulfonylureas and meglitinides, which are classes of drugs that act on the pancreatic cells to stimulate the secretion of insulin.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thiazolidinediones, such as pioglitizone, and biguanides, such as metformin, which lower blood glucose by improving the sensitivity of cells to
insulin, or diminishing insulin resistance. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alpha-glucosidase inhibitors, which lower the amount of glucose absorbed from the intestines, thereby reducing the rise in blood glucose that occurs
after a meal. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">SGLT-2 inhibitors, such as dapagliflozin and canagliflozin, are a class of medications that lower blood glucose by increasing glucose excretion in
urine. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Government Regulation and Product Approval </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The FDA and comparable regulatory agencies in state, local and foreign jurisdictions impose substantial requirements upon the clinical
development, manufacture and marketing of medical devices and new drug and biologic products. These agencies, through regulations that implement the Federal Food, Drug, and Cosmetic Act, as amended (&#147;FDCA&#148;), and other regulations, regulate
research and development activities and the development, testing, manufacture, labeling, storage, shipping, approval, recordkeeping, advertising, promotion, sale and distribution of such products. In addition, if any of our products are marketed
abroad, they will also be subject to export requirements and to regulation by foreign governments. The regulatory approval process is generally lengthy, expensive and uncertain. Failure to comply with applicable FDA and other regulatory requirements
can result in sanctions being imposed on us or the manufacturers of our products, including hold letters on clinical research, civil or criminal fines or other penalties, product recalls, or seizures, or total or partial suspension of production or
injunctions, refusals to permit products to be imported into or exported out of the United States, refusals of the FDA to grant approval of drugs or to allow us to enter into government supply contracts, withdrawals of previously approved marketing
applications and criminal prosecutions. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The steps typically required before an unapproved new drug or biologic product for use
in humans may be marketed in the United States include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preclinical studies that include laboratory evaluation of product chemistry and formulation, as well as animal studies to assess the potential safety
and efficacy of the product. Certain preclinical tests must be conducted in compliance with good laboratory practice regulations. Violations of these regulations can, in some cases, lead to invalidation of the studies, or requiring such studies to
be repeated. In some cases, long-term preclinical studies are conducted while clinical studies are ongoing. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submission to the FDA of an investigational new drug application (&#147;IND&#148;), which must become effective before human clinical trials may
commence. The results of the preclinical studies are submitted to the FDA as part of the IND. Unless the FDA objects and places a clinical hold, the IND becomes effective 30 days following receipt by the FDA. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval of clinical protocols by independent institutional review boards (&#147;IRBs&#148;) at each of the participating clinical centers conducting a
study. The IRBs consider, among other things, ethical factors, the potential risks to individuals participating in the trials and the potential liability of the institution. The IRB also approves the consent form signed by the trial participants.
The IRB also approves the consent form signed by the trial participants. The IRB of FDA may place a trial on hold at any time if it believes the risks to subjects outweigh the potential benefits. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adequate and well-controlled human clinical trials to establish the safety and efficacy of the product. Clinical trials involve the administration of
the drug to healthy volunteers or to patients under the supervision of a qualified medical investigator according to an approved protocol. The clinical trials are conducted in accordance with protocols that detail the objectives of the study, the
parameters to be used to monitor participant safety and efficacy or other criteria to be evaluated. Each protocol is submitted to the FDA as part of the IND. Human clinical trials are typically conducted in the following four sequential phases that
may overlap or be combined: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In Phase 1, the drug is initially introduced into a small number of individuals and tested for safety, dosage tolerance, absorption, metabolism,
distribution and excretion. Phase 1 clinical trials are often conducted in healthy human volunteers and such cases do not provide evidence of efficacy. In the case of severe or life-threatening diseases, the initial human testing is often conducted
in patients rather than healthy volunteers. Because these patients already have the target disease, these studies may provide initial </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
evidence of efficacy that would traditionally be obtained in Phase 2 clinical trials. Consequently, these types of trials are frequently referred to as Phase 1/2 clinical trials. The FDA receives
reports on the progress of each phase of clinical testing and it may require the modification, suspension or termination of clinical trials if it concludes that an unwarranted risk is presented to patients or healthy volunteers.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Phase 2 involves clinical trials in a limited patient population to further identify any possible adverse effects and safety risks, to determine the
efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Phase 3 clinical trials are undertaken to further evaluate dosage, clinical efficacy and to further test for safety in an expanded patient population
at geographically dispersed clinical study sites. Phase 3 clinical trials usually include a broader patient population so that safety and efficacy can be substantially established. Phase 3 clinical trials cannot begin until Phase 2 evaluation
demonstrates that a dosage range of the product may be effective and has an acceptable safety profile. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Phase 4 clinical trials are performed if the FDA requires, or a company pursues, additional clinical trials after a product is approved. These clinical
trials may be made a condition to be satisfied after a drug receives approval. The results of Phase 4 clinical trials can confirm the effectiveness of a product and can provide important safety information to augment the FDA&#146;s voluntary adverse
event reporting system. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Concurrent with clinical trials and preclinical studies, companies also must develop information about the chemistry and physical characteristics of
the drug and finalize a process for manufacturing the product in accordance with the FDA&#146;s current good manufacturing practices (&#147;cGMPs&#148;), requirements for drug products. The manufacturing process must be capable of consistently
producing quality batches of the product and the manufacturer must develop methods for testing the quality, purity, and potency of the final products. Additionally, appropriate packaging must be selected and tested and chemistry stability studies
must be conducted to demonstrate that the product does not undergo unacceptable deterioration over its shelf-life. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submission to the FDA of an NDA based on the clinical trials. The results of product development, preclinical studies, and clinical trials are
submitted to the FDA in the form of an NDA for approval of the marketing and commercial shipment of the product. Under the Pediatric Research Equity Act, NDAs are required to include an assessment, generally based on clinical study data, of the
safety and efficacy of drugs for all relevant pediatric populations. The statute provides for waivers or deferrals in certain situations. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In its review of an NDA, the FDA may also convene an advisory committee of external experts to provide input on certain review issues relating to risk, benefit and interpretation of clinical trial data.
The FDA may delay approval of an NDA if applicable regulatory criteria are not satisfied and/or the FDA requires additional testing or information. Before approving an NDA, the FDA may inspect the facilities at which the product is manufactured and
will not approve the product unless the manufacturing facility complies with cGMPs and will also inspect clinical trial sites for integrity of data supporting safety and efficacy. The FDA will issue either an approval of the NDA or a Complete
Response Letter, detailing the deficiencies and information required in order for reconsideration of the NDA. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medical products
containing a combination of new drugs, biological products, or medical devices are regulated as &#147;combination products&#148; in the United States. A combination product generally is defined as a product comprised of components from two or more
regulatory categories (e.g., drug/device, device/biologic, drug/biologic). Each component of a combination product is subject to the requirements established by the FDA for that type of component, whether a new drug, biologic, or device. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The testing and approval process requires substantial time, effort and financial resources. Data that we submit are subject to varying
interpretations, and the FDA and comparable regulatory authorities in foreign jurisdictions may not agree that our product candidates have been shown to be safe and effective. We cannot be certain that any approval of our products will be granted on
a timely basis, if at all. If any of our products are approved for marketing by the FDA, we will be subject to continuing regulation by the FDA, including post marketing study </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
commitments or requirements, risk evaluation and mitigation strategies, record-keeping requirements, reporting of adverse experiences with the product, submitting other periodic reports, drug
sampling and distribution requirements, notifying the FDA and gaining its approval of certain manufacturing or labeling changes, and complying with certain electronic records and signature requirements. Prior to and following approval, if granted,
all manufacturing sites are subject to inspection by the FDA and other national regulatory bodies and must comply with cGMP, QSR and other requirements enforced by the FDA and other national regulatory bodies through their facilities inspection
program. Foreign manufacturing establishments must comply with similar regulations. In addition, our drug-manufacturing facilities located in Danbury and the facilities of our insulin supplier, the supplier(s) of our Technosphere material and the
supplier(s) of our inhaler and cartridges are subject to federal registration and listing requirements and, if applicable, to state licensing requirements. Failure, including those of our suppliers, to obtain and maintain applicable federal
registrations or state licenses, or to meet the inspection criteria of the FDA or the other national regulatory bodies, would disrupt our manufacturing processes and would harm our business. In complying with standards set forth in these
regulations, manufacturers must continue to expend time, money and effort in the area of production and quality control to ensure full compliance. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Numerous device regulatory requirements apply to the device part of a drug-device combination. These include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">product labeling regulations; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">general prohibition against promoting products for unapproved or &#147;off-label&#148; uses; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">corrections and removals (<I>e.g</I>., recalls); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishment registration and device listing; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">general prohibitions against the manufacture and distribution of adulterated and misbranded devices; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the Medical Device Reporting regulation, which requires that manufacturers report to the FDA if their device may have caused or contributed to a death
or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Further, the company we contract with to manufacture our inhaler and cartridges will be subject to the QSR, which requires manufacturers to follow elaborate design, testing, control, documentation and
other quality assurance procedures during the manufacturing process of medical devices, among other requirements. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Failure to
adhere to regulatory requirements at any stage of development, including the preclinical and clinical testing process, the review process, or at any time afterward, including after approval, may result in various adverse consequences. These
consequences include action by the FDA or another national regulatory body that has the effect of delaying approval or refusing to approve a product; suspending or withdrawing an approved product from the market; seizing or recalling a product; or
imposing criminal penalties against the manufacturer. In addition, later discovery of previously unknown problems may result in restrictions on a product, its manufacturer, or the NDA holder, or market restrictions through labeling changes or
product withdrawal. Also, new government requirements may be established or current government requirements may be changed at any time, which could delay or prevent regulatory approval of our products under development. We cannot predict the
likelihood, nature or extent of adverse governmental regulation that might arise from future legislative or administrative action, either in the United States or abroad. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition, the FDA imposes a number of complex regulations on entities that advertise and promote drugs, which include, among other requirements, standards for and regulations of direct-to-consumer
advertising, off-label promotion, industry sponsored scientific and educational activities, and promotional activities involving the Internet. The FDA has very broad enforcement authority under the FDCA, and failure to comply with these regulations
can result in penalties, including the issuance of a warning letter requirements for corrective advertising to healthcare providers, a requirement that future advertising and promotional materials be pre-cleared by the FDA, and state and federal
civil and criminal investigations and prosecutions. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Products manufactured in the United States and marketed outside the United States are
subject to certain FDA regulations, as well as regulation by the country in which the products are to be sold. We also would be subject to foreign regulatory requirements governing clinical trials and drug product sales if products are studied or
marketed abroad. Whether or not FDA approval has been obtained, approval of a product by the comparable regulatory authorities of foreign countries usually must be obtained prior to the marketing of the product in those countries. The approval
process varies from jurisdiction to jurisdiction and the time required may be longer or shorter than that required for FDA approval. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">There can be no assurance that the current regulatory framework will not change or that additional regulation will not arise at any stage of our product development or marketing that may affect approval,
delay the submission or review of an application or require additional expenditures by us. There can be no assurance that we will be able to obtain necessary regulatory clearances or approvals on a timely basis, if at all, for any of our product
candidates under development, and delays in receipt or failure to receive such clearances or approvals, the loss of previously received clearances or approvals, or failure to comply with existing or future regulatory requirements could have a
material adverse effect on our business and results of operations. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the foregoing, we are subject to numerous
federal, state and local laws relating to such matters as laboratory practices, the experimental use of animals, the use and disposal of hazardous or potentially hazardous substances, controlled drug substances, privacy of individually identifiable
healthcare information, safe working conditions, manufacturing practices, environmental protection and fire hazard control. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Healthcare Regulatory and Pharmaceutical Pricing </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Government coverage and reimbursement policies both directly and indirectly affect our ability to successfully commercialize our approved products, and such coverage and reimbursement policies will be
affected by future healthcare reform measures. Government health administration authorities, private health insurers and other organizations generally decide which drugs they will pay for and establish reimbursement levels for healthcare. In
particular, in the United States, private health insurers and other third-party payors often provide reimbursement for products and services based on the level at which the government (through the Medicare or Medicaid programs) provides
reimbursement for such treatments. In the United States, the European Union and other potentially significant markets for our product candidates, government authorities and third-party payors are increasingly attempting to limit or regulate the
price of medical products and services, particularly for new and innovative products and therapies, which has resulted in lower average selling prices. Further, the increased emphasis on managed healthcare in the United States and on country and
regional pricing and reimbursement controls in the European Union will put additional pressure on product pricing, reimbursement and usage, which may adversely affect our future product sales and results of operations. Recently, in the United States
there has been heightened governmental scrutiny over the manner in which drug manufacturers set prices for their marketed products. For example, there have been several recent U.S. Congressional inquiries regarding certain drug manufacturers&#146;
pricing practices and proposed bills designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for
drugs. These pressures can arise from rules and practices of managed care groups, judicial decisions and governmental laws and regulations related to Medicare, Medicaid and healthcare reform, pharmaceutical reimbursement policies and pricing in
general. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The United States and some foreign jurisdictions have enacted or are considering a number of additional legislative
and regulatory proposals to change the healthcare system in ways that could affect our ability to sell our products profitably. Among policy makers and payors in the U.S. and elsewhere, there is significant interest in promoting changes in
healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by
major legislative initiatives, including, most recently, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (&#147;collectively, &#147;PPACA&#148;), enacted in March 2010. The Physician
Payments Sunshine Act within PPACA, and its implementing regulations, require certain manufacturers of drugs, devices, biological and medical supplies for which payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance
Program (with certain </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
exceptions) to report information related to certain payments or other transfers of value made or distributed to physicians and teaching hospitals, or to entities or individuals at the request
of, or designated on behalf of, the physicians and teaching hospitals and to report annually certain ownership and investment interests held by physicians and their immediate family members. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Further, if a drug product is reimbursed by Medicare, Medicaid or other federal or state healthcare programs, we must comply with, among
others, the federal civil and criminal false claims laws, including the civil False Claims Act, as amended, the federal Anti-Kickback Statute, as amended, and similar state laws. If a drug product is reimbursed by Medicare or Medicaid, pricing and
rebate programs must comply with, as applicable, the Medicaid rebate requirements of the Omnibus Budget Reconciliation Act of 1990, as amended, and the Medicare Prescription Drug Improvement and Modernization Act of 2003. Additionally, PPACA
substantially changed the way healthcare is financed by both governmental and private insurers. Among other cost containment measures, PPACA established: an annual, nondeductible fee on any entity that manufactures or imports certain branded
prescription drugs and biologic agents; a new Medicare Part D coverage gap discount program; and a new formula that increased the rebates a manufacturer must pay under the Medicaid Drug Rebate Program. There have been judicial and Congressional
challenges to certain aspects of PPACA, and we expect there will be additional challenges and amendments to PPACA. Other legislative changes have been proposed and adopted in the United States since PPACA. For example, through the process created by
the Budget Control Act of 2011, there are automatic reductions of Medicare payments to providers up to 2%&nbsp;per fiscal year, which went into effect in April 2013 and, following passage of the Bipartisan Budget Act of 2015, will remain in effect
through 2025 unless additional Congressional action is taken. In January 2013, President Obama signed into law the American Taxpayer Relief Act of 2012, which, among other things, further reduced Medicare payments to several providers. In the
future, there may continue to be additional proposals relating to the reform of the U.S. health care system, some of which could further limit the prices we are able to charge for our products, or the amounts of reimbursement available for our
products. If drug products are made available to authorized users of the Federal Supply Schedule of the General Services Administration, additional laws and requirements apply. All of these activities are also potentially subject to federal and
state consumer protection and unfair competition laws. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we may be subject to data privacy and security regulation
by both the federal government and the states in which we conduct our business. The federal Health Insurance Portability and Accountability Act of 1996 (&#147;HIPAA&#148;), as amended by the Health Information Technology and Clinical Health Act
(&#147;HITECH&#148;), and its implementing regulations, imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#146;s privacy and
security standards directly applicable to &#147;business associates&#148; &#151; independent contractors or agents of covered entities that receive or obtain protected health information in connection with providing a service on behalf of a covered
entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or
injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal civil actions. In addition, state laws govern the privacy and security of health information in certain
circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Also, many states have similar healthcare statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, that apply regardless of the
payer. Additional state laws require pharmaceutical companies to implement a comprehensive compliance program and/or limit expenditure for, or payments to, individual medical or health professionals. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may incur significant costs to comply with these laws and regulations now or in the future. If our operations are found to be in
violation of any of the federal and state laws described above or any other governmental regulations that apply to us, we may be subject to penalties, including criminal and significant civil monetary penalties, damages, fines, imprisonment,
disgorgement, exclusion of products from reimbursement under government programs, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Research and Development Expenses; Long-Lived Assets </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A significant portion of our operating expenses relates to research and development. Our research and development expenses totaled $29.7
million, $100.2 million, and $109.7 million for the years ended December&nbsp;31, 2015, 2014, and 2013, respectively. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our
long-lived assets are located in the United States and totaled $48.7&nbsp;million, $192.1 million, and $176.6 million as of December&nbsp;31, 2015, 2014, and 2013, respectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Employees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, we had 192 full-time employees.
Six of these employees were engaged in basic research and development, 105 in manufacturing, 41 in clinical research and development, regulatory affairs and quality assurance and 40 in administration, finance, management, information systems,
marketing, corporate development and human resources. Twenty of these employees had a Ph.D. degree and/or M.D. degree and were engaged in activities relating to research and development, manufacturing, quality assurance or business development.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of our employees are subject to a collective bargaining agreement. We believe relations with our employees are good.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Corporate Information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We were incorporated in the State of Delaware on February&nbsp;14, 1991. Our principal executive offices are located at 25134 Rye Canyon Loop Suite 300, Valencia, California 91355, and our telephone
number at that address is (661)&nbsp;775-5300. MannKind Corporation and the MannKind Corporation logo are our service marks. Our website address is http://www.mannkindcorp.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, are available free of charge on our website as soon as reasonably practicable after we
electronically file such material with, or furnish it to, the SEC. The contents of these websites are not incorporated into this Annual Report. Further, our references to the URLs for these websites are intended to be inactive textual reference
only. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Scientific Advisors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We seek advice from a number of leading scientists and physicians on scientific, technical and medical matters. These advisors are leading scientists in the areas of pharmacology, chemistry, immunology
and biology. Our scientific advisors are consulted regularly to assess, among other things: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our research and development programs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the design and implementation of our clinical programs; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our patent and publication strategies; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">market opportunities from a clinical perspective; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">new technologies relevant to our research and development programs; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">specific scientific and technical issues relevant to our business. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Officers of the Registrant </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth our current executive officers and their ages: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="58%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:13pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:35pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position(s)</B></FONT></P></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Matthew J. Pfeffer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer, Chief Financial Officer, and Director</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Raymond W. Urbanski, M.D, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">56</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, Chief Medical Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael E. Castagna, Pharm.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Commercial Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David B. Thomson, Ph.D., J.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, General Counsel and Secretary</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph Kocinsky</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, Chief Technology Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Linda Adreveno</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Human Resources</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Matthew J. Pfeffer </I>has served as our Chief Executive Officer and one of our directors since January
2016 and as our Chief Financial Officer since April 2008. Mr.&nbsp;Pfeffer also served as our Corporate Vice President from April 2008 until January 2016. Previously, Mr.&nbsp;Pfeffer served as Chief Financial Officer and Senior Vice President of
Finance and Administration of VaxGen, Inc. from March 2006 until April 2008, with responsibility for finance, tax, treasury, human resources, IT, purchasing and facilities functions. Prior to VaxGen, Mr.&nbsp;Pfeffer served as CFO of Cell Genesys,
Inc. During his nine year tenure at Cell Genesys, Mr.&nbsp;Pfeffer served as Director of Finance before being named CFO in 1998. Prior to that, Mr.&nbsp;Pfeffer served in a variety of financial management positions at other companies, including
roles as Corporate Controller, Manager of Internal Audit and Manager of Financial Reporting. Mr.&nbsp;Pfeffer began his career at Price Waterhouse. Mr.&nbsp;Pfeffer graduated from the University of California, Berkeley and is a Certified Public
Accountant. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Raymond W. Urbanski, M.D., Ph.D.</I> has been our Chief Medical Officer since August 2015. Prior to joining us,
he served as Chief Medical Officer at Mylan, Inc. from September 2012 to September 2014 and Chief Medical Officer at Metabolex, Inc. from October 2011 to June 2012. From June 2004 to October 2011, Dr.&nbsp;Urbanski held several positions with Pfizer
Inc. most recently as Vice President and Medical Head of the Established Products Business Unit. He also served as Vice President of Research and Development and Chief Medical Officer at Suntory Pharmaceutical, Inc. Dr.&nbsp;Urbanski earned both his
M.D. and Ph.D. in pharmacology and toxicology at the University of Medicine and Dentistry of New Jersey. He completed his residency and fellowship training at Thomas Jefferson University Hospital in Philadelphia. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Michael E. Castagna, Pharm.D. </I>has been our Chief Commercial Officer since March 2016. From November 2012 until he joined MannKind,
Dr. Castagna was at Amgen, Inc., where he initially served as Vice President, Global Lifecycle Management and was most recently Vice President, Global Commercial Lead for Amgen&#146;s Biosimilar Business Unit. From 2010 to 2012, he was Executive
Director, Immunology, at Bristol-Myers Squibb. Before BMS, Dr. Castagna served as Vice President &amp; Head, Biopharmaceuticals, North America, at Sandoz. He has also held positions with commercial responsibilities at EMD (Merck) Serono, Pharmasset
and DuPont Pharmaceuticals. He received his pharmacy degree from University of the Sciences-Philadelphia College of Pharmacy, a Doctor of Pharmacy from Massachusetts College of Pharmacy &amp; Sciences and an MBA from The Wharton School of Business
at the University of Pennsylvania. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>David B. Thomson, Ph.D., J.D. </I>has been our Corporate Vice President, General Counsel
and Corporate Secretary since January 2002. Prior to joining us, he practiced corporate/commercial and securities law at a major Toronto law firm. Earlier in his career, Dr.&nbsp;Thomson was a post-doctoral fellow at the Rockefeller University.
Dr.&nbsp;Thomson obtained his bachelor&#146;s degree, master&#146;s degree and Ph.D. from Queens University and obtained his J.D. from the University of Toronto. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Joseph Kocinsky </I>has been our Corporate Vice President, Chief Technology Officer since October 2015<I>. </I>Mr.&nbsp;Kocinsky has over 28 years of experience in the pharmaceutical industry in
technical operations and product development. Prior to joining us in 2003, he held a variety of technical and management positions with increased responsibility at Schering-Plough Corp. Mr.&nbsp;Kocinsky holds a bachelor&#146;s degree in chemical
engineering and a master&#146;s degree in Biomedical Engineering from New Jersey Institute of Technology and a master&#146;s degree in business administration from Seton Hall University. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Linda Adreveno </I>has been our Senior Vice President of Human Resources since March
2015. Prior to joining us, she was President of reOptimize, Inc., a boutique Human Resources consulting firm working with small to medium sized companies, from April 2006 to March 201, and Senior Director of Human Resources at Nektar Therapeutics
from August 2001 to January 2006. Previously, she held senior management positions at Scient, a consulting company, and Sybase. She is a member of the Society of Human Resources Management (SHRM) and is also a certified Senior Professional in Human
Resources (SPHR). She holds a bachelor&#146;s degree in liberal arts from Regents College (now Excelsior College) in New York, and a master&#146;s degree in management from John F. Kennedy University in California. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive officers serve at the discretion of our Board of Directors. There are no family relationships between any of our directors and
executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_3"></A>Item&nbsp;1A. </B><B><I>Risk Factors </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>You should consider carefully the following information about the risks described below, together with the other information contained
in this Annual Report before you decide to buy or maintain an investment in our common stock. We believe the risks described below are the risks that are material to us as of the date of this Annual Report. Additional risks and uncertainties that we
are unaware of may also become important factors that affect us. If any of the following risks actually occur, our business, financial condition, results of operations and future growth prospects would likely be materially and adversely affected. In
these circumstances, the market price of our common stock could decline, and you may lose all or part of the money you paid to buy our common stock. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>RISKS RELATED TO OUR BUSINESS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We depend heavily on the successful
commercialization of our only approved product, AFREZZA. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have expended significant time, money and effort in the
development of our only approved product, AFREZZA. We anticipate that in the near term, our ability to generate revenues will depend on the successful commercialization of AFREZZA and our ability to enter into licensing arrangements for our
Technosphere platform technology that involve license, milestone, royalty or other payments to us. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On February&nbsp;3, 2015,
AFREZZA became available by prescription in United States retail pharmacies. We must receive the necessary approvals from foreign regulatory agencies before AFREZZA can be marketed outside of the United States. Even with such regulatory approval, we
ultimately may be unable to gain market acceptance of AFREZZA for a variety of reasons, including the treatment and dosage regimen, potential adverse effects, the availability of alternative treatments and lack of coverage or adequate reimbursement.
As of December&nbsp;31, 2015, Sanofi reported &#128;7.0&nbsp;million in annual sales of AFREZZA. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of the
termination of the Sanofi License Agreement, we intend to pursue development and commercialization of AFREZZA in the United States on our own and seek regional partnerships for the development and commercialization of AFREZZA in foreign
jurisdictions where there are appropriate commercial opportunities. If we fail to commercialize AFREZZA successfully, our business, financial condition and results of operations will be materially and adversely affected. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We may not be able to successfully develop and commercialize AFREZZA on our own in the United States or find regional partnerships
for the development and commercialization of AFREZZA in foreign jurisdictions. The commercialization and development of AFREZZA will require substantially increased capital that we may not be able to fund. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sanofi has been responsible for global commercial, regulatory and post-approval development activities for AFREZZA pursuant to the Sanofi
License Agreement, and we have been responsible for manufacturing AFREZZA to supply Sanofi&#146;s demand for the product. On January&nbsp;4, 2016, we received written notice from Sanofi of Sanofi&#146;s election to terminate in its entirety the
Sanofi License Agreement. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our ability to continue the development and commercialization of AFREZZA is dependent upon
the successful transition of AFREZZA from Sanofi. Pursuant to the terms of the Sanofi License Agreement, we and Sanofi are required to use diligent efforts to facilitate the smooth and orderly transition of relevant obligations and rights to us with
respect to development and commercialization activities related to AFREZZA, and are also required to negotiate in good faith a written transition agreement for this purpose. During the transition period, we will be dependent on Sanofi to perform
certain activities related to AFREZZA, which subjects us to a number of risks, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sanofi may not perform as expected and we are not be able to control the amount and timing of resources that Sanofi devotes to the transition;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">there may be disputes between us and Sanofi that may result in the delay of the achievement of regulatory and commercial objectives, or costly
litigation or arbitration that diverts our management&#146;s attention and resources; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the manner in which Sanofi effects the transition could adversely impact the development of or sales of AFREZZA and failure to comply with applicable
regulatory guidelines could result in administrative or judicially imposed sanctions, including warning letters, civil and criminal penalties, injunctions, product seizures or detention, product recalls, total or partial suspension of production and
refusal to approve any new drug applications; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">business combinations or significant changes in Sanofi&#146;s business strategy or failure to apply financial and other resources to the transition may
also adversely affect Sanofi&#146;s ability to perform its obligations; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sanofi may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to invite
litigation that could jeopardize or invalidate our proprietary information or expose us to potential litigation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">There are also risks relating to whether we will have the available financial and other resources to implement the transition smoothly. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of the termination of the Sanofi License Agreement, we will also assume the responsibility for commercializing and developing
AFREZZA in the United States. We have no experience with commercializing AFREZZA and may not have the resources to undertake such activities on our own. In order to commercialize AFREZZA in the United States, we will need to build our
commercialization capabilities, including sales and marketing capabilities, which we will do through hiring our own personnel or subcontracting to a commercial sales organization, or a combination of these. The market for skilled commercial
personnel is highly competitive, and we may not be able to find and hire all of the personnel we need on a timely basis. We may engage in sales and marketing activities by subcontracting with a skilled commercial sales organization, though there are
risks regarding whether a subcontractor will provide the level of effort and attention to AFREZZA necessary for successful commercialization. We will also become responsible for negotiating and securing coverage and reimbursement for AFREZZA. If we
are unable to obtain coverage of, and adequate payment levels for AFREZZA, physicians may limit how much or under what circumstances they will prescribe or administer AFREZZA and patients may decline to purchase AFREZZA, which would have an adverse
effect on our ability to generate revenues. Building the internal infrastructure to further develop and commercialize AFREZZA will be costly and time-consuming, and may be distracting to management, and we may not be successful in our efforts or
successful in obtaining financing to support those efforts. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will also become responsible for the NDA for AFREZZA and its
maintenance. We have no experience with the maintenance of an NDA and may fail to comply with maintenance requirements, including timely submitting required reports, particularly if Sanofi is not fully cooperative in transferring required data to
us. Furthermore, we will become responsible for the conduct of ongoing or still required post-approval trials of AFREZZA once transferred from Sanofi. The transfer of these trials and our financial and resources constraints may result in delays or
adversely impact their reliability and completion. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also intend to seek regional partnerships for the development and
commercialization of AFREZZA in foreign jurisdictions where there are appropriate commercial opportunities. It may be difficult to find a new </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
collaboration partner that is willing to devote the time and resources necessary to successfully commercialize AFREZZA. Collaborations with third parties may require us to relinquish material
rights, including revenue from commercialization, on terms that are less attractive than our collaboration with Sanofi or to assume material ongoing development obligations that we would have to fund. These collaboration arrangements are complex and
time-consuming to negotiate, and if we are unable to reach agreements with third-party collaborators, we may fail to meet our business objectives and our financial condition may be adversely affected. We may also face significant competition in
seeking collaboration partners, especially in the current market, and may not be able to find a suitable collaboration partner in a timely manner on acceptable terms, or at all. Any of these factors could cause delay or prevent the successful
commercialization of AFREZZA and could have a material and adverse impact on our business, financial condition and results of operations and the market price of our common stock and other securities could decline. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We may not be successful in our efforts to develop and commercialize our other product candidates. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have sought to develop our other product candidates through our internal research programs. All of our product candidates will require
additional research and development and, in some cases, significant preclinical, clinical and other testing prior to seeking regulatory approval to market them. Accordingly, these product candidates will not be commercially available for a number of
years, if at all. Further research and development on these programs will require significant financial resources. Given our limited financial resources and our focus on development and commercialization of AFREZZA, we will not be able to advance
these programs unless we are able to enter into collaborations with third parties to fund of these programs or to obtain funding to enable us to continue these programs. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A significant portion of the research that we have conducted involves new technologies, including our Technosphere platform technology. Even if our research programs identify product candidates that
initially show promise, these candidates may fail to progress to clinical development for any number of reasons, including discovery upon further research that these candidates have adverse effects or other characteristics that indicate they are
unlikely to be effective. In addition, the clinical results we obtain at one stage are not necessarily indicative of future testing results. If we fail to develop and commercialize our other product candidates, or if we are significantly delayed in
doing so, our business, financial condition and results of operations will be harmed and the market price of our common stock and other securities could decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>We have a history of operating losses, we expect to incur losses in the future and we may not generate positive cash flow from operations in the future. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have never been profitable or generated positive cash flow from cumulative operations to date. Historically, we have reported negative
cash flow from operations other than for the nine months ended September&nbsp;30, 2014, for the year ended December&nbsp;31, 2014, and for the three months ended March&nbsp;31, 2015 as a result of our receipt of an upfront payment and milestone
payments from Sanofi. As of December&nbsp;31, 2015, we had an accumulated deficit of $2.9&nbsp;billion. The accumulated deficit has resulted principally from costs incurred in our research and development programs, the write-off of goodwill and
general operating expenses. We expect to make substantial expenditures and to incur increasing operating losses in the future in order to continue the commercialization of AFREZZA, after the termination of the Sanofi License Agreement is effective.
In connection with our quarterly assessment of impairment indicators and inventory valuation, we identified an impairment of our long-lived assets which resulted in charges of $140.4&nbsp;million in the fourth quarter of 2015. In addition, we have
agreed to purchase annual minimum quantities of insulin for calendar years 2015 through 2019 under the Insulin Supply Agreement with Amphastar in the aggregate of approximately &#128;120.1&nbsp;million, of which &#128;104.0&nbsp;million is remaining
at December&nbsp;31, 2015. We are obligated to purchase &#128;34.1&nbsp;million in 2016 and the remaining annual minimum quantities will be &#128;23.3&nbsp;million for the years ending December&nbsp;31, 2017 through 2019. We may not have the
necessary capital resources on hand in order to service this contractual commitment. We recognized a loss on purchase commitments of $66.2&nbsp;million in the fourth quarter of 2015. Additional impairment charges may be identified and recognized in
the future. Our cumulative net loss may therefore increase significantly. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our losses have had, and are expected to continue to have, an adverse impact on our working
capital, total assets and stockholders&#146; equity. As of December&nbsp;31, 2015, we had stockholders&#146; deficit of $350.3 million. Our ability to achieve and sustain positive cash flow from operations and profitability depends heavily upon
successfully commercializing AFREZZA, and we cannot be sure when we will generate positive cash flow from operations or become profitable, if at all. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>We will need to raise additional capital to fund our operations, and our inability to do so could raise substantial doubt about our ability to continue as a going concern. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will need to raise additional capital, whether through the sale of equity or debt securities, additional strategic business
collaborations, the establishment of other funding facilities, licensing arrangements, asset sales or other means, in order to support our ongoing activities including the commercialization of AFREZZA and the development of other product candidates
and to avoid defaulting under the covenant in our facility agreement with Deerfield Private Design Fund II, L.P. (&#147;Deerfield Private Design Fund&#148;) and Deerfield Private Design International II, L.P. (collectively, &#147;Deerfield&#148;)
dated July&nbsp;1, 2013 (as amended, the &#147;Facility Agreement&#148;) that requires us to maintain at least $25.0 million in cash and cash equivalents or available borrowings under the loan arrangement, dated as of October&nbsp;2, 2007, between
us and The Mann Group LLC (as amended, restated, or otherwise modified as of the date hereof, &#147;The Mann Group Loan Arrangement&#148;), as of the last day of each fiscal quarter. It may be difficult for us to raise additional funds on favorable
terms, or at all. As of December&nbsp;31, 2015, we had stockholders&#146; deficit of $350.3 million, which may raise concerns about our solvency and affect our ability to raise additional capital. The extent of our additional funding requirements
will depend on a number of factors, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the degree to which AFREZZA is commercially successful; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the degree to which we are able to generate revenue from our Technosphere drug delivery platform; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the costs of developing and commercializing AFREZZA on our own in the United States, including the costs of building our commercialization
capabilities; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the costs of finding regional collaboration partners for the development and commercialization of AFREZZA in foreign jurisdictions;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the demand by any or all of the holders of the 5.75% Convertible Senior Subordinated Exchange Notes due 2018 (the &#147;2018 notes&#148;), the 9.75%
Senior Convertible Notes due 2019 issued to Deerfield (the &#147;2019 notes&#148;), and the 8.75% Senior Convertible Notes due 2019 issued to Deerfield (the &#147;Tranche B notes&#148;) to require us to repay or repurchase such debt securities if
and when required; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to repay or refinance existing indebtedness, and the extent to which the 2018 notes or any other convertible debt securities we may issue
are converted into or exchanged for shares of our common stock; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the rate of progress and costs of our clinical studies and research and development activities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the costs of procuring raw materials and operating our manufacturing facilities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our obligation to make milestone payments pursuant to the milestone rights issued to Deerfield Private Design Fund and Horizon Sant&eacute; FLML
S&Aacute;RL (collectively, the &#147;Milestone Purchasers&#148;) and pursuant to the Milestone Rights Purchase Agreement dated July&nbsp;1, 2013 (the &#147;Milestone Agreement&#148;); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our obligation to bear our share of net losses, if any, if Sanofi makes any product sales under the Sanofi License Agreement after the Termination
Date; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our success in establishing strategic business collaborations or other sales or licensing of assets, and the timing and amount of any payments we might
receive from any such transactions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">actions taken by the FDA and other regulatory authorities affecting AFREZZA and our product candidates and competitive products;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the emergence of competing technologies and products and other market developments; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the costs of preparing, filing, prosecuting, maintaining and enforcing patent claims and other intellectual property rights or defending against claims
of infringement by others; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the level of our legal and litigation expenses; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the costs of discontinuing projects and technologies, and/or decommissioning existing facilities, if we undertake any such activities.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have raised capital in the past through the sale of equity and debt securities and we may in the future
pursue the sale of additional equity and/or debt securities, or the establishment of other funding facilities including asset-based borrowings. There can be no assurances, however, that we will be able to raise additional capital on acceptable
terms, or at all. Issuances of additional debt or equity securities or the conversion of any of our currently outstanding convertible debt securities into shares of our common stock or the exercise of our currently outstanding warrants for shares of
our common stock could impact the rights of the holders of our common stock and will dilute their ownership percentage. Moreover, the establishment of other funding facilities may impose restrictions on our operations. These restrictions could
include limitations on additional borrowing and specific restrictions on the use of our assets, as well as prohibitions on our ability to create liens, pay dividends, redeem our stock or make investments. We also will need to raise additional
capital by pursuing opportunities for the licensing or sale of certain intellectual property and other assets. We cannot offer assurances, however, that any strategic collaborations, sales of securities or sales or licenses of assets will be
available to us on a timely basis or on acceptable terms, if at all. We may be required to enter into relationships with third parties to develop or commercialize products or technologies that we otherwise would have sought to develop independently,
and any such relationships may not be on terms as commercially favorable to us as might otherwise be the case. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event
that sufficient additional funds are not obtained through strategic collaboration opportunities, sales of securities, funding facilities, licensing arrangements and/or asset sales on a timely basis, we may be required to reduce expenses through the
delay, reduction or curtailment of our projects, or further reduction of costs for facilities and administration. Moreover, if we do not obtain such additional funds, there will be substantial doubt about our ability to continue as a going concern
and increased risk of insolvency and loss of investment to the holders of our securities. As of the date hereof, we have not obtained a solvency opinion or otherwise conducted a valuation of our properties to determine whether our debts exceed the
fair value of our property within the meaning of applicable solvency laws. If we are or become insolvent, holders of our common stock or other securities may lose the entire value of their investment. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We cannot provide assurances that changed or unexpected circumstances will not result in the depletion of our capital resources more
rapidly than we currently anticipate, in which case we will be required to raise additional capital. There can be no assurances that we will be able to raise additional capital on favorable terms, or at all. If we are unable to raise adequate
additional capital we will be required to reduce expenses through the delay, reduction or curtailment of our projects, or further reduction of costs for facilities and administration, and there will continue to be substantial doubt about our ability
to continue as a going concern. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We have a substantial amount of debt pursuant to the 2018 notes, 2019 notes, Tranche B
notes, The Mann Group Loan Arrangement and the Sanofi Loan Facility, and we may incur additional indebtedness under The Mann Group Loan Arrangement and we may be unable to make required payments of interest and principal as they become due.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of February&nbsp;22, 2016, we had $219.6 million principal amount of outstanding debt, consisting of: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$27.7 million principal amount of 2018 notes bearing interest at 5.75%&nbsp;per annum and maturing on August&nbsp;15, 2018;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$60.0 million principal amount of 2019 notes bearing interest at 9.75%&nbsp;per annum, $5.0 million of which is due and payable in July 2016, $15.0
million of which is due and payable in July 2017, $15.0 million of which is due and payable in July 2018 and $25.0 million of which is due and payable in July and December 2019; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$20.0 million principal amount of Tranche B notes bearing interest at 8.75%&nbsp;per annum, $5.0 million of which is due and payable in each of May
2017, 2018 and 2019, the balance of which is due and payable in December 2019; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$49.5 million principal amount of indebtedness under The Mann Group Loan Arrangement, bearing interest at 5.84% and maturing and due on January&nbsp;5,
2020; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$62.4 million principal amount borrowed under the Sanofi Loan Facility to fund our share of net losses under the Sanofi License Agreement, bearing
interest at a rate of 8.5%&nbsp;per annum, with accrued interest payable in-kind and compounded quarterly, and maturing and due on September 23, 2024. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We may borrow an additional $30.1 million under The Mann Group Loan Arrangement. We anticipate using a portion of these available borrowings to capitalize accrued interest into principal, upon mutual
agreement of the parties, as it becomes due and payable under The Mann Group Loan Arrangement. As of December&nbsp;31, 2015 the accrued and unpaid interest under The Mann Group Loan Arrangement was $6.4 million. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All profits and losses from AFREZZA product sales by Sanofi or its affiliates after the Termination Date, if any, will continue to be
shared 65% by Sanofi and 35% by us pursuant to the terms of the Sanofi License Agreement, and we may borrow up to an aggregate of $175.0 million pursuant to the Sanofi Loan Facility to fund our share of net losses from AFREZZA product sales by
Sanofi or its affiliates. Our total share of the net losses are $62.4 million as of December&nbsp;31, 2015, classified as Sanofi loan facility and loss share obligation, and such amount has been borrowed under the Sanofi Loan Facility as of
February&nbsp;22, 2016. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">There can be no assurance that we will have sufficient resources to make any required repayments of
principal under the terms of our indebtedness when required. Further, if we undergo a fundamental change, as that term is defined in the indentures governing the terms of the 2018 notes, or certain Major Transactions as defined in the Facility
Agreement in respect of the 2019 notes and the Tranche B notes, the holders of the respective debt securities will have the option to require us to repurchase all or any portion of such debt securities at a repurchase price of 100% of the principal
amount of such debt securities to be repurchased plus accrued and unpaid interest, if any. The 2018 notes bear interest at the rate of 5.75%&nbsp;per year on the outstanding principal amount, payable in cash semiannually in arrears on
February&nbsp;15 and August&nbsp;15 of each year. The 2019 notes bear interest at the rate of 9.75%&nbsp;per year on the outstanding principal amount and the Tranche B notes bear interest at the rate of 8.75% on the outstanding principal amount,
with accrued interest on each payable in cash quarterly in arrears on the last business day of March, June, September and December of each year. Loans under the Sanofi Loan Facility bear interest at a rate of 8.5%&nbsp;per annum, paid-in-kind on a
quarterly basis (2.06% per quarter compounded). Loans under The Mann Group Loan Arrangement accrue interest at a rate of 5.84%&nbsp;per annum, due and payable quarterly in arrears on the first day of each calendar quarter for the preceding quarter,
or at such other time as we and The Mann Group mutually agree. While we have been able to timely make our required interest payments to date, we cannot guarantee that we will be able to do so in the future. If we fail to pay interest on the 2018
notes, 2019 notes, Tranche B notes, or on the loans under the Sanofi Loan Facility, or if we fail to repay or repurchase the 2018 notes, 2019 notes, Tranche B notes, or the loans under the Sanofi Loan Facility when required, we will be in default
under the indenture governing the terms of the 2018 notes, the Facility Agreement or other applicable instrument for such debt securities or loans, and may also suffer an event of default under the terms of other borrowing arrangements that we may
enter into from time to time. Any of these events could have a material adverse effect on our business, results of operations and financial condition, up to and including the note holders initiating bankruptcy proceedings or causing us to cease
operations altogether. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>The agreements governing our indebtedness contain covenants that we may not be able to meet and
place restrictions on our operating and financial flexibility. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our obligations under the Facility Agreement, including
any indebtedness under the 2019 notes and the Tranche B notes, and the Milestone Agreement are secured by substantially all of our assets, including our intellectual property, accounts receivables, equipment, general intangibles, inventory
(excluding the insulin inventory) and investment property, and all of the proceeds and products of the foregoing. Our obligations under the Facility Agreement and the Milestone Agreement are also secured by a certain mortgage on our facility in
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Danbury, Connecticut. Our obligations under the Sanofi Loan Facility are secured by a first priority mortgage on our facility in Valencia, California, a first priority security interest in
certain insulin inventory located in the United States and any contractual rights and obligations pursuant to which we purchase or have purchased such insulin, and a second priority security interest in our assets that secure our obligations under
the Facility Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Facility Agreement includes customary representations, warranties and covenants by us, including
restrictions on our ability to incur additional indebtedness, grant certain liens, engage in certain mergers and acquisitions, make certain distributions and make certain voluntary prepayments. Events of default under the Facility Agreement include:
our failure to timely make payments due under the 2019 notes or the Tranche B notes; inaccuracies in our representations and warranties to Deerfield; our failure to comply with any of our covenants under any of the Facility Agreement, Milestone
Agreement or certain other related security agreements and documents entered into in connection with the Facility Agreement, subject to a cure period with respect to most covenants; our insolvency or the occurrence of certain bankruptcy-related
events; certain judgments against us; the suspension, cancellation or revocation of governmental authorizations that are reasonably expected to have a material adverse effect on our business; the acceleration of a specified amount of our
indebtedness; our cash and cash equivalents, including amounts available to us under The Mann Group Loan Arrangement, falling below $25.0 million as of the last day of any fiscal quarter. If one or more events of default under the Facility Agreement
occurs and continues beyond any applicable cure period, the holders of the 2019 notes and Tranche B notes may declare all or any portion of the 2019 notes and Tranche B notes to be immediately due and payable. The Milestone Agreement includes
customary representations and warranties and covenants by us, including restrictions on transfers of intellectual property related to AFREZZA. The milestones are subject to acceleration in the event we transfer our intellectual property related to
AFREZZA in violation of the terms of the Milestone Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Similarly, the Sanofi Loan Facility includes customary
representations, warranties and covenants by us, including restrictions on our ability to incur additional indebtedness, grant certain liens and make certain changes to our organizational documents. Events of default under the Sanofi Loan Facility
include: our failure to make timely payments due under the Sanofi Loan Facility; inaccuracies in our representations and warranties to the lender; our failure to comply with any of our covenants under any of the Sanofi Loan Facility or certain other
related security agreements and documents entered into in connection with the Sanofi Loan Facility, subject to a cure period with respect to most covenants; our insolvency or the occurrence of certain bankruptcy-related events; termination by Sanofi
of the Sanofi License Agreement as a result of our breach of the Sanofi License Agreement; and the failure of any material provision under any of the Sanofi Loan Facility or certain other related security agreements and documents entered into in
connection with the Sanofi Loan Facility to remain in full force and effect. If one or more events of default occurs and is continuing, the lender may terminate its obligation to make advances under the Sanofi Loan Facility, and, if certain
specified events of default (including our failure to timely make payments due under the Sanofi Loan Facility; our failure to comply with the negative covenants under the Sanofi Loan Facility limiting our ability to incur additional indebtedness or
grant certain liens; our insolvency or the occurrence of certain bankruptcy-related events; termination by Sanofi of the Sanofi License Agreement as a result of our breach of the non-compete provisions of the Sanofi License Agreement; or the failure
of any material provision under any of the Sanofi Loan Facility or certain other related security agreements and documents entered into in connection with the Sanofi Loan Facility to remain in full force and effect) occur and are continuing, the
lender may accelerate all of our repayment obligations under the Sanofi Loan Facility and otherwise exercise any of its remedies as a secured creditor. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">There can be no assurance that we will be able to comply with the covenants under any of the foregoing agreements, and we cannot predict whether the holders of the 2019 notes or Tranche B notes or the
lender under the Sanofi Loan Facility would demand repayment of the outstanding balance of the 2019 notes, the Tranche B notes or the loans under the Sanofi Loan Facility as applicable or exercise any other remedies available to such holders if we
were unable to comply with these covenants. The covenants and restrictions contained in the foregoing agreements could significantly limit our ability to respond to changes in our business or competitive activities or take advantage of business
opportunities that may create value for our stockholders and the holders </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of our other securities. In addition, our inability to meet or otherwise comply with the covenants under these agreements could have an adverse impact on our financial position and results of
operations and could result in an event of default under the terms of our other indebtedness, including our indebtedness under the 2018 notes. In the event of certain future defaults under the foregoing agreements for which we are not able to obtain
waivers, the holders of the 2018 notes, 2019 notes and Tranche B notes and the lender under the Sanofi Loan Facility may accelerate all of our repayment obligations, and, with respect to the 2019 notes and Tranche B notes and the loans under the
Sanofi Loan Facility, take control of our pledged assets, potentially requiring us to renegotiate the terms of our indebtedness on terms less favorable to us, or to immediately cease operations. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we enter into additional debt arrangements, the terms of such additional arrangements could further restrict our operating and
financial flexibility. In the event we must cease operations and liquidate our assets, the rights of any holders of our outstanding secured debt would be senior to the rights of the holders of our unsecured debt and our common stock to receive any
proceeds from the liquidation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If we do not achieve our projected development goals in the timeframes we expect, our
business, financial condition and results of operations will be harmed and the market price of our common stock and other securities could decline. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For planning purposes, we estimate the timing of the accomplishment of various scientific, clinical, regulatory and other product development goals, which we sometimes refer to as milestones. These
milestones may include the commencement or completion of scientific studies and clinical studies and the submission of regulatory filings. From time to time, we publicly announce the expected timing of some of these milestones. All of these
milestones are based on a variety of assumptions. The actual timing of the achievement of these milestones can vary dramatically from our estimates, in many cases for reasons beyond our control, depending on numerous factors, including: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the rate of progress, costs and results of our clinical studies and preclinical research and development activities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to identify and enroll patients who meet clinical study eligibility criteria; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to access sufficient, reliable and affordable supplies of components used in the manufacture of our product candidates;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the costs of expanding and maintaining manufacturing operations, as necessary; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the extent to which our clinical studies compete for clinical sites and eligible subjects with clinical studies sponsored by other companies; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">actions by regulators. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition, if we do not obtain sufficient additional funds through sales of securities, strategic collaborations or the license or sale of certain of our assets on a timely basis, we may be required to
reduce expenses by delaying, reducing or curtailing our development of product candidates. If we fail to commence or complete, or experience delays in or are forced to curtail, our proposed clinical programs or otherwise fail to adhere to our
projected development goals in the timeframes we expect (or within the timeframes expected by analysts or investors), our business, financial condition and results of operations will be harmed and the market price of our common stock and other
securities may decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>AFREZZA or our product candidates may be rendered obsolete by rapid technological change.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A number of established pharmaceutical companies have or are developing technologies for the treatment of unmet
medical needs. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The rapid rate of scientific discoveries and technological changes could result in AFREZZA or one or more of
our product candidates becoming obsolete or noncompetitive. Our competitors may develop or introduce new products that render our technology or AFREZZA less competitive, uneconomical or obsolete. Our future
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
success will depend not only on our ability to develop our product candidates but to improve them and keep pace with emerging industry developments. We cannot assure you that we will be able to
do so. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also expect to face competition from universities and other non-profit research organizations. These institutions
carry out a significant amount of research and development in various areas of unmet medical need. These institutions are becoming increasingly aware of the commercial value of their findings and are more active in seeking patent and other
proprietary rights as well as licensing revenues. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Continued testing of AFREZZA or our product candidates may not yield
successful results, and even if it does, we may still be unable to commercialize our product candidates. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Forecasts
about the effects of the use of drugs, including AFREZZA, over terms longer than the clinical studies or in much larger populations may not be consistent with the earlier clinical results. For example, with the approval of AFREZZA, the FDA has
required a five-year, randomized, controlled trial in 8,000 &#150; 10,000 patients with type 2 diabetes, the primary objective of which is to compare the incidence of pulmonary malignancy observed with AFREZZA to that observed in a standard of care
control group. If long-term use of a drug results in adverse health effects or reduced efficacy or both, the FDA or other regulatory agencies may terminate our or any of our current or future marketing partner&#146;s ability to market and sell the
drug, may narrow the approved indications for use or otherwise require restrictive product labeling or marketing, or may require further clinical studies, which may be time-consuming and expensive and may not produce favorable results. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our research and development programs are designed to test the safety and efficacy of our product candidates through extensive nonclinical
and clinical testing. We may experience numerous unforeseen events during, or as a result of, the testing process that could delay or impact commercialization of any of our product candidates, including the following: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">safety and efficacy results obtained in our nonclinical and early clinical testing may be inconclusive or may not be predictive of results that we may
obtain in our future clinical studies or following long-term use, and we may as a result be forced to stop developing a product candidate or alter the marketing of an approved product; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the analysis of data collected from clinical studies of our product candidates may not reach the statistical significance necessary, or otherwise be
sufficient to support FDA or other regulatory approval for the claimed indications; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">after reviewing clinical data, we or any collaborators may abandon projects that we previously believed were promising; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our product candidates may not produce the desired effects or may result in adverse health effects or other characteristics that preclude regulatory
approval or limit their commercial use once approved. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of any of these events, we, any
collaborator, the FDA, or any other regulatory authorities, may suspend or terminate clinical studies or marketing of the drug at any time. Any suspension or termination of our clinical studies or marketing activities may harm our business,
financial condition and results of operations and the market price of our common stock and other securities may decline. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If our suppliers fail to deliver materials and services needed for the production of AFREZZA in a timely and sufficient manner, if
they fail to comply with applicable regulations, or if we fail to identify and qualify alternative suppliers, our business, financial condition and results of operations would be harmed and the market price of our common stock and other securities
could decline. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the commercial manufacture of AFREZZA, we need access to sufficient, reliable and affordable
supplies of insulin, our AFREZZA inhaler, the related cartridges and other materials. Currently, the only approved source of insulin for AFREZZA is manufactured by Amphastar and the only source of our proprietary inert excipient, FDKP (fumaryl
diketopiperazine), which is the primary component of our Technosphere technology platform, is manufactured by Lonza. We must rely on our suppliers, including Amphastar, to comply with relevant regulatory
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
and other legal requirements, including the production of insulin and FDKP in accordance with the FDA&#146;s cGMPs for drug products, and the production of the AFREZZA inhaler and related
cartridges in accordance with QSRs. The supply of any of these materials may be limited or any of the manufacturers may not meet relevant regulatory requirements, and if we are unable to obtain any of these materials in sufficient amounts, in a
timely manner and at reasonable prices, or if we encounter delays or difficulties in our relationships with manufacturers or suppliers, the production of AFREZZA may be delayed. Likewise, if Amphastar or Lonza ceases to manufacture or is otherwise
unable to deliver insulin for AFREZZA, we will need to locate an alternative source of supply and the production of AFREZZA may be delayed. If any of our suppliers is unwilling or unable to meet its supply obligations and we are unable to secure an
alternative supply source in a timely manner and on favorable terms, our business, financial condition, and results of operations may be harmed and the market price of our common stock and other securities may decline. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If we fail as an effective manufacturing organization or fail to engage third-party manufacturers with this capability, we may be
unable to support commercialization of this product. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We use our Danbury, Connecticut facility to formulate AFREZZA
inhalation powder, fill plastic cartridges with the powder, package the cartridges in blister packs, and place the blister packs into foil pouches. We utilize a contract packager to assemble the final kits of foil-pouched blisters containing
cartridges along with inhalers and the package insert. The manufacture of pharmaceutical products requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls.
Manufacturers of pharmaceutical products often encounter difficulties in production, especially in scaling up initial production. These problems include difficulties with production costs and yields, quality control and assurance and shortages of
qualified personnel, as well as compliance with strictly enforced federal, state and foreign regulations. If we engage a third-party manufacturer, we would need to transfer our technology to that third-party manufacturer and gain FDA approval,
potentially causing delays in product delivery. In addition, our third-party manufacturer may not perform as agreed or may terminate its agreement with us. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Any of these factors could cause us to delay or suspend production, could entail higher costs and may result in our being unable to effectively support commercialization of AFREZZA. Furthermore, if we or
a third-party manufacturer fail to deliver the required commercial quantities of the product or any raw material on a timely basis, and at commercially reasonable prices and acceptable quality, and we were unable to promptly find one or more
replacement manufacturers capable of production at a substantially equivalent cost, in substantially equivalent volume and quality on a timely basis, we would likely be unable to meet demand for AFREZZA and we would lose potential revenues.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If AFREZZA or any other product that we develop does not become widely accepted by physicians, patients, third-party
payors and the healthcare community, we may be unable to generate significant revenue, if any. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">AFREZZA and other
products that we may develop in the future may not gain market acceptance among physicians, patients, third-party payors and the healthcare community. For example, as of December&nbsp;31, 2015, Sanofi reported &#128;7.0&nbsp;million in annual sales
of AFREZZA. Failure to achieve market acceptance would limit our ability to generate revenue and would adversely affect our results of operations. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The degree of market acceptance of AFREZZA and other products that we may develop in the future depends on many factors, including the: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approved labeling claims; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">effectiveness of efforts by us or any of our current or future marketing partner(s) to educate physicians about the benefits and advantages of AFREZZA
or our other products and to provide adequate support for them, and the perceived advantages and disadvantages of competitive products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">willingness of the healthcare community and patients to adopt new technologies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">ability to manufacture the product in sufficient quantities with acceptable quality and cost; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">perception of patients and the healthcare community, including third-party payors, regarding the safety, efficacy and benefits compared to competing
products or therapies; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">convenience and ease of administration relative to existing treatment methods; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">coverage and pricing and reimbursement relative to other treatment therapeutics and methods; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">marketing and distribution support. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Because of these and other factors, AFREZZA and any other product that we get approved may not gain market acceptance, which would materially harm our business, financial condition and results of
operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If third-party payors do not cover AFREZZA or any of our product candidates for which we receive regulatory
approval, AFREZZA or such product candidates might not be prescribed, used or purchased, which would adversely affect our revenues. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our future revenues and ability to generate positive cash flow from operations may be affected by the continuing efforts of governments and third-party payors to contain or reduce the costs of healthcare
through various means. For example, in certain foreign markets the pricing of prescription pharmaceuticals is subject to governmental control. In the United States, there has been, and we expect that there will continue to be, a number of federal
and state proposals to implement similar governmental controls. We cannot be certain what legislative proposals will be adopted or what actions federal, state or private payors for healthcare goods and services may take in response to any drug
pricing and reimbursement reform proposals or legislation. Such reforms may limit our ability to generate revenues from sales of AFREZZA or other products that we may develop in the future and achieve profitability. Further, to the extent that such
reforms have a material adverse effect on the business, financial condition and profitability of any of our current or future marketing partners for AFREZZA, and companies that are prospective collaborators for our product candidates, our ability to
commercialize AFREZZA and our product candidates under development may be adversely affected. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the United States and
elsewhere, sales of prescription pharmaceuticals still depend in large part on the availability of coverage and adequate reimbursement to the consumer from third-party payors, such as governmental and private insurance plans. Third-party payors are
increasingly challenging the prices charged for medical products and services. The market for AFREZZA and our product candidates for which we may receive regulatory approval will depend significantly on access to third-party payors&#146; drug
formularies, or lists of medications for which third-party payors provide coverage and reimbursement. The industry competition to be included in such formularies often leads to downward pricing pressures on pharmaceutical companies. Also,
third-party payors may refuse to include a particular branded drug in their formularies or otherwise restrict patient access to a branded drug when a less costly generic equivalent or other alternative is available. In addition, because each
third-party payor individually approves coverage and reimbursement levels, obtaining coverage and adequate reimbursement is a time-consuming and costly process. We may be required to provide scientific and clinical support for the use of any product
to each third-party payor separately with no assurance that approval would be obtained. This process could delay the market acceptance of any product and could have a negative effect on our future revenues and operating results. Even if we succeed
in bringing more products to market, we cannot be certain that any such products would be considered cost-effective or that coverage and adequate reimbursement to the consumer would be available. Patients will be unlikely to use our products unless
coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our products. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, in
many foreign countries, particularly the countries of the European Union, the pricing of prescription drugs is subject to government control. In some non-U.S. jurisdictions, the proposed pricing for a drug must be approved before it may be lawfully
marketed. The requirements governing drug pricing vary widely from country to country. For example, the European Union provides options for its member states to restrict the range of medicinal products for which their national health insurance
systems provide reimbursement and to control the prices of medicinal products for human use. A member state may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability
of the company placing the medicinal product on the market. We may face competition for AFREZZA or any of our </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
other product candidates that receives marketing approval from lower-priced products in foreign countries that have placed price controls on pharmaceutical products. In addition, there may be
importation of foreign products that compete with our own products, which could negatively impact our profitability. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we or
any of our current or future marketing partners are unable to obtain coverage of, and adequate payment levels for, AFREZZA or any of our other product candidates that receive marketing approval from third-party payors, physicians may limit how much
or under what circumstances they will prescribe or administer them and patients may decline to purchase them. This in turn could affect our and any of our current or future marketing partner&#146;s ability to successfully commercialize AFREZZA and
our ability to successfully commercialize any of our other product candidates that receives regulatory approval and impact our profitability, results of operations, financial condition, and prospects. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Healthcare legislation may make it more difficult to receive revenues. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In both the United States and certain foreign jurisdictions, there have been a number of legislative and regulatory proposals in recent
years to change the healthcare system in ways that could impact our ability to sell our products profitably. For example, in March 2010, PPACA became law in the United States. PPACA substantially changes the way healthcare is financed by both
governmental and private insurers and significantly affects the healthcare industry. Among the provisions of PPACA of importance to us are the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">an annual, nondeductible fee on any entity that manufactures or imports certain branded prescription drugs and biologic agents, apportioned among these
entities according to their market share in certain government healthcare programs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a 2.3% medical device excise tax on certain transactions, including many U.S. sales of medical devices, which currently includes and we expect will
continue to include U.S. sales of certain drug-device combination products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13% of the average
manufacturer price for most branded and generic drugs, respectively; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a licensure framework for follow-on biological products; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">expansion of healthcare fraud and abuse laws, including the False Claims Act and the Anti-Kickback Statute, new government investigative powers, and
enhanced penalties for noncompliance; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50% point-of-sale discounts off negotiated prices of
applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#146;s outpatient drugs to be covered under Medicare Part D; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">extension of manufacturers&#146; Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care
organizations; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to additional individuals
with income at or below 133% of the Federal Poverty Level, thereby potentially increasing manufacturers&#146; Medicaid rebate liability; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">expansion of the entities eligible for discounts under the Public Health Service pharmaceutical pricing program; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">new requirements to report annually to the Centers for Medicare &amp; Medicaid Services (&#147;CMS&#148;) certain financial arrangements with
physicians and teaching hospitals, as defined in PPACA and its implementing regulations, including reporting any &#147;payments or transfers of value&#148; made or distributed to prescribers, teaching hospitals and other healthcare providers and
reporting any ownership and investment interests held by physicians and their immediate family members and applicable group purchasing organizations during the preceding calendar year; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a new requirement to annually report drug samples that certain manufacturers and authorized distributors provide to physicians; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along
with funding for such research. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The medical device excise tax has been suspended by the Consolidated
Appropriations Act of 2016 (the &#147;CAA&#148;) through December&nbsp;31, 2017. Absent further Congressional action, the excise tax will be reinstated for medical device sales beginning January&nbsp;1, 2018. The CAA also temporarily delays
implementation of other taxes intended to help fund PPACA programs. Further, there have been judicial and Congressional challenges to other aspects of PPACA, and we expect there will be additional challenges and amendments to PPACA in the future.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, other legislative changes have been proposed and adopted since PPACA was enacted. For example, on August&nbsp;2,
2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the
years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#146;s automatic reduction to several government programs. This includes aggregate reductions to Medicare payments to providers of up to 2%&nbsp;per
fiscal year, starting in 2013, and, following passage of the Bipartisan Budget Act of 2015, will stay in effect through 2025 unless additional Congressional action is taken. On January&nbsp;2, 2013, President Obama signed into law the American
Taxpayer Relief Act of 2012 (the &#147;ATRA&#148;), which, among other things, reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the
government to recover overpayments to providers from three to five years. In addition, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products. These new laws and
initiatives may result in additional reductions in Medicare and other healthcare funding, which could have a material adverse effect on our customers and accordingly, our financial operations. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect that PPACA, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage
criteria and in additional downward pressure on the price that we receive for any approved product, and could seriously harm our future revenues. Any reduction in reimbursement from Medicare or other government programs may result in a similar
reduction in payments from private third-party payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If we or any of our current or future marketing partners fail to comply with federal and state healthcare laws, including fraud and
abuse and health information privacy and security laws, we could face substantial penalties and our business, results of operations, financial condition and prospects could be adversely affected. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a biopharmaceutical company, even though we do not and will not control referrals of healthcare services or bill directly to Medicare,
Medicaid or other third-party payors, certain federal and state healthcare laws and regulations, including those pertaining to fraud and abuse and patients&#146; rights are and will be applicable to our business. For example, we could be subject to
healthcare fraud and abuse and patient privacy regulation by both the federal government and the states in which we conduct our business. The laws that may affect our ability to operate include, among others: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the federal Anti-Kickback Statute (as amended by PPACA, which modified the intent requirement of the federal Anti-Kickback Statute so that a person or
entity no longer needs to have actual knowledge of the Statute or specific intent to violate it to have committed a violation), which constrains our business activities, including our marketing practices, educational programs, pricing policies, and
relationships with healthcare providers or other entities by prohibiting, among other things, knowingly and willfully offering soliciting, receiving, offering or paying remuneration, directly or indirectly, to induce, or in return for, either the
referral of an individual or the purchase or recommendation of an item or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">federal civil and criminal false claims laws, including without limitation the civil False Claims Act, and civil monetary penalty laws, which prohibit,
among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other federal healthcare programs that are false or fraudulent and under PPACA, the government may
assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal false claims laws; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">HIPAA, which created new federal criminal statutes that prohibit, among other things, executing a scheme to defraud any healthcare benefit program or
making false statements relating to healthcare matters; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">HIPAA, as amended by HITECH and its implementing regulations, which imposes certain requirements relating to the privacy, security and transmission of
individually identifiable health information; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the federal physician sunshine requirements under PPACA, which requires certain manufacturers of drugs, devices, biologics, and medical supplies to
report annually to the CMS information related to payments and other transfers of value to physicians, other healthcare providers, and teaching hospitals, and ownership and investment interests held by physicians and other healthcare providers and
their immediate family members; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services
reimbursed by any third-party payor, including commercial insurers, and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are
not preempted by HIPAA, thus complicating compliance efforts; state laws that require pharmaceutical companies to comply with the industry&#146;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal
government that otherwise restricts certain payments that may be made to healthcare providers and entities; and state laws that require drug manufacturers to report information related to payments and other transfer of value to physicians and other
healthcare providers and entities. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because of the breadth of these laws and the narrowness of available
statutory and regulatory exceptions, it is possible that some of our business activities could be subject to challenge under one or more of such laws. To the extent that AFREZZA or any of our product candidates that receives marketing approval is
ultimately sold in a foreign country, we may be subject to similar foreign laws and regulations. If we or our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, we may
be subject to penalties, including civil and criminal penalties, damages, fines, individual imprisonment, disgorgement, exclusion of products from reimbursement under U.S. federal or state healthcare programs, and the curtailment or restructuring of
our operations. Any penalties, damages, fines, curtailment or restructuring of our operations could materially adversely affect our ability to operate our business and our financial results. Although compliance programs can mitigate the risk of
investigation and prosecution for violations of these laws, the risks cannot be entirely eliminated. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and
divert our management&#146;s attention from the operation of our business. Moreover, achieving and sustaining compliance with applicable federal and state privacy, security and fraud laws may prove costly. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If product liability claims are brought against us, we may incur significant liabilities and suffer damage to our reputation.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The testing, manufacturing, marketing and sale of AFREZZA and our other product candidates expose us to potential
product liability claims. A product liability claim may result in substantial judgments as well as consume significant financial and management resources and result in adverse publicity, decreased demand for a product, injury to our reputation,
withdrawal of clinical studies volunteers and loss of revenues. We currently carry worldwide product liability insurance in the amount of $10.0 million. However, our insurance coverage may not be adequate to satisfy any liability that may arise, and
because insurance coverage in our industry can be very expensive and difficult to obtain, we cannot assure you that we will be able to obtain sufficient coverage at an acceptable cost, if at all. If losses from such claims exceed our liability
insurance coverage, we may ourselves </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
incur substantial liabilities. If we are required to pay a product liability claim our business, financial condition and results of operations would be harmed and the market price of our common
stock and other securities may decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If we lose any key employees or scientific advisors, our operations and our
ability to execute our business strategy could be materially harmed. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We face intense competition for qualified
employees among companies in the biotechnology and biopharmaceutical industries. Our success depends upon our ability to attract, retain and motivate highly skilled employees. We may be unable to attract and retain these individuals on acceptable
terms, if at all. In addition, in order to commercialize AFREZZA successfully, we may be required to expand our work force, particularly in the areas of manufacturing and sales and marketing. These activities will require the addition of new
personnel, including management, and the development of additional expertise by existing personnel, and we cannot assure you that we will be able to attract or retain any such new personnel on acceptable terms, if at all. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The loss of the services of any principal member of our management and scientific staff could significantly delay or prevent the
achievement of our scientific and business objectives. All of our employees are &#147;at will&#148; and we currently do not have employment agreements with any of the principal members of our management or scientific staff, and we do not have key
person life insurance to cover the loss of any of these individuals. Replacing key employees may be difficult and time-consuming because of the limited number of individuals in our industry with the skills and experience required to develop, gain
regulatory approval of and commercialize products successfully. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have relationships with scientific advisors at academic and
other institutions to conduct research or assist us in formulating our research, development or clinical strategy. These scientific advisors are not our employees and may have commitments to, and other obligations with, other entities that may limit
their availability to us. We have limited control over the activities of these scientific advisors and can generally expect these individuals to devote only limited time to our activities. Failure of any of these persons to devote sufficient time
and resources to our programs could harm our business. In addition, these advisors are not prohibited from, and may have arrangements with, other companies to assist those companies in developing technologies that may compete with AFREZZA or our
product candidates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We have identified a material weakness in our internal control over financial reporting. If our
internal controls over financial reporting are not considered effective, our business, financial condition and market price of our common stock and other securities could be adversely affected. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;404 of the Sarbanes-Oxley Act of 2002 requires us to evaluate the effectiveness of our internal controls over financial reporting as of the
end of each fiscal year, and to include a management report assessing the effectiveness of our internal controls over financial reporting in our annual report on Form 10-K for that fiscal year. Section&nbsp;404 also requires our independent
registered public accounting firm to attest to, and report on, our internal controls over financial reporting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our management, including our
Chief Executive Officer and Chief Financial Officer, does not expect that our internal controls over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable,
not absolute, assurance that the control system&#146;s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their
costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud involving a company have been, or will be, detected. The design of any system
of controls is based in part on certain assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become
inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be
detected. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We cannot assure you that we or our independent registered public accounting firm will not identify a
material weakness in our internal controls in the future. In connection with the audit of our financial statements for the year ended December&nbsp;31, 2015, we concluded that there was a material weakness in our internal control over financial
reporting. A material weakness is a significant deficiency, or a combination of significant deficiencies, in internal control over financial reporting such that it is reasonably possible that a material misstatement of the annual or interim
financial statements will not be prevented or detected on a timely basis. The material weakness we identified related to impairment testing that we performed in accordance with ASC 360-10,<I> Impairment and Disposal of Long-Lived Assets</I> and ASC
330-10, <I>Inventories</I>, as of December&nbsp;31, 2015. Specifically, our review controls did not operate at a sufficient level of precision to identify certain errors. As a result of this material weakness, we and our independent registered
public accounting firm evaluated our internal control over financial reporting as ineffective. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are taking steps to remediate the material
weakness in our internal control over financial reporting, including designing additional training programs for relevant personnel and developing specific review procedures regarding the review of the impairment of assets. However, we cannot assure
you that these efforts will remediate our material weakness in a timely manner, or at all. If we are unable to successfully remediate our material weakness, or identify any future material weaknesses, the accuracy and timing of our financial
reporting may be adversely affected, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports and we may experience a loss of public confidence, which could have an adverse effect on our
business, financial condition and the market price of our common stock and other securities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We may undertake internal
restructuring activities in the future that could result in disruptions to our business or otherwise materially harm our results of operations or financial condition. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">From time to time we may undertake internal restructuring activities as we continue to evaluate and attempt to optimize our cost and operating structure in light of developments in our business strategy
and long-term operating plans. These activities may result in write-offs or other restructuring charges. There can be no assurance that any restructuring activities that we undertake will achieve the cost savings, operating efficiencies or other
benefits that we may initially expect. Restructuring activities may also result in a loss of continuity, accumulated knowledge and inefficiency during transitional periods and thereafter. In addition, internal restructurings can require a
significant amount of time and focus from management and other employees, which may divert attention from commercial operations. If we undertake any internal restructuring activities and fail to achieve some or all of the expected benefits
therefrom, our business, results of operations and financial condition could be materially and adversely affected. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We
and certain of our executive officers and directors have been named as defendants in ongoing securities class action lawsuits that could result in substantial costs and divert management&#146;s attention. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Several complaints were filed in the U.S. District Court for the Central District of California against us and certain of our officers and
directors on behalf of certain purchasers of our common stock. The complaints include claims asserted under Sections 10(b) and 20(a) of the Exchange Act and have been pled as putative shareholder class actions. In general, the complaints allege that
we and certain of our officers and directors violated federal securities laws by making materially false and misleading statements regarding the prospects for AFREZZA, thereby artificially inflating the price of our common stock. We and certain of
our directors and executive officers have also been named in similar lawsuits filed in Israel. We intend to vigorously defend against these claims. If we are not successful in our defense, we could be forced to make significant payments to or other
settlements with our stockholders and their lawyers, and such payments or settlement arrangements could have a material adverse effect on our business, operating results or financial condition. Even if such claims are not successful, the litigation
could result in substantial costs and significant adverse impact on our reputation and divert management&#146;s attention and resources, which could have a material adverse effect on our business, operating results and financial condition.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our operations might be interrupted by the occurrence of a natural disaster or other catastrophic event.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect that at least for the foreseeable future, our manufacturing facility in Danbury, Connecticut will be the
sole location for the manufacturing of AFREZZA. This facility and the manufacturing equipment we use </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
would be costly to replace and could require substantial lead time to repair or replace. We depend on our facilities and on collaborators, contractors and vendors for the continued operation of
our business, some of whom are located in other countries. Natural disasters or other catastrophic events, including interruptions in the supply of natural resources, political and governmental changes, severe weather conditions, wildfires and other
fires, explosions, actions of animal rights activists, terrorist attacks, volcanic eruptions, earthquakes and wars could disrupt our operations or those of our collaborators, contractors and vendors. We might suffer losses as a result of business
interruptions that exceed the coverage available under our and our contractors&#146; insurance policies or for which we or our contractors do not have coverage. For example, we are not insured against a terrorist attack. Any natural disaster or
catastrophic event could have a significant negative impact on our operations and financial results. Moreover, any such event could delay our research and development programs or cause interruptions in our commercialization of AFREZZA. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We deal with hazardous materials and must comply with environmental laws and regulations, which can be expensive and restrict how
we do business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our research and development and commercialization of AFREZZA work involves the controlled storage and
use of hazardous materials, including chemical and biological materials. In addition, our manufacturing operations involve the use of a chemical that may form an explosive mixture under certain conditions. Our operations also produce hazardous waste
products. We are subject to federal, state and local laws and regulations (i)&nbsp;governing how we use, manufacture, store, handle and dispose of these materials (ii)&nbsp;imposing liability for costs of cleaning up, and damages to natural
resources from past spills, waste disposals on and off-site, or other releases of hazardous materials or regulated substances, and (iii)&nbsp;regulating workplace safety. Moreover, the risk of accidental contamination or injury from hazardous
materials cannot be completely eliminated, and in the event of an accident, we could be held liable for any damages that may result, and any liability could fall outside the coverage or exceed the limits of our insurance. Currently, our general
liability policy provides coverage up to $1.0 million per occurrence and $2.0 million in the aggregate and is supplemented by an umbrella policy that provides a further $20.0 million of coverage; however, our insurance policy excludes pollution
liability coverage and we do not carry a separate hazardous materials policy. In addition, we could be required to incur significant costs to comply with environmental laws and regulations in the future. Finally, current or future environmental laws
and regulations may impair our research, development or production efforts or have an adverse impact on our business, results of operations and financial condition. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">When we purchased the facilities located in Danbury, Connecticut in 2001, a soil and groundwater investigation and remediation was being conducted by a former site operator (the responsible party) under
the oversight of the Connecticut Department of Environmental Protection. During the construction of our expanded manufacturing facility, we excavated contaminated soil under the footprint of our building expansion location. The responsible party
reimbursed us for our increased excavation and disposal costs of contaminated soil in the amount of $1.6 million. It has conducted at its expense all work and will make all filings necessary to achieve closure for the environmental remediation
conducted at the site, and has agreed to indemnify us for any future costs and expenses we may incur that are directly related to the final closure. If we are unable to collect these future costs and expenses, if any, from the responsible party, our
business, financial condition and results of operations may be harmed. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RISKS RELATED TO GOVERNMENT REGULATION </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our product candidates must undergo costly and time-consuming rigorous nonclinical and clinical testing and we must obtain
regulatory approval prior to the sale and marketing of any product in each jurisdiction. The results of this testing or issues that develop in the review and approval by a regulatory agency may subject us to unanticipated delays or prevent us from
marketing any products. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our research and development activities, as well as the manufacturing and marketing of AFREZZA
and our product candidates, are subject to regulation, including regulation for safety, efficacy and quality, by the FDA in the United States and comparable authorities in other countries. FDA regulations and the regulations of comparable foreign
regulatory authorities are wide-ranging and govern, among other things: </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">product design, development, manufacture and testing; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">product labeling; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">product storage and shipping; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">pre-market clearance or approval; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">advertising and promotion; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">product sales and distribution. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The requirements governing the conduct of clinical studies and manufacturing and marketing of AFREZZA and our product candidates outside the United States vary widely from country to country. Foreign
approvals may take longer to obtain than FDA approvals and can require, among other things, additional testing and different clinical study designs. Foreign regulatory approval processes include essentially all of the risks associated with the FDA
approval processes. Some of those agencies also must approve prices of the products. Approval of a product by the FDA does not ensure approval of the same product by the health authorities of other countries. In addition, changes in regulatory
policy in the United States or in foreign countries for product approval during the period of product development and regulatory agency review of each submitted new application may cause delays or rejections. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Clinical testing can be costly and take many years, and the outcome is uncertain and susceptible to varying interpretations. We cannot be
certain if or when regulatory agencies might request additional studies, under what conditions such studies might be requested, or what the size or length of any such studies might be. The clinical studies of our product candidates may not be
completed on schedule, regulatory agencies may order us to stop or modify our research, or these agencies may not ultimately approve any of our product candidates for commercial sale. The data collected from our clinical studies may not be
sufficient to support regulatory approval of our product candidates. Even if we believe the data collected from our clinical studies are sufficient, regulatory agencies have substantial discretion in the approval process and may disagree with our
interpretation of the data. Our failure to adequately demonstrate the safety and efficacy of any of our product candidates would delay or prevent regulatory approval of our product candidates, which could prevent us from achieving profitability.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Questions that have been raised about the safety of marketed drugs generally, including pertaining to the lack of adequate
labeling, may result in increased cautiousness by regulatory agencies in reviewing new drugs based on safety, efficacy, or other regulatory considerations and may result in significant delays in obtaining regulatory approvals. Such regulatory
considerations may also result in the imposition of more restrictive drug labeling or marketing requirements as conditions of approval, which may significantly affect the marketability of our drug products. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If we do not comply with regulatory requirements at any stage, whether before or after marketing approval is obtained, we may be
fined or forced to remove a product from the market, subject to criminal prosecution, or experience other adverse consequences, including restrictions or delays in obtaining regulatory marketing approval. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Even if we comply with regulatory requirements, we may not be able to obtain the labeling claims necessary or desirable for product
promotion. We may also be required to undertake post-marketing studies. For example, the FDA required the following post-marketing studies for AFREZZA that remain to be completed: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a clinical trial to evaluate pharmacokinetics, safety and efficacy in pediatric patients; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a clinical trial to evaluate the potential risk of pulmonary malignancy with AFREZZA (as well as cardiovascular risk and the long-term effect of
AFREZZA on pulmonary function). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, if we or other parties identify adverse effects after any of
our products are on the market, or if manufacturing problems occur, regulatory approval may be withdrawn and a reformulation of our products, additional clinical studies, changes in labeling of, or indications of use for, our products and/or
additional marketing applications may be required. If we encounter any of the foregoing problems, our business, financial condition and results of operations will be harmed and the market price of our common stock and other securities may decline.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We are subject to stringent, ongoing government regulation. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The manufacture, marketing and sale of AFREZZA are subject to stringent and ongoing government regulation. The FDA may also withdraw
product approvals if problems concerning the safety or efficacy of a product appear following approval. We cannot be sure that FDA and United States Congressional initiatives or actions by foreign regulatory bodies pertaining to ensuring the safety
of marketed drugs or other developments pertaining to the pharmaceutical industry will not adversely affect our operations. For example, stability failure of AFREZZA could lead to product recall or other sanctions. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also are required to register our establishments and list our products with the FDA and certain state agencies. We and any third-party
manufacturers or suppliers must continually adhere to federal regulations setting forth requirements, known as cGMP (for drugs) and QSR (for medical devices), and their foreign equivalents, which are enforced by the FDA and other national regulatory
bodies through their facilities inspection programs. In complying with cGMP and foreign regulatory requirements, we and any of our potential third-party manufacturers or suppliers will be obligated to expend time, money and effort in production,
record-keeping and quality control to ensure that our products meet applicable specifications and other requirements. QSR requirements also impose extensive testing, control and documentation requirements. State regulatory agencies and the
regulatory agencies of other countries have similar requirements. In addition, we will be required to comply with regulatory requirements of the FDA, state regulatory agencies and the regulatory agencies of other countries concerning the reporting
of adverse events and device malfunctions, corrections and removals (e.g., recalls), promotion and advertising and general prohibitions against the manufacture and distribution of adulterated and misbranded devices. Failure to comply with these
regulatory requirements could result in civil fines, product seizures, injunctions and/or criminal prosecution of responsible individuals and us. Any such actions would have a material adverse effect on our business, financial condition and results
of operations. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">FDA and comparable foreign regulatory authorities subject AFFREZZA and any approved drug product to extensive
and ongoing regulatory requirements concerning the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping. These requirements include submissions of
safety and other post-marketing information and reports, registration, as well as continued compliance with cGMPs and GCP requirements for any clinical trials that we conduct post-approval. Later discovery of previously unknown problems, including
adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">restrictions on the marketing or manufacturing of our product candidates, withdrawal of the product from the market, or voluntary or mandatory product
recalls; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">fines, warning letters or holds on clinical trials; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or suspension or revocation of approvals;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">product seizure or detention, or refusal to permit the import or export of our product candidates; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">injunctions or the imposition of civil or criminal penalties. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The FDA&#146;s and other regulatory authorities&#146; policies may change and additional government regulations may be enacted that could
prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or
abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and
we may not achieve or sustain profitability. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our suppliers are subject to FDA inspection. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We depend on suppliers for insulin and other materials that comprise AFREZZA, including our AFREZZA inhaler and cartridges. Each supplier
must comply with relevant regulatory requirements and is subject to </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
inspection by the FDA. Although we conduct our own inspections and investigations of each supplier, there can be no assurance that the FDA, upon inspection, would find that the supplier
substantially complies with the QSR or cGMP requirements, where applicable. If we or any potential third-party manufacturer or supplier fails to comply with these requirements or comparable requirements in foreign countries, regulatory authorities
may subject us to regulatory action, including criminal prosecutions, fines and suspension of the manufacture of our products. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we are required to find a new or additional supplier of insulin, we will be required to evaluate the new supplier&#146;s ability to
provide insulin that meets regulatory requirements, including cGMP requirements as well as our specifications and quality requirements, which would require significant time and expense and could delay the manufacturing and commercialization of
AFREZZA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Reports of side effects or safety concerns in related technology fields or in other companies&#146; clinical
studies could delay or prevent us from obtaining regulatory approval for our product candidates or negatively impact public perception of AFREZZA or any other products we may develop. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At present, there are a number of clinical studies being conducted by other pharmaceutical companies involving insulin delivery systems.
If other pharmaceutical companies announce that they observed frequent adverse events in their studies involving insulin therapies, we may be subject to class warnings in the label for AFREZZA. In addition, the public perception of AFREZZA might be
adversely affected, which could harm our business, financial condition and results of operations and cause the market price of our common stock and other securities to decline, even if the concern relates to another company&#146;s products or
product candidates. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are also a number of clinical studies being conducted by other pharmaceutical companies involving
compounds similar to, or competitive with, our other product candidates. Adverse results reported by these other companies in their clinical studies could delay or prevent us from obtaining regulatory approval or negatively impact public perception
of our product candidates, which could harm our business, financial condition and results of operations and cause the market price of our common stock and other securities to decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>RISKS RELATED TO INTELLECTUAL PROPERTY </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If we are unable to protect
our proprietary rights, we may not be able to compete effectively, or operate profitably. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our commercial success
depends, in large part, on our ability to obtain and maintain intellectual property protection for our technology. Our ability to do so will depend on, among other things, complex legal and factual questions, and it should be noted that the
standards regarding intellectual property rights in our fields are still evolving. We attempt to protect our proprietary technology through a combination of patents, trade secrets and confidentiality agreements. We own a number of domestic and
international patents, have a number of domestic and international patent applications pending and have licenses to additional patents. We cannot assure you that our patents and licenses will successfully preclude others from using our technologies,
and we could incur substantial costs in seeking enforcement of our proprietary rights against infringement. Even if issued, the patents may not give us an advantage over competitors with alternative technologies. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moreover, the term of a patent is limited and, as a result, the patents protecting our products expire at various dates. For example, some
patents providing protection for AFREZZA inhalation powder have terms extending into 2020, 2029, 2030 and 2031. In addition, patents providing protection for our inhaler and cartridges have terms extending into 2023, 2031 and 2032, and we have
method of treatment claims that extend into 2026 and 2029. As and when these different patents expire, AFREZZA could become subject to increased competition. As a consequence, we may not be able to recover our development costs. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moreover, the issuance of a patent is not conclusive as to its validity or enforceability and it is uncertain how much protection, if any,
will be afforded by our patents. A third party may challenge the validity or enforceability of a patent after its issuance by various proceedings such as oppositions in foreign jurisdictions or re-examinations or other review in the United States.
In some instances we may seek re-examination or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
reissuance of our own patents. If we attempt to enforce our patents, they may be challenged in court where they could be held invalid, unenforceable, or have their breadth narrowed to an extent
that would destroy their value. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On September&nbsp;16, 2011, the Leahy-Smith America Invents Act (the &#147;Leahy-Smith
Act&#148;) was signed into law. The Leahy-Smith Act includes a number of significant changes to United States patent law. These include provisions that affect the way patent applications will be prosecuted, subjected to post-grant challenge, and may
also affect patent litigation. The USPTO is continuing to develop regulations and procedures to govern administration of the Leahy-Smith Act, and while all of the substantive changes to patent law associated with the Leahy-Smith Act have become
effective, their true impact will only emerge with time. Moreover there will be a transitional period of many years during which some applications may be eligible for prosecution under the previous rules. There are many ambiguities in this new law
and how the courts will interpret it cannot be predicted with confidence. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. The Leahy-Smith Act and its implementation could increase the
uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition and results of operations.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moreover, patent law continues to evolve. Several further changes to patent law are before Congress. The United States Supreme
Court has exhibited an increased interest in patent law and several of its recent decisions have tended to narrow the scope of patentable subject matter related to medical products and methods. For example, in March 2014 the USPTO, in response to
Supreme Court decisions, issued new examination guidelines which call into question the patentability of biological inventions that had previously been considered patentable. While none of this has an immediately apparent impact on our core
technology and patents, the full and ultimate effect of these developments is not yet known. We also rely on unpatented technology, trade secrets, know-how and confidentiality agreements. We require our officers, employees, consultants and advisors
to execute proprietary information and invention and assignment agreements upon commencement of their relationships with us. These agreements provide that all inventions developed by the individual on behalf of us must be assigned to us and that the
individual will cooperate with us in connection with securing patent protection on the invention if we wish to pursue such protection. We also execute confidentiality agreements with outside collaborators. There can be no assurance, however, that
our inventions and assignment agreements and our confidentiality agreements will provide meaningful protection for our inventions, trade secrets, know-how or other proprietary information in the event of unauthorized use or disclosure of such
information. If any trade secret, know-how or other technology not protected by a patent were to be disclosed to or independently developed by a competitor, our business, results of operations and financial condition could be adversely affected.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If we become involved in lawsuits to protect or enforce our patents or the patents of our collaborators or licensors,
we would be required to devote substantial time and resources to prosecute or defend such proceedings. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Competitors may
infringe our patents or the patents of our collaborators or licensors. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. In addition, in an infringement
proceeding, a court may decide that a patent of ours is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover its technology. A court may also decide to
award us a royalty from an infringing party instead of issuing an injunction against the infringing activity. An adverse determination of any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or
interpreted narrowly and could put our patent applications at risk of not issuing. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interference proceedings brought by the
USPTO, may be necessary to determine the priority of inventions with respect to our patent applications or those of our collaborators or licensors. Additionally, the Leahy-Smith Act has greatly expanded the options for post-grant review of patents
that can be brought by third parties. In particular Inter Partes Review (IPR) has resulted in a higher rate of claim invalidation as compared to re-examination, due in part to the much reduced opportunity to repair claims by amendment. Moreover, the
filing of IPR petitions has been used by short-sellers as a tool to help drive down stock prices. Litigation, post-grant </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
review, or interference proceedings may fail and, even if successful, may result in substantial costs and be a distraction to our management. We may not be able, alone or with our collaborators
and licensors, to prevent misappropriation of our proprietary rights, particularly in countries where the laws may not protect such rights as fully as in the United States. We may not prevail in any litigation, post-grant review, or interference
proceeding in which we are involved. Even if we do prevail, these proceedings can be very expensive and distract our management. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk
that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, during the course of this kind of litigation, there could be public announcements of the results of hearings, motions or other
interim proceedings or developments. If securities analysts or investors perceive these results to be negative, the market price of our common stock and other securities may decline. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If our technologies conflict with the proprietary rights of others, we may incur substantial costs as a result of litigation or
other proceedings and we could face substantial monetary damages and be precluded from commercializing our products, which would materially harm our business and financial condition. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Biotechnology patents are numerous and may, at times, conflict with one another. As a result, it is not always clear to industry
participants, including us, which patents cover the multitude of biotechnology product types. Ultimately, the courts must determine the scope of coverage afforded by a patent and the courts do not always arrive at uniform conclusions. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A patent owner may claim that we are making, using, selling or offering for sale an invention covered by the owner&#146;s patents and may
go to court to stop us from engaging in such activities. Such litigation is not uncommon in our industry. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patent lawsuits can
be expensive and would consume time and other resources. There is a risk that a court would decide that we are infringing a third party&#146;s patents and would order us to stop the activities covered by the patents, including the commercialization
of our products. In addition, there is a risk that we would have to pay the other party damages for having violated the other party&#146;s patents (which damages may be increased, as well as attorneys&#146; fees ordered paid, if infringement is
found to be willful), or that we will be required to obtain a license from the other party in order to continue to commercialize the affected products, or to design our products in a manner that does not infringe a valid patent. We may not prevail
in any legal action, and a required license under the patent may not be available on acceptable terms or at all, requiring cessation of activities that were found to infringe a valid patent. We also may not be able to develop a non-infringing
product design on commercially reasonable terms, or at all. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moreover, certain components of AFREZZA may be manufactured
outside the United States and imported into the United States. As such, third parties could file complaints under 19 U.S.C. Section&nbsp;337(a)(1)(B) (a &#147;337 action&#148;) with the International Trade Commission (the &#147;ITC&#148;). A 337
action can be expensive and would consume time and other resources. There is a risk that the ITC would decide that we are infringing a third party&#146;s patents and either enjoin us from importing the infringing products or parts thereof into the
United States or set a bond in an amount that the ITC considers would offset our competitive advantage from the continued importation during the statutory review period. The bond could be up to 100% of the value of the patented products. We may not
prevail in any legal action, and a required license under the patent may not be available on acceptable terms, or at all, resulting in a permanent injunction preventing any further importation of the infringing products or parts thereof into the
United States. We also may not be able to develop a non-infringing product design on commercially reasonable terms, or at all. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although we own a number of domestic and foreign patents and patent applications relating to AFREZZA, we have identified certain
third-party patents having claims that may trigger an allegation of infringement in connection with the commercial manufacture and sale of AFREZZA. If a court were to determine that AFREZZA was infringing any of these patent rights, we would have to
establish with the court that these patents were invalid or unenforceable in order to avoid legal liability for infringement of these patents. However, proving </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
patent invalidity or unenforceability can be difficult because issued patents are presumed valid. Therefore, in the event that we are unable to prevail in a non-infringement or invalidity action
we will have to either acquire the third-party patents outright or seek a royalty-bearing license. Royalty-bearing licenses effectively increase production costs and therefore may materially affect product profitability. Furthermore, should the
patent holder refuse to either assign or license us the infringed patents, it may be necessary to cease manufacturing the product entirely and/or design around the patents, if possible. In either event, our business, financial condition and results
of operations would be harmed and our profitability could be materially and adversely impacted. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Furthermore, because of the
substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, during the course
of this kind of litigation, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, the market price of our
common stock and other securities may decline. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, patent litigation may divert the attention of key personnel and we
may not have sufficient resources to bring these actions to a successful conclusion. At the same time, some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially
greater resources. An adverse determination in a judicial or administrative proceeding or failure to obtain necessary licenses could prevent us from manufacturing and selling our products or result in substantial monetary damages, which would
adversely affect our business, financial condition and results of operations and cause the market price of our common stock and other securities to decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>We may not obtain trademark registrations for our potential trade names. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have not selected trade names for some of our product candidates; therefore, we have not filed trademark registrations for such potential trade names for our product candidates, nor can we assure that
we will be granted registration of any potential trade names for which we do file. No assurance can be given that any of our trademarks will be registered in the United States or elsewhere, or once registered that, prior to our being able to enter a
particular market, they will not be cancelled for non-use. Nor can we give assurances, that the use of any of our trademarks will confer a competitive advantage in the marketplace. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Furthermore, even if we are successful in our trademark registrations, the FDA has its own process for drug nomenclature and its own views
concerning appropriate proprietary names. It also has the power, even after granting market approval, to request a company to reconsider the name for a product because of evidence of confusion in the marketplace. We cannot assure you that the FDA or
any other regulatory authority will approve of any of our trademarks or will not request reconsideration of one of our trademarks at some time in the future. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>RISKS RELATED TO OUR COMMON STOCK </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We may not be able to generate
sufficient cash to service all of our indebtedness. We may be forced to take other actions to satisfy our obligations under our indebtedness or we may experience a financial failure. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our ability to make scheduled payments on or to refinance our debt obligations will depend on our financial and operating performance,
which is subject to prevailing economic and competitive conditions and to certain financial, business and other factors beyond our control. We cannot assure you that we will maintain a level of cash flows from operating activities sufficient to
permit us to pay the principal, premium, if any, and interest on our indebtedness. If our cash flows and capital resources are insufficient to fund our debt service obligations, we may be forced to reduce or delay capital expenditures, sell assets
or operations, seek additional capital or restructure or refinance our indebtedness. We cannot assure you that we would be able to take any of these actions, that these actions would be successful and permit us to meet our scheduled debt service
obligations or that these actions would be permitted under the terms of our future debt agreements. In the absence of sufficient operating results and resources, we could face substantial liquidity problems and might be required to dispose of
material assets or operations to meet our debt service and other obligations. We may not be able to consummate </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
those dispositions or obtain sufficient proceeds from those dispositions to meet our debt service and other obligations when due. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Future sales of shares of our common stock in the public market, or the perception that such sales may occur, may depress our stock
price and adversely impact the market price of our common stock and other securities. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If our existing stockholders or
their distributees sell substantial amounts of our common stock in the public market, the market price of our common stock could decrease significantly. The perception in the public market that our existing stockholders might sell shares of common
stock could also depress the market price of our common stock and the market price of our other securities. Any such sales of our common stock in the public market may affect the price of our common stock or the market price of our other securities.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the future, we may sell additional shares of our common stock to raise capital. In addition, a substantial number of shares
of our common stock is reserved for: issuance upon the exercise of stock options and, in the future, may be reserved for the vesting of restricted stock unit awards; the purchase of shares of common stock under our employee stock purchase program;
and the issuance of shares upon exchange or conversion of the 2018 notes or any other convertible debt we may issue. We cannot predict the size of future issuances or the effect, if any, that they may have on the market price for our common stock.
The issuance or sale of substantial amounts of common stock, or the perception that such issuances or sales may occur, could adversely affect the market price of our common stock and other securities. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our stock price is volatile and may affect the market price of our common stock and other securities. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Since January&nbsp;1, 2013, our closing stock price as reported on The NASDAQ Global Market has ranged from $0.66 to $10.96, through
February&nbsp;22, 2016. The trading price of our common stock is likely to continue to be volatile. The stock market, particularly in recent years, has experienced significant volatility particularly with respect to pharmaceutical and biotechnology
stocks, and this trend may continue. The volatility of pharmaceutical and biotechnology stocks often does not relate to the operating performance of the companies represented by the stock. Our business and the market price of our common stock may be
influenced by a large variety of factors, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to develop and commercialize AFREZZA on our own in the United States; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to find collaboration partners for the development and commercialization of AFREZZA in foreign jurisdictions; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the progress of the commercial launch of AFREZZA and other events or circumstances that we or others estimate will impact the future commercialization
of AFREZZA; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our future estimates of AFREZZA sales, prescriptions or other operating metrics; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our ability to successful commercialize our Technosphere drug delivery platform; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the progress of preclinical and clinical studies of our product candidates and the post-approval studies of AFREZZA required by the FDA;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the results of preclinical and clinical studies of our product candidates; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">general economic, political or stock market conditions; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">legislative developments; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">announcements by us, our collaborators, or our competitors concerning clinical study results, acquisitions, strategic alliances, technological
innovations, newly approved commercial products, product discontinuations, or other developments; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the availability of critical materials used in developing and manufacturing AFREZZA or other product candidates; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">developments or disputes concerning our relationship with any of our current or future collaborators or third party manufacturers;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">developments or disputes concerning our patents or proprietary rights; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the expense and time associated with, and the extent of our ultimate success in, securing regulatory approvals; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">announcements by us concerning our financial condition or operating performance; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">changes in securities analysts&#146; estimates of our financial condition or operating performance; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">general market conditions and fluctuations for emerging growth and pharmaceutical market sectors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">sales of large blocks of our common stock, including sales by our executive officers, directors and significant stockholders;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the status of any legal proceedings or regulatory matters against or involving us or any of our executive officers and directors; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discussion of AFREZZA, our other product candidates, competitors&#146; products, or our stock price by the financial and scientific press, the
healthcare community and online investor communities such as chat rooms. In particular, it may be difficult to verify statements about us and our investigational products that appear on interactive websites that permit users to generate content
anonymously or under a pseudonym and statements attributed to company officials may, in fact, have originated elsewhere. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Any of these risks, as well as other factors, could cause the market value of our common stock and other securities to decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>If we fail to continue to meet all applicable listing requirements, our common stock may be delisted from The NASDAQ Global Market, which could have an adverse impact on the liquidity and market
price of our common stock. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our common stock is currently listed on The NASDAQ Global Market, which has qualitative and
quantitative listing criteria. If we are unable to meet any of the NASDAQ listing requirements in the future, including, for example, if the closing bid price for our common stock falls below $1.00 per share for 30 consecutive trading days, NASDAQ
could determine to delist our common stock, which could adversely affect the market liquidity of our common stock and the market price of our common stock could decrease. As of February&nbsp;22, 2016, the closing price of our common stock on The
NASDAQ Global Market was $1.00. A delisting of our common stock could also adversely affect our ability to obtain financing for the continuation of our operations and could result in the loss of confidence in our company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If other biotechnology and biopharmaceutical companies or the securities markets in general encounter problems, the market price of
our common stock and other securities could be adversely affected. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Public companies in general, including companies
listed on The NASDAQ Global Market, have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. There has been particular volatility in the market prices of
securities of biotechnology and other life sciences companies, and the market prices of these companies have often fluctuated because of problems or successes in a given market segment or because investor interest has shifted to other segments.
These broad market and industry factors may cause the market price of our common stock and other securities to decline, regardless of our operating performance. We have no control over this volatility and can only focus our efforts on our own
operations, and even these may be affected due to the state of the capital markets. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the past, following periods of large
price declines in the public market price of a company&#146;s securities, securities class action litigation has often been initiated against that company. Litigation of this type could result in substantial costs and diversion of management&#146;s
attention and resources, which would hurt our business. Any adverse determination in litigation could also subject us to significant liabilities. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>As a result of the death of Alfred Mann, the stock that he previously controlled is
currently controlled by various trusts, and we cannot assure you of the manner in which the trustees will manage the holdings. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31, 2015, Alfred E. Mann beneficially owned approximately 35.7% of our outstanding shares of capital stock, including shares held in the Alfred E. Mann Living Trust, Mann Group LLC,
Mannco LLC, Biomed Partners, LLC and Biomed Partners II, LLC. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Mann passed away on February&nbsp;25, 2016. All of the
shares beneficially owned by Mr.&nbsp;Mann in the Alfred E. Mann Living Trust, The Mann Group LLC and Mannco LLC are controlled by an administrative trust during the period of administration of Mr.&nbsp;Mann&#146;s estate. The trustees of the
administrative trust are Mr.&nbsp;Mann&#146;s wife and two other trustees. The trustees have the power to sell the shares or deal with them as an owner. Relatives and other individuals may receive bequests of shares under Mr.&nbsp;Mann&#146;s trust.
The residuary beneficiary of the trust is the Alfred E. Mann Family Foundation, a charitable organization under section 501(c)(3) of the Internal Revenue Code that is a private foundation under section 509 of the Code. The same three trustees
control the Alfred E. Mann Family Foundation. The Alfred E. Mann Family Foundation will have the power to sell the shares or deal with them as an owner. If not sold by the trust, the shares owned by the trust may be distributed to one or more of the
individual or charitable beneficiaries of the trust. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The managing members of Biomed Partners, LLC and Biomed Partners II, LLC
are now controlled by trusts for which the same individuals described above are the trustees. Biomed Partners, LLC and Biomed Partners II, LLC will have the power to sell the shares or deal with them as an owner. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although we understand that the trustees now in control of Mr.&nbsp;Mann&#146;s holdings have been advised of Mr.&nbsp;Mann&#146;s
objectives, we cannot assure you as to how those shares will be distributed or how they will be voted. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>The future sale
of our common stock, the exchange or conversion of our 2018 notes into common stock or the exercise of our warrants for common stock could negatively affect the market price of our common stock and other securities. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of February&nbsp;22, 2016, we had 428,850,858 shares of common stock outstanding. Substantially all of these shares are available for
public sale, subject in some cases to volume and other limitations or delivery of a prospectus. If our common stockholders sell substantial amounts of common stock in the public market, or the market perceives that such sales may occur, the market
price of our common stock and other securities may decline. Likewise the issuance of additional shares of our common stock upon the exchange or conversion of some or all of our 2018 notes or upon the exercise of outstanding warrants, could adversely
affect the market price of our common stock and other securities. In addition, the existence of these notes and warrants may encourage short selling of our common stock by market participants, which could adversely affect the market price of our
common stock and other securities. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we will need to raise substantial additional capital in the future to fund our
operations. If we raise additional funds by issuing equity securities or additional convertible debt, the market price of our common stock and other securities may decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our
stockholders to replace or remove our current management. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are incorporated in Delaware. Certain anti-takeover
provisions under Delaware law and in our certificate of incorporation and amended and restated bylaws, as currently in effect, may make a change of control of our company more difficult, even if a change in control would be beneficial to our
stockholders or the holders of our other securities. Our anti-takeover provisions include provisions such as a prohibition on stockholder actions by written consent, the authority of our board of directors to issue preferred stock without
stockholder approval, and supermajority voting requirements for specified actions. In addition, we are governed by the provisions of Section&nbsp;203 of the Delaware General Corporation Law, which generally prohibits stockholders owning 15% or
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
more of our outstanding voting stock from merging or combining with us in certain circumstances. These provisions may delay or prevent an acquisition of us, even if the acquisition may be
considered beneficial by some of our stockholders. In addition, they may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board
of directors, which is responsible for appointing the members of our management. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Because we do not expect to pay
dividends in the foreseeable future, you must rely on stock appreciation for any return on any investment in our common stock. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have paid no cash dividends on any of our capital stock to date, and we currently intend to retain our future earnings, if any, to fund the development and growth of our business. As a result, we do
not expect to pay any cash dividends in the foreseeable future, and payment of cash dividends, if any, will also depend on our financial condition, results of operations, capital requirements and other factors and will be at the discretion of our
board of directors. Pursuant to the Facility Agreement, we are subject to contractual restrictions on the payment of dividends. There is no guarantee that our common stock will appreciate or maintain its current price. You could lose the entire
value of any investment in our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We have a limited number of unreserved shares available for future
issuance, which may impair our ability to conduct future financing and other transactions. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our amended and restated
certificate of incorporation currently authorizes us to issue up to 550,000,000 shares of common stock and 10,000,000 shares of preferred stock. As of February&nbsp;22, 2016, we had a total of 121,149,142 shares of common stock that were authorized
but unissued, and we have currently reserved a significant number of these shares for future issuance pursuant to outstanding equity awards, our equity plans and our 2018 notes. As a result, our ability to issue shares of common stock other than
pursuant to existing arrangements will be limited until such time, if ever, that we are able to amend our amended and restated certificate of incorporation to further increase our authorized shares of common stock or shares currently reserved for
issuance otherwise become available (for example, due to the termination of the underlying agreement to issue the shares). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If
we are unable to enter into new arrangements to issue shares of our common stock or securities convertible or exercisable into shares of our common stock, our ability to complete equity-based financings or other transactions that involve the
potential issuance of our common stock or securities convertible or exercisable into our common stock, will be limited. In lieu of issuing common stock or securities convertible into our common stock in any future equity financing transactions, we
may need to issue some or all of our authorized but unissued shares of preferred stock, which would likely have superior rights, preferences and privileges to those of our common stock, or we may need to issue debt that is not convertible into
shares of our common stock, which may require us to grant security interests in our assets and property and/or impose covenants upon us that restrict our business. If we are unable to issue additional shares of common stock or securities convertible
or exercisable into our common stock, our ability to enter into strategic transactions such as acquisitions of companies or technologies, may also be limited. If we propose to amend our amended and restated certificate of incorporation to increase
our authorized shares of common stock, such a proposal would require the approval by the holders of a majority of our outstanding shares of common stock, and we cannot assure you that such a proposal would be adopted. If we are unable to complete
financing, strategic or other transactions due to our inability to issue additional shares of common stock or securities convertible or exercisable into our common stock, our financial condition and business prospects may be materially harmed.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_4"></A>Item&nbsp;1B. </B><B><I>Unresolved Staff Comments</I></B><B> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_5"></A>Item&nbsp;2. </B><B><I>Properties</I></B><B> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2001, we acquired a facility in Danbury, Connecticut that included two buildings comprising approximately 190,000 square feet
encompassing 17.5 acres. In September 2008, we completed the construction of approximately 140,000 square feet of new manufacturing space providing us with two buildings totaling approximately 328,000 square feet, housing our research and
development, administrative and manufacturing functions for AFREZZA. We believe the Danbury facility will have sufficient space to satisfy commercial demand for AFREZZA. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We own approximately 142,000 square feet of laboratory, office and warehouse space in Valencia, California. This facility is currently listed for sale. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our obligations under the Facility Agreement, the Milestone Agreement, and Sanofi Loan Facility are secured by certain mortgages on our
facilities in Danbury, Connecticut and Valencia, California. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also lease approximately 12,500 square feet of office space in
Valencia, California pursuant to a lease that expires in April 2017. The facility contains our principal executive offices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_6">
</A>Item&nbsp;3. </B><B><I>Legal Proceedings</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following the receipt by us of the notice of termination from
Sanofi regarding the Sanofi License Agreement and the subsequent decline of the price of our common stock, several complaints were filed in the U.S. District Court for the Central District of California against us and certain of our officers and
directors on behalf of certain purchasers of our common stock. The complaints include claims asserted under Sections 10(b) and 20(a) of the Exchange Act and have been pled as putative shareholder class actions. In general, the complaints allege that
we and certain of our officers and directors violated federal securities laws by making materially false and misleading statements regarding the prospects for AFREZZA, thereby artificially inflating the price of our common stock. The plaintiffs are
seeking monetary damages and other relief. We expect the complaints to be transferred to a single court and consolidated for all purposes, following which the court would be expected to appoint a lead plaintiff and lead counsel and to order the lead
plaintiff to file a consolidated complaint. We will vigorously defend against the claims advanced. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following the receipt by us
of the notice of termination from Sanofi regarding the Sanofi License Agreement and the subsequent decline of the price of our common stock, two motions were submitted to the District Court at Tel Aviv (Economic Department) for the certification of
a class action against us and certain of our officers and directors. In general, the complaints allege that we and certain of our officers and directors violated Israeli and US securities laws by making materially false and misleading statements
regarding the prospects for AFREZZA, thereby artificially inflating the price of our common stock. The plaintiffs are seeking monetary damages. We will vigorously defend against these claims. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are also subject to legal proceedings and claims which arise in the ordinary course of our business. As of the date hereof, we believe
that the final disposition of such matters will not have a material adverse effect on our financial position, results of operations or cash flows. We maintain liability insurance coverage to protect our assets from losses arising out of or involving
activities associated with ongoing and normal business operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_7"></A>Item&nbsp;4. </B><B><I>Mine Safety
Disclosures</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Not applicable. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_8"></A>PART II </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_9"></A>Item&nbsp;5. </B><B><I>Market for the Registrant&#146;s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common Stock Market Price </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our common stock has been traded on The NASDAQ Global Market under the symbol &#147;MNKD&#148; since July&nbsp;28, 2004. The following
table sets forth for the quarterly periods indicated, the high and low sales prices for our common stock as reported by The NASDAQ Global Market. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;High&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Low&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Year ended December 31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">First quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.88</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Second quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Third quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fourth quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="12"></TD>
<TD HEIGHT="12" COLSPAN="4"></TD>
<TD HEIGHT="12" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Year ended December 31, 2014</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">First quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Second quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.02</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Third quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.81</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fourth quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The closing sales price of our common stock on The NASDAQ Global Market was $1.00 on February&nbsp;22,
2016 and there were 183 registered holders of record as of that date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Performance Measurement Comparison </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The material in this section is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC and shall not be
incorporated by reference by any general statement incorporating by reference this Annual Report on Form 10-K into any of our filings under the Securities Act, or the Exchange Act, except to the extent we specifically incorporate this section by
reference. </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following graph illustrates a comparison of the cumulative total stockholder return
(change in stock price plus reinvested dividends) of our common stock with (i)&nbsp;The NASDAQ Composite Index and (ii)&nbsp;The NASDAQ Biotechnology Index. The graph assumes a $100 investment, on December&nbsp;31, 2010, in (i)&nbsp;our common
stock, (ii)&nbsp;the securities comprising The NASDAQ Composite Index and (iii)&nbsp;the securities comprising The NASDAQ Biotechnology Index. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The comparisons in the graph are required by the SEC and are not intended to forecast or be indicative of possible future performance of our common stock. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g107849g85o46.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dividend Policy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have never declared or paid any cash dividends on our common stock. We currently intend to retain all available funds and any future earnings for use in the operation and expansion of our business.
Accordingly, we do not anticipate paying any cash dividends on our common stock in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors. In addition, under the terms of the Facility
Agreement, we are restricted from distributing any of our assets or declaring and distributing a dividend to our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Recent
Sales of Unregistered Securities </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of our engagement letter with Sunrise Securities Corp., our
placement agent for the registered direct offering that we completed in November 2015, on November&nbsp;16, 2015 we issued three affiliates of Sunrise Securities Corp. warrants to purchase an aggregate of 159,303 shares of our common stock at an
exercise price of $2.61 per share. The warrants are exercisable for cash, and in some cases on a cashless basis, for a period of five years following the issuance date. On December&nbsp;15, 2015, we registered for resale the shares of common stock
issuable upon exercise of the warrants. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We issued the warrants in reliance on the exemption from registration provided by
Section&nbsp;4(a)(2)&nbsp;of the Securities Act of 1933, as amended. The recipients acquired the warrants for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the
warrants. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_10"></A>Item&nbsp;6. </B><B><I>Selected Financial Data
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The information set forth below should be read in conjunction with &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations&#148; and the audited consolidated financial statements, and the notes thereto, and other financial information included herein this Annual Report on Form 10-K. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:104pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Statement of Operations Data:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands, except per share amounts)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,674</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,244</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">109,719</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">101,522</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99,959</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,960</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79,383</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,682</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,473</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,630</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Product Manufacturing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,442</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property and equipment impairment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss on purchase commitments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">344,655</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">179,627</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">169,401</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">146,995</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss from operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(344,655</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(179,627</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(169,401</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(146,960</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(140,539</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other income (expense)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,679</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(635</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,191</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,541</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss on extinguishment of debt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,049</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest expense on note payable to principal stockholder</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,894</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,894</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6,309</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10,491</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10,883</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(21,231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17,549</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15,153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11,139</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10,941</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss before provision for income taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(368,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(198,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(191,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(169,774</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(160,804</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Income taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">408</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(368,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(198,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(191,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(169,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(160,804</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted net loss per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.94</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares used to compute basic and diluted net loss per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">406,165</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">385,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">299,591</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,855</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">121,817</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="20"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:68pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Balance Sheet Data:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,074</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61,840</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,681</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">126,412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">394,439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">258,646</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">251,314</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">199,553</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior convertible notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,613</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99,355</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">98,439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">212,026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">210,642</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Note payable to our principal stockholder</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,521</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,521</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,521</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">119,635</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">277,203</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Facility financing obligation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,582</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,995</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">102,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sanofi loan facility and loss share obligation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62,371</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,034</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,863,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,494,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,296,402</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,104,912</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,935,546</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stockholders&#146; deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(350,329</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(73,770</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(30,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(110,679</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(313,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_11"></A>Item&nbsp;7. </B><B><I>Management&#146;s Discussion and Analysis
of Financial Condition and Results of Operations </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following discussion of our financial condition and results of
operations should be read in conjunction with our consolidated financial statements and notes thereto included in this Annual Report on Form 10-K. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Overview </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are a biopharmaceutical company focused on the discovery and
development of therapeutic products for diseases such as diabetes. Our only approved product, AFREZZA, is a rapid-acting inhaled insulin that was approved by the FDA on June&nbsp;27, 2014 to improve glycemic control in adult patients with diabetes.
AFREZZA became available by prescription in United States retail pharmacies in February 2015. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the year ended
December&nbsp;31, 2015, Sanofi reported a total of &#128;7.0&nbsp;million in annual sales of AFREZZA. As of December&nbsp;31, 2015, we had an accumulated deficit of $2.9&nbsp;billion and a stockholders&#146; deficit of $350.3 million. We incurred
net losses of approximately $368.4 million, $198.4 million, and $191.5 million in the years ended December&nbsp;31, 2015, 2014, and 2013, respectively. We have funded our operations primarily through the sale of equity securities and convertible
debt securities, borrowings under the Facility Agreement, borrowings under The Mann Group Loan Arrangement, receipt of upfront and milestone payments under the Sanofi License Agreement and borrowings under the Sanofi Loan Facility to fund our
portion of the loss share. As discussed below in &#147;Liquidity and Capital Resources&#148;, if we are unable to obtain additional funding, there will be substantial doubt about our ability to continue as a going concern. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To date, all sales and marketing activities related to AFREZZA have been conducted by Sanofi pursuant to the Sanofi License Agreement, and
we have been responsible for manufacturing AFREZZA to supply Sanofi&#146;s demand for the product pursuant to the Sanofi Supply Agreement. On January&nbsp;4, 2016, we received written notice from Sanofi of its election to terminate in its entirety
the Sanofi License Agreement. Sanofi&#146;s notice indicated that the termination was pursuant to Sanofi&#146;s right to terminate the agreement upon Sanofi&#146;s good faith determination that the commercialization of AFREZZA is no longer
economically viable in the United States, in which case the effective date of termination (the &#147;Termination Date&#148;) would be April&nbsp;4, 2016. In the alternative, Sanofi indicated that the termination was also pursuant to its right to
terminate the Sanofi License Agreement for any reason, in which case the Termination Date would be July&nbsp;4, 2016. We believe that Sanofi lacks a good faith basis for determining that commercialization of AFREZZA is no longer economically viable
in the United States. Nonetheless, in the interest of an expedient transition, we are currently working with Sanofi to transfer and wind down the agreement activities by April&nbsp;4, 2016, or as soon as practicable thereafter. We intend to assume
responsibility for commercializing and developing AFREZZA in the United States as soon as practicable following the Termination Date. As a result of the termination of the Sanofi License Agreement, the Sanofi Supply Agreement will terminate by its
terms on the Termination Date. We also intend to seek regional partnerships for the development and commercialization of AFREZZA in foreign jurisdictions where there are appropriate commercial opportunities. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our business is subject to significant risks, including but not limited to our ability to successfully commercialize and manufacture
sufficient quantities of AREZZA and the risks inherent in our ongoing clinical trials and the regulatory approval process for our product candidates. Additional significant risks also include the results of our research and development efforts,
competition from other products and technologies and uncertainties associated with obtaining and enforcing patent rights. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Research and
Development Expenses </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Historically our research and development expenses have consisted mainly of costs associated with
research and development of our product candidates, including associated clinical trials, and manufacturing process development. This includes the salaries, benefits and stock-based compensation of research and development personnel, raw materials,
laboratory supplies and materials, facility costs, costs for consultants and related contract research, licensing fees, and depreciation of equipment. We track research and development costs by the type of cost incurred. We partially offset research
and development expenses with the recognition of estimated amounts receivable from the State of Connecticut pursuant to a program under which we can exchange qualified research and development income tax credits for cash. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our research and development staff conducts our internal research and development
activities, which include research, product development, clinical development, manufacturing process development and related activities. This staff is located in our facilities in Valencia, California and Danbury, Connecticut. We expense research
and development costs as we incur them. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General and Administrative Expenses </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our general and administrative expenses are driven by salaries, benefits and stock-based compensation for administrative, finance,
business development, human resources, legal and information systems support personnel. In addition, general and administrative expenses include professional service fees and business insurance costs. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Product Manufacturing Expenses </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Product manufacturing expenses represent under-absorbed labor and overhead and inventory write-offs, which are expensed in the period in which they are incurred rather than as a portion of the inventory
cost. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Critical Accounting Policies </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have based our discussion and analysis of our financial condition and results of operations on our financial statements, which have been prepared in accordance with accounting principles generally
accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities and expenses. We evaluate our estimates and judgments on an ongoing
basis. We base our estimates on historical experience and on various assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making estimates of expenses such as stock option expenses and
judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. The significant accounting policies that are critical to the judgments and estimates used in the
preparation of our financial statements are described in more detail below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>License and collaboration agreements </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the Sanofi License Agreement, we granted to Sanofi exclusive, worldwide licenses to certain of our patents, trademarks and
know-how for the development and commercialization of AFREZZA. The terms of the Sanofi License Agreement provide for consideration to us in the form of a non-refundable up-front payment, product sales, manufacturing, regulatory and sales milestone
payments and profit and loss sharing. On January&nbsp;4, 2016, we received written notice from Sanofi of its election to terminate in its entirety the Sanofi License Agreement, effective either on April&nbsp;4, 2016 or July&nbsp;4, 2016 depending on
the permitted basis for termination. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We analyze consideration received under the provisions of ASC 605, Revenue Recognition,
to determine whether the consideration, or a portion thereof, could be recognized as revenue. ASC 605 provides that revenue is recognized when there is persuasive evidence that an arrangement exists, delivery has occurred or services have been
rendered, the price is fixed or determinable and collection is reasonably assured. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In arrangements involving the delivery of
more than one element, each required deliverable is evaluated to determine whether it qualifies as a separate unit of accounting. This determination is generally based on whether the deliverable has &#147;stand-alone value&#148; to the customer. The
arrangement&#146;s consideration that is fixed and determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. The estimated selling price of each deliverable is determined using the
following hierarchy of values: (i)&nbsp;vendor-specific objective evidence of fair value, (ii)&nbsp;third-party evidence of selling price and (iii)&nbsp;best estimate of selling price (BESP). The BESP reflects our best estimate of what the selling
price would be if the deliverable was regularly sold by us on a stand-alone basis. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is
not contingent upon future deliverables. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The assessment of multiple element arrangements requires judgment in order to
determine the appropriate units of accounting and the points in time that, or periods over which, revenue should be recognized. As of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
December&nbsp;31, 2015, we did not have the ability to estimate the amount of costs that would potentially be incurred under the loss sharing provision of the Sanofi License Agreement, and
accordingly we believe the fixed and determinable fee requirement for revenue recognition was not met. Given the fact that Sanofi has terminated the Sanofi License Agreement, we expect to have the ability in the future to estimate the amount of
costs that would potentially be incurred under the loss sharing provision of the Sanofi License Agreement, and accordingly we believe the fixed and determinable fee requirement for revenue recognition will be met in 2016. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Inventories </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventories are stated at the lower of cost or market value. We determine the cost of inventory using the first-in, first-out
(&#147;FIFO&#148;) method. We capitalize inventory costs associated with AFREZZA based on management&#146;s judgment and the future economic benefit expected to be realized; otherwise, such costs are expensed as research and development or as
product manufacturing expense for under-absorbed labor and overhead. We periodically analyze our inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value, and write down such inventories
as appropriate. In addition, AFREZZA is subject to strict quality control and monitoring, which we perform throughout the manufacturing process. If certain batches of AFREZZA inhalation powder, the inhaler or cartridges, no longer meet quality
specifications or become obsolete due to expiration, we will record a charge to write down such unmarketable inventory to its estimated realizable value. Inventory that is not expected to be used within one year is classified as a long term asset on
the accompanying condensed consolidated balance sheet. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We analyzed our inventory levels to identify inventory that may expire
or has a cost basis in excess of its estimated realizable value. We performed an assessment of projected sales to evaluate the lower of cost or market and the potential excess inventory on hand at December 31, 2015. As a result of this assessment,
we recorded a charge of $39.3&nbsp;million to record the inventory raw materials on hand at the lower of cost or market, inventory expiry, and write-off other inventory related assets. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with the projected sales assessment, we also evaluated our inventory purchase commitments totalling $116.2&nbsp;million for
potential impairment. As a result of this assessment, we recorded a $66.2&nbsp;million charge related to a loss on future purchase commitments both from a lower of cost or market and excess inventory perspective. The purchase commitment obligation
has been reduced to reflect our expectation that a portion will be recoverable from a third party. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Deferred product costs from
collaboration </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of product manufacturing includes costs in connection with producing commercial and clinical
product for Sanofi. Deferred costs represent the costs of product manufactured and shipped to Sanofi, not to exceed the amount of deferred product sales related to the collaboration, for which recognition of revenue has been deferred. Given that the
costs of inventory delivered to Sanofi, but for which revenue may not yet be recognized, meet both the definition and characteristics of an &#147;asset&#148; and management believes that it is probable that the amount of future revenue will exceed
the amount of deferred costs (i.e., the asset would be realizable through the recognition of probable future income), we have elected to account for the deferred costs related to the product sold to Sanofi as an asset and carry forward to future
periods until the related revenue is recognized. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Milestone Rights </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with the execution of the Facility Agreement on July&nbsp;1, 2013, we issued Milestone Rights to the Milestone Purchasers.
The Milestone Rights provide the Milestone Purchasers certain rights to receive payments up to $90.0 million upon the occurrence of specified strategic and sales milestones, including the first commercial sale of an AFREZZA product, and the
achievement of specified net sales figures. We analyzed the Milestone Rights under the provisions of Financial Accounting Standards Board (&#147;FASB&#148;) Accounting Standards Codification (&#147;ASC&#148;), 815 <I>Derivatives and Hedging</I>,
referred to as ASC 815, and determined that the instruments do not meet the definition of a freestanding derivative. Since we have not elected to apply the fair value option to the Milestone Rights, we have recorded the Milestone Rights at their
estimated fair value and accounted for the Milestone Rights as a liability by applying the indexed debt guidance contained in paragraphs ASC 470-10-25-3 and 35-4. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The initial fair value estimate of the Milestone Rights was calculated using the income
approach in which the cash flows associated with the specified contractual payments were adjusted for both the expected timing and the probability of achieving the milestones and discounted to present value using a selected market discount rate. The
expected timing and probability of achieving the milestones was developed with consideration given to both internal data, such as progress made to date and assessment of criteria required for achievement, and external data, such as market research
studies. The discount rate was selected based on an estimation of required rate of returns for similar investment opportunities using available market data. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Milestone Rights liability will be remeasured as the specified milestone events are achieved. Specifically, as each milestone event is achieved, the portion of the initially recorded Milestone Rights
liability that pertains to such milestone event being achieved, will be remeasured to the amount of the specified related milestone payment. The resulting change in the balance of the Milestone Rights liability due to remeasurement will be recorded
in our Statement of Operations as interest expense. Furthermore, the Milestone Rights liability will be reduced upon each milestone payment being paid. As a result, each milestone payment would be effectively allocated between a reduction of the
recorded Milestone Rights liability and an expense representing a return on a portion of the Milestone Rights liability paid to the investor for the achievement of the related milestone event. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Impairment of Long-Lived Assets </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Assessing long-lived assets for impairment requires us to make assumptions and judgments regarding the carrying value of these assets. We evaluate long-lived assets for impairment whenever events or
changes in circumstances indicate that the carrying value of an asset may not be recoverable. The assets are considered to be impaired if we determine that the carrying value may not be recoverable based upon our assessment of the following events
or changes in circumstances: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">significant changes in our strategic business objectives and utilization of the assets; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a determination that the carrying value of such assets cannot be recovered through undiscounted cash flows; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">loss of legal ownership or title to the assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset group), including an
adverse action or assessment by a regulator; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the impact of significant negative industry or economic trends. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we believe our assets to be impaired, the impairment we recognize is the amount by which the carrying value of the assets exceeds the
fair value of the assets. Any write-downs would be treated as permanent reductions in the carrying amount of the asset and an operating loss would be recognized. In addition, we base the useful lives and related amortization or depreciation expense
on our estimate of the useful lives of the assets. If a change were to occur in any of the above-mentioned factors or estimates, our reported results could materially change. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In connection with our quarterly assessment of impairment indicators, we evaluated the continued lower than expected sales of AFREZZA as reported by Sanofi throughout the fourth quarter of 2015, revised
forecasts for sales of AFREZZA provided by Sanofi in the fourth quarter of 2015 and level of commercial production in the fourth quarter of 2015, as well as the uncertainty associated with Sanofi&#146;s announcement during the fourth quarter of
their intent to reorganize their diabetes business. These factors indicated potentially significant changes in the timing and extent of cash flows, and we therefore determined that an impairment indicator existed in the fourth quarter of 2015.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;4, 2016, we received written notice from Sanofi of its election to terminate in its entirety the Sanofi
License Agreement. Sanofi&#146;s notice indicated that the termination was pursuant to Sanofi&#146;s right to terminate the agreement upon Sanofi&#146;s good faith determination that the commercialization of AFREZZA is no longer economically viable
in the United States, in which case the effective date of termination (the &#147;Termination Date&#148;) would be April&nbsp;4, 2016. In the alternative, Sanofi indicated that the termination was also pursuant to its right to terminate the License
Agreement for any reason, in which case the Termination Date would be July&nbsp;4, 2016. We believe that Sanofi lacks a good faith basis for determining that commercialization of AFREZZA is no longer economically viable in the United
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
States. Nonetheless, in the interest of an expedient transition, we are currently working with Sanofi to transfer and wind down the agreement activities by April&nbsp;4, 2016, or as soon as
practicable thereafter. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We identified two primary asset groups to be evaluated for impairment: the Danbury manufacturing
facility, which currently performs all the manufacturing of AFREZZA, and the Valencia facility, which was previously our corporate headquarters. The Danbury manufacturing facility is the primary asset group that has been impacted by the impairment
indicators noted above but we also evaluated the Valencia facility for potential impairment given the circumstances, and identified an impairment charge of $1.8 million based on a valuation utilizing a combination of market, income and cost
approaches. Within the Danbury manufacturing facility, we identified the machinery and equipment as the primary assets within the asset group as they are associated with the production of AFREZZA. As such, we performed the fixed asset impairment
test and performed the first step to test for recoverability of the Danbury manufacturing facility by utilizing two undiscounted cash flow projections and applying a probability weighted average to those cash flow projections. The first undiscounted
cash flow projection was developed under a scenario assuming Sanofi would continue to sell and market AFREZZA as the termination of the arrangement by Sanofi was not known as of the balance sheet date. The second undiscounted cash flow projection
assumed Sanofi would terminate the Sanofi License Agreement and that we would manufacture, sell and market AFREZZA independently. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Based on the evaluation performed, the probabilities assigned to the two undiscounted cash flows were not significant to the evaluation due to the projected negative cash flows over the estimation period,
and it was determined that the probability weighted undiscounted cash flows were not sufficient to recover the carrying value of the Danbury manufacturing facility. As such, we were required to determine the fair value of the Danbury manufacturing
facility to recognize an impairment loss if the carrying amount exceeds its fair value. We determined the fair value of the Danbury manufacturing facility by applying the highest and best use valuation concept and utilizing the market approach
valuation technique to value the machinery and equipment and a combination of the market approach and cost approach in valuing the land, buildings, and building improvements. As a result of this assessment, we recorded an impairment charge of $138.6
million for the Danbury manufacturing facility. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To date, we have had recurring operating losses, and the recoverability of our
long-lived assets is contingent upon executing our business plan. If we are unable to execute our business plan, we may require additional write downs of the value of our long-lived assets in future periods. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Clinical Trial Expenses </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our clinical trial accrual process seeks to account for expenses resulting from our obligations under contract with vendors, consultants, and clinical site agreements in connection with conducting
clinical trials. The financial terms of these contracts are subject to negotiations which vary from contract to contract and may result in payment flows that do not match the periods over which materials or services are provided to us under such
contracts. Our objective is to reflect the appropriate trial expenses in our financial statements by matching period expenses with period services and efforts expended. We account for these expenses according to the progress of the trial as measured
by patient progression and the timing of various aspects of the trial. We determine accrual estimates through discussions with internal clinical personnel and outside service providers as to the progress or state of completion of trials, or the
services completed. Service provider status is then compared to the contractual obligated fee to be paid for such services. During the course of a clinical trial, we adjust our rate of clinical expense recognition if actual results differ from our
estimates. In the event that we do not identify certain costs that have begun to be incurred or we underestimate or overestimate the level of services performed or the costs of such services, our reported expenses for a period would be too low or
too high. The date on which certain services commence, the level of services performed on or before a given date and the cost of the services are often judgmental. We make these judgments based upon the facts and circumstances known to us in
accordance with generally accepted accounting principles. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although we do not expect our estimates to be materially different
from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in our reporting amounts that are too high or too low for any
particular period. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stock-Based Compensation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We account for stock-based compensation in accordance with ASC 718 <I>Compensation &#151; Stock Compensation</I>. ASC 718 requires all
share-based payments to employees, including grants of stock options, restricted stock units, performance-based awards and the compensatory elements of employee stock purchase plans, to be recognized in the income statement based upon the fair value
of the awards at the grant date. We use the Black-Scholes option valuation model to estimate the grant date fair value of employee stock options and the compensatory elements of employee stock purchase plans. Option valuation models require the
input of assumptions, including the expected life of the stock-based awards, the estimated stock price volatility, the risk-free interest rate, and the expected dividend yield. Beginning in the third quarter of 2014, we began to assess both
historical and implied volatility in order to determine the estimated volatility rate for our stock. Implied volatility was considered due to the change in our business, which occurred with the approval for the sale of AFREEZA. The expected
volatility assumption is based on an assessment of the historical volatility and the implied volatility of our common stock, derived from an analysis of historical traded and quoted options on our common stock. Restricted stock units are valued
based on the market price on the grant date. We evaluate stock awards with performance conditions as to the probability that the performance conditions will be met and estimate the date at which the performance conditions will be met in order to
properly recognize stock-based compensation expense over the requisite service period. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Accounting for Income Taxes </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our management must make judgments when determining our provision for income taxes, our deferred tax assets and liabilities and any
valuation allowance recorded against our net deferred tax assets. At December&nbsp;31, 2015, we had established a valuation allowance of $962.6 million against all of our net deferred tax asset balance, due to uncertainties related to the
realizability of our deferred tax assets as a result of our history of operating losses. The valuation allowance is based on our estimates of taxable income by jurisdiction in which we operate and the period over which our deferred tax assets will
be recoverable. In the event that actual results differ from these estimates or we adjust these estimates in future periods, we may need to change the valuation allowance, which could materially impact our financial position and results of
operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Results of Operations </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Years ended December&nbsp;31, 2015 and 2014 </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Revenues </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the years ended December&nbsp;31, 2015 and 2014, we did not recognize any revenue. Due to the termination of the Sanofi License
Agreement and based on our current operating plan, we expect to recognize, likely within 2016, $17.5 million as product sales from collaboration, $13.5 million as product costs from collaboration and income from collaboration related to upfront and
milestone payments in excess of $100 million, which amounts are deferred as of December&nbsp;31, 2015 due to the revenue recognition criteria not being met as of such date. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Research and Development Expenses </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides a comparison of the research and development expense categories for the years ended December&nbsp;31, 2015
and 2014 (dollars in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended<BR>December 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$ Change</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>%&nbsp;Change</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Clinical</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,941</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,962</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16,021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Manufacturing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,939</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,901</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(35,962</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,554</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development tax credit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(817</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock-based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(19,328</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(86</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,674</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,244</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(70,570</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%)&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The decrease in research and development expenses of $70.6 million for the year ended December&nbsp;31,
2015 compared to the year ended December&nbsp;31, 2014 was primarily due to a decrease of $36.0 million in manufacturing process development expenses resulting from the shift to commercial production of AFREZZA of $30.8 million and decreased
expenses of $0.7 million following the completion of restructuring activities in early 2015. The decrease is also attributable to a $19.3 million decrease in stock-based compensation expense compared to 2014 as a result of a non-recurring
modification of the settlement terms (the &#147;Modification&#148;) of certain performance-based restricted stock units and the achievement of performance-based grants in 2014 and the first quarter of 2015. The Modification resulted in the
reclassification of these performance grants from equity awards to liability awards, which required re-measurement on the modification date and resulted in incremental stock-based compensation expense. Further, the reductions in research and
development expenses was also driven by a decrease in clinical trial related expenses of $16.0 million primarily resulting from the completion of the affinity trials of $11.1 million and decreased personnel costs related to restructuring of $9.0
million. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We anticipate that our overall research and development expenses will decrease in 2016 compared to 2015 due to the
focus on the transition of the AFREZZA rights in 2016 and minimal incremental cost associated with our development pipeline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>General and
Administrative Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides a comparison of the general and administrative expense categories for
the years ended December&nbsp;31, 2015 and 2014 (dollars in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended<BR>December 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$ Change</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>%&nbsp;Change</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Salaries, employee related and other general expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,264</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,118</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock-based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,696</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(20,569</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,960</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79,383</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(38,423</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%)&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The decrease in general and administrative expenses of $38.4 million for the year ended December&nbsp;31,
2015 compared to the year ended December&nbsp;31, 2014 was primarily due to decreased stock-based compensation expense of $20.6 million, resulting from the modification and achievement of performance-based grants in 2014 and the first quarter of
2015, as described above. Additionally, the decrease is also attributable to professional fees of $13.8 million related to the Sanofi License Agreement incurred in the third quarter of 2014 and decreased expenses of $3.2 million following the
completion of restructuring activities and decreased personnel costs in early 2015. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect general and administrative
expenses to remain relatively flat in 2016 as compared to 2015 due to restructuring measures in 2015 offset by an increase in professional fees related to the Sanofi termination. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect to have sales and marketing expenses in 2016 due to termination of the Sanofi License Agreement and the transition of sales and
marketing efforts to us in 2016. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">52 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Product Manufacturing Expenses </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Product manufacturing expenses were $67.4 million for the year ended December&nbsp;31, 2015, resulting from product manufacturing costs
associated with AFREZZA product sales, which cannot be capitalized due to excess capacity. We had no product manufacturing expense for the year ended December&nbsp;31, 2014, as pre-commercial manufacturing costs associated with AFREZZA were
accounted for as research and development expenses. Product manufacturing expenses represent under-absorbed labor and overhead of $21.4&nbsp;million and inventory write-offs of 36.1&nbsp;million, which are expensed in the period in which they are
incurred. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although the Sanofi License Agreement will terminate in the second quarter of 2016, we expect our 2016 production of
AFREZZA to be relatively consistent with production levels in 2015, primarily as a result of existing customer demand. With the exception of the inventory write-off, we expect product manufacturing expense to remain relatively flat in 2016 compared
to 2015. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Property and equipment impairment </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Property and equipment impairment increased $140.4 million for the year ended December&nbsp;31, 2015 compared to the year ended December&nbsp;31, 2014. The property and equipment impairment was to reduce
the carrying amount of our real property and machinery and equipment to fair value based on our impairment assessment in the fourth quarter of 2015. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Loss on purchase commitments </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss on purchase commitments increased $66.2
million for the year ended December&nbsp;31, 2015 compared to the year end 2014. The loss on purchase commitments was related to the loss on future purchase commitments resulting from our assessment of excess inventory as a result of lower than
expected sales of AFREZZA as well as a lower of cost or market adjustment due to estimated conversion costs in excess of our estimated selling price of AFREZZA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Other Income (Expense) </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other income for the year ended December&nbsp;31,
2015 was $1.4 million resulting from the relief of an accrual for potential expenses associated with the sale of intellectual property related to oncology in 2014, which was subsequently resolved without payment in the first quarter of 2015. For the
year ended December&nbsp;31, 2014, other income was $1.7 million resulting from the sale of intellectual property related to oncology in the third quarter of 2014 in the amount of $7.9 million, partially offset by a $6.4 million non-cash charge
recognized upon the conversion of 2019 notes into equity. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Loss on Extinguishment of Debt </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss on extinguishment of debt increased $1.0 million for the year ended December&nbsp;31, 2015 compared to the year ended
December&nbsp;31, 2014. The loss on extinguishment is due to the settlement of the 2015 notes through payment of cash and issuance of new debt. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Interest Income and Expense </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Interest expense increased $3.7 million from $20.4 million for the year ended December&nbsp;31, 2014 to $24.1 million for the year ended December&nbsp;31, 2015. The increase was primarily due to $5.8
million interest expense associated with the milestone payment resulting from the achievement and re-measurement of the second milestone under the Milestone Agreement in the first quarter of 2015 compared to the $1.9 million interest expense from
the payment of the first milestone in 2014. The increase was also due to an increase of $1.7 million related to the Sanofi Loan Facility and $0.8 million in interest for 2018 notes, which was offset by a decrease in interest expense of $2.7 million
resulting from the maturity of 2015 notes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Years ended December&nbsp;31, 2014 and 2013 </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Revenues </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the
years ended December&nbsp;31, 2014 and 2013, we did not recognize any revenue. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">53 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Research and Development Expenses </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides a comparison of the research and development expense categories for the years ended December&nbsp;31, 2014
and 2013 (dollars in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended<BR>December 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$ Change</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>%&nbsp;Change</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Clinical</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,962</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42,711</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14,749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Manufacturing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,901</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,530</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,371</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,351</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(510</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development tax credit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(817</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(282</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(535</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">190</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock-based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,244</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">109,719</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9,475</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The decrease in research and development expenses for the year ended December&nbsp;31, 2014 compared to
the year ended December&nbsp;31, 2013 was driven by a decrease in clinical trial related expenses of $14.8 million with the completion of two Phase 3 clinical studies of AFREZZA in 2013. This decrease was offset by a $4.4 million increase in
manufacturing spending due to supply purchases, increased headcount for commercial readiness and a $1.9 million increase in stock-based compensation resulting from the net effect of $10.4 million in increased stock-based compensation expense due to
the Modifications. The foregoing increase in stock-based compensation in 2014 was partially offset by an overall decrease in stock-based compensation of $7.1 million due to the decreased recognition period in 2014 as a result of the achievement of
milestones under company-wide performance-based grants in the second and third quarters of 2014, in addition to a reduction of other option and award compensation of $1.4 million due to a reduction in force. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We began commercial manufacturing in the latter part of the fourth quarter of 2014. As such, commercial manufacturing costs incurred in
the fourth quarter and included in manufacturing expenses above are immaterial for the year ended December&nbsp;31, 2014. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>General and
Administrative Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides a comparison of the general and administrative expense categories for
the years ended December&nbsp;31, 2014 and 2013 (dollars in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended<BR>December 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>$ Change</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>%&nbsp;Change</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Salaries, employee related and other general expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,118</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34,905</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,213</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock-based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,777</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,488</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79,383</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,682</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,701</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative expenses for the year ended December&nbsp;31, 2014 increased compared to the
prior year, driven by an increase in professional fees of $15.4 million associated with the closing of the Sanofi License Agreement, the amendment of the Facility Agreement and assessment of new product opportunities. Salaries and employee-related
expenses increased by $2.8 million in 2014 primarily due to increased compensation related to the achievement of significant corporate milestones and severance expense related to a reduction in force in the fourth quarter of 2014. Stock-based
compensation expense increased by $1.5 million as a result of the net effect of $12.6 million in increased stock-based compensation expense due to the Modifications and settlement of value during 2014 for certain performance awards, partially offset
by an overall decrease in stock-based compensation of $9.5 million due to the decreased recognition period in 2014 as a result of the achievement of milestones under company-wide performance based grants in the second and third quarters of 2014, in
addition to a reduction of other option and award compensation of $1.9 million due to a reduction in force. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">54 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Other Income (Expense) </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Other income for the year ended December&nbsp;31, 2014 was $1.7 million resulting from the sale of intellectual property related to oncology in the third quarter of 2014 in the amount of $7.9 million,
partially offset by a $6.4 million non-cash charge recognized upon the conversion of 2019 notes into equity. For the year ended December&nbsp;31, 2013, other expense was $0.6 million related to the loss on conversion of debt to equity at the end of
2013 upon the conversion of 2019 notes into common stock in accordance with the Facility Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Interest Income and Expense
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest expense decreased $1.1 million from $21.5 million for the year ended December&nbsp;31, 2013 to $20.4 million for
the year ended December&nbsp;31, 2014 due to lower principal balances resulting from the repayment of senior convertible notes and the conversion of 2019 notes into equity in 2014. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Liquidity and Capital Resources </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To date, we have funded our operations
through the sale of equity securities and convertible debt securities, borrowings under The Mann Group Loan Arrangement, borrowings under the Facility Agreement with Deerfield, receipt of upfront, milestone payments under the Sanofi License
Agreement, and borrowings under the Sanofi Loan Facility. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, we had $201.7 million principal amount
of outstanding debt, consisting of: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$27.7 million principal amount of 2018 notes bearing interest at 5.75%&nbsp;per annum and maturing on August&nbsp;15, 2018;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$60.0 million principal amount of 2019 notes bearing interest at 9.75%&nbsp;per annum, $5.0 million of which is due and payable in July 2016, $15.0
million of which is due and payable in July 2017, $15.0 million of which is due and payable in July 2018 and $25.0 million of which is due and payable in July and December 2019; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$20.0 million principal amount of Tranche B notes bearing interest at 8.75%&nbsp;per annum, $5.0 million of which is due and payable in each of May
2017, 2018 and 2019, and $5.0 million of which is due and payable in December 2019; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$49.5 million principal amount of indebtedness under The Mann Group Loan Arrangement bearing interest at 5.84% and maturing and due on January&nbsp;5,
2020; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$44.5 million principal amount borrowed under the Sanofi Loan Facility to fund our share of net losses under the Sanofi License Agreement, bearing
interest at a rate of 8.5% per annum, with accrued interest payable in-kind and compounded quarterly, and maturing and due on September 23, 2024. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, the amount available for future borrowings under The Mann Group Loan Arrangement was $30.1 million. A portion of these available borrowings may be used to capitalize accrued
interest into principal, upon mutual agreement of the parties, as it becomes due and payable under The Mann Group Loan Arrangement. As of December&nbsp;31, 2015 the accrued and unpaid interest under The Mann Group Loan Arrangement was $6.4 million.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All profits and losses from AFREZZA product sales by Sanofi or its affiliates after the Termination Date, if any, will
continue to be shared 65% by Sanofi and 35% by us pursuant to the terms of the Sanofi License Agreement. Our total share of the net losses are $62.4 million, classified as Sanofi loan facility and loss share obligation, of which $44.5 million has
been borrowed under the Sanofi Loan Facility as of December&nbsp;31, 2015. Subsequent to December&nbsp;31, 2015, we borrowed an additional $17.9 million under the Sanofi Loan Facility to finance our share of the net losses for the fourth quarter of
2015, which was reclassified from current deferred payments from collaboration to Sanofi loan facility and loss share obligation, for a total of $62.4 million, which includes $1.7 million in paid-in-kind interest. We will be required to make
mandatory prepayments on any outstanding loans under the Sanofi Loan Facility from our share of any profits under the Sanofi License </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Agreement. Additionally, if we sell our Valencia facility, which we no longer use as our corporate headquarters, we will be required to prepay the loans under the Sanofi Loan Facility from the
net cash proceeds of the sale within five business days of receipt. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">There can be no assurance that we will have sufficient
resources to make any required repayments of principal under the 2018 notes, 2019 notes, Tranche B notes, The Mann Group Loan Arrangement or Sanofi Loan Facility when required. Further, if we undergo a fundamental change, as that term is defined in
the indentures governing the terms of the 2018 notes, or certain Major Transactions as defined in the Facility Agreement in respect of the 2019 notes and the Tranche B notes, the holders of the respective debt securities will have the option to
require us to repurchase all or any portion of such debt securities at a repurchase price of 100% of the principal amount of such debt securities to be repurchased plus accrued and unpaid interest, if any. The 2018 notes bear interest at the rate of
5.75%&nbsp;per year on the outstanding principal amount, payable in cash semiannually in arrears on February&nbsp;15 and August&nbsp;15 of each year. The 2019 notes bear interest at the rate of 9.75%&nbsp;per year on the outstanding principal amount
and the Tranche B notes bear interest at the rate of 8.75% on the outstanding principal amount, with accrued interest on each payable in cash quarterly in arrears on the last business day of March, June, September and December of each year. Loans
under the Sanofi Loan Facility bear interest at a rate of 8.5%&nbsp;per annum, paid-in kind on a quarterly basis (2.06% per quarter compounded). Loans under the Loan Arrangement accrue interest at a rate of 5.84%&nbsp;per annum, due and payable
quarterly in arrears on the first day of each calendar quarter for the preceding quarter, or at such other time as we and The Mann Group LLC mutually agree. While we have been able to timely make our required interest payments to date, we cannot
guarantee that we will be able to do so in the future. If we fail to pay interest on the 2018 notes, 2019 notes, Tranche B notes, or on the loans under the Sanofi Loan Facility, or if we fail to repay or repurchase the 2018 notes, 2019 notes,
Tranche B notes, or borrowings under The Mann Group Loan Arrangement or the Sanofi Loan Facility when required, we will be in default under the applicable instrument for such indebtedness, and may also suffer an event of default under the terms of
other borrowing arrangements that we may enter into from time to time. Any of these events could have a material adverse effect on our business, results of operations and financial condition, up to and including the note holders initiating
bankruptcy proceedings or causing us to cease operations altogether. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with the execution of the Facility
Agreement, on July&nbsp;1, 2013, we issued Milestone Rights to the Milestone Purchasers. The Milestone Rights provide the Milestone Purchasers certain rights to receive payments of up to $90.0 million upon the occurrence of specified strategic and
sales milestones, including the first commercial sale of an AFREZZA product and the achievement of specified net sales figures. In the first quarter of 2015, the second milestone triggering event was achieved following our product launch on
February&nbsp;3, 2015. In connection with the milestone triggering event, we paid a $10.0 million payment to Milestone Purchasers pursuant to the terms of the Milestone Agreement in the first quarter of 2015 and we do not expect to pay any milestone
payments in the next 12 months. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Facility Agreement includes customary representations, warranties and covenants,
including, a restriction on the incurrence of additional indebtedness, and a financial covenant which requires our cash and cash equivalents, which includes available borrowings under The Mann Group Loan Arrangement, on the last day of each fiscal
quarter to not be less than $25.0 million. In the event of default under the Facility Agreement, the holders of the 2019 notes and Tranche B notes may declare all or any portion of the 2019 notes and Tranche B notes to be immediately due and
payable. In addition, our inability to meet or otherwise comply with the covenants under these agreements could have an adverse impact on our financial position and results of operations and could result in an event of default under the terms of our
other indebtedness, including our indebtedness under the 2018 notes. In the event of certain future defaults under the foregoing agreements for which we are not able to obtain waivers, the holders of the 2018 notes, 2019 notes and Tranche B notes
and the lender under the Sanofi Loan Facility may accelerate all of our repayment obligations, and, with respect to the 2019 notes and Tranche B notes and the loans under the Sanofi Loan Facility, take control of our pledged assets, potentially
requiring us to renegotiate the terms of our indebtedness on terms less favorable to us, or to immediately cease operations. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">56 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In August 2015, we issued $27.7 million aggregate principal amount of new 5.75% Convertible
Senior Subordinated Exchange Notes due 2018 (the &#147;2018 notes&#148;). The 2018 notes are general, unsecured, senior obligations, except that the 2018 notes are subordinated in right of payment to the outstanding notes issued pursuant to the
Facility Agreement and our borrowings under the Sanofi Loan Facility. The 2018 notes rank equally in right of payment with our other unsecured senior debt. The 2018 notes bear interest at the rate of 5.75%&nbsp;per year on the principal amount,
payable semiannually in arrears in cash on February&nbsp;15 and August&nbsp;15 of each year, beginning February&nbsp;15, 2016, with interest accruing from August&nbsp;15, 2015. The 2018 notes mature on August&nbsp;15, 2018. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On July&nbsp;31, 2014, we entered into the Insulin Supply Agreement, pursuant to which we agreed to purchase certain annual minimum
quantities of insulin for calendar years 2015 through 2019, for an aggregate total purchase price of approximately &#128;120.1&nbsp;million, of which &#128;98.5&nbsp;million is remaining at December&nbsp;31, 2015. We have contracted for the purchase
of &#128;28.8&nbsp;million in 2016 and the remaining annual minimum quantities will be &#128;23.3&nbsp;million for the years ended December&nbsp;31, 2017 through 2019. Unless earlier terminated, the term of the Insulin Supply Agreement expires on
December&nbsp;31, 2019 and can be renewed for additional, successive two year terms upon 12 months&#146; written notice, given prior to the end of the initial term or any additional two year term. We and Amphastar each have normal and customary
termination rights, including termination for material breach that is not cured within a specific time frame or in the event of liquidation, bankruptcy or insolvency of the other party. In addition, we may terminate the Insulin Supply Agreement upon
two years&#146; prior written notice to Amphastar without cause or upon 30 days&#146; prior written notice to Amphastar if a controlling regulatory authority withdraws approval for AFREZZA, provided, however, in the event of a termination pursuant
to either of the latter two scenarios, the provisions of the Insulin Supply Agreement require us to pay the full amount of all unpaid purchase commitments due over the initial term within 60 calendar days of the effective date of such termination.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the year ended December&nbsp;31, 2015, we raised gross proceeds of $28.4 million from the sale of 8.9&nbsp;million
shares of common stock under our at-the-market issuance sales agreements, resulting in net proceeds of $27.8 million after issuance costs. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the Sanofi License Agreement, we received milestone payments of $50.0 million in the first quarter of 2015 upon satisfaction of certain manufacturing milestones specified in the Sanofi License
Agreement. As a result of the termination of the Sanofi License Agreement, we will not receive any additional milestone payments from Sanofi under the agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During the year ended December&nbsp;31, 2015, we used $57.2 million of cash for operating activities as a result of our net loss of $368.4 million, adjusted by non-cash charges of $231.5&nbsp;million and
a net decrease in assets and liabilities of $41.0&nbsp;million. The non-cash charges included $206.6&nbsp;million of impairment charges, $22.0&nbsp;million of depreciation and accretion and stock-based compensation, $1.7 million interest accrued
through borrowings under Sanofi Loan Facility, $ 1.0&nbsp;million for the loss on extinguishment of debt, with the remainder due to an adjustment for foreign currency transaction losses. The change in net assets and liabilities was predominately due
to the net decreases in receivables from collaboration from the $50.0 million received in milestone payments and $13.5&nbsp;million due to the decrease in prepaids and other current assets at December&nbsp;31, 2015 compared to December&nbsp;31, 2014
primarily due to prepayment on insulin in 2014, which did not occur in 2015. This was offset by net decreases in inventory as we purchased significant inventory in 2014 related to Amphastar, which did not occur in 2015. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the year ended December&nbsp;31, 2014, cash provided by operations was $4.1 million as a result of our net loss of $198.4 million,
adjusted by non-cash charges of $67.2 million and a net increase in assets and liabilities of $133.8 million. The non-cash charges were predominately related to depreciation and accretion and stock-based compensation. The change in net assets and
liabilities was predominately due to the net increases in receivables and deferred payments from collaboration of $150.0 million deferred up-front payment recorded from the up-front fee associated with the Sanofi License Agreement being partially
offset by the $15.0 million deposit to Amphastar as prepayment for 2015 quantities of insulin as part of the Insulin Supply Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We used $10.2 million of cash for investing activities during the year ended December&nbsp;31, 2015, compared to $24.1 million for the year ended December&nbsp;31, 2014. The $13.9 million decrease was due
a decrease in purchases of machinery and equipment. For the year ended December&nbsp;31, 2014, cash used for investing activities increased </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">57 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
by $16.1 million over the amount used during the year ended December&nbsp;31, 2013, due to purchases of machinery and equipment for the preparation for commercialization of AFREZZA in 2014.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our financing activities provided $5.7 million of cash for the year ended December&nbsp;31, 2015, compared to $70.1 million
for the year ended December&nbsp;31, 2014. For the year ended December&nbsp;31, 2015, cash used in financing activities was comprised of a $64.3 million payment on the outstanding 2015 notes obligation and a $4.2 million payment associated with the
achievement of the second milestone to Deerfield for product launched on February&nbsp;3, 2015. These outflows were offset by $34.7 million received in net proceeds from the sale of stock on the Tel Aviv Stock Exchange in November 2015, $27.8
million net of issuance costs in proceeds from at-the-market sales of stock, and $14.3 million received in proceeds from exercise of stock options and warrants. Cash inflows were offset by the payment of employment taxes related to vested restricted
stock units. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our financing activities provided $70.1 million of cash for the year ended December&nbsp;31, 2014, compared to
$145.7 million for the year ended December&nbsp;31, 2013. For the year ended December&nbsp;31, 2014, cash provided by financing activities was comprised of $40.0 million in proceeds received from the issuance of the fourth tranche of 2019 notes to
Deerfield, $20.0 million from the sale of Tranche B notes to Deerfield, $27.8 million from warrant exercises, and $12.3 million from the exercise of stock options, which were partially offset by $26.9 million paid for employment taxes related to
vested restricted stock units and a $3.2 million milestone principal payment. For the year ended December&nbsp;31, 2013 cash provided by financing activities was comprised of $119.5 million in net proceeds received from issuance of the 2019 notes
and the Milestone Rights and $94.2 million in net proceeds from warrant exercises. Additionally, we received $48.9 million in net proceeds from at-the market issuance sales in 2013, and on December&nbsp;15, 2013 we paid $115.0 million in settlement
of our 3.75% Senior Convertible Notes due 2013 upon maturity. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, we had $59.1 million in cash and
cash equivalents. We expect to expend our capital resources for the manufacturing, sales and marketing of AFREZZA subsequent to the termination with Sanofi and to develop our other product candidates. We also intend to use our capital resources for
general corporate purposes. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we enter into strategic business collaborations with respect to our other product candidates,
we would expect, as part of the transaction, to receive additional capital. In addition, we expect to pursue the sale of equity and/or debt securities, or the establishment of other funding facilities. Issuances of debt or additional equity could
impact the rights of our existing stockholders, dilute the ownership percentages of our existing stockholders and may impose restrictions on our operations. These restrictions could include limitations on additional borrowing, specific restrictions
on the use of our assets as well as prohibitions on our ability to create liens, pay dividends, redeem our stock or make investments. We also may seek to raise additional capital by pursuing opportunities for the licensing, sale or divestiture of
certain intellectual property and other assets, including our Technosphere technology platform. There can be no assurance, however, that any strategic collaboration, sale of securities or sale or license of assets will be available to us on a timely
basis or on acceptable terms, if at all. If we are unable to raise additional capital, we may be required to enter into agreements with third parties to develop or commercialize products or technologies that we otherwise would have sought to develop
independently, and any such agreements may not be on terms as commercially favorable to us. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We cannot provide assurances that
our plans will not change or that changed circumstances will not result in the depletion of our capital resources more rapidly than we currently anticipate. If planned operating results are not achieved or we are not successful in raising additional
capital, if needed, through equity or debt financing or entering business collaborations, we may be required to reduce expenses through the delay, reduction or curtailment of our projects, or further reduction of costs for facilities and
administration, and there will continue to be substantial doubt about our ability to continue as a going concern. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Off-Balance Sheet
Arrangements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, we did not have any off-balance sheet arrangements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">58 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Contractual Obligations </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our contractual obligations represent future cash commitments and liabilities under agreements with third parties, and exclude contingent liabilities for which we cannot reasonably predict future
payments. Accordingly, the table below excludes contractual obligations relating to milestone and royalty payments due to third parties, all of which are contingent upon certain future events. The expected timing of payment of the obligations
presented (excluding payments in respect of the Milestone Rights) below are estimated based on current information. Future payments relate to operating lease obligations, the 2018 notes, the facility financing obligation, open purchase order and
supply commitments, contractual minimum purchase commitments under the Insulin Supply Agreement with Amphastar and Sanofi Loan Facility consisted of the following at December&nbsp;31, 2015 (in thousands): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Payments Due in</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:82pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Contractual Obligations</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Less&nbsp;Than<BR>One Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1-3 Years</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>4-5&nbsp;Years</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>More&nbsp;Than<BR>5 Years</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Open purchase order and supply commitments(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,411</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">904</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">360</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">348</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior convertible notes &#151; long term(2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,619</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,064</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Note payable to principal stockholder(3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,523</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,523</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Facility financing obligation(4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,376</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">87,715</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,091</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Insulin supply agreement(5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,358</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76,069</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">107,427</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sanofi Loan Facility(6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,507</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,507</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating lease obligations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">315</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">101</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total contractual obligations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,079</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">195,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,883</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,855</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">367,051</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts included in open purchase order and supply commitments are subject to performance under the purchase order or contract by the supplier of the goods or
services and do not become our obligation until such performance is rendered. The amount shown is principally for the purchase of materials for commercial production. </FONT></TD></TR></TABLE>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts include future interest payments at fixed rates of 5.75% and payment of the 2018 notes in full upon maturity in 2018. </FONT></TD></TR></TABLE>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The obligation for the note payable to the principal stockholder includes future principal and interest payments related to the $49.5 million of borrowings as of
December&nbsp;31, 2015. Interest is accrued based on a fixed rate of 5.84% and the outstanding principal amount and all accrued interest thereon will be due on January&nbsp;5, 2020. </FONT></TD></TR></TABLE>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The facility financing obligation includes future principal and interest payments on $60.0 million aggregate principal amount of 2019 notes issued in the first and
fourth tranches under the Facility Agreement, and on $20.0 million aggregate principal amount of Tranche B notes, payable in accordance with the provisions of the Facility Agreement, as amended. Interest accrues on the 2019 notes at a fixed rate of
9.75%&nbsp;per annum and on the Tranche B notes at a fixed rate of 8.75%&nbsp;per annum. </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">On July&nbsp;31, 2014, we entered into the Insulin Supply Agreement, pursuant to which we agreed to purchase certain annual minimum quantities of insulin for calendar
years 2015 through 2019 for an aggregate total purchase price of approximately &#128;120.1&nbsp;million, of which &#128;98.5&nbsp;million is remaining at December&nbsp;31, 2015. We have contracted for the purchase of &#128;28.8&nbsp;million in 2016
and the remaining annual minimum quantities will be &#128;23.3 million. Future payments due were converted to U.S. dollars using the December&nbsp;31, 2015 euro-to-dollar exchange. </FONT></TD></TR></TABLE>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">On September&nbsp;23, 2014, we entered into the Sanofi Loan Facility, consisting of a senior secured revolving promissory note and a guaranty with an
affiliate of Sanofi which provides us with a secured loan facility of up to $175.0 million to fund our share of net losses under the Sanofi License Agreement. Advances under the Sanofi Loan Facility bear interest at a rate of 8.5%&nbsp;per annum and
are payable in-kind and compounded quarterly and added to the outstanding principal balance under the Sanofi Loan Facility. Subsequent to </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">59 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
December&nbsp;31, 2015, we borrowed $17.9 million under the Sanofi Loan Facility to finance the portion of our loss for the quarter ended December&nbsp;31, 2015. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Related Party Transactions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For a description of our related party transactions see Note 7 &#151; Related-Party Arrangements in the notes to our financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Recent Accounting Pronouncements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In May 2014, the FASB issued ASU 2014-09
related to revenue recognition, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The guidance requires a company to recognize revenue to
depict the transfer of goods or services to customers in an amount that reflects the consideration it expects to be entitled to receive in exchange for those goods or services. In July 2015, the FASB issued ASU 2015-14, which delayed the effective
date of the new revenue standard by one year. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. The standard is effective beginning the first quarter of our 2018 fiscal year and is required to
be adopted using either a full retrospective or a modified retrospective approach. We are assessing the potential impact of the new standard on our consolidated financial statements and have not yet selected a transition method. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In August 2014, the FASB issued ASU 2014-15, which provides guidance on determining when and how reporting entities must disclose
going-concern uncertainties in their financial statements. The new standard requires management to perform interim and annual assessments of an entity&#146;s ability to continue as a going concern within one year of the date of issuance of the
entity&#146;s financial statements (or within one year after the date on which the financial statements are available to be issued, when applicable). Further, an entity must provide certain disclosures if there is &#147;substantial doubt about the
entity&#146;s ability to continue as a going concern&#148;. The ASU is effective for annual periods ending after December&nbsp;15, 2016, and interim periods thereafter; early adoption is permitted. We are evaluating the impact the adoption of ASU
2014-15 will have on our consolidated financial statements. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In April 2015, the FASB issued ASU 2015-03, &#147;Simplifying the
Presentation of Debt Issuance Costs.&#148; The guidance requires debt issuance costs to be presented in the balance sheet as a direct deduction from the carrying value of the associated debt, consistent with the presentation of a debt discount. The
guidance is effective for annual reporting periods beginning after December&nbsp;15, 2015 and interim periods thereafter. As permitted by the standard, we adopted the new presentation and the adoption did not have an impact on our consolidated
financial statements and disclosures. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the
Measurement of Inventory. Topic 330, Inventory, currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or net realizable value less an approximately normal profit
margin. The amendments do not apply to inventory that is measured using last-in, first-out (LIFO) or the retail inventory method. The amendments apply to all other inventory, which includes inventory that is measured using first-in, first-out (FIFO)
or average cost. The amendments are effective for fiscal years beginning after December&nbsp;15, 2016, including interim periods within those fiscal years. The amendments should be applied prospectively with earlier application permitted as of the
beginning of an interim or annual reporting period. We are evaluating the impact the adoption of ASU 2015-11 will have on our consolidated financial statements. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In November 2015, the FASB issued ASU No.&nbsp;2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. The new standard requires that deferred tax assets and liabilities be
classified as noncurrent in a classified statement of financial position. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December&nbsp;15, 2016, and
interim periods within those annual periods. As permitted by the standard, we adopted the new presentation and the adoption did not have an impact on our consolidated financial statements and disclosures. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">60 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2016, the FASB issued ASU 2016-01, Financial Instruments &#151; Overall (Subtopic
825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The update is intended to improve the recognition and measurement of financial instruments. The ASU affects public and private companies, not-for-profit
organizations, and employee benefit plans that hold financial assets or owe financial liabilities. The update is effective for fiscal years beginning after December&nbsp;15, 2017, including interim periods within those fiscal years. We are
evaluating the impact the adoption of ASU 2016-01 will have on our consolidated financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_12">
</A>Item&nbsp;7A. </B><B><I>Quantitative and Qualitative Disclosures About Market Risk </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Interest Rate Risk </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Due to the fixed interest rates of our debt, we currently do not have an exposure to changes in our interest expense as a result of
changes in interest rates. The interest rate on amounts borrowed under The Mann Group Loan Arrangement is fixed at 5.84%. As of December&nbsp;31, 2015, the total principal amount outstanding under The Mann Group Loan Arrangement was $49.5 million.
As of December&nbsp;31, 2015, we also had debt related to the 2018 notes at a fixed interest rate of 5.75%, debt related to the 2019 notes at a fixed interest rate of 9.75%, debt related to the Tranche B notes at a fixed interest rate of 8.75%, and
debt related to the Sanofi Loan Facility at a fixed rate of 8.5%. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our current policy requires us to maintain a highly liquid
short-term investment portfolio consisting mainly of U.S. money market funds and investment-grade corporate, government and municipal debt. None of these investments are entered into for trading purposes. Our cash is deposited in and invested
through highly rated financial institutions in North America. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If a change in interest rates equal to 10% of the interest rates
on December&nbsp;31, 2015 were to have occurred, this change would not have had a material effect on the value of our short-term investment portfolio. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Foreign Currency Exchange Risk </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We incur and will continue to incur
significant expenditures for insulin supply obligations under our supply agreement with Amphastar. Such obligations are denominated in euros. At the end of each reporting period, these liabilities, if any, are converted to U.S. dollars at the
then-applicable foreign exchange rate. As a result, our business is affected by fluctuations in exchange rates between the U.S. dollar and foreign currencies. We have not entered into foreign currency hedging transactions to mitigate our exposure to
foreign currency exchange risks, but may enter into foreign currency hedging transactions in the future. Exchange rate fluctuations may adversely affect our expenses, results of operations, financial position and cash flows. During the year ended
December&nbsp;31, 2015, we were required to purchase the minimum quarterly supply purchases of insulin contemplated under our supply agreement with Amphastar, and if a change in the U.S. dollar to euro exchange rate equal to 10% of the U.S. dollar
to euro exchange rate on December&nbsp;31, 2015 were to have occurred on December&nbsp;31, 2015, this change would not have had a material effect on our results of operations or financial condition. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_13"></A>Item&nbsp;8. </B><B><I>Financial Statements and Supplementary Data </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The information required by this Item is included in Items 15(a)(1) and (2)&nbsp;of Part IV of this Annual Report on Form 10-K.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_21"></A>Item&nbsp;9. </B><B><I>Changes in and Disagreements with Accountants on Accounting and Financial
Disclosure </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">61 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I><A NAME="toc107849_22"></A></I></B><B>Item&nbsp;9A.</B><B><I>&nbsp;Controls And Procedures
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Evaluation of Disclosure Controls and Procedures </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed,
summarized and reported within the time periods specified in the SEC&#146;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us
in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and chief financial officer, or persons performing similar functions, as appropriate to allow timely
decisions regarding required disclosure. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In designing and evaluating the disclosure controls and procedures, management
recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the
cost-benefit relationship of possible controls and procedures. Our system contains control-monitoring mechanisms, and actions are taken to correct deficiencies as they are identified. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of the end of the period covered by this Annual Report on Form&nbsp;10-K, we carried out an evaluation, under the supervision and with
the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)
and 15d-15(e)). Based upon that evaluation, our chief executive officer and our principal accounting officer concluded that our disclosure controls and procedures were not effective as of December&nbsp;31, 2015 because of the material weakness in
our internal control over financial reporting as described below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Management&#146;s Report on Internal Control over Financial Reporting
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f). With the participation of our chief executive officer and chief financial officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting
based on the framework and criteria established in<I> Internal Control-Integrated Framework</I> <I>(2013)</I> issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management identified a
material weakness in our internal control over financial reporting, as described below. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A material weakness is a deficiency,
or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company&#146;s annual or interim financial statements will not be prevented or detected on
a timely basis. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We did not maintain sufficient internal control over financial reporting due to the lack of operating
effectiveness of our controls over the impairment testing that we performed in accordance with ASC 360-10, <I>Impairment and Disposal of Long-Lived Assets</I> and ASC&nbsp;330-10, <I>Inventories</I>, as of December&nbsp;31, 2015. Specifically, our
review controls did not operate at a sufficient level of precision to identify certain errors, which management has determined constituted a material weakness. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Deloitte&nbsp;&amp; Touche&nbsp;LLP, the registered public accounting firm that audited our consolidated financial statements, has issued an attestation report on our internal control over financial
reporting included below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Plan for Remediation of Material Weakness </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has identified remediation measures to address the above-described material weakness and enhance our internal control over
financial reporting. To date, we are in the process of taking the following actions to improve the design and operating effectiveness of our internal control in order to remediate this material weakness: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review the processes and controls related to impairment assessments. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">62 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Design and document review controls with enhanced precision related to the review of
impairment assessments. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Design and document additional training programs for relevant personnel and developing specific review
procedures regarding the review of impairment assessments. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of the date of filing this Annual Report on Form 10-K, we are
starting the remediation measures set forth above. We expect the enhanced review controls to begin operating in connection with our impairment testing performed in accordance with ASC 360-10 and ASC 330-10 during 2016. We believes the remediation
measures will strengthen our internal control over financial reporting and, once completed, will remediate the material weakness identified. We will continue to monitor the effectiveness of these remediation measures and will make any changes and
take such other actions that we deem appropriate given the circumstances. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Changes in Internal Control Over Financial Reporting
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">An evaluation was also performed under the supervision and with the participation of our management, including our Chief
Executive Officer and Chief Financial Officer, of any changes in our internal control over financial reporting that occurred during our last fiscal quarter and that has materially affected, or is reasonably likely to materially affect, our internal
control over financial reporting. That evaluation did not identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter and that has materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting except as follows. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with year-end procedures, we have
designed and implemented new processes and internal controls to address fixed asset impairment valuation procedures to ensure that information required to be disclosed by us is recorded, processed, summarized and reported. The addition of these
processes and internal controls is considered a material change in our internal control over financial reporting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">63 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_14"></A><A NAME="tx107849_100"></A><A NAME="tx107849_200"></A>Report of
Independent Registered Public Accounting Firm </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the Board of Directors and Stockholders of MannKind Corporation </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Valencia, California </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have
audited the internal control over financial reporting of MannKind Corporation and subsidiaries (the &#147;Company&#148;) as of December&nbsp;31, 2015, based on criteria established in <I>Internal Control &#151; Integrated Framework</I>
<I>(2013)&nbsp;</I>issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company&#146;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the
effectiveness of internal control over financial reporting, included in the accompanying Management&#146;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#146;s internal control over
financial reporting based on our audit. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our
audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk,
and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A company&#146;s internal control over financial reporting is a process designed by, or under the supervision of, the company&#146;s principal executive and principal financial officers, or persons
performing similar functions, and effected by the company&#146;s board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles. A company&#146;s internal control over financial reporting includes those policies and procedures that (1)&nbsp;pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2)&nbsp;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with
generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3)&nbsp;provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#146;s assets that could have a material effect on the financial statements. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or
fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A material
weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#146;s annual or interim financial statements will not
be prevented or detected on a timely basis. The following material weakness has been identified and included in management&#146;s assessment: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company did not maintain sufficient internal control over financial reporting due to the lack of operating effectiveness of its controls over its impairment testing that it performed in accordance
with ASC 360-10, Impairment and Disposal of Long-Lived Assets and ASC 330-10, Inventories, as of December 31, 2015. Specifically, the Company&#146;s review controls did not operate at a sufficient level of precision to identify certain errors, which
was determined to constitute a material weakness. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This material weakness was considered in determining the nature, timing, and
extent of audit tests applied in our audit of the consolidated financial statements as of and for the year ended December 31, 2015, of the Company and this report does not affect our report on such financial statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">64 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In our opinion, because of the effect of the material weakness identified above on the
achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December&nbsp;31, 2015, based on the criteria established in <I>Internal Control &#151; Integrated
Framework (2013)</I>&nbsp;issued by the Committee of Sponsoring Organizations of the Treadway Commission. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have also
audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements as of and for the year ended December&nbsp;31, 2015 of the Company and our report dated March&nbsp;15,
2016 expressed an unqualified opinion on those financial statements and includes an explanatory paragraph relating to the Company&#146;s ability to continue as a going concern. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">/s/ DELOITTE&nbsp;&amp; TOUCHE LLP </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Los Angeles, California </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">65 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_23"></A>Item&nbsp;9B. </B><B><I>Other Information. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March 11, 2016, we entered into a separation agreement with Mr. Martens (the &#147;Separation Agreement&#148;) providing for the terms
of Mr. Martens separation from MannKind. Pursuant to the terms of the Separation Agreement, Mr. Martens&#146; last day of employment with us will be no later than March 18, 2016 (the &#147;Separation Date&#148;). The Separation Agreement supersedes
all prior agreements regarding Mr. Martens&#146; entitlement to receive compensation or other benefits from us after the Separation Date. Mr. Martens has agreed to provide us with a general release of claims in exchange for the following severance
compensation and other benefits: (i)&nbsp;continuation of Mr. Martens&#146; annual base salary for a period of 12 months following the Separation Date (the &#147;Severance Period&#148;); (ii) continuation of Mr. Martens&#146; health insurance
coverage until the earliest of (A) the end of the Severance Period, (B) the expiration of Mr. Martens&#146; eligibility for continuation coverage under the Consolidated Omnibus Reconciliation Act of 1985, and (C) the date on which Mr. Martens
becomes eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment; and (iii) acceleration of all time-based restricted stock units and stock options held by Mr. Martens that would otherwise
have vested through the Severance Period. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The foregoing description of the Separation Agreement is not complete and is
qualified in its entirety by reference to the full text of the Separation Agreement, a copy of which is filed herewith as Exhibit 10.8&nbsp;to this Annual Report on Form&nbsp;10-K.</FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March&nbsp;9, 2016, we entered into an offer letter agreement (the &#147;Offer Letter Agreement&#148;) with Michael Castagna, Pharm.D.,
our new Chief Commercial Officer, pursuant to which we agreed to provide Dr. Castagna with the following compensation: (i) annual base salary of $400,000; (ii) a signing bonus of $50,000; (iii)&nbsp;eligibility to receive annual discretionary
bonuses, with a target bonus equal to 50% of annual earnings; (iv)&nbsp;an annual car allowance of $14,400; and (v)&nbsp;subject to the approval by our board of directors, the grant of the following equity awards under our 2013 Equity Incentive Plan
(the &#147;Plan&#148;): (A) a stock option to purchase 329,200 shares of our common stock, (B) a performance-based stock option to purchase 1,000,000 shares of our common stock, and (C) a restricted stock unit for 80,000 shares of our common stock.
Twenty-five percent of the shares subject to the stock option in subsection (A) and the restricted stock unit in subsection (C) will vest one year following Dr. Castagna&#146;s first day of employment with us, and the balance of the shares will vest
in equal monthly installments over the following three years, subject in each case to Dr. Castagna&#146;s continued service with us. In addition, the shares subject to the performance-based stock option in subsection (B) will vest according to terms
to be mutually agreed upon in advance of the grant date. The foregoing options will be evidenced by a Stock Option Grant Notice and Option Agreement and the foregoing restricted stock unit will be evidenced by a Restricted Stock Unit Grant Notice
and Restricted Stock Unit Award Agreement, which, together with the Plan, will set forth the terms and conditions of the foregoing options and restricted stock unit. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr. Castagna will also be entitled to enter into our standard form of indemnity agreement, a copy of which is attached as Exhibit 10.1 to our Registration Statement on Form S-1
(File&nbsp;No.&nbsp;333-115020), filed with the Securities and Exchange Commission on April&nbsp;30, 2004. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The foregoing
description of the Offer Letter Agreement is not complete and is qualified in its entirety by reference to the full text of the Offer Letter Agreement, a copy of which is filed herewith as Exhibit 10.38&nbsp;to this Annual Report on
Form&nbsp;10-K.</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr. Castagna&#146;s biographical information is set forth under the heading &#147;Executive Officers of the
Registrant&#148; under Part I, Item 1 of this Annual Report on Form 10-K. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_24"></A>PART III
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certain information required by Part III is omitted from this Annual Report on Form 10-K, because we will file our Proxy
Statement within 120 days after the end of our fiscal year ended December&nbsp;31, 2015 pursuant to Regulations 14A for our 2016 Annual Meeting of Stockholders, and the information included in the Proxy Statement is incorporated herein by reference.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">66 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_25"></A>Item&nbsp;10. </B><B><I>Directors, Executive Officers and
Corporate Governance. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a) <I>Executive Officers &#151;</I> For information regarding the identification and business
experience of our executive officers, see &#147;Executive Officers of the Registrant&#148; in Part I, Item&nbsp;1 of this Annual Report on Form 10-K. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(b) <I>Directors &#151;</I> The information required by this Item regarding the identification and business experience of our directors and corporate governance matters is contained in the section
entitled &#147;Proposal 1 &#151; Election of Directors&#148; and &#147;Corporate Governance Principles and Board and Committee Matters&#148; in the Proxy Statement, and is incorporated herein by reference. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional information required by this Item is incorporated herein by reference to the section entitled &#147;Section 16(a) Beneficial
Ownership Reporting Compliance&#148; in the Proxy Statement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted a Code of Business Conduct and Ethics Policy that
applies to our directors and employees (including our principal executive officer, principal financial officer, principal accounting officer and controller), and have posted the text of the policy on our website (<I>www.mannkindcorp.com</I>) in
connection with &#147;Investors&#148; materials. In addition, we intend to promptly disclose on our website (i)&nbsp;the nature of any amendment to the policy that applies to our principal executive officer, principal financial officer, principal
accounting officer or controller, or persons performing similar functions and (ii)&nbsp;the nature of any waiver, including an implicit waiver, from a provision of the policy that is granted to one of these specified individuals, the name of such
person who is granted the waiver and the date of the waiver, to the extent any such waiver is required to be disclosed pursuant to the rules and regulations of the SEC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_26"></A>Item&nbsp;11. </B><B><I>Executive Compensation </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The information under the caption &#147;Executive Compensation,&#148; &#147;Compensation of Directors,&#148; &#147;Compensation Committee Interlocks and Insider Participation&#148; and &#147;Compensation
Committee Report&#148; in the Proxy Statement is incorporated herein by reference. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_27"></A>Item&nbsp;12.
</B><B><I>Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
information under the captions &#147;Security Ownership of Certain Beneficial Owners and Management&#148; and &#147;Securities Authorized for Issuance under Equity Compensation Plans&#148; in the Proxy Statement is incorporated herein by reference.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_28"></A>Item&nbsp;13. </B><B><I>Certain Relationships, Related Transactions and Director Independence
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The information under the caption &#147;Certain Transactions&#148; and &#147;Corporate Governance Principles and Board
and Committee Matters&#148; in the Proxy Statement is incorporated herein by reference. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B><A NAME="toc107849_29"></A>Item&nbsp;14. </B><B><I>Principal Accounting Fees and Services </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The information under the caption &#147;Principal Accounting Fees and Services&#148; and &#147;Pre-Approval Policies and Procedures&#148;
in the Proxy Statement is incorporated herein by reference. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With the exception of the information specifically incorporated by
reference from the Proxy Statement in this Annual Report on Form 10-K, the Proxy Statement shall not be deemed to be filed as part of this report. Without limiting the foregoing, the information under the captions &#147;Report of the Audit Committee
of the Board of Directors&#148; in the Proxy Statement is not incorporated by reference. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">67 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_30"></A>PART IV </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_31"></A>Item 15. </B><B><I>Exhibits, Financial Statement Schedules</I></B><B> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a) The following documents are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)(2) Financial Statements and Financial Statement Schedules. The following Financial Statements of MannKind Corporation,
Financial Statement Schedules and Report of Independent Registered Public Accounting Firm are included in a separate section of this report beginning on page 67: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_100">Report of Independent Registered Public Accounting Firm</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_101">Consolidated Balance Sheets</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_102">Consolidated Statements of Operations</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_103">Consolidated Statements of Comprehensive Loss</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_104">Consolidated Statements of Stockholders&#146; Deficit</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_105">Consolidated Statements of Cash Flows</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_106">Notes to Consolidated Financial Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">81</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All financial statement schedules have been omitted because the required information is not applicable or
not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements or the notes thereto. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3) Exhibits. The exhibits listed under Item&nbsp;15(b) hereof are filed or furnished with, or incorporated by reference into, this Annual
Report on Form 10-K. Each management contract or compensatory plan or arrangement is identified separately in Item&nbsp;15(b) hereof. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(b) Exhibits. The following exhibits are filed or furnished as part of, or incorporated by reference into, this Annual Report on Form 10-K: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:28pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:85pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description of Document</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;3.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amended and Restated Certificate of Incorporation (incorporated by reference to MannKind&#146;s Registration Statement on Form S-1 (File
No. 333-115020), originally filed with the SEC on</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">April 30, 2004, as amended).</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;3.2</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certificate of Amendment of Amended and Restated Certificate of Incorporation (incorporated by reference to MannKind&#146;s Quarterly Report on Form 10-Q (File No. 000-50865),
originally filed with the SEC on August 9, 2007).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;3.3</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certificate of Amendment of Amended and Restated Certificate of Incorporation (incorporated by reference to MannKind&#146;s Quarterly report on Form 10-Q (File No. 000-50865),
originally filed with the SEC on August 2, 2010).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;3.4</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certificate of Amendment of Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to MannKind&#146;s Current Report on Form 8-K (File No.
000-50865), filed with the SEC on May 22, 2012).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;3.5</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certificate of Amendment of Amended and Restated Certificate of Incorporation (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865),
originally filed with the SEC on July 1, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;3.6</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amended and Restated Bylaws (incorporated by reference to MannKind&#146;s Current Report on Form&nbsp;8-K (File No. 000-50865), originally filed with the SEC on November 19,
2007).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of common stock certificate (incorporated by reference to MannKind&#146;s Annual Report on Form&nbsp;10-K (File No. 000-50865), originally filed with the SEC on March 18,
2013).</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">68 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:28pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:85pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description of Document</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.2</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of 9.75% Senior Secured Convertible Promissory Note due 2019 (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), originally filed
with the SEC on July 1, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.3</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Amended and Restated 9.75% Senior Secured Convertible Promissory Note due 2019 (incorporated by reference to Exhibit 4.7 to MannKind&#146;s Annual Report on Form 10-K (File
No. 000-50865), filed with the SEC on March 3, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.4</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Milestone Rights Purchase Agreement, dated as of July 1, 2013, by and among MannKind, Deerfield Private Design Fund II, L.P. and Horizon Sant&eacute; FLML S&Aacute;RL (incorporated
by reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), originally filed with the SEC on July 1, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.5</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Guaranty and Security Agreement, dated as of July 1, 2013, by and among MannKind, MannKind LLC, Deerfield Private Design Fund II, L.P., Deerfield Private Design International II,
L.P. and Horizon Sant&eacute; FLML S&Aacute;RL (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), originally filed with the SEC on July 1, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.6</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Registration Rights Agreement, dated as of July 1, 2013, by and among MannKind, Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P.
(incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), originally filed with the SEC on July 1, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Facility Agreement, dated as of July 1, 2013, by and among MannKind, Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P (incorporated by
reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), originally filed with the SEC on July 1, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.8</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">First Amendment to Facility Agreement and Registration Rights Agreement, dated as of February 28, 2014, by and among MannKind, Deerfield Private Design Fund II, L.P. and Deerfield
Private Design International II, L.P. (see Exhibit 10.27).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.9</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Tranche B Senior Secured Note due 2019 (incorporated by reference to Exhibit 4.8 to MannKind&#146;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on
May 12, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.10</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Second Amendment to Facility Agreement and Registration Rights Agreement, dated as of</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">August 11, 2014, by and among MannKind, Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P. (incorporated by
reference to Exhibit 4.14 to MannKind&#146;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on November 10, 2014).</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.11</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Secured Revolving Promissory Note, dated as of September 23, 2014, by and between MannKind and Aventisub LLC (incorporated by reference to Exhibit 99.1 to MannKind&#146;s
Current Report on Form 8-K (File No. 000-50865), filed with the SEC on September 29, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.12</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Guaranty and Security Agreement, dated as of September 23, 2014, by and among MannKind, MannKind LLC and Aventisub LLC (incorporated by reference to Exhibit 99.2 to MannKind&#146;s
Current Report on Form 8-K (File No. 000-50865), filed with the SEC on September 29, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.13</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indenture, by and between MannKind and Wells Fargo Bank, N.A., dated August 10, 2015 (incorporated by reference to Exhibit 4.18 to MannKind&#146;s Quarterly Report on Form 10-Q
(File No. 000-50865), filed with the SEC on August 10, 2015).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.14</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of 5.75% Convertible Senior Subordinated Exchange Note due 2018 (included in Exhibit 4.18 as Exhibit A thereto) (incorporated by reference to Exhibit 4.19 to MannKind&#146;s
Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on August 10, 2015).</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">69 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:28pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:85pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description of Document</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.15</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indenture, by and between MannKind and Wells Fargo Bank, N.A., dated August 14, 2015 (incorporated by reference to Exhibit 4.1 to MannKind&#146;s Current Report on Form 8-K (File
No. 000-50865), filed with the SEC on August 18, 2015).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.16</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of 5.75% Convertible Senior Subordinated Exchange Note due 2015 (incorporated by reference to Exhibit 4.2 to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865),
filed with the SEC on August 18, 2015).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;4.17</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Warrant to Purchase Common Stock issued November 16, 2015.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amended and Restated Promissory Note made by MannKind in favor of The Mann Group LLC, dated October 18, 2012 (incorporated by reference to MannKind&#146;s Current Report on Form 8-K
(File No. 000-50865), filed with the SEC on October 19, 2012).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.2</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Agreement, dated September 13, 2006, between MannKind and Torcon, Inc. (incorporated by reference to MannKind&#146;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with
the SEC on August 9, 2007).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.3</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Securities Purchase Agreement, dated August 2, 2005 by and among MannKind and the purchasers listed on Exhibit A thereto (incorporated by reference to MannKind&#146;s Current Report
on Form 8-K (File No. 000-50865), filed with the SEC on August 5, 2005).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.4**</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Supply Agreement, dated December 31, 2004, between MannKind and Vaupell, Inc. (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), filed
with the SEC on February 23, 2005).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.5*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Indemnity Agreement entered into between MannKind and each of its directors and officers (incorporated by reference to MannKind&#146;s Registration Statement on Form S-1
(File No. 333-115020), filed with the SEC on April 30, 2004, as amended).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.6*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Description of Officers&#146; Incentive Program (incorporated by reference to MannKind&#146;s Annual Report on Form 10-K (File No. 000-50865), originally filed with the SEC on March
16, 2006).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.7*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Severance Agreement, dated October 10, 2007, between MannKind and David Thomson (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No.
000-50865), as amended, filed with the SEC on October 17, 2007).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.8*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Separation Agreement, dated March 11, 2016, by and between MannKind and Juergen Martens.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.9*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Severance Agreement, dated April 21, 2008, between MannKind and Matthew J. Pfeffer (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No.
000-50865), as amended, filed with the SEC on October 17, 2007).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.10*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Change of Control Agreement, dated October 10, 2007, between MannKind and David Thomson (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No.
000-50865), as amended, filed with the SEC on October 17, 2007).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.11*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Change of Control Agreement, dated April 21, 2008, between MannKind and Matthew J. Pfeffer (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No.
000-50865), as amended, filed with the SEC on October 17, 2007).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.12*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">2004 Equity Incentive Plan, as amended (incorporated by reference to MannKind&#146;s proxy statement on Schedule 14A (File No. 000-50865), originally filed with the SEC on April 6,
2012).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.13*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Stock Option Agreement under the 2004 Equity Incentive Plan (incorporated by reference to MannKind&#146;s Registration Statement on Form S-1 (File No. 333-115020),
originally filed with the SEC on April 30, 2004, as amended).</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">70 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:28pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:85pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description of Document</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.14*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Phantom Stock Award Agreement under the 2004 Equity Incentive Plan (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), filed with
the SEC on December 14, 2005).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.15*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">2004 Non-Employee Directors&#146; Stock Option Plan and form of stock option agreement there under (incorporated by reference to MannKind&#146;s Annual Report on Form 10-K (File No.
000-50865), filed with the SEC on March 16, 2006).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.16*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">2004 Employee Stock Purchase Plan and form of offering document there under (incorporated by reference to MannKind&#146;s Registration Statement on Form S-1 (File No. 333-115020),
originally filed with the SEC on April 30, 2004, as amended).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.17**</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Letter Agreement, dated June 4, 2011, between MannKind and N.V. Organon (incorporated by reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), filed with the
SEC on July 1, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.18**</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Insulin Maintenance and Call-Option Agreement, dated June 19, 2009, by and among Pfizer Manufacturing Frankfurt GmbH, Pfizer Inc. and MannKind (incorporated by reference to
MannKind&#146;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on May 4, 2009).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.19</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">At-The-Market Issuance Sales Agreement, dated March 3, 2014, by and between MannKind and MLV &amp; Co. LLC (incorporated by reference to Exhibit 10.31 to MannKind&#146;s Annual
Report on Form 10-K (File No. 000-50865), filed with the SEC on March 3, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.20</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">At-The-Market Issuance Sales Agreement, dated March 3, 2014, by and between MannKind and Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates,
L.P.) (incorporated by reference to Exhibit 10.32 to MannKind&#146;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on March 3, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.21*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acknowledgment and Agreement, dated as of October 31, 2013, by and between MannKind and The Mann Group LLC (incorporated by reference to MannKind&#146;s Current Report on Form 8-K
(File No. 000-50865), filed with the SEC on November 4, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.22*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-Employee Director Compensation Program (incorporated by reference to MannKind&#146;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on August 9,
2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.23*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">MannKind Corporation 2013 Equity Incentive Plan (incorporated by reference to MannKind&#146;s registration statement on Form S-8 (File No. 000-188790), filed with the SEC on May 23,
2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.24*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the MannKind 2013 Equity Incentive Plan (incorporated by reference to MannKind&#146;s
registration statement on Form S-8 (File No. 000-188790), filed with the SEC on May 23, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.25*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the MannKind 2013 Equity Incentive Plan (incorporated by reference to MannKind&#146;s
registration statement on Form S-8 (File No. 000-188790), filed with the SEC on May 23, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.26</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Facility Agreement, dated as of July 1, 2013, by and among MannKind, Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P. (incorporated by
reference to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on July 1, 2013).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.27</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">First Amendment to Facility Agreement and Registration Rights Agreement, dated as of February&nbsp;28, 2014, by and among MannKind, Deerfield Private Design Fund II, L.P., and
Deerfield Private (incorporated by reference to Exhibit 10.39 to MannKind&#146;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on March 3, 2014).</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">71 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:28pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:85pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description of Document</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.28**</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">License and Collaboration Agreement, dated as of August 11, 2014, by and among MannKind, Technosphere International C.V., MannKind Netherlands B.V. and Sanofi-Aventis Deutschland
GmbH (incorporated by reference to Exhibit 10.1 to MannKind&#146;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on November 10, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.29**</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Supply Agreement, dated as of August 11, 2014, by and between MannKind and Sanofi-Aventis Deutschland GmbH (incorporated by reference to Exhibit 10.2 to MannKind&#146;s Quarterly
Report on Form 10-Q (File No. 000-50865), filed with the SEC on November 10, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.30**</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Supply Agreement, dated as of July 31, 2014, by and between MannKind and Amphastar France Pharmaceuticals S.A.S. (incorporated by reference to Exhibit 10.3 to MannKind&#146;s
Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on November 10, 2014).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.31*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Transition and Separation Agreement, dated March 20, 2015, by and between MannKind and Diane Palumbo (incorporated by reference to Exhibit 10.1 to MannKind&#146;s Quarterly Report
on Form 10-Q (File No. 000-50865), filed with the SEC on May 11, 2015).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.32</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amendment No. 1 to At-The-Market Issuance Sales Agreement, by and between MannKind and Meyers Associates, L.P. (doing business as BP Capital, a division of Meyers Associates, L.P.),
dated September 4, 2015 (incorporated by reference to Exhibit 99.1 to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on September 4, 2015).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.33</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amendment No. 1 to At-The-Market Issuance Sales Agreement, by and between MannKind and MLV &amp; Co. LLC, dated September 4, 2015 (incorporated by reference to Exhibit 99.2 to
MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on September 4, 2015).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.34</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Stock Purchase Agreement (incorporated by reference to Exhibit 99.1 to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on November 9,
2015).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.35</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form of Escrow Agreement (incorporated by reference to Exhibit 99.2 to MannKind&#146;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on November 9,
2015).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.36*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Separation Agreement, dated December 1, 2015, by and between MannKind and Hakan S. Edstrom.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.37</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sublease Agreement, dated May 1, 2015, by and between MannKind and the Alfred Mann Foundation for Scientific Research.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;10.38*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Offer Letter, dated March 9, 2016, by and between MannKind and Michael Castagna.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;23.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consent of Independent Registered Public Accounting Firm.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;24.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Power of Attorney (see signature page hereto).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;31</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as
amended.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;32</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to Rules 13a-14(b) and 15d-14(b) of the Securities Exchange Act of 1934, as amended and Section
1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">101</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interactive Data Files pursuant to Rule 405 of Regulation S-T.</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicates management contract or compensatory plan. </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Confidential treatment has been granted with respect to certain portions of this exhibit. Omitted portions have been filed separately with the SEC.
</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">72 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_32"></A>SIGNATURES </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL> C<SMALL>ORPORATION</SMALL></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/&nbsp;&nbsp;&nbsp;&nbsp;Matthew J. Pfeffer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Matthew J. Pfeffer</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer, Chief Financial Officer, and Director</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:10px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dated: March&nbsp;15, 2016 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>POWER OF ATTORNEY </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">KNOW ALL BY THESE PRESENTS, that each person whose
signature appears below constitutes and appoints Matthew J. Pfeffer and David Thomson, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her
name, place, and stead, in any and all capacities, to sign any and all amendments to this Report, and any other documents in connection therewith, and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting
unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or
could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his substitute or substituted, may lawfully do or cause to be done by virtue hereof. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf
of the Registrant and in the capacities and on the dates indicated. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:33pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Signature</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:15pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Title</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:16pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Matthew J. Pfeffer</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Matthew J. Pfeffer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer, Chief Financial</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Officer and Director</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>(Principal Executive Officer and Principal Financial Officer)</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Rosabel R. Alinaya</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Rosabel R. Alinaya</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Finance</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>(Principal Accounting Officer)</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Kent Kresa</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Kent Kresa</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chairman of the Board of Directors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Ronald J. Consiglio</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Ronald J. Consiglio</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Michael Friedman</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Michael Friedman, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ David H. MacCallum</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">David H. MacCallum</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Henry L. Nordhoff</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Henry L. Nordhoff</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ James S. Shannon</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">James S. Shannon</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">73 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="index"></A>INDEX TO FINANCIAL STATEMENTS </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_200">Report of Independent Registered Public Accounting Firm</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_201">Consolidated Balance Sheets</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_202">Consolidated Statements of Operations</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_203">Consolidated Statements of Comprehensive Loss</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_204">Consolidated Statements of Stockholders&#146; Deficit</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_205">Consolidated Statements of Cash Flows</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx107849_206">Notes to Consolidated Financial Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">81</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">74 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_14"></A><A NAME="tx107849_100"></A><A NAME="tx107849_200"></A>Report of
Independent Registered Public Accounting Firm </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the Board of Directors and Stockholders of MannKind Corporation </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Valencia, California </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have
audited the accompanying consolidated balance sheets of MannKind Corporation and subsidiaries (the &#147;Company&#148;) as of December&nbsp;31, 2015 and 2014 and the related consolidated statements of operations, comprehensive loss,
stockholders&#146; deficit, and cash flows for each of the three years in the period ended December&nbsp;31, 2015. These financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the
financial statements based on our audits. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In our opinion, such consolidated
financial statements present fairly, in all material respects, the financial position of MannKind Corporation and subsidiaries as of December&nbsp;31, 2015 and 2014, and the results of their operations and their cash flows for each of the three
years in the period ended December&nbsp;31, 2015, in conformity with accounting principles generally accepted in the United States of America. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the
Company&#146;s existing cash resources and its operating losses since inception raise substantial doubt about its ability to continue as a going concern. Management&#146;s plans concerning these matters are also described in Note 1 to the
consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company&#146;s internal control over financial reporting as of
December&nbsp;31, 2015, based on the criteria established in <I>Internal Control &#151; Integrated Framework (2013)&nbsp;</I>issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated March&nbsp;15, 2016
expressed an adverse opinion on the Company&#146;s internal control over financial reporting because of a material weakness. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/
DELOITTE&nbsp;&amp; TOUCHE LLP </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Los Angeles, California </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">75 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_15"></A><A NAME="tx107849_101"></A><A NAME="tx107849_201"></A>CONSOLIDATED BALANCE SHEETS
</B></FONT></P>
 <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands, except<BR>share data)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ASSETS</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current assets:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,074</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Receivables from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,436</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory-current</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred product costs from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,539</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prepaid expenses and other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,206</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76,654</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">201,153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property and equipment &#151; net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">192,127</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">State research and development credit exchange receivable &#151; net of current portion</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">311</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">848</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">126,412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">394,439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>LIABILITIES AND STOCKHOLDERS&#146; DEFICIT</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,599</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,394</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,929</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,206</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Facility financing obligation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,582</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,995</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior convertible notes &#151; current</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99,355</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred product sales from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,503</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">436</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Purchase commitment liabilities &#151; current</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,475</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred payments from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">196,967</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">268,319</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">403,353</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Note payable to principal stockholder</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,521</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,521</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sanofi loan facility and loss share obligation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62,371</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,034</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior convertible notes &#151; long term</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,613</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Purchase commitments &#151; long term</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,692</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,225</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,301</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">476,741</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">468,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Commitments and contingencies</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders&#146; deficit:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Undesignated preferred stock, $0.01 par value &#151; 10,000,000 shares authorized; no shares issued or outstanding at
December&nbsp;31, 2015 and 2014</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Common stock, $0.01 par value &#151; 550,000,000 shares authorized at December&nbsp;31, 2015 and 2014, respectively; 428,670,943
and 406,059,089 shares issued and outstanding at December&nbsp;31, 2015 and 2014, respectively</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,287</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,061</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,508,633</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,416,967</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated other comprehensive loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,863,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,494,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stockholders&#146; deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(350,329</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(73,770</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">126,412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">394,439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">See notes to consolidated financial statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">76 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_16"></A><A NAME="tx107849_102"></A><A NAME="tx107849_202"></A>CONSOLIDATED STATEMENTS OF OPERATIONS
</B></FONT></P>
 <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands, except per share data)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,674</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,244</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">109,719</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,960</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79,383</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,682</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Product manufacturing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,442</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property and equipment impairment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss on purchase commitments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">344,655</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">179,627</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">169,401</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss from operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(344,655</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(179,627</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(169,401</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other income (expense)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,679</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(635</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss on extinguishment of debt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,049</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest expense on note payable to principal stockholder</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,894</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,894</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6,309</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest expense on notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(21,231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17,549</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15,153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest income</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss before benefit for income taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(368,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(198,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(191,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Income tax benefit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(368,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(198,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(191,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss per share &#151; basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares used to compute basic and diluted net loss per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">406,165</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">385,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">299,591</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:300px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">See notes to consolidated financial statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">77 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_17"></A><A NAME="tx107849_103"></A><A NAME="tx107849_203"></A>CONSOLIDATED STATEMENTS OF
COMPREHENSIVE LOSS </B></FONT></P>
 <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net Loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(368,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(198,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(191,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other comprehensive loss:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cumulative translation (loss) gain</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other comprehensive (loss) gain</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Comprehensive loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(368,451</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(198,392</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(191,488</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:205px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:205px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">See notes to consolidated
financial statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">78 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_18"></A><A NAME="tx107849_104"></A><A NAME="tx107849_204"></A>CONSOLIDATED STATEMENTS OF
STOCKHOLDERS&#146; DEFICIT </B></FONT></P>
 <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Common Stock</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Additional<BR>Paid-In<BR>Capital</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accumulated<BR>other<BR>comprehensive<BR>income (loss)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accumulated<BR>deficit</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">BALANCE, JANUARY 1, 2013</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">286,035</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,860</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,991,379</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2,104,912</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(110,679</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exercise of stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">880</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,261</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,270</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares from the release of restricted stock units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,870</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4,821</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares pursuant to warrant exercises</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">66,353</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">664</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">171,485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">172,149</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares pursuant to debt conversions by Deerfield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,095</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,489</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,501</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common stock pursuant to at-the-market issuances</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,824</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">99</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">48,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">48,888</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares pursuant to litigation settlement</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,778</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares under Employee Stock Purchase Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">557</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,258</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,263</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock-based compensation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">45,186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">45,186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cumulative translation (loss) gain</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Commitment to deliver common shares pursuant to Deerfield conversion to additional paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">998</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">998</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(191,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(191,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">BALANCE, DECEMBER 31, 2013</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">369,392</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,697</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,261,996</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2,296,402</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(30,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exercise of stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,251</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,943</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,978</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares from the release of restricted stock units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,996</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(26,946</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(26,908</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares pursuant to warrant exercises</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">115</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,664</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,779</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares pursuant to debt conversions by Deerfield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,521</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">174</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">93,327</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">93,501</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares under Employee Stock Purchase Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,361</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Remeasurement of performance based grants pursuant to the modification of terms</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,962</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,962</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock-based compensation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cumulative translation (loss) gain</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(198,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(198,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">BALANCE, DECEMBER 31, 2014</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">406,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,061</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,416,967</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2,494,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(73,770</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exercise of stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,701</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,241</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,258</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares from the release of restricted stock units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">720</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock units taxes paid in cash</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1,856</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1,856</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares pursuant to warrant exercises</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,216</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,081</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,123</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Capital contribution</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares pursuant to conversions of certain 2015 notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,874</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,907</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,926</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common stock for lender financing fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">160</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">160</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Discount on notes-for-stock exchange</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">169</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">169</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common stock pursuant to TASE stock sale</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,853</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">139</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,571</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,710</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Return of loaned common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(9,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common stock pursuant to at-the-market issuances</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,940</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">89</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,754</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,844</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common shares under Employee Stock Purchase Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">269</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">884</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">887</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(202</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(202</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reclassification of warrant liability to equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">108</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">108</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock-based compensation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cumulative translation (loss) gain</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(368,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(368,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">BALANCE, DECEMBER 31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">428,671</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,287</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,508,633</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2,863,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(350,329</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">See notes to consolidated financial statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">79 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_19"></A><A NAME="tx107849_105"></A><A NAME="tx107849_205"></A>CONSOLIDATED STATEMENTS OF CASH FLOWS
</B></FONT></P>
 <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">CASH FLOWS FROM OPERATING ACTIVITIES:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(368,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(198,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(191,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Depreciation and accretion</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,276</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,057</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock-based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">48,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">45,186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Loss on extinguishment of debt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,049</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Loss on purchase commitments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">66,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Write-off of Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36,104</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Loss on sale, abandonment/disposal or impairment of property and equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">140,582</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">817</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Interest incurred through borrowings under Sanofi Loan Facility</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Write-off of derivative liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Write-off Tranche B Commitment Asset</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,753</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Foreign exchange loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,697</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Changes in assets and liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(26,434</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(9,670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Receivables from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,413</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(50,436</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Prepaid expenses and other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(14,734</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(499</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Deferred product costs from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(13,539</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Other assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(615</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,413</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1,071</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Accrued expenses and other current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(12,467</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,276</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,675</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Deferred product sales from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,067</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Deferred payments from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,436</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Other liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,927</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,915</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">591</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Net cash (used in) provided by operating activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(57,232</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,086</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(128,732</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">CASH FLOWS FROM INVESTING ACTIVITIES:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Purchase of property and equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(10,285</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(24,097</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7,987</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Proceeds from sale of property and equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Net cash used in investing activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(10,203</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(24,097</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7,987</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">CASH FLOWS FROM FINANCING ACTIVITIES:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Proceeds from issuance of common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,146</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,341</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,534</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Proceeds from issuance of common stock under Tel Aviv Stock Exchange</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36,142</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance costs associated with the Tel Aviv Stock Exchange</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1,432</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exercise of warrants for common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,123</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,779</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">94,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Payment of 2015 notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(64,287</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Payment of debt issuance costs on 2018 notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(831</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Payment of 3.75% Senior Convertible Notes due 2013</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(115,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Proceeds from issuance of facility financing obligation&nbsp;&amp; milestone rights</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">119,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Proceeds from issuance of Tranche B of the facility financing obligation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Facility financing obligation&nbsp;&amp; milestone rights issuance costs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(598</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Milestone payment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4,219</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Proceeds from issuance of common stock pursuant to at-the-market issuance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">28,392</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">49,990</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance costs of at-the-market transactions</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(548</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1,103</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Other</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Payment of employment taxes related to vested restricted stock units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1,858</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(26,908</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Net cash provided by financing activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,668</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,062</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">145,669</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">(61,767</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,051</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">61,840</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">CASH AND CASH EQUIVALENTS, END OF PERIOD</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">59,074</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">SUPPLEMENTAL CASH FLOWS DISCLOSURES:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="9" VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Interest paid in cash, net of amounts capitalized to Construction in progress</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,355</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,218</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,452</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Payment of 2015 notes and interest through issuance of common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Issuance of common stock pursuant to debt conversion by Deerfield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">93,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Non-cash construction in progress and property and equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,768</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">856</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Capitalization of interest on note payable to principal stockholder</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,886</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reduction of principal on note payable to principal stockholder upon issuance of common stock and exercise of
warrants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">78,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Reclassification of deferred payments from collaboration to Sanofi loan facility and loss share obligation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">59,337</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,034</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">See notes to consolidated financial statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">80 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc107849_20"></A><A NAME="tx107849_106"></A><A NAME="tx107849_206"></A>NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS </B></FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1. Description of business and basis of presentation </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Business </I>&#151;&nbsp;MannKind Corporation and subsidiaries (the &#147;Company&#148;) is a biopharmaceutical
company focused on the discovery and development of therapeutic products for diseases such as diabetes. The Company&#146;s only approved product, AFREZZA, (insulin human [rDNA origin]) inhalation powder, is a rapid-acting inhaled insulin that was
approved by the U.S. Food and Drug Administration (the &#147;FDA&#148;) on June&nbsp;27, 2014 to improve glycemic control in adult patients with diabetes. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Basis of Presentation </I>&#151;&nbsp;The Company&#146;s primary activities since incorporation have been establishing its facilities, recruiting personnel, conducting research and development,
business development, business and financial planning, raising capital, and commercial manufacturing. It is costly to develop therapeutic products and conduct clinical studies for these products. As of and for the year ended December&nbsp;31, 2015,
the Company has reported an accumulated deficit of $2.9&nbsp;billion and has reported negative cash flow from operations for each year since inception, except for 2014, when the Company received the $150.0 million upfront payment from Sanofi.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31, 2015, the Company&#146;s capital resources consisted of cash and cash equivalents of $59.1 million. The
Company expects to continue to incur significant expenditures to support commercial manufacturing and sales and marketing of AFREZZA and the development of other product candidates. The facility agreement (the &#147;Facility Agreement&#148;) with
Deerfield Private Design Fund II, L.P. (&#147;Deerfield Private Design Fund&#148;) and Deerfield Private Design International II, L.P. (collectively, &#147;Deerfield&#148;) and the First Amendment to Facility Agreement and Registration Rights
Agreement (the &#147;First Amendment&#148;) that resulted in additional sales of an additional tranche of notes (the &#147;Tranche B notes&#148;) (see Note 17&nbsp;&#151;&nbsp;Facility Agreement) requires the Company to maintain at least $25.0
million in cash and cash equivalents or available borrowings under the loan arrangement, dated as of October&nbsp;2, 2007, between The Company and The Mann Group LLC (as amended, restated, or otherwise modified as of the date hereof, &#147;the Mann
Group Loan Arrangement&#148;), as of the last day of each fiscal quarter. The Company will need to continue to incur expenses for the commercialization of AFREZZA and will need to raise additional capital to finance such activities. The Company
cannot be certain that it will be able to raise additional capital on favorable terms, or at all, which raises substantial doubt about the Company&#146;s ability to continue as a going concern. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;11, 2014, we executed a license and collaboration
agreement (the &#147;Sanofi License Agreement&#148;) with Sanofi-Aventis Deutschland GmbH (which subsequently assigned its rights and obligations under the agreement to Sanofi-Aventis U.S. LLC (&#147;Sanofi&#148;)), pursuant to which Sanofi is
responsible for global commercial, regulatory and development activities for AFREZZA. The Sanofi License Agreement became effective on September&nbsp;23, 2014. The Company manufactured AFREZZA at its manufacturing facility in Danbury, Connecticut to
supply Sanofi&#146;s demand for the product pursuant to a supply agreement dated August&nbsp;11, 2014 (the &#147;Sanofi Supply Agreement&#148;). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;4, 2016 the Company received notification from Sanofi of its election to terminate in its entirety the Sanofi License Agreement. Sanofi&#146;s notice indicated that the termination was
pursuant to Sanofi&#146;s right to terminate the Sanofi License Agreement upon Sanofi&#146;s good faith determination that the commercialization of AFREZZA is no longer economically viable in the United States, in which case the effective date of
termination (the &#147;Termination Date&#148;) will be April&nbsp;4, 2016. In the alternative, Sanofi indicated that the termination was also pursuant to its right to terminate the Sanofi License Agreement for any reason, in which case the
Termination Date will be July&nbsp;4, 2016. In the interest of an expedient transition, the Company is working with Sanofi to transfer and wind down the agreement activities by April&nbsp;4, 2016, or as soon as practicable thereafter. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Sanofi License Agreement, worldwide profits and losses, which are determined based on the difference between the net sales of
AFREZZA and the costs and expenses incurred by the Company and Sanofi that are specifically attributable or related to the development, regulatory filings, manufacturing, or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">81 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
commercialization of AFREZZA, are shared 65% by Sanofi and 35% by the us. As a result of the loss share provision, and because the Company does not have the ability to estimate the amount of
costs that would potentially be incurred related to the Sanofi License Agreement, the amount of up-front cash payment or milestone payments that could be recognized as revenue is not fixed or determinable. In connection with the Sanofi License
Agreement, an affiliate of Sanofi provided the Company with a secured loan facility (the &#147;Sanofi Loan Facility&#148;) of up to $175.0 million to fund the Company&#146;s share of net losses under the Sanofi License Agreement. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional funding sources that are, or in certain circumstances may be available to the Company, include approximately $30.1 million
principal amount of available borrowings under The Mann Group Loan Arrangement. A portion of these available borrowings may be used to capitalize accrued interest into principal, upon mutual agreement of the parties, as it becomes due and payable
under The Mann Group Loan Arrangement. (see note 7&nbsp;&#151;&nbsp;Related-party arrangements). The Company cannot provide assurances that its plans will not change or that changed circumstances will not result in the depletion of its capital
resources more rapidly than it currently anticipates. The Company will need to raise additional capital, whether through a sale of equity or debt securities, a strategic business collaboration with a pharmaceutical company, the establishment of
other funding facilities, licensing arrangements, asset sales or other means, in order to continue the development and commercialization of AFREZZA and other product candidates and to support its other ongoing activities. However, the Company cannot
provide assurances that such additional capital will be available on acceptable terms or at all. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Principles of
Consolidation </I>&#151;&nbsp;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Segment Information </I>&#151;&nbsp;In accordance with Accounting Standards Codification (&#147;ASC&#148;) 280-10-50 <I>Segment
Reporting</I>, operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker in making decisions regarding resource allocation
and assessing performance. To date, the Company has viewed its operations and manages its business as one segment operating in the United States of America. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2. Summary of significant accounting policies </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Financial Statement Estimates </I>&#151;&nbsp;The preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America (&#147;GAAP&#148;) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ
from those estimates. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply
significant judgment in this process. The more significant estimates reflected in these accompanying financial statements involve assessing long-lived assets for impairment, accrued expenses, including clinical study expenses, inventory
recoverability, valuation of the facility financing obligation, commitment asset, milestone rights, valuation of stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities
and any valuation allowance recorded against net deferred tax assets. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>License and Collaboration and Supply Agreements</I>
&#151;&nbsp;Pursuant to the Sanofi License Agreement and the Sanofi Supply Agreement, the Company granted to Sanofi exclusive, worldwide licenses to certain of the Company&#146;s patents, trademarks and know-how for the development and
commercialization of AFREZZA and retained the right to be the exclusive manufacturer and supplier of AFREZZA until specified conditions are met upon which a portion of the manufacturing activities may be assumed by Sanofi. The terms of the Sanofi
License Agreement provide for consideration to the Company in the form of a non-refundable up-front payment, product sales, manufacturing, regulatory and sales milestone payments and profit and loss sharing. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">82 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company analyzes consideration received under the provisions of ASC 605, Revenue
Recognition, to determine whether the consideration, or a portion thereof, could be recognized as revenue. ASC 605 provides that revenue is recognized when there is persuasive evidence that an arrangement exists, delivery has occurred or services
have been rendered, the price is fixed or determinable and collection is reasonably assured. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In arrangements involving the
delivery of more than one element, each required deliverable is evaluated to determine whether it qualifies as a separate unit of accounting. This determination is generally based on whether the deliverable has &#147;stand-alone value&#148; to the
customer. The arrangement&#146;s consideration that is fixed and determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. The estimated selling price of each deliverable is
determined using the following hierarchy of values: (i)&nbsp;vendor-specific objective evidence of fair value, (ii)&nbsp;third-party evidence of selling price and (iii)&nbsp;best estimate of selling price (BESP). The BESP reflects the Company&#146;s
best estimate of what the selling price would be if the deliverable was regularly sold by the Company on a stand-alone basis. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are
delivered, limited to the consideration that is not contingent upon future deliverables. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The assessment of multiple element
arrangements requires judgment in order to determine the appropriate units of accounting and the points in time that, or periods over which, revenue should be recognized. Given that, as of December&nbsp;31, 2015, the Company did not have the ability
to estimate the amount of costs that would potentially be incurred under the loss share provision related to the Sanofi License Agreement and the Sanofi Supply Agreement, the Company believe the fixed and determinable fee requirement for revenue
recognition was not met. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cash and Cash Equivalents </I>&#151;&nbsp;The Company considers all highly liquid investments with
original or remaining maturities of 90 days or less at the time of purchase, that are readily convertible into cash to be cash equivalents. As of December&nbsp;31, 2015 and 2014, cash equivalents were comprised of cash and money market accounts with
maturities less than 90 days from the date of purchase. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Concentration of Credit Risk </I>&#151;&nbsp;Financial instruments
which potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents consist of interest-bearing accounts, which are regularly monitored by management and held in high credit quality
institutions. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>State Research and Development Credit Exchange Receivable </I>&#151;&nbsp;The State of Connecticut provides
certain companies with the opportunity to exchange certain research and development income tax credit carryforwards for cash in exchange for foregoing the carryforward of the research and development credits. The program provides for an exchange of
research and development income tax credits for cash equal to 65% of the value of corporation tax credit available for exchange. Estimated amounts receivable under the program are recorded as a reduction of research and development expenses.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Prepaid expenses and other current assets &#151;</I> Prepaid expenses and other current assets primarily consist of prepaid
expenses for goods and services to be received. As of December&nbsp;31, 2015, prepaid and other current assets had a balance of $4.0 million, mainly comprised of prepaid insurance. As of December&nbsp;31, 2014 prepaid and other current assets had a
balance of $20.2 million, mainly comprised of a $15.0 million prepayment for 2015 quantities of insulin, and prepaid insurance. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Sale of intellectual property</I> &#151;&nbsp;On July&nbsp;18, 2014, the Company entered into an assignment agreement with a third
party whereby the third party acquired all proprietary rights, technology and know-how that related to a small molecule inhibitor compound and all pre-clinical data and results related thereto. Under the terms of the assignment agreement, the
Company received total consideration of $9.3 million and accrued $1.4 million in expense for a net amount of $7.9 million recorded as other income. In 2015, the Company recorded other income of $1.4 million related to the relief of the $1.4 million
accrual for expenses associated with the sale of intellectual property related to oncology in 2014, which was subsequently resolved without payment. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">83 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Milestone Rights</I> &#151;&nbsp;On July&nbsp;1, 2013, in conjunction with the
execution of the Facility Agreement, the Company issued Milestone Rights to Deerfield whereby the Company agreed to provide Deerfield with pre-specified Milestone Payments upon the achievement of 13 specific Milestone Events related to the
commercial release and future cumulative net sales of AFREZZA. The Company analyzed the Milestone Rights under the provisions of ASC 815 and determined that the agreement does not meet the definition of a freestanding derivative. Since the Company
has not elected to apply the fair value option to the Milestone Rights Purchase Agreement, the Company recorded the Milestone Rights at their estimated fair value and accounted for the Milestone Rights as a liability by applying the indexed debt
guidance contained in paragraphs ASC 470-10-25-3 and 35-4. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The initial fair value estimate of the Milestone Rights was
calculated using the income approach in which the cash flows associated with the specified contractual payments were adjusted for both the expected timing and the probability of achieving the milestones and discounted to present value using a
selected market discount rate. The expected timing and probability of achieving the milestones was developed with consideration given to both internal data, such as progress made to date and assessment of criteria required for achievement, and
external data, such as market research studies. The discount rate was selected based on an estimation of required rate of returns for similar investment opportunities using available market data. The Milestone Rights liability will be remeasured as
the specified milestone events are achieved. Specifically, as each milestone event is achieved, the portion of the initially recorded Milestone Rights liability that pertains to the milestone event being achieved, will be remeasured to the amount of
the specified related milestone payment. The resulting change in the balance of the Milestone Rights liability due to remeasurement will be recorded in the Company&#146;s Statement of Operations as interest expense. Furthermore, the Milestone Rights
liability will be reduced upon the settlement of each milestone payment. As a result, each milestone payment would be effectively allocated between a reduction of the recorded Milestone Rights liability and an expense representing a return on a
portion of the Milestone Rights liability paid to the investor for the achievement of the related milestone event (see Note 17&nbsp;&#151;&nbsp;Facility Agreement). As of December&nbsp;31, 2015, the remaining liability balance of $8.9 million was
classified as long-term liability in other liabilities. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Deferred product costs from collaboration</I> &#151; Deferred
product costs represent the costs of product manufactured and sold to Sanofi, as long as they are not greater than the amount of deferred product sales related to the collaboration, for which recognition of revenue has been deferred. Given that the
costs of inventory delivered to a customer, but for which revenue may not yet be recognized, meet both the definition and characteristics of an &#147;asset&#148; and the Company believes that it is probable that the amount of future revenue will
exceed the amount of deferred costs (i.e., the asset would be realizable through the recognition of probable future income), the Company has elected to account for the deferred costs related to the product sold to Sanofi as an asset and carry
forward to future periods until the related revenue is recognized. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Fair Value of Financial Instruments </I>&#151;&nbsp;The
Company utilizes fair value measurement guidance prescribed by GAAP to value its financial instruments. The guidance includes a definition of fair value, prescribes methods for measuring fair value, establishes a fair value hierarchy based on the
inputs used to measure fair value and expands disclosures about the use of fair value measurements. The valuation techniques utilized are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent
sources, while unobservable inputs reflect internal market assumptions. These two types of inputs create the following fair value hierarchy: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Level 1&nbsp;&#151;&nbsp;Quoted prices for identical instruments in active markets. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Level 2&nbsp;&#151;&nbsp;Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in
markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Level 3&nbsp;&#151;&nbsp;Significant inputs to the valuation model are unobservable. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">84 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The carrying amounts reflected in the consolidated balance sheets for cash equivalents,
other current assets, accounts payable, and accrued expenses and other current liabilities, approximate fair value due to their relatively short maturities. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Inventories</I> &#151;&nbsp;Inventories are stated at the lower of cost or market. The Company determines the cost of inventory using the first-in, first-out, or FIFO, method. The Company capitalizes
inventory costs associated with the Company&#146;s products based on management&#146;s judgment that future economic benefit is expected to be realized; otherwise, such costs are expensed as product manufacturing. The Company periodically analyzes
its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value, and writes-down such inventories as appropriate. In addition, the Company&#146;s products are subject to strict quality
control and monitoring which the Company performs throughout the manufacturing process. If certain batches or units of product no longer meet quality specifications or become obsolete due to expiration, the Company will record a charge to write down
such unmarketable inventory to its estimated realizable value. Inventory that is not expected to be used within one year is classified as a long term asset on the accompanying condensed consolidated balance sheet. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We analyzed our inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. We
performed an assessment of projected sales and to evaluate the lower of cost or market and the potential excess inventory on hand at December 31, 2015. As a result of this assessment, we recorded a charge of $39.3 million to record the inventory raw
materials on hand at the lower of cost or market, inventory expiry, and write-off other inventory related assets. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
connection with the projected sales assessment, we also evaluated our inventory purchase commitments totalling $116.2 million for potential impairment. As a result of this assessment, we recorded a $66.2 million charge related to a loss on future
purchase commitments both from a lower of cost or market excess inventory perspective. The purchase commitment obligation has been reduced to reflect our expectation that a portion will be recoverable from a third party. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Property and Equipment </I>&#151;&nbsp;Property and equipment are recorded at cost and depreciated using the straight-line method over
the estimated useful lives of the related assets. Leasehold improvements are amortized over the term of the lease or the service lives of the improvements, whichever is shorter. Maintenance and repairs are expensed as incurred. Assets under
construction are not depreciated until placed into service. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Impairment of Long-Lived Assets </I>&#151;&nbsp;The Company
evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable in accordance with ASC 360-10-35 <I>Property Plant and Equipment. </I>Assets are considered to
be impaired if the carrying value may not be recoverable based upon management&#146;s assessment of the following events or changes in circumstances: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">significant changes in the Company&#146;s strategic business objectives and utilization of the assets; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a determination that the carrying value of such assets cannot be recovered through undiscounted cash flows; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">loss of legal ownership or title to the assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset group), including an
adverse action or assessment by a regulator; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the impact of significant negative industry or economic trends. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the Company believes an asset to be impaired, the impairment recognized is the amount by which the carrying value of the assets exceeds
the fair value of the assets. Any write-downs would be treated as permanent reductions in the carrying amount of the asset and an operating loss would be recognized. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company recorded an asset impairment of $140.4 million for the year ended December&nbsp;31, 2015 (see Note 5&nbsp;&#151;&nbsp;Property and Equipment). No asset impairment was recognized during the
years ended December&nbsp;31, 2014, and 2013, respectively. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">85 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Income Taxes </I>&#151;&nbsp;The provisions for federal, foreign, state, and local
income taxes are calculated on pre-tax income based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Deferred income tax assets and
liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which the temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce net deferred income tax assets
to amounts that are more likely than not to be realized. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Income tax positions are considered for uncertainty in accordance
with ASC 740-10-25 <I>Income Taxes,</I> The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material change to its financial position.
Therefore, no liabilities for uncertain income tax positions have been recorded. If a tax position does not meet the minimum statutory threshold to avoid payment of penalties, the Company recognizes an expense for the amount of the penalty in the
period the tax position is claimed in the tax return of the Company. The Company recognizes interest accrued related to unrecognized tax benefits in income tax expense, if any. Penalties, if probable and reasonably estimable, are recognized as a
component of income tax expense. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Significant management judgment is involved in determining the provision for income taxes,
deferred tax assets, deferred tax liabilities, and any valuation allowance recorded against deferred tax assets. Due to uncertainties related to the realization of the Company&#146;s deferred tax assets as a result of its history of operating
losses, a valuation allowance has been established against the total deferred tax asset balance. The valuation allowance is based on management&#146;s estimates of taxable income by jurisdiction in which the Company operates and the period over
which deferred tax assets will be recoverable. In the event that actual results differ from these estimates or the Company adjusts these estimates in future periods, a change in the valuation allowance may be needed, which could materially impact
the Company&#146;s financial position and results of operations. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Contingencies </I>&#151;&nbsp;Contingencies are recorded
in accordance with ASC 450 <I>Contingencies.</I> Accordingly, the Company records a loss contingency for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These accruals
represent management&#146;s best estimate of probable loss. Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. On a
quarterly basis, the Company reviews the status of each significant matter and assesses its potential financial exposure. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is
reasonably estimable. Because of uncertainties related to these matters, accruals are based only on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability related to
pending claims and litigation and may revise its estimates. These revisions in the estimates of the potential liabilities could have a material impact on the Company&#146;s consolidated results of operations and financial position. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock-Based Compensation </I>&#151;&nbsp;As of December&nbsp;31, 2015, the Company had three active stock-based compensation plans,
which are described more fully in Note 13. The Company accounts for all share-based payments to employees, including grants of stock awards and the compensatory elements of the employee stock purchase plan in accordance with ASC 718<I>. </I>ASC 718
<I>Compensation &#151; Stock Compensation</I> (&#147;ASC 718&#148;) requires all share-based payments to employees, including grants of stock options, restricted stock units, performance-based awards and the compensatory elements of employee stock
purchase plans, to be recognized in the statement of operations based upon the fair value of the awards at the grant date. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee stock options and
the compensatory elements of employee stock purchase plans. Option valuation models require the input of assumptions, including the expected life of the stock-based awards, the estimated stock price volatility, the risk-free interest rate, and the
expected dividend yield. Beginning in the third quarter of 2014, the Company began to assess both historical and implied volatility in order to determine its estimated volatility rate. Implied volatility
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">86 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
was considered due to the change in the Company&#146;s business, which occurred with the approval for the sale of AFREZZA. The expected volatility assumption is based on an assessment of the
historical volatility and the implied volatility of the Company&#146;s common stock, derived from an analysis of historical traded and quoted options on the Company&#146;s common stock. Restricted stock units are valued based on the market price on
the grant date. The Company evaluates stock awards with performance conditions as to the probability that the performance conditions will be met and estimates the date at which the performance conditions will be met in order to properly recognize
stock-based compensation expense over the requisite service period. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Warrants</I> &#151;&nbsp;The Company has issued
warrants to purchase shares of its common stock. Warrants have been accounted for within equity in accordance with the provisions of ASC 815-40, Contracts in an Entity&#146;s Own Stock, previously EITF Issue No. 00-19: <I>Accounting for Derivative
Financial Instruments Indexed to, and Potentially Settled in, a Company&#146;s Own Stock</I>. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Comprehensive Loss
</I>&#151;&nbsp;Other comprehensive loss is recorded in accordance with ASC 220-10-45 <I>Comprehensive Income, </I>which requires that all components of comprehensive loss be reported in the financial statements in the period in which they are
recognized. Other comprehensive loss includes certain changes in stockholders&#146; equity that are excluded from net income. Specifically, the Company includes unrealized gains and foreign exchange translation losses, if any, and cumulative
translation gains and losses in other comprehensive loss. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Research and Development Expenses </I>&#151;&nbsp;Research and
development expenses consist of costs associated with the clinical trials of the Company&#146;s product candidates, manufacturing supplies and other development materials, compensation and other expenses for research and development personnel, costs
for consultants and related contract research, facility costs, and depreciation. Research and development costs, which are net of any tax credit exchange recognized for the Connecticut state research and development credit exchange program, are
expensed as incurred consistent with ASC 730-10 <I>Research and Development. </I>The Company began commercial manufacturing in the latter part of the fourth quarter of 2014. As such, commercial manufacturing costs incurred in the fourth quarter of
2014 and included in research and development as expenses were immaterial for the year ended December&nbsp;31, 2014. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Clinical Trial Expenses </I>&#151;&nbsp;Clinical trial expenses, which are reflected in research and development expenses in the
accompanying statements of operations, result from obligations under contracts with vendors, consultants, and clinical site agreements in connection with conducting clinical trials. The financial terms of these contracts are subject to negotiations
which vary from contract to contract and may result in payment flows that do not match the periods over which materials or services are provided to the Company under such contracts. The appropriate level of trial expenses are reflected in the
Company&#146;s financial statements by matching period expenses with period services and efforts expended. These expenses are recorded according to the progress of the trial as measured by patient progression and the timing of various aspects of the
trial. Clinical trial accrual estimates are determined through discussions with internal clinical personnel and outside service providers as to the progress or state of completion of trials, or the services completed. Service provider status is then
compared to the contractually obligated fee to be paid for such services. During the course of a clinical trial, the Company may adjust the rate of clinical expense recognized if actual results differ from management&#146;s estimates. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Interest Expense </I>&#151;&nbsp;Interest costs are expensed as incurred, except to the extent such interest is related to construction
in progress, in which case interest is capitalized. Interest expense, net of interest capitalized, for the years ended December&nbsp;31, 2015, 2014 and 2013 was $24.1 million, $20.4 million, and $21.5 million, respectively. Interest costs
capitalized for the years ended December&nbsp;31, 2015, 2014, and 2013 were $0.1 million, $0.8 million, and $0.4 million, respectively. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Net Loss Per Share of Common Stock</I> &#151;&nbsp;Basic net loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period.
Diluted net loss per common share is computed by dividing the net loss by the sum of the weighted-average number of common shares outstanding during the period plus the potential dilutive effect of stock options, restricted stock units, warrants,
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">87 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
and shares that could be issued upon conversion of the senior convertible notes outstanding during the period calculated in accordance with the treasury stock method, but are excluded if their
effect is anti-dilutive. Because the impact of these items is anti-dilutive during periods of net loss, there was no difference between basic and diluted loss per common share for the years ended December&nbsp;31, 2015, 2014, and 2013. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Recently Issued Accounting Standards </I>&#151;&nbsp;From time to time, new accounting pronouncements are issued by the Financial
Accounting Standards Board (FASB) or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet
effective will not have a material impact on the Company&#146;s financial position or results of operations upon adoption. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
May 2014, the FASB issued ASU 2014-09 related to revenue recognition, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The guidance requires a
company to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration it expects to be entitled to receive in exchange for those goods or services. In July 2015, the FASB issued ASU
2015-14, which delayed the effective date of the new revenue standard by one year. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. The standard is effective beginning the first quarter of the
Company&#146;s 2018 fiscal year and is required to be adopted using either a full retrospective or a modified retrospective approach. The Company is assessing the potential impact of the new standard on its consolidated financial statements and has
not yet selected a transition method. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In August 2014, the FASB issued ASU 2014-15, which provides guidance on determining when
and how reporting entities must disclose going-concern uncertainties in their financial statements. The new standard requires management to perform interim and annual assessments of an entity&#146;s ability to continue as a going concern within one
year of the date of issuance of the entity&#146;s financial statements (or within one year after the date on which the financial statements are available to be issued, when applicable). Further, an entity must provide certain disclosures if there is
&#147;substantial doubt about the entity&#146;s ability to continue as a going concern&#148;. The ASU is effective for annual periods ending after December&nbsp;15, 2016, and interim periods thereafter; early adoption is permitted. The Company is
evaluating the impact the adoption of ASU 2014-15 will have on its consolidated financial statements. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In April 2015, the FASB
issued ASU 2015-03, &#147;Simplifying the Presentation of Debt Issuance Costs.&#148; The guidance requires debt issuance costs to be presented in the balance sheet as a direct deduction from the carrying value of the associated debt, consistent with
the presentation of a debt discount. The guidance is effective for annual reporting periods beginning after December&nbsp;15, 2015 and interim periods thereafter. As permitted by the standard, the Company adopted the new presentation prospectively
and the adoption did not have an impact on its consolidated financial statements and disclosures. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2015, the FASB
issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. Topic 330, Inventory, currently requires an entity to measure inventory at the lower of cost or market. Market could be replacement cost, net realizable value, or
net realizable value less an approximately normal profit margin. The amendments do not apply to inventory that is measured using last-in, first-out (LIFO) or the retail inventory method. The amendments apply to all other inventory, which includes
inventory that is measured using first-in, first-out (FIFO) or average cost. The amendments are effective for fiscal years beginning after December&nbsp;15, 2016, including interim periods within those fiscal years. The amendments should be applied
prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is evaluating the impact the adoption of ASU 2015-11 will have on its consolidated financial statements. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In November 2015, the FASB issued ASU No.&nbsp;2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. The new
standard requires that deferred tax assets and liabilities be classified as noncurrent in a classified statement of financial position. For public business entities, the amendments in this </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">88 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Update are effective for financial statements issued for annual periods beginning after December&nbsp;15, 2016, and interim periods within those annual periods. As permitted by the standard, the
Company adopted the new presentation and the adoption did not have an impact on its consolidated financial statements and disclosures. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In January 2016, the FASB issued ASU 2016-01, Financial Instruments&nbsp;&#151;&nbsp;Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The update is
intended to improve the recognition and measurement of financial instruments. The update are effective for fiscal years beginning after December&nbsp;15, 2017, including interim periods within those fiscal years. The Company is evaluating the impact
the adoption of ASU 2016-01 will have on its consolidated financial statements. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3. State research and development credit exchange receivable </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The State of Connecticut provides certain companies with the opportunity to exchange certain research and development
income tax credit carryforwards for cash in exchange for forgoing the carryforward of the research and development income tax credits. The program provides for an exchange of research and development income tax credits for cash equal to 65% of the
value of corporation tax credit available for exchange. Estimated amounts receivable under the program are recorded as a reduction of research and development expenses. During the years ended December&nbsp;31, 2015, 2014 and 2013, research and
development expenses were offset by $743,000, $816,000, and $282,000, respectively. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4. Inventories </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventories consist of the following (in thousands): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Raw materials</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,856</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Work-in-process</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,719</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Finished goods</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">95</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory &#151; current</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">89 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5. Property and equipment </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property and equipment consist of the following (dollar amounts in thousands): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Useful<BR>Life<BR>(Years)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Land</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,273</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,273</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Buildings</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39-40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Building improvements</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5-40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">131,383</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">114,131</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Machinery and equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3-15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">95,182</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Furniture, fixtures and office equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5-10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,137</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Computer equipment and software</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,707</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,465</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Leasehold improvements</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Construction in progress</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,044</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39,580</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">308,674</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">310,348</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less impairment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(140,412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less accumulated depreciation and amortization</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(119,513</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(118,221</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total property and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">192,127</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Leasehold improvements are amortized over four years which is the shorter of the term or the service lives
of the improvements. Depreciation and amortization expense related to property and equipment for the years ended December&nbsp;31, 2015, 2014, and 2013, was $11.0 million, $9.8 million, and $11.5 million, respectively. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with the Company&#146;s quarterly assessment of impairment indicators, the Company evaluated the continued lower than
expected sales of AFREZZA as reported by Sanofi throughout the fourth quarter of 2015, revised forecasts for sales of AFREZZA provided by Sanofi in the fourth quarter of 2015 and level of commercial production in the fourth quarter of 2015, as well
as the uncertainty associated with Sanofi&#146;s announcement during the fourth quarter of their intent to reorganize their diabetes business. These factors indicated potentially significant changes in the timing and extent of cash flows, and the
Company therefore determined that an impairment indicator existed in the fourth quarter of 2015. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;4, 2016, the
Company received written notice from Sanofi of its election to terminate in its entirety the Sanofi License Agreement. Sanofi&#146;s notice indicated that the termination was pursuant to Sanofi&#146;s right to terminate the agreement upon
Sanofi&#146;s good faith determination that the commercialization of AFREZZA is no longer economically viable in the United States, in which case the effective date of termination would be April&nbsp;4, 2016. In the alternative, Sanofi indicated
that the termination was also pursuant to its right to terminate the License Agreement for any reason, in which case the Termination Date would be July&nbsp;4, 2016. In the interest of an expedient transition, the Company is currently working with
Sanofi to transfer and wind down the agreement activities by April&nbsp;4, 2016, or as soon as practicable thereafter. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Company identified two primary asset groups to be evaluated for impairment: the Danbury manufacturing facility, which currently performs all the manufacturing of AFREZZA, and the Valencia facility, which was previously the Company&#146;s corporate
headquarters. The Danbury manufacturing facility is the primary asset group that has been impacted by the impairment indicators noted above but the Company also evaluated the Valencia facility for potential impairment given the circumstances and
identified an impairment charge of $1.8 million </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">90 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
based on a valuation utilizing a combination of market, income and cost approaches. Within the Danbury manufacturing facility, the Company identified the machinery and equipment as the primary
assets within the asset group as they are associated with the production of AFREZZA. As such, the Company performed the fixed asset impairment test and performed the first step to test for recoverability of the Danbury manufacturing facility by
utilizing two undiscounted cash flow projections and applying a probability weighted average to those cash flow projections. The first undiscounted cash flow projection was developed under a scenario assuming Sanofi would continue to sell and market
AFREZZA as the termination of the arrangement by Sanofi was not known as of the balance sheet date. The second undiscounted cash flow projection assumed Sanofi would terminate the Sanofi License Agreement and that the Company would manufacture, sell
and market AFREZZA independently. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the evaluation performed, the probabilities assigned to the two undiscounted cash
flows were not significant to the evaluation due to the projected negative cash flows over the estimation period, and it was determined that the probability weighted undiscounted cash flows were not sufficient to recover the carrying value of the
Danbury manufacturing facility. As such, the Company was required to determine the fair value of the Danbury manufacturing facility to recognize an impairment loss if the carrying amount exceeds its fair value. The Company determined the fair value
of the Danbury manufacturing facility by applying the highest and best use valuation concept and utilizing the market approach valuation technique to value the machinery and equipment and a combination of the market approach and cost approach in
valuing the land, buildings, and building improvements. As a result of this assessment, the Company recorded an impairment charge of $138.6 million for the Danbury manufacturing facility. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6. Accrued expenses and other current liabilities </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other current liabilities are comprised of the following (in thousands): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Salary and related expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,662</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,928</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">615</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,396</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Construction in progress</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">238</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,414</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,539</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,929</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,206</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7. Related-party arrangements </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In October 2007, the Company entered into a $350.0 million loan arrangement with its principal stockholder. The Loan
Arrangement has been amended from time to time. On October&nbsp;31, 2013, the promissory note underlying The Mann Group Loan Arrangement was amended to, among other things, extend the maturity date of the loan to January&nbsp;5, 2020, extend the
date through which the Company can borrow under The Mann Group Loan Arrangement to December&nbsp;31, 2019, increase the aggregate borrowing amount under The Mann Group Loan Arrangement from $350.0 million to $370.0 million and provide that
repayments or cancellations of principal under The Mann Group Loan Arrangement will not be available for reborrowing. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of
December&nbsp;31, 2015, the total principal amount outstanding under The Mann Group Loan Arrangement was $49.5 million, and the amount available for future borrowings was $30.1 million. Interest, at a fixed rate of 5.84%, is due and payable
quarterly in arrears on the first day of each calendar quarter for the preceding quarter, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">91 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
or at such other time as the Company and The Mann Group mutually agree. All or any portion of accrued and unpaid interest that becomes due and payable may be paid-in-kind and capitalized as
additional borrowings at any time upon mutual agreement of the parties, and has been classified as non-current. The Mann Group can require the Company to prepay up to $200.0 million in advances that have been outstanding for at least 12 months (less
approximately $105.0 million aggregate principal amount that has been cancelled in connection with two common stock purchase agreements). If The Mann Group exercises this right, the Company will have 90 days after The Mann Group provides written
notice (or the number of days to maturity of the note if less than 90 days) to prepay such advances. However, pursuant to a letter agreement entered into in August 2010, The Mann Group has agreed to not require the Company to prepay amounts
outstanding under the amended and restated promissory note if the prepayment would require the Company to use its working capital resources. In addition, The Mann Group entered into a subordination agreement with Deerfield pursuant to which The Mann
Group agreed with Deerfield not to demand or accept any payment under The Mann Group Loan Arrangement until the Company&#146;s payment obligations to Deerfield under the Facility Agreement have been satisfied in full. Subject to the foregoing, in
the event of a default under The Mann Group Loan Arrangement, all unpaid principal and interest either becomes immediately due and payable or may be accelerated at The Mann Group&#146;s option, and the interest rate will increase to the one-year
LIBOR rate calculated on the date of the initial advance or in effect on the date of default, whichever is greater, plus 5%&nbsp;per annum. All borrowings under The Mann Group Loan Arrangement are unsecured. The Mann Group Loan Arrangement contains
no financial covenants. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015 and 2014, the Company had accrued and unpaid interest of $6.4 million and
$3.5 million, in long term other liabilities respectively, which related to the amount outstanding and had $30.1 million of available borrowings. Interest expense on the Company&#146;s note payable to the Company&#146;s principal stockholder for the
years ended December&nbsp;31, 2015, 2014, and 2013 was $2.9 million, $2.9 million, and $6.3 million, respectively. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In May
2015, the Company entered into sublease agreement with the Alfred Mann Foundation for Scientific Research (the &#147;Mann Foundation&#148;), a California Not-For-Profit Corporation. The lease is for approximately 12,500 square feet of office space
in Valencia, California and expires in April 2017. The office space contains the Company&#146;s principal executive offices. Lease payments to the Mann Foundation for the year ended December&nbsp;31, 2015 were $175,000. There were no lease payments
to the Mann Foundation for the years ended December&nbsp;31, 2014 and 2013. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with certain meetings of the
Company&#146;s board of directors and on other occasions when the Company&#146;s business necessitated air travel for the Company&#146;s principal stockholder and other Company employees, the Company utilized the principal stockholder&#146;s private
aircraft, and the Company paid the charter company that manages the aircraft on behalf of the Company&#146;s principal stockholder approximately $18,000, $79,000, and $82,000, respectively, for the years ended December&nbsp;31, 2015, 2014, and 2013
on the basis of the corresponding cost of commercial airfare. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has entered into indemnification agreements with
each of its directors and executive officers, in addition to the indemnification provided for in its amended and restated certificate of incorporation and amended and restated bylaws (see Note 14&nbsp;&#151;&nbsp;Commitments and contingencies).
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">92 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8. Senior convertible notes </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior convertible notes consist of the following (in thousands): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2015 notes</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Principal amount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unaccreted debt issuance cost</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(645</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net carrying amount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99,355</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018 notes</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Principal amount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,690</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unamortized premium</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unaccreted debt issuance costs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(737</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net carrying amount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,613</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Issuance of new 5.75% Convertible Senior Subordinated Exchange Notes due 2018 in exchange for 2015
notes </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On July&nbsp;28, 2015, the Company entered into privately-negotiated exchange agreements (the &#147;Note Exchange
Agreements&#148;) with a select holder of the Company&#146;s 5.75% Senior Convertible Notes due 2015 (the &#147;2015 notes&#148;), pursuant to which the Company agreed to issue $27.7 million aggregate principal amount of new 5.75% Convertible Senior
Subordinated Exchange Notes due 2018 (the &#147;2018 notes&#148;) to such holders in exchange for the delivery to the Company of the same principal amount of 2015 notes. The 2018 notes were issued at the closing of the exchange on August&nbsp;10,
2015. The Company analyzed this exchange under the provisions of ASC 470-50 and concluded that the exchange represents an extinguishment of the 2015 notes and a new issuance of 2018 notes and recorded such notes at fair value which resulted in a
premium of $0.7 million. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2018 notes are the Company&#146;s general, unsecured, senior obligations, except that the 2018
notes are subordinated in right of payment to the outstanding notes issued pursuant to the Facility Agreement and the Company&#146;s borrowings under the Sanofi Loan Facility with an affiliate of Sanofi-Aventis U.S. LLC. The 2018 notes rank equally
in right of payment with the Company&#146;s other unsecured senior debt. The 2018 notes bear interest at the rate of 5.75%&nbsp;per year on the principal amount, payable semiannually in arrears in cash on February&nbsp;15 and August&nbsp;15 of each
year, beginning February&nbsp;15, 2016, with interest accruing from August&nbsp;15, 2015. The 2018 notes mature on August&nbsp;15, 2018. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The 2018 notes are convertible, at the option of the holder, at any time on or prior to the close of business on the business day immediately preceding the stated maturity date, into shares of the
Company&#146;s common stock at an initial conversion rate of 147.0859 shares per $1,000 principal amount of 2018 notes, which is equal to a conversion price of approximately $6.80 per share, the same conversion price as that of the 2015 notes on the
date of exchange. The conversion rate is subject to adjustment under certain circumstances described in an indenture governing the 2018 notes dated August&nbsp;10, 2015 with Wells Fargo, National Association, including in connection with a
make-whole fundamental change. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If certain fundamental changes occur, the Company will be obligated to pay a fundamental change
make-whole premium on any 2018 notes converted in connection with such fundamental change by increasing the conversion rate on such 2018 notes. In such instances, the amount of the fundamental change make-whole premium will be based on the
Company&#146;s common stock price and the effective date of the applicable fundamental change. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">93 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the Company undergoes certain fundamental changes, except in certain circumstances,
each holder of 2018 notes will have the option to require the Company to repurchase all or any portion of that holder&#146;s 2018 notes. The fundamental change repurchase price will be 100% of the principal amount of the 2018 notes to be repurchased
plus accrued and unpaid interest, if any. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On or after the date that is one year following the original issue date of the 2018
notes, the Company will have the right to redeem for cash all or part of the 2018 notes if the last reported sale price of its common stock exceeds 130% of the conversion price then in effect for 20 or more trading days during the 30 consecutive
trading day period ending on the trading day immediately prior to the date of the redemption notice. The redemption price will equal the sum of 100% of the principal amount of the 2018 notes to be redeemed, plus accrued and unpaid interest. Under
the terms of the 2018 Note Indenture, the conversion option can be net-share settled and the maximum number of shares that could be required to be delivered under the indenture, including the make-whole shares, is fixed and less than the number of
authorized and unissued shares less the maximum number of shares that could be required to be delivered during the term of the 2018 notes under existing commitments. Applying the Company&#146;s sequencing policy, the Company performed an analysis at
the time of the offering of the 2018 notes and each reporting date since and has concluded that the number of available authorized shares at the time of the offering and each subsequent reporting date was sufficient to deliver the number of shares
that could be required to be delivered during the term of the 2018 notes under existing commitments. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2018 notes provide
that upon an acceleration of certain indebtedness, including the 9.75% Senior Convertible Notes due 2019 (the &#147;2019 notes&#148;) and the 8.75% Senior Convertible Notes due 2019 (the &#147;Tranche B notes&#148;) issued to Deerfield pursuant to
the Facility Agreement (see Note 17&nbsp;&#151;&nbsp;Facility Agreement), the holders may elect to accelerate the Company&#146;s repayment obligations under the notes if such acceleration is not cured, waived, rescinded or annulled. There can be no
assurance that the holders would not choose to exercise these rights in the event such events were to occur. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company
incurred approximately $0.8 million in issuance costs which are recorded as an offset to the 2018 notes in the accompanying condensed consolidated balance sheet. These costs are being accreted to interest expense using the effective interest method
over the term of the 2018 notes. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accretion of debt issuance expense in connection with the 2018 notes during the year ended
December&nbsp;31, 2015 was $93,000. Amortization of 2018 notes premium during the year ended December&nbsp;31, 2015 was $86,000. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Issuance of common stock in exchange for 2015 notes </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On July&nbsp;28, 2015,
the Company entered into separate, privately-negotiated exchange agreements (the &#147;Stock-for-Note Exchange Agreements&#148;) with certain holders of the 2015 notes pursuant to which the Company agreed to issue shares of its common stock to such
holders in exchange for the delivery to the Company of up to $56.9 million aggregate principal amount of 2015 notes. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant
to the Stock-for-Note Exchange Agreements, the parties agreed to price the exchange transactions over a 10 trading day period spanning from July&nbsp;29, 2015 to and including August&nbsp;11, 2015. Between July&nbsp;28, 2015 and August&nbsp;10,
2015, the Company issued an aggregate of 1.9&nbsp;million shares of common stock to such holders in exchange for such holders&#146; delivery to the Company of $8.0 million aggregate principal amount of 2015 notes, resulting in a weighted-average
exchange price of $4.40 per share. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Issuance of new 5.75% Convertible Senior Subordinated Exchange Notes due 2015 in
exchange for 2015 notes </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;14, 2015, the Company exchanged $32.1 million aggregate principal amount of newly
issued, 5.75% Convertible Senior Subordinated Exchange Notes due 2015 (the &#147;Exchange Notes&#148;) for the same principal amount of the Company&#146;s previously outstanding 2015 notes. The Exchange Notes, payable at maturity on
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">94 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
September&nbsp;30, 2015, were convertible, at the option of each holder thereof, at any time on or prior to the close of business on the business day immediately preceding the stated maturity
date. The holders of the Exchange Notes did not elect to convert any of the outstanding principal amount of the Exchange Notes into shares of the Company&#146;s common stock. As a result, on September&nbsp;30, 2015, the Company paid $32.1 million to
settle the Exchange Notes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Settlement of 2015 notes and Exchange Notes </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;17, 2015, the Company paid $32.2 million to settle the remaining 2015 notes. As of September&nbsp;30, 2015, all 2015 notes,
including the Exchange Notes, have been settled resulting in a total loss on extinguishment equal to $1.0 million. The loss on extinguishment resulted from write-off of debt discount and debt issuance costs associated with the 2015 notes and
Exchange Notes and the difference between the principal amounts being exchanged for shares of the Company&#146;s common stock, pursuant to the various Stock-for-Note Exchange Agreements, and the fair market value of the Company&#146;s common stock
issued in exchange for such reduction in principal. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accretion of debt issuance expense in connection with the 2015 notes
during the years ended December&nbsp;31, 2015, 2014, and 2013 was $0.6 million, $0.9 million, and $0.9 million, respectively. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9. Collaboration arrangement </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Sanofi License Agreement and Sanofi Supply Agreement </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On August&nbsp;11, 2014, the Company and Sanofi entered into the Sanofi License Agreement, which became effective on September&nbsp;23,
2014. Under the terms of the Sanofi License Agreement, the Company granted to Sanofi exclusive, worldwide licenses to certain of the Company&#146;s patents, trademarks and know-how for the development and commercialization of AFREZZA. Under the
terms of the Sanofi License Agreement, Sanofi has the exclusive right and responsibility to develop AFREZZA worldwide, subject to certain development activities that will be performed by the Company. Sanofi will also be obligated to use commercially
reasonable efforts to file for, obtain and maintain marketing approvals for AFREZZA in certain major markets and countries. In addition, Sanofi will have exclusive, worldwide rights to commercialize AFREZZA and will be obligated to use commercially
reasonable efforts to market, promote and commercialize AFREZZA in all countries in the world where regulatory approval for AFREZZA has been received. Pursuant to the terms of the Sanofi Supply Agreement, the Company is responsible for the
manufacture and supply to Sanofi of its requirements of AFREZZA. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Sanofi License Agreement, Sanofi paid the Company
an up-front cash payment of $150.0 million in the third quarter of 2014. If certain manufacturing, regulatory and sales milestones are achieved, the Company will also be eligible to receive up to $775.0 million in milestone payments, of which $75.0
million relates to certain development and manufacturing milestone events, $50.0 million relates to the filing and completion of regulatory approvals and $650.0 million relates to the achievement of certain product sales milestones. As of
December&nbsp;31, 2014, the Company earned and recorded a total of $50.0 million in milestone payments in connection with the satisfaction of manufacturing milestones specified in the Sanofi agreement, which were received subsequent to
December&nbsp;31, 2014. In addition, worldwide profits and losses, which are determined based on the difference between the net sales of AFREZZA and the costs and expenses incurred by the Company and Sanofi that are specifically attributable or
related to the development, improvement, regulatory filings, manufacturing, and commercialization of AFREZZA will be shared 65% by Sanofi and 35% by the Company. In accordance with the terms of the Sanofi License Agreement, profit and loss sharing
commenced in the fourth quarter of 2014. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">95 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of the Sanofi Supply Agreement, the Company will be the exclusive
manufacturer and supplier of AFREZZA until the specified conditions are met, upon which a portion of the manufacturing activities may be assumed by Sanofi. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company analyzed the agreements entered into with Sanofi under the provisions of ASC 605, Revenue Recognition, to determine whether the consideration, or a portion thereof, could be recognized as
revenue. ASC 605 provides that revenue is recognized when there is persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collection is reasonably assured. In
addition, revenue arrangements with multiple elements are divided into separate units of accounting if certain criteria are met, including whether the delivered element has stand-alone value to the customer. When deliverables are separable,
consideration received is allocated to the separate units of accounting based on the relative selling price of each deliverable and the appropriate revenue recognition principles are applied to each unit. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The assessment of multiple element arrangements requires judgment in order to determine the appropriate units of accounting and the points
in time that, or periods over which, revenue should be recognized. Under the terms of the Sanofi License Agreement, Sanofi Supply Agreement and the Sanofi Loan Facility the Company determined that the arrangement contained significant deliverables
including (i)&nbsp;licenses to develop and commercialize AFREZZA and to use the Company&#146;s trademarks, (ii)&nbsp;development activities, and (iii)&nbsp;manufacture and supply services for AFREZZA. Due to the proprietary nature of the
manufacturing services being provided by the Company, the Company determined that all of the significant deliverables should be combined into a single unit of accounting. The Company believes that the manufacturing services are proprietary due to
the fact that since the late 1990&#146;s, the Company has developed proprietary knowledge and patented equipment and tools that are used in the manufacturing process of AFREZZA. Due to the complexities of particle formulation and the specialized
knowledge and equipment needed to handle the AFREZZA powder, neither Sanofi nor any third-party contract manufacturing organization currently possesses the capability of manufacturing AFREZZA. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order for revenue to be recognized, the seller&#146;s price to the buyer must be fixed and determinable. Given that as of
December&nbsp;31, 2015, the Company did not have the ability to estimate the amount of costs that would potentially be incurred under the loss share provision related to the Sanofi License Agreement and the Sanofi Supply Agreement, the Company
believes this requirement for revenue recognition has not been met. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As such, the Company did not recognize any revenue
pursuant to the Sanofi License Agreement or the Sanofi Supply Agreement for the years ended December&nbsp;31, 2015 and 2014. The Company has recorded the $150.0 million up-front payment and $50.0 million from milestone payments as deferred payments
from collaboration. In addition, as of December&nbsp;31, 2015 the Company has recorded $17.5 million in AFREZZA product shipments to Sanofi as deferred product sales from collaboration and recorded $13.5 million as deferred product costs from
collaboration. Deferred product costs represent the costs of product manufactured and shipped to Sanofi, not to exceed the amount of deferred product sales, for which recognition of revenue has been deferred. During the year ended December&nbsp;31,
2015, the Company&#146;s portion of the loss sharing was $57.7&nbsp;million, which resulted in the reclassification from current deferred payments from collaboration to Sanofi loan facility and loss share obligation to reflect amounts owed to
Sanofi. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Sanofi Loan Facility </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On September&nbsp;23, 2014, the Company entered into the Sanofi Loan Facility, consisting of a senior secured revolving promissory note and a guaranty and security agreement (the &#147;Security
Agreement&#148;) with an affiliate of Sanofi which provides the Company with a secured loan facility of up to $175.0 million to fund the Company&#146;s share of net losses under the Sanofi License Agreement. In the event of certain future defaults
under the Sanofi Loan facility agreement for which the Company is not able to obtain waivers, the lender under the Sanofi Loan Facility may accelerate all of the Company&#146;s repayment obligations, and take control of the Company&#146;s pledged
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">96 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
assets, potentially requiring the Company to renegotiate the terms of its indebtedness on terms less favorable to the Company, or to immediately cease operations. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The obligations of the Company under the Sanofi Loan Facility are guaranteed by the Company&#146;s wholly-owned subsidiary, MannKind LLC,
and are secured by a first priority security interest in certain insulin inventory located in the United States and any contractual rights and obligations pursuant to which the Company purchases or has purchased such insulin, and a second priority
security interest in the Company&#146;s assets that secure the Company&#146;s obligations under the Facility Agreement, as amended. In addition, the Company granted to Sanofi, as additional security for the obligations under the Sanofi Loan
Facility, a first priority mortgage on the Company&#146;s facility in Valencia, California, which has a carrying value of $17.9&nbsp;million as of December&nbsp;31, 2015. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Advances under the Sanofi Loan Facility bear interest at a rate of 8.5%&nbsp;per annum and are payable in-kind and compounded quarterly and added to the outstanding principal balance under the Sanofi Loan
Facility. The Company is required to make mandatory prepayments on the outstanding loans under the Sanofi Loan Facility from its share of any Profits (as defined in the Sanofi License Agreement) under the Sanofi License Agreement within 30 days of
receipt of its share of any such Profits. No advances may be made under the Sanofi Loan Agreement if Deerfield has commenced enforcement proceedings in connection with an event of default under the Facility Agreement. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The outstanding principal of all loans under the Sanofi Loan Facility, if not prepaid, will become due and payable on September&nbsp;23,
2024 unless accelerated pursuant to the terms of the Sanofi Loan Facility. Additionally, if the Company sells its Valencia facility, the Company is required to prepay the loans under the Sanofi Loan Facility from the net cash proceeds of the sale
within five business days of receipt. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s total portion of the loss sharing was $57.7&nbsp;million for the year
ended December&nbsp;31, 2015, of which $44.5&nbsp;million was borrowed under the Sanofi Loan Facility as of December&nbsp;31, 2015. Subsequent to December&nbsp;31, 2015, the Company borrowed $17.9&nbsp;million under the Sanofi Loan Facility to
finance the portion of the Company&#146;s loss for the quarter ended December&nbsp;31, 2015. The total amount owed to Sanofi is $62.4 million, which includes $1.7&nbsp;million in paid-in-kind interest. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Sanofi Loan Facility includes customary representations, warranties and covenants by the Company, including restrictions on its
ability to incur additional indebtedness, grant certain liens and make certain changes to its organizational documents. Events of default under the Sanofi Loan Facility include: the Company&#146;s failure to timely make payments due under the Sanofi
Loan Facility; inaccuracies in the Company&#146;s representations and warranties to the noteholder; the Company&#146;s failure to comply with any of its covenants under any of the Sanofi Loan Facility or certain other related security agreements and
documents entered into in connection with the Sanofi Loan Facility, subject to a cure period with respect to most covenants; the Company&#146;s insolvency or the occurrence of certain bankruptcy-related events; termination by Sanofi of the Sanofi
License Agreement as a result of the Company&#146;s breach of the Sanofi License Agreement; and the failure of any material provision under any of the Sanofi Loan Facility or certain other related security agreements and documents entered into in
connection with the Sanofi Loan Facility to remain in full force and effect. If one or more events of default occurs and is continuing, Sanofi may terminate its obligation to make advances under the Sanofi Loan Facility, and, if certain specified
events of default (including the Company&#146;s failure to timely make payments due under the Sanofi Loan Facility; the Company&#146;s failure to comply with the negative covenants under the Sanofi Loan Facility limiting the Company&#146;s ability
to incur additional indebtedness or grant certain liens; the Company&#146;s insolvency or the occurrence of certain bankruptcy-related events; termination by Sanofi of the Sanofi License Agreement as a result of the Company&#146;s breach of the
non-compete provisions of the Sanofi License Agreement; or the failure of any material provision under any of the Sanofi Loan Facility or certain other related security agreements and documents entered into in connection with the Sanofi Loan
Facility to remain in full force and effect) occur and are continuing, the noteholder may accelerate all of the Company&#146;s repayment obligations under the Sanofi Loan Facility and otherwise exercise any of its remedies as a secured creditor.
There can be no assurance that the noteholder would not choose to exercise these rights in the event such events were to occur. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">97 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subsequent to December&nbsp;31, 2015, the Company received written notice on
January&nbsp;4, 2016 from Sanofi of its election to terminate in its entirety the Sanofi License Agreement. Pursuant to its terms, the Sanofi Supply Agreement will terminate concurrently with the Sanofi License Agreement. Sanofi&#146;s notice
indicated that the termination was pursuant to Sanofi&#146;s right to terminate the Sanofi License Agreement upon Sanofi&#146;s good faith determination that the commercialization of AFREZZA is no longer economically viable in the United States, in
which case the effective date of termination will be April&nbsp;4, 2016. In the alternative, Sanofi indicated that the termination was also pursuant to its right to terminate the Sanofi License Agreement for any reason, in which case the effective
date of termination will be July&nbsp;4, 2016. In the interest of an expedient transition, the Company is currently working with Sanofi to transfer and wind down the agreement activities by April&nbsp;4, 2016, or as soon as practicable thereafter.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of the Sanofi License Agreement, the Company and Sanofi are required to use diligent efforts to
facilitate the smooth and orderly transition of relevant obligations and rights to the Company with respect to development and commercialization activities related to AFREZZA, and are also required to negotiate in good faith a written transition
agreement for this purpose. As a result of the foregoing termination, effective on the Termination Date and thereafter during any period which Sanofi is required to perform any wind-down activities pursuant to the terms of the Sanofi License
Agreement, the rights granted to Sanofi under the Sanofi License Agreement to develop and commercialize AFREZZA will become non-exclusive and the Company will have the right to engage one or more other distributors and/or licensees of AFREZZA.
Sanofi will continue to distribute AFREZZA during the wind-down period as required by the agreement until such time that the Company or its designee takes over responsibility for distribution. All profits and losses from AFREZZA product sales by
Sanofi or its affiliates after the Termination Date, if any, will continue to be shared 65% by Sanofi and 35% by the Company pursuant to the terms of the License Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition to the Sanofi License Agreement and Sanofi Supply Agreement, as discussed above, the Company and Aventisub LLC, an affiliate of Sanofi, are parties to a Senior Secured Revolving Promissory
Note, dated September&nbsp;23, 2014 and a Guaranty and Security Agreement. Both the Sanofi Loan Facility and the Security Agreement remain in effect. The original maturity date of September&nbsp;23, 2024 for repayment of the outstanding principal
amount of the loans under the Sanofi Loan Facility will not be affected by the termination of the Sanofi License Agreement. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10. Fair Value of Financial Instruments </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The carrying amounts of financial instruments, which include cash equivalents and accounts payable, approximate their
fair values due to their relatively short maturities. The fair value of the note payable to the Company&#146;s principal stockholder cannot be reasonably estimated as the Company would not be able to obtain a similar credit arrangement in the
current economic environment. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015 and 2014, the Company held $59.1 million and $120.8 million,
respectively of cash and cash equivalents, consisting of money market funds of $55.8 million and $118.5 million, respectively, and the remaining funds in non-interest bearing checking accounts. The fair value of these money market funds was
determined by using quoted prices for identical investments in an active market (Level 1 in the fair value hierarchy). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">98 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2018 notes, facility financing obligation and Sanofi Loan Facility </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of the carrying values and estimated fair values of the 2018 notes, the facility financing obligation (i.e.,
the 2019 notes and Tranche B notes), and the Sanofi Loan Facility (in millions): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31, 2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31, 2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Carrying<BR>value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>fair value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Carrying<BR>value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>fair value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015 notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">102.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2018 notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Facility financing obligation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sanofi Loan Facility</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">36.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2015 notes </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The estimated fair value of the 2015 notes was calculated based on model-derived valuations whose inputs were observable, such as the Company&#146;s stock price, and non-observable, such as the
Company&#146;s longer-term historical volatility (55%) (Level 3 in the fair value hierarchy). As there was no current active and observable market for the 2015 notes, the Company determined the estimated fair value using a convertible bond valuation
model within a lattice framework. The convertible bond valuation model combined expected cash outflows with market-based assumptions regarding risk-adjusted yields, stock price volatility and recent price quotes and trading information regarding
Company issued debt instruments and shares of common stock into which the notes are convertible. As of December&nbsp;31, 2015, all 2015 notes, including the Exchange Notes, have been extinguished through exchange for stock, exchange for 2018 notes
or settlement in cash. (See Note 8&nbsp;&#151;Senior convertible notes). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2018 notes </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The estimated fair value of the 2018 notes was calculated based on model-derived valuations whose inputs were observable, such as the
Company&#146;s stock price and yields on U.S. Treasury notes and actively traded bonds, and non-observable, such as the Company&#146;s longer-term historical volatility, and estimated yields implied from any available market trades of the
Company&#146;s issued debt instruments. As there is no current active and observable market for the 2018 notes, the Company determined the estimated fair value using a convertible bond valuation model within a lattice framework. The convertible bond
valuation model combined expected cash flows based on terms of the notes with market-based assumptions regarding risk-free rate, risk-adjusted yields (20%), stock price volatility (90%) and recent price quotes and trading information regarding
Company issued debt instruments and shares of common stock into which the notes are convertible (Level 3 in the fair value hierarchy). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Facility financing agreement </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As discussed in Note 17 &#151;&nbsp;Facility
Agreement, in connection with the Facility Agreement, the Company issued 2019 notes and subsequently issued Tranche B notes (the &#147;Facility Financing Obligation&#148;). As there is no current observable market for the 2019 notes or Tranche B
notes, the Company determined the estimated fair value using a bond valuation model based on a discounted cash flow methodology. The bond valuation model combined expected cash flows associated with principal repayment and interest based on the
contractual terms of the debt agreement discounted to present value using a selected market discount rate. On December&nbsp;31, 2015 the market discount rate was recalculated at 12.0% for the 2019 notes and the Tranche B notes (Level 3 in the fair
value hierarchy). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the 2019 notes and Tranche B notes, the Company also issued certain rights to receive
payments of up to $90.0 million upon occurrence of specified strategic and sales milestones (the &#147;Milestone Rights&#148;). These rights are not reflected in the facility financing obligation. The estimated fair value of the Milestone Rights
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">99 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
was calculated using the income approach in which the cash flows associated with the specified contractual payments were adjusted for both the expected timing and the probability of achieving the
milestones discounted to present value using a selected market discount rate (Level 3 in the fair value hierarchy). The expected timing and probability of achieving the milestones, starting in 2014, was developed with consideration given to both
internal data, such as progress made to date and assessment of criteria required for achievement, and external data, such as market research studies. The discount rate (15.0%)&nbsp;was selected based on an estimation of required rate of returns for
similar investment opportunities using available market data. As of December&nbsp;31, 2015, the carrying value of the Milestone Rights is $8.9 million, classified as a long-term liability in other liabilities and the fair value is estimated at $14.4
million. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Sanofi Loan Facility </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As discussed in Note 9 &#151;&nbsp;the Sanofi Loan Facility, consists of a senior secured revolving promissory note and a guaranty and security agreement with an affiliate of Sanofi which provides the
Company with a secured loan facility of up to $175.0 million to fund the Company&#146;s share of net losses under the Sanofi License Agreement. The estimated fair value was determined using a discounted cash flow model in which time outstanding and
discount rate were primary variables. This method considered the key elements of the contractual terms of the Sanofi Loan Facility, market-based estimated cost of capital, and time value of money, namely the amount of time to settlement and the
estimated discount rate (11%)&nbsp;appropriate for the liability (Level 3 in the fair value hierarchy). As of December 31, 2015 the carrying value of the Sanofi Loan Facility is $44.5 million and the fair value is estimated at $36.5 million.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">There were no material re-measurements to fair value during the year ended December&nbsp;31, 2015 of financial assets and
liabilities that are not measured at fair value on a recurring basis. There were no transfers of assets or liabilities between the fair value measurement levels during the twelve months ended December&nbsp;31, 2015, 2014, and 2013. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Assets and Liabilities Measured at Fair Value on a Non-recurring Basis </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In accordance with ASC 360, <I>Property, Plant, and Equipment </I>(&#147;ASC 360&#148;), land, buildings, and machinery and equipment,
with a carrying amount of $189.2 million, were written down to a fair value of $48.8 million, resulting in an impairment charge of $140.4 million, which is included in our Statements of Operations and Comprehensive Loss for the year ended
December&nbsp;31, 2015. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our assessment of the real property includes Level 3 inputs, and was based on a combination of the
income, market and cost approaches and the market approach was used for machinery and equipment which required Level 3 inputs. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Embedded Derivatives </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company identified and evaluated a number of embedded features in the notes issued under the Facility Agreement to determine if they represented embedded derivatives that are required to be separated
from the notes and accounted for as freestanding instruments pursuant to ASC 815. In 2014, the Company analyzed the Tranche B notes and identified embedded derivatives which required separate accounting under ASC 815; however all of the embedded
derivatives were determined to have a <I>de minimis</I> value. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31, 2015, all of the embedded derivatives
identified in the Tranche B notes were deemed to have a <I>de minimis </I>value. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">100
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11. Common and preferred stock </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company is authorized to issue 550,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares
of undesignated preferred stock, par value $0.01 per share, issuable in one or more series designated by the Company&#146;s board of directors. No other class of capital stock is authorized. As of December&nbsp;31, 2015 and 2014, 428,670,943 and
406,059,089 shares of common stock, respectively, were issued and outstanding and no shares of preferred stock were outstanding. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On November&nbsp;9, 2015, the Company entered into a series of stock purchase agreements to sell up to an aggregate of 50,000,000 shares
its common stock in a registered direct offering to selected investment funds in Israel that hold securities included within certain stock indexes of the Tel Aviv Stock Exchange (the &#147;TASE&#148;). Pursuant to the agreements, the shares of
common stock were sold at a price per share equal to 97% of the closing price of the Company&#146;s common stock on the TASE on November&nbsp;12, 2015. During November 2015, the Company sold 13,852,435 shares of common stock for an aggregate price
of approximately $34,710,000, or $2.61 per share, which is net of $1,433,000 of issuance costs. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company engaged Sunrise
Securities Corporation as its exclusive placement agent in connection with the offering of 50,000,000 shares. In connection with the services provided the Company issued to Sunrise Securities Corporation, or its designee, restricted warrants to
purchase a number of shares of the Company&#146;s common stock in an aggregate equal to 1.15% of the aggregate shares sold in the offering, which totaled 159,303 shares on November&nbsp;16, 2015. The warrants are exercisable for a five year period
at an exercise price of $2.61, the price paid per share in connection with the offering. The Company had an obligation to register the common stock that may be issued pursuant to the exercise of the warrants, which resulted in their initial
classification as liability and were deemed immaterial. On December&nbsp;15, 2015 the warrants were reclassified to equity as the Company registered the common stock pursuant to registration statement. As of December&nbsp;31, 2015 the warrants were
classified within equity. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Included in the common stock outstanding as of December&nbsp;31, 2014 is 9,000,000 shares of common
stock loaned to Bank of America under a share lending agreement in connection with the offering of the $100.0 million aggregate principal amount of 2015 notes. Bank of America was obligated to return the borrowed shares (or, in certain
circumstances, the cash value thereof) to the Company on or about the 45th business day following the date as of which the entire principal amount of the 2015 notes ceases to be outstanding, subject to extension or acceleration in certain
circumstances or early termination at Bank of America&#146;s option. On October&nbsp;23, 2015, the 9,000,000 shares of common stock loaned to Bank of America were returned, as the Company settled all payments and deliveries in respect of such
convertible notes on August&nbsp;17, 2015. The Company did not receive any proceeds from the sale of the borrowed shares by Bank of America, but the Company did receive a nominal lending fee of $0.01 per share from Bank of America for the use of
borrowed shares. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On February&nbsp;8, 2012, the Company sold 35,937,500 units in an underwritten public offering, including
4,687,500 units sold pursuant to the full exercise of an over-allotment option granted to the underwriters, with each unit consisting of one share of common stock and a warrant to purchase 0.6 of a share of common stock. All of the securities were
offered by the Company at a combined price to the public of $2.40 per unit and the underwriters purchased the units at a price of $2.256 per unit. Net proceeds from this offering were approximately $80.6 million, excluding any warrant exercises. The
21,562,500 shares of common stock underlying the warrants are exercisable at $2.40 per share and expire four years from the date of the issuance. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For the years ended December&nbsp;31, 2015, 2014, and 2013, the Company received $10.1 million, $27.8 million, and $94.2 million in proceeds, respectively, from the exercise of the February 2012 public
offering warrants. Any unexercised February 2012 public offering warrants expired on February&nbsp;8, 2016. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">101
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12. Net loss per common share </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic net loss per share excludes dilution for potentially dilutive securities and is computed by dividing net loss by
the weighted average number of common shares outstanding during the period excluding the 9,000,000 shares loaned to Bank of America under a share lending arrangement (see Note 11 &#151;&nbsp;Common and preferred stock). In the third quarter of 2015,
the 9,000,000&nbsp;million shares loaned to Bank of America were returned. Prior to the return of those shares, the borrowed shares were not considered outstanding for the purpose of computing and reporting basic or diluted earnings (loss) per share
because the share borrower had to return all borrowed shares to the Company (or, in certain circumstances, the cash value thereof). Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue
common stock were exercised or converted into common stock. Potentially dilutive securities are excluded from the computation of diluted net loss per share for all of the periods presented in the accompanying condensed consolidated statements of
operations because the reported net loss in each of these periods results in their inclusion being antidilutive. Antidilutive securities, which consist of stock options, restricted stock units, warrants, and shares that could be issued upon
conversion of the senior convertible notes, that are not included in the diluted net loss per share calculation and excluded the 9,000,000 shares of the Company&#146;s common stock loaned under the share lending arrangement as of December&nbsp;31,
2014, and 2013. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Potentially dilutive securities outstanding are summarized as follows (in shares): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exercise of common stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,779,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,541,664</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,237,940</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conversion of senior convertible notes into common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,072,809</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,323,080</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,415,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exercise of common stock warrants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,074,596</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,987,876</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,706,240</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vesting of restricted stock units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,804,620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,610,720</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,115,821</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,731,254</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,463,340</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78,475,367</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13. Stock award plans </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On May&nbsp;23, 2013, the Company adopted the 2013 Equity Incentive Plan (the &#147;2013 Plan&#148;) as the successor
to and continuation of the 2004 Equity Incentive Plan (the &#147;2004 Plan&#148;). The 2013 Plan consists of 21.5&nbsp;million newly requested shares and the number of unallocated shares remaining available for grant for new awards under the 2004
Plan. The 2013 Plan provides for the granting of stock awards including stock options and restricted stock units, to employees, directors and consultants. The Plan also provides for the automatic, non-discretionary grant of options to the
Company&#146;s non-employee directors. No additional awards will be granted under the 2004 Plan or under the 2004 Non-Employee Directors&#146; Stock Option Plan (the &#147;NED Plan&#148;) as all future awards will be made out of the 2013 Plan.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, the Company has two active stock-based compensation plans &#151;&nbsp;the 2013 Plan and the 2004
Employee Stock Purchase Plan (the &#147;ESPP&#148;). The following table summarizes information about the Company&#146;s stock-based award plans as of December&nbsp;31, 2015: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outstanding<BR>Options</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outstanding<BR>Restricted<BR>Stock Units</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares&nbsp;Available<BR>for<BR>Future Issuance</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2004 Equity Incentive Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,309,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">276,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2013 Equity Incentive Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,026,762</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,527,836</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,540,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2004 Non-Employee Directors&#146; Stock Option Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">443,331</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,779,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,804,620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,540,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">102
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In March 2004, the Company&#146;s board of directors approved the ESPP, which became
effective upon the closing of the Company&#146;s initial public offering. Initially, the aggregate number of shares that could be sold under the 2004 Plan was 2,000,000 shares of common stock. On January&nbsp;1 of each year, for a period of ten
years beginning January&nbsp;1, 2005, the share reserve automatically increases by the lesser of: 700,000 shares, 1% of the total number of shares of common stock outstanding on that date, or an amount as may be determined by the board of directors.
However, under no event can the annual increase cause the total number of shares reserved under the ESPP to exceed 10% of the total number of shares of capital stock outstanding on December&nbsp;31 of the prior year. On January&nbsp;1, 2013 and 2014
the ESPP share reserve was increased by 700,000 and 700,000 shares, respectively. There was no ESPP share reserve increase during 2015. As of December&nbsp;31, 2015, 2,752,703 shares were available for issuance under the ESPP. For the years ended
December&nbsp;31, 2015, 2014 and 2013 the Company sold 321,228, 305,076, and 463,290 shares, respectively, of its common stock to employees participating in the ESPP. The ESPP purchase for the period ending December&nbsp;31, 2015 was initiated prior
to year-end but did not settle until January&nbsp;5, 2016. As a result, the shares sold are reflected in the ESPP share reserves but is excluded from common stock outstanding as of December&nbsp;31, 2015. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s board of directors determines eligibility, vesting schedules and exercise prices for stock awards granted under the
2013 Plan. Options and other stock awards under the 2013 Plan expire not more than ten years from the date of the grant and are exercisable upon vesting. Stock options generally vest over four years. Current stock option grants vest and become
exercisable at the rate of 25% after one year and ratably on a monthly basis over a period of 36 months thereafter. Restricted stock units generally vest at a rate of 25%&nbsp;per year over four years with consideration satisfied by service to the
Company. There are no outstanding performance-based awards as all milestones have been achieved as of December&nbsp;31, 2015. The 2013 Plan provides for full acceleration of vesting if an employee is terminated within three months of a change in
control, as defined in the 2013 Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In accordance with ASC 718, share-based payment transactions are recognized as
compensation cost based on the fair value of the instrument on the date of grant. The Company accounts for non-employee stock-based compensation expense based on the estimated fair value of the options, which is determined using the Black-Scholes
option valuation model and amortizes such expense on a straight-line basis over the service period for time-based awards and over the expected dates of achievement for performance-based awards. These awards are subject to re-measurement until
service is complete. As of December&nbsp;31, 2015, there were options to purchase 523,487 shares of common stock outstanding to consultants. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During the years ended December&nbsp;31, 2015, 2014 and 2013 the Company recorded stock-based compensation expense related to its stock award plans and the ESPP of $8.7 million, $48.6 million, and $45.2
million, respectively. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stock-based compensation expense recognized in the accompanying statements of operations is as
follows (in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Employee-related</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,407</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,181</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consultant-related</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">318</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">103
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stock-based compensation expense recognized in the accompanying statements of
operations is included in the following categories (in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,696</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,777</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of
employee stock options. The expected term of an option granted is based on combining historical exercise data with expected weighted time outstanding. Expected weighted time outstanding is calculated by assuming the settlement of outstanding awards
is at the midpoint between the remaining weighted average vesting date and the expiration date. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beginning in the third quarter
of 2014, the Company began to assess both historical and implied volatility in order to determine its estimated volatility rate. Implied volatility was considered due to the change in the Company&#146;s business, which occurred with the approval for
the sale of AFREEZA. The Company has selected risk-free interest rates based on U.S. Treasury securities with an equivalent expected term in effect on the date the options were granted. Additionally, the Company uses historical data and management
judgment to estimate stock option exercise behavior and employee turnover rates to estimate the number of stock option awards that will eventually vest. The Company calculated the fair value of employee stock options granted during the years ended
December&nbsp;31, 2015, 2014 and 2013 using the following assumptions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Risk-free interest rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.61%&nbsp;&#151;&nbsp;1.86%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.64%&nbsp;&#151;&nbsp;2.11%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.94% &#151;&nbsp;1.82%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Expected lives</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.79&nbsp;&#151;&nbsp;5.86&nbsp;years</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.77&nbsp;&#151;&nbsp;6.09&nbsp;years</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.64&nbsp;&#151;&nbsp;5.77&nbsp;years</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Volatility</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">69.76%&nbsp;&#151;&nbsp;71.84%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73.98%&nbsp;&#151;&nbsp;84.85%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75.83%&nbsp;&#151;&nbsp;86.26%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dividends</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table summarizes information about stock options outstanding: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of<BR>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted<BR>Average<BR>Exercise<BR>Price<BR>per&nbsp;Share</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Aggregate<BR>Intrinsic<BR>Value&nbsp;($000)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Outstanding at January&nbsp;1, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,541,664</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,495</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Granted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,541,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exercised</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,700,964</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Forfeited</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(706,387</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Expired</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(896,184</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Outstanding at December&nbsp;31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,779,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vested and expected to vest at December&nbsp;31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,597,097</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exercisable at December&nbsp;31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,217,332</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The weighted average grant date fair value of the stock options granted during the years ended
December&nbsp;31, 2015, 2014 and 2013 was $2.56, $4.76 and $3.26 per option, respectively. The total intrinsic value of options exercised during the years ended December&nbsp;31, 2015, 2014 and 2013 was $6.2 million, $14.9 million and $3.1
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">104
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
million, respectively. Intrinsic value is measured using the fair market value at the date of exercise (for options exercised) or at December&nbsp;31 (for outstanding options), less the
applicable exercise price. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash received from the exercise of options during the years ended December&nbsp;31, 2015, 2014 and
2013 was approximately $3.3 million, $11.0 million and $2.3 million, respectively. The weighted-average remaining contractual terms for options outstanding, vested and expected to vest, and exercisable at December&nbsp;31, 2015 was 6.34 years, 6.31
years and 5.97 years, respectively. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A summary of restricted stock unit activity for the year ended December&nbsp;31, 2015 is
presented below: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of<BR>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted<BR>Average<BR>Grant&nbsp;Date<BR>Fair Value<BR>per Share</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Outstanding at January 1, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,610,720</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Granted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,133,404</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vested</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1,111,134</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.93</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Forfeited</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(828,370</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.88</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Outstanding at December 31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,804,620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The total restricted stock units expected to vest as of December&nbsp;31, 2015 was 1,651,859 with a
weighted average grant date fair value of $4.86. The total intrinsic value of restricted stock units expected to vest as of December&nbsp;31, 2015 was $2.4 million. Intrinsic value of restricted stock units expected to vest is measured using the
closing share price at December&nbsp;31, 2015. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total intrinsic value of restricted stock units vested during the years ended
December&nbsp;31, 2015, 2014 and 2013 was $5.2 million, $62.7 million and $13.9 million, respectively. Intrinsic value of restricted stock units vested is measured using the closing share price on the day prior to the vest date. The total grant date
fair value of restricted stock units vested during the years ended December&nbsp;31, 2015, 2014 and 2013 was $5.5million, $36.4 million and $14.9 million, respectively. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015, there was $4.9 million and $6.7 million of unrecognized compensation expense related to options and restricted stock units, respectively, which is expected to be recognized
over the weighted average vesting period of 2.7 years. The Company evaluates stock awards with performance conditions as to the probability that the performance conditions will be met and estimates the date at which the performance conditions will
be met in order to properly recognize stock-based compensation expense over the requisite service period. As of December&nbsp;31, 2015, all milestones have been achieved. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During the year ended December&nbsp;31, 2015, there was $1.6 million of stock compensation expense related to certain Executives who entered into severance agreements which resulted in a modification to
the terms of their awards. The severance agreements generally allowed for the separated Executives to continue to vest under their original award terms for a stated period of time without providing substantive services. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>14. Commitments and contingencies </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Operating Leases </I>&#151;&nbsp;The Company leases certain facilities and equipment under various operating leases,
which expire at various dates through 2016 and beyond. Future payments are deemed insignificant. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rent expense under all
operating leases, including office space and equipment, for the years ended December&nbsp;31, 2015, 2014, and 2013 was approximately $426,000, $737,000, and $645,000 respectively. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Leases </I>&#151;&nbsp;The Company&#146;s capital leases were not material for the years ended December&nbsp;31, 2015, 2014 and 2013.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">105
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Guarantees and Indemnifications </I>&#151;&nbsp;In the ordinary course of its
business, the Company makes certain indemnities, commitments and guarantees under which it may be required to make payments in relation to certain transactions. The Company, as permitted under Delaware law and in accordance with its Bylaws,
indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company&#146;s request in such capacity. The term of the indemnification period is for the
officer&#146;s or director&#146;s lifetime. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer insurance policy that may enable it to recover a portion of any future amounts paid. The
Company believes the fair value of these indemnification agreements is minimal. The Company has not recorded any liability for these indemnities in the accompanying condensed consolidated balance sheets. However, the Company accrues for losses for
any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount can be reasonably estimated. No such losses have been recorded to date. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Litigation </I>&#151;&nbsp;The Company is subject to legal proceedings and claims which arise in the ordinary course of its business.
As of December&nbsp;31, 2015, the Company believes that the final disposition of such matters will not have a material adverse effect on the financial position, results of operations or cash flows of the Company and no accrual has been recorded. The
Company maintains liability insurance coverage to protect the Company&#146;s assets from losses arising out of or involving activities associated with ongoing and normal business operations. In accordance with ASC 450 <I>Contingencies</I>, the
Company records a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company&#146;s policy is to accrue for legal expenses in connection with legal
proceeding and claims as they are incurred. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, several complaints were filed in the U.S. District Court for the
Central District of California against the Company and certain of its officers and directors on behalf of certain purchasers of its common stock. The complaints include claims asserted under Sections 10(b) and 20(a) of the Exchange Act and have been
pled as putative shareholder class actions. In general, the complaints allege that the Company and certain of its officers and directors violated federal securities laws by making materially false and misleading statements regarding the prospects
for AFREZZA, thereby artificially inflating the price of its common stock. The plaintiffs are seeking monetary damages and other relief. The Company expects the complaints to be transferred to a single court and consolidated for all purposes,
following which the court would be expected to appoint a lead plaintiff and lead counsel and to order the lead plaintiff to file a consolidated complaint. The Company will vigorously defend against the claims advanced. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following the receipt by the Company of the notice of termination from Sanofi regarding the Sanofi License Agreement and the subsequent
decline of the price of its common stock, two motions were submitted to the District Court at Tel Aviv (Economic Department) for the certification of a class action against the Company and certain of its officers and directors. In general, the
complaints allege that the Company and certain of its officers and directors violated Israeli and US securities laws by making materially false and misleading statements regarding the prospects for AFREZZA, thereby artificially inflating the price
of its common stock. The plaintiffs are seeking monetary damages. The Company will vigorously defend against these claims. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Contingencies &#151;</I> In connection with the Facility Agreement, on July&nbsp;1, 2013 the Company also entered into a Milestone
Rights Purchase Agreement (the &#147;Milestone Agreement&#148;) with Deerfield Private Design Fund and Horizon Sant&eacute; FLML S&Aacute;RL (collectively, the &#147;Milestone Purchasers&#148;), pursuant to which the Company sold the Milestone
Purchasers the Milestone Rights to receive payments up to $90.0 million upon the occurrence of specified strategic and sales milestones, including the first commercial sale of an AFREZZA product in the United States and the achievement of specified
net sales figures (see Note 17&nbsp;&#151;&nbsp;Facility Agreement). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Commitment &#151;</I> On July&nbsp;31, 2014, the
Company entered into a supply agreement (the &#147;Insulin Supply Agreement&#148;) with Amphastar France Pharmaceuticals S.A.S., a French corporation (&#147;Amphastar&#148;), pursuant to </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">106
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
which Amphastar will manufacture for and supply to the Company certain quantities of recombinant human insulin for use in AFREZZA. Under the terms of the Insulin Supply Agreement, Amphastar will
be responsible for manufacturing the insulin in accordance with the Company&#146;s specifications and agreed-upon quality standards. The Company has agreed to purchase annual minimum quantities of insulin for calendar years 2015 through 2019 under
the Insulin Supply Agreement of an aggregate total of approximately &#128;120.1&nbsp;million, of which &#128;98.5&nbsp;million is remaining at December&nbsp;31, 2015. The Company has contracted for the purchase of &#128;28.8&nbsp;million in 2016 and
the remaining annual minimum quantities will be &#128;23.3&nbsp;million for the years ending December&nbsp;31, 2017 through 2019. The Company may request to purchase additional quantities of insulin over such annual minimum quantities and will incur
a cancellation fee of approximately $5.2 million if not purchased (see Note 2&nbsp;&#151; Summary of Significant accounting policies). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Unless earlier terminated, the term of the Insulin Supply Agreement expires on December&nbsp;31, 2019 and can be renewed for additional, successive two year terms upon 12 months&#146; written notice given
prior to the end of the initial term or any additional two year term. The Company and Amphastar each have normal and customary termination rights, including termination for material breach that is not cured within a specific time frame or in the
event of liquidation, bankruptcy or insolvency of the other party. In addition, the Company may terminate the Insulin Supply Agreement upon two years&#146; prior written notice to Amphastar without cause or upon 30 days&#146; prior written notice to
Amphastar if a controlling regulatory authority withdraws approval for AFREZZA, provided, however, in the event of a termination pursuant to either of the latter two scenarios, the provisions of the Insulin Supply Agreement require the Company to
pay the full amount of all unpaid purchase commitments due over the initial term within 60 calendar days of the effective date of such termination. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>15. Employee benefit plans </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company administers a 401(k) Savings Retirement Plan (the &#147;MannKind Retirement Plan&#148;) for its employees.
For the years ended December&nbsp;31, 2015, 2014, and 2013, the Company contributed $593,000, $623,000, and $533,000 respectively, to the MannKind Retirement Plan. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>16. Income taxes </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">There is no provision for income taxes because the Company has incurred operating losses since inception. At
December&nbsp;31, 2015, the Company has concluded that it is more likely than not that the Company may not realize the benefit of its deferred tax assets due to its history of losses. Accordingly, the net deferred tax assets have been fully
reserved. The provision for income taxes consists of the following (in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">U.S. federal</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">U.S. state</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-U.S.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">U.S. federal</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">109,512</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59,379</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">U.S. state</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(29,394</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,631</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,470</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-U.S.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Valuation Allowance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(80,118</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(65,504</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(66,849</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total deferred</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">107
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred income taxes reflect the tax effects of temporary differences between the
carrying amounts of assets and liabilities for financial reporting and income tax purposes. A valuation allowance is established when uncertainty exists as to whether all or a portion of the net deferred tax assets will be realized. Components of
the net deferred tax asset as of December&nbsp;31, 2015 and 2014 are approximately as follows (in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred tax assets:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="5" VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net operating loss carryforwards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">721,588</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">699,997</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development credits</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,646</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,227</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Capitalized research</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,872</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payments from collaboration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,484</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,217</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Milestone Rights</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,242</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">251</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">768</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss on purchase commitment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,084</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-qualified stock option expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,941</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43,691</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Capitalized patent costs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,574</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,624</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">131</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Depreciation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,755</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total net deferred tax assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">962,623</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">882,502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Valuation allowance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(962,623</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(882,502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net deferred tax assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of certain realization requirements of ASC 718, the table of deferred tax assets and
liabilities does not include certain deferred tax assets as of December&nbsp;31, 2015 that arose directly from tax deductions related to equity compensation which are greater than the compensation recognized for financial reporting. Equity would be
increased by $10.0 million if and when such deferred tax assets are ultimately realized. The Company considered the requirements under ASC 740 <I>Income Taxes </I>(&#147;ASC 740&#148;) when determining when excess tax benefits have been realized.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s effective income tax rate differs from the statutory federal income tax rate as follows for the years ended
December&nbsp;31, 2015, 2014 and 2013: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Federal tax benefit rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">State tax benefit, net of federal benefit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Permanent items</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intercompany transfer of intellectual property</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Valuation allowance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(31.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(30.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective income tax rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required by ASC 740, management of the Company has evaluated the positive and negative evidence bearing
upon the realizability of its deferred tax assets. Management has concluded, in accordance with the applicable accounting standards, that it is more likely than not that the Company may not realize the benefit of its deferred tax assets.
Accordingly, the net deferred tax assets have been fully reserved. Management reevaluates the positive and negative evidence on an annual basis. During the years ended December&nbsp;31, 2015, 2014 and 2013, the change in the valuation allowance was
$80.1&nbsp;million, $65.5 million and $66.8&nbsp;million, respectively, for income taxes. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">108
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31, 2015, the Company had federal and state net operating loss
carryforwards of approximately $1.9 billion and $1.3 billion available, respectively, to reduce future taxable income. The federal net operating loss carryforwards will expire at various dates beginning in 2018 and the state net operating loss
carryforwards have started expiring, starting current year through various future dates. As a result of the Company&#146;s initial public offering, an ownership change within the meaning of Internal Revenue Code Section&nbsp;382 occurred in August
2004. As a result, federal net operating loss and credit carry forwards of approximately $216.0 million are subject to an annual use limitation of approximately $13.0 million. The annual limitation is cumulative and therefore, if not fully utilized
in a year can be utilized in future years in addition to the Section&nbsp;382 limitation for those years. The federal net operating losses generated subsequent to the Company&#146;s initial public offering in August 2004 are currently not subject to
any such limitation as there have been no ownership changes since August 2004 within the meaning of Internal Revenue Code Section&nbsp;382. At December&nbsp;31, 2015, the Company had research and development credits of $49.1 million and $37.7
million for federal and state purposes, respectively. The federal credits begin to expire in 2024, and the state credits may be carried forward indefinitely. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company has evaluated the impact of ASC 740, previously FIN 48 <I>Accounting for Uncertainty in Income Taxes</I>, on its financial statements, which was effective beginning January&nbsp;1, 2007. The
evaluation of a tax position in accordance with this guidance is a two-step process. The first step is recognition: the enterprise determines whether it is more-likely-than-not that a tax position will be sustained upon examination, including
resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the enterprise should presume that the position
will be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: a tax position that meets the more-likely-than-not recognition threshold is measured to determine the
amount of benefit to recognize in the financial statements. The tax position is measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Tax positions that previously failed to meet
the more-likely-than-not recognition threshold should be recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition
threshold should be derecognized in the first subsequent financial reporting period in which that threshold is no longer met. The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate
any adjustments that will result in a material change to its financial position. Therefore, no liabilities for uncertain income tax positions have been recorded. Tax years since 2011 remain subject to examination by the major tax jurisdictions in
which the Company is subject to tax. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>17. Facility Agreement </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015 and 2014, there were $60.0 million principal amount of 2019 notes and $20.0 million
principal amount of Tranche B notes outstanding. The 2019 notes accrue interest at annual rate of 9.75% and the Tranche B notes accrue interest at an annual rate of 8.75% and is paid quarterly in arrears on the last day of each March, June,
September, and December. The Facility Agreement principal repayment schedule is comprised of annual payments beginning on July&nbsp;1, 2016 and ending December&nbsp;9, 2019. Future principal payments for the years ended December&nbsp;31, 2016, 2017,
2018, and 2019 are $5.0 million, $20.0 million, $20.0 million, and $35.0 million, respectively. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In conjunction with the
Facility Agreement, the Company entered into a Milestone Rights Agreement with Deerfield which requires the Company to make contingent payments to Deerfield, totaling up to $90.0 million, upon the Company achieving specified commercialization
milestones. The Milestone Rights were initially recorded as a short-term liability equal to $3.2 million included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet and a long-term liability
equal to $13.1 million included in other liabilities. During the first quarter of 2015, a milestone triggering event was achieved following the Company&#146;s product launch on February&nbsp;3, 2015, which resulted in a $5.8 million incremental
charge to </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">109
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
interest expense due to the increase in carrying value of the liability to the required $10.0 million payment made in February of 2015. During the year ended December&nbsp;31, 2014, the first
milestone triggering event was achieved following the Company&#146;s entry into the Sanofi License Agreement, which resulted in a $1.9 million incremental charge to interest expense due to the increase in carrying value of the liability to the
required $5.0 million payment, which was paid to Deerfield pursuant to the terms of the Milestone Agreement. As of December&nbsp;31, 2015, the remaining liability balance of $8.9 million is classified as long-term liability in other liabilities.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December 31, 2015, the uncreated debt discount and debt issuance costs were $5.3 million and $0.1 million, respectively.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accretion of debt issuance cost and debt discount in connection with the Deerfield financing during the year ended
December&nbsp;31, 2015 and 2014 are as follows (in thousands): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2014</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accretion expense- debt issuance cost</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">326</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accretion expense- debt discount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,553</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Facility Agreement includes customary representations, warranties and covenants, including, a
restriction on the incurrence of additional indebtedness, and a financial covenant which requires the Company&#146;s cash and cash equivalents, which includes available borrowings on the principal stockholder note, on the last day of each fiscal
quarter to not be less than $25.0 million. As discussed in Note 1 &#151;&nbsp;Basis of Presentation, the Company will need to raise additional capital to support its current operating plans. Due to the uncertainties related to maintaining sufficient
resources to comply with the aforementioned covenant, the 2019 notes have been classified as current liabilities in the accompanying balance sheet as of December&nbsp;31, 2015. In the event of non-compliance, Deerfield may declare all or any portion
of the 2019 notes and/or Tranche B notes to be immediately due and payable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Milestone Rights </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Milestone Agreement includes customary representations and warranties and covenants by the Company, including restrictions on
transfers of intellectual property related to AFREZZA. The Milestone Rights are subject to acceleration in the event the Company transfers its intellectual property related to AFREZZA in violation of the terms of the Milestone Agreement. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company analyzed the Milestone Rights under the provisions of ASC 815 <I>Derivatives and Hedging,</I> and determined that the
instruments do not meet the definition of a freestanding derivative. Since the Company has not elected to apply the fair value option to the Milestone Rights, the Company has initially recorded the Milestone Rights at their estimated fair value and
accounted for the Milestone Rights as a liability by applying the indexed debt guidance contained in paragraphs ASC 470-10-25-3 and 35-4. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The initial fair value estimate of the Milestone Rights was calculated using the income approach in which the cash flows associated with the specified contractual payments were adjusted for both the
expected timing and the probability of achieving the milestones discounted to present value using a selected market discount rate. In determining the fair value of the Milestone Rights, the 13 individual milestone payments were adjusted for both
(i)&nbsp;the expected timing and (ii)&nbsp;the probability of achieving the milestones, and then discounted to present value using a discount rate of 17.5%. Once the initial valuation of each specified milestone payment was determined, the
individual milestone payments were then aggregated to arrive at a total fair value of $16.3 million. The discount rate was based on the estimated cost of equity which was derived using the capital asset pricing model. In addition, a 5% risk premium
was added to the computation of the cost of equity to adjust for non-systemic risk factors, such as the Company&#146;s lack of product diversification and history of financial losses, which were not captured in other model inputs. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">110
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Security Agreement </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with the Facility Agreement, the Company and its subsidiary, MannKind LLC, entered into a Guaranty and Security Agreement
(the &#147;Security Agreement&#148;) with Deerfield and HS (collectively, the &#147;Purchasers&#148;), pursuant to which the Company and MannKind LLC each granted the Purchasers a security interest in substantially all of their respective assets,
including respective intellectual property, accounts, receivables, equipment, general intangibles, inventory and investment property, and all of the proceeds and products of the foregoing. The Security Agreement includes customary covenants by the
Company and MannKind LLC, remedies of the Purchasers and representations and warranties by the Company and MannKind LLC. The security interests granted by the Company and MannKind LLC will terminate upon repayment of the 2019 notes and tranche B
notes, if applicable, in full. The Company&#146;s obligations under the Facility Agreement and the Milestone Agreement are also secured by the mortgage on the Company&#146;s facilities in Danbury, Connecticut, which has a carrying value of $23.0
million. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Embedded Derivatives </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company identified and evaluated a number of embedded features in the notes issued under the Facility Agreement to determine if they represented embedded derivatives that are required to be separated
from the notes and accounted for as freestanding instruments pursuant to ASC 815. In 2014, the Company analyzed the Tranche&nbsp;B notes and identified embedded derivatives which required separate accounting under ASC&nbsp;815; however all of the
embedded derivatives were determined to have a <I>de minimis</I> value. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31, 2015, all of the embedded
derivatives identified in the Tranche B notes were deemed to have a <I>de minimis </I>value. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>18. Restructuring Charges </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On September 2015, the Company initiated a restructuring of the organization as a result of its shift to commercial
production of AFREZZA. In connection with the restructuring, the Company reduced its total workforce by approximately 26% to 198 employees. The Company recorded restructuring charges of $5.9 million, $1.9 million, and $0.4 million for the years
ended December&nbsp;31, 2015, 2014, and 2013, respectively. As of December&nbsp;31, 2015, the Company paid $2.8 million and the remaining balance is expected to be paid in the first quarter of 2016. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The $5.9 million of costs associated with the restructuring are included in &#147;Research and development&#148; and &#147;General and
administrative&#148; operating expenses in the condensed consolidated statements of operations as $3.0 million and $2.9 million, respectively, for the year ended December&nbsp;31, 2015. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2015 and 2014, the Company had a restructuring accrual of $3.0 million and $0.3 million, respectively. The Company
did not have a restructuring accrual as of December&nbsp;31, 2013. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">111
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>19. Selected quarterly financial data (unaudited) </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Summarized quarterly financial data for the years ended December&nbsp;31, 2015 and 2014 are set forth in the following
tables: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>March&nbsp;31</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>June&nbsp;30</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands, except per share data)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2015</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(30,658</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(28,910</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(31,857</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(277,020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss per share &#151; basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.08</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.08</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted average common shares used to compute basic and diluted net loss per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">398,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">401,018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">405,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">419,314</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>March&nbsp;31</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>June&nbsp;30</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>September&nbsp;30</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands, except per share data)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(52,056</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(73,365</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(36,520</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(36,439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss per share &#151; basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.09</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.09</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted average common shares used to compute basic and diluted net loss per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">368,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">380,770</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">394,163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">396,793</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Impairment charges were recorded in 2015 for $242.7 million related to long-lived assets, inventory and
loss on purchase commitments. </FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>20. Subsequent Events </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Sanofi Termination </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;4, 2016, the Company received written notice from Sanofi of its election to terminate in its entirety the Sanofi License Agreement. Sanofi&#146;s notice indicated that the termination was
pursuant to Sanofi&#146;s right to terminate the agreement upon Sanofi&#146;s good faith determination that the commercialization of AFREZZA is no longer economically viable in the United States, in which case the effective date of termination would
be April&nbsp;4, 2016. In the alternative, Sanofi indicated that the termination was also pursuant to its right to terminate the Sanofi License Agreement for any reason, in which case the Termination Date would be July&nbsp;4, 2016. In the interest
of an expedient transition, the Company is currently working with Sanofi to transfer and wind down the agreement activities by April&nbsp;4, 2016, or as soon as practicable thereafter. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of the Sanofi License Agreement, the Company and Sanofi are required to use diligent efforts to facilitate the
smooth and orderly transition of relevant obligations and rights to the Company with respect to development and commercialization activities related to AFREZZA, and are also required to negotiate in good faith a written transition agreement for this
purpose. As a result of the foregoing termination, effective on the Termination Date and thereafter during any period which Sanofi is required to perform any wind-down activities pursuant to the terms of the Sanofi License Agreement, the rights
granted to Sanofi under the Sanofi License Agreement to develop and commercialize AFREZZA will become non-exclusive and the Company will have the right to engage one or more other distributors and/or licensees of AFREZZA. Sanofi will continue to
distribute AFREZZA during the wind-down period as required by the agreement until such time that the Company or its designee takes over responsibility for distribution. All profits and losses from AFREZZA product sales by Sanofi or its affiliates
after the Termination Date, if any, will continue to be shared 65% by Sanofi and 35% by the Company pursuant to the terms of the Sanofi License Agreement. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">112
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MANNKIND CORPORATION AND SUBSIDIARIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&nbsp;&#151;&nbsp;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company and Sanofi are also parties to the Sanofi Supply Agreement, pursuant to
which the Company is required to supply Sanofi or its affiliates or its sublicensees such quantities of AFREZZA as requested by Sanofi to cover its commercial requirements. As a result of the termination of the Sanofi License Agreement, the Sanofi
Supply Agreement will terminate by its terms on the Termination Date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Borrowings under Sanofi Loan Facility
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On February&nbsp;10, 2016, the Company borrowed $17.9 million under the Sanofi Loan Facility to finance the portion of its
losses for the quarter ended December&nbsp;31, 2015 (see Note 9 &#151;&nbsp;Collaboration arrangement). </FONT></P>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">113
</FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.17
<SEQUENCE>2
<FILENAME>d107849dex417.htm
<DESCRIPTION>EX-4.17
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.17</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.17 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;ACT&#148;). THEY MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL> C<SMALL>ORPORATION</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT TO PURCHASE COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrant No.:</B> 2015-[<U>&nbsp;&nbsp;&nbsp;&nbsp;</U>] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Issuance Date:</B> November&nbsp;16, 2015 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expiration Date:
</B>November&nbsp;16, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIS</SMALL> C<SMALL>ERTIFIES</SMALL> T<SMALL>HAT</SMALL></B><SMALL></SMALL>, for value received,
<B>[<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>]</B> or its assigns
(the &#147;<B><I>Holder</I></B>&#148;), is entitled to subscribe for and purchase at the Exercise Price (defined below) from <B>M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL> C<SMALL>ORPORATION</SMALL></B><SMALL></SMALL>, a Delaware corporation (the
&#147;<B><I>Company</I></B>&#148;), up to [<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>] shares of the Company&#146;s Common Stock (the &#147;<B><I>Common Stock</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Warrant is being issued pursuant to the terms of the Investment Banking Agreement, dated October&nbsp;5, 2015, by and between the Company
and Sunrise Securities Corp. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. D<SMALL>EFINITIONS</SMALL>. </B>As used herein, the following terms shall have the following
respective meanings: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>&#147;<B><I>Exercise Period</I></B>&#148; means the period commencing with the date hereof and ending five
(5)&nbsp;years later, unless sooner terminated as provided below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>&#147;<B><I>Exercise Price</I></B>&#148; means $2.61 (USD)
per share, subject to adjustment pursuant to Section&nbsp;5 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(c) </B>&#147;<B><I>Exercise Shares</I></B>&#148; means the shares
of Common Stock issuable upon exercise of this Warrant, subject to adjustment pursuant to the terms herein, including but not limited to adjustment pursuant to Section&nbsp;5 below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(d) </B>&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(e) </B>&#147;<B><I>Person</I></B>&#148; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization, any other entity and a government or any department or agency thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(f)
</B>&#147;<B><I>Trading Day</I></B>&#148; means any day on which the Common Stock is traded on The NASDAQ Global Market, or, if The NASDAQ Global Market is not the principal trading market for the Common Stock, then on the principal securities
exchange or securities market on which the Common Stock is then traded; <U>provided</U> that &#147;Trading Day&#148; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any
day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour
ending at 4:00:00 p.m., New York Time). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. E<SMALL>XERCISE</SMALL> <SMALL>OF</SMALL> W<SMALL>ARRANT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>2.1 Mechanics of Exercise. </B>This Warrant may be exercised in whole or in part at any time during the Exercise Period by delivery of the
following to the Company at its address set forth on the signature page hereto (or at such other address as it may designate by notice in writing to the Holder): (a)&nbsp;a duly executed and completed Notice of Exercise in the form attached hereto;
and (b)&nbsp;if the Holder is not electing a Cashless Exercise (as defined below) to the extent permitted pursuant to Section&nbsp;2.2 below, payment to the Company of an amount equal to the Exercise Price multiplied by the number of Exercise Shares
as to which this Warrant is being exercised (the &#147;<B><I>Aggregate Exercise Price</I></B>&#148;) in cash, by check or wire transfer of immediately available funds to an account designated by the Company (a &#147;<B><I>Cash
Exercise</I></B>&#148;). All payments hereunder shall be made in U.S. Dollars. The Holder shall not be required to surrender this Warrant in order to effect an exercise hereunder, provided that in the event of an exercise of this Warrant for all
Exercise Shares then issuable hereunder, this Warrant is surrendered to the Company by the second (2nd)&nbsp;Trading Day (as defined below) following the date on which the Company has received each of (i)&nbsp;the Notice of Exercise and, if this
Warrant is being exercised pursuant to a Cash Exercise, the Aggregate Exercise Price (collectively, the &#147;<B><I>Exercise Delivery Documents</I></B>&#148;). On or before the first (1st)&nbsp;Trading Day following the date on which the Company has
received the Exercise Delivery Documents, the Company shall transmit by email or facsimile an acknowledgment of confirmation of receipt of the Exercise Delivery Documents to the Holder and the Company&#146;s transfer agent for the Common Stock (the
&#147;<B><I>Transfer Agent</I></B>&#148;). The Company shall deliver any objection to the Exercise Delivery Documents on or before the first (1st)&nbsp;Trading Day following the date on which the Company has received all of the Exercise Delivery
Documents. In the event of any discrepancy or dispute, the records of the Company shall be controlling and determinative in the absence of manifest error. On or before the third (3rd)&nbsp;Trading Day following the date on which the Company has
received the Exercise Delivery Documents (the &#147;<B><I>Share Delivery Date</I></B>&#148;), the Company shall, upon the request of the Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such
exercise to the Holder&#146;s or its designee&#146;s balance account with The Depository Trust Company (&#147;<B><I>DTC</I></B>&#148;) through its Deposit Withdrawal Agent Commission system, or if the Transfer Agent is not participating in the Fast
Automated Securities Transfer Program (the &#147;<B><I>FAST Program</I></B>&#148;) or if the certificates are required to bear a legend regarding restriction on transferability, issue and dispatch by overnight courier to the address as specified in
the Exercise Notice, a certificate, registered in the Company&#146;s share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise. Upon delivery of the
Exercise Delivery Documents, the Holder shall be deemed for all purposes to have become the holder of record of the Exercise Shares with respect to which this Warrant has been exercised, irrespective of the date such Exercise Shares are credited to
the Holder&#146;s DTC account or the date of delivery of the certificates evidencing such Exercise Shares, as the case may be. If this Warrant is submitted to the Company in connection with an exercise and the number of Exercise Shares represented
by this Warrant submitted for exercise is greater than the number of Exercise Shares being acquired upon an exercise, then the Company shall as soon as practicable and in no event later than five (5)&nbsp;Trading Days after any exercise and at its
own expense, issue a new Warrant representing the right to purchase the number of Exercise Shares purchasable immediately prior to such exercise under this Warrant, less the number of Exercise Shares with respect to which this Warrant is exercised.
The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Exercise Shares upon exercise hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>2.2 Cashless Exercise.</B> Notwithstanding anything contained herein to the contrary, if (i)&nbsp;a registration statement registering for
resale the Exercise Shares under the Securities Act is not effective or available for the Exercise Shares and (ii)&nbsp;an exemption from registration under the Securities Act for resale of the Exercise Shares is not available for the Exercise
Shares, then the Holder may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the &#147;Net Number&#148; of shares of
Common Stock determined according to the following formula (a &#147;<B><I>Cashless Exercise</I></B>&#148;): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="60%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net&nbsp;Number&nbsp;= <U>(A x B) - (A x C)</U></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:7.00em; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">B</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">For purposes of the foregoing formula:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">A=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the total number of Exercise Shares with respect to which this Warrant is then being exercised.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">B=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Weighted Average Price (as defined below) of the shares of Common Stock (as reported by Bloomberg (as defined below)) on the date immediately preceding the date of the Exercise Notice.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">C=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Exercise Price then in effect for the applicable Exercise Shares at the time of such exercise.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the above calculation, &#147;<B><I>Weighted Average Price</I></B>&#148; means, for any
security as of any date, the dollar volume-weighted average price for such security on The NASDAQ Global Market during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg
Financial Markets (&#147;<B><I>Bloomberg</I></B>&#148;) through its &#147;Volume at Price&#148; function; or, if the foregoing does not apply, the volume-weighted average price of such security on the Tel Aviv Stock Exchange
(&#147;<B><I>TASE</I></B>&#148;) in U.S. Dollars (based on the exchange rate between the New Israeli Shekel and the U.S.&nbsp;Dollar on such day) during the period beginning at 8:30:01 a.m., Israel Time, and ending at 4:30:00 p.m., Israel time as
reported by Bloomberg, or, if no volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price in U.S. Dollars (based on the exchange rate
between the New Israeli Shekel and the U.S.&nbsp;Dollar on such day) of any of the market makers for such security as reported by any reliable financial reporting medium; or if the foregoing doesn&#146;t apply, in the over-the-counter market on the
electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for
such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the &#147;pink sheets&#148; by Pink OTC Markets Inc. If the
Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.
All such determinations shall be appropriately adjusted for any share dividend, share split or other similar transaction during such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>2.3 Limitations on Exercise</B>. The Company shall not effect the exercise of this Warrant, and the Holder shall not have the right to
exercise this Warrant, to the extent that after giving effect to such exercise, such Holder (together with such Holder&#146;s affiliates and any other Persons acting as a group together) would beneficially own in excess of 4.99% (the
&#147;<B><I>Maximum Percentage</I></B>&#148;) of the shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by
the Holder and its affiliates shall include the number of shares of Common Stock issuable upon exercise of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (i)&nbsp;exercise of the remaining,
unexercised portion of this Warrant beneficially owned by the Holder and its affiliates and (ii)&nbsp;exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by the Holder and its
affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding
sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section&nbsp;13(d) of the Securities Exchange Act of 1934, as amended (the &#147;<B><I>Exchange Act</I></B>&#148;), it being acknowledged that the
Company is not representing to the Holder that such calculation is in compliance with Section&nbsp;13(d) of the Exchange Act, and the Holder is solely responsible for any schedules required to be filed in accordance therewith. For purposes of this
Warrant, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (1)&nbsp;the Company&#146;s most recent Form 10-K, Proxy Statement, Form 10-Q, Current
Report on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2)&nbsp;a more recent public announcement by the Company or (3)&nbsp;any other notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. For any reason at any time, upon the written or oral request of the Holder, where such request indicates that it is being made pursuant to this Warrant, the Company shall within one (1)&nbsp;Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of
the Company, including the Warrant, by the Holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the Holder may increase or decrease the Maximum
Percentage to any other percentage not in excess of 9.99% specified in such notice; provided, that any such increase will not be effective until the 61st day after such notice is delivered to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>3.1 Covenants to Register Exercise Shares.</B> The Company covenants and agrees, within 30 days from the date hereof or such later time as
may be agreed upon by Sunrise Securities Corp. and the Company, to register for resale the Exercise Shares pursuant to a prospectus supplement under the Company&#146;s Registration Statement on Form S-3 (Registration No.&nbsp;333-206778), subject to
Holder&#146;s timely delivery to the Company of any information reasonably requested by the Company in connection with such registration. The Holder acknowledges that the Company has no obligation to register this Warrant. The Holder agrees to
indemnify and holder harmless the Company and each of its directors and officers from and against any losses, claims, damages or liabilities (joint or several) to which the Company or any of its directors or officers may become subject under the
Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any of the following statements: (i)&nbsp;any untrue statement or
alleged untrue statement of a material fact contained in such prospectus supplement or incorporated by reference therein or in any amendments or supplements thereto, (ii)&nbsp;the omission or alleged omission to state therein a material fact
required to be stated therein, or necessary to make the statements therein not misleading, or (iii)&nbsp;any violation or alleged violation by the Company of the Securities Act (each, a &#147;<B><I>Holder Violation</I></B>&#148;), in each case to
the extent (and only to the extent) that such Holder Violation occurs in reliance upon and in conformity with written information furnished by the Holder to the Company or its attorneys and stated to be specifically for use in connection with such
registration; and the Holder will reimburse any legal or other expenses reasonably incurred by the Company or any of its director or officer in connection with investigating or defending any such loss, claim, damage, liability or action if it is
judicially determined that there was such a Holder Violation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>3.2 Covenants as to Exercise Shares.</B> The Company covenants and agrees that all Exercise
Shares that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance, be validly issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance
thereof. The Company further covenants and agrees that the Company will at all times during the Exercise Period, have authorized and reserved, free from preemptive rights, a sufficient number of shares of its Common Stock to provide for the exercise
of the rights represented by this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4. R<SMALL>EPRESENTATIONS</SMALL> <SMALL>OF</SMALL> H<SMALL>OLDER</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>4.1 Acquisition of Warrant for Personal Account.</B> The Holder represents and warrants that it is acquiring this Warrant and the Exercise
Shares solely for its account for investment and not with a present view toward the public distribution of this Warrant or Exercise Shares or any part thereof and has no present intention of selling or distributing this Warrant or Exercise Shares or
any arrangement or understanding with any other persons regarding the sale or distribution of this Warrant or the Exercise Shares. The Holder will not, directly or indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit any
offers to buy, purchase or otherwise acquire or take a pledge of) this Warrant or the Exercise Shares in violation of any applicable law or regulation, including, without limitation: the Securities Act and the rules and regulations thereunder; the
Exchange Act and the rules and regulations thereunder; the rules and regulations of the Financial Industry Regulatory Authority (&#147;<B><I>FINRA</I></B>&#148;), including, if applicable, FINRA Rule 5110(g); and the rules and regulations of The
NASDAQ Global Market or the Tel Aviv Stock Exchange, as applicable. The Holder represents and warrants that (i)&nbsp;it is aware of the Company&#146;s business affairs and financial condition and has acquired sufficient information about the Company
to reach an informed and knowledgeable decision regarding its investment in this Warrant and, upon exercise of this Warrant, any Exercise Shares and (ii)&nbsp;it is experienced in making investments of this type and has such knowledge and background
in financial and business matters that the Holder is capable of evaluating the merits and risks of this investment and protecting the Holder&#146;s own interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>4.2 Securities Are Not Registered. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>The Holder understands that this Warrant and the Exercise Shares have not been registered under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>The Holder recognizes that this Warrant and the Exercise Shares must be held indefinitely unless they are subsequently registered
under the Securities Act or an exemption from such registration is available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(c) </B>The Holder acknowledges and agrees that the
Securities are &#147;restricted securities&#148; as defined in Rule 144 promulgated under the Securities Act as in effect from time to time and must be held indefinitely unless they are subsequently registered under the Securities Act or an
exemption from such registration is available. The Holder has been advised or is aware of the provisions of Rule 144, which permits limited resale of securities purchased in a private placement subject to the satisfaction of certain conditions,
including, among other things: the availability of certain current public information about the Company, the resale occurring following the required holding period under Rule 144 and the number of securities being sold during any three-month period
not exceeding specified limitations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>4.3 Disposition of Warrant and Exercise Shares. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(a) </B>The Holder further agrees not to make any disposition of all or any part of this Warrant or Exercise Shares in any event unless
and until: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(i) </B>There is then in effect a registration statement under the Securities Act covering such proposed disposition and
such disposition is made in accordance with said registration statement; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B>(ii) </B>The Holder shall have notified the Company of
the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have furnished the Company with an
opinion of counsel, reasonably satisfactory to the Company, for the Holder to the effect that such disposition will not require registration of such Warrant or Exercise Shares under the Securities Act or any applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>The Holder understands and agrees that all certificates evidencing the shares to be issued to the Holder may bear the following
legend prior to being registered under the Securities Act: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE &#147;ACT&#148;). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH
REGISTRATION IS NOT REQUIRED. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>4.4 Accredited Investor Status.</B> The Holder is an &#147;accredited investor&#148; as such term is
defined in Rule 501 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>4.5 Further Assurances.</B> The Holder agrees and covenants that at any time and from
time to time it will promptly execute and deliver to the Company such further instruments and documents and take such further action as the Company may reasonably require in order to carry out the full intent and purpose of this Warrant and to
comply with state or federal securities laws or other regulatory approvals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5. A<SMALL>DJUSTMENT</SMALL> <SMALL>OF</SMALL>
E<SMALL>XERCISE</SMALL> P<SMALL>RICE</SMALL>. </B>In the event of changes in the outstanding Common Stock of the Company by reason of stock dividends, split-ups, recapitalizations, reclassifications, combinations or exchanges of shares, separations,
reorganizations, liquidations, or the like, the number and class of shares available under this Warrant in the aggregate and the Exercise Price shall be correspondingly adjusted to give the Holder of this Warrant, on exercise for the same aggregate
Exercise Price, the total number, class, and kind of shares as the Holder would have owned had this Warrant been exercised prior to the event and had the Holder continued to hold such shares until after the event requiring adjustment; provided,
however, that such adjustment shall not be made with respect to, and this Warrant shall terminate if not exercised prior to, the events set forth in Section&nbsp;7 below. The form of this Warrant need not be changed because of any adjustment in the
number of Exercise Shares subject to this Warrant. Notwithstanding anything to the contrary in this Warrant, in no event shall the Exercise Price be reduced below the par value of the Company&#146;s Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6. F<SMALL>RACTIONAL</SMALL> S<SMALL>HARES</SMALL>. </B>No fractional shares shall be issued upon the exercise of this Warrant as a
consequence of any adjustment pursuant hereto. All Exercise Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining whether the exercise would result in the issuance of any fractional share.
If, after aggregation, the exercise would result in the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction a sum in cash equal to the product resulting
from multiplying the then current closing price of the Common Stock on the principal securities exchange on which the Common Stock is listed by such fraction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7. E<SMALL>ARLY</SMALL> T<SMALL>ERMINATION</SMALL>. </B>In the event of, at any time during
the Exercise Period, (i)&nbsp;any consolidation or merger of the Company with or into another Person, (ii)&nbsp;the transfer of all or substantially all of the assets of the Company to another Person or (iii)&nbsp;the consummation of a stock
purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of
Common Stock of the Company, then the Company shall provide to the Holder five (5)&nbsp;days&#146; advance written notice of such transaction (which notice shall be deemed given in the event the Company makes a broadly accessible public announcement
of such transaction), and this Warrant shall terminate unless exercised prior to the closing of such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8. N<SMALL>O</SMALL>
S<SMALL>TOCKHOLDER</SMALL> R<SMALL>IGHTS</SMALL>. </B>This Warrant in and of itself shall not entitle the Holder to any voting rights, any rights to receive notices required to be given to the Company&#146;s stockholders, any rights to receive any
dividend or other distribution of assets, or any other rights as a stockholder of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9. T<SMALL>RANSFER</SMALL>
<SMALL>OF</SMALL> W<SMALL>ARRANT</SMALL>. </B>During the Exercise Period and prior to the full exercise of this Warrant for all Exercise Shares, Holder may, subject to compliance with all applicable laws and regulations and the transfer restrictions
set forth herein, transfer this Warrant and all rights hereunder by surrendering this Warrant to the Company or its Transfer Agent, as directed by the Company, together with all applicable transfer taxes, whereupon the Company will, or will cause
its Transfer Agent to, forthwith issue and deliver upon the order of the Holder a new Warrant registered in the name of the transferee designated by Holder, representing the right to purchase the number of Exercise Shares being transferred by the
Holder and, if less than the total number of Exercise Shares then underlying this Warrant is being transferred, a new Warrant) to the Holder representing the right to purchase the number of Exercise Shares not being transferred. The acceptance of
the new Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of the new Warrant that the Holder has in respect of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10. L<SMALL>OST</SMALL>, S<SMALL>TOLEN</SMALL>, M<SMALL>UTILATED</SMALL> <SMALL>OR</SMALL> D<SMALL>ESTROYED</SMALL> W<SMALL>ARRANT</SMALL>.
</B>If this Warrant is lost, stolen, mutilated or destroyed, the Company may, on such terms as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new
Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute an original contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated or
destroyed Warrant shall be at any time enforceable by anyone. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11. N<SMALL>OTICES</SMALL>, <SMALL>ETC</SMALL>. </B>All notices required
or permitted hereunder shall be in writing and shall be deemed effectively given: (a)&nbsp;upon personal delivery to the party to be notified, (b)&nbsp;when sent by confirmed email or facsimile if sent during normal business hours of the recipient,
if not, then on the next business day, (c)&nbsp;five (5)&nbsp;days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d)&nbsp;one (1)&nbsp;day after deposit with a internationally recognized
overnight courier, specifying next day delivery, with written verification of delivery. All communications shall be sent to the party to be notified at the address listed below such party&#146;s signature on the signature page hereto, or at such
other address as the party may designate by ten (10)&nbsp;days&#146; advance written notice to the other party hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.
A<SMALL>CCEPTANCE</SMALL>. </B>Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13. G<SMALL>OVERNING</SMALL> L<SMALL>AW</SMALL>. </B>This Warrant and all rights, obligations
and liabilities hereunder shall be governed by the laws of the State of New York, without regard to conflict of laws principles that would cause the application of laws of any other jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[S<SMALL>IGNATURE</SMALL> <SMALL>PAGE</SMALL> <SMALL>FOLLOWS</SMALL>] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the
Company has caused this Warrant to be executed by its duly authorized officer as of the Issuance Date set forth on the first page of this Warrant. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COMPANY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL> C<SMALL>ORPORATION</SMALL></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Matthew J. Pfeffer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President and Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">25134 Rye Canyon Loop, Suite 300</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Valencia,
California 91355</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: Rose Alinaya</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDER:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>[<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>]</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF EXERCISE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TO: M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL> C<SMALL>ORPORATION</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(1) </B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> <I>Cash Exercise.</I> The undersigned hereby elects to purchase
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares of the Common Stock of <B>M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL>
C<SMALL>ORPORATION</SMALL></B><SMALL></SMALL>, a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), pursuant to the Cash Exercise terms of the attached Warrant (the &#147;<B><I>Warrant</I></B>&#148;), and tenders herewith payment of the
Aggregate Exercise Price in full, together with all applicable transfer taxes, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>
<I>Cashless Exercise. </I>The undersigned hereby elects to purchase <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares of the Common Stock of
the Company pursuant to the Cashless Exercise terms of the Warrant, and shall tender payment of all applicable transfer taxes, if any. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(2) </B><U>Delivery of Exercise Shares</U>. The Company shall deliver to the Holder
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> Exercise Shares in accordance with the terms of the Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(3) </B>The undersigned represents that (i)&nbsp;unless the aforesaid shares have been registered for resale under the Securities Act of
1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;), the aforesaid shares are being acquired for the account of the undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof and that
the undersigned has no present intention of distributing or reselling such shares; (ii)&nbsp;the undersigned is aware of the Company&#146;s business affairs and financial condition and has acquired sufficient information about the Company to reach
an informed and knowledgeable decision regarding its investment in the Company; (iii)&nbsp;the undersigned is experienced in making investments of this type and has such knowledge and background in financial and business matters that the undersigned
is capable of evaluating the merits and risks of this investment and protecting the undersigned&#146;s own interests; (iv)&nbsp;unless the aforesaid shares have been registered for resale under an effective registration statement, prospectus and
prospectus supplement filed with the Securities and Exchange Commission, the undersigned understands that the shares of Common Stock issuable upon exercise of the Warrant have not been registered under the Securities Act by reason of a specific
exemption from the registration provisions of the Securities Act, which exemption depends upon, among other things, the bona fide nature of the investment intent as expressed herein, and, because such securities have not been registered under the
Securities Act, they must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is available; (v)&nbsp;unless the aforesaid shares have been registered for resale under the Securities
Act, the undersigned is aware that the aforesaid shares of Common Stock may not be sold pursuant to Rule 144 adopted under the Securities Act unless certain conditions are met and until the undersigned has held the shares for the period of time
prescribed by Rule 144, that among the conditions for use of Rule 144 is the availability of current information to the public about the Company; and (vi)&nbsp;the undersigned agrees not to make any disposition of all or any part of the aforesaid
shares of Common Stock unless and until there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with said registration statement, or the undersigned has
provided the Company with an opinion of counsel satisfactory to the Company, stating that such registration is not required. </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Date)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(Signature)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Print name)</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT FORM </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:33%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">(To assign the foregoing Warrant, execute this form and </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:33%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">supply required information. Do not use this form to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:33%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">purchase shares.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>F<SMALL>OR</SMALL> V<SMALL>ALUE</SMALL> R<SMALL>ECEIVED</SMALL></B><SMALL></SMALL>, the foregoing Warrant and all rights evidenced thereby
are hereby assigned to </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" ALIGN="center">(Please Print)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" ALIGN="center">(Please Print)</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,</U> 20<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holder&#146;s</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Signature:&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holder&#146;s</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE</B>: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant,
without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>3
<FILENAME>d107849dex108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.8 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g107849ex10_40.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">25134 Rye Canyon Loop</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Suite 300</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Valencia, CA 91355</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Main: (661)&nbsp;775-5300</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Fax:
(661)&nbsp;775-2081</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.mannkindcorp.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 11, 2016 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Juergen Martens
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4444 Jardin Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Irving, Texas 75038 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: Separation Agreement</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Juergen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter sets forth the terms of the separation agreement (the &#147;<B><I>Agreement</I></B>&#148;) that MannKind Corporation (the
&#147;<B><I>Company</I></B>&#148;) is offering to you to aid in your employment transition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. Separation</B>. Your employment with
the Company will continue through no later than March&nbsp;18, 2016, which will become your employment termination date (the &#147;<B><I>Separation Date</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. Accrued Salary and Paid Time Off</B>. Upon your Separation Date, the Company will pay you all accrued salary, and all accrued and unused
paid time off earned through the Separation Date, subject to standard payroll deductions and withholdings. You will receive these payments regardless of whether you enter into this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. Severance Benefits. </B>You will be paid the severance benefits described in this Section&nbsp;4 (the &#147;<B><I>Severance
Benefits</I></B>&#148;), <I>provided that,</I> on or within twenty-one (21)&nbsp;days from the Separation Date, you sign, date, and return to the Company, the General Release of Claims (the &#147;<B><I>General Release</I></B>&#148;) attached hereto
as <B><I><U>Exhibit A</U>,</I></B> and allow it to become effective in accordance with its terms. The Severance Benefits are as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(a) Cash Severance Payment</B>. Continuation of your annual base salary as of the Separation Date for a period of twelve (12)&nbsp;months
(the &#147;<B><I>Severance Period</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(b) COBRA Coverage. </B>If you timely elect continued coverage under the
Consolidated Omnibus Budget Reconciliation Act of 1985 (&#147;<B><I>COBRA</I></B>&#148;) or any state equivalent, for yourself and your covered dependents under the Company&#146;s group health plans following the Separation Date, then the Company
shall pay the premiums for such health care coverage (such payments, the &#147;<B><I>COBRA Premiums</I></B>&#148;) necessary to continue your health insurance coverage in effect for yourself and your eligible dependents on the Separation Date until
the earliest of (i)&nbsp;the close of the Severance Period, (ii)&nbsp;the expiration of your eligibility for continuation coverage under COBRA, and (iii)&nbsp;the date when you become eligible for substantially equivalent health insurance coverage
in connection with new employment or self-employment (such period from the termination date through the earliest of (i)&nbsp;through (iii), the &#147;<B><I>COBRA Payment Period</I></B>&#148;). If you become eligible for coverage under another
employer&#146;s group health plan or otherwise cease to be eligible for COBRA coverage during the period provided in this section, you must </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;11, 2016 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Juergen Martens </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Two </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
immediately notify the Company of such event, and the Company&#146;s obligation to pay COBRA Premiums on your behalf shall cease. In addition, during the COBRA Payment Period, to the extent
permitted under the terms of the applicable plans, the Company will pay for continued additional health coverage (such as Exec-U-Care), life, accidental death and disability and other insurance programs for you and your family members, if
applicable, to the extent such programs existed on the Separation Date (such additional coverage, the &#147;<B><I>Supplemental Coverage</I></B>&#148;). Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion,
that its payment of the COBRA Premiums or, as applicable, the premiums for the Supplemental Coverage on your behalf would result in a violation of applicable law (including, without limitation, Section&nbsp;2716 of the Public Health Service Act),
then in lieu of paying such premiums on your behalf, the Company will pay you on the last day of each remaining month of the COBRA Payment Period a cash payment equal to the amount of such premiums for that month on a post-tax basis, which payment
shall be subject to applicable tax withholding (such amount, the &#147;<B>Special Severance Payment</B>&#148;), such Special Severance Payment to be made without regard to the expiration of the COBRA Payment Period prior to the end of the Severance
Period. Such Special Severance Payment shall end on the earlier of (x)&nbsp;the date on which you commence other employment and (y)&nbsp;the close of the Severance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(c) Equity Acceleration</B>. The vesting of each of your time-based RSUs and Options will be accelerated such that you will become vested
in those RSUs and Options that would have vested during the Severance Period had you remained an employee of the Company through such date. Please note that your vested Option shares will be exercisable pursuant to the terms of the Plans and
applicable grant documents, which typically provide that vested Options may be exercised during a specified period that commences on the Separation Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4. No Other Compensation or Benefits.</B> You acknowledge that, except as expressly provided in this Agreement, you have not earned, you
will not receive and you are not entitled to receive from the Company any additional compensation (including base salary, bonus, or incentive compensation), severance, or benefits prior to, on, or after the Separation Date, including, but not
limited to the Executive Severance Agreement between you and the Company dated October&nbsp;10, 2007. For clarity, if all other Senior Executives employed by the Company do not receive an annual bonus for work performed in 2015, you shall not be
entitled to receive such a bonus. In addition, if one or more Senior Executives receives additional equity awards prior to the Separation Date as part of a retention or long-term incentive program, you will not be eligible to receive any such equity
awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5. Expense Reimbursements.</B> You agree that, within thirty (30)&nbsp;days after the Separation Date, you will submit your
final documented expense reimbursement statement reflecting all business expenses you incurred through the Separation Date, if any, for which you seek reimbursement. The Company will reimburse such expenses pursuant to its regular business practice.
If you are required to travel before or during the Transition Period to discharge your duties, then you shall be subject to the same travel expense guidelines as apply to Executive Leadership Team members. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;11, 2016 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Juergen Martens </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Three </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6. Return of Company Property. </B>By the Separation Date, you shall return to the Company
all Company documents (and all copies or reproductions thereof) and other Company property within your possession or control, including, but not limited to, Company hardcopy and electronic files, email, notes, drawings, records, reports, studies,
compilations of data, business plans and forecasts, proposals, agreements, financial and operational information, sales and marketing information, research and development information, product and prototype information, personnel information,
specifications, computer-recorded information, tangible property and equipment including, but not limited to, credit cards, entry cards, identification badges, keys, computing and communication devices; and any materials of any kind that contain or
embody any proprietary or confidential information of the Company (and all reproductions or embodiments thereof, in whole or in part). Your timely return of all such Company documents and other property is a condition precedent to your receipt of
the benefits provided under this Agreement; provided that you are permitted to retain copies of any agreement that you signed with the Company (after leaving with the Company the original or another copy, if you do not possess the original). Your
return of property and information shall include return of a copy of any Company information stored on any personal computing device, and deletion of all such information from your personal devices without retention of any copy or embodiment; and
you agree to permit the Company to inspect any such device, if there is a reasonable basis to suspect that you retained any such documents, to ensure that such return and deletion of information has taken place. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7. Proprietary Information Protection and Assignment of Rights to Work Product.</B> You acknowledge and agree to abide by your continuing
obligations under your Employee Proprietary Information and Inventions Agreement. You further agree that, both during and after your employment, you will make no use or disclosure of any Company proprietary or confidential information unless
specifically authorized in writing by a Company officer. You hereby assign to the Company all right, title, and interest you may have in any and all inventions, developments, concepts, methods, trade secrets, intellectual property, or other work
product developed or obtained by you during your employment with the Company that relates to any actual or anticipated line of business, product, service, or activity of the Company, or your performance of services for the Company, or was produced
on Company time or equipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8. Confidentiality.</B> The provisions of this Agreement will be held in strictest confidence by you and
the Company and will not be publicized or disclosed in any manner whatsoever; provided, however, that: (a)&nbsp;you may disclose this Agreement in confidence to your immediate family; (b)&nbsp;the parties may disclose this Agreement in confidence to
their respective attorneys, accountants, auditors, tax preparers, and financial advisors; (c)&nbsp;the Company may disclose this Agreement as necessary to fulfill standard or legally required corporate reporting or disclosure requirements; and
(d)&nbsp;the parties may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9. Nondisparagement. </B>Both parties agree not to disparage the other party and its officers, directors, employees, shareholders and
agents, in any manner likely to be harmful to them or their business, business reputations or personal reputations, provided that a party may respond accurately and fully to any inquiry to the extent required by legal process. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;11, 2016 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Juergen Martens </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Four </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10. No Admissions. </B>You understand and agree that the promises and payments in
consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11. Dispute Resolution. </B>To aid in the rapid and economical resolution of any disputes which may arise under this Agreement, you and the
Company agree that any and all claims, disputes or controversies of any nature whatsoever arising from or regarding the interpretation, performance, negotiation, execution, enforcement or breach of this Agreement, your employment, or the termination
of your employment, shall be resolved by confidential, final and binding arbitration conducted before a single arbitrator with JAMS, Inc. (&#147;JAMS&#148;) in the Los Angeles, California area, in accordance with JAMS&#146; then-applicable
arbitration rules, which appear at the following link: http://www.jamsadr.com/rules-comprehensive-arbitration/. <B>The parties acknowledge that by agreeing to this arbitration procedure, they waive the right to resolve any such dispute through a
trial by jury, judge or administrative proceeding</B>. You will have the right to be represented by legal counsel at any arbitration proceeding. The arbitrator shall: (a)&nbsp;have the authority to compel adequate discovery for the resolution of the
dispute and to award such relief as would otherwise be available under applicable law in a court proceeding; and (b)&nbsp;issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as
to each claim, the reasons for the award, and the arbitrator&#146;s essential findings and conclusions on which the award is based. The Company shall bear JAMS&#146; arbitration fees and administrative costs. Nothing in this Agreement shall prevent
either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and
state courts of any competent jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12 Miscellaneous.</B> This Agreement, including all exhibits, constitutes the complete,
final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein,
and it supersedes any other such promises, warranties or representations, including, but not limited to, your employment offer letter, Executive Severance Agreement and Employee Proprietary Information and Inventions Agreement (insofar as it may be
inconsistent with this Agreement). This Agreement may not be modified or amended except in a written agreement signed by both you and a duly authorized officer of the Company. If any provision of this Agreement (including, but not limited to, the
Employee Proprietary Information and Inventions Agreement, incorporated by reference herein) becomes or is declared illegal, unenforceable or void, this Agreement shall continue in full force and effect, and said provision shall be deemed modified
and enforceable consistent with the intent of the parties insofar as possible under applicable law. This Agreement will be construed and enforced in accordance with the laws of the State of California without respect to conflicts of law principles.
Any ambiguity in this Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement must be in writing and shall not be deemed a waiver of any successive breach. This Agreement may be executed in
counterparts and facsimile signatures will suffice as original signatures. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 11, 2016 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Juergen Martens </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Five </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Agreement is acceptable to you, please sign below on or within fourteen (14)&nbsp;calendar days and
then promptly return the fully signed original to me. The Company&#146;s offer contained herein will automatically expire if we do not receive the fully signed Agreement from you within this timeframe. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 11, 2016 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Juergen Martens </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Six </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We wish you the best in your future endeavors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>M<SMALL>ANN</SMALL>K<SMALL>IND</SMALL> C<SMALL>ORPORATION</SMALL></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Matthew Pfeffer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Matthew Pfeffer</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Chief Executive
Officer</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit A &#150; General Release of Claims </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>U<SMALL>NDERSTOOD</SMALL> <SMALL>AND</SMALL> A<SMALL>GREED</SMALL></B><SMALL></SMALL>:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><B>/</B>s/ Juergen Martens<B></B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>Juergen Martens</B></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">March <U></U>11, 2016</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XHIBIT</SMALL> A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEPARATION DATE RELEASE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(To be signed on or within 21 days after the Separation Date.) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration for the various benefits provided to me by MannKind Corporation (the &#147;<B>Company</B>&#148; pursuant to my Separation
Agreement with the Company dated March&nbsp;11, 2016 (the &#147;<B>Agreement</B>&#148;), I agree to the terms below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I hereby confirm
that: I have been paid all compensation owed for all hours worked by me for the Company; I have received all leave and leave benefits and protections for which I was eligible (pursuant to the Family and Medical Leave Act, the California Family
Rights Act or otherwise) in connection with my work with the Company; and I have not suffered any injury or illness in connection with my work with the Company for which I have not already filed a claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I hereby generally and completely release the Company and its current and former directors, officers, employees, shareholders, partners,
agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns from any and all claims, liabilities and obligations, both known and unknown, arising from or in any way related to events, acts, conduct,
or omissions occurring prior to and including the time I sign this Separation Date Release (the &#147;<B>Release</B>&#148;). This general release includes, but is not limited to: (1)&nbsp;all claims arising from or in any way related to my
employment with the Company, or the termination of that employment; (2)&nbsp;all claims related to compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, paid time off, expense reimbursements, severance pay,
fringe benefits, stock, stock options, or any other ownership interests in the Company; (3)&nbsp;all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (4)&nbsp;all tort claims,
including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5)&nbsp;all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys&#146; fees,
or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (&#147;<B>ADEA</B>&#148;), ERISA, the
California Fair Employment and Housing Act (as amended), the California Labor Code (as amended), and the California Family Rights Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I
am not releasing: (i)&nbsp;any rights or claims for indemnification I may have pursuant to any written indemnification agreement with the Company to which I am a party or under applicable law; (ii)&nbsp;any rights which cannot be waived as a matter
of law; (iii)&nbsp;any rights I have to file or pursue a claim for workers&#146; compensation or unemployment insurance; and (iv)&nbsp;any rights I have pursuant to my Separation Agreement with the Company dated March&nbsp;11, 2016. <B>In addition,
nothing in this Agreement prevents me from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission, the Department of Labor, or any other analogous federal or state government agency, except
that I acknowledge and agree that I hereby waive my right to any monetary benefits in connection with any such claim, charge or proceeding</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I also acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may
have under the ADEA (&#147;<B>Release ADEA Waiver</B>&#148;). I also acknowledge that the consideration given for the Release ADEA Waiver is in addition to anything of value to which I was already entitled. I further acknowledge that I have been
advised by this writing, as required by the ADEA, that: (a)&nbsp;my release and waiver herein does not apply to any rights or claims that arise after the date I sign this Release; (b)&nbsp;I should consult with an attorney prior to signing this
Release (although I may choose voluntarily not to do so); (c)&nbsp;I have twenty-one (21)&nbsp;days to consider this Release (although I may choose to voluntarily sign it sooner); (d)&nbsp;I have seven (7)&nbsp;days following the date I sign this
Release to revoke it (by sending written revocation directly to the Company&#146;s Chief Executive Officer); and (e)&nbsp;the Release will not be effective until the date upon which the revocation period has expired unexercised, which will be the
eighth day after I sign this Release (the &#147;<B>Release Effective Date</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT THIS RELEASE INCLUDES A RELEASE
OF ALL KNOWN AND UNKNOWN CLAIMS. I acknowledge that I have read and understand Section&nbsp;1542 of the California Civil Code which reads as follows: <B>&#147;A general release does not extend to claims which the creditor does not know or suspect to
exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.&#148; </B>I hereby expressly waive and relinquish all rights and benefits under that
section and any law or legal principle of similar effect in any jurisdiction with respect to my release of claims herein, including but not limited to the release of unknown and unsuspected claims. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Release, together with the Agreement (including all exhibits thereto), constitutes the complete, final and exclusive embodiment of the
entire agreement between me and the Company with regard to this subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained in the Release or the Agreement, and it
entirely supersedes any other such promises, warranties or representations, whether oral or written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Juergen Martens</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.36
<SEQUENCE>4
<FILENAME>d107849dex1036.htm
<DESCRIPTION>EX-10.36
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.36</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.36 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g107849ex10_37.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;30, 2015 revised </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">23312 Happy Valley </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Newhall, CA 91321 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: <B>Separation Agreement</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Hakan: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter supersedes any previous employment,
severance or change of control agreement and sets forth the terms of the transition and separation agreement (the &#147;<B>Agreement</B>&#148;) that MannKind Corporation (the &#147;<B>Company</B>&#148;) is offering to you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. S<SMALL>EPARATION</SMALL> D<SMALL>ATE</SMALL>.</B> As we have discussed, your employment termination date will be July&nbsp;1, 2017, or
such earlier date as your employment may be terminated by either you or the Company pursuant to Section&nbsp;3 below (the &#147;<B>Separation Date</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. T<SMALL>RANSITION</SMALL> D<SMALL>ATE</SMALL></B><SMALL></SMALL>. During the period between now and December&nbsp;31, 2015 (the
&#147;<B>Transition Date</B>&#148;), you may be required to perform some services transitioning responsibilities to the new or interim Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. T<SMALL>RANSITION</SMALL> P<SMALL>ERIOD</SMALL></B><SMALL></SMALL>.<B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>a. Transition Period Duties</B>. During the period between now and the Separation Date (the &#147;<B>Transition Period</B>&#148;), you will
remain an employee of the Company, serving in a non-executive capacity, reporting to the new or interim CEO. You agree that, during the Transition Period, you will comply with all Company policies and procedures and with all of your contractual
obligations to the Company (including, without limitation, your obligations under your Employee Proprietary Information and Inventions Agreement). Your Transition Period duties will include, but are not limited to, providing information to the
Company, as requested. During the Transition Period, you will not be expected to work from the Company&#146;s office locations on a full-time basis, although you will be expected to be available as needed. While you will ordinarily be working from
home during this period, you will receive from the Company such administrative support for your performance of your Company duties as needed. For clarity, during the Transition Period, you are entitled to obtain employment from another employer
provided such employment does not conflict with your then current Transition Period duties and applicable Company policies and procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>b. Standard Compensation/Benefits.</B> During the Transition Period, you will continue to receive your current base salary, subject to
standard withholdings and deductions; you will continue to accrue paid time off (&#147;<B>PTO</B>&#148;) according to Company policy; and you will be eligible for the </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 30, 2015 revised </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company&#146;s standard benefits, including but not limited to the Company&#146;s Exec-U-Care plan, subject to the terms of such plans and programs and applicable law. On the Separation Date, or
as soon as feasible thereafter, you will receive a final paycheck for all wages earned through the Separation Date (subject to standard withholdings and deductions), and all accrued and unused PTO. Your coverage under the Company&#146;s group health
plan will continue through the Transition Period, and your premiums will be paid by the Company to the extent provided by the Company&#146;s current health insurance policies. If at any time during the Transition Period, you become eligible to
continue your group health benefits at your own expense under the federal COBRA law, or applicable state insurance laws, the Company will pay your monthly COBRA premiums through the Separation Date. Thereafter, to the extent provided by the federal
COBRA law, or applicable state insurance laws, and by the Company&#146;s current health insurance policies, you will be eligible to continue your group health insurance benefits at your own expense. Later, you may be able to convert to an individual
policy through the provider of the Company&#146;s health insurance, if you wish. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>c. Annual Bonus.</B> During the Transition Period,
you will be eligible to receive an annual bonus for work performed in 2015 (scheduled to be paid in March following the conclusion of the applicable performance year), under the standard bonus plan applicable to Senior Executives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>d. Stock Options and Restricted Stock Units</B>. You were granted restricted stock units (the &#147;<B>RSUs</B>&#148;) in, and options (the
&#147;<B>Options</B>&#148;) to purchase, shares of the Company&#146;s common stock, pursuant to the Company&#146;s applicable equity incentive plan documents (collectively, the &#147;<B>Plan</B>&#148;) and your Option and RSU grant documents. During
the Transition Period, your Options and RSUs will continue to vest pursuant to the Plan, will continue to be governed by the Plan and applicable grant documents, and will cease vesting as of the Separation Date. Thereafter, your vested Option shares
will be exercisable pursuant to the terms of the Plan and applicable grant documents. You will not receive any additional equity awards during the Transition Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>e. Termination for Cause</B>. During the Transition Period, you are entitled to resign from your employment at any time for any reason.
Additionally, during the Transition Period, the Company is entitled to terminate your employment with or without Cause (as defined below). If the Company terminates your employment <I>with Cause</I> during the Transition Period, your employment ends
due to your death or disability, or you resign for any reason, your employment will end immediately and you will not receive any further compensation or benefits from the Company (including the severance payments set forth in Section&nbsp;4 below),
except for any unpaid salary and PTO accrued through your Separation Date and any vested benefit under a written ERISA-qualified benefit program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>f. &#147;Cause&#148; Definition</B>. For purposes of this Agreement, &#147;<B>Cause</B>&#148; for termination of your employment will mean
any of the following: (i)&nbsp;your commission of any act of fraud, embezzlement, dishonesty or any other willful misconduct that has caused or is reasonably likely to cause injury to the Company; (ii)&nbsp;your unauthorized use or disclosure of any
proprietary information or trade secrets of the Company or any other party in breach of a contractual commitment; (iii)&nbsp;your willful breach of any of your obligations under any written agreement with the Company or any Company policy; or
(iv)&nbsp;your engaging in employment or performing any work activities competitive with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4. S<SMALL>EPARATION</SMALL>
D<SMALL>ATE</SMALL> R<SMALL>ELEASE</SMALL> A<SMALL>ND</SMALL> S<SMALL>EVERANCE</SMALL> P<SMALL>AYMENT</SMALL></B><SMALL></SMALL>. Subject to the terms and conditions set forth in Section&nbsp;3 (Transition Period), if you remain a Company employee
through July&nbsp;1, 2017, you remain in compliance with this Agreement and all Company policies, and you sign the Separation Date Release on the Separation Date or within forty-five (45)&nbsp;days thereafter and allow it to become effective,
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 30, 2015 revised </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
then the Company will pay you as severance, an amount equal to the average bonus that you received in respect of calendar years 2013, 2014 and 2015 (each of which was paid in March following the
conclusion of the applicable performance year) (the &#147;<B>Severance</B>&#148;). The Severance will be subject to standard employment and income tax deductions and withholdings and will be paid to you in a lump sum on or before the date in 2018 on
which the annual bonuses for work performed in 2017 are paid, or on or within seven (7)&nbsp;days after the effective date of the Separation Date Release, if it occurs later. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5. O<SMALL>THER</SMALL> C<SMALL>OMPENSATION</SMALL> O<SMALL>R</SMALL> B<SMALL>ENEFITS</SMALL></B><SMALL></SMALL>. You acknowledge that,
except as expressly provided in this Agreement, you will not receive any additional compensation, severance, or benefits after the Separation Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6. E<SMALL>XPENSE</SMALL> R<SMALL>EIMBURSEMENTS</SMALL></B><SMALL></SMALL>. You agree that, within thirty (30)&nbsp;days after the
Separation Date, you will submit your final documented expense reimbursement statement reflecting all business expenses you incurred through the Separation Date, if any, for which you seek reimbursement. The Company will reimburse such expenses
pursuant to its regular business practice. If you are required to travel before or during the Transition Period or the Consulting Period to discharge your duties or perform Consulting Services, then you shall be subject to the same travel expense
guidelines as apply to Executive Leadership Team members. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7. R<SMALL>ETURN</SMALL> O<SMALL>F</SMALL> C<SMALL>OMPANY</SMALL>
P<SMALL>ROPERTY</SMALL></B><SMALL></SMALL>. By the Separation Date, you shall return to the Company all Company documents (and all copies or reproductions thereof) and other Company property within your possession or control, including, but not
limited to, Company hardcopy and electronic files, email, notes, drawings, records, reports, studies, compilations of data, business plans and forecasts, proposals, agreements, financial and operational information, sales and marketing information,
research and development information, product and prototype information, personnel information, specifications, computer-recorded information, tangible property and equipment including, but not limited to, credit cards, entry cards, identification
badges, keys, computing and communication devices; and any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions or embodiments thereof, in whole or in part). Your timely
return of all such Company documents and other property is a condition precedent to your receipt of the benefits provided under this Agreement; provided that you are permitted to retain copies of any agreement that you signed with the Company (after
leaving with the Company the original or another copy, if you do not possess the original). Your return of property and information shall include return of a copy of any Company information stored on any personal computing device, and deletion of
all such information from your personal devices without retention of any copy or embodiment; and you agree to permit the Company to inspect any such device to ensure that such return and deletion of information has taken place. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8. P<SMALL>ROPRIETARY</SMALL> I<SMALL>NFORMATION</SMALL> P<SMALL>ROTECTION</SMALL> A<SMALL>ND</SMALL> A<SMALL>SSIGNMENT</SMALL>
O<SMALL>F</SMALL> R<SMALL>IGHTS</SMALL> T<SMALL>O</SMALL> W<SMALL>ORK</SMALL> P<SMALL>RODUCT</SMALL></B><SMALL></SMALL>. You acknowledge and agree to abide by your continuing obligations under your Employee Proprietary Information and Inventions
Agreement. You further agree that, both during and after your employment, you will make no use or disclosure of any Company proprietary or confidential information unless specifically authorized in writing by a Company officer. You hereby assign to
the Company all right, title, and interest you may have in any and all inventions, developments, concepts, methods, trade secrets, intellectual property, or other work product developed or obtained by you during your employment with the Company that
relates to any actual or anticipated line of business, product, service, or activity of the Company, or your performance of services for the Company, or was produced on Company time or equipment. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 30, 2015 revised </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 4 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9. C<SMALL>ONFIDENTIALITY</SMALL></B><SMALL></SMALL>. The provisions of this Agreement
will be held in strictest confidence by you and the Company and will not be publicized or disclosed in any manner whatsoever; provided, however, that: (a)&nbsp;you may disclose this Agreement in confidence to your immediate family; (b)&nbsp;the
parties may disclose this Agreement in confidence to their respective attorneys, accountants, auditors, tax preparers, and financial advisors; (c)&nbsp;the Company may disclose this Agreement as necessary to fulfill standard or legally required
corporate reporting or disclosure requirements; and (d)&nbsp;the parties may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10. N<SMALL>ONDISPARAGEMENT</SMALL>.</B> You agree not to disparage the Company and its officers, directors, employees, shareholders and
agents, in any manner likely to be harmful to them or their business, business reputations or personal reputations, provided that you may respond accurately and fully to any inquiry to the extent required by legal process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11. N<SMALL>O</SMALL> A<SMALL>DMISSIONS</SMALL></B><SMALL></SMALL>. You understand and agree that the promises and payments in
consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12. R<SMALL>ELEASE</SMALL> O<SMALL>F</SMALL> C<SMALL>LAIMS</SMALL>.</B> In exchange for the consideration under this Agreement to which you
would not otherwise be entitled, you hereby generally and completely release the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers,
affiliates, and assigns from any and all claims, liabilities and obligations, both known and unknown, arising from or in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the time you sign this
Agreement. This general release includes, but is not limited to: (a)&nbsp;all claims arising from or in any way related to your employment with the Company or the termination of that employment; (b)&nbsp;all claims related to your compensation or
benefits from the Company, including salary, bonuses, commissions, fees, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (c)&nbsp;all claims for breach of
contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (d)&nbsp;all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e)&nbsp;all
federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys&#146; fees, or other claims arising under the federal Civil Rights Act of 1964 (as&nbsp;amended), the federal Americans with
Disabilities Act of 1990, the California Labor Code (as amended), the California Family Rights Act, the Age Discrimination in Employment Act (&#147;<B>ADEA</B>&#148;), and the California Fair Employment and Housing Act (as amended). Notwithstanding
the foregoing, you are not releasing the Company hereby from any breach of this Agreement subsequent to its Effective Date, or any obligation to indemnify you pursuant to the Articles and Bylaws of the Company, any valid fully executed
indemnification agreement with the Company, applicable law, or applicable directors and officers liability insurance. Also, excluded from this Agreement are any claims that cannot be waived by law. You are not waiving your right to bring proceedings
before administrative agencies such as the Equal Employment Opportunity Commission, Department of Labor, or the California Department of Fair Employment and Housing, provided that you are waiving any monetary recovery from such proceedings. You
represent that you have no lawsuits, claims or actions pending in your name, or on behalf of any other person or entity, against the Company or any other person or entity subject to the release granted in this paragraph. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 30, 2015 revised </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 5 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13. ADEA R<SMALL>ELEASE</SMALL></B><SMALL></SMALL>. You acknowledge that you are knowingly
and voluntarily waiving and releasing any rights you have under the ADEA, and that the consideration given for the waiver and releases you have given in this Agreement is in addition to anything of value to which you were already entitled. You
further acknowledge that you have been advised, as required by the ADEA that: (a)&nbsp;your waiver and release does not apply to any rights or claims that arise after the date you sign this Agreement; (b)&nbsp;you should consult with an attorney
prior to signing this Agreement (although you may choose voluntarily not to do so); (c)&nbsp;you have forty-five (45)&nbsp;days to consider this Agreement (although you may choose voluntarily to sign it sooner); (d)&nbsp;you have seven (7)&nbsp;days
following the date you sign this Agreement to revoke this Agreement (in a written revocation sent to me); and (e)&nbsp;this Agreement will not be effective until the date upon which the revocation period has expired, which will be the eighth day
after you sign this Agreement provided that you do not revoke it (the &#147;<B>Effective Date</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.
S<SMALL>ECTION</SMALL>&nbsp;1542 W<SMALL>AIVER</SMALL></B><SMALL></SMALL>. In granting the release herein, which includes claims that may be unknown to you at present, you acknowledge that you have read and understand Section&nbsp;1542 of the
California Civil Code: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;A general release does not extend to claims which the creditor does not know or suspect to exist in his or
her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.&#148;</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You hereby expressly waive and relinquish all rights and benefits under that section and any law or legal principle of similar effect in any jurisdiction with
respect to the releases granted herein, including but not limited to the release of unknown and unsuspected claims granted in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15. D<SMALL>ISPUTE</SMALL> R<SMALL>ESOLUTION</SMALL></B><SMALL></SMALL>. To aid in the rapid and economical resolution of any disputes
which may arise under this Agreement, you and the Company agree that any and all claims, disputes or controversies of any nature whatsoever arising from or regarding the interpretation, performance, negotiation, execution, enforcement or breach of
this Agreement, your employment, or the termination of your employment, shall be resolved by confidential, final and binding arbitration conducted before a single arbitrator with JAMS, Inc. (&#147;<B>JAMS</B>&#148;) in the Los Angeles, California
area, in accordance with JAMS&#146; then-applicable arbitration rules, which appear at the following link: <U>http://www.jamsadr.com/rules-comprehensive-arbitration/</U>. <B>The parties acknowledge that by agreeing to this arbitration procedure,
they waive the right to resolve any such dispute through a trial by jury, judge or administrative proceeding</B>. You will have the right to be represented by legal counsel at any arbitration proceeding. The arbitrator shall: (a)&nbsp;have the
authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be available under applicable law in a court proceeding; and (b)&nbsp;issue a written statement signed by the arbitrator regarding
the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator&#146;s essential findings and conclusions on which the award is based. The Company shall bear JAMS&#146; arbitration fees
and administrative costs. Nothing in this Agreement shall prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such
arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16.
R<SMALL>EPRESENTATIONS</SMALL>.</B> You hereby represent that you have been paid all compensation owed and for all hours worked; have received all the leave and leave benefits and protections for which you are eligible pursuant to the Family and
Medical Leave Act, the California Family Rights Act, or otherwise, and have not suffered any on-the-job injury for which you have not already filed a workers&#146; compensation claim. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 30, 2015 revised </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 6 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17. M<SMALL>ISCELLANEOUS</SMALL>.</B> This Agreement, including all exhibits, constitutes
the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly
contained herein, and it supersedes any other such promises, warranties or representations, including, but not limited to, your employment offer letter, Executive Severance Agreement and Employee Proprietary Information and Inventions Agreement
(insofar as it may be inconsistent with this Agreement). This Agreement may not be modified or amended except in a written agreement signed by both you and a duly authorized officer of the Company. If any provision of this Agreement (including, but
not limited to, the Employee Proprietary Information and Inventions Agreement, incorporated by reference herein) becomes or is declared illegal, unenforceable or void, this Agreement shall continue in full force and effect, and said provision shall
be deemed modified and enforceable consistent with the intent of the parties insofar as possible under applicable law. This Agreement will be construed and enforced in accordance with the laws of the State of California without respect to conflicts
of law principles. Any ambiguity in this Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement must be in writing and shall not be deemed a waiver of any successive breach. This Agreement may
be executed in counterparts and facsimile signatures will suffice as original signatures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If this Agreement is acceptable to you, please sign below and
return the original to me. You have forty-five (45)&nbsp;calendar days to decide whether to accept this Agreement, and the Company&#146;s offer contained herein will automatically expire if you do not sign and return it within this timeframe. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Alfred E. Mann</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Alfred E. Mann</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Chairman</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I HAVE READ, UNDERSTAND AND ACCEPT THE FOREGOING AGREEMENT: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Hakan S. Edstrom</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Hakan S. Edstrom</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">12/1/15</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 30, 2015 revised </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 7 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEPARATION DATE RELEASE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(To
be signed on or within 45 days after the Separation Date.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration for the various benefits provided to me by MannKind
Corporation (the &#147;Company&#148;) pursuant to my letter Transition and Separation Agreement with the Company dated November&nbsp;30, 2015 (the &#147;Agreement&#148;), I agree to the terms below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I hereby confirm that: I have been paid all compensation owed for all hours worked by me for the Company; I have received all leave and leave
benefits and protections for which I was eligible (pursuant to the Family and Medical Leave Act, the California Family Rights Act or otherwise) in connection with my work with the Company; and I have not suffered any injury or illness in connection
with my work with the Company for which I have not already filed a claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I hereby generally and completely release the Company and its
current and former directors, officers, employees shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns from any and all claims, liabilities and obligations, both known
and unknown, arising from or in any way related to events, acts, conduct, or omissions occurring prior to and including the time I sign this Separation Date Release (the &#147;Release&#148;). This general release includes, but is not limited to:
(1)&nbsp;all claims arising from or in any way related to my employment with the Company, or the termination of that employment; (2)&nbsp;all claims related to compensation or benefits from the Company, including salary, bonuses, commissions,
vacation pay, paid time off, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (3)&nbsp;all claims for breach of contract, wrongful termination, and breach of the implied
covenant of good faith and fair dealing; (4)&nbsp;all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (5)&nbsp;all federal, state, and local statutory claims, including claims
for discrimination, harassment, retaliation, attorneys&#146; fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act
of 1967 (as amended) (&#147;ADEA&#146;&#146;), ERISA, the California Fair Employment and Housing Act (as amended), the California Labor Code (as amended), the California Family Rights Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I am not releasing: (i)&nbsp;any rights or claims for indemnification I may have pursuant to any written indemnification agreement with the
Company to which I am a party or under applicable law; (ii)&nbsp;any rights which cannot be waived as a matter of law; (iii)&nbsp;any rights I have to file or pursue a claim for workers&#146; compensation or unemployment insurance; and (iv)&nbsp;any
claims for breach of this Release. <B>In addition, nothing in this Agreement prevents me from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission, the Department of Labor, or any other
analogous federal or state government agency, except that I acknowledge and agree that I hereby waive my right to any monetary benefits in connection with any such claim, charge or proceeding.</B> </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 30, 2015 revised </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 8 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I also acknowledge that I am knowingly and voluntarily waiving and releasing any right I may
waiving and releasing any rights I may have under the ADEA (&#147;<B>Release ADEA Waiver</B>&#148;). I also acknowledge that the consideration given for the Release ADEA Waiver is in addition to anything of value to which I was already entitled. I
further acknowledge that I have been advised by this writing, as required by the ADEA, that: (a)&nbsp;my release and waiver herein does not apply to any rights or claims that arise after the date I sign this Release; (b)&nbsp;I should consult with
an attorney prior to signing this Release (although I may choose voluntarily not to do so); (c)&nbsp;I have forty-five (45)&nbsp;days to consider this Release (although I may choose to voluntarily sign it sooner); (d)&nbsp;I have seven (7)&nbsp;days
following the date I sign this Release to revoke it (by sending written revocation directly to the Company&#146;s Chief Executive Officer); and (e)&nbsp;the Release will not be effective until the date upon which the revocation period has expired
unexercised, which will be the eighth day after I sign this Release (the &#147;<B>Release Effective Date</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT
THIS RELEASE INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS. I acknowledge that I have read and understand Section&nbsp;1542 of the California Civil Code which reads as follows: &#147;<B>A general release does not extend to claims which the
creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor</B>.&#148; I hereby expressly waive and relinquish
all rights and benefits under that section and any law or legal principle of similar effect in any jurisdiction with respect to my release of claims herein, including but not limited to the release of unknown and unsuspected claims. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Release, together with the Agreement (including all exhibits thereto), constitutes the complete, final and exclusive embodiment of the
entire agreement between me and the Company with regard to this subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained in the Release or the Agreement, and it
entirely supersedes any other such promises, warranties or representations, whether oral or written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom</P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">Date</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hakan S. Edstrom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November 30, 2015 revised </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 9 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANNKIND CORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYEE PROPRIETARY INFORMATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND INVENTIONS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of my employment or continued employment by <B>MANNKIND CORPORATION</B> (the &#147;<B>Company</B>&#148;), and the
compensation now and hereafter paid to me, I hereby agree as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. N<SMALL>ONDISCLOSURE</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>1.1 Recognition of Company&#146;s Rights; Nondisclosure.</B> At all times during my employment and thereafter, I will hold in strictest
confidence and will not disclose, use, lecture upon or publish any of the Company&#146;s Proprietary Information (defined below), except as such disclosure, use or publication may be required in connection with my work for the Company, or unless an
officer of the Company expressly authorizes such in writing. I will obtain Company&#146;s written approval before publishing or submitting for publication any material (written, verbal, or otherwise) that relates to my work at Company and/or
incorporates any Proprietary Information. I hereby assign to the Company any rights I may have or acquire in such Proprietary Information and recognize that all Proprietary Information shall be the sole property of the Company and its assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>1.2 Proprietary Information. </B>The term &#147;<B>Proprietary Information</B>&#148; shall mean any and all confidential and/or
proprietary knowledge, data or information of the Company. By way of illustration but not limitation <B>&#147;Proprietary Information&#148;</B> includes (a)&nbsp;tangible and intangible information relating to antibodies and other biological
materials, cell lines, samples of assay components, media and/or cell lines and procedures and formulations for producing any such assay components, media and/or cell lines, formulations, products, processes, know-how, designs, formulas, methods,
developmental or experimental work, clinical data, improvements, discoveries, plans for research, new products, marketing and selling, business plans, budgets and unpublished financial statements, licenses, prices and costs, suppliers and customers,
and information regarding the skills and compensation of other employees of the Company (hereinafter collectively referred to as <B>&#147;Inventions&#148;</B>); and (b)&nbsp;information regarding plans for research, development, new products,
marketing and selling, business plans, budgets and unpolished financial statements, licenses, prices and costs, suppliers and customers; and (c)&nbsp;information regarding the skills and compensation of other employees of the Company.
Notwithstanding the foregoing, it is understood that, at all such
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:2%; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
times, I am free to use information which is generally known in the trade or industry, which is not gained as result of a breach of this Agreement, and my own, skill, knowledge, know-how and
experience to whatever extent and in whichever way I wish. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>1.3 Third Party Information.</B> I understand, in addition, that the
Company has received and in the future will receive from third parties confidential or proprietary information (&#147;<B>Third Party Information</B>&#148;) subject to a duty on the Company&#146;s part to maintain the confidentiality of such
information and to use it only for certain limited purposes. During the term of my employment and thereafter, I will hold Third Party Information in the strictest confidence and will not disclose to anyone (other than Company personnel who need to
know such information in connection with their work for the Company) or use, except in connection with my work for the Company, Third Party Information unless expressly authorized by an officer of the Company in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>1.4 No Improper Use of Information of Prior Employers and Others.</B> During my employment by the Company I will not improperly use or
disclose any confidential information or trade secrets, if any, of any former employer or any other person to whom I have an obligation of confidentiality, and I will not bring onto the premises of the Company any unpublished documents or any
property belonging to any former employer or any other person to whom I have an obligation of confidentiality unless consented to in writing by that former employer or person. I will use in the performance of my duties only information which is
generally known and used by persons with training and experience comparable to my own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. A<SMALL>SSIGNMENT</SMALL> <SMALL>OF</SMALL> I<SMALL>NVENTIONS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>2.1 Proprietary Rights.</B> The term &#147;<B>Proprietary Rights</B>&#148; shall mean all trade secret, patent, copyright, mask work and
other intellectual property rights throughout the world. </P></DIV><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1. </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="position:relative;float:left; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>2.2 Prior Inventions.</B> Inventions, if any, patented or unpatented, which I made prior to
the commencement of my employment with the Company are excluded from the scope of this Agreement. To preclude any possible uncertainty, I have set forth on <I>Exhibit&nbsp;B </I>(Previous Inventions) attached hereto a complete list of all Inventions
that I have, alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of my employment with the Company, that I consider to be my property or the
property of third parties and that I wish to have excluded from the scope of this Agreement (collectively referred to as &#147;<B>Prior Inventions</B>&#148;). If disclosure of any such Prior Invention would cause me to violate any prior
confidentiality agreement, I understand that I am not to list such Prior Inventions in <I>Exhibit&nbsp;B</I> but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full
disclosure as to such inventions has not been made for that reason. A space is provided on <I>Exhibit B</I> for such purpose. If no such disclosure is attached, I represent that there are no Prior Inventions. If, in the course of my employment with
the Company, I incorporate a Prior Invention into a Company product, process or machine, the Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights to sublicense through multiple
tiers of sublicensees) to make, have made, modify, use and sell such Prior Invention. Notwithstanding the foregoing, I agree that I will not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions without the
Company&#146;s prior written consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>2.3 Assignment of Inventions.</B> Subject to Sections 2.4, and 2.6, I hereby assign and agree
to assign in the future (when any such Inventions or Proprietary Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to the Company all my right, title and interest in and to any and all Inventions (and all
Proprietary Rights with respect thereto) whether or not patentable or registrable under copyright or similar statutes, made or conceived or reduced to practice or learned by me, either alone or jointly with others, during the period of my employment
with the Company. Inventions assigned to the Company, or to a third party as directed by the Company pursuant to this Section&nbsp;2, are hereinafter referred to as &#147;<B>Company Inventions</B>.&#148;
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:2%; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>2.4 Nonassignable Inventions.</B> This Agreement does not apply to an Invention which
qualifies fully as a nonassignable Invention under Section&nbsp;2870 of the California Labor Code (hereinafter &#147;<B>Section&nbsp;2870</B>&#148;). I have reviewed the notification on <I>Exhibit A</I> (Limited Exclusion Notification) and agree
that my signature acknowledges receipt of the notification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>2.5 Obligation to Keep Company Informed.</B> During the period of my
employment and for six (6)&nbsp;months after termination of my employment with the Company, I will promptly disclose to the Company fully and in writing all Inventions authored, conceived or reduced to practice by me, either alone or jointly with
others. In addition, I will promptly disclose to the Company all patent applications filed by me or on my behalf within a year after termination of employment. At the time of each such disclosure, I will advise the Company in writing of any
Inventions that I believe fully qualify for protection under Section&nbsp;2870; and I will at that time provide to the Company in writing all evidence necessary to substantiate that belief. The Company will keep in confidence and will not use for
any purpose or disclose to third parties without my consent any confidential information disclosed in writing to the Company pursuant to this Agreement relating to Inventions that qualify fully for protection under the provisions of
Section&nbsp;2870. I will preserve the confidentiality of any Invention that does not fully qualify for protection under Section&nbsp;2870. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>2.6 Government or Third Party.</B> I also agree to assign all my right, title and interest in and to any particular Company Invention to
a third party, including without limitation the United States, as directed by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>2.7 Works for Hire.</B> I acknowledge
that all original works of authorship which are made by me (solely or jointly with others) within the scope of my employment and which are protectable by copyright are &#147;works made for hire,&#148; pursuant to United States Copyright Act (17
U.S.C., Section&nbsp;101). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>2.8 Enforcement of Proprietary Rights.</B> I will assist the Company in every proper way to obtain, and
from time to time enforce, United States and foreign Proprietary Rights relating to Company Inventions in any and all countries. To that end I will execute, verify and deliver such documents and perform such other acts (including appearances as a
witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and
</P></DIV><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2. </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="position:relative;float:left; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the assignment thereof. In addition, I will execute, verify and deliver assignments of such Proprietary Rights to the Company or its designee. My obligation to assist the Company with respect to
Proprietary Rights relating to such Company Inventions in any and all countries shall continue beyond the termination of my employment, but the Company shall compensate me at a reasonable rate after my termination for the time actually spent by me
at the Company&#146;s request on such assistance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event the Company is unable for any reason, after reasonable effort, to secure my signature on
any document needed in connection with the actions specified in the preceding paragraph, I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact, which appointment is
coupled with an interest, to act for and in my behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding paragraph with the same legal force and effect as if executed
by me. I hereby waive and quitclaim to the Company any and all claims, of any nature whatsoever, which I now or may hereafter have for infringement of any Proprietary Rights assigned hereunder to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. R<SMALL>ECORDS</SMALL>.</B> I agree to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form
that may be required by the Company) of all Proprietary Information developed by me and all Inventions made by me during the period of my employment at the Company, which records shall be available to and remain the sole property of the Company at
all times. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. A<SMALL>DDITIONAL</SMALL> A<SMALL>CTIVITIES</SMALL>.</B> I agree that during the period of my employment by the Company I will not,
without the Company&#146;s express written consent, engage in any employment or business activity which is competitive with, or would otherwise conflict with, my employment by the Company. I agree further that for the period of my employment by the
Company and for five (5)&nbsp;years after the date of termination of my employment by the Company I will not, either directly or through others, solicit or attempt to solicit any employee, independent contractor or consultant of the company to
terminate his or her relationship with the Company in order to become and employee, consultant or independent contractor to or for any other person or entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. N<SMALL>O</SMALL> C<SMALL>ONFLICTING</SMALL> O<SMALL>BLIGATION</SMALL>.</B> I represent that my performance of all the terms of this Agreement and as an
employee of the Company does not and will not breach any agreement to keep in confidence information acquired by me in
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:2%; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
confidence or in trust prior to my employment by the Company. I have not entered into, and I agree I will not enter into, any agreement either written or oral in conflict herewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. R<SMALL>ETURN</SMALL> <SMALL>OF</SMALL> C<SMALL>OMPANY</SMALL> D<SMALL>OCUMENTS</SMALL>.</B> When I leave the employ of the Company, I will deliver to
the Company any and all drawings, notes, memoranda, specifications, devices, formulas, and documents, together with all copies thereof, and any other material containing or disclosing any Company Inventions, Third Party Information or Proprietary
Information of the Company. I further agree that any property situated on the Company&#146;s premises and owned by the Company, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company
personnel at any time with or without notice. Prior to leaving, I will cooperate with the Company in completing and signing the Company&#146;s termination statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. L<SMALL>EGAL</SMALL> <SMALL>AND</SMALL> E<SMALL>QUITABLE</SMALL> R<SMALL>EMEDIES</SMALL>.</B> Because my services are personal and unique and because I
may have access to and become acquainted with the Proprietary Information of the Company, the Company shall have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other equitable relief, without
bond and without prejudice to any other rights and remedies that the Company may have for a breach of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. N<SMALL>OTICES</SMALL>.</B>
Any notices required or permitted hereunder shall be given to the appropriate party at the address specified below or at such other address as the party shall specify in writing. Such notice shall be deemed given upon personal delivery to the
appropriate address or if sent by certified or registered mail, three (3)&nbsp;days after the date of mailing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. N<SMALL>OTIFICATION</SMALL>
<SMALL>OF</SMALL> N<SMALL>EW</SMALL> E<SMALL>MPLOYER</SMALL>.</B> In the event that I leave the employ of the Company, I hereby consent to the notification of my new employer of my rights and obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. G<SMALL>ENERAL</SMALL> P<SMALL>ROVISIONS</SMALL>.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>10.1 Governing Law; Consent to Personal Jurisdiction.</B> This Agreement will be governed by and construed according to the laws of the
State of California, as such laws are applied to agreements entered into and to be performed entirely within California between California residents. I hereby expressly consent to the personal jurisdiction of the state and federal courts located in
Los Angeles County, California for any lawsuit filed there against me by Company arising from or related to this Agreement. </P></DIV><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3. </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="position:relative;float:left; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>10.2 Severability.</B> In case any one or more of the provisions contained in this
Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if
such invalid, illegal or unenforceable provision had never been contained herein. If moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope,
activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>10.3 Successors and Assigns.</B> This Agreement will be binding upon my heirs, executors, administrators and other legal representatives
and will be for the benefit of the Company, its successors, and its assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>10.4 Survival.</B> The provisions of this Agreement
shall survive the termination of my employment and the assignment of this Agreement by the Company to any successor in interest or other assignee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>10.5 Employment.</B> I agree and understand that nothing in this Agreement shall confer any right with respect to continuation of
employment by the Company, nor shall it interfere in any way with my right or the Company&#146;s right to terminate my employment at any time, with or without cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>10.6 Waiver.</B> No waiver by the Company of any breach of this Agreement shall be a waiver of any preceding or succeeding breach. No
waiver by the Company of any right under this Agreement shall be construed as a waiver of any other right. The Company shall not be required to give notice to enforce strict adherence to all terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>10.7 Advice of Counsel. </B>I acknowledge that, in executing this agreement, I have had the opportunity to seek the advice of independent
legal counsel, and I have read and understood all of the terms and provisions of this agreement. This agreement shall not be construed against any party by reason of the drafting or preparation hereof.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:2%; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>10.8 Entire Agreement.</B> The obligations pursuant to Sections 1 and 2 of this Agreement
shall apply to any time during which I was previously employed, or am in the future employed, by the Company as a consultant if no other agreement governs nondisclosure and assignment of inventions during such period. This Agreement is the final,
complete and exclusive agreement of the parties with respect to the subject matter hereof and supersedes and merges all prior discussions between us. No modification of or amendment to this Agreement, nor any waiver of any rights under this
Agreement, will be effective unless in writing and signed by the party to be charged. Any subsequent change or changes in my duties, salary or compensation will not affect the validity or scope of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman">This Agreement shall be effective as of the first day of my employment with the Company, namely: <U>April&nbsp;20, 2001</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:20pt; font-size:10pt; font-family:Times New Roman"><B>I <SMALL>HAVE</SMALL> <SMALL>READ</SMALL> <SMALL>THIS</SMALL> A<SMALL>GREEMENT</SMALL> <SMALL>CAREFULLY</SMALL> <SMALL>AND</SMALL>
<SMALL>UNDERSTAND</SMALL> <SMALL>ITS</SMALL> <SMALL>TERMS</SMALL>. I <SMALL>HAVE</SMALL> <SMALL>COMPLETELY</SMALL> <SMALL>FILLED</SMALL> <SMALL>OUT</SMALL> E<SMALL>XHIBIT</SMALL>&nbsp;B <SMALL>TO</SMALL> <SMALL>THIS</SMALL>
A<SMALL>GREEMENT</SMALL>.</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: 10/13/03</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Hakan Edstrom</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>(Signature)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">Hakan Edstrom</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(Printed Name)</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>(Address)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>A<SMALL>CCEPTED</SMALL> <SMALL>AND</SMALL> A<SMALL>GREED</SMALL> T<SMALL>O</SMALL>:</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MANNKIND CORPORATION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Monique Harrington</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>HR Generalist</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10/13/03</TD></TR>
</TABLE> </DIV><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4. </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>XHIBIT</SMALL> B </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="75%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>TO:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>MANNKIND CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>FROM:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Hakan Edstrom</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>DATE:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>10/13/03</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>SUBJECT:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Previous Inventions</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1<B>. </B>Except as listed in Section&nbsp;2 below, the following is a complete list of all inventions or improvements
relevant to the subject matter of my employment by MannKind Corporation (the &#147;<B>Company</B>&#148;) that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">No inventions or improvements.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">See below:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Additional sheets attached. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2<B>. </B>Due to a prior confidentiality agreement, I cannot
complete the disclosure under Section&nbsp;1 above with respect to inventions or improvements generally listed below, the proprietary rights and duty of confidentiality with respect to which I owe to the following party(ies): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Invention or Improvement</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Party(ies)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Relationship</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Additional sheets attached. </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.37
<SEQUENCE>5
<FILENAME>d107849dex1037.htm
<DESCRIPTION>EX-10.37
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.37</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.37 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078491.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078492.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078493.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078494.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078495.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078496.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078497.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078498.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g1078499.jpg" ALT="LOGO">
 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.38
<SEQUENCE>6
<FILENAME>d107849dex1038.htm
<DESCRIPTION>EX-10.38
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.38</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.38 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">


<IMG SRC="g107849ex10_39.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">25134 Rye Canyon Loop</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Suite 300</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Valencia, CA 91355</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Main: (661)&nbsp;775-5300</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.mannkindcorp.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;3, 2016 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael
Castagna </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">638 Lindero Canyon Road, Suite 333 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Oak Park, CA
91377 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Michael, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Congratulations! The MannKind team
has been very impressed with your background and credentials, and we are genuinely pleased to offer you full-time employment with MannKind Corporation, in the exempt position Chief Commercialization Officer located in Valencia CA. In this position
you will initially report directly to Matthew J. Pfeffer, Chief Executive Officer and CFO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will target your employment to commence on March&nbsp;14,
2016. Please be advised that this offer is contingent upon satisfactory reference and background checks and receipt of results of a satisfactory drug screening test. In the coming days, you will receive an email with information regarding the test,
contact and location information for the laboratory as well as the hours of operation. This screening test must be completed no later than two weeks from the date of this letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be paid on a bi-weekly basis, on regular payroll schedule, in the amount of $15,384.61, equating to an annualized amount of $400,000.00. You will be
eligible to participate in the MannKind Discretionary Bonus Plan, with a target bonus opportunity of 50% of annual earnings. You will be eligible for a car allowance of $553.85 paid on a biweekly basis equating to an annualized amount of $14,400.00.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, you will receive a one-time sign-on bonus in the gross amount of $50,000.00, less appropriate with-holdings and other payroll deductions,
payable as a lump sum on the first pay period at the end of the first ninety (90)&nbsp;days of your employment. By accepting this offer, you agree that, in the event that you voluntarily leave the Company, or if you are terminated by the Company for
&#147;cause&#148;, within the twelve (12)&nbsp;months following receipt of payment, you will repay the full amount of the payment, net any with-holdings within thirty (30)&nbsp;days after the last day of your employment. By accepting this offer, you
further agree that the Company may deduct this amount from any other amounts The Company owes you should you be obligated to repay this amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will
be eligible to participate in MannKind&#146;s Equity Incentive Plan, under which stock options and restricted stock will be awarded to you at a future date, as approved by the Board of Directors. At the next quarterly Board meeting after your hire
date, we will recommend that you be granted an equity award of 329,200 stock options and 80,000 restricted stock units which is comparable to grants made for other individuals in similar level positions throughout the company. This is not a
guarantee for a specific </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Castagna, page two </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">number of restricted stock units, but is only intended to provide you with an understanding of grant guidelines for your position. If your start date is less
than two weeks prior to the next quarterly Board meeting, the recommendation will be submitted in the following quarter. Grants will begin vesting based on your hire date. You will also be eligible for an annual equity grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the Board will be asked to make a special grant of 1,000,000 performance based stock options, with performance based vesting terms to be
mutually agreed upon in advance of their grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a substantial list of fringe benefits, including the following: 22 days PTO annually, which
accrues on a bi-weekly basis; short term and long term disability insurance; company&#150;paid life insurance; a 401(k) tax deferred savings program; flexible spending accounts; health, vision and dental insurance, and twelve paid holidays. The
holidays and other time off benefits will be prorated based on your date of hire. All benefits, policies and rules are subject to change from time to time at the Company&#146;s discretion. All benefits outlined in this offer letter are contingent on
your continuing employment with MannKind Corporation in a benefit eligible status. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shortly after we are in receipt of your acceptance, you will receive a
welcome email from our onboarding manager, with a link to your personalized onboarding portal. Through this portal you will have access to most of the required MannKind policies and agreements that will require your signature such as, the Employee
Proprietary Information and Inventions Agreement, an Arbitration Agreement, a Policy Against Insider Trading, Code of Business Conduct and Ethics, and an Employee Acknowledgement Form, required after reading the MannKind Employee Sourcebook. Of
course, the company may require additional policies or agreements to be signed and acknowledged in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Employment at MannKind is at will, which
means that either you or MannKind can end the employment relationship at any time, and for any reason or for no reason, with or without cause or notice. The employment terms in this letter supersede any other agreements or promises made to you by
anyone, whether oral or written, and cannot be modified or amended except in writing by an officer of the company. As required by law, this offer is subject to satisfactory proof of your right to work in the United States. This at will employment
relationship cannot be changed except in writing as approved by the Board of Directors of MannKind. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We appreciate the energy and enthusiasm you
demonstrated during our interview and selection process and we look forward to a favorable response to our offer. We have many exciting challenges ahead and believe you can make a significant contribution to MannKind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At your earliest convenience, please sign and date this letter and return it to Linda Adreveno, Sr. V. P. Human Resources (<U>ladreveno@mannkindcorp.com</U>)
to indicate your acceptance of this written offer of employment. Please also include proof of your annual compensation in the form of a recent pay stub or W2/1099. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you should have any questions, please don&#146;t hesitate to contact me. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Matthew J. Pfeffer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer
and CFO</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Castagna, page three </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I have carefully read and understand all of the terms of the above letter and freely and voluntarily accept and agree to all of its terms. I represent that,
in agreeing to this offer letter, I am not relying on any representations or promises of any kind other than set forth in this letter. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Michael Castagna</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Michael Castagna</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">March&nbsp;9, 2016</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date Signed</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">March&nbsp;14, 2016</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Confirmed Start Date</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>d107849dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 23.1 </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We consent to the incorporation
by reference in Registration Statement Nos. 333-117811, 333-127876, 333-137332, 333-149049, 333-160225, 333-176409, 333-182457 and 333-188790 on Form S-8 of our reports dated March&nbsp;15, 2016, relating to the consolidated financial statements of
MannKind Corporation and subsidiaries (&#147;MannKind Corporation&#148;) (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the Company&#146;s ability to continue as a going concern), and the
effectiveness of MannKind Corporation&#146;s internal control over financial reporting (which report expresses an adverse opinion on the effectiveness of MannKind Corporation&#146;s internal control over financial reporting because of a material
weakness), appearing in this Annual Report on Form 10-K of MannKind Corporation for the year ended December&nbsp;31, 2015. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/
Deloitte&nbsp;&amp; Touche LLP </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Los Angeles, California </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">March&nbsp;15, 2016 </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>8
<FILENAME>d107849dex31.htm
<DESCRIPTION>EX-31
<TEXT>
<HTML><HEAD>
<TITLE>EX-31</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 31 </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><U>RULE 13a-14(a)/15d-14(a) CERTIFICATION </U></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">I, Matthew J. Pfeffer, certify that:
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">1. I have reviewed this Annual Report on Form 10-K of MannKind Corporation; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this report; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">4. I am are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being
prepared; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b) Designed such internal control over financial reporting, or caused such internal control over
financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c) Evaluated the effectiveness of the registrant&#146;s disclosure controls and
procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d) Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred
during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control
over financial reporting; and </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">5. I have disclosed, based on my most recent evaluation of internal control over financial
reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions): </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Matthew J. Pfeffer</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Matthew J. Pfeffer</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief
Executive Officer and</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer</FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: March&nbsp;15, 2016 </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>9
<FILENAME>d107849dex32.htm
<DESCRIPTION>EX-32
<TEXT>
<HTML><HEAD>
<TITLE>EX-32</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 32 </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:2%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirement set forth in Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended (the
&#147;Exchange Act&#148;), and Section&nbsp;1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), Matthew J. Pfeffer, Chief Executive Officer and Chief Financial Officer of MannKind Corporation (the &#147;Company&#148;),
hereby certifies that, to the best of his knowledge: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:2%; font-size:10pt; font-family:Times New Roman">1. The Company&#146;s Annual Report on Form 10-K for the period ended
December&nbsp;31, 2015, to which this Certification is attached as Exhibit 32 (the &#147;Annual Report&#148;) fully complies with the requirements of Section&nbsp;13(a) or Section&nbsp;15(d) of the Exchange Act, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:2%; font-size:10pt; font-family:Times New Roman">2. The information contained in the Annual Report fairly presents, in all material respects, the financial condition and
results of operations of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:2%; font-size:10pt; font-family:Times New Roman">In Witness Whereof, the undersigned has set his hand hereto as of the 15th day of March, 2016. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew J. Pfeffer</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Matthew J. Pfeffer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief&nbsp;Executive&nbsp;Officer&nbsp;and&nbsp;Chief&nbsp;Financial&nbsp;Officer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">This certification accompanies the Annual Report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of MannKind
Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Annual Report on Form 10-K to which this certification relates), irrespective of any general
incorporation language contained in such filing. </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>10
<FILENAME>mnkd-20151231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version:  6.22.4 -->
<!-- Round: 77f33050-bdaf-4a1d-9f8a-38d5ff9252cd -->
<!-- Creation date: 2016-03-15T21:03:45Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:mnkd="http://www.mannkindcorp.com/20151231" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="mnkd-20151231.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <mnkd:UnitsSoldWarrantPortionConvertibleIntoCommonStock contextRef="eol_PE126000--1510-K0015_STD_0_20120208_0" unitRef="iso4217_USD_per_Right" decimals="1" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_3001_3">0.6</mnkd:UnitsSoldWarrantPortionConvertibleIntoCommonStock>
  <mnkd:UnitsSoldUnderPublicOfferUnderwritten contextRef="eol_PE126000--1510-K0015_STD_0_20120208_0" unitRef="shares" decimals="0" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_3001_0">35937500</mnkd:UnitsSoldUnderPublicOfferUnderwritten>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE126000--1510-K0015_STD_0_20120208_0_1116897x1213796" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_4001_8">2.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE126000--1510-K0015_STD_0_20120208_0_1116897x1213796" unitRef="shares" decimals="INF" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_4001_7">21562500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <mnkd:UnitsSoldByUnderwritingPrice contextRef="eol_PE126000--1510-K0015_STD_0_20120208_0_1212432x1204313" unitRef="iso4217_USD_per_Right" decimals="INF" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_5001_4">2.40</mnkd:UnitsSoldByUnderwritingPrice>
  <mnkd:UnitsSoldByUnderwritingPrice contextRef="eol_PE126000--1510-K0015_STD_0_20120208_0_1212432x1272755" unitRef="iso4217_USD_per_Right" decimals="INF" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_6001_5">2.256</mnkd:UnitsSoldByUnderwritingPrice>
  <mnkd:UnitsSoldUnderPublicOfferUnderwritten contextRef="eol_PE126000--1510-K0015_STD_0_20120208_0_1212432x1272755" unitRef="shares" decimals="0" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_6001_1">4687500</mnkd:UnitsSoldUnderPublicOfferUnderwritten>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE126000--1510-K0015_STD_0_20130523_0_1105927x1246246" unitRef="shares" decimals="INF" id="id_7647232_EE2F888B-24CD-4A80-BE90-1029BA0A0870_1001_0">21500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1510-K0015_STD_0_20140811_0_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_FFEA17B5-148B-453D-81DA-D0F173C4ED9C_4002_2">775000000</mnkd:PotentialMilestonePayments>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1510-K0015_STD_0_20140811_0_1116223x1282107_1150195x1134844" unitRef="iso4217_USD" decimals="-5" id="id_7647232_FFEA17B5-148B-453D-81DA-D0F173C4ED9C_5002_5">650000000</mnkd:PotentialMilestonePayments>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1510-K0015_STD_0_20140811_0_1116223x1282107_1150195x1178830" unitRef="iso4217_USD" decimals="-5" id="id_7647232_FFEA17B5-148B-453D-81DA-D0F173C4ED9C_6002_3">75000000</mnkd:PotentialMilestonePayments>
  <mnkd:PotentialMilestonePayments contextRef="eol_PE126000--1510-K0015_STD_0_20140811_0_1116223x1282107_1150195x1231223" unitRef="iso4217_USD" decimals="-5" id="id_7647232_FFEA17B5-148B-453D-81DA-D0F173C4ED9C_7002_4">50000000</mnkd:PotentialMilestonePayments>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1510-K0015_STD_0_20150814_0_1110347x1169090" unitRef="pure" decimals="INF" id="id_7647232_320B8B6A-E230-47B1-BE63-DB2B79C73C3D_2001_1">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1510-K0015_STD_0_20150814_0_1110347x1169090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_320B8B6A-E230-47B1-BE63-DB2B79C73C3D_2001_0">32100000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1510-K0015_STD_0_20151109_0_1114584x1104394" unitRef="shares" decimals="INF" id="id_7647232_39E01904-A260-4FEA-90C1-76D35DBFD93E_2001_0">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20151116_0" unitRef="shares" decimals="INF" id="id_7647232_B0E8BF2F-4B0C-4DF2-8543-BD66579347BA_1001_1">159303</us-gaap:ClassOfWarrantOrRightOutstanding>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20160222_0" unitRef="shares" decimals="INF" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_2_500008">428850858</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE126000--1510-K0015_STD_0_20040331_0_1105927x1187350" unitRef="shares" decimals="INF" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_4001_0">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:OtherLongTermDebtCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20130701_0_1107053x1241281_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E37A9CA3-36FF-4B03-8054-5F8D98A53EAB_2004_1">3200000</us-gaap:OtherLongTermDebtCurrent>
  <us-gaap:OtherLongTermDebt contextRef="eol_PE126000--1510-K0015_STD_0_20130701_0_1107053x1241281_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_EAD4DE5F-A9B5-4D44-B53B-4955BC76501D_2001_2">16300000</us-gaap:OtherLongTermDebt>
  <us-gaap:OtherLongTermDebtNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20130701_0_1107053x1241281_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E37A9CA3-36FF-4B03-8054-5F8D98A53EAB_2004_2">13100000</us-gaap:OtherLongTermDebtNoncurrent>
  <mnkd:ContingentLiability contextRef="eol_PE126000--1510-K0015_STD_0_20130701_0_1107053x1241281_1115253x1116460_1116663x1271799" unitRef="iso4217_USD" decimals="INF" id="id_7647232_BBDAD79A-618D-4C97-A45F-3F9F9D639748_4001_3">90000000</mnkd:ContingentLiability>
  <mnkd:AccruedExpensesRelatedParty contextRef="eol_PE126000--1510-K0015_STD_0_20140718_0_1114897x1106387" unitRef="iso4217_USD" decimals="-5" id="id_7647232_243BFD1B-06B4-4FF9-93F7-184E99B19EE1_2001_2">1400000</mnkd:AccruedExpensesRelatedParty>
  <mnkd:AreaOfOfficeSpaceLeased contextRef="eol_PE126000--1510-K0015_STD_0_20150531_0_1112725x1320039_1226349x1285790" unitRef="sqft" decimals="0" id="id_7647232_D662AAE3-C230-4574-9FCF-A70E22E6DBB2_2001_0">12500</mnkd:AreaOfOfficeSpaceLeased>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="eol_PE126000--1510-K0015_STD_0_20150810_0_1110347x1169090" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_7647232_204F0977-6E56-4B04-B28F-6B967C9DFD49_2001_2">4.40</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="eol_PE126000--1510-K0015_STD_0_20150810_0_1110347x1248697" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_7647232_24919778-109E-4674-9B77-C1CF44CD96B0_2001_2">6.80</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1510-K0015_STD_0_20150810_0_1110347x1248697" unitRef="pure" decimals="INF" id="id_7647232_9C6ACD67-D00B-4174-AF2D-069996097265_1001_1">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1510-K0015_STD_0_20150810_0_1110347x1248697" unitRef="iso4217_USD" decimals="-5" id="id_7647232_9C6ACD67-D00B-4174-AF2D-069996097265_1001_0">27700000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentUnamortizedPremium contextRef="eol_PE126000--1510-K0015_STD_0_20150810_0_1110347x1248697" unitRef="iso4217_USD" decimals="-5" id="id_7647232_90C53720-E5FE-460F-9830-E8F420E4A955_1001_0">700000</us-gaap:DebtInstrumentUnamortizedPremium>
  <mnkd:OperatingLossCarryforwardsSubjectToLimitation contextRef="eol_PE126000--1510-K0015_STD_0_20040831_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_6C767FFD-4FA1-480E-B80C-7298B1DA268B_2002_3">216000000</mnkd:OperatingLossCarryforwardsSubjectToLimitation>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1510-K0015_STD_0_20140923_0_1116223x1282107" unitRef="pure" decimals="INF" id="id_7647232_84AAE7CC-1869-4580-9E31-4C2B49ED9B90_1001_0">0.085</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE126000--1510-K0015_STD_0_20140923_0_1116223x1282107" unitRef="iso4217_USD" decimals="INF" id="id_7647232_AE7B2D21-B834-46D3-9A26-92BEA8DA5759_1001_0">175000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <dei:EntityPublicFloat contextRef="eol_PE126000--1510-K0015_STD_0_20150630_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_3_600009">1461620053</dei:EntityPublicFloat>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1510-K0015_STD_0_20150930_0" unitRef="shares" decimals="INF" id="id_7647232_C48920BC-FDF4-4D68-A256-2684DBA89CE8_1001_0">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <mnkd:SharesReturnedUnderShareLendingAgreement contextRef="eol_PE126000--1510-K0015_STD_0_20151023_0" unitRef="shares" decimals="0" id="id_7647232_E7C44C61-5379-49F1-BBAD-580961186681_1002_3">9000000</mnkd:SharesReturnedUnderShareLendingAgreement>
  <us-gaap:SharePrice contextRef="eol_PE126000--1510-K0015_STD_0_20151101_0_1114584x1104394" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_39E01904-A260-4FEA-90C1-76D35DBFD93E_2002_4">2.61</us-gaap:SharePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_1006_900001">-110679000</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1510-K0015_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_7001_47">61840000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_1001_400001">286035000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_1001_500001">2860000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_1003_600001">1991379000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1113367" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_1004_700001">-6000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1283011" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_1005_800001">-2104912000</us-gaap:StockholdersEquity>
  <us-gaap:OwnshareLendingArrangementSharesIssued contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_7647232_C48920BC-FDF4-4D68-A256-2684DBA89CE8_1003_1">9000000</us-gaap:OwnshareLendingArrangementSharesIssued>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_3006_900017">-30713000</us-gaap:StockholdersEquity>
  <us-gaap:RestructuringReserve contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_06DC3D48-DDFB-4B43-867E-498D9D7C0DB2_3_0">0</us-gaap:RestructuringReserve>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_6003_47">70790000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_245D6B01-9747-4324-9FF6-D05F43B46F02_3_1">282000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:SharesReservedForEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0" unitRef="shares" decimals="0" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_3002_2">700000</mnkd:SharesReservedForEmployeeStockPurchasePlan>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_3001_400017">369392000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_3001_500017">3697000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_3003_600017">2261996000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1113367" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_3004_700017">-4000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1283011" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_3005_800017">-2296402000</us-gaap:StockholdersEquity>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_C87A7D43-072A-44F4-98FF-8464922BC0AE_2001_1">21541664</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_37">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_38">550000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:OwnshareLendingArrangementSharesIssued contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_C48920BC-FDF4-4D68-A256-2684DBA89CE8_1002_1">9000000</us-gaap:OwnshareLendingArrangementSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_40">406059089</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_33">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_34">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_AAA71D81-FFEB-4EEF-A306-E1CE6D0523D9_2001_1">2610720</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_96193E4F-0BFF-432A-9989-2CE96EB9C290_2001_1">4.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_B0994DF9-94F3-4AED-A2A8-F8004EE81B07_2001_1">5.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_39">406059089</us-gaap:CommonStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_35">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_32">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_22">403353000</us-gaap:LiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_55D31C4C-AAAA-45E4-9B42-FC0A7A4A5F15_2_0">14928000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_1002_10">118221000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_23">49521000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
  <us-gaap:LossContingencyAccrualCarryingValueNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_24">3034000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
  <us-gaap:ConstructionPayableCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_55D31C4C-AAAA-45E4-9B42-FC0A7A4A5F15_2_2">1343000</us-gaap:ConstructionPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_16">26206000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:Liabilities contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_28">468209000</us-gaap:Liabilities>
  <us-gaap:CommonStockValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_36">4061000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_41">2416967000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:InterestPayableCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_55D31C4C-AAAA-45E4-9B42-FC0A7A4A5F15_2_1">2396000</us-gaap:InterestPayableCurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_27">12301000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLongTermDebtCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_17">72995000</us-gaap:OtherLongTermDebtCurrent>
  <us-gaap:DeferredRevenueCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_21">196967000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_42">-14000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ConvertibleNotesPayableCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_18">99355000</us-gaap:ConvertibleNotesPayableCurrent>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_29" />
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_13">882502000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:PreferredStockValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_31" />
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_55D31C4C-AAAA-45E4-9B42-FC0A7A4A5F15_2_3">7539000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_43">-2494784000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_44">-73770000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_45">394439000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:RestructuringReserve contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_06DC3D48-DDFB-4B43-867E-498D9D7C0DB2_2_0">300000</us-gaap:RestructuringReserve>
  <us-gaap:OtherDeferredCreditsCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_19">436000</us-gaap:OtherDeferredCreditsCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_15">7394000</us-gaap:AccountsPayableCurrent>
  <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_715480BE-6075-449D-AA78-3A63A2950BB9_2_2">95000</us-gaap:InventoryFinishedGoodsNetOfReserves>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_8">192127000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:AssetsCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_7">201153000</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_8">43691000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_A81E37D5-816C-4F97-9BD3-91D13CD7A2C9_2001_1">33495000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_6">768000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
  <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_715480BE-6075-449D-AA78-3A63A2950BB9_2_0">4856000</us-gaap:InventoryRawMaterialsNetOfReserves>
  <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_4">19217000</us-gaap:DeferredTaxAssetsDeferredIncome>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_11">3010000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_2">120841000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:NontradeReceivablesNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_10">311000</us-gaap:NontradeReceivablesNoncurrent>
  <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_715480BE-6075-449D-AA78-3A63A2950BB9_2_1">4719000</us-gaap:InventoryWorkInProcessNetOfReserves>
  <us-gaap:Assets contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_12">394439000</us-gaap:Assets>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_12">882502000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_10">131000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_1">699997000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_6">20206000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_3">50436000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_1002_8">310348000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_11">848000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_2">73227000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_14">0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:InventoryNet contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_2_4">9670000</us-gaap:InventoryNet>
  <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_BA71E0F2-0E4F-41B9-BA5A-C7C2943CD630_2_1">118500000</us-gaap:MoneyMarketFundsAtCarryingValue>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_245D6B01-9747-4324-9FF6-D05F43B46F02_2_1">816000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:SharesReservedForEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="0" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_3003_2">700000</mnkd:SharesReservedForEmployeeStockPurchasePlan>
  <mnkd:DeferredTaxAssetsMilestoneRights contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_5">5321000</mnkd:DeferredTaxAssetsMilestoneRights>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_E7C44C61-5379-49F1-BBAD-580961186681_1001_0">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <mnkd:DeferredTaxAssetsCapitalizedResearchExpenses contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_3">28516000</mnkd:DeferredTaxAssetsCapitalizedResearchExpenses>
  <mnkd:DeferredTaxAssetsCapitalizedCosts contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1002_9">8624000</mnkd:DeferredTaxAssetsCapitalizedCosts>
  <mnkd:InventoryCurrentAndNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_715480BE-6075-449D-AA78-3A63A2950BB9_2_5">9670000</mnkd:InventoryCurrentAndNoncurrent>
  <mnkd:AvailableBorrowingsUnderLoanAgreement contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_69031461-5AAB-4AF1-800A-61F2E6AD62A5_1002_1">30100000</mnkd:AvailableBorrowingsUnderLoanAgreement>
  <mnkd:AccruedInterestOfRelatedPartyDebt contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_69031461-5AAB-4AF1-800A-61F2E6AD62A5_1002_0">3500000</mnkd:AccruedInterestOfRelatedPartyDebt>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107053x1234768_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_3002_2">20000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107455x1112342_1110347x1169090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_1001_3">99400000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107455x1112342_1110347x1169090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_1001_4">102900000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_5001_400029">406059000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_5001_500029">4061000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_5003_600029">2416967000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1113367" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_5004_700029">-14000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1283011" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_5005_800029">-2494784000</us-gaap:StockholdersEquity>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1108622" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_2002_7">39580000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1109324" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_3002_1">54948000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1110462" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_4002_3">80919000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1111159" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_5002_6">17000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1114693" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_6002_2">114131000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1116033" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_7002_0">5273000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1173496" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_8002_5">10465000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1254910" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_9002_4">5015000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_4002_0">60000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1169090" unitRef="iso4217_USD" decimals="-3" id="id_7647232_245FBE2D-949A-453E-BB4A-44A84E19F995_1002_2">99355000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1169090" unitRef="iso4217_USD" decimals="-3" id="id_7647232_245FBE2D-949A-453E-BB4A-44A84E19F995_1002_0">100000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1169090" unitRef="iso4217_USD" decimals="-3" id="id_7647232_245FBE2D-949A-453E-BB4A-44A84E19F995_1002_1">645000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1197584" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_1003_3">73000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1197584" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_1003_4">75100000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1112725x1155283" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_1004_3">3000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20141231_0_1112725x1155283" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_1004_4">3000000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_C87A7D43-072A-44F4-98FF-8464922BC0AE_1001_7">19597097</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1004_1">19779229</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_37">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1004_3">15540652</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_96193E4F-0BFF-432A-9989-2CE96EB9C290_1001_8">4.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_38">550000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_40">428670943</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_33">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_B0E8BF2F-4B0C-4DF2-8543-BD66579347BA_1002_2">2.61</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_C87A7D43-072A-44F4-98FF-8464922BC0AE_1001_8">17217332</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_34">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_96193E4F-0BFF-432A-9989-2CE96EB9C290_1001_7">4.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1004_2">1804620</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_96193E4F-0BFF-432A-9989-2CE96EB9C290_1001_6">4.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_B0994DF9-94F3-4AED-A2A8-F8004EE81B07_1001_5">4.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_39">428670943</us-gaap:CommonStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_35">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_32">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_22">268319000</us-gaap:LiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_55D31C4C-AAAA-45E4-9B42-FC0A7A4A5F15_1_0">5662000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_1001_10">119513000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_23">49521000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
  <us-gaap:LossContingencyAccrualCarryingValueNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_24">62371000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
  <us-gaap:ConstructionPayableCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_55D31C4C-AAAA-45E4-9B42-FC0A7A4A5F15_1_2">238000</us-gaap:ConstructionPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_16">7929000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_C02486D4-23D1-4D6E-B41A-C1778411F2C1_1001_0">30100000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:Liabilities contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_28">476741000</us-gaap:Liabilities>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_2001_7">20000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:PurchaseObligationDueInSecondYear contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_EUR" decimals="-5" id="id_7647232_9901C78E-6214-4971-BE9B-58177FBF9D5E_2_3">23300000</us-gaap:PurchaseObligationDueInSecondYear>
  <us-gaap:ConvertibleLongTermNotesPayable contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_25">27613000</us-gaap:ConvertibleLongTermNotesPayable>
  <us-gaap:PurchaseObligationDueInThirdYear contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_EUR" decimals="-5" id="id_7647232_9901C78E-6214-4971-BE9B-58177FBF9D5E_2_4">23300000</us-gaap:PurchaseObligationDueInThirdYear>
  <us-gaap:PurchaseObligationDueInNextTwelveMonths contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_EUR" decimals="-5" id="id_7647232_9901C78E-6214-4971-BE9B-58177FBF9D5E_2_2">28800000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
  <us-gaap:CommonStockValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_36">4287000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_41">2508633000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_2001_6">5000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:InterestPayableCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_55D31C4C-AAAA-45E4-9B42-FC0A7A4A5F15_1_1">615000</us-gaap:InterestPayableCurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_27">15225000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLongTermDebtCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_17">74582000</us-gaap:OtherLongTermDebtCurrent>
  <us-gaap:PurchaseObligationDueInFourthYear contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_EUR" decimals="-5" id="id_7647232_9901C78E-6214-4971-BE9B-58177FBF9D5E_2_5">23300000</us-gaap:PurchaseObligationDueInFourthYear>
  <us-gaap:DeferredRevenueCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_21">140231000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_42">-20000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_29" />
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_13">962623000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:PreferredStockValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_31" />
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_55D31C4C-AAAA-45E4-9B42-FC0A7A4A5F15_1_3">1414000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_43">-2863229000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_44">-350329000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_45">126412000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:RestructuringReserve contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_06DC3D48-DDFB-4B43-867E-498D9D7C0DB2_1_0">3000000</us-gaap:RestructuringReserve>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_2001_9">35000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_2001_8">20000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <us-gaap:OtherDeferredCreditsCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_19">17503000</us-gaap:OtherDeferredCreditsCurrent>
  <us-gaap:PurchaseObligation contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_EUR" decimals="-5" id="id_7647232_9901C78E-6214-4971-BE9B-58177FBF9D5E_2_1">98500000</us-gaap:PurchaseObligation>
  <us-gaap:PurchaseObligation contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_44A3C82D-0F50-400D-BC9E-FCE5EA052CBA_1001_0">116200000</us-gaap:PurchaseObligation>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_15">15599000</us-gaap:AccountsPayableCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_8">48749000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:AssetsCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_7">76654000</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_8">16941000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_6">251000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
  <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_4">52484000</us-gaap:DeferredTaxAssetsDeferredIncome>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_11">48755000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_A81E37D5-816C-4F97-9BD3-91D13CD7A2C9_1001_7">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_42DCB03D-0277-4019-A318-2971C5F4D06B_1_1">15000000</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-8" id="id_7647232_6C767FFD-4FA1-480E-B80C-7298B1DA268B_2001_0">1900000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_2">59074000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-8" id="id_7647232_6C767FFD-4FA1-480E-B80C-7298B1DA268B_2001_1">1300000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_A81E37D5-816C-4F97-9BD3-91D13CD7A2C9_1001_8">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:Assets contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_12">126412000</us-gaap:Assets>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_12">962623000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_10">7186000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_1">721588000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_6">4018000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_3">23000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_1001_8">308674000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DeferredCostsCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_5">13539000</us-gaap:DeferredCostsCurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_11">1009000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_2">73646000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_14">0</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_BA71E0F2-0E4F-41B9-BA5A-C7C2943CD630_1_1">55800000</us-gaap:MoneyMarketFundsAtCarryingValue>
  <mnkd:EstimatedAmountsCreditExchangeReceivable contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_245D6B01-9747-4324-9FF6-D05F43B46F02_1001_1">743000</mnkd:EstimatedAmountsCreditExchangeReceivable>
  <mnkd:DeferredTaxAssetsMilestoneRights contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_5">3242000</mnkd:DeferredTaxAssetsMilestoneRights>
  <mnkd:DeferredTaxAssetsCapitalizedResearchExpenses contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_3">5872000</mnkd:DeferredTaxAssetsCapitalizedResearchExpenses>
  <mnkd:ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_36B6251D-02A1-4EC4-9418-D7648316ECD9_1001_0">1651859</mnkd:ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest>
  <mnkd:DeferredTaxAssetsCapitalizedCosts contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_9">8574000</mnkd:DeferredTaxAssetsCapitalizedCosts>
  <mnkd:AvailableBorrowingsUnderLoanAgreement contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_69031461-5AAB-4AF1-800A-61F2E6AD62A5_1001_1">30100000</mnkd:AvailableBorrowingsUnderLoanAgreement>
  <mnkd:WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_36B6251D-02A1-4EC4-9418-D7648316ECD9_1001_1">4.86</mnkd:WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest>
  <mnkd:AccruedInterestOfRelatedPartyDebt contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_69031461-5AAB-4AF1-800A-61F2E6AD62A5_1001_0">6400000</mnkd:AccruedInterestOfRelatedPartyDebt>
  <mnkd:DeferredTaxAssetsLossOnPurchaseCommitment contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_1356080C-2641-4615-8408-EAB6597FF4F2_1001_7">24084000</mnkd:DeferredTaxAssetsLossOnPurchaseCommitment>
  <mnkd:PurchaseObligationCurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_20">12475000</mnkd:PurchaseObligationCurrent>
  <mnkd:PurchaseObligationNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_29AE2785-46B4-41CE-847E-53F67BA74F39_1_26">53692000</mnkd:PurchaseObligationNoncurrent>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1104490x1107650" unitRef="iso4217_USD" decimals="-5" id="id_7647232_7C284218-86CB-4E06-B3DD-11BABE1D5847_1001_0">4900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1104490x1109005" unitRef="iso4217_USD" decimals="-5" id="id_7647232_7C284218-86CB-4E06-B3DD-11BABE1D5847_2001_1">6700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1104490x1115311" unitRef="shares" decimals="INF" id="id_7647232_10D0B3DB-E4FC-4A56-AD34-FE762072EB6E_5001_6">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1142515" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1001_1">11309136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1142515" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1001_2">276784</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1180376" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1003_1">443331</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1187350" unitRef="shares" decimals="INF" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_4004_0">2752703</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1246246" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1002_1">8026762</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1246246" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1002_3">15540652</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1246246" unitRef="shares" decimals="INF" id="id_7647232_592A3B3C-4449-4D62-8A27-DF0E72A8CC74_1002_2">1527836</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <mnkd:LineOfCreditFacilityRestrictedBorrowingCapacity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1234768_1110347x1158750_1115253x1107704_1116663x1271799_1156564x1281090" unitRef="iso4217_USD" decimals="INF" id="id_7647232_CC98A7F9-810D-436F-AF97-19F2C41AC2F2_1001_0">25000000</mnkd:LineOfCreditFacilityRestrictedBorrowingCapacity>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1234768_1110347x1158750_1116663x1271799" unitRef="pure" decimals="INF" id="id_7647232_45596A1B-422B-43FC-8D30-21FF14DB423A_1001_1">0.0875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1234768_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_3001_2">20000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1241281_1109902x1105152" unitRef="iso4217_USD" decimals="-5" id="id_7647232_BBDAD79A-618D-4C97-A45F-3F9F9D639748_2002_1">14400000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1241281_1110347x1158750_1112725x1321372_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_DB56AF57-9028-44D0-BAAD-CB0AC9023F3A_1001_0">23000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:OtherLongTermDebtNoncurrent contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1241281_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_490DD469-0779-49E4-8D91-39771FF35678_1001_0">8900000</us-gaap:OtherLongTermDebtNoncurrent>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107455x1112342_1110347x1248697" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_2002_1">27600000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107455x1112342_1110347x1248697" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_2002_2">21300000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:SharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_7001_400053">428671000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_7001_500053">4287000</us-gaap:StockholdersEquity>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementShares contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_7001_400044">9000000</mnkd:CommonStockLoanedUnderShareLendingAgreementShares>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_7003_600053">2508633000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1113367" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_7004_700053">-20000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1283011" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_7005_800053">-2863229000</us-gaap:StockholdersEquity>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107576x1111055_1112725x1155283" unitRef="iso4217_USD" decimals="-5" id="id_7647232_21DAFE31-DE2A-4CAF-A146-BFEA5060E89A_1001_0">17900000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1108622" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_2001_7">8044000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1109324" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_3001_1">54948000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1110462" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_4001_3">95182000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1114693" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_6001_2">131383000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1116033" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_7001_0">5273000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1173496" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_8001_5">9707000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1254910" unitRef="iso4217_USD" decimals="-3" id="id_7647232_4E773F79-0632-4DD1-9012-A3372A118545_9001_4">4137000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1108100x1114560" unitRef="iso4217_USD" decimals="-5" id="id_7647232_7FD967D8-C758-45E1-BA68-08D9E58EAFB3_1001_0">189200000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:DeferredRevenue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1109648x1111362_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_AF1A1253-4A7B-4ACB-84DD-77CC58BE205F_2001_2">17500000</us-gaap:DeferredRevenue>
  <us-gaap:PropertyPlantAndEquipmentFairValueDisclosure contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1109902x1105152" unitRef="iso4217_USD" decimals="-5" id="id_7647232_7FD967D8-C758-45E1-BA68-08D9E58EAFB3_2001_1">48800000</us-gaap:PropertyPlantAndEquipmentFairValueDisclosure>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1158750_1116663x1271799" unitRef="pure" decimals="INF" id="id_7647232_45596A1B-422B-43FC-8D30-21FF14DB423A_2001_0">0.0975</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_4001_0">60000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1158750_1116663x1271799_1156564x1281090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_839C52BB-3E94-4323-A697-594955BCB64B_1001_1">100000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1158750_1116663x1271799_1156564x1281090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_839C52BB-3E94-4323-A697-594955BCB64B_1001_0">5300000</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1197584" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_2003_1">74600000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1197584" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_2003_2">78400000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1248697" unitRef="iso4217_USD" decimals="-3" id="id_7647232_245FBE2D-949A-453E-BB4A-44A84E19F995_2001_6">27613000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1248697" unitRef="iso4217_USD" decimals="-3" id="id_7647232_245FBE2D-949A-453E-BB4A-44A84E19F995_2001_3">27690000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:DebtInstrumentUnamortizedPremium contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1248697" unitRef="iso4217_USD" decimals="-3" id="id_7647232_245FBE2D-949A-453E-BB4A-44A84E19F995_2001_4">660000</us-gaap:DebtInstrumentUnamortizedPremium>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1248697" unitRef="iso4217_USD" decimals="-3" id="id_7647232_245FBE2D-949A-453E-BB4A-44A84E19F995_2001_5">737000</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1111765x1113433_1112725x1145423" unitRef="pure" decimals="INF" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_6001_2">0.0584</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1111765x1113433_1112725x1145423" unitRef="iso4217_USD" decimals="-5" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_6001_1">30100000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:LineOfCredit contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1111765x1113433_1112725x1145423" unitRef="iso4217_USD" decimals="-5" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_6001_0">49500000</us-gaap:LineOfCredit>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_2004_1">44500000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283" unitRef="iso4217_USD" decimals="-5" id="id_7647232_8ED5153B-E2F8-4E15-9142-FBEA191C5663_2004_2">36500000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:DeferredRevenue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_AF1A1253-4A7B-4ACB-84DD-77CC58BE205F_3001_0">150000000</us-gaap:DeferredRevenue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_DDAB076B-1137-4173-B663-A4FE434BADBE_2001_4">44500000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:LongTermLoansPayable contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_CDBBCA0A-791D-40C1-A26D-C7649DA3F0D4_4002_1">62400000</us-gaap:LongTermLoansPayable>
  <us-gaap:DebtInstrumentFairValue contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_DDAB076B-1137-4173-B663-A4FE434BADBE_2001_5">36500000</us-gaap:DebtInstrumentFairValue>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="INF" id="id_7647232_DDAB076B-1137-4173-B663-A4FE434BADBE_2001_0">175000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:DeferredCosts contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_AF1A1253-4A7B-4ACB-84DD-77CC58BE205F_3001_3">13500000</us-gaap:DeferredCosts>
  <mnkd:PotentialMilestonePaymentsToBeReceived contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_AF1A1253-4A7B-4ACB-84DD-77CC58BE205F_3001_1">50000000</mnkd:PotentialMilestonePaymentsToBeReceived>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112759x1107054" unitRef="iso4217_USD" decimals="-5" id="id_7647232_6C767FFD-4FA1-480E-B80C-7298B1DA268B_3001_5">49100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1112759x1108964" unitRef="iso4217_USD" decimals="-5" id="id_7647232_6C767FFD-4FA1-480E-B80C-7298B1DA268B_4001_6">37700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE126000--1510-K0015_STD_0_20151231_0_1173463x1281716" unitRef="shares" decimals="INF" id="id_7647232_1F104C51-3E18-42D6-9000-043511B0496E_1001_0">523487</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:DebtIssuanceCosts contextRef="eol_PE126000--1510-K0015_STD_1_20100818_0_1110347x1248697" unitRef="iso4217_USD" decimals="-5" id="id_7647232_FC1DE77B-6BB0-471E-A534-EF1904E8AA67_1001_0">800000</us-gaap:DebtIssuanceCosts>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrants contextRef="eol_PE126000--1510-K0015_STD_1_20120208_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_1_6">80600000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrants>
  <mnkd:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription contextRef="eol_PE126000--1510-K0015_STD_1_20120208_0_1111765x1254496" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_1001_2">Each unit consisting of  one share of common stock and a warrant to purchase 0.6 of a share of common  stock</mnkd:UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription>
  <mnkd:WarrantsExercisableExpirationPeriod contextRef="eol_PE126000--1510-K0015_STD_1_20120208_0_1116897x1213796" id="id_7647232_D82E110D-2B9E-46AB-AB6D-DD753E7D1D8E_2001_9">P4Y</mnkd:WarrantsExercisableExpirationPeriod>
  <mnkd:ProfitLossSharingAgreementAllocationPercentage contextRef="eol_PE126000--1510-K0015_STD_1_20140811_0_1112725x1155283_1116223x1282107" unitRef="pure" decimals="2" id="id_7647232_FFEA17B5-148B-453D-81DA-D0F173C4ED9C_1002_6">0.65</mnkd:ProfitLossSharingAgreementAllocationPercentage>
  <mnkd:ProfitLossSharingAgreementAllocationPercentage contextRef="eol_PE126000--1510-K0015_STD_1_20140811_0_1116223x1282107" unitRef="pure" decimals="2" id="id_7647232_FFEA17B5-148B-453D-81DA-D0F173C4ED9C_2002_7">0.35</mnkd:ProfitLossSharingAgreementAllocationPercentage>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="eol_PE126000--1510-K0015_STD_1_20150817_0_1110347x1169090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_9F20023F-EAA3-4B54-B948-82884D32BC05_1001_1">1000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <us-gaap:RepaymentsOfSeniorDebt contextRef="eol_PE126000--1510-K0015_STD_1_20150817_0_1110347x1169090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_9F20023F-EAA3-4B54-B948-82884D32BC05_1001_0">32200000</us-gaap:RepaymentsOfSeniorDebt>
  <mnkd:StockIssuedDuringPeriodSharesNewIssuesPercentage contextRef="eol_PE126000--1510-K0015_STD_1_20151109_0_1114584x1104394" unitRef="pure" decimals="2" id="id_7647232_39E01904-A260-4FEA-90C1-76D35DBFD93E_1001_1">0.97</mnkd:StockIssuedDuringPeriodSharesNewIssuesPercentage>
  <mnkd:ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice contextRef="eol_PE126000--1510-K0015_STD_1_20151116_0" unitRef="pure" decimals="4" id="id_7647232_B0E8BF2F-4B0C-4DF2-8543-BD66579347BA_1_0">0.0115</mnkd:ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice>
  <us-gaap:ProceedsFromRelatedPartyDebt contextRef="eol_PE126000--1510-K0015_STD_1_20160210_0_1106880x1108681_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_CDBBCA0A-791D-40C1-A26D-C7649DA3F0D4_1001_0">17900000</us-gaap:ProceedsFromRelatedPartyDebt>
  <us-gaap:FairValueInputsEntityCreditRisk contextRef="eol_PE126000--1510-K0015_STD_1_20130701_0_1107053x1241281_1110347x1158750_1116663x1271799" unitRef="pure" decimals="2" id="id_7647232_EAD4DE5F-A9B5-4D44-B53B-4955BC76501D_1001_1">0.05</us-gaap:FairValueInputsEntityCreditRisk>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1510-K0015_STD_1_20130701_0_1107053x1241281_1110347x1158750_1116663x1271799" unitRef="pure" decimals="3" id="id_7647232_EAD4DE5F-A9B5-4D44-B53B-4955BC76501D_1001_0">0.175</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="eol_PE126000--1510-K0015_STD_1_20140718_0_1114897x1106387" unitRef="iso4217_USD" decimals="-5" id="id_7647232_243BFD1B-06B4-4FF9-93F7-184E99B19EE1_1001_1">7900000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
  <mnkd:ConsiderationReceived contextRef="eol_PE126000--1510-K0015_STD_1_20140718_0_1114897x1106387" unitRef="iso4217_USD" decimals="-5" id="id_7647232_243BFD1B-06B4-4FF9-93F7-184E99B19EE1_1001_0">9300000</mnkd:ConsiderationReceived>
  <us-gaap:LongTermPurchaseCommitmentAmount contextRef="eol_PE126000--1510-K0015_STD_1_20140731_0" unitRef="iso4217_EUR" decimals="-5" id="id_7647232_9901C78E-6214-4971-BE9B-58177FBF9D5E_1_0">120100000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1510-K0015_STD_1_20150728_0_1110347x1169090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_38F6C3FB-5D34-4C9E-9F09-21F75DE83406_1001_0">56900000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="eol_PE126000--1510-K0015_STD_1_20150810_0_1110347x1248697" unitRef="pure" decimals="2" id="id_7647232_41704A3D-CC5C-496B-A7EF-19908F83A97A_1001_1">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
  <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays contextRef="eol_PE126000--1510-K0015_STD_1_20150810_0_1110347x1248697" id="id_7647232_41704A3D-CC5C-496B-A7EF-19908F83A97A_1001_3">P30D</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays>
  <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="eol_PE126000--1510-K0015_STD_1_20150810_0_1110347x1248697" unitRef="pure" decimals="INF" id="id_7647232_F0A52ED6-088A-44AB-B6DE-09396C88D64D_1001_0">1.00</us-gaap:DebtInstrumentRedemptionPricePercentage>
  <us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="eol_PE126000--1510-K0015_STD_1_20150810_0_1110347x1248697" unitRef="D" decimals="INF" id="id_7647232_41704A3D-CC5C-496B-A7EF-19908F83A97A_1001_2">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
  <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="eol_PE126000--1510-K0015_STD_1_20150810_0_1110347x1248697" unitRef="pure" decimals="4" id="id_7647232_24919778-109E-4674-9B77-C1CF44CD96B0_1001_0">147.0859</us-gaap:DebtInstrumentConvertibleConversionRatio1>
  <mnkd:PrincipalAmountPerShare contextRef="eol_PE126000--1510-K0015_STD_1_20150810_0_1110347x1248697" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_7647232_24919778-109E-4674-9B77-C1CF44CD96B0_1001_1">1000</mnkd:PrincipalAmountPerShare>
  <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated contextRef="eol_PE126000--1510-K0015_STD_1_20150930_0" unitRef="Employee" decimals="INF" id="id_7647232_0F656263-61CB-4251-A29D-D2E7809F383F_1_1">198</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
  <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent contextRef="eol_PE126000--1510-K0015_STD_1_20150930_0" unitRef="pure" decimals="2" id="id_7647232_0F656263-61CB-4251-A29D-D2E7809F383F_1_0">0.26</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
  <us-gaap:RepaymentsOfSeniorDebt contextRef="eol_PE126000--1510-K0015_STD_1_20150930_0_1110347x1169090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_320B8B6A-E230-47B1-BE63-DB2B79C73C3D_1002_2">32100000</us-gaap:RepaymentsOfSeniorDebt>
  <us-gaap:PaymentsForRestructuring contextRef="eol_PE126000--1510-K0015_STD_1_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_76CFD271-4387-4919-9F02-25F2D6936791_1_0">2800000</us-gaap:PaymentsForRestructuring>
  <mnkd:TerminationDateOfLicenseAgreement contextRef="eol_PE126000--1510-K0015_STD_1_20160104_0_1106880x1108681_1116223x1282107" id="id_7647232_F5182DF3-50A8-4FB5-9DC6-3021180DE57F_1001_0">2016-07-04</mnkd:TerminationDateOfLicenseAgreement>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="eol_PE126000--1510-K0015_STD_13_20150810_0_1110347x1169090" unitRef="shares" decimals="-5" id="id_7647232_204F0977-6E56-4B04-B28F-6B967C9DFD49_1001_0">1900000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE126000--1510-K0015_STD_13_20150810_0_1110347x1169090" unitRef="iso4217_USD" decimals="-5" id="id_7647232_204F0977-6E56-4B04-B28F-6B967C9DFD49_1001_1">8000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <mnkd:PercentageOfCommonStockSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_31_20040331_0" unitRef="pure" decimals="2" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_1_3">0.01</mnkd:PercentageOfCommonStockSharesOutstanding>
  <mnkd:EmployeeStockPurchasePlanAnnualIncreaseInReservedShares contextRef="eol_PE126000--1510-K0015_STD_31_20040331_0_1105927x1187350" unitRef="shares" decimals="INF" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_1001_1">700000</mnkd:EmployeeStockPurchasePlanAnnualIncreaseInReservedShares>
  <mnkd:PercentageOfShareReservedForShareBasedCompensation contextRef="eol_PE126000--1510-K0015_STD_31_20040331_0_1115253x1116460" unitRef="pure" decimals="2" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_2001_4">0.10</mnkd:PercentageOfShareReservedForShareBasedCompensation>
  <mnkd:NetOperatingLossCarryforwardAnnualLimitation contextRef="eol_PE126000--1510-K0015_STD_31_20040831_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_6C767FFD-4FA1-480E-B80C-7298B1DA268B_2_4">13000000</mnkd:NetOperatingLossCarryforwardAnnualLimitation>
  <mnkd:LoanAgreementWithRelatedParty contextRef="eol_PE126000--1510-K0015_STD_31_20071031_0_1111765x1113433" unitRef="iso4217_USD" decimals="-5" id="id_7647232_315053C7-B724-4F7B-BD44-8B97C2A1EB34_1001_0">350000000</mnkd:LoanAgreementWithRelatedParty>
  <mnkd:LoanAgreementWithRelatedParty contextRef="eol_PE126000--1510-K0015_STD_31_20131031_0_1111765x1113433" unitRef="iso4217_USD" decimals="-5" id="id_7647232_315053C7-B724-4F7B-BD44-8B97C2A1EB34_1002_0">370000000</mnkd:LoanAgreementWithRelatedParty>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1510-K0015_STD_32_20151101_0_1114584x1104394" unitRef="shares" decimals="INF" id="id_7647232_39E01904-A260-4FEA-90C1-76D35DBFD93E_1002_2">13852435</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_32_20151101_0_1114584x1104394" unitRef="iso4217_USD" decimals="-3" id="id_7647232_39E01904-A260-4FEA-90C1-76D35DBFD93E_1002_3">34710000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE126000--1510-K0015_STD_32_20151101_0_1114584x1104394" unitRef="iso4217_USD" decimals="-3" id="id_7647232_39E01904-A260-4FEA-90C1-76D35DBFD93E_1002_5">1433000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_3_4">0.7583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_3_1">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_3_4">78475367</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="shares" decimals="INF" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_2_5">463290</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_3_5">0.8626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_3_4">-0.307</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_3_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_24">-128732000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_3_0">0.0094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_17">-0.64</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_D7A179C2-59AD-46B9-8420-25E73A830E83_3_0">3.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="shares" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_18">299591000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_3_1">0.0182</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_3_3">-0.043</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="INF" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_3_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="pure" decimals="2" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_3_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" id="id_7647232_475252C0-6496-4D82-A7B2-A22644FF3526_1_1">P6Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_12">-2000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_23D39344-E59E-4E61-9D5B-E05BF620E64D_3_4">-191488000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_26">7987000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="INF" id="id_7647232_EEA350C7-9604-402C-B52C-4844B31ACA38_3_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
  <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_39">598000</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900008">48888000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900013">45186000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_9">-635000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900012">1263000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_8">-169401000</us-gaap:OperatingIncomeLoss>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_14">-191490000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:InterestPaidCapitalized contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_54">7886000</us-gaap:InterestPaidCapitalized>
  <us-gaap:SalesRevenueNet contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_0">0</us-gaap:SalesRevenueNet>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_13">8000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900015">998000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_44">4801000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_42">1103000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_50">13452000</us-gaap:InterestPaid>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_5CC77007-78CD-402F-ADD2-EEA8A1363850_1_0">66800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900002">2270000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_16">499000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_16">-191490000</us-gaap:NetIncomeLoss>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900014">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_23D39344-E59E-4E61-9D5B-E05BF620E64D_3_3">2000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_53">856000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_52">6500000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900003">-4801000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_A26FF0B3-4D61-4E1B-A569-490A50CAB196_3_0">21500000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_41">49990000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E99253A8-141E-412B-B69A-C815A31618F7_3_1">14900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_B9C8D635-D2C8-4AEA-8959-8A1E65B44C8A_3_0">645000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_2">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_9">-66849000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_3">14057000</us-gaap:DepreciationAndAmortization>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_7">169401000</us-gaap:OperatingExpenses>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_8">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_45">145669000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_57556F65-FD1F-4A0F-9BCD-C3C09BD78F2B_3_0">11500000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_15">0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_3">59682000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_6">59379000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_37">119500000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_A26FF0B3-4D61-4E1B-A569-490A50CAB196_3_1">400000</us-gaap:InterestCostsCapitalized>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_2">109719000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_4">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_475252C0-6496-4D82-A7B2-A22644FF3526_1_0">2300000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E99253A8-141E-412B-B69A-C815A31618F7_3_0">13900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_D7A179C2-59AD-46B9-8420-25E73A830E83_3_1">3100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="INF" id="id_7647232_EEA350C7-9604-402C-B52C-4844B31ACA38_3_0">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_10">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_46">8950000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_11">6309000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_3_12">15153000</us-gaap:InterestExpenseDebt>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_33">94147000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_A3D5914A-C92B-47E2-AC83-65A90C092DBC_3_0">533000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_C424AFAC-4669-4A6A-960E-C8C9EAC75B53_3_0">45186000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_23">591000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_1">0</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:RestructuringCharges contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_0F656263-61CB-4251-A29D-D2E7809F383F_4_2">400000</us-gaap:RestructuringCharges>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_19">-1071000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_7">7470000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_4">45186000</us-gaap:ShareBasedCompensation>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_61AF4BE5-27F4-479A-A237-43DBF9E12707_3_0">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_28">-7987000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_20">3675000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_3">0</us-gaap:CurrentForeignTaxExpenseBenefit>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900007">5501000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_8">-817000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_55">78000000</mnkd:CancellationOfPrincipalOnNotePayableToRelatedParty>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_3_11">0</mnkd:IncomeTaxExpenseBenefitNet>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4006_900005">172149000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3_30">3534000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_2A97455F-7AEE-4453-8872-AE1FCDE3B2C9_3_0">82000</mnkd:PaymentsForUseOfAircrafts>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1106131x1261992" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA3C09E1-92B1-45CA-B3D2-D9E9943F4735_1003_0">45181000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1106131x1281716" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA3C09E1-92B1-45CA-B3D2-D9E9943F4735_2003_1">5000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_400012">557000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_400009">9824000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_400003">1870000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_400002">880000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_500008">99000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_500012">5000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_500002">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_500003">20000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_500007">12000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_500011">28000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodSharesWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_400004">66353000</mnkd:StockIssuedDuringPeriodSharesWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_500005">664000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_400010">2778000</mnkd:StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodSharesForDebtExchange contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4001_400006">1095000</mnkd:StockIssuedDuringPeriodSharesForDebtExchange>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600008">48789000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600013">45186000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600012">1258000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600015">998000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600002">2261000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600003">-4821000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600007">5489000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600011">-28000</mnkd:StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4003_600005">171485000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1113367" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4004_700014">2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1283011" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_4005_800016">-191490000</us-gaap:NetIncomeLoss>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1112578x1105469" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_1003_3">9115821</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1112578x1107650" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_2003_0">24237940</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1112578x1108838" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_3003_2">19706240</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1112578x1112342" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_4003_1">25415366</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <mnkd:OfficeLeaseExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1112725x1320039_1226349x1285790" unitRef="iso4217_USD" decimals="INF" id="id_7647232_D662AAE3-C230-4574-9FCF-A70E22E6DBB2_1004_2">0</mnkd:OfficeLeaseExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1113993x1105782" unitRef="iso4217_USD" decimals="-3" id="id_7647232_36E2F33F-1DF4-4416-959D-8AED615E10A8_1003_1">24777000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1113993x1109593" unitRef="iso4217_USD" decimals="-3" id="id_7647232_36E2F33F-1DF4-4416-959D-8AED615E10A8_2003_0">20409000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1115253x1107704" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_1003_2">P2Y7M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1115253x1116460" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_2003_3">P5Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1116613x1199471" unitRef="iso4217_USD" decimals="-5" id="id_7647232_35F1500F-12AE-4CBF-9586-43783D6E365A_1003_0">900000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:RepaymentsOfSeniorDebt contextRef="eol_PE126000--1510-K0015_STD_365_20131231_0_1116613x1262418" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_4003_36">115000000</us-gaap:RepaymentsOfSeniorDebt>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_2_4">0.7398</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="2" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_2_1">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_2_4">51463340</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="shares" decimals="INF" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_3_5">305076</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_2_5">0.8485</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_2_4">-0.318</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_2_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_24">4086000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_2_0">0.0164</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_17">-0.51</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_D7A179C2-59AD-46B9-8420-25E73A830E83_2_0">4.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="shares" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_18">385229000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_2_1">0.0211</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_2_3">-0.041</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="INF" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_2_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="2" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_2_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" id="id_7647232_475252C0-6496-4D82-A7B2-A22644FF3526_2_1">P6Y3M22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_18">615000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_12">10000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_23D39344-E59E-4E61-9D5B-E05BF620E64D_2_4">-198392000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_26">24097000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="INF" id="id_7647232_EEA350C7-9604-402C-B52C-4844B31ACA38_2_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6006_900026">25660000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_9">1679000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6006_900024">1363000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_8">-179627000</us-gaap:OperatingIncomeLoss>
  <us-gaap:LoansAssumed1 contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_56">3034000</us-gaap:LoansAssumed1>
  <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_14">9670000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_14">-198382000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:SalesRevenueNet contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_0">0</us-gaap:SalesRevenueNet>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_13">9000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6006_900025">22962000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_44">26908000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_50">11218000</us-gaap:InterestPaid>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_5CC77007-78CD-402F-ADD2-EEA8A1363850_2_0">65500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6006_900018">10978000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_15">50436000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_16">14734000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_16">-198382000</us-gaap:NetIncomeLoss>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6006_900027">-10000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_23D39344-E59E-4E61-9D5B-E05BF620E64D_2_3">-10000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_53">1768000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
  <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_52">93500000</us-gaap:DebtConversionOriginalDebtAmount1>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6006_900019">-26908000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_A26FF0B3-4D61-4E1B-A569-490A50CAB196_2_0">20400000</us-gaap:InterestExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E99253A8-141E-412B-B69A-C815A31618F7_2_1">36400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_B9C8D635-D2C8-4AEA-8959-8A1E65B44C8A_2_0">737000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_2">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_9">-65504000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_3">18575000</us-gaap:DepreciationAndAmortization>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_7">179627000</us-gaap:OperatingExpenses>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_8">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_45">70062000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_57556F65-FD1F-4A0F-9BCD-C3C09BD78F2B_2_0">9800000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_15">0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_3">79383000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_6">57873000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_37">40000000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_A26FF0B3-4D61-4E1B-A569-490A50CAB196_2_1">800000</us-gaap:InterestCostsCapitalized>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_2">100244000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_4">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_475252C0-6496-4D82-A7B2-A22644FF3526_2_0">11000000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E99253A8-141E-412B-B69A-C815A31618F7_2_0">62700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_D7A179C2-59AD-46B9-8420-25E73A830E83_2_1">14900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="INF" id="id_7647232_EEA350C7-9604-402C-B52C-4844B31ACA38_2_0">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_10">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_46">50051000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_11">2894000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_2_12">17549000</us-gaap:InterestExpenseDebt>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_33">27779000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_A3D5914A-C92B-47E2-AC83-65A90C092DBC_2_0">623000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_C424AFAC-4669-4A6A-960E-C8C9EAC75B53_2_0">48622000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_23">2915000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_1">0</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:IncreaseDecreaseInCustomerAdvancesAndDeposits contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_22">200436000</us-gaap:IncreaseDecreaseInCustomerAdvancesAndDeposits>
  <us-gaap:RestructuringCharges contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_0F656263-61CB-4251-A29D-D2E7809F383F_3_2">1900000</us-gaap:RestructuringCharges>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_19">3622000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_7">7631000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_4">48622000</us-gaap:ShareBasedCompensation>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_61AF4BE5-27F4-479A-A237-43DBF9E12707_2_0">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_28">-24097000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_20">2276000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_3">0</us-gaap:CurrentForeignTaxExpenseBenefit>
  <mnkd:WriteOffOfDerivativeLiability contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_10">363000</mnkd:WriteOffOfDerivativeLiability>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6006_900023">93501000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:NominalLendingFee contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_E7C44C61-5379-49F1-BBAD-580961186681_1_2">0.01</mnkd:NominalLendingFee>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_8">-97000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_2_2">0.009</mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_2_11">0</mnkd:IncomeTaxExpenseBenefitNet>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6006_900021">27779000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_30">12341000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <mnkd:MilestonePayments contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2_40">3150000</mnkd:MilestonePayments>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_2A97455F-7AEE-4453-8872-AE1FCDE3B2C9_2_0">79000</mnkd:PaymentsForUseOfAircrafts>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1106131x1261992" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA3C09E1-92B1-45CA-B3D2-D9E9943F4735_1002_0">48622000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107053x1234768" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1002_38">20000000</us-gaap:ProceedsFromIssuanceOfDebt>
  <mnkd:WriteOffOfCommitmentAsset contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107053x1234768" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1002_11">1753000</mnkd:WriteOffOfCommitmentAsset>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107053x1241281_1110347x1158750_1112725x1155283_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E37A9CA3-36FF-4B03-8054-5F8D98A53EAB_1002_5">1900000</us-gaap:InterestExpenseDebt>
  <mnkd:PaymentForContingentLiabilities contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107053x1241281_1110347x1158750_1112725x1155283_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E37A9CA3-36FF-4B03-8054-5F8D98A53EAB_1002_6">5000000</mnkd:PaymentForContingentLiabilities>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_400024">324000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_400019">3996000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_400018">3251000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_500024">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_500018">35000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_500019">38000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_500023">174000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:StockIssuedDuringPeriodSharesWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_400020">11575000</mnkd:StockIssuedDuringPeriodSharesWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_500021">115000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:StockIssuedDuringPeriodSharesForDebtExchange contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6001_400022">17521000</mnkd:StockIssuedDuringPeriodSharesForDebtExchange>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6003_600026">25660000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6003_600024">1361000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6003_600025">22962000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6003_600018">10943000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6003_600019">-26946000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <mnkd:StockIssuedDuringPeriodValueForDebtExchange contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6003_600023">93327000</mnkd:StockIssuedDuringPeriodValueForDebtExchange>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6003_600021">27664000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1113367" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6004_700027">-10000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1283011" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_6005_800028">-198382000</us-gaap:NetIncomeLoss>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1112578x1105469" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_1002_3">2610720</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1112578x1107650" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_2002_0">21541664</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1112578x1108838" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_3002_2">9987876</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1112578x1112342" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_4002_1">17323080</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <mnkd:OfficeLeaseExpense contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1112725x1320039_1226349x1285790" unitRef="iso4217_USD" decimals="INF" id="id_7647232_D662AAE3-C230-4574-9FCF-A70E22E6DBB2_1003_2">0</mnkd:OfficeLeaseExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1113993x1105782" unitRef="iso4217_USD" decimals="-3" id="id_7647232_36E2F33F-1DF4-4416-959D-8AED615E10A8_1002_1">26265000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1113993x1109593" unitRef="iso4217_USD" decimals="-3" id="id_7647232_36E2F33F-1DF4-4416-959D-8AED615E10A8_2002_0">22357000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1115253x1107704" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_1002_2">P5Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1115253x1116460" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_2002_3">P6Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1116223x1282107_1150195x1230904" unitRef="iso4217_USD" decimals="-5" id="id_7647232_FFEA17B5-148B-453D-81DA-D0F173C4ED9C_3003_1">50000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1116613x1199471" unitRef="iso4217_USD" decimals="-5" id="id_7647232_35F1500F-12AE-4CBF-9586-43783D6E365A_1002_0">900000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1116663x1271799" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA06E7FA-611D-49E1-BBEE-A99EF2CBCE4C_1002_1">7550000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE126000--1510-K0015_STD_365_20141231_0_1116663x1271799" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA06E7FA-611D-49E1-BBEE-A99EF2CBCE4C_1002_0">326000</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_94949F75-8185-4B00-810D-841177EA417F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Fair Value
 of Financial Instruments&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company utilizes fair
 value measurement guidance prescribed by GAAP to value its
 financial instruments. The guidance includes a definition of fair
 value, prescribes methods for measuring fair value, establishes a
 fair value hierarchy based on the inputs used to measure fair value
 and expands disclosures about the use of fair value measurements.
 The valuation techniques utilized are based upon observable and
 unobservable inputs. Observable inputs reflect market data obtained
 from independent sources, while unobservable inputs reflect
 internal market assumptions. These two types of inputs create the
 following fair value hierarchy:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level
 1&amp;#xA0;&amp;#x2014;&amp;#xA0;Quoted prices for identical instruments in
 active markets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level
 2&amp;#xA0;&amp;#x2014;&amp;#xA0;Quoted prices for similar instruments in active
 markets; quoted prices for identical or similar instruments in
 markets that are not active; and model-derived valuations whose
 inputs are observable or whose significant value drivers are
 observable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level
 3&amp;#xA0;&amp;#x2014;&amp;#xA0;Significant inputs to the valuation model are
 unobservable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The carrying
 amounts reflected in the consolidated balance sheets for cash
 equivalents, other current assets, accounts payable, and accrued
 expenses and other current liabilities, approximate fair value due
 to their relatively short maturities.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <dei:DocumentType contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5CDA9016-DEE6-403E-9784-F9797854F918_1_0">10-K</dei:DocumentType>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_C87A7D43-072A-44F4-98FF-8464922BC0AE_1_5">896184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_8EBD5446-3F30-4F09-8779-077B1B277DE9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s effective income tax rate differs from the
 statutory federal income tax rate as follows for the years ended
 December&amp;#xA0;31, 2015, 2014 and 2013:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Federal tax benefit
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State tax benefit, net of
 federal benefit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent items&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Intercompany transfer of
 intellectual property&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.1&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(31.8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30.7&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective income tax
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <dei:TradingSymbol contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_1_400000">MNKD</dei:TradingSymbol>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_1A18594D-9B79-488A-AAC4-4E4B12E6B822_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;5. Property and
 equipment&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment consist of the following (dollar amounts in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="70%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" rowspan="2" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 Useful&lt;br /&gt;
 Life&lt;br /&gt;
 (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" rowspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Land&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Buildings&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Building
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;131,383&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Machinery and
 equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3-15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;95,182&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;80,919&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture, fixtures and
 office equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-10&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,137&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Computer equipment and
 software&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,707&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;10,465&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,044&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39,580&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;308,674&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;310,348&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less impairment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(140,412&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
 depreciation and amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(119,513&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(118,221&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total property and
 equipment, net&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,749&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;192,127&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements are amortized over four years which is the shorter of
 the term or the service lives of the improvements. Depreciation and
 amortization expense related to property and equipment for the
 years ended December&amp;#xA0;31, 2015, 2014, and 2013, was $11.0
 million, $9.8 million, and $11.5 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In connection
 with the Company&amp;#x2019;s quarterly assessment of impairment
 indicators, the Company evaluated the continued lower than expected
 sales of AFREZZA as reported by Sanofi throughout the fourth
 quarter of 2015, revised forecasts for sales of AFREZZA provided by
 Sanofi in the fourth quarter of 2015 and level of commercial
 production in the fourth quarter of 2015, as well as the
 uncertainty associated with Sanofi&amp;#x2019;s announcement during the
 fourth quarter of their intent to reorganize their diabetes
 business. These factors indicated potentially significant changes
 in the timing and extent of cash flows, and the Company therefore
 determined that an impairment indicator existed in the fourth
 quarter of 2015.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 January&amp;#xA0;4, 2016, the Company received written notice from
 Sanofi of its election to terminate in its entirety the Sanofi
 License Agreement. Sanofi&amp;#x2019;s notice indicated that the
 termination was pursuant to Sanofi&amp;#x2019;s right to terminate the
 agreement upon Sanofi&amp;#x2019;s good faith determination that the
 commercialization of AFREZZA is no longer economically viable in
 the United States, in which case the effective date of termination
 would be April&amp;#xA0;4, 2016. In the alternative, Sanofi indicated
 that the termination was also pursuant to its right to terminate
 the License Agreement for any reason, in which case the Termination
 Date would be July&amp;#xA0;4, 2016. In the interest of an expedient
 transition, the Company is currently working with Sanofi to
 transfer and wind down the agreement activities by April&amp;#xA0;4,
 2016, or as soon as practicable thereafter.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 identified two primary asset groups to be evaluated for impairment:
 the Danbury manufacturing facility, which currently performs all
 the manufacturing of AFREZZA, and the Valencia facility, which was
 previously the Company&amp;#x2019;s corporate headquarters. The Danbury
 manufacturing facility is the primary asset group that has been
 impacted by the impairment indicators noted above but the Company
 also evaluated the Valencia facility for potential impairment given
 the circumstances and identified an impairment charge of $1.8
 million based on a valuation utilizing a combination of market,
 income and cost approaches. Within the Danbury manufacturing
 facility, the Company identified the machinery and equipment as the
 primary assets within the asset group as they are associated with
 the production of AFREZZA. As such, the Company performed the fixed
 asset impairment test and performed the first step to test for
 recoverability of the Danbury manufacturing facility by utilizing
 two undiscounted cash flow projections and applying a probability
 weighted average to those cash flow projections. The first
 undiscounted cash flow projection was developed under a scenario
 assuming Sanofi would continue to sell and market AFREZZA as the
 termination of the arrangement by Sanofi was not known as of the
 balance sheet date. The second undiscounted cash flow projection
 assumed Sanofi would terminate the Sanofi License Agreement and
 that the Company would manufacture, sell and market AFREZZA
 independently.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Based on the
 evaluation performed, the probabilities assigned to the two
 undiscounted cash flows were not significant to the evaluation due
 to the projected negative cash flows over the estimation period,
 and it was determined that the probability weighted undiscounted
 cash flows were not sufficient to recover the carrying value of the
 Danbury manufacturing facility. As such, the Company was required
 to determine the fair value of the Danbury manufacturing facility
 to recognize an impairment loss if the carrying amount exceeds its
 fair value. The Company determined the fair value of the Danbury
 manufacturing facility by applying the highest and best use
 valuation concept and utilizing the market approach valuation
 technique to value the machinery and equipment and a combination of
 the market approach and cost approach in valuing the land,
 buildings, and building improvements. As a result of this
 assessment, the Company recorded an impairment charge of $138.6
 million for the Danbury manufacturing facility.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_DB667DE8-3E20-4FC9-A38E-8C989A2A52FA_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;is a summary
 of the carrying values and estimated fair values of the 2018 notes,
 the facility financing obligation (i.e., the 2019 notes and Tranche
 B notes), and the Sanofi Loan Facility (in
 millions):&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;/p&gt;
 &lt;table style="FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="67%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2015 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;99.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;102.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;2018 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;27.6&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;21.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Facility financing
 obligation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;74.6&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;78.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;73.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;75.1&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Sanofi Loan
 Facility&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;44.5&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;36.5&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;3.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 30px; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
  <dei:EntityVoluntaryFilers contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_1_400006">No</dei:EntityVoluntaryFilers>
  <dei:EntityCentralIndexKey contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_1_400002">0000899460</dei:EntityCentralIndexKey>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_B0994DF9-94F3-4AED-A2A8-F8004EE81B07_1_4">4.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <dei:DocumentPeriodEndDate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5CDA9016-DEE6-403E-9784-F9797854F918_1_2">2015-12-31</dei:DocumentPeriodEndDate>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_A849E91A-E4C4-4269-B556-214C13AC6368_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;6. Accrued expenses and
 other current liabilities&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
 and other current liabilities are comprised of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Salary and related
 expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,662&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;14,928&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued interest&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;615&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,396&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;238&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,343&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,414&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,539&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses and other
 current liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,929&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;26,206&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_1_4">0.6976</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <dei:EntityFilerCategory contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_1_400007">Large Accelerated Filer</dei:EntityFilerCategory>
  <us-gaap:InventoryDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5DAE1269-E7E5-4A50-B5D7-A9B35B02B1EA_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4.
 Inventories&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inventories
 consist of the following (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="79%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Raw materials&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,856&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Work-in-process&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,719&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Finished goods&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;95&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inventory &amp;#x2014;
 current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,670&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total Inventory&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;9,670&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"&gt;&amp;#xA0;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
  <us-gaap:DebtDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_B8B7A407-E620-4DC9-981A-53C564B75FE9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;17. Facility
 Agreement&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2015 and 2014, there were $60.0 million principal
 amount of 2019 notes and $20.0 million principal amount of Tranche
 B notes outstanding. The 2019 notes accrue interest at annual rate
 of 9.75% and the Tranche B notes accrue interest at an annual rate
 of 8.75% and is paid quarterly in arrears on the last day of each
 March, June, September, and December. The Facility Agreement
 principal repayment schedule is comprised of annual payments
 beginning on July&amp;#xA0;1, 2016 and ending December&amp;#xA0;9, 2019.
 Future principal payments for the years ended December&amp;#xA0;31,
 2016, 2017, 2018, and 2019 are $5.0 million, $20.0 million, $20.0
 million, and $35.0 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In conjunction
 with the Facility Agreement, the Company entered into a Milestone
 Rights Agreement with Deerfield which requires the Company to make
 contingent payments to Deerfield, totaling up to $90.0 million,
 upon the Company achieving specified commercialization milestones.
 The Milestone Rights were initially recorded as a short-term
 liability equal to $3.2 million included in accrued expenses and
 other current liabilities in the accompanying condensed
 consolidated balance sheet and a long-term liability equal to $13.1
 million included in other liabilities. During the first quarter of
 2015, a milestone triggering event was achieved following the
 Company&amp;#x2019;s product launch on February&amp;#xA0;3, 2015, which
 resulted in a $5.8 million incremental charge to interest expense
 due to the increase in carrying value of the liability to the
 required $10.0 million payment made in February of 2015. During the
 year ended December&amp;#xA0;31, 2014, the first milestone triggering
 event was achieved following the Company&amp;#x2019;s entry into the
 Sanofi License Agreement, which resulted in a $1.9 million
 incremental charge to interest expense due to the increase in
 carrying value of the liability to the required $5.0 million
 payment, which was paid to Deerfield pursuant to the terms of the
 Milestone Agreement. As of December&amp;#xA0;31, 2015, the remaining
 liability balance of $8.9 million is classified as long-term
 liability in other liabilities.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of December
 31, 2015, the uncreated debt discount and debt issuance costs were
 $5.3 million and $0.1 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion of
 debt issuance cost and debt discount in connection with the
 Deerfield financing during the year ended December&amp;#xA0;31, 2015
 and 2014 are as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="86%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion expense- debt
 issuance cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;326&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accretion expense- debt
 discount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,553&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,550&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Facility
 Agreement includes customary representations, warranties and
 covenants, including, a restriction on the incurrence of additional
 indebtedness, and a financial covenant which requires the
 Company&amp;#x2019;s cash and cash equivalents, which includes available
 borrowings on the principal stockholder note, on the last day of
 each fiscal quarter to not be less than $25.0 million. As discussed
 in Note 1 &amp;#x2014;&amp;#xA0;Basis of Presentation, the Company will need
 to raise additional capital to support its current operating plans.
 Due to the uncertainties related to maintaining sufficient
 resources to comply with the aforementioned covenant, the 2019
 notes have been classified as current liabilities in the
 accompanying balance sheet as of December&amp;#xA0;31, 2015. In the
 event of non-compliance, Deerfield may declare all or any portion
 of the 2019 notes and/or Tranche B notes to be immediately due and
 payable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Milestone
 Agreement includes customary representations and warranties and
 covenants by the Company, including restrictions on transfers of
 intellectual property related to AFREZZA. The Milestone Rights are
 subject to acceleration in the event the Company transfers its
 intellectual property related to AFREZZA in violation of the terms
 of the Milestone Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 analyzed the Milestone Rights under the provisions of ASC 815
 &lt;i&gt;Derivatives and Hedging,&lt;/i&gt; and determined that the instruments
 do not meet the definition of a freestanding derivative. Since the
 Company has not elected to apply the fair value option to the
 Milestone Rights, the Company has initially recorded the Milestone
 Rights at their estimated fair value and accounted for the
 Milestone Rights as a liability by applying the indexed debt
 guidance contained in paragraphs ASC 470-10-25-3 and
 35-4.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones discounted
 to present value using a selected market discount rate. In
 determining the fair value of the Milestone Rights, the 13
 individual milestone payments were adjusted for both (i)&amp;#xA0;the
 expected timing and (ii)&amp;#xA0;the probability of achieving the
 milestones, and then discounted to present value using a discount
 rate of 17.5%. Once the initial valuation of each specified
 milestone payment was determined, the individual milestone payments
 were then aggregated to arrive at a total fair value of $16.3
 million. The discount rate was based on the estimated cost of
 equity which was derived using the capital asset pricing model. In
 addition, a 5% risk premium was added to the computation of the
 cost of equity to adjust for non-systemic risk factors, such as the
 Company&amp;#x2019;s lack of product diversification and history of
 financial losses, which were not captured in other model
 inputs.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Security
 Agreement&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In connection
 with the Facility Agreement, the Company and its subsidiary,
 MannKind LLC, entered into a Guaranty and Security Agreement (the
 &amp;#x201C;Security Agreement&amp;#x201D;) with Deerfield and HS
 (collectively, the &amp;#x201C;Purchasers&amp;#x201D;), pursuant to which the
 Company and MannKind LLC each granted the Purchasers a security
 interest in substantially all of their respective assets, including
 respective intellectual property, accounts, receivables, equipment,
 general intangibles, inventory and investment property, and all of
 the proceeds and products of the foregoing. The Security Agreement
 includes customary covenants by the Company and MannKind LLC,
 remedies of the Purchasers and representations and warranties by
 the Company and MannKind LLC. The security interests granted by the
 Company and MannKind LLC will terminate upon repayment of the 2019
 notes and tranche B notes, if applicable, in full. The
 Company&amp;#x2019;s obligations under the Facility Agreement and the
 Milestone Agreement are also secured by the mortgage on the
 Company&amp;#x2019;s facilities in Danbury, Connecticut, which has a
 carrying value of $23.0 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Embedded
 Derivatives&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 identified and evaluated a number of embedded features in the notes
 issued under the Facility Agreement to determine if they
 represented embedded derivatives that are required to be separated
 from the notes and accounted for as freestanding instruments
 pursuant to ASC 815. In 2014, the Company analyzed the
 Tranche&amp;#xA0;B notes and identified embedded derivatives which
 required separate accounting under ASC&amp;#xA0;815; however all of the
 embedded derivatives were determined to have a &lt;i&gt;de minimis&lt;/i&gt;
 value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
 December&amp;#xA0;31, 2015, all of the embedded derivatives identified
 in the Tranche B notes were deemed to have a &lt;i&gt;de minimis&lt;/i&gt;
 value.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_EB0A1220-E0FC-441B-80B4-C0F7965395CE_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;13. Stock award
 plans&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;23,
 2013, the Company adopted the 2013 Equity Incentive Plan (the
 &amp;#x201C;2013 Plan&amp;#x201D;) as the successor to and continuation of
 the 2004 Equity Incentive Plan (the &amp;#x201C;2004 Plan&amp;#x201D;). The
 2013 Plan consists of 21.5&amp;#xA0;million newly requested shares and
 the number of unallocated shares remaining available for grant for
 new awards under the 2004 Plan. The 2013 Plan provides for the
 granting of stock awards including stock options and restricted
 stock units, to employees, directors and consultants. The Plan also
 provides for the automatic, non-discretionary grant of options to
 the Company&amp;#x2019;s non-employee directors. No additional awards
 will be granted under the 2004 Plan or under the 2004 Non-Employee
 Directors&amp;#x2019; Stock Option Plan (the &amp;#x201C;NED Plan&amp;#x201D;) as
 all future awards will be made out of the 2013 Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2015, the Company has two active stock-based
 compensation plans &amp;#x2014;&amp;#xA0;the 2013 Plan and the 2004 Employee
 Stock Purchase Plan (the &amp;#x201C;ESPP&amp;#x201D;). The following table
 summarizes information about the Company&amp;#x2019;s stock-based award
 plans as of December&amp;#xA0;31, 2015:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="65%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Restricted&lt;br /&gt;
 Stock Units&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Shares&amp;#xA0;Available&lt;br /&gt;
 for&lt;br /&gt;
 Future Issuance&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2004 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;11,309,136&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;276,784&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,026,762&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,527,836&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,540,652&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2004 Non-Employee
 Directors&amp;#x2019; Stock Option Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;443,331&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,779,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,804,620&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,540,652&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In March 2004,
 the Company&amp;#x2019;s board of directors approved the ESPP, which
 became effective upon the closing of the Company&amp;#x2019;s initial
 public offering. Initially, the aggregate number of shares that
 could be sold under the 2004 Plan was 2,000,000 shares of common
 stock. On January&amp;#xA0;1 of each year, for a period of ten years
 beginning January&amp;#xA0;1, 2005, the share reserve automatically
 increases by the lesser of: 700,000 shares, 1% of the total number
 of shares of common stock outstanding on that date, or an amount as
 may be determined by the board of directors. However, under no
 event can the annual increase cause the total number of shares
 reserved under the ESPP to exceed 10% of the total number of shares
 of capital stock outstanding on December&amp;#xA0;31 of the prior year.
 On January&amp;#xA0;1, 2013 and 2014 the ESPP share reserve was
 increased by 700,000 and 700,000 shares, respectively. There was no
 ESPP share reserve increase during 2015. As of December&amp;#xA0;31,
 2015, 2,752,703 shares were available for issuance under the ESPP.
 For the years ended December&amp;#xA0;31, 2015, 2014 and 2013 the
 Company sold 321,228, 305,076, and 463,290 shares, respectively, of
 its common stock to employees participating in the ESPP. The ESPP
 purchase for the period ending December&amp;#xA0;31, 2015 was initiated
 prior to year-end but did not settle until January&amp;#xA0;5, 2016. As
 a result, the shares sold are reflected in the ESPP share reserves
 but is excluded from common stock outstanding as of
 December&amp;#xA0;31, 2015.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s board of directors determines eligibility, vesting
 schedules and exercise prices for stock awards granted under the
 2013 Plan. Options and other stock awards under the 2013 Plan
 expire not more than ten years from the date of the grant and are
 exercisable upon vesting. Stock options generally vest over four
 years. Current stock option grants vest and become exercisable at
 the rate of 25% after one year and ratably on a monthly basis over
 a period of 36 months thereafter. Restricted stock units generally
 vest at a rate of 25%&amp;#xA0;per year over four years with
 consideration satisfied by service to the Company. There are no
 outstanding performance-based awards as all milestones have been
 achieved as of December&amp;#xA0;31, 2015. The 2013 Plan provides for
 full acceleration of vesting if an employee is terminated within
 three months of a change in control, as defined in the 2013
 Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In accordance
 with ASC 718, share-based payment transactions are recognized as
 compensation cost based on the fair value of the instrument on the
 date of grant. The Company accounts for non-employee stock-based
 compensation expense based on the estimated fair value of the
 options, which is determined using the Black-Scholes option
 valuation model and amortizes such expense on a straight-line basis
 over the service period for time-based awards and over the expected
 dates of achievement for performance-based awards. These awards are
 subject to re-measurement until service is complete. As of
 December&amp;#xA0;31, 2015, there were options to purchase 523,487
 shares of common stock outstanding to consultants.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the
 years ended December&amp;#xA0;31, 2015, 2014 and 2013 the Company
 recorded stock-based compensation expense related to its stock
 award plans and the ESPP of $8.7 million, $48.6 million, and $45.2
 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Employee-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,407&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;45,181&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Consultant-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;318&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,725&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is included in the following categories
 (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and
 development&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,029&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;22,357&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;20,409&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;General and
 administrative&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,696&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;26,265&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,777&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,725&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 uses the Black-Scholes option valuation model to estimate the grant
 date fair value of employee stock options. The expected term of an
 option granted is based on combining historical exercise data with
 expected weighted time outstanding. Expected weighted time
 outstanding is calculated by assuming the settlement of outstanding
 awards is at the midpoint between the remaining weighted average
 vesting date and the expiration date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Beginning in
 the third quarter of 2014, the Company began to assess both
 historical and implied volatility in order to determine its
 estimated volatility rate. Implied volatility was considered due to
 the change in the Company&amp;#x2019;s business, which occurred with the
 approval for the sale of AFREEZA. The Company has selected
 risk-free interest rates based on U.S. Treasury securities with an
 equivalent expected term in effect on the date the options were
 granted. Additionally, the Company uses historical data and
 management judgment to estimate stock option exercise behavior and
 employee turnover rates to estimate the number of stock option
 awards that will eventually vest. The Company calculated the fair
 value of employee stock options granted during the years ended
 December&amp;#xA0;31, 2015, 2014 and 2013 using the following
 assumptions:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="46%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.61%&amp;#xA0;&amp;#x2014;&amp;#xA0;1.86%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.64%&amp;#xA0;&amp;#x2014;&amp;#xA0;2.11%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.94%
 &amp;#x2014;&amp;#xA0;1.82%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected lives&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.79&amp;#xA0;&amp;#x2014;&amp;#xA0;5.86&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.77&amp;#xA0;&amp;#x2014;&amp;#xA0;6.09&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.64&amp;#xA0;&amp;#x2014;&amp;#xA0;5.77&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;69.76%&amp;#xA0;&amp;#x2014;&amp;#xA0;71.84%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73.98%&amp;#xA0;&amp;#x2014;&amp;#xA0;84.85%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;75.83%&amp;#xA0;&amp;#x2014;&amp;#xA0;86.26%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividends&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes information about stock options
 outstanding:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="70%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;br /&gt;
 per&amp;#xA0;Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
 Intrinsic&lt;br /&gt;
 Value&amp;#xA0;($000)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
 January&amp;#xA0;1, 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.53&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;33,495&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,541,100&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.11&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,700,964&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.91&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(706,387&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.78&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expired&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(896,184&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.70&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
 December&amp;#xA0;31, 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,779,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.54&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vested and expected to vest
 at December&amp;#xA0;31, 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,597,097&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.53&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable at
 December&amp;#xA0;31, 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17,217,332&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.47&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The weighted
 average grant date fair value of the stock options granted during
 the years ended December&amp;#xA0;31, 2015, 2014 and 2013 was $2.56,
 $4.76 and $3.26 per option, respectively. The total intrinsic value
 of options exercised during the years ended December&amp;#xA0;31, 2015,
 2014 and 2013 was $6.2 million, $14.9 million and $3.1 million,
 respectively. Intrinsic value is measured using the fair market
 value at the date of exercise (for options exercised) or at
 December&amp;#xA0;31 (for outstanding options), less the applicable
 exercise price.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash received
 from the exercise of options during the years ended
 December&amp;#xA0;31, 2015, 2014 and 2013 was approximately $3.3
 million, $11.0 million and $2.3 million, respectively. The
 weighted-average remaining contractual terms for options
 outstanding, vested and expected to vest, and exercisable at
 December&amp;#xA0;31, 2015 was 6.34 years, 6.31 years and 5.97 years,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A summary of
 restricted stock unit activity for the year ended December&amp;#xA0;31,
 2015 is presented below:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Grant&amp;#xA0;Date&lt;br /&gt;
 Fair Value&lt;br /&gt;
 per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at January 1,
 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.20&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,133,404&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.14&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vested&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,111,134&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.93&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(828,370&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.88&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,804,620&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.85&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The total
 restricted stock units expected to vest as of December&amp;#xA0;31,
 2015 was 1,651,859 with a weighted average grant date fair value of
 $4.86. The total intrinsic value of restricted stock units expected
 to vest as of December&amp;#xA0;31, 2015 was $2.4 million. Intrinsic
 value of restricted stock units expected to vest is measured using
 the closing share price at December&amp;#xA0;31, 2015.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total intrinsic
 value of restricted stock units vested during the years ended
 December&amp;#xA0;31, 2015, 2014 and 2013 was $5.2 million, $62.7
 million and $13.9 million, respectively. Intrinsic value of
 restricted stock units vested is measured using the closing share
 price on the day prior to the vest date. The total grant date fair
 value of restricted stock units vested during the years ended
 December&amp;#xA0;31, 2015, 2014 and 2013 was $5.5million, $36.4
 million and $14.9 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2015, there was $4.9 million and $6.7 million of
 unrecognized compensation expense related to options and restricted
 stock units, respectively, which is expected to be recognized over
 the weighted average vesting period of 2.7 years. The Company
 evaluates stock awards with performance conditions as to the
 probability that the performance conditions will be met and
 estimates the date at which the performance conditions will be met
 in order to properly recognize stock-based compensation expense
 over the requisite service period. As of December&amp;#xA0;31, 2015,
 all milestones have been achieved.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the year
 ended December&amp;#xA0;31, 2015, there was $1.6 million of stock
 compensation expense related to certain Executives who entered into
 severance agreements which resulted in a modification to the terms
 of their awards. The severance agreements generally allowed for the
 separated Executives to continue to vest under their original award
 terms for a stated period of time without providing substantive
 services.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="2" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_1_1">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_AAA71D81-FFEB-4EEF-A306-E1CE6D0523D9_1_4">828370</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_1_4">29731254</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_917F98AD-2CCE-4378-8ECA-F497D94EDFB5_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses
 and other current liabilities are comprised of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Salary and related
 expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,662&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;14,928&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued interest&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;615&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2,396&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;238&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,343&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,414&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,539&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accrued expenses and other
 current liabilities&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,929&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;26,206&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_8D205C54-E9C7-43E1-BCA8-8B17D69C487B_4_5">321228</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_C87A7D43-072A-44F4-98FF-8464922BC0AE_1_4">706387</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5E8AF109-EE64-4900-91F6-2E35814430EA_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Principles
 of Consolidation&lt;/i&gt; &amp;#x2014;&amp;#xA0;The consolidated financial
 statements include the accounts of the Company and its wholly-owned
 subsidiaries. Intercompany balances and transactions have been
 eliminated.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_1_400003">--12-31</dei:CurrentFiscalYearEndDate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_1_5">0.7184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_7C284218-86CB-4E06-B3DD-11BABE1D5847_1_2">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5CDA9016-DEE6-403E-9784-F9797854F918_1_4">FY</dei:DocumentFiscalPeriodFocus>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_DE9D93EC-913B-40CF-B435-1D9D99B0BD8E_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt; &amp;#x2014;&amp;#xA0;Financial
 instruments which potentially subject the Company to concentration
 of credit risk consist of cash and cash equivalents. Cash and cash
 equivalents consist of interest-bearing accounts, which are
 regularly monitored by management and held in high credit quality
 institutions.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_45DE14A7-837E-4EFD-BDCC-FD5B349BAE66_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Net Loss Per
 Share of Common Stock&lt;/i&gt; &amp;#x2014;&amp;#xA0;Basic net loss per common
 share is computed by dividing net loss by the weighted-average
 number of common shares outstanding during the period. Diluted net
 loss per common share is computed by dividing the net loss by the
 sum of the weighted-average number of common shares outstanding
 during the period plus the potential dilutive effect of stock
 options, restricted stock units, warrants, and shares that could be
 issued upon conversion of the senior convertible notes outstanding
 during the period calculated in accordance with the treasury stock
 method, but are excluded if their effect is anti-dilutive. Because
 the impact of these items is anti-dilutive during periods of net
 loss, there was no difference between basic and diluted loss per
 common share for the years ended December&amp;#xA0;31, 2015, 2014, and
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_1_4">-0.338</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_C460FE27-76F3-4214-BF6A-EF5C87C5AD51_1_0">&lt;div&gt;
 &lt;p&gt;&lt;font size="2"&gt;Components of the net deferred tax asset as of
 December&amp;#xA0;31, 2015 and 2014 are approximately as follows (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred tax
 assets:&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="5"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net operating loss
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;721,588&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;699,997&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and development
 credits&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73,646&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73,227&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized
 research&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,872&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;28,516&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Payments from
 collaboration&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;52,484&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,217&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Milestone Rights&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,242&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,321&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accrued expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;251&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;768&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Loss on purchase
 commitment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,084&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-qualified stock option
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;16,941&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;43,691&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized patent
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,574&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,624&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,186&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Depreciation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,755&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;962,623&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;882,502&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(962,623&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(882,502&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_96193E4F-0BFF-432A-9989-2CE96EB9C290_1_2">4.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_FABDFB21-AC02-44E9-9115-70307EB1A4B8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;10. Fair Value of
 Financial Instruments&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The carrying
 amounts of financial instruments, which include cash equivalents
 and accounts payable, approximate their fair values due to their
 relatively short maturities. The fair value of the note payable to
 the Company&amp;#x2019;s principal stockholder cannot be reasonably
 estimated as the Company would not be able to obtain a similar
 credit arrangement in the current economic environment.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2015 and 2014, the Company held $59.1 million and
 $120.8 million, respectively of cash and cash equivalents,
 consisting of money market funds of $55.8 million and $118.5
 million, respectively, and the remaining funds in non-interest
 bearing checking accounts. The fair value of these money market
 funds was determined by using quoted prices for identical
 investments in an active market (Level 1 in the fair value
 hierarchy).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2018 notes,
 facility financing obligation and Sanofi Loan
 Facility&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 is a summary of the carrying values and estimated fair values of
 the 2018 notes, the facility financing obligation (i.e., the 2019
 notes and Tranche B notes), and the Sanofi Loan Facility (in
 millions):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="67%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,
 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 fair value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2015 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;99.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;102.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2018 notes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;27.6&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Facility financing
 obligation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;74.6&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78.4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;75.1&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Sanofi Loan
 Facility&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;44.5&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;36.5&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2015
 notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The estimated
 fair value of the 2015 notes was calculated based on model-derived
 valuations whose inputs were observable, such as the
 Company&amp;#x2019;s stock price, and non-observable, such as the
 Company&amp;#x2019;s longer-term historical volatility (55%) (Level 3 in
 the fair value hierarchy). As there was no current active and
 observable market for the 2015 notes, the Company determined the
 estimated fair value using a convertible bond valuation model
 within a lattice framework. The convertible bond valuation model
 combined expected cash outflows with market-based assumptions
 regarding risk-adjusted yields, stock price volatility and recent
 price quotes and trading information regarding Company issued debt
 instruments and shares of common stock into which the notes are
 convertible. As of December&amp;#xA0;31, 2015, all 2015 notes,
 including the Exchange Notes, have been extinguished through
 exchange for stock, exchange for 2018 notes or settlement in cash.
 (See Note 8&amp;#xA0;&amp;#x2014;Senior convertible notes).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2018
 notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The estimated
 fair value of the 2018 notes was calculated based on model-derived
 valuations whose inputs were observable, such as the
 Company&amp;#x2019;s stock price and yields on U.S. Treasury notes and
 actively traded bonds, and non-observable, such as the
 Company&amp;#x2019;s longer-term historical volatility, and estimated
 yields implied from any available market trades of the
 Company&amp;#x2019;s issued debt instruments. As there is no current
 active and observable market for the 2018 notes, the Company
 determined the estimated fair value using a convertible bond
 valuation model within a lattice framework. The convertible bond
 valuation model combined expected cash flows based on terms of the
 notes with market-based assumptions regarding risk-free rate,
 risk-adjusted yields (20%), stock price volatility (90%) and recent
 price quotes and trading information regarding Company issued debt
 instruments and shares of common stock into which the notes are
 convertible (Level 3 in the fair value hierarchy).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Facility
 financing agreement&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As discussed in
 Note 17 &amp;#x2014;&amp;#xA0;Facility Agreement, in connection with the
 Facility Agreement, the Company issued 2019 notes and subsequently
 issued Tranche B notes (the &amp;#x201C;Facility Financing
 Obligation&amp;#x201D;). As there is no current observable market for
 the 2019 notes or Tranche B notes, the Company determined the
 estimated fair value using a bond valuation model based on a
 discounted cash flow methodology. The bond valuation model combined
 expected cash flows associated with principal repayment and
 interest based on the contractual terms of the debt agreement
 discounted to present value using a selected market discount rate.
 On December&amp;#xA0;31, 2015 the market discount rate was recalculated
 at 12.0% for the 2019 notes and the Tranche B notes (Level 3 in the
 fair value hierarchy).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In addition to
 the 2019 notes and Tranche B notes, the Company also issued certain
 rights to receive payments of up to $90.0 million upon occurrence
 of specified strategic and sales milestones (the &amp;#x201C;Milestone
 Rights&amp;#x201D;). These rights are not reflected in the facility
 financing obligation. The estimated fair value of the Milestone
 Rights was calculated using the income approach in which the cash
 flows associated with the specified contractual payments were
 adjusted for both the expected timing and the probability of
 achieving the milestones discounted to present value using a
 selected market discount rate (Level 3 in the fair value
 hierarchy). The expected timing and probability of achieving the
 milestones, starting in 2014, was developed with consideration
 given to both internal data, such as progress made to date and
 assessment of criteria required for achievement, and external data,
 such as market research studies. The discount rate (15.0%)&amp;#xA0;was
 selected based on an estimation of required rate of returns for
 similar investment opportunities using available market data. As of
 December&amp;#xA0;31, 2015, the carrying value of the Milestone Rights
 is $8.9 million, classified as a long-term liability in other
 liabilities and the fair value is estimated at $14.4
 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Sanofi Loan
 Facility&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As discussed in
 Note 9 &amp;#x2014;&amp;#xA0;the Sanofi Loan Facility, consists of a senior
 secured revolving promissory note and a guaranty and security
 agreement with an affiliate of Sanofi which provides the Company
 with a secured loan facility of up to $175.0 million to fund the
 Company&amp;#x2019;s share of net losses under the Sanofi License
 Agreement. The estimated fair value was determined using a
 discounted cash flow model in which time outstanding and discount
 rate were primary variables. This method considered the key
 elements of the contractual terms of the Sanofi Loan Facility,
 market-based estimated cost of capital, and time value of money,
 namely the amount of time to settlement and the estimated discount
 rate (11%)&amp;#xA0;appropriate for the liability (Level 3 in the fair
 value hierarchy). As of December 31, 2015 the carrying value of the
 Sanofi Loan Facility is $44.5 million and the fair value is
 estimated at $36.5 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;There were no
 material re-measurements to fair value during the year ended
 December&amp;#xA0;31, 2015 of financial assets and liabilities that are
 not measured at fair value on a recurring basis. There were no
 transfers of assets or liabilities between the fair value
 measurement levels during the twelve months ended December&amp;#xA0;31,
 2015, 2014, and 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Assets and
 Liabilities Measured at Fair Value on a Non-recurring
 Basis&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In accordance
 with ASC 360, &lt;i&gt;Property, Plant, and Equipment&lt;/i&gt; (&amp;#x201C;ASC
 360&amp;#x201D;), land, buildings, and machinery and equipment, with a
 carrying amount of $189.2 million, were written down to a fair
 value of $48.8 million, resulting in an impairment charge of $140.4
 million, which is included in our Statements of Operations and
 Comprehensive Loss for the year ended December&amp;#xA0;31,
 2015.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Our assessment
 of the real property includes Level 3 inputs, and was based on a
 combination of the income, market and cost approaches and the
 market approach was used for machinery and equipment which required
 Level 3 inputs.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Embedded
 Derivatives&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 identified and evaluated a number of embedded features in the notes
 issued under the Facility Agreement to determine if they
 represented embedded derivatives that are required to be separated
 from the notes and accounted for as freestanding instruments
 pursuant to ASC 815. In 2014, the Company analyzed the Tranche B
 notes and identified embedded derivatives which required separate
 accounting under ASC 815; however all of the embedded derivatives
 were determined to have a &lt;i&gt;de minimis&lt;/i&gt; value.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
 December&amp;#xA0;31, 2015, all of the embedded derivatives identified
 in the Tranche B notes were deemed to have a &lt;i&gt;de minimis&lt;/i&gt;
 value.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_D688FEB5-AB12-44C7-9CDD-B53DAEE62F7F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Cash and
 Cash Equivalents&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company considers all highly
 liquid investments with original or remaining maturities of 90 days
 or less at the time of purchase, that are readily convertible into
 cash to be cash equivalents. As of December&amp;#xA0;31, 2015 and 2014,
 cash equivalents were comprised of cash and money market accounts
 with maturities less than 90 days from the date of
 purchase.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_1_5">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_412BD20B-AE69-4E73-9ACD-D606B50D74B6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Income
 Taxes&lt;/i&gt; &amp;#x2014;&amp;#xA0;The provisions for federal, foreign, state,
 and local income taxes are calculated on pre-tax income based on
 current tax law and include the cumulative effect of any changes in
 tax rates from those used previously in determining deferred tax
 assets and liabilities. Deferred income tax assets and liabilities
 are measured using enacted tax rates expected to apply to taxable
 income in the year in which the temporary differences are expected
 to be recovered or settled. A valuation allowance is recorded to
 reduce net deferred income tax assets to amounts that are more
 likely than not to be realized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Income tax
 positions are considered for uncertainty in accordance with ASC
 740-10-25 &lt;i&gt;Income Taxes,&lt;/i&gt; The Company believes that its income
 tax filing positions and deductions will be sustained on audit and
 does not anticipate any adjustments that will result in a material
 change to its financial position. Therefore, no liabilities for
 uncertain income tax positions have been recorded. If a tax
 position does not meet the minimum statutory threshold to avoid
 payment of penalties, the Company recognizes an expense for the
 amount of the penalty in the period the tax position is claimed in
 the tax return of the Company. The Company recognizes interest
 accrued related to unrecognized tax benefits in income tax expense,
 if any. Penalties, if probable and reasonably estimable, are
 recognized as a component of income tax expense.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Significant
 management judgment is involved in determining the provision for
 income taxes, deferred tax assets, deferred tax liabilities, and
 any valuation allowance recorded against deferred tax assets. Due
 to uncertainties related to the realization of the Company&amp;#x2019;s
 deferred tax assets as a result of its history of operating losses,
 a valuation allowance has been established against the total
 deferred tax asset balance. The valuation allowance is based on
 management&amp;#x2019;s estimates of taxable income by jurisdiction in
 which the Company operates and the period over which deferred tax
 assets will be recoverable. In the event that actual results differ
 from these estimates or the Company adjusts these estimates in
 future periods, a change in the valuation allowance may be needed,
 which could materially impact the Company&amp;#x2019;s financial
 position and results of operations.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_170E71E8-1CB3-4D36-8534-1A451266E827_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Contingencies&lt;/i&gt; &amp;#x2014;&amp;#xA0;Contingencies are recorded in
 accordance with ASC 450 &lt;i&gt;Contingencies.&lt;/i&gt; Accordingly, the
 Company records a loss contingency for a liability when it is both
 probable that a liability has been incurred and the amount of the
 loss can be reasonably estimated. These accruals represent
 management&amp;#x2019;s best estimate of probable loss. Disclosure also
 is provided when it is reasonably possible that a loss will be
 incurred or when it is reasonably possible that the amount of a
 loss will exceed the recorded provision. On a quarterly basis, the
 Company reviews the status of each significant matter and assesses
 its potential financial exposure. Significant judgment is required
 in both the determination of probability and the determination as
 to whether an exposure is reasonably estimable. Because of
 uncertainties related to these matters, accruals are based only on
 the best information available at the time. As additional
 information becomes available, the Company reassesses the potential
 liability related to pending claims and litigation and may revise
 its estimates. These revisions in the estimates of the potential
 liabilities could have a material impact on the Company&amp;#x2019;s
 consolidated results of operations and financial
 position.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
  <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_E5CA7053-7E26-49A1-B3C8-C01355B8C4F8_1_0">&lt;div&gt;
 &lt;p&gt;&lt;font size="2"&gt;The provision for income taxes consists of the
 following (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="73%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;109,512&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;57,873&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59,379&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(29,394&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,631&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,470&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 Allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(80,118&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(65,504&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(66,849&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_10D0B3DB-E4FC-4A56-AD34-FE762072EB6E_1_4">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ReceivablesPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_998F8FBD-3A67-4F18-B6E8-9C23FB28CE7A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;State
 Research and Development Credit Exchange Receivable&lt;/i&gt;
 &amp;#x2014;&amp;#xA0;The State of Connecticut provides certain companies
 with the opportunity to exchange certain research and development
 income tax credit carryforwards for cash in exchange for foregoing
 the carryforward of the research and development credits. The
 program provides for an exchange of research and development income
 tax credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
  <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_B8DA4F89-CCB4-4CE8-BC40-079034B468D7_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A summary of
 restricted stock unit activity for the year ended December&amp;#xA0;31,
 2015 is presented below:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Grant&amp;#xA0;Date&lt;br /&gt;
 Fair Value&lt;br /&gt;
 per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at January 1,
 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.20&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,133,404&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.14&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vested&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,111,134&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.93&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(828,370&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.88&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at December 31,
 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,804,620&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.85&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:InterestExpensePolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_552A4F16-0B13-4EAE-8AB1-0323F4E66971_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Interest
 Expense&lt;/i&gt; &amp;#x2014;&amp;#xA0;Interest costs are expensed as incurred,
 except to the extent such interest is related to construction in
 progress, in which case interest is capitalized. Interest expense,
 net of interest capitalized, for the years ended December&amp;#xA0;31,
 2015, 2014 and 2013 was $24.1 million, $20.4 million, and $21.5
 million, respectively. Interest costs capitalized for the years
 ended December&amp;#xA0;31, 2015, 2014, and 2013 were $0.1 million,
 $0.8 million, and $0.4 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:InterestExpensePolicyTextBlock>
  <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_C3438390-C74A-4BB3-9AA4-D8F148557CF1_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Summarized
 quarterly financial data for the years ended December&amp;#xA0;31, 2015
 and 2014 are set forth in the following tables:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="58%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30,658&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(28,910&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(31,857&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(277,020&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per share &amp;#x2014;
 basic and diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.08&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.07&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.08&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.66&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per
 share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;398,916&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;401,018&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;405,199&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;419,314&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(52,056&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(73,365&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(36,520&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(36,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per share &amp;#x2014;
 basic and diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.19&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.09&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.09&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per
 share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;368,784&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;380,770&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;394,163&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;396,793&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &amp;#xA0;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_BC29ED2B-2AF7-4C58-AFE3-DD6FD88CB549_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;12. Net loss per common
 share&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic net loss
 per share excludes dilution for potentially dilutive securities and
 is computed by dividing net loss by the weighted average number of
 common shares outstanding during the period excluding the 9,000,000
 shares loaned to Bank of America under a share lending arrangement
 (see Note 11 &amp;#x2014;&amp;#xA0;Common and preferred stock). In the third
 quarter of 2015, the 9,000,000&amp;#xA0;million shares loaned to Bank
 of America were returned. Prior to the return of those shares, the
 borrowed shares were not considered outstanding for the purpose of
 computing and reporting basic or diluted earnings (loss) per share
 because the share borrower had to return all borrowed shares to the
 Company (or, in certain circumstances, the cash value thereof).
 Diluted net loss per share reflects the potential dilution that
 could occur if securities or other contracts to issue common stock
 were exercised or converted into common stock. Potentially dilutive
 securities are excluded from the computation of diluted net loss
 per share for all of the periods presented in the accompanying
 condensed consolidated statements of operations because the
 reported net loss in each of these periods results in their
 inclusion being antidilutive. Antidilutive securities, which
 consist of stock options, restricted stock units, warrants, and
 shares that could be issued upon conversion of the senior
 convertible notes, that are not included in the diluted net loss
 per share calculation and excluded the 9,000,000 shares of the
 Company&amp;#x2019;s common stock loaned under the share lending
 arrangement as of December&amp;#xA0;31, 2014, and 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Potentially
 dilutive securities outstanding are summarized as follows (in
 shares):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="67%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 options&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,779,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Conversion of senior
 convertible notes into common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,072,809&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17,323,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;25,415,366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,074,596&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,987,876&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,706,240&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vesting of restricted stock
 units&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,804,620&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;29,731,254&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,463,340&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78,475,367&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_C83B4F7E-2C9F-4655-81D4-AF6A955D0AA3_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Senior
 convertible notes consist of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="83%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;2015 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unaccreted debt issuance
 cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(645&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;99,355&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;2018 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;27,690&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unamortized
 premium&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;660&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unaccreted debt issuance
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(737&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;27,613&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_B0994DF9-94F3-4AED-A2A8-F8004EE81B07_1_2">4.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_04A67B34-F061-41F5-A1D1-68880D57BB69_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
 equipment consist of the following (dollar amounts in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="70%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" rowspan="2" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 Useful&lt;br /&gt;
 Life&lt;br /&gt;
 (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" rowspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Land&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,273&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Buildings&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;54,948&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Building
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-40&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;131,383&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;114,131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Machinery and
 equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3-15&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;95,182&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;80,919&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture, fixtures and
 office equipment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5-10&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,137&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,015&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Computer equipment and
 software&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,707&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;10,465&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
 improvements&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Construction in
 progress&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,044&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;39,580&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;308,674&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;310,348&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less impairment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(140,412&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
 depreciation and amortization&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(119,513&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(118,221&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total property and
 equipment, net&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,749&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;192,127&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &amp;#xA0;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_37703D73-AF5F-4E7E-95A6-33B329EBDC1E_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;9. Collaboration
 arrangement&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Sanofi
 License Agreement and Sanofi Supply Agreement&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 August&amp;#xA0;11, 2014, the Company and Sanofi entered into the
 Sanofi License Agreement, which became effective on
 September&amp;#xA0;23, 2014. Under the terms of the Sanofi License
 Agreement, the Company granted to Sanofi exclusive, worldwide
 licenses to certain of the Company&amp;#x2019;s patents, trademarks and
 know-how for the development and commercialization of AFREZZA.
 Under the terms of the Sanofi License Agreement, Sanofi has the
 exclusive right and responsibility to develop AFREZZA worldwide,
 subject to certain development activities that will be performed by
 the Company. Sanofi will also be obligated to use commercially
 reasonable efforts to file for, obtain and maintain marketing
 approvals for AFREZZA in certain major markets and countries. In
 addition, Sanofi will have exclusive, worldwide rights to
 commercialize AFREZZA and will be obligated to use commercially
 reasonable efforts to market, promote and commercialize AFREZZA in
 all countries in the world where regulatory approval for AFREZZA
 has been received. Pursuant to the terms of the Sanofi Supply
 Agreement, the Company is responsible for the manufacture and
 supply to Sanofi of its requirements of AFREZZA.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Under the
 Sanofi License Agreement, Sanofi paid the Company an up-front cash
 payment of $150.0 million in the third quarter of 2014. If certain
 manufacturing, regulatory and sales milestones are achieved, the
 Company will also be eligible to receive up to $775.0 million in
 milestone payments, of which $75.0 million relates to certain
 development and manufacturing milestone events, $50.0 million
 relates to the filing and completion of regulatory approvals and
 $650.0 million relates to the achievement of certain product sales
 milestones. As of December&amp;#xA0;31, 2014, the Company earned and
 recorded a total of $50.0 million in milestone payments in
 connection with the satisfaction of manufacturing milestones
 specified in the Sanofi agreement, which were received subsequent
 to December&amp;#xA0;31, 2014. In addition, worldwide profits and
 losses, which are determined based on the difference between the
 net sales of AFREZZA and the costs and expenses incurred by the
 Company and Sanofi that are specifically attributable or related to
 the development, improvement, regulatory filings, manufacturing,
 and commercialization of AFREZZA will be shared 65% by Sanofi and
 35% by the Company. In accordance with the terms of the Sanofi
 License Agreement, profit and loss sharing commenced in the fourth
 quarter of 2014.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Pursuant to the
 terms of the Sanofi Supply Agreement, the Company will be the
 exclusive manufacturer and supplier of AFREZZA until the specified
 conditions are met, upon which a portion of the manufacturing
 activities may be assumed by Sanofi.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 analyzed the agreements entered into with Sanofi under the
 provisions of ASC 605, Revenue Recognition, to determine whether
 the consideration, or a portion thereof, could be recognized as
 revenue. ASC 605 provides that revenue is recognized when there is
 persuasive evidence that an arrangement exists, delivery has
 occurred or services have been rendered, the price is fixed or
 determinable and collection is reasonably assured. In addition,
 revenue arrangements with multiple elements are divided into
 separate units of accounting if certain criteria are met, including
 whether the delivered element has stand-alone value to the
 customer. When deliverables are separable, consideration received
 is allocated to the separate units of accounting based on the
 relative selling price of each deliverable and the appropriate
 revenue recognition principles are applied to each unit.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The assessment
 of multiple element arrangements requires judgment in order to
 determine the appropriate units of accounting and the points in
 time that, or periods over which, revenue should be recognized.
 Under the terms of the Sanofi License Agreement, Sanofi Supply
 Agreement and the Sanofi Loan Facility the Company determined that
 the arrangement contained significant deliverables including
 (i)&amp;#xA0;licenses to develop and commercialize AFREZZA and to use
 the Company&amp;#x2019;s trademarks, (ii)&amp;#xA0;development activities,
 and (iii)&amp;#xA0;manufacture and supply services for AFREZZA. Due to
 the proprietary nature of the manufacturing services being provided
 by the Company, the Company determined that all of the significant
 deliverables should be combined into a single unit of accounting.
 The Company believes that the manufacturing services are
 proprietary due to the fact that since the late 1990&amp;#x2019;s, the
 Company has developed proprietary knowledge and patented equipment
 and tools that are used in the manufacturing process of AFREZZA.
 Due to the complexities of particle formulation and the specialized
 knowledge and equipment needed to handle the AFREZZA powder,
 neither Sanofi nor any third-party contract manufacturing
 organization currently possesses the capability of manufacturing
 AFREZZA.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In order for
 revenue to be recognized, the seller&amp;#x2019;s price to the buyer
 must be fixed and determinable. Given that as of December&amp;#xA0;31,
 2015, the Company did not have the ability to estimate the amount
 of costs that would potentially be incurred under the loss share
 provision related to the Sanofi License Agreement and the Sanofi
 Supply Agreement, the Company believes this requirement for revenue
 recognition has not been met.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As such, the
 Company did not recognize any revenue pursuant to the Sanofi
 License Agreement or the Sanofi Supply Agreement for the years
 ended December&amp;#xA0;31, 2015 and 2014. The Company has recorded the
 $150.0 million up-front payment and $50.0 million from milestone
 payments as deferred payments from collaboration. In addition, as
 of December&amp;#xA0;31, 2015 the Company has recorded $17.5 million in
 AFREZZA product shipments to Sanofi as deferred product sales from
 collaboration and recorded $13.5 million as deferred product costs
 from collaboration. Deferred product costs represent the costs of
 product manufactured and shipped to Sanofi, not to exceed the
 amount of deferred product sales, for which recognition of revenue
 has been deferred. During the year ended December&amp;#xA0;31, 2015,
 the Company&amp;#x2019;s portion of the loss sharing was
 $57.7&amp;#xA0;million, which resulted in the reclassification from
 current deferred payments from collaboration to Sanofi loan
 facility and loss share obligation to reflect amounts owed to
 Sanofi.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Sanofi Loan
 Facility&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 September&amp;#xA0;23, 2014, the Company entered into the Sanofi Loan
 Facility, consisting of a senior secured revolving promissory note
 and a guaranty and security agreement (the &amp;#x201C;Security
 Agreement&amp;#x201D;) with an affiliate of Sanofi which provides the
 Company with a secured loan facility of up to $175.0 million to
 fund the Company&amp;#x2019;s share of net losses under the Sanofi
 License Agreement. In the event of certain future defaults under
 the Sanofi Loan facility agreement for which the Company is not
 able to obtain waivers, the lender under the Sanofi Loan Facility
 may accelerate all of the Company&amp;#x2019;s repayment obligations,
 and take control of the Company&amp;#x2019;s pledged assets, potentially
 requiring the Company to renegotiate the terms of its indebtedness
 on terms less favorable to the Company, or to immediately cease
 operations.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The obligations
 of the Company under the Sanofi Loan Facility are guaranteed by the
 Company&amp;#x2019;s wholly-owned subsidiary, MannKind LLC, and are
 secured by a first priority security interest in certain insulin
 inventory located in the United States and any contractual rights
 and obligations pursuant to which the Company purchases or has
 purchased such insulin, and a second priority security interest in
 the Company&amp;#x2019;s assets that secure the Company&amp;#x2019;s
 obligations under the Facility Agreement, as amended. In addition,
 the Company granted to Sanofi, as additional security for the
 obligations under the Sanofi Loan Facility, a first priority
 mortgage on the Company&amp;#x2019;s facility in Valencia, California,
 which has a carrying value of $17.9&amp;#xA0;million as of
 December&amp;#xA0;31, 2015.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Advances under
 the Sanofi Loan Facility bear interest at a rate of 8.5%&amp;#xA0;per
 annum and are payable in-kind and compounded quarterly and added to
 the outstanding principal balance under the Sanofi Loan Facility.
 The Company is required to make mandatory prepayments on the
 outstanding loans under the Sanofi Loan Facility from its share of
 any Profits (as defined in the Sanofi License Agreement) under the
 Sanofi License Agreement within 30 days of receipt of its share of
 any such Profits. No advances may be made under the Sanofi Loan
 Agreement if Deerfield has commenced enforcement proceedings in
 connection with an event of default under the Facility
 Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The outstanding
 principal of all loans under the Sanofi Loan Facility, if not
 prepaid, will become due and payable on September&amp;#xA0;23, 2024
 unless accelerated pursuant to the terms of the Sanofi Loan
 Facility. Additionally, if the Company sells its Valencia facility,
 the Company is required to prepay the loans under the Sanofi Loan
 Facility from the net cash proceeds of the sale within five
 business days of receipt.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s total portion of the loss sharing was
 $57.7&amp;#xA0;million for the year ended December&amp;#xA0;31, 2015, of
 which $44.5&amp;#xA0;million was borrowed under the Sanofi Loan
 Facility as of December&amp;#xA0;31, 2015. Subsequent to
 December&amp;#xA0;31, 2015, the Company borrowed $17.9&amp;#xA0;million
 under the Sanofi Loan Facility to finance the portion of the
 Company&amp;#x2019;s loss for the quarter ended December&amp;#xA0;31, 2015.
 The total amount owed to Sanofi is $62.4 million, which includes
 $1.7&amp;#xA0;million in paid-in-kind interest.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Sanofi Loan
 Facility includes customary representations, warranties and
 covenants by the Company, including restrictions on its ability to
 incur additional indebtedness, grant certain liens and make certain
 changes to its organizational documents. Events of default under
 the Sanofi Loan Facility include: the Company&amp;#x2019;s failure to
 timely make payments due under the Sanofi Loan Facility;
 inaccuracies in the Company&amp;#x2019;s representations and warranties
 to the noteholder; the Company&amp;#x2019;s failure to comply with any
 of its covenants under any of the Sanofi Loan Facility or certain
 other related security agreements and documents entered into in
 connection with the Sanofi Loan Facility, subject to a cure period
 with respect to most covenants; the Company&amp;#x2019;s insolvency or
 the occurrence of certain bankruptcy-related events; termination by
 Sanofi of the Sanofi License Agreement as a result of the
 Company&amp;#x2019;s breach of the Sanofi License Agreement; and the
 failure of any material provision under any of the Sanofi Loan
 Facility or certain other related security agreements and documents
 entered into in connection with the Sanofi Loan Facility to remain
 in full force and effect. If one or more events of default occurs
 and is continuing, Sanofi may terminate its obligation to make
 advances under the Sanofi Loan Facility, and, if certain specified
 events of default (including the Company&amp;#x2019;s failure to timely
 make payments due under the Sanofi Loan Facility; the
 Company&amp;#x2019;s failure to comply with the negative covenants under
 the Sanofi Loan Facility limiting the Company&amp;#x2019;s ability to
 incur additional indebtedness or grant certain liens; the
 Company&amp;#x2019;s insolvency or the occurrence of certain
 bankruptcy-related events; termination by Sanofi of the Sanofi
 License Agreement as a result of the Company&amp;#x2019;s breach of the
 non-compete provisions of the Sanofi License Agreement; or the
 failure of any material provision under any of the Sanofi Loan
 Facility or certain other related security agreements and documents
 entered into in connection with the Sanofi Loan Facility to remain
 in full force and effect) occur and are continuing, the noteholder
 may accelerate all of the Company&amp;#x2019;s repayment obligations
 under the Sanofi Loan Facility and otherwise exercise any of its
 remedies as a secured creditor. There can be no assurance that the
 noteholder would not choose to exercise these rights in the event
 such events were to occur.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Subsequent to
 December&amp;#xA0;31, 2015, the Company received written notice on
 January&amp;#xA0;4, 2016 from Sanofi of its election to terminate in
 its entirety the Sanofi License Agreement. Pursuant to its terms,
 the Sanofi Supply Agreement will terminate concurrently with the
 Sanofi License Agreement. Sanofi&amp;#x2019;s notice indicated that the
 termination was pursuant to Sanofi&amp;#x2019;s right to terminate the
 Sanofi License Agreement upon Sanofi&amp;#x2019;s good faith
 determination that the commercialization of AFREZZA is no longer
 economically viable in the United States, in which case the
 effective date of termination will be April&amp;#xA0;4, 2016. In the
 alternative, Sanofi indicated that the termination was also
 pursuant to its right to terminate the Sanofi License Agreement for
 any reason, in which case the effective date of termination will be
 July&amp;#xA0;4, 2016. In the interest of an expedient transition, the
 Company is currently working with Sanofi to transfer and wind down
 the agreement activities by April&amp;#xA0;4, 2016, or as soon as
 practicable thereafter.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Pursuant to the
 terms of the Sanofi License Agreement, the Company and Sanofi are
 required to use diligent efforts to facilitate the smooth and
 orderly transition of relevant obligations and rights to the
 Company with respect to development and commercialization
 activities related to AFREZZA, and are also required to negotiate
 in good faith a written transition agreement for this purpose. As a
 result of the foregoing termination, effective on the Termination
 Date and thereafter during any period which Sanofi is required to
 perform any wind-down activities pursuant to the terms of the
 Sanofi License Agreement, the rights granted to Sanofi under the
 Sanofi License Agreement to develop and commercialize AFREZZA will
 become non-exclusive and the Company will have the right to engage
 one or more other distributors and/or licensees of AFREZZA. Sanofi
 will continue to distribute AFREZZA during the wind-down period as
 required by the agreement until such time that the Company or its
 designee takes over responsibility for distribution. All profits
 and losses from AFREZZA product sales by Sanofi or its affiliates
 after the Termination Date, if any, will continue to be shared 65%
 by Sanofi and 35% by the Company pursuant to the terms of the
 License Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In addition to
 the Sanofi License Agreement and Sanofi Supply Agreement, as
 discussed above, the Company and Aventisub LLC, an affiliate of
 Sanofi, are parties to a Senior Secured Revolving Promissory Note,
 dated September&amp;#xA0;23, 2014 and a Guaranty and Security
 Agreement. Both the Sanofi Loan Facility and the Security Agreement
 remain in effect. The original maturity date of September&amp;#xA0;23,
 2024 for repayment of the outstanding principal amount of the loans
 under the Sanofi Loan Facility will not be affected by the
 termination of the Sanofi License Agreement.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_24">-57232000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_6C84F182-8264-4FFE-B92F-99C4C0AE92FF_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
 table summarizes information about stock options
 outstanding:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="70%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
 of&lt;br /&gt;
 Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Weighted&lt;br /&gt;
 Average&lt;br /&gt;
 Exercise&lt;br /&gt;
 Price&lt;br /&gt;
 per&amp;#xA0;Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Aggregate&lt;br /&gt;
 Intrinsic&lt;br /&gt;
 Value&amp;#xA0;($000)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
 January&amp;#xA0;1, 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.53&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;33,495&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,541,100&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.11&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,700,964&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.91&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Forfeited&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(706,387&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.78&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expired&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(896,184&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7.70&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
 December&amp;#xA0;31, 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,779,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.54&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vested and expected to vest
 at December&amp;#xA0;31, 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,597,097&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.53&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable at
 December&amp;#xA0;31, 2015&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17,217,332&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.47&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:DebtPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_8AE16995-E1C3-4FB4-9AB4-2007500A89B0_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt; &amp;#x2014;&amp;#xA0;On July&amp;#xA0;1, 2013, in conjunction with
 the execution of the Facility Agreement, the Company issued
 Milestone Rights to Deerfield whereby the Company agreed to provide
 Deerfield with pre-specified Milestone Payments upon the
 achievement of 13 specific Milestone Events related to the
 commercial release and future cumulative net sales of AFREZZA. The
 Company analyzed the Milestone Rights under the provisions of ASC
 815 and determined that the agreement does not meet the definition
 of a freestanding derivative. Since the Company has not elected to
 apply the fair value option to the Milestone Rights Purchase
 Agreement, the Company recorded the Milestone Rights at their
 estimated fair value and accounted for the Milestone Rights as a
 liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones and
 discounted to present value using a selected market discount rate.
 The expected timing and probability of achieving the milestones was
 developed with consideration given to both internal data, such as
 progress made to date and assessment of criteria required for
 achievement, and external data, such as market research studies.
 The discount rate was selected based on an estimation of required
 rate of returns for similar investment opportunities using
 available market data. The Milestone Rights liability will be
 remeasured as the specified milestone events are achieved.
 Specifically, as each milestone event is achieved, the portion of
 the initially recorded Milestone Rights liability that pertains to
 the milestone event being achieved, will be remeasured to the
 amount of the specified related milestone payment. The resulting
 change in the balance of the Milestone Rights liability due to
 remeasurement will be recorded in the Company&amp;#x2019;s Statement of
 Operations as interest expense. Furthermore, the Milestone Rights
 liability will be reduced upon the settlement of each milestone
 payment. As a result, each milestone payment would be effectively
 allocated between a reduction of the recorded Milestone Rights
 liability and an expense representing a return on a portion of the
 Milestone Rights liability paid to the investor for the achievement
 of the related milestone event (see Note
 17&amp;#xA0;&amp;#x2014;&amp;#xA0;Facility Agreement). As of December&amp;#xA0;31,
 2015, the remaining liability balance of $8.9 million was
 classified as long-term liability in other liabilities.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
  <dei:EntityCurrentReportingStatus contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_1_400005">Yes</dei:EntityCurrentReportingStatus>
  <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_B1D3ACEA-6F56-4126-AAB8-597B79CD3D89_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accretion of
 debt issuance cost and debt discount in connection with the
 Deerfield financing during the year ended December&amp;#xA0;31, 2015
 and 2014 are as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="86%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accretion expense- debt
 issuance cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;35&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;326&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Accretion expense- debt
 discount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,553&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;7,550&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
  <dei:AmendmentFlag contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5CDA9016-DEE6-403E-9784-F9797854F918_1_1">false</dei:AmendmentFlag>
  <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_7E25A052-B83E-46FB-A5C7-ACBC8AA264BE_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Stock-Based
 Compensation&lt;/i&gt; &amp;#x2014;&amp;#xA0;As of December&amp;#xA0;31, 2015, the
 Company had three active stock-based compensation plans, which are
 described more fully in Note 13. The Company accounts for all
 share-based payments to employees, including grants of stock awards
 and the compensatory elements of the employee stock purchase plan
 in accordance with ASC 718&lt;i&gt;.&lt;/i&gt; ASC 718 &lt;i&gt;Compensation &amp;#x2014;
 Stock Compensation&lt;/i&gt; (&amp;#x201C;ASC 718&amp;#x201D;) requires all
 share-based payments to employees, including grants of stock
 options, restricted stock units, performance-based awards and the
 compensatory elements of employee stock purchase plans, to be
 recognized in the statement of operations based upon the fair value
 of the awards at the grant date. The Company uses the Black-Scholes
 option valuation model to estimate the grant date fair value of
 employee stock options and the compensatory elements of employee
 stock purchase plans. Option valuation models require the input of
 assumptions, including the expected life of the stock-based awards,
 the estimated stock price volatility, the risk-free interest rate,
 and the expected dividend yield. Beginning in the third quarter of
 2014, the Company began to assess both historical and implied
 volatility in order to determine its estimated volatility rate.
 Implied volatility was considered due to the change in the
 Company&amp;#x2019;s business, which occurred with the approval for the
 sale of AFREZZA. The expected volatility assumption is based on an
 assessment of the historical volatility and the implied volatility
 of the Company&amp;#x2019;s common stock, derived from an analysis of
 historical traded and quoted options on the Company&amp;#x2019;s common
 stock. Restricted stock units are valued based on the market price
 on the grant date. The Company evaluates stock awards with
 performance conditions as to the probability that the performance
 conditions will be met and estimates the date at which the
 performance conditions will be met in order to properly recognize
 stock-based compensation expense over the requisite service
 period.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_1_0">0.0161</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_D02E31CB-8DA0-4674-AC67-1CA3F3F0830A_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Research and
 Development Expenses&lt;/i&gt; &amp;#x2014;&amp;#xA0;Research and development
 expenses consist of costs associated with the clinical trials of
 the Company&amp;#x2019;s product candidates, manufacturing supplies and
 other development materials, compensation and other expenses for
 research and development personnel, costs for consultants and
 related contract research, facility costs, and depreciation.
 Research and development costs, which are net of any tax credit
 exchange recognized for the Connecticut state research and
 development credit exchange program, are expensed as incurred
 consistent with ASC 730-10 &lt;i&gt;Research and Development.&lt;/i&gt; The
 Company began commercial manufacturing in the latter part of the
 fourth quarter of 2014. As such, commercial manufacturing costs
 incurred in the fourth quarter of 2014 and included in research and
 development as expenses were immaterial for the year ended
 December&amp;#xA0;31, 2014.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_AAA71D81-FFEB-4EEF-A306-E1CE6D0523D9_1_3">1111134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_AAA71D81-FFEB-4EEF-A306-E1CE6D0523D9_1_2">1133404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_96193E4F-0BFF-432A-9989-2CE96EB9C290_1_4">5.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_96193E4F-0BFF-432A-9989-2CE96EB9C290_1_3">1.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_964ED7AB-B46E-40D6-AC51-58933152F8A8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 calculated the fair value of employee stock options granted during
 the years ended December&amp;#xA0;31, 2015, 2014 and 2013 using the
 following assumptions:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="46%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.61%&amp;#xA0;&amp;#x2014;&amp;#xA0;1.86%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.64%&amp;#xA0;&amp;#x2014;&amp;#xA0;2.11%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.94%
 &amp;#x2014;&amp;#xA0;1.82%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected lives&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.79&amp;#xA0;&amp;#x2014;&amp;#xA0;5.86&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.77&amp;#xA0;&amp;#x2014;&amp;#xA0;6.09&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.64&amp;#xA0;&amp;#x2014;&amp;#xA0;5.77&amp;#xA0;years&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;69.76%&amp;#xA0;&amp;#x2014;&amp;#xA0;71.84%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73.98%&amp;#xA0;&amp;#x2014;&amp;#xA0;84.85%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;75.83%&amp;#xA0;&amp;#x2014;&amp;#xA0;86.26%&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividends&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_C87A7D43-072A-44F4-98FF-8464922BC0AE_1_3">1700964</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_17">-0.91</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_B1F16382-FC5B-4755-AAF4-A4B83138A094_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Segment
 Information&lt;/i&gt; &amp;#x2014;&amp;#xA0;In accordance with Accounting
 Standards Codification (&amp;#x201C;ASC&amp;#x201D;) 280-10-50 &lt;i&gt;Segment
 Reporting&lt;/i&gt;, operating segments are identified as components of
 an enterprise about which separate discrete financial information
 is available for evaluation by the chief operating decision-maker
 in making decisions regarding resource allocation and assessing
 performance. To date, the Company has viewed its operations and
 manages its business as one segment operating in the United States
 of America.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
  <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_A5666486-C71C-4381-81CA-4FD88C80272F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;18. Restructuring
 Charges&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On September
 2015, the Company initiated a restructuring of the organization as
 a result of its shift to commercial production of AFREZZA. In
 connection with the restructuring, the Company reduced its total
 workforce by approximately 26% to 198 employees. The Company
 recorded restructuring charges of $5.9 million, $1.9 million, and
 $0.4 million for the years ended December&amp;#xA0;31, 2015, 2014, and
 2013, respectively. As of December&amp;#xA0;31, 2015, the Company paid
 $2.8 million and the remaining balance is expected to be paid in
 the first quarter of 2016.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The $5.9
 million of costs associated with the restructuring are included in
 &amp;#x201C;Research and development&amp;#x201D; and &amp;#x201C;General and
 administrative&amp;#x201D; operating expenses in the condensed
 consolidated statements of operations as $3.0 million and $2.9
 million, respectively, for the year ended December&amp;#xA0;31,
 2015.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2015 and 2014, the Company had a restructuring
 accrual of $3.0 million and $0.3 million, respectively. The Company
 did not have a restructuring accrual as of December&amp;#xA0;31,
 2013.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_D7A179C2-59AD-46B9-8420-25E73A830E83_1_0">2.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_C8AA7813-44A8-4D5B-8716-69A12E194066_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;1. Description of
 business and basis of presentation&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Business&lt;/i&gt;
 &amp;#x2014;&amp;#xA0;MannKind Corporation and subsidiaries (the
 &amp;#x201C;Company&amp;#x201D;) is a biopharmaceutical company focused on
 the discovery and development of therapeutic products for diseases
 such as diabetes. The Company&amp;#x2019;s only approved product,
 AFREZZA, (insulin human [rDNA origin]) inhalation powder, is a
 rapid-acting inhaled insulin that was approved by the U.S. Food and
 Drug Administration (the &amp;#x201C;FDA&amp;#x201D;) on June&amp;#xA0;27, 2014
 to improve glycemic control in adult patients with
 diabetes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Basis of
 Presentation&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company&amp;#x2019;s primary
 activities since incorporation have been establishing its
 facilities, recruiting personnel, conducting research and
 development, business development, business and financial planning,
 raising capital, and commercial manufacturing. It is costly to
 develop therapeutic products and conduct clinical studies for these
 products. As of and for the year ended December&amp;#xA0;31, 2015, the
 Company has reported an accumulated deficit of $2.9&amp;#xA0;billion
 and has reported negative cash flow from operations for each year
 since inception, except for 2014, when the Company received the
 $150.0 million upfront payment from Sanofi.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
 December&amp;#xA0;31, 2015, the Company&amp;#x2019;s capital resources
 consisted of cash and cash equivalents of $59.1 million. The
 Company expects to continue to incur significant expenditures to
 support commercial manufacturing and sales and marketing of AFREZZA
 and the development of other product candidates. The facility
 agreement (the &amp;#x201C;Facility Agreement&amp;#x201D;) with Deerfield
 Private Design Fund II, L.P. (&amp;#x201C;Deerfield Private Design
 Fund&amp;#x201D;) and Deerfield Private Design International II, L.P.
 (collectively, &amp;#x201C;Deerfield&amp;#x201D;) and the First Amendment to
 Facility Agreement and Registration Rights Agreement (the
 &amp;#x201C;First Amendment&amp;#x201D;) that resulted in additional sales of
 an additional tranche of notes (the &amp;#x201C;Tranche B notes&amp;#x201D;)
 (see Note 17&amp;#xA0;&amp;#x2014;&amp;#xA0;Facility Agreement) requires the
 Company to maintain at least $25.0 million in cash and cash
 equivalents or available borrowings under the loan arrangement,
 dated as of October&amp;#xA0;2, 2007, between The Company and The Mann
 Group LLC (as amended, restated, or otherwise modified as of the
 date hereof, &amp;#x201C;the Mann Group Loan Arrangement&amp;#x201D;), as of
 the last day of each fiscal quarter. The Company will need to
 continue to incur expenses for the commercialization of AFREZZA and
 will need to raise additional capital to finance such activities.
 The Company cannot be certain that it will be able to raise
 additional capital on favorable terms, or at all, which raises
 substantial doubt about the Company&amp;#x2019;s ability to continue as
 a going concern. The financial statements do not include any
 adjustments that might result from the outcome of this
 uncertainty.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 August&amp;#xA0;11, 2014, we executed a license and collaboration
 agreement (the &amp;#x201C;Sanofi License Agreement&amp;#x201D;) with
 Sanofi-Aventis Deutschland GmbH (which subsequently assigned its
 rights and obligations under the agreement to Sanofi-Aventis U.S.
 LLC (&amp;#x201C;Sanofi&amp;#x201D;)), pursuant to which Sanofi is
 responsible for global commercial, regulatory and development
 activities for AFREZZA. The Sanofi License Agreement became
 effective on September&amp;#xA0;23, 2014. The Company manufactured
 AFREZZA at its manufacturing facility in Danbury, Connecticut to
 supply Sanofi&amp;#x2019;s demand for the product pursuant to a supply
 agreement dated August&amp;#xA0;11, 2014 (the &amp;#x201C;Sanofi Supply
 Agreement&amp;#x201D;).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 January&amp;#xA0;4, 2016 the Company received notification from Sanofi
 of its election to terminate in its entirety the Sanofi License
 Agreement. Sanofi&amp;#x2019;s notice indicated that the termination was
 pursuant to Sanofi&amp;#x2019;s right to terminate the Sanofi License
 Agreement upon Sanofi&amp;#x2019;s good faith determination that the
 commercialization of AFREZZA is no longer economically viable in
 the United States, in which case the effective date of termination
 (the &amp;#x201C;Termination Date&amp;#x201D;) will be April&amp;#xA0;4, 2016. In
 the alternative, Sanofi indicated that the termination was also
 pursuant to its right to terminate the Sanofi License Agreement for
 any reason, in which case the Termination Date will be July&amp;#xA0;4,
 2016. In the interest of an expedient transition, the Company is
 working with Sanofi to transfer and wind down the agreement
 activities by April&amp;#xA0;4, 2016, or as soon as practicable
 thereafter.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Under the
 Sanofi License Agreement, worldwide profits and losses, which are
 determined based on the difference between the net sales of AFREZZA
 and the costs and expenses incurred by the Company and Sanofi that
 are specifically attributable or related to the development,
 regulatory filings, manufacturing, or commercialization of AFREZZA,
 are shared 65% by Sanofi and 35% by the us. As a result of the loss
 share provision, and because the Company does not have the ability
 to estimate the amount of costs that would potentially be incurred
 related to the Sanofi License Agreement, the amount of up-front
 cash payment or milestone payments that could be recognized as
 revenue is not fixed or determinable. In connection with the Sanofi
 License Agreement, an affiliate of Sanofi provided the Company with
 a secured loan facility (the &amp;#x201C;Sanofi Loan Facility&amp;#x201D;) of
 up to $175.0 million to fund the Company&amp;#x2019;s share of net
 losses under the Sanofi License Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Additional
 funding sources that are, or in certain circumstances may be
 available to the Company, include approximately $30.1 million
 principal amount of available borrowings under The Mann Group Loan
 Arrangement. A portion of these available borrowings may be used to
 capitalize accrued interest into principal, upon mutual agreement
 of the parties, as it becomes due and payable under The Mann Group
 Loan Arrangement. (see note 7&amp;#xA0;&amp;#x2014;&amp;#xA0;Related-party
 arrangements). The Company cannot provide assurances that its plans
 will not change or that changed circumstances will not result in
 the depletion of its capital resources more rapidly than it
 currently anticipates. The Company will need to raise additional
 capital, whether through a sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means, in order to continue the development
 and commercialization of AFREZZA and other product candidates and
 to support its other ongoing activities. However, the Company
 cannot provide assurances that such additional capital will be
 available on acceptable terms or at all.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Principles
 of Consolidation&lt;/i&gt; &amp;#x2014;&amp;#xA0;The consolidated financial
 statements include the accounts of the Company and its wholly-owned
 subsidiaries. Intercompany balances and transactions have been
 eliminated.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Segment
 Information&lt;/i&gt; &amp;#x2014;&amp;#xA0;In accordance with Accounting
 Standards Codification (&amp;#x201C;ASC&amp;#x201D;) 280-10-50 &lt;i&gt;Segment
 Reporting&lt;/i&gt;, operating segments are identified as components of
 an enterprise about which separate discrete financial information
 is available for evaluation by the chief operating decision-maker
 in making decisions regarding resource allocation and assessing
 performance. To date, the Company has viewed its operations and
 manages its business as one segment operating in the United States
 of America.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <dei:EntityRegistrantName contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_1_400001">MANNKIND CORP</dei:EntityRegistrantName>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_6CDF2D50-BFDF-432B-B94B-F6C399990FCD_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;16. Income
 taxes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;There is no
 provision for income taxes because the Company has incurred
 operating losses since inception. At December&amp;#xA0;31, 2015, the
 Company has concluded that it is more likely than not that the
 Company may not realize the benefit of its deferred tax assets due
 to its history of losses. Accordingly, the net deferred tax assets
 have been fully reserved. The provision for income taxes consists
 of the following (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="73%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. federal&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;109,512&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;57,873&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;59,379&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;U.S. state&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(29,394&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,631&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,470&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-U.S.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 Allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(80,118&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(65,504&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(66,849&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total deferred&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred income
 taxes reflect the tax effects of temporary differences between the
 carrying amounts of assets and liabilities for financial reporting
 and income tax purposes. A valuation allowance is established when
 uncertainty exists as to whether all or a portion of the net
 deferred tax assets will be realized. Components of the net
 deferred tax asset as of December&amp;#xA0;31, 2015 and 2014 are
 approximately as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="80%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred tax
 assets:&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="5"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net operating loss
 carryforwards&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;721,588&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;699,997&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and development
 credits&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73,646&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;73,227&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized
 research&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,872&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;28,516&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Payments from
 collaboration&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;52,484&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,217&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Milestone Rights&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,242&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5,321&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accrued expenses&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;251&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;768&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Loss on purchase
 commitment&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,084&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Non-qualified stock option
 expense&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;16,941&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;43,691&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized patent
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,574&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,624&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,186&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;131&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Depreciation&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;48,755&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,010&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;962,623&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;882,502&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(962,623&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(882,502&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
 assets&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As a result of
 certain realization requirements of ASC 718, the table of deferred
 tax assets and liabilities does not include certain deferred tax
 assets as of December&amp;#xA0;31, 2015 that arose directly from tax
 deductions related to equity compensation which are greater than
 the compensation recognized for financial reporting. Equity would
 be increased by $10.0 million if and when such deferred tax assets
 are ultimately realized. The Company considered the requirements
 under ASC 740 &lt;i&gt;Income Taxes&lt;/i&gt; (&amp;#x201C;ASC 740&amp;#x201D;) when
 determining when excess tax benefits have been realized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
 Company&amp;#x2019;s effective income tax rate differs from the
 statutory federal income tax rate as follows for the years ended
 December&amp;#xA0;31, 2015, 2014 and 2013:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Federal tax benefit
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State tax benefit, net of
 federal benefit&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent items&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Intercompany transfer of
 intellectual property&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.1&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4.3&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
 allowance&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(34&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(31.8&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30.7&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective income tax
 rate&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As required by
 ASC 740, management of the Company has evaluated the positive and
 negative evidence bearing upon the realizability of its deferred
 tax assets. Management has concluded, in accordance with the
 applicable accounting standards, that it is more likely than not
 that the Company may not realize the benefit of its deferred tax
 assets. Accordingly, the net deferred tax assets have been fully
 reserved. Management reevaluates the positive and negative evidence
 on an annual basis. During the years ended December&amp;#xA0;31, 2015,
 2014 and 2013, the change in the valuation allowance was $&lt;a id="c84" name="diff"&gt;&lt;strike&gt;&lt;font color="#FF0000"&gt;62.6&lt;/font&gt;&lt;/strike&gt;&lt;/a&gt; &lt;font style="BACKGROUND-COLOR: #ffff00"&gt;80.1&amp;#xA0;&lt;/font&gt;million, $65.5
 million and $&lt;strike&gt;&lt;font color="#FF0000"&gt;80.1&lt;/font&gt;&lt;/strike&gt; &lt;font style="BACKGROUND-COLOR: #ffff00"&gt;66.8&amp;#xA0;&lt;/font&gt;million,
 respectively, for income taxes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
 December&amp;#xA0;31, 2015, the Company had federal and state net
 operating loss carryforwards of approximately $1.9 billion and $1.3
 billion available, respectively, to reduce future taxable income.
 The federal net operating loss carryforwards will expire at various
 dates beginning in 2018 and the state net operating loss
 carryforwards have started expiring, starting current year through
 various future dates. As a result of the Company&amp;#x2019;s initial
 public offering, an ownership change within the meaning of Internal
 Revenue Code Section&amp;#xA0;382 occurred in August 2004. As a result,
 federal net operating loss and credit carry forwards of
 approximately $216.0 million are subject to an annual use
 limitation of approximately $13.0 million. The annual limitation is
 cumulative and therefore, if not fully utilized in a year can be
 utilized in future years in addition to the Section&amp;#xA0;382
 limitation for those years. The federal net operating losses
 generated subsequent to the Company&amp;#x2019;s initial public offering
 in August 2004 are currently not subject to any such limitation as
 there have been no ownership changes since August 2004 within the
 meaning of Internal Revenue Code Section&amp;#xA0;382. At
 December&amp;#xA0;31, 2015, the Company had research and development
 credits of $49.1 million and $37.7 million for federal and state
 purposes, respectively. The federal credits begin to expire in
 2024, and the state credits may be carried forward
 indefinitely.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company has
 evaluated the impact of ASC 740, previously FIN 48 &lt;i&gt;Accounting
 for Uncertainty in Income Taxes&lt;/i&gt; , on its financial statements,
 which was effective beginning January&amp;#xA0;1, 2007. The evaluation
 of a tax position in accordance with this guidance is a two-step
 process. The first step is recognition: the enterprise determines
 whether it is more-likely-than-not that a tax position will be
 sustained upon examination, including resolution of any related
 appeals or litigation processes, based on the technical merits of
 the position. In evaluating whether a tax position has met the
 more-likely-than-not recognition threshold, the enterprise should
 presume that the position will be examined by the appropriate
 taxing authority that would have full knowledge of all relevant
 information. The second step is measurement: a tax position that
 meets the more-likely-than-not recognition threshold is measured to
 determine the amount of benefit to recognize in the financial
 statements. The tax position is measured at the largest amount of
 benefit that is greater than 50 percent likely of being realized
 upon ultimate settlement. Tax positions that previously failed to
 meet the more-likely-than-not recognition threshold should be
 recognized in the first subsequent financial reporting period in
 which that threshold is met. Previously recognized tax positions
 that no longer meet the more-likely-than-not recognition threshold
 should be derecognized in the first subsequent financial reporting
 period in which that threshold is no longer met. The Company
 believes that its income tax filing positions and deductions will
 be sustained on audit and does not anticipate any adjustments that
 will result in a material change to its financial position.
 Therefore, no liabilities for uncertain income tax positions have
 been recorded. Tax years since 2011 remain subject to examination
 by the major tax jurisdictions in which the Company is subject to
 tax.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_623E940E-9744-4313-8777-1F62D736FF8D_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2. Summary of
 significant accounting policies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Financial
 Statement Estimates&lt;/i&gt; &amp;#x2014;&amp;#xA0;The preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;)
 requires management to make estimates and assumptions that affect
 the amounts reported in the financial statements and accompanying
 notes. Actual results could differ from those estimates. Management
 considers many factors in selecting appropriate financial
 accounting policies, and in developing the estimates and
 assumptions that are used in the preparation of the financial
 statements. Management must apply significant judgment in this
 process. The more significant estimates reflected in these
 accompanying financial statements involve assessing long-lived
 assets for impairment, accrued expenses, including clinical study
 expenses, inventory recoverability, valuation of the facility
 financing obligation, commitment asset, milestone rights, valuation
 of stock-based compensation and the determination of the provision
 for income taxes and corresponding deferred tax assets and
 liabilities and any valuation allowance recorded against net
 deferred tax assets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;License and
 Collaboration and Supply Agreements&lt;/i&gt; &amp;#x2014;&amp;#xA0;Pursuant to
 the Sanofi License Agreement and the Sanofi Supply Agreement, the
 Company granted to Sanofi exclusive, worldwide licenses to certain
 of the Company&amp;#x2019;s patents, trademarks and know-how for the
 development and commercialization of AFREZZA and retained the right
 to be the exclusive manufacturer and supplier of AFREZZA until
 specified conditions are met upon which a portion of the
 manufacturing activities may be assumed by Sanofi. The terms of the
 Sanofi License Agreement provide for consideration to the Company
 in the form of a non-refundable up-front payment, product sales,
 manufacturing, regulatory and sales milestone payments and profit
 and loss sharing.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 analyzes consideration received under the provisions of ASC 605,
 Revenue Recognition, to determine whether the consideration, or a
 portion thereof, could be recognized as revenue. ASC 605 provides
 that revenue is recognized when there is persuasive evidence that
 an arrangement exists, delivery has occurred or services have been
 rendered, the price is fixed or determinable and collection is
 reasonably assured.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In arrangements
 involving the delivery of more than one element, each required
 deliverable is evaluated to determine whether it qualifies as a
 separate unit of accounting. This determination is generally based
 on whether the deliverable has &amp;#x201C;stand-alone value&amp;#x201D; to
 the customer. The arrangement&amp;#x2019;s consideration that is fixed
 and determinable is then allocated to each separate unit of
 accounting based on the relative selling price of each deliverable.
 The estimated selling price of each deliverable is determined using
 the following hierarchy of values: (i)&amp;#xA0;vendor-specific
 objective evidence of fair value, (ii)&amp;#xA0;third-party evidence of
 selling price and (iii)&amp;#xA0;best estimate of selling price (BESP).
 The BESP reflects the Company&amp;#x2019;s best estimate of what the
 selling price would be if the deliverable was regularly sold by the
 Company on a stand-alone basis. In general, the consideration
 allocated to each unit of accounting is recognized as the related
 goods or services are delivered, limited to the consideration that
 is not contingent upon future deliverables.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The assessment
 of multiple element arrangements requires judgment in order to
 determine the appropriate units of accounting and the points in
 time that, or periods over which, revenue should be recognized.
 Given that, as of December&amp;#xA0;31, 2015, the Company did not have
 the ability to estimate the amount of costs that would potentially
 be incurred under the loss share provision related to the Sanofi
 License Agreement and the Sanofi Supply Agreement, the Company
 believe the fixed and determinable fee requirement for revenue
 recognition was not met.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Cash and
 Cash Equivalents&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company considers all highly
 liquid investments with original or remaining maturities of 90 days
 or less at the time of purchase, that are readily convertible into
 cash to be cash equivalents. As of December&amp;#xA0;31, 2015 and 2014,
 cash equivalents were comprised of cash and money market accounts
 with maturities less than 90 days from the date of
 purchase.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt; &amp;#x2014;&amp;#xA0;Financial
 instruments which potentially subject the Company to concentration
 of credit risk consist of cash and cash equivalents. Cash and cash
 equivalents consist of interest-bearing accounts, which are
 regularly monitored by management and held in high credit quality
 institutions.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;State
 Research and Development Credit Exchange Receivable&lt;/i&gt;
 &amp;#x2014;&amp;#xA0;The State of Connecticut provides certain companies
 with the opportunity to exchange certain research and development
 income tax credit carryforwards for cash in exchange for foregoing
 the carryforward of the research and development credits. The
 program provides for an exchange of research and development income
 tax credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Prepaid
 expenses and other current assets &amp;#x2014;&lt;/i&gt; Prepaid expenses and
 other current assets primarily consist of prepaid expenses for
 goods and services to be received. As of December&amp;#xA0;31, 2015,
 prepaid and other current assets had a balance of $4.0 million,
 mainly comprised of prepaid insurance. As of December&amp;#xA0;31, 2014
 prepaid and other current assets had a balance of $20.2 million,
 mainly comprised of a $15.0 million prepayment for 2015 quantities
 of insulin, and prepaid insurance.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Sale of
 intellectual property&lt;/i&gt; &amp;#x2014;&amp;#xA0;On July&amp;#xA0;18, 2014, the
 Company entered into an assignment agreement with a third party
 whereby the third party acquired all proprietary rights, technology
 and know-how that related to a small molecule inhibitor compound
 and all pre-clinical data and results related thereto. Under the
 terms of the assignment agreement, the Company received total
 consideration of $9.3 million and accrued $1.4 million in expense
 for a net amount of $7.9 million recorded as other income. In 2015,
 the Company recorded other income of $1.4 million related to the
 relief of the $1.4 million accrual for expenses associated with the
 sale of intellectual property related to oncology in 2014, which
 was subsequently resolved without payment.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Milestone
 Rights&lt;/i&gt; &amp;#x2014;&amp;#xA0;On July&amp;#xA0;1, 2013, in conjunction with
 the execution of the Facility Agreement, the Company issued
 Milestone Rights to Deerfield whereby the Company agreed to provide
 Deerfield with pre-specified Milestone Payments upon the
 achievement of 13 specific Milestone Events related to the
 commercial release and future cumulative net sales of AFREZZA. The
 Company analyzed the Milestone Rights under the provisions of ASC
 815 and determined that the agreement does not meet the definition
 of a freestanding derivative. Since the Company has not elected to
 apply the fair value option to the Milestone Rights Purchase
 Agreement, the Company recorded the Milestone Rights at their
 estimated fair value and accounted for the Milestone Rights as a
 liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones and
 discounted to present value using a selected market discount rate.
 The expected timing and probability of achieving the milestones was
 developed with consideration given to both internal data, such as
 progress made to date and assessment of criteria required for
 achievement, and external data, such as market research studies.
 The discount rate was selected based on an estimation of required
 rate of returns for similar investment opportunities using
 available market data. The Milestone Rights liability will be
 remeasured as the specified milestone events are achieved.
 Specifically, as each milestone event is achieved, the portion of
 the initially recorded Milestone Rights liability that pertains to
 the milestone event being achieved, will be remeasured to the
 amount of the specified related milestone payment. The resulting
 change in the balance of the Milestone Rights liability due to
 remeasurement will be recorded in the Company&amp;#x2019;s Statement of
 Operations as interest expense. Furthermore, the Milestone Rights
 liability will be reduced upon the settlement of each milestone
 payment. As a result, each milestone payment would be effectively
 allocated between a reduction of the recorded Milestone Rights
 liability and an expense representing a return on a portion of the
 Milestone Rights liability paid to the investor for the achievement
 of the related milestone event (see Note
 17&amp;#xA0;&amp;#x2014;&amp;#xA0;Facility Agreement). As of December&amp;#xA0;31,
 2015, the remaining liability balance of $8.9 million was
 classified as long-term liability in other liabilities.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Deferred
 product costs from collaboration&lt;/i&gt; &amp;#x2014; Deferred product costs
 represent the costs of product manufactured and sold to Sanofi, as
 long as they are not greater than the amount of deferred product
 sales related to the collaboration, for which recognition of
 revenue has been deferred. Given that the costs of inventory
 delivered to a customer, but for which revenue may not yet be
 recognized, meet both the definition and characteristics of an
 &amp;#x201C;asset&amp;#x201D; and the Company believes that it is probable
 that the amount of future revenue will exceed the amount of
 deferred costs (i.e., the asset would be realizable through the
 recognition of probable future income), the Company has elected to
 account for the deferred costs related to the product sold to
 Sanofi as an asset and carry forward to future periods until the
 related revenue is recognized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Fair Value
 of Financial Instruments&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company utilizes fair
 value measurement guidance prescribed by GAAP to value its
 financial instruments. The guidance includes a definition of fair
 value, prescribes methods for measuring fair value, establishes a
 fair value hierarchy based on the inputs used to measure fair value
 and expands disclosures about the use of fair value measurements.
 The valuation techniques utilized are based upon observable and
 unobservable inputs. Observable inputs reflect market data obtained
 from independent sources, while unobservable inputs reflect
 internal market assumptions. These two types of inputs create the
 following fair value hierarchy:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level
 1&amp;#xA0;&amp;#x2014;&amp;#xA0;Quoted prices for identical instruments in
 active markets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level
 2&amp;#xA0;&amp;#x2014;&amp;#xA0;Quoted prices for similar instruments in active
 markets; quoted prices for identical or similar instruments in
 markets that are not active; and model-derived valuations whose
 inputs are observable or whose significant value drivers are
 observable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level
 3&amp;#xA0;&amp;#x2014;&amp;#xA0;Significant inputs to the valuation model are
 unobservable.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The carrying
 amounts reflected in the consolidated balance sheets for cash
 equivalents, other current assets, accounts payable, and accrued
 expenses and other current liabilities, approximate fair value due
 to their relatively short maturities.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Inventories&lt;/i&gt; &amp;#x2014;&amp;#xA0;Inventories are stated at the
 lower of cost or market. The Company determines the cost of
 inventory using the first-in, first-out, or FIFO, method. The
 Company capitalizes inventory costs associated with the
 Company&amp;#x2019;s products based on management&amp;#x2019;s judgment that
 future economic benefit is expected to be realized; otherwise, such
 costs are expensed as product manufacturing. The Company
 periodically analyzes its inventory levels to identify inventory
 that may expire or has a cost basis in excess of its estimated
 realizable value, and writes-down such inventories as appropriate.
 In addition, the Company&amp;#x2019;s products are subject to strict
 quality control and monitoring which the Company performs
 throughout the manufacturing process. If certain batches or units
 of product no longer meet quality specifications or become obsolete
 due to expiration, the Company will record a charge to write down
 such unmarketable inventory to its estimated realizable value.
 Inventory that is not expected to be used within one year is
 classified as a long term asset on the accompanying condensed
 consolidated balance sheet.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We analyzed our
 inventory levels to identify inventory that may expire or has a
 cost basis in excess of its estimated realizable value. We
 performed an assessment of projected sales and to evaluate the
 lower of cost or market and the potential excess inventory on hand
 at December 31, 2015. As a result of this assessment, we recorded a
 charge of $39.3 million to record the inventory raw materials on
 hand at the lower of cost or market, inventory expiry, and
 write-off other inventory related assets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In connection
 with the projected sales assessment, we also evaluated our
 inventory purchase commitments totalling $116.2 million for
 potential impairment. As a result of this assessment, we recorded a
 $66.2 million charge related to a loss on future purchase
 commitments both from a lower of cost or market excess inventory
 perspective. The purchase commitment obligation has been reduced to
 reflect our expectation that a portion will be recoverable from a
 third party.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Property and
 Equipment&lt;/i&gt; &amp;#x2014;&amp;#xA0;Property and equipment are recorded at
 cost and depreciated using the straight-line method over the
 estimated useful lives of the related assets. Leasehold
 improvements are amortized over the term of the lease or the
 service lives of the improvements, whichever is shorter.
 Maintenance and repairs are expensed as incurred. Assets under
 construction are not depreciated until placed into
 service.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Impairment
 of Long-Lived Assets&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company evaluates
 long-lived assets for impairment whenever events or changes in
 circumstances indicate that the carrying value of an asset may not
 be recoverable in accordance with ASC 360-10-35 &lt;i&gt;Property Plant
 and Equipment.&lt;/i&gt; Assets are considered to be impaired if the
 carrying value may not be recoverable based upon management&amp;#x2019;s
 assessment of the following events or changes in
 circumstances:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;significant changes in the Company&amp;#x2019;s strategic business
 objectives and utilization of the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;a determination that the carrying value of such assets cannot
 be recovered through undiscounted cash flows;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;loss of legal ownership or title to the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;a significant adverse change in legal factors or in the
 business climate that could affect the value of a long-lived asset
 (asset group), including an adverse action or assessment by a
 regulator; or&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;the impact of significant negative industry or economic
 trends.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;If the Company
 believes an asset to be impaired, the impairment recognized is the
 amount by which the carrying value of the assets exceeds the fair
 value of the assets. Any write-downs would be treated as permanent
 reductions in the carrying amount of the asset and an operating
 loss would be recognized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 recorded an asset impairment of $140.4 million for the year ended
 December&amp;#xA0;31, 2015 (see Note 5&amp;#xA0;&amp;#x2014;&amp;#xA0;Property and
 Equipment). No asset impairment was recognized during the years
 ended December&amp;#xA0;31, 2014, and 2013, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Income
 Taxes&lt;/i&gt; &amp;#x2014;&amp;#xA0;The provisions for federal, foreign, state,
 and local income taxes are calculated on pre-tax income based on
 current tax law and include the cumulative effect of any changes in
 tax rates from those used previously in determining deferred tax
 assets and liabilities. Deferred income tax assets and liabilities
 are measured using enacted tax rates expected to apply to taxable
 income in the year in which the temporary differences are expected
 to be recovered or settled. A valuation allowance is recorded to
 reduce net deferred income tax assets to amounts that are more
 likely than not to be realized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Income tax
 positions are considered for uncertainty in accordance with ASC
 740-10-25 &lt;i&gt;Income Taxes,&lt;/i&gt; The Company believes that its income
 tax filing positions and deductions will be sustained on audit and
 does not anticipate any adjustments that will result in a material
 change to its financial position. Therefore, no liabilities for
 uncertain income tax positions have been recorded. If a tax
 position does not meet the minimum statutory threshold to avoid
 payment of penalties, the Company recognizes an expense for the
 amount of the penalty in the period the tax position is claimed in
 the tax return of the Company. The Company recognizes interest
 accrued related to unrecognized tax benefits in income tax expense,
 if any. Penalties, if probable and reasonably estimable, are
 recognized as a component of income tax expense.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Significant
 management judgment is involved in determining the provision for
 income taxes, deferred tax assets, deferred tax liabilities, and
 any valuation allowance recorded against deferred tax assets. Due
 to uncertainties related to the realization of the Company&amp;#x2019;s
 deferred tax assets as a result of its history of operating losses,
 a valuation allowance has been established against the total
 deferred tax asset balance. The valuation allowance is based on
 management&amp;#x2019;s estimates of taxable income by jurisdiction in
 which the Company operates and the period over which deferred tax
 assets will be recoverable. In the event that actual results differ
 from these estimates or the Company adjusts these estimates in
 future periods, a change in the valuation allowance may be needed,
 which could materially impact the Company&amp;#x2019;s financial
 position and results of operations.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Contingencies&lt;/i&gt; &amp;#x2014;&amp;#xA0;Contingencies are recorded in
 accordance with ASC 450 &lt;i&gt;Contingencies.&lt;/i&gt; Accordingly, the
 Company records a loss contingency for a liability when it is both
 probable that a liability has been incurred and the amount of the
 loss can be reasonably estimated. These accruals represent
 management&amp;#x2019;s best estimate of probable loss. Disclosure also
 is provided when it is reasonably possible that a loss will be
 incurred or when it is reasonably possible that the amount of a
 loss will exceed the recorded provision. On a quarterly basis, the
 Company reviews the status of each significant matter and assesses
 its potential financial exposure. Significant judgment is required
 in both the determination of probability and the determination as
 to whether an exposure is reasonably estimable. Because of
 uncertainties related to these matters, accruals are based only on
 the best information available at the time. As additional
 information becomes available, the Company reassesses the potential
 liability related to pending claims and litigation and may revise
 its estimates. These revisions in the estimates of the potential
 liabilities could have a material impact on the Company&amp;#x2019;s
 consolidated results of operations and financial
 position.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Stock-Based
 Compensation&lt;/i&gt; &amp;#x2014;&amp;#xA0;As of December&amp;#xA0;31, 2015, the
 Company had three active stock-based compensation plans, which are
 described more fully in Note 13. The Company accounts for all
 share-based payments to employees, including grants of stock awards
 and the compensatory elements of the employee stock purchase plan
 in accordance with ASC 718&lt;i&gt;.&lt;/i&gt; ASC 718 &lt;i&gt;Compensation &amp;#x2014;
 Stock Compensation&lt;/i&gt; (&amp;#x201C;ASC 718&amp;#x201D;) requires all
 share-based payments to employees, including grants of stock
 options, restricted stock units, performance-based awards and the
 compensatory elements of employee stock purchase plans, to be
 recognized in the statement of operations based upon the fair value
 of the awards at the grant date. The Company uses the Black-Scholes
 option valuation model to estimate the grant date fair value of
 employee stock options and the compensatory elements of employee
 stock purchase plans. Option valuation models require the input of
 assumptions, including the expected life of the stock-based awards,
 the estimated stock price volatility, the risk-free interest rate,
 and the expected dividend yield. Beginning in the third quarter of
 2014, the Company began to assess both historical and implied
 volatility in order to determine its estimated volatility rate.
 Implied volatility was considered due to the change in the
 Company&amp;#x2019;s business, which occurred with the approval for the
 sale of AFREZZA. The expected volatility assumption is based on an
 assessment of the historical volatility and the implied volatility
 of the Company&amp;#x2019;s common stock, derived from an analysis of
 historical traded and quoted options on the Company&amp;#x2019;s common
 stock. Restricted stock units are valued based on the market price
 on the grant date. The Company evaluates stock awards with
 performance conditions as to the probability that the performance
 conditions will be met and estimates the date at which the
 performance conditions will be met in order to properly recognize
 stock-based compensation expense over the requisite service
 period.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants&lt;/i&gt;
 &amp;#x2014;&amp;#xA0;The Company has issued warrants to purchase shares of
 its common stock. Warrants have been accounted for within equity in
 accordance with the provisions of ASC 815-40, Contracts in an
 Entity&amp;#x2019;s Own Stock, previously EITF Issue No. 00-19:
 &lt;i&gt;Accounting for Derivative Financial Instruments Indexed to, and
 Potentially Settled in, a Company&amp;#x2019;s Own Stock&lt;/i&gt;.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Comprehensive Loss&lt;/i&gt; &amp;#x2014;&amp;#xA0;Other comprehensive loss
 is recorded in accordance with ASC 220-10-45 &lt;i&gt;Comprehensive
 Income,&lt;/i&gt; which requires that all components of comprehensive
 loss be reported in the financial statements in the period in which
 they are recognized. Other comprehensive loss includes certain
 changes in stockholders&amp;#x2019; equity that are excluded from net
 income. Specifically, the Company includes unrealized gains and
 foreign exchange translation losses, if any, and cumulative
 translation gains and losses in other comprehensive
 loss.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Research and
 Development Expenses&lt;/i&gt; &amp;#x2014;&amp;#xA0;Research and development
 expenses consist of costs associated with the clinical trials of
 the Company&amp;#x2019;s product candidates, manufacturing supplies and
 other development materials, compensation and other expenses for
 research and development personnel, costs for consultants and
 related contract research, facility costs, and depreciation.
 Research and development costs, which are net of any tax credit
 exchange recognized for the Connecticut state research and
 development credit exchange program, are expensed as incurred
 consistent with ASC 730-10 &lt;i&gt;Research and Development.&lt;/i&gt; The
 Company began commercial manufacturing in the latter part of the
 fourth quarter of 2014. As such, commercial manufacturing costs
 incurred in the fourth quarter of 2014 and included in research and
 development as expenses were immaterial for the year ended
 December&amp;#xA0;31, 2014.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Clinical
 Trial Expenses&lt;/i&gt; &amp;#x2014;&amp;#xA0;Clinical trial expenses, which are
 reflected in research and development expenses in the accompanying
 statements of operations, result from obligations under contracts
 with vendors, consultants, and clinical site agreements in
 connection with conducting clinical trials. The financial terms of
 these contracts are subject to negotiations which vary from
 contract to contract and may result in payment flows that do not
 match the periods over which materials or services are provided to
 the Company under such contracts. The appropriate level of trial
 expenses are reflected in the Company&amp;#x2019;s financial statements
 by matching period expenses with period services and efforts
 expended. These expenses are recorded according to the progress of
 the trial as measured by patient progression and the timing of
 various aspects of the trial. Clinical trial accrual estimates are
 determined through discussions with internal clinical personnel and
 outside service providers as to the progress or state of completion
 of trials, or the services completed. Service provider status is
 then compared to the contractually obligated fee to be paid for
 such services. During the course of a clinical trial, the Company
 may adjust the rate of clinical expense recognized if actual
 results differ from management&amp;#x2019;s estimates.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Interest
 Expense&lt;/i&gt; &amp;#x2014;&amp;#xA0;Interest costs are expensed as incurred,
 except to the extent such interest is related to construction in
 progress, in which case interest is capitalized. Interest expense,
 net of interest capitalized, for the years ended December&amp;#xA0;31,
 2015, 2014 and 2013 was $24.1 million, $20.4 million, and $21.5
 million, respectively. Interest costs capitalized for the years
 ended December&amp;#xA0;31, 2015, 2014, and 2013 were $0.1 million,
 $0.8 million, and $0.4 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Net Loss Per
 Share of Common Stock&lt;/i&gt; &amp;#x2014;&amp;#xA0;Basic net loss per common
 share is computed by dividing net loss by the weighted-average
 number of common shares outstanding during the period. Diluted net
 loss per common share is computed by dividing the net loss by the
 sum of the weighted-average number of common shares outstanding
 during the period plus the potential dilutive effect of stock
 options, restricted stock units, warrants, and shares that could be
 issued upon conversion of the senior convertible notes outstanding
 during the period calculated in accordance with the treasury stock
 method, but are excluded if their effect is anti-dilutive. Because
 the impact of these items is anti-dilutive during periods of net
 loss, there was no difference between basic and diluted loss per
 common share for the years ended December&amp;#xA0;31, 2015, 2014, and
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Recently
 Issued Accounting Standards&lt;/i&gt; &amp;#x2014;&amp;#xA0;From time to time, new
 accounting pronouncements are issued by the Financial Accounting
 Standards Board (FASB) or other standard setting bodies that are
 adopted by the Company as of the specified effective date. Unless
 otherwise discussed, the Company believes that the impact of
 recently issued standards that are not yet effective will not have
 a material impact on the Company&amp;#x2019;s financial position or
 results of operations upon adoption.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2014,
 the FASB issued ASU 2014-09 related to revenue recognition, which
 requires an entity to recognize the amount of revenue to which it
 expects to be entitled for the transfer of promised goods or
 services to customers. The guidance requires a company to recognize
 revenue to depict the transfer of goods or services to customers in
 an amount that reflects the consideration it expects to be entitled
 to receive in exchange for those goods or services. In July 2015,
 the FASB issued ASU 2015-14, which delayed the effective date of
 the new revenue standard by one year. The FASB also agreed to allow
 entities to choose to adopt the standard as of the original
 effective date. The standard is effective beginning the first
 quarter of the Company&amp;#x2019;s 2018 fiscal year and is required to
 be adopted using either a full retrospective or a modified
 retrospective approach. The Company is assessing the potential
 impact of the new standard on its consolidated financial statements
 and has not yet selected a transition method.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In August 2014,
 the FASB issued ASU 2014-15, which provides guidance on determining
 when and how reporting entities must disclose going-concern
 uncertainties in their financial statements. The new standard
 requires management to perform interim and annual assessments of an
 entity&amp;#x2019;s ability to continue as a going concern within one
 year of the date of issuance of the entity&amp;#x2019;s financial
 statements (or within one year after the date on which the
 financial statements are available to be issued, when applicable).
 Further, an entity must provide certain disclosures if there is
 &amp;#x201C;substantial doubt about the entity&amp;#x2019;s ability to
 continue as a going concern&amp;#x201D;. The ASU is effective for annual
 periods ending after December&amp;#xA0;15, 2016, and interim periods
 thereafter; early adoption is permitted. The Company is evaluating
 the impact the adoption of ASU 2014-15 will have on its
 consolidated financial statements.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In April 2015,
 the FASB issued ASU 2015-03, &amp;#x201C;Simplifying the Presentation of
 Debt Issuance Costs.&amp;#x201D; The guidance requires debt issuance
 costs to be presented in the balance sheet as a direct deduction
 from the carrying value of the associated debt, consistent with the
 presentation of a debt discount. The guidance is effective for
 annual reporting periods beginning after December&amp;#xA0;15, 2015 and
 interim periods thereafter. As permitted by the standard, the
 Company adopted the new presentation prospectively and the adoption
 did not have an impact on its consolidated financial statements and
 disclosures.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In July 2015,
 the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the
 Measurement of Inventory. Topic 330, Inventory, currently requires
 an entity to measure inventory at the lower of cost or market.
 Market could be replacement cost, net realizable value, or net
 realizable value less an approximately normal profit margin. The
 amendments do not apply to inventory that is measured using
 last-in, first-out (LIFO) or the retail inventory method. The
 amendments apply to all other inventory, which includes inventory
 that is measured using first-in, first-out (FIFO) or average cost.
 The amendments are effective for fiscal years beginning after
 December&amp;#xA0;15, 2016, including interim periods within those
 fiscal years. The amendments should be applied prospectively with
 earlier application permitted as of the beginning of an interim or
 annual reporting period. The Company is evaluating the impact the
 adoption of ASU 2015-11 will have on its consolidated financial
 statements.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In November
 2015, the FASB issued ASU No.&amp;#xA0;2015-17, Income Taxes (Topic
 740): Balance Sheet Classification of Deferred Taxes. The new
 standard requires that deferred tax assets and liabilities be
 classified as noncurrent in a classified statement of financial
 position. For public business entities, the amendments in this
 Update are effective for financial statements issued for annual
 periods beginning after December&amp;#xA0;15, 2016, and interim periods
 within those annual periods. As permitted by the standard, the
 Company adopted the new presentation and the adoption did not have
 an impact on its consolidated financial statements and
 disclosures.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In January
 2016, the FASB issued ASU 2016-01, Financial
 Instruments&amp;#xA0;&amp;#x2014;&amp;#xA0;Overall (Subtopic 825-10):
 Recognition and Measurement of Financial Assets and Financial
 Liabilities. The update is intended to improve the recognition and
 measurement of financial instruments. The update are effective for
 fiscal years beginning after December&amp;#xA0;15, 2017, including
 interim periods within those fiscal years. The Company is
 evaluating the impact the adoption of ASU 2016-01 will have on its
 consolidated financial statements.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:UseOfEstimates contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_D2604F17-364F-4BA8-9B27-2165D107A26E_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Financial
 Statement Estimates&lt;/i&gt; &amp;#x2014;&amp;#xA0;The preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America (&amp;#x201C;GAAP&amp;#x201D;)
 requires management to make estimates and assumptions that affect
 the amounts reported in the financial statements and accompanying
 notes. Actual results could differ from those estimates. Management
 considers many factors in selecting appropriate financial
 accounting policies, and in developing the estimates and
 assumptions that are used in the preparation of the financial
 statements. Management must apply significant judgment in this
 process. The more significant estimates reflected in these
 accompanying financial statements involve assessing long-lived
 assets for impairment, accrued expenses, including clinical study
 expenses, inventory recoverability, valuation of the facility
 financing obligation, commitment asset, milestone rights, valuation
 of stock-based compensation and the determination of the provision
 for income taxes and corresponding deferred tax assets and
 liabilities and any valuation allowance recorded against net
 deferred tax assets.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_18">406165000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_05ED3402-5B27-478E-9818-76A53397C724_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;19. Selected quarterly
 financial data (unaudited)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Summarized
 quarterly financial data for the years ended December&amp;#xA0;31, 2015
 and 2014 are set forth in the following tables:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="58%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(30,658&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(28,910&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(31,857&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(277,020&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per share &amp;#x2014;
 basic and diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.08&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.07&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.08&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.66&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per
 share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;398,916&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;401,018&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;405,199&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;419,314&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="60%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;March&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;June&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;September&amp;#xA0;30&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;(In thousands, except
 per share data)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(52,056&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(73,365&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(36,520&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(36,439&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per share &amp;#x2014;
 basic and diluted&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.19&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.09&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.09&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Weighted average common
 shares used to compute basic and diluted net loss per
 share&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;368,784&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;380,770&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;394,163&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;396,793&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Impairment
 charges recorded in 2015 for $242.7 million related to long-lived
 assets, inventory and loss on purchase commitments.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5CDA9016-DEE6-403E-9784-F9797854F918_1_3">2015</dei:DocumentFiscalYearFocus>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_E68DB8C1-7741-467D-B85A-0681AA3EA53E_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;14. Commitments and
 contingencies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Operating
 Leases&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company leases certain facilities and
 equipment under various operating leases, which expire at various
 dates through 2016 and beyond. Future payments are deemed
 insignificant.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Rent expense
 under all operating leases, including office space and equipment,
 for the years ended December&amp;#xA0;31, 2015, 2014, and 2013 was
 approximately $426,000, $737,000, and $645,000
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Leases&lt;/i&gt;
 &amp;#x2014;&amp;#xA0;The Company&amp;#x2019;s capital leases were not material
 for the years ended December&amp;#xA0;31, 2015, 2014 and
 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Guarantees
 and Indemnifications&lt;/i&gt; &amp;#x2014;&amp;#xA0;In the ordinary course of its
 business, the Company makes certain indemnities, commitments and
 guarantees under which it may be required to make payments in
 relation to certain transactions. The Company, as permitted under
 Delaware law and in accordance with its Bylaws, indemnifies its
 officers and directors for certain events or occurrences, subject
 to certain limits, while the officer or director is or was serving
 at the Company&amp;#x2019;s request in such capacity. The term of the
 indemnification period is for the officer&amp;#x2019;s or
 director&amp;#x2019;s lifetime. The maximum amount of potential future
 indemnification is unlimited; however, the Company has a director
 and officer insurance policy that may enable it to recover a
 portion of any future amounts paid. The Company believes the fair
 value of these indemnification agreements is minimal. The Company
 has not recorded any liability for these indemnities in the
 accompanying condensed consolidated balance sheets. However, the
 Company accrues for losses for any known contingent liability,
 including those that may arise from indemnification provisions,
 when future payment is probable and the amount can be reasonably
 estimated. No such losses have been recorded to date.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Litigation&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company is subject to legal
 proceedings and claims which arise in the ordinary course of its
 business. As of December&amp;#xA0;31, 2015, the Company believes that
 the final disposition of such matters will not have a material
 adverse effect on the financial position, results of operations or
 cash flows of the Company and no accrual has been recorded. The
 Company maintains liability insurance coverage to protect the
 Company&amp;#x2019;s assets from losses arising out of or involving
 activities associated with ongoing and normal business operations.
 In accordance with ASC 450 &lt;i&gt;Contingencies&lt;/i&gt;, the Company
 records a provision for a liability when it is both probable that a
 liability has been incurred and the amount of the loss can be
 reasonably estimated. The Company&amp;#x2019;s policy is to accrue for
 legal expenses in connection with legal proceeding and claims as
 they are incurred.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In addition,
 several complaints were filed in the U.S. District Court for the
 Central District of California against the Company and certain of
 its officers and directors on behalf of certain purchasers of its
 common stock. The complaints include claims asserted under Sections
 10(b) and 20(a) of the Exchange Act and have been pled as putative
 shareholder class actions. In general, the complaints allege that
 the Company and certain of its officers and directors violated
 federal securities laws by making materially false and misleading
 statements regarding the prospects for AFREZZA, thereby
 artificially inflating the price of its common stock. The
 plaintiffs are seeking monetary damages and other relief. The
 Company expects the complaints to be transferred to a single court
 and consolidated for all purposes, following which the court would
 be expected to appoint a lead plaintiff and lead counsel and to
 order the lead plaintiff to file a consolidated complaint. The
 Company will vigorously defend against the claims
 advanced.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Following the
 receipt by the Company of the notice of termination from Sanofi
 regarding the Sanofi License Agreement and the subsequent decline
 of the price of its common stock, two motions were submitted to the
 District Court at Tel Aviv (Economic Department) for the
 certification of a class action against the Company and certain of
 its officers and directors. In general, the complaints allege that
 the Company and certain of its officers and directors violated
 Israeli and US securities laws by making materially false and
 misleading statements regarding the prospects for AFREZZA, thereby
 artificially inflating the price of its common stock. The
 plaintiffs are seeking monetary damages. The Company will
 vigorously defend against these claims.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Contingencies &amp;#x2014;&lt;/i&gt; In connection with the Facility
 Agreement, on July&amp;#xA0;1, 2013 the Company also entered into a
 Milestone Rights Purchase Agreement (the &amp;#x201C;Milestone
 Agreement&amp;#x201D;) with Deerfield Private Design Fund and Horizon
 Sant&amp;#xE9; FLML S&amp;#xC1;RL (collectively, the &amp;#x201C;Milestone
 Purchasers&amp;#x201D;), pursuant to which the Company sold the
 Milestone Purchasers the Milestone Rights to receive payments up to
 $90.0 million upon the occurrence of specified strategic and sales
 milestones, including the first commercial sale of an AFREZZA
 product in the United States and the achievement of specified net
 sales figures (see Note 17&amp;#xA0;&amp;#x2014;&amp;#xA0;Facility
 Agreement).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Commitment
 &amp;#x2014;&lt;/i&gt; On July&amp;#xA0;31, 2014, the Company entered into a
 supply agreement (the &amp;#x201C;Insulin Supply Agreement&amp;#x201D;) with
 Amphastar France Pharmaceuticals S.A.S., a French corporation
 (&amp;#x201C;Amphastar&amp;#x201D;), pursuant to which Amphastar will
 manufacture for and supply to the Company certain quantities of
 recombinant human insulin for use in AFREZZA. Under the terms of
 the Insulin Supply Agreement, Amphastar will be responsible for
 manufacturing the insulin in accordance with the Company&amp;#x2019;s
 specifications and agreed-upon quality standards. The Company has
 agreed to purchase annual minimum quantities of insulin for
 calendar years 2015 through 2019 under the Insulin Supply Agreement
 of an aggregate total of approximately &amp;#x20AC;120.1&amp;#xA0;million,
 of which &amp;#x20AC;98.5&amp;#xA0;million is remaining at December&amp;#xA0;31,
 2015. The Company has contracted for the purchase of
 &amp;#x20AC;28.8&amp;#xA0;million in 2016 and the remaining annual minimum
 quantities will be &amp;#x20AC;23.3&amp;#xA0;million for the years ending
 December&amp;#xA0;31, 2017 through 2019. The Company may request to
 purchase additional quantities of insulin over such annual minimum
 quantities and will incur a cancellation fee of approximately $5.2
 million if not purchased (see Note 2&amp;#xA0;&amp;#x2014; Summary of
 Significant accounting policies).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Unless earlier
 terminated, the term of the Insulin Supply Agreement expires on
 December&amp;#xA0;31, 2019 and can be renewed for additional,
 successive two year terms upon 12 months&amp;#x2019; written notice
 given prior to the end of the initial term or any additional two
 year term. The Company and Amphastar each have normal and customary
 termination rights, including termination for material breach that
 is not cured within a specific time frame or in the event of
 liquidation, bankruptcy or insolvency of the other party. In
 addition, the Company may terminate the Insulin Supply Agreement
 upon two years&amp;#x2019; prior written notice to Amphastar without
 cause or upon 30 days&amp;#x2019; prior written notice to Amphastar if a
 controlling regulatory authority withdraws approval for AFREZZA,
 provided, however, in the event of a termination pursuant to either
 of the latter two scenarios, the provisions of the Insulin Supply
 Agreement require the Company to pay the full amount of all unpaid
 purchase commitments due over the initial term within 60 calendar
 days of the effective date of such termination.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_4BE2DF77-B52F-48A3-8304-CF37C799C180_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;20. Subsequent
 Events&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 6px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Sanofi
 Termination&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;January&amp;#xA0;4, 2016, the
 Company received written notice from Sanofi of its election to
 terminate in its entirety the Sanofi License Agreement.
 Sanofi&amp;#x2019;s notice indicated that the termination was pursuant
 to Sanofi&amp;#x2019;s right to terminate the agreement upon
 Sanofi&amp;#x2019;s good faith determination that the commercialization
 of AFREZZA is no longer economically viable in the United States,
 in which case the effective date of termination would be
 April&amp;#xA0;4, 2016. In the alternative, Sanofi indicated that the
 termination was also pursuant to its right to terminate the Sanofi
 License Agreement for any reason, in which case the Termination
 Date would be July&amp;#xA0;4, 2016. In the interest of an expedient
 transition, the Company is currently working with Sanofi to
 transfer and wind down the agreement activities by April&amp;#xA0;4,
 2016, or as soon as practicable thereafter.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;Pursuant to the terms of
 the Sanofi License Agreement, the Company and Sanofi are required
 to use diligent efforts to facilitate the smooth and orderly
 transition of relevant obligations and rights to the Company with
 respect to development and commercialization activities related to
 AFREZZA, and are also required to negotiate in good faith a written
 transition agreement for this purpose. As a result of the foregoing
 termination, effective on the Termination Date and thereafter
 during any period which Sanofi is required to perform any wind-down
 activities pursuant to the terms of the Sanofi License Agreement,
 the rights granted to Sanofi under the Sanofi License Agreement to
 develop and commercialize AFREZZA will become non-exclusive and the
 Company will have the right to engage one or more other
 distributors and/or licensees of AFREZZA. Sanofi will continue to
 distribute AFREZZA during the wind-down period as required by the
 agreement until such time that the Company or its designee takes
 over responsibility for distribution. All profits and losses from
 AFREZZA product sales by Sanofi or its affiliates after the
 Termination Date, if any, will continue to be shared 65% by Sanofi
 and 35% by the Company pursuant to the terms of the Sanofi License
 Agreement.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;The Company and Sanofi
 are also parties to the Sanofi Supply Agreement, pursuant to which
 the Company is required to supply Sanofi or its affiliates or its
 sublicensees such quantities of AFREZZA as requested by Sanofi to
 cover its commercial requirements. As a result of the termination
 of the Sanofi License Agreement, the Sanofi Supply Agreement will
 terminate by its terms on the Termination Date.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; MARGIN-LEFT: 21px; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;&lt;i&gt;Borrowings under
 Sanofi Loan Facility&lt;/i&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;On February&amp;#xA0;10,
 2016, the Company borrowed $17.9 million under the Sanofi Loan
 Facility to finance the portion of its losses for the quarter ended
 December&amp;#xA0;31, 2015 (see Note 9 &amp;#x2014;&amp;#xA0;Collaboration
 arrangement).&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_96193E4F-0BFF-432A-9989-2CE96EB9C290_1_5">7.70</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_B0994DF9-94F3-4AED-A2A8-F8004EE81B07_1_3">4.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_8CAF4216-9433-4FE6-B619-44A329DD21A7_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Potentially
 dilutive securities outstanding are summarized as follows (in
 shares):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="67%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 options&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,779,229&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;21,541,664&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;24,237,940&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Conversion of senior
 convertible notes into common stock&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,072,809&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;17,323,080&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;25,415,366&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercise of common stock
 warrants&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,074,596&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,987,876&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;19,706,240&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Vesting of restricted stock
 units&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,804,620&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,610,720&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,115,821&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;29,731,254&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;51,463,340&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78,475,367&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="4" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_1_1">0.0186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_89C6C9B0-FF3C-49DA-9660-83EE716EA071_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;7. Related-party
 arrangements&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In October 2007,
 the Company entered into a $350.0 million loan arrangement with its
 principal stockholder. The Loan Arrangement has been amended from
 time to time. On October&amp;#xA0;31, 2013, the promissory note
 underlying The Mann Group Loan Arrangement was amended to, among
 other things, extend the maturity date of the loan to
 January&amp;#xA0;5, 2020, extend the date through which the Company can
 borrow under The Mann Group Loan Arrangement to December&amp;#xA0;31,
 2019, increase the aggregate borrowing amount under The Mann Group
 Loan Arrangement from $350.0 million to $370.0 million and provide
 that repayments or cancellations of principal under The Mann Group
 Loan Arrangement will not be available for reborrowing.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2015, the total principal amount outstanding
 under The Mann Group Loan Arrangement was $49.5 million, and the
 amount available for future borrowings was $30.1 million. Interest,
 at a fixed rate of 5.84%, is due and payable quarterly in arrears
 on the first day of each calendar quarter for the preceding
 quarter, or at such other time as the Company and The Mann Group
 mutually agree. All or any portion of accrued and unpaid interest
 that becomes due and payable may be paid-in-kind and capitalized as
 additional borrowings at any time upon mutual agreement of the
 parties, and has been classified as non-current. The Mann Group can
 require the Company to prepay up to $200.0 million in advances that
 have been outstanding for at least 12 months (less approximately
 $105.0 million aggregate principal amount that has been cancelled
 in connection with two common stock purchase agreements). If The
 Mann Group exercises this right, the Company will have 90 days
 after The Mann Group provides written notice (or the number of days
 to maturity of the note if less than 90 days) to prepay such
 advances. However, pursuant to a letter agreement entered into in
 August 2010, The Mann Group has agreed to not require the Company
 to prepay amounts outstanding under the amended and restated
 promissory note if the prepayment would require the Company to use
 its working capital resources. In addition, The Mann Group entered
 into a subordination agreement with Deerfield pursuant to which The
 Mann Group agreed with Deerfield not to demand or accept any
 payment under The Mann Group Loan Arrangement until the
 Company&amp;#x2019;s payment obligations to Deerfield under the Facility
 Agreement have been satisfied in full. Subject to the foregoing, in
 the event of a default under The Mann Group Loan Arrangement, all
 unpaid principal and interest either becomes immediately due and
 payable or may be accelerated at The Mann Group&amp;#x2019;s option, and
 the interest rate will increase to the one-year LIBOR rate
 calculated on the date of the initial advance or in effect on the
 date of default, whichever is greater, plus 5%&amp;#xA0;per annum. All
 borrowings under The Mann Group Loan Arrangement are unsecured. The
 Mann Group Loan Arrangement contains no financial
 covenants.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;As of
 December&amp;#xA0;31, 2015 and 2014, the Company had accrued and unpaid
 interest of $6.4 million and $3.5 million, in long term other
 liabilities respectively, which related to the amount outstanding
 and had $30.1 million of available borrowings. Interest expense on
 the Company&amp;#x2019;s note payable to the Company&amp;#x2019;s principal
 stockholder for the years ended December&amp;#xA0;31, 2015, 2014, and
 2013 was $2.9 million, $2.9 million, and $6.3 million,
 respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In May 2015, the
 Company entered into sublease agreement with the Alfred Mann
 Foundation for Scientific Research (the &amp;#x201C;Mann
 Foundation&amp;#x201D;), a California Not-For-Profit Corporation. The
 lease is for approximately 12,500 square feet of office space in
 Valencia, California and expires in April 2017. The office space
 contains the Company&amp;#x2019;s principal executive offices. Lease
 payments to the Mann Foundation for the year ended
 December&amp;#xA0;31, 2015 were $175,000. There were no lease payments
 to the Mann Foundation for the years ended December&amp;#xA0;31, 2014
 and 2013.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;In connection
 with certain meetings of the Company&amp;#x2019;s board of directors and
 on other occasions when the Company&amp;#x2019;s business necessitated
 air travel for the Company&amp;#x2019;s principal stockholder and other
 Company employees, the Company utilized the principal
 stockholder&amp;#x2019;s private aircraft, and the Company paid the
 charter company that manages the aircraft on behalf of the
 Company&amp;#x2019;s principal stockholder approximately $18,000,
 $79,000, and $82,000, respectively, for the years ended
 December&amp;#xA0;31, 2015, 2014, and 2013 on the basis of the
 corresponding cost of commercial airfare.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company has
 entered into indemnification agreements with each of its directors
 and executive officers, in addition to the indemnification provided
 for in its amended and restated certificate of incorporation and
 amended and restated bylaws (see Note
 14&amp;#xA0;&amp;#x2014;&amp;#xA0;Commitments and contingencies).&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <dei:EntityWellKnownSeasonedIssuer contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_91C3FA59-887C-44D7-A83B-C1C7868E1D91_1_400004">No</dei:EntityWellKnownSeasonedIssuer>
  <us-gaap:LongTermDebtTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_A491B62C-27B4-41D1-A98A-75F43F8BBE63_1_0">&lt;div&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;8. Senior convertible
 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Senior
 convertible notes consist of the following (in
 thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="83%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;2015 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;100,000&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unaccreted debt issuance
 cost&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(645&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;99,355&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;2018 notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Principal amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;27,690&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unamortized
 premium&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;660&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Unaccreted debt issuance
 costs&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;(737&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Net carrying
 amount&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;27,613&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Issuance of
 new 5.75% Convertible Senior Subordinated Exchange Notes due 2018
 in exchange for 2015 notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On July&amp;#xA0;28,
 2015, the Company entered into privately-negotiated exchange
 agreements (the &amp;#x201C;Note Exchange Agreements&amp;#x201D;) with a
 select holder of the Company&amp;#x2019;s 5.75% Senior Convertible Notes
 due 2015 (the &amp;#x201C;2015 notes&amp;#x201D;), pursuant to which the
 Company agreed to issue $27.7 million aggregate principal amount of
 new 5.75% Convertible Senior Subordinated Exchange Notes due 2018
 (the &amp;#x201C;2018 notes&amp;#x201D;) to such holders in exchange for the
 delivery to the Company of the same principal amount of 2015 notes.
 The 2018 notes were issued at the closing of the exchange on
 August&amp;#xA0;10, 2015. The Company analyzed this exchange under the
 provisions of ASC 470-50 and concluded that the exchange represents
 an extinguishment of the 2015 notes and a new issuance of 2018
 notes and recorded such notes at fair value which resulted in a
 premium of $0.7 million.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The 2018 notes
 are the Company&amp;#x2019;s general, unsecured, senior obligations,
 except that the 2018 notes are subordinated in right of payment to
 the outstanding notes issued pursuant to the Facility Agreement and
 the Company&amp;#x2019;s borrowings under the Sanofi Loan Facility with
 an affiliate of Sanofi-Aventis U.S. LLC. The 2018 notes rank
 equally in right of payment with the Company&amp;#x2019;s other
 unsecured senior debt. The 2018 notes bear interest at the rate of
 5.75%&amp;#xA0;per year on the principal amount, payable semiannually
 in arrears in cash on February&amp;#xA0;15 and August&amp;#xA0;15 of each
 year, beginning February&amp;#xA0;15, 2016, with interest accruing from
 August&amp;#xA0;15, 2015. The 2018 notes mature on August&amp;#xA0;15,
 2018.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The 2018 notes
 are convertible, at the option of the holder, at any time on or
 prior to the close of business on the business day immediately
 preceding the stated maturity date, into shares of the
 Company&amp;#x2019;s common stock at an initial conversion rate of
 147.0859 shares per $1,000 principal amount of 2018 notes, which is
 equal to a conversion price of approximately $6.80 per share, the
 same conversion price as that of the 2015 notes on the date of
 exchange. The conversion rate is subject to adjustment under
 certain circumstances described in an indenture governing the 2018
 notes dated August&amp;#xA0;10, 2015 with Wells Fargo, National
 Association, including in connection with a make-whole fundamental
 change.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;If certain
 fundamental changes occur, the Company will be obligated to pay a
 fundamental change make-whole premium on any 2018 notes converted
 in connection with such fundamental change by increasing the
 conversion rate on such 2018 notes. In such instances, the amount
 of the fundamental change make-whole premium will be based on the
 Company&amp;#x2019;s common stock price and the effective date of the
 applicable fundamental change.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;If the Company
 undergoes certain fundamental changes, except in certain
 circumstances, each holder of 2018 notes will have the option to
 require the Company to repurchase all or any portion of that
 holder&amp;#x2019;s 2018 notes. The fundamental change repurchase price
 will be 100% of the principal amount of the 2018 notes to be
 repurchased plus accrued and unpaid interest, if any.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On or after the
 date that is one year following the original issue date of the 2018
 notes, the Company will have the right to redeem for cash all or
 part of the 2018 notes if the last reported sale price of its
 common stock exceeds 130% of the conversion price then in effect
 for 20 or more trading days during the 30 consecutive trading day
 period ending on the trading day immediately prior to the date of
 the redemption notice. The redemption price will equal the sum of
 100% of the principal amount of the 2018 notes to be redeemed, plus
 accrued and unpaid interest. Under the terms of the 2018 Note
 Indenture, the conversion option can be net-share settled and the
 maximum number of shares that could be required to be delivered
 under the indenture, including the make-whole shares, is fixed and
 less than the number of authorized and unissued shares less the
 maximum number of shares that could be required to be delivered
 during the term of the 2018 notes under existing commitments.
 Applying the Company&amp;#x2019;s sequencing policy, the Company
 performed an analysis at the time of the offering of the 2018 notes
 and each reporting date since and has concluded that the number of
 available authorized shares at the time of the offering and each
 subsequent reporting date was sufficient to deliver the number of
 shares that could be required to be delivered during the term of
 the 2018 notes under existing commitments.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The 2018 notes
 provide that upon an acceleration of certain indebtedness,
 including the 9.75% Senior Convertible Notes due 2019 (the
 &amp;#x201C;2019 notes&amp;#x201D;) and the 8.75% Senior Convertible Notes
 due 2019 (the &amp;#x201C;Tranche B notes&amp;#x201D;) issued to Deerfield
 pursuant to the Facility Agreement (see Note
 17&amp;#xA0;&amp;#x2014;&amp;#xA0;Facility Agreement), the holders may elect to
 accelerate the Company&amp;#x2019;s repayment obligations under the
 notes if such acceleration is not cured, waived, rescinded or
 annulled. There can be no assurance that the holders would not
 choose to exercise these rights in the event such events were to
 occur.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 incurred approximately $0.8 million in issuance costs which are
 recorded as an offset to the 2018 notes in the accompanying
 condensed consolidated balance sheet. These costs are being
 accreted to interest expense using the effective interest method
 over the term of the 2018 notes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accretion of
 debt issuance expense in connection with the 2018 notes during the
 year ended December&amp;#xA0;31, 2015 was $93,000. Amortization of 2018
 notes premium during the year ended December&amp;#xA0;31, 2015 was
 $86,000.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Issuance of
 common stock in exchange for 2015 notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On July&amp;#xA0;28,
 2015, the Company entered into separate, privately-negotiated
 exchange agreements (the &amp;#x201C;Stock-for-Note Exchange
 Agreements&amp;#x201D;) with certain holders of the 2015 notes pursuant
 to which the Company agreed to issue shares of its common stock to
 such holders in exchange for the delivery to the Company of up to
 $56.9 million aggregate principal amount of 2015 notes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Pursuant to the
 Stock-for-Note Exchange Agreements, the parties agreed to price the
 exchange transactions over a 10 trading day period spanning from
 July&amp;#xA0;29, 2015 to and including August&amp;#xA0;11, 2015. Between
 July&amp;#xA0;28, 2015 and August&amp;#xA0;10, 2015, the Company issued an
 aggregate of 1.9&amp;#xA0;million shares of common stock to such
 holders in exchange for such holders&amp;#x2019; delivery to the Company
 of $8.0 million aggregate principal amount of 2015 notes, resulting
 in a weighted-average exchange price of $4.40 per share.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Issuance of
 new 5.75% Convertible Senior Subordinated Exchange Notes due 2015
 in exchange for 2015 notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 August&amp;#xA0;14, 2015, the Company exchanged $32.1 million aggregate
 principal amount of newly issued, 5.75% Convertible Senior
 Subordinated Exchange Notes due 2015 (the &amp;#x201C;Exchange
 Notes&amp;#x201D;) for the same principal amount of the Company&amp;#x2019;s
 previously outstanding 2015 notes. The Exchange Notes, payable at
 maturity on September&amp;#xA0;30, 2015, were convertible, at the
 option of each holder thereof, at any time on or prior to the close
 of business on the business day immediately preceding the stated
 maturity date. The holders of the Exchange Notes did not elect to
 convert any of the outstanding principal amount of the Exchange
 Notes into shares of the Company&amp;#x2019;s common stock. As a result,
 on September&amp;#xA0;30, 2015, the Company paid $32.1 million to
 settle the Exchange Notes.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; margin-left:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;&lt;i&gt;Settlement of
 2015 notes and Exchange Notes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 August&amp;#xA0;17, 2015, the Company paid $32.2 million to settle the
 remaining 2015 notes. As of September&amp;#xA0;30, 2015, all 2015
 notes, including the Exchange Notes, have been settled resulting in
 a total loss on extinguishment equal to $1.0 million. The loss on
 extinguishment resulted from write-off of debt discount and debt
 issuance costs associated with the 2015 notes and Exchange Notes
 and the difference between the principal amounts being exchanged
 for shares of the Company&amp;#x2019;s common stock, pursuant to the
 various Stock-for-Note Exchange Agreements, and the fair market
 value of the Company&amp;#x2019;s common stock issued in exchange for
 such reduction in principal.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Accretion of
 debt issuance expense in connection with the 2015 notes during the
 years ended December&amp;#xA0;31, 2015, 2014, and 2013 was $0.6
 million, $0.9 million, and $0.9 million, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_E3A87D57-EA96-4267-BB4B-89E7FD10D0E6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Comprehensive Loss&lt;/i&gt; &amp;#x2014;&amp;#xA0;Other comprehensive loss
 is recorded in accordance with ASC 220-10-45 &lt;i&gt;Comprehensive
 Income,&lt;/i&gt; which requires that all components of comprehensive
 loss be reported in the financial statements in the period in which
 they are recognized. Other comprehensive loss includes certain
 changes in stockholders&amp;#x2019; equity that are excluded from net
 income. Specifically, the Company includes unrealized gains and
 foreign exchange translation losses, if any, and cumulative
 translation gains and losses in other comprehensive
 loss.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="3" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_1_3">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_94080AE2-0A95-466B-81EB-197F598969F6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inventories
 consist of the following (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="79%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Raw materials&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,856&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Work-in-process&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,719&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Finished goods&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;95&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inventory &amp;#x2014;
 current&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;9,670&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total Inventory&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;9,670&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"&gt;&amp;#xA0;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_6187E74F-4560-4DF7-8DDF-F29B8F444FE6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Property and
 Equipment&lt;/i&gt; &amp;#x2014;&amp;#xA0;Property and equipment are recorded at
 cost and depreciated using the straight-line method over the
 estimated useful lives of the related assets. Leasehold
 improvements are amortized over the term of the lease or the
 service lives of the improvements, whichever is shorter.
 Maintenance and repairs are expensed as incurred. Assets under
 construction are not depreciated until placed into
 service.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Impairment
 of Long-Lived Assets&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company evaluates
 long-lived assets for impairment whenever events or changes in
 circumstances indicate that the carrying value of an asset may not
 be recoverable in accordance with ASC 360-10-35 &lt;i&gt;Property Plant
 and Equipment.&lt;/i&gt; Assets are considered to be impaired if the
 carrying value may not be recoverable based upon management&amp;#x2019;s
 assessment of the following events or changes in
 circumstances:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;significant changes in the Company&amp;#x2019;s strategic business
 objectives and utilization of the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;a determination that the carrying value of such assets cannot
 be recovered through undiscounted cash flows;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;loss of legal ownership or title to the assets;&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;a significant adverse change in legal factors or in the
 business climate that could affect the value of a long-lived asset
 (asset group), including an adverse action or assessment by a
 regulator; or&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="2%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2022;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;the impact of significant negative industry or economic
 trends.&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;If the Company
 believes an asset to be impaired, the impairment recognized is the
 amount by which the carrying value of the assets exceeds the fair
 value of the assets. Any write-downs would be treated as permanent
 reductions in the carrying amount of the asset and an operating
 loss would be recognized.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 recorded an asset impairment of $140.4 million for the year ended
 December&amp;#xA0;31, 2015 (see Note 5&amp;#xA0;&amp;#x2014;&amp;#xA0;Property and
 Equipment). No asset impairment was recognized during the years
 ended December&amp;#xA0;31, 2014, and 2013, respectively.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="shares" decimals="INF" id="id_7647232_C87A7D43-072A-44F4-98FF-8464922BC0AE_1_2">1541100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="INF" id="id_7647232_B33BF0E4-E59C-4BA9-8119-A334A86EE04C_1_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_74999BC4-9B50-4827-9426-5443DA8569B4_1_0">&lt;div&gt;
 &lt;p style="margin-top:0px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;15. Employee benefit
 plans&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 administers a 401(k) Savings Retirement Plan (the &amp;#x201C;MannKind
 Retirement Plan&amp;#x201D;) for its employees. For the years ended
 December&amp;#xA0;31, 2015, 2014, and 2013, the Company contributed
 $593,000, $623,000, and $533,000 respectively, to the MannKind
 Retirement Plan.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_D5754959-0E23-4D11-8424-39A8349F55F3_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is as follows (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Employee-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8,407&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,181&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Consultant-related&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;318&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8,725&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
  <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_F655671D-0E74-4B9C-B41A-68FA276E40CD_1_0">&lt;div&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The following
 table summarizes information about the Company&amp;#x2019;s stock-based
 award plans as of December&amp;#xA0;31, 2015:&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="65%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Outstanding&lt;br /&gt;
 Restricted&lt;br /&gt;
 Stock Units&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Shares&amp;#xA0;Available&lt;br /&gt;
 for&lt;br /&gt;
 Future Issuance&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2004 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;11,309,136&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;276,784&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2013 Equity Incentive
 Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8,026,762&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,527,836&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;15,540,652&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;2004 Non-Employee
 Directors&amp;#x2019; Stock Option Plan&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;443,331&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#x2014;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;19,779,229&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;1,804,620&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;15,540,652&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
  <us-gaap:InventoryPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_C997DD3D-ED4B-4D78-ADBF-E75812F0A267_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Inventories&lt;/i&gt; &amp;#x2014;&amp;#xA0;Inventories are stated at the
 lower of cost or market. The Company determines the cost of
 inventory using the first-in, first-out, or FIFO, method. The
 Company capitalizes inventory costs associated with the
 Company&amp;#x2019;s products based on management&amp;#x2019;s judgment that
 future economic benefit is expected to be realized; otherwise, such
 costs are expensed as product manufacturing. The Company
 periodically analyzes its inventory levels to identify inventory
 that may expire or has a cost basis in excess of its estimated
 realizable value, and writes-down such inventories as appropriate.
 In addition, the Company&amp;#x2019;s products are subject to strict
 quality control and monitoring which the Company performs
 throughout the manufacturing process. If certain batches or units
 of product no longer meet quality specifications or become obsolete
 due to expiration, the Company will record a charge to write down
 such unmarketable inventory to its estimated realizable value.
 Inventory that is not expected to be used within one year is
 classified as a long term asset on the accompanying condensed
 consolidated balance sheet.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We analyzed our
 inventory levels to identify inventory that may expire or has a
 cost basis in excess of its estimated realizable value. We
 performed an assessment of projected sales and to evaluate the
 lower of cost or market and the potential excess inventory on hand
 at December 31, 2015. As a result of this assessment, we recorded a
 charge of $39.3 million to record the inventory raw materials on
 hand at the lower of cost or market, inventory expiry, and
 write-off other inventory related assets.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In connection
 with the projected sales assessment, we also evaluated our
 inventory purchase commitments totalling $116.2 million for
 potential impairment. As a result of this assessment, we recorded a
 $66.2 million charge related to a loss on future purchase
 commitments both from a lower of cost or market excess inventory
 perspective. The purchase commitment obligation has been reduced to
 reflect our expectation that a portion will be recoverable from a
 third party.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="2" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_1_6">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_475252C0-6496-4D82-A7B2-A22644FF3526_3_1">P5Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_18">-150000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInDeferredCharges contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_17">13539000</us-gaap:IncreaseDecreaseInDeferredCharges>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_10">-1049000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_12">-2697000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_23D39344-E59E-4E61-9D5B-E05BF620E64D_1_4">-368451000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_26">10285000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PartnersCapitalAccountContributions contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900035">40000</us-gaap:PartnersCapitalAccountContributions>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="INF" id="id_7647232_EEA350C7-9604-402C-B52C-4844B31ACA38_1_1">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
  <us-gaap:StockIssued1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_51">8253000</us-gaap:StockIssued1>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900045">27844000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900050">8725000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_9">1366000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_5">-1049000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900047">887000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_8">-344655000</us-gaap:OperatingIncomeLoss>
  <us-gaap:LoansAssumed1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_56">59337000</us-gaap:LoansAssumed1>
  <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_14">26434000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900048">-202000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_14">-368445000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:SalesRevenueNet contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_0">0</us-gaap:SalesRevenueNet>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900032">-1856000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_13">18000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:GainLossOnContractTermination contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_6">-66167000</us-gaap:GainLossOnContractTermination>
  <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_44">1858000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_42">548000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900037">7926000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:InterestPaid contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_50">13355000</us-gaap:InterestPaid>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_5CC77007-78CD-402F-ADD2-EEA8A1363850_3_0">80100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900030">3258000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_15">-50413000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_16">-13485000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_16">-368445000</us-gaap:NetIncomeLoss>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900051">-6000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_23D39344-E59E-4E61-9D5B-E05BF620E64D_1_3">-6000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:InterestExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_A26FF0B3-4D61-4E1B-A569-490A50CAB196_1_0">24100000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_41">28392000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E99253A8-141E-412B-B69A-C815A31618F7_1_1">5500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_B9C8D635-D2C8-4AEA-8959-8A1E65B44C8A_1_0">426000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_2">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
  <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_9">-80118000</us-gaap:DeferredOtherTaxExpenseBenefit>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_3">13276000</us-gaap:DepreciationAndAmortization>
  <us-gaap:OperatingExpenses contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_7">344655000</us-gaap:OperatingExpenses>
  <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_8">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_45">5668000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_57556F65-FD1F-4A0F-9BCD-C3C09BD78F2B_1_0">11000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_15">0</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:PaidInKindInterest contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_9">1652000</us-gaap:PaidInKindInterest>
  <us-gaap:InventoryWriteDown contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_28C7B4F6-4AE2-465F-8FFE-ED283CEED04F_1_0">36300000</us-gaap:InventoryWriteDown>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_3">40960000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_6">109512000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
  <us-gaap:InterestCostsCapitalized contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_A26FF0B3-4D61-4E1B-A569-490A50CAB196_1_1">100000</us-gaap:InterestCostsCapitalized>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_2">29674000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_4">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_EEC6996F-3392-4555-BF41-B623DC34E386_1_0">242700000</us-gaap:AssetImpairmentCharges>
  <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_21">17067000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_475252C0-6496-4D82-A7B2-A22644FF3526_3_0">3300000</us-gaap:EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_27">82000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E99253A8-141E-412B-B69A-C815A31618F7_1_0">5200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_D7A179C2-59AD-46B9-8420-25E73A830E83_1_1">6200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="INF" id="id_7647232_EEA350C7-9604-402C-B52C-4844B31ACA38_1_0">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_10">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_46">-61767000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_11">2894000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_12">21231000</us-gaap:InterestExpenseDebt>
  <us-gaap:ProceedsFromWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_33">10123000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_A3D5914A-C92B-47E2-AC83-65A90C092DBC_1_0">593000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_C424AFAC-4669-4A6A-960E-C8C9EAC75B53_1_0">8725000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_23">2927000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_1">0</us-gaap:CurrentFederalTaxExpenseBenefit>
  <us-gaap:ManufacturingCosts contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_4">67442000</us-gaap:ManufacturingCosts>
  <us-gaap:IncreaseDecreaseInCustomerAdvancesAndDeposits contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_22">950000</us-gaap:IncreaseDecreaseInCustomerAdvancesAndDeposits>
  <us-gaap:RestructuringCharges contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_0F656263-61CB-4251-A29D-D2E7809F383F_2_2">5900000</us-gaap:RestructuringCharges>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_19">8413000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_7">-29394000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
  <us-gaap:ProductionRelatedImpairmentsOrCharges contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_7">36104000</us-gaap:ProductionRelatedImpairmentsOrCharges>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_43">40000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_4">8725000</us-gaap:ShareBasedCompensation>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_5">140412000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_28">-10203000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_20">-12467000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
  <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_3">0</us-gaap:CurrentForeignTaxExpenseBenefit>
  <mnkd:StockIssuedDuringPeriodValueShareLendingAgreement contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900039">160000</mnkd:StockIssuedDuringPeriodValueShareLendingAgreement>
  <mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_8">-140582000</mnkd:GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900049">108000</mnkd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity>
  <mnkd:BasisOfPresentationPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_36510C1B-EA2B-4108-B91A-318913B31ED9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Basis of
 Presentation&lt;/i&gt; &amp;#x2014;&amp;#xA0;The Company&amp;#x2019;s primary
 activities since incorporation have been establishing its
 facilities, recruiting personnel, conducting research and
 development, business development, business and financial planning,
 raising capital, and commercial manufacturing. It is costly to
 develop therapeutic products and conduct clinical studies for these
 products. As of and for the year ended December&amp;#xA0;31, 2015, the
 Company has reported an accumulated deficit of $2.9&amp;#xA0;billion
 and has reported negative cash flow from operations for each year
 since inception, except for 2014, when the Company received the
 $150.0 million upfront payment from Sanofi.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
 December&amp;#xA0;31, 2015, the Company&amp;#x2019;s capital resources
 consisted of cash and cash equivalents of $59.1 million. The
 Company expects to continue to incur significant expenditures to
 support commercial manufacturing and sales and marketing of AFREZZA
 and the development of other product candidates. The facility
 agreement (the &amp;#x201C;Facility Agreement&amp;#x201D;) with Deerfield
 Private Design Fund II, L.P. (&amp;#x201C;Deerfield Private Design
 Fund&amp;#x201D;) and Deerfield Private Design International II, L.P.
 (collectively, &amp;#x201C;Deerfield&amp;#x201D;) and the First Amendment to
 Facility Agreement and Registration Rights Agreement (the
 &amp;#x201C;First Amendment&amp;#x201D;) that resulted in additional sales of
 an additional tranche of notes (the &amp;#x201C;Tranche B notes&amp;#x201D;)
 (see Note 17&amp;#xA0;&amp;#x2014;&amp;#xA0;Facility Agreement) requires the
 Company to maintain at least $25.0 million in cash and cash
 equivalents or available borrowings under the loan arrangement,
 dated as of October&amp;#xA0;2, 2007, between The Company and The Mann
 Group LLC (as amended, restated, or otherwise modified as of the
 date hereof, &amp;#x201C;the Mann Group Loan Arrangement&amp;#x201D;), as of
 the last day of each fiscal quarter. The Company will need to
 continue to incur expenses for the commercialization of AFREZZA and
 will need to raise additional capital to finance such activities.
 The Company cannot be certain that it will be able to raise
 additional capital on favorable terms, or at all, which raises
 substantial doubt about the Company&amp;#x2019;s ability to continue as
 a going concern. The financial statements do not include any
 adjustments that might result from the outcome of this
 uncertainty.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 August&amp;#xA0;11, 2014, we executed a license and collaboration
 agreement (the &amp;#x201C;Sanofi License Agreement&amp;#x201D;) with
 Sanofi-Aventis Deutschland GmbH (which subsequently assigned its
 rights and obligations under the agreement to Sanofi-Aventis U.S.
 LLC (&amp;#x201C;Sanofi&amp;#x201D;)), pursuant to which Sanofi is
 responsible for global commercial, regulatory and development
 activities for AFREZZA. The Sanofi License Agreement became
 effective on September&amp;#xA0;23, 2014. The Company manufactured
 AFREZZA at its manufacturing facility in Danbury, Connecticut to
 supply Sanofi&amp;#x2019;s demand for the product pursuant to a supply
 agreement dated August&amp;#xA0;11, 2014 (the &amp;#x201C;Sanofi Supply
 Agreement&amp;#x201D;).&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
 January&amp;#xA0;4, 2016 the Company received notification from Sanofi
 of its election to terminate in its entirety the Sanofi License
 Agreement. Sanofi&amp;#x2019;s notice indicated that the termination was
 pursuant to Sanofi&amp;#x2019;s right to terminate the Sanofi License
 Agreement upon Sanofi&amp;#x2019;s good faith determination that the
 commercialization of AFREZZA is no longer economically viable in
 the United States, in which case the effective date of termination
 (the &amp;#x201C;Termination Date&amp;#x201D;) will be April&amp;#xA0;4, 2016. In
 the alternative, Sanofi indicated that the termination was also
 pursuant to its right to terminate the Sanofi License Agreement for
 any reason, in which case the Termination Date will be July&amp;#xA0;4,
 2016. In the interest of an expedient transition, the Company is
 working with Sanofi to transfer and wind down the agreement
 activities by April&amp;#xA0;4, 2016, or as soon as practicable
 thereafter.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Under the
 Sanofi License Agreement, worldwide profits and losses, which are
 determined based on the difference between the net sales of AFREZZA
 and the costs and expenses incurred by the Company and Sanofi that
 are specifically attributable or related to the development,
 regulatory filings, manufacturing, or commercialization of AFREZZA,
 are shared 65% by Sanofi and 35% by the us. As a result of the loss
 share provision, and because the Company does not have the ability
 to estimate the amount of costs that would potentially be incurred
 related to the Sanofi License Agreement, the amount of up-front
 cash payment or milestone payments that could be recognized as
 revenue is not fixed or determinable. In connection with the Sanofi
 License Agreement, an affiliate of Sanofi provided the Company with
 a secured loan facility (the &amp;#x201C;Sanofi Loan Facility&amp;#x201D;) of
 up to $175.0 million to fund the Company&amp;#x2019;s share of net
 losses under the Sanofi License Agreement.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Additional
 funding sources that are, or in certain circumstances may be
 available to the Company, include approximately $30.1 million
 principal amount of available borrowings under The Mann Group Loan
 Arrangement. A portion of these available borrowings may be used to
 capitalize accrued interest into principal, upon mutual agreement
 of the parties, as it becomes due and payable under The Mann Group
 Loan Arrangement. (see note 7&amp;#xA0;&amp;#x2014;&amp;#xA0;Related-party
 arrangements). The Company cannot provide assurances that its plans
 will not change or that changed circumstances will not result in
 the depletion of its capital resources more rapidly than it
 currently anticipates. The Company will need to raise additional
 capital, whether through a sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means, in order to continue the development
 and commercialization of AFREZZA and other product candidates and
 to support its other ongoing activities. However, the Company
 cannot provide assurances that such additional capital will be
 available on acceptable terms or at all.&lt;/font&gt;&lt;/p&gt;


 &lt;/div&gt;</mnkd:BasisOfPresentationPolicyTextBlock>
  <mnkd:CommonAndPreferredStockTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_D5F78D7C-4E15-447E-A4A5-6D7D05706687_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;11. Common and preferred
 stock&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company is
 authorized to issue 550,000,000 shares of common stock, par value
 $0.01 per share, and 10,000,000 shares of undesignated preferred
 stock, par value $0.01 per share, issuable in one or more series
 designated by the Company&amp;#x2019;s board of directors. No other
 class of capital stock is authorized. As of December&amp;#xA0;31, 2015
 and 2014, 428,670,943 and 406,059,089 shares of common stock,
 respectively, were issued and outstanding and no shares of
 preferred stock were outstanding.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 November&amp;#xA0;9, 2015, the Company entered into a series of stock
 purchase agreements to sell up to an aggregate of 50,000,000 shares
 its common stock in a registered direct offering to selected
 investment funds in Israel that hold securities included within
 certain stock indexes of the Tel Aviv Stock Exchange (the
 &amp;#x201C;TASE&amp;#x201D;). Pursuant to the agreements, the shares of
 common stock were sold at a price per share equal to 97% of the
 closing price of the Company&amp;#x2019;s common stock on the TASE on
 November&amp;#xA0;12, 2015. During November 2015, the Company sold
 13,852,435 shares of common stock for an aggregate price of
 approximately $34,710,000, or $2.61 per share, which is net of
 $1,433,000 of issuance costs.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The Company
 engaged Sunrise Securities Corporation as its exclusive placement
 agent in connection with the offering of 50,000,000 shares. In
 connection with the services provided the Company issued to Sunrise
 Securities Corporation, or its designee, restricted warrants to
 purchase a number of shares of the Company&amp;#x2019;s common stock in
 an aggregate equal to 1.15% of the aggregate shares sold in the
 offering, which totaled 159,303 shares on November&amp;#xA0;16, 2015.
 The warrants are exercisable for a five year period at an exercise
 price of $2.61, the price paid per share in connection with the
 offering. The Company had an obligation to register the common
 stock that may be issued pursuant to the exercise of the warrants,
 which resulted in their initial classification as liability and
 were deemed immaterial. On December&amp;#xA0;15, 2015 the warrants were
 reclassified to equity as the Company registered the common stock
 pursuant to registration statement. As of December&amp;#xA0;31, 2015
 the warrants were classified within equity.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Included in the
 common stock outstanding as of December&amp;#xA0;31, 2014 is 9,000,000
 shares of common stock loaned to Bank of America under a share
 lending agreement in connection with the offering of the $100.0
 million aggregate principal amount of 2015 notes. Bank of America
 was obligated to return the borrowed shares (or, in certain
 circumstances, the cash value thereof) to the Company on or about
 the 45th business day following the date as of which the entire
 principal amount of the 2015 notes ceases to be outstanding,
 subject to extension or acceleration in certain circumstances or
 early termination at Bank of America&amp;#x2019;s option. On
 October&amp;#xA0;23, 2015, the 9,000,000 shares of common stock loaned
 to Bank of America were returned, as the Company settled all
 payments and deliveries in respect of such convertible notes on
 August&amp;#xA0;17, 2015. The Company did not receive any proceeds from
 the sale of the borrowed shares by Bank of America, but the Company
 did receive a nominal lending fee of $0.01 per share from Bank of
 America for the use of borrowed shares.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;On
 February&amp;#xA0;8, 2012, the Company sold 35,937,500 units in an
 underwritten public offering, including 4,687,500 units sold
 pursuant to the full exercise of an over-allotment option granted
 to the underwriters, with each unit consisting of one share of
 common stock and a warrant to purchase 0.6 of a share of common
 stock. All of the securities were offered by the Company at a
 combined price to the public of $2.40 per unit and the underwriters
 purchased the units at a price of $2.256 per unit. Net proceeds
 from this offering were approximately $80.6 million, excluding any
 warrant exercises. The 21,562,500 shares of common stock underlying
 the warrants are exercisable at $2.40 per share and expire four
 years from the date of the issuance.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;For the years
 ended December&amp;#xA0;31, 2015, 2014, and 2013, the Company received
 $10.1 million, $27.8 million, and $94.2 million in proceeds,
 respectively, from the exercise of the February 2012 public
 offering warrants. Any unexercised February 2012 public offering
 warrants expired on February&amp;#xA0;8, 2016.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:CommonAndPreferredStockTextBlock>
  <mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_E6865865-0960-4B46-A339-80DED60163AC_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Recently
 Issued Accounting Standards&lt;/i&gt; &amp;#x2014;&amp;#xA0;From time &lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;to time, new accounting
 pronouncements are issued by the Financial Accounting Standards
 Board (FASB) or other standard setting bodies that are adopted by
 the Company as of the specified effective date. Unless otherwise
 discussed, the Company believes that the impact of recently issued
 standards that are not yet effective will not have a material
 impact on the Company&amp;#x2019;s financial position or results of
 operations upon adoption.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In May 2014, the FASB
 issued ASU 2014-09 related to revenue recognition, which requires
 an entity to recognize the amount of revenue to which it expects to
 be entitled for the transfer of promised goods or services to
 customers. The guidance requires a company to recognize revenue to
 depict the transfer of goods or services to customers in an amount
 that reflects the consideration it expects to be entitled to
 receive in exchange for those goods or services. In July 2015, the
 FASB issued ASU 2015-14, which delayed the effective date of the
 new revenue standard by one year. The FASB also agreed to allow
 entities to choose to adopt the standard as of the original
 effective date. The standard is effective beginning the first
 quarter of the Company&amp;#x2019;s 2018 fiscal year and is required to
 be adopted using either a full retrospective or a modified
 retrospective approach. The Company is assessing the potential
 impact of the new standard on its consolidated financial statements
 and has not yet selected a transition method.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In August 2014, the FASB
 issued ASU 2014-15, which provides guidance on determining when and
 how reporting entities must disclose going-concern uncertainties in
 their financial statements. The new standard requires management to
 perform interim and annual assessments of an entity&amp;#x2019;s ability
 to continue as a going concern within one year of the date of
 issuance of the entity&amp;#x2019;s financial statements (or within one
 year after the date on which the financial statements are available
 to be issued, when applicable). Further, an entity must provide
 certain disclosures if there is &amp;#x201C;substantial doubt about the
 entity&amp;#x2019;s ability to continue as a going concern&amp;#x201D;. The
 ASU is effective for annual periods ending after December&amp;#xA0;15,
 2016, and interim periods thereafter; early adoption is permitted.
 The Company is evaluating the impact the adoption of ASU 2014-15
 will have on its consolidated financial
 statements.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In April 2015, the FASB
 issued ASU 2015-03, &amp;#x201C;Simplifying the Presentation of Debt
 Issuance Costs.&amp;#x201D; The guidance requires debt issuance costs to
 be presented in the balance sheet as a direct deduction from the
 carrying value of the associated debt, consistent with the
 presentation of a debt discount. The guidance is effective for
 annual reporting periods beginning after December&amp;#xA0;15, 2015 and
 interim periods thereafter. As permitted by the standard, the
 Company adopted the new presentation prospectively and the adoption
 did not have an impact on its consolidated financial statements and
 disclosures.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In July 2015, the FASB
 issued ASU 2015-11, Inventory (Topic 330): Simplifying the
 Measurement of Inventory. Topic 330, Inventory, currently requires
 an entity to measure inventory at the lower of cost or market.
 Market could be replacement cost, net realizable value, or net
 realizable value less an approximately normal profit margin. The
 amendments do not apply to inventory that is measured using
 last-in, first-out (LIFO) or the retail inventory method. The
 amendments apply to all other inventory, which includes inventory
 that is measured using first-in, first-out (FIFO) or average cost.
 The amendments are effective for fiscal years beginning after
 December&amp;#xA0;15, 2016, including interim periods within those
 fiscal years. The amendments should be applied prospectively with
 earlier application permitted as of the beginning of an interim or
 annual reporting period. The Company is evaluating the impact the
 adoption of ASU 2015-11 will have on its consolidated financial
 statements.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In November 2015, the
 FASB issued ASU No.&amp;#xA0;2015-17, Income Taxes (Topic 740): Balance
 Sheet Classification of Deferred Taxes. The new standard requires
 that deferred tax assets and liabilities be classified as
 noncurrent in a classified statement of financial position. For
 public business entities, the amendments in this Update are
 effective for financial statements issued for annual periods
 beginning after December&amp;#xA0;15, 2016, and interim periods within
 those annual periods. As permitted by the standard, the Company
 adopted the new presentation and the adoption did not have an
 impact on its consolidated financial statements and
 disclosures.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;font style="FONT-FAMILY: &apos;Times New Roman&apos;" size="2"&gt;In January 2016, the FASB
 issued ASU 2016-01, Financial Instruments&amp;#xA0;&amp;#x2014;&amp;#xA0;Overall
 (Subtopic 825-10): Recognition and Measurement of Financial Assets
 and Financial Liabilities. The update is intended to improve the
 recognition and measurement of financial instruments. The update
 are effective for fiscal years beginning after December&amp;#xA0;15,
 2017, including interim periods within those fiscal years. The
 Company is evaluating the impact the adoption of ASU 2016-01 will
 have on its consolidated financial statements.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock>
  <mnkd:LicenseCollaborationAndSupplyAgreementsPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_02D3E820-DF23-4940-965B-B70406912E2C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;License and
 Collaboration and Supply Agreements&lt;/i&gt; &amp;#x2014;&amp;#xA0;Pursuant to
 the Sanofi License Agreement and the Sanofi Supply Agreement, the
 Company granted to Sanofi exclusive, worldwide licenses to certain
 of the Company&amp;#x2019;s patents, trademarks and know-how for the
 development and commercialization of AFREZZA and retained the right
 to be the exclusive manufacturer and supplier of AFREZZA until
 specified conditions are met upon which a portion of the
 manufacturing activities may be assumed by Sanofi. The terms of the
 Sanofi License Agreement provide for consideration to the Company
 in the form of a non-refundable up-front payment, product sales,
 manufacturing, regulatory and sales milestone payments and profit
 and loss sharing.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
 analyzes consideration received under the provisions of ASC 605,
 Revenue Recognition, to determine whether the consideration, or a
 portion thereof, could be recognized as revenue. ASC 605 provides
 that revenue is recognized when there is persuasive evidence that
 an arrangement exists, delivery has occurred or services have been
 rendered, the price is fixed or determinable and collection is
 reasonably assured.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In arrangements
 involving the delivery of more than one element, each required
 deliverable is evaluated to determine whether it qualifies as a
 separate unit of accounting. This determination is generally based
 on whether the deliverable has &amp;#x201C;stand-alone value&amp;#x201D; to
 the customer. The arrangement&amp;#x2019;s consideration that is fixed
 and determinable is then allocated to each separate unit of
 accounting based on the relative selling price of each deliverable.
 The estimated selling price of each deliverable is determined using
 the following hierarchy of values: (i)&amp;#xA0;vendor-specific
 objective evidence of fair value, (ii)&amp;#xA0;third-party evidence of
 selling price and (iii)&amp;#xA0;best estimate of selling price (BESP).
 The BESP reflects the Company&amp;#x2019;s best estimate of what the
 selling price would be if the deliverable was regularly sold by the
 Company on a stand-alone basis. In general, the consideration
 allocated to each unit of accounting is recognized as the related
 goods or services are delivered, limited to the consideration that
 is not contingent upon future deliverables.&lt;/font&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The assessment
 of multiple element arrangements requires judgment in order to
 determine the appropriate units of accounting and the points in
 time that, or periods over which, revenue should be recognized.
 Given that, as of December&amp;#xA0;31, 2015, the Company did not have
 the ability to estimate the amount of costs that would potentially
 be incurred under the loss share provision related to the Sanofi
 License Agreement and the Sanofi Supply Agreement, the Company
 believe the fixed and determinable fee requirement for revenue
 recognition was not met.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:LicenseCollaborationAndSupplyAgreementsPolicyTextBlock>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900040">169000</mnkd:AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion>
  <mnkd:DeferredTaxAssetIncreaseDecreaseInEquity contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_75CEB52C-9F99-4BC9-A879-1F3B8EF1C282_1_0">10000000</mnkd:DeferredTaxAssetIncreaseDecreaseInEquity>
  <mnkd:StateResearchAndDevelopmentCreditExchangeReceivableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_E847F0E0-95FA-452C-A5F8-509ED0230706_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&lt;b&gt;3. State research and
 development credit exchange receivable&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
 &lt;p style="margin-top:6px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;The State of
 Connecticut provides certain companies with the opportunity to
 exchange certain research and development income tax credit
 carryforwards for cash in exchange for forgoing the carryforward of
 the research and development income tax credits. The program
 provides for an exchange of research and development income tax
 credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses. During the years ended December&amp;#xA0;31, 2015, 2014 and
 2013, research and development expenses were offset by $743,000,
 $816,000, and $282,000, respectively.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:StateResearchAndDevelopmentCreditExchangeReceivableTextBlock>
  <mnkd:BusinessPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_CB91BCA3-EF17-43C0-BA80-1AFC972C53BB_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Business&lt;/i&gt;
 &amp;#x2014;&amp;#xA0;MannKind Corporation and subsidiaries (the
 &amp;#x201C;Company&amp;#x201D;) is a biopharmaceutical company focused on
 the discovery and development of therapeutic products for diseases
 such as diabetes. The Company&amp;#x2019;s only approved product,
 AFREZZA, (insulin human [rDNA origin]) inhalation powder, is a
 rapid-acting inhaled insulin that was approved by the U.S. Food and
 Drug Administration (the &amp;#x201C;FDA&amp;#x201D;) on June&amp;#xA0;27, 2014
 to improve glycemic control in adult patients with
 diabetes.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:BusinessPolicyTextBlock>
  <mnkd:ValueOfRestrictedStockUnitsVested contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_36B6251D-02A1-4EC4-9418-D7648316ECD9_1_2">2400000</mnkd:ValueOfRestrictedStockUnitsVested>
  <mnkd:LongtermPurchaseCommitmentRenewalTimePeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_AD643D18-3315-4957-8984-E9E3E3D65458_1_1">P2Y</mnkd:LongtermPurchaseCommitmentRenewalTimePeriod>
  <mnkd:LongTermPurchaseCommitmentExpirationDate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_AD643D18-3315-4957-8984-E9E3E3D65458_1_0">2019-12-31</mnkd:LongTermPurchaseCommitmentExpirationDate>
  <mnkd:StockOptionsGrantedVestingRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="2" id="id_7647232_10D0B3DB-E4FC-4A56-AD34-FE762072EB6E_1_0">0.25</mnkd:StockOptionsGrantedVestingRate>
  <mnkd:ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_3646DF0E-8769-435C-8ADC-2A57FFB5492A_1_0">&lt;div&gt;
 &lt;p style="margin-top:12px;margin-bottom:0px; text-indent:2%"&gt;
 &lt;font style="font-family:Times New Roman" size="2"&gt;Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is included in the following categories
 (in thousands):&lt;/font&gt;&lt;/p&gt;
 &lt;p style="font-size:6px;margin-top:0px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;Year Ended
 December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"&gt;&lt;font style="font-family:Times New Roman" size="1"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Research and
 development&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;3,029&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;22,357&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;20,409&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;General and
 administrative&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;5,696&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;26,265&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;24,777&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:1px solid #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-left:1.00em; text-indent:-1.00em"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;8,725&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;48,622&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;45,186&lt;/font&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;font style="font-family:Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="border-top:3px double #000000"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mnkd:ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock>
  <mnkd:ClassOfWarrantsOrRightsExpirationDate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_57C623CF-607D-4C01-BB10-20D639167D49_1_1">2016-02-08</mnkd:ClassOfWarrantsOrRightsExpirationDate>
  <mnkd:MaturityPeriodOfCashEquivalents contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_4A266A62-84FB-432E-A19F-C78B78F62684_1_0">90 days or less at the time of  purchase</mnkd:MaturityPeriodOfCashEquivalents>
  <mnkd:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5A809740-8CF4-42E7-8246-EF40646528F5_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Prepaid
 expenses and other current assets &amp;#x2014;&lt;/i&gt; Prepaid expenses and
 other current assets primarily consist of prepaid expenses for
 goods and services to be received. As of December&amp;#xA0;31, 2015,
 prepaid and other current assets had a balance of $4.0 million,
 mainly comprised of prepaid insurance. As of December&amp;#xA0;31, 2014
 prepaid and other current assets had a balance of $20.2 million,
 mainly comprised of a $15.0 million prepayment for 2015 quantities
 of insulin, and prepaid insurance.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock>
  <mnkd:IncomeTaxExpenseBenefitNet contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_3BD51F08-7314-4082-8064-6664B375AC01_1_11">0</mnkd:IncomeTaxExpenseBenefitNet>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9006_900034">10123000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:WarrantsPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_5DD60EA0-C2E9-4E67-9A57-A8C168775476_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Warrants&lt;/i&gt;
 &amp;#x2014;&amp;#xA0;The Company has issued warrants to purchase shares of
 its common stock. Warrants have been accounted for within equity in
 accordance with the provisions of ASC 815-40, Contracts in an
 Entity&amp;#x2019;s Own Stock, previously EITF Issue No. 00-19:
 &lt;i&gt;Accounting for Derivative Financial Instruments Indexed to, and
 Potentially Settled in, a Company&amp;#x2019;s Own Stock&lt;/i&gt;.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:WarrantsPolicyTextBlock>
  <mnkd:PercentageOfCreditExchangeReceivable contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="pure" decimals="2" id="id_7647232_7817BA5D-9585-4B82-91BA-6540E97D360C_1_0">0.65</mnkd:PercentageOfCreditExchangeReceivable>
  <mnkd:ClinicalTrialExpensePolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_3C9A00A0-3EE8-46CA-9AA9-7EB1702BBC84_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Clinical
 Trial Expenses&lt;/i&gt; &amp;#x2014;&amp;#xA0;Clinical trial expenses, which are
 reflected in research and development expenses in the accompanying
 statements of operations, result from obligations under contracts
 with vendors, consultants, and clinical site agreements in
 connection with conducting clinical trials. The financial terms of
 these contracts are subject to negotiations which vary from
 contract to contract and may result in payment flows that do not
 match the periods over which materials or services are provided to
 the Company under such contracts. The appropriate level of trial
 expenses are reflected in the Company&amp;#x2019;s financial statements
 by matching period expenses with period services and efforts
 expended. These expenses are recorded according to the progress of
 the trial as measured by patient progression and the timing of
 various aspects of the trial. Clinical trial accrual estimates are
 determined through discussions with internal clinical personnel and
 outside service providers as to the progress or state of completion
 of trials, or the services completed. Service provider status is
 then compared to the contractually obligated fee to be paid for
 such services. During the course of a clinical trial, the Company
 may adjust the rate of clinical expense recognized if actual
 results differ from management&amp;#x2019;s estimates.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:ClinicalTrialExpensePolicyTextBlock>
  <mnkd:AmortizationPeriodOfLeaseHoldImprovements contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_894E9241-3662-4FD2-99AC-42ACD6DD845E_1_0">P4Y</mnkd:AmortizationPeriodOfLeaseHoldImprovements>
  <mnkd:SaleOfIntellectualPropertyPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_458D9080-06B6-488F-9995-A86A737CED9F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Sale of
 intellectual property&lt;/i&gt; &amp;#x2014;&amp;#xA0;On July&amp;#xA0;18, 2014, the
 Company entered into an assignment agreement with a third party
 whereby the third party acquired all proprietary rights, technology
 and know-how that related to a small molecule inhibitor compound
 and all pre-clinical data and results related thereto. Under the
 terms of the assignment agreement, the Company received total
 consideration of $9.3 million and accrued $1.4 million in expense
 for a net amount of $7.9 million recorded as other income. In 2015,
 the Company recorded other income of $1.4 million related to the
 relief of the $1.4 million accrual for expenses associated with the
 sale of intellectual property related to oncology in 2014, which
 was subsequently resolved without payment.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:SaleOfIntellectualPropertyPolicyTextBlock>
  <mnkd:LongTermPurchaseCommitmentCancellationFees contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-5" id="id_7647232_9901C78E-6214-4971-BE9B-58177FBF9D5E_3_6">5200000</mnkd:LongTermPurchaseCommitmentCancellationFees>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_30">4146000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <mnkd:MilestonePayments contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_1_40">4219000</mnkd:MilestonePayments>
  <mnkd:PaymentsForUseOfAircrafts contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="0" id="id_7647232_2A97455F-7AEE-4453-8872-AE1FCDE3B2C9_1_0">18000</mnkd:PaymentsForUseOfAircrafts>
  <mnkd:NumberOfAssetGroups contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="asset_group" decimals="INF" id="id_7647232_BE1FE81A-63F2-4CD3-A7AF-3A3073DB7EE3_1_0">2</mnkd:NumberOfAssetGroups>
  <mnkd:ClassOfWarrantExercisablePeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_B0E8BF2F-4B0C-4DF2-8543-BD66579347BA_2_3">P5Y</mnkd:ClassOfWarrantExercisablePeriod>
  <mnkd:DeferredProductCostsFromCollaborationPolicyTextBlock contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" id="id_7647232_4571A844-CC84-441B-84F0-8AC895E9FA9B_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%"&gt;
 &lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Deferred
 product costs from collaboration&lt;/i&gt; &amp;#x2014; Deferred product costs
 represent the costs of product manufactured and sold to Sanofi, as
 long as they are not greater than the amount of deferred product
 sales related to the collaboration, for which recognition of
 revenue has been deferred. Given that the costs of inventory
 delivered to a customer, but for which revenue may not yet be
 recognized, meet both the definition and characteristics of an
 &amp;#x201C;asset&amp;#x201D; and the Company believes that it is probable
 that the amount of future revenue will exceed the amount of
 deferred costs (i.e., the asset would be realizable through the
 recognition of probable future income), the Company has elected to
 account for the deferred costs related to the product sold to
 Sanofi as an asset and carry forward to future periods until the
 related revenue is recognized.&lt;/font&gt;&lt;/p&gt;
 &lt;/div&gt;</mnkd:DeferredProductCostsFromCollaborationPolicyTextBlock>
  <mnkd:GainLossOnPurchaseCommitments contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_F464F829-0087-4969-B2B7-C300DCCE65BF_1_6">-66167000</mnkd:GainLossOnPurchaseCommitments>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1104490x1105469" id="id_7647232_10D0B3DB-E4FC-4A56-AD34-FE762072EB6E_1001_3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1104490x1107650" id="id_7647232_10D0B3DB-E4FC-4A56-AD34-FE762072EB6E_2001_2">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1106131x1110946_1109893x1109150" unitRef="iso4217_USD" decimals="-3" id="id_7647232_61ACCBCA-CAFC-43C0-ABC2-D479C156EFAE_1001_0">1600000</us-gaap:ShareBasedCompensation>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1106131x1261992" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA3C09E1-92B1-45CA-B3D2-D9E9943F4735_1001_0">8407000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1106131x1281716" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA3C09E1-92B1-45CA-B3D2-D9E9943F4735_2001_1">318000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107053x1241281_1108976x1113560_1109902x1105152" unitRef="pure" decimals="3" id="id_7647232_BBDAD79A-618D-4C97-A45F-3F9F9D639748_1002_0">0.150</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107455x1112342_1108976x1105702_1109902x1105152_1110347x1169090" unitRef="pure" decimals="2" id="id_7647232_3A970087-DEDA-42DD-81E9-442ACAA41D33_1001_0">0.55</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107455x1112342_1108976x1105702_1109902x1105152_1110347x1248697" unitRef="pure" decimals="2" id="id_7647232_287BEABA-9F58-4397-8CA1-DCC1C897587B_1001_0">0.20</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107455x1112342_1108976x1105702_1109902x1105152_1110347x1248697" unitRef="pure" decimals="2" id="id_7647232_287BEABA-9F58-4397-8CA1-DCC1C897587B_1001_1">0.90</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_400047">269000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_400046">8940000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_400036">1874000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_400031">720000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_400030">1701000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_500045">89000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_500047">3000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_500037">19000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_500030">17000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_500031">7000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <mnkd:StockIssuedDuringPeriodSharesShareLendingAgreement contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_400038">39000</mnkd:StockIssuedDuringPeriodSharesShareLendingAgreement>
  <mnkd:StockIssuedDuringPeriodSharesWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_400033">4216000</mnkd:StockIssuedDuringPeriodSharesWarrantExercises>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_500034">42000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9001_500043">-90000</mnkd:CommonStockLoanedUnderShareLendingAgreementValue>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034_1114584x1104394" unitRef="shares" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_10001_400042">13853000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034_1114584x1104394" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_10001_500041">139000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PartnersCapitalAccountContributions contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600035">40000</us-gaap:PartnersCapitalAccountContributions>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600045">27754000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600050">8725000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600047">884000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600048">-202000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600032">-1856000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600037">7907000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600030">3241000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600031">-7000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <mnkd:StockIssuedDuringPeriodValueShareLendingAgreement contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600039">160000</mnkd:StockIssuedDuringPeriodValueShareLendingAgreement>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600049">108000</mnkd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity>
  <mnkd:AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600040">169000</mnkd:AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion>
  <mnkd:StockIssuedDuringPeriodValueWarrantExercises contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600034">10081000</mnkd:StockIssuedDuringPeriodValueWarrantExercises>
  <mnkd:CommonStockLoanedUnderShareLendingAgreementValue contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9003_600043">90000</mnkd:CommonStockLoanedUnderShareLendingAgreementValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784_1114584x1104394" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_10003_600041">34571000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1113367" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9004_700051">-6000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1283011" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_9005_800052">-368445000</us-gaap:NetIncomeLoss>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1109324_1115253x1107704" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_1001_0">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1109324_1115253x1116460" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_2001_1">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1110462_1115253x1107704" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_3001_4">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1110462_1115253x1116460" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_4001_5">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1111159" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_5001_9">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1114693_1115253x1107704" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_6001_2">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1114693_1115253x1116460" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_7001_3">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1173496" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_8001_8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1254910_1115253x1107704" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_9001_6">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1254910_1115253x1116460" id="id_7647232_E6316660-BF67-44B5-83AD-2A5BBACFF415_10001_7">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1108976x1113560_1109902x1105152_1110347x1158750" unitRef="pure" decimals="3" id="id_7647232_4285937E-7C34-451E-9144-E0B0146F01EF_1001_0">0.120</us-gaap:FairValueInputsDiscountRate>
  <mnkd:LossSharingAgreementAmount contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1109456x1153470_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_CDBBCA0A-791D-40C1-A26D-C7649DA3F0D4_2002_3">60700000</mnkd:LossSharingAgreementAmount>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1109902x1105152_1112725x1155283_1116223x1282107" unitRef="pure" decimals="2" id="id_7647232_DDAB076B-1137-4173-B663-A4FE434BADBE_1001_3">0.11</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1110296x1116207" unitRef="pure" decimals="2" id="id_7647232_10D0B3DB-E4FC-4A56-AD34-FE762072EB6E_3001_1">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
  <us-gaap:DebtInstrumentRedemptionDescription contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1110347x1248697" id="id_7647232_41704A3D-CC5C-496B-A7EF-19908F83A97A_1002_0">On or after the date that is one year following the original issue date of the 2018 notes, the Company will have the right to redeem for cash all or part of the 2018 notes if the last reported sale price of its common stock exceeds 130% of the conversion price then in effect for 20 or more trading days during the 30 consecutive trading day period ending on the trading day immediately prior to the date of the redemption notice. The redemption price will equal the sum of 100% of the principal amount of the 2018 notes to be redeemed, plus accrued and unpaid interest.</us-gaap:DebtInstrumentRedemptionDescription>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1110347x1248697" id="id_7647232_AE237F37-9CCF-44E5-BB33-5FCD8AAF1398_1001_0">2018-08-15</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1110347x1248697" unitRef="iso4217_USD" decimals="-3" id="id_7647232_B24F39A9-FAFD-4C60-8C19-527E87CC9867_1001_1">86000000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1111076x1227250" unitRef="iso4217_USD" decimals="-5" id="id_7647232_BE1FE81A-63F2-4CD3-A7AF-3A3073DB7EE3_1001_1">1800000</us-gaap:AssetImpairmentCharges>
  <mnkd:AvailableLoanBalanceCancelled contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1145423" unitRef="iso4217_USD" decimals="-5" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_1001_6">105000000</mnkd:AvailableLoanBalanceCancelled>
  <mnkd:RelatedPartyTransactionPrepaymentPeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1145423" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_1001_5">P90D</mnkd:RelatedPartyTransactionPrepaymentPeriod>
  <mnkd:NumberOfMonthsAdvancesOutstanding contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1145423_1115253x1107704" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_2001_4">P12M</mnkd:NumberOfMonthsAdvancesOutstanding>
  <mnkd:RelatedPartyTransactionDebtInstrumentPrepayment contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1145423_1115253x1116460" unitRef="iso4217_USD" decimals="INF" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_3001_3">200000000</mnkd:RelatedPartyTransactionDebtInstrumentPrepayment>
  <us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1166445" id="id_7647232_315053C7-B724-4F7B-BD44-8B97C2A1EB34_2003_1">2020-01-05</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1157540_1112725x1277729" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_4001_8">The interest rate will increase to the one-year LIBOR rate  calculated on the date of the initial advance or in effect on the date of  default, whichever is greater, plus 5% per annum.</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1157540_1112725x1277729_1115193x1106038" unitRef="pure" decimals="2" id="id_7647232_ADB5CBB8-BAD7-41B8-BAAE-3B70966D2317_5001_7">0.05</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112578x1105469" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_1001_3">1804620</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112578x1107650" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_2001_0">19779229</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112578x1108838" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_3001_2">4074596</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112578x1112342" unitRef="shares" decimals="INF" id="id_7647232_E356A037-DA56-437D-9E70-A7B128B50214_4001_1">4072809</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:PaidInKindInterest contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-3" id="id_7647232_CDBBCA0A-791D-40C1-A26D-C7649DA3F0D4_3002_2">1700000</us-gaap:PaidInKindInterest>
  <us-gaap:ProceedsFromRelatedPartyDebt contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_CDBBCA0A-791D-40C1-A26D-C7649DA3F0D4_3002_4">44500000</us-gaap:ProceedsFromRelatedPartyDebt>
  <mnkd:ProfitLossSharingAgreementAllocationPercentage contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1155283_1116223x1282107" unitRef="pure" decimals="2" id="id_7647232_AFE1AAEC-8861-42E6-B6C7-991F66FE7E2F_1001_0">0.65</mnkd:ProfitLossSharingAgreementAllocationPercentage>
  <mnkd:UpfrontFee contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_357A4AEC-6986-40A9-897B-BB5CA27CFE58_1001_1">150000000</mnkd:UpfrontFee>
  <mnkd:LossSharingAgreementAmount contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1155283_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_AF1A1253-4A7B-4ACB-84DD-77CC58BE205F_1001_4">57700000</mnkd:LossSharingAgreementAmount>
  <mnkd:LeaseExpirationMonthYear contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1320039_1226349x1285790" id="id_7647232_D662AAE3-C230-4574-9FCF-A70E22E6DBB2_1002_1">2017-04</mnkd:LeaseExpirationMonthYear>
  <mnkd:OfficeLeaseExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1320039_1226349x1285790" unitRef="iso4217_USD" decimals="0" id="id_7647232_D662AAE3-C230-4574-9FCF-A70E22E6DBB2_1002_2">175000</mnkd:OfficeLeaseExpense>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1321372" unitRef="iso4217_USD" decimals="-3" id="id_7647232_7E179F7E-048A-4058-869E-B93D4C211517_1001_0">138600000</us-gaap:AssetImpairmentCharges>
  <mnkd:ResearchAndDevelopmentCreditsBeginToExpire contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112759x1107054" id="id_7647232_6C767FFD-4FA1-480E-B80C-7298B1DA268B_1001_7">2024</mnkd:ResearchAndDevelopmentCreditsBeginToExpire>
  <mnkd:NetOperatingLossCarryforwardsBeginsToExpire contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1112759x1107054" id="id_7647232_6C767FFD-4FA1-480E-B80C-7298B1DA268B_1001_2">2018</mnkd:NetOperatingLossCarryforwardsBeginsToExpire>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1113993x1105782" unitRef="iso4217_USD" decimals="-3" id="id_7647232_36E2F33F-1DF4-4416-959D-8AED615E10A8_1001_1">5696000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:RestructuringCharges contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1113993x1105782" unitRef="iso4217_USD" decimals="-5" id="id_7647232_0EBD66F7-0C17-4890-B84A-EC80D9AC7037_1001_1">2900000</us-gaap:RestructuringCharges>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1113993x1109593" unitRef="iso4217_USD" decimals="-3" id="id_7647232_36E2F33F-1DF4-4416-959D-8AED615E10A8_2001_0">3029000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:RestructuringCharges contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1113993x1109593" unitRef="iso4217_USD" decimals="-6" id="id_7647232_0EBD66F7-0C17-4890-B84A-EC80D9AC7037_2001_0">3000000</us-gaap:RestructuringCharges>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1114584x1104394" unitRef="iso4217_USD" decimals="-3" id="id_7647232_07379C4B-D55A-4521-9A13-52BB7CDB7D78_10006_900041">34710000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1114584x1104394" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2001_32">1432000</us-gaap:PaymentsOfStockIssuanceCosts>
  <mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1114584x1104394" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_2001_31">36142000</mnkd:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1114897x1106387" unitRef="iso4217_USD" decimals="-5" id="id_7647232_243BFD1B-06B4-4FF9-93F7-184E99B19EE1_1002_3">1400000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1115253x1107704" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_1001_2">P5Y9M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1115253x1116460" id="id_7647232_F7AECBB6-E239-4B18-A783-B15D435F9B87_2001_3">P5Y10M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1115253x1116460" id="id_7647232_10D0B3DB-E4FC-4A56-AD34-FE762072EB6E_4001_5">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <mnkd:ProfitLossSharingAgreementAllocationPercentage contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116223x1282107" unitRef="pure" decimals="2" id="id_7647232_AFE1AAEC-8861-42E6-B6C7-991F66FE7E2F_2001_1">0.35</mnkd:ProfitLossSharingAgreementAllocationPercentage>
  <us-gaap:RepaymentsOfSeniorDebt contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116613x1199471" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_3001_34">64287000</us-gaap:RepaymentsOfSeniorDebt>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116613x1199471" unitRef="iso4217_USD" decimals="-5" id="id_7647232_35F1500F-12AE-4CBF-9586-43783D6E365A_1001_0">600000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116613x1318041" unitRef="iso4217_USD" decimals="-3" id="id_7647232_60FBD36D-B99F-4E99-9D32-50FA6AD0774C_5001_35">831000</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116613x1318041" unitRef="iso4217_USD" decimals="-3" id="id_7647232_B24F39A9-FAFD-4C60-8C19-527E87CC9867_2001_0">93000000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:DebtInstrumentDateOfFirstRequiredPayment1 contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116663x1271799" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_1001_4">2016-07-01</us-gaap:DebtInstrumentDateOfFirstRequiredPayment1>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116663x1271799" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA06E7FA-611D-49E1-BBEE-A99EF2CBCE4C_1001_1">1553000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116663x1271799" unitRef="iso4217_USD" decimals="-3" id="id_7647232_DA06E7FA-611D-49E1-BBEE-A99EF2CBCE4C_1001_0">35000</us-gaap:AmortizationOfFinancingCosts>
  <mnkd:DebtInstrumentDateOfLastRequiredPayment contextRef="eol_PE126000--1510-K0015_STD_365_20151231_0_1116663x1271799" id="id_7647232_31FCDCC9-27D7-433D-8E69-A4190199103B_1001_5">2019-12-09</mnkd:DebtInstrumentDateOfLastRequiredPayment>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_1_1">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_1_0">-52056000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_90_20140331_0" unitRef="shares" decimals="-3" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_1_2">368784000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_90_20150331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_1_1">-0.08</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_1_0">-30658000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_90_20150331_0" unitRef="shares" decimals="-3" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_1_2">398916000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:InterestExpenseDebt contextRef="eol_PE126000--1510-K0015_STD_90_20150331_0_1107053x1241281_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E37A9CA3-36FF-4B03-8054-5F8D98A53EAB_2003_3">5800000</us-gaap:InterestExpenseDebt>
  <mnkd:PaymentForContingentLiabilities contextRef="eol_PE126000--1510-K0015_STD_90_20150331_0_1107053x1241281_1110347x1158750_1116663x1271799" unitRef="iso4217_USD" decimals="-5" id="id_7647232_E37A9CA3-36FF-4B03-8054-5F8D98A53EAB_2003_4">10000000</mnkd:PaymentForContingentLiabilities>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_91_20140630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_2_1">-0.19</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_91_20140630_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_2_0">-73365000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_91_20140630_0" unitRef="shares" decimals="-3" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_2_2">380770000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_91_20150630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_2_1">-0.07</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_91_20150630_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_2_0">-28910000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_91_20150630_0" unitRef="shares" decimals="-3" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_2_2">401018000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_92_20140930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_3_1">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_92_20140930_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_3_0">-36520000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_92_20140930_0" unitRef="shares" decimals="-3" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_3_2">394163000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <mnkd:UpfrontFee contextRef="eol_PE126000--1510-K0015_STD_92_20140930_0_1116223x1282107" unitRef="iso4217_USD" decimals="-5" id="id_7647232_FFEA17B5-148B-453D-81DA-D0F173C4ED9C_2001_0">150000000</mnkd:UpfrontFee>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_92_20150930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_3_1">-0.08</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_92_20150930_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_3_0">-31857000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_92_20150930_0" unitRef="shares" decimals="-3" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_3_2">405199000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_92_20141231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_4_1">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_92_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_4_0">-36439000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_92_20141231_0" unitRef="shares" decimals="-3" id="id_7647232_26227BFB-E9EF-468C-A09B-D77EAA63D397_4_2">396793000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE126000--1510-K0015_STD_92_20151231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_4_1">-0.66</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:NetIncomeLoss contextRef="eol_PE126000--1510-K0015_STD_92_20151231_0" unitRef="iso4217_USD" decimals="-3" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_4_0">-277020000</us-gaap:NetIncomeLoss>
  <mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding contextRef="eol_PE126000--1510-K0015_STD_92_20151231_0" unitRef="shares" decimals="-3" id="id_7647232_D0C6E632-F138-4B59-A58C-E4B810C80FB0_4_2">419314000</mnkd:BasicAndDilutedWeightedAverageNumberOfSharesOutstanding>
  <context id="eol_PE126000--1510-K0015_STD_92_20151231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2015-10-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_92_20141231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-10-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_92_20150930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2015-07-01</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_92_20140930_0_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_92_20140930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-07-01</startDate>
      <endDate>2014-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_91_20150630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2015-04-01</startDate>
      <endDate>2015-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_91_20140630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-04-01</startDate>
      <endDate>2014-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_90_20150331_0_1107053x1241281_1110347x1158750_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_90_20150331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_90_20140331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1116613x1318041">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandEighteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1116613x1199471">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandFifteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1115253x1107704">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1114897x1106387">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1114584x1104394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XTAE</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1113993x1109593">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1113993x1105782">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1112759x1107054">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1321372">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:DanburyFacilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1320039_1226349x1285790">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:LeaseAgreementTypeOfAgreementAxis">mnkd:SubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AlfredMannFoundationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1112725x1155283_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1112578x1112342">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1112578x1108838">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1112578x1107650">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1112578x1105469">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1157540_1112725x1277729_1115193x1106038">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LetterOfAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1157540_1112725x1277729">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LetterOfAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyDebtMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1166445">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AmendedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1145423_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1145423_1115253x1107704">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1111765x1113433_1112725x1145423">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1111076x1227250">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mnkd:ValenciaMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1110347x1248697">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandEighteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1110296x1116207">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1109902x1105152_1112725x1155283_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1109456x1153470_1112725x1155283_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseAxis">mnkd:OperatingLossSharingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1108976x1113560_1109902x1105152_1110347x1158750">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1254910_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1254910_1115253x1107704">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1173496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1114693_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1114693_1115253x1107704">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1111159">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1110462_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1110462_1115253x1107704">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1109324_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107911x1109324_1115253x1107704">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1283011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1113367">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784_1114584x1104394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XTAE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1108784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034_1114584x1104394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XTAE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107486x1105034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107455x1112342_1108976x1105702_1109902x1105152_1110347x1248697">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandEighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107455x1112342_1108976x1105702_1109902x1105152_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1107053x1241281_1108976x1113560_1109902x1105152">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1106131x1281716">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1106131x1261992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1106131x1110946_1109893x1109150">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ExecutiveOfficerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1104490x1107650">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0_1104490x1105469">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20151231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1116613x1199471">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandFifteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1116223x1282107_1150195x1230904">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:MilestoneEventsAxis">mnkd:ManufacturingMilestoneEventsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1115253x1107704">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1113993x1109593">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1113993x1105782">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1112725x1320039_1226349x1285790">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:LeaseAgreementTypeOfAgreementAxis">mnkd:SubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AlfredMannFoundationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1112578x1112342">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1112578x1108838">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1112578x1107650">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1112578x1105469">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1283011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1113367">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1108784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1107486x1105034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1107053x1241281_1110347x1158750_1112725x1155283_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1107053x1234768">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0_1106131x1261992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20141231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1116613x1262418">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandThirteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1116613x1199471">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandFifteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1115253x1107704">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1113993x1109593">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1113993x1105782">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1112725x1320039_1226349x1285790">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:LeaseAgreementTypeOfAgreementAxis">mnkd:SubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AlfredMannFoundationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1112578x1112342">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1112578x1108838">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1112578x1107650">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1112578x1105469">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1283011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1113367">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1108784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1107486x1105034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1106131x1281716">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0_1106131x1261992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_365_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_32_20151101_0_1114584x1104394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XTAE</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-10-01</startDate>
      <endDate>2015-11-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_31_20131031_0_1111765x1113433">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_31_20071031_0_1111765x1113433">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2007-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_31_20040831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2004-08-01</startDate>
      <endDate>2004-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_31_20040331_0_1115253x1116460">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_31_20040331_0_1105927x1187350">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_31_20040331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2004-03-01</startDate>
      <endDate>2004-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_13_20150810_0_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-07-29</startDate>
      <endDate>2015-08-10</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20160104_0_1106880x1108681_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2016-01-04</startDate>
      <endDate>2016-01-04</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20151231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2015-12-31</startDate>
      <endDate>2015-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20150930_0_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-09-30</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20150930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2015-09-30</startDate>
      <endDate>2015-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20150810_0_1110347x1248697">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandEighteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-08-10</startDate>
      <endDate>2015-08-10</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20150728_0_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-07-28</startDate>
      <endDate>2015-07-28</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20140731_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2014-07-31</startDate>
      <endDate>2014-07-31</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20140718_0_1114897x1106387">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-07-18</startDate>
      <endDate>2014-07-18</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20130701_0_1107053x1241281_1110347x1158750_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-07-01</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20160210_0_1106880x1108681_1112725x1155283_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2016-02-10</startDate>
      <endDate>2016-02-10</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20151116_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2015-11-16</startDate>
      <endDate>2015-11-16</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20151109_0_1114584x1104394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XTAE</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-11-09</startDate>
      <endDate>2015-11-09</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20150817_0_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-08-17</startDate>
      <endDate>2015-08-17</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20140811_0_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-08-11</startDate>
      <endDate>2014-08-11</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20140811_0_1112725x1155283_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-08-11</startDate>
      <endDate>2014-08-11</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20120208_0_1116897x1213796">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:WarrantLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-02-08</startDate>
      <endDate>2012-02-08</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20120208_0_1111765x1254496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:RelatedPartyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-02-08</startDate>
      <endDate>2012-02-08</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20120208_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <startDate>2012-02-08</startDate>
      <endDate>2012-02-08</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_1_20100818_0_1110347x1248697">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandEighteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-08-18</startDate>
      <endDate>2010-08-18</endDate>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1173463x1281716">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:StockAwardPlanTypeAxis">mnkd:ConsultantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1112759x1108964">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1112759x1107054">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1112725x1155283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1111765x1113433_1112725x1145423">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:PrincipalOwnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1248697">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandEighteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1197584">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:FacilityFinancingObligationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1158750_1116663x1271799_1156564x1281090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnkd:AgreementsAxis">mnkd:FacilityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1110347x1158750_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1109902x1105152">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1109648x1111362_1112725x1155283_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1108100x1114560">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1254910">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1173496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1116033">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1114693">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1110462">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1109324">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107911x1108622">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107576x1111055_1112725x1155283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1283011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1113367">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1108784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107486x1105034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107455x1112342_1110347x1248697">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandEighteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1241281_1110347x1158750_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1241281_1110347x1158750_1112725x1321372_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:DanburyFacilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1241281_1109902x1105152">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1234768_1110347x1158750_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1107053x1234768_1110347x1158750_1115253x1107704_1116663x1271799_1156564x1281090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnkd:AgreementsAxis">mnkd:FacilityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1246246">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1187350">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1180376">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1105927x1142515">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1104490x1115311">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1104490x1109005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0_1104490x1107650">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1112725x1155283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:SanofiAventisMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1197584">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:FacilityFinancingObligationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1110347x1158750_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1254910">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1173496">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1116033">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1114693">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1111159">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1110462">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1109324">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107911x1108622">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1283011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1113367">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1108784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107486x1105034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107455x1112342_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0_1107053x1234768_1110347x1158750_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:TrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20141231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1283011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1113367">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1108784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20131231_0_1107486x1105034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1283011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mnkd:DeficitAccumulatedDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1113367">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1108784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20121231_0_1107486x1105034">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151101_0_1114584x1104394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XTAE</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-11-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151023_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2015-10-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20150930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2015-09-30</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20150630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2015-06-30</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20140923_0_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-09-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20040831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2004-08-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20150810_0_1110347x1248697">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandEighteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-08-10</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20150810_0_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-08-10</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20150531_0_1112725x1320039_1226349x1285790">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:LeaseAgreementTypeOfAgreementAxis">mnkd:SubleaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:AlfredMannFoundationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-05-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20140718_0_1114897x1106387">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-07-18</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20130701_0_1107053x1241281_1115253x1116460_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20130701_0_1107053x1241281_1110347x1158750_1116663x1271799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:TwoThousandNineteenNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-07-01</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20040331_0_1105927x1187350">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-03-31</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20160222_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2016-02-22</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151116_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2015-11-16</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20151109_0_1114584x1104394">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XTAE</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-11-09</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20150814_0_1110347x1169090">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:SeniorConvertibleNotesDueTwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-08-14</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20140811_0_1116223x1282107_1150195x1231223">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:MilestoneEventsAxis">mnkd:FilingAndCompletionOfRegulatoryApprovalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-08-11</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20140811_0_1116223x1282107_1150195x1178830">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:MilestoneEventsAxis">mnkd:DevelopmentMilestoneEventsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-08-11</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20140811_0_1116223x1282107_1150195x1134844">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:MilestoneEventsAxis">mnkd:AchievementOfProductSalesMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-08-11</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20140811_0_1116223x1282107">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-08-11</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20130523_0_1105927x1246246">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-05-23</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20120208_0_1212432x1272755">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">mnkd:UnderwritersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20120208_0_1212432x1204313">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="mnkd:CommonStockIssuedToByPartyAxis">mnkd:PublicMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20120208_0_1116897x1213796">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mnkd:WarrantLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <context id="eol_PE126000--1510-K0015_STD_0_20120208_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
    </entity>
    <period>
      <instant>2012-02-08</instant>
    </period>
  </context>
  <unit id="iso4217_USD_per_Right">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>mnkd:Right</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="sqft">
    <measure>utr:sqft</measure>
  </unit>
  <unit id="iso4217_EUR">
    <measure>iso4217:EUR</measure>
  </unit>
  <unit id="D">
    <measure>utr:D</measure>
  </unit>
  <unit id="Employee">
    <measure>mnkd:Employee</measure>
  </unit>
  <unit id="asset_group">
    <measure>mnkd:asset_group</measure>
  </unit>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>mnkd-20151231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Schema, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.22.4 -->
<!-- Round: 77f33050-bdaf-4a1d-9f8a-38d5ff9252cd -->
<!-- Creation date: 2016-03-15T21:03:45Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<schema xmlns="http://www.w3.org/2001/XMLSchema"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31"
  xmlns:us-types="http://fasb.org/us-types/2015-01-31"
  xmlns:mnkd="http://www.mannkindcorp.com/20151231"
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:country="http://xbrl.sec.gov/country/2013-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31"
  xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31"
  xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31"
  xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31"
  targetNamespace="http://www.mannkindcorp.com/20151231"
  elementFormDefault="qualified" attributeFormDefault="unqualified">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DocumentandEntityInformation" id="DocumentandEntityInformation">
        <link:definition>101 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassified" id="Role_StatementOfFinancialPositionClassified">
        <link:definition>103 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical" id="Role_StatementOfFinancialPositionClassifiedParen">
        <link:definition>104 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfIncomeAlternative" id="Role_StatementOfIncomeAlternative">
        <link:definition>105 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfOtherComprehensiveIncome" id="Role_StatementOfOtherComprehensiveIncome">
        <link:definition>106 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome" id="Role_ci-StatementOfShareholdersEquityAndOtherComprehensiveIncome">
        <link:definition>107 - Statement - Consolidated Statements of Stockholders' (Deficit)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfCashFlowsIndirect" id="Role_StatementOfCashFlowsIndirect">
        <link:definition>108 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
        <link:definition>109 - Disclosure - Description of business and basis of presentation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" id="Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
        <link:definition>110 - Disclosure - Summary of significant accounting policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock" id="Role_NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock">
        <link:definition>111 - Disclosure - State research and development credit exchange receivable</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock" id="Role_NotesToFinancialStatementsInventoryDisclosureTextBlock">
        <link:definition>112 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock" id="Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock">
        <link:definition>113 - Disclosure - Property and equipment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Role_NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
        <link:definition>114 - Disclosure - Accrued expenses and other current liabilities</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" id="Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
        <link:definition>115 - Disclosure - Related-party arrangements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock" id="Role_NotesToFinancialStatementsLongTermDebtTextBlock">
        <link:definition>116 - Disclosure - Senior convertible notes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock" id="Role_NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock">
        <link:definition>117 - Disclosure - Collaboration arrangement</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock" id="Role_NotesToFinancialStatementsFairValueDisclosuresTextBlock">
        <link:definition>118 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommonAndPreferredStockTextBlock" id="Role_NotesToFinancialStatementsCommonAndPreferredStockTextBlock">
        <link:definition>119 - Disclosure - Common and preferred stock</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock" id="Role_NotesToFinancialStatementsEarningsPerShareTextBlock">
        <link:definition>120 - Disclosure - Net loss per common share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <link:definition>121 - Disclosure - Stock award plans</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" id="Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
        <link:definition>122 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="Role_NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock">
        <link:definition>123 - Disclosure - Employee benefit plans</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock" id="Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlock">
        <link:definition>124 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock" id="Role_NotesToFinancialStatementsDebtDisclosureTextBlock">
        <link:definition>125 - Disclosure - Facility Agreement</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock" id="Role_NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock">
        <link:definition>126 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock" id="Role_NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock">
        <link:definition>127 - Disclosure - Selected quarterly financial data (unaudited)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock" id="Role_NotesToFinancialStatementsSubsequentEventsTextBlock">
        <link:definition>128 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies" id="Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies">
        <link:definition>129 - Disclosure - Description of business and basis of presentation (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsInventoryDisclosureTextBlockTables">
        <link:definition>130 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables">
        <link:definition>131 - Disclosure - Property and equipment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables">
        <link:definition>132 - Disclosure - Accrued expenses and other current liabilities (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables" id="Role_NotesToFinancialStatementsLongTermDebtTextBlockTables">
        <link:definition>133 - Disclosure - Senior convertible notes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables" id="Role_NotesToFinancialStatementsFairValueDisclosuresTextBlockTables">
        <link:definition>134 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables" id="Role_NotesToFinancialStatementsEarningsPerShareTextBlockTables">
        <link:definition>135 - Disclosure - Net loss per common share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables" id="Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables">
        <link:definition>136 - Disclosure - Stock award plans (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables">
        <link:definition>137 - Disclosure - Income taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsDebtDisclosureTextBlockTables">
        <link:definition>138 - Disclosure - Facility Agreement (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables" id="Role_NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables">
        <link:definition>139 - Disclosure - Selected quarterly financial data (unaudited) (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation" id="DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation">
        <link:definition>140 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
        <link:definition>141 - Disclosure - Summary Of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation" id="DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation">
        <link:definition>142 - Disclosure - State Research and Development Credit Exchange Receivable - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfInventories" id="DisclosureComponentsOfInventories">
        <link:definition>143 - Disclosure - Components of Inventories (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipment" id="DisclosurePropertyAndEquipment">
        <link:definition>144 - Disclosure - Property and Equipment (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation" id="DisclosurePropertyAndEquipmentAdditionalInformation">
        <link:definition>145 - Disclosure - Property and Equipment - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities" id="DisclosureAccruedExpensesAndOtherCurrentLiabilities">
        <link:definition>146 - Disclosure - Accrued Expenses and Other Current Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureRelatedPartyArrangementsAdditionalInformation" id="DisclosureRelatedPartyArrangementsAdditionalInformation">
        <link:definition>147 - Disclosure - Related-Party Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSeniorConvertibleNotes" id="DisclosureSummaryOfSeniorConvertibleNotes">
        <link:definition>148 - Disclosure - Summary of Senior Convertible Notes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSeniorConvertibleNotesAdditionalInformation" id="DisclosureSeniorConvertibleNotesAdditionalInformation">
        <link:definition>149 - Disclosure - Senior Convertible Notes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCollaborativeArrangementAdditionalInformation" id="DisclosureCollaborativeArrangementAdditionalInformation">
        <link:definition>150 - Disclosure - Collaborative Arrangement - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation" id="DisclosureFairValueOfFinancialInstrumentsAdditionalInformation">
        <link:definition>151 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility" id="DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility">
        <link:definition>152 - Disclosure - Summary of Carrying Values Estimated Fair Values of Notes and Facility Financing Obligation and Sanofi Loan Facility (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformation" id="DisclosureCommonAndPreferredStockAdditionalInformation">
        <link:definition>153 - Disclosure - Common and Preferred Stock - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation" id="DisclosureNetLossPerCommonShareAdditionalInformation">
        <link:definition>154 - Disclosure - Net Loss per Common Share - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePotentiallyDilutiveSecuritiesOutstanding" id="DisclosurePotentiallyDilutiveSecuritiesOutstanding">
        <link:definition>155 - Disclosure - Potentially Dilutive Securities Outstanding (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockAwardPlansAdditionalInformation" id="DisclosureStockAwardPlansAdditionalInformation">
        <link:definition>156 - Disclosure - Stock Award Plans - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedAwardPlans" id="DisclosureStockBasedAwardPlans">
        <link:definition>157 - Disclosure - Stock Based Award Plans (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation" id="DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation">
        <link:definition>158 - Disclosure - Stock Based Compensation Expense Recognized in Accompanying Statements of Operation (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory" id="DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory">
        <link:definition>159 - Disclosure - Stock Based Compensation Expense Recognized in Accompanying Statements of Operations by Category (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfEmployeeStockOptionsAssumptions" id="DisclosureFairValueOfEmployeeStockOptionsAssumptions">
        <link:definition>160 - Disclosure - Fair Value of Employee Stock Options Assumptions (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfStockOptionsOutstanding" id="DisclosureSummaryOfStockOptionsOutstanding">
        <link:definition>161 - Disclosure - Summary of Stock Options Outstanding (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitActivity" id="DisclosureSummaryOfRestrictedStockUnitActivity">
        <link:definition>162 - Disclosure - Summary of Restricted Stock Unit Activity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation" id="DisclosureCommitmentsAndContingenciesAdditionalInformation">
        <link:definition>163 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformation" id="DisclosureEmployeeBenefitPlansAdditionalInformation">
        <link:definition>164 - Disclosure - Employee Benefit Plans - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureProvisionForIncomeTaxes" id="DisclosureProvisionForIncomeTaxes">
        <link:definition>165 - Disclosure - Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAsset" id="DisclosureComponentsOfNetDeferredTaxAsset">
        <link:definition>166 - Disclosure - Components of Net Deferred Tax Asset (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation" id="DisclosureIncomeTaxesAdditionalInformation">
        <link:definition>167 - Disclosure - Income Taxes -Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureEffectiveIncomeTaxRate" id="DisclosureEffectiveIncomeTaxRate">
        <link:definition>168 - Disclosure - Effective Income Tax Rate (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFacilityAgreementAdditionalInformation" id="DisclosureFacilityAgreementAdditionalInformation">
        <link:definition>169 - Disclosure - Facility Agreement - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing" id="DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing">
        <link:definition>170 - Disclosure - Accretion of Debt Issuance Cost and Debt Discount in Connection with Deerfield Financing (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureRestructuringChargesAdditionalInformation" id="DisclosureRestructuringChargesAdditionalInformation">
        <link:definition>171 - Disclosure - Restructuring Charges - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialData" id="DisclosureSelectedQuarterlyFinancialData">
        <link:definition>172 - Disclosure - Selected Quarterly Financial Data (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataAdditionalInformation" id="DisclosureSelectedQuarterlyFinancialDataAdditionalInformation">
        <link:definition>173 - Disclosure - Selected Quarterly Financial Data - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation" id="DisclosureSubsequentEventsAdditionalInformation">
        <link:definition>174 - Disclosure - Subsequent Events - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="mnkd-20151231_cal.xml" xlink:title="Calculation Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="mnkd-20151231_def.xml" xlink:title="Definition Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="mnkd-20151231_lab.xml" xlink:title="Label Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="mnkd-20151231_pre.xml" xlink:title="Presentation Links, all"/>
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://fasb.org/us-types/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2015-01-31" schemaLocation="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
  <element name="AccountsAndOtherReceivablesLineItems" id="mnkd_AccountsAndOtherReceivablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AccountsAndOtherReceivablesTable" id="mnkd_AccountsAndOtherReceivablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="AccruedExpensesAndOtherCurrentLiabilitiesLineItems" id="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AccruedExpensesAndOtherCurrentLiabilitiesTable" id="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="AccruedExpensesRelatedParty" id="mnkd_AccruedExpensesRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AccruedInterestOfRelatedPartyDebt" id="mnkd_AccruedInterestOfRelatedPartyDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AchievementOfProductSalesMilestoneMember" id="mnkd_AchievementOfProductSalesMilestoneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity" id="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion" id="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AgreementsAxis" id="mnkd_AgreementsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
  <element name="AgreementsDomain" id="mnkd_AgreementsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AlfredMannFoundationMember" id="mnkd_AlfredMannFoundationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AmendedAgreementMember" id="mnkd_AmendedAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AmortizationPeriodOfLeaseHoldImprovements" id="mnkd_AmortizationPeriodOfLeaseHoldImprovements" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AreaOfOfficeSpaceLeased" id="mnkd_AreaOfOfficeSpaceLeased" type="num:areaItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AvailableBorrowingsUnderLoanAgreement" id="mnkd_AvailableBorrowingsUnderLoanAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AvailableLoanBalanceCancelled" id="mnkd_AvailableLoanBalanceCancelled" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="BasicAndDilutedWeightedAverageNumberOfSharesOutstanding" id="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="BasisOfPresentationPolicyTextBlock" id="mnkd_BasisOfPresentationPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="BusinessPolicyTextBlock" id="mnkd_BusinessPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CancellationOfPrincipalOnNotePayableToRelatedParty" id="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClassOfWarrantExercisablePeriod" id="mnkd_ClassOfWarrantExercisablePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice" id="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClassOfWarrantsOrRightsExpirationDate" id="mnkd_ClassOfWarrantsOrRightsExpirationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClinicalTrialExpensePolicyTextBlock" id="mnkd_ClinicalTrialExpensePolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CollaborationAndLicenseAgreementMember" id="mnkd_CollaborationAndLicenseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommitmentsAndContingenciesLineItems" id="mnkd_CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommitmentsAndContingenciesTable" id="mnkd_CommitmentsAndContingenciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="CommonAndPreferredStockTextBlock" id="mnkd_CommonAndPreferredStockTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommonStockIssuedToByPartyAxis" id="mnkd_CommonStockIssuedToByPartyAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
  <element name="CommonStockIssuedToByPartyDomain" id="mnkd_CommonStockIssuedToByPartyDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommonStockLoanedUnderShareLendingAgreementShares" id="mnkd_CommonStockLoanedUnderShareLendingAgreementShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommonStockLoanedUnderShareLendingAgreementValue" id="mnkd_CommonStockLoanedUnderShareLendingAgreementValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ComputerEquipmentAndSoftwareMember" id="mnkd_ComputerEquipmentAndSoftwareMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConsiderationReceived" id="mnkd_ConsiderationReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConsultantMember" id="mnkd_ConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ContingentLiability" id="mnkd_ContingentLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConvertibleDebtLineItems" id="mnkd_ConvertibleDebtLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConvertibleDebtTable" id="mnkd_ConvertibleDebtTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="DanburyFacilityMember" id="mnkd_DanburyFacilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DebtInstrumentDateOfLastRequiredPayment" id="mnkd_DebtInstrumentDateOfLastRequiredPayment" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeerfieldManagementCompanyLpMember" id="mnkd_DeerfieldManagementCompanyLpMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredProductCostsFromCollaborationPolicyTextBlock" id="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredTaxAssetIncreaseDecreaseInEquity" id="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredTaxAssetsCapitalizedCosts" id="mnkd_DeferredTaxAssetsCapitalizedCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredTaxAssetsCapitalizedResearchExpenses" id="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredTaxAssetsLineItems" id="mnkd_DeferredTaxAssetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredTaxAssetsLossOnPurchaseCommitment" id="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredTaxAssetsMilestoneRights" id="mnkd_DeferredTaxAssetsMilestoneRights" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredTaxAssetsTable" id="mnkd_DeferredTaxAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="DeficitAccumulatedDuringDevelopmentStageMember" id="mnkd_DeficitAccumulatedDuringDevelopmentStageMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DepreciationAndOtherAmortizationExpensesLineItems" id="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DepreciationAndOtherAmortizationExpensesTable" id="mnkd_DepreciationAndOtherAmortizationExpensesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="DevelopmentMilestoneEventsMember" id="mnkd_DevelopmentMilestoneEventsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DocumentAndEntityInformationAbstract" id="mnkd_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EffectiveIncomeTaxRateReconciliationPermanentItems" id="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EmployeeMember" id="mnkd_EmployeeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EmployeeStockPurchasePlanAnnualIncreaseInReservedShares" id="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EmployeeStockPurchasePlansMember" id="mnkd_EmployeeStockPurchasePlansMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EquityIncentivePlanTwentyThirteenMember" id="mnkd_EquityIncentivePlanTwentyThirteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EstimatedAmountsCreditExchangeReceivable" id="mnkd_EstimatedAmountsCreditExchangeReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="FacilityAgreementMember" id="mnkd_FacilityAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="FacilityFinancingObligationMember" id="mnkd_FacilityFinancingObligationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="FairValueOfFinancialInstrumentsLineItems" id="mnkd_FairValueOfFinancialInstrumentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="FairValueOfFinancialInstrumentsTable" id="mnkd_FairValueOfFinancialInstrumentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="FilingAndCompletionOfRegulatoryApprovalsMember" id="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="FurnitureFixturesAndOfficeEquipmentMember" id="mnkd_FurnitureFixturesAndOfficeEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="GainLossOnPurchaseCommitments" id="mnkd_GainLossOnPurchaseCommitments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" id="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IncomeTaxesLineItems" id="mnkd_IncomeTaxesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" id="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" id="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="IncomeTaxesTable" id="mnkd_IncomeTaxesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="IncomeTaxExpenseBenefitNet" id="mnkd_IncomeTaxExpenseBenefitNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="InterimReportingLineItems" id="mnkd_InterimReportingLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="InterimReportingTable" id="mnkd_InterimReportingTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="InventoryCurrentAndNoncurrent" id="mnkd_InventoryCurrentAndNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LeaseAgreementTypeOfAgreementAxis" id="mnkd_LeaseAgreementTypeOfAgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
  <element name="LeaseAgreementTypeOfAgreementDomain" id="mnkd_LeaseAgreementTypeOfAgreementDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LeaseExpirationMonthYear" id="mnkd_LeaseExpirationMonthYear" type="xbrli:gYearMonthItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LetterOfAgreementMember" id="mnkd_LetterOfAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LicenseCollaborationAndSupplyAgreementsPolicyTextBlock" id="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LineOfCreditFacilityRestrictedBorrowingCapacity" id="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LoanAgreementWithRelatedParty" id="mnkd_LoanAgreementWithRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LoanArrangementMember" id="mnkd_LoanArrangementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LongTermPurchaseCommitmentCancellationFees" id="mnkd_LongTermPurchaseCommitmentCancellationFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LongTermPurchaseCommitmentExpirationDate" id="mnkd_LongTermPurchaseCommitmentExpirationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LongtermPurchaseCommitmentRenewalTimePeriod" id="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="LossSharingAgreementAmount" id="mnkd_LossSharingAgreementAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ManufacturingMilestoneEventsMember" id="mnkd_ManufacturingMilestoneEventsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="MaturityPeriodOfCashEquivalents" id="mnkd_MaturityPeriodOfCashEquivalents" type="us-types:durationStringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="MilestoneEventsAxis" id="mnkd_MilestoneEventsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
  <element name="MilestoneEventsDomain" id="mnkd_MilestoneEventsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="MilestonePayments" id="mnkd_MilestonePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="MilestoneRightsLiabilityMember" id="mnkd_MilestoneRightsLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NetIncomeLossPerCommonShareLineItems" id="mnkd_NetIncomeLossPerCommonShareLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NetIncomeLossPerCommonShareTable" id="mnkd_NetIncomeLossPerCommonShareTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="NetOperatingLossCarryforwardAnnualLimitation" id="mnkd_NetOperatingLossCarryforwardAnnualLimitation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NetOperatingLossCarryforwardsBeginsToExpire" id="mnkd_NetOperatingLossCarryforwardsBeginsToExpire" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NominalLendingFee" id="mnkd_NominalLendingFee" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfAssetGroups" id="mnkd_NumberOfAssetGroups" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfMonthsAdvancesOutstanding" id="mnkd_NumberOfMonthsAdvancesOutstanding" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="OfficeLeaseExpense" id="mnkd_OfficeLeaseExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="OperatingLossCarryforwardsSubjectToLimitation" id="mnkd_OperatingLossCarryforwardsSubjectToLimitation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="OperatingLossSharingMember" id="mnkd_OperatingLossSharingMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" id="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" id="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="PaymentForContingentLiabilities" id="mnkd_PaymentForContingentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PaymentsForUseOfAircrafts" id="mnkd_PaymentsForUseOfAircrafts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfCommonStockSharesOutstanding" id="mnkd_PercentageOfCommonStockSharesOutstanding" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfCreditExchangeReceivable" id="mnkd_PercentageOfCreditExchangeReceivable" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfShareReservedForShareBasedCompensation" id="mnkd_PercentageOfShareReservedForShareBasedCompensation" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PotentialMilestonePayments" id="mnkd_PotentialMilestonePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PotentialMilestonePaymentsToBeReceived" id="mnkd_PotentialMilestonePaymentsToBeReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" id="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PrincipalAmountPerShare" id="mnkd_PrincipalAmountPerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ProceedsFromIssuanceOfCommonStockAndWarrants" id="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ProceedsFromIssuanceOfCommonStockAndWarrantsNet" id="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ProfitLossSharingAgreementAllocationPercentage" id="mnkd_ProfitLossSharingAgreementAllocationPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PublicMember" id="mnkd_PublicMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PurchaseObligationCurrent" id="mnkd_PurchaseObligationCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PurchaseObligationNoncurrent" id="mnkd_PurchaseObligationNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="RecentlyIssuedAccountingStandardsPolicyTextBlock" id="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="RelatedPartyDebtMember" id="mnkd_RelatedPartyDebtMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="RelatedPartyMember" id="mnkd_RelatedPartyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="RelatedPartyTransactionDebtInstrumentPrepayment" id="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="RelatedPartyTransactionPrepaymentPeriod" id="mnkd_RelatedPartyTransactionPrepaymentPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ResearchAndDevelopmentCreditsBeginToExpire" id="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SaleOfIntellectualPropertyPolicyTextBlock" id="mnkd_SaleOfIntellectualPropertyPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SanofiAventisMember" id="mnkd_SanofiAventisMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ScheduleOfIncomeTaxesLineItems" id="mnkd_ScheduleOfIncomeTaxesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ScheduleOfIncomeTaxesTable" id="mnkd_ScheduleOfIncomeTaxesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock" id="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SeniorConvertibleNotesDueTwoThousandEighteenMember" id="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SeniorConvertibleNotesDueTwoThousandFifteenMember" id="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" id="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest" id="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SharesReservedForEmployeeStockPurchasePlan" id="mnkd_SharesReservedForEmployeeStockPurchasePlan" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SharesReturnedUnderShareLendingAgreement" id="mnkd_SharesReturnedUnderShareLendingAgreement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StateResearchAndDevelopmentCreditExchangeReceivableTextBlock" id="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockAwardPlanTypeAxis" id="mnkd_StockAwardPlanTypeAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
  <element name="StockAwardPlanTypeDomain" id="mnkd_StockAwardPlanTypeDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodSharesForDebtExchange" id="mnkd_StockIssuedDuringPeriodSharesForDebtExchange" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement" id="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodSharesNewIssuesPercentage" id="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodSharesShareLendingAgreement" id="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodSharesWarrantExercises" id="mnkd_StockIssuedDuringPeriodSharesWarrantExercises" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodValueForDebtExchange" id="mnkd_StockIssuedDuringPeriodValueForDebtExchange" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement" id="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodValueShareLendingAgreement" id="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodValueWarrantExercises" id="mnkd_StockIssuedDuringPeriodValueWarrantExercises" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockOptionActivityAndChangesLineItems" id="mnkd_StockOptionActivityAndChangesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockOptionActivityAndChangesTable" id="mnkd_StockOptionActivityAndChangesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="StockOptionsGrantedVestingRate" id="mnkd_StockOptionsGrantedVestingRate" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SubleaseAgreementMember" id="mnkd_SubleaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SummaryOfSignificantAccountingPoliciesLineItems" id="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SummaryOfSignificantAccountingPoliciesTable" id="mnkd_SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="TerminationDateOfLicenseAgreement" id="mnkd_TerminationDateOfLicenseAgreement" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TrancheBMember" id="mnkd_TrancheBMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TwoThousandEighteenNotesMember" id="mnkd_TwoThousandEighteenNotesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TwoThousandFifteenNotesMember" id="mnkd_TwoThousandFifteenNotesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TwoThousandFourEquityIncentivePlanMember" id="mnkd_TwoThousandFourEquityIncentivePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember" id="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TwoThousandNineteenNotesMember" id="mnkd_TwoThousandNineteenNotesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TwoThousandThirteenNotesMember" id="mnkd_TwoThousandThirteenNotesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UncategorizedAbstract" id="mnkd_UncategorizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnderwritersMember" id="mnkd_UnderwritersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnitsSoldByUnderwritingPrice" id="mnkd_UnitsSoldByUnderwritingPrice" type="us-types:perUnitItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnitsSoldUnderPublicOfferUnderwritten" id="mnkd_UnitsSoldUnderPublicOfferUnderwritten" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription" id="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnitsSoldWarrantPortionConvertibleIntoCommonStock" id="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock" type="us-types:perUnitItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UpfrontFee" id="mnkd_UpfrontFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ValenciaMember" id="mnkd_ValenciaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ValueOfRestrictedStockUnitsVested" id="mnkd_ValueOfRestrictedStockUnitsVested" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantLiabilityMember" id="mnkd_WarrantLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantsExercisableExpirationPeriod" id="mnkd_WarrantsExercisableExpirationPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantsPolicyTextBlock" id="mnkd_WarrantsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest" id="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WriteOffOfCommitmentAsset" id="mnkd_WriteOffOfCommitmentAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WriteOffOfDerivativeLiability" id="mnkd_WriteOffOfDerivativeLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>mnkd-20151231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Calculation Linkbase, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.22.4 -->
<!-- Round: 77f33050-bdaf-4a1d-9f8a-38d5ff9252cd -->
<!-- Creation date: 2016-03-15T21:03:45Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DocumentandEntityInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DocumentandEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfIncomeAlternative" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfIncomeAlternative"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfOtherComprehensiveIncome" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_ci-StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureComponentsOfInventories" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfInventories"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePropertyAndEquipment" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipment"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePropertyAndEquipmentAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureAccruedExpensesAndOtherCurrentLiabilities" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureRelatedPartyArrangementsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureRelatedPartyArrangementsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfSeniorConvertibleNotes" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSeniorConvertibleNotes"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSeniorConvertibleNotesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSeniorConvertibleNotesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCollaborativeArrangementAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCollaborativeArrangementAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFairValueOfFinancialInstrumentsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCommonAndPreferredStockAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureNetLossPerCommonShareAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePotentiallyDilutiveSecuritiesOutstanding" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePotentiallyDilutiveSecuritiesOutstanding"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockAwardPlansAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockAwardPlansAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedAwardPlans" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedAwardPlans"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFairValueOfEmployeeStockOptionsAssumptions" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfEmployeeStockOptionsAssumptions"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfStockOptionsOutstanding" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfStockOptionsOutstanding"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfRestrictedStockUnitActivity" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitActivity"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureEmployeeBenefitPlansAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureProvisionForIncomeTaxes" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureProvisionForIncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureComponentsOfNetDeferredTaxAsset" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAsset"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureIncomeTaxesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureEffectiveIncomeTaxRate" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureEffectiveIncomeTaxRate"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFacilityAgreementAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFacilityAgreementAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureRestructuringChargesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureRestructuringChargesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSelectedQuarterlyFinancialData" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialData"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSelectedQuarterlyFinancialDataAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSubsequentEventsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsLongTermDebtTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsLongTermDebtTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCommonAndPreferredStockTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommonAndPreferredStockTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsSubsequentEventsTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DocumentandEntityInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="us-gaap_ConvertibleLongTermNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCostsCurrent" xlink:label="us-gaap_DeferredCostsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:label="us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NontradeReceivablesNoncurrent" xlink:label="us-gaap_NontradeReceivablesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="us-gaap_OtherDeferredCreditsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="us-gaap_OtherLongTermDebtCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PurchaseObligationCurrent" xlink:label="mnkd_PurchaseObligationCurrent"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PurchaseObligationNoncurrent" xlink:label="mnkd_PurchaseObligationNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_NontradeReceivablesNoncurrent" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.0900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DeferredCostsCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="1.1800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LossContingencyAccrualCarryingValueNoncurrent" order="1.1900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ConvertibleLongTermNotesPayable" order="1.2000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mnkd_PurchaseObligationNoncurrent" order="1.2100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.2200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1.2300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1.2400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1.3000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1.1000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.1100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLongTermDebtCurrent" order="1.1200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="1.1300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherDeferredCreditsCurrent" order="1.1400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="mnkd_PurchaseObligationCurrent" order="1.1500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="1.1600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1.2500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1.2600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.2700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="1.2800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.2900" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfIncomeAlternative">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:label="mnkd_GainLossOnPurchaseCommitments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1.0900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1.1000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="1.1100" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestExpenseDebt" order="1.1200" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InvestmentIncomeInterest" order="1.1300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.1400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.1500" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ManufacturingCosts" order="1.0400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.0500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="mnkd_GainLossOnPurchaseCommitments" order="1.0600" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SalesRevenueNet" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1.0700" weight="-1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfOtherComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="1.0300" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnContractTermination" xlink:label="us-gaap_GainLossOnContractTermination"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" xlink:label="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestonePayments" xlink:label="mnkd_MilestonePayments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt" xlink:label="us-gaap_RepaymentsOfSeniorDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WriteOffOfCommitmentAsset" xlink:label="mnkd_WriteOffOfCommitmentAsset"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WriteOffOfDerivativeLiability" xlink:label="mnkd_WriteOffOfDerivativeLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="1.2100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="1.2400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="1.3400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" order="1.2500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1.2600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="1.2700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="1.2800" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="mnkd_MilestonePayments" order="1.2900" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.3000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.3100" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" order="1.3200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="1.3300" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_RepaymentsOfSeniorDebt" order="1.3800" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.2200" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.2300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetIncomeLoss" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_DepreciationAndAmortization" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ShareBasedCompensation" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" order="1.0400" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_GainLossOnContractTermination" order="1.0500" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" order="1.0700" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_PaidInKindInterest" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="mnkd_WriteOffOfDerivativeLiability" order="1.0900" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1.1000" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.1100" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="1.1200" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.1300" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="1.1400" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="1.1500" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.1600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="1.1700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="1.1800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits" order="1.1900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="1.2000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="mnkd_WriteOffOfCommitmentAsset" order="1.3700" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfInventories">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="1.0300" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipment">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionPayableCurrent" xlink:label="us-gaap_ConstructionPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_InterestPayableCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_ConstructionPayableCurrent" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureRelatedPartyArrangementsAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSeniorConvertibleNotes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="1.0300" weight="-1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSeniorConvertibleNotesAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCollaborativeArrangementAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePotentiallyDilutiveSecuritiesOutstanding">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockAwardPlansAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedAwardPlans">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfEmployeeStockOptionsAssumptions">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfStockOptionsOutstanding">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitActivity">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureProvisionForIncomeTaxes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxExpenseBenefitNet" xlink:label="mnkd_IncomeTaxExpenseBenefitNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1.0500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="1.0700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredOtherTaxExpenseBenefit" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_IncomeTaxExpenseBenefitNet" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="1.0400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_IncomeTaxExpenseBenefitNet" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1.0900" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAsset">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsMilestoneRights" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="1.0400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsMilestoneRights" order="1.0500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" order="1.0700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsCapitalizedCosts" order="1.0900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" order="1.1000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="1.1100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1.1200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.1300" weight="-1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureEffectiveIncomeTaxRate">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="1.0400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="1.0500" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFacilityAgreementAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureRestructuringChargesAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialData">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommonAndPreferredStockTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock">
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>mnkd-20151231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Definition Linkbase, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.22.4 -->
<!-- Round: 77f33050-bdaf-4a1d-9f8a-38d5ff9252cd -->
<!-- Creation date: 2016-03-15T21:03:45Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DocumentandEntityInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DocumentandEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfIncomeAlternative" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfIncomeAlternative"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfOtherComprehensiveIncome" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_ci-StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureComponentsOfInventories" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfInventories"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePropertyAndEquipment" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipment"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePropertyAndEquipmentAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureAccruedExpensesAndOtherCurrentLiabilities" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureRelatedPartyArrangementsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureRelatedPartyArrangementsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfSeniorConvertibleNotes" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSeniorConvertibleNotes"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSeniorConvertibleNotesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSeniorConvertibleNotesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCollaborativeArrangementAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCollaborativeArrangementAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFairValueOfFinancialInstrumentsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCommonAndPreferredStockAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureNetLossPerCommonShareAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePotentiallyDilutiveSecuritiesOutstanding" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePotentiallyDilutiveSecuritiesOutstanding"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockAwardPlansAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockAwardPlansAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedAwardPlans" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedAwardPlans"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFairValueOfEmployeeStockOptionsAssumptions" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfEmployeeStockOptionsAssumptions"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfStockOptionsOutstanding" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfStockOptionsOutstanding"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfRestrictedStockUnitActivity" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitActivity"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureEmployeeBenefitPlansAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureProvisionForIncomeTaxes" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureProvisionForIncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureComponentsOfNetDeferredTaxAsset" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAsset"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureIncomeTaxesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureEffectiveIncomeTaxRate" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureEffectiveIncomeTaxRate"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFacilityAgreementAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFacilityAgreementAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureRestructuringChargesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureRestructuringChargesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSelectedQuarterlyFinancialData" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialData"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSelectedQuarterlyFinancialDataAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSubsequentEventsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsLongTermDebtTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsLongTermDebtTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCommonAndPreferredStockTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommonAndPreferredStockTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsSubsequentEventsTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DocumentandEntityInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="us-gaap_ConvertibleLongTermNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCostsCurrent" xlink:label="us-gaap_DeferredCostsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:label="us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NontradeReceivablesNoncurrent" xlink:label="us-gaap_NontradeReceivablesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="us-gaap_OtherDeferredCreditsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="us-gaap_OtherLongTermDebtCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PurchaseObligationCurrent" xlink:label="mnkd_PurchaseObligationCurrent"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PurchaseObligationNoncurrent" xlink:label="mnkd_PurchaseObligationNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_NontradeReceivablesNoncurrent" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DeferredCostsCurrent" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LossContingencyAccrualCarryingValueNoncurrent" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ConvertibleLongTermNotesPayable" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mnkd_PurchaseObligationNoncurrent" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.3300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="1.3400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="1.3500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="1.3600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.3700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLongTermDebtCurrent" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherDeferredCreditsCurrent" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mnkd_PurchaseObligationCurrent" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="1.0600" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfIncomeAlternative">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:label="mnkd_GainLossOnPurchaseCommitments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ManufacturingCosts" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="mnkd_GainLossOnPurchaseCommitments" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SalesRevenueNet" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfOtherComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementShares" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementValue" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeficitAccumulatedDuringDevelopmentStageMember" xlink:label="mnkd_DeficitAccumulatedDuringDevelopmentStageMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_ExchangeDomain" xlink:label="dei_ExchangeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PartnersCapitalAccountContributions" xlink:label="us-gaap_PartnersCapitalAccountContributions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesForDebtExchange" xlink:label="mnkd_StockIssuedDuringPeriodSharesForDebtExchange"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement" xlink:label="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement" xlink:label="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesWarrantExercises" xlink:label="mnkd_StockIssuedDuringPeriodSharesWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueForDebtExchange" xlink:label="mnkd_StockIssuedDuringPeriodValueForDebtExchange"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement" xlink:label="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueShareLendingAgreement" xlink:label="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueWarrantExercises" xlink:label="mnkd_StockIssuedDuringPeriodValueWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd#exch_XTAE" xlink:label="exch_XTAE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_ExchangeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1.3700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.3800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="1.3900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="mnkd_DeficitAccumulatedDuringDevelopmentStageMember" order="1.4000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_ExchangeDomain" xlink:to="exch_XTAE" order="1.3600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesWarrantExercises" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueWarrantExercises" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesForDebtExchange" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PartnersCapitalAccountContributions" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueForDebtExchange" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementValue" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementShares" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_EntityListingsExchangeAxis" order="3.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty" xlink:label="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_ExchangeDomain" xlink:label="dei_ExchangeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_ExchangeDomain" xlink:label="dei_ExchangeDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnContractTermination" xlink:label="us-gaap_GainLossOnContractTermination"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" xlink:label="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaidCapitalized" xlink:label="us-gaap_InterestPaidCapitalized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansAssumed1" xlink:label="us-gaap_LoansAssumed1"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestonePayments" xlink:label="mnkd_MilestonePayments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt" xlink:label="us-gaap_RepaymentsOfSeniorDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandEighteenNotesMember" xlink:label="mnkd_TwoThousandEighteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFifteenNotesMember" xlink:label="mnkd_TwoThousandFifteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandThirteenNotesMember" xlink:label="mnkd_TwoThousandThirteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WriteOffOfCommitmentAsset" xlink:label="mnkd_WriteOffOfCommitmentAsset"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WriteOffOfDerivativeLiability" xlink:label="mnkd_WriteOffOfDerivativeLiability"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd#exch_XTAE" xlink:label="exch_XTAE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnContractTermination" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PaidInKindInterest" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_WriteOffOfDerivativeLiability" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_WriteOffOfCommitmentAsset" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_TrancheBMember" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandFifteenNotesMember" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandEighteenNotesMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandThirteenNotesMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_ExchangeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_ExchangeDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_ExchangeDomain" xlink:to="exch_XTAE" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_RepaymentsOfSeniorDebt" order="1.3300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="1.3400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="1.3500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="mnkd_MilestonePayments" order="1.3600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.3700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.3800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" order="1.3900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="1.4000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="1.4100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="1.4200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.4300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.4500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.4600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="1.4700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="1.4800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.4900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="1.5000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="1.5100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_EntityListingsExchangeAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="1.5200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_StockIssued1" order="1.5300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" order="1.5400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" order="1.5500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidCapitalized" order="1.5600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty" order="1.5700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_LoansAssumed1" order="1.5800" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsAxis" xlink:label="mnkd_AgreementsAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsDomain" xlink:label="mnkd_AgreementsDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsDomain" xlink:label="mnkd_AgreementsDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FacilityAgreementMember" xlink:label="mnkd_FacilityAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" xlink:label="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProfitLossSharingAgreementAllocationPercentage" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UpfrontFee" xlink:label="mnkd_UpfrontFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mnkd_AgreementsAxis" xlink:to="mnkd_AgreementsDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mnkd_AgreementsAxis" xlink:to="mnkd_AgreementsDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AgreementsDomain" xlink:to="mnkd_FacilityAgreementMember" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_TrancheBMember" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_UpfrontFee" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_TerminationDateOfLicenseAgreement" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_ProfitLossSharingAgreementAllocationPercentage" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="dei_LegalEntityAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_RangeAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="mnkd_AgreementsAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_CreditFacilityAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="7.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="8.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesRelatedParty" xlink:label="mnkd_AccruedExpensesRelatedParty"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConsiderationReceived" xlink:label="mnkd_ConsiderationReceived"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:label="mnkd_GainLossOnPurchaseCommitments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestCostsCapitalized" xlink:label="us-gaap_InterestCostsCapitalized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MaturityPeriodOfCashEquivalents" xlink:label="mnkd_MaturityPeriodOfCashEquivalents"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="us-gaap_OtherLongTermDebtNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfCreditExchangeReceivable" xlink:label="mnkd_PercentageOfCreditExchangeReceivable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IntellectualPropertyMember" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_MaturityPeriodOfCashEquivalents" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_PercentageOfCreditExchangeReceivable" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_ConsiderationReceived" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GainLossOnDispositionOfIntangibleAssets" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_AccruedExpensesRelatedParty" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OtherLongTermDebtNoncurrent" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InventoryWriteDown" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PurchaseObligation" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_GainLossOnPurchaseCommitments" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InterestExpense" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InterestCostsCapitalized" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_CreditFacilityAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="4.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccountsAndOtherReceivablesLineItems" xlink:label="mnkd_AccountsAndOtherReceivablesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccountsAndOtherReceivablesTable" xlink:label="mnkd_AccountsAndOtherReceivablesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EstimatedAmountsCreditExchangeReceivable" xlink:label="mnkd_EstimatedAmountsCreditExchangeReceivable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfCreditExchangeReceivable" xlink:label="mnkd_PercentageOfCreditExchangeReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_AccountsAndOtherReceivablesLineItems" xlink:to="mnkd_AccountsAndOtherReceivablesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AccountsAndOtherReceivablesLineItems" xlink:to="mnkd_PercentageOfCreditExchangeReceivable" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AccountsAndOtherReceivablesLineItems" xlink:to="mnkd_EstimatedAmountsCreditExchangeReceivable" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_AccountsAndOtherReceivablesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfInventories">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InventoryCurrentAndNoncurrent" xlink:label="mnkd_InventoryCurrentAndNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryCurrentTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryNet" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="mnkd_InventoryCurrentAndNoncurrent" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipment">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BuildingImprovementsMember" xlink:label="us-gaap_BuildingImprovementsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ComputerEquipmentAndSoftwareMember" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FurnitureFixturesAndOfficeEquipmentMember" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandMember" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingImprovementsMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_FurnitureFixturesAndOfficeEquipmentMember" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_ComputerEquipmentAndSoftwareMember" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_RangeAxis" order="3.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AmortizationPeriodOfLeaseHoldImprovements" xlink:label="mnkd_AmortizationPeriodOfLeaseHoldImprovements"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DanburyFacilityMember" xlink:label="mnkd_DanburyFacilityMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorPropertyClassAxis" xlink:label="us-gaap_MajorPropertyClassAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorPropertyClassDomain" xlink:label="us-gaap_MajorPropertyClassDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorPropertyClassDomain" xlink:label="us-gaap_MajorPropertyClassDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NumberOfAssetGroups" xlink:label="mnkd_NumberOfAssetGroups"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ValenciaMember" xlink:label="mnkd_ValenciaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="mnkd_DepreciationAndOtherAmortizationExpensesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="mnkd_AmortizationPeriodOfLeaseHoldImprovements" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="mnkd_TerminationDateOfLicenseAgreement" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="mnkd_NumberOfAssetGroups" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="us-gaap_MajorPropertyClassAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MajorPropertyClassAxis" xlink:to="us-gaap_MajorPropertyClassDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MajorPropertyClassAxis" xlink:to="us-gaap_MajorPropertyClassDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MajorPropertyClassDomain" xlink:to="mnkd_ValenciaMember" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_DanburyFacilityMember" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionPayableCurrent" xlink:label="us-gaap_ConstructionPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_InterestPayableCurrent" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_ConstructionPayableCurrent" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureRelatedPartyArrangementsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedInterestOfRelatedPartyDebt" xlink:label="mnkd_AccruedInterestOfRelatedPartyDebt"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AlfredMannFoundationMember" xlink:label="mnkd_AlfredMannFoundationMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AmendedAgreementMember" xlink:label="mnkd_AmendedAgreementMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AreaOfOfficeSpaceLeased" xlink:label="mnkd_AreaOfOfficeSpaceLeased"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AvailableBorrowingsUnderLoanAgreement" xlink:label="mnkd_AvailableBorrowingsUnderLoanAgreement"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AvailableLoanBalanceCancelled" xlink:label="mnkd_AvailableLoanBalanceCancelled"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseAgreementTypeOfAgreementAxis" xlink:label="mnkd_LeaseAgreementTypeOfAgreementAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseAgreementTypeOfAgreementDomain" xlink:label="mnkd_LeaseAgreementTypeOfAgreementDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseAgreementTypeOfAgreementDomain" xlink:label="mnkd_LeaseAgreementTypeOfAgreementDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseExpirationMonthYear" xlink:label="mnkd_LeaseExpirationMonthYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LetterOfAgreementMember" xlink:label="mnkd_LetterOfAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LoanAgreementWithRelatedParty" xlink:label="mnkd_LoanAgreementWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LoanArrangementMember" xlink:label="mnkd_LoanArrangementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NumberOfMonthsAdvancesOutstanding" xlink:label="mnkd_NumberOfMonthsAdvancesOutstanding"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OfficeLeaseExpense" xlink:label="mnkd_OfficeLeaseExpense"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PaymentsForUseOfAircrafts" xlink:label="mnkd_PaymentsForUseOfAircrafts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrincipalOwnerMember" xlink:label="us-gaap_PrincipalOwnerMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyDebtMember" xlink:label="mnkd_RelatedPartyDebtMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyTransactionDebtInstrumentPrepayment" xlink:label="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyTransactionPrepaymentPeriod" xlink:label="mnkd_RelatedPartyTransactionPrepaymentPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SubleaseAgreementMember" xlink:label="mnkd_SubleaseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mnkd_LeaseAgreementTypeOfAgreementAxis" xlink:to="mnkd_LeaseAgreementTypeOfAgreementDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mnkd_LeaseAgreementTypeOfAgreementAxis" xlink:to="mnkd_LeaseAgreementTypeOfAgreementDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_LeaseAgreementTypeOfAgreementDomain" xlink:to="mnkd_SubleaseAgreementMember" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_PrincipalOwnerMember" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_RelatedPartyDebtMember" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_AmendedAgreementMember" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_LoanArrangementMember" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_LetterOfAgreementMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_AlfredMannFoundationMember" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_LoanAgreementWithRelatedParty" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LineOfCredit" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_NumberOfMonthsAdvancesOutstanding" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_RelatedPartyTransactionPrepaymentPeriod" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_AvailableLoanBalanceCancelled" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_AccruedInterestOfRelatedPartyDebt" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_AvailableBorrowingsUnderLoanAgreement" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_AreaOfOfficeSpaceLeased" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_LeaseExpirationMonthYear" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_OfficeLeaseExpense" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_PaymentsForUseOfAircrafts" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RangeAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_VariableRateAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="mnkd_LeaseAgreementTypeOfAgreementAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember" order="1.2300" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSeniorConvertibleNotes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" order="1.0200" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSeniorConvertibleNotesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:label="us-gaap_DebtInstrumentRedemptionDescription"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="us-gaap_DebtIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PrincipalAmountPerShare" xlink:label="mnkd_PrincipalAmountPerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt" xlink:label="us-gaap_RepaymentsOfSeniorDebt"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandEighteenNotesMember" xlink:label="mnkd_TwoThousandEighteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFifteenNotesMember" xlink:label="mnkd_TwoThousandFifteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_TrancheBMember" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PrincipalAmountPerShare" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionDescription" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtIssuanceCosts" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfSeniorDebt" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandEighteenNotesMember" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandFifteenNotesMember" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.2700" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCollaborativeArrangementAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AchievementOfProductSalesMilestoneMember" xlink:label="mnkd_AchievementOfProductSalesMilestoneMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DevelopmentMilestoneEventsMember" xlink:label="mnkd_DevelopmentMilestoneEventsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FilingAndCompletionOfRegulatoryApprovalsMember" xlink:label="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="us-gaap_LongTermLoansPayable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LossSharingAgreementAmount" xlink:label="mnkd_LossSharingAgreementAmount"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ManufacturingMilestoneEventsMember" xlink:label="mnkd_ManufacturingMilestoneEventsMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneEventsAxis" xlink:label="mnkd_MilestoneEventsAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneEventsDomain" xlink:label="mnkd_MilestoneEventsDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneEventsDomain" xlink:label="mnkd_MilestoneEventsDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OperatingLossSharingMember" xlink:label="mnkd_OperatingLossSharingMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PotentialMilestonePayments" xlink:label="mnkd_PotentialMilestonePayments"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PotentialMilestonePaymentsToBeReceived" xlink:label="mnkd_PotentialMilestonePaymentsToBeReceived"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProfitLossSharingAgreementAllocationPercentage" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UpfrontFee" xlink:label="mnkd_UpfrontFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" xlink:to="mnkd_OperatingLossSharingMember" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_UpfrontFee" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_PotentialMilestonePayments" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_ProfitLossSharingAgreementAllocationPercentage" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_PotentialMilestonePaymentsToBeReceived" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredCosts" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_LossSharingAgreementAmount" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_LongTermLoansPayable" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaidInKindInterest" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_TerminationDateOfLicenseAgreement" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mnkd_MilestoneEventsAxis" xlink:to="mnkd_MilestoneEventsDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mnkd_MilestoneEventsAxis" xlink:to="mnkd_MilestoneEventsDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_ManufacturingMilestoneEventsMember" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_DevelopmentMilestoneEventsMember" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_AchievementOfProductSalesMilestoneMember" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ProductOrServiceAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementGeographicalAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="mnkd_MilestoneEventsAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" order="7.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="8.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="stpr_CA" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ContingentLiability" xlink:label="mnkd_ContingentLiability"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="us-gaap_FairValueInputsDiscountRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FairValueOfFinancialInstrumentsTable" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="us-gaap_MarketApproachValuationTechniqueMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="us-gaap_OtherLongTermDebtNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:label="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain_2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_FairValueOfFinancialInstrumentsTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueInputsDiscountRate" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_OtherLongTermDebtNoncurrent" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_ContingentLiability" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_CreditFacilityAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="7.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="8.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="dei_LegalEntityAxis" order="9.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_RangeAxis" order="10.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_IncomeApproachValuationTechniqueMember" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_MarketApproachValuationTechniqueMember" order="1.2700" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConvertibleDebtLineItems" xlink:label="mnkd_ConvertibleDebtLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConvertibleDebtTable" xlink:label="mnkd_ConvertibleDebtTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FacilityFinancingObligationMember" xlink:label="mnkd_FacilityFinancingObligationMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_ConvertibleDebtLineItems" xlink:to="mnkd_ConvertibleDebtTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ConvertibleDebtLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ConvertibleDebtLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_FacilityFinancingObligationMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.0500" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantExercisablePeriod" xlink:label="mnkd_ClassOfWarrantExercisablePeriod"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice" xlink:label="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantsOrRightsExpirationDate" xlink:label="mnkd_ClassOfWarrantsOrRightsExpirationDate"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockIssuedToByPartyAxis" xlink:label="mnkd_CommonStockIssuedToByPartyAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockIssuedToByPartyDomain" xlink:label="mnkd_CommonStockIssuedToByPartyDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockIssuedToByPartyDomain" xlink:label="mnkd_CommonStockIssuedToByPartyDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementShares" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_ExchangeDomain" xlink:label="dei_ExchangeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NominalLendingFee" xlink:label="mnkd_NominalLendingFee"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PublicMember" xlink:label="mnkd_PublicMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyMember" xlink:label="mnkd_RelatedPartyMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SharesReturnedUnderShareLendingAgreement" xlink:label="mnkd_SharesReturnedUnderShareLendingAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage" xlink:label="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnderwritersMember" xlink:label="mnkd_UnderwritersMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldByUnderwritingPrice" xlink:label="mnkd_UnitsSoldByUnderwritingPrice"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldUnderPublicOfferUnderwritten" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwritten"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock" xlink:label="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantLiabilityMember" xlink:label="mnkd_WarrantLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantsExercisableExpirationPeriod" xlink:label="mnkd_WarrantsExercisableExpirationPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd#exch_XTAE" xlink:label="exch_XTAE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_ClassOfWarrantExercisablePeriod" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementShares" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_NominalLendingFee" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_SharesReturnedUnderShareLendingAgreement" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_UnitsSoldUnderPublicOfferUnderwritten" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_UnitsSoldByUnderwritingPrice" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_WarrantsExercisableExpirationPeriod" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_ClassOfWarrantsOrRightsExpirationDate" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mnkd_CommonStockIssuedToByPartyAxis" xlink:to="mnkd_CommonStockIssuedToByPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mnkd_CommonStockIssuedToByPartyAxis" xlink:to="mnkd_CommonStockIssuedToByPartyDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommonStockIssuedToByPartyDomain" xlink:to="mnkd_UnderwritersMember" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommonStockIssuedToByPartyDomain" xlink:to="mnkd_PublicMember" order="1.3500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_ExchangeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_ExchangeDomain" xlink:to="exch_XTAE" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_RelatedPartyMember" order="1.3300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_EntityListingsExchangeAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="mnkd_CommonStockIssuedToByPartyAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mnkd_WarrantLiabilityMember" order="1.3400" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementShares" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetIncomeLossPerCommonShareLineItems" xlink:label="mnkd_NetIncomeLossPerCommonShareLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetIncomeLossPerCommonShareTable" xlink:label="mnkd_NetIncomeLossPerCommonShareTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OwnshareLendingArrangementSharesIssued" xlink:label="us-gaap_OwnshareLendingArrangementSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_NetIncomeLossPerCommonShareLineItems" xlink:to="mnkd_NetIncomeLossPerCommonShareTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_NetIncomeLossPerCommonShareLineItems" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementShares" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_NetIncomeLossPerCommonShareLineItems" xlink:to="us-gaap_OwnshareLendingArrangementSharesIssued" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_NetIncomeLossPerCommonShareTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePotentiallyDilutiveSecuritiesOutstanding">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="2.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockAwardPlansAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConsultantMember" xlink:label="mnkd_ConsultantMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="us-gaap_EmployeeSeveranceMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares" xlink:label="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeStockPurchasePlansMember" xlink:label="mnkd_EmployeeStockPurchasePlansMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfCommonStockSharesOutstanding" xlink:label="mnkd_PercentageOfCommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfShareReservedForShareBasedCompensation" xlink:label="mnkd_PercentageOfShareReservedForShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest" xlink:label="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SharesReservedForEmployeeStockPurchasePlan" xlink:label="mnkd_SharesReservedForEmployeeStockPurchasePlan"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockAwardPlanTypeAxis" xlink:label="mnkd_StockAwardPlanTypeAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockAwardPlanTypeDomain" xlink:label="mnkd_StockAwardPlanTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockAwardPlanTypeDomain" xlink:label="mnkd_StockAwardPlanTypeDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionsGrantedVestingRate" xlink:label="mnkd_StockOptionsGrantedVestingRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ValueOfRestrictedStockUnitsVested" xlink:label="mnkd_ValueOfRestrictedStockUnitsVested"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest" xlink:label="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EmployeeStockPurchasePlansMember" order="1.3400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="mnkd_StockAwardPlanTypeAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="7.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="8.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_SharesReservedForEmployeeStockPurchasePlan" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_PercentageOfCommonStockSharesOutstanding" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_PercentageOfShareReservedForShareBasedCompensation" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_StockOptionsGrantedVestingRate" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ValueOfRestrictedStockUnitsVested" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1.3500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1.3600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="1.3700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mnkd_StockAwardPlanTypeAxis" xlink:to="mnkd_StockAwardPlanTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mnkd_StockAwardPlanTypeAxis" xlink:to="mnkd_StockAwardPlanTypeDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_StockAwardPlanTypeDomain" xlink:to="mnkd_ConsultantMember" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_ExecutiveOfficerMember" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_EmployeeSeveranceMember" order="1.3300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="1.2900" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedAwardPlans">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFourEquityIncentivePlanMember" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember" xlink:label="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_TwoThousandFourEquityIncentivePlanMember" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1.0400" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConsultantMember" xlink:label="mnkd_ConsultantMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeMember" xlink:label="mnkd_EmployeeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="mnkd_EmployeeMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="mnkd_ConsultantMember" order="1.0300" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1.0200" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfEmployeeStockOptionsAssumptions">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:to="us-gaap_RangeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.0200" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfStockOptionsOutstanding">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionActivityAndChangesLineItems" xlink:label="mnkd_StockOptionActivityAndChangesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionActivityAndChangesTable" xlink:label="mnkd_StockOptionActivityAndChangesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="mnkd_StockOptionActivityAndChangesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_StockOptionActivityAndChangesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitActivity">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1.0300" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommitmentsAndContingenciesLineItems" xlink:label="mnkd_CommitmentsAndContingenciesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommitmentsAndContingenciesTable" xlink:label="mnkd_CommitmentsAndContingenciesTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ContingentLiability" xlink:label="mnkd_ContingentLiability"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongTermPurchaseCommitmentCancellationFees" xlink:label="mnkd_LongTermPurchaseCommitmentCancellationFees"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongTermPurchaseCommitmentExpirationDate" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="us-gaap_PurchaseObligationDueInFourthYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="us-gaap_PurchaseObligationDueInSecondYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="us-gaap_PurchaseObligationDueInThirdYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember_2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_CommitmentsAndContingenciesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_ContingentLiability" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligation" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligationDueInSecondYear" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligationDueInThirdYear" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligationDueInFourthYear" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongTermPurchaseCommitmentCancellationFees" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongTermPurchaseCommitmentExpirationDate" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_CreditFacilityAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_RangeAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.1300" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureProvisionForIncomeTaxes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxExpenseBenefitNet" xlink:label="mnkd_IncomeTaxExpenseBenefitNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredOtherTaxExpenseBenefit" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="mnkd_IncomeTaxExpenseBenefitNet" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:to="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAsset">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsLineItems" xlink:label="mnkd_DeferredTaxAssetsLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsMilestoneRights" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsTable" xlink:label="mnkd_DeferredTaxAssetsTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsMilestoneRights" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsCapitalizedCosts" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_DeferredTaxAssetsLineItems" xlink:to="mnkd_DeferredTaxAssetsTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_DeferredTaxAssetsLineItems" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_DeferredTaxAssetsTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetIncreaseDecreaseInEquity" xlink:label="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_2"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesLineItems" xlink:label="mnkd_IncomeTaxesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesTable" xlink:label="mnkd_IncomeTaxesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetOperatingLossCarryforwardAnnualLimitation" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetOperatingLossCarryforwardsBeginsToExpire" xlink:label="mnkd_NetOperatingLossCarryforwardsBeginsToExpire"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OperatingLossCarryforwardsSubjectToLimitation" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ResearchAndDevelopmentCreditsBeginToExpire" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_IncomeTaxesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_NetOperatingLossCarryforwardsBeginsToExpire" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_OperatingLossCarryforwardsSubjectToLimitation" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_NetOperatingLossCarryforwardAnnualLimitation" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_IncomeTaxesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureEffectiveIncomeTaxRate">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfIncomeTaxesLineItems" xlink:label="mnkd_ScheduleOfIncomeTaxesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfIncomeTaxesTable" xlink:label="mnkd_ScheduleOfIncomeTaxesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="mnkd_ScheduleOfIncomeTaxesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_ScheduleOfIncomeTaxesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFacilityAgreementAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsAxis" xlink:label="mnkd_AgreementsAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsDomain" xlink:label="mnkd_AgreementsDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ContingentLiability" xlink:label="mnkd_ContingentLiability"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DanburyFacilityMember" xlink:label="mnkd_DanburyFacilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DebtInstrumentDateOfLastRequiredPayment" xlink:label="mnkd_DebtInstrumentDateOfLastRequiredPayment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FacilityAgreementMember" xlink:label="mnkd_FacilityAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="us-gaap_FairValueInputsDiscountRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsEntityCreditRisk" xlink:label="us-gaap_FairValueInputsEntityCreditRisk"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" xlink:label="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="us-gaap_OtherLongTermDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="us-gaap_OtherLongTermDebtCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="us-gaap_OtherLongTermDebtNoncurrent"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PaymentForContingentLiabilities" xlink:label="mnkd_PaymentForContingentLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mnkd_AgreementsAxis" xlink:to="mnkd_AgreementsDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_AgreementsDomain" xlink:to="mnkd_FacilityAgreementMember" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_TrancheBMember" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentDateOfLastRequiredPayment" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_ContingentLiability" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OtherLongTermDebtCurrent" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OtherLongTermDebtNoncurrent" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PaymentForContingentLiabilities" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FairValueInputsDiscountRate" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FairValueInputsEntityCreditRisk" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OtherLongTermDebt" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RangeAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="mnkd_AgreementsAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_DanburyFacilityMember" order="1.2900" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureRestructuringChargesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCharges" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_PaymentsForRestructuring" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReserve" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="2.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialData">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding" xlink:label="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingLineItems" xlink:label="mnkd_InterimReportingLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingTable" xlink:label="mnkd_InterimReportingTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_InterimReportingLineItems" xlink:to="mnkd_InterimReportingTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_InterimReportingLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_InterimReportingLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_InterimReportingLineItems" xlink:to="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_InterimReportingTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingLineItems" xlink:label="mnkd_InterimReportingLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingTable" xlink:label="mnkd_InterimReportingTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_InterimReportingLineItems" xlink:to="mnkd_InterimReportingTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_InterimReportingLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_InterimReportingTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProfitLossSharingAgreementAllocationPercentage" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mnkd_TerminationDateOfLicenseAgreement" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mnkd_ProfitLossSharingAgreementAllocationPercentage" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BasisOfPresentationPolicyTextBlock" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BusinessPolicyTextBlock" xlink:label="mnkd_BusinessPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClinicalTrialExpensePolicyTextBlock" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock" xlink:label="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpensePolicyTextBlock" xlink:label="us-gaap_InterestExpensePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock" xlink:label="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SaleOfIntellectualPropertyPolicyTextBlock" xlink:label="mnkd_SaleOfIntellectualPropertyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantsPolicyTextBlock" xlink:label="mnkd_WarrantsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_BusinessPolicyTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_BasisOfPresentationPolicyTextBlock" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UseOfEstimates" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_SaleOfIntellectualPropertyPolicyTextBlock" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtPolicyTextBlock" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryPolicyTextBlock" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_WarrantsPolicyTextBlock" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ClinicalTrialExpensePolicyTextBlock" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpensePolicyTextBlock" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock" xlink:label="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebtTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommonAndPreferredStockTextBlock">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonAndPreferredStockTextBlock" xlink:label="mnkd_CommonAndPreferredStockTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_CommonAndPreferredStockTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock" xlink:label="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>mnkd-20151231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Labels Linkbase, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.22.4 -->
<!-- Round: 77f33050-bdaf-4a1d-9f8a-38d5ff9252cd -->
<!-- Creation date: 2016-03-15T21:03:45Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="id_7647232_1114462_1_1">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="id_7647232_1114462_2_1">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccountsAndOtherReceivablesLineItems" xlink:label="mnkd_AccountsAndOtherReceivablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AccountsAndOtherReceivablesLineItems_lbl" xml:lang="en-US" id="id_7647232_1268859_3_1">Accounts and Other Receivables [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AccountsAndOtherReceivablesLineItems_lbl" xml:lang="en-US" id="id_7647232_1268859_1_1">Accounts and Other Receivables [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AccountsAndOtherReceivablesLineItems_lbl" xml:lang="en-US" id="id_7647232_1268859_2_1">Accounts and Other Receivables [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccountsAndOtherReceivablesLineItems" xlink:to="mnkd_AccountsAndOtherReceivablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccountsAndOtherReceivablesTable" xlink:label="mnkd_AccountsAndOtherReceivablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AccountsAndOtherReceivablesTable_lbl" xml:lang="en-US" id="id_7647232_1260738_3_1">Accounts and Other Receivables [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AccountsAndOtherReceivablesTable_lbl" xml:lang="en-US" id="id_7647232_1260738_1_1">Accounts and Other Receivables [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AccountsAndOtherReceivablesTable_lbl" xml:lang="en-US" id="id_7647232_1260738_2_1">Accounts and Other Receivables [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccountsAndOtherReceivablesTable" xlink:to="mnkd_AccountsAndOtherReceivablesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1106022_1_1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1106022_2_1">Accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="id_7647232_1120517_1_1">Accounts Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="id_7647232_1120517_2_1">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US" id="id_7647232_1123893_1_1">Accounts Receivable, Net, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US" id="id_7647232_1123893_2_1">Receivables from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems_lbl" xml:lang="en-US" id="id_7647232_1255915_3_1">Accrued Expenses and Other Current Liabilities [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems_lbl" xml:lang="en-US" id="id_7647232_1255915_1_1">Accrued Expenses and Other Current Liabilities [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems_lbl" xml:lang="en-US" id="id_7647232_1255915_2_1">Accrued Expenses and Other Current Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable_lbl" xml:lang="en-US" id="id_7647232_1193068_3_1">Accrued Expenses and Other Current Liabilities [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable_lbl" xml:lang="en-US" id="id_7647232_1193068_1_1">Accrued Expenses and Other Current Liabilities [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable_lbl" xml:lang="en-US" id="id_7647232_1193068_2_1">Accrued Expenses and Other Current Liabilities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" xlink:to="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesRelatedParty" xlink:label="mnkd_AccruedExpensesRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AccruedExpensesRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1217928_3_1">Accrued Expenses Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AccruedExpensesRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1217928_1_1">Accrued Expenses Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AccruedExpensesRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1217928_2_1">Accrued expense associated with intellectual property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccruedExpensesRelatedParty" xlink:to="mnkd_AccruedExpensesRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedInterestOfRelatedPartyDebt" xlink:label="mnkd_AccruedInterestOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AccruedInterestOfRelatedPartyDebt_lbl" xml:lang="en-US" id="id_7647232_1234496_3_1">Accrued interest of related party debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AccruedInterestOfRelatedPartyDebt_lbl" xml:lang="en-US" id="id_7647232_1234496_1_1">Accrued Interest Of Related Party Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AccruedInterestOfRelatedPartyDebt_lbl" xml:lang="en-US" id="id_7647232_1234496_2_1">Accrued interest of related party debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccruedInterestOfRelatedPartyDebt" xlink:to="mnkd_AccruedInterestOfRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1117931_1_1">Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1117931_2_1">Accrued expenses and other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1117931_6_1">Accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1117465_1_1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1117465_14_1">Less accumulated depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1119401_1_1">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1119401_2_1">Accumulated other comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" id="id_7647232_1113367_1_1">AOCI Attributable to Parent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" id="id_7647232_1113367_2_1">Accumulated Other Comprehensive Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AchievementOfProductSalesMilestoneMember" xlink:label="mnkd_AchievementOfProductSalesMilestoneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AchievementOfProductSalesMilestoneMember_lbl" xml:lang="en-US" id="id_7647232_1134844_3_1">Achievement of Product Sales Milestone [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AchievementOfProductSalesMilestoneMember_lbl" xml:lang="en-US" id="id_7647232_1134844_1_1">Achievement of Product Sales Milestone [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AchievementOfProductSalesMilestoneMember_lbl" xml:lang="en-US" id="id_7647232_1134844_2_1">Product Sales Milestones</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AchievementOfProductSalesMilestoneMember" xlink:to="mnkd_AchievementOfProductSalesMilestoneMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US" id="id_7647232_1118734_1_1">Additional Paid in Capital, Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US" id="id_7647232_1118734_2_1">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="id_7647232_1108784_1_1">Additional Paid-in Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="id_7647232_1108784_2_1">Additional Paid-in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xml:lang="en-US" id="id_7647232_1118896_1_1">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xml:lang="en-US" id="id_7647232_1118896_2_1">Commitment to deliver common shares pursuant to Deerfield conversion to additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US" id="id_7647232_1119146_1_1">Adjustments to Additional Paid in Capital, Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US" id="id_7647232_1119146_2_1">Remeasurement of performance based grants pursuant to the modification of terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity_lbl" xml:lang="en-US" id="id_7647232_1161909_3_1">Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability To Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity_lbl" xml:lang="en-US" id="id_7647232_1161909_1_1">Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability To Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity_lbl" xml:lang="en-US" id="id_7647232_1161909_2_1">Reclassification of warrant liability to equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="id_7647232_1117811_1_1">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="id_7647232_1117811_2_1">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US" id="id_7647232_1118841_1_1">Adjustments to Additional Paid in Capital, Share-based Compensation, Restricted Stock Unit or Restricted Stock Award, Requisite Service Period Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US" id="id_7647232_1118841_2_1">Restricted stock units taxes paid in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion_lbl" xml:lang="en-US" id="id_7647232_1177096_3_1">Adjustments To Additional Paid In Capital Stock Option Issued Upon Debt Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion_lbl" xml:lang="en-US" id="id_7647232_1177096_1_1">Adjustments To Additional Paid In Capital Stock Option Issued Upon Debt Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion_lbl" xml:lang="en-US" id="id_7647232_1177096_2_1">Discount on notes-for-stock exchange</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US" id="id_7647232_1118448_1_1">Adjustments to Additional Paid in Capital, Warrant Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US" id="id_7647232_1118448_2_1">Issuance of warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="id_7647232_1105757_1_1">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="id_7647232_1105757_2_1">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsAxis" xlink:label="mnkd_AgreementsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AgreementsAxis_lbl" xml:lang="en-US" id="id_7647232_1156564_3_1">Agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AgreementsAxis_lbl" xml:lang="en-US" id="id_7647232_1156564_1_1">Agreements [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AgreementsAxis_lbl" xml:lang="en-US" id="id_7647232_1156564_2_1">Agreements [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AgreementsAxis" xlink:to="mnkd_AgreementsAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsDomain" xlink:label="mnkd_AgreementsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AgreementsDomain_lbl" xml:lang="en-US" id="id_7647232_1150489_3_1">Agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AgreementsDomain_lbl" xml:lang="en-US" id="id_7647232_1150489_1_1">Agreements [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AgreementsDomain_lbl" xml:lang="en-US" id="id_7647232_1150489_2_1">Agreements [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AgreementsDomain" xlink:to="mnkd_AgreementsDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AlfredMannFoundationMember" xlink:label="mnkd_AlfredMannFoundationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AlfredMannFoundationMember_lbl" xml:lang="en-US" id="id_7647232_1320039_3_1">Alfred Mann Foundation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AlfredMannFoundationMember_lbl" xml:lang="en-US" id="id_7647232_1320039_1_1">Alfred Mann Foundation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AlfredMannFoundationMember_lbl" xml:lang="en-US" id="id_7647232_1320039_2_1">Mann Foundation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AlfredMannFoundationMember" xlink:to="mnkd_AlfredMannFoundationMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="id_7647232_1123429_1_1">Allocated Share-based Compensation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="id_7647232_1123429_2_1">Share based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="id_7647232_1123429_12_1">Stock based compensation expense related to stock award plans and the ESPP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AmendedAgreementMember" xlink:label="mnkd_AmendedAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AmendedAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1166445_3_1">Amended Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AmendedAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1166445_1_1">Amended Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AmendedAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1166445_2_1">Amended Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AmendedAgreementMember" xlink:to="mnkd_AmendedAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" id="id_7647232_1111599_1_1">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" id="id_7647232_1111599_2_1">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US" id="id_7647232_1121218_1_1">Amortization of Debt Discount (Premium)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US" id="id_7647232_1121218_2_1">Accretion expense- debt discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US" id="id_7647232_1121218_12_1">Premium of issuance of 2018 debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US" id="id_7647232_1121683_1_1">Amortization of Financing Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US" id="id_7647232_1121683_2_1">Accretion expense- debt issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US" id="id_7647232_1122526_1_1">Amortization of Financing Costs and Discounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US" id="id_7647232_1122526_2_1">Accretion of debt issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AmortizationPeriodOfLeaseHoldImprovements" xlink:label="mnkd_AmortizationPeriodOfLeaseHoldImprovements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AmortizationPeriodOfLeaseHoldImprovements_lbl" xml:lang="en-US" id="id_7647232_1257842_3_1">Amortization period of lease hold improvements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AmortizationPeriodOfLeaseHoldImprovements_lbl" xml:lang="en-US" id="id_7647232_1257842_1_1">Amortization Period Of Lease Hold Improvements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AmortizationPeriodOfLeaseHoldImprovements_lbl" xml:lang="en-US" id="id_7647232_1257842_2_1">Amortization period of lease hold improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AmortizationPeriodOfLeaseHoldImprovements" xlink:to="mnkd_AmortizationPeriodOfLeaseHoldImprovements_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="id_7647232_1107326_1_1">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="id_7647232_1107326_2_1">Potentially dilutive securities outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="id_7647232_1112578_1_1">Antidilutive Securities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="id_7647232_1112578_2_1">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="id_7647232_1111080_1_1">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="id_7647232_1111080_2_1">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="id_7647232_1104730_1_1">Antidilutive Securities, Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="id_7647232_1104730_2_1">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AreaOfOfficeSpaceLeased" xlink:label="mnkd_AreaOfOfficeSpaceLeased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AreaOfOfficeSpaceLeased_lbl" xml:lang="en-US" id="id_7647232_1199236_3_1">Area Of Office Space Leased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AreaOfOfficeSpaceLeased_lbl" xml:lang="en-US" id="id_7647232_1199236_1_1">Area Of Office Space Leased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AreaOfOfficeSpaceLeased_lbl" xml:lang="en-US" id="id_7647232_1199236_2_1">Area of office space leased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AreaOfOfficeSpaceLeased" xlink:to="mnkd_AreaOfOfficeSpaceLeased_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" id="id_7647232_1113479_1_1">Arrangements and Non-arrangement Transactions [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" id="id_7647232_1113479_2_1">Arrangements and Non-arrangement Transactions [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US" id="id_7647232_1122186_1_1">Asset Impairment Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US" id="id_7647232_1122186_2_1">Asset impairment charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US" id="id_7647232_1122186_12_1">Impairment charge</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" id="id_7647232_1123375_1_1">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" id="id_7647232_1123375_6_1">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="id_7647232_1110678_1_1">Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="id_7647232_1110678_2_1">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="id_7647232_1121346_1_1">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="id_7647232_1121346_6_1">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="id_7647232_1104780_1_1">Assets, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="id_7647232_1104780_2_1">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis_lbl" xml:lang="en-US" id="id_7647232_1109456_1_1">Securities or Other Assets Sold under Agreements to Repurchase [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis_lbl" xml:lang="en-US" id="id_7647232_1109456_2_1">Securities or Other Assets Sold under Agreements to Repurchase [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1114579_1_1">Assets Sold under Agreements to Repurchase, Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1114579_2_1">Assets Sold under Agreements to Repurchase, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AvailableBorrowingsUnderLoanAgreement" xlink:label="mnkd_AvailableBorrowingsUnderLoanAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AvailableBorrowingsUnderLoanAgreement_lbl" xml:lang="en-US" id="id_7647232_1228702_3_1">Available borrowings under the loan agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AvailableBorrowingsUnderLoanAgreement_lbl" xml:lang="en-US" id="id_7647232_1228702_1_1">Available Borrowings Under Loan Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AvailableBorrowingsUnderLoanAgreement_lbl" xml:lang="en-US" id="id_7647232_1228702_2_1">Available borrowings under loan agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AvailableBorrowingsUnderLoanAgreement" xlink:to="mnkd_AvailableBorrowingsUnderLoanAgreement_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AvailableLoanBalanceCancelled" xlink:label="mnkd_AvailableLoanBalanceCancelled"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_AvailableLoanBalanceCancelled_lbl" xml:lang="en-US" id="id_7647232_1140997_3_1">Available Loan Balance Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_AvailableLoanBalanceCancelled_lbl" xml:lang="en-US" id="id_7647232_1140997_1_1">Available Loan Balance Cancelled</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_AvailableLoanBalanceCancelled_lbl" xml:lang="en-US" id="id_7647232_1140997_2_1">Aggregate principal amount cancelled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AvailableLoanBalanceCancelled" xlink:to="mnkd_AvailableLoanBalanceCancelled_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1104490_1_1">Award Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1104490_2_1">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding" xlink:label="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1228822_3_1">Shares used to compute basic and diluted net loss per share applicable to common stockholders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1228822_1_1">Basic And Diluted Weighted Average Number Of Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1228822_2_1">Weighted average common shares used to compute basic and diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding" xlink:to="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BasisOfPresentationPolicyTextBlock" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1162747_3_1">Basis of Presentation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1162747_1_1">Basis Of Presentation Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1162747_2_1">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BasisOfPresentationPolicyTextBlock" xlink:to="mnkd_BasisOfPresentationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BuildingImprovementsMember" xlink:label="us-gaap_BuildingImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingImprovementsMember_lbl" xml:lang="en-US" id="id_7647232_1114693_1_1">Building Improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BuildingImprovementsMember_lbl" xml:lang="en-US" id="id_7647232_1114693_2_1">Building Improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingImprovementsMember" xlink:to="us-gaap_BuildingImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US" id="id_7647232_1109324_1_1">Building [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US" id="id_7647232_1109324_2_1">Buildings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BusinessPolicyTextBlock" xlink:label="mnkd_BusinessPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_BusinessPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1181656_3_1">Business.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_BusinessPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1181656_1_1">Business Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_BusinessPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1181656_2_1">Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BusinessPolicyTextBlock" xlink:to="mnkd_BusinessPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="stpr_CA_lbl" xml:lang="en-US" id="id_7647232_1111055_1_1">CALIFORNIA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="stpr_CA_lbl" xml:lang="en-US" id="id_7647232_1111055_2_1">CALIFORNIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty" xlink:label="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1189919_3_1">Cancellation of principal on note payable to related party.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1189919_1_1">Cancellation Of Principal On Note Payable To Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1189919_2_1">Reduction of principal on note payable to principal stockholder upon issuance of common stock and exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty" xlink:to="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xml:lang="en-US" id="id_7647232_1114560_1_1">Reported Value Measurement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xml:lang="en-US" id="id_7647232_1114560_2_1">Reported Value Measurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_7647232_1122823_1_1">Cash and Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_7647232_1122823_4_1">CASH AND CASH EQUIVALENTS, END OF PERIOD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_7647232_1122823_5_1">CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_7647232_1122823_2_1">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_7647232_1122823_12_1">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US" id="id_7647232_1122809_1_1">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US" id="id_7647232_1122809_6_1">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109015_1_1">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109015_2_1">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" id="id_7647232_1104385_1_1">Class of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" id="id_7647232_1104385_2_1">Class of Stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantExercisablePeriod" xlink:label="mnkd_ClassOfWarrantExercisablePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ClassOfWarrantExercisablePeriod_lbl" xml:lang="en-US" id="id_7647232_1318888_3_1">Class of warrant exercisable period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ClassOfWarrantExercisablePeriod_lbl" xml:lang="en-US" id="id_7647232_1318888_1_1">Class Of Warrant Exercisable Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ClassOfWarrantExercisablePeriod_lbl" xml:lang="en-US" id="id_7647232_1318888_2_1">Warrants exercisable period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ClassOfWarrantExercisablePeriod" xlink:to="mnkd_ClassOfWarrantExercisablePeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice" xlink:label="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice_lbl" xml:lang="en-US" id="id_7647232_1255123_3_1">Class Of Warrant Exercise Price Of Warrants Stated As Percentage Of Offering Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice_lbl" xml:lang="en-US" id="id_7647232_1255123_1_1">Class Of Warrant Exercise Price Of Warrants Stated As Percentage Of Offering Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice_lbl" xml:lang="en-US" id="id_7647232_1255123_2_1">Percentage of shares of common stock issued for offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice" xlink:to="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="id_7647232_1113088_1_1">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="id_7647232_1113088_2_1">Exercise price of restricted warrants per share in connection with the offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="id_7647232_1115984_1_1">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="id_7647232_1115984_2_1">Number of warrants are exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" id="id_7647232_1113902_1_1">Class of Warrant or Right, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" id="id_7647232_1113902_2_1">Restricted warrants issued to purchase number of common stock for offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantsOrRightsExpirationDate" xlink:label="mnkd_ClassOfWarrantsOrRightsExpirationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ClassOfWarrantsOrRightsExpirationDate_lbl" xml:lang="en-US" id="id_7647232_1206693_3_1">Class Of Warrants Or Rights Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ClassOfWarrantsOrRightsExpirationDate_lbl" xml:lang="en-US" id="id_7647232_1206693_1_1">Class Of Warrants Or Rights Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ClassOfWarrantsOrRightsExpirationDate_lbl" xml:lang="en-US" id="id_7647232_1206693_2_1">Warrants expiration, date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ClassOfWarrantsOrRightsExpirationDate" xlink:to="mnkd_ClassOfWarrantsOrRightsExpirationDate_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClinicalTrialExpensePolicyTextBlock" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1253363_3_1">Clinical Trial Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1253363_1_1">Clinical Trial Expense [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1253363_2_1">Clinical Trial Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ClinicalTrialExpensePolicyTextBlock" xlink:to="mnkd_ClinicalTrialExpensePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CollaborationAndLicenseAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1282107_3_1">Collaboration and License Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CollaborationAndLicenseAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1282107_1_1">Collaboration and License Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CollaborationAndLicenseAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1282107_2_1">License and Collaboration Agreement with Sanofi</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CollaborationAndLicenseAgreementMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110745_1_1">Collaborative Arrangement Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110745_2_1">Collaboration arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US" id="id_7647232_1114243_1_1">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US" id="id_7647232_1114243_2_1">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="id_7647232_1119602_1_1">Commitments and Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="id_7647232_1119602_2_1">Commitments and contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1110978_1_1">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1110978_2_1">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1114461_1_1">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1114461_2_1">Commitments and contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommitmentsAndContingenciesLineItems" xlink:label="mnkd_CommitmentsAndContingenciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CommitmentsAndContingenciesLineItems_lbl" xml:lang="en-US" id="id_7647232_1200190_3_1">Commitments and Contingencies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CommitmentsAndContingenciesLineItems_lbl" xml:lang="en-US" id="id_7647232_1200190_1_1">Commitments and Contingencies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CommitmentsAndContingenciesLineItems_lbl" xml:lang="en-US" id="id_7647232_1200190_2_1">Commitments and Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_CommitmentsAndContingenciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109643_1_1">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109643_2_1">Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommitmentsAndContingenciesTable" xlink:label="mnkd_CommitmentsAndContingenciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CommitmentsAndContingenciesTable_lbl" xml:lang="en-US" id="id_7647232_1252802_3_1">Commitments and Contingencies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CommitmentsAndContingenciesTable_lbl" xml:lang="en-US" id="id_7647232_1252802_1_1">Commitments and Contingencies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CommitmentsAndContingenciesTable_lbl" xml:lang="en-US" id="id_7647232_1252802_2_1">Commitments and Contingencies [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="mnkd_CommitmentsAndContingenciesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonAndPreferredStockTextBlock" xlink:label="mnkd_CommonAndPreferredStockTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CommonAndPreferredStockTextBlock_lbl" xml:lang="en-US" id="id_7647232_1163115_3_1">Common and preferred stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CommonAndPreferredStockTextBlock_lbl" xml:lang="en-US" id="id_7647232_1163115_1_1">Common And Preferred Stock [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CommonAndPreferredStockTextBlock_lbl" xml:lang="en-US" id="id_7647232_1163115_2_1">Common and preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonAndPreferredStockTextBlock" xlink:to="mnkd_CommonAndPreferredStockTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US" id="id_7647232_1104204_1_1">Common Stock, Capital Shares Reserved for Future Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US" id="id_7647232_1104204_2_1">Shares reserved for issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockIssuedToByPartyAxis" xlink:label="mnkd_CommonStockIssuedToByPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CommonStockIssuedToByPartyAxis_lbl" xml:lang="en-US" id="id_7647232_1212432_3_1">Common stock issued to by party.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CommonStockIssuedToByPartyAxis_lbl" xml:lang="en-US" id="id_7647232_1212432_1_1">Common Stock Issued To By Party [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CommonStockIssuedToByPartyAxis_lbl" xml:lang="en-US" id="id_7647232_1212432_2_1">Common Stock Issued To By Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonStockIssuedToByPartyAxis" xlink:to="mnkd_CommonStockIssuedToByPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockIssuedToByPartyDomain" xlink:label="mnkd_CommonStockIssuedToByPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CommonStockIssuedToByPartyDomain_lbl" xml:lang="en-US" id="id_7647232_1222678_3_1">Common stock issued to by party.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CommonStockIssuedToByPartyDomain_lbl" xml:lang="en-US" id="id_7647232_1222678_1_1">Common Stock Issued To By Party [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CommonStockIssuedToByPartyDomain_lbl" xml:lang="en-US" id="id_7647232_1222678_2_1">Common Stock Issued To By Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonStockIssuedToByPartyDomain" xlink:to="mnkd_CommonStockIssuedToByPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementShares" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares_lbl" xml:lang="en-US" id="id_7647232_1187292_3_1">Common stock loaned under share lending agreement, shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares_lbl" xml:lang="en-US" id="id_7647232_1187292_1_1">Common Stock Loaned Under Share Lending Agreement Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares_lbl" xml:lang="en-US" id="id_7647232_1187292_2_1">Common stock loaned under share lending agreement, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares_lbl" xml:lang="en-US" id="id_7647232_1187292_12_1">Return of loaned common stock (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares_lbl" xml:lang="en-US" id="id_7647232_1187292_14_1">Return of loaned common stock (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonStockLoanedUnderShareLendingAgreementShares" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementShares_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementValue" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementValue_lbl" xml:lang="en-US" id="id_7647232_1318037_3_1">Common Stock Loaned Under Share Lending Agreement Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementValue_lbl" xml:lang="en-US" id="id_7647232_1318037_1_1">Common Stock Loaned Under Share Lending Agreement Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementValue_lbl" xml:lang="en-US" id="id_7647232_1318037_2_1">Return of loaned common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonStockLoanedUnderShareLendingAgreementValue" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="id_7647232_1105034_1_1">Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="id_7647232_1105034_2_1">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_7647232_1106440_1_1">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_7647232_1106440_2_1">Common stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="id_7647232_1108209_1_1">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="id_7647232_1108209_2_1">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="id_7647232_1115337_1_1">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="id_7647232_1115337_2_1">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1110276_1_1">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1110276_2_1">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="id_7647232_1118710_1_1">Common Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="id_7647232_1118710_2_1">Common stock, $0.01 par value - 550,000,000 shares authorized at December 31, 2015 and 2014, respectively; 428,670,943 and 406,059,089 shares issued and outstanding at December 31, 2015 and 2014, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1111696_1_1">Compensation and Retirement Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1111696_2_1">Compensation and Retirement Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1111626_1_1">Compensation Related Costs, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1111626_2_1">Stock-Based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US" id="id_7647232_1112291_1_1">Components of Deferred Tax Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US" id="id_7647232_1112291_2_1">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1117403_1_1">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1117403_6_1">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115783_1_1">Comprehensive Income, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115783_2_1">Comprehensive Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ComputerEquipmentAndSoftwareMember" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember_lbl" xml:lang="en-US" id="id_7647232_1173496_3_1">Computer equipment and software.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember_lbl" xml:lang="en-US" id="id_7647232_1173496_1_1">Computer Equipment And Software [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember_lbl" xml:lang="en-US" id="id_7647232_1173496_2_1">Computer Equipment and Software</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ComputerEquipmentAndSoftwareMember" xlink:to="mnkd_ComputerEquipmentAndSoftwareMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" id="id_7647232_1108276_1_1">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" id="id_7647232_1108276_2_1">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConsiderationReceived" xlink:label="mnkd_ConsiderationReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ConsiderationReceived_lbl" xml:lang="en-US" id="id_7647232_1251423_3_1">Consideration Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ConsiderationReceived_lbl" xml:lang="en-US" id="id_7647232_1251423_1_1">Consideration Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ConsiderationReceived_lbl" xml:lang="en-US" id="id_7647232_1251423_2_1">Total consideration received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConsiderationReceived" xlink:to="mnkd_ConsiderationReceived_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1107528_1_1">Consolidation, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1107528_2_1">Principles of Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" id="id_7647232_1120450_1_1">Construction in Progress Expenditures Incurred but Not yet Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" id="id_7647232_1120450_2_1">Non-cash construction in progress and property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US" id="id_7647232_1108622_1_1">Construction in Progress [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US" id="id_7647232_1108622_2_1">Construction in Progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionPayableCurrent" xlink:label="us-gaap_ConstructionPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionPayableCurrent_lbl" xml:lang="en-US" id="id_7647232_1117674_1_1">Construction Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConstructionPayableCurrent_lbl" xml:lang="en-US" id="id_7647232_1117674_2_1">Construction in progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionPayableCurrent" xlink:to="us-gaap_ConstructionPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConsultantMember" xlink:label="mnkd_ConsultantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ConsultantMember_lbl" xml:lang="en-US" id="id_7647232_1281716_3_1">Consultant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ConsultantMember_lbl" xml:lang="en-US" id="id_7647232_1281716_1_1">Consultant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ConsultantMember_lbl" xml:lang="en-US" id="id_7647232_1281716_2_1">Consultant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConsultantMember" xlink:to="mnkd_ConsultantMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ContingentLiability" xlink:label="mnkd_ContingentLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ContingentLiability_lbl" xml:lang="en-US" id="id_7647232_1276228_3_1">Contingent Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ContingentLiability_lbl" xml:lang="en-US" id="id_7647232_1276228_1_1">Contingent Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ContingentLiability_lbl" xml:lang="en-US" id="id_7647232_1276228_2_1">Contingent liability for milestone payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContingentLiability" xlink:to="mnkd_ContingentLiability_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConvertibleDebtLineItems" xlink:label="mnkd_ConvertibleDebtLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ConvertibleDebtLineItems_lbl" xml:lang="en-US" id="id_7647232_1286839_3_1">Convertible Debt [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ConvertibleDebtLineItems_lbl" xml:lang="en-US" id="id_7647232_1286839_1_1">Convertible Debt [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ConvertibleDebtLineItems_lbl" xml:lang="en-US" id="id_7647232_1286839_2_1">Convertible Debt [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConvertibleDebtLineItems" xlink:to="mnkd_ConvertibleDebtLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xml:lang="en-US" id="id_7647232_1112342_1_1">Convertible Debt Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xml:lang="en-US" id="id_7647232_1112342_2_1">Convertible Debt Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConvertibleDebtTable" xlink:label="mnkd_ConvertibleDebtTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ConvertibleDebtTable_lbl" xml:lang="en-US" id="id_7647232_1230315_3_1">Convertible Debt [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ConvertibleDebtTable_lbl" xml:lang="en-US" id="id_7647232_1230315_1_1">Convertible Debt [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ConvertibleDebtTable_lbl" xml:lang="en-US" id="id_7647232_1230315_2_1">Convertible Debt [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="mnkd_ConvertibleDebtTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="us-gaap_ConvertibleLongTermNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_lbl" xml:lang="en-US" id="id_7647232_1118439_1_1">Convertible Notes Payable, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_lbl" xml:lang="en-US" id="id_7647232_1118439_2_1">Senior convertible notes - long term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US" id="id_7647232_1119477_1_1">Convertible Notes Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US" id="id_7647232_1119477_2_1">Senior convertible notes - current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US" id="id_7647232_1107053_1_1">Credit Facility [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US" id="id_7647232_1107053_2_1">Credit Facility [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditFacilityDomain_lbl" xml:lang="en-US" id="id_7647232_1111796_1_1">Credit Facility [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CreditFacilityDomain_lbl" xml:lang="en-US" id="id_7647232_1111796_2_1">Credit Facility [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1123641_1_1">Current Federal Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1123641_2_1">U.S. federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="id_7647232_1107588_1_1">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="id_7647232_1107588_2_1">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1124680_1_1">Current Foreign Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1124680_2_1">Non-U.S.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1122131_1_1">Current Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1122131_6_1">Total current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1107218_1_1">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1107218_2_1">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1120943_1_1">Current State and Local Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1120943_2_1">U.S. state</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DanburyFacilityMember" xlink:label="mnkd_DanburyFacilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DanburyFacilityMember_lbl" xml:lang="en-US" id="id_7647232_1321372_3_1">Danbury Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DanburyFacilityMember_lbl" xml:lang="en-US" id="id_7647232_1321372_1_1">Danbury Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DanburyFacilityMember_lbl" xml:lang="en-US" id="id_7647232_1321372_2_1">Danbury Facility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DanburyFacilityMember" xlink:to="mnkd_DanburyFacilityMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US" id="id_7647232_1117130_1_1">Debt Conversion, Converted Instrument, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US" id="id_7647232_1117130_2_1">Principal amount of debt converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US" id="id_7647232_1108820_1_1">Debt Conversion, Converted Instrument, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US" id="id_7647232_1108820_2_1">Number of shares issued up on conversion of debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US" id="id_7647232_1120542_1_1">Debt Conversion, Original Debt, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US" id="id_7647232_1120542_2_1">Aggregate principal amount for conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US" id="id_7647232_1120542_12_1">Issuance of common stock pursuant to debt conversion by Deerfield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1113559_1_1">Debt Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1113559_2_1">Debt Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1106541_1_1">Debt Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1106541_2_1">Facility Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="id_7647232_1116613_1_1">Debt Instrument [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="id_7647232_1116613_2_1">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US" id="id_7647232_1113705_1_1">Debt Instrument, Basis Spread on Variable Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US" id="id_7647232_1113705_2_1">Interest rate (LIBOR)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US" id="id_7647232_1119098_1_1">Long-term Debt, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US" id="id_7647232_1119098_2_1">Carrying value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US" id="id_7647232_1119098_6_1">Net carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US" id="id_7647232_1109257_1_1">Debt Instrument, Convertible, Conversion Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US" id="id_7647232_1109257_2_1">Conversion price of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xml:lang="en-US" id="id_7647232_1116779_1_1">Debt Instrument, Convertible, Conversion Ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xml:lang="en-US" id="id_7647232_1116779_2_1">No of convertible shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" id="id_7647232_1111964_1_1">Debt Instrument, Convertible, Threshold Consecutive Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_lbl" xml:lang="en-US" id="id_7647232_1111964_2_1">Consecutive trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xml:lang="en-US" id="id_7647232_1108816_1_1">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xml:lang="en-US" id="id_7647232_1108816_2_1">Percentage of conversion price equaling stock price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xml:lang="en-US" id="id_7647232_1116682_1_1">Debt Instrument, Convertible, Threshold Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xml:lang="en-US" id="id_7647232_1116682_2_1">Number of trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl" xml:lang="en-US" id="id_7647232_1110637_1_1">Debt Instrument, Date of First Required Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl" xml:lang="en-US" id="id_7647232_1110637_2_1">Principal repayment schedule, start date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DebtInstrumentDateOfLastRequiredPayment" xlink:label="mnkd_DebtInstrumentDateOfLastRequiredPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DebtInstrumentDateOfLastRequiredPayment_lbl" xml:lang="en-US" id="id_7647232_1259774_3_1">Debt Instrument Date Of Last Required Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DebtInstrumentDateOfLastRequiredPayment_lbl" xml:lang="en-US" id="id_7647232_1259774_1_1">Debt Instrument Date Of Last Required Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DebtInstrumentDateOfLastRequiredPayment_lbl" xml:lang="en-US" id="id_7647232_1259774_2_1">Principal repayment schedule, end date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentDateOfLastRequiredPayment" xlink:to="mnkd_DebtInstrumentDateOfLastRequiredPayment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xml:lang="en-US" id="id_7647232_1116183_1_1">Debt Instrument, Description of Variable Rate Basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xml:lang="en-US" id="id_7647232_1116183_2_1">Description of variable rate interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="id_7647232_1119656_1_1">Debt Instrument, Face Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="id_7647232_1119656_2_1">Debt facility principal amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="id_7647232_1119656_12_1">Principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xml:lang="en-US" id="id_7647232_1120044_1_1">Debt Instrument, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xml:lang="en-US" id="id_7647232_1120044_2_1">Estimated fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" id="id_7647232_1115612_1_1">Debt Instrument, Interest Rate, Stated Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" id="id_7647232_1115612_2_1">Senior notes, effective interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" id="id_7647232_1112703_1_1">Debt Instrument [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" id="id_7647232_1112703_2_1">Debt Instrument [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US" id="id_7647232_1113732_1_1">Debt Instrument, Maturity Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US" id="id_7647232_1113732_2_1">Maturity date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="id_7647232_1109675_1_1">Debt Instrument, Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="id_7647232_1109675_2_1">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:label="us-gaap_DebtInstrumentRedemptionDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionDescription_lbl" xml:lang="en-US" id="id_7647232_1105583_1_1">Debt Instrument, Redemption, Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionDescription_lbl" xml:lang="en-US" id="id_7647232_1105583_2_1">Debt Instrument, redemption description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionDescription" xlink:to="us-gaap_DebtInstrumentRedemptionDescription_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US" id="id_7647232_1113458_1_1">Debt Instrument, Redemption Price, Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US" id="id_7647232_1113458_2_1">Percentage of repurchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" id="id_7647232_1106436_1_1">Schedule of Long-term Debt Instruments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" id="id_7647232_1106436_2_1">Schedule of Long-term Debt Instruments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US" id="id_7647232_1122879_1_1">Debt Instrument, Unamortized Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US" id="id_7647232_1122879_2_1">Uncreated debt discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium_lbl" xml:lang="en-US" id="id_7647232_1120356_1_1">Debt Instrument, Unamortized Premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium_lbl" xml:lang="en-US" id="id_7647232_1120356_2_1">Unamortized premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="us-gaap_DebtIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtIssuanceCosts_lbl" xml:lang="en-US" id="id_7647232_1123714_1_1">Debt Issuance Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtIssuanceCosts_lbl" xml:lang="en-US" id="id_7647232_1123714_2_1">Debt Issuance Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCosts" xlink:to="us-gaap_DebtIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110890_1_1">Debt, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110890_2_1">Milestone Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeerfieldManagementCompanyLpMember_lbl" xml:lang="en-US" id="id_7647232_1271799_3_1">Deerfield Management Company Lp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeerfieldManagementCompanyLpMember_lbl" xml:lang="en-US" id="id_7647232_1271799_1_1">Deerfield Management Company Lp [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeerfieldManagementCompanyLpMember_lbl" xml:lang="en-US" id="id_7647232_1271799_2_1">Deerfield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeerfieldManagementCompanyLpMember" xlink:to="mnkd_DeerfieldManagementCompanyLpMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCosts_lbl" xml:lang="en-US" id="id_7647232_1123818_1_1">Deferred Costs, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCosts_lbl" xml:lang="en-US" id="id_7647232_1123818_2_1">Deferred cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCostsCurrent" xlink:label="us-gaap_DeferredCostsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCurrent_lbl" xml:lang="en-US" id="id_7647232_1123995_1_1">Deferred Costs, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCostsCurrent_lbl" xml:lang="en-US" id="id_7647232_1123995_2_1">Deferred product costs from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCurrent" xlink:to="us-gaap_DeferredCostsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1121851_1_1">Deferred Federal Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1121851_2_1">U.S. federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1121013_1_1">Deferred Foreign Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1121013_2_1">Non-U.S.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1122732_1_1">Deferred Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1122732_6_1">Total deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1111453_1_1">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1111453_2_1">Deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1120952_1_1">Deferred Other Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1120952_2_1">Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOtherTaxExpenseBenefit" xlink:to="us-gaap_DeferredOtherTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock" xlink:label="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1320072_3_1">Deferred Product Costs From Collaboration [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1320072_1_1">Deferred Product Costs From Collaboration [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1320072_2_1">Deferred product costs from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock" xlink:to="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US" id="id_7647232_1117248_1_1">Deferred Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US" id="id_7647232_1117248_2_1">Deferred revenue from collaboration product shipments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US" id="id_7647232_1119295_1_1">Deferred Revenue, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US" id="id_7647232_1119295_2_1">Deferred payments from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1123915_1_1">Deferred State and Local Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1123915_2_1">U.S. state</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetIncreaseDecreaseInEquity" xlink:label="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity_lbl" xml:lang="en-US" id="id_7647232_1179516_3_1">Deferred Tax Asset Increase Decrease in Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity_lbl" xml:lang="en-US" id="id_7647232_1179516_1_1">Deferred Tax Asset Increase Decrease in Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity_lbl" xml:lang="en-US" id="id_7647232_1179516_2_1">Amount Equity would be increased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity" xlink:to="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts_lbl" xml:lang="en-US" id="id_7647232_1218883_3_1">Deferred Tax Assets Capitalized Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts_lbl" xml:lang="en-US" id="id_7647232_1218883_1_1">Deferred Tax Assets Capitalized Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts_lbl" xml:lang="en-US" id="id_7647232_1218883_2_1">Capitalized patent costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:to="mnkd_DeferredTaxAssetsCapitalizedCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses_lbl" xml:lang="en-US" id="id_7647232_1199231_3_1">Deferred Tax Assets Capitalized Research Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses_lbl" xml:lang="en-US" id="id_7647232_1199231_1_1">Deferred Tax Assets Capitalized Research Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses_lbl" xml:lang="en-US" id="id_7647232_1199231_2_1">Capitalized research</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:to="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US" id="id_7647232_1121946_1_1">Deferred Tax Assets, Deferred Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US" id="id_7647232_1121946_2_1">Payments from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" id="id_7647232_1123508_1_1">Deferred Tax Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" id="id_7647232_1123508_6_1">Total net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsLineItems" xlink:label="mnkd_DeferredTaxAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeferredTaxAssetsLineItems_lbl" xml:lang="en-US" id="id_7647232_1260706_3_1">Deferred Tax Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeferredTaxAssetsLineItems_lbl" xml:lang="en-US" id="id_7647232_1260706_1_1">Deferred Tax Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeferredTaxAssetsLineItems_lbl" xml:lang="en-US" id="id_7647232_1260706_2_1">Deferred Tax Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsLineItems" xlink:to="mnkd_DeferredTaxAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment_lbl" xml:lang="en-US" id="id_7647232_1321423_3_1">Deferred Tax Assets Loss on Purchase Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment_lbl" xml:lang="en-US" id="id_7647232_1321423_1_1">Deferred Tax Assets Loss on Purchase Commitment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment_lbl" xml:lang="en-US" id="id_7647232_1321423_2_1">Loss on purchase commitment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:to="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsMilestoneRights" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights_lbl" xml:lang="en-US" id="id_7647232_1180786_3_1">Deferred Tax Assets Milestone Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights_lbl" xml:lang="en-US" id="id_7647232_1180786_1_1">Deferred Tax Assets Milestone Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights_lbl" xml:lang="en-US" id="id_7647232_1180786_2_1">Milestone Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsMilestoneRights" xlink:to="mnkd_DeferredTaxAssetsMilestoneRights_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US" id="id_7647232_1124418_1_1">Deferred Tax Assets, Net of Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US" id="id_7647232_1124418_6_1">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" id="id_7647232_1123787_1_1">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" id="id_7647232_1123787_2_1">Net operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US" id="id_7647232_1122508_1_1">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US" id="id_7647232_1122508_2_1">Federal operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xml:lang="en-US" id="id_7647232_1121925_1_1">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xml:lang="en-US" id="id_7647232_1121925_2_1">Research and development credits not subject to expiration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US" id="id_7647232_1122850_1_1">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US" id="id_7647232_1122850_2_1">State operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xml:lang="en-US" id="id_7647232_1121972_1_1">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xml:lang="en-US" id="id_7647232_1121972_2_1">Research and development credits subject to expiration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US" id="id_7647232_1122007_1_1">Deferred Tax Assets, Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US" id="id_7647232_1122007_2_1">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsTable" xlink:label="mnkd_DeferredTaxAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeferredTaxAssetsTable_lbl" xml:lang="en-US" id="id_7647232_1285113_3_1">Deferred Tax Assets [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeferredTaxAssetsTable_lbl" xml:lang="en-US" id="id_7647232_1285113_1_1">Deferred Tax Assets [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeferredTaxAssetsTable_lbl" xml:lang="en-US" id="id_7647232_1285113_2_1">Deferred Tax Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsTable" xlink:to="mnkd_DeferredTaxAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" id="id_7647232_1124344_1_1">Deferred Tax Assets, Tax Credit Carryforwards, Research</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US" id="id_7647232_1124344_2_1">Research and development credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xml:lang="en-US" id="id_7647232_1121728_1_1">Deferred Tax Assets, Tax Deferred Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xml:lang="en-US" id="id_7647232_1121728_2_1">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US" id="id_7647232_1121348_1_1">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US" id="id_7647232_1121348_2_1">Non-qualified stock option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xml:lang="en-US" id="id_7647232_1123547_1_1">Deferred Tax Assets, Tax Deferred Expense, Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xml:lang="en-US" id="id_7647232_1123547_2_1">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" id="id_7647232_1119664_1_1">Deferred Tax Assets, Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" id="id_7647232_1119664_14_1">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeficitAccumulatedDuringDevelopmentStageMember" xlink:label="mnkd_DeficitAccumulatedDuringDevelopmentStageMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DeficitAccumulatedDuringDevelopmentStageMember_lbl" xml:lang="en-US" id="id_7647232_1283011_3_1">Deficit accumulated during the development stage member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DeficitAccumulatedDuringDevelopmentStageMember_lbl" xml:lang="en-US" id="id_7647232_1283011_1_1">Deficit Accumulated During Development Stage [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DeficitAccumulatedDuringDevelopmentStageMember_lbl" xml:lang="en-US" id="id_7647232_1283011_2_1">Deficit Accumulated During the Development Stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeficitAccumulatedDuringDevelopmentStageMember" xlink:to="mnkd_DeficitAccumulatedDuringDevelopmentStageMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xml:lang="en-US" id="id_7647232_1123396_1_1">Defined Benefit Plan, Contributions by Employer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xml:lang="en-US" id="id_7647232_1123396_2_1">Employer contribution savings retirement plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_lbl" xml:lang="en-US" id="id_7647232_1111218_1_1">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_lbl" xml:lang="en-US" id="id_7647232_1111218_2_1">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_lbl" xml:lang="en-US" id="id_7647232_1116239_1_1">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_lbl" xml:lang="en-US" id="id_7647232_1116239_2_1">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US" id="id_7647232_1120978_1_1">Depreciation, Depletion and Amortization, Nonproduction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US" id="id_7647232_1120978_2_1">Depreciation and accretion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesLineItems_lbl" xml:lang="en-US" id="id_7647232_1292329_3_1">Depreciation and Other Amortization Expenses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesLineItems_lbl" xml:lang="en-US" id="id_7647232_1292329_1_1">Depreciation and Other Amortization Expenses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesLineItems_lbl" xml:lang="en-US" id="id_7647232_1292329_2_1">Depreciation and Other Amortization Expenses [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="mnkd_DepreciationAndOtherAmortizationExpensesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesTable_lbl" xml:lang="en-US" id="id_7647232_1256998_3_1">Depreciation and Other Amortization Expenses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesTable_lbl" xml:lang="en-US" id="id_7647232_1256998_1_1">Depreciation and Other Amortization Expenses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesTable_lbl" xml:lang="en-US" id="id_7647232_1256998_2_1">Depreciation and Other Amortization Expenses [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="mnkd_DepreciationAndOtherAmortizationExpensesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="id_7647232_1121432_1_1">Depreciation, Depletion and Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="id_7647232_1121432_2_1">Depreciation and amortization expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DevelopmentMilestoneEventsMember" xlink:label="mnkd_DevelopmentMilestoneEventsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DevelopmentMilestoneEventsMember_lbl" xml:lang="en-US" id="id_7647232_1178830_3_1">Development Milestone Events [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DevelopmentMilestoneEventsMember_lbl" xml:lang="en-US" id="id_7647232_1178830_1_1">Development Milestone Events [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DevelopmentMilestoneEventsMember_lbl" xml:lang="en-US" id="id_7647232_1178830_2_1">Development Milestone Event</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DevelopmentMilestoneEventsMember" xlink:to="mnkd_DevelopmentMilestoneEventsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="id_7647232_1111598_1_1">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="id_7647232_1111598_2_1">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="id_7647232_1106621_1_1">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="id_7647232_1106621_2_1">Stock award plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xml:lang="en-US" id="id_7647232_1116573_1_1">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xml:lang="en-US" id="id_7647232_1116573_2_1">Stock Based Award Plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DocumentAndEntityInformationAbstract" xlink:label="mnkd_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" id="id_7647232_1164234_3_1">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" id="id_7647232_1164234_1_1">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" id="id_7647232_1164234_2_1">Document And Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DocumentAndEntityInformationAbstract" xlink:to="mnkd_DocumentAndEntityInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="id_7647232_1108117_1_1">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="id_7647232_1108117_2_1">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="id_7647232_1114425_1_1">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="id_7647232_1114425_2_1">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US" id="id_7647232_1104406_1_1">Document Information [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US" id="id_7647232_1104406_2_1">Document Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationTable_lbl" xml:lang="en-US" id="id_7647232_1111508_1_1">Document Information [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentInformationTable_lbl" xml:lang="en-US" id="id_7647232_1111508_2_1">Document Information [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="id_7647232_1105779_1_1">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="id_7647232_1105779_2_1">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" id="id_7647232_1104186_1_1">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" id="id_7647232_1104186_2_1">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="id_7647232_1111180_1_1">Earnings Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="id_7647232_1111180_2_1">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="id_7647232_1112315_1_1">Earnings Per Share, Basic and Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="id_7647232_1112315_2_1">Net loss per share - basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1108356_1_1">Earnings Per Share, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1108356_2_1">Net Loss Per Share of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110279_1_1">Earnings Per Share [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110279_2_1">Net loss per common share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US" id="id_7647232_1109142_1_1">Effective Income Tax Rate Reconciliation, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US" id="id_7647232_1109142_6_1">Effective income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="id_7647232_1116297_1_1">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="id_7647232_1116297_2_1">Federal tax benefit rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" id="id_7647232_1108372_1_1">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" id="id_7647232_1108372_2_1">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US" id="id_7647232_1115791_1_1">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US" id="id_7647232_1115791_2_1">Intercompany transfer of intellectual property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xml:lang="en-US" id="id_7647232_1184951_3_1">Effective Income Tax Rate Reconciliation Permanent Items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xml:lang="en-US" id="id_7647232_1184951_1_1">Effective Income Tax Rate Reconciliation Permanent Items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xml:lang="en-US" id="id_7647232_1184951_2_1">Permanent items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" id="id_7647232_1106861_1_1">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" id="id_7647232_1106861_2_1">State tax benefit, net of federal benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeMember" xlink:label="mnkd_EmployeeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_EmployeeMember_lbl" xml:lang="en-US" id="id_7647232_1261992_3_1">Employee [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_EmployeeMember_lbl" xml:lang="en-US" id="id_7647232_1261992_1_1">Employee [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_EmployeeMember_lbl" xml:lang="en-US" id="id_7647232_1261992_2_1">Employee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EmployeeMember" xlink:to="mnkd_EmployeeMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1117422_1_1">Employee-related Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1117422_2_1">Salary and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions_lbl" xml:lang="en-US" id="id_7647232_1122368_1_1">Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions_lbl" xml:lang="en-US" id="id_7647232_1122368_2_1">Cash received from the exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US" id="id_7647232_1122387_1_1">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US" id="id_7647232_1122387_2_1">Unrecognized compensation cost related to non vested stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" id="id_7647232_1107970_1_1">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" id="id_7647232_1107970_2_1">Weighted average vesting period for unrecognized compensation cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="us-gaap_EmployeeSeveranceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeSeveranceMember_lbl" xml:lang="en-US" id="id_7647232_1109150_1_1">Employee Severance [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeSeveranceMember_lbl" xml:lang="en-US" id="id_7647232_1109150_2_1">Employee Severance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeSeveranceMember" xlink:to="us-gaap_EmployeeSeveranceMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="id_7647232_1107650_1_1">Employee Stock Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="id_7647232_1107650_2_1">Stock Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares" xlink:label="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares_lbl" xml:lang="en-US" id="id_7647232_1263050_3_1">Employee Stock Purchase Plan Annual Increase In Reserved Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares_lbl" xml:lang="en-US" id="id_7647232_1263050_1_1">Employee Stock Purchase Plan Annual Increase In Reserved Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares_lbl" xml:lang="en-US" id="id_7647232_1263050_2_1">Share reserve automatic increase each year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares" xlink:to="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeStockPurchasePlansMember" xlink:label="mnkd_EmployeeStockPurchasePlansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_EmployeeStockPurchasePlansMember_lbl" xml:lang="en-US" id="id_7647232_1187350_3_1">Employee Stock Purchase Plans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_EmployeeStockPurchasePlansMember_lbl" xml:lang="en-US" id="id_7647232_1187350_1_1">Employee Stock Purchase Plans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_EmployeeStockPurchasePlansMember_lbl" xml:lang="en-US" id="id_7647232_1187350_2_1">Employee Stock Purchase Plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EmployeeStockPurchasePlansMember" xlink:to="mnkd_EmployeeStockPurchasePlansMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="id_7647232_1105747_1_1">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="id_7647232_1105747_2_1">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1105436_1_1">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1105436_2_1">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="id_7647232_1111017_1_1">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="id_7647232_1111017_2_1">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US" id="id_7647232_1105520_1_1">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US" id="id_7647232_1105520_2_1">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="id_7647232_1106302_1_1">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="id_7647232_1106302_2_1">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingsExchangeAxis_lbl" xml:lang="en-US" id="id_7647232_1114584_1_1">Entity Listings, Exchange [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityListingsExchangeAxis_lbl" xml:lang="en-US" id="id_7647232_1114584_2_1">Entity Listings, Exchange [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_EntityListingsExchangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US" id="id_7647232_1119113_1_1">Entity Public Float</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US" id="id_7647232_1119113_2_1">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="id_7647232_1113330_1_1">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="id_7647232_1113330_2_1">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" id="id_7647232_1105267_1_1">Entity Voluntary Filers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" id="id_7647232_1105267_2_1">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" id="id_7647232_1115598_1_1">Entity Well-known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" id="id_7647232_1115598_2_1">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="id_7647232_1108516_1_1">Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="id_7647232_1108516_2_1">Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="id_7647232_1114655_1_1">Equity Component [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="id_7647232_1114655_2_1">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember_lbl" xml:lang="en-US" id="id_7647232_1246246_3_1">Equity Incentive Plan Twenty Thirteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember_lbl" xml:lang="en-US" id="id_7647232_1246246_1_1">Equity Incentive Plan Twenty Thirteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember_lbl" xml:lang="en-US" id="id_7647232_1246246_2_1">2013 Equity Incentive Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EstimatedAmountsCreditExchangeReceivable" xlink:label="mnkd_EstimatedAmountsCreditExchangeReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_EstimatedAmountsCreditExchangeReceivable_lbl" xml:lang="en-US" id="id_7647232_1138428_3_1">Estimated amounts credit exchange receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_EstimatedAmountsCreditExchangeReceivable_lbl" xml:lang="en-US" id="id_7647232_1138428_1_1">Estimated Amounts Credit Exchange Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_EstimatedAmountsCreditExchangeReceivable_lbl" xml:lang="en-US" id="id_7647232_1138428_2_1">Estimated amounts receivable under program</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EstimatedAmountsCreditExchangeReceivable" xlink:to="mnkd_EstimatedAmountsCreditExchangeReceivable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_ExchangeDomain" xlink:label="dei_ExchangeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ExchangeDomain_lbl" xml:lang="en-US" id="id_7647232_1109634_1_1">Exchange [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ExchangeDomain_lbl" xml:lang="en-US" id="id_7647232_1109634_2_1">Exchange [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ExchangeDomain" xlink:to="dei_ExchangeDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExecutiveOfficerMember_lbl" xml:lang="en-US" id="id_7647232_1110946_1_1">Executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExecutiveOfficerMember_lbl" xml:lang="en-US" id="id_7647232_1110946_2_1">Executive Officer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExecutiveOfficerMember" xlink:to="us-gaap_ExecutiveOfficerMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1117990_1_1">Extinguishment of Debt, Gain (Loss), Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1117990_14_1">Loss on extinguishment of debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FacilityAgreementMember" xlink:label="mnkd_FacilityAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_FacilityAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1281090_3_1">Facility Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_FacilityAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1281090_1_1">Facility Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_FacilityAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1281090_2_1">Facility Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FacilityAgreementMember" xlink:to="mnkd_FacilityAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FacilityFinancingObligationMember" xlink:label="mnkd_FacilityFinancingObligationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_FacilityFinancingObligationMember_lbl" xml:lang="en-US" id="id_7647232_1197584_3_1">Facility Financing Obligation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_FacilityFinancingObligationMember_lbl" xml:lang="en-US" id="id_7647232_1197584_1_1">Facility Financing Obligation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_FacilityFinancingObligationMember_lbl" xml:lang="en-US" id="id_7647232_1197584_2_1">Facility financing obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FacilityFinancingObligationMember" xlink:to="mnkd_FacilityFinancingObligationMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xml:lang="en-US" id="id_7647232_1115387_1_1">Asset Class [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xml:lang="en-US" id="id_7647232_1115387_2_1">Asset Class [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" id="id_7647232_1116811_1_1">Fair Value Assumptions, Expected Volatility Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" id="id_7647232_1116811_2_1">Fair value assumption, stock price volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" id="id_7647232_1104992_1_1">Fair Value Assumptions, Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" id="id_7647232_1104992_2_1">Fair value assumption, risk-free rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US" id="id_7647232_1107455_1_1">Asset Class [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US" id="id_7647232_1107455_2_1">Asset Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="id_7647232_1109902_1_1">Fair Value, Hierarchy [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="id_7647232_1109902_2_1">Fair Value, Hierarchy [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xml:lang="en-US" id="id_7647232_1108100_1_1">Measurement Basis [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xml:lang="en-US" id="id_7647232_1108100_2_1">Measurement Basis [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain_lbl" xml:lang="en-US" id="id_7647232_1111662_1_1">Fair Value Measurement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain_lbl" xml:lang="en-US" id="id_7647232_1111662_2_1">Fair Value Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="id_7647232_1108753_1_1">Fair Value Disclosures [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="id_7647232_1108753_2_1">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="id_7647232_1108503_1_1">Fair Value Disclosures [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="id_7647232_1108503_2_1">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="us-gaap_FairValueInputsDiscountRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsDiscountRate_lbl" xml:lang="en-US" id="id_7647232_1116040_1_1">Fair Value Inputs, Discount Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsDiscountRate_lbl" xml:lang="en-US" id="id_7647232_1116040_2_1">Discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsDiscountRate_lbl" xml:lang="en-US" id="id_7647232_1116040_12_1">Market discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsDiscountRate" xlink:to="us-gaap_FairValueInputsDiscountRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsEntityCreditRisk" xlink:label="us-gaap_FairValueInputsEntityCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsEntityCreditRisk_lbl" xml:lang="en-US" id="id_7647232_1105548_1_1">Fair Value Inputs, Entity Credit Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsEntityCreditRisk_lbl" xml:lang="en-US" id="id_7647232_1105548_2_1">Risk premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsEntityCreditRisk" xlink:to="us-gaap_FairValueInputsEntityCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" id="id_7647232_1105152_1_1">Fair Value, Inputs, Level 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" id="id_7647232_1105152_2_1">Fair Value, Inputs, Level 3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems_lbl" xml:lang="en-US" id="id_7647232_1106389_1_1">Fair Value Inputs, Liabilities, Quantitative Information [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems_lbl" xml:lang="en-US" id="id_7647232_1106389_2_1">Fair Value Inputs, Liabilities, Quantitative Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable_lbl" xml:lang="en-US" id="id_7647232_1111094_1_1">Fair Value Inputs, Liabilities, Quantitative Information [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable_lbl" xml:lang="en-US" id="id_7647232_1111094_2_1">Fair Value Inputs, Liabilities, Quantitative Information [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:to="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="id_7647232_1104516_1_1">Fair Value Hierarchy [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="id_7647232_1104516_2_1">Fair Value Hierarchy [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_lbl" xml:lang="en-US" id="id_7647232_1122520_1_1">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_lbl" xml:lang="en-US" id="id_7647232_1122520_2_1">Transfers of assets between fair value measurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl" xml:lang="en-US" id="id_7647232_1117539_1_1">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl" xml:lang="en-US" id="id_7647232_1117539_2_1">Transfers of liabilities between fair value measurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems_lbl" xml:lang="en-US" id="id_7647232_1270752_3_1">Fair Value of Financial Instruments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems_lbl" xml:lang="en-US" id="id_7647232_1270752_1_1">Fair Value of Financial Instruments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems_lbl" xml:lang="en-US" id="id_7647232_1270752_2_1">Fair Value of Financial Instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_FairValueOfFinancialInstrumentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="id_7647232_1104180_1_1">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="id_7647232_1104180_2_1">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FairValueOfFinancialInstrumentsTable" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable_lbl" xml:lang="en-US" id="id_7647232_1174559_3_1">Fair Value of Financial Instruments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable_lbl" xml:lang="en-US" id="id_7647232_1174559_1_1">Fair Value of Financial Instruments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable_lbl" xml:lang="en-US" id="id_7647232_1174559_2_1">Fair Value of Financial Instruments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="mnkd_FairValueOfFinancialInstrumentsTable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FilingAndCompletionOfRegulatoryApprovalsMember" xlink:label="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember_lbl" xml:lang="en-US" id="id_7647232_1231223_3_1">Filing and Completion of Regulatory Approvals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember_lbl" xml:lang="en-US" id="id_7647232_1231223_1_1">Filing and Completion of Regulatory Approvals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember_lbl" xml:lang="en-US" id="id_7647232_1231223_2_1">Regulatory Approvals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember" xlink:to="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US" id="id_7647232_1116897_1_1">Financial Instrument [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US" id="id_7647232_1116897_2_1">Financial Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="id_7647232_1114897_1_1">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="id_7647232_1114897_2_1">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="id_7647232_1107434_1_1">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="id_7647232_1107434_2_1">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US" id="id_7647232_1117341_1_1">Foreign Currency Transaction Gain (Loss), before Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US" id="id_7647232_1117341_14_1">Foreign exchange loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FurnitureFixturesAndOfficeEquipmentMember" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember_lbl" xml:lang="en-US" id="id_7647232_1254910_3_1">Furniture, fixtures and office equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember_lbl" xml:lang="en-US" id="id_7647232_1254910_1_1">Furniture Fixtures And Office Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember_lbl" xml:lang="en-US" id="id_7647232_1254910_2_1">Furniture, fixtures and office equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FurnitureFixturesAndOfficeEquipmentMember" xlink:to="mnkd_FurnitureFixturesAndOfficeEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnContractTermination" xlink:label="us-gaap_GainLossOnContractTermination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnContractTermination_lbl" xml:lang="en-US" id="id_7647232_1119085_1_1">Gain (Loss) on Contract Termination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnContractTermination_lbl" xml:lang="en-US" id="id_7647232_1119085_14_1">Loss on purchase commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnContractTermination" xlink:to="us-gaap_GainLossOnContractTermination_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets_lbl" xml:lang="en-US" id="id_7647232_1118631_1_1">Gain (Loss) on Disposition of Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets_lbl" xml:lang="en-US" id="id_7647232_1118631_2_1">Intellectual property sold, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="us-gaap_GainLossOnDispositionOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:label="mnkd_GainLossOnPurchaseCommitments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_GainLossOnPurchaseCommitments_lbl" xml:lang="en-US" id="id_7647232_1321399_3_1">Gain (Loss) on Purchase Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_GainLossOnPurchaseCommitments_lbl" xml:lang="en-US" id="id_7647232_1321399_1_1">Gain (Loss) on Purchase Commitments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mnkd_GainLossOnPurchaseCommitments_lbl" xml:lang="en-US" id="id_7647232_1321399_14_1">Loss on purchase commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GainLossOnPurchaseCommitments" xlink:to="mnkd_GainLossOnPurchaseCommitments_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" xlink:label="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1153388_3_1">(Gain) loss on sale, abandonment/disposal or impairment of property and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1153388_1_1">Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1153388_14_1">Loss on sale, abandonment/disposal or impairment of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" xlink:to="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" id="id_7647232_1117231_1_1">Gains (Losses) on Extinguishment of Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" id="id_7647232_1117231_2_1">Loss on extinguishment of debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="id_7647232_1121835_1_1">General and Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="id_7647232_1121835_2_1">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" id="id_7647232_1105782_1_1">General and Administrative Expense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" id="id_7647232_1105782_2_1">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US" id="id_7647232_1124084_1_1">Impairment of Long-Lived Assets Held-for-use</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US" id="id_7647232_1124084_2_1">Property and equipment impairment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US" id="id_7647232_1124084_14_1">Less impairment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember_lbl" xml:lang="en-US" id="id_7647232_1113560_1_1">Income Approach Valuation Technique [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember_lbl" xml:lang="en-US" id="id_7647232_1113560_2_1">Income Approach Valuation Technique</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeApproachValuationTechniqueMember" xlink:to="us-gaap_IncomeApproachValuationTechniqueMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="id_7647232_1118461_1_1">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="id_7647232_1118461_6_1">Loss before benefit for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="id_7647232_1105195_1_1">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="id_7647232_1105195_2_1">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" id="id_7647232_1113993_1_1">Income Statement Location [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" id="id_7647232_1113993_2_1">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" id="id_7647232_1112681_1_1">Income Statement Location [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" id="id_7647232_1112681_2_1">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US" id="id_7647232_1112759_1_1">Income Tax Authority [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US" id="id_7647232_1112759_2_1">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" id="id_7647232_1106188_1_1">Income Tax Authority [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" id="id_7647232_1106188_2_1">Income Tax Authority [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1111023_1_1">Income Tax Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1111023_2_1">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1113411_1_1">Income Tax Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1113411_2_1">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesLineItems" xlink:label="mnkd_IncomeTaxesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_IncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1181661_3_1">Income Taxes [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_IncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1181661_1_1">Income Taxes [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_IncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1181661_2_1">Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_IncomeTaxesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1258293_3_1">Income Taxes Provision Benefit Summary Of Income Taxes [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1258293_1_1">Income Taxes Provision Benefit Summary Of Income Taxes [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1258293_2_1">Income Taxes Provision Benefit Summary Of Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:to="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1274197_3_1">Income Taxes Provision Benefit Summary Of Income Taxes [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1274197_1_1">Income Taxes Provision Benefit Summary Of Income Taxes [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1274197_2_1">Income Taxes Provision Benefit Summary Of Income Taxes [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" xlink:to="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesTable" xlink:label="mnkd_IncomeTaxesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_IncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1163561_3_1">Income Taxes [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_IncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1163561_1_1">Income Taxes [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_IncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1163561_2_1">Income Taxes [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncomeTaxesTable" xlink:to="mnkd_IncomeTaxesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1121469_1_1">Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_7647232_1121469_14_1">Income tax benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxExpenseBenefitNet" xlink:label="mnkd_IncomeTaxExpenseBenefitNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_IncomeTaxExpenseBenefitNet_lbl" xml:lang="en-US" id="id_7647232_1234873_3_1">Income Tax Expense Benefit Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_IncomeTaxExpenseBenefitNet_lbl" xml:lang="en-US" id="id_7647232_1234873_1_1">Income Tax Expense Benefit Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mnkd_IncomeTaxExpenseBenefitNet_lbl" xml:lang="en-US" id="id_7647232_1234873_6_1">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncomeTaxExpenseBenefitNet" xlink:to="mnkd_IncomeTaxExpenseBenefitNet_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109202_1_1">Income Tax, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109202_2_1">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US" id="id_7647232_1119761_1_1">Increase (Decrease) in Accounts and Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US" id="id_7647232_1119761_14_1">Receivables from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US" id="id_7647232_1123908_1_1">Increase (Decrease) in Accounts Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US" id="id_7647232_1123908_2_1">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xml:lang="en-US" id="id_7647232_1124678_1_1">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xml:lang="en-US" id="id_7647232_1124678_2_1">Accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits_lbl" xml:lang="en-US" id="id_7647232_1123755_1_1">Increase (Decrease) in Customer Advances and Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits_lbl" xml:lang="en-US" id="id_7647232_1123755_2_1">Deferred payments from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges_lbl" xml:lang="en-US" id="id_7647232_1117222_1_1">Increase (Decrease) in Deferred Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges_lbl" xml:lang="en-US" id="id_7647232_1117222_14_1">Deferred product costs from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCharges" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US" id="id_7647232_1122320_1_1">Increase (Decrease) in Deferred Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US" id="id_7647232_1122320_2_1">Deferred product sales from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US" id="id_7647232_1118430_1_1">Increase (Decrease) in Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US" id="id_7647232_1118430_14_1">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="id_7647232_1111632_1_1">Increase (Decrease) in Operating Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="id_7647232_1111632_2_1">Changes in assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" id="id_7647232_1117055_1_1">Increase (Decrease) in Other Operating Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" id="id_7647232_1117055_14_1">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" id="id_7647232_1123581_1_1">Increase (Decrease) in Other Operating Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" id="id_7647232_1123581_2_1">Other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="id_7647232_1119835_1_1">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="id_7647232_1119835_14_1">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US" id="id_7647232_1106387_1_1">Intellectual Property [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US" id="id_7647232_1106387_2_1">Intellectual property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestCostsCapitalized" xlink:label="us-gaap_InterestCostsCapitalized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestCostsCapitalized_lbl" xml:lang="en-US" id="id_7647232_1121952_1_1">Interest Costs Capitalized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestCostsCapitalized_lbl" xml:lang="en-US" id="id_7647232_1121952_2_1">Interest cost capitalized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestCostsCapitalized" xlink:to="us-gaap_InterestCostsCapitalized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US" id="id_7647232_1120734_1_1">Interest Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US" id="id_7647232_1120734_2_1">Interest expense, net of interest capitalized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US" id="id_7647232_1123036_1_1">Interest Expense, Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US" id="id_7647232_1123036_2_1">Interest expense on notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US" id="id_7647232_1123036_14_1">Interest expense on notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpensePolicyTextBlock" xlink:label="us-gaap_InterestExpensePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpensePolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110230_1_1">Interest Expense, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpensePolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110230_2_1">Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpensePolicyTextBlock" xlink:to="us-gaap_InterestExpensePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US" id="id_7647232_1119468_1_1">Interest Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US" id="id_7647232_1119468_2_1">Interest paid in cash, net of amounts capitalized to Construction in progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaidCapitalized" xlink:label="us-gaap_InterestPaidCapitalized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidCapitalized_lbl" xml:lang="en-US" id="id_7647232_1118619_1_1">Interest Paid, Capitalized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidCapitalized_lbl" xml:lang="en-US" id="id_7647232_1118619_2_1">Capitalization of interest on note payable to principal stockholder</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidCapitalized" xlink:to="us-gaap_InterestPaidCapitalized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US" id="id_7647232_1118999_1_1">Interest Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US" id="id_7647232_1118999_2_1">Accrued interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingLineItems" xlink:label="mnkd_InterimReportingLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_InterimReportingLineItems_lbl" xml:lang="en-US" id="id_7647232_1141902_3_1">Interim Reporting [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_InterimReportingLineItems_lbl" xml:lang="en-US" id="id_7647232_1141902_1_1">Interim Reporting [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_InterimReportingLineItems_lbl" xml:lang="en-US" id="id_7647232_1141902_2_1">Interim Reporting [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_InterimReportingLineItems" xlink:to="mnkd_InterimReportingLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingTable" xlink:label="mnkd_InterimReportingTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_InterimReportingTable_lbl" xml:lang="en-US" id="id_7647232_1182834_3_1">Interim Reporting [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_InterimReportingTable_lbl" xml:lang="en-US" id="id_7647232_1182834_1_1">Interim Reporting [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_InterimReportingTable_lbl" xml:lang="en-US" id="id_7647232_1182834_2_1">Interim Reporting [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_InterimReportingTable" xlink:to="mnkd_InterimReportingTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xml:lang="en-US" id="id_7647232_1107054_1_1">Internal Revenue Service (IRS) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xml:lang="en-US" id="id_7647232_1107054_2_1">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="us-gaap_InternalRevenueServiceIRSMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InventoryCurrentAndNoncurrent" xlink:label="mnkd_InventoryCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_InventoryCurrentAndNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1223638_3_1">Inventory Current And Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_InventoryCurrentAndNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1223638_1_1">Inventory Current And Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_InventoryCurrentAndNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1223638_2_1">Total Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_InventoryCurrentAndNoncurrent" xlink:to="mnkd_InventoryCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryCurrentTable_lbl" xml:lang="en-US" id="id_7647232_1116406_1_1">Inventory, Current [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryCurrentTable_lbl" xml:lang="en-US" id="id_7647232_1116406_2_1">Inventory, Current [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryCurrentTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1113127_1_1">Inventory Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1113127_2_1">Inventory Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1106381_1_1">Inventory Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1106381_2_1">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US" id="id_7647232_1121002_1_1">Inventory, Finished Goods, Net of Reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US" id="id_7647232_1121002_2_1">Finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLineItems_lbl" xml:lang="en-US" id="id_7647232_1105986_1_1">Inventory [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryLineItems_lbl" xml:lang="en-US" id="id_7647232_1105986_2_1">Inventory [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US" id="id_7647232_1124440_1_1">Inventory, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US" id="id_7647232_1124440_2_1">Inventory-current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US" id="id_7647232_1124440_6_1">Inventory - current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1116673_1_1">Inventory, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1116673_2_1">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US" id="id_7647232_1121868_1_1">Inventory, Raw Materials, Net of Reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US" id="id_7647232_1121868_2_1">Raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US" id="id_7647232_1123299_1_1">Inventory, Work in Process, Net of Reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US" id="id_7647232_1123299_2_1">Work-in-process</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US" id="id_7647232_1121800_1_1">Inventory Write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US" id="id_7647232_1121800_2_1">Inventory charge</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" id="id_7647232_1118879_1_1">Investment Income, Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" id="id_7647232_1118879_2_1">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US" id="id_7647232_1116033_1_1">Land [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US" id="id_7647232_1116033_2_1">Land</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseAgreementTypeOfAgreementAxis" xlink:label="mnkd_LeaseAgreementTypeOfAgreementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LeaseAgreementTypeOfAgreementAxis_lbl" xml:lang="en-US" id="id_7647232_1226349_3_1">Lease Agreement Type Of Agreement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LeaseAgreementTypeOfAgreementAxis_lbl" xml:lang="en-US" id="id_7647232_1226349_1_1">Lease Agreement Type Of Agreement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LeaseAgreementTypeOfAgreementAxis_lbl" xml:lang="en-US" id="id_7647232_1226349_2_1">Lease Agreement Type Of Agreement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LeaseAgreementTypeOfAgreementAxis" xlink:to="mnkd_LeaseAgreementTypeOfAgreementAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseAgreementTypeOfAgreementDomain" xlink:label="mnkd_LeaseAgreementTypeOfAgreementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LeaseAgreementTypeOfAgreementDomain_lbl" xml:lang="en-US" id="id_7647232_1145289_3_1">Lease Agreement Type Of Agreement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LeaseAgreementTypeOfAgreementDomain_lbl" xml:lang="en-US" id="id_7647232_1145289_1_1">Lease Agreement Type Of Agreement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LeaseAgreementTypeOfAgreementDomain_lbl" xml:lang="en-US" id="id_7647232_1145289_2_1">Lease Agreement Type Of Agreement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LeaseAgreementTypeOfAgreementDomain" xlink:to="mnkd_LeaseAgreementTypeOfAgreementDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseExpirationMonthYear" xlink:label="mnkd_LeaseExpirationMonthYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LeaseExpirationMonthYear_lbl" xml:lang="en-US" id="id_7647232_1134227_3_1">Lease Expiration Month Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LeaseExpirationMonthYear_lbl" xml:lang="en-US" id="id_7647232_1134227_1_1">Lease Expiration Month Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LeaseExpirationMonthYear_lbl" xml:lang="en-US" id="id_7647232_1134227_2_1">Lease expiration period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LeaseExpirationMonthYear" xlink:to="mnkd_LeaseExpirationMonthYear_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="id_7647232_1111159_1_1">Leasehold Improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="id_7647232_1111159_2_1">Leasehold Improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="id_7647232_1116663_1_1">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="id_7647232_1116663_2_1">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LetterOfAgreementMember" xlink:label="mnkd_LetterOfAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LetterOfAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1277729_3_1">Letter agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LetterOfAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1277729_1_1">Letter Of Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LetterOfAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1277729_2_1">Letter Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LetterOfAgreementMember" xlink:to="mnkd_LetterOfAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" id="id_7647232_1118197_1_1">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" id="id_7647232_1118197_6_1">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="id_7647232_1120090_1_1">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="id_7647232_1120090_6_1">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_7647232_1104367_1_1">Liabilities and Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_7647232_1104367_2_1">LIABILITIES AND STOCKHOLDERS' DEFICIT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1117290_1_1">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1117290_6_1">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="id_7647232_1105566_1_1">Liabilities, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="id_7647232_1105566_2_1">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US" id="id_7647232_1120058_1_1">Financial and Nonfinancial Liabilities, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US" id="id_7647232_1120058_2_1">Fair value of Milestone Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock" xlink:label="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1175009_3_1">License Collaboration And Supply Agreements [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1175009_1_1">License Collaboration And Supply Agreements [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1175009_2_1">License and Collaboration and Supply Agreements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock" xlink:to="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US" id="id_7647232_1120094_1_1">Long-term Line of Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US" id="id_7647232_1120094_2_1">Principal amount outstanding under credit facility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="id_7647232_1120471_1_1">Line of Credit Facility, Maximum Borrowing Capacity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="id_7647232_1120471_2_1">Maximum secured loan facility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US" id="id_7647232_1117981_1_1">Line of Credit Facility, Remaining Borrowing Capacity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US" id="id_7647232_1117981_2_1">Amount available for future borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" xlink:label="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity_lbl" xml:lang="en-US" id="id_7647232_1206740_3_1">Line Of Credit Facility Restricted Borrowing Capacity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity_lbl" xml:lang="en-US" id="id_7647232_1206740_1_1">Line Of Credit Facility Restricted Borrowing Capacity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity_lbl" xml:lang="en-US" id="id_7647232_1206740_2_1">Available amount of credit facility under covenant restrictions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" xlink:to="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LoanAgreementWithRelatedParty" xlink:label="mnkd_LoanAgreementWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LoanAgreementWithRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1275186_3_1">Loan agreement with related party.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LoanAgreementWithRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1275186_1_1">Loan Agreement With Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LoanAgreementWithRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1275186_2_1">Loan agreement with related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LoanAgreementWithRelatedParty" xlink:to="mnkd_LoanAgreementWithRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LoanArrangementMember" xlink:label="mnkd_LoanArrangementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LoanArrangementMember_lbl" xml:lang="en-US" id="id_7647232_1145423_3_1">Loan arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LoanArrangementMember_lbl" xml:lang="en-US" id="id_7647232_1145423_1_1">Loan Arrangement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LoanArrangementMember_lbl" xml:lang="en-US" id="id_7647232_1145423_2_1">Loan Arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LoanArrangementMember" xlink:to="mnkd_LoanArrangementMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansAssumed1" xlink:label="us-gaap_LoansAssumed1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansAssumed1_lbl" xml:lang="en-US" id="id_7647232_1118384_1_1">Loans Assumed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansAssumed1_lbl" xml:lang="en-US" id="id_7647232_1118384_2_1">Reclassification of deferred payments from collaboration to Sanofi loan facility and loss share obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansAssumed1" xlink:to="us-gaap_LoansAssumed1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xml:lang="en-US" id="id_7647232_1106038_1_1">London Interbank Offered Rate (LIBOR) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xml:lang="en-US" id="id_7647232_1106038_2_1">LIBOR</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" id="id_7647232_1118970_1_1">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" id="id_7647232_1118970_2_1">Facility Agreement, total principle payment in 2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US" id="id_7647232_1120364_1_1">Long-term Debt, Maturities, Repayments of Principal in Year Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US" id="id_7647232_1120364_2_1">Facility Agreement, total principle payment in 2019</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US" id="id_7647232_1120423_1_1">Long-term Debt, Maturities, Repayments of Principal in Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US" id="id_7647232_1120423_2_1">Facility Agreement, total principle payment in 2018</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" id="id_7647232_1118319_1_1">Long-term Debt, Maturities, Repayments of Principal in Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" id="id_7647232_1118319_2_1">Facility Agreement, total principle payment in 2017</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xml:lang="en-US" id="id_7647232_1112977_1_1">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xml:lang="en-US" id="id_7647232_1112977_2_1">Fixed borrowing rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115644_1_1">Long-term Debt [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115644_2_1">Senior convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1110347_1_1">Long-term Debt, Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1110347_2_1">Long-term Debt, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1115457_1_1">Long-term Debt, Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1115457_2_1">Long-term Debt, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="us-gaap_LongTermLoansPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLoansPayable_lbl" xml:lang="en-US" id="id_7647232_1119784_1_1">Loans Payable, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermLoansPayable_lbl" xml:lang="en-US" id="id_7647232_1119784_2_1">Secured loan facility, amount owed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xml:lang="en-US" id="id_7647232_1117611_1_1">Long-term Purchase Commitment, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xml:lang="en-US" id="id_7647232_1117611_2_1">Purchase commitment amount under Insulin Supply Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongTermPurchaseCommitmentCancellationFees" xlink:label="mnkd_LongTermPurchaseCommitmentCancellationFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LongTermPurchaseCommitmentCancellationFees_lbl" xml:lang="en-US" id="id_7647232_1267102_3_1">Long Term Purchase Commitment Cancellation Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LongTermPurchaseCommitmentCancellationFees_lbl" xml:lang="en-US" id="id_7647232_1267102_1_1">Long Term Purchase Commitment Cancellation Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LongTermPurchaseCommitmentCancellationFees_lbl" xml:lang="en-US" id="id_7647232_1267102_2_1">Purchase commitment cancellation fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LongTermPurchaseCommitmentCancellationFees" xlink:to="mnkd_LongTermPurchaseCommitmentCancellationFees_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongTermPurchaseCommitmentExpirationDate" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate_lbl" xml:lang="en-US" id="id_7647232_1203504_3_1">Long Term Purchase Commitment, Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate_lbl" xml:lang="en-US" id="id_7647232_1203504_1_1">Long Term Purchase Commitment, Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate_lbl" xml:lang="en-US" id="id_7647232_1203504_2_1">Supply Agreement expiration period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LongTermPurchaseCommitmentExpirationDate" xlink:to="mnkd_LongTermPurchaseCommitmentExpirationDate_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod_lbl" xml:lang="en-US" id="id_7647232_1188667_3_1">Long-term purchase commitment, renewal time period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod_lbl" xml:lang="en-US" id="id_7647232_1188667_1_1">Long-term Purchase Commitment, Renewal Time Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod_lbl" xml:lang="en-US" id="id_7647232_1188667_2_1">Supply Agreement renewal period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" xlink:to="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:label="us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAccrualCarryingValueNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1117573_1_1">Loss Contingency, Accrual, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingencyAccrualCarryingValueNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1117573_2_1">Sanofi loan facility and loss share obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="us-gaap_LossContingencyAccrualCarryingValueNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LossSharingAgreementAmount" xlink:label="mnkd_LossSharingAgreementAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_LossSharingAgreementAmount_lbl" xml:lang="en-US" id="id_7647232_1192069_3_1">Loss Sharing Agreement, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_LossSharingAgreementAmount_lbl" xml:lang="en-US" id="id_7647232_1192069_1_1">Loss Sharing Agreement, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_LossSharingAgreementAmount_lbl" xml:lang="en-US" id="id_7647232_1192069_2_1">Company's total portion of loss sharing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LossSharingAgreementAmount" xlink:to="mnkd_LossSharingAgreementAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US" id="id_7647232_1110462_1_1">Machinery and Equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US" id="id_7647232_1110462_2_1">Machinery and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorPropertyClassAxis" xlink:label="us-gaap_MajorPropertyClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorPropertyClassAxis_lbl" xml:lang="en-US" id="id_7647232_1111076_1_1">Major Property Class [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MajorPropertyClassAxis_lbl" xml:lang="en-US" id="id_7647232_1111076_2_1">Major Property Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorPropertyClassAxis" xlink:to="us-gaap_MajorPropertyClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorPropertyClassDomain" xlink:label="us-gaap_MajorPropertyClassDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorPropertyClassDomain_lbl" xml:lang="en-US" id="id_7647232_1115782_1_1">Major Property Class [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MajorPropertyClassDomain_lbl" xml:lang="en-US" id="id_7647232_1115782_2_1">Major Property Class [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorPropertyClassDomain" xlink:to="us-gaap_MajorPropertyClassDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ManufacturingCosts_lbl" xml:lang="en-US" id="id_7647232_1123699_1_1">Manufacturing Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ManufacturingCosts_lbl" xml:lang="en-US" id="id_7647232_1123699_2_1">Product manufacturing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManufacturingCosts" xlink:to="us-gaap_ManufacturingCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ManufacturingMilestoneEventsMember" xlink:label="mnkd_ManufacturingMilestoneEventsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ManufacturingMilestoneEventsMember_lbl" xml:lang="en-US" id="id_7647232_1230904_3_1">Manufacturing Milestone Events [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ManufacturingMilestoneEventsMember_lbl" xml:lang="en-US" id="id_7647232_1230904_1_1">Manufacturing Milestone Events [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ManufacturingMilestoneEventsMember_lbl" xml:lang="en-US" id="id_7647232_1230904_2_1">Manufacturing Milestone Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ManufacturingMilestoneEventsMember" xlink:to="mnkd_ManufacturingMilestoneEventsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="us-gaap_MarketApproachValuationTechniqueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketApproachValuationTechniqueMember_lbl" xml:lang="en-US" id="id_7647232_1105702_1_1">Market Approach Valuation Technique [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketApproachValuationTechniqueMember_lbl" xml:lang="en-US" id="id_7647232_1105702_2_1">Market Approach Valuation Technique</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketApproachValuationTechniqueMember" xlink:to="us-gaap_MarketApproachValuationTechniqueMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MaturityPeriodOfCashEquivalents" xlink:label="mnkd_MaturityPeriodOfCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_MaturityPeriodOfCashEquivalents_lbl" xml:lang="en-US" id="id_7647232_1217581_3_1">Maturity period of cash equivalents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_MaturityPeriodOfCashEquivalents_lbl" xml:lang="en-US" id="id_7647232_1217581_1_1">Maturity Period Of Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_MaturityPeriodOfCashEquivalents_lbl" xml:lang="en-US" id="id_7647232_1217581_2_1">Maturity period of cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MaturityPeriodOfCashEquivalents" xlink:to="mnkd_MaturityPeriodOfCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US" id="id_7647232_1116460_1_1">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US" id="id_7647232_1116460_2_1">Maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneEventsAxis" xlink:label="mnkd_MilestoneEventsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_MilestoneEventsAxis_lbl" xml:lang="en-US" id="id_7647232_1150195_3_1">Milestone Events [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_MilestoneEventsAxis_lbl" xml:lang="en-US" id="id_7647232_1150195_1_1">Milestone Events [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_MilestoneEventsAxis_lbl" xml:lang="en-US" id="id_7647232_1150195_2_1">Milestone Events [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneEventsAxis" xlink:to="mnkd_MilestoneEventsAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneEventsDomain" xlink:label="mnkd_MilestoneEventsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_MilestoneEventsDomain_lbl" xml:lang="en-US" id="id_7647232_1224868_3_1">Milestone Events [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_MilestoneEventsDomain_lbl" xml:lang="en-US" id="id_7647232_1224868_1_1">Milestone Events [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_MilestoneEventsDomain_lbl" xml:lang="en-US" id="id_7647232_1224868_2_1">Milestone Events [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_MilestoneEventsDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestonePayments" xlink:label="mnkd_MilestonePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_MilestonePayments_lbl" xml:lang="en-US" id="id_7647232_1291863_3_1">Milestone payments include payments to our partners related to alliance and collaboration agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_MilestonePayments_lbl" xml:lang="en-US" id="id_7647232_1291863_1_1">Milestone payments for intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mnkd_MilestonePayments_lbl" xml:lang="en-US" id="id_7647232_1291863_14_1">Milestone payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestonePayments" xlink:to="mnkd_MilestonePayments_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_MilestoneRightsLiabilityMember_lbl" xml:lang="en-US" id="id_7647232_1241281_3_1">Milestone Rights Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_MilestoneRightsLiabilityMember_lbl" xml:lang="en-US" id="id_7647232_1241281_1_1">Milestone Rights Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_MilestoneRightsLiabilityMember_lbl" xml:lang="en-US" id="id_7647232_1241281_2_1">Milestone Rights Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneRightsLiabilityMember" xlink:to="mnkd_MilestoneRightsLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US" id="id_7647232_1107704_1_1">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US" id="id_7647232_1107704_2_1">Minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_lbl" xml:lang="en-US" id="id_7647232_1124494_1_1">Money Market Funds, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_lbl" xml:lang="en-US" id="id_7647232_1124494_2_1">Cash equivalents, money market funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_7647232_1121242_1_1">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_7647232_1121242_6_1">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1111965_1_1">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1111965_2_1">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_7647232_1124621_1_1">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_7647232_1124621_6_1">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1109601_1_1">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1109601_2_1">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_7647232_1110793_1_1">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_7647232_1110793_6_1">Net cash (used in) provided by operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1105190_1_1">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" id="id_7647232_1105190_2_1">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="id_7647232_1119943_1_1">Net Income (Loss) Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="id_7647232_1119943_2_1">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="id_7647232_1119943_6_1">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetIncomeLossPerCommonShareLineItems" xlink:label="mnkd_NetIncomeLossPerCommonShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_NetIncomeLossPerCommonShareLineItems_lbl" xml:lang="en-US" id="id_7647232_1250064_3_1">Net Income Loss Per Common Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_NetIncomeLossPerCommonShareLineItems_lbl" xml:lang="en-US" id="id_7647232_1250064_1_1">Net Income Loss Per Common Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_NetIncomeLossPerCommonShareLineItems_lbl" xml:lang="en-US" id="id_7647232_1250064_2_1">Net Income Loss Per Common Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NetIncomeLossPerCommonShareLineItems" xlink:to="mnkd_NetIncomeLossPerCommonShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetIncomeLossPerCommonShareTable" xlink:label="mnkd_NetIncomeLossPerCommonShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_NetIncomeLossPerCommonShareTable_lbl" xml:lang="en-US" id="id_7647232_1176520_3_1">Net Income Loss Per Common Share [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_NetIncomeLossPerCommonShareTable_lbl" xml:lang="en-US" id="id_7647232_1176520_1_1">Net Income Loss Per Common Share [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_NetIncomeLossPerCommonShareTable_lbl" xml:lang="en-US" id="id_7647232_1176520_2_1">Net Income Loss Per Common Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NetIncomeLossPerCommonShareTable" xlink:to="mnkd_NetIncomeLossPerCommonShareTable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetOperatingLossCarryforwardAnnualLimitation" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation_lbl" xml:lang="en-US" id="id_7647232_1133343_3_1">Net Operating Loss Carryforward Annual Limitation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation_lbl" xml:lang="en-US" id="id_7647232_1133343_1_1">Net Operating Loss Carryforward Annual Limitation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation_lbl" xml:lang="en-US" id="id_7647232_1133343_2_1">Net operating loss and credit carryforwards, annual use limitation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NetOperatingLossCarryforwardAnnualLimitation" xlink:to="mnkd_NetOperatingLossCarryforwardAnnualLimitation_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetOperatingLossCarryforwardsBeginsToExpire" xlink:label="mnkd_NetOperatingLossCarryforwardsBeginsToExpire"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_NetOperatingLossCarryforwardsBeginsToExpire_lbl" xml:lang="en-US" id="id_7647232_1238922_3_1">Net Operating Loss Carryforwards Begins To Expire</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_NetOperatingLossCarryforwardsBeginsToExpire_lbl" xml:lang="en-US" id="id_7647232_1238922_1_1">Net Operating Loss Carryforwards Begins To Expire</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_NetOperatingLossCarryforwardsBeginsToExpire_lbl" xml:lang="en-US" id="id_7647232_1238922_2_1">Net operating loss carryforwards, expiration year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NetOperatingLossCarryforwardsBeginsToExpire" xlink:to="mnkd_NetOperatingLossCarryforwardsBeginsToExpire_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NominalLendingFee" xlink:label="mnkd_NominalLendingFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_NominalLendingFee_lbl" xml:lang="en-US" id="id_7647232_1144970_3_1">Nominal lending fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_NominalLendingFee_lbl" xml:lang="en-US" id="id_7647232_1144970_1_1">Nominal Lending Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_NominalLendingFee_lbl" xml:lang="en-US" id="id_7647232_1144970_2_1">Nominal lending fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NominalLendingFee" xlink:to="mnkd_NominalLendingFee_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NontradeReceivablesNoncurrent" xlink:label="us-gaap_NontradeReceivablesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NontradeReceivablesNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1123047_1_1">Nontrade Receivables, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NontradeReceivablesNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1123047_2_1">State research and development credit exchange receivable - net of current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NontradeReceivablesNoncurrent" xlink:to="us-gaap_NontradeReceivablesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1117483_1_1">Notes Payable, Related Parties, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1117483_2_1">Note payable to principal stockholder</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NumberOfAssetGroups" xlink:label="mnkd_NumberOfAssetGroups"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_NumberOfAssetGroups_lbl" xml:lang="en-US" id="id_7647232_1315274_3_1">Number of Asset Groups</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_NumberOfAssetGroups_lbl" xml:lang="en-US" id="id_7647232_1315274_1_1">Number of Asset Groups</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_NumberOfAssetGroups_lbl" xml:lang="en-US" id="id_7647232_1315274_2_1">Number of primary asset groups</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NumberOfAssetGroups" xlink:to="mnkd_NumberOfAssetGroups_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NumberOfMonthsAdvancesOutstanding" xlink:label="mnkd_NumberOfMonthsAdvancesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_NumberOfMonthsAdvancesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1147104_3_1">Number of months advances outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_NumberOfMonthsAdvancesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1147104_1_1">Number Of Months Advances Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_NumberOfMonthsAdvancesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1147104_2_1">Number of months advances outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NumberOfMonthsAdvancesOutstanding" xlink:to="mnkd_NumberOfMonthsAdvancesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OfficeLeaseExpense" xlink:label="mnkd_OfficeLeaseExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_OfficeLeaseExpense_lbl" xml:lang="en-US" id="id_7647232_1278225_3_1">Office Lease Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_OfficeLeaseExpense_lbl" xml:lang="en-US" id="id_7647232_1278225_1_1">Office Lease Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_OfficeLeaseExpense_lbl" xml:lang="en-US" id="id_7647232_1278225_2_1">Lease payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OfficeLeaseExpense" xlink:to="mnkd_OfficeLeaseExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" id="id_7647232_1120986_1_1">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" id="id_7647232_1120986_6_1">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="id_7647232_1115413_1_1">Operating Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="id_7647232_1115413_2_1">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="id_7647232_1118206_1_1">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="id_7647232_1118206_6_1">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US" id="id_7647232_1120919_1_1">Operating Leases, Rent Expense, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US" id="id_7647232_1120919_2_1">Operating lease rent expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OperatingLossCarryforwardsSubjectToLimitation" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation_lbl" xml:lang="en-US" id="id_7647232_1243208_3_1">Operating Loss Carryforwards Subject To Limitation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation_lbl" xml:lang="en-US" id="id_7647232_1243208_1_1">Operating Loss Carryforwards Subject To Limitation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation_lbl" xml:lang="en-US" id="id_7647232_1243208_2_1">Net operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OperatingLossCarryforwardsSubjectToLimitation" xlink:to="mnkd_OperatingLossCarryforwardsSubjectToLimitation_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OperatingLossSharingMember" xlink:label="mnkd_OperatingLossSharingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_OperatingLossSharingMember_lbl" xml:lang="en-US" id="id_7647232_1153470_3_1">Operating loss Sharing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_OperatingLossSharingMember_lbl" xml:lang="en-US" id="id_7647232_1153470_1_1">Operating loss Sharing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_OperatingLossSharingMember_lbl" xml:lang="en-US" id="id_7647232_1153470_2_1">Operating loss Sharing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OperatingLossSharingMember" xlink:to="mnkd_OperatingLossSharingMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="id_7647232_1105148_1_1">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="id_7647232_1105148_2_1">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xml:lang="en-US" id="id_7647232_1214919_3_1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xml:lang="en-US" id="id_7647232_1214919_1_1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xml:lang="en-US" id="id_7647232_1214919_2_1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xml:lang="en-US" id="id_7647232_1227387_3_1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xml:lang="en-US" id="id_7647232_1227387_1_1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xml:lang="en-US" id="id_7647232_1227387_2_1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1113317_1_1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1113317_2_1">Description of business and basis of presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1119842_1_1">Other Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_7647232_1119842_2_1">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1124048_1_1">Other Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1124048_2_1">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1120120_1_1">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1120120_2_1">Other comprehensive (loss) income - cumulative translation (loss) gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1120120_12_1">Unrealized gain/(loss) on foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1120248_1_1">Other Comprehensive Income (Loss), Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" id="id_7647232_1120248_2_1">Other comprehensive (loss) gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US" id="id_7647232_1109130_1_1">Other Comprehensive Income (Loss), Net of Tax [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US" id="id_7647232_1109130_2_1">Other comprehensive loss:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="us-gaap_OtherDeferredCreditsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDeferredCreditsCurrent_lbl" xml:lang="en-US" id="id_7647232_1120436_1_1">Other Deferred Credits, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherDeferredCreditsCurrent_lbl" xml:lang="en-US" id="id_7647232_1120436_2_1">Deferred product sales from collaboration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDeferredCreditsCurrent" xlink:to="us-gaap_OtherDeferredCreditsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1119182_1_1">Other Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1119182_2_1">Other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="us-gaap_OtherLongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebt_lbl" xml:lang="en-US" id="id_7647232_1119541_1_1">Other Long-term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLongTermDebt_lbl" xml:lang="en-US" id="id_7647232_1119541_2_1">Fair value of milestone rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebt" xlink:to="us-gaap_OtherLongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="us-gaap_OtherLongTermDebtCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebtCurrent_lbl" xml:lang="en-US" id="id_7647232_1119210_1_1">Other Long-term Debt, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLongTermDebtCurrent_lbl" xml:lang="en-US" id="id_7647232_1119210_2_1">Facility financing obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLongTermDebtCurrent_lbl" xml:lang="en-US" id="id_7647232_1119210_12_1">Short term liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebtCurrent" xlink:to="us-gaap_OtherLongTermDebtCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="us-gaap_OtherLongTermDebtNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebtNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1120382_1_1">Other Long-term Debt, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLongTermDebtNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1120382_2_1">Long term liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebtNoncurrent" xlink:to="us-gaap_OtherLongTermDebtNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" id="id_7647232_1117832_1_1">Other Nonoperating Income (Expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" id="id_7647232_1117832_2_1">Other income (expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OwnshareLendingArrangementSharesIssued" xlink:label="us-gaap_OwnshareLendingArrangementSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OwnshareLendingArrangementSharesIssued_lbl" xml:lang="en-US" id="id_7647232_1108861_1_1">Own-share Lending Arrangement, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OwnshareLendingArrangementSharesIssued_lbl" xml:lang="en-US" id="id_7647232_1108861_2_1">Shares loaned under the share lending arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OwnshareLendingArrangementSharesIssued" xlink:to="us-gaap_OwnshareLendingArrangementSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaidInKindInterest_lbl" xml:lang="en-US" id="id_7647232_1121504_1_1">Paid-in-Kind Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaidInKindInterest_lbl" xml:lang="en-US" id="id_7647232_1121504_2_1">Interest incurred through borrowings under Sanofi Loan Facility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaidInKindInterest_lbl" xml:lang="en-US" id="id_7647232_1121504_12_1">Paid-in-kind interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PartnersCapitalAccountContributions" xlink:label="us-gaap_PartnersCapitalAccountContributions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalAccountContributions_lbl" xml:lang="en-US" id="id_7647232_1117507_1_1">Partners' Capital Account, Contributions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PartnersCapitalAccountContributions_lbl" xml:lang="en-US" id="id_7647232_1117507_2_1">Capital contribution</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountContributions" xlink:to="us-gaap_PartnersCapitalAccountContributions_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="id_7647232_1114902_1_1">Payables and Accruals [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="id_7647232_1114902_2_1">Payables and Accruals [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PaymentForContingentLiabilities" xlink:label="mnkd_PaymentForContingentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PaymentForContingentLiabilities_lbl" xml:lang="en-US" id="id_7647232_1176443_3_1">Payment For Contingent Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PaymentForContingentLiabilities_lbl" xml:lang="en-US" id="id_7647232_1176443_1_1">Payment For Contingent Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PaymentForContingentLiabilities_lbl" xml:lang="en-US" id="id_7647232_1176443_2_1">Required payment pursuant to the terms of the Milestone Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PaymentForContingentLiabilities" xlink:to="mnkd_PaymentForContingentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRestructuring_lbl" xml:lang="en-US" id="id_7647232_1118200_1_1">Payments for Restructuring</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRestructuring_lbl" xml:lang="en-US" id="id_7647232_1118200_2_1">Payment to restructuring</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRestructuring" xlink:to="us-gaap_PaymentsForRestructuring_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PaymentsForUseOfAircrafts" xlink:label="mnkd_PaymentsForUseOfAircrafts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PaymentsForUseOfAircrafts_lbl" xml:lang="en-US" id="id_7647232_1291967_3_1">Payments for Use of Aircrafts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PaymentsForUseOfAircrafts_lbl" xml:lang="en-US" id="id_7647232_1291967_1_1">Payments for Use of Aircrafts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PaymentsForUseOfAircrafts_lbl" xml:lang="en-US" id="id_7647232_1291967_2_1">Expenses related to charter service on behalf of principal shareholder</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PaymentsForUseOfAircrafts" xlink:to="mnkd_PaymentsForUseOfAircrafts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US" id="id_7647232_1117547_1_1">Payments of Debt Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US" id="id_7647232_1117547_14_1">Facility financing obligation &amp; milestone rights issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_7647232_1119385_1_1">Payments of Stock Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_7647232_1119385_2_1">Issuance costs associated with the Tel Aviv Stock Exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_7647232_1119385_14_1">Issuance costs associated with the Tel Aviv Stock Exchange</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US" id="id_7647232_1119212_1_1">Payments Related to Tax Withholding for Share-based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US" id="id_7647232_1119212_14_1">Payment of employment taxes related to vested restricted stock units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1117468_1_1">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1117468_14_1">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1116467_1_1">Pension and Other Postretirement Benefits Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1116467_2_1">Employee benefit plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfCommonStockSharesOutstanding" xlink:label="mnkd_PercentageOfCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PercentageOfCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1280226_3_1">Percentage Of Common Stock Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PercentageOfCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1280226_1_1">Percentage Of Common Stock Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PercentageOfCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1280226_2_1">Share of common stock outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfCommonStockSharesOutstanding" xlink:to="mnkd_PercentageOfCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfCreditExchangeReceivable" xlink:label="mnkd_PercentageOfCreditExchangeReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PercentageOfCreditExchangeReceivable_lbl" xml:lang="en-US" id="id_7647232_1252029_3_1">Percentage of credit exchange receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PercentageOfCreditExchangeReceivable_lbl" xml:lang="en-US" id="id_7647232_1252029_1_1">Percentage Of Credit Exchange Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PercentageOfCreditExchangeReceivable_lbl" xml:lang="en-US" id="id_7647232_1252029_2_1">Percentage of credit exchange receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfCreditExchangeReceivable" xlink:to="mnkd_PercentageOfCreditExchangeReceivable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfShareReservedForShareBasedCompensation" xlink:label="mnkd_PercentageOfShareReservedForShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PercentageOfShareReservedForShareBasedCompensation_lbl" xml:lang="en-US" id="id_7647232_1174361_3_1">Percentage Of Share Reserved For Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PercentageOfShareReservedForShareBasedCompensation_lbl" xml:lang="en-US" id="id_7647232_1174361_1_1">Percentage Of Share Reserved For Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PercentageOfShareReservedForShareBasedCompensation_lbl" xml:lang="en-US" id="id_7647232_1174361_2_1">Shares reserved under ESPP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfShareReservedForShareBasedCompensation" xlink:to="mnkd_PercentageOfShareReservedForShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PerformanceSharesMember_lbl" xml:lang="en-US" id="id_7647232_1115311_1_1">Performance Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PerformanceSharesMember_lbl" xml:lang="en-US" id="id_7647232_1115311_2_1">Performance-based stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="id_7647232_1105927_1_1">Plan Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="id_7647232_1105927_2_1">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="id_7647232_1111488_1_1">Plan Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="id_7647232_1111488_2_1">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PotentialMilestonePayments" xlink:label="mnkd_PotentialMilestonePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PotentialMilestonePayments_lbl" xml:lang="en-US" id="id_7647232_1292082_3_1">Potential Milestone Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PotentialMilestonePayments_lbl" xml:lang="en-US" id="id_7647232_1292082_1_1">Potential Milestone Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PotentialMilestonePayments_lbl" xml:lang="en-US" id="id_7647232_1292082_2_1">Potential milestone payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PotentialMilestonePayments" xlink:to="mnkd_PotentialMilestonePayments_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PotentialMilestonePaymentsToBeReceived" xlink:label="mnkd_PotentialMilestonePaymentsToBeReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PotentialMilestonePaymentsToBeReceived_lbl" xml:lang="en-US" id="id_7647232_1256309_3_1">Potential Milestone Payments To Be Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PotentialMilestonePaymentsToBeReceived_lbl" xml:lang="en-US" id="id_7647232_1256309_1_1">Potential Milestone Payments To Be Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PotentialMilestonePaymentsToBeReceived_lbl" xml:lang="en-US" id="id_7647232_1256309_2_1">Milestone receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PotentialMilestonePaymentsToBeReceived" xlink:to="mnkd_PotentialMilestonePaymentsToBeReceived_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_7647232_1116186_1_1">Preferred Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_7647232_1116186_2_1">Undesignated preferred stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="id_7647232_1110884_1_1">Preferred Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="id_7647232_1110884_2_1">Undesignated preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="id_7647232_1113611_1_1">Preferred Stock, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="id_7647232_1113611_2_1">Undesignated preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1115342_1_1">Preferred Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1115342_2_1">Undesignated preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="id_7647232_1119717_1_1">Preferred Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="id_7647232_1119717_2_1">Undesignated preferred stock, $0.01 par value - 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2015 and 2014</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" id="id_7647232_1123793_1_1">Prepaid Expense and Other Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" id="id_7647232_1123793_2_1">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US" id="id_7647232_1122447_1_1">Prepaid Expense, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US" id="id_7647232_1122447_2_1">Prepayment for 2015 quantities of insulin and prepaid insurance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1222978_3_1">Prepaid Expenses And Other Current Assets Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1222978_1_1">Prepaid Expenses And Other Current Assets Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1222978_2_1">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:to="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PrincipalAmountPerShare" xlink:label="mnkd_PrincipalAmountPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PrincipalAmountPerShare_lbl" xml:lang="en-US" id="id_7647232_1131861_3_1">Principal amount per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PrincipalAmountPerShare_lbl" xml:lang="en-US" id="id_7647232_1131861_1_1">Principal Amount Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PrincipalAmountPerShare_lbl" xml:lang="en-US" id="id_7647232_1131861_2_1">Principal amount per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PrincipalAmountPerShare" xlink:to="mnkd_PrincipalAmountPerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrincipalOwnerMember" xlink:label="us-gaap_PrincipalOwnerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrincipalOwnerMember_lbl" xml:lang="en-US" id="id_7647232_1113433_1_1">Principal Owner [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrincipalOwnerMember_lbl" xml:lang="en-US" id="id_7647232_1113433_2_1">Principal stockholder</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrincipalOwnerMember" xlink:to="us-gaap_PrincipalOwnerMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="id_7647232_1120882_1_1">Proceeds from Issuance of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="id_7647232_1120882_2_1">Proceeds from issuance of common stock pursuant to at-the-market issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl" xml:lang="en-US" id="id_7647232_1291259_3_1">Issuance of common stock and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl" xml:lang="en-US" id="id_7647232_1291259_1_1">Proceeds From Issuance Of Common Stock And Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl" xml:lang="en-US" id="id_7647232_1291259_2_1">Net proceeds from offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:to="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet_lbl" xml:lang="en-US" id="id_7647232_1291405_3_1">The cash inflow from the additional capital contribution to the entity including any warrants issued. Proceeds are net of cash outflows for issuance costs related to the transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet_lbl" xml:lang="en-US" id="id_7647232_1291405_1_1">Proceeds From Issuance Of Common Stock And Warrants Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet_lbl" xml:lang="en-US" id="id_7647232_1291405_2_1">Proceeds from issuance of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" xlink:to="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US" id="id_7647232_1121857_1_1">Proceeds from Issuance of Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US" id="id_7647232_1121857_2_1">Proceeds from issuance of facility financing obligation &amp; milestone rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xml:lang="en-US" id="id_7647232_1124039_1_1">Proceeds from (Payments for) Other Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xml:lang="en-US" id="id_7647232_1124039_2_1">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US" id="id_7647232_1124302_1_1">Proceeds from Related Party Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US" id="id_7647232_1124302_2_1">Secured loan facility, amount borrowed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1122372_1_1">Proceeds from Sale of Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_7647232_1122372_2_1">Proceeds from sale of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1123214_1_1">Proceeds from Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1123214_2_1">Exercise of warrants for common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1123214_12_1">Proceeds from exercise warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges_lbl" xml:lang="en-US" id="id_7647232_1124001_1_1">Production Related Impairments or Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges_lbl" xml:lang="en-US" id="id_7647232_1124001_2_1">Write-off of Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductMember_lbl" xml:lang="en-US" id="id_7647232_1111362_1_1">Product [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProductMember_lbl" xml:lang="en-US" id="id_7647232_1111362_2_1">AFREZZA product sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductOrServiceAxis_lbl" xml:lang="en-US" id="id_7647232_1109648_1_1">Products and Services [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProductOrServiceAxis_lbl" xml:lang="en-US" id="id_7647232_1109648_2_1">Products and Services [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductOrServiceAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductsAndServicesDomain_lbl" xml:lang="en-US" id="id_7647232_1114361_1_1">Products and Services [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProductsAndServicesDomain_lbl" xml:lang="en-US" id="id_7647232_1114361_2_1">Products and Services [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="us-gaap_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProfitLossSharingAgreementAllocationPercentage" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage_lbl" xml:lang="en-US" id="id_7647232_1150535_3_1">Profit Loss Sharing Agreement Allocation Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage_lbl" xml:lang="en-US" id="id_7647232_1150535_1_1">Profit Loss Sharing Agreement Allocation Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage_lbl" xml:lang="en-US" id="id_7647232_1150535_2_1">Profits and losses sharing percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ProfitLossSharingAgreementAllocationPercentage" xlink:to="mnkd_ProfitLossSharingAgreementAllocationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" id="id_7647232_1111731_1_1">Property, Plant and Equipment [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" id="id_7647232_1111731_2_1">Property, Plant and Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1107911_1_1">Property, Plant and Equipment, Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1107911_2_1">Property, Plant and Equipment, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1104964_1_1">Property, Plant and Equipment Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1104964_2_1">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:label="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_lbl" xml:lang="en-US" id="id_7647232_1121588_1_1">Property, Plant, and Equipment, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_lbl" xml:lang="en-US" id="id_7647232_1121588_2_1">Property, plant, and equipment, fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:to="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="id_7647232_1123917_1_1">Property, Plant and Equipment, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="id_7647232_1123917_2_1">Property and equipment - gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" id="id_7647232_1112866_1_1">Property, Plant and Equipment [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" id="id_7647232_1112866_2_1">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="id_7647232_1121241_1_1">Property, Plant and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="id_7647232_1121241_32_1">Total property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="id_7647232_1121241_2_1">Property and equipment - net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="id_7647232_1121241_12_1">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115902_1_1">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115902_2_1">Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110586_1_1">Property, Plant and Equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110586_2_1">Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1115514_1_1">Property, Plant and Equipment, Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1115514_2_1">Property, Plant and Equipment, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="id_7647232_1106565_1_1">Property, Plant and Equipment, Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="id_7647232_1106565_2_1">Estimated Useful Life (Years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PublicMember" xlink:label="mnkd_PublicMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PublicMember_lbl" xml:lang="en-US" id="id_7647232_1204313_3_1">Public.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PublicMember_lbl" xml:lang="en-US" id="id_7647232_1204313_1_1">Public [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PublicMember_lbl" xml:lang="en-US" id="id_7647232_1204313_2_1">Public</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PublicMember" xlink:to="mnkd_PublicMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligation_lbl" xml:lang="en-US" id="id_7647232_1120513_1_1">Purchase Obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PurchaseObligation_lbl" xml:lang="en-US" id="id_7647232_1120513_2_1">Purchase commitment obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PurchaseObligation_lbl" xml:lang="en-US" id="id_7647232_1120513_12_1">Purchase obligation remaining amount in 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligation" xlink:to="us-gaap_PurchaseObligation_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PurchaseObligationCurrent" xlink:label="mnkd_PurchaseObligationCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PurchaseObligationCurrent_lbl" xml:lang="en-US" id="id_7647232_1321424_3_1">Purchase Obligation Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PurchaseObligationCurrent_lbl" xml:lang="en-US" id="id_7647232_1321424_1_1">Purchase Obligation Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PurchaseObligationCurrent_lbl" xml:lang="en-US" id="id_7647232_1321424_2_1">Purchase commitment liabilities - current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PurchaseObligationCurrent" xlink:to="mnkd_PurchaseObligationCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="us-gaap_PurchaseObligationDueInFourthYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInFourthYear_lbl" xml:lang="en-US" id="id_7647232_1119284_1_1">Purchase Obligation, Due in Fourth Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PurchaseObligationDueInFourthYear_lbl" xml:lang="en-US" id="id_7647232_1119284_2_1">Purchase obligation, due in 2019</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInFourthYear" xlink:to="us-gaap_PurchaseObligationDueInFourthYear_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xml:lang="en-US" id="id_7647232_1118687_1_1">Purchase Obligation, Due in Next Twelve Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xml:lang="en-US" id="id_7647232_1118687_2_1">Purchase obligation, due in 2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="us-gaap_PurchaseObligationDueInSecondYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInSecondYear_lbl" xml:lang="en-US" id="id_7647232_1118385_1_1">Purchase Obligation, Due in Second Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PurchaseObligationDueInSecondYear_lbl" xml:lang="en-US" id="id_7647232_1118385_2_1">Purchase obligation, due in 2017</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInSecondYear" xlink:to="us-gaap_PurchaseObligationDueInSecondYear_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="us-gaap_PurchaseObligationDueInThirdYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligationDueInThirdYear_lbl" xml:lang="en-US" id="id_7647232_1118465_1_1">Purchase Obligation, Due in Third Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PurchaseObligationDueInThirdYear_lbl" xml:lang="en-US" id="id_7647232_1118465_2_1">Purchase obligation, due in 2018</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInThirdYear" xlink:to="us-gaap_PurchaseObligationDueInThirdYear_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PurchaseObligationNoncurrent" xlink:label="mnkd_PurchaseObligationNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_PurchaseObligationNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1321425_3_1">Purchase Obligation Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_PurchaseObligationNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1321425_1_1">Purchase Obligation Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_PurchaseObligationNoncurrent_lbl" xml:lang="en-US" id="id_7647232_1321425_2_1">Purchase commitments - long term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PurchaseObligationNoncurrent" xlink:to="mnkd_PurchaseObligationNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1108202_1_1">Quarterly Financial Information Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US" id="id_7647232_1108202_2_1">Quarterly Financial Information Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US" id="id_7647232_1114402_1_1">Quarterly Financial Information [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US" id="id_7647232_1114402_2_1">Selected quarterly financial data (unaudited)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US" id="id_7647232_1115253_1_1">Range [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US" id="id_7647232_1115253_2_1">Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeMember_lbl" xml:lang="en-US" id="id_7647232_1111418_1_1">Range [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RangeMember_lbl" xml:lang="en-US" id="id_7647232_1111418_2_1">Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109961_1_1">Receivables, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109961_2_1">State Research and Development Credit Exchange Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1172951_3_1">Recently issued accounting standards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1172951_1_1">Recently Issued Accounting Standards [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1172951_2_1">Recently Issued Accounting Standards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" xlink:to="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyDebtMember" xlink:label="mnkd_RelatedPartyDebtMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_RelatedPartyDebtMember_lbl" xml:lang="en-US" id="id_7647232_1157540_3_1">Related party debt.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_RelatedPartyDebtMember_lbl" xml:lang="en-US" id="id_7647232_1157540_1_1">Related Party Debt [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_RelatedPartyDebtMember_lbl" xml:lang="en-US" id="id_7647232_1157540_2_1">Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RelatedPartyDebtMember" xlink:to="mnkd_RelatedPartyDebtMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="id_7647232_1104357_1_1">Related Party [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="id_7647232_1104357_2_1">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyMember" xlink:label="mnkd_RelatedPartyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_RelatedPartyMember_lbl" xml:lang="en-US" id="id_7647232_1254496_3_1">Related Party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_RelatedPartyMember_lbl" xml:lang="en-US" id="id_7647232_1254496_1_1">Related Party [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_RelatedPartyMember_lbl" xml:lang="en-US" id="id_7647232_1254496_2_1">Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RelatedPartyMember" xlink:to="mnkd_RelatedPartyMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US" id="id_7647232_1112725_1_1">Related Party Transaction [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US" id="id_7647232_1112725_2_1">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyTransactionDebtInstrumentPrepayment" xlink:label="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment_lbl" xml:lang="en-US" id="id_7647232_1128808_3_1">Related Party Transaction Debt Instrument Prepayment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment_lbl" xml:lang="en-US" id="id_7647232_1128808_1_1">Related Party Transaction Debt Instrument Prepayment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment_lbl" xml:lang="en-US" id="id_7647232_1128808_2_1">Amount prepaid for cancellation of indebtedness</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment" xlink:to="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US" id="id_7647232_1116235_1_1">Related Party Transaction [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US" id="id_7647232_1116235_2_1">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1122827_1_1">Related Party Transaction, Expenses from Transactions with Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1122827_2_1">Interest expense on note payable principal stockholder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" id="id_7647232_1122827_14_1">Interest expense on note payable to principal stockholder</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" id="id_7647232_1107954_1_1">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" id="id_7647232_1107954_2_1">Related Party Transaction [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyTransactionPrepaymentPeriod" xlink:label="mnkd_RelatedPartyTransactionPrepaymentPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_RelatedPartyTransactionPrepaymentPeriod_lbl" xml:lang="en-US" id="id_7647232_1281069_3_1">Related party transaction prepayment period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_RelatedPartyTransactionPrepaymentPeriod_lbl" xml:lang="en-US" id="id_7647232_1281069_1_1">Related Party Transaction Prepayment Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_RelatedPartyTransactionPrepaymentPeriod_lbl" xml:lang="en-US" id="id_7647232_1281069_2_1">Related party transaction prepayment period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RelatedPartyTransactionPrepaymentPeriod" xlink:to="mnkd_RelatedPartyTransactionPrepaymentPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="id_7647232_1106160_1_1">Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="id_7647232_1106160_2_1">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="id_7647232_1111765_1_1">Related Party [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="id_7647232_1111765_2_1">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115417_1_1">Related Party Transactions Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115417_2_1">Related-party arrangements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt" xlink:label="us-gaap_RepaymentsOfSeniorDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfSeniorDebt_lbl" xml:lang="en-US" id="id_7647232_1120425_1_1">Repayments of Senior Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfSeniorDebt_lbl" xml:lang="en-US" id="id_7647232_1120425_2_1">Payments on senior notes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfSeniorDebt_lbl" xml:lang="en-US" id="id_7647232_1120425_14_1">Payment of 2015 notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSeniorDebt" xlink:to="us-gaap_RepaymentsOfSeniorDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ResearchAndDevelopmentCreditsBeginToExpire" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire_lbl" xml:lang="en-US" id="id_7647232_1207930_3_1">Research and Development Credits, Begin to Expire</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire_lbl" xml:lang="en-US" id="id_7647232_1207930_1_1">Research and Development Credits, Begin to Expire</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire_lbl" xml:lang="en-US" id="id_7647232_1207930_2_1">Federal research and development credits begin to expire</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" xlink:to="mnkd_ResearchAndDevelopmentCreditsBeginToExpire_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xml:lang="en-US" id="id_7647232_1122061_1_1">Research and Development Expense (Excluding Acquired in Process Cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xml:lang="en-US" id="id_7647232_1122061_2_1">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" id="id_7647232_1109593_1_1">Research and Development Expense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" id="id_7647232_1109593_2_1">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US" id="id_7647232_1111669_1_1">Research and Development Expense, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US" id="id_7647232_1111669_2_1">Research and Development Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" id="id_7647232_1105469_1_1">Restricted Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" id="id_7647232_1105469_2_1">Restricted Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" id="id_7647232_1109005_1_1">Restricted Stock Units (RSUs) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" id="id_7647232_1109005_2_1">Restricted Stock Units (RSUs)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract_lbl" xml:lang="en-US" id="id_7647232_1113961_1_1">Restructuring and Related Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract_lbl" xml:lang="en-US" id="id_7647232_1113961_2_1">Restructuring and Related Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_RestructuringAndRelatedActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1112593_1_1">Restructuring and Related Activities Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="id_7647232_1112593_2_1">Restructuring Charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_lbl" xml:lang="en-US" id="id_7647232_1106067_1_1">Restructuring and Related Cost, Number of Positions Eliminated</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_lbl" xml:lang="en-US" id="id_7647232_1106067_2_1">Number of employees eliminated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_lbl" xml:lang="en-US" id="id_7647232_1111929_1_1">Restructuring and Related Cost, Number of Positions Eliminated, Period Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_lbl" xml:lang="en-US" id="id_7647232_1111929_2_1">Percentage of workforce reduction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCharges_lbl" xml:lang="en-US" id="id_7647232_1123801_1_1">Restructuring Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringCharges_lbl" xml:lang="en-US" id="id_7647232_1123801_2_1">Restructuring charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xml:lang="en-US" id="id_7647232_1109893_1_1">Restructuring Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xml:lang="en-US" id="id_7647232_1109893_2_1">Restructuring Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_RestructuringCostAndReserveAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US" id="id_7647232_1112288_1_1">Restructuring Cost and Reserve [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US" id="id_7647232_1112288_2_1">Restructuring Cost and Reserve [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringReserve_lbl" xml:lang="en-US" id="id_7647232_1120232_1_1">Restructuring Reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringReserve_lbl" xml:lang="en-US" id="id_7647232_1120232_2_1">Restucturing accrual</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="id_7647232_1119892_1_1">Retained Earnings (Accumulated Deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="id_7647232_1119892_2_1">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xml:lang="en-US" id="id_7647232_1119150_1_1">Revenue Recognition, Milestone Method, Revenue Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xml:lang="en-US" id="id_7647232_1119150_2_1">Milestone payments earned</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SaleOfIntellectualPropertyPolicyTextBlock" xlink:label="mnkd_SaleOfIntellectualPropertyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SaleOfIntellectualPropertyPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1262620_3_1">Sale of intellectual property [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SaleOfIntellectualPropertyPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1262620_1_1">Sale of Intellectual Property [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SaleOfIntellectualPropertyPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1262620_2_1">Sale of intellectual property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SaleOfIntellectualPropertyPolicyTextBlock" xlink:to="mnkd_SaleOfIntellectualPropertyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US" id="id_7647232_1118694_1_1">Revenue, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US" id="id_7647232_1118694_2_1">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SanofiAventisMember_lbl" xml:lang="en-US" id="id_7647232_1155283_3_1">Sanofi Aventis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SanofiAventisMember_lbl" xml:lang="en-US" id="id_7647232_1155283_1_1">Sanofi Aventis [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SanofiAventisMember_lbl" xml:lang="en-US" id="id_7647232_1155283_2_1">Sanofi-Aventis Deutschland GmbH</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SanofiAventisMember" xlink:to="mnkd_SanofiAventisMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1107338_1_1">Schedule of Accrued Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1107338_2_1">Accrued Expenses and Other Current Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="id_7647232_1116150_1_1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="id_7647232_1116150_2_1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115087_1_1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115087_2_1">Potential Dilutive Securities Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1105194_1_1">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1105194_2_1">Summary of Carrying Values Estimated Fair Values of Notes and Facility Financing Obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US" id="id_7647232_1108027_1_1">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US" id="id_7647232_1108027_2_1">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109706_1_1">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1109706_2_1">Provision for Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110321_1_1">Schedule of Long-term Debt Instruments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110321_2_1">Summary of Senior Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1108395_1_1">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1108395_2_1">Components of Net Deferred Tax Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1104480_1_1">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1104480_2_1">Effective Income Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfIncomeTaxesLineItems" xlink:label="mnkd_ScheduleOfIncomeTaxesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ScheduleOfIncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1130469_3_1">Schedule Of Income Taxes [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ScheduleOfIncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1130469_1_1">Schedule Of Income Taxes [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ScheduleOfIncomeTaxesLineItems_lbl" xml:lang="en-US" id="id_7647232_1130469_2_1">Schedule Of Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="mnkd_ScheduleOfIncomeTaxesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfIncomeTaxesTable" xlink:label="mnkd_ScheduleOfIncomeTaxesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ScheduleOfIncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1169182_3_1">Schedule Of Income Taxes [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ScheduleOfIncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1169182_1_1">Schedule Of Income Taxes [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ScheduleOfIncomeTaxesTable_lbl" xml:lang="en-US" id="id_7647232_1169182_2_1">Schedule Of Income Taxes [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfIncomeTaxesTable" xlink:to="mnkd_ScheduleOfIncomeTaxesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115877_1_1">Schedule of Inventory, Current [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1115877_2_1">Components of Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1111495_1_1">Schedule of Other Assets and Other Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1111495_2_1">Accretion of Debt Issuance Cost and Debt Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" id="id_7647232_1107869_1_1">Property, Plant and Equipment [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" id="id_7647232_1107869_2_1">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110267_1_1">Schedule of Quarterly Financial Information [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110267_2_1">Selected Quarterly Financial Data</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" id="id_7647232_1114330_1_1">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" id="id_7647232_1114330_2_1">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US" id="id_7647232_1106900_1_1">Schedule of Restructuring and Related Costs [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US" id="id_7647232_1106900_2_1">Schedule of Restructuring and Related Costs [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock" xlink:label="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1206117_3_1">Schedule of Share Based Compensation Activity by Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1206117_1_1">Schedule of Share Based Compensation Activity by Category [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1206117_2_1">Stock Based Compensation Expense Recognized in Accompanying Statements of Operations by Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock" xlink:to="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1116510_1_1">Schedule of Share-based Compensation, Activity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1116510_2_1">Stock Based Compensation Expense Recognized in Accompanying Statements of Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="id_7647232_1115516_1_1">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="id_7647232_1115516_2_1">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110211_1_1">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110211_2_1">Summary of Restricted Stock Unit Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110806_1_1">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1110806_2_1">Summary of Stock Options Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1112257_1_1">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1112257_2_1">Assumptions Used to Calculate Fair Value of Employee Stock Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" id="id_7647232_1109933_1_1">Schedule of Stock by Class [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" id="id_7647232_1109933_2_1">Schedule of Stock by Class [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentGeographicalDomain_lbl" xml:lang="en-US" id="id_7647232_1104519_1_1">Geographical [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentGeographicalDomain_lbl" xml:lang="en-US" id="id_7647232_1104519_2_1">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1112517_1_1">Segment Reporting, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1112517_2_1">Segment Information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember_lbl" xml:lang="en-US" id="id_7647232_1248697_3_1">Senior Convertible Notes Due Two Thousand Eighteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember_lbl" xml:lang="en-US" id="id_7647232_1248697_1_1">Senior Convertible Notes Due Two Thousand Eighteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember_lbl" xml:lang="en-US" id="id_7647232_1248697_2_1">Senior convertible notes due August 15, 2018</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember_lbl" xml:lang="en-US" id="id_7647232_1169090_3_1">Senior convertible notes due two thousand fifteen.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember_lbl" xml:lang="en-US" id="id_7647232_1169090_1_1">Senior Convertible Notes Due Two Thousand Fifteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember_lbl" xml:lang="en-US" id="id_7647232_1169090_2_1">Senior convertible notes due August 15, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="id_7647232_1124071_1_1">Share-based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="id_7647232_1124071_2_1">Stock compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="id_7647232_1124071_12_1">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" id="id_7647232_1109797_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" id="id_7647232_1109797_2_1">Vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US" id="id_7647232_1111073_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US" id="id_7647232_1111073_2_1">Restricted stock vesting rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xml:lang="en-US" id="id_7647232_1122377_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xml:lang="en-US" id="id_7647232_1122377_2_1">Total intrinsic value of restricted stock units vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" id="id_7647232_1107159_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" id="id_7647232_1107159_14_1">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1105751_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1105751_2_1">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="id_7647232_1112049_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="id_7647232_1112049_2_1">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1110330_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1110330_2_1">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" id="id_7647232_1113709_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" id="id_7647232_1113709_4_1">Outstanding at December 31, 2015</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" id="id_7647232_1113709_5_1">Outstanding at January 1, 2015</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" id="id_7647232_1113709_2_1">Outstanding Restricted Stock Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" id="id_7647232_1104944_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" id="id_7647232_1104944_2_1">Number of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1115050_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1115050_4_1">Outstanding at December 31, 2015</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1115050_5_1">Outstanding at January 1, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" id="id_7647232_1110787_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" id="id_7647232_1110787_2_1">Weighted average grant date fair value Per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" id="id_7647232_1111895_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" id="id_7647232_1111895_14_1">Vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xml:lang="en-US" id="id_7647232_1120898_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xml:lang="en-US" id="id_7647232_1120898_2_1">Fair value of restricted stock units vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1114894_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1114894_2_1">Vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" id="id_7647232_1110115_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" id="id_7647232_1110115_2_1">Options granted expiry term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="id_7647232_1116754_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="id_7647232_1116754_2_1">Dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="id_7647232_1104471_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="id_7647232_1104471_2_1">Expected lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US" id="id_7647232_1107833_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US" id="id_7647232_1107833_2_1">Volatility, maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US" id="id_7647232_1106267_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US" id="id_7647232_1106267_2_1">Volatility, minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US" id="id_7647232_1115179_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US" id="id_7647232_1115179_2_1">Risk free interest rate, maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US" id="id_7647232_1111649_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US" id="id_7647232_1111649_2_1">Risk free interest rate, minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="id_7647232_1107897_1_1">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="id_7647232_1107897_2_1">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" id="id_7647232_1113876_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" id="id_7647232_1113876_2_1">Equity incentive plan, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" id="id_7647232_1107185_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" id="id_7647232_1107185_2_1">Shares Available for Future Issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xml:lang="en-US" id="id_7647232_1200827_3_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xml:lang="en-US" id="id_7647232_1200827_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xml:lang="en-US" id="id_7647232_1200827_2_1">Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" id="id_7647232_1123070_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" id="id_7647232_1123070_2_1">Exercisable at December 31, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" id="id_7647232_1113104_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" id="id_7647232_1113104_2_1">Exercisable at December 31, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1107476_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1107476_2_1">Exercisable at December 31, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" id="id_7647232_1116972_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" id="id_7647232_1116972_2_1">Weighted-average remaining contractual term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" id="id_7647232_1122473_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" id="id_7647232_1122473_2_1">Total intrinsic value of options exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US" id="id_7647232_1104193_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US" id="id_7647232_1104193_14_1">Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" id="id_7647232_1107513_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" id="id_7647232_1107513_14_1">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="id_7647232_1116282_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="id_7647232_1116282_2_1">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1112891_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_7647232_1112891_2_1">Weighted average grant date fair value of the stock options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" id="id_7647232_1121359_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" id="id_7647232_1121359_4_1">Outstanding at December 31, 2015</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" id="id_7647232_1121359_5_1">Outstanding at January 1, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="id_7647232_1106403_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="id_7647232_1106403_4_1">Outstanding at December 31, 2015</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="id_7647232_1106403_5_1">Outstanding at January 1, 2015</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="id_7647232_1106403_2_1">Number of shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="id_7647232_1106403_12_1">Outstanding Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" id="id_7647232_1105209_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" id="id_7647232_1105209_2_1">Number of Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1114011_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1114011_4_1">Outstanding at December 31, 2015</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1114011_5_1">Outstanding at January 1, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" id="id_7647232_1109574_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" id="id_7647232_1109574_2_1">Weighted Average Exercise Price per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US" id="id_7647232_1122136_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US" id="id_7647232_1122136_2_1">Vested and expected to vest at December 31, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US" id="id_7647232_1105407_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US" id="id_7647232_1105407_2_1">Vested and expected to vest at December 31, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1113617_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1113617_2_1">Vested and expected to vest at December 31, 2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest" xlink:label="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest_lbl" xml:lang="en-US" id="id_7647232_1213746_3_1">Share Based Compensation Arrangement Restricted Stock Units Number Of Units Expected To Vest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest_lbl" xml:lang="en-US" id="id_7647232_1213746_1_1">Share Based Compensation Arrangement Restricted Stock Units Number Of Units Expected To Vest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest_lbl" xml:lang="en-US" id="id_7647232_1213746_2_1">Restricted stock units expected to vest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest" xlink:to="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="id_7647232_1109638_1_1">Equity Award [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="id_7647232_1109638_2_1">Equity Award [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1112244_1_1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1112244_2_1">Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1114823_1_1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1114823_2_1">Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1112151_1_1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1112151_2_1">Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1108424_1_1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="id_7647232_1108424_2_1">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US" id="id_7647232_1116207_1_1">Share-based Compensation Award, Tranche One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US" id="id_7647232_1116207_2_1">Tranche One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" id="id_7647232_1111559_1_1">Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" id="id_7647232_1111559_2_1">Share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1108151_1_1">Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1108151_4_1">Ending Balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="id_7647232_1108151_5_1">Beginning Balance (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SharesReservedForEmployeeStockPurchasePlan" xlink:label="mnkd_SharesReservedForEmployeeStockPurchasePlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SharesReservedForEmployeeStockPurchasePlan_lbl" xml:lang="en-US" id="id_7647232_1159303_3_1">Shares Reserved For Employee Stock Purchase Plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SharesReservedForEmployeeStockPurchasePlan_lbl" xml:lang="en-US" id="id_7647232_1159303_1_1">Shares Reserved For Employee Stock Purchase Plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SharesReservedForEmployeeStockPurchasePlan_lbl" xml:lang="en-US" id="id_7647232_1159303_2_1">Share reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SharesReservedForEmployeeStockPurchasePlan" xlink:to="mnkd_SharesReservedForEmployeeStockPurchasePlan_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SharesReturnedUnderShareLendingAgreement" xlink:label="mnkd_SharesReturnedUnderShareLendingAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SharesReturnedUnderShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1208304_3_1">Shares Returned Under Share Lending Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SharesReturnedUnderShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1208304_1_1">Shares Returned Under Share Lending Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SharesReturnedUnderShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1208304_2_1">Returned shares of common stock under share lending agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SharesReturnedUnderShareLendingAgreement" xlink:to="mnkd_SharesReturnedUnderShareLendingAgreement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="id_7647232_1113490_1_1">Significant Accounting Policies [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="id_7647232_1113490_2_1">Summary of significant accounting policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US" id="id_7647232_1108964_1_1">State and Local Jurisdiction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US" id="id_7647232_1108964_2_1">State</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="id_7647232_1107486_1_1">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="id_7647232_1107486_2_1">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US" id="id_7647232_1107576_1_1">Geographical [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US" id="id_7647232_1107576_2_1">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="id_7647232_1107485_1_1">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="id_7647232_1107485_2_1">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="id_7647232_1114174_1_1">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="id_7647232_1114174_2_1">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="id_7647232_1109954_1_1">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="id_7647232_1109954_2_1">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US" id="id_7647232_1108154_1_1">Statement of Comprehensive Income [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US" id="id_7647232_1108154_2_1">Statement of Comprehensive Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_7647232_1106595_1_1">Statement of Stockholders' Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_7647232_1106595_2_1">Statement of Stockholders' Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" id="id_7647232_1113040_1_1">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" id="id_7647232_1113040_2_1">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock" xlink:label="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1180402_3_1">State research and development credit exchange receivable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1180402_1_1">State Research And Development Credit Exchange Receivable [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock_lbl" xml:lang="en-US" id="id_7647232_1180402_2_1">State research and development credit exchange receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock" xlink:to="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockAwardPlanTypeAxis" xlink:label="mnkd_StockAwardPlanTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockAwardPlanTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1173463_3_1">Stock Award Plan Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockAwardPlanTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1173463_1_1">Stock Award Plan Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockAwardPlanTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1173463_2_1">Stock Award Plan Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockAwardPlanTypeAxis" xlink:to="mnkd_StockAwardPlanTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockAwardPlanTypeDomain" xlink:label="mnkd_StockAwardPlanTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockAwardPlanTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1155734_3_1">Stock Award Plan Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockAwardPlanTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1155734_1_1">Stock Award Plan Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockAwardPlanTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1155734_2_1">Stock Award Plan Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockAwardPlanTypeDomain" xlink:to="mnkd_StockAwardPlanTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_7647232_1119999_1_1">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_7647232_1119999_4_1">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_7647232_1119999_5_1">Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_7647232_1119999_6_1">Total stockholders' deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_7647232_1110838_1_1">Stockholders' Equity Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_7647232_1110838_2_1">Stockholders' deficit:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US" id="id_7647232_1117582_1_1">Stock Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US" id="id_7647232_1117582_2_1">Payment of 2015 notes and interest through issuance of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US" id="id_7647232_1109992_1_1">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US" id="id_7647232_1109992_2_1">Issuance of common shares pursuant to conversions of certain 2015 note holders (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" id="id_7647232_1107343_1_1">Stock Issued During Period, Shares, Employee Stock Purchase Plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" id="id_7647232_1107343_2_1">Issuance of common shares under Employee Stock Purchase Plan (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" id="id_7647232_1107343_12_1">Shares sold to employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesForDebtExchange" xlink:label="mnkd_StockIssuedDuringPeriodSharesForDebtExchange"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodSharesForDebtExchange_lbl" xml:lang="en-US" id="id_7647232_1265565_3_1">Stock Issued During Period, Shares, For Debt Exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodSharesForDebtExchange_lbl" xml:lang="en-US" id="id_7647232_1265565_1_1">Stock Issued During Period, Shares, For Debt Exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodSharesForDebtExchange_lbl" xml:lang="en-US" id="id_7647232_1265565_2_1">Issuance of common shares pursuant to debt conversions by Deerfield (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesForDebtExchange" xlink:to="mnkd_StockIssuedDuringPeriodSharesForDebtExchange_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement" xlink:label="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement_lbl" xml:lang="en-US" id="id_7647232_1250537_3_1">Stock Issued During Period Shares Issued Related To Legal Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement_lbl" xml:lang="en-US" id="id_7647232_1250537_1_1">Stock Issued During Period Shares Issued Related To Legal Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement_lbl" xml:lang="en-US" id="id_7647232_1250537_2_1">Issuance of common shares pursuant to litigation settlement (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement" xlink:to="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="id_7647232_1109759_1_1">Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="id_7647232_1109759_2_1">Common stock shares sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="id_7647232_1109759_12_1">Issuance of common stock (Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage" xlink:label="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage_lbl" xml:lang="en-US" id="id_7647232_1243420_3_1">Stock Issued During Period Shares New Issues Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage_lbl" xml:lang="en-US" id="id_7647232_1243420_1_1">Stock Issued During Period Shares New Issues Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage_lbl" xml:lang="en-US" id="id_7647232_1243420_2_1">Percentage of shares price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage" xlink:to="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="id_7647232_1110437_1_1">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="id_7647232_1110437_2_1">Issuance of common shares from the release of restricted stock units (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement" xlink:label="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1192105_3_1">Stock issued during period shares share lending agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1192105_1_1">Stock Issued During Period Shares Share Lending Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1192105_2_1">Issuance of common stock for lender financing fees (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement" xlink:to="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="id_7647232_1112283_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="id_7647232_1112283_2_1">Exercise of stock options (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="id_7647232_1112283_14_1">Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesWarrantExercises" xlink:label="mnkd_StockIssuedDuringPeriodSharesWarrantExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodSharesWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1230707_3_1">Stock Issued During Period Shares Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodSharesWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1230707_1_1">Stock Issued During Period Shares Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodSharesWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1230707_2_1">Issuance of common shares pursuant to warrant exercises (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesWarrantExercises" xlink:to="mnkd_StockIssuedDuringPeriodSharesWarrantExercises_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US" id="id_7647232_1119462_1_1">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US" id="id_7647232_1119462_2_1">Issuance of common shares pursuant to conversions of certain 2015 notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xml:lang="en-US" id="id_7647232_1118041_1_1">Stock Issued During Period, Value, Employee Stock Purchase Plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xml:lang="en-US" id="id_7647232_1118041_2_1">Issuance of common shares under Employee Stock Purchase Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueForDebtExchange" xlink:label="mnkd_StockIssuedDuringPeriodValueForDebtExchange"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodValueForDebtExchange_lbl" xml:lang="en-US" id="id_7647232_1135282_3_1">Stock issued during the period in exchange for the extinguishment debt obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodValueForDebtExchange_lbl" xml:lang="en-US" id="id_7647232_1135282_1_1">Stock Issued During Period, Value, For Debt Exchange</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodValueForDebtExchange_lbl" xml:lang="en-US" id="id_7647232_1135282_2_1">Issuance of common shares pursuant to debt conversions by Deerfield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodValueForDebtExchange" xlink:to="mnkd_StockIssuedDuringPeriodValueForDebtExchange_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement" xlink:label="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement_lbl" xml:lang="en-US" id="id_7647232_1205553_3_1">Stock Issued During Period Value Issued Related To Legal Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement_lbl" xml:lang="en-US" id="id_7647232_1205553_1_1">Stock Issued During Period Value Issued Related To Legal Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement_lbl" xml:lang="en-US" id="id_7647232_1205553_2_1">Issuance of common shares pursuant to litigation settlement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement" xlink:to="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="id_7647232_1117804_1_1">Stock Issued During Period, Value, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="id_7647232_1117804_2_1">Common stock shares sold aggregate price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="id_7647232_1117804_12_1">Issuance of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="id_7647232_1120665_1_1">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="id_7647232_1120665_2_1">Issuance of common shares from the release of restricted stock units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueShareLendingAgreement" xlink:label="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1134622_3_1">Stock issued during period value share lending agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1134622_1_1">Stock Issued During Period Value Share Lending Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement_lbl" xml:lang="en-US" id="id_7647232_1134622_2_1">Issuance of common stock for lender financing fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement" xlink:to="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" id="id_7647232_1119615_1_1">Stock Issued During Period, Value, Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" id="id_7647232_1119615_2_1">Exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueWarrantExercises" xlink:label="mnkd_StockIssuedDuringPeriodValueWarrantExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockIssuedDuringPeriodValueWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1239380_3_1">Stock Issued During Period Value Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockIssuedDuringPeriodValueWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1239380_1_1">Stock Issued During Period Value Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockIssuedDuringPeriodValueWarrantExercises_lbl" xml:lang="en-US" id="id_7647232_1239380_2_1">Issuance of common shares pursuant to warrant exercises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodValueWarrantExercises" xlink:to="mnkd_StockIssuedDuringPeriodValueWarrantExercises_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionActivityAndChangesLineItems" xlink:label="mnkd_StockOptionActivityAndChangesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockOptionActivityAndChangesLineItems_lbl" xml:lang="en-US" id="id_7647232_1204739_3_1">Stock Option Activity And Changes [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockOptionActivityAndChangesLineItems_lbl" xml:lang="en-US" id="id_7647232_1204739_1_1">Stock Option Activity And Changes [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockOptionActivityAndChangesLineItems_lbl" xml:lang="en-US" id="id_7647232_1204739_2_1">Stock Option Activity And Changes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="mnkd_StockOptionActivityAndChangesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionActivityAndChangesTable" xlink:label="mnkd_StockOptionActivityAndChangesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockOptionActivityAndChangesTable_lbl" xml:lang="en-US" id="id_7647232_1270804_3_1">Stock Option Activity And Changes [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockOptionActivityAndChangesTable_lbl" xml:lang="en-US" id="id_7647232_1270804_1_1">Stock Option Activity And Changes [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockOptionActivityAndChangesTable_lbl" xml:lang="en-US" id="id_7647232_1270804_2_1">Stock Option Activity And Changes [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockOptionActivityAndChangesTable" xlink:to="mnkd_StockOptionActivityAndChangesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionsGrantedVestingRate" xlink:label="mnkd_StockOptionsGrantedVestingRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_StockOptionsGrantedVestingRate_lbl" xml:lang="en-US" id="id_7647232_1205812_3_1">Stock Options Granted Vesting Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_StockOptionsGrantedVestingRate_lbl" xml:lang="en-US" id="id_7647232_1205812_1_1">Stock Options Granted Vesting Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_StockOptionsGrantedVestingRate_lbl" xml:lang="en-US" id="id_7647232_1205812_2_1">Stock option grants vest exercisable rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockOptionsGrantedVestingRate" xlink:to="mnkd_StockOptionsGrantedVestingRate_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SubleaseAgreementMember" xlink:label="mnkd_SubleaseAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SubleaseAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1285790_3_1">Sublease Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SubleaseAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1285790_1_1">Sublease Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SubleaseAgreementMember_lbl" xml:lang="en-US" id="id_7647232_1285790_2_1">Sublease Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SubleaseAgreementMember" xlink:to="mnkd_SubleaseAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" id="id_7647232_1109845_1_1">Subsequent Event [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" id="id_7647232_1109845_2_1">Subsequent Event [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="id_7647232_1108681_1_1">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="id_7647232_1108681_2_1">Subsequent Event</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="id_7647232_1113041_1_1">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="id_7647232_1113041_2_1">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="id_7647232_1114691_1_1">Subsequent Events [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="id_7647232_1114691_2_1">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" id="id_7647232_1115826_1_1">Subsequent Event [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" id="id_7647232_1115826_2_1">Subsequent Event [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1106880_1_1">Subsequent Event Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="id_7647232_1106880_2_1">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1110811_1_1">Subsequent Event Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="id_7647232_1110811_2_1">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_7647232_1206985_3_1">Summary Of Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_7647232_1206985_1_1">Summary Of Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_7647232_1206985_2_1">Summary Of Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_7647232_1197167_3_1">Summary Of Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_7647232_1197167_1_1">Summary Of Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_7647232_1197167_2_1">Summary Of Significant Accounting Policies [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="id_7647232_1107147_1_1">Supplemental Cash Flow Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="id_7647232_1107147_2_1">SUPPLEMENTAL CASH FLOWS DISCLOSURES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_TerminationDateOfLicenseAgreement_lbl" xml:lang="en-US" id="id_7647232_1248876_3_1">Termination Date Of License Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_TerminationDateOfLicenseAgreement_lbl" xml:lang="en-US" id="id_7647232_1248876_1_1">Termination Date Of License Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_TerminationDateOfLicenseAgreement_lbl" xml:lang="en-US" id="id_7647232_1248876_2_1">Termination date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TerminationDateOfLicenseAgreement" xlink:to="mnkd_TerminationDateOfLicenseAgreement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TextBlockAbstract_lbl" xml:lang="en-US" id="id_7647232_1104271_1_1">Text Block [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TextBlockAbstract_lbl" xml:lang="en-US" id="id_7647232_1104271_2_1">Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_TextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="id_7647232_1106131_1_1">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="id_7647232_1106131_2_1">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="id_7647232_1106304_1_1">Relationship to Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="id_7647232_1106304_2_1">Relationship to Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" id="id_7647232_1104492_1_1">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" id="id_7647232_1104492_2_1">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_TrancheBMember_lbl" xml:lang="en-US" id="id_7647232_1234768_3_1">Tranche B [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_TrancheBMember_lbl" xml:lang="en-US" id="id_7647232_1234768_1_1">Tranche B [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_TrancheBMember_lbl" xml:lang="en-US" id="id_7647232_1234768_2_1">Less portion of commitment asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TrancheBMember" xlink:to="mnkd_TrancheBMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US" id="id_7647232_1115210_1_1">Financial Instruments [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US" id="id_7647232_1115210_2_1">Financial Instruments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandEighteenNotesMember" xlink:label="mnkd_TwoThousandEighteenNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_TwoThousandEighteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1318041_3_1">Two Thousand Eighteen Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_TwoThousandEighteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1318041_1_1">Two Thousand Eighteen Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_TwoThousandEighteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1318041_2_1">2018 Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandEighteenNotesMember" xlink:to="mnkd_TwoThousandEighteenNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFifteenNotesMember" xlink:label="mnkd_TwoThousandFifteenNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_TwoThousandFifteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1199471_3_1">Two Thousand Fifteen Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_TwoThousandFifteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1199471_1_1">Two Thousand Fifteen Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_TwoThousandFifteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1199471_2_1">2015 Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandFifteenNotesMember" xlink:to="mnkd_TwoThousandFifteenNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFourEquityIncentivePlanMember" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember_lbl" xml:lang="en-US" id="id_7647232_1142515_3_1">Two Thousand Four Equity Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember_lbl" xml:lang="en-US" id="id_7647232_1142515_1_1">Two Thousand Four Equity Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember_lbl" xml:lang="en-US" id="id_7647232_1142515_2_1">2004 Equity Incentive Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandFourEquityIncentivePlanMember" xlink:to="mnkd_TwoThousandFourEquityIncentivePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember" xlink:label="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember_lbl" xml:lang="en-US" id="id_7647232_1180376_3_1">Two Thousand Four Non Employee Directors Stock Option Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember_lbl" xml:lang="en-US" id="id_7647232_1180376_1_1">Two Thousand Four Non Employee Directors Stock Option Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember_lbl" xml:lang="en-US" id="id_7647232_1180376_2_1">2004 Non Employee Directors Stock Option Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember" xlink:to="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_TwoThousandNineteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1158750_3_1">Two Thousand Nineteen Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_TwoThousandNineteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1158750_1_1">Two Thousand Nineteen Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_TwoThousandNineteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1158750_2_1">Senior convertible notes due December 31, 2019</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandNineteenNotesMember" xlink:to="mnkd_TwoThousandNineteenNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandThirteenNotesMember" xlink:label="mnkd_TwoThousandThirteenNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_TwoThousandThirteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1262418_3_1">Two Thousand Thirteen Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_TwoThousandThirteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1262418_1_1">Two Thousand Thirteen Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_TwoThousandThirteenNotesMember_lbl" xml:lang="en-US" id="id_7647232_1262418_2_1">2013 Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandThirteenNotesMember" xlink:to="mnkd_TwoThousandThirteenNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" id="id_7647232_1116223_1_1">Type of Arrangement and Non-arrangement Transactions [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" id="id_7647232_1116223_2_1">Type of Arrangement and Non-arrangement Transactions [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xml:lang="en-US" id="id_7647232_1110966_1_1">Type of Restructuring [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xml:lang="en-US" id="id_7647232_1110966_2_1">Type of Restructuring [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_TypeOfRestructuringDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xml:lang="en-US" id="id_7647232_1121064_1_1">Unamortized Debt Issuance Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xml:lang="en-US" id="id_7647232_1121064_2_1">Uncreated debt issuance cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xml:lang="en-US" id="id_7647232_1121064_14_1">Unaccreted debt issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UncategorizedAbstract" xlink:label="mnkd_UncategorizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_UncategorizedAbstract_lbl" xml:lang="en-US" id="id_7647232_1125179_3_1">Uncategorized [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_UncategorizedAbstract_lbl" xml:lang="en-US" id="id_7647232_1125179_1_1">Uncategorized [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_UncategorizedAbstract_lbl" xml:lang="en-US" id="id_7647232_1125179_2_1">Uncategorized [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UncategorizedAbstract" xlink:to="mnkd_UncategorizedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnderwritersMember" xlink:label="mnkd_UnderwritersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_UnderwritersMember_lbl" xml:lang="en-US" id="id_7647232_1272755_3_1">Underwriters.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_UnderwritersMember_lbl" xml:lang="en-US" id="id_7647232_1272755_1_1">Underwriters [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_UnderwritersMember_lbl" xml:lang="en-US" id="id_7647232_1272755_2_1">Underwriters</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UnderwritersMember" xlink:to="mnkd_UnderwritersMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldByUnderwritingPrice" xlink:label="mnkd_UnitsSoldByUnderwritingPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_UnitsSoldByUnderwritingPrice_lbl" xml:lang="en-US" id="id_7647232_1189887_3_1">Units sold by underwriting price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_UnitsSoldByUnderwritingPrice_lbl" xml:lang="en-US" id="id_7647232_1189887_1_1">Units Sold By Underwriting Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_UnitsSoldByUnderwritingPrice_lbl" xml:lang="en-US" id="id_7647232_1189887_2_1">Purchased Price of the units by underwriters</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UnitsSoldByUnderwritingPrice" xlink:to="mnkd_UnitsSoldByUnderwritingPrice_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldUnderPublicOfferUnderwritten" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwritten"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwritten_lbl" xml:lang="en-US" id="id_7647232_1253968_3_1">Units sold under public offer underwritten.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwritten_lbl" xml:lang="en-US" id="id_7647232_1253968_1_1">Units Sold Under Public Offer Underwritten</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwritten_lbl" xml:lang="en-US" id="id_7647232_1253968_2_1">Number of Unit Sold in an Underwritten public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UnitsSoldUnderPublicOfferUnderwritten" xlink:to="mnkd_UnitsSoldUnderPublicOfferUnderwritten_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription_lbl" xml:lang="en-US" id="id_7647232_1210054_3_1">Units sold under public offer underwritten composition description.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription_lbl" xml:lang="en-US" id="id_7647232_1210054_1_1">Units Sold Under Public Offer Underwritten Composition Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription_lbl" xml:lang="en-US" id="id_7647232_1210054_2_1">Units sold composition description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription" xlink:to="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock" xlink:label="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock_lbl" xml:lang="en-US" id="id_7647232_1134635_3_1">Units sold warrant portion convertible into common stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock_lbl" xml:lang="en-US" id="id_7647232_1134635_1_1">Units Sold Warrant Portion Convertible Into Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock_lbl" xml:lang="en-US" id="id_7647232_1134635_2_1">Warrant to purchase of a share of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock" xlink:to="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UpfrontFee" xlink:label="mnkd_UpfrontFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_UpfrontFee_lbl" xml:lang="en-US" id="id_7647232_1169121_3_1">Upfront Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_UpfrontFee_lbl" xml:lang="en-US" id="id_7647232_1169121_1_1">Upfront Fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_UpfrontFee_lbl" xml:lang="en-US" id="id_7647232_1169121_2_1">Up-front fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UpfrontFee" xlink:to="mnkd_UpfrontFee_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="id_7647232_1113910_1_1">Use of Estimates, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="id_7647232_1113910_2_1">Financial Statement Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ValenciaMember" xlink:label="mnkd_ValenciaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ValenciaMember_lbl" xml:lang="en-US" id="id_7647232_1227250_3_1">Valencia [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ValenciaMember_lbl" xml:lang="en-US" id="id_7647232_1227250_1_1">Valencia [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ValenciaMember_lbl" xml:lang="en-US" id="id_7647232_1227250_2_1">Valencia</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ValenciaMember" xlink:to="mnkd_ValenciaMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US" id="id_7647232_1119485_1_1">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US" id="id_7647232_1119485_2_1">Change in the valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US" id="id_7647232_1108976_1_1">Valuation Technique [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US" id="id_7647232_1108976_2_1">Valuation Technique [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xml:lang="en-US" id="id_7647232_1112189_1_1">Valuation Technique [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xml:lang="en-US" id="id_7647232_1112189_2_1">Valuation Technique [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ValueOfRestrictedStockUnitsVested" xlink:label="mnkd_ValueOfRestrictedStockUnitsVested"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_ValueOfRestrictedStockUnitsVested_lbl" xml:lang="en-US" id="id_7647232_1183597_3_1">Value of Restricted Stock Units Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_ValueOfRestrictedStockUnitsVested_lbl" xml:lang="en-US" id="id_7647232_1183597_1_1">Value of Restricted Stock Units Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_ValueOfRestrictedStockUnitsVested_lbl" xml:lang="en-US" id="id_7647232_1183597_2_1">Total intrinsic value of restricted stock units expected to vest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ValueOfRestrictedStockUnitsVested" xlink:to="mnkd_ValueOfRestrictedStockUnitsVested_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US" id="id_7647232_1115193_1_1">Variable Rate [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VariableRateAxis_lbl" xml:lang="en-US" id="id_7647232_1115193_2_1">Variable Rate [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableRateDomain_lbl" xml:lang="en-US" id="id_7647232_1104337_1_1">Variable Rate [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VariableRateDomain_lbl" xml:lang="en-US" id="id_7647232_1104337_2_1">Variable Rate [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US" id="id_7647232_1110296_1_1">Vesting [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US" id="id_7647232_1110296_2_1">Vesting [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingDomain_lbl" xml:lang="en-US" id="id_7647232_1115014_1_1">Vesting [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VestingDomain_lbl" xml:lang="en-US" id="id_7647232_1115014_2_1">Vesting [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantLiabilityMember" xlink:label="mnkd_WarrantLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_WarrantLiabilityMember_lbl" xml:lang="en-US" id="id_7647232_1213796_3_1">Warrant liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_WarrantLiabilityMember_lbl" xml:lang="en-US" id="id_7647232_1213796_1_1">Warrant Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_WarrantLiabilityMember_lbl" xml:lang="en-US" id="id_7647232_1213796_2_1">Warrant Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_WarrantLiabilityMember" xlink:to="mnkd_WarrantLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="id_7647232_1108838_1_1">Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="id_7647232_1108838_2_1">Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantsExercisableExpirationPeriod" xlink:label="mnkd_WarrantsExercisableExpirationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_WarrantsExercisableExpirationPeriod_lbl" xml:lang="en-US" id="id_7647232_1192227_3_1">Warrants exercisable expiration period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_WarrantsExercisableExpirationPeriod_lbl" xml:lang="en-US" id="id_7647232_1192227_1_1">Warrants Exercisable Expiration Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_WarrantsExercisableExpirationPeriod_lbl" xml:lang="en-US" id="id_7647232_1192227_2_1">Duration for Expiration of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_WarrantsExercisableExpirationPeriod" xlink:to="mnkd_WarrantsExercisableExpirationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantsPolicyTextBlock" xlink:label="mnkd_WarrantsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_WarrantsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1245960_3_1">Warrants Policy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_WarrantsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1245960_1_1">Warrants Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_WarrantsPolicyTextBlock_lbl" xml:lang="en-US" id="id_7647232_1245960_2_1">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_WarrantsPolicyTextBlock" xlink:to="mnkd_WarrantsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest" xlink:label="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest_lbl" xml:lang="en-US" id="id_7647232_1232798_3_1">Weighted average grant date fair value of restricted stock units expected to vest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest_lbl" xml:lang="en-US" id="id_7647232_1232798_1_1">Weighted Average Grant Date Fair Value Of Restricted Stock Units Expected To Vest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest_lbl" xml:lang="en-US" id="id_7647232_1232798_2_1">Weighted average grant date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest" xlink:to="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="id_7647232_1113925_1_1">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="id_7647232_1113925_2_1">Shares used to compute basic and diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WriteOffOfCommitmentAsset" xlink:label="mnkd_WriteOffOfCommitmentAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_WriteOffOfCommitmentAsset_lbl" xml:lang="en-US" id="id_7647232_1278248_3_1">Write Off of Commitment Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_WriteOffOfCommitmentAsset_lbl" xml:lang="en-US" id="id_7647232_1278248_1_1">Write Off of Commitment Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mnkd_WriteOffOfCommitmentAsset_lbl" xml:lang="en-US" id="id_7647232_1278248_2_1">Write-off Tranche B Commitment Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_WriteOffOfCommitmentAsset" xlink:to="mnkd_WriteOffOfCommitmentAsset_lbl"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WriteOffOfDerivativeLiability" xlink:label="mnkd_WriteOffOfDerivativeLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mnkd_WriteOffOfDerivativeLiability_lbl" xml:lang="en-US" id="id_7647232_1130093_3_1">Write Off of Derivative Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mnkd_WriteOffOfDerivativeLiability_lbl" xml:lang="en-US" id="id_7647232_1130093_1_1">Write Off of Derivative Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mnkd_WriteOffOfDerivativeLiability_lbl" xml:lang="en-US" id="id_7647232_1130093_14_1">Write-off of derivative liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_WriteOffOfDerivativeLiability" xlink:to="mnkd_WriteOffOfDerivativeLiability_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd#exch_XTAE" xlink:label="exch_XTAE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="exch_XTAE_lbl" xml:lang="en-US" id="id_7647232_1104394_1_1">TEL AVIV STOCK EXCHANGE [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="exch_XTAE_lbl" xml:lang="en-US" id="id_7647232_1104394_2_1">TEL AVIV STOCK EXCHANGE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="exch_XTAE" xlink:to="exch_XTAE_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>mnkd-20151231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Presentation Linkbase, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.22.4 -->
<!-- Round: 77f33050-bdaf-4a1d-9f8a-38d5ff9252cd -->
<!-- Creation date: 2016-03-15T21:03:45Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DocumentandEntityInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DocumentandEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfIncomeAlternative" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfIncomeAlternative"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfOtherComprehensiveIncome" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_ci-StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://www.mannkindcorp.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureComponentsOfInventories" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfInventories"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePropertyAndEquipment" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipment"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePropertyAndEquipmentAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureAccruedExpensesAndOtherCurrentLiabilities" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureRelatedPartyArrangementsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureRelatedPartyArrangementsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfSeniorConvertibleNotes" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSeniorConvertibleNotes"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSeniorConvertibleNotesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSeniorConvertibleNotesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCollaborativeArrangementAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCollaborativeArrangementAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFairValueOfFinancialInstrumentsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCommonAndPreferredStockAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureNetLossPerCommonShareAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosurePotentiallyDilutiveSecuritiesOutstanding" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosurePotentiallyDilutiveSecuritiesOutstanding"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockAwardPlansAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockAwardPlansAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedAwardPlans" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedAwardPlans"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFairValueOfEmployeeStockOptionsAssumptions" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfEmployeeStockOptionsAssumptions"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfStockOptionsOutstanding" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfStockOptionsOutstanding"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSummaryOfRestrictedStockUnitActivity" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitActivity"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureEmployeeBenefitPlansAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureProvisionForIncomeTaxes" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureProvisionForIncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureComponentsOfNetDeferredTaxAsset" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAsset"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureIncomeTaxesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureEffectiveIncomeTaxRate" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureEffectiveIncomeTaxRate"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureFacilityAgreementAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureFacilityAgreementAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureRestructuringChargesAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureRestructuringChargesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSelectedQuarterlyFinancialData" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialData"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSelectedQuarterlyFinancialDataAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#DisclosureSubsequentEventsAdditionalInformation" roleURI="http://www.mannkindcorp.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsInventoryDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsLongTermDebtTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsLongTermDebtTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCommonAndPreferredStockTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommonAndPreferredStockTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="mnkd-20151231.xsd#Role_NotesToFinancialStatementsSubsequentEventsTextBlock" roleURI="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DocumentandEntityInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DocumentAndEntityInformationAbstract" xlink:label="mnkd_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassified" xlink:title="104000 - Statement - Statement of Financial Position, Classified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="us-gaap_ConvertibleLongTermNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCostsCurrent" xlink:label="us-gaap_DeferredCostsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:label="us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NontradeReceivablesNoncurrent" xlink:label="us-gaap_NontradeReceivablesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="us-gaap_OtherDeferredCreditsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="us-gaap_OtherLongTermDebtCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PurchaseObligationCurrent" xlink:label="mnkd_PurchaseObligationCurrent"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PurchaseObligationNoncurrent" xlink:label="mnkd_PurchaseObligationNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_NontradeReceivablesNoncurrent" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DeferredCostsCurrent" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LossContingencyAccrualCarryingValueNoncurrent" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ConvertibleLongTermNotesPayable" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mnkd_PurchaseObligationNoncurrent" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="1.3500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="1.3600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.3700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLongTermDebtCurrent" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherDeferredCreditsCurrent" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mnkd_PurchaseObligationCurrent" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfIncomeAlternative" xlink:title="124100 - Statement - Statement of Income">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:label="mnkd_GainLossOnPurchaseCommitments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ManufacturingCosts" xlink:label="us-gaap_ManufacturingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ManufacturingCosts" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="mnkd_GainLossOnPurchaseCommitments" order="1.0500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SalesRevenueNet" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="1.1200" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="1.1300" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentIncomeInterest" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.1600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfOtherComprehensiveIncome" xlink:title="148400 - Statement - Statement of Comprehensive Income">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementShares" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementValue" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeficitAccumulatedDuringDevelopmentStageMember" xlink:label="mnkd_DeficitAccumulatedDuringDevelopmentStageMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_ExchangeDomain" xlink:label="dei_ExchangeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PartnersCapitalAccountContributions" xlink:label="us-gaap_PartnersCapitalAccountContributions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesForDebtExchange" xlink:label="mnkd_StockIssuedDuringPeriodSharesForDebtExchange"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement" xlink:label="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement" xlink:label="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesWarrantExercises" xlink:label="mnkd_StockIssuedDuringPeriodSharesWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueForDebtExchange" xlink:label="mnkd_StockIssuedDuringPeriodValueForDebtExchange"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement" xlink:label="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueShareLendingAgreement" xlink:label="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodValueWarrantExercises" xlink:label="mnkd_StockIssuedDuringPeriodValueWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd#exch_XTAE" xlink:label="exch_XTAE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_ExchangeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1.3700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.3800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="1.3900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="mnkd_DeficitAccumulatedDuringDevelopmentStageMember" order="1.4000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_ExchangeDomain" xlink:to="exch_XTAE" order="1.3600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesWarrantExercises" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueWarrantExercises" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesForDebtExchange" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PartnersCapitalAccountContributions" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueForDebtExchange" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueShareLendingAgreement" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementValue" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementShares" order="1.1900" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_2" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_2" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="3.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_EntityListingsExchangeAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/StatementOfCashFlowsIndirect" xlink:title="152200 - Statement - Statement of Cash Flows">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty" xlink:label="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_ExchangeDomain" xlink:label="dei_ExchangeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnContractTermination" xlink:label="us-gaap_GainLossOnContractTermination"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" xlink:label="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaidCapitalized" xlink:label="us-gaap_InterestPaidCapitalized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansAssumed1" xlink:label="us-gaap_LoansAssumed1"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestonePayments" xlink:label="mnkd_MilestonePayments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt" xlink:label="us-gaap_RepaymentsOfSeniorDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandEighteenNotesMember" xlink:label="mnkd_TwoThousandEighteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFifteenNotesMember" xlink:label="mnkd_TwoThousandFifteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandThirteenNotesMember" xlink:label="mnkd_TwoThousandThirteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WriteOffOfCommitmentAsset" xlink:label="mnkd_WriteOffOfCommitmentAsset"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WriteOffOfDerivativeLiability" xlink:label="mnkd_WriteOffOfDerivativeLiability"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd#exch_XTAE" xlink:label="exch_XTAE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" order="1.1300" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnContractTermination" order="1.1400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment" order="1.1600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PaidInKindInterest" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_WriteOffOfDerivativeLiability" order="1.1800" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_WriteOffOfCommitmentAsset" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1.2000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_TrancheBMember" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandFifteenNotesMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandEighteenNotesMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandThirteenNotesMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_ExchangeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_ExchangeDomain" xlink:to="exch_XTAE" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.2100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="1.2200" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.2300" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="1.2400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="1.2500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_RepaymentsOfSeniorDebt" order="1.3300" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="1.3500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="mnkd_MilestonePayments" order="1.3600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.3700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.3800" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" order="1.3900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="1.4000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="1.4100" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="1.4200" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.4300" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2" order="1.4400" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.4500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.4600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="1.4700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="1.4800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.4900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="1.5000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="1.5100" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="4.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CreditFacilityAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_EntityListingsExchangeAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="1.5200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_StockIssued1" order="1.5300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" order="1.5400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" order="1.5500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidCapitalized" order="1.5600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty" order="1.5700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_LoansAssumed1" order="1.5800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsAxis" xlink:label="mnkd_AgreementsAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsDomain" xlink:label="mnkd_AgreementsDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FacilityAgreementMember" xlink:label="mnkd_FacilityAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" xlink:label="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProfitLossSharingAgreementAllocationPercentage" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UpfrontFee" xlink:label="mnkd_UpfrontFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AgreementsAxis" xlink:to="mnkd_AgreementsDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AgreementsDomain" xlink:to="mnkd_FacilityAgreementMember" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_TrancheBMember" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_UpfrontFee" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_TerminationDateOfLicenseAgreement" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_ProfitLossSharingAgreementAllocationPercentage" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="dei_LegalEntityAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_RangeAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="mnkd_AgreementsAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_CreditFacilityAxis" order="15.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="16.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="17.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesRelatedParty" xlink:label="mnkd_AccruedExpensesRelatedParty"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConsiderationReceived" xlink:label="mnkd_ConsiderationReceived"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:label="mnkd_GainLossOnPurchaseCommitments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestCostsCapitalized" xlink:label="us-gaap_InterestCostsCapitalized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MaturityPeriodOfCashEquivalents" xlink:label="mnkd_MaturityPeriodOfCashEquivalents"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="us-gaap_OtherLongTermDebtNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfCreditExchangeReceivable" xlink:label="mnkd_PercentageOfCreditExchangeReceivable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IntellectualPropertyMember" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_MaturityPeriodOfCashEquivalents" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_PercentageOfCreditExchangeReceivable" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_ConsiderationReceived" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GainLossOnDispositionOfIntangibleAssets" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_AccruedExpensesRelatedParty" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OtherLongTermDebtNoncurrent" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InventoryWriteDown" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PurchaseObligation" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_GainLossOnPurchaseCommitments" order="1.1200" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InterestExpense" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InterestCostsCapitalized" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_CreditFacilityAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccountsAndOtherReceivablesLineItems" xlink:label="mnkd_AccountsAndOtherReceivablesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccountsAndOtherReceivablesTable" xlink:label="mnkd_AccountsAndOtherReceivablesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EstimatedAmountsCreditExchangeReceivable" xlink:label="mnkd_EstimatedAmountsCreditExchangeReceivable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfCreditExchangeReceivable" xlink:label="mnkd_PercentageOfCreditExchangeReceivable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UncategorizedAbstract" xlink:label="mnkd_UncategorizedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccountsAndOtherReceivablesLineItems" xlink:to="mnkd_PercentageOfCreditExchangeReceivable" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccountsAndOtherReceivablesLineItems" xlink:to="mnkd_EstimatedAmountsCreditExchangeReceivable" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccountsAndOtherReceivablesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccountsAndOtherReceivablesTable" xlink:to="mnkd_AccountsAndOtherReceivablesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_UncategorizedAbstract" xlink:to="mnkd_AccountsAndOtherReceivablesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfInventories">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InventoryCurrentAndNoncurrent" xlink:label="mnkd_InventoryCurrentAndNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="us-gaap_InventoryCurrentTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="us-gaap_InventoryLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryCurrentTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryNet" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="mnkd_InventoryCurrentAndNoncurrent" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipment">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BuildingImprovementsMember" xlink:label="us-gaap_BuildingImprovementsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ComputerEquipmentAndSoftwareMember" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FurnitureFixturesAndOfficeEquipmentMember" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.1400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.1500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandMember" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingImprovementsMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_FurnitureFixturesAndOfficeEquipmentMember" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_ComputerEquipmentAndSoftwareMember" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="3.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_RangeAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AmortizationPeriodOfLeaseHoldImprovements" xlink:label="mnkd_AmortizationPeriodOfLeaseHoldImprovements"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DanburyFacilityMember" xlink:label="mnkd_DanburyFacilityMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:label="mnkd_DepreciationAndOtherAmortizationExpensesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorPropertyClassAxis" xlink:label="us-gaap_MajorPropertyClassAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MajorPropertyClassDomain" xlink:label="us-gaap_MajorPropertyClassDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NumberOfAssetGroups" xlink:label="mnkd_NumberOfAssetGroups"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ValenciaMember" xlink:label="mnkd_ValenciaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="mnkd_AmortizationPeriodOfLeaseHoldImprovements" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="mnkd_TerminationDateOfLicenseAgreement" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="mnkd_NumberOfAssetGroups" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="dei_LegalEntityAxis" order="5.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="us-gaap_MajorPropertyClassAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DepreciationAndOtherAmortizationExpensesTable" xlink:to="mnkd_DepreciationAndOtherAmortizationExpensesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorPropertyClassAxis" xlink:to="us-gaap_MajorPropertyClassDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorPropertyClassDomain" xlink:to="mnkd_ValenciaMember" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="mnkd_DepreciationAndOtherAmortizationExpensesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_DanburyFacilityMember" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" xlink:label="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConstructionPayableCurrent" xlink:label="us-gaap_ConstructionPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_InterestPayableCurrent" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_ConstructionPayableCurrent" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" xlink:to="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="mnkd_AccruedExpensesAndOtherCurrentLiabilitiesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureRelatedPartyArrangementsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AccruedInterestOfRelatedPartyDebt" xlink:label="mnkd_AccruedInterestOfRelatedPartyDebt"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AlfredMannFoundationMember" xlink:label="mnkd_AlfredMannFoundationMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AmendedAgreementMember" xlink:label="mnkd_AmendedAgreementMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AreaOfOfficeSpaceLeased" xlink:label="mnkd_AreaOfOfficeSpaceLeased"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AvailableBorrowingsUnderLoanAgreement" xlink:label="mnkd_AvailableBorrowingsUnderLoanAgreement"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AvailableLoanBalanceCancelled" xlink:label="mnkd_AvailableLoanBalanceCancelled"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseAgreementTypeOfAgreementAxis" xlink:label="mnkd_LeaseAgreementTypeOfAgreementAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseAgreementTypeOfAgreementDomain" xlink:label="mnkd_LeaseAgreementTypeOfAgreementDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LeaseExpirationMonthYear" xlink:label="mnkd_LeaseExpirationMonthYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LetterOfAgreementMember" xlink:label="mnkd_LetterOfAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LoanAgreementWithRelatedParty" xlink:label="mnkd_LoanAgreementWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LoanArrangementMember" xlink:label="mnkd_LoanArrangementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NumberOfMonthsAdvancesOutstanding" xlink:label="mnkd_NumberOfMonthsAdvancesOutstanding"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OfficeLeaseExpense" xlink:label="mnkd_OfficeLeaseExpense"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PaymentsForUseOfAircrafts" xlink:label="mnkd_PaymentsForUseOfAircrafts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrincipalOwnerMember" xlink:label="us-gaap_PrincipalOwnerMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyDebtMember" xlink:label="mnkd_RelatedPartyDebtMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyTransactionDebtInstrumentPrepayment" xlink:label="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyTransactionPrepaymentPeriod" xlink:label="mnkd_RelatedPartyTransactionPrepaymentPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SubleaseAgreementMember" xlink:label="mnkd_SubleaseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_LeaseAgreementTypeOfAgreementAxis" xlink:to="mnkd_LeaseAgreementTypeOfAgreementDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_LeaseAgreementTypeOfAgreementDomain" xlink:to="mnkd_SubleaseAgreementMember" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_PrincipalOwnerMember" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_RelatedPartyDebtMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_AmendedAgreementMember" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_LoanArrangementMember" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_LetterOfAgreementMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_AlfredMannFoundationMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_LoanAgreementWithRelatedParty" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LineOfCredit" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_RelatedPartyTransactionDebtInstrumentPrepayment" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_NumberOfMonthsAdvancesOutstanding" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_RelatedPartyTransactionPrepaymentPeriod" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_AvailableLoanBalanceCancelled" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_AccruedInterestOfRelatedPartyDebt" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_AvailableBorrowingsUnderLoanAgreement" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_AreaOfOfficeSpaceLeased" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_LeaseExpirationMonthYear" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_OfficeLeaseExpense" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mnkd_PaymentsForUseOfAircrafts" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="dei_LegalEntityAxis" order="5.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RangeAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_VariableRateAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="mnkd_LeaseAgreementTypeOfAgreementAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSeniorConvertibleNotes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="1.0500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSeniorConvertibleNotesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:label="us-gaap_DebtInstrumentRedemptionDescription"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="us-gaap_DebtIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PrincipalAmountPerShare" xlink:label="mnkd_PrincipalAmountPerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt" xlink:label="us-gaap_RepaymentsOfSeniorDebt"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandEighteenNotesMember" xlink:label="mnkd_TwoThousandEighteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFifteenNotesMember" xlink:label="mnkd_TwoThousandFifteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_TrancheBMember" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PrincipalAmountPerShare" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionDescription" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtIssuanceCosts" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfSeniorDebt" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandEighteenNotesMember" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandFifteenNotesMember" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCollaborativeArrangementAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AchievementOfProductSalesMilestoneMember" xlink:label="mnkd_AchievementOfProductSalesMilestoneMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DevelopmentMilestoneEventsMember" xlink:label="mnkd_DevelopmentMilestoneEventsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FilingAndCompletionOfRegulatoryApprovalsMember" xlink:label="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="us-gaap_LongTermLoansPayable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LossSharingAgreementAmount" xlink:label="mnkd_LossSharingAgreementAmount"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ManufacturingMilestoneEventsMember" xlink:label="mnkd_ManufacturingMilestoneEventsMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneEventsAxis" xlink:label="mnkd_MilestoneEventsAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneEventsDomain" xlink:label="mnkd_MilestoneEventsDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OperatingLossSharingMember" xlink:label="mnkd_OperatingLossSharingMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PotentialMilestonePayments" xlink:label="mnkd_PotentialMilestonePayments"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PotentialMilestonePaymentsToBeReceived" xlink:label="mnkd_PotentialMilestonePaymentsToBeReceived"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProfitLossSharingAgreementAllocationPercentage" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UpfrontFee" xlink:label="mnkd_UpfrontFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain" xlink:to="mnkd_OperatingLossSharingMember" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_UpfrontFee" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_PotentialMilestonePayments" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_ProfitLossSharingAgreementAllocationPercentage" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_PotentialMilestonePaymentsToBeReceived" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredCosts" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_LossSharingAgreementAmount" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_LongTermLoansPayable" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaidInKindInterest" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_TerminationDateOfLicenseAgreement" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_MilestoneEventsAxis" xlink:to="mnkd_MilestoneEventsDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_ManufacturingMilestoneEventsMember" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_DevelopmentMilestoneEventsMember" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_FilingAndCompletionOfRegulatoryApprovalsMember" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_MilestoneEventsDomain" xlink:to="mnkd_AchievementOfProductSalesMilestoneMember" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="dei_LegalEntityAxis" order="7.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ProductOrServiceAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementGeographicalAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="mnkd_MilestoneEventsAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis" order="15.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="16.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="stpr_CA" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ContingentLiability" xlink:label="mnkd_ContingentLiability"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="us-gaap_FairValueInputsDiscountRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FairValueOfFinancialInstrumentsTable" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="us-gaap_IncomeApproachValuationTechniqueMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="us-gaap_MarketApproachValuationTechniqueMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="us-gaap_OtherLongTermDebtNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:label="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="mnkd_FairValueOfFinancialInstrumentsTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueInputsDiscountRate" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_OtherLongTermDebtNoncurrent" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_ContingentLiability" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_CreditFacilityAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="15.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="16.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="17.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="dei_LegalEntityAxis" order="18.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_RangeAxis" order="19.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="mnkd_FairValueOfFinancialInstrumentsLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_IncomeApproachValuationTechniqueMember" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_MarketApproachValuationTechniqueMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConvertibleDebtLineItems" xlink:label="mnkd_ConvertibleDebtLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConvertibleDebtTable" xlink:label="mnkd_ConvertibleDebtTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FacilityFinancingObligationMember" xlink:label="mnkd_FacilityFinancingObligationMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ConvertibleDebtLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ConvertibleDebtLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="dei_LegalEntityAxis" order="4.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ConvertibleDebtTable" xlink:to="mnkd_ConvertibleDebtLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="mnkd_ConvertibleDebtTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_FacilityFinancingObligationMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantExercisablePeriod" xlink:label="mnkd_ClassOfWarrantExercisablePeriod"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice" xlink:label="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClassOfWarrantsOrRightsExpirationDate" xlink:label="mnkd_ClassOfWarrantsOrRightsExpirationDate"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockIssuedToByPartyAxis" xlink:label="mnkd_CommonStockIssuedToByPartyAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockIssuedToByPartyDomain" xlink:label="mnkd_CommonStockIssuedToByPartyDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementShares" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_ExchangeDomain" xlink:label="dei_ExchangeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NominalLendingFee" xlink:label="mnkd_NominalLendingFee"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants" xlink:label="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PublicMember" xlink:label="mnkd_PublicMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RelatedPartyMember" xlink:label="mnkd_RelatedPartyMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" xlink:label="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SharesReturnedUnderShareLendingAgreement" xlink:label="mnkd_SharesReturnedUnderShareLendingAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage" xlink:label="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnderwritersMember" xlink:label="mnkd_UnderwritersMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldByUnderwritingPrice" xlink:label="mnkd_UnitsSoldByUnderwritingPrice"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldUnderPublicOfferUnderwritten" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwritten"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription" xlink:label="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock" xlink:label="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantLiabilityMember" xlink:label="mnkd_WarrantLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantsExercisableExpirationPeriod" xlink:label="mnkd_WarrantsExercisableExpirationPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd#exch_XTAE" xlink:label="exch_XTAE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_ClassOfWarrantExercisablePeriod" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementShares" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_NominalLendingFee" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_SharesReturnedUnderShareLendingAgreement" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_UnitsSoldUnderPublicOfferUnderwritten" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_UnitsSoldByUnderwritingPrice" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_WarrantsExercisableExpirationPeriod" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_ClassOfWarrantsOrRightsExpirationDate" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommonStockIssuedToByPartyAxis" xlink:to="mnkd_CommonStockIssuedToByPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommonStockIssuedToByPartyDomain" xlink:to="mnkd_UnderwritersMember" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommonStockIssuedToByPartyDomain" xlink:to="mnkd_PublicMember" order="1.3500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_ExchangeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_ExchangeDomain" xlink:to="exch_XTAE" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_RelatedPartyMember" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_LegalEntityAxis" order="4.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_EntityListingsExchangeAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="mnkd_CommonStockIssuedToByPartyAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mnkd_WarrantLiabilityMember" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonStockLoanedUnderShareLendingAgreementShares" xlink:label="mnkd_CommonStockLoanedUnderShareLendingAgreementShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetIncomeLossPerCommonShareLineItems" xlink:label="mnkd_NetIncomeLossPerCommonShareLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetIncomeLossPerCommonShareTable" xlink:label="mnkd_NetIncomeLossPerCommonShareTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OwnshareLendingArrangementSharesIssued" xlink:label="us-gaap_OwnshareLendingArrangementSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="mnkd_NetIncomeLossPerCommonShareTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_NetIncomeLossPerCommonShareLineItems" xlink:to="mnkd_CommonStockLoanedUnderShareLendingAgreementShares" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_NetIncomeLossPerCommonShareLineItems" xlink:to="us-gaap_OwnshareLendingArrangementSharesIssued" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_NetIncomeLossPerCommonShareTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_NetIncomeLossPerCommonShareTable" xlink:to="mnkd_NetIncomeLossPerCommonShareLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosurePotentiallyDilutiveSecuritiesOutstanding">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="dei_LegalEntityAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockAwardPlansAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConsultantMember" xlink:label="mnkd_ConsultantMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="us-gaap_EmployeeSeveranceMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares" xlink:label="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeStockPurchasePlansMember" xlink:label="mnkd_EmployeeStockPurchasePlansMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfCommonStockSharesOutstanding" xlink:label="mnkd_PercentageOfCommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PercentageOfShareReservedForShareBasedCompensation" xlink:label="mnkd_PercentageOfShareReservedForShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest" xlink:label="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SharesReservedForEmployeeStockPurchasePlan" xlink:label="mnkd_SharesReservedForEmployeeStockPurchasePlan"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockAwardPlanTypeAxis" xlink:label="mnkd_StockAwardPlanTypeAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockAwardPlanTypeDomain" xlink:label="mnkd_StockAwardPlanTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionsGrantedVestingRate" xlink:label="mnkd_StockOptionsGrantedVestingRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ValueOfRestrictedStockUnitsVested" xlink:label="mnkd_ValueOfRestrictedStockUnitsVested"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest" xlink:label="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EmployeeStockPurchasePlansMember" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="7.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="mnkd_StockAwardPlanTypeAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="15.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="16.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_SharesReservedForEmployeeStockPurchasePlan" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_PercentageOfCommonStockSharesOutstanding" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_PercentageOfShareReservedForShareBasedCompensation" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_StockOptionsGrantedVestingRate" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ValueOfRestrictedStockUnitsVested" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1.3500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1.3600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="1.3700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockAwardPlanTypeAxis" xlink:to="mnkd_StockAwardPlanTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockAwardPlanTypeDomain" xlink:to="mnkd_ConsultantMember" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_ExecutiveOfficerMember" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_EmployeeSeveranceMember" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedAwardPlans">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFourEquityIncentivePlanMember" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember" xlink:label="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_TwoThousandFourEquityIncentivePlanMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ConsultantMember" xlink:label="mnkd_ConsultantMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EmployeeMember" xlink:label="mnkd_EmployeeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="mnkd_EmployeeMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="mnkd_ConsultantMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfEmployeeStockOptionsAssumptions">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:label="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:to="dei_LegalEntityAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:to="us-gaap_RangeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationTable" xlink:to="us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfStockOptionsOutstanding">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionActivityAndChangesLineItems" xlink:label="mnkd_StockOptionActivityAndChangesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StockOptionActivityAndChangesTable" xlink:label="mnkd_StockOptionActivityAndChangesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="mnkd_StockOptionActivityAndChangesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1.0400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="1.0500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="1.0600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockOptionActivityAndChangesLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockOptionActivityAndChangesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_StockOptionActivityAndChangesTable" xlink:to="mnkd_StockOptionActivityAndChangesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitActivity">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="1.0600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="1.0700" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommitmentsAndContingenciesLineItems" xlink:label="mnkd_CommitmentsAndContingenciesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommitmentsAndContingenciesTable" xlink:label="mnkd_CommitmentsAndContingenciesTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ContingentLiability" xlink:label="mnkd_ContingentLiability"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongTermPurchaseCommitmentCancellationFees" xlink:label="mnkd_LongTermPurchaseCommitmentCancellationFees"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongTermPurchaseCommitmentExpirationDate" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="us-gaap_PurchaseObligationDueInFourthYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="us-gaap_PurchaseObligationDueInSecondYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="us-gaap_PurchaseObligationDueInThirdYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="mnkd_CommitmentsAndContingenciesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_ContingentLiability" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligation" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligationDueInSecondYear" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligationDueInThirdYear" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_PurchaseObligationDueInFourthYear" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongTermPurchaseCommitmentCancellationFees" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongTermPurchaseCommitmentExpirationDate" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_CreditFacilityAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_RangeAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="mnkd_CommitmentsAndContingenciesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureProvisionForIncomeTaxes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" xlink:label="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxExpenseBenefitNet" xlink:label="mnkd_IncomeTaxExpenseBenefitNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredOtherTaxExpenseBenefit" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="mnkd_IncomeTaxExpenseBenefitNet" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesTable" xlink:to="mnkd_IncomeTaxesProvisionBenefitSummaryOfIncomeTaxesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAsset">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsLineItems" xlink:label="mnkd_DeferredTaxAssetsLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsMilestoneRights" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetsTable" xlink:label="mnkd_DeferredTaxAssetsTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsMilestoneRights" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsCapitalizedCosts" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.1400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DeferredTaxAssetsLineItems" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DeferredTaxAssetsTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DeferredTaxAssetsTable" xlink:to="mnkd_DeferredTaxAssetsLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mnkd_DeferredTaxAssetsTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredTaxAssetIncreaseDecreaseInEquity" xlink:label="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesLineItems" xlink:label="mnkd_IncomeTaxesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_IncomeTaxesTable" xlink:label="mnkd_IncomeTaxesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetOperatingLossCarryforwardAnnualLimitation" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_NetOperatingLossCarryforwardsBeginsToExpire" xlink:label="mnkd_NetOperatingLossCarryforwardsBeginsToExpire"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_OperatingLossCarryforwardsSubjectToLimitation" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ResearchAndDevelopmentCreditsBeginToExpire" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mnkd_IncomeTaxesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_DeferredTaxAssetIncreaseDecreaseInEquity" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_NetOperatingLossCarryforwardsBeginsToExpire" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_OperatingLossCarryforwardsSubjectToLimitation" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_NetOperatingLossCarryforwardAnnualLimitation" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesTable" xlink:to="dei_LegalEntityAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesTable" xlink:to="mnkd_IncomeTaxesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureEffectiveIncomeTaxRate">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfIncomeTaxesLineItems" xlink:label="mnkd_ScheduleOfIncomeTaxesLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfIncomeTaxesTable" xlink:label="mnkd_ScheduleOfIncomeTaxesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mnkd_ScheduleOfIncomeTaxesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ScheduleOfIncomeTaxesLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ScheduleOfIncomeTaxesTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ScheduleOfIncomeTaxesTable" xlink:to="mnkd_ScheduleOfIncomeTaxesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureFacilityAgreementAdditionalInformation">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsAxis" xlink:label="mnkd_AgreementsAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_AgreementsDomain" xlink:label="mnkd_AgreementsDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ContingentLiability" xlink:label="mnkd_ContingentLiability"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DanburyFacilityMember" xlink:label="mnkd_DanburyFacilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DebtInstrumentDateOfLastRequiredPayment" xlink:label="mnkd_DebtInstrumentDateOfLastRequiredPayment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_FacilityAgreementMember" xlink:label="mnkd_FacilityAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="us-gaap_FairValueInputsDiscountRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueInputsEntityCreditRisk" xlink:label="us-gaap_FairValueInputsEntityCreditRisk"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" xlink:label="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:label="mnkd_MilestoneRightsLiabilityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebt" xlink:label="us-gaap_OtherLongTermDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtCurrent" xlink:label="us-gaap_OtherLongTermDebtCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="us-gaap_OtherLongTermDebtNoncurrent"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PaymentForContingentLiabilities" xlink:label="mnkd_PaymentForContingentLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TrancheBMember" xlink:label="mnkd_TrancheBMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TwoThousandNineteenNotesMember" xlink:label="mnkd_TwoThousandNineteenNotesMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AgreementsAxis" xlink:to="mnkd_AgreementsDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_AgreementsDomain" xlink:to="mnkd_FacilityAgreementMember" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_TrancheBMember" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentDateOfLastRequiredPayment" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_ContingentLiability" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OtherLongTermDebtCurrent" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OtherLongTermDebtNoncurrent" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PaymentForContingentLiabilities" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FairValueInputsDiscountRate" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FairValueInputsEntityCreditRisk" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OtherLongTermDebt" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RangeAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="mnkd_AgreementsAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="15.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_TwoThousandNineteenNotesMember" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_DanburyFacilityMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:label="mnkd_DeerfieldManagementCompanyLpMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureRestructuringChargesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCharges" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_PaymentsForRestructuring" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringReserve" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="dei_LegalEntityAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialData">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding" xlink:label="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingLineItems" xlink:label="mnkd_InterimReportingLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingTable" xlink:label="mnkd_InterimReportingTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_InterimReportingLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_InterimReportingLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_InterimReportingLineItems" xlink:to="mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_InterimReportingTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_InterimReportingTable" xlink:to="mnkd_InterimReportingLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="mnkd_InterimReportingTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingLineItems" xlink:label="mnkd_InterimReportingLineItems"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_InterimReportingTable" xlink:label="mnkd_InterimReportingTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_InterimReportingLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_InterimReportingTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_InterimReportingTable" xlink:to="mnkd_InterimReportingLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="mnkd_InterimReportingTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:label="mnkd_CollaborationAndLicenseAgreementMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ProfitLossSharingAgreementAllocationPercentage" xlink:label="mnkd_ProfitLossSharingAgreementAllocationPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SanofiAventisMember" xlink:label="mnkd_SanofiAventisMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_TerminationDateOfLicenseAgreement" xlink:label="mnkd_TerminationDateOfLicenseAgreement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_SanofiAventisMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mnkd_TerminationDateOfLicenseAgreement" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mnkd_ProfitLossSharingAgreementAllocationPercentage" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="dei_LegalEntityAxis" order="4.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BasisOfPresentationPolicyTextBlock" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_BusinessPolicyTextBlock" xlink:label="mnkd_BusinessPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ClinicalTrialExpensePolicyTextBlock" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock" xlink:label="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpensePolicyTextBlock" xlink:label="us-gaap_InterestExpensePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock" xlink:label="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_SaleOfIntellectualPropertyPolicyTextBlock" xlink:label="mnkd_SaleOfIntellectualPropertyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_WarrantsPolicyTextBlock" xlink:label="mnkd_WarrantsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_BusinessPolicyTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_BasisOfPresentationPolicyTextBlock" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UseOfEstimates" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_SaleOfIntellectualPropertyPolicyTextBlock" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtPolicyTextBlock" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryPolicyTextBlock" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_WarrantsPolicyTextBlock" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ClinicalTrialExpensePolicyTextBlock" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpensePolicyTextBlock" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock" xlink:label="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LongTermDebtTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommonAndPreferredStockTextBlock">
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_CommonAndPreferredStockTextBlock" xlink:label="mnkd_CommonAndPreferredStockTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_CommonAndPreferredStockTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="mnkd-20151231.xsd#mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock" xlink:label="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g1078491.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078491.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" -6 I0# 2(  A$! Q$!_\0
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M%09/J?SHR?4_F: )Z*K[R20"<C/?T_'WI#)@XRWY_P#UZ +-%5A)DXRWY_\
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M0Y]QFACCZGH*8S<@@_\ Z^>QI0RG!;J.G7H/7%.,K+NRE%O83<V0K=^W'0D
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M.O"'ARU^)GQEU"TUBW\5^'+?6$OVTORU62R>[C?[&R,S*^W&XXK\^/$7Q_\
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M9Q[^F*MP$F,9X.3_ #JF6(.-I/O_ )%7(#F,'&.3Q^-:PV?J93W7H344459
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M/-+<Z!X@N9&BU12=LT]ND5K<,#) A4[C_JEX )4#;M)P#VR2?RS7\;'[%/\
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M!OVPKV/3-$\8FYTE-,^'.I/$4:T\:0/<><'CU)7MIO)0^4R%V&/EKS'XF?\
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M>_X)A_M(?%G3-6'Q,^)W@_PWKO[2'[7>F?M+_M1:A\-6OK6/PMX?^%_@S2]
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MLN?!K]J'5/VA=$^(&G3:^OQ6UZQ?Q%XD\2:3X6O]!9Q96MPM[KSB:X1B#'$
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M>,+;2XIV^&OC_P"-L?Q/E^$GCZ_O(LO/X:U'4O!=GITZO^YA>^A=B"<5]S>
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MZ9Z9_(\T .)&<(0I[D@G(.>GIS_*FCD]1GN3P,T_*'J![?+G'Z5$RAB>O)X
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M_!?BCX<^./#WQ)LHM1\ ZKX6UBU\86,IN0EUX?:RE;4X2;-A,6-LK[1$?,+
M!/F(!<?B0'YR_#'_ (*Q_ WQ)X"U'QQ\4=%UOX5PV'CW1? 2PED\46\MWK^E
M6FJZ=JLD]C'&]MI7DWD*22O'M5S@9'->E'_@IA^S1>SM-HFN:A>:#HGC7Q%X
M.\;>(-0T^XT:T\.OX9\)>*/%E]JD$-TOF:I8M!X5OXHV15\QV!7(KR#5/V<?
M^";\G[/6B?'/Q#\/-3O?A9>WFC^*;#7-;U#X@ZGXHO[BYDMO#NAQW=M=7\E_
M-&D=M;106[H%MXHOE5 ":^G=#_85_9(M?[7U:P^$VG72^,[O^W]8?4-2UN]7
M4Y-0\/:QH6;F*ZU [H_[%\3:S&$8?+]M)!!1-NP',?&O]O'P9\,_@3\/_CEX
M<\'ZWXATOXB_$W3?AEI>D>*I1\/[W2]2U#1_$VM"]UW^UH9&L+<6_AMUC78S
M2M?P[>&S6!X8_P""F_[.>J^&=,U7Q+;^//!?B*?0O FI:SX-U3PEJESJ^BZM
MX\\#+\1--\-,]O&%O=8A\(":^GC0 QVT#2D <5]-:%^S5\&_#W@[P#X*L/"C
M7N@?#+QH/B'X,M=?UO7/$=SIWC!;#6M+CUB;4-=U"XGOIDL/$&IQ1I-(\4:S
M+Y:+Y:8^5/VT-._8V^%>D3^(/CS\.O%>NR_&?QS;>)-3F^'VF>,]6\1#7OAW
M\.O^$?G\4@^#YOM6BZ?8?#BR>VN7@\N-[0NLBON)HW WO$O_  4N_9=TO3K6
M[\/^+E\374NKV]C=V,$,]G)IVFRW)MVUN\::,^58/M8VI('VO81%DBK.E_\
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MP[?7OB7Q3I?@[2['0KV+7+Q]:UC3[C5;.*[M],:1K&U_LVUGG>:4)''&NYW
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M^RC9?&G3O@9X2T[X_O//\3;&?7+;5;R[U1=7U&^TY-9O3H=[JMTN1'J,FEM
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ME.Y0<D*<5Z3X5\2Z=XQ\.:!XLT9G;3/$6DZ?K.GM* LAMK^WCN(A(H/RN%<
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MN]MHTFJV26D7G W)G,<H5UW(HAVD;G6O-3\</%"_'CXC_#^X\-:7:_#GX9>
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M9X!\2^ ] U>YTB']HYTO?'<,?B6>_O=>9Q=ZA<6-M&L=G%#&(_V.$>>A/?\
MA/;_ /73EC(/<\>A_P ]JGVGD!\I>'OBI\5O#^@Z-H(_9+^/5\FC:79:8E[<
M>*_V:TFN5LK>.W6>6/\ X7V^R1EB!(W'&<;CC-;I^-7Q5*)C]D3XZ$D?,O\
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MW/\ ,U&QSC@@^X _+!IJJ&)Y/'N>OTS3]GOVSTQ^>>E+F]UQMN SG^Z0.Q(
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M\H),LS-P=PD"\;<D SO^&4? G_0Z_&C_ ,.OXI_^2:=_PREX#[^-?C0!W/\
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MW'' _NC_ !%-W'()9FY'<G(SGCGFG*7+T \@_P"%W>$NWA[XO_\ AB?C-_\
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M3>(FS_Q>/XC\?]/MI_\ &J]MVJ.<=.>I_P :B4DYVD'UZ'UJP/%?^%3^(?\
MHL?Q'_\  VU_^-4X_"7Q&%W?\+C^(V/^OVU]O^F7N*]IVMZ>O<?G2D.1@C@?
M2IC).]D!XD_PD\1E"!\9OB0A*G:XO+0E"P." 8L$@YQV]:D_X5)XC_Z+'\1O
M_ VU_P#C->T'=@9Z=NG]*<-^!CICCITJ@/%?^%2>(_\ HLGQ&_\  VU_^-53
MF^#OBR1KDQ_''XDP++;^5"%N-/?[+* <W*%K<F1^1\K97CI7NW[S_.VCY_\
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MH_WG^=M: >9:'\&/A3X9FN+CP]\.?!FB37DE]+<S:9H&G6DEQ)JB/%J#RM#
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M%MOA&"R_X1OQ5;SZG _A:&WM-9N9/$*II\5A/F4B1Y'QYC;\#]#-\OJWY?\
MUJ:SRXX+'G^[G]"*.>/8.21^-VE?%O\ X*.ZGX=TG5]%\(Z]K U/P^^L?#Y]
M6^%6F:0_BZUN]/TZX\0W'Q2MY?%D;^ -4TV.?59/#MFJQOK<EG;0R#,N&M1G
M]OCP-XN\:W-[J'Q&^(-FUOX;N+_Q?:^ ;%X]$TW7O WP2D\2'X8> [/64M_$
M&HV7BF'QM;I97(N+J'R;R?S'(:.?]A\L>I.3R0#T]>!TYQ2AG'0\^@.?TR2*
M.==F')(_/O\ 9Q\0_MTZMXXTK5?CUHNCZ/X4U73]<T^[\*66@6EFNB3:9X?T
M&\T+7KKQ!%K4["]U#6;S6(9K98Y8H1:!5961F;SGX?Q_MG?$SXW?#W_A99\=
M^%OAMX+^(FI^(?% @\,V/@_2[V\L=.UK^R?"T-U:Z]--XM\!%H])D^V[=DMS
M*(I#*A9$_4HM(1AB?Q.!^9QFC+XQNX_WA_C1SKLPY)'Y#?9_V_?#GQR^)/B/
M0I?&WB30-#\9^(4\-^&O%&D:++\/O%WA'Q+XQ^!MEH6CZ5J%G?V\NFO8^'KK
MXCWG]I!)VMAI,Z3HX+1OL:-=_MX?%C]B_P =6'CO1KO0OCUJ'Q.^%EAX:ATR
MP\2?#V\@\.R>*/AA?_$2#5)K62UO8O#-G<3^/K1K_3W#3:/8!K2XOV"7UW^L
M.7]S^OZTGS_[7ZT<\>P<DC\K[[1_VX_@AH%_X<T;Q%J?CO0]*CTV[_M/P_X!
MU7XCZY8GQ3JGBC4K^Q\,7GB?QJNH^*;31DC\-:=&MX9+EH+J2[GE."8O%]%_
M:#_X*'>(]8LI_AGX%T+7-*7Q-XFTOQ-+)H>M:_I,_BW2[C3[;4/#EWJ5EJT]
MKX6MK;3Y)9U;[5#:?:\VZ32L#$W[<AV'R[BI[?-M.#R?\_G3(XU@0I#&D499
MF9841$+N<NY$:8WL<[CU-'.NS#DD?GW^S]K/[4FK>,_$_B7XBMXZGT*Y^"=S
M_P (SI'BKX<6'PYTU?'UAK-C-="XTR+Q)J,\&H;KNZMK=KB2T^TV=F9DMV5!
M<S_).B_'[]O.+3? UM\)? 7B7QEX$E^!6@ZIJOC_ ,2^"M7\4/>_$75?!NC>
M*/%.L>9HUV]Q=ZE:_$B\\:>'[G1XH_M^G/H_D1:(\,%K+J'[?JY4$9.<G'W@
M>G&/?(]Q1"%A3RXU2) SL$1$C0-(QDD(10 "9'8GU+$GDFCG79AR2/S9^+?C
MC]KS5_V</@U>Z)X3\:^&OB!XT\/;/B=#X=\!C7_&'A_Q(S^&Y-*T]M&T[Q(I
M\+Z=="3Q"+J_9I_L*V\8GBC8[&^<9=2_X*,?$QX(O&'A_P 0^#K3X?\ B6>_
MBT/PCHGB71+CQ')8:'C3]$U/Q'+J-NGBG09;A8W>XTZ>6%KES&\Q *C]M68D
M@JV<9)PWTSWII9S_ !9]L@D?A1SKLPY)'X\>*?BC_P %//#/A_PT=(\#:'K-
MQKL\-YJEZWPXU^_E\&?Z?XXL=+\-7&E:'KE]=ZW;W(T_P0;O4"D*62:I-/<2
MQ6[-/;^G_#W6?VO_ !G'^V%=?$+1_'.A^(D^!-UX?^&?A_3?##>%-!TKXD6^
MJ?'B.TM/AEKUWK-W#XYU"719OAE<_P!MQM%;F:_MX&2*2WFAA_3I7;G<Q'ID
MXSU_^M3"6))&XC)Z9HYUV8<DC\5K?XL?\%('\/>%O"^G>"]<U'1+K1?$^BQ^
M,_$7P@\8>&O'?B:ZM]*N+/&NZ1::A=CX=W]M*CR6.I7\D5KJDHB>W#!P@V;O
MXX_\%)/#-AJ=OX:^#EWXTOM%BL])FT/7OAUK^EFRFNKF#3-$OM+\9G6S!X^4
MVA>_U2:UBC2U ,3A)?W=?LAE\8)(^IQGVY/(HRP/5CD<<L>F<=.@R/I1SKLP
MY)'YO? KXW?&]_BG\/H?CQI>H>'=>\;_  QNXO'W@+2]+U2ZL? 'BV?XA^&/
M"/PUEN[.S%X-+?5XY?%]TUS)<1PFP>&2=$^R2,,/7/$O[;^E_M'?M#>&/#.A
M:K9?"?Q3\0/A;%\(?'6H^$+SQMIVE6=[H?P1T+XGSM9QZQ81Z-X<TVQOO%-_
MIY,DL>I:E_;0FFMCI:P7WZ=J@21YDB1)9 BR2B)!+(L>[REDD"Y<+N;:"3C<
M<=:>&;.YB1Z]>_'84*:;2[AR2/R!O/C_ /\ !1RVM-1U+2_@B=<\0Z7H&GW-
M_P"![CX8>(=!TQVNM'\*6^FZGH7C:[\1/::YJ=YK^OZY/?:5"3<Z-:^$Y8KG
M]XR22^B?![XJ_P#!03Q3XB\"ZM\4/AII7@;0+G5=$L_%O@Z'P-J5[=BPNM?N
MM&U?4QXK3Q28M+CBT^&&^C0VLS+',/-P"#7Z=&=L[5+''0ANGKQGCK1OD(QN
M/?C(SSQTZ]J<I).S6X<DC\I/CO\ M ?MV:!\8/B]X8^%/PFU&\^'OA_P[(_A
M'Q/?_"#QWXA@NM4METBXCNM&O_#,URGBLW4=SJ5NJ0H)H)K=7FM%B4M)^E/P
MGUSQ1XH^&/P^\1^-M!O_  QXPUSP=X<U3Q3X=U6QATS4='UZ]TNUFU;3[S38
M-2NUT^>.]>8& 7,QB(\MI&96KLQ)(N!N(&<\XSZYP>3TKR_XB?!?X3_%BXTN
M[^)/P\\)>-[G1(;NWTF?Q+I%IJDMA#?/#+=QVKW*L8TD>UMBX4X)A'I24UHD
MA<DCY4\4^+_VGO!OBGXHQV6@>-_$6@_#A-7N/!^IP>%[?Q+IWQ)?XJ>)[&_\
M++#I.BVEO>7UIX(T/[79W\=HR7,JGS MXZ[CO^#?BI\7-;MO@1XF\4^!OB)I
M7C77O!OCM?''A'3/A]X^TWP1%KUGIS/X<CUJ?6?#+'PK+<:K"RV[WUS;LB3
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MC67G]I.,CT_X57X%S^7]F4S_ (5K^T7_ -'(Q_\ AJ_ W_RMI/\ AJSX=?\
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M^'WP^\.W'AY+'38Q;:;<3Z[X6UMC=QQ"9(-8R'#9"_<?[.?PZ\5?"?X-^"O
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M+N.\TOX1^%].NX;=[2&ZL8+RUN(K61C));QS072F.!I&9B@(4L22,U7,K7Z
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M>W!J7*+:OJ!].X;T/Y&E&Y<X4G/7@_3^7\J^7O\ AC+]GG_H1]5_\+OXA_\
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M=5O?@QI.J^(/&-]:>'C/'I6F6%M)?7U]I>I"T*ZG&]II44J/:2.)DBA96;"
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MX?O5M[B"YDF2[N8U=2OZ8ZGXH_9RT+4M?TW7?$/P4TS6/!^H6_CGQ-8ZM?\
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M;W4M9L;1#X@6.32-1M]QFG-J]N8I/*+("FD]&!ZIT_SFBI/+]_T_^O1Y?O\
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M9(-3G6!/LP1)(B)?WTL# BN_^)W[;PTKX$?#OXP_#7P)J]U=?$3XK:!\+H=
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M7PW^*MUX4M=073]=\40^&;SS/#QCT#2=9U:?5-!1&O+.+39]4^SZB98D^SO
M9/G0@UV_P[_X*$_LW?%GQ]I_PW^&^I^+_&'B'5O$*Z%I+Z)X,\07FEWMN+:>
MZNO$+:M%:^19>'[>*VG,]Q</$(_+)(Q@GU;0?V<OV8-$U>32] \$>"[;6CH,
M^A7&DVNLWES?2:1%:P:1?_:M,?5W:6Z:VM8(;J[DC-W+Y0%Q.[9)VO W[,?P
M)^%?B*'Q=X"^&VE^'=>MI;F6ROK>^UR:#2%NM/FTZ[AT>QO]3EMM$L9+*YF#
MP6L4,#O*TK1F7YZ /*U_;4^&VD_%SQU\)?&FA^+/!]WX:^)7A?X9>%_%-UI%
M_?>%_'FN>)K?X=B.#2-5LH'BMKRVU#XD:*ES#.R-' K7))B5BG$7/_!07X3C
M6+N+2-!\2^)=(N(]9MM#O?"^C:MK'B#Q+K^C:9X*U&'0++P[;Z8)[FYEM/%-
M[,LT;2V\=MHCR&4;]B^W:S^RS^S7\2M8\6^/-3^'WA[Q/JGQ"\H>(/$%MKVN
MW,%WJ&DW6APKJ^C2:7KH@\/>)X+WP?H"'4],6TU&.3P]!&US^X '*Q?LL?L:
M+X5O?#EGX*^'5EX<\.VD%C>C3O%.HZ?-X8A\G1=%A=M;L?$<=WX>NW@\*:7:
M_:!<0SR+920F1Q-<+( >>^'?^"@GP=U#2-#N_&NA>*O#XU>WMM4O#;^&M>\2
MZ9X3L)+>2>&Z\8:A;:/Y.C2"YAEB49?,B *Q-=9H/[>OP'\0>-O"/P_:'XCZ
M3XI\;>(U\-:)8>(/A]XHT:.:ZFMOMEC=M>7M@L/V&XM#'+"RNQ:.0.5"!F'H
M5E^RU^S?J7A"YT?0OA[X5E\-ZYHEMI<5YI$T^IPSV%MYLFFS6]W=W=Q%?+#/
M,TL9D$L;MCS5D3*UYI\(O^"?/P'^%\%I<:M;>)?B;KVG^.O^%A:7KWCK6[J1
M].UR&5'TI+?1=#>ST^6PLS%&;6">UFCA>-7B1"%( .P^(7[77PP^%WCO5_ W
MC&W\2"YT^]TF%KCPYX;\2>)8["POK4W5]KOB232=*:/0M$M0UMYEP\K)_I&.
M& #<Q\=?VS_#'P#^,7A[X4:[\.O'^N1:KI'AS7M0\5^&]*GUBPT[2]?TSXR:
MI,;/3;)9+S6K^SM?@_J<US!;0NZ6]]YW*PN*]_\ $OP"^$OC#5]>U_Q+X#T?
M5]6\3Z9+H^O7URVH+<ZGIDT,5O):RB*\1%3RX80"@5UV JP:LWQQ\)O@;XP\
M<V_CGQYHGAC4/'7AWP==VR:AJVKW%K?Z7X)>U\6Z5<WEUIR:I%%%IB6?BWQI
M"+V6',*:S>(DZ;G  /,_AE^VC\ OC'K/Q.\-_#+Q1>^*M<^%FC:EK>MVZ:3J
MEA:7UOIBWT=U'I.I7UHD-Y)'?Z?=6\@#;DDB)(V%6/SI\*?^"FO@+Q;:6VH^
M.O!NM>&M*UI(CX?UKP2FO?$G2/M>Z]DOO#GB.]T?P]&-#\26>G6,EY=1#SK>
M&W4LUR& 0_:7@;]G7X)>!-0\2:WX&\$VFCOXVTA]*UE+#6-?N- N]*NUG:[3
M3-#N-7ET_1OM3W=S+=36-O;R7<MPT]Q)+*V\],GP5^%R^'O"WA-O ^DR^'?!
M%KJ=EX6T>9+F>STBTUFRN=-U*W@2:X)ECFLKNYC82F3B4E<$9 !\E7G_  4>
M_9NT[[3=ZCK?B#3=.M+331-8ZGX2\7:?XQEU?7[SPZOAG3[+P?>:&EU>6U_I
M/B%;Z&X0%3;VLD@4JDK1]?IW[;WPH\5Z_P##72/AYH?Q&\=Z9\3/B%8^ =,\
M8Z;X'\1:;X+AEN?"7BSQ3>ZK!XFURQMK35H;!_"5S9W\%G+-=6ES/MFA18Y"
ML*?L!?LY+JM^[^%M7;PY=Z+I^G6?AR#Q-XEM+S2-6L-9TO5K;Q5IWCVWU9?$
MMOKL,>A:+96A35TAL=/L!96D<-M(\9[K3?V,OV;=(U5-<TOX8QV.IV^L6/B#
M3;B#Q-XVC70=9L-*U+1AJ7A>W7Q)Y?A:ZN;'5]4.H-IR6W]I3WLEWJ'VFZ/G
M4 >]^*[O6-*\,ZWJ?AG3;76M>L-/GN],TC4M5DTBRU"X@7S/L]QJD=I.;*,Q
MJ_SB&3! &.<U^?O@C_@H)90ZGX3T_P".GPSU/X8V?C+P+)X[T[Q#X>U'5/B%
MX<T;3U\33^&(;?Q=JND:#&GAR26[MY&CEF MVR$\[>=M?HZEA%'9KIXC=K5;
M?[)LFDGF=[?RO)*RSS.[RDQ\,SL7.22Q/->)I^SQ\ =<TRTA7P'X7UG2;/0X
M_"EH$N+O4+--"LM:EUU-&\U;]Q-;)KDDDQ5BS"0[6^4;0 >"^*/V\?A*G[-7
MQ(_:/^&<=]XZT;X=W>G:;=:3JT.I^"#)>ZM/IB:?<7-UK^GJUOHSVNK6MR+M
M(I4,&XJ&==E<_P"&O^"B'PCM?!=UXB^+.E^(?A]J.FW.I0WSZ3I7B#QIX(U.
MRC\;1?#WPYK?A3QUI>BK::WHVL^+)FL-,<B&6XN=/NU$(BMVEKZ"\(? 7]G3
M3/!&M_!OPQH&AZKX/N=6M/$VN>$+GQCK7B^>.]M-0@.E2SR:MX@N[RPTJWOM
M#AAL[59([.V_LTVT$,:1O&.H^(7[/_PE^*EWX@O?'G@FW\07_B7P]X8\+:KJ
M9U#6=+U/^Q_!?B:_\9^$XM/O](U&"71K_3O%&IW][:WMHT-W%-<?+,$ 50#Y
MMT3_ (*-_LM>)-5T;3=#\2>.+]/$$=E)IFMP_#+X@?\ "-2"]_L-6:;Q%_PC
M_P!DMX[>X\3^'X;LO*!;3:K'%*5?<%DN/^"BO[,6AV&N2>+_ !?J&@7_ (8T
MC2=6UVV_X1SQ/>6:/KUW/::3IVF:G'I BU?49S Q2&$LQSC'%>N6'[(/[.>F
M65EI]E\+-.BMM.MY+2U$FJ^);F4127?AR^E,MS/K3RW,SWOA'P](TDCO(S:<
MI+DO+OP-6_8:_9:\07TU_JOPJANK]]'AT2WN3XK\;PRZ+96UR]W'+X<,7B('
MPSJ8N)'<WEA]GNF+<S&@#6^!_P"UW\"?VB?$NO>%?A)XGU'Q'JGAO1K/7-4E
M?P[K^G:7%:7C6ZI&FJW]A'!-=K)=Q(\:R%PRR  F*3;QGQ1_;8^'OPD^*-[\
M-_%/A+XDO%HEWX6B\0>+-'\(:SK>B6-CXG\"?$_Q\FM01:/:SW%_I%AI?PMU
MC^U+B.(Q6(N$EF=8XYFC[?0OV0O@CX1\60^./!^@^)/"WBVV3P[:#7],\<>,
M;Z\DT;0=<T;7YO#@AUS6KJ&VT;4KS0=/75HX8XGU&-7%R[,[,>M\4? ?X+^.
M/&VN^)?$WAJRU;Q=K?A2'0-:C/B+7K>>3PS+HGCOP?;R-H=EK"06COHGC[QW
M9"^CMTG=-3D03EK:$P@'G'AG]LWX"?$'3_CG/\-?%S>-=4^ 7ASQ#XA\8Z/8
MVM_8/<0>'[;7FF&D7^HVT4&I6\FI>&]7M%GBD>+SK1LMLPQ\J^ 7_!0GX2?&
M7P[K>N:U;7?@J71)W5K9;E_$UI>6T7A^U\1SRQ7NC0/Y-Q#8WD"S12QH?.8I
M$90"U?27@W]F+X)> K+XB:5X2\%R:5I/Q5L]6T[QII!\1^*[S2+S3]>.J/K%
MAI.F:AK4L'A:RN)M;U:1X],2S'F7[N 'VE?,(OV'?V5M3T^?18_"6M:N+#5;
M0ZA?-\8_BKJ'B))-+T^WTJR\/:OXE/CM]0E\/P:7;6T":/<7!L$BB"?9-O%
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M1X!\40V_@BRE\0Z;:7FLO)8:@-*\*>$K8W$9@NK5-D]C<VEW*ET0#UZ+XU^
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M/VS/&"P>!X(F\1P6GQP\,RRZ49D4V=I+;Q:/F*XF9HXX8P-SO(J*,D"OIO\
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MN]9\TNWYC23O=V/';RP^!GP(^'/AG3-:C^'OPX^&?@,Z9I/A<^)[C2M+\/\
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MW?7]Q=/J<]Y!.NV0AD_:0OG/&,\Y]SGGIVR?^^C36;=U&,=,'IDYZ]_3Z"K
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MKX8T8_\ ;C!_\10!H?\ "4^%LY/B7P^Q]]:TWTQVNJ8_B;PP6^7Q-X=4<?\
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M'Y5&!,^#Y:J 3D!F;..V3&.P'8U3C=)7V 0<G!Y!.""/\\5,4CP5V*58$,K
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MSM\*K#3]!AO(8HO#=CK^H0Q17Z2A5^U?A9^RK:?"[]G'5_V<;;Q79:CHU_\
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MHNG?$;6KOQ%XPM/"1U+R_#\.K:QJ,4=Q?/Y"2,CW$:2['7>H-?6?ER?(0Y#
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MV#DY/;_./6E'09Z]ZB4[.UM@)/,]OU_^M2[C_</Z_P"%0XZXZGU)/-)^\/\
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M;:N8(U>U/]GRV[&XN8S<!F*LNP'TPW[5/AE&*/\ ##XWK(L)N)(F\"6:RPP
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M7.G66EVD3BYEG9F:4J$54%?9&2.Y'KVJ%D61T=D1VB+&-V4,R;@4)0G[N5+
MXZC([U#FDVK; 2@ = !]*#[>O]?>@<X]?2C!'!Z_X]*S;NV^Y7-[O*%%+M*]
M?Z?TH((ZT)V:?8D5F'RXX..>W?@9[]!^8IN<\]::T;R@!)3&4<,< '>H!#1G
M/0$D'/4;!ZU,1\N!R0>3T]>M4U=<_?\ X8+ON1T[< O (..H[]">:5MN,<9S
MC@$4RH >6!'<-QS@9XQU.?:F<]^??N?K2X/7_/K_ "I* "K</*<^IJI5N'[@
M^IK6&S]0):***L JG)V_'^E7*K%0>HJ)1<K6Z 08)X'7_/O3@SYV]QQCCMW^
ME*G4_3^HH8@$[<[L\_UZ_7]*R &7('!W'DX)].>GO2;=OWN!_O*/YGFG(23S
MGI_6E?H/K]>QH 9N)^4 ^F<K@@=.E)R#Z$4Y V03T/MCL>V>*<=F3GKWZ_TH
M 9N9N.N?IVYIX(4 '@^GX^U(-F>.OXYIQ .2PZ?7I_DT7?< #(,  ^@.>.?J
M*1R1C!]: %."!],Y'3V-*V.,_AG(_D*T4U97N!'O;U_0?X4;V]?Y?X4C8SQT
M_'^M9/B#6(/#GAW7_$5S;RW4&@:-JNM36\!03SPZ583WTD$)D8*)72!E4L0
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M\,>&M+^)?CWQ#X5T!]-\,ZUXSLM9\3W2>)=$U6YOH?#^CZM+86KK>3JD3$J
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M_P"\<?E4R3=K.P$", ><CCN#ZCVH&"QSR,GUY';@=.34V\>J_DO^%-7:I)7
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M!7<EQ/&,*_'+>#/^":'P#^'J:#'X4U?Q[H\.BZSHM]<06.MVUI:ZYH?A;6_
M/B#PIX3U>UM=/1)=(T_4OAKX7=)HUCO[H03K>W=P+JX\S]$0[<D@ #_9&>3Q
MU%#L0DA &[ V\#.3Z#T_K4J:;MW ^5/BY^R3\.OC+XT3QIXBUCQ=ILTNDVFC
MZSH^AZK'9Z1KZ:;IWB32]'O+^*2U>2*\M+7Q5JPC>WDA#[H_.63R8PO&:'^P
MA\)])TG5M.O_ !+\0/$EWKK*=7UO6]=BDU6[C35EUA(/,M;&*.&(31Q1@1QI
M^ZC"^I/V[YAVJ?EW$#(P.N,GBG!P0,E1^"TW-)VL!^8?Q?\ ^"==AXHUK0M1
M^%GQ!U+X?6^H1>'_  W\26NSJ6LW?B+P#HLFD/)X=TV(ZC':V'VK^Q;0W$C6
MTDK2QI(LBA"C?7?Q'_9V\#?$[X@>'_B+X@O==BU7P_IEEI<5A87446E7\6EZ
MVVOZ;+?6\ELS230WDEV%*NBLEX^]6(3;] E\ X*D_1: VX<[<G.1@?YZ4N>^
MB5FP/C?X&?L3?!O]GSXD:Q\2_ B:O_;FLZ'%HDRZF=-NEA1K;3(-1NH]0334
MO9Y;I]+M9)8YKF2"-]WV>*)6*UYGXI_X)I_ 'Q9XLG\7:O?>,9KZZFNYKN..
M\TH-+YVK+K%I';:@^D&[TR.WF&Q!:SP>9&Q6X,QYK]%@<< #\A_A2;L=2H_!
M?\*:ND^9[ ?)R?L@_"4>)SXN":]'K!UNPUU)!?1[(KK3?$W@;Q7;Q1D6VY+4
MZE\/M"5E#<QM,O\ 'D,^-/[('PV^.7BK4/$WBS6O%]I!K?A_3=#\1>'-$U2*
MRT3Q!)X=L/&]EX1U6_5K1YX[[2W^(/B2>!89HH)IIH'O(;G[- $^M-P]5_)?
M\*4M@X)7\E_PIIIJZ ^;_C'^S7X#^-NE^ M'\67GB"ULOA]>PW.F)H][':C4
M((IM&G:PU82VT@N+)[G0-+D95V,3 1NVNRGP_P 2_P#!._X*^(-0.H1:YX[T
M6XE\;6'CN9](U6SAE75-.-N(H;"ZETUI=%B*6T:-)9O!.$9E64*[ _?^\>J_
MDO\ A1O'JOY+_A0I*6W0#YF^)W[,WA_XG^.XO'EUXS\;^&;Z7P!J?PP\0:9X
M?NM)_LKQ5X*UC4M/U2_TG5DU32+F6-GN=-M_W]M+;W"C=ME&<U\QZ9_P2R^
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MG:7J&DM8W"0NNMIJF[31/Y,H7WF;_@JWX:U3Q-X!\+>$/@OXVN+KQK\7=)\
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M\:?@YXT\+:'/X8\&>(O!^H^&Y-)\1VNH:IX@^#?P5^).J^!;B:WO<KX@AO\
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MTEOX:^%>HZ+ITRVJVFH07M]I=\R>*?#UXQ%FTM@EY&98I8Y=J1L] 'C.N_\
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M+^!WPJTV'4+K6+N]@L?!6@6L=S<>(8K:WUMYHXK,!OM5O96<<R_=>.U1-NU
M!:\9?LX_L_\ Q"U;1/$'C7X0_#SQ1KGAG2X-#T'5M6\.:;=ZAH^D6FS[-I5C
M=-%OMK",QQ[858(IC7"\"@I1;U/A"3_@KW^SU =&6X\&?%2.35_B[XA^#)MX
M] M[J[M/$_@T1MXSNC:VUVTEWIFG_:]-^>!9#=B_4V0G$<Q3NI?^"G/P1A\(
M7?CZ[\->.[#P@[_%*;PSK%W8Z;"GB_2_A/X<\<>(]8U/2;5[\36XND^'_B.W
MM8+E(;EI8HV>)(Y$8_4MO^RW^S=!+830_ GX402:9JMAKEB\/@G0HVMM8TM+
MF*QU-&6S'^G)'>72F0Y9Q.PDW56U#]DS]EW4K76]/O\ ]G[X/W=EXF\43^-=
M?@F\!>'6CU?Q5=VFH:?<Z_?@60^T:A)8ZMJL;N>'35+D'_7R[DW978K.]NI\
M$Z=_P5@\-_\ "5:O8>*/A3XI\.Z)9ZCXST70[4/!J/B;Q7J>A^/(_!6@#3K>
MT=K:PBO9W+2"[GA$#0MR4VN?2OAY_P %1/@S\3?'&B^"/"O@7XF2SZW?:?X>
MCUC4=+T[2]'M/&>JV-Y>V/@Z[N;^_0IJ<GV*X02 &WW(#YNP@GZ]O?V8?V<=
M0?Q'+>_!#X6W<GB^*XM_%#S^#M#F;78+N2UFN8]4+6A^U*\UE:2-NZR6ZOG>
M,UR'Q"^''[-OP:^&OBCQ[>_!7P,- ^'>@Q^(3IGA[P5I#7_E^&;"2TTF'2K:
MWME/VZ*WF:&W92&C$Q"L!FA6:\F-Q:5V?3]G.UU:6MR\$EL]S;03O;2M&\EN
M\T22-!(\3%6D0L5)4E25)4D8-.9FP=PP <Y]!C^76ODCP=^VA^S[JGA_P?YF
MMZMX<U37;3PII^E^#SX(\=ZEJ*ZIX@ET/2+3PWH9TCPQ-%XIO++4]>T>RU!M
M+>ZATZ6X'VR6! 6$/Q'_ &V?A)\+?BQ<_";Q=IWQ T^XTV[T&TUSQ?!X'\0Z
MKX0TM/$?A'Q7XRL;TZGH^FW37&G0:9X0U(:A<K%Y&G>=')>210^;+%#@[Z;$
MGUZP&,J2>@]>#TX'N::P(<*N2,#)QWZFO"? _P"T_P# +XBWGQ"T_P #?$O1
MO$EU\*[6]O\ QVEC;:N$TC3],GU2UO\ 4;:XGTU(]=TZ.[T75X6N-/:ZA,^G
M30AS*A6O/'_;U_9$MY-+AU#XS:3HMUK-U=6EK8>(_#_C+PWJ-O):L07U?3=>
M\.6]QH%I,RXM)[^.W@O2RBTDG+#*Y)/<#ZXP5'(('K@]S[T]""P/..<$#.<=
M>/\ /6ODW3_VWOV=[BY>+4/&-QHUM<7-J-+N]3\,^+H?M&DW-O:W'_"3ZS9'
M01<>"_"B?;;,/JFM1V&G@7D+_:=DL1:WX;_;$^#?C"R^-NN>%I?%FN>'O@1X
M>\/^)?%.LV?A'7;>+6].\16?B34+67P18:I96]SXMM/L7AR>6&[LH9;*_6[A
M.FW-T=X04&FGV ^K<KV)_%2!^=-* G//^?PKY\\.?M2_!3Q1#/?:?XJDBTE?
M&R_#[3M;O=*U6'1M;\2&STZ\$6E:DEF\4]@6U2VA2ZD:.WDG)BBD<A=WJ&D_
M$?P+KNKC0-(\4Z5?:TYU8#28;@B^_P")%=&RU<FWDC#*MO=_NY&8 !^!DUJ!
MV6P CD]>^/K0P4GYCVQ@<]_3OUKR[Q9\4[/P?XM\.>&M2\,>)9M/\1/):Q>+
M+,:*VAV>H"UN;R*PFMIM834+IS;6D[RS6ME/!:HOF74L$?SCD?#G[0>B^)-!
MMO$,?@GQU8VT_BWP1X;,%S#X8>>#2?B*VG?\(9XXF:U\2R1MX7NQJ^G!TBDD
MU*W>XV7&GQE)"J22V ^@ J[3@G'^T-I!]@:85_N\C'UKRCPU\8_#GBGXC>,_
MAG9V6HV.L^"Y/)OI]4NM!LTU-UM;"ZGGT32#K+:G?:9'%J=H&O#9):F20HLI
M88KU8NJ\*RD'GJ/Y@^U"26R 5B(\8(Y[,?\ /K2D%?NC.?7GZ=/K0SJ.A1LY
MZG..G3GBD9U& "ISD=00.G;-9\LEL!&O/3J>W!..<#BG8;^Z?RH&7SEBVWGA
MD7 SWXYZ4]W Q@CN.H)'3-04HM@NT<Y[<C'O2. !NSU/YYR1BH\CU'YBI&*[
M%Y';N/0T7?<?)(0JI4$;B3@D%<#ID\_4"@LRXZ@#_8+9Q3PZC W <#N/3Z\<
MBD8QMU9>/]H53:TMH^I*3>P@._@\@G.<%2,9(X[4X*JGDL"/]DD 8QUI!LR,
M."?]Y:<74=2/S'^--:JT59]1\DO0:Q)R ,@_[)!_6D4889#]_P" D=#WI^Y2
M,[EQZY&*3>-^W*X^OM]:N_*E<23;:2U0$9RV>5'H1TYYS3.&7+'D=NG(YZ?6
MGLRX/S#H>,CG@U&-A!)<#\0/QYK)MMO70KDD-!!(&>IXSUY)'^-2XP< 9#=3
MCGT/(IN54C;("#C/*D=>YQZ5)O3^\O\ WT/\:0<DA-BGU.?ISG\.:3&_A@0
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M#J20* /-1X(_:E73I])M;7X$:7:77B&X\573:->?%K2+N[UJ[OI-2N[B[O\
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M8>'S'X74S%K*<65]+< J)E)M2,A"6'T6_P )%::[G?XA>/WGOH!:W\[_ /"
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M%&]O7]!_A7@Q^#GB($C_ (:#^.7!Q_Q\?"G_ .=71_PISQ%M9O\ AH/XY?*
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MLM["L^Q$5.-W&.#^?X4JJW4$#_/TJUA0H)4$ #L#2;D_N_H*T4%97*YI+J1
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M.&78B_:HW'BD,TF58X9BN9#\N!QF>+9O%O@&'0IO''[2G@OPI%XF\1:9X/\
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M/\%[?4UT7Q+IL=G-J6CZH]G\86%MJ44-W"SVTGERQK=1,YP1OVA\.?VFL_\
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M_P *Z_:;_P"CD/!'_B/\W_SXZ3_A7/[37_1Q_@?\?V?IC[_]%CH ]9_X5?\
M#)E5?^%;> 6\L$(&\'^'B%R03M!T[Y<D<XZTG_"K?A>.&^&G@#<.H_X0WPYC
M\_[.KR?_ (5S^TU_T<?X'_\ $?IO_GQT'X<_M-GG_AH_P.3[_L_3<_\ F8J
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M #33P ?KX-\.C'Y:=7/CPY\;"#M^*W@3_P ,]J7X?\U7Z4A\-?&TD;?BMX#
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M %$?SHIQ(/10/\_2FUF%W+SL.!QUR1C@=?YT_.WYCG:>@'./3^M1J0#DC/\
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M_A5\3T_U;;2?^12X4\[3W'-6!\;O ) (D\;<=!_PJ_XGC\./"/%>2?'WXO\
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MB-GW?$23S0C$$CY=^,92AM+=V ]_\H 9*J0R;.54_(1]SI]SVZ<=*9Y28VD
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M_P#!GQ$T&Z\+^-O#>F>)/#U[);2WFCZA$39W36DJSVXN(X70S1K*B'8Q*-M
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MH"JB(NGX5 H  Q@ 8HS^V3_SY_LW?^%)\2O_ )A:4']LCO9_LW_AXD^)7]?
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M*0KY.X')JUYG[97_ #Z?LW?^%)\2?_F%I-_[96<_8_V;L_\ 8R?$KZ?]"+3
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M-/DCW%9]CQ<_M6_LU]_C1X"_\'2#I_P&D_X:N_9K/_-9_  QZ:XOZY2O9_\
MA'?#X_Y@.B?^"NP/\H*3_A'?#_\ T =%_P#!58?_ "/4M15M;^@[/L>,_P##
M5W[-?_19_A__ .#Q>?\ QRD'[5O[-Q)Q\9_A\1V']NJ._P#N5[/_ ,([X?\
M^@%HF.W_ !*K#/X_N*0>'O#QR!H6B9'7_B56 _G;U/N^86?9GC7_  U=^S83
MC_A<_P /P<]M<4_S2E_X:M_9K_Z+1X!_\'2?_$U[*?#OA\?\P'1.O;2]//XG
M]Q1_PCOA_MH.B?CI=@/_ &WI^[V8K/L>-']JW]FP=?C/X  ]?[<3/Y;:3_AJ
MW]FO&1\:/ /U_MI,9Z?W.F:]F_X1WP__ - '1?PTJP/Z_9Z/^$=T#MH.A_0Z
M78#_ -M_Z4W)-)-;#L^QXS_PU=^S7T_X7/X ^O\ ;:Y_+92_\-6_LUCK\:/
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MMI_BY6T75OLVL0>'I-+N[/3ILRWL4\_BC1K=%B5I?M-XD+1J[(&Z[XK?M0^
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M"<'CFQDUG3?AE\!RD&IWNG:VNM_"3X<Z5J&@BQA$LFI:S:ZII23?V:T>T))
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M_LUZD\DNBQ1V?AWX5?#[6[MSXA5VTEPMGX>*1PR"-B[NZK OS3F)<L-6"?\
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M]U#6=:TGQYXITN&X_M ZU%+XO\4)X@T?Q%;0:I>)/=26%V($N'M9(D73M?\
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MX2WWP;TSX56&D>&]0^'=U\,YM3TZ^U"'Q4-!N]#ET%[L:Z\[22ZT+>9Y5N)
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M *_YTE*ZO8#XRT=K=;,L/B!^U(<R%O\ B=:/J)NU. "J[]+4^5TXQUSS2ZI
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MIJ^"223GOGGK]:868DG<<$GZ]\=S[?RYJG)))]P/B^V\50W9C"?&/XQ)YAD
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M2I)!.0>![[3QSZ]Z=EO4_7-4Y6C>P'X,?#/_ ()S?MU7VN>'K?X[?M2V.O\
MP^M?%WBC6=?\'V\=_K^G:Q:W.BW]G82ZC:WLT7]I6=[J5Q;RW%@SB&#R<J<J
M ?K3]B']F3]JCX ?%SXYZC\9?BUHWQ ^$_B9H(OAGI5FMU'>Z5;VE_%_8UM:
MZ8SF'P]HMCX?0V2VJ$EBJD%D4$_IHK,""2>#W/./PXH<ECGMC&#DXY)P.>F3
M4.=TU;<!XD!'(/<?D<>M*'!('//T_P :B_/'Z_\ ZZEWKZ']/\:E.S3M>P#Z
M:S!<9SSZ#-,9B<8)&.OO^O2G;Q[_ *?XU3G=-6L GFKZ-_WR:7>/0_I_C36;
M.,$].<X'\NM,'/YG]#BDI6Z 3D@#)I P)P,U%D^IH!QTX/\ ^K]*3=Y7*46U
M=$I8 D$$_@/K3&E503@_@/P[>U*' '?/&>.OXY]J83DY&0"!UZ]N/TJ_:>0F
MFG9DJL&4-S@C.#UJ>,AE!'OU^M5@X  P>.OY?7UJS&0R@CWZ_6JB^97M80^B
MBBJ *KGERW8C&.^15BJ]3*/-;6U@( ,G'/X _P!*5F&, '(Z\=<#'K3WR ,<
M<]N/7TIJ<DYYXY]#D_Y_.L0&A=W'3C/O^AI",$CTX_*E)Y)Z<FDH+4+J]]Q5
M."#_ )Z4K 8+C./3].!FFT<^IQZ=A]* E'E5[W%!P03V]A_GK4N05)'<'^M1
M 9..E#94@9)![=O7U]C^=.+Y7>UQR^&/]=!*<K #&3^&/ZTVE!Q@]<'/OQ2;
MNV^X)\RY=M [?>8<D8 X. .N?K7BG[1/QFTW]GOX,^-OC!J>GPZM#X0M+*6'
M2[G4KG1[;4+S4M4L=*M+:XU2TTJ^DL83/>HSR+:3D+&0(V8@'VQB">"",=B#
MR>3T/6O+?C7X4^'?C?X4^,_"_P 5[Z/3/A]JFGVZ^)=1EU>30%L;:UU&RO;.
M[36H9HWTZ>/4[:R:.1'5@X4 \\U#XD2W9<O+9GR?\*?VY8O''Q4\(?#3Q;HO
MP[\.CQKX8UCQ!IFM^&_B!XWU<64VC6D=Y-8:I;>-_@]X;A"R12!4EANY_G7'
MEX^:OM__ (33P<>?^$R\,E<XW?\ "0:0>@(/_+X/\:^./AW\&_V4O&?B:!;?
MX@2?'75=&T"2TT_P_P".O']_\0[32-)E98IKVQT;6KN5(7(1$:=4W;1M+8J_
MXH^!_B6SU'4M%\!? /\ 9GN? J7 DTN+7=.U"WOY1) @GDOK2R A24R&0?*!
ME0N:V)/K<^-?!IS_ ,5EX7Y_ZF'21GM_S^>F>QZU7M_$_P /[,2BS\3^#;0W
M%Q/=7!MM7T&#SKJZD::ZN9C'<@RW$DS%I'8EW;YF);)KX7_X9V\;#_FV7]D$
M'M_Q*]7[8 ^G:NNM/V=A]FC%]^S%^S4UR 1)]FMG2 @,0@19=/9A\@7.2><]
MJ /L'_A,_!?_ $./A;_PH-(_^3:/^$S\%_\ 0X^%N.O_ !4&D<>__'Y7R/\
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MX&\>$!NR!D<#KBD;]G#PHN/^,._@("3QG6M/_P#F1XXH ^WQ=6'.R^M%]?\
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M5/!BZAING7FJ2:'8ZYI]_K]S;6-A#J<RV6DPW'FW5PUE<6[Q1J-THN$\L,6
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MQ\8=+:+QE<>+=!DL/$=I"?"JW@UQ;[3_  _']A*V-Y*-;(;5@O\ :P%C !>
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M*R^*?Q1U ,]E^TW\"+@+MW%/".H\;@=O#1CKM/Y5ZJGQ^^%#NB#X5?&5=S
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M\VM^!]'\,:[%8W-]H-SJ_B?2[JWF@@EO-0T^> 0BULDN;R5GXME(Q0!]AO\
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M\1^*/$.MZ9I1\.7-AINI:QIY:RCFECOK.^T>UTZ>WE6<'&I>4ZK-%)&+=_\
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M?ZKH/BN^\.75R=1^(/B:ZO=.M/#%Z=2TW2-(N&O\V&F_VA)<2O&N-S73<XP
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M6DRRV6EZC9V4NF6\T,]Q##+&PA^TF.+$:(JR_P#"KM'&,_LE?'#\?C1=]O\
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M RE:^U8/^"K7[&%W<6EO:?$6[N)M2\20>'=*AC\.ZR'U.%[CQ';7'B33_,M
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M$M2OA=_$J7L<>D)/+)IR*JPW$WEB.!CO=@H)JK2Y;7U$?HNC#+<@<\=.G/\
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MGG_MZK<T'QKX.\533P>&?%&A>();2-)KJ+1]5LM1EMHG<(LLR6LK&*,L0 2
M"3BB]DFP.I\J$GD\'KAJ D*Y"9Y&<,V#D?TY%(0 0,Y'&3QZ\TI5 "=W0'N*
MB4HM/34=G:]M!P"8'0?C_P#7HPGJ/^^O_KU$.>G/TY_E3F7;CU.<U*LFF^@A
MCQ0\9W'TVG/^>E/7;E@>G\)/''3J>IIVT=MI]=SA<=?;FH\8S]3_ #IN3;NG
M8"5O+ .PG/(]B,]*J-"C$$[LAE.02.1T^H]:FQW_ *G^52!$X)(.1T)X'X>O
M^-24HMW:(B Q);ECR>3]*>GE\!B^ /3CH.,XIVU "0?PW#\AGM3<+O(R<$<<
MC QCOCW- FI+?0?B/MT]SS_.K$8 48Z<]\]ZIG ; Y],].G<CIS5N+[@X Z]
M#D9^M:PV?J(DHHHJP"J,A.\C'RCH?7GGZ\8J]5-R#C!!Z_TK.IT 9@CJ"/PI
M57)P00,9STS]#2AMW#$ #GCCG\?8TNX]  <<#@G@?2LP(SP2!V]>OXT.&!38
MI8,!NZG''.,>_K2GJ<^M.#D #CCZ_P"- W:RLM>HK \  XP.F>V:CI^]O0?D
M?\:#@?,Q(/<8)]N1GIC- AF".HQ0.>G/TI(_,; F*^9E@QC!5>"<;0?;'XYI
MY^4@C/3///7(YXH 3!R!@\G&<'CW-# #[ISSSSG'3],&I0PP,D#VZ5$P ^Z=
MV3V_ =O;^5 "4X,5Z8Z]P&_3_/7J*;W .1DXR1T_/\/SI^U.<-S[D=?\*$[:
MHI/I*[0WDG)C5^>25#']132%(QY<:GV1>#UQG'3/\JE1N"#@8/&3UX%,/4_4
M_P Z=WW8K7?NHIS:?IUTXDN=-T^X?&-]Q96TK@8 QNDC)' 7CVKG]9\"^"O$
M/]EG6_">@:E_8NJ1ZUI)N-+M6-AJT5I>6$6H6Y1%,=PMGJ%[&&!X6Y;CICJZ
M*.9]P::=F>37GP*^#VHZ8FC:A\-_"VHZ<GAN\\(K;W^G"[;_ (1J^N&N[O2#
M/<2-(UL]TQD)+%PX#JZD*1O>"_AA\._AUX:TSP?X*\%>'?#OAK1TE33])L].
MA:&$W$SW$\KS70DEN;B2>1W>65WD=F)=B:[L'!!'X=^O]*<0"-Q//I^/IZ\4
M<TNXC,_L;1AS_8ND]0 ?[,L^I.!C]SUS7@GB/]D#]F'QA\3K?XR>*?@5\.];
M^)<$=JA\4ZAH4,MS<&QL)M+L+G4;'<+/5+Z#3;B:WM[BYMY9X(',44D:84?1
MQ(\OKR".AP<AO8TBC"A -J 8R<G'.>K'GGWIJ336N@'Q/<?\$W_V&;B&WMY/
MV9_ABT-MK']OPK]AU%95U,1Q0[S+'J8:2T\N"%1:L3:@1KB'@5U.M?L)_L@^
M(KCPG>:S^SY\/;NX\""['A1CI]W;II2WNK1Z]<((K6\C2]C.L1I<*+A91'*N
M^,(:^K\ ,,$8SU_$'_&INH.#UXX/KP?T-6YJP'R;<_L.?LC7LVESW'[/7PWE
MET:UCL+ _P!BNJ+IT7@74?AFFF7:1W 74=+_ .$$U6_TYK6X66W:*<2-$9HX
MY$C\(?L)?L@^!+2&T\)_ 3P/H:P:/?: MQ;Q:I-JEQI>IZ_'XGOHK[6+K4GN
M]2N)-;BBE:XN)I;G9$MN)1;KY5?61)7 '0C)SP0?P^E-+$D'@8^N?YU,9VO=
MW#<\TUOX*_"'Q#HESX<UKX8>"+_1;ZWBM;NRD\-:5&)X(9(I8XVG@MTEP)((
MF)WACLYSW\Y\2?L>?LP>*XK^'7/@CX&OAJ=S-=W<L.GSZ==_;)[6&R:\MK[3
M+B&;3[M;:V@$4L#QR0M$'B9)!NKZ55@1\Q Z^W;BHPQ'3]?;/K4\TNXVFMT?
M-&N_L8?LL^*-%\&^'M?^"'@G4=)^'[R2>%K:6UOHGMEN)8Y[RUU2\@O5G\3Z
M?=7$$$E[:ZG)=V]X\2O=Q3NH(Q++]@S]C_31J/V/X!^!D?5-0GU2YEN+:^U)
MX[RXN+>[VV@U:]G6STZ.ZM89(;*-5L86,GE6R"></]:;SZ#]?\:-Y]OR-:<Z
M\Q'YP_#K_@E?^R9X+M]<'BGP6/BC?ZSXC37H;_Q,7TE=&MK:UL;*R\/Z;9>$
MY;&+^P4@TVR9[.57M9)H3*L$8.RO7I?V!/V.9K5;*3]G[P6]NM\M_@G7!*TB
MK>(UI)<KJXEFT=TO[Q9K!W-C,MP5E@=< ?8FX>H_,49'J/S%'/$#Y)U[]A7]
MD/Q'#9Q:M\!/ \D5E;_88$M8M4TD'36U'6M6FT:X&E:C!]LT2:_\0ZRUQ8S;
M[2Y2\\FX@D@CBC3?\6?L??LO^._%+^,O%GP0\!ZMXAFT;^P9[MM-DLK6XT];
M6]L(7N=(L+B*SN-4AL-1OH+>^>!KZW@NGA@N(XCMKZ1=B3@8(!_#OSG\J%Y/
M/ ^O^(J.:7<#P;Q)^R]^SSXLU;2-<\0?![P1J&J:#8Q:;I5S_98MA;V,#7#P
MP26]F\<5WL>[N2K3)(X,S$,":P_"?['G[,O@7Q)?>+/"OP8\(Z5JVI6#Z;=H
M(;^\T5[>9'CN9H_#=_>RZ=;ZC-%(Z3W:6R74R'9+,Z8%?2AX)'8=_7K_ (?K
M4G_+/_/]ZES2[@?%\_\ P3T_8OO+34=/N?@'X7DMM3F$K-_:OBR.[TR'S=3F
M?2O#>H1^(%N/"?A^236=4\[3=,EM+"9;QXY;9TVJ)M/_ ."?/[%VER:V;;]G
MKP))#X@>*34+.^CU75-.B:*"^@==)T_4M3EAT&&4:C=/<1V4<"7,SK/.LLT4
M3I]C44<TNXVFK7ZGQE+_ ,$]?V.9;>QL[GX*:1J-KIHN6MHM5\0^,M6'VNZN
M)+H:K.^I>(IFNM:@FF<V=[*6N;)0L=K+%&B*M6/_ ()T?L5+'#$WP"\+SP0Z
M7<:3+!<7WB2X@U%9]^=5UF.76F&M>)8_,8V^JW0EU&V)S!=1$"OMG *Y!^;L
M,CG\/I2;F7*D8SC\<Y''Y4<TNXCY-U[]AK]E#Q/\/-%^%>M_!G0;SP5H.I76
MK:=:?VGXDMM<%_J%O=V6JSWOB^TUF/5M2%Y8ZA?V]XMQ?2)=6]T\,P>-MHH>
M)?\ @G[^QKXLT&U\,ZM^S_X(.CV5I=V%FFEKJFBWEG9ZAJNMZS?16^K:/J$%
MU$9;WQ)KH9A-N$&J26RE;?;&OV$H4@G/.?7O@$4Y" .N,GC/4\>_T-6FU:3>
MC ^/=#_8!_8[\.ZW::_I/P%\%I=V%_9:EIUK>17^I:)I=]8VUU;+/IWA_4+V
M6QLC*M[<O<B.W"W4LGFW E=59>@U7]BK]E+6O%.J>,]2^ OP^F\0:SIQTK4+
MB+1C9V,UFU@VE,J:-92QV=O<-I[&)IHX%E*\F0L :^HCE!@8.<GGZ"D$C=P!
M^?\ C3YUV8'RSX1_8H_99\!>+[3QUX2^"OA32O$-A;ZC;V#[-2OM)L&U9+R+
M4[VQ\/ZC?36-KJD\%]=PRW26XN'@G,/F>6%4<-J'_!.']BK5!KRWGP'\-DZ_
M.TSR0ZEXCMI]!235[W7KJR\%W$&KK)X(TRXU?4K^:XM=*:TMYOM)C>,Q)%&G
MW"K9SG _3^9IC #D')/_ -<U//[V]D!\,:3_ ,$TOV&M#GN)[+]GGP;<QW"6
MR#3]6GUG7-*M#;646G&6PTO5]3F@LIY;.W@2X>-%:X,"/,7<;ZH3_P#!,C]A
MV[-J;GX#Z/.UM,TKL=>\5J]\IN#=06NJM%KB'4["WF.;:"<O% H"1*J@+7WL
MP4=#GGGG/Y>U(#C.._\ ];_"AR=]'H-)O8^(-"_X)P?L5^'=8TK7M-^!/AU=
M8TG4EU,7U[J&NZC)JLL5S87=G:>)$OM3D7Q+I=O<:;8-;VE\L]O"+<HD8620
M/T-Q^P/^Q_>^/+OXC7/P'\%S>)[R^BU/<]M<?V)9WT<.FP37.F>%Q<?V=IKW
M$.CZ6MT(+:-;C['ND5F>7S/K\88DGC\0.?QH)"L,8/7&6&23P,#'7)I*4NX[
M))IK4^"]/_X)B_L*Z5=+-9_L^>%T@BM;FSM].EO]?N=(M8KZ*".^DM=+NM4>
M&"ZF-O&\LH7S&<LV[+OGL/&7[ ?[(7CS4/"-]XD^"'A6X'@S14\.:786/VS2
M-%O=!CE>XBTGQ%HVF7,5OXFM$N'9U^VQS,K8(;  'V&3DG/7N/T_I3Q&"NXL
M!WP"/UR/\*'*2>KU)MI?H?!_B+_@G;^SC-\'/%OPC\">$-&\%KXFU*PUFW\4
MZAIC>-]:T'4M*O(;S2SI-SKM^+K3[.U,"I;0V=Y:&W4Y@DC?#CB?!7_!)[]C
M#PUX=T'3-;^&Z^,]:TCPE;>'+[Q)J&HZEI4FK:I _F3^,WT;1;V&SM?&#LEO
M'_: C>[^SV4,,D\H$KS?I*57!PW8\9'^%(K$#@#GGD>M"G*ZN] /A<?\$U/V
M)D\-3^%8/@-X<MM.NK]]1NKJWO=:CUZ>XFL[W3[M9/$7]H&]-O/9:C>1SQ"<
M)()%8C='$RZLG_!.O]BJ32(]"/[/'@5=,A618X$MKY90LU_/J4J-=F[,KHUW
M<S,07(VN(_N*%'VH'.1TQGGKT_.E9R#Q@C'Z_A5\\0/S_MO^"7_[#MJMBI^!
M>C77V629;HZCJFN:@WB"P9H7MM"\4&[U!_\ A(?#MJ]K:FTLKGS(+?[,OEJ
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MI>FZ'H6GV6BZ-I%I!I^EZ1IEM%9Z?I]A:1K!:V=G:0*J6]M'"BJB(H50H
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M:O\ %">X\'6F^ZT37FN+B33+2S=XOLCH)L2BOLKQS_P6P\&^'M>N?A/^R_\
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M7\"?TI*>9%&?E( ST))'TQU'^%,+?,&/\P>G/S8 (X- A2NTD>O/U[?TI0V
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M+^Q_^TOX7\-^*/ /CWPKX=^'?PU^(OQQL]'UCQ_X6\<Z3X;L].NE\1:4=/\
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M1PIDGA5'7IFM6@ )('L!T'08]/05"QWL,\9X]>IYI[-M.,9_'_ZU)YGM^O\
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MCMQ)XE?6_AJFI2QW;M(\,VR96 XK^DX!CWQTZD]Z<'*\$MD>_P#]?T-+FCW
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M+GJPQ],9_6I'7J>W?^7^%-"DC(Q6#O=W-/=M&[V$RW3<-OT['KSF@ =2P!Z
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MYJ6,,%PV<Y/4YJBGFLN#("YS\P'R_P#?/I5]!A1T_   GUP*(VMIL(=1115
M%4Y.WX_TJY4!C)ZC]?\ Z]2XJ5K]!IM;,K@@')Y&/R]^:3CMT[?2K'E?[/Z_
M_7H\K_9_7_Z]1&-WJK(1!D^II*L>5_L_K_\ 7H\H]@!UZDD>PQFB4;6M=@1*
M3D#)QZ9]J1OO'_/:IA&1SM&?8\?SI3$2<E?U_P#KTHQN]4T!$'  SDG_ #[T
M%E.>.3W('TJ3RO\ 9_7_ .O2^5[+C!X.<]^^:ODB!&@&,GDDDYQTYZ4T$$88
M9R<<\]<#O4X0C@#]1_C3?*Q_#^O_ ->J:35@(@ @P0"22?P[4RK)C)ZKG'N.
M_P"/M1Y1[!1]<G\N>*R<6F[)M#3:V*U%6/*_V?U_^O1Y1P,@'Z<8^ISS2L^S
M"[O>^I7IQ!"C)R#V^N<<?2IO*_V?U_\ KTIC)&"N1QW';ISFJY?=OK<&VW=E
M:BK'E?[/Z_\ UZ/*_P!G]?\ Z].,+K706Q#@@;@?\>N*4#^)N1Z=2>PZU-Y9
MQC''U_'UH\LXQCCZ_P#UZ3C:25KIEJ7NO74@8@G*C:/2FU8\K_9_7_Z]'E?[
M/Z__ %ZIP5GN+FE:URO2@9!(QQS_ )]:G\K_ &?U_P#KTHC(SA>O7G_Z]9V?
M9D[$ 4D9&*;5D1D=!^H_QI/*_P!G]?\ Z]5*-K6N[CNWNRO15CRO]G]?_KT>
M5_L_K_\ 7J;/LRI--12=[%=E8#D$9''ZX-."-@<CH/7_  J<QD]0?^^O_KTN
MQAV_4?XU:@K*]R4VMBMT/T/\J3)'0XJQY623MY)R>>_YT>5_L_K_ /7J+/LQ
M\\NY7IZKT/&.>/S%2^5_L_K_ /7IP0C@#]1_C5J"LKW#GEW(F4YX(QQQV]>@
M'K49!4GGG_ZW:K.QO3]1_C2&(DY*_K_]>B4$EI=L3DWNROGD$\\\]Z4X)&!C
MMZ<Y]JF\K_9_7_Z]'E8_A_7_ .O2<?=3UN$79ILA*,.>,#ZYIM6BC'@C]1_C
M3?)_V?U_^O4V?9C<O>;CI<KT=>,@'T/?V'O5@1<_=_,\?SI@MRTI9@%V']V5
M[ ]1@]>]6H)K6Z8<TGU(^1W(_$_K2LI&,]\U.8N3QGWS_P#7H,9/4?J/\:'!
M).UVR2MDDX)/;^N/ZT_8WJ/U_P *F$77Y5!..3S_ %I2C9/'Y'C]34\ONMV=
MP("0!C S@<XP1P#^--! .3T'7_)JP8B3DK^O_P!>D\HXZ+CT[]?[U-1NFW>X
MTVDTGHR D$Y'0]/\BDJQY7^S^O\ ]>CRO11^)X_'GFA1NFW>XBO15CRCW /T
MX_3-'E?[/Z__ %ZFS[,:;6W4KT5/Y3<X"CCC.2<_7/%(L+8^8 GV/_UZ.5]@
M;;W9#2].FX>N6)J?RO\ 9_7_ .O1Y1P< #COR3].>*J4+6MK<:=_B>Q"S X
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MTP("><CCT[=O:K4))09.>3UIGE?[/Z__ %ZF1=JXQCK[_P!:V225D ZBBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g1078492.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078492.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" -6 I0# 2(  A$! Q$!_\0
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M!@V<9X]: %HI&.T9ZTHY /K0 44@8$D<\4!@21SQ0 M%%-P=V<\>F3Z>GUH
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M<9Y]Z=O7U_0_X4H(()!X%  >0?H:100.?7_"C.02#TS_ "]Z8"Y''(Z=J '
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M?&/_ *-L\2?^%KH?_P KJ/\ A<7QC_Z-L\2?^%KH?_RNH ^DR$'7^M)\@&>
M/4DCGKC!ZU\V'XP?&(]?V;/$I^OC;1/_ )7UZG\/_$_BGQ99:A/XL^'M]X F
MM+F&.TLM1U>RUA[^-HV>2YC>TMT$*HP5<-DDMD8Q0!Z$-N#CISGKZ<_I2!4/
M0?SH*D<+T/7_ ":;AU!QT_ T *R=-H^O/^)IVQ?3]3_C2(2<Y.>G]:?0 W8O
MI^I_QH5<$^AZ4WY_3\L?UIY(')H :RC!P.3[^_UII"@8_BP/7KQFI:0J#R10
M P;,#/7'/7K1@9)(^7 QU[XIVQ?3]3_C36#<@#Y<>W]: %&S(QU[=?ZT^HP
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MO&FL@@YQ@C^W_6C_ (07]B\8)?P, 1D9\::STSC_ *#_ #S70M\&O$CLSO\
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M,\LQ)))/))H HGX+?LL'KJFF>G_)2=2_^7M7K?X4?LRVC(UOK>FQF.59T/\
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M_)_\LZXR\^#7BA,C3_V>/V0KAL)Q=K=V@R?]9GR?@_,< ?=X.X]<5G?\*?\
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MG4,^AZ'<A1/HNE3!?N^;I]I)C/4#=#Q0!\7?\+M\2?\ 1Y'[%_M_Q2%SU_\
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MZT]AA,>@ _(BHE."#_GI0 XL-P/. /\ '_&E+C!P#^G>FL03D>G^-(IP0?\
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M.IWFFW44=G/-8>$UC@T"VTF/18-%^Q1:&(995LX8\7[QM?;EW?:,FNE\1?\
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M0%MNX@>+^0%R3].*C/QO\3&;;_PSW\;-N_9YHT[P?LQNV[\?\)?G'&?7GUH
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M'4^F.:<6 ZG^=0D%2.1GJ*7!8%LCC^G/8>] "LPSP3C&._OU]>M*A4 YP/\
M#'Z]ZCIZ[<'/7Z?RH 94V]?7]#_A4-% #T(&<GT_K0Y!Q@^O]*910 ]B"H /
M(Q_*A6P>2<8X]*:!GCVS3MA]1^O^% $A( R3P:8[ C@]_?WH?A0/3'\C4= $
MG_+/_/\ >IR?='X_S-19.,9X_P FE4MP <?D??TH E(R"/6D&!A<\CV_&F%F
M!QG]!_A3<G.<\_Y% #V^\/P_F:0D%EQ[?SI &?DX]/\ /'O1@@@9YXQZ=>]
M#F^\/P_F:4LI!Y['L?\ "D*L>I'^?PIA!!P: $I[D'&#_P#JIH4GIC\:=L/J
M/U_PH $8#.3_ #J0D#K4%2OT'U_H: &,I&3D'\\]?I3B1LP.N!QCZ9IQ(8$
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M>#['9 K,92(C5M?%<K6L^F746CV'ACQ7XE\-Z_XP\&Z=\(OBW=:3X<N?"K>
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M/\*3:OK^H_PIY (QVX_2D" '//\ G\* $V+ZG\Q_A1L7U/YC_"G$9&* ,#%
M#=@]3^G^%-501DYZ_P"%2T@  P* &E%'4D?4C_"HY&AACDEEE2**)&DEED=$
MCCC12SO([8"(JJ222  ">@-3%0V,YXICQH\;Q.JO'(K(Z. RNK JR,I&&4KD
M$'J"<T >6-\<O@>C.C_&3X6(Z,R.C?$/PBK(Z,5='4ZOE6# @@\@C!IO_"]/
M@;_T67X5?^'$\(?_ "WK<;X7?#8EG?P'X09G8LS'P_I99F8Y8DFVY8L22?4Y
MIK?"WX:X&/ /A#Z'P[IASD8Z?9NO- $EK\2_AI>P1W5G\0O!%W;3*'BN+;Q9
MH$\$J$ JT<L5^5=2I!!!/!J?_A8'P_XQXZ\(8SV\3:)C_P!+?7^=0I\-/A\J
MA1X(\+(HZ!="TY0,8&,?9\=,=ATJ3_A6OP^_Z$KPO_X)-._/_CWZT (WQ&^'
M2]?'W@M3DCYO%6A#D<'.;[D^M-'Q'^&XX_X6!X)Z_P#0U:#^7_']6)>? _X-
M7Y!OOA=X"NR&=P;GPMHTI#R,6D<;[0_,S')/4GK5(_L^_ S&1\(?AR?3_BD-
M#/?VLJ .H_X61\-_^B@>"O\ PJ]!Y'_@?TH_X61\-^?^+@>"OQ\5Z#]>OV[U
M)KEC^S]\#0N?^%0?#G/I_P (AH?K_P!>?I2C]G[X%\9^$/PX!]/^$0T/\./L
M= '5#XE?#@#'_"P/!1]3_P )7H6?_2_BD_X63\./^B@^"_\ PK-"_P#D^N7_
M .&??@7_ -$A^'/_ (2&A_\ R%33^S[\#0P'_"H/AR0>_P#PA^A\?^2= '5?
M\+)^''_10?!?_A6:%_\ )]2P?$+X?W,JPVWCOPA<3.0J10>*-$EE=F.%58X[
MTEB3P !R:Y+_ (9]^!8_YI%\. >W_%(:'W_[<Z='\ O@? XDB^$OP[CE4Y1T
M\):(K*0005(LP0<@4 >@Q^)/#DJ+)%XAT:2-AE7CU:Q=&'J&6?!%2'Q!H#?\
MQW2/;&IV7?\ [;\UQ$?P8^$J!47X9^!T0=%7PQI*@#GC'V7 Y_G4O_"F?A+_
M -$U\$?^$UI/_P BT =G_P )%H'?7-'[_P#,3LOP_P"6_7 H77]!&<:WI1Z#
M_D)69_+$WO7"R?!3X0&5)C\,? AF6*6%)6\,:072*8QF5%;[+D(QCCW#^+8,
M]!6+=?LV?L_7TJS7OP6^&-U*L:Q+)<>"M E<1J24C#/8DA 6.!VSQWR >J?V
M[H7_ $&]+_\ !G9__'J/[=T+_H.:7_X,K/\ ^/5Y%_PS#^SD.OP-^%0_[D;P
M[_\ (%-'[,/[.9)_XL9\*L=C_P (+X>Y_'[!0!Z^==T(X_XG>E#'_42L\G\Y
MO\]L4#7="'_,;TH_74K/\_\ 7?YQ7D#?LP_LY@<? SX5'_N1?#W]+"F_\,Q?
MLZ_]$+^%7_A"^'O_ ) H ]A.NZ$<_P#$[TKZ?VE9X_2;I0-=T,?\QO2C['4K
M/_X]7D(_9A_9R./^+&?"OGIGP+X='_MA2_\ #,/[.6<?\*-^%.?3_A!O#N?_
M $@H ]=.NZ$3G^V]*'TU*S_3]]QT%']NZ%_T'-+_ /!E9_\ QZO(O^&8/V<O
M^B&_"K_PA?#W_P KZ/\ AF']G+./^%&_"G/I_P (-X=S_P"D% 'KHUO0R0!K
M>F$MA0!J5F22>!QYO)Z?TI6UO1%)5M:TP,#@AM2M 0>^09>#7D _9B_9U#?+
M\#OA6I!!##P+X>R".<@BPX.>E/;]F+]G1V+/\#OA6S,<LS>!_#Q))[DFPY-
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MX=@^G_"-:;_+R/2@#Z&(^7 Y/8\ ]<YR/?\ E2!3@9+ ^@/ _2OGH_LF_LV
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M.2#C)_'GH*&7&, G]?Y"@!VQ?4_I_A044=21]2/\*$!&<@CIU_&G%0V,YXH
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M:I** (_,]OU_^M3))@D<CEDC"([,[GY(PJEB[X(^4 9/(X'6E(VD=^A]._\
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MZIIM]"MQ9W^GW,5W97<#Y*3VUS [)/$W9E)![$U;\SV_7_ZU?C%J_P#P6?\
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M98R'12\V 9,;1I?$SXB_L!?';XI>)/A9\0?%-M8^/9O$FGV-SJ-]>W/AMO\
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M_P"">/PQ?QP?B5X+^'^C2:=XIL/&7BZ.?19I&?Q%JOA[Q_XG@N#!;*?M)N=
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M/XO\5ZM)XVM8YE37=5C\5RWNC^)8K:.S^RPWD,?F0V\7D0HP@DCPY!\O\/\
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M!ZS=WNBQ>&;>S\2:C+IAN;2;4)X))5<%5F)C 4 Z;X[_  >_8E^!_B;PE/\
M%JZ_:#\8^+M7\+?$SQK<?$C2(/%OCZ[\->!+^'P[X?\ B]XQ\;:GX,\-/9Z%
MX9U?3]1\ 6>IS/:!)(/!^E/;)!]@FF?W;6_@Y^PU;:1JFD:U\7O"^B0:7<:;
MX3UB:[^,_AC0M2T75;R#XA+I.B:A/+?12Z/KLB?$CQ6T%O)Y5R[>5M0^2P/9
M_&G]A?X#_'6U\'P^+EAF/PQ^%DGPP^%]X;7P[?77PYU@:UX#\0^&O'WAJYU#
M396L/&-A?^ /#GD8/V:XMVFM;FVGMKAXV^>O W_!+CX!IK7Q \5:=\1]=\73
M>*-?\?07=["O@R^N-(U?Q$WQ%LO%EA-J=IHIDGU"U\1?$#Q+(J3N6M)[:.(H
M&6;S #.\,?L/_P#!/K6OAWXTETCXFW>J>"/!/BC7=)\9^*=6\=^#6T/PSXUT
MK6_[5U"\U6YUGPRNDQ:E::E.622:![1Q-EDFSNKT3Q5\/_V"/B_HGPZ^&EY\
M:_#MOIO[.WB'P_HVBV&B_$7PIX8>[UK5]/;6-&T1M5%A&=0EU"P22=5T"6UE
MGC=TC<1,T9++]GO]G.;X,?$;]D73OCMI]^/&/Q%U;3Y;*_O/!FL>*M$\;FVM
MM7U'PU)8WFF.+G5(H8H[G9-";J%"'CD0!6KR?Q+_ ,$LOA5X@O=*\(WW[1WQ
M!^T7,>F>)+_0+J_\&7&N>)(?#5@N@WNM3--HYNKFT3[5:1&0^9!;ED7'F,K4
M 9WA#]CO]C#QU-XD\0V'[5FN>(/"'BG2]/N]"TZP^)_@W1M4L/A9\);_ $[P
MOXD\(:C=76F"74_A;9^)/ASX;C>X:TM[NSF\*M')K$J7$V^/P7^S=_P37\(>
M =2^)!^*NMZY\/OVA]=\7? N/QYXQ\9I+H.M:S)%>:!?:5!XB7P_;1(T#?#2
M=;75;V:2*[FTT2R7EX;I#-M^-/\ @E/\$H=:U[XK>)/BWKVBQZ'IK^*7\0:U
M8>!?L/@W4O"'B7QMXU\-^(GN]3T,VUIX=T^S\7:C#J-I,OV34K6U/VXR+<7I
MN/9?A1^S)^SO\6/V;?AS\._"?Q1TOXO>!O /Q"\>>-)O%6BIX2O-/U;QUXKM
M/B!:^(EU#2--TX6.CFWO_B)J]Q#9Q6T"VS06ZJ@B4!@#J[#]G_\ 9,\-_!G_
M (9]UCXG:5?^$]!\5:=XMUMM9\?^ M'\02:WK;3G1SKYT&PTZWM(;HW?^CHM
MG;M<[4*M*V2WE,'[+_[&^DZM;:E??&[Q'J7FQO-XR\4W_C[P7_PB_BO1/!&J
M^'8=)\&^-_$FG>'(=-TBUTC4['05M[>TFTS4I/**W<UTLDN[S7P7_P $^OV6
M;?Q%HOC:'XSZ=XJT#QWXJ=/ B3Q^#;R;Q!KX?5)-6T>R\0'3VDUHK<W4[6T$
M6T6IMAM5F!8]Y\*_^"4OPQ^&]O86]QXWU[Q%#I_B*TUAK6^T?06M-1L],\4:
M/XETW3]3CFLI&O75])6&61GPXN&9$BH X'XH_P#!//\ 9Z\*S:+\2?!WQR\3
M^%/BA!H]KK_P?^(/Q(\3Z9KOP]\'1^$[CP'KTGB*/5+30K:WL+)=&\&Z"MDU
MY=S:5'),US_9M^\]S%<[7PB_9B_8X_8B\8?L[>,?&GQ::X^+'C?P9-X)\)>(
M+H6"^%/BKXN\.?#[19/%7BS2Y+71KJ>RU>]\)^&[:=+5=86QF2%VM+629F)^
M@?C'^P+X1^+7P7^%WP>N?%^IZ?8?";PE+X7T&\N=(T;4H-1"IH1LKG5;*:U7
MR3!/H%E)"]C)9W-O(BRVMQ;S112)G?&/]B;X5^-_A'\"OAW\6_B5KTNC?!WP
M5JWPPTCQ3J\VC:;KNO>(?%_AO0?"&A>)QJ<%E$NF>,K;4M&L;O3Y+-83]L<+
MM93L(!X=\/(OV#_!GQ#\!>--'^)GQ7\8ZKH4^GO\/]<U'PUXMUGP7X2M]?TV
M>]\+_#'_ (2'1/AQ#86>J36S3S:?I6HW3Z_<23;=\Q9(ZZ70_A;^Q'\;=%^/
MGQ=E\2?%.'P3>ZGJU]\4=2^(WAGQK\,?#OA6:UUCP]XC\166DW'Q"^'VESVU
MM#J'A'2WO5BFN/LH)#M$TJ$=U\/_ /@GAIGP\T[PGX*TGXM>*KGX6:3K7@WQ
MAXK\'7^DZ!/?^,_&_@JQ2SM-8NO$S6)NM-LKN2..XO+:W*!YP3%)#&3&??[W
MX*>"-&^$WC_X+:YXU^P6GQMU[QE!;7FI2Z1:ZC)JGC:(-+I>AVEW'Y>HW,20
MEHXC'*SA265A0!\X_"S]ES]B6#X ZG\ O"_C?3=?^&_Q)\0^'OB \.IZSX)T
M_5O%FF_"'4?!^N:=]E@MO#MC%XI\%6=EX/T*&\NVL[L7-A)+]IOI!+YJU_B;
M\%OV"OC)X)\5>-)/&WAKPKX!U;6?AE\&5U_P->>%=#\$:5XQ^'/Q+\6WWA"P
M\+V=SX=GTG4=6N/&WQ(UNWF;R+VROOM491-\?GUXGK__  29^$7B[QJFGZM\
M</$4GB2/X?W,'B#0]..D:?J\$%Y#XZTK1?$^AZ7:;8M TYM1\9:P+E3:RQ7@
ML([56BB^T)+]46W[">C3?LX^*?@+XB\>75RWB[XKW_Q>U?Q1H/AO0/"L%GK>
MI>/T\=WMEHOA[2;5;73--#^=;Q8#2J)//DEDG!D(!SGA;]AO]CU?!VN_\(QX
MM?4?"5E<ZZNNZSI?C+P7=Z7HM[+JTNL:W'/?:?HWV70WAO3)YD0$(@5-K*N*
M\_\ $7[ O[%?C'4+F[O/C#J3W/B'2/#>M:1:V?Q%^'#V*V_AG6(-7TOQ;9Z-
M+X?DM?%)^U6J1?;-3@U*-8F>*%H\\>C_  P_9'\!Z1\$?B3\,8_BUX=\81?'
M[2[*QTO6;+1?!]GHMWHWA;1].T?3Y-)\.Z.$MM>N4L+&TDOKN,M*\TAF#P-L
M*_.=Y_P2;OK27P9IVF?& :OHEKI6J:=XIU+7_"'AZ3Q19W!\*^(=#\/WOAC6
M(K+SUTNVN-9C+Z?<S2+*EN#+.[;@P!]7?!K]E+]FWX >-/&U]X1^(VH1ZOXY
M^'=UX6U+PGJ/B[P/IVFVOA;0+?2M.U;Q!:>&O#VBZ>DM_;+HEM'/J=S%.UHK
M2VQ>*#$*<>W[#'[*FN^%_$'A_P +_$?7=-CM]"TBXUS5_"?CSPJVIZ?I-OX1
M^!6CZ9J>JW%II;B'3Y?#G[//@63=($M[B*XU!L-#<1K!XUJW_!)U_%7BG_A*
M?&7[0/B/6[F[T?XD6FL6\7@_PWI5K<ZC\2] ^+^@:U/!!80K$=-6#XN7KI!<
MI<R*VBPHDZ13723>M_L_?LI_L\?#?]H7XS^/?AU\3/">M:W\9] \8367@71K
MG1);[P_X:O\ Q+)H_B2.SL[*]82^%]/\2Z/-IEI'%:V\%HUA)9RM--$2@!S'
M[&G[/_[-7@KQGI?QS^$7Q6TCQ5\/K/X+:5X*^&1U;5I[77;CP]I=[<?V]\0?
M$46HVFG0SO,D=KI]O>V^G0PG3M'M@9Y>M9WQ+_8H_8E^+VI'PA<?&;5]"UC0
M?#VE#7K3P[X\\'VIU7PUXKU;4;_19M8-_H4MMJ!N;N]O$L9AOVE%V([CGF?&
M'_!-WX3:%<V\>M_'/1?".E6/AWP\FD6&LZ-X.LM0;7K"Q\/>%K)]2OKZ2.34
M_ -W-H-@LNA!$LY[JZD4N28DCR_''_!(6P\8>&Y="L_C?J.@?VQ]EN/$HTWP
M3H=M827\0NE:3PO!:2Q2^%=/A%VS65G;S_9877]]%/&SHP!Z=XU_X)S?L8^(
M(->MF\<7OA_4K#QMH_B36KYO&7@?6)?#Z7/@2_\ AA=^#9-'\7:+>V&C>'-6
MT/Q'KSR6LMH';5/$EQ?6S),ZI7M_[0G['7P,^-OB'11\3/''B+0M"U[P-I7P
MNNOAS9:_X6T31?'ND>$V\6WOA=4DOM$?54U;3;CQSKLR?V7?6Z3"2!;J&:*/
M8_YUZ9_P2+\>>)]3\;Z'XZ\9>#M(\%Z7]BM/A[J46BVGB?Q)XV6Z\0>*M1U[
M4OBW-:Z;I,OB&;^S_$;K8+/<W,EK<11-Y\D$#03_ &A^T;^P=X?_ &FF^!^G
MZ5\7[CP_I?[/=EI/A*ZMM+LM,U;57O?#>K> O$5J)M1M+J-])UEH?">GQ75O
M=+<0&VU7S4M(I_*N  >"ZO\ \$T_V%?!_A[1_%?B3XK:A;:)HU]-H>KZXNM_
M#[R/$NI7VOWQTW3+R.Q\+R*VK6^J>(I8"+=/M,BN@G)*N[?8NO?L^?!,^"O%
M?P:T_P"(/B3X?SZYXP\.?$F+7K.;0]-O])\4%;"+09M!NO$'AM]+OY)3I\/^
MB-%<RLS'<HXQ\G>)_P#@EW\*]&U#P'H&B_%/P_X.M[A_"FG:=X2UOPKX6O4\
M03>"=/\ !3ZEK7A/3+J:'R/'\\_A*":YU.&.:=(=2=7C;".OL_[5/[$WAGXW
M_$?PCXPUCXN67@/66U;PI9^%;:^TS3KG4WU'PW;L)AX7EO-0B-SKD]L&S&\5
MU;[-PFM)UXH X&^_X)7?LUQWDFAW?Q1\?1ZOJ^E:2-+TS4M:\#1WM[KOAOQ=
MIGC^#Q=>:/!X9MQXKU.+6-#@?=<PS+! TZ1M&I0P^G_LX?LO?LZ? 7XN>%K;
MX7?&6\U75+3X;>.;[P;\*!J_P_O+$>&]=U+X9^&OB'XTLO[!\/0ZC?:>_B7X
M<>%(F!NFL;"]N+FV@BC1XH+?KOCS^PUX)^/'C?6OB!K/B'4-*\3:EX7\#>$;
M#7K'3K%]<\/:7X4UG6-5U;^Q=2FC+6$VJQ:MY%RR*!Y<.W!1F6L#]FG]A.#]
MG[XJVOQ=7QKI6J:S=>!_%7@O7?#OA[P-I'@WP?#!K%U\-VT:3P=HNFSM_P (
MQ:0VWP^:6]@\VX6_U+Q'>7S&)F"  Z7X/_LD? +X1>(['QMX1\7WFHZOX4US
MQ5J5Q?3ZWX=N&%]J?A[PQX7UO3M7?3+"-Y(H++PMI68'8/%+PW&Q%\$T[]BK
M]CGQWH_B*YTOXGZUK_A[XLZG=ZS;W5GJ^A2:=IMOX:U"[U>_T^QU1-!_XE4,
M-R;DS&\E$S*I7)KS_P -_P#!,5_[ U^+X?\ [1>DP^'O%GB7Q#)??\(YX-T_
M4]+MO#^IZMX/OM1TG1=1B\0RRV^N#5/!I6:62XFM(1J$]O;Z?:Q1Q1Q\=KG_
M  2LU62:U^&T?Q'T/1?"?B3PYK=I>^(/#>FQ^"+B:]L[*XMM)L;SPEI5ZLOB
MR_NTN&DUF^6_M7E@3RXXX22U 'US9_LO?LL_"SX%^"_@GKWQ*TJQ\(Z5X_\
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M&/LNC21JPDD739+E4;$-Y$N00#M?&W[ 7[+'Q'\/_9M"M-,\'Z;XD^%-_P"
MM'?P?:^%[2SN[+5-;\)^+AXN6!]-+:SK0NO".D!VDD:*6U>6":,HPV^4Z/\
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M]:?P]J>LZMX?U&]U/Q%X?_M62VAM9M,U2XNM7E>.ZD$AF@CC18SRY^2/A_\
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M&LZUI.K>#O%>J^)[E=,U!+.RNKRVT&YA\/C6[=YHSJ=A'JDBL(-VQG(+@J*
M/M4#@ X. *:%P23C'.!^/TK\,/$$/_!5_1;[QEI>G:KK6LZ;8V7A![35K71O
M#UU=76BR'P]-KT_AV3[8OG>,A<OXACEMUCD40QQ$8X)_43=\?C^RK<O;)ITO
M[2I^"]^^G)?)9VNGR?%;_A%+@Z4MY"ETUO &\0?9?,7SO)5RP,@0%@ ?13;<
MJF4#MDA20&8+]X@=2!D9^M.PHP#MR< 9QR?;/4U^:7[*?@']I#4_CGJ_Q?\
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M06K3<<Q"<H6]@:L$D]:S-9O7TS2-5U-$65].TR_OTC<[4D:TM9;A4=^JJ3&
M2.QZB@#\8]+OOVG? 7AV^OO ?PZ_:IL_B;=RV5M\;_%WBZ)_B1X6DU%_$%Z9
M+SX4^ M6\1,FL7!LA9 W&@B'2;>RD/F0O=*VWT31_%W_  4KFUVR\1:QIVFV
M6D"ZT*ZOO 47PYL[M)K2/6?AAI>HV,7B2'QIOLWN-(\2>.]0F8Q3&VD\+F&,
MR)&SS>=Z-_P48^.%]<^&O&EU\/;;5OAI;ZQ):>(M9\$>$?&4WAF]TC4+6X::
MX234[*XU&35-"NH4BNI;9UM+R63]U'MPM=+IO[?7[4OB&\O]>T+]GC1)/A_I
MNHW[%K[2_B/8>+=;T#29(+FYOM'AN;%8H;R[TVX06:2P/LN!^\20#RP 65\>
M?\%1?#?@S6M;N_#_ (8\:>*&\$3267ANW^&=WI%OI?B.^^'7PZ\8W>H"^M_&
MMU+K;Z7XCU?Q[H\%A#;++J%QX=CAC+W#H)LCPK\5?^"HLWAV7Q?KG@_1+M;?
M3]&TNT\+6WPCU_2]5U2VU#PY=ZMJ?CV2TUOQ7:WMCJUE-';P_P!AR6B2S79-
MJ3%(Z*.2L_V_/VI8]7M/#>B_#N+XDWVG?%'QMX9&OV'A;Q3X=T&>/4?&7Q,\
M,^$?!GQ AN_"PDT_6=(TW1/">J75WI;6]M<V>KVA,K;I)KGU;2/^"C7Q#L?C
M)\+?A9\2_AOX-\!'Q!XCO?"7CF6]U#Q=]N672],\<W^I^./!LEQI"VK>"XI?
M!ZQ!+V4W;?;?-4F$(\@!Q-A\=/\ @I5J/BY--TGX?:@_A.Y\)V[>'M;\5_ ?
MQ+X:UG6KBY@M1?\ B+7]+7Q9-:>#M3M+^6Z2+1[[48;V[BMQ*+>,'-9/BCXX
M_P#!5'PGX4U.&V^&%GXNU:;6K GQ):_";Q%!_P (_H-MXK\0:'*+7PMX>UW6
M+WQ)>7MA;Z!=.8(B;.WOI)WC\E&D3Z-_;A_:&^.?PE\:?!2Y^$,>H:AX"U#2
M?$GB;QU%H7AN#6;SQ!;VZ64>AZ;#J]YX?U%-)MV,[RGRXHYY@VU9  ,8/PU_
M;H^.GB7]H;X9?!KQ;\!-.TG1?'NE/K=UXHLK[Q#;2:=IM[<>*8[&:UMM2L2;
MN:RB\.6IU*-XXT!UR';-!M19P#G?#?B[_@H3K/B3X(WOQ%M+[1-"UWXHZ%K_
M (]T?P3\+;RU_P"$1\-6/BSQ7X+N_!FN:I=>(;\ZEX=U'3+[0-9FOUAM)K&+
M3UG8&V,I$_QLU7]H#3?VDOB#??#;1_VD=8\2:;XP\!W?P_L=+\-:[)^S]>?#
M:P^$.F7WCB#4]8U#3(=#O]0G\8G4K=+9-4BU>34C!'!Y=LL[+3^,'_!1[Q_\
M,_BM\8/AG/\ #KP5HUMX-\<^!/"7@SQ?XMU+Q?'X9O\ 3O$VGVT^HZSXIU'2
M-&=K&_\ [1N?L]EIT4*R3B,3P3W<7VEK-K?MT_M,ZU/X3U/P]\ ])L+7QYKF
MM^%/!WA?7M0\1V]Q;WVGQ>"VNM;\?W9\+B72[>WN]:U>."*U,:S1VQ,I$A"0
M@'S:?VC/^"J-YI%WXO@^%GBFTU?3QXDT72_#6H? +QY%I%_I\^HBYLO%.L:9
M:--J7]JV5@Z1PVMG',+WYA L[(6K[L^)OQD_;!\/? 3X'^)=!^'S2_$_Q);7
M<_Q*@\-?##QOXZCT[5['1]4O= T+_A"TN-.U3PUIVL:O:Z59W.HWR+%I U)Y
M+M(TC,B_,J?\%%_V@)O$GB2QN_@[K&DZ;IMSX#\1:0L>DW&I2>(["_T:^N?%
MW@#PM.-$7[5?6U[9JTM]=F*:..X00PN/F;W#]EW]OWQS\<?$,:_$/X5^'/@]
MX)L=(O;W6_%.L>)[ZY:?5+[4]#TGPKH6BH-/^RG4GO\ 7H;>]CENS)'-;,$C
M#,4C .]\2>(?VN=0_9+\4^+]0-_X<^-MS\6=#O--\-^"_AO?:MKGA/X;:1\=
MO#NDZSH5OH1UJZE\;W,WPVTS7;IM0MTM_M-MJ_FVMDNR-I/D#0OC9_P4[^'_
M (1^"7AFX^'">+)-9_X0B]\5^+?%OPO^(-YX@T:+Q#9>&;B[^'GB"#P0FH*V
MMV0O/$<=WXAG@T_3HI-+C%W#9L0)?HK]I;]K[XN_ S]H_4_">F>&)?$/PVL/
MA7X&\06T3Z3<6^ECQ3XGD^-=EJ.H>(/$]IH-W/'X=L7\)^$[R]CM2+B"VM9G
M57\\12>%1_\ !0O]HK7]"\:^,?"/@7P+J'AF2TTW0/#FIV<WB'6-"T7QAILW
MB:;7M;L;V#PZDGB_P7=:/X7NI@S203V<]]%"0VQPP![1^TK=_'R']J#P3J&A
MVWQ(;X=67PMTC438^&/#WQRUCPW=^.8M=U*>]TYI?A1X+U"P.HM:I:(T?B"^
MTVU,3KB5 6<?-DO[0/\ P4[^*_A7XDZ%I_PJUKX<P6>C^-]0T+Q4/@UXOT3Q
M7J<MAI]V^@>'=&@\1>($M]-U1M1AMD%V$U."9)&\E6R&'M5O_P % _C'X>T]
MM3U?X.V_B?PW8*;+4_$+ZGJVDZH^O:G%;76F2P:5I_@PP0^$;>"XS<W),MR$
MA;",V37UQ^SA^TY:_M!?##5O$+/X/L/&^E?\)*;GP]X4\07'B6PDTW2)S:6>
MO6,M_IUI<7&EW%PRHIDMHSO1DP: /!/"7QL_:4^-/[.?[:VHP:%;:7XO^''A
MCXN?";X/:C\/+>2_UCQS\4_!OA?QA(?&7@Y1>W:75K<7FJ> [/3[8!Y8M9T?
M5;>4N52-/$M+U7]O[]FK1?!5FUC?_$B'XBQ:;K-GX=_L7XC_ !YO/#WB73M.
M^&^CW_P_UWQY;:!H-QX CUIKKQ[KKZMK-C+I6DS::=-BFF C#Y&F?\%*?BO\
M,=)^&O@;Q;^SK;:QXQ\07VE7]WJGA[4;SPOX3U#P]XHEO[^PM[ 3^%(8+;XF
MWSV^IF+1XO.$TUHY5F:0&L:X_P""IWQ5\=6Z:KX"^&5EHWAW1?B-+X5UV2,:
MSK&N:]HNK6?PZU/PM<^&_M_AGRM.U80^)/$<6H6MY:&X5-'FS!93Q-L -73/
MVR/^"B9B\*O/^SIJ6L7MSXS\4:'K&EVGP0^)6C1:M!!H[W>A)HNL:[K<,6BZ
M7#J06WO=2U=+!7?<MA;7BC?53PO^V#_P4DEUSPK%XF^!=A)H^K2:\FH)H?P*
M^.)O[2YMS"L5MJ$VL6]I!I]A82-.);N%[M]0CB\[3K:=1M/4^)?^"HGQ5\#>
M&M$U7QG^SQH/A^^UW2]%\5V)U+Q[KL.D/X:UI="^S:1-J+>!E,7C]CK9VV0C
M^SDVK_OP3M7]"/C'^TA8?"[X(VGQTTCPY<?$#PQ;W.@/XDM?"=Q<:QJ.EZ1J
MEU!::OJ&GVNCV5R^KW%A+,_G0(J,PA8$J010!^;.D_M4?M]77@O3/'5W\(/$
M6A:WJ/AV*PUF>[^!'Q0US2;CQ+I9^*=SX>TWPU\,]/UM-8L+;7M=L/ ^DR:M
M>O --AU<7^H6,$ C ^X/@=\3?VI/$^N?$5/B_P"!K3PWHS^%?$VM>#=/TCPA
MK5A?>&=:T3XE?$_P9;^%;OQ#>:Q=6_CF\N?#7A?PGJ]O=6UM8)+%XAC>*WEM
MIH9F^6-'_P""EWQB\0^/?$OPOTO]E=M/\8:5JV@>'[3^W_'K6^DZ=J]_9>&[
MW4CXJ:P\.7%YI=D1K]T+"46>R[_L"?$H#!HO,?#_ /P4Q^-&N:O-XNU'P;8>
M'_AZNHWOBNVT5M-OY-4M/AE<_"S2OB)X>L/$F= GO!XEG6]):^LD\A8#C^SG
MD*D '%Z%\?/VN_A5\-QXF^$'AK]I[XK:A?\ @_P];^-+'XZ_ [XB7\'ASXP7
M%YXCNM9T_P ,:5/X;\/:S>>'WMK72;>6ZLTU32[9[J/R)F+,J^CZ!^U?_P %
M#]&\9^"K;7_A VI^$_$WC9K[QM>:U\)?B1I!\):%<0^'Y)_">C7.CVMU]FM;
M33Y];O!JVH1M 6L&M93YI&,/3?\ @JM\5_%VK:'?:5\)]+T;PV7U33+S3[/5
MY-4U'Q'XCT#6_&<%PNBZO)H4\)\,3Z1H.EO+*D!GMWO5*R\E#[S!_P %'O&]
MEXJ\#^#_ !A\%_"OAC5M>\2^'M$UW[;\2[^.&:'Q9JNB:9I4/@,W?@F$^+-;
MBBUN.:[M76U"1VLFUR/G4 ]Q_:Q_:%_: \%_#/X:?$3]DWX6?\+Q7X@W9LTT
MJ70?$J76FV.HZ%=>(='\6:I!''#<:7H(@TJXM95FMQ.;G6;-%3<2C?*MK\:_
M^"@]TFO>,[SX;ZO-HOQ#N? ^O^&_A3%\/O$&B>+OA]++X7_9Z\6P^'9O%SZC
M<VL-K);>+?&&C:[%<V;?9];T#6)8[V."![2V]>_:Z_X*,S?LN_%P?"[3OA.W
MQ$,'PVUGQI<'3M>O=+U6&^M?"7C_ ,3:)9"Q_P"$=G1M*GF\ SV<MQ;O<M!)
MJL321(1''<\\_P"WW\4[_P"+_P +_@U<?#;P9X)\0WOQ7M? GQ)EN_&.HZQ+
MJ"?VQ\6=(O/^%5Z==>%+5O%6F0+\.]/GU&^EDLWTX^(K:)H) \<DP!Q6E?M!
M?MWZM?>'O'NE>#[[7+;0_"+MXW^&MY\!OB=X&L=6\27^JR(WA+0=5\3Z@)3K
M6F2.MN^MQ"[TR]BMO/CM858LIX!_:[_X*%:];V?]K?LPZ?+<>)-9UK1M+FM/
M"GQ"T6W\'W6B0W6M7@\;KXFL[7_0SI=I]CL[NR:XMK[4+F,1R+N6,]Y^T-_P
M4ANOA%\>?%GP)TOX=W.K-X?TBWO(O%>G:B\MZNKVUGX5UV]TZ^T&^T+9%I]Q
MIGB)H8;J&6=!):N=WF9CC^@]3_:O\3>'OV>? ?QJ\3?#+1?#NL>/_$&D:3;^
M'-7\?O8^&/#%EK>I2V=AJ_B[QS)X3(TFW%O'YD@&GR*K2+$'.=U 'DO[%W[0
M7[9_QN\7M%\=OA7X:^&'@S3/"%]J]]<0^!?B;HNHZOXENI=#AL/#MC=>.(+"
M.RET^>ZUQ;UXHM0BNO[.C-O)&KNT?CGAOQ_^WCX%\5>.HX;75O'DGB'QQ\6?
M$$&J^.OAOXQ/A/PYX.\/^-OVLI?"'A/PUH_A*W-RLUQH/PX^#MM;W?G7LMQ;
M>-K6XCLKJXN+5;SLM#_X*5>+/%^L:?X:\'? 71]=\1>)M=A\/^'],B^*TT8T
M6X@U+1=-O[OXBN/AZTOA"SNH]7DO="/D3OJ]AI[SA+;<53Q?7_\ @JA\1_$^
MK^%+CX;_  NTK0-*U/3M4@F\):]KYUKXC'Q%YOPA?1;SQ;X7M?#BR>#/ TX\
M=:LMA?I-=/K-I;F]MQ:&+RJ /I']DKX^_M3?%GQ1K/B#XM^#M1T#07^#3:KH
M/A.+X:>(_">BZIXZTCQWXZTR>?1O$>O7DTY%YH5AX>9(+M(G>&YBN8H%67!\
MBTO]MO\ :WN[R)+KX07%MI=SK-U86VN_\*"^.Y&H>)8+"\G7X3KH0MOM5AJ
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MKP1+M22<2*8P ?7M(2!U-1;V]?Y']0.:0DGK0!+O7U_0_P"%&]?7]#_A4-%
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M^C15OKB27P1K$4=RI\N#?;Y3;(=M35?^"EOP@T[QOKVB:7\"];AO_!WQ N_
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MASP[XG^(/_"5^#=0TO4=$3Q'X2M=<AMKJZNE2+6KNUTB01.5\T6S;TC9"[Y
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M7"AG*9XR?B&?_@H5\#;/XB^']"\*_L^2W?A_P[XI^*]OX]U)= T.R\2^!(?
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M7F.T 9\4OV'?V+O"7A32M9^('Q*U71O#NE^)+71M O\ 4?$D&HVUEKUM)<W
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M>)[[PI^T5X$\7?%BYTC0HM2^'5^;FSU;2M"U.'X9V7CRTATF+4IUL]'MM \
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MOU_M+Q1IU]XNC2SF7"BVT:#!#85/9_V@?V/9/BZ_P@\)#XP6?AW5?#_PZN/
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MN]6N=1CU[4)/%^LV6O:Q8-J-LD^M6<>K);0V]E,\[V'A\,EW;*!#!XO\$_\
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M?\(_X=\(:/I.JW6EZO%X6TVZTTZUXFTN34+^SCG42"[D26XE:1R?-8_V,_\
M@H/K'A76O"OQ$^,VN_$?1M8\03BYTC7/CUXATRT4I=RR6/B@2Z1\.4GO_#:V
M_P!G$GA>]GGLYGA\Q[E6'S@'H6N_\$N_'_C[P78>!_''QVM+>"V\1>(?$<GB
M7PSX?CN==D'A/P_)X*_9PTA(?$-K-;QVGA?P]J.J:A)<((Y_[>\F\M2N-Z_2
MGP-_9Y^-'PM\;6%_XYN_V>-9T6Z\>>+OBGXE\=V6@:NWQ3U?QE\1- LK+6=
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MYHFCZ@/"FIQW%WMEOH%NH?+,P,H'&?%K]AWXK?%;]GGX%?##7_B!X:UOQO\
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M%8XSGI[>] $M-8XP<9YQ_G\A2;QZ']/\::S C SUSS0!*#D ^HS148<  <\
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MI/B34/ E[X8/CW7+NXTZVT=8[?4'#Z&+2XGU$2P ,TZV8;@$X /D?QG\.O\
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MT^*7Q$T#5/$7@KP_\.(M2\1>#-4\/7UIXK\1:W<>-O@IX3EOM#NS"HCU??\
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MT ?0U%,WCT/Z?XTX,""1GC\Z %HIF\#J"/P_^O1O'H?T_P : 'TUF"@LQVJ
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M3Q=X@.H^.&:ZCLQ:I:PV,B%99(P9@#'\%_MR?ME37/CGXN>(?A?I6L_"33?
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M/AWP;J-MI\%SK^C:MH>IZR+6WN=)NGTS3FT5X],A:.2W:V @9QABHKU'P_\
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MU?&W[:7PYB_9\\'?''0_A5XM\8W7Q"A\7IX2\ ZIHWAO1O$%MJW@;2?$6O\
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MH]0DF-FD=SY$;I(WT)\./VX?@I\0/@;XP^*V@?#SXB:-X6\->)+7PF?!6O\
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M4O[*_B+5?''PZ\0_!SQKKFJZ5?\ BKX+Z1-H_A;1+*\\7R>$?$&NZ'XN\/\
M@;6EUJ"2ULK#5/"&ILQD>U&VS1HLD@5K?!WXT_L$^!_$FM>+O FG>%O 7BV?
M0]?T#5-2M+6[N=0M?!G@B6^40ZQ-&TH\/07!\&WCQVLWE33S: WF!Y8B:BU7
MXX_\$V_B-;"QU?5/AWJ\'B*/Q=XINV-E>0R6UQ)XC\7:EXLOM2O+0J^EZG/X
MD\/>,'ERZ23365T!D;@0#9'BO]B[]F#]G/X=?%V+P'%IGPFN(F/A_6I] AUW
M6M*E\3O/>3IJ5W?SO/\ :[K4(I4<B60R3X&3D&O)D_;R_8->:QO+'X<RW6F^
M.K1M=37;7P%X?:TU2XTG2$\1VL=]_IH>.]$NGW$$9G5%6]TJ6(,3$2/M+1=4
M_9C^-O[/EGJFGV/A3Q;\ =+@2:TM;G3_ #/#MC#X5F!CD6SD7Y!:2KO!Y*G+
M<\U\2>/O&W_!+_0+2'Q':^#OAMXZ_P"$6T/QM;3V?@FU&I7>C:+X;T?4/&'B
M"(Z393#[2Y77IRJA6DW:R[+\H; !V>I_MP?LH?#^ZCU3Q%\'/%?@E_$OC3P7
MX8U;5-0\"^&K9UUO5O#?@V2VN]22QUB6>:#2=#^*?@Z&^E2-TME\2B-6?Y@:
M6B_MU?LT:/KNF7GACX(^)]&LO'D<<7CGQ$_A'0=&NM/\"+H.D7_ACQEK-K%?
MNVI^"[C3=<?#%P]M!9W$DD.Q>>^^%=Q^PY^VY_:LNG?#[0-?\0?#GQ=KU[J.
M@^)=(O-.UC3-1T_Q!%\/&\0I"[H+O3;NY^#FC1QR*7C/_"+VR.!)#BO#/B+X
M[_91UUO&W@34O@GK_@G1-.U_QG^SKH?Q:L+2RAM)_$?@*QF^'^M>$]&E>Y+6
M /AN36K2SDN4,4T5K*8\NJ&@#ZWMOB1^S!X1^ >J?'_0/ .E6?PPF@E>$Z5X
M3T6QN_$UFU^L%M/IUK--%'?65U<*CV[-(OF* P7.!7*_L\_M,_LI_%CQCJ7P
MM^$_@FYT34/'GA9O'.O17G@G3?#^B>)+:674[*_MKV7S_P#B=:I%);:DDZI'
M*J G<X#YK/E^-7[!.K?!31?A+K'B_P  ZM\)=.N])^&UKH%_*[Z4NIZ)%:&T
MTYY(@JB6*1K<[PP >0=S7F'@+XS?L$_#V\T'XF_#/P=I6G^,-/N]8^&*66F1
MSQ^(O#%M#J/B&WFC_L^\F.VPNKG3-2;SH@0Z3EF;&: -R#]I3]E.#5?B+\"/
M%OP,_P"$=\.^$/B;:_!_4K./P?H&K>#9]%TF_P#A'+H?BS6XHIHSIOAD>._C
MMX9L[=/)N9H[J]>X"!'<IU?[0_QV^&'[-?B_P]\/;/\ 9SF\8VVO^&_"^J3W
M7A/0] :TCTF[\83^$;71+;39FB:\U&W\^YN8HBRQ>4\@W*2<^?)\7O\ @GSX
MT\8Z_P"/_%?A_P ,:#J_A#QDGC'Q)XL\2^;I]E+\08]/^"5MI$J;9A'XGFG'
MBCX9) 8TE@-YH5L2GG11L?JOPYXP_90_:7\<&X\.:WX&^)_C;P#HVCW?VC3;
MEKZZT;1=>^SZ_HTNZ)@A@E80W$7WL%\C&XT >._ 3X^_L7_$?Q]<?!GX.>!K
M6RU.73I=8N#;_#JUTSPM-=6MM;ZQJ&ES:K K1G7+9;N-IHG7 D8A'?!K!^)'
MQO\ V%O@_&]SXA^&FG27/A3QMXFLX+;P_P##?3-2O;+Q;'J&B:=XCOK54D3R
M'>X\0Z<TUR[(NQV>1D5<G0TGQG^Q'\"_VH/&OA33_#NB?#KXD^&?AA9>(?$/
MC#;)8^&8]&VQ)+HT<GVDQ-X@33)K":=1&9FANHLDDXJ?PEX _84_:G\??&*Y
M\-^#=*\8>)O)\,W7C[7UAUNRM-17Q)YM]936$DLL<3322>'XOM9BC#,UK&)<
MB@!_P>^,G[&W[22^-/V5_A5X>NK?0-%TY/%-]::%X9?PQX2^VZ9J'@WQ!<7W
MAKQ%HT_EIXGTW7/$GA6<R1M'-'=*);>200,ZNL_VN?V??&OQ!U+0?'OPOUS3
M?%NA^-?&WP/FUW7O#&D:UIVFZ%/\4?%7PMT:;5M:-T7T[0/%/BCP#J<=K;I%
M*7ELPER%"K(U_P"'WB+]@3X)?$C79OAOK'PY\&^/]8U7P]\)+_3]&NKF*6\U
M>2:/2=+\-:;IR%HI[LW/AF"WN'A5F5]#59G!C.>I^*/@+]C#X5^/?!GC3XH6
M'@KPEXR\7>.]0U?PM?:S>75HGB#QOJ6N0:G-=O;^?Y-Y>+XF\0BXA\U2L5YK
MSR1!9)B: /E'X\>$/^"8_P $==\4_!WXM_#W2]"UKXPZWI?CC5;&/1[G=XMF
M&I'4M+T^RU.&X5D\/)JT(MTT]2EHC@0"/:0*N>$?VO?V/KWPOX:U/5O@(/!2
M".]\/CPWJ7@+2/[3;3!HGBNR\-V?A*TMV*ZM;W]C9ZC9QQR&VV'4)86 4EC]
M!>+/%'[ ?[0GB&R\8^,=8^%7CSQ%X,BBTO3M6U.<2WVF6]IJMEJD$-IYNTM"
M-4O[&:,J&#-<J5)#5L_&+X:?L6>"+7PY8?%K1/!.A#QI-+X7\(VVJW$]I<ZQ
M?R6NJW L=(:.0.EZMOJ>J.CH0T?VEF# @8 /'_A%XB_9!^)/Q<NO@Y'^RSI/
M@O7/"&EZGX>\#7_B'X;^&[;3)M&F\,6/B3Q7X2BN+9Y#HVLPP>)[X7E@!)$T
M<LD@G?SME<OXO^(7[.GPV^+OC+]GKQ)^S!\,]"^#7AOPYJL%_K=QI&FQ1^(K
M.Y\.Z5\4]?/AWP_%H+V.KZ>-2B,=S8R7T&I?;-":]%L]LJ./4_AK\7_V"/!O
MB/P;H_AWQ1X(\*?$!]9>UT71K_5KJX\0P^(_%-MH7@R>"[O)WD$NIW=K<^'(
M)3)(3G4;;<5,JYYF_P#%W[ _Q-\=>(/&GQ BT#2_%7B3Q7>_"YF\8:C?6FG^
M)?$E]X!\,Z)>W6DV9N/LW]HMX4\9:/I+7:*DF;DP9WDF@!/&7[9_[-NA^*KS
MP&WPKN]<TGX6>'-5TWPYX@3P[IP\+Z#K\MWKWA2^\">9,"WA\7D7AB>&.2**
M6&>,*D@0 9\EMOVM?^":(?7-/;X2Z0VI#2='^'WB2/3?A-IUWI%UI>KM91WO
MAU=;D2&UO/#]E?:JL5R9FAC5F8QHXKW_ $OX$_L+'X7I\;/"GA#2/%O@7PW9
M:Y=0:UI%[J^J0ZJKZMJ"ZG<,DUQG5[E=5U34V220.0]R[(<$5Y^_A;_@E[XD
M'BZUO[KX76<['3M4\8Z5>:U-I36']GZ?;:D$O;0S(EO&+2WA>XP"',/)W<T
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M?C"_T_Q'/X?U1=6MK'Q)HL46FSZ ]RBA818V\,<"0#/E*"I).30!]/["!U'
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MXJ\5>+;KQAX2U/PSI$6EV:Z&UM<V"2V6_3K.)VLI/)A\N/- 'U%\*M-_9/\
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M]\)7^AO\+Y-$\7^']/N](N(8IVD^%7@8NUS!<V<YMY,PGS\CNO@!^S+^S?\
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MOK;5+XPZ?;"SN'T[Q)$6:()9M'<1>7$I&3X;\+O^"<W@+P+^S5^T=^S7H?Q
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M\(:?8>(M<TSX@^,+S5?'=VE@-2*Q^*KWP;J-UH\&HW$UTUN8[>Y:&9(5M3\
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MOP8_8IT_XC:=\+]:UV_B^(6NV^JZQ)XDU'3YY+%+2359-/TZ![2WBWI$=7O
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MT\+^(_$FM7&@Z):7.N7VI:+\3($U7Q1!<:).L$CV[1FRU6YBN8Y]Q)B\8?\
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MD@8LTQE=@#V?8OI^I_QIK+CH. ,DY_QI<N!]T# _+\C32Y((XY&._P#C0 (
M<Y'I_6G[4/3!_$_XU$I*YP!SUX[TH8KG&.?6@!Q4'&W!]>?R[_6GD ]:B#%<
MXQSZT_+^@_S^- #2AR<#CMT_QI-C>GZC_&I 6[@#_/UI#O.0,#T)Y_K0 @"9
M"G&X@G&>?EP"< ^I'YT;1N(QP!ZGKQ_C3-G[P-M!D564-W ;:6 R?4"EW$,3
M@9[_ *8[^WZT *4()].HZ?XT]/NC_/<TPLV"2!MQU[\^V:<A!4$>_P#.@!]%
M%% !114?F>WZ_P#UJ 'D ]: H'0?SIGF>WZ__6H\SV_7_P"M0 \@$<]/KB@
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MZ$^.Z?MJW7Q ^%/@GX5ZKXH?Q!;? '1-2\3^(;34-'T?X?1?$F#Q$EIXDO\
MQ=#*I&KR7.DVM]'9VMHV(9IXYSF,"@#S[]HK_@G9\2_BW^T+\0OB/X9\71>'
M?"_BAOA=K6A7MEXV\9Z/XDT/7?AYX(UOPS#%:0Z7J4<5A"-2N=,N5G@V2.B/
M%)N4 '4_97_9%_;&^&WQ(^,&O_'S]I.[^*'AGQ7\+9/!NA:1<>(M0N]*CUZ]
MTJPLH+BZT&\RND/9R6UWMN(Y#+="^8N%);=!+\,_^"CFD>);W3=$^(.O:M#I
MW@[3]5T/Q#K_ (GT:?PWJVK6N@:3-=>$]8TT1"9=<N?%L.L(U\/W4=E<QXX
M->/_ !3_ &=O^"C/B'3]4TK_ (2*]UB;QSJ7AC63)X:\6Z9H&F>'_%5I=VVI
MWS^+I97$VL^#+:U>ZLX;>#;)(]M&YR&H Z/X'?\ !*'7?@?X.^"@T_XR>*[/
MQK;>*OAY=_'W5=#\4W_@_2==\%_#;PI\3O\ A&/!>@VWA?[&+S2$^(7C'0KN
MY-X9+B^M[ PW4\H5%'F'@;_@F[^W[/X#T?P[\3_VO_B#>ZQI>MZ]J<MWI'Q<
M\:V\E[?:MXK^!AO-6;4=/FMIVTZZ\,^%/BY/#IDSRQZ?=>,DCBD<[Y:["Z^#
MW_!2[Q=X6LO"WQ#\0>+M?M-2\>Z7)?IIWB[POH2V%[IOB_P1JM]JNI75NPFU
M'X5RZ'IOBU+?3U(N5ENH%!.<5]G_ +4WC']H3Q-H/P!'P/T/XB>%M>\=:MXK
M.LZ1ITVGZ3?Z#<VOAF6Y\+S>-KR]4Q0>'(==%M)?0 A[F%C"ARV: /@WXA_\
M$_/^"@EYX0MK+P-^T(T'B72= \!:!9:A<?$?QK97^LV_A'Q7XJO\^)_$!FFN
MM6A;1-4TA9U=B]Q):$"2(JK50\9?L%_\%.-9@^-5Q:?M5ZG-JWBZ]\$WO@VW
MLOB1XGT'PW'!I%UHL^I:2NFM!//H%M%%9ZA&S)<2_;X[MA*$9BU?1>N_#_\
MX*/::ND-H_CCQ!J_B'6;37[UK@Z_H<?A3PSK\^L>("UKK6GR)OO]!'A^304T
MR.(YBN4=W)^:L?Q;X._;S^$W@?QKX@D^)GQ/\?R3Z9/IMG86VH:-?:[;SW,&
MEO:7/AN%(0(-4;5);Z)97RD<*9;Y: /2_P!I+]DK]J/XU^"OV?=&T#XZZ_\
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M/B'XB^%>F^&OA?%KFHVUS'H\FFO<7]BFK:3:/]FM_$<UPD":A*@VL9,@\$4
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M1/@E\*OBGXL_9]^&D7A^Z_:.N?"W@+2=7TCQ5+\5;Z[T/1=-M=7U:]BU%_\
MA'X[;1-1F?P]:ZAM&O7$>I_9X[8-0!:U'1OVY?A)\!?V4/"_PVMO$GB3QZ+B
M_C^-ZZO!:>*]4N=1OC//$VJ^)+G5##I5DES(S-(WEVNQ1&+B$A5/)W/Q*_X*
M,>)O$,D=_P##KQ_X/\#(UGX>MSHG@KPQJ/B;6O&4%OKUKJ$]W'>>+H$TCX<7
M$O\ 9D@U4NFPJFT[7)'A&L_\%!?V\_$%_P#!WQ5X7^"FH1VD/QA\0^%OBYX
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M7QDTW4;74I?#NA>,M5L;#P:MIX5>3Q7+:7?A:TMO$"V27#Z2=;C:5?-\JVF
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M>>(OBEXCTW3_  G/:W=Y;3>%?B1,OPO=O#WQ(N([17L=*@6Z$HNXO,N(RV2
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MKFVTRQM(KVTL[2\:"XW^7/.2(@ ?IUU[]_3W_P /\BFE<YYQ^6/;_/I7XO\
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M\"=3^$6C^,/AA'=V7BSPWX@\6>$[^T\+:2FG>'K%-.NM0N[.%)X!Y&K7:17
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MM%?#7QCX7T7X'W'CO2="NY=0\0:#\3-+2S\+W\%OX:\3ZYHEXURT0,$-U?\
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MMXQ\+RZ1;:9]JG\3?VA+I/B*":W'_$SL+V'2[UHI3_# 0 !Q0!]B^9[?K_\
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M8WNJ1:;I/Q#T&34=4^#&O6>NZA<M9R1W.A67@?2-#M$D-MK\]CHQDAT.T?\
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M0V:R[LJU 'M_BBX_83_:<3X=>#O$7CK2M4'@CQAJG@[P3X9F\9ZYX;;6-?\
M#932+RR6Q6_@_P"$EMO-C"132"5)FSY3LQ(KSF]^ G[ GPY^('BGPQJWCSQ1
MX'\:^&D\-W7B&XU?XP^/]'F;POXK3Q ^E^!(=6N_$*_:/ \MO9:R\NCQ/]BB
MC@$DD2J@9>!\8_LJ_L;? SQG\&_BUXE^)NN74D/BW5-:\%6D%M:>*HM=2*]C
M\07JZ?+8*[VVG6=T1/+<VY+")MK96O<_VDOV??V=_BIXBLOC%XJ^,@\#W/C&
M+PEX.M=1M+O0I+&]M=7LM6\)0:>8M4!%I<7^F>/Y[4S2!9+22_MY5*2*E 'I
MOCC3/V6/V?/">J>%O%,;Z#X3^-'@#PC\)M3EAU#4+ZWU;PC:7OAOX*>%].6>
M+4#/; S?%W1[7[9 O"7_ )\\ZF.-FPD_9T_8E^*/P_U#7+<^&O%/PYT6_O-4
MU/6[;QG>RZ%I]]I_Q"U'XL:A=W>J1:FJPJ/%6KZA<2LTGERVM\UNV^T?8=?X
M@_"G]G[XW0^&/#<7Q%M]*F^%FG)\,M AL-<TXW%O/H^N? GXQPK -0E/]J7E
MO:_#KP%+YR;U%MK$K%LOFN5^$7[+GP%^&_P)^(?P$L/B[#XC\+?%JXUOQ"UR
MVO\ AZR?3;866GV4DWARRTZZ\F.RMIM$@N+A@"LUR+AY\>8X !Y!>?LL_P#!
M-W5KJ\U"U\;>'=+7XAZ])XXMK;2/BE=:7IMP^CZC_:6J+IVGQ:JD-MIYU.!W
ME0H"KAEC*_=KD_C%^R-^RO\ $KPC;>(_A;^T5I?PRL(KFXM?$_CFU\=W>JNW
M@S7+'Q)_:/AJQU.?Q#&-(AN+:_UN0)(9+>5$<3VTT7RUZ!X=_P"">/P3NK_5
M[K1OC;JFJW_Q)TRYN?'"Z7)X2F/C."'4C?6&HZ1:6I<>&M/MKM(5E3352&X6
M#9.3EJ\_^*'["O@/QI/XO\#6W[3>LV7CC2O#6BW&MZ5K6G>&M/\ #,WB2YT/
MQ/H'@/6-4LK9(H[;RK#5-59-/@^6=K822*2* .KTK]EK_@GG:7^K:UI_Q1MO
MM7Q)TSQ3XC>Z7XR:AY%_X?L_#OQ;TOQ;-!G61&FGPZ)\1?BC]H+C=%$TN-L>
MGQK;]7IOP9_X)_+J4.MQ_$WP_>Q^-;7Q1#X/L;OXKSRZ5I.@:X_C7P_XAT3P
M;I\NK^7H^CMK/CCQE^YB5 MY=2*@!M$6+Y]\4_L%?LNZE:6WQ8\7?M+>(;/1
M=/\ $/CCP)XCOIX] T;2+_XC^*(_B)\/O$VFVEG%$B^&[BY'CJ_M)-,M5%O<
M_P!F6<FW!+-ZW+^QO\%_&&G>.?B-\'_C#I.I67Q_T?Q3?:1X=O;CPY/X1UJ]
M\4)XLUWPY:Z%=P_Z7X>T^PU'QW=7;0:=Y<TC16[3*&C6@#Z!_:$^ /[*_P 9
MO"/@?Q)\5_%@L_!7P>N)-)TC6K'X@WF@Z+:W%O)8VKZ?J-[9:BB7-\D^FVR@
MEC<*T; ,,M7 ?"'P]^QSX:\,_M7> ?!6M:YK7A***V\1?'CQ'J&OZKK6CK#X
MET;4;^"+3=;:_DDE=='%W)(]NF=K(&ED95"]FG[,WP^T?]FGP+^SGJ?Q1LO#
MVK?#2#PYK]YXNDO-$O\ 4_\ A)=,CN!/XAUW3/$$QCOX;J:^N2YO%VR%E8DL
M!71_#7]G'X,?"_X9_$+P=I7CBVNM ^)FBIIWB#7;[5M$!<6^FZE#<7\-TDWE
M;BNIW4VUB4B4*BXC4"@#QKX=ZO\ L(^*?@;\4/A=X+^*UCH_P\TGQSI_CG6S
M<>-;S0-;\'>*+[4? OQ$\->)O"]U>7J7>GVJ^)]0\)7]@\'[L:A?K"J[Y/*;
MQOXO_LI?L"_![0_"?BWQC:>/?&%O\6K2'PKX?N] \2ZMXOO?&VM:?H]]XUMO
M&<EY)K"QZCJL6B:')<)=O.T<JV<9"2.PST?B+_@FM^S1K?@W1?#>J?%M1J>E
M7FG^)X/$MQ<^$O.U74S<?!M-%U/6--:X6#6=,W_!718XK:7=;2-JEUM&_;7L
MWC/X#_LM31_LQ_LT_$+Q9H\LO[/?AZV^(/AOP3K%S9Z?;^(/#>@^&KOX71ZU
MXBB:>-+'3#?:W(T(215:YM_+3<BD4 >;^!/@G_P3QO/A_I5KHOCS0I-"\1)I
MT@76?B3+8Z]-?:_H?AZUM5U.&YU6.YT_5)=.T'2G$4@0HV651YF3Z/\ #SPS
M^QA\'M$^.-IX/^*>B^(D\?V&H:O\0]+M/B59^*]:&F:+9W.GWRVMI%JSRQO!
M;7-R)9"?.VIF20K&-OF'QV_8._94\8WNG7OB#XC:3X&>#X@7NLP6-L_AIK=Y
MO'$&FVFF^&UL9I08%\K2(5TZ?'FQ@,(C@UT-O^P3^S?9Z1/9:3\1[?2Y-7M[
M[PS+K%C?>%TOKV27PQXB\+S::+I)1Y]Y';^(+B9X\EVEM4+J<' !'JW[)_[
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M>&[6SDQIGANXEF.^&']U&$Z4 >=:/_P3>_9&^'6K:9;77QBU[3-?\):GJ7Q
MU:+5/'/A#1O$$T=W8Z3:3:GJ<D5I;W>C:/Y&@6ANI+9K6*^"3#4&N%EF#0:Q
M_P $^?V3?!WP\\%:5K/QL\9:1X%\9O#\-;:\@\3^';71OB5=^,=3\17W@+0X
M[C2M)%O;P6.L>)==N-*@TTVMHTUW)+<I-DFM'XY_L'>#OV@OV@/'GQ$N/VA6
MLK_7? Q\-KX'CM-&O[.ST[Q=X9\1^&;2VN/-D!OM+G-Q=W,*J6<SZ<=H^4U[
M9X^_9>\#:O\ LW_"#]DWQE\66M-1T?4/#@T/Q%=C38O$FO3>#X-8U_5QIEG(
M1]DN%\+VVOB.Y0*]M'9^>'#QF@#@/B+^Q?\ L9^)_A)XN\0:OXSM[7P! ^I:
MWK?CO1_$VB:KI6EZM'XAT+5'UF[NXX;JSO+FUU'0;" 0W$<T(0M!)"P.T6?V
M5O@S^R3\*/%'B7XQ?"SXV#4X[+1K7X::_;:QXM\-:1HNFW&G7!19-8L+:"S9
MM0EN&(M?MF^.)6"6$<<>%KM?"W[,O@SX=_ 7XO\ PY\5_%'2+Q/C-]BN;[6[
M?3='TSP_I1FT3PQX \,RZ#X6M"UNMH\FBZ&\[*A2ZOKV:9R7E)KYH^(W_!-+
MX2^-K?2_#\'QMD\.^*88;SQ)J?\ 94.G6FG>)I/^$BO+R[U/Q#8V[B*[BMWN
MY+>+S#NB:->E 'H]Y_P3G_9>\+>*?%7Q&\5?$SQ5'J?Q.N-6MXK_ ,2>,M"L
MEO3XB35+@Z=I-W+;Q2:]<>7JER+4S275P(HXHXV,2*H];^.7PT_9._:ATO6/
M^%@_$3P];?;_ (:2>&+BUG\7^'M'U#0=#MOB1X#\>:;XBO-%UJ?=;2VOCCP%
MX4=&O(3:3@_9KB*:&Y,;M^-_['.@_&CP5\"? FF_$V7PW=? :?1;S3];L[73
MM1UN6VTWP\- >]C6:1A97,EG(QW$%")MN0"#7RSKO_!-_P +_&%]9N[3X]Z/
MXCT*]T?PWH7@F[L-&T:;6=%7X8?$*]\0ZWHSZG82[M8T6\\9&XCUA9-[E]'L
M8"0+55H W/&7_!-/X)^%-,\/^(?!?QWU?X4:A-=_#G3=*\5ZEJ?@Z+3+I- U
M;2=5W:5#=64%GJ>NWXTJ,6<4PN;.T^VW!L+*-9Y0V9X:_9>_8>A\+ZKX^TWX
MS>*8OA?\-/&Q\,WUQ?:[;)X4M/BAI.I:=HFOZK%J$^E^=JFI7NHV%M!,@EDL
M@Y=K6*(L6KZ;^(?[&GAKQ?\ "'X)_!_1_B0=(C^!?A=? <=[J-GIFO'4M#NO
M"NF^'-4N+[3;^9ELO$JZ;ID=Q8W?^MLY)'DC(#$UA>&?V<_@[I'[,VL?L[:)
M\6-+N].\0_$_6WTWQ+/!I%]=0>-Y?%0\0R:+)8$&*ZU"&YLIHF$@W$!F)R*
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M^"[ZYCGTOQ%:>*]6^'E_?:G>^1<A[]8(? H@EA.^)UU>3S@2%H ^>M._9-^
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MASW]>A_.GEE(Z<XZ^_KGO3*<I //3'IGTH ;4R?='X_S-1D M@=#_ASQ4JC
MQZ9_F: %HHHH *0D#J:6F $_>'T_KT_"@"*EP0,]OJ*>Z@#@=_?WI1M8 =<
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M3\,/"WP^\,^*-)F\1V.H:1<:3>WMQK&HPQ:;JD4.H6MS;W4:+!=I*%:$$L"
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MU\*:E<PQW/DK+H\L*.SQ1,?F+4/^"8'Q_P#$NH?$)_''[15QXQL_&-K=._\
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M5G&TMIH[/=RZ8BS#:1(OU'H?[&_C#3/V6OB7\&/$/BW1_B=X[\?7\^I7.O\
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M=Z+-:?$2+PFNF>-+:";4]0U73[W7_!4]Q]ML6L;EM G%M9V2K91P 'F6E?\
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MVU3Q5I-S!X[BM-#U"%M O8[77V2]\&V\?B.+R]4LHH;B],M]?6\ E (O#?\
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M !9?#0[3QQX=^(V@7UQ=SV\QDTB6*R\:6$MC:PQRVXFT 2)/!&\4-OQ6C?\
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M.#*. ?T-&U?3]3_C3,#=T^7U[=/7ZT .WC<.?EQSQWY]OI1NRP .01S^1_\
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M-=JKR"?!+_@IIXGL?'^E:7\1?%O@CQ!I,-MHUQXGO?C!XCU/2O&.EIH6G%]
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M_19KKPF+I;S28X)8'VV?EF6&)"FUJ<<W_!7&\F\$V-K)=Z793>'K^ROM2O\
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MS_;AU'P/\&++]FF6>R\<PK;W/Q UBUU32+73TU>"QTT"VUG3[VW O=%EO%U
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M4=7/@OX-Z+-/XE>YMXXK.Q_X1[P]XSLXEM+&>W_MV8WHL8P\5Q#WOC'XK?\
M!2?1-1O_  _H'A&ZUO6M/TVZMO"UY'\/]!;PSXS2WN]435?$?B;5Q(/^$8U:
MWL!IDFG6$"^3?R$I)@$UZO\ M+^&/VM-;\#_  'L_!'BSQN/%\_@7Q3:_$K4
MO".CZ580/X[OM(\,ZCH6JZO80%8K&WL=7L]7$$,8,4S?N905D- 'S)X=\,_\
M%7+:T^'L<NO>);J\@\.?$32-:G\0ZYX-BB>ZENO%$^@^+=?BM=.G,7B-XGT.
M&RT\MJ5I%^ZE$]HL4UO/]??LG^#/VNHOB!J'B+X]^-/&9^'VG>&=1L?!'@_Q
M!J'AB[U6YN[SQ#=&.\\>SZ%IR_VEKD.E+;_9WCF\M(F"R"24%ZXCX6?$;]O>
M7]IKPIX$^(^@P#X/6]IK]MJ_B-/ EM!%XDT_2+O7["S\47>OV,XC\.:S<W%M
MHCQV"(87M[MI5P2,>0RZY^UE\._C[\7O%OAKX??%[Q=H]OJ^M:I??VK#=W%A
M_P (VWB"'['I/AC3#>?V;XQ)TF20Z8;>*&ZMHXL3.Q- $FKZ=_P4NO/B)\3K
MF=?'%C\+[[Q7:'3-'\)>*/ \7BR/2+;7;>*VF\":WK.E306-E+I?[R\CEM+8
MK%YJ*D\P60U-!^$W_!2.P\,^,/#]QXRUG1+JX\4?%+QKX'U#PMXE\.@V6FS>
M%_C+K_@OPCXFFU#P\PU/6;SXO7?P^DO;N&*WLY-)N$L8K*T@MKB*Y\XU7Q/_
M ,%$_%>M_$XZ?X:^+NEV_P 1]/76-'\.7?AJQT72_#&C:/IOBQM&N-%\20W)
MN-&\3SZDOA>*[TT?))'=O(Y++5Z__:1_X*K66C6,@^#>IZKXCF^)-W!<:;I/
MPXTR#3H-%T^[>2[\*/?7]RQO=,ETP0FRUB$([LLQF!P@H [7Q+X5_P""K=\/
M%-_X(\8-H7B*77/LD]IXJO?">H^"R=8\0>-'.L_#ZSL]&6>U\/:9X.M_ $2V
MUZXDFOI;UG1G$ES=<M>?#/\ X*N:;=^'?$&A^+K&Q\0>-/$.E>)?B/\ 8)=%
MU"SLM=_X1'P_96^E>3>I'#!X#L;JWU.W=(H9I96Q*T,S%67JH?CI_P %-)]5
M\/01_#ZXBT>3XX^)=!UG5K[X;6;2S^"XM5\$G0-,BTJUN1+INCKHMYXU6?6)
M7=VNM(4J/*917T!\=OB-^V[IOQC\0>%OA)X;O6\+-I'AL^&+Q?!6E:OX<:RO
MM,TO_A*/$%YXDO'\Q?$MCKD^HQVVELODSV]L)&R: /@3XCZE^WA\'-0UO6=0
MO_CB=?\ B9K^BV&DC0M3T7Q)>7_C;1].UNVLWA33_"EQ:Z1\+!<7=L?L4WV>
M>1#EWW)7LFB>&_\ @J[:>,=#U'7/%.KZSH]K\<]/O-5\/VS>$=(T&]\&S^)M
M334R=75YKM/!</@]M*:"(19>ZMW2736>0WB_7W[1OC7]KOP/XQ^ 6E_"/09_
MB#HFIZ=<6_Q.N8?"&D22_P!MQBV$6KSZE<'R?#]HD9NY)(($WR ;8B#7S.WC
MS]N;XH:[I7C4^!/BA\/M&\*^)?A/_P 2^T\.6.E:QXMT[2_%/P5N?B5I=YHM
MQ<LC:'=7DWQ%3S&.\V&CL5Q$P4@'MW[6/P-_:%^)?QX\/:W\,?%/Q"\,^$$\
M$>$ -4\,>,;?1]*T3Q5X2U#XPW]Q<MHMS'(LNJ7;>)O!L#2F&6.:UAFAF $4
M=?.ESX'_ ."DOC#XG3S>-;SQK8?#G1]?\!:LNG>%/%_AW3IM5GT&YOK?4+S2
M+JSA@:*SN;*:WFO+%HX(FD!21KHJ)&\Y\(_%;_@IKXJOO"GC#QAX"^(VDZO>
MVGC7PCI^@V_@/1[?PSK^E:L?A%JUB?'-K!<!/"NJV4=U\4X;;5+8;Y9-#A@X
M67)[;3+?]OCP_P"(9M<O9/'7A+P[I?C$ZU=7\]G::WI?_"/QV_B^?[!JUM?2
MMY?A2WDBTAIV0>8J3H<$J!0!]V_M+Z'X[UOX1_#'3+.Q\3ZA$_Q!\,?\)E8W
MKQWVLRV7V^?[$==_LB+R[S2UOS:M>($,)MQB5&4,"[]C3P_X_P##TOQ;L?%E
MGJ&GZ3%?_#"SM;6Z)CL&\;Z=\*_#=C\2KKP];?9XU@T1]5BTN-3"!;R7-I<O
M$ 2^?+HO'W[5?Q9_9,\!?%/1M.U/PW\3M<^)WA3Q OA/PYIUG)<?\*]L?$4-
MI?:9J:7*J)-.NK:RNKF9P YM;U .E>Z_LB^,/CYXP\.^+KKXZZ1J6FW%KJ>C
M1:#+K?A>Q\'ZO)>2:+#)XQT]=*TYVCNM LO$)D@TV_)$M[ &DDY44 ?7>57C
MIW[FD.U@3UP#Z_6G$*WO^/\ @:,*..!GMGKGB@"$,1T/IU]/3GI4@*#H?YT8
M3V_/_P"O1A/;\_\ Z]  23]T_7C_ !I%?J&)X]0??/:G@*,XQ[\YHX;CT/\
M+([4 1,Q.?3/&!SC/IBE1_7( '<'BGC8.A'Y_P#UZ7@\9!_'_"@!C,""._'8
M^M&X!>#S@?YY%&1DJ3\H '/'IWI<)[?G_P#7H 9O;U_0?X5(IRH/UZC'>@!0
M<CM[\4Z@ HHHH *9@M]X$8Z=NOU^E/IN]/[R_P#?0_QH 16).#CI_A3B 1@T
MP% <AQ_WT*4NN.&7\P?ZT .*@@#GBHPH+$<\9_G3PP(!R!D X)&1D9P?>D!0
M$G>,G.<L/6@!I+8*XXZ X/0=*49("D$#UP<^O\Z=O3^\O_?0_P :-Z?WE_[Z
M'^- "@8&*0J&ZYX_SZ4;T_O+_P!]#_&C>G]Y?^^A_C0 TK@K@'KR?Q%24W>G
M]Y?^^A_C2[E/1@?Q%  5!()[<BO*/CA?_$?3OA-XWOOA-9)??$*VTE7\.6S6
MR7DC2_;;1=0EM;&6>,7VH1:2U_+;0%U\ZXACB!RX!]6WI_>7_OH?XUX)^U#K
MWQ(\-? #XI:_\'WE'Q)TCPT][X5:VT)_%%PEY#>V9N9(?#\3J^K2KIWVQEA0
M[V*C:&("D _-Z7XF?\%&8;22:W\+^-;EH=%O!X)1OA59_:?%.G_:HTO=9^(E
MO<>((AX)\4V]J9VLM.!DENS&GEH6;;5?Q]^T;^VYX \!^)KP>#/B)<V^D^&=
M2\3Z9XZU_P"#KV-T='LO _CMDAU;P_8:Q,L'BU_&D'@]8-,:9+J>.7F*-9"5
MR?AS^VO^WOXXDU32I?@7X>\,2Z9J-E -1\3?#GXJ2:A;6=C8I<ZA::KIUO);
M6MWJ=_ DDMM<VU]&ENTXCDLGVDF[HG[=7[97CWQSXD\%^'/@-#X:@-_H46AZ
MKXW^$?Q6%AI$/V6WN_$EIKL]M?1QZAF"61K*Z9M-!,87[--N#  ]<^!7QH_:
MX\0_M%^#?@YX[MK4>%I_"7B;XQ^)-?U/PU_PC?BK1_ .B>*O'_PZ\&>$_$_A
MF:]>70O%'B:74/ VNVI?#1P>"M;@>-7(">&:+<?\%*/AW:>)O%&A:?XK^(?B
M*W;7_"\?A+QGX?M6T_53_P )K\=[_2/$FFZI%?PK;V5IH]O\.T0QQ2B\M[^V
MC#AF#5O^!/VVOVE]%^*GPZTGXC?#"XN/"WQ*\?>+E\67&F?!CXEKXM^'_@V#
MPKX2\2>$](-S%916VOZ)I<6N:[)?ZQ$;JX5G2!](M2TDR_LSIFHVFKZ?9ZG8
MO(]G?VL%Y:M-;7-G,UO<QK+"TMI>PQS6SF-E)26-'4G#*",4 ?D?K-M^VI\=
MOV8OAII_B'2=3T?XE7_[0?AV#Q*JZ9XO^%:R?#"TO+DWUQXGM$M'U/2-*"E5
MEE@C;S51'CRAKS_Q+>_\%,?@7X7UWPCX*NT^)%EX1U[P=HFB:_=_#W7?%EQ=
MZ)X@B\6Z[K&H6%W8S?;_ !-;6&H6WAG11(;1&AM[UKNY(VFOV^) ZD#ZTFY1
MU8#\10!^,TOQ'_X*6-=W-QKOA!;S1-4T-8;[POH/PZN;6?3[[Q!?_&OPI<PZ
M=XE.M-(R:;;>&/AQK"R&V$DB>*4C9(Q(C'A_$/[0'_!3K1#XYT3PW\)+J\MM
M$\7^&-/T#7[SX8^)+BUMO#<FE>*-]G'%;RO=^*+V34--\,1W=]:P/9VR:LTK
M2[F*1_NB&4]&!^A!_E02!U('U./YT ?F_P#LP_M ?M':K\0_'/AC]IGP/K7A
MBPU+Q/8:+\,;NQ\ :WI>CRW$]NLUU8-JUR6>_MXH@7:]:&.SRX592WRCPZ?X
MZ?\ !0_Q)\8_B1X)\.?#?5_"O@./7IX_"OC;Q'\)K^>+2K'2=1@A>VMV_M>.
MVUZ'4-/>:2"Y6=/+V@M&"-I_9#>G]Y?^^A_C1N7^\OYC_&@#\J?V;OB7^V-\
M0/CS<Z]\7_!GC/P=H.G_ +._CVY?P'=^!-0\/^#-#^(MUK_P@N_!EG'XMN9'
MB\::]>Z./&+F.V9#I9BO+.='<!A\UZ#\3/VE_P#A7NC^/8;WQOJFAWGAGX5:
MSX9\47SSVUKXG^)7B./]G"+7_#EROE[4>3Q;J_Q5L&LRJ&#^S;J/DP.R_O66
M'J/S%9J:9I*016B:=IRV\%Q]L@MEL[98(;LR/*;J&%8]L=QYTDK%P-VYV;<2
M30!\3S7_ .T(W[5WAMC'XFTOX/2S20ZY;VV@S:AH.I7$_P ,?#MQ 9]4.!I=
MM!XI;58@ZY1IXW5SN&!Y=\ /BA^UW/\ M!R?#?XC>"M9M_A,WA3Q3J-IKL_@
MO5[6XT_5X-:\22:=)JOB_4WBM;K[1;QZ2EK!;+*5$R>:8U8-7Z=;E'!8#/."
M1GJ0>_T_R:7(QG(QZY&/SH _#_X??$[]J_X.>.OBCK&H>$OCI\3/"\?BN?\
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M+3O%%I/-:I//HUN(W;2K^STUWN+II R&1&SL3YJ_9W>G]Y?^^A_C1O3^\O\
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MVMGI]K:Z?86]M8V5G;PVEE8VD,5M:VEK;1K#;VMK;0J$M[>.%$1$10JJ@"@
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MN6%SX'\0Q#Q%)\/_ !*;*V\(:UI^H_">#6K?]GBVN])EO[[3=FNZ/>:CXO\
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M,Z_JMHUIH*7=U SP,6A*[2Q!^_MR_P!Y?S%)O3^\O_?0_P : %  '!XZ]O\
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MO@YJ5]IVJ*^B^%!'X"L$U?QOJ-S?S^'=671+::18Y-#2PLF2664QDK#L*E0
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M7:+JFIWWAZYUOP%>ZGK'@6XG\+V-MY[:%K=B=7D<HNDM=PFUD8+AI%"A<8-
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M<*2<'X]O_C1_P37%]-?7?PUT:ZU#Q)XEL?&<LX^',DLNL6EE-XLURR^+3[W
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MFDUKJ,/Q"DU#0Y=/U#4E^)"2KJ$GB.2&YM;B:)=1\PNPFM4W%FM@: / K_\
M;)_X)[_$/7=6\1SRP^,=?N(KW0=<U*#P7XFU"6+1;*V^PG4=6E@M/+L_#DL#
M)##>R;8)1($24YKLOV5?B_\ L>:OXUFT+X+>"9?AW\3_ !EX:N-8UCPS-X9U
MG2+N+0/#NIZUHEF;QYMUGIZRGPI<RQQPE&E6%))%9^:V?#'[/?[!GA".XL_#
M]U\/+6+QCI#F"T?XL37<>H>'==NHYH(=#@NO%;B+0Y;E(Q;BT"Q$_+&3G%=7
MX>^!'[(7PK^(\/Q.L-0\.Z%XT\"6>H>'X;G6_BE?7%KX23Q>^J3W5HVEZYXE
M>'2)[Q=:U,1QNB!TN_W:$QQL@!YYX0\<?L;?%3QMH/PJO_ >B)\09_B'XM\:
MZ?93>'[^ZL4^(=GK/Q*BN[L^-;5?LTWBB[T[X?>,[X6#73.+;293Y CM@$P-
M7\9_\$^O%6NV_P .KWPC9:YK*^-[#P9H5A9>$O%TL^L:]9^)?'MNUQX7U'3E
M5]7T.U\2VWC]+^\M97M(I1=+=N5X'M'P\\&_L=WOC&'4_ .H>#+OQEX4^+_B
M.>VBMO&5\^HVWQ;T3PYXXA\36]KIEUK .HZG;>'?C?XN:XMTCFABC\4K(R P
MV[1<[>?#[]BSX+_$ZS\<:UXA\/>'O'6I?$V"'18]9\?:A<V?A+QQXET[QGKB
MZ)IVC2ZJ]MX*L=075?&-[]GECM[6>XO&*<BVC4 \R\?_ !"_8;T?Q=XP^%/Q
M*^'4NAW?@37M%T0SR>&O$BVURNH6MMXQ?6],U/1)!+9:#;7.KH;R]9XH4EG*
MR.4.*XOQOX\_83_9N^,<GA:X^ ^I:=J=Q#X6O]0\<^'/"7B#6/#D5AXNTK6]
M6L;Z":SGE66%(/#\KW7D1_NTD%Q)\BR.ONWQV^''[&-YXCUSXD?%;Q+;VFNO
MK'AR+Q.^B^._$ N))7TI+/2=)USP_P"&+^22/1[S3=*C\R*2!(KD6V2<L=VU
MK7A?]C_XG_%K2;'5-:TNY^)7BCX3Z?K>C^&3XAU?1%UGX:WFDW.AZ;JMAHKS
M00R[=&\17<"^4!<Q0WKEXUV[E //_A5\9_V&O"&H?M(>+?V?[?0=1\:?#'X:
M7GB[XEQ>%DU&2_USPA\.=(OI[:P\/WVJ7#6U]I]K-:/9[;1U@AO+@)-B1LU\
MZ^"OVKOV!OB-K^M_%+XE_!_1_ GC+7[*[\67'C&]LM.\8)X@TV[^'G@;5?$>
MK3>*?!=Y=VMK-9^&=*\$6>H1S2QRV[PV43J'N4,OV'\/?V5?V./AAX6^*.K>
M![3PWI'@3XI>$M4^''C2^@\<EO"B>&[RUFT;Q#H]EJ7]J>1IES<SM,]Y+YQN
M1=EV$D9++7<^(?A3^RUXL\*^&O!FL2>!KOPS8>%O%'P1\-:;%XLT^&&;3==M
M_#EEX@\+6;0:B#?Z\B^$/#^0-]Y ^FJPP2P(!\A>#/VJ/^"97A:XMM8\"MI5
MK<3ZGIWB*2]T;PAXMO'TS7+5IDT\:DP@D&E:E EQ<.+:388HRS^6$!-=3\1O
MCC_P3^\?^/[W4OB_#H=YXP\*>&=<O&UC41KLFG/X$\-V^E^*IIM3N=(O%LKO
M3)?.LYX+.\61IFB&(FZ'KO G[/'["_AI]?\ ASX8OM#.I:!J.FZ=XF2X\=7C
M7ZZ]K6D&QTZQO-5>^CBDUJ;3'*K:0N'7.?(1JSOBO^QO^P1IMW>^(OBU%HFD
M1:!X2UV\U73O$?Q*U+3[&W\-76CVF@:GKMWI$^LJ\=M%IMK;1F:,+"60-,LC
MX( .&\!I_P $R_VB_'UCX6\%>&?#/BGQIXU\*^(]52QM],\361TZQF\1:[K.
MOB\1Y4A\-^(Y->L=<N&C(ANW\AS@Q@"N.^.NI?L/_LN_&3X?_"#6OV?K&6X\
M2^$O!4-E>67B&WAL[72/%GQ!U3P=I$6G>&-8\2K=>(=5M-8LIIKB:SMI[FVL
MKPDR")G6O3_$?[,'[&OP5T3PY\0-/\1>/O"NIWEGK7PP\">,_A_K/C#QOXN/
MB#QY;ZNM[-X6T;PEI6I37GBE]/N-615@L7MHXH!-+:^9;131:GB;4/V'/VJ+
M#QC^T1K'CS7M2\*_!;4+#X6_%"XDNO'O@70(M7^'7BFW\8:?X,\9^%-5TFRN
M=6U:P\7^(;1EM8X?/>^O$L"LLN;:@#SCXG_$C_@GOX(L/"&HW'@#1/$.E7AT
M7R7TXW-G#I6EZQHFC2:??ZC;W^HQ"ZTT: ^GO(")!%%!EU!)SQ'A#XD_\$V-
M/\::G)8?#U= MO@[XRL-?T3Q+=IKLMK>^+=7U.R?1[SPWH)U![C4HSJ5U:O:
M,+8PH64PX5L'V#PY^RY^P#XR^'6L^*0=5USP+I\^H7NKP>-O%/CK2[[PS!HN
MFQ://HEYX=\2&TU30+.STW2$ABLI[:.1!;':K,2:Z_X<_LQ_L3Z)KFGZKX9U
MBZUW6M=TG2OB;IVLZY\0M>UEKGPWIFJZ0FAWL>I7]YY,>D6M[)I<$$#.KHKK
M$RGG !V\'Q/_ &+_ -I;XF:-X1EE\)?$WQOK/PV\4:?H4.IZ5/J=A<^"==L?
M"FO^,--TNYNHC:IJ'V"[\*RWJ1$7D$=S$K,BN0WS+XP^(O[(O[,O[1-C\.%^
M"VHZ?>^%?$'@CQ,_C33_ !4EQ;^%-6\6^%O'DEKK.F^$+WQ*VH2:)!I$OBN7
M5;BULFM4?5YKJY)9'=.Y\&?\$_?A?\-?C2OQ1\&_&G6/!/ACPA9)I7A#X=^'
MK^.WMO"6H>)=3\ 7>NSZIK'B#Q'J$=]<ZSIW@6WT^15L+*:6VUF?][+*L4@^
MM_&/@CX :?/\8_B+XO7P];7/BCPC/X;^)WB*ZOX9;ZR\-Z)X5U*RN=,@EB=Y
M]&G7PY<Z@[0VP2:0,9 C/B@#Y4^(WQS_ &#/C#K6F^(_%;Z3XQ\2Z3HT5G;)
MJAU7P]%-H=_/ TUAJ)O;BVM=0:TBUY;S[-<>9+;I>^?&BLZFN@U;]K/]A'QA
M\+=5^%W_  EVB>*_ 4NF:AX.O/ ^DVFK7TLVBZ?:W"/']FM%,Z:,ZV<L<-X6
M$4CI@2DU8\8?L0_L^_%MCXL\*>);ZP2_;P[?:A"-:O?$/AF/3+:TTT:E<VWA
MJ?5;>+1O$&J:)IFF07-]/YNV&)G6U$LC2TSPO_P3^_9-\*/'JWAC4/$^D1_:
M+R.6]T3XESZ1'>^&M4>XG?P-<7>AM;L_A$SRRR+"LBW+M&/,NY%7  .!CMOV
M#/AO\!?AMXY@T?3?@]X:^+W]B^*?A[JOB#2]7FU30O$[V6NWF@^*-1TO4[EO
ML]QI\WBC5[B0W.VVS?L93L=:TO#?[2?[$G[-O[-LWP>\,^*GUGP3\&O"MY\+
MG\)Z;9ZE)XE\2)H]AK^E:[-9QVZ))>_:M2T'Q.+S486$$=[#<[ID9#CUCXD_
ML3_LW_%KX?\ PM^&7BS4_$5UX8^%FE:D?!L-MXVA:\F\-W=L;*>.^N;RWG%_
M806TULD%Y&D=S:B"(17:$R>97\4?L2_LT>-+33XSJ_B72+F+PWJ5A;:SX7^(
M+:=J5[X-OM?\;^(/$]C+<*LL=UH%]J7Q$UY;Y_+QL-ND<L!@#$ \%\#ZU_P3
MI\)W5WH3^&?#W@:[L9O'^F6[:Y=W\TFH:?#JVO7'B'4IKQ+^188K^_M-?EMQ
M,R2W*V\K0J57-=-\4H_V6M9TOX>S^#OV>]9^.NJ?%S0O$>O>'='\(N=)OV\&
MFWMYO$7B&:ZU[5K.*W@9+"U\J+?Y]Q)$B01NS 'T/Q5^Q+^RCIGA[3_%OB%M
M=LO!7@SPE##JA3Q9=/X>UZRTFRU2WTOQ/XG$$#OK6N6EOK6I"WN(Y%WFZ4O'
M,RQ;=;6=%_9L_:"N_!7AG1_'_C?PKXJ^''@R?4?#FI^&[OQ'\._%3?#N2P@T
M+5/,O_$GA^-=5\-S6C1)/*B,T3R":.6&0"0 'GOPA^*7[ _[-ECXGT_X?W>B
M_#C4+*'P[;>+M'DCU637)M8UO5--M;?0F@F:0ZGXBA\0^*M-M;NWM@TEO=ZK
M%%(JEU%<3\1_'G_!,CXJZEX?^.?CO6_">LZ@/&\3Z;XI-SK< O?$ND:/\*-:
MTZ[N(;>0++9C2[7X275I-L6*97T]D9TGVR=;\#O@=^PY\0_%6I^(/A+XPU?Q
MM>?#SQ%I&KZ=I-[XOU^]TOP;J-AK.CZC+K?A>+7[9)]6TC5-=^'UD]SJ1N-1
MM+R?0[E;:Z1C= ]AHGP'_8WN[#0)-(\2Q:E8P>+--^#.C2Q>,!=I)XW^%.G^
M /"1\',$B(DUZU@_9KT.*ZB<;F?0;UL#SFP <]\,?'W_  3J^!>M7/B_X87O
MP\\$:OXV\&+JFH:SI,=U$U]X>75=7\1P65_/*S+;:@^H:KJ]Q':OMN&5WVH8
MXP%Q?C?_ ,,)ZQ\"?$7[3GB3PU;>/_!2^-F\;3S>'GOI=<\0>/+F.+1+C3+:
MP,RO)J=Q:E8I;0A=\8Y ZUZCK/[ _P"S=XG9)[R7Q=+H=Q)#K5WH5EXVE@\.
MZOK.GSRRZ=XJO8X(/,EU6TM)Y;:&2.>. 6S%9(9'S)7I>K_LI? 7Q/X;TGP;
MXET)?$_A#3_'%U\3U\+:YJ2:GH&K^(;F*&);O6--G0QZOIT)AC>&*4-'')\Q
M+&@#\^M?\+_\$NM N-4U;QKXUT?2='^(-A\,O$%OX3U+Q9K-C;:!%XBTCQK=
M:7;6#VVH"2QTK4- \4>*?M]BK"VCM;:Y=T5$=E]-\10?\$R=8M_''A75M9\#
M))=_%;PT_B>"+6KV*]E^(UX/B=8Z+=6K^>=PEM9_BK:-)$#"8H=2CR#"3'W<
MW[!W['7C2SO?AIIIOI[CP!XJTOQ ^F6>NZ5J.H>#I]3T?Q;8V&@6=OKFBW<.
MG:%<>&O$WB.UB@6$R16C*;6:"6WAE3,G_P""5W[+,]WXKN$O/B=:W7BW7-)U
MO57B\<6TMU'_ &1KOCGQ%I-E:3WFB2S0K!>?$'Q4EK?.\FL6EO=1PV.I6Z6L
M'E@'>^*;7]EG]@D:W\9HO#-_H%[\7]430+Z\TG^T]7;4;G1O#_BOQM9Z;%#-
M*\>G6?V?3-<>,L0HEN5C#!-BKY[X5\>_\$[_ (@?\(K>6OB'P4NL_%_6I;_3
M]"U/69X-8U#Q%?ZV-9N[._T^6X#07)U^<@HP56E.Q,CBOIKQG^S7X.^*/PUL
M_AM\4_%GB7QMI^E>+=8\5Z?KCWNFZ3K5B-6A\2:99:-'<VEFR'3[3P]XGO=/
MB9T,TL,<;RRO-N<^;W/[ '[.4WQ'\._%.&U\0V?BGPU<Z5+(\.L:9<6>L6VC
MM#+I.FZU%J6CSRI8PW,$4J&SFLYF?[\SQG90!\3:O9?\$_M,^+7B+X,>,?A'
MXET*U\*>.KOPGJ_Q%U?Q-.^G7M_X>\&1?$./P_JZPZVVICX>6>AV:26[74":
M7%-IX19-XP>U\7^-?^"94'A[PC8V6HZ7XE;Q7J=K9>$X?!>JZM<ZYI.IWE_H
M&@6NM)>V4V[PU)#J_P"SIH]K]KF:-89/"DB.=KS;ONO7OV3/@?XBM/C;%/H$
MUKK?QW.JKX\\8Z5>16?CNV36_#]GX:N;;P]XLCMS>Z#9?V98P^7;QR&!7>1_
M*/F.#Y-X&_X)S_L]?#WP/K?@;PY)X[M['Q%XAT+Q1JVK-XATU-8FUK0?$GCW
MQ-%<P"RT&*SLXKB\^)7BV*XAAM$A-O?I'!' T22  ^8XM/\ ^"5>FZKXCUS5
M/$O@_1/%U_%X9M?%,.H>/+^\UO3+_46L;ZVL);O^TY7>_P#M6F1_:\2R;7CD
M5BH)6OH'Q+\./V#/@UXQ\$7'BV]\->$M?\8FTU?P'9ZSXGU"'3Y[B R79UG1
M[&YO/(M+NY8.9YE4&X*X8G&*Q]2_X)5?LL7[^*FM8O'6AIXON+6\OX]'UCPY
M'):7:--+J=YI]]?>$[BYCN[ZZN)IIY))YF@F99-.-B4CV^B?'S]@3X)_M#WG
M@B^\<7WCMI_AYX;M/#GANQM_$\C:)-'IC22Z5?:U;W%L]U/?QW+@RSV=Y97%
MS&IBFF*$  'C_P /OB7_ ,$U_ GQ%O?BOX+^(7@72_&EIHGBK2+C49/$EXT>
MF:1;R-XF\53K:W4VRUMG^V),\C?NBMPAB +C=OW]K_P3R_:2^+NDI-XF\$^.
MOB/\2M(M]=T_PY8^*[D1Z_<:#I^O:?:Z]+HEE>K&_BNVT#P_XHM%E=1<+8Z1
M>Q%=D#E</X8?\$R/ .B^$OBGX?\ C/XVU_XN:I\5=$N_!M_JOE0Z)'H7@EX=
M#AT[1M$@G^V,9[5M L&AEN6G&(Q%*DXWL_IOPE_X)R?LX_!?XG>#_B[X-L_$
MJ^,_"-I=(+G4+GPW+:Z]K-W:>--//B?6(++PM;M:ZNFF_$#Q1 D6F2:=IQCO
M4:2P>2*.0 '.:_\ M6_L=?M +JWP7\<:])::2J:KJ<8\1)?>'+;4KGX>^-?'
M?A35X=/NY1&[3VNJ?#3Q#(0<"6VC$B;D)QR/@CPW_P $]?C/\58;WP+IVD>(
M_%W@WPG9_$&Z\7:7/J)TRWT3PS>2>&%T_5-6,AB+VLNF$RVI*NGE>8PYKW77
M_P!A;X'^([;Q?9ZG<>.O^*UUK5M=O9K3Q.EG=Z;=ZQKGQ,\12IH=S;Z<K6=O
M#J?Q9\7-"',K!9($=Y%A(:_\#_V)?A#\ (M6A\"ZAXWD&OZ!XB\/:X^M:OH]
MS_:EGXFU6YUF^GGAT_P]:Q0WJ7UW,87@2(*"!(LO6@#G/'/CK]C+]I+0=&UO
MQ'\0/#6NZ3X,O=4UG3M:TOQ1=:+-IZ)<VWA#6A+?Z=<Q2'2IWU^WLKA&;RY5
MU(+D$@U\V^&W_P""9T?CS2OA?H\^AW]_\8?#GC7P9H=]<ZYJUYI-[HVI:AHW
M@2[^&VCZE<71-AI]Q/\ $^ :7:QL(F;76>V8LZ5ZY9?\$P/V=;&P@TRWUWXN
M+8OJ6HWNNVJ^-+"WLO%6G:EJFC:U+X9UK2[7PY':0>'5U/0-*E$6GP6$SO S
M3W$S2RE_0=%_8/\ @_IMG8V=WXE^*GB%=&@\$:9X=GUWQA:33>&O#7PZ^(GP
MV^)O@[PEH0T[0[9++0;/Q!\*?"4>THUS<VL<Z75S/-,)T /%?$WA'_@G'\,/
MB9J'@#Q1K_ACP_\ $R[\<67B6_T'4/%6I#6'\2>)8O!S:?;W,;W.9+=H3X)E
M$4FXJMS922/B5">%^(EO_P $P["X^(7Q.UKQ'H5YXDM];N)KZ[T+QAJ_]OVN
MM&^NM6NU\%16MZ&LEN-3N[MI9+0"-I+A@6' 'V;\0_V-?@S\4?%NM>-O$T/B
MA-=UV?4+F^N-+UT6,9FU/3/A3I-P\""R8PD67P:\&!=K95DNCR9AL\MOO^";
MOP&NW6YA\0_%?2]2L=-F\,^'-7TWQ9I<>I^$/ =ZS-J7P\\/2S^&I43PG=,S
M&874=U?$L3'?1GH ?&>@:_\ \$Y?&WC6Q\.6O@?7=%:[\/2^-]3^(,WBV\TK
M2_"-KJ4-M<7NG2Z^^M[Q>7=CHX:^@@:5_+207&TR'/T_I'[0?_!/C]GK0IO&
M/@[Q7X3T9?!/PH^)WBO3=$T"6ZGU4^!HWA\7^.++1]$.9+N\;_A5Z3BW5&F$
M7AR0J B/7HUO_P $[_V;K?PTOA,:9XKFT<6RVXBG\1[Y@J6-]80R^:MBN;A(
MK^9E8@Y=%9MP7!Y77O\ @F?\!?&'BMO&WC_Q7\8_B)XCG\*>*_"-[?>,?&6C
M:C]KMO&/@?QW\.M6OQ%;^%($TZ]'A3XAZ]!%#9"UT\20VES)927$'F. <C=>
M(/\ @GUXG^(MW\4O%VN>'M'\?:U<ZKXMEL];\47$%O;77@+7;>VF\5+I,-X;
M73=7N!\*["5F(6XFMM .],K/GV[7?B3^QS^U5?>#_AEJOC'P?\0=1U..;QEX
M9\,0ZM(E[.ND7AMIKPV\$B.KQ7EN5*/@AH^1U%8T_P#P3V^ UXSQW%[\0Y=.
MO=0O-?U[1SXFL1IWB;Q;<R^)O(\8:SMT,3?VY;6OB_7+> 6LUM9>3-'YUI-+
M%'(MJ_\ V#OA0OQ(M/BUX7\3?$'P?\0-+?Q!=:5JNE:KHTUG;:AXGU1M3U&]
MN+.ZT(RWZ*\DZ16LMT;(+*7DMY)@)* .#^+OPF_8 \&_$+38_BW-X7\/^,-1
M\/\ BF_M-/UOQ'>6D!T;5K*/3=<U&>W:YV6Z/:I'$CL55FP &?!KRG1?#_\
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M7Q VKEVCABB0<#X7^*G_  47\)^&?#=QXJ\#ZOXUO]0TW7?&"BT^'/BFVO\
MP9'=Z]/IT/ACQ-'%>_\ %8W5IH\9OX(8H-.N9U5;=(69ED8 ^B/VH/A]^TQJ
M'Q"^''Q+^&5WXL>7PI\);W1_%5AX7OM-P-8US7] @\2W?AK1+VZ6"]\7KX=_
MMK^SVE,D2'@98KGN/V9[/]JVP\(?%7Q9^T1KM\WB%]*M[7P!X7%OI;6FFZ;I
MN@2W=MK-S_9LCF7Q1<S36RZC'N\N.ZLY5B!5@1\6^(_VC?\ @HAX>\5:;>>
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MGX4_X*>^(M,\+75[XN^$OAN_O]-B\13W\GASQ)!;VEY?I)XCN='N]%A?3/\
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M_P"&C?Z2NG'Q%XLU+PQI7A75;;Q?>60@\.Z#<1:T[S/-&YMDM]KNV!G)M/\
M@IKX \/>+U\)^(/@Q+?7=SJ/B:?0K[P@-":PTK0H?"V@:A9V2:A<1I%K6H7.
MMWVJ6]W-:/%##:)!=R*\;[2 ?0O[-'[7?Q,^/WQ3UCP+)\+O".G^$_!GAMM2
M\5_$[0?&FK:SX:\0ZK>^(-<T;1H_AC]I\,P#Q'H930KX7EW+-#Y%U$\$2SJO
MFGP_P]_P4<^+EQ;WWB'Q5^SOH^A^#(=/O+VUO[7QGXEO-:_TC2I-5T&&]T<^
M 081Y* 7C1M($+XC! +#WSPA^VMX,UC]F;PQ^T)X=^&KV \4^,9_AYIO@=-9
MT33%T_Q%:Z_KNDRV6N>*?L26>C6*7&D:B\DSQF))IUB&YY0S?-&D?\%']>U/
MQ-<7DGP#TW_A6-G=W<M^L6K6(\66WA0>&O#NJ6WB%K)[1HKHK<ZV\0MT5?M$
M48:-QF@#HOV7/V]D^)6O?#3P;H7[/&E>"M0^,WB3Q)+#>^&;Q(-!N6\(S:?>
M_$/Q#J#V^A1JUY%H>H)<VWF2N][):R1&1'X63X]?M_>,/@?\4-2M8?V:;3Q3
M;R_$J\^%^D^+M/\ $D-AXA\0:%X3\.^!O%>O6(_M71;>/^W+J]^(EI!H.FPW
MMV+R71]0E**8BBI^SS^VO\&OV@OVA?#UGX!_9WUS3/&8C\2>$[3QMJEQH^FV
M^@^![235;S5M1BLXK3?;7$]UX<"O9*J2N)8BTQ4D#1\2?MY7OAKX]^-/ ?CK
MX1>')?AK\/OB'<^%=>\66^L64^L>'Q?ZU^S5X;\,^.+[3+RQ<O&=4^.;1S0Q
M%)3!IZ31R_N)$< Y7PU_P5.GU6UUJYU+X9^&H9(/LL6B6.F^.+ZYGF\0>(-*
M^%>O>'/AUX@DNO#$0T7XAIIOQ)NDU"RV2"*?PQ<F(NGFB#R^;_@J'\9K?['X
M$L_AGX?N/',7A'1_$&K>)-777K:SL9Y+CPU>:M]M\-VVDQ-'9OIFO-!:O#,\
M37%HTAG/S0I=_9Y_;:_98\.:/K,?PA_9JB\.Z5J/Q*;4_B#-8ZIH5U::;'?'
MX,Z7I?CT7$FEEM422U^+7@^*&W189(8-+N%60K"N?</C/^TM\9?"W[5.L?#O
MX:_"OPUXO^'W@OP'X,\8>,)T\%R7^ISZ#KL5[?:M<3^)(M3A711:Z?8JUO$;
M>X$[[5(&00 :WPA_;R^(7QM^&?[2_BO1O@];^"M;^#NC7U_X.&NZP^LV>N7D
M U.&&S\2:;ID:W6CW/FZ9YS0_+*UM=QN(UP&;Y_/_!3'X]?#WX>W/B3XA?!G
MPOXQO/$6L6'_  @FN^%-?OM#\,0:3)>^$-.URY\83ZUI,$.BZ1%>>(I1IUV;
MV3[6PBBF,;N#7J/@K_@I_P""?&&D>*-3\(?L\>*C;:3I>L>(-:675/#NFPZC
MI-C=1Z;87$;I8,+V\N+NXACEAD4/;>;\Y<"L3XA?\%%;BS^$GBSQ9HG[/<>E
M:]X3LO%-Y!X(\7SZ;J6F^(-+\/>$/CSJS3_;--LHQIME%XD^ >N!LHWFV\$$
MR%/-7RP#VKXU?MB_$+X<Q_ OQ3I/@W1[#2/BO\(7\7:QH'CC4YM.T3P/XDU:
MX\$WE@_C+QWI.DW1T_2[&RU/6;%VBMMEU?7EHJ[%(Q\^+_P5FUFZ\6ZUX6C^
M!$VBB+PEI>K6.L>)M?U33-,\.ZS=+;QWZ^.YSX8:32- BN)QLND@975HRK.)
M,KNZO_P5-\%>&==E\"_$SX(:C<ZW;:O\3-+O?^$9OM*U_P /Z9I/A7XI?%7P
M%X.CEN;JT NA>+\*VGU&2,+#IO\ :$$[QM$RA/4KK]IWQCKW[+OC#XU:-\.?
MAOI?C1/BOXE^'%EHFHW^D:]IB:+HWC"^T&WE75X6@MO$VK?V=8))'#YT%O/+
M\H9, $ ^>?A'^W%\8-+T27QCKGP'\&^(?$>L(_B;XEZ]X5\_PX;_ $*RU.\T
MZT?PS-I_@V27Q5?O;BU,+7]P/D^<%0VRONS]D/\ :JO/VFU^)BW_ (?\+:'/
MX U7PU:"/POXGOO$H2+Q3I5YJ\&D^(%O]#L7T?Q38V\,4-_:A)4264[)"I K
MY7\+?\%!]+/AC2UUOP)X8\;7^M77AOPM)H_A^?3O M[-/JMIK<^NS6.A:\UT
M=1M[.TTMY+N*&X,<(#^7+("H'L__  3T^*'P-^)G@[XFWOP.^"][\'M&A\9Q
M7^K+=+8/_P )==:O:W7V'6S/:8=;I;/3MDEK.HDM T<89@> #]#2 V67IU/N
M>O\ 6FA203QQU_"G*P (/<GL/\:7<N" ",Y]/3'K0!'2Y(Z$BG!ASD ^G I=
MR?W?T% #5('49_ ?Y]*0]3CUI^Y/[OZ"C<G]W]!0 U02>#@XS_G\ZE!YV\Y
MZG\*867''!/H,'KZTS)ZYYZ9_P _2@"4$[R.V/\ #_&F,3N."1TZ'V%!88X!
MW8&3^7>@L",8YXR2/3WH 7>,8YSCKGOZYS3E.5&?\\U#4R?='^>YH =1110
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MIWPE^&>C6]U;:5X \):=;7IN6O(+30M.ABN?MES'=W*S*D/[Q'N8HW93\NY
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M@!6V\;>_Z4+M_B_K_2FT4 2LH ) _4^M1[3C../P[TI8G(/0T'=MYZ<>GX4
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MBT+PDOAOQ/J/AC7-.TZV37H9]#^&\-IJT-I?WNGS7?@TQO$;R-PW$>,/AO\
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MKTUR+>UGD9(;\/M7(#NK*J;>M;WA;X#?L0:KI_PM\:_#WXLW?@>_^&>A?:/
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MHOB[3M)&HQP#Q+X>T75X=-UZ/2)O'.IM87VJP2?V1<^*FDL[BVN+E6/&R?\
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M9S1W443P75OY=U%Y85)0HQ0!7L?@9_P3ZUG5/#,=O\1DUKQ!<>-KU!--\?\
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MXFE0VNIV,EK+>0C=/=O9ZO>1_:0(Y%0H ,KEOU-"X.03_CQQTH* G//^?PH
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MFG:M>I'H7C2Y^($UEHNCW&FW]CI^IV!T7Q##<:QXBL$NU6WAN[B.U>./#N&
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M_P!NCPWX!30_A'\6-<\*+XAU>VUSQAH%E\4=0DNH)XM2TU8[?PEKFJZ;<)H
M-A!<27I@A5+PILD0E]X /V$^)&B-XG^'OCCPI'>6FGS^+/"GB#PM9WU^VVS@
MO_$FE7.BZ>TPR#(IO+Z !%.]RP1 68"OEC]D3]EAOV;/ ?CGP=?ZEX6O?$?C
MV/PE=7EUIT%[+:WMQX9^#7P_^&=]=W>EW]TIN+5M4\+7,WEQ&-#;WD4;,KDF
MN8^+GP._:7\6S^#M3T#XE:E#=^#_ (9_"BV-E+K\ZZ!K/Q2T#XJ> /$/C?Q?
MK_AFUACM/$5V/"/A_718B5%0W%Z8XE@\P.GY^_ GX.?ML_&ZYUSXIZGXE^*'
M@;4O"0L_"?@F#Q]\2?%$=_?7=_IOP _X6?=RQ[EEN?!VH:IX>^*,MO83;HK.
MYO%B@W(L<M 'O7A;]B;]J#P1I^I3>!?%7PS\+SK=:9IVB>'K3Q=X^U#2QH<-
MC>Z?=S6GC"XTC^W=(T*'[2DVF^&+B\U>QL)D8VU_$" .2T[_ ()U?'S3[C7;
M:P^-'A_P'?:GJ5SXBLM9T;Q5XX\0:CKGBR2ST54\='P_XFG:Q\,>(=/&FWL<
M4FGQ.;A=3>:XE#*R2?8?P9^'/QY\)_LHWWP% U'PI\5O 7P_LM)\,_$F;Q3+
MK>G^(O%KVYUB*XM;^:(7,.G+?[+2Y\TL=DL@08 KXRL?V2_^"AOBK1+67XY?
M%;2O'FK:-KFFZAI-EX?\8:GX5WZ?#<QZY>6QU.TMM\%Q_:,DEFA *M9V<8D5
MMS"@#&\'_P#!.?\ :VTVPT99OVC=0U.WC^&_Q4\&W;3_ !J^*>I3V#>,?#&N
MZ%867AO5=-L[%=/U :]>V=__ &S%!&M@\4D<FBZK-':75M'>_P#!./\ ;7OE
MT:1?VL-<T*[LOA7!X.AA\/?$GQI8:1ILMM>:LUYX2&FWNAW!UFRU2PN+-KK6
MA+8FVN(V-GH*6<-K:0^A7?[,?[='P^T>+PS\-/B#X@N_"MW+JNK6.F0_%W6=
M*O\ PM\1?$^L_%>>UUQ=0N+29KSX9:2^N>!+V[\-KLM=1>SFC(01MYGIOA/X
M._MG^(OC3\,=>^+.K-<> _@[X_6[MY+#XBWD3>.4FG_:"M[[QG=Z%9V$:):'
MP[XV^%ME%IMP\VS^PIB) (UW 'H^I_ CXY^$_P!@^]^"FG^(M<\??&"'1]-L
M+>];XC^(=/O[Q)?$VF7-YHX^)5O;V.I6MA'HRW<!O(8(+CR P2WR1&?E"R_8
M$_:[C\3QS7G[4.OVNFW7A#5-*TCPOI_QA^(,-MX&M+N#4(9/">DR?V:NJ>+=
M-5KNV<:W<ZE::A&]NI:!V6(I[=\4?@G^VJ?&/BWQ/X+^*7C+5O"_B;QQXOO]
M2\"6?Q)N_#C6O@:'4[L^!M'\!ZJEDY\%ZB;2>V:\EMP&D2V,;L^<UX1I?[,O
M[?7A_P 2ZUXHN/%=WJ\NMI%?^*7T3XDWNE>)=7M;B]T\7>@^%=>NK&5_"FK#
M0[62"2]MPBRW#>?Y89J /<+?]ACXUZ7\4SXZT?X[^,H]$MM<@O+#PQJ/Q>^,
MVK:2FF0>./"TJ6MWHVJ>*I["^!^&6G>(M)>*:WECDFUEKB0M.[SCS7X0_L!_
MM#?"KXR^"/&>C_%/26\-Z;X^L_&7Q*T^U^(?Q$@L_%5WJ'PK\ ^&?$L^I>";
M*&*VU+Q"^O>&[F2UNY[V(&RFB-];WA:.&W]+_9T\,_MT?#?XS^(O$GQQU7Q)
MX[^&?B$Z'X5T+PHGC.S\1P>&X=?U?P+IVCZ[(TVEPF2[T32;7Q?-K-W'Y;Z@
MU[YCJ[M'Y?7_ !3^"?[5NL_&[QCXQ^'?Q"U3PGX./B[1?$_AS2M'\3R:98:_
M+;V'[..BWUIXNTJ.V*:GI_\ 8GA;XO0I#*70'5(I  [1F, [G]J;X#_'WXJ^
M./"NM_"?X@_\(CI5GX=.D2W+>/O'OA.7P=K2WVJ7=SXJT_PSX4<6'C^ZOM/N
M[*P>VU<I%9I9_:H&:8J@Z3Q5\%/B/IO[)&J?!SX?>-'3XES>%9=,3QAXF^('
MC^:6XUV[E\[4[L^.7U:?6M/D=G<0RK*YM\JJ0&,".OG/]H_P-_P4$U[]HC^U
M_@?XECT'X31^%].T^>!O&5S9V=^)M+LW\1&'0FMGAT_Q/_:,-_%8WJJ7B%PD
MV[Y0H^4%_9._;RN[&ST>YO/$\^E7'Q*F\=:'::W\9KG5$\/V[7UK<ZBGQ =M
M+'_">:O<^0ILYI OV01;1G- ';Z1_P $]_VJX-0\*>,M:^+GA_Q!XY\/>#I-
M U5Y?B#XYMO$WBK0I?%WBO49/",_Q1T[2(=7T2TN?!>NQ:+_ &Q:1)=VJEIK
M>+]VD9ZFW_8B_;RA\6>%;FS_ &M];TKX;FTA/BSP*WCSX@ZUJME%KMQJ%_KG
MAS2/'6I2'4=472+?P%\%=)T;5I6@NY;;5_&5_=P?;-6 ; M/V<OVXO!-EK<?
MA.^\3^4^HZVLQTSXM2VWBK5'U)?%&K>'I-)\3WVFRR:7X8L?%.H^%GNM/P8I
M[32+F$J8IWC?[/\ @/\ #']JG1==\;WGQE^(U_XAMO&_@[Q;;W%O_;CW.D>&
M_&A\?>,X?#=WX+TN."-?#VCMX!N_#+-%"5 GM\,&D0NP!8_98^"?[0_PG_9Y
M\;_#KXF^/(_%?Q!O9?&G_"#>(-3\=>-O&]_IT&K6-TF@CQ%XSU:.SO+BYCU"
M9)'DL+:Q$*8\B,2('/R3\._V+OVR=+T&ZE^)7QR\1-=:#J>HZ]X5M?"_QU^,
M.KS6*WNJVMYJ%I-+.EB=>0:9#?1V=MJ0OHXGN40..9*],_8Y^%G[9WPV\8^!
MO#_Q9UC7K[P'X9\%7.E:Q=:KXZ'B'1;Z&+2M%MO#&FZ?H\UD)5\16^HV^LR7
MNH/,7N%NH]Q8!53@&T'_ (*9:%?^,Y=.N+_Q%97WC/Q78>'H=0\7Z5'/;Z7K
MFDWD'A[6F>;2WCMM%TK4VM)!';QQ&90=R;@20#Z\_9!\&_'#3_@?KUY\9/%^
MOR?$_P <ZSXEF\/MXAFN9K_PEX/TI)/#'PXBN](N-4NH[;7WT#3+'5-5\N5C
M/J&LSM*Q<;5\*_9J_8S^,/A'XP_#;XL_''Q2/$[_  P\*?$#1/"^D7_Q7^)/
MQ.OM)\5^-O#OP;T7Q7X]M=<\8I;M+_PD>K>"?&&HW&DR0FTT/^UH;?3FE$DS
MIY?=_ /]NCQAK@\1ZGXS\9^'O&7P]MOBGJ7AWQ$/'MA)HWB?Q?JFCZS'X+T_
M3-$M=&3^S? #@^'H;RTG>5&EMY7" ^8TOM?[7?P^_;)\>_$#5="^#7B#4M(\
M >)_A#>^'M/NM-\10Z-H>@Z_>Z%\3M/\:?\ "2Z<MJUQJFLWKZM\-AH=W%*O
M]GR:3=2H$8/YX!SOQF_8:^)/Q%_:#\?_ !>\*^-)_!K:G*-?\$^(=!^)OQ#T
M77-+\66_@KX7^%[.#4] TQQ8/H*77@G66N+7?):WL.I11W=H[("GIO[%WP"_
M:7^#%S\5=0_: ^,FO_%2_P#%<]M-H[WOC2]\2:2M[$DS76L:)H6H>&K+_A"4
MFWQH;""YO+?,0<.A.*^/-2_9X_X*"^ /!'BMO@YXTU_1;[QGXCUC7=9\.W?C
M!-=GTN.37M3FMKGPO=W=NK:=J]Y#/I]Q>F.1 Y216+9;=]=>$?AY^V!8_LZ_
M%V+Q1\0M:U;X\^*;M8/!UQ'JUM'IWAG3X1IMO!-H*P6J1:;=/!]NDE8HQ,PW
M$G- 'SCX%_97_;0\3_VMXEUGXM^+?AQ;7&K_ !)U/3M!O/CO\4_$U]>^*XA\
M6['X>^-]8B,L=OHFB07FL^ G;PM;2W.B26VAI/<QSRQI;5'9_L'?M.WMYXL\
M;3_$ZZ\+>+)_!&G>#/AMX?'QR^*WCNT\):-?>)]'NO&WAWQIXR\0V$5W\6=(
MN[&/QA>6(UJTFCTR?QG):6=O"+2WO%\;^)'A?]LFT^(MS^SGI^L_$;4;'QIH
MGQ L]&FT;4YK;PH?#>O>%_BH9M4\<:E%I*Q7FOSZK%X,:*Y:Y\ZUF8;(V\UR
M>X^)?P)_X*(:!=^+]8^&_P 0/'^KZIIV@VO@GP1>OXVM[BZUCPUX9^*'COQ%
MI3Z^D]NA34M0T7Q1X6M;F^B9+U+3PRRRS30A[>4 99_\$^/VHY/#'CKX?GQ=
MH&B>%_$#^,+R^C/Q?^(?B?0O%^I>*].\9+8:A:^$M1\/0VWPUU#3[C6]-CGG
MTEFEU3,MS<.KHJ/;M/V-_P!OK38_$VDS?&&_UKP2^BZ/H]AX#7]H+QSX8\/Z
MOH,5FMB_A?3]2T;P"VJ^"GM8@=^HVU[<2:DF8;B!4):OI+]J.R_;JN_%WP)?
MX#Q7%KI6G^&XY_B7/;>(K9-/F\03K<VVI6&I64UNJZ@B1-9RV\[K(F_?LCB=
M2S>%^.?@O^WOJ47AOPIJ/B_QWXR\)MXF\-ZQ+/:>,-)TV_AU ZA;ZCK<?BR[
M&FB;5/!T,"/#!9QNN' XQ0!];_$WX'_'A_V./ 7P8^%/B.QT#XG^&]&^&NBZ
MMJUCXU\5^&(6L/#UQI*^*;?3/%N@PQ7[O+86UY'&\L:"[WXN4"R2+7R%>_L:
M_MJ^+?!^E^&/B3\0[/QKXHT"X^#'B>+QYJ/QT^)\.E:GJ?@BS\ V&H^'K7X>
MZ?X>@TW1[^UU+0?&FJR>(2DUYKLOBE;6_MHT!D@]6_:Q\#?M]:MXP^(>M_ ;
MQWJ^C^$YK_X7Z;X:T/2KZR6Y30OLWBZ;QUJ.E6[I']GU<:^O@OS)))3NL%NX
MT&&97YRT^$W_  4?M-7U#Q3'\9M2N]<9#/IOAO5;S1I? 0UZ[OOB9X?DFN=+
M@TM2/#T&B+X U!;1<)]INI)<;X1D X[7_P!A7]LWQ/X5L? WB3XZ:5KO@_0M
M$TG3M&T+_A+?%^DO+-K7PX\16OQ"^VZIIVFK+%''\0-2TZ#03;B)M/T.V>*/
MRRSV\CM3_8^_;HT[4/#-EX%^,NI>$?"EMI/B".?2?!WQ@U7P_%I-_?7?F^=J
MCZG\-M2/CC4;FQ5(8[^[2.ZLG0/%)N&^O+==^#?_  4L\:?#_P +>'_'6L>+
MO%,R:Q:ZM9VL?B32- 2TO=.U359]7C\?&"WDFUK2I%;2'TE%G952&2)U2)RE
M=/KG@C_@JC;7'CI=,\5ZI;Z?;W&BIX5T7PS-H]II<FC6=[&UC8V%Q,OFVERU
MF-FHR6YMW/WF>89! /NWX8_"3]IO1?V,]8^%?B?XB2-^T!<>&_%.FZ'X^N_&
M?B?Q/J%K>WPE&A7.J>--7C>^;5$# 274$06%BLEM;H%6(?GSH7[!W[=GAV<Q
M^"OC-XC^&7AWQ#XB^*/C$^'?"W[0GB[4;WPOJ_C+4]3O)/\ A,/%GBKX?:A<
M?%G6;_19-'L8M2U* SZ'/IHO;$22Y+_4W[3GP4_:;^+7B3]GR?PGX@\:>#_)
M\$^'+'XD:EX5\8"SL/#GBRW\=_#;Q'JVISZ<85CUF\BTO1?$R6MP$7;(ZC9L
M<@?,WQ0^'G_!4;QE=ZAX.BUO7K;PE)\-]3\-:IK>E>([&POM<ET6VFU?0-8T
MY["*$:3XROM:T#2K2ZE1-[0:Y<,]P8)/LZ 'I?A+]F/]O2U\-Z/HOBCXI:YJ
M.J+X.;0[+Q/#^T?\5;*\\*;_ !MXAO-6DUK3XM-=?B#XKO\ PGJ6BK'JEU-$
M=*FTQX-,2WMTBWYVH?L2?M<>'OBYXP\5?#/XCMX<7Q5%<P:9X^3XR^/I+[2=
M&MGO)(M*\5?#^[T2:P\>ZW=">()K&H74M[8NF]))"!GZQ^)?PV^.&J_M4?!S
MQ[X?GUZ'X6^&T\&P>++/2-<2P_M&4:-\4K?5CK]BH!U?3;:[U'PNWE,Q ENA
M(@RK9\L\<> OV\$^+'C/QIX-^(.OW7A"#Q5J&I>%/A]/J>A6OAZ]TB+Q'=V>
MFZ>\TNE22V]FWAK[-,Z.7!F.6!(H \P\!_LB_MDKK_P1E^*?Q%USQ_X?\'?$
MKP9XXO[?Q3\?_&&JOX/7PEXK\.:YJS76FV7@BU@^+S:C;Z1J7V"'7&4Z-+?H
M;>Y('[OZ8_:2_9M^.GQB^-W@CQ+X+^*NI_#SX667A3^P_'-EX1\8^)? WCK6
M9+?5[C6X['3O$7A*""^L--GN8-'6<PZC S)"P*..'^,_!^H?\%*-$\8Z!X<\
M9:_JVF1?$KXOVGA;2[2]$7B.?PO\/=4L=?O_ !KXQ34_L<D<4NDKI^CM81W$
MD<,BW#QP0(6VGZ._:$^%_P"UU:?%WXL?%7X!Z_KJQ:WX%\/^%-(\'CQ!96OA
M[56LOAO\>7FUR&SO;.467B:T\>ZI\,A;SIM+([IN5=Y(!Z7^T%^SM\5_C5^R
M5X%^%&H:[8:M\6-#LO ][XGUJZ\5>(/#^FZ[XET;PS>:1KU[-K&AV(GO[>;4
MK^>X\F>V\BY"@31)D;/D/6?V'?VO/"_@"+PI\,OC#X@M_P"PO#NE6/AN\/QE
M\9VOBJSO/[/MCK&DV_C#5-%O]1L/"CZX)Y?L5O>6ZK!B*V>U7"5)IOA#_@JD
M_@8:=;^,H+._NO"'C#5SJ6N7-E>>)=-\0>'_ !SKGA_PCX4B0QOYZZK\+=3T
MW4Y;F6:2>/6=$19)F,CR'ZQ^#]K^T-KW[./C/X0?%F7Q@?C&GPVUQ;3XA736
MFG27U]X@L+^/0;"#4=,D#1Z_:%H$GDW,ZL QE<Y- &I^T#^S;\0?CU^SU\'_
M (6:UKVAQ>*O#_CKX*^)O'VN7EM8>*+*>#P/X@T?5_%-SI]CX\T#6;3Q%?R1
M65R8(]7LKF"XD8?:AAF-?'GC+]B']K_P1XMTWP;^S+\7[[PA\$=&^'?C[1+>
M2\^*'B+POJ-UXE^(V@?&*;6=57P1X.\,0^'_  ]J%CX_\8^!K_16T;3]-BTV
M#0'2V\D0Q03>O_LB^%/VX?"_BR+2_C-JVLW/A#2? -WI,YUO5=-U33;J[L-&
MT6S\&GP\$@-S%KZ7\&LOJD\\C+<)*A?>^TIXA?\ @/\ X*FZ?XB3^R_B3K>H
M:9J/PS\<S)]J/AN9+#QIK%O\58;>SO)C9"&WN+.<?":71WCMVV&WNU9T66Y$
MX!SWQI^"'[?O@'Q;\7?&VA>-O'?BSX)RS_V-X:^%_@[XZ_&2Y\?Z_HFGE[3P
M9/I_B:9KG4O >IBU^QS:W?Z=--/>WMH894EM;FYNZZS6/V;OV_\ 7OA_\-]4
M\+_%GQ/H/C'4?$&G>)?&)U_XX_$J'4/#^A:=8Z$=-\.#2;,3:;J<A2VU>/4(
MI+:07<UT))979F=>IU7P!_P42\+:1XET^+XA>-O'EC>:[=-;7>GZIX7T[Q?;
M>'M*\=_&S3/"<&A7LFD>5;WT_A*'X(7FL2.I^T!M04?,\PEPOB!X2_X*J?V%
M?6FA>-M/WZ5K'AK[-J&B-ITFN^(K'78;G7-:E2)X(H[)=(U&ZM-+*!@ES;Z>
MTQ7#LA ,'PA^R7^V-\3[;3_&WC'QYXU\!:GI-_XPUOPEI>M?'KXCZOXITOQE
M/I/B[1--\4+JME"A\+>';HWNDK/X:MI+C26M$W2PRMF)OM3]M;X&?$?X\?#'
MP)X&\,> ?A5XYO7UOR?'6K?$+6I='U+POX9U+PKK&@^*]2^%ER?!&LVVG?$&
M\M-3NM/LM3N;!QI4.K3WT$+W44*#C/CII7[;MSJ_P?'PSU&[#0^"M&3Q3=:5
M?:/IVB_\+!%SI8\077C.PNK%_P"T-"?21JXMX[<*J7+1E44A77,^+_PH_:S_
M .%+?LV7?P_\<^,-=^.7@-O%.N^,]1O]>L;*VU+Q-XC^"7Q(T^TB\26D5H+/
M6]'LOB#KF@PVT#P-#&MO#,T;B,JP!C?&C]FCXZ>)_P!ICX8?M"^'-$\,:GI?
MP^\&Z-HMEX&U/Q1I>J_\(_)\/]5^*NHO_8LWB/X>S3:CKWBK3_%7A.V6_CU#
M2)='ETV5KF758%C4_2O[4GPE\;?'[X/^'-!T&SCT+Q/:^*=!\57FDWOB[5]"
MAMA;Z1K5C>Z=<:SX;@<Z@L<NJQ[HGC>VN%@8,N"*^!;WP[_P5<CN?!$'@3Q'
M;VO@W4M5U#^V1\1+W1M5\>>'_"3>.=7\*Z5:ZS?6]AY>H>)E\ ^*K/7FF4G-
MWX!@M96E:YED;W#]IO2OV]KOXV^$H?@'>W-K\.].\'VL&J:C+J>FQZ5JNN16
M6H7M[)J%A-;%H[J75+/3+8,5D98=0D>)X@-I /$=7_8Q_;G\-+X)\/?"G]H3
MQ)HW@KP\_P#HNE/\8?%YDT;4+JW#WM]>WVN^']3F\1^&XY1+%;:-,_V2W2;?
M;) R #]"OV6/A+\5/@]X5USPY\3?B%K?Q$:[F\,ZCI6H^(_&7B;QUJ]IJ/\
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M?\CWH :3DYZ5*GW1^/\ .HRI!. 2/I4B_='X_P S0 ZBBB@ HHI P;.,\>M
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M!FC?MZ?MUZ'#I/PST7X7>(OB%IGB?PY\9=5\ ?';XB>"O$/@;Q9XL\.Z)?\
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M:9JWB^>SB?Q7;^(-?FN4.@75A*TIL;159KUHP@KQQ/VV_P!LC4O#EEXGTO\
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MWB#^SM/NG;6+Z33=2U!8[0<-'I@E!W;P/-[[XF_\%(_$?C+P-<:_X(\66_\
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M5U#4K?Q+J>JS2@OXRM])_LMK;P^1YEWYAW%2<5['\%?B?^W-XH\9>'=0\9:
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MX]^+_AS]K7QQ)X:\$>'O"WP<^&?A/QA\/;3PWXE3Q]K<6I:W\-=>\=:II7Q
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M  I-QSG/(^E!!'6C:<9QQ^':@!=[>OZ#_"C>WK^@_P *;2'.1@<=_I_G/Y4
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M\1,+1YKFRT[PGI&@7M_;:YX:UBT,OA32--@MDM#;>&+2(V\2)'(\\DY7S2'
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M (270_$4&CJT%U8:_=Z?XFT&%?)UF6\FEE\N+RH-/FA1+.UMXXDC7Y ^*?\
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M:TOPWKEM-<7,-I8^(=:ABN-*T(ZQ+;"RN-8GBGB*6T5P\WSX*!@0/SE\0?\
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MWM=4^'OBF77_ !5JY\(>($LK<W=U/=ZK+)=O8R:JD\GDJ[Q[)0H10-H^1?\
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MQ'JZ^#?B2G@+6?#OBKQ-976JI)/I.DW6N3Z)<6\5K\MNEBSPVT3_ "/\RO\
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M MI[OQ^FKZI'8^*+KPMJ>C76M:+9#[)<RO?6FMB%XF+PP;&,%KYWV>+@K?\
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MS+:^%;?Q=HLW@9;+1?&'POL#9W.EV_AWS9M+'PWL_B8K0)<*TES?VYR'$6T
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M_A=](\2"^DO/&=E8W,VC:3'J1TB6=HH7>3R5B .\U]@;SZ#]?\:-Y]!^O^-
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M1PFI?$#XC:KI>MHVE^";*5O-O+RZ8>88F1&)#LH!ZQ^U;\%+_P )_L)?L_\
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M?^S'X!_9D\*2KBP\9?M)^+DU;Q0\,L:R+-_PKGP,MW-;R@,04N+B':PVG!R
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M#M!CETS7X8VBAUFPD2PS::FL3%5F3#@' :O7AC P .!T&* (EX8#TS_(]O\
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M(]!_A2$9<CU_PI?,]OU_^M3MWR[L?AGWQZ4 ,)P-GIW_ %Z4RI0^2!CK[_\
MUJ4MAMN.X&<^OX4 1JVT8QFACN.<8_'_ .M4A;! QU[TZ@"$+D$YZ4*N1G-2
M%L$#'7_&AFVG&,\9Z_\ UJ (:<R[<<YS4BMNSQC'O_\ 6J-FW8XQB@!TG;\?
MZ42=OQ_I4E1^9[?K_P#6H CI5.TYZU..0#ZT4 1,VX8QC\?_ *U-4[3GK4H;
M)(QTS^AQ0&R2,8QGG\<=* /'/V@?B);_  F^"GQ*^)MW%XEGM? WA74_$EQ;
M^#DT63Q/-#IT?FO%HB>(HGLC?$9V?:4,>1\PQ7\DWQY_:I\7^//VQO _Q<_8
M/^*GQ#\/_ME>/+J?]E_7O"_[17@SX9ZGX03PT?'>CZ5X5U/1=1TG0;7^Q]&U
M+6+[5);;4;&.]28Z)J%G<[)83$W]CGBKPSX>\:^'=9\(^+-&L/$/AOQ!83:7
MK>BZK;Q7>G:GI]TNVXL[RUF0K/ Z<%6!![UXC#^R+^S/;^(/"/BRU^"'PUM_
M$O@*[%]X-UV'PGI46J^'+O\ X2!_%0ETR_CMQ);L/$DLMZNUAMN96E&&8D@'
M\AWQK^*O[7?QY_9IT7QG_P %"/VE?A]I7PUO/"7P8^/7P_\  _A+]F;X)?$'
MQCK&A?%7Q5XU\->&M5TG5?'OB:UT_P />+++P_X'\7:I?1+%<+%80FW4W5PZ
MQ-]):U^QM^RQX;_9Z\2?&+7?B-^V_P#M-:+\+/B7:_#JS\$6WQ:^'WACX8>*
M([ZT:Z;Q/IGPW\'?#V?3=/\ !R:>A>2WMK*^G"X=HGB1Y8_Z:3^RM^SFTG@^
M6X^"_P .[N3X?>&;'P9X+:Z\+:3./#GA33+;7K+3M TJ.:U86NF06GBGQ%'%
M$HVJFLW  _?/N\\;_@GY^QC-HVK^'S^SI\,%T/76MY-4TJ+PU8PV%S/:'%M=
M&UCC"1W:)E5E4"148H&VDB@#AOV.?@#\-_#'PK^&7C?X'>*M?\$^ =?T33/$
M-OX*\.:+\"(=$OK690[Z9JVO^"?AG;SZW$)8V1YDOEE9DRS1RAE7[^#Y(&.O
MO_\ 6K!\)^$O#7@/PUHO@[P;H>F^&_"WAS3X=+T/0M'M8;'3-+T^W!6&TLK2
M!%2&%06.  ,DD\DFNB^M #6'.[/09QZXYII?((QU]_\ ZU2'@$^E1^9[?K_]
M:@!JKNSSC'M_]>AEVXYSG-.\SV_7_P"M3F;;CCK[_P#UJ !EW8YQCV_^O3?+
M]_T_^O3E;=GC&*4')(QC!H ",C%1YV,>_&/3T-2T4 0$Y.:D/W/P7^E/I"<
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MAI/@#P3I=AJ44<&I6.G>%-!L;34(()C<PPWUM:V")=Q)<.\BK(K!78L &)-
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M*GVC&,#IZ4T+@$'&><'\/I0 GF>WZ_\ UJ/,]OU_^M2;#ZC]?\*-A]1^O^%
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MCK^E2;5';]3_ (TI /6@""BIMB^GZG_&C8OI^I_QH AI0"3@5+L7T_4_XTH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g1078493.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078493.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" -6 I0# 2(  A$! Q$!_\0
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M_C1O'H?T_P : 'T4S>/0_I_C07&#C/3_ #WH ?135^Z/Q_F:0N!ZGZ?_ *Z
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M2[&]/U'^-(&(X!_S^(IZMUW'TQ^OI0!&1C@T4I.23[TE "@9.!WHP<X[TJD
M@DXQ]?2G$KR0?F[=?Z^U #",$CTI*4DDY-)0 #J,].].(!R5Z#_/%-I<G&,\
M4 )2@D=#244 .WMZ_H/\*<IR1NZ@\?7\/I2+M/4<^_2F4 %.;;P%]\]:;10
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M.W-Z_P J;0 I)/4T D'(I** 'AG/0_RI"6Z$]/I_2A2 >?2E8J>1USSU_K0
MRG';@8Z\9Z^G/ZTVB@ HHHH 4#)P.]&#G&.?\FDI<G.<\_Y%  00<$<F@@C@
MT$DG)/(IV00=WWN<=?P_6@!E%%% !3R'.,_T_I2+MYW?AU_I0&;U_D?YT .;
MY<;>,Y]_3UIHW$DCOUZ>_K2L0<8]\_I3@4&<<9]C0!&>ISZFGHI'/J/\*/W?
M^=U 8 ]?EQQP: $8D,<'T_E3>6)/7_ZW^12L022/\\4@)'3^E "@ '#?C^7M
M4HQ@8Z=O\FH@03EOQ_+VJ48P,=.W^30 M%%% !3 $/0?SI],((^Z/K_3K^-
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M"_O+?Q)>>*O#6G?VKI>F:'JNH:!<RIK\5[I,VK:CJD%G;LTMGI^GI;RQW;2
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M MEJ^H:%IVHMHFO:#J\/A3XRVFAZ-J&MO)#J.CWDEUH3W4T(:6-HIH%= SY
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M['6V\;> K'2=?\*Z3XENM9N;;X>ZC<W,]MIWAVRQC2]*262]N#'&2\?E2.0
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M;>V@C*/I<WD"%H=J_%VK?\$M+1[)(O#GQ%TS2Q=6BIK.C7G@ZTN_"NI:Q?\
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MM;2^LVTO3]<LH_$&LS:M,9)=?N/[65I_(80KY&(L9%?H1D2 .CAE]58,,>S
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M$6JW4GA#6?#W]OVVI^'])U;7/[5\01W+^=LN+J\@:6)QAXUR&3;7Z_@A@26
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M"GA[XBZ9XAU#4]=O/^$CCUN>:[GN+S;/:S:8]_86ULY.YX[56!. :^%O"_\
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M/#<UOI/@22TLO"?B?1_%T]W9S7.M0^)K?6M),DMK'#')*DB>8LD]KP[\<?\
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M#4L>L^ ="T7Q=>6CZ+%XENIIK_Q#'%X?CBGUJ%HQJ#1-<8*Q%WQD \=\2?\
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MU'0[+1[-O,M;L:#%?$O<6\%H82Z&?!93:^,O[1'PP\ _LV_ OXB^&_A!X?\
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M^$TM_ .M:IIVB7L^CZ'JR::MM97>GPWNC_:IF%G:%HHEBDEFB$:)^T#^TO\
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M  F.H^,9?%OC#5]3U#Q/'>S,-3O?$ZW<FL2ZI%<--&5=_,A1#$RJBX !Y[\
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M\*OC)H^A^(O''C:7PS):67BZ>XTWQ)J/P^TW5K?4/ \-G+$(XM,L[OQO'>7
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MUC1(_A]XC_XK]I?$:Z9X"U:]\2'39+XP!%DLYM#O(I),[A#H[0;MT) ]#O\
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MW!_PLY+KQ_XHCU_4]%\?^*;77DN[_P #//#+:2+IJ:9-=Q2E+BYE*XKR]/\
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M33?#7Q"\)ZU?+XF,4DX\/FTT[59)#K!ABD<6X7S2J,P4@$U[-Y: G&X$]_\
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MGAWXGWWB77/#]R-*:Y6\U;QMX@T6.TLU$LFDWFGV^G6%NJ-YUMXED<O,UL6
M!U?[*GP0_:-^'/Q'\&+\8=7NO$USX>\,_$I]<\8/J+WUI=Z+XF\2O<^"?!8N
MR<7UUIT8EG/&V-)P :_3BOPOM/AS_P %A;#P_J+Z=\0]-O/$DWB22W>'Q1=^
M#!IL>FV-F+MM1T.;3KIG:PO-2!MTCN%CFBB;>5P,U+XFN_\ @IQ\-KGX@^/-
M;O;VYTS1_"6F7'AG0VUCP[XATGQ;\0SK'A74-)\*Z/IFB6;:A966H7$_B#2)
MI'B988ECN#(-PH _<X*"I/((SCTXKX3_ &A/V9O%'C_XCZS\4_AU%X>T;Q@O
MP9O/!NB>(LQ:=XCC\2R>*[74Y#;:Q''OTZ6X\,#4-/2]!+V_V\,#M7%<%^SO
M8?ME?#+XN>.K7XZR>,OBI\.?$"?#S0/"7B".Z\*RPZ/X@O;6Q3Q1JMOH6C.;
MBU\)071UB2:]NWCF"B&+[*/E=N)^)/@/_@HIXC_:,^(,'AKQWJ'ACX%ZSKVB
M0>'+OPW/X,A_LGP1'9>&]\NE2ZK=/>VOBP:G#XG^W&6RFAEBNX_)P%0N >B7
MW[/7[1VO?LW^&_AS/\0->\/>,[?QWJNOW=S8^/+V76]%\(O_ &E-X?\ "DGC
M.,"76WM9I=/664C;,(,G(KP;Q7^RW^W9'J/PPTWPE\4]0N_#'AGQ2VJ^(+O5
M_B)<S:C>Z7=CPF=6L-3CND/]K6LR6_BR-$&'B^WJ,[&(K'\._"G_ (*0:%<^
M.M9N/$GC%+N\TG5_$ M+?QMX)U&#7?%<FA:19:)I^EQ36\ATJTAGCU%Y8414
M>;Y@V& +? /A#_@JW)X2N/$7BCQ7,GBO3]+M--T/PM?7_@K[!J\%Z^MC4M8U
ML0$.OB&WLVTHVY#PQ^:HWPD!Q0!>^%_[)W[>W@GQ)^SEI^L_&FYOO!7PQ\1K
M+XQ;1O$T%O;ZYHHUGX?7]O!J.BWT;&YTFV\&:1XH\-+96Y4N9O[1)W7<U>M?
M&S]FO]ICXJ_%WQ+(_BK6[3X=S?$;P_XM\+:WHOQ,N_#\6B>&-%\(:5::?X>T
MWPA:)FR\0V_BQ-=GEU$L1<0ZJR@?.]> >(M._P""IMWXC$G@R]\?:-X#N?AQ
MJ::%:^)A\+M7\=VFMMI/CF/4KKQ>]GK$5B?$::S<>")='6WEP8('22WE<S>5
M];^'/B+^T?I7['WC.+X@>%/'&C_M > _A3%J-QKT5IIFM3>(_$&H+?36/_".
M2V2K;ZEXDCT^&S-S T4:P7=XL,BJ58  ^=],_9U_X**ZYXZU.V\7?%_4-%\"
MZCIFAZ3?7_AGXA2IJ$B6EQ$]WJFD1/%YVEZE):JR2E3M+%BO6O!?%/P\_P""
MD5Y\3M1^%?A7XB_$S^UM/T3Q)/-\0;GQ*]KX,U'PC]EU*+PUX9LS.A@MO'#N
MUE_Q-B"3*09%^4Y]%U:7_@JS=W7A2/PC;>)(=)N=+UN6+4?$%YX'?46T+5;N
M_?07\86EO(L4'CFTL6L/,\J58MP($3X)J71?A7_P4C\'S?$[3WU?7?%<6J^-
M='\2_#CQ'=ZSH-W=V4S6GAQ/%=YXALCJ$2H3>+?MIMO"HM$BM91+&7D3< ?2
M_P"RI\)?VR?!7QGU?5OC?XZUSQ3\,[WX6MH]I:ZYXUL]8FT_Q3_:FDSZ2+73
M-,@2-M1BTQ-3AO+Q\[V6-H@/-DKG?V7/V?OVLOA/XQ^$NC>+_$^M3^ O!/AJ
MTT?6C<_$9_$&@W>@6G@NTT9_#TOAR=#)J'BN7XA6M]K2ZRSY2PU%+ @LA->3
M:E\4/VN_AA^T7\!?@UXU\8^-/$T7B/XE^&K#2;O2-$\.SQ^*OA[+XBTBZ\?:
M[\34M7,ME!:Z)+JD-E-9(@MQ:&2[ 5HW;;^/?C?]O#P;\4/BS;Z'8^/KOX;>
M)?B)X+T3X57_ (/TOPK=ZO9Z;<Z#XIENM%T#3KR\VSF6]TO3[NZU&YF"1PR/
M!-%:S!58 XO2/V-/VVO MQ\0O$_PU^)&I:#XTU?Q3X@L-)EU;XA7>K>'-0\&
MZQKOB[5VU2\T:8,G]K11ZAHR6:O\UL5X^5#7ONC_  %_:>U7]ESP/X3^+U[)
M\5_''AOXL:=XN\6>#?$GBJR5_'?@'3KVSN&\'W_B2T1('D)CNY(Q,IC.]8Y0
M5KQG_A(O^"HD/BS7G\0>$M?C\*R:1I_]I_\ "(IX0U74K*2TEF2>;P';7>H1
M17&JW4;6#&.2>94 F\SR6&T<]J^O?\%6A=>,;BVTK7;>UMM6T.71-+C\.>&9
MY;C0SJ.F/:0V^JV>L3+%J<^E_P!H)JGDQW<=K*=S/$HH ](UCX'?MQVSRZ9\
M*A#\(O#=SX6URU\+^&_#?Q&CD\+_  _L=3T[XBFYT)M,N8F?4/&DWB/5? ][
M!JT;""Q_LZ:*% BXK?UGX ?MV6NE:IX>\.?&KQA+::AJ/B.ZBUO4OB 'U[2K
M32=5_:;7P)9Z;=O!N2&XT?4/V<5U%6XF?3[QY/G64GTW]H_XT?&4?!GX9ZA\
M.]&^(_A/QGK/QC\)_#GQM9Z'X-M]<\7;#83_ -O2>'+*]N%MKK2Y-:6&)=16
M1[8PK-+$S@ GYFT+7O\ @JCXE^)UMX8\1Z'+X+\(ZI'\-]-\8>(;#2=*O[#0
M;JS@\(OXUU'P==F[\FXLKZ"Z\2?,LURUO- !(L3Q>6P!Z3XK^%/[?^D?V1H_
MA/X@^)_$$4&IZ]_8NOW7CG3X)-.^T:C<W<5YX[2YMR_B?26TF:&UL[9-K6L\
M(E)(%>H6OP?_ &M5_9]^+7PSU+QS<^)/&GCM=#TGPSXH\6>)/[2N_#%CK]O+
M;>.+L7]NJR26UH9 ;2!2&*_+&1UKY>\":%_P4HA\(_#[PUXD35/#WBS2EU31
M=4\5:;:V6OV5GX5&D&\\+R@WNK+_ &CX@E>VLK?5);B,-%>37 AS#L=NS_9\
M_:)_:F\4?M1W7PJ^(L=_#=Z/\/\ Q5J/BGPE;:%I3^'M(N].THIX0NQKUOJ3
M/;^(+W5 #<VTH$1$R[' !( .4/[.O_!0[P/\,I_!WA#XGZE"WPVB\*>!/ L7
MA?Q4MK;>*?A];^+[S6=9UK[+J*/+9>*K?PO+I&E023.TA@TR4J=TV:YC7OAU
M_P %:)[GX@+!XRU***Y\#^'=+LY](\7Z5"+CQ=H[_#1SK?AB V^W0XK^*'QV
MFI):X(,X9>2*T] \5?\ !6?7=&^(U^FAQZ!?^'=/^(OB+P-I?B3PQ8Q2^+-;
MBTPP^%O!MU(M^OV?3TU)GFADB$B3^4L23NL@D$%K\1/^"JDFHZ)I\?A74%L$
M\#^,EN=?N_A[+Y=S(^F?$V[\*ZM=Z9/<PS#Q3#J>F_#ZVEM)1:W,JZ@\D5DX
ME)C /O;QA:?'[XD?L_6^A:=H-QX6^+_AS6='L;^ZU'4K<VFKWFB64R7^OZ3J
M&/W^G2:DT;PLXW.%W$<U\M'X4?MZZ+KL>A:KXU\=>// EQ9LNGS6OCG2].UJ
M#Q'K.F3G5Y/%U]/;DZKX*MYY!%;VBX9205.!7OG@WQM\<_B/^S)XE\(>+?"O
MC7P]^T+I7@?2Y-1-SIC:+)J&HZG>1R65SI-[#(8UO'L(#)-!N6>V\WRYXHI,
MH/D/Q7\5O^"FVB>%;N#PO\-/$VK:W9W&FZ;>^?X#@\C3=9MM@%MH,\&KS3>)
M_"D]DB>;J4<)6.YD996C4;@ = O@C_@H;8>$M#^'Z0^)+70?!^D06&M:SX7\
M=:18Z[XKT:ZU+X;):Z9X3O9H&DTO5;'1[#QFCW$I)99V5<F92,3X;? K_@H;
MX$^'6D0Z;XQGT+Q#X.LO"%[I>D7/B&TO](\1Z@EC^SGX9\0MX[2)"=?CMO#>
MA?&&8#(,URT,BXD>(CGDUW_@I7XE^(4WBN]\'>*].UC2/AKKRC0+CPQ_9W@'
M0_'-S!#J'AR/0KN'7-GCB,M;V@N93M$$KSVK*I8,.\UG]HC]K#X8_'[X/_ [
MXA>)5U&YUSXC^'-(TFZTSX?V[3?$SP3K.NZROB?7_$"6VMR'P?8:;I%E#'9W
M"+,EQ+;3F3R\8 !Z9_P3X^*7QZ\;_P#"Q-(^*VG_ !6U30]7UUX_"GC?QK)$
MZ:1-H?@+P/#XKMK.5H(Y$TVZ\=:EXEDTU-FV%+%XLD("?)7^$_\ P4W\5ZSX
MOT?Q_P"+=$G\!KJCS^$#I&L0VVKM!8SZCH5G)>3QJ&BDFTR:UU,L#F.Y38.E
M=I\4O'O_  49U#]HCX@>"?AEX7N]'^$\VNZ5I'A[QEJ'@9+VUT71?MFCBX\1
M:3?SZI%:ZZ7LIM59T\\3(80)8HF 4]=\(M5_;2\1?M"> _\ A;ECXFTOPMH7
MA3QDM[:V/A#^S/ >H7-QX;FM-"UO5_$JZE(DFOSZQ'"QTLH#:^9N#LIW4 >"
M^!_@=^W_ /"GX?6TV@^*_&^KS:WK=FWCSPK/XMT_4=?M_#ND:/\ #JQO+SP3
MJVH(WV;Q5>OH_B9$=N-DRYP[ UK:SX,_X*2>,M.T#P'XR&KQZ?I]]IWC?Q%X
MM\,>*M+TF37-.L]5^ -UX:\$P&VC$T6O6C^&/BE-JC@B"YDUARH\N= -W7OB
MQ_P4=U_5O$5OX3\ ZSX9T_P-X=UK46DU3X:RR_\ "?>+= T_XHZC:>&=!N+O
M5X%FT?4I].^'5M'>P^8@.I2!-SL0F;)\0O\ @H3X'L=7LM,\"^.-;EALO'NH
M:/H"^ 1XDSX?UB]^).J6/B&;QG)J\$,GC>P\4R^#;*S\.[/M%QH;?:H!+P
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M?CZ/PUXEEEU#0'UB!'1K>YDX,1*H,U^BV>0![_7MU'X^G?\ , _!3Q-\<O\
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M^&)M.UKQI/81^(/$"?#G4K0^(Q-H(>UT>+2/'=VL[QDLMUX?E7*J66/$O_\
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M?#Q^ RIY/X>IYS_];%9W]DZ4-2.L_P!F:?\ VP;?[&VK?8K;^TS: [A:M?\
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M-3U/0K'3KF_LK31+._6^O8K?7$M7O[A&6]TZ"0R/%($\X+B N2,@'Z))X?\
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MIE&A:O?>)?\ A'8?#&N:G/=?9M.UXI%?7J+ODM9+.RW+=&6>VBF^I/BU\>_
M'P5TGP]JGC5]:9O$[79TO3=!T6ZUS5&LM,L8]3U_5[FVM!BWTG3["6*:\F9A
MY:2KL21V"T >UE3U'0\@#/&>G'8\TVOE63]L[X)1_"/Q5\;7O/$J?#OPGX@D
M\-7&LS>'YK4ZQJ,#!9)- AO)X_M]CD-B=C%&=A ). >?T/\ ;\_9AU]XC9>-
M;^'3;E-'>U\17_AK6;+PW<G69M#MXUCUN:U\@?9Y?$6DB\=V6.V%SF1]JL0
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M#3-(\9>*-*MM4\#VUSX9OQX/\6BQU>,^*] ?4_!OABYE@OS,))=)3>61Y5D
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M@-!'?2R_&#X>I%INI:=I&HN_BC2P+/4]6MS=:;8W.;C]S<30!G16QE5)Z X
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M%SZ?HGBCP_+IC^,_"_B);WQ#JFN:A<RZ5X&\#/X$N9;K5=:N)S+9:-I<VB>
M;33@N3!]GMK>!<#%?8<'QS^$TPG6;X@>&=/N+73M?UFZL=4U6STZ^M]&\,:U
M?>']:U::SNI5=-.AU72[R/S2NQO++*64@U\N?&#P7^S]^UQJFMRGXFZ%>Z+\
M,?"'B'X?_%,:7J<+0V&A?$C3_ 'Q'T6Y&IJYBLKV#^Q/#-]$[!DDAO7C?L"
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MA>TMO"5II<VFW&DZ]##;^+9;WP@QN[R%I)+B*ZD$JK([J/T(^%O['&C?"O\
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ML-0UO3;.[M]+B/[S4;BWN+E7BLE .964(-I); J[+KV@P&T$VNZ-"=0CM9;
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MENVT+7-'UI=/N'L[XZ3J=GJ0LKN,L)+6[-G,_P!FN5*L"C[6!4Y'%?F#??\
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M;2M"TV\UC6]3T[1M'TZ!KK4-5U:]MM.TVQMDQON;R]NY4BM806&7=U SUYH
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MNE:-?RQQR.(SJJ9.&6@#Z2V;NV<>^.OX^U)M"GI@]/\ /Y5\8_MP0?M"Z_\
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M7Q!?Z%XYTK4=1NK33S(?%.B37.DRZ?;Z')J:M EC=727.,$2NV5KDOAQ>?\
M!0'PE</\0;QHM5T3QUXRN/"4/A7QPD_BS68$N_BA=6UMXR_L#PQ\/]!G\$:/
M:>"+2>&.&\U/55F-]!<M+$@+-['X$_;C^)&L67B[5/$W[.'BV>UL_#$WC#PC
M9> ISK.J+I<;7]N+7QI%XD&F+IEW]LL6#&P^W,JS BW;J?FSPE_P5F^(6KV6
MD7.K_LTW%O\ VG:^)[R>32?$FIZC!I*Z!IEGJ]C8:I-8^'+F"TU/4FNWTVRB
M^TLYU.#RY$C4NL8!'X._;4_X*!>/A91Z1\!?!NALVHW(U34-<\&?%L6>B7+^
M-/A%X+E\#ZN)-)@6'Q!I,GQ"\07UU>VTUW;7EIX/N&CBM529XNF\2_ME_M=>
M"M<\ W%S\%M3UM?%=_X3TGQ1I=EX.\<7=M)?11_V9K4?@&V318A:S7-Z);MT
MO;ZYN+6V3S5M;BWBNKB#5?\ X*3:[X6UCQ'?^--%\&:QX8B^%-QKFB7O@*\\
M5ZIX3NOB3I.C?&;Q!9>$M#\3WG@ZWG\07VO1^"M"L((4A86]S;S_ &>2Y:7R
MQ'I7_!2[QAJVI>,KJ?X17-I8_"OQ5\0(O&&AZ#?W_B.2[^'GA6^\* >*(;R/
MPF6GU^'P_J>LW_\ 9=NT-TWV-K>YMXG,)(!P/@'_ (*(?M@Z[KGPS@\6?LY6
M6AZ#XH^*3>$O$5SIWA_X@:KK%II4\$)_LVTL5TE((=8L+N22.]E>Z>4+"93I
MT*[@O8_&C]LW]JCX0?%']H?P]X0^'*_%W3/#5U)=>$/#Q\(>,]*O?!7A]-%@
MN1XTU7Q);Z1_9OB?P?\ V@7B:"WG^W+(Q'F8PM>V_ ;]O#Q?\8OV@T^">L_
M;4/ UK)X5@\3?V_?^*K274X8+O0[+7K*XG\,7%A;W0TZ6&_CA$P7:L\+J79@
M47DOB-^WI\1?!/CWQC GPKT^W\'>&?%GB;X>:-=ZWXIN],T?6-5T6]\*VTOC
M+QGK(\!SOX-\,PCQ'E6MFOEE6VD+E-H*@'E'P\_;5_;,U[4+C4=7^!L5MI]A
MJ-IKVNZ9=Z-XSFM-;\(+?? _POY7PW\06WAN&WMKV^?XCZ]JT"7DE\JIH-S&
M)WMHY;F'T;X2_M^>/O'GP1_:)^)5[X2\/ZMXC^#D_P .XK3PWX3TGQO+<:?J
M/C[P]X-UK4/#7B73M3T>*YDU#0IO%,T5Y>PJNGR0Z6UY)/9V_G/;^0Z%_P %
M)OV@O%'@36/B'8?"CX?Z9X5\6^)/#NG_  YUG4?%>K:A;Z#!9Z;\.=7\>6>O
MVUOX5MQJN@?V-K?B:?3]9%Q$1.]O%/8B&*1S]-_';XOVG[$_C#X?>&OA-\(/
MA!H/PU^(7AWQKK_B&RL?LOPS@/CZ/Q?\*_">DZ[JNJZ+H,UI8^'+:P\87,^J
MW<MO+,L-I#@K''F@#P?1O^"BG[1VH_#0>++W]F34]%NU\!-X]N=5U/3_ !9'
MX:M].34[?PR+-IX]%98]:E\1IJ;QVTL\:+I\,-Y+<)#*'KQO4/\ @H!^T_J5
MAI_Q&U?X-:Q:>$F\,:A<:IX)UWP=JVK>"CK26FM6^BZK-X@'A8?V9I@U&SL;
M@RS7;6H\U"][#"1*_P"DFN_MAW&F?LR>#/C_ &W@335O?&.JZ3HD6CZUXO.D
M>#=&NM2:^#ZYJGCP^'Y/*\' :?(8=0_LX>=]K@_=)YG'SA'_ ,%.]0OEAFL_
MA/X0T.+4-5T3PU:6OCWXO_\ "*ZKINK:K=+!+XJ\3V"^!+I="^%3*':RUQY3
M]LW1A;6,O@ '@7@S]O?]J#QYK$L5W\/5T[4_$.I_#37M#\'6?A'Q/-X_^'GA
MR>^\)V'B[5HY=2\*+I^J>#-8EDU73+:Z6[^U6]SXF0,6BA#-[5X+_:\_:I^/
MO[)?Q:\=:?\ #BW^!_Q1T?XD_##P5X8EB\_Q5<6-GXM\4?#NT\9:?=:9+IS"
MV\6Z'%XFU[2[M9HW2"\TII[NWMF26UBV];_X*DZ#:R>&=#TOP-X-'B[7=1U#
M3=6A\4?%RV\,>#O!1M?$G@'0-.U'Q5XOF\'3-IVE:A#XSN+JPDEL8GNX=*4P
MQLL^^+Z%_9M_;0@_:+\=77@"V^%?B?P5JVC?#KPI\3O%$FMWGG6^B:!\2]%T
M#Q%\+H1(=+A%_J&J:3J/B#[1&I5M.G\*30RAS*A4 ^=O@C^W#^T'\4OBC\.?
MAJWPAT&TL_$>H:A)XR\5W$_C)(/A];Z1I5C=:EX!\2!_"44)^*EO<W:_:85>
M*R0.-LH<&,1:A_P48\<>%OB-\7O"_C+X9:7I7A[X?^/9_#.EZ_;W7B6\L[G3
MIM,D;01K%_%X=,&F:]?:QY,,5G*8IF67?%',G[P9=O\ \%%OBOX6\6?$.?Q_
M\(_#6O\ @/P9J?BG0+B'X<^*+^Y\5Z7JFC^,/'NCZ(MSI>HZ PU&ZN]+\(P_
M:HC<6OV1[CST$Z-Y:^\:#^V1XE^*O[&'Q5_:*\$>!3X+\5>%-(\2?\(]HUSJ
MNB_$33[O4]+M;.>TNK2ZTJYLXM6!:^1)+:5K1XYXFBD8#YJ /F'6/V\?VGO$
ME]IU[\//A[X#COO#M_XNUSQA\+]6D^(</B>S\,^%/A%X^\5_V'XPU%_A_P#8
M_#NNZQJ^A:9/X?\ (N9C<131^>@C>1D]S_:&_;N\:?!WXB^%/"?A;X;:'X[/
MB3X.^%?B=9> +;6]?7XPZQ)XI3XEF\;1?#.G>%KJVF\.Z(W@73VU:Z>[$L<>
MN,8[=Y(HH[GSR;]NK]H?X#^#_$.H?'[X$:CXK.EZ#X@\=Z1K5K=:%X"\37?@
MBQU'X9>$M+?Q'X-\/WGB73].OYO''Q!F22>'5A%::-HTVH3P^8A@EQ/"_P#P
M4NTW7_%6E^-=-_976SG\5Z?9^%?$'CF7X@:1)X@CTCP1=> M3UC3P-+\#W#Z
MYH.GW/QVMKG1U-Y$+XWUXY@TZ21E8 S)?^"GWQ1L=6T:P?X/^#_$&EZE:^,X
M-/\ %?A?Q5XIO?#?BW5- 74I=/N?#4\G@A)X_"X6P:&^U:: :=:W4<L4MTB+
M%+-YQKG_  5#\3^+K7P\FN_LJ^"?$8MO!C>.;=O&'B:VCTV36[:&:0ZQX'D\
M1^$3_;7A[3IXQ%?:O9J8+=G#).R9(]5\0?\ !6K1_ )U72_$GPDU7Q)J6F>%
M[?7-.N-)\1Z?ILFOWM]J6FVB6,FDQZ7=KX8TFVBU6V-U?WUU&1LW0VDR.K5[
MS^S'_P %#_"7[1GQ#D\ 7'P]'PUD'@VQ\3V%WX@\<Z!JUQJ-Q=W[Z;<:5;6>
MDV'D10K>JJ0O)>)<7)E4K8H"< 'S_I?_  4S\?\ C'6=,\-Z=\)_L=QJO@OP
M%XST>;POJ.L>(];UB\NOB/IOA[Q7HS:++X13^Q]%&E23"UU&\:"VU$W'_$KG
MN#L=M;P]_P %)?BSKUC!JMI\$_".L:3I#V6N>-]2\-^-/%FJV6E^'KV_^!FG
M:CX/TF4_#F/[?\7-!O\ XQW-OX@TF86T%A/X3G@>]\YIHK;]+?CQX]NOA-\$
MOBW\4=+L[*?4_AY\-_&'B^PM[RW>6UFG\-Z#?:M;6]U%#/$\EJTMHH9%EC)7
M(#J>1\U?#OX_?&+6/@%^T]\7_%FF?#/2=4\ ^.?C1I7PFTT7.KVWA=- ^'%I
M'HNBWOC_ %7RFGCENO%^EZU=7\L*)'!:7,:AT$32J ?/W[2/[;S> ?CQK?@:
MR^ _PY^*7B/X=-X-B\+?;]<>3XFZ/-X]T3P;J<?C632#X'O'\-?#R"Y\4M8W
M6I6MW+,USI[(+8DL$XRR_P""D?Q:\/7?B;0?$'PHT'5?$&A^)=;T6#0+KQIJ
M5GXI\12"2,1:WX,TBW\" :O\-]*E=8]5U*4QW%J&W?9I6XK0^%G_  4#\/:!
MI7C36/B#X>\"W/QAUVY9;_5?#VG>'?!C^)]1TI-!T70-%NY]/\=>([;QKJ-I
MI.I:>RRZ9K-QBRM51[>RG#P1<_#_ ,%8=5T7PYHWB7QC\*M$U2YL-(F/B;3_
M  %K]EKUIJ^LZO+>1>'(-)\3278M_"D"-;)_:L5^ER]H3@R-U ![[^T+^V#\
M:/@;XD^ IO\ PE\/%T/XA_"[Q!KGCDWVO:]:>&?"OC&37/ 6E:7?WWCB3P\/
M[.\":5I_B?6-2U>ZETXW(T_1+BZCME6!P>9^.'[9_P <-,^!/P*^*?PX\.>!
MO#NI_%/3_C+9ZGI_BN]UF^L[KQ'X+\->(KSP+<>!=2MM,C&L>&M;O_#-UJ-C
M<W$$,MYH=_;7<5N)&:-.;U'_ (*W>#K:W\09^!GB8W>D>'] UN'2;_QQX/2[
MOXM8UK1=#U8JVG)>0QZ?8'65FE$<L^H3P1*\.F$3)B'5?^"O_P -K2\\2VNF
M?!;QGJMEH^I:)H.@:I-XA\,Z5I^JZ_>MX:CO%U>.^7S_  ?X9$?B-WTW5IX)
MK?4XM,D*I:F:V68 ZSX??\%!OBKK_P"T1X%_9Z\6?L^P:+?W^JZWX:\9>,;3
MQY9C1I=4T;6/%FDR:S\-M.US2[&]\<>&D_X1:![J5+>&:U?6XXI85,3$\Q?_
M +:GQ"\$Z_\ $?Q5XL^('A&YUW0/%_C;PO\ \,L7FA-I6J>#_#FAW,-MX?\
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MUKPA;>(K1]2DMF:]\3_$?3=!*6H(^WZMI8'[H3,0"S\7/VN_B/\ #?\ :?\
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M!N=$\0Z';-XH>WNHO%MWXAUCQ!<3:]9737D$BPSS-<QQG!'RA: -6^_X*?\
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M0!KB\N/#NF6>JPX+*ECJ=JW#,F/B;]GK_@I%X*\$>"_%?Q4^*?POT+2OB/\
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M?B#<W.D6=XNJZO%?>*O#NH6'CA9M4U\:_P"+X[Z31_"\]YC^U+?7=%\:"_\
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MUSIFH^);[PP=2T^_TRVT'5[MVU58I-=NPEU;0?:(WE22UN4958 'SQX<TO\
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MQMX*N?V@](_X1+3?#W@SX@^)M0U[XO3:K%X<N-;\46NM0:AJ=OXK\4WJQ?\
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M<3R2R.\;AH<[\^R>/?\ @GO\.=8\.>/?^$-USQ!IOC7Q/XM_X6)I6J>(+_\
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M_P#7H CHJ3R_?]/_ *]'E^_Z?_7H CHJ3;@'YF'3H,?SZTT#<3R>G4\D].M
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M+XC6_DZ^4B:XWO=6]I:R1(&MH6>8&6XB*7-S%B&>1X\K6GK'[&NNK\*?A?\
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M&H.70$8'+* #G&.#Z@_CQ5:^U*QTVSN[^^NHK:SL8FFN[B5L1P0J-S22;0<
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M&\<S^*M"L(T\4WU[KMU)/<SQ^*O$!UO49(--\7I!<"T462&W^S1#+LQP./\
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M?_MC?M3?LAV.M6<5MX>\;>,OC)X5@T>QTFY\2^%=/LOA?X?O;O3-7\3ZC?\
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M* &J".ISGWS_ /JIVT#HQ;/KVHHH , =,_B<T8_SDT44 %)@YSVQC'OFEHH
M0@D8'!_*DV''W^?3YJ=10 P*VX;CE1V!.>X_K5E,;1C/?J<]_6H:F3[H_'^9
MH =1110 57JQ5>@  ."64KS@ G)('.[(_K13BV[@@8SGC_Z]-H *80^3@C';
M_.*?1D#J<4 )SCKSCK[T#..>M+10 G.>V._K2T4JXR,]* $HIS8SP1]!VIM
M!2'=AMN ^UMA8$J&P=I8 C(#8S[=*6C\<=,'T/2@#\CO"'P'_:]\6?&GX9Z[
M\7];\07_ (%^'WQ2;QCJ5M?>.DO;#4-8LXKM;35]!TJTL(A#X0^S26Z0Z;(S
M"*X0S#G-<]/^S#^UKI'Q5^,'CGPQXP\6BRU3Q/J]CH.DZMXX.K:!XH\(^*M1
MT&745N](O[=TMH++3H=22SCZP2#='@D$?LCQCC'MZ?I2X [#W![]\?F!^5 '
MYA_!+P'^V*O@G]KKP7\9Y]7U^R\2^#FTGX,2_P#"66>BWMM>:AX6\4Z+?^'O
M"][IFG^7X;T^* ^&C:Z@(0Z7,[R302S023S_ #7X-^%7[<?PK\+ZCX:^&7@*
M[T?PEXL.M:';:.FI^%M&U/3KZ^E\!-)XY\5:;I6GIIUA+]@MO&5FHTN"#[5N
M2^F07-Q(]?ND26SZ=AUZ<?J3^HKY\_:BU75]&^"?C"_T/7O%OA?4D@MDM?$'
M@JPO-0UO39Y)=EK<,FGV\L\&F?:_LZW4T,;R1P,^U3F@#\D='^#G_!1K0/ N
MF7/A:X\4V.K^"="E\.Z"GB;7M#UOQC:V=UN3Q5+H,L=JD%\]Q/M;2WNV,D40
M*EDZ5N:G:_\ !6>?5/$,-MJ.M6.E?\*YAM8=0AA\)W=_-K\5SI=Q9WFDV0CC
MCBUR2R%];WD<?D.ARZW;NR,OLOB_XO\ QRN?@7^SX]GK'Q6T;XU6]WX;@\66
M%IX6U5;#Q;J<\EM->Z=X@NX;-@DLND2&:W2?RH7<L)G5QMK];<EE#%60E02I
MQE25R5X[@Y'X4 ?A8EK_ ,%'KI?&D_QN>>*VG7X$2?"S1M#AM;[3],^)B?%'
M]GY]#E76M*6.>?R;*#XMMXF+106S6EX5D:XB\E(OV[\.:C>ZQHFFZEJ&DWFA
M7UW:QRW.DZB83=V4Y7#P7!MW9-^0?NL1SUK;(1UR54E3O&0.""<%<]#@\?7B
MOQU_X*$?%3]ISX>_M(?LUVWP;UOXD_\ "#ZA+X?C\3>!_!'A>]NK?QA?ZGX_
MM]-U1YO$7V1[&9K/PVLDEW87DD'E6C_;(F9R%H _8>0N,*J@[N"W0I[CCGM0
M>V<YQSZ$\YX[C].:_G9^+/\ P4$_;>U6;P7/X-^%VK>"!X(\5Z(_Q&N9?!GB
MO4=%U'4!>:Q9:IX-U9+.P:2XTMDMM/\ W]L& ENU).P9K0\$_M\_M_Z'XE\$
M:7KW[.NJ:O;?$WXR>(4U-O%-EJMC'X3\.)H_@1K3P5X;D@MB7DC_ +5UZ]BD
MN=H=;*2,MN4@ ']"_7MZ#WYY]?<=/2CVQW] >P.?Y?E[5_/EX6_X*B?MC7EE
M\(;G7_V:77_A+/VDM4^%?C-M(\*^,[AD\'PR^#4TZ_\ "JO8@:E<@>(=7%TQ
MVF!]'<-Q'-MATG_@I]^W5J.EZ-?W7[)>EZ4VL?'[4OAW<"^;Q!"WA[1;+^S/
M)\.:Y$;/=9^))FO[D173#[(_V,X?AJ /Z% ,],<8!_+('3ZT$8Z\Y)/MVZ<?
M2ORJ_:U^*_Q>\-_'GX7:%'XY^*WPL\!ZEX%T+7/#J?"_X?'QU'XZ^*5QXJ^R
MZMX&\22B-EBL8_#WDL(V,8VR-/O^7%>!S_\ !1;]LK4M2\5:/X5_9ST.ZU'2
MO%-QIL9U[3O&NF6'A>VT[4-3MY= \4W7]G_Z9K]WI5A'?VTMEYELL=QY;N#B
M@#]T,]>O\SSP/KT'^%*5/?!Z_IUSZ\'^IK\#O'?_  5(_:A^'NC_  K@\1_
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M.]"TBQUMM&UC4?[:TB^\176A7]KJ%GJ=I&+*[B:PE=I(BT12X1P<5]B?'/\
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M]: (Z*** "ID^Z/Q_F:AJ9/NC\?YF@!U%%% !4+!1C'X\YJ:H=C'T'UY_D:
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M'<&@VT&I2Z%XG^&'A'PC:7EI+?-#)=Z9:^'[V[@N(XM44J[-LS+\\7F+^\H
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MSG<#70:EX4_X)SZ7X(\/>(M3\%>#[/PI\:)=3N]!,VCZL)-4MMMO-J>IV]F
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M/3PWI'VZREN-?@O[O4VM;6&- )X&O[>[\V09A&QE=@O% &%XE_;+_8E^*?Q
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M!_A[:VOQ7UC4? _PCTG_ (1;PA>6]W:1^)_^$#\&Z@NEW\MG;V^I:7I$&H>
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MO  90R.A9$13FO.D\??L/?M!>.;OXK_$'2O&_@T:MX;_ .$ITK5OB"NJ>%O
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M&#Q5\.[U]>@MU;1#867PC@DLKIP8X!X9"NY((H X+X=V/[!'Q*N?B/IWP_\
M@II,O@[]F#PS\//&</B>VL;O0M,EGA\'6]Y8^&K"S>TCF@&G:#X<\/V]];S
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M1*(]GX;_   _84U_XAZ]!X5G\3:KK?@31=4N1=ZMXDU.3P[X;\.VUM80W_\
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M>ZE'XKM-2TN^UBRLXM6:?3;+[/;$^(/%<,<ENHRD]\6(P2PS=!_:6_8E\/\
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MZUH^@:7X:M=($MU+JUSJD5U:Q:>AO[R>XUB9C=*]NS?9XC=1WDOFRRL\0_\
M!+3X=:[X>_L"/XE^,;,6M_87NBWSZ'X0N+S16LK_ $"_\RRN8M'@FAU#SM @
M,5U%-#)&9W#B:/$= 'G?PP^$W_!/;6KCXGSI\3?$&NW&CR6OP6\8^-/B#XAL
M=#LM0M-&\3> KG0_".EZS-H-C::E#8ZC\.O#NG6[VNZ5TM[J.2269_,3T7PK
M^RA^S!XN\:M\*_#OQT^)'B_Q+\&M#\,VOB3P[8^+/#NH1:9X#M-?T^#X>_#W
M7YK'POY=II^DZE\([1(+='BU(C3FDO99?M",8OB7_P $I_A-\2[&SM=2\<>*
M$DLM1NKY3=Z1X:U"QU :I_PEUKK*:SID=C;QZC-/I?C35HU<E$CE2*5H98A)
M;2>W_ ']B^T_9T\:>(/$W@SXE:S=:-JXL-*M?#-]X3\'P&U\'6/B?XJ>-QX<
MU#7M,TV*ZUV\/BKXJZE,-3N/],$&C6MNYD+W,TP!C^//^"<O[._C_0]-T'4K
M?Q-9?V3K'AW6+/5+'4--.H(_AWP?HG@:*SD6[T>6">TG\.^'].BF$D3,'1GB
M:/=@=AX1_8<^#G@/Q!X%\2>%KOQAIEY\/8]"AT6V35K)M/GM] NYKJ"'4+0:
M4!.91/)'*Z&-C'PA7K7V&6E8$>7C/N3QGCJ!VH7S,$; .3U..PZ<T ?GYJW_
M  30_9HUGXJ>.OC)-8^*H/&?CZ/Q9'JTD&N*=-LU\7Z)INB7XTK3Y;-DM5AB
MLKV>T!+""ZU^_F&6G./4/A[^QK\*?ASKND^(M'N_$]]JNC^.H/'=A=:O?V%U
M-%>6>C_%'0-,TAI8M-C9]%M=+^+?B:.&,G?^ZMRTA*R>9]:9D7 " YSSN;CT
MZ(?YTH:0_P  'U/]* /A_P 9?L!?!3Q\WC]/%5_XTU*T^(VNW^N:G:QZS9V?
M]FMJ?B/QGXIO=/TBYMM,66VTY]4\>:\2K/(Y1XT+D(=UWPE^PQ\+O ?P2UWX
M(>%]?\7:9HGB#Q%!XDO-<3_A&9M7:]M2@M;6ZM;CPZ]CJVF"")(Y(+RTG$Z#
M$K,>:^T5,@XV#KU/3^?M3BT@_@!^AYH _-+Q5_P2V^"GBKP@G@J?QS\4[#1Y
M;#3K#4XK+6-&BBU)+#4?%U_YC6J:(L=DIC\;Z_#'! J6<,<D(2VVQ%7^B?@]
M^R-\-/@9JWA/6/!%[XC6?PI8?%/3(DU*[L+H:I;?%G7O _B/7?[4FBTZ-YWM
MK_P!HRV)5E\J&2:)Q(&4I]1^9(?^60_[Z;^1C'\Z/,D)(\L<>C,3W[%!W]Z
M/S4UC_@F%\*=:\#V_@/4_BA\8+W1=#L)-%\$QSZUHB#P7H=YJ<VIZMI6F)8Z
M' ;R&\D>!)WN7D<I86X4KL?S*H_X)5? 2&Y\)W=OXD\=&Z\)/8/;27\^@ZFM
MX+&P6R+W,-UHI1;B22.*5I57(:,!  :_3,O*1CRP,=3ECZ\_,@Q^=.Q(N2%!
M[8R2?PXH ^5/BC^RGH?QO\+^!?#_ ,5?&7B+7;[P<_BA+[6=-@TS2SXJT[Q7
MI&M>']1TK5["6UGB6T&CZRJ#9@E[)'/5E/FGAS_@G9\$_"7[0^E_M'Z)>^([
M;Q3I^N:[XFFT8R:>VB7.N:O>_$BZM+B&%;-3I]K:I\6/&2+%" 9#<0.9%,<P
MN/O<-*?^68'U./3/^?:F@R%R=@'IRWICNF/UH _/[QW_ ,$[OAK\1?&/B_QE
MKWCOQVEUXFU*XU>PBL/[ L;C1-0N_&&A>-)O.U2VTA)_%%E;ZIX?LH],AU0W
M/]FVTDD4+,'R.4^'_P#P2_\ A+X$U3Q%K$GCWX@>)KWQ#I>NZ=<2:T^BS%'U
MK0AH"ZH6?3G9]5@LU5DD4I&7'^J5?EK]+<R$E2@P><AF]L=4Q^M,/F*?]6"!
M[L<_@$Q^M 'QS\1?V/M.^(A\(VQ^*GCOPQI>C?"O_A37BJRT"'1(I?'/@>:X
MT&>]M+^\N[*1M(O)CH%NKS6R9"W$@0*2K+\^ZC_P2:^!NKZI\2+[5O&OQ#N[
M3XD/?V^H:>+S3XDT[1-2U3QA?S:/82FU;'EVGCKQ)96\P17AM;B-</*LDLWZ
MF9E(/R <'@GG\J8#* 1LZY_48]: /S\B_P""=/PIB_9JU/\ 9KM?$GB*TT+6
M/&LWCV_\2PV>DC6%\03O.&N=.A>!ET]TMKDI%(KF9'C#M(ZF2-^<\:_\$QOA
M)XM\/KH:^._B#I%TWV\7NMVD^D/J&M1:EK%YK-S'KKK81MJ!\^]F5'$D;* O
M)P0?TD'FYQL'U)(X_P"^3S^(J4>8!@*O_?7_ -:@#XD^&G[!WPM^&OAGQ1X4
MM?$'C'7--\7?#S5?AOK#ZK>V@NWT;5H=!@GN(9[6U0Q7JQ>'K((<%0&;CD5Y
M9%_P3'^&<BZNUW\1_'<MYXST?4_#?Q+OK:Q\*6DWC+P]=:!X>\-Z9IMG"=&D
MA\'O:Z9X4T16N-.CCFN3%*SLCNC1?I<1(>JK_P!]?_6I@60YRH_$XH _,/Q#
M_P $O_ _C)ISXG^+_P 0+V/7-"M=!\;P6&C>#-#M_%]MH]M\0+#PN9[?2]%2
M/3Q86/Q'U]!L5WN76&2>0E65O<OC1^Q3X%^,?_"LK2\\2:UX;T/X=^&9/!<F
MC:3IFASPZ_X5E%D9M.>>\M"VBW1DL+=A<6H5A\R["",?9V9/[J_G4860_P /
MY\?XYH ^'?A!^PUX8^$GQ T/XCK\1?%_BW5_#%U/%X<M]<L]$CM]+\.2:'XI
MT*W\.B2RM$DFBBM_%=\XG+"1G@BW+@-GDO$__!//P[XF\9^,O'B?%WQQHWB7
M6=5TOQ%X3OM+TO0+-O#'B+1?B5X1^*FC:KKZ64$*?$.2P\2^"M'AT\ZDJS6F
MFRW-D)Y!-YJ?HA^\8;=F .^<=..M- <DC:.,]_?UH _+[PG_ ,$K/A7X;DT^
M*^^)'CSQ!IFFVFAM%#=VGA^RU>?7]-TWP#H^J:[>>(K&Q6YG-]I_P[T8-;C;
M';RW-Q-$<L@CYW0?^"1?PDT!_#S6OQ&\61/X=UJZOK2\L]%T&VU5]);3'T>S
MT>74)4F^T-]@94NYKB.=+L)_Q[P$DU^LKF3  0'&/XFSP/\ 94TNZ4+_ *M2
M< 8#M_,(3^E 'Y3:=_P2<^&%E96>ER?$SQ>^E/<73:]86NC:%:+?V(U>SUO2
M=/T2YD$LWA6*WU"Q@:5K>1S<J[H1$"FSZ4\<_L0_"'Q_\._A/\-?$$<UQX;^
M$'@A/ WA^W.G:-+'=V7]E:-I%Q?WEM+9&)-1FM]'!E>)4W&_GSQ(:^Q=TNW/
MEKTZ;VS^>S.?PH!E8?,BC/4!R>_8E!_*@#\P_B+_ ,$QOAUXL\4Z#XUT_P 2
M:G<MX+T7Q[!X7^'FKBVT[P7<:EXRN_C#J!L;V]TBR:;3/#?VGXQ:PDL4=I=2
M(FD64EL8FCDCEZF]_P""=_@KQ3^S%\(_V?\ QGXHU*]U+X;:O:>+=0\6;6U8
M>)?&,\-Y'XCU/6+2[>W.J+>-J-Z0TAC9&D60J<%#^B9\P+C8I''\1!ZY/13_
M "I 9-A!50/JWK[J/Y4 ?E7J'_!)7X%W.LQ:E!XI\46T']A-HT]N]KI]S=0-
M:Q!-#N=$OY& T6.V<$S0I#(+M3L=XUKZP^ O[+^D? SQ3XM\;0>+M1\4>)?'
M?A?PKX;\43S:#H'AS2[@^#]1\2WVD7VF:1H%K''IF(_%-_$\>Z4R"-)'D9Q7
MU('9<!4##NV6&./0(1^HI^YS]U1[Y- $=%2$R$$;5Y_VJC*R9 VC\\_KVH *
MEV+[_3UI@$BYPHY]6/\ AQ2CS!T53_P+TS[?6@ 90N,#&<_TIVP>I_3_  IF
M9%_@!S[YQC_/Z4H\P$G:O/\ M?\ UJ &G@D>AI*>6D ^X#]&/]%--4R%B2@!
M(]3CMT) _EVH /D[H/SZ_I2<=A@>G^14A+$;=HW8!/(QUIH$BY(4'VSG^E #
M>@SG_/K4R?='X_S-1;Y"=I3!(]_?O4J@A0",'GOGO0 ZBBB@ J/S/;]?_K5)
M5>@"95VG.<\8Z?\ UZ:OWF_'^=1TT*0Q/'.?YT 2O)MZ 'G'7_ZU DR <=0.
M_P#]:H@N&)R.<_AS_A3J )R<+NQV!Q]::'R0,=??_P"M45)\V>OR^G^1ZT 3
MO]T_A_,4P-A=N.Q&<^OX5'EL]?E]/7_)I: 'A\ #'3W_ /K4*VT8QGG/7_ZU
M,);@ X'<>H_SFCZ<'M0!,IR,X_7_ .M3?,]N?K_];Z5&"W\1R<\>PJI>V\]W
M8WEI%=RV4US:W%O#>P8,]I)-"\:7,(88,L;LKKGC<@SQ0!1T7Q;X9\1WNO:=
MH.NZ3K%]X7U(Z/XCM=-O[>\FT/5A&)3INJ) Y-G?",@F)\. 1D"MXOCM^O\
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MA3PO'X)_X2C0!\2[/POXQO/$-YXH^)=W$R.^O-9W>R%$+J)8R68JV*Q/%O\
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M]G9:K\5/'GAWPQX+\6^('ND\1Z[X(M]-\-V=B]U)^^LH_$4-U<);2'9&;H$
M,*\J_9J_8Y_X*/\ C-/ _CGQ+\3?&_P=\/:1\4;^\NOAMXE\9^(#K<&EV^F:
M+#)XL2XN7>6\@N[RWUA?L4I*;=2=HQM44 ?TPE\'&W]?IZCWIK-G'&,>_P#]
M;BOSC_8$^ _[3_[.GA_QMX0^.GC;3OB-IWB/XC>)?$VB:S=^(]1UKQ!HNAW%
MA:-9P3SWQ/VQ[C53<%@,&&*-2X#-7Z,$M_ WUP<C\P.O- $WF>WZ_P#UJ/,]
MOU_^M41)R-IP._7G_.#2T 2>9[?K_P#6IA.23ZG--.[^$X/(/\R.GTIV.,T
M.#X &.@'?_ZU+YGM^O\ ]:H_Z<'V/I1[X//L>W6@";<-NZF^9[?K_P#6J/V]
M^GO_ (T4 2>8>RD^P//\J822<D$>Q]*;^\YPW /8\#GZ4N&XSDG _P CCIF@
M!ZM@8QG\?_K4OF>WZ_\ UJCH]_\ /K0!)YGM^O\ ]:CS/;]?_K5'_P#KZ^E(
M2W\)(]_4?_KQ0!+YGM^O_P!:E0Y+'U.?YU!F3^__ #_PIPWG.3NYX[\C/M0
M]FSQCH?Y9%+YGM^O_P!:H_GR<G(SQSG'/']:!N.<MP.B^W0<^M #]_)..V.M
M+YGM^O\ ]:H\G^$X/U]^_P"5&3@;CDX^OO0!)YGM^O\ ]:EW\9V]/K_/%14W
M+YP&^7TSV[]J )O,]OU_^M32V2#CI[TTYQQU['T/;^5-_>_W_P!?3J>G2@";
MS/;]?_K4>9[?K_\ 6J',G=LCOSV_*E)?^%L#_//3Z4 2[_;]?_K4>9[?K_\
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M?A9_PD3O'BSMKBU>[^R!B8?K?X^_M5?&'X,>._V<+?1=$TCQAI7Q"^%UU?\
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MP^^&EIX-=+^_LM,\&>"M<\::Y:16^M3RZ[?ZCJ6L^*(8-.C5)+*[T$V"M=3
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M"V[\:_#7PQ>Z-XK-GIL=Y<>(+;1]4\6W5W=,)(DNBC Q6L1CC /EOPI\8?\
M@I_H5_H7@&T\#ZGJUF+%[&X\:^.?A?XAN=2GU#4/'NHZ9KNOW,NE,MC%::39
MO"+&U>XC>_T^&._1_+DX]\M?B!_P41T_Q#?7VH6.D:MX>T_5M2M;?0[;X/:O
M:W&IV$.O:SHEE>?VJGB65HP=,LM.U%A%;2;UO/+3(97/E]S_ ,%.OBY\,M%\
M*Z)\1/@9I_BWQ7XAGTW4+#Q)I?C*7PEX7OO#NO:IK-GHEIJ=WXC\)6]MHWQ
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MY"J>;]L?$+]I+7=(U7]F[_A#;?X4ZC<?&.RT*75/"NHW,L?B_4AJ<%O<:V-
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M/$\;:[X7L-(T/7=$TSQ/XK\)1SZ,J!O]&7Q)X:UZ-5=(V"DRJN),GXX^"?\
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M_$GA[4M2LM8T>Y>*S N8$BT?6;C[0%C5H;,DQAGPOB/B#_@HQ?:C#::OX*^
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MNCX0\.>%+;QG9W?CW49U^%]S9QVTMY)=:3'=ZXUOI?\ HE[=LDT4*-C<LG
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M]JR>-7-L+F_NY6@MH+>-"-P24$!* .V^,WPS_9:^$OB1O"/@W]D:S\>ZS:_
M;7KOQA;>%-2MO"]GHWP,\,W-OI=Y:22ZEXDLH]:U=W\03I:1P>;J3A[AA,@+
M$]#\-?VJ/^"?OP+\'W.F_#?5;'X=>$?#VC>'])TS2++P_P"+[73M2MWF35+?
M2O!]C>0.OB;5K:\\:"74UT]9[J*;5BVH,7P1Z?XYTG]C7]I_QBWA[4/B5X>U
M[QWX*\%ZC)K^G?#SXO:EX9UZ?X6:P-!O=<TCQ@O@SQ%;2:OX!N5N/#<MS'<E
MXH_M=LZR0F<%_E33OA7_ ,$T/$-KXK\4Z_\ '[P/XVLOB-XV\7>-_!.H1?&&
M+3=%^&Z:6OA[7=4LOA%I6DZ\++PC!::7>>%3=75G!&][!J%B\A=+J!7 .T\5
M_&__ ()I>-]7U;Q[XE32/$TOB?6?^$0U'Q,-"\;W/A?5?$%Q;Z79N8Y;11IB
MZTHETJWDU")%NHIG2)KA93BO,O _Q%_X)D6<>CZQJ?PV@^'RZB;K1=)C\56G
MC.XD-C U[_:.J^);*34KB/2+.'[$[#4=25&1) T=PHS7HOB/X-_\$U-9\&>$
M[]->\*^*/"OAWQXWB#1+30/B]+J1O_%GBN\T#7;J2ZFNO%7F7C&1-%OYE:=9
M8H?F&(Y#&^G:^#/^"<NG:)XBAB\:^#KOPCXC\/\ B;2=8\5:I\3X-5\,1VEU
MJK:/JF@?VG>Z^2MZ-2O62*",%N=BO_#0!:T#PA_P3U^)'AOXN^*_!WP\T_Q9
M:?"N1/B-XQT:%/&&FPRRF+Q/JFF:CI&EZG?P6M[HNHSZ+XAEMS;H=/NYHGFP
MS ./&_A=XZ_X)Y>.O GA?XP>+OA3X?\ AMIOC#QOI?B#PAJNH>,[7Q3JGB#Q
MSXQ\/>%O%,?AZ]O_  -XMOV@U:>RBT 1Z!?R*+AM%;R;)UMI"OI/P$\+_LD?
ML_:7^T+H7BW]K/X=?$!?B+:>';;QE:ZGXTTK1(/!?PWECO\ 2O!'A6QM9_&6
MHSV.G^3\1$A@DAN(8G;7+-;6TMA+$K^R^'OV-_V;?&7P]T7P+I_C;QW\2O!G
MPWN-)MO D=_\5=5\26OPYU[1O"FC6_A'5?#E[ID\1BU?3O"]WITFGRS2S[;?
M6Y)!O2\=F /'/#?QP_X)H>$?AQJG@C1/$&C^'/ GQ?UN&VU+P_>/XVL9M3-]
M::+<Z9J,46HS_:]$\*FRO] -G=0M!IXCNK<0MM< X4GB'_@ECK'@[P[X%DTK
MPJOA>YUQM \/Z.VE^,+.66\.BW<3:S"Q*ROI7]B1WC'4R3;&-6D,Q(W5Z_X.
M_P""8O[-?A_PQX'TGQ&OC3QYXG\%PZ= WQ \1>)K]_$NN6VFZ=I6F0Z3?2*S
M);^'UMM$TP0VD.WR1 =DN9)FD[KQ;_P3V_9?\:VFF6&N>%_$4EAIBZ)"+*U\
M:^)K6UN[3P_!<VNFVEU#%?X4)!=SJ9H?)NB'P)P.* /%/@U\2O\ @FGX7\7^
M ].^#>I^"K7QE)XQU#P?X,BT?^WK_4XM?U&R\0V5Y?'[1)*8],NK7Q'X@0:A
M+_HLQU%Q'*3MQT7Q2_94_8;^#?P\\4>)_CAX=_M70_$7C_Q#XFUKQ#XBU'Q-
MJFJR:QXPU[XB^+KK1M*BTR\WZ;HB0^.O&H:TLHXH6M;B::=6D7S5[K1O^"=7
M[,&@-X8;1_#?B+31X.\8VGC7P_';>*=1BBL]3TRZCO=&MML(4FPLKJ(&##+<
M[))(9;F2"62)O5_B9^S!X"^-'P=\+_!OXKZMXM\9:/X<N=%U&;7)M62QU[Q!
MJNCZ;J&DO>Z\T-JUMJ2W-GJ^HB>&6!H@]PMQ"(;F"WGB /&OV8=)_9/N/$OQ
M]T_X/>)M(\=:GXY;1KCQ[:VD+-96'A*V\)67A+PKX.M;E01=Z;:>%=.M[=BT
MLD[R&66<B20UXE\&/V@/^"<'@VWLOBKX<OM(^&>OW%W<^"8].\57FN+JFF3R
MR3VEY):Z/?7L\$4,]M!FXU"W39)"5$TY48'V+\&_V0_@Q\!_%>L^,/A[:>)[
M;5=;\+:+X-GBU?Q1JFLV=MH&@1R1V%M"E\[2W$JF63$MU+<R1JPB@:*!4B7S
M_P 2_P#!/3]F7Q-;>%X)_#_B'3I/!Z6]MHM[I?B6^6^ATZ*662YTN2>_2X#6
M5R)I4G*JDQ1L1S1$;J /F/6_$?\ P3"O)?$=I]J\/ZWK^K_V[KME8_\ "4>)
M[*^,_AW77\1WD7@[6=1UB*/PU9W?BC2I'B^R3VUM>W-FR(7",@N0M_P2U\*:
M1XRU>[M_!]KHW@S4_#>C^)['5K[Q1J>DZ#?V8O-$M9+#3[R^E@CL0_PEO;?4
M;JU4V\C>!9/MCL;9R/I36?\ @GQ^S1K.KZ7J[^'M?L6TWPQ?>$)K/3O$5W#:
M:SHMU?ZYJMG!JTLT,ES+)8ZCXBU:6S:&> *;G9.)XU""C\3/^"=?[-GQ6\-+
MX4\26'C2UTH"_@E71_%]]:/>6&JZU\4==U33+^"Y@GM[ZRFOOC#XW(\Z!Y;8
MW5K-9R6UU96MQ& ?"/A'XI_\$N;KQ?XT\*:SX)U'P+:? /6=<TS1/%/BO4O%
M$7A_Q"]QKOBGP+=ZCX0NX];D:^;[9HGB2*WX6<6EHTT:^2@9?K;X>?![_@GM
MXFTOQ#XB\!:3X:U'PU\+4NU\4ZI::[XA/ABUN9HSJT]YK$LFH"TUG581*SI-
M)YLMNS[5*'BMK7/^"9'[*>NZ.='GT3Q;!"LUQ<Q7">*)KZXAN[CQ-XE\5?;%
MCUNRNX)KA+_QCXFCC,L$@$&KNA#/'#)%]*^&_P!G/X2^%/A9XC^#6D:#,GP_
M\5'5VUC1I[ZYF,KZWM-\T%P"&M0941T"86-E!50!B@#X.^(/[2O_  3M^+WA
MZPA^(&H6]Q:?#RZU[PUX.TNXN-?T+6-=TSP[I.@2W%CIUM87<%QJ'AZ^.J:)
M:V\%W^ZO[J2&-$D=HR<CX1^,O^"=FI:98ZGJ.CVGPV\0?&RS\17LOA7XA>);
M]]4T_1O&/A;68]8M+X+K<]OX0T>;3/BCXAM5MR]ND=WXAEBC43M'CW,?\$SO
MV9)]7T?7-8M?&_B;6-+FN7N=5\3>)+76+[6H95T,65GJ5S<Z+OM;:S;PUH;6
MIT\V,H-EMN)9TDF23T>Y_88_9UO]&\4>']5\.:OJVB^,].\*Z/XFT[4-=O)H
M=5TKPCK&@:YIMA*457BMY+WPWIWVD1LC2QF1-R[EV@'PA\=;G_@G[\;?!/@O
MPWX$^(\&BZWXO\=#P?IE]\.O[0U+Q9#_ ,)-XB\6/K6GWEN^J0/H%C=ZOX^\
M077GRNHD%X2B3Q 1C[:_: TS]F#X/>$? 'C#XVVT=R?A]I4'ACP*\UYJ+ZWJ
MWV&VA_T&VT[3[A5U6;Y4E8R(RQ-+O+*#D\AX;_X)L_L^>"K'2K;PAJ?Q&\/7
M.F7,5W-?:=XBTRU_MV;2KJ2^\*)XDL++P_#;:A!HU[*9+#RH;>5CG[;-=EG)
M]U^(7[-/A?XK>"_!/A/QYXR\?W^I^!Q+]D\=:/K%CH7BS53?6RV6M0ZK+;:4
M]K-:7UG'''<QI:IE4'E-&WS4 ?->C^)OV"O@OJ6E_';1]0\/^%/$7C+0)X-,
MM8]:OO,U6>^FM8-0AAT9KUH)?$'VOQ%!:3S$%D^V;"P4 CS&VN?^"8'B.ZU#
MQW=77A:TUNS\,6T6O:8=;U=[N:W^*CG5H=*DM+&\<>(=32;XPRB..W:<6P\:
MQE!LDM63Z4T7_@G]\ ]#\6Q>+X;CXA7MQ8P7-IH>C:CXRGNO#_AVSOXM/34;
M31=.6R1H8KF73+268RRS2&13LD124KD/B#_P3V\ 7/P]\.^'/@WXCU;X;>,?
M ES8W7P_\8ZE<ZOXB;PW<VP^%5G<7<-M::I8O)J+:-\(?"]O%+)+)"F^Y::U
MN5N'2@#I_%%]^Q3X%\&>#_CEXGU?P?HG@[XD:UIGBGP=XNNM5N8[+Q+JGB?Q
M)XE^+-EJNGXG_P!(236?%GB/578+L2*[=WVPQ@+P7Q'\5_\ !.WXJS^-['Q_
MXF\ ^(;R?Q'IR^)(9M8N&N)O$&J65IHFF:CI\44_^D$6^FV\:3PJT<;6C$G(
M:O4=?_8=^$_CSX#? WX&?$>^USQ);_ C1?#.F>'/%MK_ &98ZQ>7FA^%!X1O
M[ZZL=2TZ_LMFH::UP)T:"1XC*'MIXI5$@\[T/_@F!^S3X7\3WOC;PS?_ !2T
M#QA/=P7&F^*=.\;1C7?#\45]<7T]CHVHW.BR2+:3&ZDBD-R;F=8=L<,T6Q"
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M\,ZGXP\/'2_$%PV@^&?#UI;Z)>;=:U"WN"K)=)-I9AC<F5C%\I7)W>I>$?\
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MXLS_ !N7P1X,M_#<&B76A117UG*+$Z?_ &?J=M>WEO<I#/8W#-O+.!(A.U2
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M2^$EA)U*1_(M]2D@CE>- K?K*Q)RN >>..>#3P0 !D9 S@G\>?04 ?BC;_\
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M\=:WJX\6^)9[.3X>65Q\61J'B2.ZLU237KE_B#I6CVG]C:7J6HQK+8VF'-A
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MNZO]/T[3-#^%$GC9=0O+N'S-?T_5K_P]X\LK:U9)_LR:SO!@282VYXK^!?\
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M@9*$,2>0#G'7TH /E7)!YZ8)'J*83DD\#/I0"I8[B!U/4#G\:0E03A@1]10
M4Y0"<'/2F9'J/S%2 HHR&4G'3</;- #B@ )Y/!ZTJ?='X_S-1F3(/*\\>_\
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MW48M?B=XBCN8[F=I]]INB9%A.0#ZC_:E_;"^.7P@^/VB?"_X<_"]_%?AZ_\
M#"WEYJ]QHNN2PPZIJ-O,UA=QWUG:.MQ90W4:13)")-I8B1D;Y:^??$O[?W[7
M_@[5?B5HFN? W2)&\(6/AZRL=6TZSURXB.J:L-!V:[-8M:!HM GEUBZA22<P
MQQOI;EY,;MO1>#_^"M,_B#7/AY8Z[\&]&\+Z1XQ\<-X6U?6G^*^CZZ_ANUDM
M5N8A<:-X?T*YO7\06S%X]5LYH+>/3&A9KBZ6+$A]]_;._:S^(/P O_AGXW^'
M>CZ)\0OABWA;QQXO\5V&D:I"NI>*5TO2&7P];Z=XA-I<6.D^&EOIH[F^U!W/
ME06S%0PS0!QO[-?[;_Q$^*/Q!D\)_'SX:V'PX\)^*/AQ\--0T S:?K-RO_"9
M?$"7P-H#^#/$TFH:>D5G=WOB3QK/;64$P N(K F+S-ET(?=/VI/CO\8_@WK>
MF0?#3P%HOB+PIIOP[UGQ=XLU/44UL'37M_%_@_PII\5E#H^G3*UE9:=K^LZQ
M?@D2K9>'9!"CLQ"_(.D?\%2M<\1^&-9\8:O^SII5GX5\.W%CI/V^_P#B78ZC
M!#X[;P_XP\8Z5KL][:^$9K#3_AA;67@:[NKKQ +Q[NPAGCN3I1,4PCS/%W_!
M7/4_"WB7Q/X:@^!OAOQ.OA3PQ:7]WXO\/_&[PTW@77=9N#H##5/!NM:KHMK<
M>*_AD5UUH(M=M;)FFO\ 39K%;'S=I(!RTG_!2_X^:1XE\/Z%I?[-EMJ-AK&D
M:IJ>I:AI-EXATVUO996@N(/B/I\=SHL4EYX.N;:>:[DE"-.$A=)0)PR"MX3_
M ."A_P"UKH5MH%CJ?P#N_B['XU\2>(+W2/&_A+3_ !);^&[/PW)J-OX:T18D
MN-&25K-?$VH:4N^1!(;*2YN2NV'GZ@^,W_!2OPU\(_A5^SW\3O\ A"(O$B_&
M_0K'Q-)H=IKNJ:?>:9HMS)IEO/+HMQJ'A-(]9N8[G4T_=7G]ELT<)<?,0E>+
M_$O_ (*I^,?"?@W6)#\'/"_A#Q?>^&KCQ?X-O_%OQ.MAX1U#0G&M#3;%;UO#
MUO)J7Q$F;1V\GP_"H\\70,>HX1R "IX*_P""E7QXUW6=0T6]^!%E,=3^*OAO
MX->"]1M)==MH+SQG\0#XSM_"LNIVE]IB3V>@V%YX(N6UF9T$EI#J]O(\85@3
M]D?L9?M8ZW^T-I/BBV^(NAZ1X)\:Z;XV\4Z/H.@Z=+J,T&M^'O#NG^$M0O-1
MT^_OK.)-3:T/C'2;>\,!?[-<2_9[@1W*2PIXS^U'^W9X#^!?Q5\$Z+X[^%?A
MO7]0\*Z7I'BC2_$WB+Q58>']>TK4?%WP\^*^KW6N^ _#-]H]S-JVCVECX!U'
M3]7U"">.2P'BVU01S+)*!\^P?\%:]7OX_P#A8!_9^T:XL+.TN_!6FZ1)XQMK
M7Q%IWCFW^)GQ,\*>*[ZZ\7ZQH-O!HOPQFTKX9:+(MW/;V\S:EJ%G:W=O&'CE
MC /H_P#:!_;N\;?!_P",WQ)^'FA^#O#?B;2_ .CZ/+-96LOB6]\91/KGA?0-
M=M?%.I:;I>B30P>%([[73:R.LK2;K8N4"[BOSG'_ ,%$/VL?%GP^\.?$CP_^
MS[Y6GZ1XT\#Z)XA\/Z0^K7^O>)!K=_?)J]Y:V]QIJ):>$K73K07-Q<*[W(7*
M10LU?7'[*/[<'P_^/_Q2^)WA%_ ^B?"SQ3:C0+Y)+WQ9X?UC6_'?GI<:+8FZ
MGT*W:QGU&"/1YH([:'4KVY2*TV21PE"H\>^)O_!467PE\7O'_P ,-)^#OB;[
M%\+?&UOHNN>(IVM[N3Q#INFWNGPZ];Z9HGG6T^FW5S%?HNF7(-W#*\;>>D.
MK '(:W_P4[^-6C:SXTT"3]F;4)+7P7I.JW\WC]G\1CP1K8\/Q0W6JW&F7,.B
M-,MG)8>,_A/+:.\:B3_A(]0!P-,G(+'_ (*A_%C4_!9U&V_9\M+;Q8GPWO?B
MW-:ZEK]]9>'+?P/8?$K4/A!]HN=8ETS_ $?5[KQCI-_<V=LZ@SZ5Y=RI^<"M
M?PU_P5RT37/#1U/7_@1XB\,7]WX;\7>,=-34?%6DW7A;4?"/P[\*MXM^(VLR
M>);>P/V"#2;'4_"%M+%<VL<MQ>^*HH;=)(@)Y.!\(?\ !3/3-5\3>*OB5%\
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M/M7TS2-/COO#_A_PG8WFMVVK31:QXJU/5]8E58],BF:V6'R'4W&(WY'X5?\
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MDR7TGV%=/F2[,4-S-:20RA-GF94<7X _;F^$>GZWJ7A;2O@1KG@C0;.X\/\
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M_P#K_$]311\V?NG;_>[?YS1\V?NG;_>[?YS0 44GS=E)'K1\_P#</Y__ %J
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MUTK)XCNT\"ZA9IJND>(IO&>M3R2*+R*R?PAITEON"PQ_V>L[>8^]GKZ=J?\
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M'3G\*W^D26;^&='\(Z]HRZ7XC\+7T2VFI:/X=\/+<2L)+B&31U>SEM_-G60
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M6_QD^'TVC:1-9V^IZC'XFT]K:QN-0>\CLH+AQ+^[DD?3[]5'7-E*#C8V.O\
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MIMIXE.LQ1Z=!X6MYVT^TNQ?:#8WMXFD";5]5T^\,WD7U^]TK1W4BRV;2%94
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MK7XG?\+$BG@UW0+*YC%WJFF-\0IK[3Y@P2/4M!LYF0JK*7:G^P-H\O[/5_\
M S3_ !5;SS7?QFU3XNR>*==THWMYJ6HZIJFIS7%SK)AE22[\0G3-4<->JP<W
M42S=,B@#[['B/P^X8IKVBL4M7O9"NIV+;;*)VCDNW(N/EM5D5E,A^0,I!.01
M63HWCSP9XCUK7O#6A>*=$UCQ!X7%@WB#1K#4+>YU'25U.%[G3I+RVC8M'%-
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MN(OB'I&HZO:Z@=4UG6-=TS5;B_U75I+Q$/B%IH-14QZ]'HXD@BF'W3)R"O%
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M(QG R#Z\#\N@Z5%-+#;02W-Q)';00127$]Q-*(H((84,DD\TC,%CB6-2S,2
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MEDU:WM/$VC>(;KQJ%N-<9(O%6HC2I8KA$"P 7C?(0!7+>.OV!?B;X'T4^.?
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M29/J?S-(.0#ZT4 &3USSZU,OW1^/\S4(8!@"#Z_S_P *G!!&1W_QH 6BBB@
MJO5BJ] !1110 4$9X(_I2-G'R]<^W3\:1=V?FZ8]NOX4 .Z48YSS^9Q^5%%
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M-LS)" ?L65//'!Y.<?7U]?\ .:@:2*-HT>2.-YB4B1Y51I9 -S+$&(+MMY.
M3CFOSQ^.'P9_:U\7?%[5O$_PZ^+7BWPMX&LO[-;P[X=TC7O!MII=_P#V9H/@
MUUCU2SU;PW<7.RX\1)XQ^TD3H7B,00QJ5KY+\0_!?_@J+XF\;>*=27Q&NC:-
M+KEW>^&'F\5_#749O#WG:?\ V>U]X4NVMFDAC:*25E6ZM+9D<X:)P-Y /W&
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MEYKS^!M1L;/P]!\/-9^/]CIO@>*ZNKQ4UZ?5;;X;> $?55S%#-XP94(+QK"
M>Z_#<_&S]J?]C_XBZW\6H-4M?$_BM]?;X9:/X*U75_AYJ%O'X8M9]%T#Q%IG
MB#PY>:9?)%K-_;-JL:3SJL2ZFL&/*C51XAK^I_M]_"OQGX?^&'P+^'_BN7X7
MZ)\+;'_B:^(;SPIXY>Z\>W/@>YN3>W?B/QQJT^K74A\=)9P7:3:A*@@FD:&)
M%Q(.>^'O[3W_  4=\9Z%9>5\,?!OAB:UU"*S>>Y\%:NUM=PWT^JV]Q&MNTT
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MYH /\_\ ZO3H.GI1_G^?^)_.@<C.1CO@C(_ ^V*0,,9[8X.#U^A[?X4 .S[
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M?#NR;X=>&?&OQ8^&W@?3A?ZIH?B2>3Q-NTCXC6UW86>D&_%J]S&U[':QR;F
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MQ+J?PR\=^'/$&AVNE:5J<=AH.GZ+?W@A'CB^97#7UU:_94@R=EJ[*4/<Z/\
M\%3[SQ'I^CW^A?LR^*;Q;Z ?VDDGQ+\*)'IEV=*\1:_^[N+72YUO],71?#&J
M227'[J5)8Q#]E((D.I\-/VR/@M'\/_$NJ_$#X:>"/#/C/X?:'KFH?\(]X;T2
M&"&VMI[H61TN33]7"SZ5J<U_(%EA26XCEC_?QRE2%JIH/_!0KX(:-IOA"/Q'
M\&-4\'&]\-V4NH>&K?P[I=UJ\6O>(-5TG0?"&F^&[+3[J2/4-(U)_$6HE)Y)
M(GCCCD\V)=^" 9OBO_@K-X;L[OXB:%X5^#^KR:KX=LM;A\*ZWXR\<>$_"GA:
M]US0?!UWXLU"/QE+>S>?X0TZ2.SGATB5DN8];GA$$<MD\\#/[U\2OVRO$'PE
M\$?LW>,M>\&Z)XBM/B_X(U#7/%1L-;3P[+INOQV/@8:/9Z!%JDDL"Z7/JWB^
M074US<M]BM+(SYF*LK>2:U^WO^Q5/H7C_P 0:K\+/$-YIUO:?"RZ\3I=_#;2
M3=:_:^(M+T[6?#MQ/:W%V'N;'1[>^@6\N) (+":%HI)$V@GUNX_;*_9Q\;ZE
MH/@C_A7WBGQ?%KOB$^"OA_ /".C:AI/BI9K_ %SPQK][X::75-JZ!8W'AG6(
M;V1Q%^[LU,22JPP =+/^V9ILWP T+X[6OA"YM(;KQ^O@?5_#C:EINNJ+RUN+
M^VU(Z!XBTZ\AM-7LGEL\6M^FZ*0/O\@C@>+:7_P4K6YT_6IM:^ 'B3PWJ5C!
MHB:19ZC\1/!7]GZQJFNZW\/](ALI];VI#HEK#%\2?#D\]S<+A56X01L8T:7L
MOC'^V'^S]\&O$P^ ,O@1K[5/#R:?=:;X?72-+A\(PPV\"WM[%8O;32"UU.ST
MV9Y!%)!$7)VJ<'=7E?C;]L7]ACQW'>?#WQW\-O%*6UMI-E\0[S2M3\!V]C;7
M T"9O%&@6=]=6^H>1YU]#X#CGMX)YEBN(].@CE*EE2@#2/\ P56^'+Z)JNNV
MGPM\6WD%GI-U#I]A!XF\)RZUJOCC2K3PSJ&NZ!%HUO=R7*^%8;'Q9ISV>OQQ
MSQ:HT4D-A92SR64=WV7P#_;.^"?QW_:!UKP'X1^$6OVFN>)?"7AKQ;JWQ*N;
M?1;[PWK>HZ5X.\&>(+*R>6*<F\NK'1?&FCVUO?)&[,UC)$PACBMC+Y7J7[;'
M[$>K1^#M=T/X0GQ'X>\;7S?"[XA>))/A_IL-GX(T'PSX2^)GC*X\->(&\PR7
M-U8#X-WDSV<2/#':68NA/F%8S])W'Q[_ &5?AWI7@WXT>'/!4D\7CVU\2>%/
M#OBOP/X)T^6_G\&?#421ZIJTETES"4\#6VFV$5Q!.CN);3R9(HB&5: /!=)_
MX*'?!/P!XF\=?";X=?!_Q)?:MX<\4ZI?2V&A:YX;BM_$AN]8U1/%/B[^U-6U
M%4GD2YTV]FG(FN7D("M(LF47Z4^,'[:G@'X3>#OAMXT?P[KWB;2_B1X2G\>V
MPT[4/#FGOI/@^QT*+Q!J>I3/K.K6\>IZA#9S(%L;61YIW#"-MHW5X+X?_:]_
M86^VZSXMT/X::A;)J-Y?SZYXTMOACI<5I>)+J-[I9UB[OH[[SI[*]U2.\AA<
M1EY9&.]%#;C9\=_MC?LK>);6RLU^'"?%;2/!NE'7/AOI5CX5L-3O+WQ-H5MI
M\TEAX5M+V18+>/3].O1]JG$B_9C:RQ[':-EH XBS_P""F.J7<&E:?=?#[3M"
MUXZYXJ;5KF>[BUW1[WP3::M\6-$\*:]HUKI?B)+FPU>?4/AJRWNGZBT$\*3R
M/$&(\N/>U;_@J3\&M$T>XUW6/A=XJ@M?[4T":QBCU+P)J.IZMX5\7Z;:ZZ/%
M5OI&F:W<7,%S'I=_I4VHV,T:36DE]'%=S1_*S</X(_X* _\ !/FX\'ZEXI'P
M_72=4O+/PQX]\<:9H7P[M=4@D\7>+M/\/IX@\K6(S%#J-WIEUXTMK;4;N<VT
M:BYD=2X+XS?%=C^Q[^RSXDM_"L7[.7BSXOV_Q+G\#?%ZY\0ZE:6WCRXM1XO/
MBW0-)CTBWUV\>5M2LM+\#,_DQNJR6[LYD,B$. =EX"_X*5^$;C4_$ECJ/P9N
M-'UF>ZNM2O\ 1/#=YX02XNM&L(TEU/Q3K&O:EKEI#JEXFC36DGV!8#>L[F"-
MIBH+?2GP3_:H^&'[1<7CC3K7X7:SIGAS2?"MYXKTZ?Q1IWA.^TKQYX0BG-E?
MW=KIEG?W#VA^V11Q/:W\,3,>2 %P/.OAW\7?V!/C7XX\0?#_ ,&^!O#&OZUH
M5M+\1-3N6^'5O_9,VIZ+ -1OY8+\0-YWB.QP/.B**RR+L1I",50T3]OK]AGP
MS_85QI;R^&Y_%-SX@\-Q06O@5K74++3M+U>*'4YM<LK#?+INA2ZY>P!#(F7E
MN5=XD!+  BN_^"@W[-RZ7X5\:+\,_$&I6>F>&=&\:S:K9Z-X FO_ (<^'/$&
MA6U[?7S17'B%+I=1M],&GPSV.E)<7TJM$D4$J*,<_=_MW?LV6NDZ=X?L/V=O
M%&L:-J>FCQIHOA_1?"/PHN-+N/AI:66L^-H?B-/82>*4MM(L8SI>LW8L+D1:
MM%='>;-9[A2>-N_'/_!.JZU[X?\ Q*T_X7:3I'BC0O$%CJFD>'-9\*)X7M[.
MQ^*&H^!!)\7]?T2-989;*.PGTMM/U*>-G$\CV<1B>>0CT33_ -IO_@G[X.O[
M.VC\#6OA2^^*<6M>+IHF^%LD-QJ^C^*M-MX9/%NJ0V-O+(VB:Y9/';VTNUOM
M)C:)XXRK  'H_P"TO^TEK?P/UCX7W?@/P'X&N=!\5:7/XC\5>*=>2=[GPUH=
M[>Z>L;7FC^$Y3JND:=<R7L[3:TMEJ=E;3Q;+JVPQE7S3Q1^WS\'/">K>#]0\
M _!N]\5'Q5<7OB[QQ?>']-\#Z=JMKI=G8:M$_B6PO[W7;1->UA/[,G?$SI<3
M6&6AW3$05]%^'_%'[+O[5'POTWXR77A70_%W@?P'+K-YI=_XP\,P+>>&O^$5
M:1M0E@LKA7>S2-;#>L?!(B7Y W%>(^ ]=_8'^*_BZ'P1X8^"^B7OBOQUJ]WX
MOU/2KWX7P6,ZW>A6J7EKXK\023H%M+::TN4:RG+-YPGP%!)  /+HO^"H7[-I
MU^_L_$GPG\7:]XMU'0_$>HW&H>#?A]9^)+>[\+6__"PI?!&DZIJFHO;S_P!K
M:SH'@?Q 4LY%-O!<7:VLD@\XE>U\-?\ !1;]F.+59-/\/?"OQ;H^I_$30-%\
M7H+#PU\/=,_X6'XQ\7Z[I?A:#PA'=6_BA$\1^-/[9UNQ@U"2=VBLA.W]HW%O
M@ YG@CXE?LN?%3XI:YX4\?\ [-O@[PA>6^M^)/AQX8U+7-.TZ[US6#KOBC6_
M#NIV>IZ++HEN=.T[4Y7U:\AN+:XO[1K;4F$TT,TOEOQ&G_&[_@GS-)JWV7X"
M^&+2PTVR\'^!/#>NW/A#3;/1/$OPO\3Z/\+_ !7<ZGHNI"T80V6FZ?\ $;PY
M=7UF0)E%LLB.YQL /I[X0?M3?!S]H.W^*FC>"/@_XL2Q^''A:XN?&<VO:!X/
MT32+?Q!<Z9/J5YX$@N=/U^::?Q!&% FN;:)[ 22"2&^EQN'#_LJ?'?\ 9Y\3
M6G@GX4>$/V=[GX6V_B.#Q%IXM)M&\#ZEX6M_%9L=3UWQ)X3U#5;+6IK_ %;6
M)M$MKFYN+J:R:VN%E$+W3O\ *'?#+]M']@OP_I.EZ)\,WT_P]I/BU-4TUM-T
M7P3<:=;26GA#1?+(U)+> +-"=!M4%LJ&:5X0@*)FH/ /QS_X)Z^&=7\.?$GP
M+H7ACPUK-]H=U;V7BS2_ TEI<:)IEY<3P06&IW]I;L-*GO[BYFCMHV;?,;AD
M.W+  '*>*/V[?V;_  G=^-/A;\,O@K<ZT_PH3Q]X0DT!/ASIOA;P+K=KH7AW
M4->\9^#O!.KFW%A;++?VEA!<P7$5O;W!GDE\NX$+-7.>%/V_/V:?!_@I+7QW
M^S=K/PSF_MOQ7X;\!^"_"/P[\%:[I?C;2?"^O>/?"M]!X'BT6^BCEGLM,TSQ
M*FHVMQ!8JO\ :5S%8_;8;G?+Z;XO^)G[$WA#QU\-?$.O_"32+=?VHO#'B7QN
M?B)<>!MK/::6_ASPZUYXOM18-<6<5Y:>,K9&N90JK"3YO##&3??%?_@FIXZT
M32?A[J&A^ ]7TFR^(D?PHTKP_/X+D*Z9XLUR\'BU+6)3:?\ $O@O;RYDNB^Y
M7F:67>FXR"@#U"'XU_!'6OA5\:OC_P##KX"VM]+X3O)K+4M1U[P)X0\,ZG\2
MM3TTV^B74-O=+++?7+11WMQ9*=5BM7WHT.T6[>8? ;S]L3]A/5-7\/:=XF^
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M;C0O!FD2ZQJ4&G+;M>S0I+% L5O]KGBB1VFFC&Z66.) 2\CJBE@ >8S?L?\
M[,=S::797/P9\(7-OHU]/J6GK<6]Y-)%>W!#332W$MZ9+P%@"%G>1%Q\JBG+
M^R'^S2GA_4?"Z?!_PHFBZJUR]Y;""[,K/=7%G>.T-ZUV9[7;=6%G)'Y4B>4U
MNIBV<@^7^ ?^"@?[./BVPN+GQ/XNT[X5WL/B!?#D.G>.M?\ "@34[U]+76/-
MT;7?#NOW^F:Q:)8L&GDMKV46S_NKGRI/EKT7P9^U_P#L\_$?QKX0\!?#WXC:
M/XWUSQL?%2:._AAVU;3TD\'Z=_:FL1ZAJ%J&BL&^R!C#YC*)S&PB+%6P .N_
MV-?V8-1CUN"\^#GA6XB\1:9HNC:U')%>E;[2?#]M;6>EZ=)B\^6S6VM+9'C&
M%F6 >:'.376Z!^SC\#/"OB0^+?#_ ,-?#FE>(5U.VUB'4+2VD1K/4K2"_MHK
MG3X#-Y>GG9JFHEUA2-9'O9'=6=MU4T_:1^#\/Q*D^$.K^--$\/\ Q&F\47OA
M;1/">JZMI<6L^)+JP\,>'?%=Q=Z58P7LD@M/[/\ $EFJ^>L,CR0R!8ROEL]3
MXH_M1? SX.>+O#/@3X@?$'0-#\6>*+B);31)[^V%]8Z?+8:SJ"ZYJ\+2@Z;H
MGDZ'?C[1+MC+( ">< #]?_99_9[\4^.=3^)7B'X6>&M5\<:S&(M2\07=O,]Y
M<@6HL=S@7 3S#:*L98*&*C!-4?$O[)'[-_B^[GO?$7PF\,:E<W7AF/P?<O)#
M<QK/X=ABN8(-.FCAN5658X+RZ2-V4NJSL P!KI8_VB?@7-XNT;P%#\5_ TGC
M+Q#>W>G:+X:7Q#IQUC4KZR=8Y[6ULA<;Y)A(P55QEV^5<GBL'4_VJ/@/X?\
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MW$VZ3 "LYS7UAX)^+7PP^)5SJ]G\/?B!X/\ &UWH"V+:Y;^%_$&F:W-I"ZG
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M*0>.?7 I%."2<X]O7_.:;3RPV[<'.!]/>@!V\>A_3_&FAAN)YP?_ *WO3**
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MQJEYXO73])T.VM]8N/$&I?M WE]?WUKY(7,MM\<M2M$:0$?9_#5N@).\G?\
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MPD;*A(ED0Y7[P /R"T;_ ()>Z?=Z=?\ B:Y^/OA:^\.:=;Z];^)+?3K[68O
M?AC6+?4H[Z?3=+TPS^1_8ZRJGVL73^=OQC-=SX=_X)^>*/%=O\0?' _:5\+Z
MUX1\<V&KH+O1H;Z?0;,'1/%.AK=M'/<&&S-K:^))49 <,MA&[X)P/K7P%^R+
MKG@C]B_Q/^S:D_A/6_$6NIXFGO9+Z_U_^P-4O=?U?^TW&H:H(S?02NBQ@S^7
M(4=%)BD0%3\TC]B[]KI/!%QX"TOQOX"T[PQXP-]:Z_IO_"4ZG:R^%](7Q1X*
MUJ*W,_AKP-96OC?5;O3?#NM6%S<FRTW%MK2QR"<K([ 'G]I_P3"\5W.BZWX6
M_P"&@O#WC.Y\87VMZ_%:^*]4\3:W;ZMX0U[49[ZV^)/]FI= 1^.+.?5;>WM7
MA#Z48[G#$LR"OKW]IK]A_P 0_'OXIZ!XYL/'EAH6B6'PEU;X;ZUH6H#6+J#5
M6NK/Q#%8LVFVTRVHMC>:U;RRSL#<*+ 1H&4@CX^D_P""<W[5,?@/2+7PU\2M
M$\ :UH/AOPCX+TSP]X=^(GC'5;JU\#^'(O"T.K^#K'XE:QH2ZA9Z3J7B3P\/
M$+!8L12A=,54MCA-^3]AW]N*RF\0QVWQX_M:&\\=^!/$VGWNL_%+Q@^H:@="
M34UUB/4DLO#UI"F@2)<V8&FVL=DQDM2TDURJ@2 #]._X);?%F37-=UOQ%\;M
M!G>XN]&N]"@TRW\36]IH5]I;74)U[3[6><KINL#39XH(VB.S;'N..*N?#_\
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M^/H(=+UOPYIV@?"A+_1/"U_<^'DCT/Q)<ZYH?Q!QJ#@)C6,OM65/( .CU?\
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M0=8DTB[\4W]GI,<L_C*?6%TK%Q:2K:%OW3(DA,9 (_"_[&G[3^K1^&;3QO\
M%[Q)HVDZ5KFCW4_AS2OB7J-UJ+0Q>*?AA_PF][/K,,>;U=8\+Z-\0FCM^EHW
MB!$&UW;:[5?V-/VN-4E\+ZN_QMURUUO0/!EIH[I:>-=0CLKC6_"_PX^&6F>$
M[N[MO*V7F[Q_H7C:]O';F:/64WY+8KJOBC\!/VN;G]HGXA?$/X8^)/%6E>']
MNJ>*/!4TGCCPV^B76O\ _"&6.@Z7X3'A?4UD-MX<N-0AO);X2+"^_P N6"X0
MEF7V#]DO3_VR-#L?CS<_M.ZS<:I=+J4K_#D&U\*'3Q);R>*;R_O/"C>&-6N;
MB;PG)97/A6*SBU."VOUET^Y\R-M^$ /GV[_9(_; U[Q!XJ_M?XKZK8:%JFKZ
MQ?WDUEX\O5F\2ZDG_"9W7AC7+"UAC_XIJS@.J>$[:2R&-_\ 898@IM)]8_:=
M_98^/GQZM?@M9Z#\2-.\(2?!OPY9^+(-3G@&J7'B+XPZ=%96FGRW&9D-K81Q
M0W,HN?F/FSY"FOG?P/HG_!2_QS\,&\3:?XF\=>$=2E\#7FI^&],\?7WPM7Q-
MJOC2?2?!L4PU6QTVT,5EH$MVGC.72+69K6Y@>>V&IR1J-E5;#0/^"J?_  B6
ML6-UJ'C0^,Y?"Y/@_6[K4?@I:Z'86_DA-4M_&FCV>M7,M]\1_M&\Z;)93KI1
M4J;LIR* -K7?V6/VZ+?Q3\/?%^B?&R_TR9_^$J\0^-=%N/&Z/H6F>,=5\23Z
MBMM#)=*);KPR_A(1:;#!;*S6N9)B/F+#UCX4?LU_M1-^QM\5O@U\8/%UKK/Q
M)\1>.-.\0^$GU3Q')JUE+X3TU?AMKNI> ]5UG3VWPZ5JFN^'?&UG*RME;3Q0
M7?!+J/ M8^%'_!1'QA_PBD'BZX\>:[<:)I7BO4-)FFU[X8>'?#ABU+P'\3-%
MTVS\=Z5H?B"2ZOO'B:WK/@X1O:3MIHBB>:2..6)VCS/VD/&?[='P"\'7.O:U
MXT^)FKZ7XU.O/IT/@^W^'VH>,M%^)=S<_M!/X'\(^%F?3#;)X-;3[;X)FZM;
MJ.>_NY&D@L;F2YDN(8@#HO$/[,O[6-O\2+?4_AKI$OPFTCXB:[K'B"3PAX&\
M:VUEX'^%NH^'=!^%^@:5XF\0FV4V_B*YU%](\47)TVU 63[:^X>89#6QX(_9
M<_;]TG3_ !%)XS^.&N^*]5@;Q1J.C))XUM]*TW5_$DV@RV>@W$::;$SZ?H#:
ME()&M9\-&R@M@"OJG]ISQ7^T+H^D?LY:?\'=;6S\<?$+Q-;>"_%NDWVEBXCA
MTG5-&M-5UOQM/*MI(MA/HW]E2QA)"D4C^(U4AF1%/PG+IG_!7ZRTN\AGN]6U
MG5U\<B2UGTR?X76%D+&RC"O&HO-2WWOA"[*@H)!:W,3L3YS+@  V/"'[&_[;
ML4EEXB\5>.A+XY_X1G4M'M]=?QVMR^A+%="^T2UCM8]T4E['=W5VZ7<8+1^0
M QPP%;ESX%_;(^'O[1_P7\"1^(/B?XU\!Q_$/P_JFE>)[77KZ_T#P]\,K6_\
M7W_CNP^)%W+;+'XCU*^M;K1[6V5B)++[!:N,B85]@:GHO[7%G^Q_X^/A_6[V
M^_:@UN/QCJOAV#77\*3GPU)>:[>QZ'HFBFR:+3W,'AR*S>U%S/*/M%P1/,1E
M5^.X=-_X*EQ1Z')J5[XMO?"J>'+&'Q(FBGX46/Q+FUC_ (6,+F_NM(2\U:33
MT(^!R_9XS+\S^*V$S6T=H#;@ ]B\0?LT?':R_:(_:&^)?A;35N+3XFW/]H>!
M_$$/BGP]8IX>O8OA;X=\'Z=<36]XC:A936^NZ1-,PM\1NAR%RQS\YZ/\#O\
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M3X;T7^S-5T#5];L=-?PS$;R4>+K2]@L-.;5)A93)9O>&.V$:LT\'8Z+\=?\
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M 'S+X[^+'_!2FRU.'X<1:1+J$>H>#/B5H4OQ \%?!ZYM-0'B5? ]EJ_AKQM
M^H>);G3+"TLM?O+NTBM'FBGN9;&-HK;4"9HE]1_:PN/CO>>#?V:=>\)W7QUN
M-1@^&FI:EXFT'P1IOC'09?%OQ!N],^'=SI%EXCU3P!JD=WX"\=I/!XA_L_\
MX2+1M;\$;M1U&#Q#91/%9.<S]J']I7XF^$/C!JUY\'O%?CNZLO!_P;\<>,]7
M\(ZCX#OX/AY//H?AKQE'8Z98:E/X5+ZSXUN?$]AITQ,M_!;6=GH4C()?M:I+
M<\0_M7_%RRMM=T2SU2P-W\._%_P?TG177PSKJZ_\3](UGXA_";P3_;.I^*)H
M_P"P-9L/&&@>-O%&IZ?;Z-''<V)TE9)2$@F! /'?BK\??V\M8U7P?9>'/ ?Q
M6\!O\-/%%_+XRU+2_A%<>*M.\6:E'J/Q-TWP]X;E@LM=5/%GA2]TNR\"/=:C
M8 0VLNJ"Z9HOWD=M+K?QX_X*6>%?%]UI/AWX76L^AZG-XMUE;WQ;X,\8^+%C
MO+V>W?[%8S>&976PTC38#*;&UFN8&N22(OMN/+/U)^U[^T?\;_AC\0/ G@GX
M9^'XA9ZA8:3XHN)V\)^)_$>J>,VCA\9RZSX1TC4-(0V/AV.T71-">[EO5\V9
M=;C2U9'&3Y9-^VA^T-\1HO%EYX#^&2Z7X(\,V46H0^(!X7\=VGB/Q)<V]];6
M5UI6B1:JD*6K)?&=96DM9Q+"A:+'WZ /&C^U9_P4PCT72[[3_@C?:OK-[\%_
M$5_)I5_\(-<TJ.S\?Z9_PD<T/B74;QM= DT:6&RT?[)I420ZU-)+Y3Z(1<K<
M6O:> /B__P %%/BE\0_"?@#XB^#;;X?> -3\&-KT_CKP?X2\::5KFK7'A74-
M?\3Z5K\MSKFDPP>%;W4M5\*^%-!U+P]J!L[RYT[Q;J-S:VL F@ET^WX[_P""
M@_[07PPM=/;Q[\/?AIX6DU*YAU+3-2U31?'\&FZ]I]_>7=KIW@;3+1-9::#Q
MJXMT>2_F<Z=&&"R6\9>,-[Q^VC\9?VE/AY\4?@_X/^"!T^+2_'%CH\%Y-J7@
MC5?$U@?$=U^T=^SIX0FFU+4M*FC;3=*MOA[XO\>374)D@:>U:XGCFCDM$EB
M.3\(?$K]JGXJ_L4?$'5?B1I7COX=?&BP\2_V/;ZKX&^&6KZ7JFH:-:^(=)FN
M=5\.>#-3\26NN7/AZ339+VUFE@>RUI+=)IM/2ZN(X9[CPOX??$S]O+P18/XQ
MTSP=\0O%?A#2-(TSPR/!'CSP_P")?&'B/Q&D^L:BA\=^%]1UJ[\/ZK81PV:6
MSG3]>M9=4:%MMU>O+B1O??V=OVT_V@/BO^T#IOPF\=? 2U\'^&9/!-OJVI>)
M4@\4V-W#K*>&_"^JW>I6IU2)K9_#D^KZUJEG;VS/]KB.CEI)I275>4\6_MX_
M'=/C'XT^&'PW^&7@SQE'H/Q:O/ADMS#I/CRYF\(1:?J_V)=:\;W]O=):7GVV
MU5C;Q6;1?9W8&Y?;P0#SW1_VIO\ @I)K/POUGQC_ ,*9\/:-J_AJQUR>;3M6
M^$GQ#-UXBMFUOP#IUCJUGI47B)=1AN-/TK7_ !=?OIUMI][<ZC_PC(MK4DYF
MF^@OB#^T!^UYX?\ @3^S_P",M&^'=C/\0?&6F:W=?$*VTKX4>._%MNGB>RTJ
MYNO 7@W_ (0R+Q+IVJ> =/\ $NI);07>M:G)-;>'0S'4(D5Q)%XEX3_X*'_M
M&ZYK=SI/B3X'>&O!5M:>*=7TQ-6U'1/B3JD&HC2)]:MXO \%GI]N6M/&.H#3
M+:6TOGDDTY8[W;) 2$,GFM]_P4C_ &L/$_P_UBXL_@78?#7Q#<:REEHFL3>'
M/'/B*5[B3Q1X*T63X<VVDFS*Q?$:#2?$>L7\E_<&729(/#5T@MXY-CT ?25C
M!^TMH_[*6E:C\2?$/Q?O/%FN?M%>+M7^,5WX)T^ZE^).A?!;4?'WC=K'2_!&
MEZ;!-=6FGVFGKX*A']AP?;?[,2>:R5I&+GD5^._[5OA&YTCPG\)/!7Q/\8>$
MTTRW_P"$2N?CO\)_$>K>//$>@7\;M<^-O$GCC1/$.G6NAG2[IDB@T+5;)/$.
MI0()+DPR[FJO9_MU?M':)X9BUK7/A3HLFAC1]#TU-<UO2/%EIJ6E:_-H7P<U
M36_$_BU8IH(+GPU;S?$[54-K9Q074C>%I4BE+EUC]_T7]LWQ#=?L9:1^U<WA
M'1?$4<,XN?$>E>%Y-4AL;S0(M6FT>XU3PO%JDGVEI'N#9-##.S-MF8-N*T >
M1Z;\8O\ @HNN@WUIJ7AGP!>>(]2FTS^QM9LO@?XUT_3=!MK;Q/I6F:M_:VBW
M/Q<F;6)KC1K^]N(BEY9K;?V?N*SIO Y^']IK_@H+H^C^#5\4?"30KCQ)J-[H
M%]]DT#X/^/I[/QGJ/B/P[\$]9/PLDN(/'%U%\*9-/G\:_%6*Z\5:I/?:7O\
MA[&CV\,[-;W/$:I_P4N_:1TF?QM9:M^S79Z->:++H]MHL3Z;XUUR:&;5;W0A
M:7.N6VG,D<NG76G:Q,8I8;F'R9=/D$@E7<J_=O[/WQ\^,WQM^$7Q*^),_P -
MM$\.:QI^DV#?"WPC?IX@T^\UGQ!/\*/#GC&XM/$\NJ>6\-D?%_B(:8CV\43)
M%ILQ<M+G: >;_#SXS_M@6_P2^*_B'XK?#S3=9^)UE\-O!OBGX:Z/X&\#>(_"
MT4_C'XA>&;9H/ 5]9:UK^JR7TVA^++V"+4K\-;JENDLLUI"(&9OE;P9\;/\
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M\:_I&F327>K7TFGV-O;HYDB@D<;HR6"MQ#_\%&?BQ=7R:7J_P%LTTR?XV_\
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M%;V^K7'A'1KRUN-9TKQI'867BR_CT1KNVU"\C51=:*KZI/Y;*D+D6I'G.=V
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M5MXTT+2X&V>,O D,_@+2)=56"2*33K9Y)O,E+A%M2_\ !6#5['6/%6FW_P
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M<> O!.O_ !(^-&GZC>^);=&73;'2!>2:+J'A30M,V)F5Y+36)(',F"IMFE<
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MM]=\%>&Y)[VQU#33JUKH^G66OVMKJP*ZG'I^MP6HN=/:X0NLK0R*T@=MQ.:
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M8HO/D**"[4 =W1110 4H;!.TMS_>'3\2/>DHH **7GL%/U./R]:2@ HHI1]
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M(]7\2>(K.PB>[T3X4W^B_"[3O&'PUT:UDE,,LNLR_"C0!>7ERDR?9;B:W%N
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MZVM[RRGANK2ZACN+6YMY%E@GMY4#Q2PR*2'C9&4J0<$&IZXKX;^$9O /P_\
M!G@BXUBX\03^$_#6C>'YM;NH(;:XU632K&&S>_FM[<!(7D:(L50;1NP.*[6@
M HHHH >J@YSFFG@D>A-)10 4444 %%%% !1110 X+D$^G3^M-HHH *>RA<8S
MSGK^%,HH >RA<8SSGK^%,HHH ***#GL<4 *,=2< <D_I_,BDZ<>GXT<]SD]S
MZT4 /VC;NYS^G7%?DY_P5 _:QU[X;> H_P!G'X)_\)%-^T-\<;OP!X-T36-"
M9-/L/AMX?^)WQ+\-_#%?%?B+Q+,=GAF6\N]?N-/TJX 9TOYTE  A)K]4=4O+
MFPTV_O;33KK5[JUM9I[?2[)[:.[U":)"R6MM)>31Q),[#:ID=5!/+ <U\"_&
M3X/?#KXR>-_AS\:?BS^RUXXD\5_!_4-(\3Z!K]Q\0O!.@65H_AG6;+Q7I'_"
M56]KX^BM-;TW3]>TVTOX([Y)8K>XMC-'M^;(!\4_M"_LK?M'? ?]CKXJZ_\
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M4K'<<]* $IS-NQQTIM.9MV..E #:**D\SV_7_P"M0!'10>I[4XME=N/3GZ4
M-IRC<<9QQFFT4 *1@XJ5/NC\?YFHT^\/Q_D:FH **** "J]6*KT %%%.*D '
MCF@!M%%% !12@9.*",'% "4444 %%%% !7BWQ^^.7A;]GCX<WWQ&\6V6JZG8
M07]EI%CI6B0+<:GJFKZCYQM+&W5R%C#1V\[,[?*BQ$XKVL*2,C%>:?%GX1^
M_C?X)U'X?_$72&UCP[J,MO<M%#<S6=W:7MHS-:7]C=P,&MKR,R.%89&)""K
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MQ9:VEIH\$>H:3::C)XR@O--UB*:Y M-:L;CP+KT5S;;M_FQ)&F6<5]X_$O\
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M?#&Y71H]/TG7?%.GZA<^'8M"NH[W3HM"NFT!1#$MU$&=;A+@/DAN#BL[2_V
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MR_\ ","VFO$U65HX&6"V>VMIG0N1N$9QSU_.WQS_ ,$3?V</'=EI&C:CXO\
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M^\@%" P=>67(QD;A^(&!3SU/:G*">AQC'_UJ;0 4N6'0@>N1G^M)3BI R<4
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M<$<$]B!QC]:9D^I_,T9/J:   [L9YYY_GS3MC9SD9]<G/\J92Y/J?S- $H4
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MT]2H'(SSZ _SI^Q?3]3_ (T;%]/U/^- $-.*D#)QUQ_.I-J^GZG_ !I2 >M
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M*4&.!S]3Z_6@"*BI@@P,CG'/)Z_G1L7T_4_XT 0U,GW1^/\ ,T;%]/U/^-.
M X% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
K!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g1078494.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078494.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" -6 I0# 2(  A$! Q$!_\0
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M!M%%% !1110 444$@=2!]: "BBB@ HHHH 7C'?/X8_SBDHHH **** "BBB@
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M:MI.K:K=^5H_Q+U7XA:YK=Y;HUE%I4J?#\1Z-(\J_;GN76\-G]GN3!?\2_\
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M!_B;XN\0Z%J-OX\L?#=OKWA6?P/;ZK,S1'56FL7O8]=M)88':]AMU:Z\Z.X
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MXH;BXM&D7::[GXT?&+]F;]GCQ5XCU+1?V=[?Q-XQ_P"%:^%8YM5T3P7X:L]
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ML=IXE>]T'3M+G^(^CRR37MO$TIO[JYMP\$-S.G%)_P %(/@UX,NM:\,:_P#
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MG\%G7'L?%VAK\._AP/ GA%+C6UTVSUW7-(CU[[+J5E=:G)$\;V%O>2GS!(R
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M%'Q?CO$U#_A(EUR2PT>W^'VB:;HFJ/9V5Q9+%X<G@M?#%O*UPPCF+VH99/N
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M]2UCQQ83:9XINKE'<:O97%K]BN(KF$OL_>6H".0 6'7- 'QI^SK\;/V*]/\
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M613ADO9$X7:!];5'--%;Q2SSR)#!!%)-/-(P2.&&)#))+(S$!8U16))/ &:
M/FVP_8__ &=M*T7QYX=TKX>V>FZ+\1XXHO$VGV=U=0V\L4+B5(K&,2XL8_M
M\QE08:1BQ!S3/&/[(/P$\<^'?AWX3UWPA,?#_P +;>\L_"&G6&KZCIT=K8:E
M;36FJ:?>/:SAKZQN8+B<3QN=K^:>@.*/A-^V)^SC\;8?$UU\//B5INH67A2\
MMK+5=0U>RU3PQITCWEP]I9W.DW_B*SM8=<T^:YBDCBN;1YH)'0JLA(KW+_A-
MO!WVZ?2QXJ\._P!I6LEC%<Z?_;.G_;()=294T^.6W%QO22=W00@C,A8!<Y%
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M])UVQCU+1=2L=6T^:2YABOM-NH;VTDEL[J>RNXDN+=V5I(KNVN(G4$E7A96
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MXRO-0N7\57&L_;[74H+F36=-O!K@_LR_U"P%U%>I:B .TP+,Z+L(!]9_"?\
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MR0_V9J'PZ\36TL;;7E@\3QO%.@^T1R@&?_PZRMK'Q5X0\1:'\2_#%B?#.O\
M@?7B\_PI:XU5I?!^BZ7H+6UG/#XSALY+::QTF(0C4+#46LS*S6S(P!KK_P!H
MC_@G%J'[0?Q]U/XP:E\9?[!T'4] 'ANZ\'6W@:22\NM'DT/4=&O-(U#Q%8^*
M;5M2TF5M0$_DSV[A7@ &,YK?^$O[(7Q=\*_!/XV?"[Q;\3A?WWQ*\8V>LZ1J
M]OJ7B.]NM,TF.XTR36(9=6O-1-X?MJ6EX%4SM)$EWY<DTV"Q\HOO^"?GQ<\.
M>%8O#_@KXIOJEI<:M;ZCJ&C^)/$OCB.R;5#!XFM+?Q)'>6VN&87VF_VMHUS:
M0;A$\NA(K8^4J :7A_\ 8>\)?![]I'P5\6=2^._PTTWP[X!\2:_\2--\(>*/
M#-KIGBWPGX?&A?&.RA\'>!/$EUX^BM_!_P +H].^(^H7E_;?V3.DD_A".>-[
M>-2+?G/'O_!.M?CEXBUWXI>%/B[\(_%/A[Q!XY\5>/?#8U3X?:KXWT3QHWC/
M4O'EZ9?B;J>E?$V"+QCJOAC_ (3B2P\'W5HMB-'LO#\-K+!/N_<\!XG_ ."9
MOQQ\9:CXO/B7XIZ#JZ>)_"WB3P?XI\1WU[XJNM;^*%AJ_@[XKZ3I>H^+[:;5
M#!8M:ZKXY\.K]FMU$3Q>'0YPPB$?5^+O^"?_ .TU-\09]6\"_M 77AWP);6?
MBVS\.^$K36->TW3-$T#4?B%\2/$P\#M;V,ZRS:5J^@^)_#%E>SQSQ&U&@@QQ
MR&.V,(!Y'\7O^"?/Q#TJP%[X!^*_A7XYW_B:\U7P'#X*\:3V5MH3:U+J.MRW
M7B;4[6\\>P1^(/'6D&^;RV@=+RTGM9)S;7#$0)Z!X>_X)A>//",NL^.?'O[0
M/@.XVP^!=;NO^$A^'SPZ#I6I^";O2+]_$VKZC/XOA1=7@L-/NK2._!B?9+YT
MTA&Z*O3M3_85^)S?L]_"[X>:/=>$+/Q=X*^,OCOXGRPQ>(O%MAI^F#QE>ZU<
MV+Z;XEM;U;^^U339-4AE$EP["Z>WQ(.01TOP_P#V:?CGK7@/]J7P)XZ\;^)+
MRR\3>'KKX7?""?QA?W5UY6G7NF65QXD\2W<:ZC.;FVF\10[[&5V6=(&EC8 '
MD \F^%7_  3R\*^.UTS59?VA/ ?QP^'NE316&LW7A6VFUQOB;.EA;,%^*NN:
M7X^OK+7M5T69+6/P_LAA:PTV[DMYEN"XD/O'P'_80\;_  BUWXWZCJ?QKFUQ
M/C!\'O#WPYFURUT773XQM_%&E^"H/"5Q\0;KQ%KWBR_N4OD,2306=M/#9B0&
MXABM9I)VE\<\7?\ !//XS>%[#X.0_ GXR:EIFM>'=3\)>)/B3XJ\4Z_K4NJ:
MWXB\'2>"K'2?L=M:R"V.@IX7TCQ3IYMTBAF=-<7?<-&9XIN(\8?L3?MG^%+7
MPOK7@?XZ:MJ4/@_X;LGBVSL?$OBJ^\2?$7Q+-X?\;MXPTZ--7UDF*;4]=UC1
M3:30W5J+2*S&U?M$4,Z 'UE^S?\ L*R?!CXBR_%#7]<\#:AKA\*ZSX4T[1O!
M_@2_T3P]X:M=4,"W-QX>CU[Q)JDUFU\]JEYJL1D,5W?W4TV%5\5Y7'^P]\6O
M!$.KZAHOQU^'7@XR>(M(;P7H5QX:\=+X!%Y)KUS>RO)HVL_%21_#E]>0WDD"
M:3X=NM-TB6X/VHV#S-@>'>"_V1_VRO&?P7\:ZO+XMU_X?>.O&&KZI:^#O!?B
MKXD>,IIO!'@FY\8>+=42P6]36;J.+4#8:AH!@>9;DI%IY@/W8V3?\,?L3?M2
M^/M1U/2_C!XTNK30M,\1:$NIZH/B%XTO9?B%9Z!]ADM)M,TH:F$\*PV=S$9K
M6[@9;J>1")-BF@"_K/\ P3WU'PP]Q:>(_P!IOP)\,+_7+.*RT;Q1HFF77A+Q
MKXBUV7PGX4\+-XBU:ZUWX@/'K7B'3+_0B^C2VT22VR>([B%Y&=A))S&@_P#!
M-+5-(\1Z/X-B_:2\#2>,+'X5^.]+UWP6]QXUU#Q F@>,)?$]G9'0=&O/BFU]
MX*\'_;]<CFDN-#CTB.:[AN$NH]026&.U^_Y?V=?&/BGP)^SCX$^)FNZ1XTM?
MA?XUM_%/Q#OM06[N[KQ;;^#Y-;UGX>:?%<7\LLLOD^*+?P/<7C3.QG71) Q(
M?%9;? [XI>(?VK_AS\===TSP%X:T;PAX>\10ZO/X<U'5YM6\0W/B7PWI6A7.
MCZYIDZB#5+^UO=#TZ>RUC]W)!8*VF+;YDEGD /D:/_@G1XO\/:=X2T3QC^T?
MX+MH+O2M$\'1ZK>^&]7\/>)K^"UM-.M'^$OA2>'X@VMF? MW8:3=W<ME#8?;
M9[^:6[+@>8I]Q_:5_9*\8?%[QM\);GX:?&_PK\,_#_PB\,VME=Z.ME=7.JVT
M>E7RF2^633_$%O)%IKPYMYE,MMM)_>S3C]T>:^'G[%_QEB^.G@[XE_%+QU!X
MFT/X>^.;_P 3Z99WGBCQ7XAE\1:U=VNL6DWCO^S=7O6MO"^IS6&H65J=/M4-
MO%'I@=26;CF=:_8,^+=MXX\8>.O ?C:U\+:W?>+]?U+P_<VGBCQ-#;W.@>*/
M&=OKNMV?B'3$G\F_$FDQRPB&19$5R"FW% #;K_@FWKT4W@*X\.?%GPS?^"-!
MU[P3XJFTGQ+I?B_5M*TN]T.[^'NO:YX[\#[?'OV:R\5ZG?>"KW_2+I+FW2W\
M3SMMD(?S^_\ B9^S!K'[17Q9\2_%#X4_&SX;:?\ #[QC9'1O$/BOX=SZ_J_B
MU+W1_ 7B'P./#]ZNA>.I?"OB/4(+GQ#]ML]>N-*@\4^'S UEI^H+!)&UOM_
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MMW':6 1--$4EE<Q&U6Q[;6_V#OB'+\8=9\=>&/B1H7AWP[KOQ1UOX@11Z?\
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M/O\ C1Q^/7'M^= "YYR./3GI^/TI/\_7T_3'Y4=B>./QHZ=>/KQ]<YZ?S]J
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M3O%G[?N@>*?$?Q.T,W.M^"-9^,'BWX?Z3X)^(5O?^(_/T2^\<WMCX9\3Z=X
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MRQN]1LXI$EBCNKET*CZ?D^".AS+LF\<?&*5,AMDOQ;\>R+N!RIVOKQY&./\
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M%(DRV>_2FWNE?M)B+&F>+/A09]LHS?Z!KPBWD*(O^/=L[/O[OPQWJG_PUO\
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M\<5U]G:_M&);1K?:I\&Y[H9\R6&Q\7QQ,.VU"WRG%4_^&HOV<?\ HN/PM_\
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MG3Q+<:G8Z#X6FN='U#6O"EE):'XB?$;P;\-/ >EV%[#93QW-GJ.L^-H'E?\
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M/Q?XJTO19-;TVSTC3/#M_%?ZK;Z7?:_;Z+:K>2!+#4'M[*<HT[Q$2.#LVEG
M!Y=HO[3U]K7PB_:G^(UO\//@M;W'P?\  -OXQ\"C5O#MCI&CR/J'B;XLZ=8Q
M>,=3FOGBMK :9X+T$SW$;Q1Q-)=3Y:(HJ7?A-^W1\-_BE\?_  ;\ XOV:-*L
M+S7XM;M=8\<6>J^ ]7\'P:OHNL?$?2%O? MR^DVLWQ(\ 71^&VHR6VM6D5O(
MZZQ9DZ:J?:9+?IO#/[>?@#XC?%+X;?!7PK\(-1LT\>_$2_\ A3\3W\5V^@V]
MEX8U?3_"_P 8-=F\--86EZSZ]>>?\,=4Q,(9+'R-2(W^<Y";GQ;_ &XO@1\
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MO58A?^&D^)?C-?!.B>!5OTLM+U/^W/"4=U]M,:1W1O(6G,?E12+]+O\ MO\
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M\-Z?HEM+XSU#Q+=0ZQ--X>_LN;4XK>'4K>+P]K;3[KL1*--DV2OE-WRO8?\
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M+/2-1\/_  ]^,?B'3?$5]<66@WNF^#9-NI);>(OAKX.>\CBFN%:.V/C'XN^
M],4L,FYU.08Q;N:]*^%?[8_P6^/_ (VL?A9HVD^(WO-=^'&E?$K9XGT-;/2Y
M-*O(].OI=.N!=.0^IVDE[9+<1@,(IHV5MI0%O&M1_:O_ ."=/A?1KW6;K7/"
M]GHW@O5_#^FQ75MX9UY[6+6/%D_ASXQZ=;:,(+0C4IC+\/O#>MSB 2"W'AF.
M:;8D;@]#KOQ._8M^!'Q$TGQ7)X;TK3-8U/X8:!>^&?%_AK2-=\3RW?@WQ@OB
M/4)(+/2=)^U-8Z1_8_@:XO+R]^SI&T-FIFF*Q84 XN\_;\_9&\1ZUXI\(/\
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M'Q'X)M]*A^%5_P"&])\>6-JWB*9F/V&_7_A5E];V<";]\-K$Z%0B8L?"J?\
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M/>VOABXUZTMQJ3>(X;77]7MM-\.^(72>00;3'=7<LLD5O')(66L/Q?\ #/\
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MXENH-<'@WP1XSC\8^#8K]Q>!GUN7Q=K-A=R.N+Z^>\L_,+QBW"@'A=E\4_\
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M.KC6I- FL+CQ!I_A_5K33+34-]CX:74-2\0QK;70>*2X1HYE=K.)(/+/"?[
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MGN/ .E:?)XTU9I;6U>);^V:*&7-L@CH ]<^!G@O]DFV\;3ZU\(?''BK7]9^
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MJ/A2;2_"]_X8OK#0+7P]*?$^AR3&YNM.O;NZMY&O-),@8RQOYOED%H7A;)H
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M(L9A_P )V-)M=+LY+K9=Z X\;+'J*W0:>Y32H\,"Q->W^-_V$-,US]FGP?\
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M,T7VI+9W\P6C3PSJCL,$Q,N2RG$HN;5KF2S2ZMWNX8TEGM4FC:YACD_U<DL
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MJ@D)$S$;5)'Y_?%+X??M!^$?V2-2\ >$K_Q-XZ^)$/C?3=/T271_$,B^))?
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M** "EX]3^7_UZ2B@!>/4_E_]>DHHH **** "K</W!]352K</W!]30!+1110
M50<Y=F'0XQ^&?\:OU08;6*]Q0 E%%% !1110 4444 %%%% !1110 4J]1QGD
M?AUYZ?U[?6DH[_3Z#\C0!^._Q&_8*^,'B#]H/QCXP^'7[0>G^"].\3>.=:^(
M5_X,\/>/O$GA?6[*77T")XDU;0]-\/7J:[=(%6V2"1[6W>(F47:R 1UN^+/^
M"=_Q*U2)9= ^/OB3PYJ>G>"IM*@ND^*GQD,4?B5_ 7C73;/7=0MCXF*2VJ?$
M36] UG$BDLGA_P @J8PL!7X@?LL?M$)^T#\1OBI\*]&\%Z)=:Y?:[KVF^+;W
MQ'9S:O?F\L[.WLK#1-1D\&/KW@G6)E@F@NXX]<NM#\J7=%I*$E:\?UW]E']N
MKX@:Y\2M7\5ZA;Z=<?%[PWJNA^((8?C3K]UX4M/!RV?Q"MM/^'VJ^$8O#$5K
MK5_Y7B/0EMM858KC3V@G:  9$@!] Z_^Q3^T)/'XJUWP_P#&^TA\;WT7C2U\
M-W%YXN^*%AX8M=+\9V/[24NI6&I:!H5[;P"XE\0?%#X57'VZ&+[;;'X?M);3
MIY-O#/XQX:_X)W?M3Z9H[W%]\<M 7Q]<V7V(>,CXX^(>NZMH^A:9XR^+VOZ#
MX-L[O4M!A-UIZ^'_ (A:/IIU 1V]S:_8)IH(I"D&ZQ+^SW_P4JT_5=8U"U^,
M^NZK#!\<M*U[2- 'Q0N]'\(7_@.T\1>,IK6QDL['PZ+_ $CPO%X-U'P?9SZ7
M:W\=O<7>@>?<6UX7G>YV[;X0_P#!2.UL;J&3XC:C=7,WC_Q!=:+<R?%6\^UZ
M3;ZA/X3N]+USQ [>'3!KGA>SCL/%EJFBV]O9VDL>I0RM;1R$F$ ],^$/[&G[
M07A'QKH7CKQ9\:KXIH7BC0M0T'P)8?%+XF^*/#/A/PG#JT]WXD\*K=:_9V[>
M.&N;%XXDNM5MFD491/)"ASM?M7_LC_'#]H#QEXOB\/?$'3='^'WC#P4GAF6.
M]\?>/]'DTVP.A^(].UWPJW@'0M.;2M8T_6;W4](DN-6GN5O[%-)_T:&1B%/1
M>(/AI^UIHG[%T/@SP]X[UGQ5^TS?&WN_$WBR[\:WUK=K=WNHSS:P/#&LQV\+
M6-K%;- +2TB%I&B HLB8^;YP\._!?_@I3;>#;C5_$_Q=UW4/&4EH="N] T[Q
MY:VMG=>%(_#NLM<MH\TGAYXM+\<SZN-&C@U0J\]NQ:4RL-_F 'NO[87[$FL_
MM!>#/@CX0\"ZQX<\.Z=\+_#OB#P1/%JFO>*-(MH=!UKPWH6@POI;>'K>1K^\
MMW\.VD44=P(GC%S]HBFCGA57\QU']C;]K31O&GAG6/!'QJM;CP_H7Q<MM52S
MUGXE>/A,?A;9:K9-8:%XN\K1OMWCG5+;PS:-:0)=:J%6>99+E[R-Y<:'C/\
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MX9MG\*>,]3NM<\.V7P?T+4O#_AJSM;SPY./L^K12":XU&W/A_P JXN#%=*&
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MY+:WD-POGW<2M.)E!AEX'2/C5_P5//AGP+>I\,KG6/$EW?\ Q2L[O0]6\,^
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M;>%O"W]L>&-3D^':^+?#NHZ89YI-#M[*#6?&5QIEZOV&2[M])WS7$DD4,-X
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MQ-XDF"QSM#$EKY9M+3RXGN@#]&,8X]./3I[#I112]L@9]@1D>YSVH 2BBB@
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MN(VBF3=?H7CD!5E#I>!D.,\J01ZB@#O_ /A)O#?_ $,.A?\ @WT[_P"2:/\
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M^)EFM3(T#GQUXP?RS*AC<E7UDB3*8'S!L8R,'FK\7[.WPOA+-';^)T+$D_\
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M([:SMK>TMH@1%;6L,=O!&..(X85"H,^@%>.?\* ^&^<>5XFQZ_\ "8^),_\
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M%.MVWQ7\/6>KQ>+]3N&:--;D,8MXM6N;*1;-;&> 1RVZH%MC(!)7N?P3\6?
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M1/"!UG1XK!]4&O\ AZZU35UMO$&B_P!G1M-)-9SS"V5=ET+>3Y*]P^#/PW\
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MC;QCX \,ZD'N?#6_P+J=C)XXT[3SI&L7>K:V/#KW;2_9I0CV3W'EPD*-N<Y
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M .$BURVN?!>F16V@:2]Q%:P7&OZDWQ2%OH;2S3Q"%+J6)YA(#$K YKS;4?\
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M?QC%HWB&QOW(;3QJ?@[0TU/37*K?Z9J=S:RB/[1',@!TRZ7^U8^G+K$7QO\
MV=9-(>Q74TU9?@YXP;37TUX/M2ZBM^/C68FL3:D2>:'V;#NWX^:LK3[G]I#5
MI=,M]*_:)_9?U.XUK3WU;1H-/^%OB6]FU;2D<QOJ.FQVWQQ9K^P60%3-$&C!
M&"P-:%M^S&-._94U7]FNP\;WFGOJ7AW7=-N/&T6@Z*J65[XC\07OB?5I-.\,
MR6YLM.T!+R^N[:UL8P%LK#RH;>5)(8YE^9/V:_\ @G7HOP9^(7PZ^*^B?&*Y
M\86WAG3O%@C6UT*Q>VU^T\4ZU>:U:64&KOJ5VJ:#9RWTPMMHDN@#M6]$7[L
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MTJ[<6DYTVWCM9=S>8R[BPYJSJ/\ P2;\&ZGXB\.>(T_:0U"WTRQ^&OBKX-Z
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MQ9J=AH=AI7A?3O#\?A=O%DNG3)*][>K-%++!*JH89@Q1]Q-7IO\ @DU!X?\
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MH08OI'QM^U5\=_#WAK]F7Q'8?!>.T\1?&#P'H.M>-/#L_@?QWX@U%O'$^O\
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MW%O;^$/B]J.LQZ1]HU*"&W%FL<<,-_;BVL9+O41<30F*]:2WTZ3RPKYFE_\
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M4 ?:+BX225L  &0@  5^7OB?]N;]HKPCK$T6I_ /PM=>'])T^&_\0:MI.O\
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M'::S9:)XB\2^'-7T/Q9%)HNFV8^#'AOQ#I/@JW7RYFOI=5^('B"^@-Z9@8M
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MH?";1[2T\<Z4;;3;06OBE8K^2+P9!&A42W9TJS2[B/\ JEMM3@R09,5\5_\
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M !-=799#*R0?:;>)I@\TT#] #W+Q9^U'X-^+_P"S%<?&WX?_  0T[XB7M_\
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MPT\.W#>'?@XNHZCI?A71++4$LC;VUE<>%KJUNTTZ%'BTN'Q)-IDLL=T+NWH
M[?X1_M&?!GX_V/B/P)J/P2U[PAHOP[T:Z\0P^'/B?X)\&IX=%IX2UG6O#U])
MX>L+#5-0LX6T_6-!U*)7VPIB$2VKO"PD/A/AC_@H?\)_B3KUAX!^&7PRMKK1
M-4\96?A'QKI?B6WT/3X8KG7-6CTV'45T[0S?V.N6=S9QF8,TP=A$J3*AP!R/
MA#_@H1^S%INK_$-_&/PB\-?#[P]I>CZY8:WK&@ ^*]4O+76/&_B/21X:\6^'
M_P#A ]-CL[C6]6BUZ\A@@O=3M;CS+EIIU<DOT/P^_:&_X)I>'=>TC1_ /PWT
M7PY)?ZKI]YI_B.P^!U_INC?;8+V&&+5)?$+:./+AL-2NX8FD<_Z/)(%A!&*
M.J^*W[5?P2^&?BKXF^#OB3\$_"NK^%OAQ>+I^DZ9I7ASPIJ>HZY<V^H?"\:<
MMGIWB*WL].M'34OB,9%B-T)%-D980\C,H\GUK_@HQ\*?B'X4\2:MXO\ @)9:
MQ8:9KFJ:U\!KWQ]HFC:WX<^('A[0] ^$NJ:GJ-A'=65U>>#O%EI+\6=!MKF.
MXL8HE*L;>[N!#<B'M_'W[3G_  3\\=ZSXDM?%_@#0/&M_;>,?^$>\5-=?#RY
MOO&<OBY]:T;2/#;:5I]CH\MSJL^H^(= TRV@E^U6LZMHL9EC$:QYHZ-\2/\
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MHH **** "K</W!]352K<((09&.3UH EHHHH *SZT*H.,2.!TXX_$T )1110
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MX+TBRT__ (3GQEJ/B34[=K 0:KI,-WX!\26_VQ!<0I<:-L4!E+5RNM?LO_\
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M\1!XABU7P[J=I/J'BN6_^R#PWXCO?$EI9 S6Y,MJ][J>IQRACS;WK0J5 W4
M>9?$F;_@GH_CZ'X)^/?#BZ3KGAS4]4\"?VL^DZ[IUEINJSP:#XS6T;Q%8Q;B
M3)XQM7M[MF$<$U[.JRQ[R6O:J_\ P3OT_P"$'Q;^)WA[3O#GQ%\*? W2-:N?
M'MKX5DN-;URSACNX-1U*&.TN9(VO9IKS38Y ZL4ED@8J['.?I_QM^R5\)_'O
MB[QAXQ\1+K]UJ'C:(1ZK:Q:H8].@9M/\)Z9<2V-OY.;=Y;3P9HH<@GE)",;^
M.*\"?L%? /X??#[XH_#+1K+Q#+X5^+=HFF>)+:\U2-KF#1XYY;F+3-.NX[56
MBMQ+/*27+DAL9 H ^1? >H?\$P-)\1^)/$-KHUEX;DT*/X+?%G5/$_B,:Q<Z
M5::SX_N=?^('@6S@E22?[/J&GW6D:C>74!1(;$S?O&7<<>IW%[_P3AT/5)--
MM[CPI-+K/B7X@^ ]:UBS34KO1]#UG0]-\/?$?QQ:>(-8EC$%E:1#X%>'I)6W
M/&UQX:2#EF<':UC_ ()9_LN:GH&K>&H(/'.F:5KNJ:EJFKQV'BJXC:^?58/%
M5G<6LS/$=UI%8>+]3AM8SE+=(+?8O[H [_\ P[=_9]FM/'6GZA<^-]0L?'^K
MW^K:M:W&OHD2C4?"OC+PI=VT4<%JJ /;^.M;G>78LDDT5JTI?R,N >7?LT_#
MG]D+PI\.?CGX2T+XN?\ "_M&\:Z /'OC.PD NETKP7X+T2'0M(T[2[73K&"W
MT,V<7A1?LT0,-Q'<VH=%7:"-M_AW^P#)X'^$>I^+]4;0+?XBWC>*_!MSXW\:
M^((_&7C%[ZR_LV:S\3:G+?RW&LZ3_9Z"V:WO97M1%B'H0*^B?@S^QW\(_@CX
M<\;>'?"PUVZ7XA^'Y?#OBW4-3O89+W4K6Z@U"&XN$:VMD6VG9=3N3D \D'D\
MGR34O^"<7P<UFW\!6VM^,?B;K*_#>RNM"\,OJ.OVMQ<67A.\E>XF\-+*]@0E
MB+HK*CA?-5D&&Q0!X%\3?A%^P/\ $_Q!X$B\.?&S2OAW';^/O^$8UC0O"L\E
MG/XYU"PUV#Q3<>"]2N[O3C<66E?;H6>0(\5JT<Q8N=D;+WOASX'_ /!.J\^&
MOB+XA^ ;?3?&G@C3O'F@:?K^HZ)XLUF_%OKOB*[\-^&-)T:Z^V7B.F@BU\2>
M'I8;9O\ 16MUMIK=9 D1K4TG_@E3^SOIDD<AUSXC:@7\867B_44O?$2R#4+C
M3XYXH+1I/(\RV5XI0MQ)&X,R!E9<-\ONOPT_8F^#_P +_@[KGP1T$ZY)X1US
MQ/X-\23R3W5M%J$!^'M[X0G\'Z?%<Q0?-:VMKX&T&%FDWO*L<C,1O"J >6^#
MOAE^PP_@76_BCX#%KXM\'VNH-X2N=:M-?UK4K/1K;6KFRT+_ (1?1GU2=!IG
MANV>]C-O:6Q%K )Y'MURY)D^']_^Q7\%/!OQ:_:%^$>OWNKZ-X3GBU#X@7?A
MS7O$NNW+S65JNDZ9I+:/>R SV2QD"TB5#;ALR1DG+5Z?\/?V*?A5\._A)XR^
M#FG:EXGU#POXW\7V_C+5'OM0C6\MK^RN]+NK.VL3#$J6MN#H]EO55 D;S'VJ
M7('0:#^R5\*/#?A3QUX-TF'4K;1_B#H'AKP[KJI/$LC6?A9/+T^6+9"%^TE?
MON02V>: )/$_[7WP5\)>%?#7BS5->N;JV\2Z7<:M%I^DVPO]5TZVLM#U76[[
M^TK7S$\AHDT74+=N21<PF/'>K_C3]JWX,_#OXH:C\*O&_B&3PWJ^C_#_ $+X
MBZGK.HV=PN@VVE^*-?UCP_X>TY+N&-WN=9N9O#?B6X\F)',-EH-S=3%(HW=?
M%Y?^">_PCOK[Q%<:EXG\>:C:ZV=8BL-+N-6A6Q\.6&M6NOPW^GZ0J0 I \_B
M75)LN2=QC' 49](^-O[('PX^.'B&X\7:UJWB'0/%9T_PQI5GKFB7,"SZ=8>'
MM(^+'AJ>&VBN(F1S>^&_C1XVM)RX.WS[>6,"2$9 .P/[5?[.(U1]&'QA\&2Z
MC%K%SH,D45_)+!'JEE'%+>02WL4!@CBB$\0DF,@@1W$;2"3Y:WM)_:$^">O>
M"M?^(VB_$KPQJG@GPO>7%AX@\165X\]EI%Y;/LFMKQ4A,BRYY4",[Q\R;EYK
MYBE_X)S_  *@T'1O#/AZ]\3^%]'L(/'&DZO!HUW:K>>)O#'CO7;KQ%JOAW5;
MZZMG<0I?7)$4Z?OQ%&L>X84BUHG_  3\^$'A[X!^,_V?=*UKQ98^&O&^N6NN
MZGJ]I=PVVKI-I[*MA:K)&F);5+=5C<,=T@&2P- 'OD7[4/[/EQ*T,/Q;\'/(
MGAY?%9"ZBV&T%UE=;U7:$*S%;>X(A!^T'R'Q'\C8AT/]J+X&ZQ\,=)^,4_CO
M2_#WP\UWQ3XE\'Z/K_B=O[&BU/6_"GB'Q)X;U2"TBN"6D3[9X3UN>-MO-K9/
M<2!$1ROSM9_\$XO@?9^#]-\)V6J>*K5M(GCO=/UV.[M/[4MM0M--U^PT^ZWO
M 1+#!)XBNYEA?=&SQ1A@0#G>\:?L#_";QS\"_ OP-UW6?$-S8> /&_BSXA:3
MXGD^S/JT_B?QW<^/)/%]Y>6>U;=TNK;XC^*HD0*%M_/B9 ?*VL 6?#G_  4-
M_9?\3^-O$W@R+Q?>Z3_PB)U\:MXKU_3VT;P:_P#PCWBW4_!4S:?K=U*!J"W&
MOZ%K:6AB1O.BTN:;Y47->QR_M0_ 8^)O#'@^R^(FB:YX@\7>)+7PKHECH$QU
M?S=8O87GACFN+-6CB@V1L&DWLJ,NUB&R*^;/''_!-?X"^-O"L/A>>Y\0V"6-
MS'>:1?0RVLTFGSKXO^(7BYC)!)&J7B&?XE^(K<+(=JQ);L 6B /1?#7]@CX:
M?"OQ!X>U3PWXL\8+H_A#Q=:>,O"?ABZ;39-,T;4UDGGU.);A;87%U;W5U<2L
MP>3$8PJ# S0!]$Z_^T/\#/"^I^(M%\2?$[PKI&K>$UMF\0:=>7YCN],%W=V=
MA;B6%8B96>]U"QB"Q[R'NT4@%A4.B_M$?!WQ)\2=!^%'A?QCI_B7QAXA\*:K
MXUM;;0I%U&RM_#VD0^'+B6\OK^%_+MWE@\6:&\,>6=DO S!5*D_-K?\ !/#X
M17?QM\7_ !PUCQ%XLUC7/%VOV.O7&C:C/:W&DVLMCKGASQ EBL<B,)]/&H>&
M-.*1LHV*T@RV_CL/@I^Q'\./@3\2[+XB>$?$?B6XBTOPMJGAW3/#.I26DNFV
M=SKVG>!M)US6!=QPB:::;3_AWX91(6/E0F&9HQF7"@&M\/OVZ/V8OB3K7B'0
M= ^)-A;W_AK3(]9O1K=M<:-'=:889YIKK3&O%!O5B6VN!*JKY@,1*JR\UZ/X
M1_:0^"?CK5O$6D>$?'FD:T_A7PG9>-]<U&T:1]&LO#5\TXAU"34RHC&W[//Y
MB$B2/8=ZBOF.]_X)N?!*XT;Q9IT.L>*;*]\5:L-576H9K*34-)6#1M5T.STR
MR?R 1I:66K3"6+<HGV MAOF'5?!']A#X6_ WPUXG\+>&]>\37VG^,? 5WX$\
M0+J,MOY=S:7NHW^HSW]M$BDVMWNU":,#<ZB-%7G!- 'O>C_M&_ G7W\-QZ+\
M5?!NHR^+KR33_#L=OJT;2:I>Q/#&UO#&P#1/YES;*IE"!VN8U0L77.;XV_::
M^!_P_P#'-I\.?%GC[1M(\4S:5KNO7UI/<1K!H&C^'M(DUN_OM?N2X734-BL?
MDQDM-*]U"J1GS4+?/-G_ ,$[?@[I7CS3O&^C:SXDTY8M3\/:CK6@P-8G3-:3
MPHV@7&B6L?[H-HZIJ'AO39IGMPK7 #H_#9$_QM_X)\_"KX[^,/&OB;Q7XB\3
M6UMXV@FO;W0;$V*V,'BQM)T#0XO$:W;*)[B!=.\+Z$C6#.+>0VLC$@S,0 >K
M:9^V9^SIJOBS7?"=M\1M*0^'X? OVCQ'<.L/A>_O_B'9W6H>'='TS6&?;=ZH
M;*V62XCVJMM]KCCE=9"478^(_P"U=\!OA?8:7J7BKQYIXL-5.8;G2E;5A#$;
MF&RCNKJ.SR\5H]W/'&L@5@6##C!KY%U[_@E=\&]:\%:)X(M_&?C'1[+3-0T[
M5-3FTV.PB36;^QT^RM%NVMF)^PW"W5I]HMF21_L[74J!7#Y'70?\$X/AP1J$
M>H_$+QIJELT$=CH%M>1Z>W_".:;;7D5_9V4$@0F_"7T(D+2 %R[9 S0!]B:]
M\;_A#X2O](TCQ/\ $7PMH&K:[I']O:1IVJ:I#:7U[I'DK/\ ;8[:4AEC,<BE
M0P#.>%!.17-0?M._ JXU3^RQ\2/#*R7.JZ1H>CWAU2SELO$.KZR-0%M8Z%+;
MSNVH2(VFW"RL%$2,57>2?E\$^,W[ 7PP^-'Q,\-_%C6-?US3?&&@>$+#PB]]
M:06EREW!I,/EZ;?P07,GEZ=<H[2LZHC+()-K8P#7"V'_  3!^#6CVW@#3]%\
M6>+K#3OAOXK\%:]X9AD&GW-[9:7X&O=6U#2M"@U!U$D3O<ZQ=++=D/*\#F)T
M?(8 'V'\+?VB?@Q\9X=&/PZ\=Z-X@O=?\+6/C2QT:.5H-;3PYJ/E?8]1O-,F
M DLPZSP,$D"R;)XY-NQT9JUS^TO^S]:.1<?%[P/"_P#;LGAE5?6H 7UR+RED
ML8QC]X09X?W@S#^]4^9R*\,^#/["O@#X+?%;3_BIHGBGQ#J>I:7\-Y/AE!I5
MQ;V5G;W&A Z5%:-J-S:$-?26VFZ+I\%N"JE")9"Y,H1..T/_ ()L?!K2]1;4
M-0UOQ#K\UEX?U;PAX9348--\OPYX7U!-/6TL[=$CQ>ZK;?V>"-0ES<R&9MQ&
M!0![[\4/VO\ X"?!SQGI'@/Q_P",1HVO:P_ALVZBRN+BQ@MO%FHQZ7HM_=W\
M0,<5D]W*@9P254[L8KU;PO\ %[X8>-M?U/PKX0\>^&/$?B+2-.M=6U+1]'U:
MVOKVUTZ]BM;BVO7BA<AX&@OK%B5+;%O8=^WS8]W@?Q%_8T^'/Q)\;^$?&6OZ
MGJ[2>$](\+:9%I(BL;FQU-O"%Q!/HUW>FX1F9U:'#H 5?>2<&N5_9R_8)^$G
M[,WQ,U_XG>"=1UF\U36_#3>'8[750DC6:W5IX4M=7NVO5E+70N%\&Z,4B9%2
MWQ((RP<!0#[F8JWKG'MBF4=NOX'.?Y44 %2%PW!W #L",?E3 "V< \>I'^-)
M0!)YGM^O_P!:G,VT9QFH@">@H(QW'TSS^5  3DD^M*IVG.,\8HVL.WZBFT 2
M>9[?K_\ 6H\SV_7_ .M3,#'4?3G_  I* '[LL#R,#C&,Y_'ZU:C.Y0<D\GKC
M/Z52JW#]P?4T 2T444 %49/]:_X?UJ]5!SEV8=#C'X9_QH :!CN3]3F@#!/)
MY['I^%+10 4T* 2><FG44 %%%% !1110 4444 %*!R#Z$'MVY]>O^?2DHP3T
M.,D#_P#7[?Y% 'YQR_\ !,[X->)-+U.#XB^,/B/XJU;4/$6K:M9ZE:ZU9Z3;
M:!H^JZI+JTWA+1M);2YX1H#74IDD6Z%U-YOSPRPGBOH3X;_LC_!?X3ZAX2U+
MP5INL:?<>#O#7BWPEIT<VJF>WO-$\:KX?778=6C-HIO9F?POHCQR!D=&M!RR
MDK7KOAGXH_#KQIK.M^&?"GC7P[K_ (C\-)'+X@\/Z=J,<NM:+%-(T,$^HZ6<
M36EM)*I$<CQA'(.QFKNP<]#Z'O\ A0!\F_";]B_X-_!OQ7HGC3PM+XOOM?\
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M[O4KB9F5BFVMX4_X)9_ ;P=%IUMH?C#XI6]II7A3PYX3MX!JOAV 3VGAK5M
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MU+5=,TZ]U&*[FL+._P!0M+.ZOH=/$#7\MG;W$RM<Q0"YMS,R!A%Y\>_:)$)
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M^GQ+'J_BFVTFZ\'6SZ@KK&(H7102KM0!\%W_ /P3#_;,?PW?WWAK]I*V\/\
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M^K_%KQAXWM;;XJ>$;?3+"[T;1/!=C=Q&ST72[4S^3HT+*9VEU!S^]10)=O%
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M !1X=\-^'+?7)O$7@*[?Q?;>%[M](33+S4_"5E*RKJ4^J6^I)+(K&46L;W+
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M&D)"]>* "BB@@J-QX7'ZGO0 44#GH"<^U% !5N'[@^IJI5N'[@^IH EHHHH
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M[_6?'7@S7-3_ .$F$T<^GZ3XPM8;6ST/1YK.&,RWR3ZM=HHD;*F.!E!#,IH
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MKK$A39;2PB.,!@9(7P<]=^TE^UC^U?\ #OXN^&M.^'7@V?4?"'CO]GRS72M
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MI6#CDF_X*'_LM>'-7\26>H_"2:+Q?X1TGPI<ZY-H?AC1KBU!O[N/2+EHM26
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M^(-0LK*VB>PB_M5)8"A:=8V"#SSYBBOCC4OVY?V6/$%]XO\ !T7PAU;Q=?\
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M$M&O- ,5Q+X_GUW6/AA>:A:LR07C:3$D\]R+/RTZ_P 7_MI?L)^-K#PSX_\
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MAUBYL8M27[$QB2XLU3S%FAF7'U;X:_8X^!'A36_C=K>D^&;F-_V@=,\3:/\
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MWG@?6K.];3+>WB=8I]*%WX0_>K$2]Q)'+*HR]>:R_P#!/']DGQC?^'O$=O\
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M[6E"G!-=E;ZGIMU.]K:ZG87=U'$D\EM;7=O-<1PR?ZN:2&.0LD39^5B #V-
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MGB.UL?C3H/@>:>76)M$U?P?)XZGU*_U/5(8POB_5H=:U-[;0O$L022V1M-A
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MXJ6'Q&T2*+0=1N+C1+T3++J5ZEY?^(;@ZAJUS$JIMNO/2,XDMY(/]6>7M/\
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M3].\6>+[CPYKNGOX7UG_ (G;);W=A<WH5;:.6ZGCM+,JTB,"#]^_L[?L?3?
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M?'S]B/Q=\7/C]IOQ&TK7+?1?"UA:>#I(;ZR^)GQ(\-^+H+WP=IFH6-E:01:
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M>+/\,1\.=MI&-/L(+637#:Z$=#F66$Y3Q&+HZZNH1CY@I3S2?E%>*>!O"?\
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M36?Q1UGQAX;?5'U?11X@OG\'OH5T]T1J>B75DLC7]R-IM8GM\@[C7+-\1?\
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MFBS%OF9B0#]%**** #)]:/Y=SV'UHH[8['M_C0 4444 %%%% !2Y(Z$BDHH
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M2OV@/ WA/2_"=QX:U^[M[SPM\.?&WA.\AUO1_#?PF\0PI/=^(?&&HQF&XO\
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M^.+[P[HFJCP!>:F9DG_LJW%Q-;BYW.('9"<@'Y\^''Q\_P""A>O>%E\;^.?
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M75_);06EV[31P6NL:3)*5!V1ZI;.Q59XBP!U-%&1U!!'KD8_,&DROJ/S'^-
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MZM_B1X0=]1\.^,]4&NW+ZI>:BTKV.AOJTT,UM>6CVL@RB)<F,[3ZEX4_8_\
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MEHH A4L,X&?7@]JFHHH CP5Z<Y]NF/I]:<I)Y(QZ=>V0>I]J=10 A&1@]_\
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M=0\9>/+#6-8TW1M&\+6>J>'[^TTB6+R;1M;T+5-1M[E-4=I'\1S1/;0@RR7
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M"[M+FWE2:WNK6ZC66VG@F0[9(I(W5D8'#*P()J4#)XY)[9[GU]^OYU^$4?\
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MTJC^( _A_IG[!?[;VGZE$_AWXV1_#[PW<:#XU@A\+>'OC-XTU&U\,7WBF_\
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MK3K:WL-%DAW/(9+;3Y_M!\L6]S$!<D ^\:*** "BBB@ HHHH **** "BBB@
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MLR>&=)759H-"\7^*YK&YUCQ#X3AUC51.]BNHP3-%:01Q7<<5NMN_U/\ MM?
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MV^+>N^%8CX-@U"5M TCP9?1:1<)\/]::TD@\^[LX_,<0,CM)NS7OO[-/PO\
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MECM/$7AC2O#^@ZKXUN=!T*34?!^A7;V,3W.@3WIOUAN74R0FWQD9KUNTL/\
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M"S\7Z]\"[S0_#7B'P_8:;-I__"&MI_A[QW!$&7S MNL\-KICRI".YF\;?\%
M/"WQ1\$;O"FM:YX;U?XD>&_#_CJ:S\)Z 1XE\+6?BGQ+I-QKL5S+(;?PE /"
MJZ5?W)MX5,F\I%L?;2_&VT_:J\._M5?$+Q[\+?"OQ*\51V^BZQ-X1L;J[NH?
M!%AIFE?!0&P719HM173=:TJ\^(-O&CZ-?V,EXNLWLEY%=+ H2@#RCP]\%O\
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M;D?M':E:_9;R"XQ<V+[[=H[>VA_7T$DX([''.>GT^M.PWH?R- 'X#^%_!O\
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MCS'_ +QI=R?W?T%*&3NN?R'ZT -\Q_[QH\Q_[QI=R=EP/?G'XT;D],_@/ZT
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M&Z#XPAUK3O$DGB,?9M6M;G65;0O#6K:)IUWXEL%L[1;.XN(HT6"]O54!@ 6
M/H#X3?M8_M5:UX%_:O\ $WQ'^$<.E>(/A%\,8?&WP\T1-%UK0=+U+7E\(ZIJ
MUQX6OM2UN"*2ZNQJ5C$7_=(5@G1HPZN#7A?PL_;/_:\\>1^*_B%X3\$+\6_#
M6E^*K;X2:1<^'_#>L:!IFMW6K>-_B'X7T+Q]#HEY 6L;/3-53P@WB%C,S0Z9
M*UP%"QY;,O/^"O.LWF@(WBC]G/2+33]7^(Q\$:CX>U[QO#=75YX4GO8]*U^S
MN].3PU/;1>,;&&[B;4-$O989O)N6,2SHDYCN>$/^"H%[X7_X0GX>^$/V8/"V
MD6=W\8?$WPV;2_ _C31-,\%:+9:?K7@*.UT[P_J?]@V.D>(?'U]:?$1]1_LG
M3+B=DCT2\6ZEAO!/;P 'T;\'OVF/VM_$^F?M.?\ "?\ PGTK0=9^%VDZC/X!
MMXM.UH07>M6NH:I8Q:5>)% TFJ1&QL[*^\R)0QCO@-OE!7/E^@?MU?M0R>%-
M#34?@AK]UXUUW2M!U'2X%\">(;;3=4B472>+KL2P0R+:V]M)'"8,L?-7A<N<
M#K/VDOVNOBA\&_VF+?P_:>)] NO!-EX>TBZMOA=I>E6&H>-M5N;SPKJ6OZA)
MKFFZEK%GJL^EM<62I#K/ARVUNQTX(\&JVZ3 E?*];_X*D>+;[XBZE'X%\/>
M-6\!V?A?4M.L-,7Q;<ZEXL\:^,!>:9"M_P##-=,T>6#QC)I_VZ87VEB2!Q'9
M22FYC93'0![/\"/CM^U;XM^,'A?4/$D5KK_PA\3/X2\+:DR^ ?%/A%H;^]\/
M_%?6[SQ;H2:W91O9VD.H:#X=T^]67=#(T\+1R!FVGFO&'[9?[3>D7WC6'2_
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MW9?8O#,RIJ%_X9CTSRXKS4RB0VM\6MBKX#D _3/SG/I^5,5V7H<#.2!7Y/\
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M[5?JC)_K7_#^M #:*** # /^?2ESZ<'N<G)I** %R>^2/0D\T'&>!CVZTE%
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M/A3X??#?3-$OUN&E\?ZP/$L3:;<:\UAY>I>';U]",]CJH@MXE@PSQ$R#'?\
M@;]IS]F?]K[Q?XP^ [?#O5M3TKPW9)XDO+[7O#MM;>'-1N?#TT<][;1RKC$]
MK=PH.24E$0Z*,5YY!^VA^RMX\\<>'[W3_AGXFU?QC\(O$NI1^']/M++2K"ST
M:!-%\0)>^,+=+B[@M+A;?1])U81'<TD?F*(6!<D '0?M _\ !2'2O@G\6/%O
MP'MOA!XXUSQUING3R:)K=DZ3>&[FYU+PW#XE\+7-W<2:=B*.[T?1/BO=LI9D
MBC^$UXDTBM?6U<+\)?\ @H1\6?%?Q%M= \4_"3P_<>#+7Q0_@KQ5JFAZ]-8^
M(?"^I:I\3_%/@#P;K5YI5Y821ZG)>QZ DMW:Q2P+;Q3QW4$TT4RQ#T/5?^"C
M/[/<%_X0N-1^'GC2]N/'ES-/H]_!X:TC5KEO ]EJNF>%$\<7IM[J26STC[7X
MQBB6"81SB#4+DJI7S$.'!_P47^#KZE97%K\)-:T_1[SP/J'Q$UN[O[7P_9:L
MD:GX67_@'[+;1S,-3GU.R^*FFSKAC-:O$04+,-P!7^-'_!22+P?\7/B!\#?!
M?@_2Y?$W@=I_)\3ZKK4NHZ=J,^E0W9US2Y_#EO86<UA=PS1P;9$O+F-@2&53
MBO2?BA^W7_PJ;1/A='J7@&'Q%XA\>_#G3_&]\T.OKX?B2;4KS3M&M=.\)Z/<
MZ;<S>,M5_M74[=Y+&&>"6*SBDF,KE I\X\/_ /!0O]E?Q:DOCJT^%7B:6TUZ
MPTEAXNN?!VD*-9\4ZSI.F:A8^#VNWD\R36FMM7LT9G C#,P=ABO8O _[7GP$
M^+/QOT/X&S>!=9L/B'H6E2:C:IXB\,V%S9^$]4@TF_U2?05U.S:>&UOUTG3[
MJ3,4FT[47 8\ '@?C+]M_P"/?PS^%'[-NLZSX#^&NM_$3XY>"O&7BG5[6TU'
M5=.T6RU^'Q'X7T[P1X7\/IY._4A<VWBVRANIYF$L26<UX(Y8XI$KU#X;_P#!
M1+0_B+\?_"'[/9^$?B?1O$FM0:G9>*M9D\1:5>:3X4\4Z3)XRCO-+L8Y+.WE
M\6^'E?P7J,7]J0"!A/=P1/8+^_:&KK7[9O@'Q;\2/A%\+/ /PDG\1ZGK_P 8
MK7P3I6K^*-&M+;0]+\$:/J7BO0?'7CSPT8I_,1;#5?!NIZ?%$RQEIIX9MCPJ
MRUS7C_\ ;%\*?"K]JSQ-X$U?X9^#K/1_ VJW>AW?C2WTJ_C\7IH<7P1@^/OC
M#Q!9:J(18M!:IJSPR:<&^VW#W9G3*F0@ P/&'_!3:VT?7-)L?"WPW\-'38_$
M5S'J'_"0?$/0],FF\%V_]L6\KW-Q#:%/!'CTWVB71AT&[CNI+F.>#;.C2G;B
MS_\ !4JQ\-VNI:QXK^'2ZJAT_4-;TN&VNK7PC!8^';"R_M=H-0UW6IKJ.X\1
MO:X2&P2.(W,_$;!3D=%%^W%^QYXL\-^(]=TGX+Z]KDA-UXRUFVU#X=:?80OX
MCLX];D\/W.LW-Z59+V^DT"[^SSK')M4AFP214_[2/B[]G?QQ\._V<?$OQ@^"
MNNZAX#^)5EJ7CK5+'PQ(+?4?"UMI/A.;7I'\0V>FW5NNN:,J1B*XC8R+M;<(
MSTH XO5_^"J>F:]K'B3P]\-?A?IDTW@_4M6E\0>(->UZ*[L(=$3X??&;Q%9Z
MSI%G;V-I_:?B :Y\*)[>6P^T>5-!>%%OTGW+#Z%/_P %+/#TMW?Z7X9^"&K^
M*]7AU?7I=&L+#QEX5M+FZTGPJOQ9/B;7_$-L]K,_@O7-WP@\0R6NF7/G75U#
MJ=I*TT69TA]/M/C;^SOJGPC_ &A_B3\'?AKH&OWGP<\%>(/&7B71[OPU8:)!
MJ'BG0M+\:M;>%M2NO+8V^L;= O//4C=#::_!*1BZQ7S;X7_X*-_LVV.I>*/$
MNK?!V+P]HG_"K?AG\1/'FO:)HVE7^LCXN^+=-\<6OQ ^&][:$PM>ZQX8T'0)
MK?4I@2_F:I-"8^)" #Z/^&O[?WP[^);_ !TO?^$'U[1(O@5X87Q3<&\O-*U3
M6_$>@S27]J+K3K/3XWCL;5[S3YTR;N;8H)N%@='C7$^"G[8_B3X\?%>Z\.>%
M?A_X9\+^!/!GPX\7^*/%U]JNK1ZY=OXJT^[LK?1++0-<TB**U.A&+489;R=(
M99497BVJ5#-@R?MN_LL>&?$^OV'A#X<W<JZUK-AI_P 2?$=MX7TW2=/G\,W/
MA?7M;E\22EI/-\1:7':Z)=0[8XRC/*0&SD5Z#^S!^UI^S-\9O$T'P_\ @1X'
MU[3[JU\-ZOJNHE?!-MX?TC0?#T>HV\?_ !,IVF!$-]?W-JT"*CB0N"VW% 'S
MMX%_X*2V^AP^*#^T#8> 1=1:3K7B73&\&+ING:1;:-H'@WXC^.;6VD\1W/C7
M6+/Q;;7MCX!:WTR4/I>I&[GE6[T6VV)6 W_!4<6>BPZOXM^$^CI!I'B3XCZ[
MXPMO#]Y9^*;[6?A[X0O_ (\:'X0NM*L+6[#^&O'C^)_A%HT5S#J/VB.*TO)[
MU/+ ,=MZKKG[0_['_@WX+:-\0/BS\'_#VCZ3X_\ C3\1O"=GX7T/P=9>)Y]1
M\1?#/6?&UIJ'B>YM885VJGA[PEK%]*W)C25X@K%SE-'_ &S?V&V:X-A\.KJP
M@\<?%C5?AYJUY<_#O3M/M[_6YK.YTR_\4:]]IN%>S\-W-CJ]VB75RL9N8]2?
MRDD:5@0#EX/^"LWPUOK.\@O?@QXQMIE\%ZEXA31]1USPY&VN:SINKVNEW_AS
M28+B$"]1!=)<&69(+J2%28M-E8IOV3_P58^%W]E6FH:?\+_%6HV6I6MIIVCP
M6.LZ&;K4_&,MBMZOAZ/3Y84DAT18 475Y52W\U/+,*X)'H/@/XQ_L@_$/Q7X
M+\ >'/@?>/K7BO2KG1/#EK=?#C2H8$^'<FEZ=XB@\1S3_;&%IX+NK;4;!HI.
M97DE"M$-N:XI_P!IOX >$/BW\5O!7BW]G*ZTG_A7-S_PB7AW7?#?@G3-9;6O
M#V@3VMD)KN47$2Z7:2:_<VUM80XW.[?,0.: /2OC/^V3/\$?C!H_@?6OA!IU
MY=Z]\+K/Q-H>H)XP\/:%J?\ PDESJ,<OB#PKJ&KZO:Q6VGZ1::9:7DWVK>QO
M+N""VCAWS(11^*O[;OA+X<^(_A)?:C\.(-4^$WQE^#NA_&'7-5E.D6OC;1&U
M[Q7\.?#/A7SO#%U<G_A++E1XXL?M-K:>;=P#3G>&239'#+R_CS]M?]CWQA?W
M%KXT^&'B[QI<Z?8W.G:Y<7GPXL=:3P]_9H\1>(==T#59Y=1W6MSI]M\/?$5]
M=1KN14T%F1G8HI]!_:Z^+/@SX-^(/@IKE[\%O"?Q (L_$VH:=XRU]X+&P^'.
MBZ$WA01VEO<Q:;=2Z6U_%J8>WN'A6PMSX>87,D;-$: /&[S]IO\ 9R_:S_9P
M\5_%;X@? ;Q)>>&/ ?CCPQINB>$_%6H:?X;O_$NH^,(]$D\-W<&K0:E:)9:=
M<V?B6U%_!?,+?]W/$PO(Q&TV3I7_  5!^ *WP\+^%_@1\0+Z:+2=.BF@TW0_
M#%KIJ>($MTCL/#?]HW=W%#>1I @2.^5W@^0%1L^>M+XS?&[]C@?#[PO\,&^%
M-SXF^'GQ.\8_\)!XL\+^#-(BLS;6_A/5O%EWJ'BFZLK2:-=7M;?7OAQJ27$8
MD3?;PA_F4^73H_VQ?V$?#VMB37/ -GI>O:7!?Z#I%[X?\ ?V^MOX,TRZAA\/
MO<W&GVX;3HKR1U^S6Y5BK)AG4#- &/X>_P""DWA_PM:^)]3^+_P3;P]JMCXD
MU WT/@=O#]Y=Z-H<>LZKX2\"#57U35X[GQ;KUSJVAZW'<S:; +73(3&TH$>9
M&] T;_@HEX+L/'-EX;UC]GOXA>"+O6[WPCI6O>)99_ <MCI,.H:W\%?"*/K4
MNEZL;BXCT[7/VA_AE:>4D<I;^TKQK<%+7,V5K'[8_P#P3^NYM(\8>*?"<<4^
MG_#KQ%XYTW7=<^'5H);'PY??VU-K&E0W!N6WZ[>26&HYLH_,D+W"^:8C(2/5
M_AW^U3^Q_P#%WXE^'_AKX9T2>?QUXFM[FX%KJOP_EL5TG5]-O;O5!X?\0WD\
M;#3?$/F?!E;V&-MT;KX.M94F+1P"@#P$_P#!3[X>2:!='X4?!#Q+;Z])?V5[
MX>C\3)X7\*>&]0\):WXC\)Z?=>+9;B+5(YR\DGBR%S90QO<M-&68NN"WT5\4
M/VP?@G\'?$'BOP]XD\%SOXGTR/PK=:G#IUCX;MSXCO\ QAH$&MVS:<]_<QRZ
M@B+<1PSRR*!'(WS$CFN#U'XM?L+V7BV'P(/A/;W^O7GQ9N;/PU:Z=\-+2ZA\
M5?$.RUS5/#VO:_X7E,Z_;8M-UOPO?Q7]RPB6%K!757&QJZ[]H3XV_L;?#KXL
M:7HGQL\(:=J'Q'N?"_GZ7JUQX+M-;G;3EC2ZM] BOO.\Q=0D58S# 4"L5 #B
M@#QS7O\ @HYX \+7&C:A8_!;5O#B6FN:?;_&&]UA/"HU'P781V6IRPP:9::%
MJKW7BW6&TO3;A;=K:.6WM_.2.8@,17K_ .S;^VU\//VH_$^L:5X+^#_C?3+W
M3?A^OB_QAKGBC3="LK:RM+J_EMO#'AV:9IC=:I>W\-G<3Q@PK! +-PS,!&SM
M\&_&7]BWXK^-_"%M9^#=+7XEW]Y)I_AS2?$W@2WL/%=M=:U&/[97[+(SF,0V
M4=K+?L"P@@N86<X?%6++]HK]D;X"ZWXI\'^#/",WA_4-"U"W\$PVO@?P/#Y7
MC+7[?Q9X2T:[\&^$I+>X3^V]6T_Q+\6?#@NH'$*0-XA9U=@LFT ^.M-_X*6?
M"SQ/\,=>C^/G[.M]H?@OXC6'AV_TC3?"CZ9XETKQUXAUOPK\)_&%[X5U6/3Y
MH[IM<35/B+HNZ[>V%N\$&'9I4*2>_>._V[/!/@#X?_LP?$;P_P##.RT[X._%
MJ76K7Q<?%%O'H6M?#C0O#>BH^ESQ:?;I)#*1JK0VC"0[5%Q&5PS8KJ/A1\:_
MV#?C?XJM/@1X!\*>&=5OKSPTWB&'1)_ D,&@Q0:QX9\'ZSJ>DO/L9+;7H_#V
MI^$OM4&!L6&*(2,T)"\)KG[;?[#D%G#X*M?"-MXB\$_#IO$NA:A:Q^"O,TWP
M]I>B1619_#.E20,NK:9<7Z10 QM$5>UW. HW4 >?Z-_P5"^%=[X-T.V^+7P-
MU&3Q'XB\->,?$5SX5\.V/AW7]-B?P_)XFUC1?#5Q#J]\I76KSP[X42XVW'ED
MW15(875"R5-6_P""B_P!U#Q%X/\ %GBOX)>*;S2/!NJ>&=<^#UQX9O8-=N$U
MK7? GBR+XC:UJGA+2+E;#3]7\.:!8SZ?:270DN2VIW,4+:>\=SL]^\!_$3]@
M+XU?%^'X<^'/ G@[5_B5JO@Z>_8WG@6U2,Z9?Z9J6I:CX>N=6BWQ1ZN-(EU.
M6>WW$"*:0"1B^T^<#]H/]A'3%O-,\>_"/PAX2M/!'Q.T#X>6<*>&M-U2+1=1
MT'Q?X\\,>&-?ODACB.F:/!?6^L3))&)WA3Q ^]""[4 >_P"H_M,:'XQ\$_"G
MQA;_  JMSX9^,?Q_F^"D]O\ $!-%FFO/#=KIGCBXF\7QPV4UQ$]M->^ +46]
MO=.'\B1&FBCD1$7QOQ__ ,%#?V:_A9XT^*?AF3X2>)[O5/AC=2^#+G6]+\*>
M'++3?$4NCW%S%JFBZ-J4\B&ZL[1[.Y9((Q,SJ@985!)7EM8_;@_9%\6_#_P!
MX=^)?P?FTWP3J#Z_XJO?"_B7P_9RV7A>;1C'%H?B#0].CCVZ[#JNIZ[J5I87
M$)@9IQ.'558L?>[6Z_8;\:_#[P]\3W^''@V_\+?%0,EI+JG@:--0U&X\)V4]
MR;75K*XCW17EI;QSJ,EN<@,P.2 ?-_Q$_P""@W[(GCSPKJFA^+_A-X]UK2I+
M[P1+H/AFTTRUL]1\?)KCZ7JD365EX?U59;[PW \]L+Y)C)9W @>WN8FW)%)^
MI?AW4_!GQ7\,>!?']OI5EJNGZA8:'XV\*MKNE6DFK>'[G5]'@O["?R+E)&T/
M7HK#4E238RRQ><R;R&!/YW7OQ@_X)\W%CXLCB^#NG:M/*N@VJZ3;_#"W-YXY
MEL[C2$T:T\-*S_\ $RCL[V]TD.08E@)#?,$KMOAE_P % ?V2GL-(\/>%5U'0
M_$.N6_@&]G\%>'_#%W>NOB3QW8>!K&Q\.6T]NB17>MV=MXJ\(17:_NQ%#*C+
MN$;A0#[YUGPOX9\1:5_8/B#P[H>N:&9(IO[&U?2;#4=*\ZWD\Z"7^S[RW>(2
M)+\R'9E6Y!!JA>> _ VHR:E-J'@SPI?2ZQ:VMEJTMWX=TBYDU2SLD6.SM=0>
M:S)O+>)$41I(65 H"@ 5\N?&K]MKP-\"_B>?AQXH\%>.=16UM?!VHZMXDT33
M([[3;+3/&&B?%37$O((%D#W8LK7X4:L]V 5V1W@<$^65;IO!O[9_P'^)-Y\2
M](^'GB63Q3K7PQ\,:WXHUBQ@L+FTM;VST*.]%[%IFJ2Q&*XE2[L)X'Y!1QG:
MRX) /H27P7X.GGTVZF\*>&Y;G1IQ<Z1<2:'ICSZ7<+;?8UGTZ5K4M93"T_=!
MHRI$?R [>*J6GP]\ Z?+IL]CX(\(V<VCOJTFDRVOAS1X)-+DU[/]MOI[Q68-
MF]YN;[48]IGR?-W5^>WPZ_X*E_!?QS:^#K^^\->(_#5EKOPN\0?$?Q2]S+;W
ML_@6YT7Q%#H%KX1U2")8_M&M7B3)=0X:-?(^8C'->DS?\%%OV=+N32[?PGJ'
MB+QE=ZG??#2!8M(T9XHH-.^)?CKPYX"LM8DN+N5?,L['4?$MK+?>6K"-+:10
MY<8H ^UM#\-^'?#-G:Z=X;T#1?#]A96HLK.RT72['2[2TLUGFN1:6UO8P(D%
MM]IN)Y-B@+OG=L;F),%EX1\*:=JD>N:?X8\/66M0VT]E#JUIHNFV^I16=U.U
MU<VL=]%;"5+>2Y=Y'0,%=W+,"Q)KYJ^%?[;O[/WQI\1>&_"OPX\0:UXAU;Q7
M)JTFD"'PY?0VKZ5I.B>'O$1\03WLV$CT*XTCQ5X?EM9P3YO]I(C*CAE5-1_;
M*^%7A7P?X[\;^/CJ'A31?!/QH\5_!)%6$ZQ?:_XC\+ZIJ6G>=I=G9J&9+B+2
M[N=8SED2)LL3C(![5H_P7^$V@V.N:9IGPZ\'Q6'B7Q#)XL\06T^A:??1ZSXD
MED69M:U(WT$AO-0$BJ4D<EH\?(5%:?@WX:^"O %_XOU3PKHJ:;J7CO6H=?\
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M.N:6\U[-;:C:RL;R<7J7L<=M%;_2/Q%_9O\ AI^TQ\%OAKX#\*^+]$N? '@
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M;SQ7JLVGP>/->\??&D>&M>T6WCL(V\'Z6/AGXG^'%M+%9D"";19%"220F>8
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M9[8+);+?>'[J1%PV#<\ _M5?M7+^T[\)/@;\2;:33[W5-?N=,\2Z-%X+\/\
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MX$\(6?P7\47^M^!!X4OM*TC0O&%WJ/PKE\.7&H>);B^EA\1:E<V-WXQ:"*(
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M4G_"1^"]2\0ZX]Y<1R7&J^#]=^R:]XDTOQ'\0$T[X7Z%8Z;;,NCZKJMA:Z-
MNH,QAB%DLC$%P#]3^ _C]^TS=?#/X[^*/&?@C0(/$/AGP5'X]^&%LNE:W8V4
MD>I:YXWT>U\+^(0T!>ZU&UM?"NG7=S-""H375/\ JU!/DGQV_:Z^+7P=_:6\
M<:39ZG%XV\-^&O"NL:GX<^#GAK3-+GUS6GT3X5>+_&\D/B**\U.'6])CN]9T
M2SC@\1:=IVJZ%;)&]G>F&X9I(N3\9?\ !1SQG+XVUJ_^&MKX'\3_  ^U+POK
M6@>#M.L]=N-2\3:WXFT?5/B#!)\1O!-M8Z<T/C+PW9KI&G?VW;K<6ZV-MIIN
M([B;SF1 #+T?]L;]L"VLIOBW<_#&^UGP1KNC>'--G\'_ /"*^(/[0\.:^_A:
M*[O/%&CB"US=>&'U)7\TG@[S(OR"NV_9?_::_:<^-GQ0\ ZMXZ\&^(O!'A35
M'UVQUC1(]%N5\.W*:/X4U>ZMM66^GA!ABN=16R9!T+QA5SFO/A_P55^(6GVG
MBN*^^ U@7\&>)]#\,7NK:KX\L=&DFBGU74-&U/5;WPXEI<:A9WDQT];K3[*W
M@NIKF"^0C!5JZF#_ (*F:O+J'B[2;CX8>$]&N_#OB1;*VN]:^(=W;:#=:*FA
MMK<=O<ZY;^%Y8(/&M^5%MIND(SSR7,R1W7V4YP 6/&?[9W[7W@MYSJ?PA\,Q
MZ5K%YXLU'0/$::7XJN+#2;#P[J/Q1T[P]X.UFV@LFDN/%/B"\\&^%;>RDB!A
M23Q8I+?ZK/L7AGX^_M(6WP,7Q!>^%[?6_B[KO[3WQ(^'L7AB_P!%U&WB\*>$
M+3Q'X\UK0-'O%LXF^T7%OX3T'2K&"^_X]KB;4()"X$@KH]8_;'\<Z'^RAXQ_
M:9O?A-IMI+I?B_\ L3PKX)U'QM'I=Y>: ?&UCX*;5O%.H:EI42:)JT=S-J,S
M:=;K>2R?8XX(&EN)EC'SQI__  4B\<Z)X:\6^/?%WP^T&[\$>(-2:Y^$NK6^
MK>(-/F2V?2?V>&;1/%^GOX7DN+*U&J_&B^-M?QQ/++%H#_:K.SRI(!YCH'[<
MO[8OC+14\977P7UC2[O01JXD\$>'+>^DC\0ZA!86FHQZ+=W<EMFWOK2]>YL9
M@.&,#$G>,5Z)X%_;O_:W\1>%]%U*Y_9MM]1U#Q3>>+;70[G1GU2;2K2?P7&F
ML:S;:_-]G L&;1!=16QZ3WEOY0Y->D_LF_ML>/?VD?B1IMS)HUIX:\ >(_!%
MYXDL?#UQ933:KI5Y:>%/"NJR1/KOGJE[:_VEJVHA'^SQEXU7A6!%>&V?_!0O
MXD_#?3%\4ZGXE\&?M"V6MZ/J%YKWASPW:V'@Q/@EKI\;W7AO1[+QWXK77+^'
M3M$EM8XM[W=O;W*N0XB>,G !Z9+^W#^T7'^R!;_':;X3Z!!X\7XFVGA:ZT*.
M35;ZSG\,2:=INJ7]_IUI:6IFFU>*XO;S3T@*CSKBRVH3*X%/\4?M\_%>+4UT
M#2/AS:>'KO3+K5K/QYXD\3^'O&,NA^ )6^('Q-TSP?%J=II^GO<W5UJ?A'P;
MX2E2*-69)O'=JQPI6O)=/_X*C_$_PDVE>*OB+\+=+OM$^*?Q8TCPAX+\&Z!K
M[2ZYX/\ "BP_#+2K[5)-3MM+FL_%M]/KGQ)BN(S'/;PFSLU\MVD++787G_!2
M_P 6>.?&_@_3/A%H/@M/#]K>?"C3OB%?^(=>EU#3;;4/B/J7[.W]OZ/#J^C6
M[C3-=\/K\5M>TNXM[B/<=0ME:7R#"87 /6_@W^T%\=/#_@;X_P"O_$#PKH3Z
M7X2\+_$OXK?#ZZBT;5?#[O:V/CGQ[I]GX<\36\MF@\\6/AZQN3)$&FD@U!6<
M%R"?F^3_ (*!_M M>^#?$FD_LY>"?%DFKZ=>>1\1-/BU6SM_&%H3;B.R\'3W
M>F"^E2WBN&:>,[0_D-Y893FOKOXW?M8^)/ GQ0\:?#-/AMI_Q"\.6=OHTFLP
MZEJD6EVEOX;N=(\!2ZZ]NCZ?=#7+IYO',7EV\JP1NMG*K2@;<\O^TK^V)X]^
M GQ2\%>&?"'ACPYJG@>XTO1KO6[/6[M- :"PNM(>>PTO1-5#FULK^6:.&%/M
M1B@0#"L>!0!Y9=?MY?M(Z%XDUCPSXJ^&'A#3 OA7X;ZS'XLM;/QA=^%_"">,
M;OPT=>UKQJZ::9M/L--L_$;*8MI>273F8#8LI6W<?MW_ +4=IX&U3Q[=_ 'P
M[IUD]M/8Z)I6IW7B6SU&/5-+\-?!'Q!?:]K$TEAY5MX;O%^)WB-=.&?/)\-Q
MB95+2A/:+;]O&+4OV9?AW\>(O"'A^RU+Q]XT7P-/I'B+QL/#_@KPIJL<]TM[
M+XE\:ZIHL?V>Q2*S,<;I9.+BZN888=ZRK(?DO7_^"H?Q)32O%CZ5X,\,6UQ-
MXV\+W/A.UO+M[_Q=X=^'^H:?\#K[6=,^)?@E9HG\.:K,GQ:N8](OOM,MO?-H
M]PSQ1)'&TP!],_%#X^_M ZIX6_90^)OPSTRWTZ'QIX-USQEX_P#!-_I.O16]
M_J5\GP\TK1-(U*069NM+TNUN_%NJ73JZ+/(NFD;?D('!:M^W#^TU!?Z[X=TG
MX.^"=3\2Z7J$EI<V\;^,A;>&7T_4);6:P\3L-,RNHWUI";FQ6#>ACF4R%:P/
M%G_!5>/P3:^(I;WX;Z1?2:+I%X]E92>-HM.\4W>J:/JLFCWG_"0>$(M(N+GP
MYIE]):7=SI,ZFZ6\M7BEQ&K.8S0/^"F7B;4SJ?B"\^'_ (<AT.^>P_X1C2SX
MBALWM+?6(HS8:G\1O$-U&(O"5A"_FF2X\N>(Q!7W DJ #VRX_:,^/GB+]F+Q
M5\0;GP7'X-^*/ASXA_#[0_[(\/6FIZE;7F@Z_P#\*^US47M8=3MDF9H],\4Z
MC9W#[-B2Z?(ZD[37R%XA_P""BO[0EYXGL?A_HG@_3/"%KX;F^$6IZ_\ $GQ5
MI7BP:99V9O/AC;>.=+\=PPZ87M;*\B\<W[PW=D),#2&8#:)"OM+_ /!4#6CX
M;\4>,;;]G_4V\.:2FL:-HE]<^-M%T_\ M[Q?H.CMKNJ6\)O(41O"QTZWN9+6
M_MY+B:[#6X@LW:=%KZ"\8_MP^"_"'PJ^"_Q8OM&T]_#_ ,;? /B?Q58R2ZY9
MZ?"NMZ#X:T_6M.\*6\VIVT)U2^OY9[NTMU*1RE[0+Y))95 /@[XA_MC?M4:]
MXA:71_ E_IWAS7O NB:K%X7U7PY=:KHFE^(-5^'/B#QB)+\7%FSWVEP:CI]M
M&863<9(XRVUSBON#]FS]K#QC\1_&&K?#;Q_X6T?1;GP+I'A6UUSQGIG]H+H'
MB/Q!XUMHK_P;8^&H)H 8Y;C1_,GN(9-IMG7RB!BO$_'G_!2O6_#?A[6)#\(+
M7P[K>KZ5XGU;X=ZQXK\;Z#:>$[O2-&N?'NCV6I>(]18J-*U2XU/P/<&UTS+2
MW4=TJ+(CB14S_@;^WOIWBKXC+X(\$_LZ7&F^)OB'XXTVT\1>)9-=T31K?5]8
M0166N>(];LY)YKNS"*'?3XMDBS6^U5>,G;0!^O8!'<C''Y>OXX_*C=VSCT]<
M''7UX!_*ORB^-7[>/Q8^%?[17B#X;Z=\._"?BOP9X-GU'5->M[77WL?&4_@S
M3OA=XO\ '%WK$4=[&EO;7:WOAO9!&69;D*\6^)B''HG@/]N>_P#C'\-OVM?$
MG@WX>W_@[6?@-\/_ !QXG\(7WBVXL[_3M>O=%@^)NFZ.VMZ987*W&F2#7/AS
M-//;-]^QU&W,<_FF:.$ _1ACD'#$'H/^^>A Z\8_*E!*@#)& 0<_KS^5?A'8
M_P#!67XB>'X-0\0^-_A3ITVB^&/A9X5T[Q#H=A/=Z9K=[^T+H(\73_&_P_H<
MMTLGVS0-(DT 65J(X9&EN;*X=Y$A5G3UR3_@J8=7U:V30/AG#IVBV&O:7)JS
M^(?$=E_:^L>#;S2[Z[EOO#D-@DEO-JYU"S:WC@:X)5U9)Q#(#& #]@"2>0>H
MYYX'7IZT$GL3QTZXYR?7MDCZ"OSW_9B_;FN/VG-473M&^$^M>$8;3PIXC\3Z
MYJ.NZQ8[=/CTQ=%_L:UM=/1!<7\MR^OV0EW1PK!Y4I#.NPOXS<?\%/\ 1O"7
MP7^#WC'5O"I^)GQ!\?>+/B-H7BKP]\.+JV-IX,L_ ?B/Q7;3'6FFN9?[(UJ?
M0]#MOL=M=O"EU/YSM-;P1221@'ZWY([GC.,G/^3@C_)I 3ZGOW/'0?@*_'F+
M_@KCX0N=;UK2;'X3ZW>6FB_$+P[X>N-;M_$NBR::G@GQ+JFIZ/I_C9YD8F:/
M^T](NH72V$]I&Y027JAES]5?LF_MI:'^U-J?CG3[7P-X@\!IX9U*&+P_<>(K
MK3B?%NE30B87EA!%+O2ZB4CSX@LD:*RLDSJ0: /ML$C<<\].IX[\\=>GYTN<
M\Y.!CIQD#@9]_P"1K\D+/_@H;\3=!^('BBS\=?"#3;KX=>%M1\0:1KNL>#O$
M-MJ&MZ)=6_C?1?"?AAY;*\\L:A<78U=))[:+$L"@N-X&#O?!O_@I=_PM_5?!
M-I:? CQAH&G:_K_@_2/$VHZOK6C6S>'++XC>*OAUX0\$ZE9V,TJ3:XLFJ_$W
M0OMJ1*OV9+.[>-IT%NTX!^J.2.YSSCL.W ]!S_*DR><DG''7CL?7FOR1_:*_
MX* ?$WX)_''XP_""Q\#Z!K+V>L_!73/@I>L+[&IIJMGX)UWX[R^+G60) FB>
M&O&FDW5HT957;6K6.3!!+9VG_P#!6KPCJ+7*6_PKUV2&W\:Z;X8;71KFDKH$
M.G:UI%CJ&D:[-=&3<\,USJ%O"?LZSVR,I_TH[HRX!^P&<]#T'/?U_H>/K1S@
M8)]QDG!XQC_/:OQ?T;_@K:UG:6NG^)_@3XEU#Q)'I$<FIR^%M5TYO#__  D6
MK:WK]AH.CVM_K+VRB"2ST7,\LI1XI9@!$T>7'W!XB_:7NO!7QZE^&WC>UT;0
MM M/V:-3^,UW;"\BN/$4OBO2?$VA:3>^&M)E,ZPZLBVM_=I&(EW2S1QLIV-R
M ?8&<=R>..>W;OQU!_ 49;G)SVQGVXR/7^HYK\??!'_!6OPYXJC\&3ZM\$?&
M/A&U\6Z5XBU&"ZU[7/#MA;RW-KX,C\<>%M$L)KR[C5M4U'2IUA+79M+9;J&6
M.VN+I(S)6WI'_!5/PGJFD:=JH^%>OETL[R+Q/IL/B3PZNJ:-KXGUVWTW1++2
M[ZZ@NM9+2Z!=+>31PA+(SH),D2! #]9R?<@9'?)]#QCGBDY_#M_6OG;5_C_I
M_AC]GC6/CMXGT>'3)_#G@6+QGX@\'1^(='O[K2)KFQCU&TT6\U:VN#;)=M;S
MVY+;MHWD+N(KQ+]D']L[4/VJO%'BB"#P''X,\,:-X#T'7;3^T=9AN/$DGB.3
MQYX\\%^(+.72TC5ET1'\(VTUM<D(["]V30Q2$* #[VHHHH **** "BBB@ HH
MHH **** "K</W!]352K</W!]30!+1110 5GUH5GT %%%% !1110 4444 %%%
M% #@N1G)_P"^2?UIM+D^I_.DH *\M^-7B[6? GPN\6^+/#UO+=:SH]K82Z?;
MPQ)/)+/<ZQIUB0(GM)PR^5=2%OW3X4$@9 (]2KS[XJ_$/2OA7\/_ !!X\UNS
MFU#2= _LM[^V@:)&\C4M:TW1S<R23*5CMX&U!9Y6882*W=CC&0 ?GG^S3^W?
M\2?B+\5OAM\%_B7X&\*KJ?C#PKK>M7_C#PKJ6O,]IJNG23RP:3<^$Y- 9])C
M2UC2.>YN;B.U,S8257(@K,\6?\%(/$7A[Q%K_A__ (5Y\,M,6'QG=>%=)U7Q
MA\4-=\/Z=X<ET_73HIL?BC*G@";_ (1GQ/JD"2WNA65M]K-];QY:2/(>NSU7
M_@HO\+O#VMSW$/PVU:^\*6=Z^B77C_1-0T2]MO[8O;DVFB:?IUO:6I>^@O;G
M&9DF6.%<NX8 BOGRT_X*:?"3Q7XTM?#7Q)_9W;4_$_ASQ[KFK:3/HC:#XCL_
M"\6CZ1X?@T+Q ^MS1>3K.N2S^)[J.>6T*"SM@6VNPVR %/0O^"F_QF'BWQ':
M^,/A?X3\,6<EUXH7PW:^+=9USP5X4\$:98^'OAUXMT<?&#Q7<>%+ZZTC7YK/
M7-;L;-K>%+>_O]4T^W%K$S&0?:OP%_:]\4_&/QFNCZU\'+KP!X4U7PSK6N^'
M]4U/7]2NO%(N?#&E^%+_ %W3_$OAB3PM!%I1\WQ3%%;-!?73RG393)%&Q$8^
M=I_^"FWA/PW'*_Q?^"'_  BESK'Q-\+>$=,\/VGB+1/$&OKX3\3>%/@?K=GX
MIUVT33@LEW'?_&GPPAMAY4/D12$7)F@5)SX8?\%6OAMXJ\*?"C4]6^'/B$>*
M/B#JU_H.H6'AZUMX(-(N-)U+PSH&O:K#;:K*)CI']M>)+(6H>3S+RR@^WQEH
MGB5@#+\+_P#!575O&FKZ]HGA?]GHZI=>'=1U2:]O!\1;Z+2I_"VCZ9!JEY?V
M4Z?#J2;_ (20Q3^7%IMS;VH>6,J]U&,&O7?@S^VG\0OB]XV^.$^G?#SP^?!_
MPV^$W_"7^'?".E^*Y-5\:7GB:+7=6L1H?C><>'H!X+UVXLM'EE335@U QPW,
M4_VA]ZH9?BO^V:?@O\7O$7@=O@I:7W@OPQ<6=YK_ (@T:]TV+6FT'4/!=CXK
MO?$*Z4\2+'#:R7@2:-B[31I\A#==[X._M^_ GXIZ+\=_%?A'PKXDTW0/A!X?
MO_&6N:Q)HEI9?\)=HFGM>VT]Y9!O*9[OS].F18Y2P*,KF0 E: /D:_\ ^"LO
MB/X@>&;O7/A#\(+_ ,'SZ//KLL=Q\7'O;#0?$.F7'@#QQX]\%:E.T&A+/INE
M7?@WPH^M7,BNLUCYEM9W,9$\CIV:?MWZ]I4.J7'Q5^!'PPU#Q;KEKXKTG2O&
M$WCX:%X8\7?"/2_&/Q0TRP\/ZIJFI_#^=[/Q1>+X4U&/2M 5[^WU:?5VD6[M
MC++$O5:Q_P %$O"6G:UK.CW/P5%EI.D^#+V/5/ML^A7D^@?$2X:YTGPYH%[%
MI\Y37O"M_9ZEH4+WE@"UFNI7"W"A(7 MVW_!1_X/IHOAV;QM\-W=+B]U'3=7
MOK&WT.'1/#^MZ>_CW4] T]8=9NS-<I+9>"]3D^U1YBBGOT0@22-&H!:T?_@H
M7#XC\<?"?X8?#;X=^%M%FUCQ7H6A^.K'Q-XL6R?X?^&K[Q)J?ABWTS^Q])T<
M-I?BB4:='/;6]V(8A%( !("&JE\2?^"BWB+X,_$3X^^%_%?PST+QQI'P]\0S
M:;X'@\%>-+33O&(MK?1-+OFF^(F@ZM:2)X=\-R7E^R)KIN!;@@1&SR"]9'AK
M_@I/\*_$^I3:_9?"*31O",(MIO$?B;4;73KC6_\ A(K+Q3JOAV[TJWT^%87G
MEBGT]7@O)&VCSLM&!R/1+7]O[X&:OJE]'JWPD\76]^8+"R\>WTFB>&M2BT.U
MUK4O#VG:!%J]^E\!JUK=R>)M(8"(R+&"X?E!N /// 7_  4WU/Q-=ZG<W/P8
MNY]*M];M)]4L[#QAICZSX2\)OJ'[/WA&:XTU;+3+JV^(>HR>+?C?;SVXAN-,
M22QT]DWK<*(3[7X"_;ZTKQE\'/C%\7+SP!9Z?#\*+CP/"^CZ5\1M*\2PWJ?$
M/1?!NL:*GB378= MH_!%_8CQI9QZ];SPW(TG^S+N5I;A(PS:_AW]L;X(^(_@
M9HOQCT#P'K-SIWBGQ_I_PBT3P5#HVA6WB6Z\7Z@NGW%GH=_#-=1P:-MM(;2:
M3[5+'L%C$5#_ .CE_G/]GKXJ_#OPU\!/VHO'7P$^!VDV/PZLO&'@V/P?8^(M
M3EN=8^*\_C'P+\-YY=4\2_VQJP#I;Z?XEM;2STQ9XVD@T*.S@FS+$P ,1?\
M@J)XIU+7O%^G:9\/_!5K80IH.C^&Y(_'EKXBU1?$]Q-;VVJZGINF6EI;'XB_
M#5F^T-!KUD]C%&&C#6TF2:U[C_@JI9>$H[*W\6_#^SOV%GK[WVL2>-+'PC?C
M4=,TGQ/K5J;?P4='U*XG\)-%X<-K+K*7+)'<7D8^QOA@.ITW]MKX*>'_ (9K
MXO\ %OP\\,0?$'PYI<F@V>D>&/#\45C%>3ZKK6C6&A+'K CN] #:AH$ZW5J[
M3"U.T":8?-7B>L_M7?LEP?$O1?C3\0_@/KUOXY;P19Z)<:0;'^W-6L_$OB&/
M2-+DTBS\.6M]+ITNG2>&O%=_(][M\XPY1P"V" ;-]_P5]33='D\:3_!634O#
M&I:7H>F^'M#TSQFT6NQ>.(?%7QKT;QI%XBUB_P##4=M9>$8=,^$3/I]]]E1Y
M]0UBULKB.'[5YMM[O\)_^"@.L?&GQ9\5T\)>!-)T?PCX(^ &N?%?PQ8^(?$D
M-UX\U'7M%\3_ ! \,OI?CS0=+0CP#&]YX')2V+WTDEM>)=)<@L8(^7N_^"@'
M['LOAG5V;X6ZW=>'="U7P1X?ATV?P1X?@-QI'BNRN_%MGKB:;=7J_8_#=I+H
M]TT]Q)M@BO(E222-B[+Z5X8_;4_9UO?B'H_A7PE\-/%3>+?C+XMG\*>&[RP\
M(Z#:_P#"P]*TV^\8:+J_BZ6[_M)6_P"$7L[OP/XK23[2%G9+-62W;S2% +G[
M/7[=T/QD\5Z%X)UKP+8Z#J^J^$]8UB>]\.>-K#Q2(]7\+:99:AXEA_X1I-/B
MO-/\,NUZB:1J<TC)JGE,5A@ !/AL/_!4*S3Q+XK@O?A;X?.@VS6-[H$=K\2?
M#=MJT^E6=OXBN_$-YXDU&ZMQ;V?B\0>'Y/[/T$1^?+)*J27R EX_H+QI^UC^
MSM\%/%,^D67@'6+CQN^K:[X!M]/\&^%M%&KZC/X-^S+-IEO.][!_H06[B\@,
MRKM5N!C!^?/%?[>G[(_AV]\/ZHGP=GOO 6O:CKVI^,?&$?@S0I6T[Q[X;TJ]
MN;/0+33+:XDFUKQC_:L7V5R5CCC,Q9)WY% 'NW[0'[?WP\_9]\=>%O#?BGP-
MKU]!XJ^%FI_$+3?$0U#0;&\;R-$U?7K'P5_9-RSW%GK=W%H<V3>R65HHADDC
MFN#:W$:>R_!S]HKP=\6/A?XJ^(,7A^UT*]^'%[\0-)\0>&K;6?#OB6.VF^']
M]J^F:G<^&?$.CD6VL^'KJ31[I;:\C2&-F66WFCBG@GC3P:;]K3X!?$WP%\:O
MCCX8^#GB3QUJ'[/7PKUSQ%?W'B?P=I.B:A<PW.AZOJ-]X"TJ^UB=Y[:^ELM-
MNDNU>%(%CER&D#$'@/!7[8/P#\+7>K6\GP/U/X8ZKH6J?$KX7W-G'X5L?L>N
M_"SX0>(?C9]J/@U-)NF&K/'KG@_74GLGBB47NMRI&9U*RD 2R_X*5^'9-(\8
M:YXP^ 'B#P?8:)I=Q?V5WJOBSP;?6_BO6+!- GM](LY;6U9S=-:>(=,*2>7(
MXE26".)V16?U[]GS]N7X=_M"^(_#/A+0?A_X@TC7O%7A:;XB36^H?V1>V=CX
M8L5U&V/B"[O;>$>?M\0::NG!759X[F\AWI&I.W ^)'[0WPQ\0_LU:!\7_AS\
M(-$^('A_QIX@?PNWA[Q=HEC"-'M4>YCUJ]U_0=+-S<W<=O-I,$<UK:K)<H3&
M[Q8B9:X33OVF_P!G3X:>')_C-X(^'ESJ/Q&U7P[HO@>7POX0N/M>D1Z9IMM-
MKT_AWP5)=RP066GD03S>4EO:^?=0HER%D7< #)\=_P#!5?X;>!=<MO#7B_X'
M?$B;3]0MO%6H7-QI;^']:LQX<TCQ;XD\#Z7JDEO+Y5M,;_Q'X5U836SW"/9V
MWE7$AF>0PKKW_P#P4R^%\G@7XLS^(?A])X>\2?#F2Y\/W_A74]>\$^*;'6]<
M75?&>B7": UAJD$7B[1K6?P2;BX\EX2\%Q$NZ!T++%K'[<G['UGXWTZ#Q[\/
M#8W>C:K=^'?"&HW'@BRU?7O#ZZG>ZKI_Q(GURTMQ)_PCVG6.MP^1?F"6Y\Y[
M\NBR LU<3X"^/_\ P3?\*ZA+X>\,?"A[2>Y^,WB'2G2\\#Z1J.E>'/$WQ"M=
M)U'5O$5OJEQJTMIH/A'4[:^LY(U@F42GS5BMB^Y6 .RTO_@J!X,@U/P!HUS\
M%?'=Q%XV\6:GX0T[Q%X>7P])I<MOH&MVGA+6_$$>F6M[/-INGQ>)IWMQ:W,R
MOY-JTOG-F-7ZSXN?M6>+/AI^T-J_P]U#PO\ "S_A2ENFAV>KR/ISZUXG\2ZS
MK>EW6H2Z=J-_IWBA/^$/UG-N%L;34O#%Y8:@C,[:W9;2*S3^U=^S'\1/@MXT
M^+OP?^#I^(MQ\%O%&C-X7T'5?!-EX<-SX@\=:MI$%GXD\,W]ZA1+"Y_M:&YD
MN8F65O*9717Z:$'[8/[)WBK6=+^(/BCX8:U;^*+;3(;'4O&FM?#S2Y6T2/4)
MI]#LK9]5?47N3I]_J<-[:6)",90I,@B0[J .)\1_\%)/!=KXVMK33_A=:ZEX
M)T?P[;SVWBM[OPU=:AH/C'7;7X5V_AMM-L4U1&U+0/-^*NEV.H/I^+JS%I/,
MY6VCVOR.B_\ !6'X76/AR>6^^ ?C;S].T_PI=:YJV@Z7X?TWP3>:UK6G66L?
M$:^LKO4+CS$T/3]8FE,=P5NWO!&+F[>SBCFN4^BO@1\3?V0_C#J$FG_#[X(_
MV'JW@;P_XE\3Z/:^(?AIHGA]X;=;7PJWB:VT)X[F91?M8^+?![3@%4:/5[<%
MV9'5/ ?#O[8'[&GB3P_XJ\4_%/\ 9RF^'NDWNF?#345N=>^'^@ZW;^+&N_AG
M\)/&'AOPV);!C]H\46%K\6-#MK>V:/ROLR1S+,ID:", [3Q%_P %3/@EHFIZ
M_IM[\+O'NIZQ9^,CX5TS3M)M?"^M:CXDTBUC=YO%]NMIJ#H/#1CM#]EF$LT-
MQL2/S8IDEBA[7X??M]> OCOX!^-?C#X>_"+Q=/<_"GPP_B?1[?X@Z-INA6/C
M.V@+6]K'#>R22_V;.MR)$*/O"(I=9&4XJGXI^,W[*I\&_#'QMX?^!FC^)_#7
MQWO=5\40:IJ/@G3=$CTW6/!U]H-L-0\76=]:&X@U!;GQ $A94D*R0GDJVZJ'
MAG]M/]B3P]>^,K.S\'ZAX#A\0P3:CXUU:?X;VVEZ#XD*Z;/<6[7U[9W#G5/M
M=G;3K9^9&/-V!6"9H ]4^ _[5WPW^-DI^'TOPUF\+V=KX!N?&D=K?_\ "%7_
M (.O8_#9\+_\)A966EV&HR3:1'8ZYXJL%MY-0L[5+M4>YA(7:7^4;W_@IUX8
M\42R:Q\*/V>X/$%W<Q:Y:>+9_&^N^$_"^J7L>B77P%NO!USI5Y MTOBS1;G0
M/CHEYO\ ,*6W]FAK=IK>;[17U%X1_: _90T/P!:_'#P!X!U"Q7XD:[_PKI[#
MP_\ #:*P\=Z]?^'=$?5)=)O],9H?/L+/PQ8R719IS"MI:Y1F9!'7D?@[XH_L
M[3?!KQC\3?#_ .RMH*_#.P_:%T?X1>!;+P_X=\-_:O&UKX_OOAYX+N?B4MA)
M!''INC3WFN6T31LQFEM/#T(8*2@0 \FTG]L#]D#2?B#KGQ"TC]FWQMJ/Q!^*
M^B:EK=YJ5YJ'AGQ!%K7PW\.6WB/7-5\1'2-:\=75EX*LUO/"NJ,VD+:V-_/,
ML$TMJ=P=/IS4OVM/"$_[/7CKXSZ3\"I8'\*:OH_A[Q/X$\6?\(9:74VAZB;6
M6+4);_1)K^UO; :-<)/';%BYVB$HK<5XWX)_;,_8/L=*\-W^M?#*P^&WCOXH
M7UK/K?A"7X>:9)K!NO&&@^')+OQ!?367&H>'+K3?%NC1&]&7GCO"K6XQ(J^^
M?%/]IW]C[X=>*_$_P)\=:;;W%S+X:LO&'BO1+3P0NI>';C34TV'5;$ZH54)/
M=KH\,=PJM&0L5O\ >#*%H P;S]L#P=XQ^!'[0_C7P#\*;9_$/PB^%]YX]\/^
M#?'UMX</A[QEHVI:1XBA\(W5W/X;O;Q=-TR_D\+WMO/:3^3>V\"JKP@':OS6
MG_!4OX:W.D>+-5\=?!2UU3P%\,? 'PCU.PL-#'AW6-:;XPW.D?%/4_C5X)\.
M:'X@GMX_)\#VOPWGLVDM8FNFNX[M"D=M;S3V_KNA_ML_L >%;;Q7X5\'Z$EM
M8^+[*SUS6M'\-_#,-9^/IO$C&/3K5+6U &L:C?6%RMU$DRHDEK=AMX>3RS2\
M<_M%_L,7VC0/XR^"MEJ'@K49/''BSS]>^%]FS:]?^'?$DEAJFL^&=)6WE777
MF\8>//$L-S<2RVWE37UY/-FWN&G8 YWQG_P4S^ $IELY?@IJFO\ A;1/$]O%
MX@G\4VO@6T<^$H/#GB[Q/IWC?PEX;O+NYF\2(VJ^'-1M[6-5A'FW$D@G29)X
M8_?/V?\ ]KKX6_'76]3G^'WP1\6>&=:_X1'5O&?BG7?$WAGPKX;DT]O#TKZ5
MI%KJ\R7@U'5KFX*(+6:"":*.!OFECP%KF/AQ\2O^"?GQ.^(OB7X>>#O ?@>X
M\5S:!:^/?$ES<?#O3HM+O(].\.6VHRF[U>.%TGU;3]!\8H)D/RHNL2QPR2GS
M0K_A?^TG^SC9?$GX8_![X"?!\Z?=?$:[\1Z7?S67A:P\'66@^$=-TYO$;Z\\
M 1FU31KYI3);*NS<6+R*A.V@"GK/[>_PS\&_"3X+_%OXA?"[7-;\2_&R\\6Z
M/%HOPT\.V?C#4-.TOP;J'B>WU:\O;N]:*:XT^+1]#GD,1)W27)BPJ,7&)HG_
M  4>_9LL9/,'PN\6>#E\;_%S7/A[XWNKWP]X%T4Z?J&G6ND65EXN^)0CUU7@
MM-5M]5L8-+%[NN=2CMY8;+[5(+>WGS]6^,W_  3?\(:;XDO[[X7^$=/T_P +
M_%&32=8 ^&FDQ-;^-;'^V;N[\216DCK(L$1M]:=[GRUE8/(T<4HD!;:\->/_
M -CW7?BQ\*/AQX5_9Y\*ZKXG\7_&'QREQX@TOP=I/_"/>!/'7AO1/B7XG;Q'
MJ.L3Z<AF\6WUK\)_-2)(UDC6_AE-P3"%D /0/AW^U;\'_C]XR\,?"^#X%>)+
MS5O%4-YXGGL_%6B?##4=,T'P?%HGA?QOX>\<:VT7B6Z1K74K+QQH,]M;VRW&
MHPW-Y(US;Q!?.>/P)^TY\)]>^*<OPVG^#DEOJ^O>,9?#>H^-M*\+>"HO"QUR
MRN;FR\-66N/<:Q_:=[J;6EO)LG6RF@@!VAXP=M4- _:+_8D^#VHZY!X-\+V7
M@^^T77->T_S?#'P\%D^L@W&NV7BW7M!GLHE-_P"'XKCX;:Q'>W!* ?\ ".+\
MC(("W/>%OVQ/V39]4U;7(_ !T,6?B+4Y]&U:#PE;W6O>*=7T37;W2I/$FB6-
MC;EYK(1P7%U]K:56CC9MRYY(!SGQ"_X*-?L\_!O7/B%\)/AO\--2G^+7@/3/
M$#0^!=-\,^&_#.E7.I::\>J:QIDU[9:A'';J-/=M5N% #&U1KAEWC NZ%^T_
M^SDWBR\\/67[-5K;:_K&H:?XGO\ PE9^ OA'I?BNP\7^"M<^+<?CGQ3XQUB_
M\30:-<W&@'X>ZC=6MY!J%Q>.VJL]J[M)+Y/J7@[XO_L:?&/Q-X[U+PAX-\/^
M+_%EIX8\2>,-3UB3P):Q77C/2[32M.TOQ))I.LWMN#K<OV#7-.LKD%@=MYY3
M94.!!\+OB'^Q]^TC<^$].@^&6@-XF\4:=I7Q)M=*\3^!K(-!XKBT&Q^(5YIJ
MZHT!BNO&&FZ?\2_MMR$.!_PD,[J[.\RJ <A\)OVF_@5XS^#OCGXK_$#X 6O@
M+4?A[X6T;XX^+]+3P)X,UE/$$&K3Z])X<\<>";G3+B>36M1O+O3-5^S2WJV>
MIQ33MYJ1>86;CK7_ (* ?L;:9]D\>R?";QYX0\:1QZ[XML])G^%>E:%XXO(K
MUK71/%/B=;2QU)!J:"Z6PLKN\DDD8.R+O*@L-3PQ^W9^P[=>%['2-2\/?\(C
M?>,OACX8BU7X</X$:^OT\,:U*EOX6\!:I%I=LT$UQ+#XE2:ULB1'Y.L[P59V
M6E\/_'C]@*2!_AYX<^&6F6T.FZ+XE\*6&E7WPK?2M%_L^ZEU"XU;0%U.6Q>.
MWT^]UC2[Y& #+)<VK,RD@$@&5=?\%%O@@?#OB_Q#X-_9R^)%UJNGV#ZK=KXA
M\(> /!EGJ'C@Z;JFOV?AG6;Z[\0R7BZY+:^'9I?MJV5S:JT<!-UO*XW_ (^?
MM9^"_P!DSQYX4\$1_ KPI;>%/%?P1\=?$G1)=!LM$T>_?XUZ5J/A_5/AK\*H
M=,T[31;S:EXF\0/J$%I>(X9=9L+(@LTJR+0T;]HO_@GMHWP^U.SB\#^&M"\+
M:/8Z;=ZAH*_#N-=,O$NA::)=-I,EQ:Q1:S!:2^)H[6XF^38NH,,89A6_!^U[
M^R=\0=5AO=8^'W]K67AS4-*TOX=:Q?>$8=9UCQ5?:0/A%XH\%?\ "O=(6T>6
M> S?$GP_=6TC2P&UDT=YF4 ;XP#A=/\ ^"F7[/LNEV+?$'X5Z_=?$N7X4^"_
MB5XJTSPAX?\ !OB[3[C5M>T/X92^)]#T+5[O7X[B\FT:7Q?X8BO'U&*T>*UT
M<2O^ZMXB<]?V[OV4?#_B271?&'[/#:$9/&VJZGX5U+P[X#^'_BV"\L]-A9H?
MB)J$^ARE=)O[BZBGA1H7N;E7CWM+Y)$E>D> +O\ X)S?'+QIXE\,^$OAM\.M
M=U?4?#,D^J:S<?#J*QT?5M$T70O NJ:EIMCKEQ9*DTMAHVH> VO+==IB_P!'
M1@SPLL?/:;\1_P!B/X@_%[X1?#KP-\"/#GC'Q-XKU?Q!+!K%UX(M="@\)Z-X
M?\.64W_"4(=0TXMJ6G7NE7MK':>45\Q&)<H1M(!]&Z-XU^&VO:S\ ]<L?@?X
M>\.I\94\8);WOBSPSX,M?%^@Z)H_AG5/%\,B_P!@&_B>.^GL8W:$7A(%R)73
MS@5KYD\2_P#!1K]C?Q%XFFU'Q!\)O&?BS4_A]\1/^$-TSQMKGPI\)W%EH4]I
MK?BS3=0\9:5XN\4:K&GA[PY9ZYX U=)KAY[2X66&UE2%EE1UPO$W[6G[&GQM
MM9OAY\4?@S-+HOPWDO;WP';^._#JQ>&O[<T6;5=$6RTS4K>TFB\/7,L>G7*6
MI8'SXY-H48(KU703^P[X^\%?'+QCX'^"7A/QM=?!B\E\6^-_#5AX+LHM1U7Q
MAX8T#7+G3[31_MELBZE>3?9-;M()"BK,]W(Q1HYPT@!SVC_M@_LA+?ZC8Z'^
MSUJEKJO@+Q-\1+/5+"U^&7PFTK5/"7AW1[W1M*\=?$^2RG\1P3:?X.OG\2:6
MV^%#J6L6]V9[>QNX0S#TO4?VA/V<?"7P(T+]H5_@-JEIX%LM<E\(^"[/2_AO
M\.WU]-*UNXNUN=;T>RL]7\CPYX0N$MKB>Z>XN+,B-M]U A8@>._#CQM^Q#XO
MT:_UGQ1\$OAQX,\86_B>7XAW&AV^EV^O27>N?V]X.\-V_B,W\N@V-U:73^(?
M%_AFU>WO[*TFCE'F^2\$<4[K??MD?L4>,_A3X9T#X@> K;2?AE-I<GB._P#"
M'BGPQ%';>&+^SCT^\T*WM]#DM574)KZ+6-UI/#L1D,A;:&(H R_!/_!0#X P
M>$?BKXE\5? [5_#^GZYXEOX88]#L_A_K>D?&;PWI^H:1X8M-3T];[Q9%%J=[
M"NK0QW%E-'&OE1M]@-Z@S7NG[+/[1GP]^,_C[4](^''PQ\(^$_"EEX&?5O"?
MB;1[#2M-UB]\+L/AYJ]GI5S8Z;IZ1Z;:F7QN[RVT4\D,=QI@8%V;<OC_ (F_
M:$_X)D:GX<'AW7] \$ZGX9TGPJ/&6G:6WP]6:T;2X[Z"]N(])M$M,I=PWUG#
M)*NV.-6M@_FD+FO?/@1\;/V,M0^*'_"H_@7#X4T?QY;>#H[X:;X=\,QZ3%%H
MAT?PUK,NAB\M(@D=Q!HK^&)I(.(Q'%"$=S'M !]N4?B?T_PHHH **** "BBB
M@ HHHH **** $SCU_(G^0JY"<IWZGJ"/YU4JW#]P?4T 2T444 %9_P#GU_E6
MA5!L;CM^[QC]<_TH 2BBB@ HHHH **** "BBB@ HHHH *\6_:(\=:?\ #7X+
M^.O&>K>%/^$YTS2K'3;:^\(^5%.VOVVMZ[I6@26$<$ORSRL-4W*A^\T84$$Y
MKVFO%_VAM4\"Z-\&_'%_\2_#LGBSP,EII=MXA\/PRF"6_M=0U_2=/MRDZW=N
MUN8KZZM9_,6:)X_LN]&# 4 ?%:_M;?LD:1\./$-WX>^%I2[\)1Z?!<_#V?P5
M;:3>P^(IH)#:Z*\=U%Y<-S%)YBO+DK$6R6&:J_$_XT? #X&>(?V88]=^ ?A+
M2/!7Q6\!>,?&M]XL_L[3HD^&DTWA'3-2L=+O8HX\7<FJ:QJ&DZ5ORP-Q-#M_
MAKA=3^)G_!-S1/#VA>()? >GZEKV@^ 4O],\*:9'XFUR_F\+ZE<&.[$$T.J2
M67C#5XXY6EE;SKS4$0_*V[ KU?Q5^T)^P%XEM='\-_$B/PF/"OAN#PMX'\$R
M>+M/N[C3Y;4RS:P-,M]/D=[G3+71[WP%:/J,NH0PBQ?3XO/D0!L@'BOA+]M7
M]D#QEX=\+>+/C#\"T\*?$S5?A9)\7KWPZ?!J>([K3;?P[)I&FV7AZ#4+:,_;
M/$EMX?M?"4SVV-T*6<8*_P"AHR]!K'[9G[$6EZGI%SXL^$4VC:=INK> M0^'
M&MGP+%))JG]M> _"/B :UIUGIZ;[6UTG3-=T&TNC)PK01'!V*1M^/V_X)_>
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MWAOXE?\ !/?X40W.I>'_ !O\./#%IX7NM2^&4DB:F\%O8W'C*VTZ]U30H%D
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M@;Q%X)U/4C9^%=5TG3]'L+%M)UJ(Y\/:S#I_P<\.+*V"QCM82RE9SGZ.TO\
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MUOB%X_N+W4=0.B7/PYTS4I/#4=I;ZD94.FK'-XOOI@$(E5;B1S)A5"Y.C_\
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M7LO^$MA-I)IVHS:7<V>C:<^JW.MR:;I5S!I$-Y-:'5+N>4"]NKMDW;$95XH
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MC[PL5\=:#J'BCPA*VJVT=OX@\.Z59KJ&I:UI]S(PCDT^"R99)9&8*B\DC!H
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M\TC 7K8.U(E0 +'_ ()\_LK?$+3_ !;HTGQO\:>,M(^'%U-X;G9=5\ 6>G^
M+;48G\51>'KK5M)\%6T&M)'>:Y]L,][+>3@7 MYYSL,8H67_  2\_9C34_#1
MMOCCXND_LS0KF>PT*/5?A)<:1J0O;*;3[_71H%QX/EMY=/N;>7_25CA\F5HP
M2^ 5/L_@?]A*^\%_ 'XU?!BT^(]C;7_Q;UO1-5/B'1/!&CZ)9:1!H&G^'=+M
MK>72+0 7EY<VGA]&O+L2)<O/=R31R1OM(\7\)_\ !++0OAOX%U9+'Q;>_$/Q
MW#IBQ:->ZPMOI$K&WT?5["'18-?E@N;G3=+:]U..X8LTS9LU#;B2: -RU_8;
M_9Y_9HU_PI\<[GXX?$73O$/A2T7P=H.L/I/A?QWK5WXQU%?%^C:$/#'AVR\!
MZG?W>LP6OCW7+>VTC3K>5#&(A);M#%,)/TO\)_$+P9X[\.Z?XM\+Z]:WN@ZH
MEP]I/>17>B7<1M+_ %+2KRVU#2->M[6\TF^AU/1M7MYK>ZMX)X9],N(I(U>&
M15^4M"_93\3:5^S_ /!;P+:_$,V7Q?\ A3JUC\0)OB!J>EP>(-/\2?$F_L=5
MA\9W?B/391&VIZ;?CQ#K4):)[>XC1XI;>6"6*-U\!U[_ ()M>+=8T;0O#T7[
M17B"TTV'3VN/$EQ=Z#;ZWJMSXEL-;^/.O^&%T&ZUN:<6'A&QG^/>M6WV"X6Y
M>2U\.V$9GW"9Y0#]-?\ A-O!?V:.]_X3#PI]CFMY[N*[_P"$CT?[-+:VLH@N
M;F.?[;M>WCG(1W!*HYVL0W%4->^)7P[\+Z?>:KXB\<^$]'T[3[>TN[ZZO=?T
MV..UM=0GCMK&YF N"R037$L:1.1MD:0!2217Y8:!_P $HK30_A[XZ\,'XMMJ
M/B3Q>OD6&O:CX:6\@\,Z7=>-];\8ZQH.C?:;QKRRTNZDU>*-VBNTN =/C<3<
ML#O:-_P2P\-:9X+L-"NOB--JWBF"TN+#4/&6H:!;7&HZKIO]D/INF:3?-+*7
MN=.M)Y//@21W9'C5@P?YJ /U,/B;PTOF[O$>@ 0WZZ5,3K.F@1:FZATTZ7-S
M^[ORC*1"<2$,"%P:E_M_0?['/B'^W-'_ .$?$)N#KO\ :EC_ &,(!)Y)G.J^
M?Y A\X;-WF8W?+G/%?F9I'_!-#1%U'4-0\3>,-(UU9/^$KCL=-'@ZUM],GDU
M[P_\1M)L/$7B&W-PYU?QC:W7Q"F<WP:,M#I,,:)&[2.WHNA_L2:EHG[*/@_]
MG63X@:7K6I>"_B"/'NGZGKWA<ZGX.U)(?%&JZ[9^$?$/AFXOS/KGAN&TU01*
M;F\DO'GL+>ZDN7EC!(!]7R?'#X2Q7?Q*LY?'FA1R?!ZVL;KXF3/+.NG^#X]3
MTJ#6[&/4]4,'V9KR32[JUF%O%+)<*MS$&B#2(K6O!/QB^&?Q$\+77C3PCXLL
M[_P[8B[-_=7MGJOA^]T\6,9FN#J.B>(K"TOM/Q"N]?.MD\Q"'CWJ03\Q_"C]
MB?1?A/\ !CXK?"?2?%,>H7?Q3T_0+;4O$^J^&](U.1KC1/ WAOP@YU73-1@E
M@UG3YV\/N[03(RI#?-#&5V*P\&E_X)S>/1X;G\-:=\>+?0]+UNWO=%UW1M-\
M,:A<:%I/A:;4EU2+1/ EMJNO3R^'[=KE!YR22SPA"4MXH4PH /T9T[XP?"[5
MY?#L.F>//#=Z_BS0-4\4>'FAU&(PZGX?T06IUC58[EL1PVUL+ZT\[S61D\\;
M@.:[HZGIBB4G4M/ A@M[F8F^M1Y-M=DK:7$O[W]W!*P(C<X60C"$FOR,O/\
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M4T]+R_N9+;6+Y-*DGU:428O+FYW[450I\C3_ ()>Z3!_;>I:5XST#P[XIO\
M5[R.P\3:#X2.GZC:^#;ZZ^/MY>^'+B2._P W/VNZ^-=O)>X*P3/X5AD\D.RF
M, _6".XMY1*T5Q!*L+O',8YHW$,B*&>.;:W[EPI!(;! Y(KF_#GCCP=XP_M7
M_A%_$NCZ[_8FN:IX9U;^SKV&X^Q:_HDI@U?2I=K?-=6\HVRA<A3U-?$/PI_8
MFU_X?^#_ -J7PAJ'Q/BN[']H76M>U?26T?1)K.;PK+KGVR:]FO[V_P!0N+G6
M6NKFZQ<P>=':I!O@M(+>-R!\]Z+_ ,$L=1T>2[DT_P")GACPXVOZUJ^OZG+X
M2\&WNCS>#KS4+[4[U[#X6L=<?_A&M)O%ODCU2.;[2UTJ,5:,OP ?L,MS;/&L
MJ7-N\3$A94GB:-B&V$"17P3O!'7J,=:C^WV)CEF%]9F&"+SYY1=6YC@A!D4S
M3.),11;HI1N8A<Q,,Y!Q^4M__P $\?B3<V2Z3HOQ:\">"=$U71_#VE^)='\)
M?#^^TZRCD\(ZC:W^D7OAV%O$#BTO+R2WD?59+C[0UR\Y,?E!0*H:I_P2WLH?
M!.K>&?!WC^Q\+W>K?V8VI&RTG5++2_$D.A>,/@MXMTK0_$<6E:S!/-X=,_PT
M\2K+;PS1?/XYN9%*EIA, ?JWJOB'0-"M7O=:US1])LX[C3K22ZU+4[*RMX[K
M5[R+3M*MWEN9U5)KF_GAAMU)!FEE6.,,S %FO^)?#WA73KC5O$NMZ9H6F6B0
M27-]J=Y!:6\$=U<QV=O)(\KC9&]W-%&K'Y2T@&<FORF\-?\ !+>W\.:'X:MC
M\1=.UO7=+O-+N_$6IZ[H.HZI'XPA\.Z[\#]9\+:9KPO-:>:_L=-;X4ZVMGYT
MKR0'Q:[1NI67SO6/V@?V$M2^./QJOOB1+XW\/:9X5USP5H_@[Q-X1O?#=[K1
MUNPTR]T6[:Q9KS5S;6.G/_9<H(M[:.9Q<[)I)%4"@#] ==\2^'O#&D7NO^(-
M;TO2-%TZR?4K[4[V]@AM+;3X]OF7TLI?BU&Y<O\ =&X<TNC>)- \1:1;Z_H>
MLZ=JFB74MS!;:K:7<,MC--9ZA/I5U%'<AMK2)J5M/ PSGS8BGWN*_(KQ!_P2
M_P#'FH^-K;5-(^.>D:/X'TNPU[1=#\+P^$+L7.E^&M=L=6M'\*"[BUE8[K0H
MFU-)(HY8F,+6X$)C!KZF\=?LAZOXE^#'PQ^%]CXE\*ZE<_#OQWXL\836WC;P
MW?:WX&\41^*G^('E6^N^&;/6+=[N?3)?&]O?V#-.4CU+P[:SLC*"E 'W&;FU
M0N)+FW7RI%AES/$OE3N(V2&3<_R2D2Q$*<,1(N!R,X6N^,?"7A@6_P#PD'B7
M1-&>[GDM;.#4-1MH+J]NH81<2VMG:E_,N[I8&5S'&K.$.[;CFORUD_X)F:OJ
MLFM1>)/B=H.HVMP/$CV4R>%;T7^O:YJFF?%Z/0OB)X_>YUF2+7OB)I^K?$W3
M7CO8HH(Q!X1ME2%9-LBYUI_P3,\71^)]>\3:E\5_"VK76J>+T\56S7_@_4KZ
M\M[RZLI;36-334;[7Y)[759@T.R.!X[*!8RL5JH/ !^JMIXX\%W^@7OBJQ\6
M^'+OPSIOVG^T=?@UFPDTC3S9*K7JWU\)_+LWA#KYJR,K1DX< \5N6.IZ=JEM
M!>:9J%EJ-I<VMI>V]S8W4%W#-9ZA"+BQNXY('8-;30,KQ/\ ==#N4D<U^4?_
M  [@\7VUKKOA'2OB5X'L/AOXKU^PU_Q/H/\ P@U^]]J4FDR1SVEL)%UX6RI<
MW"R-?%K=FE# *4Y)]1_9%_89US]FGXK^,/B3JOQ'@\60^(_!EOX6MM,LX/$%
MBMN?)\%(5FL[W7[BQ_LVR;PBZ::D5K%+;P:DT33/\Y< _1BBC_/^<44 %%%%
M !1110 4444 %%%% !5N'[@^IJI5N'[@^IH EHHHH *HN<R,1R#C!_.KU9]
M!12DCL,?B324 %*,9Y.!_GVI** '$+C@G/\ GVIM%% !12XX_P#KC^5)0 44
M44 %>;_%[X:6'Q>^'7B#X?ZA?'3(=;DT6=+\6EO?_9;G0M?TKQ%92&SNP8YU
M^V:3"K!OX9&QSBO2*J7U_8Z7:RWVI7EM864)C6:[O)X[:VB,TJ0Q"2>9@J%I
MI(U7)Y9P!R10!^5_CG_@E9X%\8:9X>MX?B3KNDW>BR:9+>)::596^D:[>VSR
M"^U;5-)M65)]2DAD*Q2-EH2H*FOHKX;?L5>#?A]X>^*FB1^)]8U&[^)W@6+X
M?2^(?+BL]=T#0DN/%-RZZ5?QN7C=Y?$<3'D?/ID3$D]/LB"^L;F>XM8+NVGN
M;18'NH(;F&26V2YC\VW:>-6)B#Q_,F[&X<C(J<R1*Z1NZ+)*6$2-(BO(41I'
M"*QRY"(Q..@4D\4 ?EG<?\$V)]1C2'4/B]!"E_X:T[PYKC:'X$TC198(O"]I
MKUMX9E\+36DN= DN'UV1]>:+#:L+.*.?<JBN8^+/[ WPNT;Q)X9U+4/CXWPE
MT[6;_7_#GA_3K:UT_2[F4^*?"Y\/ZEH/AZX>4;([C4;IKZ7:%*W%R,/^]P?U
MRFECMX9;B>1((+>-YYYI6$<44,*F26621B B*BEB3P I)X%?"W[9'[*GB3]J
M+4?@SJGAOQ+H.F67P]U74=0E&IW&H6Q1M5U?P9K%OX@TR;3+"Y&LRVZ>%)(O
M[.F^SV]U_:*2/=Q^3A@#Y>\&_P#!-/X5>%=4F\*ZS\8XM3\?:KHENEGIRVL1
MN[&U36;W4)M3L;*:Y9HQ=V]TL5PQ"I+M)Y!KZ0^)7[#%IX]\)?!G0K3QS'H>
MJ?!OP%K'@33KR#0K5],U>RO[*UAMUO--5E$5HT^G6'VJ)"%GB,T1XD.=&[_9
MC^(]_P#M,^#OCJ-8\'>'VTJTT*R\6ZMH>L>)Y]>\1Z%H6F'3QX/D\/WVF)IS
M:7=3!;EKH217%N_R(LH^<_=Y4#GU/7<HS]..F: /SR^(?[ ^B?$;X!_#CX*:
MYXOB8^#?$WQ(\0:EJIT2WFLKNW^*VA_$G1O$V@:+83,?[&TB&'XCW45DB-^Z
MM]+BC. 2!Y?H?[$OPW^'7[3&G_&F#XZ6^F:3\,==N-4U3X=W6I)9V/A%?&.N
M^-=4\):#;6IN@FE:7<)\1%C5)0IG>PMS$&#87]5%N+:2XEM8[B![FW2&::V2
M:-[B&.8MY$DL2MNC1VC?:2 &V';DBOR8_:1_X)[^./C;\;_BA\2-(^(WA7P[
MX1^)6I_"S4/&?A*[EU@7&OQ_!NP\%R_#9M4N+2V*V#6_B&V\9W,RH)%N8_[*
MC9L+*(P!OQ-_X)>:?\1?'FH^+K;XL76@:-JWB?Q?K\VCZ5#-:06T7BC7KWQ"
M%MH;258Y=2,M])#<3.09(8QU-=;!_P $W/AM<S7.NZ!XKMUO;FSN;;3-4LH7
MG3398=#T3P]93V4D5V51K.\T:[F&.5GO'R0P)KP33/V ?VP)&EN[WX[^&KJ&
M?XA:-XIM;6P^(OQ-71(;"SM;>RU22:P2P\V_CN(X9F2Q2\A@CDD#[R,K4MK_
M ,$Y_P!H^RUZ\L]-^/">%_"%SHGB'1;'1/#OQ+\<V45I!K6I>+=0NX(]-GT2
M1I);P:]9S2SI=13VTFD_N'(P6 /IKP;^Q?=>#_AS^T)\&E^+EJU_\;_&=U\4
M?">D)!*J>'K+2?%^G^(+ZWNK:2X^TZEH%[J-UI5CJJ(?+2WOFBB8M.!6A\/_
M -@^W\*_#K]H'PQK?BK2]5\1?M >"1X=UW4K;0W32-#O%/B&YL[33+*Y=I)?
M"]A=:Z(K&V=LQVMBD9Y->H^._@]\4M.^//PO^*?PD3P7=Z#X4^!WCGX'ZI8>
M,?$FOV6M:58>+/%_PIUZQ\2:3<Q:)J']O7=I8_#RY5XKN:%YY;J,O.<NP^$?
M"/[#?[:GAJ3P UY\>7UF7P_XCUN?6)]5^+'C"\LM1M[[PQX>T:XUTV2^%H'%
M]?7^D:G?0VK/=0:9-JIV6\B,5C /5/\ AV?9Q6:?V9X^CT;4M0_MZX\5C2].
MOK'3_$M]JVI:E?VTES!;W ,"0+?K$K( X2($'->AV_[$GB:U_9<\"? 6?QCX
M7\1:[X%\1MKMKJOB/2]5FTQXUF=[.WM-1AE_M'3[VU#AX+V,^=YD8#@H2#\]
M^%?V,/VTM-TG2].U;XS6!FCO?$46D:M+\2O&L^I^![:_U35;V&^N";!H?'6J
MWEE>VUNZSK!!:"V#6\2%1GZ%_:,_9G^/WB?]GCX4_"7X%_$*#0/%GA:[M)/%
MGBK7?&7BR#4+^9-)N(Y-3M];MW>YOPNOS1W#13_(T*%%A8[8R >-^*_^"?'Q
M/UNT\/>#=9^.?A+6_"MOJ^C>*;+P[XIT.^\SQ;XZT/0_ ]O=:3JD%G(B7'A$
M:9\/9I!%;J+C;?W%PX$B;JQ]:_X)<^-M3N/ 5[%\=KNSF\->);7Q#JUE8MKF
MG:893HWPSL))-,CM)M]U+8R> );338[MC&NFZGY,I#*<NU7]B?\ :YUW5/#N
MLW/Q3TFV\1^"OB/:_$&_\4M\0_%FHR?%6QA\-^+M+G\#RZ))X>2'X9Z/>:9X
M@CT.\O--D-R;666\2)ID4G0N/V./VL]-T'2K73?C$^MZS?I>ZMXKT^Z^)_BN
MP2'QWJFL_$(:3XYLKXZ<[G2M&T?6/!VS28UBL[Z71'22$A=TH!Q6G?\ !,/X
MIZ#';W^J?M$Z59RVGCR#Q.VJB/Q%;6^G6MQHNFZ#?BQLKFZ$!U&YFLQ,J2GR
M8I[C*$GK]I?LF_LS^*?V5-.\8V?B#XBZ?XGT'Q/KCZQ?ZAJVI:U<WZR1&_6P
MN6N=:D\JSNI6OE^U(A$9:%=F>WQIJO[#'[=^KW'C'2]6_:DTGQ!X3O+06_A&
MQUB?53);7F@:MI\7A+5M7BBL")9_[&L$N;U SK)?NV,IS65/^Q'^VU=^"KC0
M?%OQ83QZ;W6+JYGL=3^(FK6MGIE^FH?;8_&MM#;Z"[:K;M"@1=&ED$8<K@1A
M?F /W""@9W9&/;\^WTJ&66*".2:>6."&)#)++-(D444:C)>21R B =22!7X)
M>%_@I^W_ /%JYFO=-\5^/OA/I&@?$O1EO8O%?BS4M&O_ !E<65AKUMJ'Q$T:
M+6=!\V+P_#>WFGS3:5';O9SLRI:-<+"U?7G@K]F;]I*X_9R_:O\ A#\2_',.
MIZQ\3-9\3O\ "W7+WQGJ6JZM9:/?:=IZK!J^N6UM -,L)-4M+D6[6\<,D=I<
M!YK2"7?%0!^EUM=6U[&9K.X@NX1))$9;:6.>,2PN4EC+Q,0)%<$,,Y!&#S4D
M4T$WF>7-'((G:*0Q2(_ERIC?%)M)V2 $94X(R,CFOQ=\6_L:_M>Z#X)UW2_@
MA\2(;"3QCKMUX@UJT_X6)?BWTK4I_%/BG4K>]\/RW-NBPHNF7F@)=QB=4<VK
MD1S."K?97[)'PS^,'PCTSQIX)^*=JFMW?C/7-?\ '=S\0++Q=+KMG-?ZG8Z%
MI9TA;:]2*XL;AI;>_G_=0+ HP5PQ H ^V(I(IT\R"1)XBSJLD3K(A*.R. Z$
M@L'5@1V*D'D&H4OK.2X:UCO+5[M%D9K9+F%KE5B9$E9H%?>JJ\L08XX,B@XR
M,_E]\ /V:OVI?A?\6/!LNI^+F3X7^'O%'C74[M9?'=SK]O+X/UO6?B=J4GA.
M;0+N$S7^KW^I^*/!E_%?/(!8IH$UON4*D-Q@ZG^Q;\?C\8OB/\3/"OCNX\.Z
MK)\3_'/C'X=ZROC._ELI--^(7B_X0:G?6.M^'Y1*)-(L_#?AKQ=:K8L(X_."
M/!M$ZL@!^LT]Q;6L+3W=S';0H5#RW$J0Q(7<(@:24@*2[*!D\E@!R14PVX!!
M8@C(QR"/4<<CI7Y6?#S]F_\ :MMOV4_CA\,OBYXNN?B5\1O&.O:1>>&%U+Q;
M9::S6MA?>';S6FTSQ#8QSC0(KR[TS4[FT67F!KM%>.W&8T\DO?V7?^"ATVKZ
M9+;_ !GUG3-#A^'^H:/IVE6/C;0Y;W0YWL[Q/[%U/4[RS4:SKLDSVGEZ@D$D
M2B(EKB#K0!^U'F1,[Q)(K2QJC2Q!E,D2R;O+:1!R@8H^"1@[#CH:A>_T^.\@
MTZ>^M8]1NHI[BUL)+F%;VYM[8Q+<3P6K-YDT,;31!V52JF50Q&X9_-+X!_L_
M?M4^#/!?QTO?%WBJTM_C!\1/@EX4\*>#/$EUXPG\0V6@^-?"[_$VWTVXOK0I
M+%92K!X@\,3S7$"3H\B2QF2Y\E6?;_9E_9N^,/A?XRVGQC^,,LCR:/\ "_Q9
M\/?!&CZQXZ7QQK?@_2-<\;:;KR:9>ZG!9Q0:IJ,LFEW-S)?QAF%MJ=K8L[?9
M6"@'Z%V^JZ7=K;-::EI]TMZ9A9M;7MM.MV;8@7 M6BE(N#&2 ^S.PD!L5<DD
M2)&DE=(D7&YY&"(N3@;F8@#FOP>\.?L&_ME?#6V\/'P/XRT>XM/AGX?\76OP
MZT6+QU<QWT&K?%:Y\,^)/B+)?7.J1&"XGAUJ'6K32C+(J+:01 RVXEW)U4'[
M,7_!0OQ-IH\.?$#Q]>W^EWOPWBT[4"/B#HFGV\?B?3+W[9IALGT=3=&]>18?
MM)?-N4A.V]?/EL ?M\<@<%_QST_*J\<\,S3+#-%,UO-Y%PL<B2-!/Y<<WDS!
M&)BF\F:%]K8;;*K8PP)_+GX"_ G]MC3OBMH^J_&;XI:UJ'P\TSXCZWXIUNSB
M\5Z 4UZUMK/QV_A6UT:PTJSFF7PNTVJ^#8;RSNI+2<OH3L$\LEY>F^+?P[_:
M_P#[._:<\)?!?2[#0F^)OQ8\)_$SP?\ $B#Q;H(U"3PS9^&O@OX<\9^";+1M
M4O87T;Q%>6'@KQ;#:W$ICLE-[&[W,)D\Q #])<'T/IT[^E(Q"J68[5 +%FX4
M* 222>@ !/X5^*6I_ 7_ (*4O:^(;>W^(GB1VU+X6>#M,@O(_'/@-+V#Q?I,
M.A"ZATNVD*1/?2R6VJ'49II;:#,[/9W5YO6-/0?#_P "/V\=9UBPL/'/Q#UW
M3-*U#4-(C\>ZCI?C_P +7.GZCX4%Y&W]D^#K!-#^TZ5JMMIZR1:C<7* 77FE
M;4R<24 ?K-!<6]S"ES;3PW%O("4G@E26%PI*L4EC8JP#*P.#P01VIT4L4\23
M021S0RJ'CFB=9(I$;E721"0ZD="#@U\(?!?X._'GX<_'_P"+=M<7=XW[-]]X
M/N-.^&>DW_B?2+RVT35/,TB2TM='TJU:2^P\\GB*:YN+XP&-[A5B-RD@\CYM
M^'/[-/[>GA?P5X0\/:O\4WA\0> ?MNHZ'=Z-XITFV\*ZJC^*_@<GA3PKK^CW
M-C<W-QIVD^!-/^,UK?.)O^)C=ZC!>1S*]Q';VP!^PP'/S9 ^GUQ3%FCD:1(I
MDD,3F.14=7:-\#*2*I^1L=C@U^-&M?!W_@J$?#,<_@3XBP:+XG_M:T36=/\
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M[JUH;OXDRV>N:MX&LK_2YO&^@:1\2;7PN]SX3FU:VBU06+M%=/8_:52.6S7
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M/2].^&>G_$#789M4M;2*/4=0L3&8'NY89(9OV?/OSS_^KZ#BB@#\G=9^"O\
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MDPS[QLN$&Y0<8&* /8:*/T_SQ^&** "BBB@ HHHH **** "E R"<CZ$\TE%
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MO _AOP@WB?4_C8_POA\0W&@Z[>3H--\&^)KFW\0:99MJ,L)E*QVZO-&8B)$
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M#[<44 %%.RN,;3GUW?TQ3: "BBC_ #U_SB@ HIQ*GH"/QS_2@E3T!'XY_I0
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M,*P/.:C'ACPT)[ZZ'AW01<ZI)#-J=P-'T[S]1FMR&@EOIOLVZ[D1@"C2%BI
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M!5EK[+\+;CQ%J'BJ\N[^RT;3_B;?Z7_;7A+P)<WT<+06EO>Z8#(TLD@D0E5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g1078495.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078495.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" -6 I0# 2(  A$! Q$!_\0
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MOTJW"Q= QR>3UZ\4 2T444 %9<O^L8'J2-W3@XXSCVQ6I65+_KY?JO\ Z"*
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M7EWUXTOB;3H7MHW:6)WW/A#D 'Z#T5\Y>.OVM?V>OAM\._A_\5O&7Q*T;1_
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MAE9ZG>>,XO#U[%J-YI,>DV<M_=K)"K#S&^SP2[&4F-RN%<D' !ZS17B'@?\
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M/"#<<CY<<<]^/_KTQEP>G':@!3LQP,_G_6KUM_JA]6_G6>HR0#WS_*M& 8C
M'J: )J*** "LN4_O&.!\W)(]N,?E6I65+Q*ZY^Z0/S&?ZT /7:O(;GUR*=3-
M@]3^G^%/'  ]* &/T'U_H:BJ5P2.!GG_ !J*@!02IR.M2#!(8GYCVS^'3Z5%
M2@X.: )6; /(SZ4PN2"..?K_ (TN%;DG!/49 ]N])M&X '@CKQ[_ .% "!R
M!Q@?7_&EWGT'Z_XTXHHZDCZD?X4U0I')P?J* !0I')QSZ@?SIO3GC&<>O/\
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MU"'6M!UF#29_#>DBRU6UT'1-1L);2*POHY9KO44,3J;N[:X79NVUZ]8_LW_
M/3/V>[3X!Z+XO&F^ 8O$EK?VNL6>N>&%U63Q!INIPZNL!G@LUMI[OSK2,-&(
M XC7:H  P >3?"7X:?L0_LO>&/'O[1?PM\4ZEJ>C?"RR\9IXYUW3?$MSXSF@
MCO='\&:/K.DWUC;V_F7UP+3X?>%5ME R9=/+J[[G(X:\^'W[&?Q$T7Q_\=O%
M7BOXE^#KPPZIK$VG^(O$4WA_Q-\.;R+QC>^+KV\\%:>]L9HIKWQ/X(OY+)FD
MNXIDL)(K,)&Q4>F_!'X'_L\?\*S^*O@WX>?&G5_%&G_%2V\.>#'\96=YX4MI
M--T;PT/$6C^"/"OA@QZ&-,\0R6;Q>(X+DS0WLM\R2Q7P9=J#A;__ ()L?!K7
M/#/V>[^-/C$^&([G49_&T>CMX)TKPOJ-Y8ZWXRU;3;2ST^VTXVG@?1])U'QQ
MXB$-A9;(0;@>9EP[2 'G7ASX*?\ !-EM$LG@^)FJ7_P^E\(:?XAB7Q#X[D?P
M;;^;<P>%I=4N+JXMH_(\5W,F@107,;MYCK;E_+ )-6],_9,_X)N>'[FUN;3X
ML0VZ>%O&NEZ@\,7Q*LUMX-:U:5[[PYH$LEO;AWM@UZ6MX%<[XY=LFY2:OR_L
M!?LN?$K4O&WPTO?B[KWB_P ?^%H?"WB?Q7/%%X?@M?#Z7+:AJ'A:ZO\ 2M(L
MH-/V/H.IR(L3.7DAV7,@)8L_&:S^P3^QU'X&^('BF']H'4]$\$:)?1:KJVIZ
M=/X0AL?"LGP[@M#KNH6GV:P4QZK'!&BRW=LL91)0DJW  % 'H5I^S#_P3U\)
MV.K:5-\6X8M.TGQ+;>%_'EA>_%"R%KK6MOJ>G>(?#/AOQ3;*@7&G:WX8L[VQ
MAB$20W%A,[D_O /K'XI?#;X)^+I/@O\  V^^)^N_#SQ?X#CM-<^%^G>"_&,'
MA[QO<:7I?A35?!KBVF-M(;RR?PY+J:2;4W-Y#R+CRR1\2:+_ ,$K_P!D3XAZ
M4/%'A7Q]XBO--\3ZU9_$'2)99-(GNX])\9Z'XSU#4K+6K;4($GOI-2TGXB>(
M[I&NTB>V\R)A;,L<R2_2US\#?@+\7/VK_#_QPT#XRW]]X]^ ]IIEA>?#G2]7
MT2?3M#/A<_$_X<&YU&T>(3VEI+>:KXPM9W<.7NM (@GB2.:)P#RW6/V3/^"?
M_A3Q)K%W?>+[#PO?Z/8>'?"6MZ7_ ,)U;6[6&IZ9'I6G:?>7+31--'K\L7AV
MRBG</EC#(7"DG&%H'[&/[!R7_B'3O#_QAUY];UC4IE\0BS^*T$M_=VLVGZA!
M=Z!.S0MOTV33M6N5E49<I(@WCBMWXR_L:_L_VWB.^\2^.?CIJW@D^)/%WB_Q
M+X7CU"R\#2:;X?N_&-[</XZM'U/4-':;5(KF77I(;=]0N6%B9D\A6EWL_P [
M:#_P3V^%FM^!;72/"_QST+7)/$GQ&&B^!O$&FW L)?!7@G3/$>E>)?$6FZ7J
M&CZ.9O$7C&:VT%HY)=0D@MO*D>)9EC(( /I3XE?LA_L16L^C:QXO\?:EX8BU
MZ/2O'VG6=MX[BL%\1VOA:X\9^)X=9LU$)E=&@\?ZV/,A=#)#<01+N( ;LOBA
MX$_9*_:OT;X0_'#QYXUU_P *Z+\9_ >A:1X0L;W7G\#CXD>$=0N+_7_">GZQ
MHM_ 9+DQ7'C2[N;5"4(;78R<ED%;O[0G[*GP/^(WC/X;^(O%WQ C\!Z1J%OX
M5^%>E>%8#X96Q\;2>'M7B\4> ?#GAG4]4B:YT?4K?5]&61X]/9GOK6U>WD55
M42)5^.O["/PU^/7AO]GKP?JOQ$\1:-HWP&T+1-!\/6VC2:*]QXAM?#.H?#[4
M;*]=D:,VFII=_#?2T=XQ-;>3?7<?V42^3-" <5J/[,W[#OQ2U+5-=TCXC0&W
MOWT^S\6:?X6\>V$.DZ_IWAB.WT_3]%U>W$;;].MI;]&41E&,NHY+G>*]%^!7
M[/\ ^R;^S!\0M<?P/XGLX?B(WARWTC4[?Q!XDL+K6-.\-:QJL>HZ9:?9Q!&U
MO;M<I&D#-EF3Y<D<UXMK_P"P%\#-"\=? /PMH'B72O#?_",WVBZ]J^C7.HVN
MC^(_%WA;X6^'M(TN72AINE:4(M6L+W4(_#]YJ\MY-#METVV,8E,C!/4OB_\
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M'\3-'\>^%?@AH'Q>^'/A^YTJZT/49M'N/B;JD=A<WL,$G%A?V4GA:[@T>:-
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MO]E3X*>$=+^(WP/U?XMC6-=^+?A[1M)U?1-:?0X-;N;&#4+:]B>TTAKDF_\
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MUU^S]!\"/A'XJL_V<OA)\0]+!\):#XUNKKX:/);7.MZEJ-YKGAKQ!=^+9]2
M$FHC3[+68K1G^;*ZP@=MT8%?'^G?\$X/AG_PM/Q-XF\%_M+6%AXOTSPT-&TW
MP_8^%?#ES-X/'AN?37:;5]+T[Q5;?VAI]G?):L\#PV\D9NPDEUEE-?3'[/G[
M&WA3X4^/O#'QBT7XFP^/-4A\)^+-#OM1D\,:3%_;]KXQ_P"$<N+F^T[5+35I
MY-'@35/#23")6N$D2\DB)X$A /O"BBB@!P8KG&.?6FT44 %%%% #BQ(Q_P#K
M/UI4P"<D#CO^%,IR@$_-TQZ@?J10!+D>H_,4TD'() 7'7Z8/7O4;#!XZ=CZT
ME #LA6XY_P ]JT(#F,'W/\ZS:T;;_5#ZM_.@">BBB@ K*F_U\OU7_P!!%:M9
M<P/G2GL67'_?(_K_ #H 57R><#CZ?S-/JO4Z]!]!_*@!<X]/Q_\ KU >I^I_
MG4C]!]?Z&HJ "BBB@ IRCD'''/)Z=#2[?ESSGT_'TH!.W ![\_C]* %<@XQ@
M]?Z5'110 H!X(&<'T/:G-N;G'<?P_*?K^O\ GJ].!R,<_P!!3?,]C^!_KB@#
MX6_:$_8J^'WQZ^(3^*O%?Q UCPW:ZWHFD:?X@\*VEGX(DDUP>%I9I=#OM/UO
M7-%FU'1((9+EOM,5I,L5P,;O+?YB[XV_L@>"OBIX*^$_@!_B;-X-TCX3^$K+
MPKI]Q!H?P]U3Q!;Z=INGZ3I%OXJ\+>(=<TE[_P"'?CNV738Q:ZQI%S;F%KV5
M98)@RA<O]H']B_4OC-\3]9^(VE^.=(T:36_".E: D>N^%4\1ZIX7U'0)DN-.
MO/!FI2W2?V!:7,T:'45C7SIP28Y8V.:^=M>_X)=:SXLT+QC?^*OBY8ZM\2O&
M&K^!M5N=9_X1[4]/\-6]MX5\1ZQKNJ>'(;*QUI+Z/P]J U&T$L*WJDRZ3!([
M/C% %+QK_P $ZOA7>>,]<L-;_::U:/Q%%X5\1:Y8Z#KO@_X;^(+GPQ\%+?4?
MC;+XQ6>*^T)_M5]'?_M/>)7M]<N@UY:S0Z?+''.([H3ONO\ @E'\ /B'JMM\
M2-%^*^K^(-#\0>&)H[*74-/\+^*;>Y_M#4]8U#1+_3-0O8@++3!9ZY<13011
M)/<3(+J.[MKHNS>P_ []@*X^$'B[Q]XBNO'FD:]%XI^"?B[X/VFL1>&YX?'E
M_%XSN?#E]-J7C'Q)=7\O_"00Z3+H1M=&A"1_9[&X\J5I7!<^4_#?_@G7XW^'
M/Q!^!CVGBK1(O _A/5+K4_B1I_@NQG\)^$]>\/\ A?PSX5TCP'X4C\)37%PY
MU"7Q/HEWX@O;M+A%_M"^N<1^7,%0 \W\,_L$_L_:?\3Y_AUH_P"UEXEOOBMH
M?A?3M%N]'U'P?X+O;?4M:\,6Z3:6GB:>\\-#3_&ATNQ:,C1YKJ;48+<JEY<2
M0@+7USX'_9<^ /P=^'?[0WPPU'XI1MJ7COX?*_Q7\3W*>#]!\2>&/#VIP^*)
MIM8M;?2]+6+2M!:\U/6)K:V:*2TMELQ&%.&=LWXB_L-^,_&7Q:^(7Q%T/XHZ
M)X4L?&T>K7+6NF>&[ZSU/4-0O$L6TNS\8)8:K#8Z_I]G/8YCNC:)JKQRF.2^
M8 5X>/\ @F!X]U77/$?B/Q5\7O!%[XA\91ZO<:YXGTWP-JEKXBL)K^/Q(D?A
MOP_J%SK\GV7P1-_;L:WUG*)9+B.R $J%B: )7_X)'?#K5=:T?Q'K7Q<NM0U&
M.V\46^N+HG@?PKX7T&74/$L>H7ND#POX/T&\ATCPY:>9J^_4[*XL-2_MB!53
M-J9))9+MA_P27\'?\(UIOA/4OBRNM:*;32=-\31WOPJ^'^LWTW_".?$#6_&]
MCHO@W6_$PU&^\&Z$PUN^T^_MS<W]_>00(T^H>8]Y]JY*'_@E5\1K#Q:_BJR_
M:*>[O8_C!8?$NUOM=M/%NLW$D-IXI\8>(2^I:1=^*&TN^\016'BH:5;R-9?9
M4L]-A)MS-%'(E>Z_X)1_$B[.E6Z_M(7.F:5I/C?Q)XFL-)T6W\7:6-*37QX.
ME75[/5[/Q2M[J7BRWN_"]R\$VH7%U;0Q:J;9(!%&%(!V?CK_ ()A_">PN_%'
MB/Q/\;F\&_#74[O4;RXMKKPWX1T*Z\(ZAJ&I7EWI=GX3\?-=12^%]#-WJ)BN
M]/B0KJ"A4W0LV:T/V?O^":'@/X=:Q\*OB'X(^+VG^*M&\,>)M!\63/#X'TW4
MK35[[P??PQV,?@?Q!K'B*_OO D$\NG/#J\=O<W2:@R_<A\M%7H?AY_P3MU_P
MI^S;\3_@=XA^)>F^*]6\=>+= \366N:W9>)==T>*X\.W%M)%>ZKI.N>(+AFU
M2[^SM+=-:R6\332%UC%>>^,_^"6.MW^E^'M+\#_%RU\*Z98:E_;.L>&K"U\2
M:/X;U#Q%?6GC6VU#QG%!X?\ $%K/%XD@D\4V,UG()<!]&42A\@J ?1&L?L2_
M"KPQX[\3_M!>+?&]MIU_HWC'PS\4&\6Z]I&@6@\!:+X)^)%S\5/$=A;>(KJ8
M/I&CZC:%[#4IP\1:RA8/O5GC/B&N_L0_ S]I3XO>*_VLO^%]6/C/P!?>((M<
MUK0D\-Z#+HMA!X0N/ U_J/AGQA<7-Q$LNFV9^'T9:*_TV*_ACU"47=Q<QQP@
M>X?#_P#8@O/AW\+?CS\,[+QSH^L6?QL^&NC>%KJW\0>&VUG07\9QS?$4>+?%
M_B/2[Z\<ZTFN6/B[P_:7L8>.7R?#*[)5D,;1^$W'_!/[]H.Y\,ZKX:A^._AS
M3M/\<0-IWBZRN-/\9>(&T/0+#7;S7-(TCPMJVM^*9KR]:634KF*[FU*:[?R(
MHK>W\F!%C4 [']GS]DGP7\,?C!XVC7X@:+=:3XL^#</A_P"$/ANSUZRO;NZT
M_4])DTGQU\6M/T"/3H(]&FOFD@M9(HKB\MY(]/CD\R)F,:YFL_\ !*3X=L+>
MV\*^*=(\-Z/+IUAI6M:/<_#'P[K-C'G2[_3M9\8>$;=M3@B\'_%&Z-ZLD6O1
M1SO"8BKVUQN)'B_B+_@E!\2=>T#2[73_ (S>'? \VDZ;)IL7A;P7I/B+2_!T
MUJMW/(]DB-KKW=I97KS"\O4CG >^4R1[%(46[W_@ES\:9+3QM8)\>=+O+;Q.
M_@.]1M33QE?WESK'A&[TF>/4=5N[WQ/(][;Q0Z<Z1V,A>QE$BF2 L"6 /<+7
M_@F%I&EZOHFH:'\3K&VL]*6]THZ=JWPG\):_'H^EWWB>Z\31^)/!%MJEY)9>
M%/C':3RVD.G^)FL[M[5)+N1+ SW*202_#S_@GCX3^!7[+7CSX,ZI\5M.?3=<
M\<^!_'%SXF\5Z)JL_@.:Y\%#P5I&@Z;XV\%>)_'UXFOV&J/X6T[^W8H=1TZ/
M4KS4Y);>.S=D5?FOQ!_P2D^/6K6GBF&/]J#4Y)-;\;MXCN%DU+QM96OB%'L/
M'5OI6JZO#IWB6+^SM=T*]\7Z7-I$EEY!C7PQ C'Y8C%]9?M _L2?$3XS?%NW
M\6V?Q1L+?P)J'PGT3X:^,/#FOV^KZS<:TNDZJNH3W=L)M3\G3+FZ_>&>X@C2
M:;A;AI=D90 L^ ?V$?!_P;^#_P =_#ES\3-.LXOC'H/@Z#6?&DGA#1- T3PV
MGAG2-)TN""&P&IE;GP=/<V*A=-FNPL=I>O9K.V?./RGI_P#P2I^&GB[5/"FN
M7OQ^^'^MQ:_8^)M.TC1O!G@)_#O@^>[4->WMK\-_".E_$]]/L]&CM[.=]4L+
MBWU87*Q,YDMPIKJ/$G_!-SX]W_Q%\*WNA_'/0].^'/A>UDTJST.XT_6;J^'A
MAKLS+X4G>;5#]JL$"0>46(6,1A1'D9KZ)\6_L+ZKXI^#WPF^',OC/38-;^%5
MY\0=:TG7X;/4;<0>(_%&AZSIWA[5K%;2_26"6QO]2@F;]X2X@(!4G- 'B\'_
M  2Q\9Z-XW\?^._"/[1FFZ#JOBV._L]'L!\%;6+P[I-A?V?B;0HFU?0M#\>V
M%OK.JV'A3QAK%EI]S;I8%6$$UXEZ$DBE^A?AQ^PWX0^$<OQCU/7_ !KH6J:'
M\6/A1=?#'Q/J.K>$M-T+6+"QN?%?Q%UJTOF\62:P=UM'#\1FM%MY$ \W28)X
MY8R_E+\Y>'O^"??[2[ZK\4]3\0_M(PZ5>>._'/A75H+WPQ;ZU;K_ ,(K-J7C
M?0_BE9/8S:J4M]6U?X6^.[NQL[DAYK'5="L=0#L((HD[?X4_L!_$#PK\)?VG
M?AGX[^)T7CN7XRZGISZ%?Z[?^)=9L[A-"\3WWBFS\0>(]+U#5GCL]:NS=V-G
M=BR$(:'0;4DMY:*H!Y-\*_\ @E!X(ETC5?$"?M+:I\<7UXWS6GB7Q7X<T?QI
MH46IWMSI>I^*I;2&/7Y(I+>\\=6&K:E-;K(JVYU9K6#RTA4GT_6?^"9OA+3]
M+MM/M?BEH7@]O$<4VB^(WL/ASI6G6_C;6M9:6W1KFT_X2.-;V]>&=K:*.;[3
M(82(@Q!->/:Q_P $M?BKI/PYT'PE\-_C/;^#G36+'7O&.A:%/XAT?PYXIUL:
MKK-S-JD@34WDM)K>SO['[/L(<O8YW@["OTE\:OV.?BAXQ\07OCS0_B7J UC0
M_AI\.?#/A>*VOM8;5HM4\'-#-XHN+&6XU/RTO-7$!C,TF93YI,KN230!T7C?
M]B7PAX@^%?ACX ^'_B5HO@R;P-\3/$?QC\,PVGAG2)-1\(>&]>/B'2IK/PCH
M/]L1-X4^P6WBRZ33=7M2BV-\D,Z0$YB/C7[/G_!+'PI\-I?"7CBY^(^@>*?%
M7AZX^&>J^"/$GA?PMKEMH^@:1X2UW6-:U23P<=?^(NMRZ3_PE>CZM;)K,UE=
M1VMU+]HN1;NET\=>*? ;_@GW\:_$NGQ?$KXA7*_"GQO9^+M&M_"OA>;5-<U,
M^%_A]%XI^#EYXZTF /KUQMM?$'A?P9XWM9K:2:91-XGEE)"3/'7TYXF_8H^*
M5Y\+OV2OAYX6\9Z!H$7P)^&?AGX;:[!:W?B&RTK2M1T*Z\!-+\1/"%O8ZC&U
MSKTNC>$];TT0WK2HMMXMF7)0SI, <C\6?V"$_:2\6?$KXF?#WXY_#=='\?2^
M(;2T\20_"NQ\>^*3-J.H:)!K_A+6O'P\:)!KG@FQF\.&#3+&"RMY=/,T@%TY
M4&O)[/\ X)?^+=93Q=\+-6^+&D/X<\-_#3P5HWA&+4+;4M2L=1\<Q7MW-X@^
M)-QX#TSQ7;W?A\S:/.--BAN-5NX9MBSM$X4Q5],6W["7B.R_9S^!'P3T;XAC
MPSJGP@\">.M*EU_P\^HV$=YXZ\2Z-966D^*X($O,2O;WD6IR$3^:0=29T*N,
MU\\>&_\ @FA\=X_!-QX9\4?'6YNY9(+RXT]X]>\4N^E:K_9GV72Y([N'5(RU
MO%J*O=B- D0>8X0'+$ ]W^.G["6L_&X_LQ^$7_: T?3M8_9UT3PO-K$<O@31
M6\4^(5\/^(_!FJQ^)-(M]$UVQD\(V]T/",^F-$B2V1AUM]RRRP(K>4>*_P#@
MD-I5[J?@.Z\#_%+2_!.G^$5^'BZAH.C_  ZN-"TWQ!?>#-'L=#G\67Q\(>,=
M->3Q;';Z<KZ-=2,XTQM9U0,+DW2O!.W_  3P^.$/BO0-2T[XL:7"=%L]2T/1
M?&KZCXL7QAX-\-7'B/1O%%QI&E&+60FKPZA/::W9W0NBX2WU^78!R"2_L&_M
M(^*]*^*>L_$/XJZ?/XQ\5>$;#0_!6E^'?%'C*PT3PI=VNE_!CP_JCQSRZHXE
M_M#3OAAK$DI>-X]_BNZADBDAGN5F />_B5^P#8>+?V7_  E^SMX9\5:)HFH>
M&O'&F^.KWQQ?^#+RX;7?$%K-J,MUKNH:+IGB2T34]=>749)=^I2ZA;2RQYN;
M:8[63Q'X>_\ !)71_#WQ#U?Q9\0OBK<_%;0]1U:]U:?1_%WAO4;^?6[R[T\0
M6FH>(X+SQ/+I5SJFGW@5M/E@TN$VT:K$FT**Y32_^"=O[35_X@U*\\<_M!S:
MQINK>&O!VC7\6F:YXJTNR>VT'1M%L)]#@TR#4QY-C#J6EW=Q#)YA+G4)#M1G
MD+ZGC/\ X)Y_M'SZ)X1T+P/^T;XDT[3]#UZVU>_CN?&'BN.[N-1;0[K3YM>_
MM$ZDTK7$%^UO-% K("(1M=6^:@#I+G_@FEK%DGAJ"\^.?AGQ[XE9R=4L?C+X
M N?%GAOQK+8Z;XBT'3]3NO!]AX^TYY]5T3PE?>'WTQX;@+;ZCX0AU"8,TK"/
MNO@?_P $[M<^$7@3]JOP9<?&[Q'X@U']HS2I]'M?&;P^*$\0:;NO_'FI)XA\
M6"Y\9RP:YXCE_P"$W2PO;C38M'DNM-T*WMVE 6V^R:/P>_8N^(7PW^,OPJ^)
M6N?$ >+[7P3%XD?4TUK6?$>IW_\ ;/B[PQ\0=&\0ZWI']H:C(D$MU<ZUX1$L
M94KY6DOLPRQD>'V7[ W[4>N^)?BE?^-?CQ=QZ!XJ\8Z_XL\.Z'HWBWQ7;6]E
MK*:'^T19^%-:BEM+^*6S2+5OB)\*KB6VDDG;=X!"F5DCM$A /HOX _L6:-\'
M]>^*EUJ?BCX=WWQ#^)GPNOO"@T7P=X+D\(:9X$\/ZMXE\=:C;P>#M'C\6SZK
MI7@5;CQ&T*6T-]"//TJ:2WN(&=4M_E&#]@O7_A!HNG> =9_;&^&/P\TK7':\
MOM.NO#S>&?$$.CV/BB;5M.7P3>ZA\3(9&=I[I;6\O=1BU2:<R?-)YI!KZ(^%
M/[(GQV\)>+/VA?$OB7XDV5UXB^(_PQN_ 7A3Q];ZSXBO_$%SJ,GB+QGK^GZU
MJ-G?7S1^'4M;3Q-8V"1V)C(733,C(Q0+X7:_\$S?'GBPQ>(?B9XCT*Z\16R:
M%#H-B?$7BK7CX2L]$\5/KKVFE>([_4/M3B<@39RODSOA!M6@#W#X:?\ !/JX
M\$>+O 7Q(UGQ?\/;3Q%\.[KP8^E7?@#P)KG@[3[?P_X<UW2=4\1PM)J'CN_;
M[9X@TW3)DU>8RBVGEOY97MBI=9.'^*/[ <'B+X@:EXN\/?'3PC%XX^*_Q)\:
M?%%?!GC>SU;5_"WQA\+"Y^#6H:%\/O%GAO3?'UI/XU\">';7P9JUU$UFT8AN
M/&4$F(;;[3#?>06W_!/G]LR\;P#I?B']HJ_E\&:1?^*[76?#\7C#69;I='UW
M4M N;B?6-5,8E\5SWVEV&N6$L6;8Q0:Z=[RGS_.^C_$O[#OBOQ:/V6+^?5+/
M0]5^"_P"^'WP8\47.A>*-?TV\:STKX@?!#7?'.GZ)JEC-%+)INH^&/ASXALW
M9RLDZ:@D,Q,;R9 .#A_X)A^+]%\/ZGIFC_&/0]9O[V;2M5U1O%G@SQ#<Z7\1
M]5M?#'PXT"\M_BK#HGC>UN?$NBRW/@BYF54NHKI5N[9)KB8P2M<^G?L[_L&>
M-_@K\3OB?X\UKXS-XBB^(?@_6= @BT:Q\=:3-H%QK<4J6UCINGZE\0;ZQ@\-
M:+YJIH\;027D,<2@W:]O&+?]@?\ :1UL7&F>*OC=KMMH]E'?.G]D?$OQX+GQ
M9XS6WT^"/XGZG(-4631KR]078FTN"0VUN\$<L9+LQKV7XH?LL_M$7G[+-O\
M!+X=?$N;_A*+'XCW>JV>OZUXR\2)JEOX'-P\^DZ8GB.>:::ZNK9V4[+E9HV
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M%]]H^E+JGFVEWX(LX'U__2_ 5G;7MY>Z=%(42WU*T@DBLX($C2+J?AE^R_\
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MX-TJ]\)?'GX-_&3X96?B[0]>UKP9H6G_  KU7X4^(;KP=?6UOKB7PL=1\1^
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M>_;ISWYXZUJ5ES9\Z7/3<N/^^?\ '- #57<<9Q4P& !Z<?E58!E/WB>,=?\
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M/K^?I[YK^>/3OV=_^"F.G_&&^UU+CQHWA"\\<>&-2\.:#<^/-%?P)967AO\
M:V\+>+]0U?Q:G_"0R:E%]I^$ZWCHELLBS6=E<V4MNI:.&3O-)LO^"RVL>%0T
M]W>>&M;TJXU?6KE-;L?A5=7^O>)M/\*>#3=^&;!='\37%O%\,;KQK)XL&B3S
M2Q:F+"VQ>[7:*1P#]X<Y ."23PN,!B>@4YZX%1A]S&/ W@ LH=2Z@]RJG([?
MG7X<> =(_P""HWQ _:=\&ZE\8?"&O^%_@?X4^-'A'Q7##%XE\'P+:^'[:QN[
M'Q';3GPUK0?6?#CR&&9+2:.X<&09D;:0/%_$W[/O_!27PW^U]\<OBE\*-/\
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MPHX]!_GK495NS$\D=^2/0D^G\_K2[3_?.>_M^34 .8!NO'<8[?A2CCTZ8_\
MU?Y[TS8W9_7@YZ]N_3_)Q2A2#G<3P.N>_P"/L?RH =367<,9QSGB@J3T;\/S
M]2/\_D%53U)) _#^9_SVH     .U+28^;.3CTI2"1C."?S'3WZ_Y]< !12 8
MXSGKR>M(00<[NA^Z#GCIZ_Y_"@!W6D4;<^Y/X9XI:* "BD P.I/UI: "BBB@
M IZL%!!SSQ^&<_S_ )TRB@!2<DGU.:D "C=_LC(]SCGK3%7<<#TS^5.8@#;S
MD #^5 #&.23_ )Z4E%.4;B1Z#/3/2@!^]<?AC'_UZN6W^J'U;^=9Y&"1Z5H6
MW^J'U;^= $]%%% !67+]\_Y[FM2LN7_6.O\ =(&?7//]: (Z>N2< D8&>_;\
M:93E!).#CB@!#U/?DTE2O]T#N",GGG@U"&!..<CKTQ^% "T444 %%%/# +CO
MS].: &Y/J?SI*** %))ZG-)_G_/YT4N,^OIQ_0^M "9)XR<?7ICTYZT'W/.<
M>IZ].O!Y_/ZU^:?[3'[7'[07PF^/.D?#'X9_!R3QQX6OM$T^2;7)/"'BG45M
MM2U:W=HKHZQIE^MK-I]O<@"XC/DRIG'S?>#_ (6_M9?M":W\:?AW\"/'?PP\
M-6VO^*9_$5_KGBG2])UW2-*TWPMX$TWP]JWB;5SI&I:U<3VT5[_PE%AI^E3-
M(\1O;*<2;P @ /TH) ]QTR.??CU..@[TR82-%(L#E)7BD$+B-)"LIB81L(Y7
M59")"I"LR@]"0"37Y'_'+]O3XV_"[XC>(_"Z^"O">B^%T^*ND_#:'Q+XD\"_
M$74X? &GZIX@\ Z/X;\6Z]+HU^B?$*/Q)'XKU]]+LM&"3V4GA:1;P."<\7H?
M[9O[8<3WVO>+? 5KH<E]=6<O]D7WP_\ &EUX<^%^A:YX,^%VMPZCK]MHS_;?
M&$4&HZ[KT:);3"Z22Y,4I MI54 ]5_92O/VI2WQQ\-_$R_\ BE8:9KUC+I'P
MX\7:[I^NZUXB@\?6FE7TWB/Q):VOBW03:^$=':=K9;.RC:^T,SH!I]Q/'D5]
MT_L[6_CRT^"OPZMOB;?Z]JOCRVT%[3Q-J?BA;*/Q!J-_:ZE?P)J&KQZ=;PVZ
M7LUK';2,(8HXQYHV1HN%'S3^SI^TC^T3\5?B'HMC\0OA;HOA#X?:[8:K;Q31
M:#XKL/$-CJNC:+%JZZI>7VJ:@UN-(OI)!';V[6Z31[MKRNX(KC?#'[6G[1WB
MWXPP?#O3/A?X6MM*O/B*WAW4M6U+PG\081X T'3]9O+*>V\07\U[!;>(-;U'
M1+1[^PN[%DLK=9%BN$D<@$ _3+<-VTC!]2!CIGUZ=/\ #FOFW]K5O'(^!7BU
M?AUK7C/0/$TMUX=2/5_ ?AZZ\4:_8Z>NNV4FJ;]%TK4[35)M*FL$DM[N719'
MUBVM[I[C3X9I8BA^9?VB_P!J+]H#X5^./&M_HGP^TB7X7?#7Q/HFBV>ISV7B
M$S:__;GP;\<>+M;\1>*;N*X$#>"M(U:VT$-%:+%=7%U!]GCN?.>.)_FZT_;9
M_;!\8>'/B-\1/AOH/@SQ5X5E\,:QH7A"[T'P3XLO-)B\:>'&^+D0\8^$8[RZ
M\Z\\/7,7P^TTW&GZ@UQ/'=:U%&DL>5B< 9'^T-^VYX?^%T_P]M/A7\7[G5=7
M\,V,7@?QW=^#/%'C'Q:(TU'4HO$6O7GB.\TG2WT^2*R@LY=*L_$&F6NLR1R>
M5=K=SMYHY>?]I+_@I3H5QI_BCP]\,]:\8Z$WA'P]X8EUCQI\)/'WA[299[>3
M1+BZ\97OPLT:;4/$-OXKN[O^TM/G".]M$@:]>"&W(>OMOX\?M;?%?X,R_LY6
MND?#RR\;Q_%'P['>>-KRW\/>+[S4].UC^PQ=16^D:3I;1QV,<FI*RS&ZE9H$
M;B%N#7SUKG_!07XV7?BSPIXA\$^ XM0\(F&?P_J/@FZ\$^/8[[QMXFFN/#:W
M]CX:U>73X_[)UK3I+S4U$MUNL9(;:7Y7<*X .=C_ &T_^"@H#1W7[/5J+FT^
M,?@GPUJD.G_!'XJ36MUX2\26GBAK[2/#-WJ7B:U^VZ]:7.F:$;K4[U;+0((-
M4W+JSSRI;0?0/P&^/W[9GQ/^(7A+0/&'P^T/P1X4DU#4K[XCZIJGP9\=>'W\
M*WMCIUNU]\)=(U+7/'_D>([BTO[J Q>,;59M*U6,/'9Z>C1NZ_--K_P4:_:>
MN(H?&&H_"_P]I.B6?A7XBZ-?>'8O ?C[4=,N_B-8?%#]GGP]X7N;?6&OHKNY
MTFW\(_$SQ1/<OFSBD?3;AVCC-FZQ[EE_P4#_ &K_ !QX(M?%>D? _0_A[IVI
M3_#VV2XUCPSXVU?6M(N;FQ^ /B+QK)?Z;.42XTN:Q^+'B'3[0K&DMK/X6EDE
MDE82>2 :7Q[_ &\?VI/A1\7/B]H#_#G2/"/P8\+7MQI>A?%[QC\)O&UWI.@M
M9W%\%U=Y+3QM:VOQ(@O;:WMVM+73[JTO)!.S_9X]ACK-O/VTOV\[_P !?#_X
MB> _@]X&\9Z+XSU^VTN%?^%7?%334N;&#PU/J]KJ=O/INN:G/:6&N:LMM:6]
MU/9QV>E^>WVFYN'48\N^('_!0GX_^*-&'PVLO@Y=2W=YX,M-5O-;UWX9ZSK6
MHV?B2SALM0FMK[3-2L)-,U"SN(KMEA*VD30M <2RG-??_P"S!^T[\1_B1XG\
M0_"OQ3\/[/2;[X5> -.\1^)?$$,-SIUG>_\ "0V]O+X%L=/L((1%87ES;VVM
MM=6XC#6RZ:H6,>8* /D?PI^VY_P4&O\ QUX;TSQE^S7HWAGPWJ'QKT3P?KMA
MH_PP^+GBGQ+I7AW4_%=WH>H:7!K$\VFZ)>BPT/\ L_5+CQ%]NBT]K>[D>VMK
MA[<6<OMO[2_Q+_;5\+_M!:Y8?!2X%_X$\+>&]!\9Z3X6U3X->(?$VA>)+:P^
M'/Q0U7Q-X=E\9:'K=D+K5M2\4:%X;L[6$7"3Z?<W,,K6]U%-'!/Y[X9_X*!?
MM">,K>2\T/X*V<?B&+6_$7A2/0;JT\4)X)62+QS\*]-T[6[K5S8"\O+N#PWX
MIUUSY4EM$TELZ2VT31DQPI^WC^T5KOAOPQXDN_A9?^!M8M;;3O$'B30-*\/Z
MSK.D77A_7?"7P+^(^GZ?)-JNC270UJ'0_B=J^EW;0% EYHEV5A\Q-D( O@']
MKO\ ;1^*/QJTCPS??"?6/A;\,[/XD^#?[8UF^^!WCV/53X:OK[Q+I.M>$M4O
M=3U6XM;N+&GZ9=MK%GY(B2]CWP0*<'ZD\-ZK^T)KO[:6JZ?J6J>*-$^ GA+2
MO%US#H<GAF0:'XNUB:VT^RT63_A*YP@2V@^UW4T5K%N666#<S$*<>7?LB?MT
M_%S]IOXCIX.U?X*6O@GP[IUIXHO/$'BZ9/$<5M>)IFL2:;HL7A];H&$RS1Q[
MY3)<2XZHJ]!PLW[97[4?@_Q_XXNM;\ :-X^\ >$_$GB+PY=^'M \/Z[I/B +
M_P )?X=T+PG+HMVUO(NHWXL]3N'N@Y:*2-6=-A7< #D?#O[2'[2WPM^+_C_4
MO%6G?&7XF_#Y_B(\/B:YU+X8>+SX;^'7P]NOB[X?\.[K'P1I/PR@OG\66/A'
M4;MM+N/#/B#Q?INL6$$^JZO9:9<1QI7+>&?VK_V[=<TO4KH_#;Q;JNN2>)+;
MXAR^ K;X2>.O!FM>$-)F\*^$M=T;X;R^,O%-O-IGB7PWK>JZKXCM8TLX1J6A
M?\(ZT6IW<LTJE=CP_P#\%0OV@-?^&?B'XA#]EZSM+;PUI_AV;58;C4->(%QX
MS\6>!?"^ES[&1473]&'C#4+C7=USN2/PS,%:U\QS;ZWP[_X*1_'/7/$;V/BG
MX*Z1IJZSXU\%KI?AN:'Q19^(K/PGXO\ #?P6N$\.:9=QV36_B+Q5;W7Q'UO5
MGN&6.W_LS16C:-9%FE@ ,72OV^OVZ;J7PA+>?LW^$9+'Q&GB%9KO3?A=^T$L
MZW-A#J<UG_:%CJMM;GPY8VTEI;07LJ2:K+.Y\ZTMC#/$5;IG_!0;]N;4(='N
M+;]E#3)M_@;4M;N;+5/ GQ?\/WGBS7+(3_:Y?!S6[ZFFF:+9&.,FWU8P7VJ*
MQ^S_ &-_D'W'^U?^UIJ'P)^&GP[\??#3P#)\68_B'XFM-'L;JSEE&@:7ITUF
M]Z]]?WELZF$S[1!;,6"&8G(? 1OC6T_;>_:NU3QCY>B^!_"\>CQ7>G:K%X2U
M_0=7CUI_#J:1=:CXBM)M9L;&)0Z2*D=K+'&I,H59=X8B@#V37OVO/VH-,_8W
M\/?'+3?@AH&L?%74_B%IOA;6=+M?"_Q1A\,Z'X-NM=BL;OXAS> M7MK+Q)-9
MQ6;E39K,0)?](^UM;!B/GOQ/_P %#?VYM+T2YO\ 3?V3-%\RWN?!$,>J7GA#
MXQRZ-?G7?!FOZ[XO$-HUG:W]M#HOQ!TNQ\%>9+!YU]>W@UZ"T_LZ6WLI?6?A
M=_P41^,7Q<^+6G_"[0OV:O[%M=;^(&C>'K76?$NJ:G:Q>'O"G]GZMK'B#5/$
M-O'9$-JCZ5I$\VFQ_P"BI+YL:,'W;QT/QR_;E^*?P7^/?Q8^&_\ PK31O$WA
M'PY'X%U?P?J-S;ZYICW>EW?P]/BCQ!HAU&VMYXM7\8:MXDCN;'P_%&B0B;2[
MJ.X+.JB@#C==_:Z_;&;P^G]L?#'0/!VH^)_#7BK5_#.@:-\*/C1KGBG4[ZPU
MS7M$L_!^G>([&>YL_#OB&VL-+TW4I=4U73H[*YAUR*&"QC*>9)YA>?\ !0K]
MM[0]+N;-?V9+#6-5TOQEH'A^34)OA_\ & Z5%HEQX?AO9K:^U!3'<:QXMN=3
MS;F>'3K.RM))"_V>[7"U]=?M*?MM^+/@9\5_AA\/-$^#EQXGT_QKX(B\9:GX
MBU2]NK"VT>2^EUJ"/1K=K:VD,UW:MI,<EXJI+((KY"$3"E_D>3_@J3\;X[S4
M];_X9YM7T/5HO#MOX:\'W3:S8>(?#E]-K*Z7K.J^-]8OK6&#[,_RFTCA567[
M7"SNVY@ #ZX^"G[5OQR\;?#G]JGQA\0_A-'X?USX*6^K7_@30-!\#_$#9XEB
ML])\3ZC;:,O]MW<5YXWUY'T73TN$T^STW+:G&D,3K-#,?G[X:?MK_MS_ !$T
M^;4/^&?O ^AP:1806]Q=:_X&^*7A^P\6:KX@\5?&'P_X?UO3+S4?$AB\'^&K
M.P\">$+[5!<OJJ_9_%#2I?6\#6\S;GBK_@H?\6M+\.ZI>CX(Z'X/N-?28^"]
M:\3:OK\VAZ$VF1Z9%K,OC^2UT+,$LFIZI;6NG^6JQS3!!*2CD+TG[0G[2?Q[
M\/?"S]D./PIX:\):W>?M$?"^!OB9:>)_#5Y/8S>(=7TKX-;-"BMK>W:'2+*]
MB\:^-$NH9H#MMK:0Q*K6YP =Y9_M??%OQ/\ LE:%^TGX>^&%CHEQX[\601>&
MM,U?P_XM\6?\(?\ #2^N=2CT[Q[XR\+>$;S^T?$#206-DQM-+EC93KD)#LD3
ML_R;/_P4!_:V\=P>)M+\(_#KP]X1U?PS?VL/B:UM?A-\4_$^N>!["Q>&XGU3
M7+BYG73M036;9Q'9Z;;*-3TLW*27BS[&0_1_P5_;>\4>*OC-\._V?W_9RN/"
M&A7GAF*'4]<LM1^SZ)H5[8V\V8_#VER:;&=0\,1-:"W\P)'Y<K;,C&#Y3JW_
M  4$^(WPK^./COX2:K\ M*\3R'XD^-(!XG\-/<>'(KW0K*_MM/T.(02V,S^(
MO$*1-YM[(A;,0W*J@;J )-+_ &U?VP+S43X2T'X'6%]XBN=;M_#=E8>+? 7Q
M1BO= L[[QKH.C6/Q1\5^)[);'2-9\(76G:W?+;Z59"TU"V.B&XNKR2#S3']!
M_$_]JGXX>!?V>_A7\1T^%NGQ^/?%6K^,=&\9V4WA/XC>(]"TF_\ !>G^-'TV
MTTOPOX:MSK-L?%FM^%M-L]'FN7D@TX>)89;EM0*1177DFE_M_?'5]9N(M7_9
MCTRVT72O[*N==U&S\6:V;]-,.B>"O$FM/IEI/X9 U"YAT[QO:1P(70276GW"
ML5VD+[/^U)^U[XP^"_C[4OAKX-^'6F>(]03X<P>)-.U36-1O8KR^\1^([+XF
MC0O^$=\/6VF2#Q#HVC7_ ,/8;CQ"RSQO:VOB"U.$+QF4 Z/1/CI^T-JWP%\;
M_%&Z^%WAS1?''_"RIO"?P\^']WIWC">YL/#B_$&S\$IJ_CA(V6?4+L6;WFHN
MVGI!:^0L>V0QAIS\#>(?V_OVI--\3W'P0LO"6D:=\0]5;Q1IFCW>K^&?%5_X
MQGN]/TZ/6++QCHMG::-'IDGA%7+6XL;B%M0,+>=Y[$;J^G/BM^T=^TG\,_A5
M^S)<Z=8^"O$7Q ^)WP]N+_QW=ZOIUQ903^.H;OX8QV]MHUGIUJL5I92R>*]<
M\Q6@WI%")44&%J\'NOVY-/\ #OQ9\*>/?%?[-_AG_A.->U?PW\.?$GC"$V3:
MQX,CNM.\G4[;1M:7PZNH>(;*:]*JD09C$C?ZHIF@#Z=^!GQ\_:=\1>(OC')\
M5/!.CM;^ ?A39ZEX:\'>&?"?BG13XL\=:/JNNVVL7VB>*->#^?IE];6^D*EB
M8I9K>2<2)+(CXKDOV7OV@?VE_P!H+X[^"[KQ;96/@[X/Z%\+/B%J.M6OA;P1
MXLTSP[X^\?W,GP3ET>VDUGX@6":AIK>'$\8^,])FMHQ"M]J7A^\O!E87LK'I
M_P!H;]HWXG?"O]IKP'X1TGQ!HEK\-KRV\%Q:OX<M] M-8\3ZUJ7BKQ-_8[QW
M-O>6R7EQI)MEVQW>C79;3)F%QJ=K/;$+7SOJO_!4;6S\0?"H\'?#_0M3^'4W
MP]AO?$NE1ZK._BJZ\>>(E_9RN+;1_!IATK9KFNZ-=?&?68-3TL%))$\-W,[-
M$\$@A -3P#^T7^VSX7LO$D?B/PY!\0M>NHOB#XV:^\9^$/$_AGPCH.BZ*^I:
MEHOA+0+/PEX9:\@D,-QIMJLUW/J$C1V#S;&=V*^N?LP?M8?''XN0>._&7C_P
M?9:)H>D_!)?&WAWPCIW@?Q=I4UUXNTNZOK?5H[36=4DG?7--N);:-8(K??*%
M?S$W9 'ROH7_  5]\4:3X10^,_@1>7VNZ9\._!.IZCKRWXT'3-7\7:WX6\*:
M_JX;07M'N-%\/32>)I8K"24+%))ITB-.2P"]G?\ _!72VL['59K']GS5YKL>
M'O!&I^&M*B\0VJRW:^*GECO+C7)_L"0>'M'M9(G!>XDB+-(FS>IR0#A/B7^W
M=^W9KNJ7'P@\%_!'2_ WBO7?"GP^UBQ^)6BZ#XHU9]%C\:QV^KW6KZ5H7B33
MKB*ZM;.PF33)A>0JL&HSF>1L1K93>LZS_P %)_B=;ZW\/M,\._!*ZU;2W\9?
M#?P/\4KV^\*_%%M<T37=<UGQMHWC7PUX8L%\,VT'B3Q%IRZ%X:N)##*[1PZM
M-/#I]_&C"#['\=?M&:O!^R3XJ_:(^'WAC1F\9:+\/SXE_P"$/\27JW46@:G%
M9P7]SHFO76D;G#16\R2@(0&C>.0 *P-<K\"OVQ(?C%KWQ6TRY^&(T&V^'?A7
M6_'MC?:=K,.MF[AT#Q;XQ\&76E>)8DTV+_A&?%MU<^$9]1L8"TS3Z5JT%P&V
M@23 'B?[*?[:OQJ_:/\ C<GA+7_AI?>!O!.A77CH7.JP>$O$.G:3XETJ?0OA
M_J?A&/4+SQ'!)+H_B33[W4_$UI>0":WD>6$K<V-I/"UM%Y!K7_!3OX[6>O\
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M"WVJUM=0T"S\,:C\6S=1ZQ;M!_HVIS>'?A(UW;P, 96URUC7.!FM^TO^U_\
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M9-\ ^&-&UFW^#_B*'PKXMUV>R\!R>'?AGX>:S\<V]NBZSKWB'0M/L,,+:T>
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M/!8M-/-MJ&K0:SXSLQ=):L[VSR-*[!=S#T?XQ^+_ -@GX3?!30OVA_B%\/\
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M4OA5K^G^%OB'X=\'6VEQQ:UH%S>Z,EOX@TZ*&[T^.V=&;)38@^0T ?.GC/\
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MFH_%77X_&?A];M/!>@>%=#TW5XKA_#^C6^^T$9OOL]SJB(4TY(E<C9(!6_\
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M5_MNLKI-Q%X/UAA.OA[P/IUC+?R+%8[+^R3P,FG"TR)'6&1=D4;EU !NVO\
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MKP;H=_=_#;5O"O\ ;]U9Z5Y^B)>O\1=!N)]=\V&:QN+>)+^Z5V0Q\\_[4_\
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MZ)\=-1G-S<M;:7K&G_$5H'DO+.?RE]4\0_\ !.K]E[Q5%\/(-;\.^*KR'X:
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M#[I<I>"2)(_L4&]58"7:?,#;CF/4/V4_@;J?PU^)/PDO?"L]SX%^+/@7P_\
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MN/1M0\9V*:I-*;&7PMJGC&]N%U*03VW]OVT4MB5@CBTZXLC;(94(" 'ZU_\
M"]O@NEK%>GXH>"%M9]7_ + BG;Q!8JCZR#&/[/!:7BX_?18'0B52#AAFWJ/Q
MC^&&F>$/&_CS_A-- O?#'PZL]0O?&>IZ7?0:FFAPZ9!)<7BW:6KL5E$<;X7^
M(J0.0:_!CXD?\$=O":>+O#'A#X??'^75O$_CF^EU?Q1%XMU^XTV_3P1HX\/P
MWUWX:\-Z2MW#<:G]FTY5DO1):R++.K1IL 5/L#X+_P#!,G]E_P "^$?C3\-O
M#_Q8\:^*8O%VI7'A+7TB\97$%YX=N8;>[F_L36+&'6)4UO6DBUEW<W"(621-
MT .68 _0;P[^TA\$O$OA6T\86WQ%\,:;I5SI7AG6)H=<U6RTG4M+MO&-K;WG
MAZ/5M/N)Q)875Q!=6Y$;#<GF#?MKT?6_&O@[P[>:#I^O^)]"TB\\4320>';?
M4-3M;636I8XA,RZ?YLH%Q^[92"#@^8H!)8 _@5\</^"37[$'@3Q#:WOQ#_:&
M\;> =0\;:I._@_3M9U.XNK,K+:Z/X?\ $=WXAMO[9C36=(C>YTM+2YF%E!H\
MVHVZEYMT:M]5?M*_\$Y?@;\5[SX,^$]<^/GCOP6FC^'X/!G@[PQ=>*1=WGBJ
M?PA-8ZU'>:1K\U\EYHFJBWTH0W<UO]H#P*&6$2Q;F /T?A^-OP=N(Y98OB;X
M%>*"2]AE9/$FF9273462^1@;C.8XV5FXX#J>01F5_C-\(X%BGE^)?@>*&?23
MKL,DOB72T631P#G459KG_CV^5OF] 3C ./Q"^!O_  23\!^.O"'Q UGXM_&"
MRU75O$SWOASPM=?#?5H;G3O#ND^'XM$T;[7=73QV9O\ 5OM'AR-;UD6(S)(R
M2RJW([S3/^"&O[-%E>V%S=_%[Q_J<-O;6M]J-M=ZHKQW-U;BY1GL1/KTD>E^
M%I(;F1&TXQSQ=Q/R00#]CHOBQ\+)]/.L0_$3P4^F+=6=DVH#Q+I/V1;O4(I9
MK*V>?[5M6:6&"=D4D$BWD./W;[:=Y\:?A39:[H'AF7Q]X5EUWQ-XLN/ ND:5
M;:M:7=Y<^+;72M9UNXT-XK:1C!>IIWA_69&5]O.GR)]]2H_+7QK_ ,$8_P!G
M;QEHL/A[3/B5XQT6*&XM]1DL[:>&[TVZ@:Y^)[7-S=:)8:K:">\.G_%&]@M+
MLN3:MI%M(JRJSQ5U7@'_ ()E_LZ:+X_T?6_!7Q?\87'B;X/^//.\2:>-6L;O
M49M?U"Z^*7CB6P\1R)<+<1Z_-X?^/UBBWKEKG[/IME(-PN'10#],K;XD^!;O
MQ%?^%#XBTRT\16.KOH9TB^O+>TOKS48K6&\DBTZVEF#WJB&9"61<9R.H-9WC
M?XR?"KX<6NK3^-?'OAGP_P#V)%:W&JV]YJMJ+^QBO)DM[:2XL4D,J1O)(@!V
M?Q9.!7YM?%#_ ()]? #PK\:-#_:5\5?M!^,/ +ZEX^TFW1?$.OVLEI?ZGKKO
M:Z1X2\/Z[J=^!I5U?WH96=8IIYEC2*$Q;26YOQM_P36^ _[0'QA^(WCK3OVC
M_$%W<VFJ:CX2U?P[I-SI&LZAX5\4IIL5O>:)K.L3:F9-26WB>.5;&XA$L;.-
MTN,4 ?J!X:^-WPC\7V<-]X>^(WA"_MIQK[QA=:L8)GA\+ZCJ>EZ_<>1/*KBW
MMKO1]261R-H%E(^=JDAFD_'+X0ZYX@\0>%M+^('A.YUGPSH^E>(-7MSK5DB0
MZ)K5E/?V.JPSO.%N++[-:W#2.A(B,+!RI4@?D=J__!'_ .!^M>+I+&X_:;\8
M6\AT?QUK5EX=LCH-CKMA9^)1XTTC4+NVO[/54DE\)0:C\2<W-M-'+'<3P012
M31K.ZG>O_P#@C/\ !O7="U:W\0_'KXGZCXEOKEM5U_Q/HXT/P_$(7\/^*;$Z
M$=*T<K_9W@C[5XA6[&FB<1O%IYBDE=IGN  ?JW/\9_A;::QX+\/GQWX9N=8^
M(E__ &?X.T^QU2SO[K6Y_LMS>,UK%;2L3 (+.X)?&T>7@G-86D_M&?!+5_'F
MH?#.U^(OAJ3QGIESJMC=Z-+?P6TL5_HE[%I^IZ>'N'4/>Q7,\:F-26PV1QFO
MRV^$/_!)7X(Z9XK^%_QJ\)_M)>.M=\.Q,_C'3%\/7&G6FE^(-7UBSN[>*_\
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M,']?Y&G9'J/S% #U"DG/X<X%(V 3CI2J 3R<<?3^=(0 3CD4 )1129'J/SH
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M\)P:TMKX5B\3:%8QZ1HNMW-Y;1OJ$6B1V88S:9'FTNI0HDVH2E>%Z3_P1?\
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M;PX-5NM*\"V4-IIWA#5KY6TF[TI]!\5C^U_MTMWJC^*);FX"R224 >8^!?\
M@E#\9H8=!U/5/VY/%+^(?!>LVFL>&--\$:!X?'A/P1J#Z_X;U.[NM&MM0T^:
M07FI>&M,NI+@SH4:[U^24)+:R3K=>Q_M9?L._%+QWKO@OQI:_P#!1KXH_"?^
MR(AIEU<>,E^%>B6&M:K;7HO?#L<"^'/"N@6USY<ES?K-!,D\MRLT2B15C"GY
M0\'_ /!.O_@HW\./#'D?#O\ :E\/>$-7O_#^B>%=>TW2M1\3G3]1\/\ A?P)
M\.?#NGI;S7%T\=MXAEN/"^M6PU5;9;V""\W>:RR&)/;_ !3^P;^V[\6OA/\
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M]<T'PWXC^&$.FZ5J_B&*_P#!E_J</B/1_#IAL[71U?PBPM%M(C)$]]YH6/\
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M-KI^IW]Q)'83W6IP.GV=<I*VT(OS]=_L6_\ !6;2M2>'P_\ MBS:MH]MX/\
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M:=!'#)&8E9%#KN9 #M/A/^RK^WGX ^$GQ:^&NH?&KP!K6G^-OA[K&G:)IOB
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MH5QX)\!P7%K8^-I)-4@TS1-=\)-XEM?#MX4S%\4=5T=?%#7&H/S;*OE1_/)
M5YI/VC_^"P$EM9&T_9LO993X"D@5K[PE):/+J,7]LS:KXVOXI;U1:ZE%%;:>
MFG: &.I7DKJK0(L^Z/WGX/\ QB_X*?2:)\5_&?Q5^#/@JP\.^%_AW)-X%TO7
M+L^%=:U2\L/^$SU+_A,=9A=I9$U*71=.\,+<Z1Y:-:S7<H>0,_EH =-\'_AI
M_P %%)_A!\<]/^-OCCP'K?CCQEX'N_"W@?1YK[6EAT9)OAC;::EW87FF.L<'
MB*;Q+=7QNKE_E:YA,R@1;0/GV7P'_P %=_ -OX+\%^#M;\.^)-.T*>Q73/$M
M]KTL]NUB+14U#3/&2W8+ZC!"QQ;2'.2H YKS7PC^U9_P6,\0>$OAUXJTS]G'
M2M9TG7UBU"+5+[PEJVEZGXDN;_2O#5ZVF:EH$+RS>$?#L-Q?>(1::G>>7#=K
M91!6^4;]?4OCC_P6%\":GKE_?_!#5/%^H^*H?"6IZ;8Z'X234O"_A^ZAT>W:
M\\,00V.H/+9^=>&=+JY=G6.5,N(Q0!]7_#Q/^"EUI^S!\6;;Q79^%+_XS17>
MOQ>#)=0U;4(O%.IQ2PH$N=!N+=OLFF0QS&46*RJ=PC5NC"N5^!/A7_@JC_PF
M/P\\3?$[Q9X0B\/Z=K<.AZYX1UN^O+FRU3P+?_\ "^KJ77/$4=B1))XKMQ_P
MI:(/&0X$A!)*W9;QNX^+/_!6T>&;JUB_9LCDTC4([_3?^$=>[D/B:"XUJU\?
M:T^M_P#"2I>;X(;.^L_#=M'#Y'2[CBWCSE(\\_:!_;E_X*D_L_\ @_4=>\=_
M!WP)H$>NQ:UJG@_5DTI=4N8-<A@^+\^A_#>+P]#K EUZ66#PEX0FN;V-E>"'
M5H)#!LO5,8!]4_$?X2_\%+=2^(GQ*U?P%XT\!>%O"5SKFIZEH6BZ->:M!8^+
M3KESX<T6XEU4W$C36XM?#T.K30C(VR!6'[Q5->"^%_A?_P %C=/U;P[X.L?&
MNA:'X.T[2/"NFW%]=ZM-J*QZ)#"JZE+_ &I(3<2^+AJ*R-<R9/FP2X4@ 5[G
M^T-\7/\ @I%X4^(.D^+/AW\%[R?P5/\ "#2+;4].\,6R?$&WTWQ+-KVM7&HZ
M^-#M6@FU#Q$(YM M5T^.4L+2XENLD0N*YG]HKQA_P4X\5_#7]GJ^\%?"G6_!
MWC'7M&OT^)NE^"KS2M4BTSQ#='1I=-OM:B>8R:3:0!+IS [*I+R0M*I4D 'G
M$/A[_@M!;:^([_6-!UG0(?' M;NUAU(61U*,#6[:&>VO1^\M_ ;V<^C23 _.
M+BV;.<OG[8^"^D_MN>&/V;?$OPK6W\$V_P 7_ 7@CQ9IWAWQ?XVN?$^K1^(_
M&&NW/C/4/"MW:ZS)<>5?PVLAT4.9EV1+<0QR!E1Z\+^%WQ__ ."I5W\>/!G@
MKXC_ +..AQ> G-S;:]K4%C+I^GZWI=G+XBBN_%K^)X[R:R\+:BK6VA&#2IY&
MDN5NF:*1@PQP.B>%/^"HWAOQ=XR^*?AOP9IEC'K7Q5\6^&;;P_K7Q#O_ !GJ
MFI^%_&GQK\':-I'B2\\":GIUCIVB>'O#WP\C\27UE<6>ILTD<L<]ROE"0H >
MS?L\:/\ \%.9/%=EJ_Q%U/P?;>"M,T*_31O#_P 0-5UBYU>_O[W5[B.27Q?+
MH4BO=7T,<$LEH"=B6EW"I^9:Y[X/? S]OO0_&OQI\<>*X?A:U_XK\!:SX1\,
MV=]XB\93:18P3ZIK=["^@:?:7833]3E-Y"S3."6)7)!!KR&R_:,_X+'Z]'KU
MC9?LX^&M$U+1]8ODN[R\\,W3007MOJ^CZ>?"NF?;-3MX?$FBIIU_->Q:W9S2
M07*Q2HB?N)&%_7?CW_P5A\.7VCZFW[-PGGGFTK2_$-S8::VNQ>(#8W@ACAT+
MP_8ZF8O#4M[&SF6ZN[E;>W1=\DG&" >0?LP?LU_\%6?ASI^KV%I-X!^&EG>Z
MM:ZI<R#5K]YM;N-"T7Q;<06=[8QW$BF&_P!=NM'6[O 1+,JHK@('SU_AGP%_
MP69N-<L?B"EWX&L-0MO"GB7PW:Z3XOUV2?5I+J]MO"LVF2ZK) WEOI<7C^TU
M34#'C,VE6GV,D02*HT-,_:Z_X*U)XNT=/$'[*$T7A8>*UB\11:7X-O9M2M5D
MN[^)?!UG=WNI16US:+8I93R:\)?L(+-&K%V13]4_M,_M.?MG6?P;\,>-OV<_
MV==7O]:\1:GXDBLC%I2^.KE6T30_%;Z-I>M>%[.]M[[1[?5/%&DZ7:1WGER+
M";Z,2JBS"10# _9FT/\ X*B1Z_8:U\6/$/@B;PSIGA.:WTW0_',NK0WFHZOJ
M7B359+RY\2_V%(LEUJ5G:6UNMF6;8UE=P$_/NK%^"&A_\%0/"WQILK3Q/9?#
MEOAN^A:IML;S4=9;P+I\CF*2*\F%G-]KN=?EOVNMB;L)$0S':5%>5^(?VM?^
M"IWP[T9_&'C;]GGP?%8>(_$\OA[P[X0NS9:5?6&J^)?B)XV^&_@/P_I]^VL2
M'Q!=>4O@CQ!=.\5N[:1;7T\<9C=&'HOQV_:N_P""AW@OXK_#;X<^ /V;K?5M
M8O\ X?1^+/$6BZ8-(\5P:W-;ZCJEAJMW-X@T[7!!X.LU%I$;6*YW/<3#R?EW
MA@ >'6/P+_X*R^&/C;\1?'WA+Q+X;4CQ#X@DT&TUGQ1K6L>#O$NC^(O%_A>Z
M&G1Z=>RDV>FVVDVFH-!O&^$1L =Y6O7=.\1?\%3_  5^QU\4-=\<P^$M0^)]
MG=02:"J1:S>_$M3<?\(W9:M:>&X[%_LDL#:Q)KK:>\ZG9!.A&(DC \AO/VB/
M^"NOQ*\&^,[#1/V?/$GA!-%2_P!4L/%4?@[2]$\5>);>+4-+-KH6CZ)K7B("
M.[CA>_C>2'[0;@(3&N%)KV?]H?QI_P %/]9^.'@J3X._"C6/"GAB'PUI&KO8
MW%UX4\1>$9];TI/%DFK#6KRUUR*."6[@O-%@^QSW4+(XCEC\UHF0@' ZGX<_
MX+&6_@[^VVUW2+^]+^'],L?#.CZM)'XEBT2:T\:W.GZAJ=S*?*EUVWU*?P/%
MKDOWI8[6;'R&X#:#7W_!93PQK6OZE-X=\'>-FM]2N8+BRLM:-GX>O;35[2_M
MM!G\(V3'?;Q6&_3Y+XL?FF1BV3NS#IO[2?\ P5_U[QI:Z4G[,GASP]9W^K:$
M-2TJXTJ4IX9TF;PU_;-J;?Q9J>HVVG:P^J7]O<P7I$R2:%*5@N(FEVJWGEC^
MUS_P6/EN;;3[S]EE&-S.+6UO[/P1?VZ7'B-XK==:\*ZDVHZC&-'T2P62ZDMM
M<7S[6^DA$2 8)H [N/X=_P#!7S4M=T74=1USP7IVH:RUSIFLZM;ZK?-<^%-&
MDU[P_(+;29%?"0RV,>I.[(N\[6.=VRNX_9 ^)_[>^I?MFK\+_P!H>[@O?"WA
MOX:>*G\9MH\&H#PO'?6&C_#Y?"-U$9X5BC\1SZIJ>MO-,CNMR'N!M'D)CN/@
MS\8/VXO#?[-6KZ!#^SIKOC+XZ^#O#>I:MJ]WXV\:>'+2\N_$OB"^UG4]*B;2
M)=0$]S"EE"@2VA&\+%&F%,BY[/\ 8V^,/[?7Q1^(T4?[0?PBB^'WPCLO!FJ7
M,7B#4="M= \2>)O$3W=NFD27VD2:W+-H0B9=4C^R*EP\B+#<R-$DF" ?J!11
M10 4444 %%%% #E4'.32$8)'I244 %%%% !6C;?ZH?5OYUG5HVW^J'U;^= $
M]%%% !69*=S;NF>WT_\ UUIU1D^_(1U# ?IG^M %6G%L@#'3'Z#%#+M[YIM
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MX4UC4-9U33-#>;4H=5T"UB-SK6FPZGK$-H?"%UJT>HVENDUP+F*2V4--.[;
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M"WB[P1^Q-XX3Q]JEWXMM?%>EW&H^%M1\*7&HVW@_QE9Z7-KGAO0_%%SJNCZ
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M(];A\1^(=3T/3?%^H2ZIX1@DT=XM0\-*OA2,3L99+B--4\Q!*L&)NO\ %_\
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M:VSVWD3W5M_0F4+<Y/'()"DJ1TYQQCITIFT [..223M7)+ Y.<<YP<_3G/-
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MMKJ&*STWPM=ZEXP"V6FZ=;2NVI:A<B2.5K=A!!"A=X_J7]C']LW]J?\ :/\
MB9I_ACXA?LOZU\-?AS8^%?$VKZU\5M2LI=)TOQ'JMF= 30[?PQH^J>)9+JPM
MA?ZEJEG<"1;V2632!-$(HFN?L7ZF", 9!8[<E?E7Y2<9_A&,_KFGJNT8/0#L
M,<$YX /3.>/;VH =R1G#'U(&1^))_I1110 445')V_'^E $E%%% !13E.TYQ
MGC%*7R",=??_ .M0 RBBB@ K1MO]4/JW\ZSJT;;_ %0^K?SH GHHHH *S)FR
MY/([D$_7\JTZS)\>:X Q@@' _'^M $5%%% !1110 4[;\N[/X?CBFT9/3/'I
M0!(B]&SZ\?F*<R[L<XP/3W^M-5P !S_D_6D9\XQD8'J?7TS0 A7! SU./Y?X
MT,NTXSG_ /6?\*;D]<\^M&2>IS0 4OH,_>./?M@_J?UI*.,@\^GX'KB@#RGQ
M3\59_"U[J%I_PK/XJ^(8=/=5%_X9\,)JEG>@C):P8WZ&=!]!TK@!^TLI./\
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MU33_  IJ::?;:7JTL5S::0MGXML@VHSQI9F6VEB$I8H& / OA]_P4U^(FL?
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M']!UK3?&NE?$#2[BT>XNM*\.:EXPU."?31=+'?#5+>02VMO);N8_=?'^H?\
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MK%]<>+M5TWPUIVJ7&AV'B*X\-^([]O$^HKJ>D:99MX4\.:+I=WJ>MZ?<SZO
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MGSV$6KW=S=O)I]ZE_I=I*9;3RP<%-@!! !<^#WP%_P"">'PM\)^-_B?\.8?
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M8:C<W=_J_B#3+]+Z2]L=,T![QM.TJY>XOI%22-$:!3N5G90" <7)_P $Y?\
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M$D-I82>()(XK2UN=&O-$O%D,1!O[^:&^D9[N8M/\BINV*!7MOP*_X)G?LU_
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M)JEUJVJ:8D!A\"Z#I=C:237'BRTDEE-^ZJZ1Q0/<-#%;I-+#]-:'^WM^T?\
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MO(=471_$FIZ>?#NM)K<.C:%I=I:6C3:GX^:XTQ&:QC5I'1Y&6#8ADKZ'U/\
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MW5-5TC6?!&H>'-1N[?3?"UWH>H>+=7;3["Q2ZBU"T71M *V3&R,)\E"SQ"1
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M?I?A/P_I_A2!R\?AZTTRUATE7\T3F3[&D81I/."L6(+%ADG- 'XX7W_!:O\
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M&7]G/X#/!?0/\(/A\8=1U&RU6[C7PW8(DM_IVW[%/\D0\H1^6F$3;&=OS*:
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M$L-OH.H>';FQN;/2T,&C)_:<]U/?.X:)OW<A#-WK]$U_98_9O:**(_!3X?\
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MYT%I>/!=>T_ #]C?]GOPE\6?CG\8?"'B?P]XLM?''PJ^'?P+L],\-SQ65O\
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M_#UM/U/QWIMUJ-SX=1-9@T#[?_:6F'5+Y+?3XKL1S"0?;+:Y**1]1?"3PUX
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MBDG>(RW,V_Z4\._LP_"L_#'XE6-K\3/$7BGPS\7+7PAXD\0>.Y_$NF7ZC5O
MFG^'XM.\9Z=K4"_9X_F\*:3/,FXV8^RLGEK$S*?F+P'_ ,$TO@O<:=9-HOQ8
M'B+X=V7BJ+Q+-IFFZ%HA@NO'&BZKI^D^(M/GUT:C++_P@TJ>';BT/AQV:RMK
MV6:[3,JA:^PO!/[.3^#?AC\2_@C%XIT^Z^%_BG2_&%AX;LETF.+4/"J>/+G7
M=2U^TNXX[@17&DPS:T8K*W5HUCMK54.T'@ \C^#GP[_9/\ ZA\1OAKH'Q7TW
MQ5XI^*/@AKSQG>:SXNT:XO\ Q'HNI0W.GZEKFF7EO.L;M(\LS3K:?NH&7.U
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MUZ.?4?A;X=;^S-0DN[2W^W7,8MT\[%>@:!_P3M^"%MX5UGP+X4^-_BZT\&:
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M!>)O#_AKX=?#K0M-T[1Y=<T6YL=$M9;F6^>R@DCO;JZU#3YKQ/M4:Q!3L4D
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M_P#\$_/'?PG^.?P?^)WB+XI:+XQL_A/+XMOY8+O5/%.M>)[&/Q;X \:>#8/
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M9-',=TWBK1KF]U1%OY;B^@:WBM(UMXKAL(O?^,?V./VJM2^(WQ?UWP5\68_
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M3>#O"]GX1\4/X%\+FUU/Q'=V>M>,)_#/BO4++5=*O[+_ (5W/HDF@L_A._\
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M@W3/!@\&^+?%UWX&M+'3C\1O#GBN]@@L/AK>^+(YY+N?3$.JZ9"X.FO#+\]
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M>^$O >D_$_PI\/\ P+>2Q_;_ !;;>#[6YTG[9KYNK6SMFBDBE1M'FF ,LC8
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M5ER_?([CJ/3))'Z$4 1?.2=Q7;C "K@@Y[Y]J6BB@!#G'!P: .G SW([TM%
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M@X9P5Z'P?^UC\5?B-^SMKGQF\-?"VPTG6KKXJ:/\,O!/A_7'U>6WOW'B_2/
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M>)?"6D2^)]3_ +5\-:3J<M_%>PR/X4BMI?%%HR.1<M/';R%5C.S< >?^)?\
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M>(KO3_$3>%/A5\=O%'A1[2*U\-QO::B?$?P?<7-M(#%+%=+##=%I?,3UU/\
M@IOXCUGQ3?\ A3PO\&]&\0WMA?>-)KZ2R^(4ZGPQH?@"+XO_ -K6_C>%/#+O
MX;\9WP^%*W6D:7B87>G>*;2ZDN8-D\:9VI_\%9/AUX<\.CQ"G[,OQ6?3KGQ#
M::!<Q::G@@2W7C5]"\<^+/%6GPVBW2SS26GA7P!K]VEY>06BWCW=K!-]C\VY
MDM;4/_!5KX6>(/%VN?#KX;_"'Q:WQ)T_Q!I%CXATSQ3H^D:/IT=ZVI6'@OQ1
M%J&H6]]&9+_3/%UU;>&[N=&N?L]W*K"*YMXFBH S/$__  5&^)'@WQ1X6^'V
ML?LO:G>>-]=CMKB:TT;QY;W.A3)K-A:7^@:9X?UR_P!&MUUCQ"T%]:F]M72!
M;8.3'+/\N[I=&_X*0>*/B-XW^&W@'P1\-+/PK:_&>^U_PSX'\<>,->O)I+3Q
M-H-[!HMY)=^";#2#=R:2FO->0"YEDM[>06;,DI8JA[K]G?\ ;0E^/GBVQ\&_
M$_X/Z#X/LO$&@P7WAWQ9I7B;1M6T:RU:;P'X9UWQ/X9N;Z2ZBO['58HO%,$-
MM?6L<"R+^[PDBAFC^-/[;_[-_P"Q9XV\/_ &[^&7B2#Q'IGA]9_AM:>'-!T[
M4M+DA\06E_+IT%KJMW?BZL5OO%!M],=W=FFO]7C$CD,6  W]L+]JSXQ?LM_$
M/P+J.B^#O#GC3P3<?#B6_P#&FE6<EQH^J:[X_P!9^(GPQ^&NA:C?ZZ]C)'H?
M@^P/C34KV>5EGN'6WCA2+.%;YGOO^"S>I)9^*M0@_9HU_3+30=!\,:K!#XI\
M<:/H^HR7.J:#X"U_57N=.MK:YDN]'-MXQN#I%SI@U%]330GF$,,4T+OZ9#_P
M5-\-V'@CP%#\:OV<O'X\<^.K:VN-8\'^%[+PSXJT&+P9JC>*KA/$L,]]JY,N
MG&U\)W&;*[$$DDS1D,(V#KG>'?\ @I9HD&F^*O$_QC_9XAT_PM;^&[(7NJ^!
M9/#OBR;_ (233-7^+W]@^!O$%AK<MG>W4TFC?"PW=BXLO(T^;46AG\ID!4 _
M07Q;^T?X?T/]GK6/CUX?BL_$]MI6CZ->2Z/%JR6=OI^J:Q?:7I[6/B#47MV;
M0[:SGU-'O9)X1);PVTCO%N78?A#Q5_P53F\*PZPY^&/A;Q)+H^B&1D\)?%?2
M=8@U36CHUWK*:II-[_9:17/PUQ:^0VLLZ.+AQ&MFW6O?O@!^V)\,?BMI?Q:U
M30O@IXK^'GAOP5X8UGX@_%"]UK3?"*+?:N\6HWVM67]D:/J,L_B/49[&PDG-
MV\:PSK<(A.[>B4?@A^VE\,/CI\3]&^$OA?X(>(K#6=0\)WFK:WJ5W!\.+_PY
MX;\"_9UO=#_M'4="U>X6[@U!)(PNF0AI;61]EY#$PH ^9--_X*L^)8==TS4]
M>^&OA63X?>+?$WPGTC1-2LO%M_9:KX>TGQG9>,H?$FKZAINH:&MYKT4'B+PL
M]I;-;6:0J0[7LULH+#Z&_; _X*':7^RA\6O#?PND\ 7?Q N=8\$S^+-0_LO5
MY;+5M/EO='^*>I>&+6.UGTPVDUG=7/PMU.WEDDO8IHVOXWBMYTCF*8\__!0'
MX5R7LFF_\,]^+'U>Q\0:QIG@"SU(_"?2X?$^E_#C5?'>EZ]XGT;5-4\21V_A
MNRTQO ?B*2T@NG@NY_-B2SBWRN%Z[1/VU? 7B;X!_$7]IKQ3\,D31O!/Q*?X
M<^![">30I_%OC'0_$$WA$^$KQ!KL$4F@ZIJ,?C"UDFTG,MPA@=(H[EWC#@'D
MNM_\%#OB7%XI\$?#F;X5^&? WC:]^(7AOPSXV3Q!XZM+^S&G:UK>HZ>;?X>P
M?9;:X\9ZO'8V<$UZ@C@-B+U"5E&37=?M$_\ !16'X!_&[Q3\(YOA)K7B&R\)
M^#+;Q5?>*9_$6D^'X;ZXN]*FUBWTW1+'52C:L##"8-T+,YNI(XEB(;<)O'G[
M>7PIT+X._L^_M)K\.KK7/ 'Q9T#5_%^GVMSH&GW?Q#T6\:#PO;:/8Z1:Q,T2
M:K/?Z_'#<S"7"1V^]2^ C<!:?\%0O@#XEMI?&5[\%_&L%MIVAZY#/KOBZT^&
M^CZS9:[H6EOKMYX)-EK^O1ZBGFI$H@N1"+.>9E$99J .(U3_ (*_Z#I7A[5]
M?;X.:CJ30^'X-3TOPQH/C31-5\9VM[J&GKJ5E'XV\/PKYGA#0X4FBM-1OIB\
M5AJ2R6<HWQDUU&F_\%0_$-YX-U?QV/V<-8@\/6<=]X;TE?\ A87@^2_U7XDZ
M/X3\+^,-3\/QI%=FWC\/C2O$+?9KU)WFN);5;:*S-S*D-=U\&/VIO@%XS\#_
M +2W[1=C\)M'\+^$=,\#:#XS\=2ZG9Z!#XS\7M*WQ T/Q#X;\3G7+]+!$CNO
M *Q6\,D\-O-]L+W$22D@>;ZK_P %-O@[J?P5\=Z_\/\ ]G+Q!XKM/A]X0UZ'
MQ=X'\1I\./!?ASPYXBTS5O'W@K3/ .H6NO:A'/K,%Y#\*_%0W:1I=^+:RMK2
M.XMDWW$=F <N/^"Q.FWEGKE]X8_9_P#%>OV.C>!O#GB5+F'Q)H^DQW^J:SH/
M@_Q!>6FG6^KBWFU#0[>V\6[%N;:*:>:72I56T&^'S/K/XF?MB+H/PD^"/Q4T
M3PBOB'1/C+X>\0W\GA$3VL<UXR:%#<0::=5NYX19Q_;+EDED\B0[0P9(R,UX
M#!_P4,^ <6@:OK/C']GO4;^'3)M1^&FO7GASPE\/+ZW@OK/7O$%EX0^&$>F:
MGXB^VZQ!<6V@7,@DCB_LB"5E#_9R_EQ_3>H?M5^#;?X+^&_BS<?##6]&M=/^
M(,7PYU3P#K.C>'-1\3>&;^ >1J.F:1!H>L2V+78@6W2$V]T\3;@A0[<4 ?._
MAW_@HAX6\%:>WAO_ (4]H/P\\.?#^*VT?Q'HK_$#PAH\VB:I=^(_$^FW1\*:
M#<2Q2>)?#%N/#NHW=[?P*/*6?S'C(2=X][2O^"CT_B>;7=2\$_!74/$G@K2/
MB#KG@<>)K+Q7HQEUEO"^F_'?Q1K^N:-I<*/+J5JO@?X!ZQ=VP3]Y>77B#3[2
M ,?.DA[36?VQ_P!GV;]G'2/VJ+WX.:OKF@:[JC?#B^T >%/ VJ>,=#CU_5(+
M36]*\4-)J+Q:5H8:>.?4X)YEVIE[J +\]9&N?MU?"/PU!\.[#X2_"Q_$USJ7
MC&[M9?#FA1_#K1IM/\*Z4_Q2\/W/B+PO>GQ);:9_:37G@[46M/-NX+:YTS4+
MIH;II&\EP#YST+_@K+JWQ,MO"EGX/^#$WA/5=2\;_#33-;E\?^)=%M;9/#7C
M_P 1VMA8S^$M)>:*[\3:W'8/*;R".*/[ \L<FZ:)E9OKKXY?MC:[\'/BGX@\
M":=\.#XY32[+2M6NO(U/3- DT[1O[%L]7U[46O+VY8ZG=+#>*(H%BC+%"N_'
MS5X7<_\ !13]C#1GL[&R^"_B6ZO]#UNUOO VAZ/\+/ *ZSJ4_B72]6\2:KXK
M\%Z3%JBR6UNMKH-Z]Y>QB(W%PBPK)+<K)'%Z?I/_  4,_9Y\5^+K#37^&GCY
M%\4:=<7>@>--9\+>!O[-\1Z;97-WI6HQ'=XGDU+398+NPE@:VU*TM9&V#8C)
MR #8_:@_:F^*?PC\:?#+PQ\+O 7@_P 51^/?"^D>(=,@U_Q!'HFL7.HZI\2_
MAYX2?0[2,P&*UBDT;Q??/)=>8WD2P*[1R(&!Y;]FK_@H[X<_:1^.&F_"/0_A
M-XPT"#4?"M]?7/C'4OLHL;+Q=X>T+P]KVOZ#-&\:&^TB)/$'V:VO[=Y1+<V$
M@:*&-H9'YN+_ (*=?LT^+M;TR#1O@U\7_&VLP^(=!\(^"+U?A]X)1-3\2ZY=
M^%HSH7A_Q!XD\56UMHUU:2>)-&EG\^YM4=;=VMC.8E#9GA3_ (*'?!VR\8ZQ
M\0/$/P8L_A?\,]/T6\T]OC%-8>%'\3P>$)#^SEJN@ZGXD31Y?-\/^"EU?X_1
M0ZC \T_V6[M[2XC26&>YD@ -O5O^"D\=CX]\3^!;'X-WWB.^T#Q9XFTNPFT/
MQIX7U%Y?#?@K6?BIH_BG6=3MHYR^@:ZJ_"77)K/2Y/\ 2+N/4+95*OYR1>=>
M'_\ @K;HVLKIVH:I\ /%>@:*TDVH:I>:IXB\*VFH?V%]L:WL[WP[H=[=QW?B
M+55'ER75M#"#;KO?S&12]?2=]\</V<OV>['0=0T/X(^(-(C^(GA7Q#^TQXUG
MTGPOX+L=9\&Z-K-Y<ZEKGC7X@W/BKQ1;7-[KDNKZ_J5O]DTZ34KR)YI8(H8[
M8PJWSY?_ +7/[(6D?$30?$-K^R1X]O/BQX8TR2#3]/T'PI\&1J7A31O&MRVI
MV.L10)\38=,676'N#,;FW,E\@F,=ZT#!HP 0^'O^"LVF>+%\:2Z%\%]5DTSX
M<V?C/7?&/B.^\6:+IOAW3_"OANTCN=,U:VN[Q$EOY[ZYG@@2&*%B))<PO,,,
M?/?#_P#P4OTK7_'MK\4C\$=(L;./X?'PSI%Y<:I:#QM+?7/BCXVZ!XF\/7-Q
MJ<EK!X1\!_\ ">_"'PS<RZI,G%G+)/J$-OY&V+WP?MS_ +-VCG4="T?]F#XB
MR>&;^PU"7Q9J6D_#SX,V7A>&./3-6USQE8Z]9S>-X)=7:PTO1M4EOQ#:W<=P
M8!';&YDEC#8MI_P4+_9&EUOQ;X3\)_ 'QWJ[>!V\<^&KN72/A1\/-)T.]\">
M#+?XI2_$?7-%O=<UZRAN?"5A:_#SQ\;K35VW]VMTOV?39_MK@ 'I_P &/V]A
M\6OB;X=\ V_PDU/1M)O/$6I_#[6O&$/BGPYJVAV/C_2T\8RFR\.QV%R6\2^$
MIK7P/K$MOJL $,BSVP";FD6+EOB%_P %*/#?A+X\?$CX!:'\+-7\9>*/!\2P
MZ1=6.M:%;:=KWB2UO;>PU'2]0O;IQ#I$L,MPN&>2290A$L4+84Q:[_P46_9;
M^%UGX'=/A!X]T[0_%&NZMH_PNO/"G@+P#+#KOA3P3J7_  B.I?$#0-%T3Q*;
M_P /^#[*XNGMX4O+*POV@E=;>Q8>:@ZGX?\ [4GPT^)>M?&WQYH?P.TS2+'P
M7X \)>.M'\?^*O#W@Z'Q-\1M*U]4DL=2?^P[V\NX-(4;?)34)K6^5EQ):18%
M '/?"3_@H)/\:?C[\)OA=X4\":=X>\-^*[_QWHGCJ[UWQ!I%SXEM?$WA'PGX
MHU:XLM$T+29Y)IM*35/#K1_VI<(MK<)E(FW@A>'^+?\ P5=\(_"KQI\2O 5_
M\$/'6O>)?!GCM/"NE:=I$NDW\GBC1-.\.>)?$>K>+C<P.]OI^E1?\(S/9VYE
MF(6^O8H;MK,B=HOH?X3?M1?L^>/=7\8^+K;X7W?@?Q)\/?AY>>,9O&&L>#/!
M-OJ6O>";2?['KUYX0U'0-6N]2&D1ZO=O"T%XMDTC76\1,K.:\PUW]LC]F.>R
MU6]\=_LV^)K?3]=L/ GC?XA3Z_X!^"FO16%MXID+_!K6_&4%AXTO)-=O]7O(
M@FE>3'>W6F21^;J*Z=$%F8 R=8_X*41VVE3[_@9XPT35?&J?$M_@XVJW'A?4
M8?&]A\'M5\7:1\0M;U&TLM8W:,-"/AFPN;JUO)(I3#XDL4A8R2,$YKQC_P %
M9?!OA#1;75+OX2>)M>_MOQG/X3\.:3HNK>'+_P 0WMOH]XNFZ_K7B#PG%?27
MOA&W%Z)39I>PJMPHQYJ2*ZKZ;-_P4%^ UM;VX\2?!#XI^&;71M(?7O'7]L^"
MOAK=Q_";0/';:-<V6H^++?2/&5V]S#KT7B71+B2/1DU*5AJ)&I)%+%,B><Z?
M^WG^RQ\2/#GC#4_!/[,/B;QQJUK9W'CSQ-I&M_#?X4^'8G;1K:ZG\*>,?$.H
M>*M=@74TN9K79:W%HNH:A:9R\$9&* /??VAOVU-#^#&J>"_#I^'&L^(?^$^\
M!6_BR[F>^T32I=,T[7+G3M%TO3;73KB]2Y\4ZJ-4UFS6YM=.$TD,*RR#)55;
MFO"G[0_B?X._LD_LY>+KWX-V&K^+/B!I7B&23X?_  WU31M#\/>';'1O!'Q$
M^+^IS65YXCU8)<E?#/@V[7)F>>[U"]#L%\QRG 6G_!0SX#ZP;#7/BQ\%M>A\
M1> [VUFNK^+PAX1\4GX3P:]:^'[+2;B+6-3UA;B>6\U'Q%;V8ET"*X4*X:X6
M!-V/<M-_;1^!%Y\ ]6^.WB?P7XJ\#?#WX?ZWX/T;Q)I/C#PYX02_\!:-\1-&
M\,3:+XMO;73->N[&R\*-X3^(.GSWK6MS)/;V=Q>P7%N#%+"0#Y@\3?\ !4RT
MU6RL;CX<?"Z0->ZWK4NDZQXTUC0H!;^%]!3XF:%JFKZEI5EJ#S^&O%!\2>!X
M!8:5J)LIM2L-09H9%*R*FIK_ /P52\-^%M&MKNU^#WB'Q)>7_B2\\*:9IV@^
M(? UKK%]>Z#/J%MXFU/5/"1\0/J'A?3!/IMPUG)>0*ET)D59 X<+S\/_  4)
M_9R\7:1<^+O@Y^S?;>-M!\:V/A36?$E_KW@[P7X)NV\1Q^ ?B1XF4^,H+I)I
M=5U'PY=?#^3P]?PO')>Z?JB7]K"2ED#+[E%^T9^SCK'P&^)?QS\<_LV-;WOA
M36/#NE_%CX=O\-_AMXM\:7GB6V@LKKP]+*=/U&ZL]?M(+*[M;JRNKF\5[6V(
MD=+<JR* =U^SU^VSX*^/C_&!(/ VO>$+OX6:9:^)-1TG76T6?6]=T=]-6_CU
M*"ST^ZE$B"5C"DF]T$BE2ZD@'SWX%?MO^+OVBOCWX!\ ^$/ .E^&/ +^"?&W
MC;XBZCJNNZ+XAU<VZZ+X*OO .G:#<^&M5GM;?4)?^$TM9=5AE9[BR^R+!)"H
MG24;5G^VG^R[X-TN7Q7X4^'NHP:KX\O;&TFLO!?A+X?6VM^,]?N= EU/2=.O
M=5T[Q#%:ZK=O;6[6D<]S>FWBE CDN(HP66]^S[^TU\-_$?Q>\2_!32?V>-7^
M"UW:>)_%NF^&->M_#?@&T\,:WXBM/"OAGQS\0=!U"[\%ZM-_9WC-6OGEO#''
M<6%Z-*24:E/<XAC /OX*!TQCKU&?YFC&<]/Q(']:11QRJYSP<<_H:7 [@'W/
M7]*  *!TP/7Y@?ZT!0.F!Z_,#_6C"_W%_7_&FJA4G<$(/0 =/Q!H <% Z8'_
M  ('^M+CZ?F/\:8HZ[D7VX_P-.PO]Q?R/^- #MC>GZC_ !HVMZ?J/\:4$G@*
MOY?_ %Z0G^$JOKC'^!H :1G@X]^1CMWS0$QR /3.<_UI&Z<*/IV'YFE&,?=
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M'..W0_GT_"@#PT_LP_L\>?H-ZWP8^';77A=KI] E;PQI;-I37JP1W+6I-O\
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M??\ R*TK;/E#(QR>_OWXH L4444 %9<OWS_GN:U*SI68R,54'/4$^A(H 0*
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M>^)G_!-W]F;Q9H[:SKWC3Q/X.M]%USXR^(XO%VF>(_ FF6ND>,_B]\:OA?\
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MQ?XB\#:F_P#PG3:?\5->L?"&J :!-?>(;E[OQUXYU*U$Q&I?\2Z!(&+02O.
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MDHG6>:/?)(I=J[#1_P#@DKX3\&^,?#/Q*\#?&37+/QAX(\&>-/"WA?[?\/\
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MB'Q)XN7PWI-SHFA>$M%FTA88-56TCE;0=]RT[1W,LL,+J@!XR0#9^'__  4
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MN_A__P (B+6VT30%MO%4<<]ZJZSJ?B>QOYH[Y8)II1#]CM[64/$4N;NY3,=
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MP!&H1AKCY[,@C$@^3GK4A\6^%0D\A\2:$$MGMXKE_P"V=/"P27>/LL<Q\_\
M=O)D; <%L_+FOPO\/?\ !)7QSHOCOX>?#Z\U;X?^,/@=X0LM+U#7/B?XL\.V
M^J_%#7QIVC^#])B^'.E:;<&631OAV(_"IA;2)]0O;8QSF[-S)-.]K#ZAXO\
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MJ\D8KB?!WQF^$_C^'5;GP;\0O"7B2WT2.UFU6?2M<L+B"SM[VTCO[6YEE6;
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ME6_;BZR\? -?3GP5^!_[7/P>\3Z!\2/'GC_7OBM>W-SJGASQ?X);Q4;S1_\
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M33^4CNE['YLS.\T$/TM\%O#/_!0KX4_&6W\0_&#Q%XR^+WP:M_ _@O1;G0+
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MF ?4G[2W@/\ :J%M^S[J7P<\1^,?$'B+P3X5\7Z)\1]2T;4O#&E+KU_JEO\
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MY^UE\2OV\/ WBGQ#?_ +PEH?B'P-'XK\">'=.@O? &I^)+^PT?4/#=OJ>O\
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M;VV@QZ38Z\RZH+#_ (1_4+._>2YT'RVTK;]KC!$@<M*>57X!TWQQ_P %2?&
M\$?"3Q-X6\7^$/"'AS3/@)J/B+Q3H/A/Q$?BEXCM/#OA'X;:_KIU+QJVJVVD
M27WB+QA-XQLM>LK;5UO+!-/%K.UE"TMU>>N^ _VK/^"ATUAJ3^,/@3KLUAJ.
MJWOA_P )7$'P:\9V7B2WU.Y3PK<63Z_83ZHL>EZ-;P:AXCADU"1Y;0S:8NR^
MNMHEF .HOM8_X*;:YXG\%:EI7A7Q)X=TBV\0)I.MZ!JS_#R&ROK>TL&M[KQ%
MJNI6NKW,BZ))?9FB@187F7'[Z)\1M].?L7:[^U)I^A7'@W]JZS\1:QXWUB[\
M0>)])\4R:%I%EH6C:3HD'@S3KSPW<W^BZA*A>X\0:QJ\VD+*D4TUEI\Y.]81
M(_ ?L\:Y^UIX?^%_[1FH^,K+Q?XR^(6CV=MJOPC\+^/= .G032M;:_)_9NGZ
MM%,G_"0*T\=FTL;2),FV&(E0ZFKO[*7Q3_;*^(OQ1N;'XQ^&QX>^#N@>!K[4
M=(\3:G\)]3^'WB+XF^(+V[T&V@.H:-JOBJYF\ 3:==W?B&(6+0W$E_!H\-X)
MHX9E,@!^C]%1J^!SDG\#^N>:7>/0_I_C0 ^DP#U'3UQ3=X]_T_QIJOC.<G_/
MUXH <26^Z<8Z]1].GTIS D<'!_\ UTW>HZ _D/\ &D#@$YR0>GM^M $A&:*0
M @DY.#V]*6@ I""0<<$]^G?-+2$X&: &[@O![#D_AU]ZU+8@Q @Y&3S^M9I
M(R0#D9Z G'O6C:X\E<# R>.G>@"Q1110 5ER_?/X_P S6I6:^T2R9QAB"O'
M X/TYH 8Q4C@8Y] /Y4RBB@ P#U&:3 '0 ?A2TF03@=1]>W% !@>@_(4M%%
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M4MA=7GAJ#2++P4D=KCQ'XG-OXJL9[ZUCYAC@E/(*D>,:W_P4+_:$\56FOQ^
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M5_H.AZ9XGMO$>IZ!HN@W%MX_\3Z/=>'-<N!I=W.\,L<EM8@>6^H2.PK&T_\
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M3^&.DZQ:6.J:XEJ]GH4UG\1;3^REOX[:$K8N)T@  K'T3_@IQ\'=/\:6ZO\
M!3Q(L&JVNFP>']5\,^%=(&J^%?!\.FN^K_\ "4:C$4CCT^WU:*2..*QFGA,*
MB=1Y7S5SGC#]K?\ 9S)\1:W9_L7_  ]\=ZEXDTRU\+&67PUX0L]5\1Z=;^)/
M#7A'0_#GB:+Q)X'AN+'3+>>YTGSH)5GBM#I*I;QW B@<_3%E\5/V5_'?C_\
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MOV<7^#6C?#W]E[P!XT^'GQ#^'WC+XGS:AI^A/X:G\-^$;J32M)\1KINA:?\
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M+/!?CNX\*:+JWAWPW)XDT.SU,Z+HFNW_ (8U/5M-L'N86^SVEQ?^#?"\DB#
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MD:N/T'U_QJ+I0!!@^A_(T8/H?R-3T4 08/H?R-&#Z'\C5@$@@CJ*"222>IH
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M7_%NO>(++P[?>.M5-WJ-OJ&L^'=<31M&OY,OX6T,0Z0;2S#%KFS*AS(T:Q*
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ML]_ C4-=\(Q^*/A%<? BXEEU?7=3T;0M8O?A9#I]KX@^Q:AY_P!IN5%DMY/
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M7-$G%E:0V\5[/HPW^0Y29?T$_:'_ &:=8^/=Q\!].O\ QA>:/HOPYUCQ=?\
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MNJ>!,7R%[C['Y@\HY=.@A\5?\%-?@U;>#M3T/XA? &;Q/?Z=X5^%5W!I-O\
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M;PIX<;6?&FM3ZEH6I>%UUNYOY+7^P],2PL%C\312P0RS_;H\0LB,-I.:^6-
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MRMX_V>O$"^%];T+2M.\1C5=?TJ:W\%FTU+PC9Z78>)UN;]2;2"%;@22!)?G
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M&:1MA]>UG]IS_@GCX+N8/#NKOX2TF]&@^%O%^EZ)_P *6\;//J6GS:WX/O\
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M?"0:)?>'1X"T)M U._T'5-0TB2*XEL;V_P#"]K:6&@3W-O)<E9A:VEC:)&C
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MY/[OZ"G@#J !D>E $9(#G(R/H#V'K2[U'08_ ?XT_ ]!^5(0H&2HQ]!_GO0
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MVOX5\"77@W73IT&G?\)#X5\4^*])UAA 8%.IW%W#K)^U^(Y+:!()M4F#ZC+
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MFL13V]E>W'B36$NXE?9/#<K"ZE(X@F?H7[ '[,'AW6X=:TCP?KUJEA&(=$T
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MGBCPM8W4\H@N[C7]0&EI<QR,T2V!EBF#&15K1T#_ ()P7>D^!O@OX&U_XO\
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MY\ W,OE)#X$OI/$LCRV<N^:"]MB4D9965/$]#_8+_:1\$R>&?B[X:\ ?"_\
MX:$\/?L)>*OA'HNLV?BV[72?#_[2VL>)_#&G>$?&+-KNIW)NX-'\ _V^);QI
M;@E()+"T9XY;=1E_"3_@F9\:_#_@G]F7X1?&S1O /Q3T#]FK]J?5?$>C>.U\
M4ZM>S:Y^SAXH^&_C'7[CP_J(\1W*ZGJ4^G_&?Q+:PBRN_,\V'2+6[A)@B&T
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M1OA/X@>$_P!F'7O%::YMTS3X_!&GZY>"[L+BXTFUO_L^AF[FT</O .>\+_\
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M<]:6@!2".HI*4DGJ2?K24 %%-4L<Y&*=0 H!/04]5()SQP1V]J1.I^G]14M
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M^#OPLM-'\:_M%OK/P^OO!&H?$"'Q%KT?A"]\"KX=\?:1;ZGK+Z9H]KJVL_\
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M8\*:*=8TCXG6-M;)=ZY!!JNI%]/%S=V#Z<J!98 [\'PN\\7_ /!2?PM=>&?
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MIL/PO\:Z;X+5);*T!U>+6(+DSP W$0CK^F0R,!A6Y! ()]-W][ZG\SZT[S&
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MM+NPT6".V2$0R_9+2_O$MFDC=X1<N8V4DFG>*OV7_P!GCQQX!\%?"[Q;\'?
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MZ6'6M*AM[FUBL]>M9/%9BUY1:WEU'NO$G?9,5W;<"G^*?V$_V/\ QD)UUO\
M9^^'ZI=2:4]U%H=E>^%(+I='TS4]%M;6Y@\+7UFEQI\FC:QJ5I>6SJ8-1M;G
M[/?QW,21J@!X)^RM^WCKO[2GQV^*_P .+;X>:-X9\"?#KQ1X]\*V_BQM:O=0
MO=:N/!>LV&D07L-Q%!_9SVUW)=NZ)'.9 H0A2&K]*PN.F<$]3Z#OQ]:^;M%_
M9 _9N\.>)?$/B[P]\+M.T'7/%>ISZSK\NBZ[XNTK3]0U6YU73]<N-0;0K#Q#
M'8074FJZ782N\5M&6%OY;9B9T;Z24!0%&<  #))X P,D]>* &E 23SR<]O\
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M%\,>(]<U+6+67Q L+V*Z!XQT"[B%G<7=Q-'=E5@\Z-XU\9^"_P "/^"9U_\
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MOX>CT+7;[QAX0\0:P&?QUX=\(7VGVVL1Z;/I82ZTRX\073&ZMW*[K>X8@Y4
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M@O"@@ZAIVI7^G*LLB+&N1\8/^"9?QVTGP3KEO\,OA3XJOOMG[;GQO\;IX?\
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M ^)M5_X)"?'J^UKX::E:^-OAU;ZQI;R^)/%-^=;UU;70/%%_\6X/B1=2Z9I
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MG^5 #_O8/(P>^.>?8^U.IJ?='X_S-.H B9@V,9XSU_"N0\?Z=JVJ^ /'.FZ
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M>D^#+C36\(Z''I"67@#PG^UQX;UC2[5=4COEDDE\27EO]I\R>33YD?97UO\
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M'QA\!:3\+HM9UWP[I5C^R/X8^(^K>)]/TS1/ EO<V,(^*]_J275W'KMRC/\
M\2Z'3"R@KUN@_MY?M=^+OCIX/\-Q^+KO0OAYXGG\>^+?"4D_@K1O#,7C_P (
M3_M(_%WPG\,M/MKSQ!\*]3FN'NOAIX7\'1F%9=)N]NHI>2W/F7'FH <9KF@_
M\%)=<_:0\6^.](T']IS2M'\2W>O3?\(E!XOU+3?!NC^'M7\#V$=JEE?7?QKN
MM C^Q>)X[DPV6G>#K'5#))O&N[ 0?HKP?X@_;&?X1^*_@MXM\ _M5M\3;O\
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M<RJH;\\/B+\:O^"A%KHO[1NEZ;XN_:O>V@^.7@&?3O'</P_\6^'K;PKX=O\
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M_ XQP20#PW&.&X'R^N/<U_.=XO\ ^"O_ ,<-+^#FG^*/"'@C1O&/Q"\1^+?
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M/P)^RW\"=5\$Z7X_^)EE;:L;#7;NU\0^!/!WQZ'PMM=5M[V#4.(9= \RZ::
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M1_'WB;X>?%KPSK/@SX>^)9V\9^$-0%OJ1F\1Z=ITT'BJR^U'?!=%W+9R0C9
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MW5+4A-9FNWMGF%P4C\LLP.*_1G]F[]H#XR_%_P"/7QK^#OC+X<> M#\"?L_
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MJT6TU2'3KHPO;2/:>='F%)+5Y(98U/ES12&.5'C)4X%[^S7\ -2\87GQ!O\
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M%WX!L+.#PS8QV]IX*OO%T?CZ\\+0Q)  NB2^-(DU-X/N->CSR-Q- 'YP6/\
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MC(5*WS[@<C%"?]GGX(77PU\&_!^X^&/A.;X8_#_5/"6M>"_ ]Q8O-H/AK5?
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M_!VGZE8_;Y]23PYK^NV?B?7+"[U"_N9IM2EO/$%A97=S<7#RW,\UJIDF;&*
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MV]G=:YI\=PVO-8W.I+I$D/VC=;W_ /9]G=S>7(%;RX&;&*ZR)DD598G22&1
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MF59&*B+Y1Y1SUKU2+4]+E!DAU.PD7+#='>VK+G^)2RR]O2I?[0L/^?\ LO\
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M5H,8ZW4( R,C(,GI0!\R?\-%^,^W[,7QP_\ !39?_'J/^&B_&?\ T;%\</\
MP4V7_P >KZ;^WV(_Y?+(?]O4/_QVC[?8_P#/Y9?^!4/_ ,=H ^9/^&B_&?\
MT;%\</\ P4V7_P >H_X:+\9_]&Q?'#_P4V7_ ,>KZ;^WV/\ S^67_@5#_P#'
M:/M]C_S^67_@5#_\=H ^9T_:)\9.Q#_LS?'! <<MH]D1R0#]V7L"3[X]:ZZT
M^-.JW$2R3?!/XNVDC#)AE\/!W4Y(PQ27&< '/H:]K%[9-TNK,XQG%S$<9Z=)
M:?YMOG=YL'_?Y,=,?WZ /'/^%PZA_P!$=^+7_A--_P#'J/\ A<.H?]$=^+7_
M (33?_'J]E\^'_GK!_W^3_XNCSX/^>L'_?Y/_BZ /&C\8=0Q_P D>^+0]_\
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MOU+>9"DIVXF_A9RK?[2&K?\ PN&'H/AG\8QGN?A]?G'OS+7L7X+_ -]?_94
M<C(7'?YO_LJ /G.[_:4T*RGN+:?X4_']Y+67RI&MOA+K<L+G&?W,B28E7'\0
MXJE_PU#X=_Z)-^T/_P"&?U[_ ..5]-DE20IX_P!_C/?HP_SWHW/Z_P#CY_\
MBZ /F3_AJ'P[_P!$F_:'_P##/Z\?_:E'_#4/AX]?A-^T-GV^#VO ?^C*^F]S
M^O\ X^?_ (NC<_K_ ./G_P"+H ^9/^&H?#O_ $2;]H?_ ,,_KW_QRC_AJ'P[
M_P!$F_:'_P##/Z]_\<KZ;W/Z_P#CY_\ BZ-S^O\ X^?_ (N@#YD_X:A\/'K\
M)OVAO;'P>UX?G^\H/[47AX?=^$W[0W_ O@]KQX_[^5]-[G]?_'S_ /%T;V/?
M_P ?/_Q= 'S)_P -0^'NWPF_:&S[_![7L?EYG%'_  U#X=_Z)-^T/G_LC^O
M>_\ RTKZ<+' PW/&1O/_ ,5ZTFY_7_Q\_P#Q= 'S)_PU#X>_A^$W[0W;[WP>
MUXCW_P"6G%*/VHO#G?X2_M#D^WP?U\#WQ^\KZ:WMC.[C_?/_ ,71N?U_\?/_
M ,70!\R?\-1>'L_\DE_:&V]A_P *?U[/TSOH_P"&H?#O_1)OVA__  S^O?\
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M1&#(%O--O()X#N .8I$/X5NT4 >%R_LU?!*:%X)/!<I221)&\OQ;XYBDW1A
MNV>+Q,KQK^[7*JP4G)()9B<B^_9-^ 6H1V<5UX,U79868L;?[)\1/B?8G[.I
M3!G>Q\:1F]N/W:'SIC),<',AR<_1=% 'R_\ \,:_LZGG_A"_$)^OQ8^,>?\
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M;$TC2OCXP_&/>'8@GRG_ .$^S;QY ^6,JH[#!(KVZB@#Y];]E[X/-OW6GQ)
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MQGCN/6F@E3D8Z8YIP!8\@C([#OQCK0 K!>3GGTR/85'@GH,TK#!(H!QTQ^-
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MG!VC)[#UH 6BCC"D<Y )]CW _$44 %%.5=V><8_^O_A3.?X6V^N.] "T444
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M'7]9\5GP/X0T#PH?$WB*9+C7_$!T+3;;3CK&LW$:JLVI7'V;S)F55!>0D#%
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M/Y=,T !?((QU]_\ ZU(GWA^/\C2[#ZC]?\*>JX X&?6@!20"!ZG'^?T_.@D
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M:SB\,W/Q<M-<NKF]:*SL;CX$Z=X=U;XJ1-<&/;(^DZ9XKT&:<(6+)>CRPQ!
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MMC2FX1]X5: /V7.<GV)!^H)']*4'!!]*>4)+$$8))ZGN2?3WH"$$9P1_GVH
M8QR2?7'\J3Z=>U3,H(.  ?I[U$PP<>V: #<<@L<XZ8&*?YGM^O\ ]:FA203Q
MQ3D (.0#SZ?2@!ZG<.GK^@S43-N&,8IVUO7]3_A32I'7% #:<K;>V?QIM/\
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M/B7X<_##X:>-=)OM5AO(8[OP]=^'_ 6IVUM!Y"/;6GB;R'DF>V69_K+XP?\
M!-*Z^)&B?LL:-H?Q2TGPW_PSIX-L?!!UV;P6E_KVHZ;91JAN='DDU!H+83QJ
M(Y;6X@E0!?,CF22@#[\T[X]_!/5I5@TSXK> ;V>74CHT44/B;2VDEU18KFX-
MC$#<?O)_)M+I@%SD6[X/RFI_#OQR^#GBS6]*\,^%_B;X+\0>(=<L3JFCZ/H^
MNV6H7VIZ9MG?^T+**WD8SV>VWFS*OR#RF7.>*_#S4?\ @A$^IZ/)IR?M&S>'
MKJWU*/5-)UCP]X-:WU*QU6S7Q(NGZX)9M6_=ZFB^(IXF1?W)B#<988^[OV??
M^"</A+X"V'@^RT7QO=65SX,_9Z\1? '1_$WA;0=(T;QGI=CK'Q#D\9:?XET?
MQ#?V]V;75[32V73D,D4H8.TA^5C&0#[VO/B/X"T]/&LE]XR\-V<'PY2"3Q[)
M/JUFB^$%N=.@U:V_X2 F7_B7-)IMS;3HLF&:.YC8 [AG,'Q@^%30Z?<I\1/!
MS6^J:#9>*-.F77K!EO?#NHW8L+'6X"LQWZ9+>D11S#Y&?*@Y!K\HI_\ @D?K
M":'^TSI,7[6OQ7U%OV@_'7A[XEW\VO6&AW8U[Q7X=BT::VM/BELL2?%?AMK[
M0-,B%K9FP5+& 089 $K&^#?_  1JM/A9X_\  OC34OVA/$WCW1=+\.>'/"_C
MCP/X@T.%-!U+0O#MU>ZE;>&_"'DW6[P[X874[M98K1E?:8R6D+'( /UHN?CE
M\&[+2=.UV[^*/@:WT;5I=9M],U.3Q'IJV>H2>'TEDUQ;2<SXN#:1PRF<J2$$
M9W$5V_AKQ3X<\8Z1;Z]X5UFQU[1;J22.WU+3I1-:2O"^V98Y,?,58\CU-?B;
M\5/^"*&B_$"U\-P:%\?==\)V/A.U^)VFZ'X7C\*VE[X1T[3/B1-=7%[%8:>=
M022TN_,N0MQ+ND::-2%,>ZOUJ_9_^%>H?!KX6^'_ (>ZC?Z-J4VA-= 7FA6-
MWI]E-#*Z.C&"]GDD$Y(8NQ;!+ +@"@#V4<$'TJ4'<K'Z_P J8%)!/'%*%)'!
MX[C)H 913BI7&<<TA4KU[T )1110!)YGM^O_ -:G9PN['X?_ %_QJ( DX%2D
M$KCO@?IB@!OF>WZ__6I"^1C'Z_\ UO:E08?! ..?Y&@H23C '^?:@".M&V_U
M0^K?SJCL/J/U_P *OVXQ&![G^= $U%%% !6:Y42R,1D,1C('&!@]ZTJRY?OG
M_/<T *JD$DXZ=LT.!CH.O^-(A))R2>/7W%(P/4GC/ R?>@!E3KPHQQD GZ^O
MUJ"ID&%P><G(]AS@<_4?E0 [ SG SZ]_SHP,YP,^O>BB@ HHHH ***0D X/?
MIU_PH 6BBB@!IV@9([^@_G49*D<#'X <<\<4F3C&3CTR<?E4BKC.<']?YB@
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M))_7^9H >%P2>.>@%.IH8'IG\:=0 8'7'/K11P>N?P__ %T@!!//'8<^ON:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g1078496.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078496.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" -6 I0# 2(  A$! Q$!_\0
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MS2LXQP>?I_C3-[>OZ#_"@":F$8;<>G_UL4H<8&3SCG@]?RHRK<9SGZ_6@!0
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MQ/?7NGZ-=_8=>\^>?3889]0FN=.72C<Z=IT$%U;2375Q#%;(EPC&4!@2 ?5
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M.1UZ<\\8-+L!Y.>>?S_"@!V1ZC\Z8SD$CC_(^M* H.<\CU(I2H8YR>?0CZ4
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MU^,_QO\ B'\5]0^*U[H.G^/_  3XF\*7&F:1X:LHM<MSXB\$:OX+6UNM<6X
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MTC4M%T1-'M[FQ\4ZQ=V-]!JFE^"K34_ T=KX@\M6M9U=/$+3I<Q1QBTDC9L
M'Z3[F&?ESQCH>O!X]33=[#J!UX/;GGUYX_&ORKU+Q/\ M#Q6VI_V/KO[1EWX
M2\0^&?BUX/\ ACJDWP_L[?Q^GBZZG^#MU\-O$GCS2KCP6A\*V\>I?\+6MH]1
MU6STS3QI\*M>1(QM;B?SGP_XW_;&;5-:3QU?_'ZS\$Z1>:S;Z%XK\*_#N.Y\
M0ZUX=N/C7KVEZ=;:KX*7P'=:B?%UEX%TM93J%O:"POM,U2PO(K=9GE0 '[,$
M[CR.1CIZ?_K/Z5('Z[B!C_Z]?DYX8^)G[7^I?$_PKI][IGQ3T_X5S^'F\"^(
M/$VM_#NTBU6V\1^(OM%]X9^([Z%!:B=WLM-6&'50 ME#=-MF%M(&A'2>'M:_
M:,L?A/9ZSKWQ%^-.J>*;[XX^$O#EQ8CX1K;>(-,\"Z;XM_L[Q7J_]GV_A1VF
M\.7OAJ0W:79MQ'"UN#%<2AMM 'Z?L^.F#U]^G3I2%V[@#\"*_)?XH?%#]K5$
M^)-EX N_B#;>-;#4O&L$UI+\++_5_ W@_2X?&7A>R^$NN>$KVST1G\=6UWHC
MRS:[:V5U>7'V2]U5E.G2Z>K'[<_9@UOXF>(/AUJ6M_&*U\1:)XNO_B%\00OA
MWQ7;Z9:W>@Z+8>+=4TO1K#2Y--@B34O##V%C'<:7>.#+=V%Y;W$AW2%0 ?2&
M0>AS41)4G@<D\D?YXK\A=&\6_M9BPUCQ?X@^(?Q/L? %U\2/$OA*X&F_#6;7
M/'FB>'-.NKY]%\3Z9X2_X0"UN["WFN%BMF/V?5[>6"*.9+E?/!7K?A9\4_VI
M+SX[^"['QQ#X_MO .HVWAFP\2SZEX)EC\)0WNJ:1X@D2W6WL_#HO-,U2=[31
M9;F^FO?[/TZ>Z:VN5C=E4 'ZGJ!USR1R,^M..3D*,D'D=?Y'UKX@_;$\=?%K
MPE%X'B^$E_XI2:Z3Q1?:E:>#/"=YXEUC5[S3K&U70-,@NCH5WIT9DO[O<;"^
MNM*;4$A=;?4H'B8-Q^N>/OBM)JGQOU"/X@?$'1O%?A30/C6VB_#"S^$NIZCX
M8BM='NEMO@]KOAKQ+#HLJ:]JU_906%R\2WD_]H2:[<V]O;6[Z?-L /T0(? (
M7)[C'3U_6F[@OWR%/IGOG&.O%?DYXZ^-/[26GZW\(H?#6H^/9_#NL_!WPMK_
M (PU1/A7KMSJT7C*ZOM8CU.V/A^/PV6EU62V@TXS:?)/92V*R^<XD!V'Q+6/
MVK_C[X(^&?B;XA?M#_%5_@'IOA.U\+PG7/$7P_M](T+Q;/KVJ7]I;7GAZ/Q%
M)#<1W4-HD!U.T>-Y('C!&U)E8 '[I @C(((]1TH[9[>O:OS)T;X]^(?%4WB+
MQ'\/?C1JOQ,\"M^RKK_C3PEXJ\"?#X:WX-\2>.].%]%!K/AK7+*.6'6M<:&W
MDE71H9Y',UJT9QPASO#?C_\ :/TCP+^S#K'Q%^(NL66O?%OXV:<FLZ/IO@2'
M7+JR^&-[X.GN%TWQ'?Z99^7HK2^)=+TN0W$T-LUBGC,V,WF36AG8 _48D@9
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MB%+))=2U>UED:Y@BDB $:B%G9ANKN;/]LS]J>XT?XA7D7A;48XK_ ,.>$_\
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M<^(9L6D!$VHS74RG>5D!D?=Z^#@@^E>?^-]3^*-E>Z*/A[X:\+:_I\L&IGQ
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M/ZT -((ZC%)CT%.9LXXQBA6VY[YXZ^^?YT -HI2<DGUIR-M/) X/4XZX'?\
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MJ\R_;4_X*"?L]_L+>"D\1?&'Q%+/XEUJ&Z7P3\-?#JC4O'/C2ZME4,FF:4C
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M?\&^W_!/CX?ZW-K>K^'_ (A?$>+[:]SIV@^,/&#1^'[&%G,BVAM/#]C9RWJ
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MR6\$#/<S2Q#,B?./@']F_P ?>!/'7[->E_\ !0RY^'7P^^$_[3GQ"^)/QO\
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MD>#/B+'X1T>+XAZS(L>@P>"_!^@7@BTC1;:_='GNKQGQ;P,\V.15+X(?M/\
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M:4IVX[9Q5>?]GGX!W4307?P5^%5W Y#/!=^ O#-U [+RK-#/IK*S ]"1D=J
M/#K?_@HU^PI-;6UZG[5'P=$%S$)H2_BJV1V0HKD,A7*, XR#SGBN8M?^"FG[
M('B'51HOP\^(EQ\6-5=IXX[7X::+>^)U\VW4F6*2YA5(X2&VY+-@;LU]"?\
M#+G[,QSG]G?X'Y8CG_A57@?.1Z_\23GBM*V_9W^ -E%]GLO@E\)[* DL;>S^
M'WA:T@8GJS16^F*I; !)P?N\G% &?\/?COX?\<IJEQJ6G-X#LK-K<:8_B_7?
M#]C>ZNLWG><Z:6M^9;$1"./=YH!/VGC[IKTN/QSX*ED2&'QAX6EGE98XXH_$
M&DO))(Y"HD:)=DLS,0 !DG.!7$?\,^_ C.?^%,_"_)X/_%#>'/;_ *A_M5FU
M^ _P/LIX+NS^#_PTM;RVFCN;:ZM_!7AZ*>WN(G$D4\,J6 :*5752K*000""*
M /6%8;2.N<X(Z<BFTJ@' & !@#\.@ [<?R_"E88/)SD9H  V 1CKG]1BD!P<
M^GK24]5W#.<?A_\ 7H 0L3U I58+G.><?UI&7;CG.?;_ .O3: "E(/'&.W3K
M24XYY!).T@'TY&>#0 I?(QCK^--! ZJ&]CTI** %)!/  'H.@I**<HW'&<?A
M_P#7H ;5N'[@^IJ QX!.>![?IUJ>'[@^IH EHHHH *IR=OQ_I5RJ+,&QCM0
MVI X 'WNGMC\*CIRD*<D9XH 0G))]2324IY)/J324 %%%% !3]_RX.2<$9^M
M,IRG!'U_GQ0 TL0.,\#H#2C@*V>O) ZK['/4U*S!6(QDCCZ^G>H: %8Y/?\
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M\,I,^M7WA^]>WMM5O-*BFN_"VAZUH.D?8[:RN(U58M*U_4U*1C:QG$C LJD
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M:\OACXF76E6OB[PW?3QRR>'?$*'03]IL6FC4*R%)E#LB2!78$ _EP\$^//\
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M?PYW6]G+:6UO&0_F%5C!1E;)H \(^!?_  3)_P""<?[-/Q(\,R_"63Q3\/\
MXT_$3PO!)X?UR[^,7B^;XA^+=$ALYM4E?3KC6;N5;.]:WAN)Y8]/2VE=+.;Y
M#!%(H^DY;+]G>T\.:#XLUK]J/XL^&]"\4ZUKWA_PQ?:[^T-JMA%XBU#PWK<^
M@:JFCR+J;K?I'>P%G\MF:&*57N%A.\)R,_[,7CC4OB1\,/BCK/AK4;SQ+\*8
M?!X\/23_ !:T^[BGO_"%AX@T"QU&\+> @Z&;P_XIUN*\MX'AM;QVCEFA:>*.
M5=>Z_9,OM3\+:=X7U*U\47]CI=S\9;JTGE^(&B)>+-\<9Y;SQJ6DA\&*K8OK
MF\FLR%!MFO75"(PBJ >]?\,S^'[F)'3XO?M$O%*BRQ2V_P ;O%NR6.10R2))
M'/AXRI4@C(((Q2I^S'H2<CXN?M&'C'S_ !M\7N/R:<\UN6GB/XP:'IFEZ-9_
M!^PU2'3+"VL$NKGXF6D$TD5C"EI"\Q7PH1),\<*LQ  R<8IR^.?CEG'_  HG
M2 N"0W_"UK;L?[I\'],9H PE_9GT;>0/BO\ M&9Y+$_&OQ04 ]=HN21V[=ZD
M'[-&A@Y'Q:_:(.?[WQH\6?H/.K<'COXY9Q_PHO2<?]E6ML8^G_"'TT^.?CE@
M?\6*T@G(R!\5K88X.?\ F4/7% &./V:]$!4K\5_VA<@@Y_X7-XL(R#T*F;GG
MV]ZG?]GF$(8[3XT?M V*&3S/D^) OG!*%=GFZQHER^SOC=G(ZUK)XY^-S% _
MP.TJ->K$?%*U=P #Q_R*(SVK4LO&'Q6=2;WX16MK('.V.#X@6MV"HZ%F;PZG
MS9)XQ0!Q3_LYS.01\?OVC4Q_"GCW0@#]=W@TG]:;_P ,XS?]' ?M'_\ A?:#
M_P#,97H,WC3XE1+N7X3"7E1M7QO8JV&(!;YM#Y'-<_-\3?BM')*B? 75IEC=
MD61/&NCA9 IP'3=IF=I'(R <'D"@#GO^&<9O^C@/VC__  OM!_\ F,I#^SA,
M2/\ C(']I#CL/'V@X_'_ (HRMA_BG\6N/^,>];89YQXWT0$?A_9O--_X6I\6
M1R/V>]:R#W\<Z(/YZ=0!0C_9VEC!!^/?[1;G.07\>:(2,8('R^$!QD>AI?&/
MQ#^#?P4C^%'PX^,'C-]:UKQ?_P )7;> =1^(6GVFOZYXIU+P-H4WBW7VEU"S
MT2*U77(]"1I(56&WDN1:>7 DDJG.BOQ4^+9)#?L^:TN%)7_BM]$.Y@#A?^0;
MQGCGM7#_ !P_9A\(?M:>'_!UY\4[7Q-X-U+1?"/Q$TBQTK2-3M#J/AW4_B+I
MFD:<VN6FL0VNZ#Q#I4V@V5UI]S 8PDKG>KJ2M &UX+\>_LG^'=/\3Z_X9\<_
M"C18I=93XC^-KW6?&.D0:KHVN^-PT]OKGB<^)M6:Z\.7=VC-%;QSFW$<<0MK
M>-(XQ$NMXK\;?"_XFZ5H=IX5_:<TWP4VH^('TS2]9^&7CWX47.H>(=8AC'F^
M&K9O%>C:U;ZC<JK*S6]M +D$@YVU\D^%_P#@EM\)= \?>)/'E_\ $+XA^*9O
M$=GHNF2:-X@&@76E6UAH#:U+IMN(SHX:Y6*?6[ET,K/M\F,+C!S+>?\ !+/X
M&W7CKPKX[/B#Q,UUX6U+2M0@TFZL/#=_H\@TEO/C^RV5YH[KI5[)<!7DNK81
M7/R;1(%H ^7/^"EGAS6K'P;X?^$D/QW_ &C_ (OPW_C;X<:O\8O@[/;_  ^T
M>/QG\(M6\50:/<:+!\0]*^"=EHOA?4;O6'LPD&NZG;Z=J$5O-97BFVFD8/\
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M>#]:M6GT:1Y(]MJGCRUD,4LKAMRNC +C@$@@&#\4?C%\.O@UX%\._$CXA?\
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M5I^O^(7AR(6UO6;3P6ESJI3+;#/+(5W'&*ZH_!_X_#K^UKXP]O\ BU?P?_\
MF7XKH]0^.5QIQ42?!;XX7.Z2:(?8_"WAN<!H02S$GQDO[ML?*>_M60/VBW"
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M4:9X=\*P7Y9=#;7Q+!-=1G]V@$@&>*_1Y_V8O@#*1YOPO\-G:JHHV7X 500
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MXWXB^-_[8GBKX?\ [4&E:AI</@35M)O=#T[X;7_@W2#J'B32+*Y^*RZ!JO\
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MZ#:?'/X#:A-J_AW1_C7\)9-0T*QU<ZKIVD?$'P9)?^';+089#K-Q=V4>I/\
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M4J\KI$I?X7_$]%W2.J)EF\(81<GDD@#J>!0!B8_;,P!]H_9GP.@_L_XG<?\
ME1HV_MF=KC]F;\;#XG#]?[1KIKS]I;X+6$ZVUYXLO[:=Q.RQR^"O'JEEMI)(
MYV4CPP055H9.<X.W(R"#69_PU?\  /\ Z'FY_P#"*^('_P RM &9M_;,[7'[
M,V?>Q^)P'Y_VCS4D2_MCYE$TO[-3YAE$/EVOQ,CVW!4B%Y-]XVZ$-@LJE2PR
M R]:O_\ #5_P#_Z'BY_\(KQ__P#,K3A^U?\  0=/&]U_X1/C\_E_Q2M &JDO
M[2HAC$EI\#C/]G@69DO_ !VL+788?:9(XSIS&.W9<^6A9F4XW2..*MF?]H@
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M#4=<O&)VF86<#O;V<.1\]U<77DP1*,LTEPJ@$D4 ?E#>? S]I[P%\.O 6A^
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M"C;=OQ'&W*G'PA^)AR02#DCPQANG44__ (:L^$/<?$?_ ,-%\3!Z_P#4K\T
M?.WCC]DKXM?$GQ;>^-O'$WP!\0:YJ=OX<M-3ANA^T7!X8U2U\(W=]J/AFWU/
MP59_&>/1M1ALM1U*^N(5FL7 GN6E.7PPK']CWXHM'*LMQ\"9KBZ2^M]2U::[
M_:1F\1:WI^IZ9I6C7^BZ_P")9OC8]_K_ (>DTK0]*@&GWMQ<6:1V85(%W/N^
MD?\ AJSX1=Q\1_\ PT/Q,'_NKTO_  U9\(?[OQ(_\-%\3/\ YEJ /F+X/_LG
M?M+?"3Q%K_BN#XD? 3Q'K>J>(/%6LZ-]M\&_&.QT/PC9^+KW[;JFD^'_  O)
M\9+K3[(LXC1[JWM[:6:.%%D7*YKZ1_LO]L<<#QC^S6<<?\B'\2_I_P!%!]OT
MK4MOVH?A)=&0"?Q[:K%&9))[WX3_ !+@@C0'!9G/A<Y^@!/M5F?]I[X)V<C1
M7?B;Q!'*NT.H^&GQ0;!91(O*>#2#E'!X/>@#%32/VP@\;2^+OV;FCWJ9%3P-
M\2(W9-P,BQR-X^8(Q7H2K 'DJ>E;C6_[4<9<)>? 2\5C*RL]MX]T]H@(X_(A
M8"ZN?.S,LA:0&/ 90(V*DM5_X:I^!?\ T-6O_P#AL?BI_P#,52C]JGX%=_%/
MB#\/AC\4\_CGP70!ER/^V0-GE67[-# HGF>9K7Q,4B3'SJ@30&W)GH3@GJ0#
M3 _[9I_Y</V9!]==^)^?_4>K8_X:I^!/_0U>(?\ PV7Q3_\ F*I/^&J?@5G_
M )&KQ!C_ +)E\4\_^H5ZT 8Y?]LSH;#]F0_]QSXGD?\ J/4@/[98Y&G_ +,@
M_P"X[\4/Y?\ "/5O0_M2? ZYE2W@\3Z\9)&5$,GPW^)\*EF("AGF\&*J#+#+
M%@ .20,FK%U^TW\#K$S"]\;2VSV\D,,ZS>%?&B-%+<1&>"-PWAS*NT(+ 'M0
M!CVDO[7@9/MNF?LXNF6\S[+XB^),3%<Q[ IF\+L 0/-SG(R5P.#FU+J'[5\4
M4WD^#OV>KZ=9G%N)?B9\1=,BDM_,41F4I\*+LPS"(L3C>I8  @'(/^&L/V?!
M_P S\#[_ /",>-1G\/\ A&J/^&KOV?.WQ  ]1_PB_C8\_4^&J ,_^V/VP^<_
M#G]FLY]?C3\3N?K_ ,6'X_SZUJ^+_P!G_P $?&ZS\/:Q\>/ _AS7_%6G^!/$
M?A"32+34[WQ)X3\-2^,I-+E\0:IX0EUC1[1X?$:MHVFBRUH65KJ5LD!$!@WR
M;H3^U?\ L^ $_P#"P5X'?POXUZ^__%-_3\Z^>?VU(_#/B:W^$]_IOCK3O"VK
MZQ!JVBZK<ZC:^+PFI? [XCV%K9^.+W2QH6B7'E^*X%L])FTG[2L+P2O/M,?F
M/D VI?\ @G5^S9!87ML\GQ-M;.4VT$1/Q5\2PIH^APRR33^%M)DENL:=X7NI
MI2US:#Y)& ^9>0>PUG]A?]G;7H_AP;O0-;4?#&SO=.\+R6GB&X\TZ3J%S]MF
MTZ^N)8I'FM?M>V5'A:&8%0/.*?*?B-/B1XYO?$/QYM/$OCKP/XE^ /BKX?>*
MO!7P_P# 6N:[KEC8?V['<74'A*XMK3Q1X2+:9')H=S8/=[)&ACN=/810?=>G
MO\5OB)]K^ J:#\>/#7@?PGX/\%:/H_C#P;H/BZWE5/$&GW:1WLNLWUWX<=/$
M6DS:.ABA588VMW(:,!P)  ?7/@S_ ()Y_L\>!->\'>)O#8^(5EK?@/6?%'B/
MPW?/XZOY39ZYXLM4M+_41;M;B) D,<9CMXTCLY9(Q+>6UVY)/W#!;K!#;PM-
M)*8888O-N75[B80QI'YTS!1OE( +' RSYP.E?C)H'Q7^(UCX9\2Z-K'Q_.I'
M6M1\,ZO/<+\6'_X2>&UA^('B1_$7ASPCXA;PSGPRK^ )O#N)$4&26TDC5H)F
M:X/K6B_'72]!^)WPQUR/QSIGB;2M(_9^\1^"?$>N>,_BFNHFU\<7^I:1XAT6
M6\LK?PG&^IWQN-"^QZEJ<)@:XCO;61H'-F-P!I>)?V;/C)KOB'XWW^H> M"\
M4:=\:-1L9-4B\2_M0275MINGZ%K"ZIX?L_#VE7O[)%W_ &3HL30QXT>ZN=4T
MP!Y-\4\DDLTD]I^SI\3H)OA,;G]GSX2:G;_!?3[JR\#VU_\ M)ZD3;2W)G_T
M^?4K/]E"&^CD1KB8Q6UM=VVG1EOEL1A<</\ L]_M0^)OAUX<\;2?&_X@:+X^
MOM:\=>&7\%:=:^,VUB^T/2-9TK2X/%4=QJ-YIS20:'9:]'K=S;K)).[6TL,2
M^3D)']4?%;]HCX2^(_AQXTT'P-\:O"NC>+M4T.\L]"U,:C?6K6U[*%"[;J*S
M+VKO'YD8E7+1F4..10!\_7_[-/QOOO!7B7P&?AMX671_%U_ITGB":]_:@FU^
M^OO#VCG4?[)\&JWB/]C^[CL] M/[6OS:S0Q)JEO)*LR:CYL<;+[3\3M _:1^
M*GP[UWX9:[\%_A7IV@>(++3;"[OM&_:=\1C6HK?3-0L-1@$%SK7[,%[#(SRZ
M="DIG@G$D<D@8;FW#\Z_&&OZA<:=\.S\$/%NA?"&[\!^,7^)]Y9^*?C5XJ\1
M+XJ\4>']#2QM/"2V]C-'%%X<UJ^GN)+S[7]LM7-LMQ<V$DDC*/UYB_:-^"AA
MTI[WXD^#["[U:UCG2R_MJ*X,=P;.>ZN;-+B.,+-+&+2[7&%9A;-A!TH ^$=%
M_9#^*'A>UDTSPE\)_"?ASP]J&IR7_B;P[:_M6ZQJFG^*+%/&]]\0=,\/7USX
M@_9.N[O1] L/$FHW!LH=*N; PVHCLR[6T<<:]LOP4_:.L? NJ^"=.^'WAFV?
M4_B OQ(L_$MA^TAI:^)-$\527LEZ^H6JR_L>QV%W9"60EX[^SOV<  [NM9_[
M1/CC3/&_Q>^"GB+X6?M#>#]"TCPUJ-K+XPFNOB-I]CX<TK1[;57O=6DMM(L=
M?MWU+Q/?V3+8,EW;W-JML P6&:/<W-W_ ,5O"VI_#?\ :#\'3>(OL;ZYXOU3
M4_AU=O\ '?0]5U>Z34"[V>IZ=?2>+XI].L+>]\N3[$]U'&L>%C4A=A .NE^#
MGQ_'Q!TSXG:C\-)==\2:9XB\'^(C#%^T-X+CTS4+_P %Z#X@\.V:ZHO_  S5
M9SFQN;7Q#J$UPD,\;>=*OD&UC5HFJ?'SX,?&?]HO4=(OO'WP.O=/C\/>%O%&
M@>&].\*_M.:%H]AH&L^)[O0;Q/B)8";X)SS3>.]-D\.VBZ7+<RSZ?;K<W!DT
M^9Y=R\?I_C^ZLOBO\'/%5W\:O"^MP67PT\,>%?'\6I?%;07\(^'[^Q\.:K8:
M_P"(]"$&OI<7_C6YO9K3S//MI;:9P&,B[-U>K_LG_%_PQX,\'>(_#_Q/^,'@
MJ06OB"SE\.:[XI^(>B:AXW\31#P_I=MK6K^*FA\27MM'*VL6TRVYMY(EEB7S
M)((W/(!YSXB_9N^(/BH_$N76OV=([JZ^*-QX1OM9N?\ AIG1U71=3\(ZA9:T
M-2\+:>OP6%KI%SJ?B&S?4=84P2Q7][>S3/&F8UBQK/\ 99^)6GMIYLO@?+8P
MZ=#H$"6>G?'OX9Z=8S)X>O\ 4-2B:6WL?V<8PCW-SJ=U]K,90N"#&8GRY_0C
M_AHGX!G)_P"%S?#88Z8\9:&!GZ&[Y[_E2?\ #1?P$'_-9?AK_P"%CHA_E>4
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M@$G&<]CTJ-EVC.<\XZ?_ %Z-O .2<]@,_P!: &MU/U/\Z#T'!^IZ?AQ1C).
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MXNT[1=(FL+&Z6U^(7CG5K^;4-4NXM/TG3+'3H];ED>_N;V>&&"-%#.\BJ.M
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M>:/I&K:7I^OZ/XOU2T-N'L_"-WH.K:3>6UZX$4T-\I0EMP !ZKI/Q&_:1N_
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M-8\-_&CQAH^O7>M^'=0@U/0]5NKR7]F*XCU"XM[VWAD5;R&ZB.PJ\;*2#]U
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M23L=HSB@#[(I0"<X[#/_ -:OFD? ?QT6VC]I;XRYQG[_ (5_^45'_"A_'/\
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M%[=?^9IH ^E1@D]<>I'MGUJ5=NT_/@G. 1ST^M?,O_"K/C]_T<PW_AIM%_\
MFIJ2/X7?'M2X?]I-I-R,JY^%&BKL8]'!_P"$H.2/0T ?280,,AOT_+O7Q]^T
MI^T;XA^"_P 0O@=\/_#F@:5JUQ\6Y?&'VK4-4MM5O%TB+PQJOP_TN(+;:3=P
MM%',_C8L]Q*S10BR&5._CV;POX4^*^E:[IEYXE^+6G^)] M;6]BU#1(OA[::
M'=ZI=30M%8W0U>'Q%.;189"KLBPMYI7!90<CRS]HV\_9/B\0?#.U_:.OO!]M
MXFGN-8'PQA\0:MJ&F:M,\E_X=AUP:.=+OH)9[5M0;PTLX;=$9/L^X;L4 >5Z
M%_P4-^&6KZM?6%_X#^)'A_3;'0]:U]?$VK:3;6^A:A8Z5ITFJ6TEG.UWG%[9
MV]P]MOQP@W'YA63\(?\ @HCX"^.VL>$(_AOX>U*]T?Q%J&IZ9>Q7T;V^N:9>
M:1$7GCBC$ODW>Z0QA<8&ULDU]6-\&O@1J%C+I9\%>"KZPN-*.ES66R&>%](3
M3CIAM9(OM!Q;+IK^4<XVJW.#\U<IX;^$'[+/P]N]*\,>&/"GPZ\+7TPE_L;3
M--N([.\E%Q&#.]B4O=[NT2#+*Q;"]>* +?CK]H.P^'GQ2\+> =>\+:_<:-XL
MT*PU./Q5I-LMY9^';S4/%&@^%H(?$X\]?[.LWOO$-D$F4/RC\<5Y#HG[??P>
M\<Z%XCO/AQI_C3Q7KUE>-IOAKP];>&KR.Y\837.B>+]9TW4](DF>-)]#:U\"
M^(Y)I0X:*.T4E?WB5TGQS^$UEK7C'0O$^H_$[X?^"8-4;PMX+\-6?BKP9+K5
MW?:O%KUGJ.@Z99ZBWC>Q2]N)->M-+>W@^SLS36R L^[;7D$_[*6DZ=9)HDWQ
M@^$^G6/CKQ8]QI]I;?#BXT\7_BK3]+\0W4EKX>GM/B@ATV2/2KGQ,9+2R:&)
MK>6Z1XS'D* >@^$_V[/AEKFE>%K:]T;Q/%XZU_X5V7Q,F\,:=IOVJS@6Y\#V
MOCMM"@UB6<)/>_V7>0JNT-^\;:V,$UZ3>?M2>$=,TGX8W^K^!?BK9:C\6'NK
M?PQX;C\'M=ZX+RSLXKZXM=0M8+W%J?LDHE1F;:Z*6XZ5X'I?[&&L>&=<L-:\
M.ZW\&+'4]*\.Q>&M-N;GX=:_<2V7AZ'1HO#J6EM:77C>2*UM_P"Q;:*VWHN[
MRTVF0G)-NU_9,\=6LGA"6V\<_"X2>!M9O=9\(RGPMXSFDT?5]179>36TDOQ
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M4U'Q&-VL:C\$[H'[4KNOPZ\0P-.FH7EYJ-Y;R20>,U,D,U]J%Y+(F1O:8D\
M"NBE_9$\>O$L*^+OA2462\E6,^"?%ZQJVI2027[%4\<\"1K6 D'@>4  !D$
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MA&Y^$MMX5\5^'H?&.C7^L:?/:>)DAO[OQ)-<6G@.QURV%^ZVKPQM;2PV%I;
M-<%P#[!/QL^(^?\ DTSX_''!;^VOV=A^6/CMTX'&:/\ A=WQ$/W?V3/V@#]=
M:_9W'TZ?'?ZUZ5\/]6G'@CPFOB?Q#;ZAXB&@Z:-:O+]],TR^N=16V074UYI]
MK=O':W!D#;E5V .>2378?VKI7_05TS_P86?_ ,>H \$_X79\2/\ HTOX_?\
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MGKNS\W3'MU_"D._)QTSQTZ4 ,*D=<4W ]!3R'(.>@Y[?3M]:90 4NTXW=O\
M(I*7)QC/'I0 8)'J!^F?2E! & #G.<^A!.,9[9I-IQGMZY'^-!X/_P"K^AH
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MVHR>)[&(8Z\B+5P#V[=ZRC\!/V.O^@3\-_\ PJ[4'_T\UZ ?V>OV>>WPY\!
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MTI!8=CC(R:^@=AZD@?4CV_Q%+\W]Y?T_PH \;_X5!*Q(_P"%H?%<$=_^$RU
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M^/\  4'[VX$ 'H20/;G- %6QLYK.QL[2:[GOYK6VA@EOKK;]HO)(HU1[F?8
M#*Y!9L<9;BK)4@@<<T!F(SD?IGCKQ2$DG)/(H =L/J/U_P *-A]1^O\ A0"Y
M!(/ ^E*I8D8Z9&>@],T -*E<9QS05*]<<_Y]*D9"V,%>,YR1_C4>UO3]1_C0
M NP^H_7_  II!!QW_P :7>WK^@_PI"".3WYS_P#JH =L/J/U_P *-A]1^O\
MA2JYS\QXQZ=_P%*7&#@\]N#0 W8?4?K_ (4;#ZC]?\*7]X?\BC]Y_G;0 FP^
MH_7_  JQ#]P?4U!^\_SMJQ$"$ /J: )**** "JQ('4U9JBYRQP?E_A_7/]*
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MK.\^RSRQ?:8V<H_ER.F]&VNRX8@&B-O*C R>0>.3]:<$P"!C!_VA_C4 Z?\
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M\1/ GQ M(;WP1XLT'Q5:7%LU[#=:%J5OJ,+VJ3_9GG22!B/+%Q\A.?O8'<4
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M_P @&S_^(IW_  H'X)G_ )I9X(_\$-E_\;KU\*2>00/H?\*"I!.,D=N/;V%
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MTOQ/J6A:9JMWI%KXEDTB&\6RTG7+G3Y(YYM(%U<QW+112QEIK&%BV$P?7PY
MP /O,>Y/S'/\Z^7OVPOAQXW^*GP)\4^#_A[INFZEXKN@ESI46H>(_$GA2:"[
M@CE6"ZTS6?#&HVL]MJ"O(0N^98<.Q8$@ @'S1<_\$H/V<IGN5M]>^*MOI\U[
M93V^F'QCJ%W;:?:64,EE%I%C)=,TD6G?V?*T 4NS(ARK U[!\._V!_@=\,I-
M6BT*?XBQZ/JDS7,6B6GQ/^(.@6FG74D.GP2R6I\.>*+0M&T>FPGRW#*&D9^2
M$V_G?XG^"G_!370]=\-6G@#3/#>G>$-'N+BWL-!TKXF:TFBRRV^F6\UAJOB]
M]3D:\U6,7R.BN)I9&)821%&S7UC^R;JO_!27^S=23]I/P_X)OM0?6]<.C_;M
M1T;2D33DCLL+?2>$=)G+V_VYISI139(UIYHOU$HAP >V>,/@YH_@#5-/D\ _
M!/XM?%7[;8W2WNH6O[1>NV$>BF.>$I9M;?$#XP63N\V]GWV\<@ M]LCJ2H/F
M-S\.==NYWGF_9*_: C>3&5M_VM[*VC 50@VP0_M"*J< 9P.2<]Z[S5OC=\9=
M+U/4--NO%?[&^F7%A>SVLVG:M\6-8M=3L7@E91;:C;2R1M!>(NT2*40AP1M4
M#%2V/QC^.VK*9=-\1_L=:D$8QR-8_$_7KM$<*I*,UM(P# ,AP<'!![T >=0?
M"_4I)XXY_P!E3]H:WA9@)9A^UW#*8DSR_EI^T/EL>@!K;U+X6:7I_D"']F7]
MJ/5S*C,[:3^TW;.ENRD#9,;_ /:9MSDDG&T,"%.2._9GXJ_M"*2&U;]D16!
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MWQ%_\XJM^U\8P66FG3[3Q'_P4&4^7.L=[=? C6KR]CDGE$@F$MQ\"BK.@W!
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M\;U?L/CA=ZDTRQ?MO> +86\<<LLNI_L[:OH]LJRS1VT0^TZI\088V=IYHE5
MVYBXPIKZ./[2LA_YH'^T3^'@WPD/_=_I]O\ M*I<7D%I)\"_VA+!90[-=W'@
MKPZUI!&A16DF>U\;2N,%QA41W;!(4X. #YJD^/MA$[QR_P#!0?X&121NT<D<
MGPITU'21"5='5OBP"K!@001D$8[4S_AH'3/^DA?P)_\ #5Z7_P#/9KZ;OOVF
MO#VG7,UI<?#3XZ/+!(T3&U^&.I7<6Y#@E)X+UDE7.<,K$'CG'6G_ ,-4>&/^
MB8_'W_PU&L?_ "50!X#;_M(:3:PA3^WC^SMJ$Y!!EO/ABB(,;BKB*S^,2D'E
M-V6((7@#-5A^TPO(_P"&Z_V6CS_T2B^..IP<?'+TKZ(;]JCPPP'_ !;'X^#'
M]WX3ZP#T[_Z32#]JCPR/^:9?'P^Q^$^L9_$FZH ^>?\ AIE%Y/[=?[+&!US\
M*+[CUX_X7G733?&O6H+>&ZN?VY?V2;&VN(TFAFOO %O8K)$XRC@7/Q_0A3GO
MC[I]*]A'[5/AC.?^%8?'SGU^%&L8'_DU6[:_M!^#]4MIKJY\%?%>SCA)5HM3
M^%?B1YB@ 8O%!#:S%TYZ#+>B]Z /G ?M!#O_ ,% OV,/_"6TC'_K1%!_:"'_
M $D"_8Q'T\*Z0?\ WXBO='_:5^$\+A9/"GQ4!YSM^ WQ*=3SCAH_"A_G^=,_
MX:;^$N<CPK\5U/J/@'\3?Z^$C0!XVG[1UI#;K&/VX?V,-0N!;WA-W-;Z=IJ-
M=,\7V &TC^-5P$ME7S1*WFEF^4A1R*R'_:3U+?A/VV?V%PIQC=,AQTSEA\7<
M?K7OG_#3GPEQSX5^*YZ=?@'\3B>,D=/"?N?SI?\ AIWX3?\ 0J_%?&,8_P"%
M!_$[&.G_ $*5 'F7P]^.VJ>)/&OAO0Y/VL_V/?&4>I:G!;2>%O!$BOXLUQ&;
MYK#057XG7>=0<<)_H\W/\!K[I9<'@''OSCKUKYFA_:@^#,4@:ZTSXCZ0R_/"
M]]\!_BVAD8'_ )8O9>!YL..O)7\:^BM+U>RUS2]/UC3FN&T_5+."^M'N["]T
MVY:WN$#Q-/8:E!#<6<OEL-T4T22(<AU4@X +N">@)_"G!1_$<'L,@?H:0%@"
M /7)P>/\*3G.>3CZD<<T *RA<>__ -:FTXDMVZ>F>])@GL3^M !@GH":,'T/
MY&I&!CQ@'GKN'IZ?G2;G_N_H: &8/H?RI,9Z9-/+,0<C ^A%-!(.10 XJ,=R
MV <=QT["@J ,YYP.,CO[4[. 6!&2!D=NPI" 1D'YB!P"/QXH 3:N.O.,XR.N
M/2K$((09&.3UJL-P.0#^1JW&24&1@Y/MW]Z 'T444 %46).,C'X$?SJ]5.3M
M^/\ 2@".ER?4_F:51N.,XXS2$8)'H<4  )Y(S[TA)+8R2-JD$GN<Y%*#C/N,
M?RIH& !Z "@!V?4DCT!-&<CC./0YI** "G9Z'+;AT/;K3:* %)/<GCZG\J3<
M6Y))^N?ZTA'.<G\^#^%+0 #J/Z=?PIQ/H3CKSUS3"<8X)SZ=OK7/^+?%OAKP
M)X;U?Q?XPUK3_#OAG0;;[9K&M:I<):V%A;>9'")KB>0@(OFRQKR>2X% '19/
MJ?SI&<@#+$<C'UY/&1]:XF?XD> [6\T+3[OQ=X?M;[Q/97&I>'K.;5+-+C5M
M-M;%-2GU"UB:4%K-;"1)3(0%"-G-3Z5XZ\&^(M+36-%\4Z#J&DN9'CU*VU.S
MDM&6WU"?3)6\X3;0@U"UN(=V<&2)E!)&* ,Z^^%'PRU.\NM0U#P#X3O;Z^N)
M+J\N[G1+&6XNKF5BTL\\KQ$R2LQ)+$Y)-)!\)?AA;C$'@#PI N<D0Z+91@G
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M_P"?SH#9!(Z!BI^H&"/R_G0!\S#]C_\ 9_\ ^A*?_P '6L#]/ME'_#('[/\
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M_IVKZ0P3D#.>G0]#]X<&G$8XQC H ^;?^&7? V3CQI\;?_#S>/<_C_Q-J/\
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MG'QAK?FEP\>E^./ JFW"!65ISJ=_;#:Q8A=A8YC.0."<;_A='QFVA1^RE\2
M!G_F>_A@ !G/!/B3Z4 >7%-3N<7"?'O]LBT24"06S_ 296A#?-L=9/@)N5AG
M!!YXYIAM]3568_M#?MC$*"QQ\!I2< 9/RCX!DDX!Z9/I7JG_  NCXS;2O_#*
M7Q)P3@_\5Y\,,^F?^1DZ4?\ "YOC,1S^RI\2"1P/^*Y^%A..GWCXBR#C^= '
MSL?'.DJ3G]I#]M0<MD#]FK7L%L\G/_#.?/-*/'>CY_Y.0_;5/M_PS9K_ /\
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MI].:LWO[1*Z?#%+<_!CX^EI"ZF&W\%Z)>2Q/&5#K*+3QA(O\7!5F5L$JQ H
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MY5)5;C]F/XEV\P )!WPS?"D,AR. 0..>A%2_\+<_9!!P?#%J3U&?V:OB*I_
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M3/'';^'5".ZJH<C!8* <@ 4 >M?\)3^U5C/_  J'X(?^'R\48_/_ (4]2?\
M"5_M5=3\(?@>/K\<_%.#_P"8?Z=:\U_X3/\ X)_8QC]G;'I_PB7AS'_ICK,O
M-:_X)UZA+YUY9_LY3R"-8O,?PGH&[RU<2*N!HN.)%4_44 >\>'/$G[1MUKFF
MVWBCX8?"32?#TURB:KJ.B?%[Q!K>K6=J>))K'2;SX8V:7TX'2-[F$'^^*]VP
M,'GGL,'FOC/X9:+^PGJ?CS2KGX4Z!\#F^(D$\VIZ+<>&/#FD6FOP7%LAEFN[
M&>&P1H94C!8LK @=*^S_ "_]K]/\: (Z4' (P/J1S3RF 3GH,]/_ *](J[AG
M..<=/_KT ,HJ3R_?]/\ Z]-5=V><8H ;2D\ >F?YYI_E^_Z?_7H\OW_3_P"O
M0 >9[?K_ /6I"^01CK[_ /UJ"A R,GZ#_P"O2!<G'3C/2@!M2!\ <=O6CR_?
M]/\ Z].5=N><T 1$Y.:M0_<'U-,J9,[1D8//&<]Z '4444 %4Y.WX_TJY5;*
M[BI(#+W.<'/I^5 $%2;\ #'/3KU_^OUIV5;C!/?@@?CS2%0V,@@*=PRRCIP
M2?8T /'(!R0>#D8/;FC]?<]3]::PW=&7KGEE]_>ER !R#T'#*?ZT 1'ACG/4
M].O>ERH(;#%@, D]B<]N^:3&6..Y/^>*0J1G@G'I_P#7H ?YGM^O_P!:G@Y&
M>F<_YZ4P<Q]@?0E0>OIFF8((((!R.05R/UH GI"N=IST.<8^G_UZ/E(P" 2.
M?F7DXP3C/!J,*>,COSR.GYT *6!Z[AVP#V]Z^3OVQ?'O@?X9_"8>,_'O@+1/
MB+I&EZ[IL8\/ZOXITKPM<&34KJVTI+K2IM5A=+^[2YOK4/"H#")GER!&0?J_
MAN@VG/=ASZ=Z\L^,7A7X2^,?!-WH/QHL?"M]X,OKNQ26/Q6UE'9B^MKNWU*S
M6WGO!^YNO/T^-L1D.RQ,O*[A0!^6U[\=/^"9NEZC<^&]:T?P%9^-]&N-'B\9
M:!#K<=W8>&WU.4KJ;1^(U9+?6?[/R#<K H.#\F>M6;;X^?\ !*34=/TZ]TFY
M\%WSZG_:*VUL8[RS:UDL9=/MHO[9EN+@)I-O<W&KZ1';RR_*YU&,G $A3ZZU
M']@#]C/QGK6J^.+CX->$-7NO%K6VH7EU;01'3+TJN3=6T$ \N,3J!YI3B0 9
MQ7F,7_!+/]BK3_%_AK76^'=E%::38:CINF^$99RNG:UJ5U>:/JGV[4@SAM8F
MMK7PY:)!"ZE(XX-V/E)(!Y3\/?VDO^"8VIZ#X,UO3-2\,^$[GQS;PSWFDW<E
MY:7?A:X2TTFZCB\6,MP%TR%I];TV"UG;Y+B6Z7R\*'*=KIO[2'_!-/Q(WA_2
M8/B1X0MKOQCJ%WHVDV5UJNJZ=?&YMG^4W7F2 Z9!.2AMI9603"1=IYKT_P 5
M_P#!-[]B;5+S2=>\0?";P_9-H\<5L9!?'2["_A@\->'_  SIMMK4>5CU"&UL
M_"VD3VRR?ZN\A>XY:1P;U]_P3?\ V-[[Q%HOC"?X1:/'JV@3VM];W,<@BMKG
M^S]+L-.T]=2C\O9=V]O%I]M-$#@+/NE);<10!QWA31/V)_'GB;Q9H^EZI8P0
M>%ET=;S6;_XFOI>GWM]J]G]M%AI\-QKR/)+!",3G;A7^7WKT7_A2O[&W&?%?
MA<X_ZJ^I_0^(JS4_90\/^!]=\0^)/A%X&^$WBW2O'!L+_5M+^(=O(WV35-)T
MX:?#J&BZKI5E*+A+H#=<*ZHH9=R9- ^$?Q/)P/V=_P!E?_P,UK_Y24 ;UK\"
M?V1I6BN[/7]#E\J57CG@^*LDJ1RPLCJ=\>OD;@RH?;()J+X<1?LW_$7PO'XA
MT[Q%=Z+Y6J:[H.HZ-K7Q*FM-1TK6_#6LWNA:S87,?]ND,(]2L+D)(I*2H%D3
MY6%=5X'^ GA+5HK\_%?X-_!S2-?25#IMGX)DOKNWDTD1@?:KR*ZB@:.4W9=
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M)#\:?CQ<@A5/G_%;Q/>1J0P8822_8(QP,^H.#Q7SK_PI^#_HR?4O_#Y:)_\
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MOR?$G[3?Q"BT@:!X831/!/BV:^U5;>#3ULAK]S90:?O>"**R7S6#'!N@.2U
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M8#C(9E)PV1 ?%^H<@?&/]KH+DE0WP8U-R 3P-QL.>,4 ?6W_  K_ .*N,_\
M"6_#S'_9.;#Z?\]*R+WX>?'-I(3IOC/X31PBX!G6]^&*2R-:_(&6)H+Q L^1
M-AB"O*_+US\P?\)AJ6,?\+D_:Y_\,OJ?\OL-"^+M2+!1\9?VN025&3\&-2"@
M,< DFQX' SZ4 ?0S?#G]I3>VWQW\#A'G*@_">Y+;<\ G^U^3C&>@H/PY_:4
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M&D2^5XJ\;VY*( !N$'B51(_'+-EB>2:K-^QS^SB#Q\/9.!SGQEX__P#FJ]*
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M2BG;N ( *H^*?QYZ']EKQ9VZ_%7X/<8Y[>.13O\ A:?QW_Z-;\5_^'5^#_\
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M &XJQ + 9)XJJ/CSX[!S_P ,N?'W/_=-C^A^(U6/^&6?AMC'_"3_ !_[\_\
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M5,VIEF:*5I07C@>']Z0#Y\^(EG_P51T?XI_$'Q?X(^'GAW5_#&J>.9M1\/\
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M?]G;XK3(X,:.)$'_  B;;?OE2#A@RL"!4?\ PT1X1_Z(_P#M _\ B-WQ5_\
MF0IG_#-.K<Y_:4_:9^@\7^##T^OPZYJ:T_9QU>"9)U_:0_:3E*;@([GQ5X*F
MA;(QEHI/AQAASW';I0!&?VB/"(_YH]^T$<_]6W?%7^OA"L^Z_:<\"6=S9V=Q
M\(?VB%GOWV6JQ_LQ_%^=&;<JGS9H/!3);KEAS(RCWKH9_@)XPEN))H/VI?VC
M;&.58A]EMO\ A1\]NAB4H6C;4/@E/(-P(+9D()Y !S47_"@?&_\ T=C^TGW'
M^I^ /?/)_P"+#=>1^7% &'=?M/\ P\T^>&WU#X7?M!6<DP1@3^S'\8YXUB9G
M432RVO@5U1 ZD')!''%6YOVC_A#. )_!?Q<D^5T_>_LV?&.0>7)PZD2?#X_*
M1P1T/0YK2_X4#XWX_P",L/VD^O\ SQ^ /Y_\D%_SFC_A0?CD]?VK_P!I(#MB
M'X _KCX""@#F?^%Z? @9)^&GQ% QQC]EWXL9Z]3_ ,6[X]_>@?'3X#G_ )IK
M\1__ !%WXL#TZY^'7!YKK+?X$>.+>:.4?M4_M%7.QLF&[M_@&T#X(&)%3X$J
M6'T8?6F77P7^++3R/8_M9_&FRMY'W+;2>#OV>[[RLA5V+//\%PS1_*N <G)/
M)S@ '+_\+T^! Z?#3XB'_>_9>^*^/T^'5(?CK\"55F/PU^(@"JS$K^R]\6!A
M0,]/^%=\C KI/^%+?&3_ *.]^,O_ (07[.O_ ,Y:C_A2_P 9!U_:\^,Q^G@+
M]G7_ .<MTH YNX^//[/MD6-_X,\5Z?&L,4XN;_\ 9Z^(EE:,LI552.ZN? BI
M)-N9<QABZG.X#%8=S\=OV3[TDWOA+[86<RL;KX!>+;@F4KL,A,O@8YDV\9ZX
MXKT#_A2_QC/_ #=W\9A]? ?[.A'OG_BRWM1_PI;XR?\ 1WOQD[_\R'^SIV]_
M^%+T >9_\+F_9 _Z$:T_\1Z\3_\ S!_3\ZT-*^/O[*NA7L>I:)X9GT;48598
MM0TKX#^,-.O8E? D6.[L_ Z.@8  A6&<5ZC8?"OXL6$,T<_[3GQ'U>20N8KG
M5?!'P51X&95551='^&MFCQJZ[L,"Q9V!<@*%Q)_A1\?GN/,A_:M\1PVS.I6!
MOA3\*IFV J7C,W]@+NS@\[01F@#M=%^/'PJU^/PG)I?B>.8>-]6NM#\-12Z=
MJMK/?ZM98^UV+0W-BCVD\98;EF6/!X/2O8S&3TVC''WO3ZBH+1+F*TM8I[M[
MVXBMH(;F\DBC@>[GCC5);EX((U2)I) S%44*N_"@ "ICE1\Q0X'?KB@!?+P#
MG!/;##\._K3-C>GZC_&@-N!(52!U.,?S-+GC.$'L1@GZ4 )M;T_4?XT;&[C]
M1_C2@Y[(,>HQ^5!/ )="/?'7\J %=0 .GIP0?SP:;L;T_4?XTF2W0#VVCL?7
M]:<21U*GG&#U'7_"@!50D\@8QW(']:=L7.,#\_ZYI >?F*D>F13BK'ILVGH"
M1B@"-D.3@<?4'^M)L;T_4?XTY@5ZJGN1@]_K2X; .U.>W?\ *@!JH=P!''KD
M8_G5M %4 >_?/>JIXZ^7QSC\*L1$% < =1Q]?_KT 24444 %0!B,X/7\:GJJ
MS;<=_P <>GM0 \''8'Z\T X).!]".*B\SV_7_P"M1YGM^O\ ]:@"0[3G=@#D
MCMSV%,1CDC(QC'0=L>U,+;AC&.<]?KCM2 XS],4 6\+C=A2V._Z\9^M-+>R_
M@!4/F>WZ_P#UJ0R@<D?K_P#6H ER3_G@?0"DP,Y(!QZ]/YTP2 \@?K_]:@OD
M$8[8Z_\ UJ )0?0+CM@ _P Z 0/NA1SV (J$/@ 8Z>__ -:A6VC&,\YZ_P#U
MJ )CAC]U2>G3_P"O7#^.?AA\._B7;:;9_$/P/X7\:6FCWAU#2K?Q-HUCK,6G
M7K*B-=V<=[$XMYRJ("RX)"@$\"NS\SV_7_ZU>"_&Z_?3D\-W(3XX3[CJ</D_
M!JRO+]CO2V(EU]+.-M@7!^SENYD S0!I:C^SM\!]8N-)NM3^#OPVO[C0+>>T
MT6:[\'Z'+)I=I=2K<7%O8L]G^XB>9%9@N 6&>HK(C_95_9N75[W7D^"/PPCU
MG4(+RVO=1'@[11=7-OJ$-[;W\,LRVF62:#4KU)!G#K<L&R*^7FGU%B6_M;]O
MI<LQ"C0=4 4$DA1FUY S^E7YHQ:VC7=[XY_;CM0D8D>"31M8:X"LRJ/W:61R
M=S'(_P!D^E 'K?QG_8?_ &:_CK\/].^&OBSX;:%IWA_1M0U34-'D\+V5OX?U
M+2SXAU<ZQXHMK&_TZ))+:UU2^=I+U%8"60K*?WB(R];I/[(W[,NC2:S)I_P,
M^&=O/XAMKJRURZ_X1/1WN-9MKV:RN;Z+4)GMBURD]UIUG+*&R'E@WMELD_+W
M]NZ0,'_A8'[=/X>'-?'_ +8=?\:U(O&ME:V LK;QG^V<6$DD@O;_ ,":Q?W9
M,D<BA#)+:KF-6964=O+ Z4 ?4/B[]F#X >._!OA_X?>*/A1X,U3P=X5N+2X\
M.Z#+HMFECH\EB6^RBPCCB'V>-5=UVK@%6*D8-<QK?[&'[+6O^'AX7U/X%_#:
M;P_%-?S1::GAK3X(HI=6L;;3+^2 P0J8R]G96B'!&/LJ$8*@U\T?\)+J)R1\
M5/VS<<8'_"K;W]/W/-;$%_?2V\5S+\;OVK+)9IH[>.*_\!3V\[2RG" Q-;D@
M$]SQ0!]-7G[*_P"S]J7PS'P@O_A5X3O/AX&MG70+G3()HUFL=<B\1V=PERZ&
M5+B'6H(+B)PX9'A4J1@"O/=4_P""?O[&FN2)<:O^SM\,]3NTTV;2_MEYX=LY
M[MX)KG[8TTES)&7DO5N0SI.Q,L9=MKC<:\'/CG2U)!_:#_:CR&*D#P#><%3@
M\"S]0:T-/^).D6#,Q^.W[2UZ"\;[+WX=7DR@1L"44&T&%;&&'<&@#W2]_8._
M9!U#2=%T*Z_9\^&K:7X=NIKS1;2/PY80IIUQ<W"W5U);&.(%3+.-TG.')(;.
M372:!^QW^S)X6T;Q-X?\/_!/P!IND>,'E?Q#:6^@6*K?>;#<0>7O,6Z&)8KN
MY"*A"H+A]H&XU\W:C\6ENF!L/CM\>=,^=VPOP::[^1VRD>9XA@*.,]3U-9G_
M  L_4!P?VB_CV3_V0V'OTZ)0!]=^%OV7_@!X)L4TSPQ\)/ NF6D5HEG;6HT&
MREM(4CO-2U"-A \>%<WNJW;.RX=U**6Q&F.6G^'O[1L\;VSZ_P#LVR6CJL9M
MY/A)XJ=#%$Q,2,O_  G6"%'3C (X %>%OXQO85B>Y_:F^*]IY_E^2+GX2V<;
M.[V<E\T:CRC^\2WAD,@_A*%3SQ6)_P +7TPXQ^V#\20#T!^%%MU['FV_SB@#
MZ"A^$WQS60&:\_9CDB (*)\(/$L;$Y&#G_A.#QC/YU8U/X=_&Y)472-"_9AF
M@"_O)+_X?^*TD9L* 56'Q>!@G=].*\&T_P",VEZ>+@G]K+QU?23(J1-?_"*V
MN([<AB2Z1" !F(.#D]J:?C>^21^UOXA R2/^+#Z:2!Z9V=<8H ]I'P]_:%[>
M'/V4_P / 'C'^GC&H7^''[0$VSS?#7[*3^6Z2Q[O /C+Y)4SL=<^,!AADX(Y
M&:\A@^-<T\T4"_M=ZXCSRI$AE^!.F(F^1@B[G*?*,D9)X%6!\9K1@/,_;;6W
M<%E>&?X.:1'-%)&Q5XY8VARCAE((]J .Y?X)?&!W9W\ ?L@N\C,[LWPX\7$N
MS'+%B?%_)+9R>_4UH6/P3^(T4=R=3^&G[*EW)Y8^R1Z=X&\16*B0'D3R77B&
M?*8Z;0N.O->:2_&6V:)UA_;CM4F*XC=_@YI#JK9')3R>>,_G5N^^/*>7:QZ;
M^V)X8C:*%4N;B^^$-M+)=2A</-M2'$9+8.!P .* .IE^$GQ<6201?!#]E)X@
MQV,VDZTC%>Q*B<X/XTS_ (5+\8/^B'?LH?\ @KUK_P"/5Q7_  O;4P!_QF7X
M*QT'_%FX#^'^I^M:%K\8=>OOL_E?MD^!L7(NC 9/A#:1!_L2AKCEXQ@JAW8/
M4 D9Q0!O7/P<^+5[";>[^!7[)UQ 2&\J32M;9,KG;\IGQU9O^^JQ3^SWX]YQ
M^SI^R!GKSH>L?_'N35/_ (75?8Y_;:^&PY(_Y);I_4<$?=]:FA^-]TDBM-^V
MM\-9T (:/_A6-C%N.#M.Y$R,$@_A0!T&F_L^ZXENYU?]FO\ 9:N+HR_NO[,T
M^ZM(%@$3G,@O+:8O(9@HX*@!LD'&#D?\*0\8?]&@?LN?^#H?U\,52O/C]KAN
M7.G?M;?!868""+[7X'OS<-MC0.TODV^W)E#$ < '%5C\?O%(Y/[6WP,_\(74
M_P#Y&H UO^%(>,/^C0/V7/\ P=K_ /,Q39/@=XOE0QO^R!^RXR'.5.MC:=PP
MW \,]UX_&H(/C9XTN86N8?VL/@6T2,J-*_@R\A0,X)5?WT2Y8@&I/^%T>-3U
M_:S^ I(Z?\4G,,?ACF@"HO[/6O*5(_8T_967##E=8&5&1R/^*9Z]:WOCQ_P3
M9_9D_:7^)ND?&#XJ^$]1G\::=X(L/!&S2-?O].TW^S+&T\0VMI$;>TE19O)A
M\4:K$. LJQP>:K&"/;!IWQC\;SZCIL"_M4? C4#-J5A$UA'X6GBDOHI+N%9;
M2"5!F.XDC+HC#H[J>QKT3XP?%GQ?X3\>:AHVE?&'X(>$;"&PTN>+0/'5KKC^
M(K.2XMR\TT\NG1&-[68A7BYW 9!XH ^>==_X(_\ [&/B+Q/K/BG4O"_BI[W4
M;G4KG2K6'QGK\&F^$3K$XN]4C\)6,=X(]#CFO9+Z5A"JD'4IE7"-M&'X;_X(
MQ?L8^&;36;;3]*\<^=KMU:W5_?3>-=::\+6,GF6"13+=#RDARVS&#\Y)R>:]
M6/Q_^('4_M#_ +,/?_ER\4__ "/Z5?M/C7\3+Z9;>V^/_P"R_-.RO(L0A\11
MR;8N7(5T!( .3Z4 ?,WQ)_X(N?L\^-/B/X=US0]3UOP?\+(XY(_&OPMT[5]=
M73]?%O816NEIH\L>J+%X?"7$,4\KQQ&5Y4#JZ-DGK]"_X(P_L<:!I%CIMEIO
MCEKVS\8Z5X[;79?&>JOJUSXBTM(Q'-/*)MGV-Y4,CVX40[G^5 , >[M\6?BR
M<@_'S]ET$$\$:WP?0_-2K\6_BNK#/QY_9<*%'#?-K@;?QL(YQM^]G\,4 >??
M%S_@E#^RM\8O&?ACQOK5EXOT?4O"^CR:-9QZ%XIU&UCDAD?4W-PL\TKS6=R6
MU2?<T#Q^8B(D@91BO/?%?_!%[]DGQ"NAV^EMXV\):9H>JZ;KL&BZ/KL=SHMQ
MK=AIRZ=)K$^FZM;SQ?VI<1H))KA564R_.K XKZ0;XV?$]%B1/BO^RA<E88A-
M-/K'BR%I+C8OG,D<*D+%YF[;WQC/--/QM^*/_14/V2S]==\8_P#Q- '/^/\
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M,Y[4 >*6?@^/3X[A--_9Z_:LTUKH()IK#XWZQ:7!5&WA!/#XX#*N>H!YI?\
MA%[_ !G_ (4O^V;@9'_)Q/BGMV_Y*!UKV_\ X6G^T7_T)GP/_P##HQ__ !VI
M+?XH_M JTC7?@SX,M$L,[I#9_%&V666?86BB5IY=B!G&TLW W4 >5MX(L(-.
MAO;CX:?MJO/(^R33M/\ CCXMO;N$Y<;V\SXFPJ8L(,G=D%P-M9__  C>E_\
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M<BM6W_9E^$]I9FQL;7XAV,):1LV/QU^.-K.AD54?9=1^/_,4%47@,.5!X(H
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M_<T[?+D?NU]SO?C_ ,A<T *Z@8V@CUYSGVQB@ -VQ]#G].U&Y_[B_P#?3_\
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MV^)^NZ5X@L=D_CZU\($VNEZ_9W&GW'VCPG%-YN^'1H=:>SNXF7Y@U@J+^[-
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M!W\O[9K1T_XN?"?5Q*=*^*'PYU,0 -,=/\<>&+WR58A09?LVJ-Y8+,!SCDT
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MH "I')'ZBDI1UP03[<@T$'^Z1^!H 2G;FQC/;_/:DP?0_P!?RI 03@<GT'-
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M?L5L<^V?+_6JESH>B7BJMUHVE7*IRJS:?9R!2>"5#Q<'G\>]?/P^"7Q4P/\
MC)WX@]/^A;\+G_VC36^"7Q5)&/VG?B%^'ASPN/\ VA0![HGA'PFC*R^&= 5E
M8,"ND6&05.=P/D#&#7QE\;?VH_'?P^^*?BCPYH*?#:Q\,_#>S^$-UK.@^,I-
M53QY\4C\4_%$N@SP_#8VNJ6\5LNFVZP!&^R:F;J^,EJZVRH';Z<\#> O&?A?
M43=^(?BWXB\>6?V*:V&F:OHVC6$0N))(WCO3/IZ!S*@0J!]TB0YKI=:^'O@3
MQ-K^@^*O$7A/0=9\2>&#+_PC^M:CIMO=:AI ED24_8[B1"4Q-&CKUV/ATVOD
MT >!_ O]JFU^.6M:CI%E\/-?\)K:&"^M+K7=7TB4ZGX<U"W$^CZ];6MJ=X%P
M5G5K?)>#R@SL=X ^K23DY)'7O^G%<]IWA'PKIMW;7UCH&DV5Y9PBWM;FULH8
M)((-HC$4;1*,1A%4 = !P!7D5Y\+_C+=7MW<6G[2.N6-M-<2RV]BGPW\$S):
M0R.S1VR32QEYE12%#-\QVY/- 'OI< <2%N<8!/X]Z<KA<YY'7UX[XY]_\]_G
M3_A57QK!.?VG-?/;_DF7@3C!/_3+GK6MI?P\^,%@S&[_ &@M2U8,7(6[^''@
MV(+O$04#R(QD+Y;$9[RD&@#W;>03\Q ).#C/&2<@9ZXS7!:A\+/AGJ=U<7^H
M> _"-_?7<S3W5W>>'-*GN;B9SEY9II+4M)(3U)))KF+SP;\79+:5+/XUF"X.
MSRY9/AYX6E1<.ID!C*?,"@<#T+"N<N_A_P#M#/(7M?VA+*"(9_=R?"SPI*W)
M^7YBG84 >@#X0?"; '_"M_! .!R/"^CDY_\  3FHKGX,?""[MKBRNOAIX&N;
M*Y5%N+6;PMHSPSK&ZR()8FM,/B1$89!&4%>=#X??M'=_VBM/_P##4>$R?_0:
M#\/?VC2,_P##1>G<<@?\*I\)YSGTVT =-_PSA^S\.?\ A2WPRQR2/^$)\/GG
MG//V'CGG\:/^&</V?L_\D6^&('I_PA'A[^?V&L>S\#?'Z +]J^.VF7N P;=\
M-?#MN7)D#KQ"/E 0;>/7)YK<_P"$5^,Q!S\5](R./^1(TK![#MS0 S_AG']G
MS_HBOPQ_\(GP]_\ (-'_  SC^S[SCX*_#'/_ &)/A[K[_P"@UCZIX1_:%>)A
MI'Q?\+6\IE!!O? 5C,GD;1\I$1!,FX=?3BL+_A"_VI^O_"ZO GI_R3NWS_Z%
MT_PH [5/V<_@"F[;\&/ADH8 .%\%:  ZAEDVL5L1D;T4XZ94'M5:\_9D_9QU
M&=[N_P#@9\*[RYDY>XN?!'AZ::0#IN=[+)_^M7)_\(7^U/\ ]%J\"?\ ANX/
M7_>JW9^$?VG8I,W?Q@\"7<>Y"8QX C@)52=R[HVSR#C/:@#6/[*W[,_;X!?"
M/IDY\!>'?Z6-#?LJ_LSCI\!?A*WKN\ ^&Q@\8_YA_/?\JOR:'\>O*;R?'7@0
M3!"(_,\,77E^9CY68*V=N1SCUXKG+W0OVIS</_9WC[X2+:[8PHO/"NMFXW^6
MOF[C#+M*^;NVX_AQGG- &H?V5OV9CT^ ?PD'_<A>'#_.QJQ;?LR?LZVC(]K\
M#OA7;O$YEA>#P3H,3Q2%2K21M'9 HY4D9'..]<R="_:U_P"A^^#(_P"Y4\0_
MUFI/[!_:U_Z'_P"#7_A)^(/_ ([0!HS_ +(O[,<\CS2?!/X?O+(Y>0GP[9<L
M3N8\)CK47_#(/[,/_1$?A\/^Y>LOZ1UIZ-IG[2ELDXUKQ3\)-1D9E,#VV@^(
MK01J 0X<++\Y)VX^E;7V3X\]]8^%N.__ !*_$G3_ +_4 <C_ ,,@_LQ9.?@A
M\/<=B/#UEZ^Z4I_9!_9A&"OP1^'I/4Y\.V7'_CG-69[7]JKSI?LNK? 4V_F-
MY!N=-\="<PY/E^=Y4^T2[<;MO&2<#%1_9?VL?^@K^S__ ."[Q[_\?H NZ;^R
MW^SUHSM)I'PE\&:9+("LCV&D06I<$8(<P@%A@GK67J'[)'[/NJ7;WMY\/;'S
MI%16^SW^JVT>(QA2(8+U45L=2!SWJ;[)^UE_T%OV?L8Z?V;X]QT_Z^.E7K2#
M]J%%<7M_\"9G.WRS;67CF,+RI.\/<<\;NGK0!@?\,=?LY8Q_PKR#'_86UOZ_
M]!&@?L<_LY Y'P\@X_ZB^M_R.I>]>@(?CP -Z?"-C@;C_P 5=M+8P2%\[A>^
M*Q]8F_:3C6#^Q++X+73%C]H%]/XRA"* -IC,<WS-][- %;PM^S#\$/!6OZ9X
MI\->"H-.UW2)Q<:=>KJ.JS26TRC'F[)[UE?@G@@CFO?-Q.,N<G@ DY)ZX K@
MO <OQ,EL]0;XF6O@NUU 7,8TM/!4VL36LEIL)E-ZVL,66?S-H4)QMSGFN[(!
M(..5)(/<$C!_2@"0-P0<DG/\J9DXQGZ^E%%  "1WQ]/3\^:=N(R <#\,^_:F
MT4 *"1W/YG_&C)]3^9I** %R<YR<^O>C)]3^9I*%Y5MPPV1M .>.^?>@!<GU
M/YFC)ZY.?7-'?CGGBDH 7)]3^9JU"24&3GD]:J J=P!!9<97N,XP3^&:MP_<
M_$T 2T444 %46W<;OPZ?TJ]5.3M^/]* (Z4''8'Z\TH7$9WCYB1CH>.?2G%<
MJ,#GC//M[F@!& V@@8)Q^H)IE*TFP %=^3M P?E/K\HZ4F1G&0: "E'X?CC^
MM)2YP.V?QS_A0 W!!QSCV((_$YSG-+G';/MTS2]1VS^.?\*!C(ST[_Y% "GH
M&V[1G'7.<].G^>:9M&=V.?6I&P0 .F<]^WU]Z9TH :6VKN88 ./7.?IT[5!)
M>V=LZ037%NMQ-@Q6\ES"EQ(.1^[B9PSC(/0=JM,S$8)R.N,=_P !_G''6OQ?
M_;?_ &,OVC_C1^U+X6^+?PPN].TOPEI/AWX9V3^)6\:/I6J>%I?"?B;Q'JGB
MR[L] M/#%WJ-W=2Z-JEO]E33+JV-[<6T<%XDL VL ?LR]PD4;23+Y$2?ZR:>
M2..- .[NY  P.IJ&._MLS'S80MNH,K-/"5B60;D9CO\ W:,G()QGJ.*_&W1?
M@]^V+^T=^P/\?O"/Q.U_Q(GQ6^*NHZEX:^'FD^)3-\-]1T/P5X>U3^R]$UNZ
M/]G0WFAZUJFGQ&^N1/&'$BJ%1%;!^6?#7_!._P#X*"W?PS^+?PR\1^.] L-9
M_:!U[X5V7CGX@R?$+6[FQ\)?#_X26OB>PM=(\.Z=HEY!J/V[5M)TGP;!=M!/
M 7EUZ[EED1874 ']'4E[;12F&6X@CF$33F&6>&-Q N2\VQF#>2,'+?='K31J
M%@=N+VT^8[1_I,)RV<;1\_)SZ5^&_AS]DG]K7QA^U#\$_B7\9O ME?:;-\,_
M#O@'X_ZY-\9VU'P/?Z%H_P +_'?@;Q5'X8T'0;K3=;\.>*-8\2ZKI>H"PB&I
M^'KNUU!;R^EL-9TZ#'%6'[ /[0G@7Q)^S=J>C>"]<\0:+X9\.:S'\4],@^+T
MVONOC"\\?R:EINLW \9?$S3Q<K#X86R3[1:O=O&+<PI9R$#< ?T!QW$$Q80S
MPRE#M<1R(^PGC#[6.T_6B2XMX5$DL\,4;'"R22QHC'GA79L,>#T/:OQQ_84_
M9$_::^ NO?$_4?BQJ&J:M_PL7X37]IHDECXYGO;+PQXNFU?5IO[%\4V6H>+=
M0.L>)?+N+1[;7-/%M;"UVVTMM'*F^O*/&_P-_;.^(7P'_9M^%^O_  ,^+%CJ
MWP4\?:_>?$'5(/B9\(O$\OQ#T;4[#QU%IVHZ7;/^T#HCZU8Q7FJ:&S1ZMJ.G
MSPDJ\5M,8-E '[S+- SLJ2Q,ZH)'59%9EC895V4-\J$#@]#2"YM]B2":%HY6
M"QOYJ;)&/0(V[#G@\ FOP;3]F/\ ;$7XS?M'^(=$^'OQ/T?PG\0?V=_B!X1T
MB6\_:!T'1[RUUO4_AO\ #GPMX#T/X5:OIGC#58M%\0B[T'Q')/;:WX?^Q>'M
M3B>YT[Q=J<&IR3#RW0OV8?VTK#X:^'])\7? SXO^-='MM!^*F@_"KPKX?_:)
ML/ 'C+X:_$/7/$MQJ'@;XR?%&Q7XW7UC;VZV5S:[K+2?$?B.WTU=$D6WT91J
M#6R ']'>]"<!EW]2H9<@<_P@Y%+D>HK\.? 7[,7[;7@G]HA/C%XQ\2_$;Q'X
M;N;WQI8W>E> ?'5O=>(H+IO"EE8^'-7N-&\>_$C_ (1;7/!T^IQ7#16D>AZ;
MJ%M=?O;B:2%R*_:OPX;\>'?#W]IC4CJ9T/2/[4.L+I<>K_VB;" WIU6/0W>R
M74?M/F>>+1VM1+N%NQB"9 -LXVG&=V#CIC/./Z4IQQ].?S/],48R2!S@9Z'I
MGK^E)0 'CG&?;U]J4'[I *MSGH<$]ACM24]-O4GZ>GM0 TDGJ:<2!]PGI@Y]
M:91TZ\?Y_P#K&@ IX7'+#@]#G^6/QI@R0#A@#TW C^=*22 /2@ /4_4_SI*4
M GI1R,]NQ_'MS^'YT !&#C(/T.1^=)13OEV_[7X^N>WM0 VEP<;CT]?TI?EV
M_P"U^/KGM[4F3C':@!**** % R1]?\]>].*'L#^)']*:O4<XYQWX]^.3SC\J
M_ GXY_'?]N_P#^VQ\8)/A]>^/M5^$O@SQ)/?Z/X?\8> -2TSX,#X>Z5^S/IG
MB[6+O4/&MU\-K#28-"C^* D@?5O^$_75([W41:Q>'[JUBD< '[ZU(%8=&3_O
MI:_(WQI^T7^TQ\2?V0/@W\<]+\->,_AUI?Q4\?KK?BY/A!X6?Q7\5_ WP+U6
MWUZ]\%7%MI%QH/B,2Z[<^7X:CU:[M](OQ9B]DD@LV0%E^=+3]I?]MFV\#:%]
MJT#]H[2M7\>?#"QTSX:)XH^#J:[XFO?'>G_%*T@O]2\7W?A'X>1V/A6ZN/ 8
MNI$?6+71H)(!YOV:&X(% '[^%3R2R$^S+GK3<'!/&!R3D8 ]3SQ7X$:O^TC_
M ,%'O$.L?M+Z?I7PZ^*'@_3/B+XC\*7/[)>MW/@/0;:#P[H/A?XG^'/ ?C+3
MK_4(]'U^70_[7T/4M4UA+GQ+H:-;VEDT]K;74*L*R[+]K3_@H?X=7]G6#4OA
MM\6?%EM\+/&?C76/VU[Q_A9HCR_\(9X@^,VJ_#;P3X"T_5I-.T1/'FJ:!X*M
M=0\1RZSX(TF[CUB*RTMOL-I:7\DH /Z"\8]/S!_D:4L2,'_Z]?SUZ1^T+_P4
M@\7?$[XM_#[76^('@7P+IGA_]L'XA?"3XH>$_AEHLU_KEE\.?%KZ7\,? >OZ
M;XE\"W4-IJT3Z5?+;!8O,UG2]6M)X99;C,@WI?CS^VIX/U+PYH^M_$SXSZQX
M]GT+X+ZS\+? \_[/^EZCH/QLG\8+:W'Q+LOB!XL\/_#J&W\'#2[B6XMU2*[T
M:6QBA$US]L/) /WTP3P/Z?UI<$=2/Q*CW_E7\]NC?M1?MZ^#/'7BN/XJ:UKN
M@^!_'OC?2O#OPYUG7_"&A:EI6C:/J_[2>@_#C4-<TO4-/\ Z1#X4FTGP3?79
M-CX@O-4FU07MMJ-C,\,5S&NY\,?VROVIHOC!\0]$\6^+?$'B/2=._:7^$/A7
M1-.UCX43^#_#B^%_B'\8/B)X!U/X81_VOX,TW4]&\<V/@5_#_B V23^)H[BR
M\%-KL'B+['J/]E4 ?OL1C_\ 6#TX/3WH&,C/3//TKS[X4>+-1\<_#;P9XOU@
M:/\ VIXBT#3]5O/[ M_%%IHWGW<"2/\ V?;>--"TO58+;G"K?Z?:7( Q+!&W
MRCT$=L],T *VW/R\C'OU_&FT\[,<=>W7^M,H **48QV_'=D?E24 *1CT_,'^
M5)2G\/PQ_2DH 4X[9_'']*2BB@!2"!DC@TE*23M!Z \_3!ZXH;&3CIDX^F>.
MOM0 8XS_ %%)3A@D9!;CHHY.,=A]:0CD\$8['J/K0 E'MW]/U_E2CN0>F,Y]
M\=/7@TI(*Y/WC_C[<=* &TH&3C('U( _,TE% #\!>N&/7 ((^AQ0?FY"A0.N
M#^/>F]^?QQQ_*G%@.%X!'/U/UH :,=\_AB@X[9_'']*4;<')^;G'7G\O>A=N
M/F_K_2@!M* 3T%/_ '?^=U,!(Z&@!R '.1G&/UI-I).!T)[CU^M(&(Z'_(.?
MYT!B,X/7KTH 7:1U'ZC_ !JK=7=M8P27-Y/#;6\0!DGGD2*) QP-TCL .?>K
M0<YYP1@]1_A7#>,_!.B^/%T.T\01276DZ+KMKK4NE*)39:E=64<K64%_''(!
M/:I<M%*8Y Z,\*AEQQ0!V@DCD :,Y 7+$$$ ]N.IR,$8]:5&#J&&<$=P0?Q!
MZ&A(TB 5(UC&%R NTG  &[C).!W^G0"GKMSSTY['KF@!RKC)(X;!/3H!D'/7
ML*LQXV#'3GUZY]Z@++C ]#C\CQS4T/W!]30!+1110 53;)Q@'OV/M5RH=[>O
MZ#_"@")B&&%Y.?Z'UIF6Z#MQC /3\*G)/<(/]T@G_P#52[BH'W1[@C/T.?84
M 5\D$XXR"#D _4=..:;@>E2NV1U!Y[ 9[^E.'*@'I@>WIZ4 0[CC&>/P[4E3
M990>%P.F1DXX]:<KD@?<SZ' S^GI0!7HJ9MQRI"X/< $?3./:E4E!M.SN<DY
M//U]Z (![=N?RHR6Y/TZ8_I5C>/5?R7_  IB%L<;<9[@9[>U $#'&#QC(!R#
MW..U?/GQ]^*'B7X9W/P@A\-ZS\/]-/CWXI:1X(U>#QQ'<R3W&DZA8WU[<7/A
MHVWB*P":G$;!8OWBW*;]1AS&" K_ $4Q(93QGD<@8[<GBOD_]H=?AK>Z[H,/
MCGXL>*_A]?:1X;U7Q58V/A^[>UMYM+TO4;.SO]<4?9)!]NAO-2TZ+*$2XGBP
M,8- 'R0G[;_QUU_QAXX\&^&M%^#&E3>"M(^('B63Q-K\/BG4/"6I^%O"&M2V
M%IK4&M6'B6"&RU'RX_)O-,EE$L=R<K.L1Q70Z/\ MC?&:PUSX2Z'XS7X%3/\
M2?#WA?Q3/JOA?^VAH^FZ5XKU32;+3!<3W?CJ2XL[N?\ M&YMK98K74$>]M%$
MLL$+2/%N1Z5\"O[*\<7T'[37Q0-AX$U6R\.^.K>'5IC+I&H>)!%<6]GJ5A'I
MI:2.Y-Q$SMM="S_O#NKH-9LO@E\-O&&D^"?$_P >/'$7BN\T71;K1].U:,ZG
M-;:3=74W]C26\PTIEL4:[60(H9=C1@X7K0!PGA3]M/XK^-OA_P"./%NG:%\*
M/#[^ /$O@?3];U3Q=+K.C:9<Z1XQDU'3HKS1-*M_%TTNK:;_ &HWAU[353?0
M6MW'>7ENMK'=6,HI]Y^V=\7-#^+7C+X6^)K3X%>'I_!GAA+V]U34=5UJ'2I=
M>7X6:%X]N+:'4CXI,\MJE_JL\!1M.C7[-:M-]L,Z^0VU>>,?V>M4T2\N](_:
M>U=M(_LOP3,YT:PLM7AU#3?%=OJ^O^#IK2TBTE_[2MC8Z#XAF1$5EM?L-PSB
M.1"*L/X ^%^OZIJM_/\ M->(+_5[;P';_$+5KN\\/Z)->Q?#S4[%IK?7[RXG
MT<M)I,FGPRJ,DL4MW0K\C* #Z"_9-^.6N_M"?"S_ (6%XBT_PSH5]<Z_J>FQ
M^'= N[JZOM"M["80Q6GB5+JXD:UUQP/-:(!46.9"-V2:^7?%?[=WCKPR/C/>
MV_@3PKK>A?"CQI/X-NM:T^[UF6UM[XZ]X0TW3+6] N2-3U>\LO$MXT5K:,KK
M-HY1B/, 'M7@;X+_ -M>%K+Q;\//VG/',_A/Q-;#7K+5_#MOH$&GZO!-'D:D
M#;V:^<[1)@LR[L+CM7&Z?J7P27PAXSUB+]I.UN_#'A>ZAU;Q]J%SX7T<PQ7U
MKJ+6D>O:U#)HX>]FCU.V93=^6X22#EQB@#-\&_MK^(O&>J^#KFW\.^ K#P]?
MZQ\-/#FO:7?^(KNV\>:U>_%3QAJWA32-8\%Z$'?R;'3+:RL;[4[.[BFN8EFO
M[2>:SGTF9I_*V_X*&_$I_A[9>-X?A;X6^R:KXRM_"NEZFVJ:U'H=[=C1O%]]
MJ=AIZW<UN^KW%C/X4B:XN[>0VAM]=B=,RPRHWMVHV7P6T?Q#I][=_M Z-H_B
M73/#&J^-M.O[CPMX9M[S2]$O]%O/%=UK:W\NF!;*8Z-#J6H- [+.\/G3>5@L
M3QNK>'/A?=:</"6K?M;:#J&DZ7-Y@T%? 7@"_P!,TZXU+2+#Q TJPV>FO':R
MRZ)K>GW+L"O[C4T9B%DP0"?3OVT_B+K'Q-'PRT?P?\,=8U?4O"T.LZ)+8>,M
M6.EI?R^%K+Q*YU#Q%/9K:3Z<@N98VA@'VW$'F^4(SNJY'^UI\>[3PA\.]?U#
MX4_##5;KXJ^+;WP#X-E\+_$*\NM%E\327L]CHDNI7=W:JUOHS3V%^+IX?/FC
MS$8XVRU5='\ ?#JYN-9&A_M1Z2UWX;BN]3U?[#\.? L<NGQ:/:'3;ZZ+)I8+
M?9K#]Q+Y6XQQ85@!4R^#OAAX;T+P,M]^TYHD/ANZEC\1_#FVN? /@J&PLKR>
M]2W@\0Z);IIW_$OE:\N%19W$:L]Q@-EJ /IC]I/XZW'[.OPSM_B-_P (A?>.
MW_X37X>^%+[PYHMS]GU:>S\8>*M*\/:Q>Z#;FVE;5M4L['4+N[M[%5\V_:P%
MJCI),KCXW\-_\%,M*UO6/A_IVJ_#-/"__";Z;\49=3MM9\3S?VIX USPAXH\
M=:#X(T7QDMMHCVNFSZ[#X!U9V26Z@FL[@I;I%=;@X^A-1\0^$-;T6UU/6/VG
M=&UK2-*^)^F> [>ZO?"'A&]@LOB[I6HPKI>AA!8L;;Q5#JPMS"I 99BA4Y*Y
M?XD_9BMK:Q\1:A-X^\,:/H^H17&O>+I+SX1?#ZYAO[VQEO=3&O:K<3V>2\$M
M[J,S-P-UU*YY=C0!\RV__!3M)/!Y\73_  LTZSN8/$/@;0]2\%3>,[F;Q=IR
M^(K(:CXDO)+6Q\-S1S6^FZ:R7:2H3;W5K(LK309 'HOCG]O6Y\/V&N>*?#/@
M;PGXA\$6UKXW?PY>WOCZ[TWQ'X@F\%>$!XNN)QHMKX6N(K:RN('BCC3[2TX0
MM.$=5VU6TWX0>!=;NO#%W8?M#?#.]O=5FU'PKX4DC^$?PQCN+^X72UTW4-#L
M5>S5Y[G^QU6)HB"Y@4!1LQ64?@;\+KJVU<-\?/A@UKI=G'X0UE'^$GPWCBLK
M*_9O#ZZ//&]J!''*TWV0X&6\P1%N0* .3UW_ (*A7/@K2-.O?$7P&UG6[G6_
M"WBWQ#I2^"/$LM_9V]UX6USP[8C3?%ZZIX=AN? T,VC:GK^H&XOH (H_#2(8
MV;4;3/I;?\% )8G\9O+\&[Z[@\#>,9O">LQZ5XN>;49(K#XCZW\/]7UG1[+4
M?"UNOB*TM+?1)]4F^P2SJD!>T>07J+&_7> ?V7?#UUX6OV\->/O WB7POXGL
M=6T.[NK#X5>"5T_5-+FOX(]8TR62UAQ=V[:EI$/FY)W/9*I.U<5T+?LAV<$G
MVW3M:\&6UZ=3_MAKL_#'PU(3?MJ5[K4ETN5.)VUB^N;EC_%).[,"S&@#A_AC
M^VSXX^+&N_#RU\._ *VN?#/Q&34+_1?$]I\5K&[:X\-Z/+'%JWB&PTP^$(Q>
MV\#RQ*8VGAD9MP7A03^@$<T,RL]O-%/&KO&9(9$E0.APZ%D)&\'@CJ#U%?$.
MG_LJ?$'1]6\)Z]H_Q$^'^F:OX%T[4-'\&7UA\(O#5K+X<TK5)3-?V.EK"JI;
MV\TI+.H4[CS74>$?@A\?O NB0^'O#GQXT>TTR&ZOKWRYOAOH-U*]WJ5Y-?7D
MTL\ZEI'>YN)#R> %4< "@!OQ:_:BUWX3ZQ\<+>;X4MXCT?X,_![2OBXM[I/C
M."'6O%T6J:CJ=A!X:L-"NM \O3]1(T+5VCEDO)(W=8$(C\YGBX[PS^VAJGQ&
MN]5L/A9\(&\;:AI1U[5+FS;X@6.AS2>%=&U2ST02J+OP\_V?QK_;3:O:7>BS
M>6-/N- N(KF^#O&&3Q'^R1XY\6ZEXOUKQ/\ $'P!K6J>/O#5OX.\9WU_\)?#
M\L_B/PM:7*WMOH6IMD";3TND614P,-N/<YV;W]DV:_BLFGN?AJ;[3M6U?Q);
M7=OX!MM.9_$FOW<.IZYJEP+"1/--[J]I;W5RA)62:,/C))(!]G6T_GPQNZ"&
M<Q0/<6IDCDEM)9HDD-O,8S@2+NQGH<9'%3U\MP_#+X_Z1?:OJGASXB_#;3]3
MU^XLY]:NI/ LC2:BUA8P:?923[9L>;':6\4:X &V,=^:NCPE^UD3S\7/AF/^
MY#F_^.T ?3&#C.#CU[4G^?TS_*OFH^$OVL@#CXN_#,^W_"!S<\_]=?\ .*V=
M*\._M+VT,RZI\1?AOJ,SSPR12IX0O;7RH5/[Z$I%-ARW/S'E1TH ]_P-O^T/
MKV/M_GFFX/H:\9GT?]H#RI3;^+OAN;@QOY)E\/:L8O-QA/-$<^2F2,XYQG%<
MK_97[7(.#XR^!F,\_P#%,^+0"/\ P-Z4 ?2"]1]1_.OS[^-G[;/P^\#?&SQ%
M^SO\1OAI<:[X+C\/Z7)XQ\12)>ZU8MIWB/P3XW\9/#>>')/"DFG7FEKIW@>^
MMY89]7BO9YKZ(6VGW"9-?0VDZ9^U"FJZ:^N>*_@Q<:,M[;-JD&F^'O%,6H2Z
M>)E^UQV,L]X4CNS )!&7!4,03QFN2^(WP!_9W\:_$W6OB!KS:)8?%LZ-HOAI
MM7DU>!KK2;[5M+\2:#X&U2Y\.W4_D76L);ZMKT>FO/&3+^^C3< P !ZK\*?B
MSX ^*NCPWWPS:74_"$%M-'I.O66FK;>&+Z'3=4O]"DM]$N@^VYC2XTN0KL01
MF&2*1&*L /5N1C('RDXR!P?;C@]:\O\ A%\%_!7P5\)^%O!O@FSGM-(\(>#M
M$\$Z9$\SE#I.B&=[:22W7Y/MKSW,\DL@&Z0R?,2 *U?%\?Q9>X+> KCX?Q6H
MMU B\66VORSM=;OG(ETF=%\C'3C=ZF@#N\DJ1@ @97Y5XP<XQ@@9P/2FAMP)
MP"#C>-HPQ&>#D8/S =<],>]?+-GXT^/>K>(=3\,Z)XL_9AU/7=)W_;]$M[SQ
MA<:S9!$B:8WFGV^JF2$JTT>[*C:)%W8R,[*7W[4;V<M^E[^SD=/@^TM->;?'
M8M(?L<LL%X9+@ZCMC$4L$JR$D!#$P;&#0!]'<?W4')S\JY^?[P''0G\\>]'!
M*MM0E,A244E,]0IQ\O/I7SO+)^U7#"]Q--^SQ#!%&TTL\L7CY(8HE4NTLDKZ
M@%2,("2Q. .3Q6UI3_M'O 7U1?@I<,Y5[>72O^$Q2!X'4,K$W%XV\D$$%3@@
MT >KZ]X?T+Q3IEQHOB71=*U[1[OR_M>EZO86FH6%P8I%FC\ZTNHG1R)HT894
MX90W7H:EH&A:S/I5SJVBZ5J=QH>KIK^BSWVGVES+I.NPV%_I<6L:>\L1-KJ2
MZ;JFI0"9")!%J$T88*[ ^=%OCR.3;?"CCG[_ (JZ<9/_ !\5R=UJ?[5D4FVR
M\._!&:(%_FFU'Q9&V W[L[?/[IR?>@#Z(Q@<*%7C&  H[8 '2BOF_P#MC]KG
MI_PC'P-^G]J^+/Y>?1_:W[76,CPM\"R/7^UO%@Z?]MZ /I#I2DD]3GM_G\Z^
M:SJG[7+?-_PBOP,.,]-7\6C/'3'G\UU%KJO[112/[;X6^&!?RSYWV76-95/.
M_=E?+,KD^5_K,YY^[[T >UT9!Z9_'_\ 57AFJ:[^T9;V\;Z5X%^'&I3-,$EB
ME\2ZA9JD14DR"20'<VXC@=<^U<V?%'[5Y_YI1\,<=O\ BN;H9Y."1L]#0!],
M$D]325\T#Q5^UBOW?A/\+^>N[QS='_V2KMAXM_:A:[A&I_"KX<)8DMY[V?C>
M9KE1L8IY0EB*D^9L!SV)QS0!]%45XS#XG^.OE1FY^&7A-+@HAF$7C*(QB7:-
MXC+09*9SC/8U2O\ Q9^T!:HSZ?\ "#POJ;E0PC/Q LK(;BQ!0-/;$#"@'IWQ
M0![G0.HKYQ_X6!^TR.OP"\+Y_P"RJ:/Q_P"25(/'G[3 );_A07ACYN.?BKH^
M/FYZ?8^* /HXC(922H;@E6*MU!ZKR.13@2._8@$\DGW)_#GKZFOG(>//VF'8
M+)\ O#"IG+%?BKH^0,-C@67K780>,OC!@B?X.Z>C# 4)\1-$?(VC<239?WN*
M /7<GGWZ\#G%)7D5SXS^+Z0L\7P9M+AE&Y8D^(NA1-)SC =K'"]LYKF3\3/C
MXN0G[-C.JLX5O^%L>%!O4,0&&=.X!&"/3O0!]"9.,9X_R:2OGS_A9_Q]_P"C
M:'_\.SX2_P#E=1_PL[X^,,?\,U-SQQ\6?">?TTZ@#Z#]N_3'OZ45X_X4\;?%
MG6-:M;+Q/\$'\(Z5,V)]:/Q"\/ZVMHH!.\V%E9K)+R.@->T$]CCGM@#^E %>
ME R0/4U.,+P,#)[X/MWH(!() R.G;^5 $3 #&!CKZ^WK2_N_\YIYQWQ^)Q0-
MJ]".?4@_SH @I<$] 35C/T_(?X4R1W"G854X/.T$CT('?G'% $-+D\#. /3C
M/N<=33XU90I<AFQRV,98]3MZ#O4Q8X.%CZ=?P]* *QR<DY]SCZ?_ %J,'T-3
MAFQR5VX__5UH+!A@L"...!T^E # J[02.W)Y],]JL1XV#;TR?7KGWJ'*XQD8
MP1R?;VJ6/&T8QU/0Y_6@"2BBB@ JO5BJV1ZC\Q0  ^I/X(W]34;DG(QP#P2"
M.WO2>;UY7CD\]!ZGGB@.K?>90,9!R!_,_6@!N#C)!'^?6IE[<GH.,8Q^..:B
M+9XX(!X_ <?IS3ED!X)4 #CD#I@>M #SSD9_\=;^=1_=;([>H([4XR( <.F?
M0L#W^M-+(PW;ER>P8>N/Y4 /#$C).,]>#_,\4A4=02>/[O&?8BF!P1MRN.>X
M!XR>OX5(&0 #<O?^('O0 T+ZDCVVDTUBR!?+^9BPR&7"XR.2<=:EWI_?7\Q_
MC4>\-C)7(/'S >G8T .8%B/<@<*1C\._&:^7OVB/A7)\3-5^'<W_  B7B[6A
MX&UY/$L>H>%O$OA+0H]1A+Q/>>#]<@\0ZI!)>Z'<WFG:+<S+&I#/IL*[Q\XK
MZ@$G!^[_ -] ?H3S3#(K8^9?P8=\>] 'X]/^S-\2-&U#QIK/@WX=?'/0/$WQ
M"^UGQSKT_B/X/Z];^);I_$*:_9WYTR[^(\4=C)"T44$8B*J8%"D"M&[^"?[0
MFI_$+1_B9J_A7XP:CXHTVP?3YKV8_!E/.MIKZXNKJULX/^%LF"RM);:<6Y22
M"Y=(E8PRQR,&'Z[ Q@?.RJ<\98*?P!//>D5U)(1E;Z,#P,\\&@#\A/A9^S%\
M0/A?=P:QX-^'WQ4\+>*[$>&VTW6=3_X4_K?A?3/[)\&^(O"&M6VF^"M/^((%
MG::F?$%SJ,L:7(6#4WDFB)AGFAKVCX@_#_XI>);?QI._A3XF6<'C#X6^$OA1
MJEIX>TGX=1:H-#T+5K^_U*?3KF+QJOV>2^76M9B>-8]D$-\!'N,>6_1(R!N,
MKW/!';CGGWH#A<G(Z<DD8'(]^N: /SU^!$OC?X!?#^;X:^'?@/\ ';6/#EEJ
MNKW7A4:L/ KW/AK3-1<O!HR3)XI/]HVMO(28V98R5.TJ.M?-^@? WXH:%H7Q
M:TP^!?C5J&J_%3P?JW@JXU:Z\&^!I;73-'UKQ->^([N231Y_B9(M]?+]ON;>
M(Q2VD2H^]HG< C]FS("""5XZCOQR>_'3T-?*7[3O[7G@?]EJ3X4V_BGP_P")
M/$]S\4?'5EX4CA\*VD-XWA;P_&CW?B?X@>(S/.@M_"NDZ7%-/=N@:0@"-$+,
M* /DWQM\,?B%\3F\0:3K?PS^*^CZ%XPO=.\1ZY%-X'\ W\*>.-,^%]Q\,(-<
MB>W\:F=/#S6!LKA])VR!FMI;8W1@NI:QH/V1M)\.0PV/@3P+\2?"VAVWB2Y\
M5PZ6W@NTU6<ZQ=^'?"^@O+=:@/%\4FIVJ2>&H7BMIQ);I:R16+1O#;J3^O+N
M!(<,NX$9!()Z<\;O8_3H>:#("I/RXZ$AAQSW&>* /R?MO WC;PYJ.LW7_"'_
M !>U.4W/Q-O_  Z+/X+6,4.FZO\ %*);?6I]2GL?$#?VWID$0/V>V A3<=S-
MCBECT[XB65SH>HZ?\,_B7<:G'\/]!^'GBU=?^ <>LZ-K&G>&KD3Z5J&@Z7+K
M(&@7.%7S8]TD<DJK-NW1H*_5Y74G"E2_LX))S_=!R:^$]"_;FTOQ3\:;'P3X
M<^&6O:G\&+CXBZC\$Y?VA1X@T"/PW)\9K*U$_P#PA^F>%X[E]2O=+^V/!82:
MHZP0K?W45O%',/-DB /BO1/@I\1/"EA=0>'- ^-TEQKGCWX6_%[Q/)XC^"W]
MIVNI_%CX?>.==\<:IXJL+6VU"$:9#J\VHZ5:SQ$RS10Z'%^_D^55^Z]"\7^-
M]3^"-]\//&GA7XSZWXPUSP?XE\,ZMXRU3X7WEJ)+S7K74K'^T6T6T>1!:0I=
MIY</F,6BA17;<2:ZO3?VO_AQK'[5=]^R;I&D^)M0\4Z/X-U;Q%KGC:WL(1X
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M?Q-IX96[J?WO!SZU[_(D$PQ+'"^#N7?&DF&&.1NS@X'6J1M+,DEK"QW9.?\
M1K=R?<L$YS0!X4O[5O[-0!!^./PU&<_\S1I_IU_UM*/VK?V:0"/^%Y?#7G_J
M:-/'_M6O=#9V(ZV%C_X"6_\ \12_9+$ C[!8\_\ 3I!]/[E 'B^G_M-_L]:I
M<+::7\9_AY?7)5I!;V_B33Y965,;FVB3E1N7/UK?_P"%Z_!P##?$SP6,<<:[
M8C _[^UZ.;33\8;3]/(ZX:T@QZ=-E,_L[2WY&F:81W_T&V(/;DE.* /(#^TU
M^SY&S(_QE^'*,A*LI\4:6"K+E65@T_!!_E41_:9_9YXQ\:/AS^/BK2_T_?\
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MCI8--_:FFDO88?BO\&I9-,E6#4$7P=JI-I-);Q7B1S_Z;^[8VDT4@!_@D!H
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MX!W>E:QI][I>I6;>'?'(CN;&_MI;6ZMW/]K\(\$K@_[U?EKX/_X)#?$+X/\
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MT$/<^(_"X_\ =5I?^&>/%(&3^TO^T%CV\1>&#_[JO^>E-_X79\7/^C8_'/\
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MJ ,Z'XQ_"F:)I(?B)X/DCC*!Y!KM@$0RQB6,,3-C)C=".>0P-*?C!\*=P/\
MPL7P:<#'_(P:9_\ )'^<5=N_A9\+]1@-O?\ PV\ 7MNQ!:"\\&^'+J$E?NDQ
M3::RDC'''%8[? [X(@@#X-_"KI_T3SPAUY_Z@U &C%\7/A=<2QV\'Q!\(2SS
MR)##%'K^G-))+*P2.-%6XRSL[* !R2:] \OGKT]0,_0UYE!\%/@O;RQ75O\
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M'=GCC\_Z4 *N5S\Q.?K[^]-VG^\?U_QI/,_V5/\ O?-^5'F?[/Z__6H ><D
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MJ?\ ^0*0_LV7W_1PW[1P[<?$N;U]]/KZ>!<#@<'J1^77;3AD<,I(Z@8[]0:
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MQV]J ';?EW9'O_A]:93B<C&T#W'7^?\ G-"KGVXSG% "A,@'/7V_^O5J,;4
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ML\?^AU)%^T_^S_,^R+XQ> ))"&(5->M&8A%+L>&Z!5)_"OC3XL?M!^-/A_\
M'/XD:#H7P*\->,?A+\'-#T/Q-\0I],\#11:G9>%KOX=>/_&VO:U_PF^H7EOI
M%CJMO>>&="M+32)8VFO3K9D:XMHU#UG>(_VV?"/@ZY\7:;K7[/UMJ&L>%!=W
M/B73](/PV:/P) OA_0KFRL==O'\0DZY?/XCUR"SD.FQ2B(+(Y4I%O< ^^O\
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MP#^-$TUQ'YDD&FZ-HE\+5LX,4LO]LQC<.O Q4/\ PO\ UP C_AGCX]<XP?\
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ME5?^&J_!O7_A7WQG^G_"N;O/3/3[=UJVG[4GP_2S>^O_  U\3M*A2;RME_X
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MPRZ;\<?[06YGDN1$UL%N?A=:F,I!NE9FXX"*&))';-\</@U_#\5/  (R"/\
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MM#UM[^U$<ZPV.J:3>:EIPN(K6\5)/L\C6,<Z(Z@E+A?45B#]F#X-8 _LOQV
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MNG>.;(/(5C6,+MO_  [<)&@5!PBIDDDY))K(_P"&9XAT^.O[0_'3_BM_#?\
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MH"6ZGDL?VDK6TM'D)@MI_@[I5Y+!'@8CDN5\:Q"9O4B-.OW157_A5W[17?\
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M-^-L-OXCM+>ZM;>>&"^2>!)8_,$>X9KU;X]6&H?%']FSXFZ/X1T-O$FM>/\
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M%>#>,-D<]0#0![U_9>D ?\@C3#VP+"T_GY6/_P!5-.DZ5_T"M,'_ &X6@_\
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M)SX<?_,O0!["?AS\.V))\ >!R3DDGPIH))SR3DV')S_.D_X5S\.O^B?^!_\
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M3^G^%-90.A_ T )P>BG\R:"5_NX/U/!IR#.>OX$_AP*78/4_G_\ 6H BHIS
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M;X(\?#PW\6/%/CCQ9K'AO6--T&V\4^.1-#I&HF\M9M*OM)O38>9:78B:[#2
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MUF+"TTNXT[6-3/AO2I])>X\(>&--TOQ'#?\ A76=1U;Q#XG<>()'\+>)K'Q
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M@^A_*@J1V/K4^U@!@$CMTZ>IQ0%9E)VD<'C(R>* (,$]J2I@K!6R".N/R_\
MK&HL'T/Y'M0 E+M/H?RH /!P3SGI4F\CJI'^?I0!'@CJ"/PHP1U!'X4]B6&-
MI'.>_P#A2,21C:>N?\\4 -P1U!'X4F">@S4H^?(((P1W_P#K?YS3!PQP"<9'
MZ_2@!,'T/Y&C!Z8.?3%2;C_</Z_X48_CP<^GZ>GI0!%13V&1NZ$]C^7\J90
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M[U&XUV&W_L734WVFW3YYI;RVCD:7:D!=FE*JK5ZKJGP/^#.N1K!K/PK\!:E
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M\=]'TN/P?H\OA[PFEE\%- A'AO0)X["&?1M&QXM_T'3GATK3%:-, K81+T0
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M*K>5#&. ,[<GG.<GR_VPQ_RU_9W_ /!E\0"?T\+4FS]L/_GK^SQ_X,?B#_\
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MK!<YSSC^M,HHH D\S &,Y&/Y>QI?,'?.>_\ G-144 /9@1@9Z_Y[TH<  <\
M>G^--*D#/'/O_C3: '[ANW<X_7IBDW#=N[?_ %L4VGJP!!.<!2#QGJ<YZ^E
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M %Z* '*.>?3L,_I@T C)SGGIPO'Z4G(]1G([]NO^?:DQ_C[?GWYH ?L'J?\
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M_/X_RHQ_C^F?Y4 *.3_];-+M!.W)SC/W&Z<_X4WT[<_Y(_*ER?4_G]>/\^M
M"D =R?PQ3:,D]<]NO^??]:/3/&<=>V?6@ H(3<S*N"V-QR26QTSS@8!/04=:
M/_K?KW_SZ4 %."ELXQQZTWL3V'^?\_2C)'3(]\_3W_SB@ /!(]*4#/?'X$_R
M%&/Z?K2 ^F>?3Z?RZ4 /7@D9/X#W],4F,DC/KS@^O<#I3<D$]<^N>N2!U[__
M %OI2YP>I!/X$YYZT !&#CK^?]12Y^7&3^F.N::3U.?SY)_QX_E1GOS_ %H
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MEM2+ZV+36[EI0KB2 L!@BMWX/_LG_M]_#WXL?$W4-=_:[D\1^#/$7[/:>%?
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MR"7DL0#9_9Z\9?\ !2?X[_LP_#O7;'5+WP!X_'QR^(D7B?4_B9X8T/3M?O\
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M%K6GA)AJ9MY.8=+N89%6")_WA>-LBN?_ &8_BM_P50NOVC_!7@;XU?!+2?\
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MX2U7Q#C7$\5:5<Z]J%AJ/AG15TK2E^Q?OFBU/7+^2Y;&1:Z/(Z9:OH7XF?\
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M3D(SM[CJ/3/_ .HU<JBP.<MU/]/_ -= #:=N;&,\8Q^%-IQVX&.O&>OIS^M
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M0=@!DY]. 1@'G&<X/3_.*9+&MQ&\,T22Q2+MDAEC22)U;JKQR*0RY X((R*
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M /WMW3(.!^1_^O\ CTI"['^(_7O^O_ZOPII!'!Z^F1G\J I/('ZCMU_F/SH
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M**4G/I^0'\J )"XP<'GMU_'J*C))SD]?89[=^W&:78W8?R_QI""#@T /)!7
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M[8>#Y-2\<>%O%8U>/POJ^F7.FZU+9-=WQT:]4V>HW%O>VP*"[@AW"@#Y(/\
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M9?CAX$\(_!V_^'7C8:I^SM\6/C#K'P;N]#UFX\5ZK#X1^'WB_7]#UK2_%EM
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MD9'I0 F#UP<>N*!D<X_'''I2EB1CC''Z4[^#'?T[]?2@!I)/..V,]NII0Q&
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M!ZG]/\*BJ=>@^@_E0 W8/4_I_A5B,!5 'OU^M5'^\?P_D*LP_<'U- $M%%%
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M:7X*\=ZY\2?"IU2ZN+JZT7QGK^NZMXBO=:LYT>/,HU/6M1:-75D19@N&V@T
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MZ^@H 87R,8Q^--!(Z'%38'H/R%-)4'&!GCL.] #=YP0><]__ *U,J4KD@C
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MI0P(QDY_$G^=+L/J/U_PH ,9#-[COZ]ORIH)4Y!P:D52,YP1Z=OK^E*5R,
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MTM1(^S/ .<=?:@/C.<G/Z=?4T 2TN%ZC=D]<GCGDX_&JY8Y/)'XFC)]3^9H
MGHJ#)]3^9HR?4_F: )<-NSGCTR?3_&G5!D^I_,T9/J?S- $]%09/J?S-&3ZG
M\S0!/14 8Y')/XFI"XP>H_+_ !H >0#R2WT['Z\TTJ<C& .XZ9]>/I408Y')
M/XFG%B2,$CMZ<Y]J )< = !3')&,$CK_ $HR5^\2<]._3Z_6F,P;&.U $Q"]
M@3_O<_E2D+VW9/J?K5?)]3^9IQ;T!'ON)H EHJ#)]3^9HR?4_F: )Z*A&XG
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M^' _4TAC).2O/U^OO[F@"+&\Y' '!]?\\BHZLB-@#C:H]\G\>O%)Y7^S^O\
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M?XTWRO\ 9_7_ .O0!$K<$=ST/N>*"K=2<X]R34OE8_A_7_Z].V,>WZC_ !H
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%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g1078497.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078497.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" -6 I0# 2(  A$! Q$!_\0
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MC...?SJ2J[_ZW/<+Q^E "ACN!]3R?;_(%3!@>A_G30$/3^M+A5YZ=NY_STH
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MWJ.I%"''KCGK0 GS9)4'G.#CMU[U+3,J.,].,<TTLP)Y[GL/\* )&SCY>O\
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MOI[U'1WQG!()_ =>GU_6@ IPVX.<YP?7\,8I54$$]^<?E1@ $,.><?EQ^N:
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M8QQT_'^M !@ $=NIZTT*A' _G_GO3^M( !TH   .G\S00#U%+1C/_P"LC^5
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M7KVI[ !UP,=/YFG,%ZM].] "(2<D^WX9SZ]*23M^/]*4@C[OX\_EUJ,DGJ:
M'EF')QSV_*@L!]T\D\\'W]:>0#U_F?\ &FE4')'ZF@!0P/'4_3%.I  .@I:
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MPR,8/.?7_/>G9'J/S%1,%&,'/XCMC'3WH8*, ')Y[CM0!+N'J/S%12NRH3&
MS9XW'"@\D!B#P,\4T_>('(P#GZ_Y_2C_ #^= "PM(T:&4*C%$9@IX#$ L%)Z
MKG//?-2X!8,#R 1@'L2#S^5,!W<'  YZ^V._U_K3@%7G/7U/KS0 ;!ZG\_\
MZU/P,8P,>G:DR#T(/XTF3NQCCUP?3-  % .>>_TY_"E;&#G@4W=\V.,>OX9I
MQP1UX]<^_K0 S 4%ASZ9P1UQVI-Y]!^O^-/^7&,C'UJ,A<@ \'&>1QDF@!X;
MY23@8SCMT'UI5;(Y('/T_G32JX.&Y[<BD4*1R<'ZB@!ZMD<X!SBG5"0%((.>
M_7/3Z4N\^@_7_&@ WD$CKR>O\J>P!')QS_C3!AB2>/QQGKZT\[2,%A^8H =1
M32 PQG./0BA_NG\/YB@ *@G.3SZ8_P *!M QD<>I%*. /3 _I32JL>O)]"*
M%)4C&1^8HR ."#@''(I-B^I_,?X4TJN#AAT/7!_E0 ]3D<XZX_2@D@@8X[GL
M!WI$QCC/7G/KQT]J&)R!V(Q^9(S0 %N0 1CU]/UIV1ZC\Q3"BC/.._./I^/2
MH_Q!^@(_G0!,S$8QCGU_"ER/4?F/\:B+%L9QQ3@J>OZB@!X4+G&>?6D7:HZC
M\Q_G%+D>H_,5$H4YR<=.^/7UH E(##]:8<*#@Y)X.3DCK^52#H,>E,*KG).,
M^X_K0 X=!]!3&&W)'4Y'Y\\5(.@QZ4C $<G'/T_G0 B_='X_S-*3@9 S].]
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MQGK_ /6X^M #BP*@<\8_E2*0#S^=-R/?/TP/S[T4 *3DDCO3PX  YX ]/\:
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MZU%_G\J* )&8$KCL>OY4,P)7'8\_F/\ "HZ..Q!^G2@"<$'I4(/(/OFE#$<
M_P"?6F\=B#],_P"% #W=3QGD#/3L,_UI@Y /K2A"3GCIMYZ8Z^E*%)R!CY>/
M\_E0 VBG!221QQ0%))''% #:*#P2/2E R<4 *I ()_SQ1D;\YP,]<'L/_K4A
M&"02!CN>G\J7*[<#!/J/KZXH D+*00#R>!P>_P"%,"$')(P#GOP!^%-'7W/
MZ<'UY%.8L."1R/3M^5 #PRGH>O3K3'Y8#U _F:5,8R0.#UQSQ@TC,NX'<.W!
MR,X/TH >HP,>],5@ 0?_ -?M_GUI^]?7]#_A2*N,YP?UZ9]10 UR#C'O_2AB
M#C'X^W2F4X*6SCM_]?VH 5"!G/?&*53\S?B<_C_]>FN"&SQM(X'N/:D!(Z<?
M_KH F!!) /(I:A7))P0#R3^)Y[>M.#$$ACT]N_X"@"2D+ <$_H:BWMZ_H/\
M"D))Y- $H93QG/X'ZTI8 X)_0TU2O XS]/ZXIC_>/X?R% "L,_,#QZ8_#^=,
MIP)/RCIZ?K01M(YYZT (1@X/IGBGJ0!SZYZ>U,+,3C .>,G&1G\/>I  .#C)
M/IGVZXXYH C'49Z<9^GX5(<,,*1P?<>OM3"NTC..OU^N13RP RI&2>P_G0 B
MD+G)YSCN>GX4IPPXZC_.*8 6R>./USFE4A203_/MF@!4&">>G'ZG_#]:DJ)6
M +>A/7G_  ]Z"YR<'C/' Z?E0!+4; \GL,8_0?A3@ZX&3SWX-,9B20#Q]/\
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MJ/C]HND^*;B*ZNK>ZC\'>&+[1K>YB:"#Y)[.2]\2).1(2/.T2$JA.77\P/\
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M%-H *,?7\S12\=R>O89_K0 8SZ?F!_,T$8]/S!_E3?XERH*G@D]NO_UOSIQ
M!. !SV[T .4*<YQVQDX]:=A/;\__ *]0Y'3(SZ9I>!US^ S_ %H EPGM^?\
M]>F';OP",<=_;)IO';/XC']:3:,[N<_ITQ0 YAR< [>.1G'Y_6FXQ]/<DGMZ
M_C3]QQMXQ^O7--H D 4@=,\9R3GWX]::P (QVY_&FT@&!U)^M $R 8;W8D^Y
M(&:"JX.!SCCKUI@8@8&*7>?;\C_C0 @+#@9'?&/_ *WM3F .-O/KCKC_ !IC
M'=U_3(_K32 >@V_[N1GZT 2. ,8[_7^M.PG;'Y__ %ZA QW)^IS3U"D9)P0?
M4=N] "H <Y'^>?2G83V_/_Z]1[MKLJG)&.".!U[]Z"<G)[T 283V_/\ ^O2*
M,,3T'.#VZC'-1TI8D >GY^E  <Y)P<$\9]Z2G%B0!QQ2 X.: %"G(R#C_P"M
M2L2,J.GI^O\ .G;OESD9]/Q],U&3DY^G\J %7[PR<?\ ZJ>Q0]QG!QSZ<U%1
M@=P#[GK0 ]0N.<9^N/ZT[">WY_\ UZBH_#/L: )MJGH,_B?\::Z@#@=_?WI@
M8+P JY/T_K07+ =,9]_>@"4;0.HSQGFFMMQD=2>QS^=1T4 +M/H?R-2;4Z=3
M]3G]*89".N/R/^-(&Y+#OZ^_-  !_K,\$-\N?3V]L4\*-F<<^W7J<4PG)S3E
M8C XQSSWH ;@^A_(T\!<#/![Y.#3BP .""?K4+'J3Q0!* @Z$?G_ /7I3L/4
MC\__ *]5]R9"G:6/3)YQ[8-.H EPO;&1TYSSV_6HR23SU^F*0<$'TI#(K'J.
M./3^??F@!Z $?-C/'?'U[TK!>,8]^<^E(P Q@Y_$>U-'(!'0_P">E $D??\
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M]ATS4*NC*&# @X((.>" 1_.@"?:-PX^7'OZ?XT\#' Z=OUS2*R[1R.@[TZ@
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M1T# D$C.#@'/IB@"38OJ?S'^%&Q?4_F/\*1<%2I/7(QGU]*<  ".<'KG''%
M#=J?WOU%&U/[WZBEV*>A)_$?X4U5.Y@0< C:<]1[T *5 [ Y_O-M^O0?2FL
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M9S^E+L]_T]?QH DHIK+G\,_CT[]JAH L4UB0,CU_QJ-5W9YZ5(5R ,XQC^5
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MW'0L >/89X_^M0!-484,6SG@]OJ:'[?C_2H^M %BBD(R"/6F>7[_ *?_ %Z
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MAU-) 4(7]X\W@9OM*F$*#OR2WSDY/)R[7=KAS:VL[H_19GR.F!QSGCV_I3U
M7/.?7CIBOS3US]BG]HZ;3I(?#G_!17]I;3=6.XV]UJ=G\-M4L\%MV)K./P;
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M;PK=SP)M4_),;I51#C +DG@U_1O#&C;7)$BDL0IY(Y)&?0@@CVK^=C53,/\
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M^Z/\]Z '4444 %55C8RROD%6P #G@ <\>E6JKY(Z'% %C '0 44QRRJQ5=S
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M6]/O;>15:.Y@O6MK:6UE#, 8)4D$<G.=DC8YK^=W2/V1_@]\(/@)X'\?>/\
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M #%*"1PY!)/& 12MG'R]<^W3\: # ]!^0J-EQD^IX'M3R2<[>H.#].?7WI2
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M"0-QY&>O![4CDD@'. W.-O3WSVQZ<TX!=X(!S@@'* 8.,XQSV_2@!<..!T'
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M&=_[+TJ4++::5"A.V!@NW>%  "[?4&<OI4</1>9XRFJE.FW&A3>U:KH[-?\
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M?,F)+@;PC$'((6GW _2_.!D\>M-RF<]_Q[5'O)!YX^F.G&.?U^O6D/KGIUI
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MCQ0C AE(==:N=P*ES\V>_'L,4 ?9 ( R.GX^O^-&1C.>/\BH<G&,\?Y-)O\
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M(J,.I7K_  X_2G)]T?C_ #- #J*** "FKNYW?AT_I3J8K%LY[8_K0 X*!T%
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MS]Z$=H+U>ESCRK!5<75>?YE!X7&5H25.#:;H89M2C&;DK*<DKS:V^&]C\_\
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M \_6G$*3DM^HH 14Z[A].?\  TP@CJ*GJ-R#C!!Z_P!* &!2>E !/04^/O\
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M-/#9'. ?KU_.@!,%< #()Y[XZ>E&P>I_3_"E#9ZX7ZL#_(T,V!P0>?K_ "H
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M<?ACK3J:_P!UOICCKSQWH ^&O^"@L?V[]DWXN:7F..35O^$&TJW?S0CF>_\
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MJ,I+!\Z?,J-N55[:J,JJYI)VNH225M4?FC+\=/$?[-/Q_P#CK\0-6^+.C_M
M^%?B?\6=#^%D'P^\/^*M66?]GO4-!L+KQ ^GZWIUW!-!HLK:'JWGW,$,<LMP
MD2W0GCM_+@3G?^"C'Q(LOB!^T9^Q5\%/ FIQ3^(M-^/=_;^,+^W6%[30X]:\
M!"1M.2Y:8;M672GG>6,*=BRJ&*N<5K?M?^(KVRU#Q58_$?P';V>OGQ5JVE?
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MM5\5_#73_%$.MZO:SVFH7GB'QEXC\4277VF837%U<OK=_,USJ#D -<3-),5
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ME 'E?QUNIK/X*?&"]MV5)[#X8?$"]B9U+IYEKX3U:9-R@C<NY!D$]NU?$_\
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MU_X>:O8:$Z>$/AY+I&H132:M8K'IC17TT<:$D&0<*#S7[J?!+X)^$_@S\/\
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MI&BW_AH6H2]TS6+"RNM&^QV:B11<65Y&T+6\0@5E#+A/*4C&T5^;WCF]U?\
M:?\ BAH_P]\*PRZ?\._"\@,A@C6+3K;2K=S;MJOE1H$BEEMU\FR10 J$$ 8.
M-\#AI9WCJV*QLU#!X>U2O-NRC3CRJ-.-K*\E%1BDM]=3@S/$1X?RNEA<JH*I
MF.)_=X>GNYU97_>3NV^6,I.<Y>BN]CN?V3]?^-7Q#\=>-/B)XHUF\;X?ZN)E
MT_1;F9IK*'4A+F.+2(I%/V>V@APC,A <CG)%?!/_  5$G"?&OP9'AY&CO_AY
M(\1)1'']J  ;Q]WJ.<U^[WAGPYI'A/0=,T+1;6*ST[2K6*SM8(D"92)0A=P
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M-?LZ?\%"O&WQ_P!2.C/^VM??"_7]6\2Z=X;\&Z'XU^#?@VZNO&U]J4,<L?\
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M4"VN;FXFN[ATZJLZ*WS*<;UK^R9^S;IY8V/P>\'6N\ /]GLY8\@= 0MQSUH
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ME?M4_%[P]X:.KZI=:M)IFBZ)=:;;6^D6<EW-));V,"N%BB+84'@8/)!#$_\
MP5'U4S*C12?L?VT+QR*"LF_XAP*=ZLN'!C8J001@X(YP=C_@FGX$^)G@GX >
M)=0^+/A2^\#^+_B5\8?B!\4;GPOJEW8W5_81^+CI3O+=?8K2%;,3WMG>2QV[
MIYD,+Q"0[R0.(_:(^!_[2UO^U3H_QZ^"6A>%O&OA/6O@^OPP\?>&=0\7WG@/
MQ.PM-=EUN$Z5KT5C.MAI\Q2P61X5^U,GVF%9+?<DJXNSEO\ IT.R%^2-[_/<
M]T\03>*?#FIZK:?!"VU#4O :7OE>._LJK=0^$")@=2D^'$<DF=6U,;YC<V:,
MT-K@M$?, MZ\R_;0L_"EA^QGXM?P@8KS3-0U+PW</?K*]S>7]Y-K-OY]UJEQ
M)\\M[O+"0/AD(V84#%?0'P\O/VAQX1T9=2^$7PE\!7$:M"WA.W\?:[J@TBV2
M1EB U*R\'B&YN#& [%5^9G.7+9-?$_[0'PR_;$^-=EJOP]\/_!/X?_#KPUXJ
M\5:6/&7B*?XI2>(M&U#3-.U&*Y_X2O3?#EMX?L9K#6C%'R@?,A.V8,?GJ2S]
M./"C8^&GA5@"V? ^BG:,#(_X1ZWX /0X)Q[X%?CI^Q+^TU\'?A9^PY_8WQ)\
M8CPQ>:G\0?VAO#/AN/5]*U18]5O]3\?^,9=*TC2[JWL6BU&\E$X 2%W8N2GW
M@5'[1Z?I#:1X6T_0()OM/]E>'[71XIW4(UP;/3$L4F9%)"%C&I(!.-V.<9K^
M4CQS\$?VS;[X?:/\&X/"7CGP+X.^".O_ !5OK+7_  _8W-CK'B_0OB1XTE\7
M>*?#_B9I=(EMK_P;*T)D$]H5U 1Q[!=A U5%)[NUK?\ !$VUJE<^ /V=O@QX
M\FUSP(?&ECI_P;\::;KVJ/H_A[XU0>*M \<C1_#EY'=P>*OAMHD?A^0^)[FZ
MTJVU.&.SEA>TMMP=IA*&$?[H?LC^+_V??AU\#O!6@?$CXF7UO\2OV@M(\8ZO
MX5\!:C;R+I&HZMH,6M:=HFI7PL]/Q9W$H4QQ)>3QQ3S96)"XP/CSQYHG[3O[
M1OQ5\+_%^V\,>(=*TSP+IVC>&3X?^$L=_K/@7QT?#MO?6.F-X@U'5+.ZN=]D
MMR IT[4+<,]N?M)9FD#6;#X*?'O3KCX0ZAJ?P+OM5UCX+:7K>E>#-;U+P1XD
MO[^6WUW4+[47FUF'3KBVAOKR":_F-O)Y*"(JO#<DZN4)J\+Q2TL^C737I<YK
MS@^6HN9-WT71[;:7/W8_8[\5:%X&_83^%7CCQ7JT&B^'/"_PXUG7O$&LW3,E
MKINE:7JVO7>H7LQVDK'';Q2,< GY> >_YZP?M+>%/VC/^"I'[-.J_#7Q,OB+
MX70? .WUK17N-,GT*]M/%.H^)?CEX?\ $UGJ5EK5G%>6FIK%X1TY&M)XXI$$
M!=/]80W :=XP_;(LOV9H_P!F:P^%E[#X23PEK7@R?7;_ .%VL7^M:AH&M-J
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M1:QDFM$D];Z^;.@,(&X[GYY!WDY;@YP3@\YK\^)O@%X=_9RTOXB^*/#?Q_\
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MO[2WQ4UGQSXNTOX&?#@_;YK_ %&.U\1RVTC>5<WB.)&TPS1@^5:VZ(\ER>Q
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M[*YRY=E5>IEKQM/BG,X8?%*4HU*WLDX4XRNZCO3TC.,?=E_*T[:G)7O[3?\
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MP1ZU$L:J" 3A,*/F)[<D@CW_ $J7<W3:,XSUX]_PIN9<_<7IUW'\NGN: '!
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M^(_B&VU*^T_[&AM;J\A.C*(;HHJ>8@0 %@% %?%?B_7_ -IG2-6UCX,_"?\
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MY+>7/%+2,C\BO^"(?BC2](^$W[1,GF6&E^$?#OC33_$/E9TZ2^T<7_AFQO\
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MC%=W3=L345VFWJW=[][$X^7 +%LGC..*5@2.#@Y]?KZ5$225RV-K9/4Y'''
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M:^U)6NG$UU(QDN'!D?YF-?@5;^'?^"J<-^^EP_&CPRU]Y2K%;2^#/%!N#+&
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MCXR^)4\4R:_K%M%87]U<>(%\2_:YXY+2-4\LR[  "%%?GUX)^*6N>(OV+/\
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M/\ZE8,<8SWSSCTJ, D_CR?Z^] #:=D;<8P>.>/YT]@-IX'Y>](JG/(!!^AH
M:Q!0@##$8S@=?6FY!) ZC /UP*G(4<D#\JC*DDE1P<'L.WI0 *IR"0,?_6ZU
M+2#@#Z"EH **** "BBB@ HHHH **** "D) '/2C<,XSS^/:E(!X- 'Y2?\%=
MOB#X@^&W[/'PWUGPM?2Z9J.J?M+?"/PA+>P6JW9BT;QC;>*_#_B,212(P16T
M*_U%0Y& 6!!)&VOT;^'UK"?!'@\"-)8X?#NCA'(4AE^P08=.FT%0#QCK7Y._
M\%O[DVW[-?P=M-]Q$NI_M:_!>#?;'DK'9>,))$D(PRJ45P"",'&3C@?K1\,X
MU3X>^"U7<5_X1C1%&[[Q5=.MU&>3S@<\FK:]V$MF[K[K&2UJ5$U=>Z[=+I;V
M[^9UXCC4+\FT9 !Y.23WPW7/_P"NI'C0E6.-PS@%L<G';=R.H_'O2NO.,-C*
ME<$?>!YZ_6GMU3Z]\9ZBL[6VT-++L5TM( WF>1$),!1($7S-OR\>8.<' R/;
MFI5A3.YE^;&,DDX7KMZXZDU-1D>M-ZVOK8:TNEHGV*Y@1PRO&&#'HV&7!P2,
M$_Y^E*MM!']R)$&#\J *G_?(P,GZ?6IZ*5D_3?\ 05E>]M;6^7;T(5AC4C:F
MW (ZL,=QCGW/2G[1D'!RO0YQWZ8S3Z*$DM4K#>N^I&(T."1SG<.3P3VZTTQ(
M6&4X[')XX/;/'4U-13Z6OH*R>ZN0&(;MP4[O7<<=!@_>]5';-((%'(7#=^3U
M!X[^@_E4K%ADCH/I2;_EZ_-_]?\ PH>N^H))7LK7(A&H.TJ -P. 1R2<Y.#D
MG.?SJ5HT(((X(SR6(_GP:4#(W8RV"?Q'3C- )*G/8$?I2LEMH#5[WUN5E@09
M*J6)R#\Y*C/<#=C=_C3C&I(W(,\'KSP3M(YP#S4Z'(/U],>GI3B >O;D4PLE
MLO/YE<P*<9C&0.N>?O;L'GD9)_.I/(ASN\M<XQGV^E2 YZ9]\@C\LBEHNUL[
M#(C#&004!!.2#G ^@_I3?*@9L;49D ZC)7.<'^=3TP% <C S@$@$9ZD9./3-
M#UWU%RIWNKW&>4@_@!.<Y(&,^HYR*7R8R>8TY'IGWQ[#.:EHH"Q7,$2DD+@L
M3E@Q&<@^GL/\,TBQID,R;< J"&;G=C=P&]NOXU9(SP:CR,D-T'3VQQVI678$
MDMM+D1@3J$)!]&()SWY;I_C7Y$?\%<M,M7^'OP!O$M;8:A:?';P^MK=20I+<
M1136\R7<$5PWS0K+$2K$'&#S7Z_ KT';ZU^3/_!6@Q?\*[^!0E9L-\=O#:QJ
MD;R;I6MY=BMY:DHN[JQX7J<5[_"BIKB/*/::1]K&[M=[6['S?&"<N&<Y5N9R
MHR^^ZUU^\^@?AIX3\2^-?V+M"\(^$]131]<UK0]=L[:YEG:*-8'\9ZT;RT^T
MQKN@$ED)XE<#(##IU'N'P'^#^D_!;X?Z9X6LDAFU>2-;[Q+J:(F_4-7GP\X$
M@4%K*$OY5NIX$<>0,LU<W^R4(A^SQ\-6A?S(WLM>E#>:9@WG>+O$$IQ)DY0%
MSC!X   P*]!^+?Q+TCX3^!]8\6ZK+'YUO"]MHEBV6?5-;FC<6-E&B,"Z>8N^
M4\!(HF;(( ;DHU\=7I+)<->5/%UU/DBO>J5':,5)[M+5J]U%MR].O$87+,-6
M_P!8<8E"K@<-*'M)N\:5*_/-P3TC*6B;CK))1]?C_P#:W\8ZWX\\4>&_V?O!
M!,USJE]9R^)WC.%\R4++:V<C#^"& --*/4@'D5]F_#+X?Z1\,?!>B^#M&C A
MTZW3[5<$#S+S4)0K7=U*0!N=I<@$CA0*^2/V/O &K:M-KWQQ\:Q2W.M^*KNX
M_P"$>EOHG$GV.:1I+O5X4G7=&)Y69(FZ&*)2IPW/T'^T%\6;?X1^ +_5XI(O
M^$AU)9-,\-6\JEUDU"6,[KF9-ZG[/#'F1SG^$8!/%>]FL)2JY=PEE;558625
M62VJXN=O:2;7V:>L5=/E2?1(^<R2M%8?,N-\WO1^O0YJ49:.C@X?PHI.WOU7
M[[VNY*R]YW\@\2?M.>%)/VB/"_P@L?!.G^+;Z'6+'27\5;K&ZN_#FJ7Y#7DF
MFA[>1H4MX%#7#))$PVD8.TX[W]J?XX+\$?AC=ZEI;_:O'7BJ[@\*^ -(B'VB
M[OO$&J.MND\-H#NFCMXI&D;Y=OF>4A.7KYV_8R^%@T.T\8?M#?$+R;;4]974
MFTK4]546XM=$1FOM;\32RW2J+47+^:BR!E40Q2 ':PS-\#=+O/VGOC1K7[2_
MBNSN(/ 7@>_NO"?P4T2Z1'M;O["9X-0\4R13K^\<RRM(KH@!N9_*$I-@M>GB
M<KR/#9C5J)<^5<,TJ:Q,G-OZYC&_=H4TW[JG.ZJ<B:A3A5ET5_+P.;\0XO+:
M=*O/DS?BZO5E@X1A%?4,!%)2Q%244N;V=.SI\[YIU:E&">K4?@/_ (*[PZWX
M7_8N^!FE_%37M-U7XCWWC*UGO=3N)+:SNKZ_BALI[FUA,:H;P00W:1NH'S;0
MV*_=;X-6=E9_"CX;06-O!:VR>!?"GE06T8A@C5M$LWQ'&@ 4%F8G ZL:_G<_
MX.,-8:RTG]CW3VN<PWOCWQ@DUA*B/!>)/-X)M"1)O5XIPLC;<-CGGFOZ,_AD
MB0?#WP+;HHCCA\&>%HXT[JBZ'8JJ]>?U^M?,9EBHXC+LN=N2I.>(J3C%*--.
M=2Z4(IV22T2LK+1:(^JRC!U,+F^;1NYX>C2PE&$Y2<ZDO9T5S.<Y:RD[IR;;
M;>K.[(R?P[].?Y]/_P!595]HNDZJHCU72--U*)6WK'J%C:WJ*X).Y5N(F .2
M>PZ]:UO6HF9EYZC(' R?F( &!]?UKPTW%J46XR6S3LUZ,^EE&,TXSBI1>Z:N
MON9RC^ ?!#QLC^#/"KJQ!9?^$?TK:V,=1]EZ_*/RKE;GX'?!^[=FG^&_A)F+
M^8S1:/;0DONR3^Y"X.2:]9) Y/T[TF%7+=/7J?TKHCC,9"_)BZL+]JDU^IRS
MR[+ZME5P-&HH[<U*#MZ7BSX_\1?LE_#RUM_&Z>!/!7@K3AXVTW4+?4[#4]/<
M6D6J7E@]BNL6%Q"DC6C^2^)H]A678K94YS\??"C]G?X7Z#9?LS^%-5\">&-9
MN/#OQS^.7@W4+B/3,6EX=%\*?$BREN3"WS?9S=P2R1[@&0SY^4\#]?)2K1N1
MDX!W8SQ@'''?G%?!G@J-?^$H^$@C=X=W[3?[3D[A%R9REC\38VCDX( (*G)P
M?W8 ZU7U_'<W-]=K<V]_:3O?UY@AEV7TX>SA@:,*:^RJ4$N^RC;=MGO'_#,/
M[/[/%-)\(_!K30!UC)TT_('8EP!YN"#QU'TK4C_9P^ ZQK&OPC\""/))4^'[
M%CD\$EV0ENGK7M P#AA@#/7TZ+T]@*E&,#'3M_DUM/.,WG;GS7$SM;>O5>WK
M,RAD^4POR97AX<VKM0I*[VN[1U>G4\#N?V7?V>KS=Y_P>\"LLD1A<+HD$7[M
MB0VWR]NQ_P#:7##/!JOIW[*7[.6DPM!8?!_P;%$Y?<LFGR7))DVB0AKN=V4G
M8O0\=>.37T+136=9PH.FLVQ*IMWY57JI7[VY[7\Q/)\H<G-Y7AG-]?84K^>O
M+<\)7]F?X!QSO.GPC\#F28 2,VB6[Y"YQ\LN5 YZ #KFC_AF3X!%F;_A4W@U
M2RA6$>EI&& .0I1'"D9]N>XQ7NU%)9QFR?,LTQ*EW]O5O_Z4']C91;E_LK#.
M-[V]A2W[_#OY[GBD/[./P*MQ(L/PK\&(LI!=1I$!#;6##@CY<$ \8]Z?+^SS
M\#G),GPJ\$R[V#,)-#M)%8J%"Y5D(. %_*O:*0@'&>U3+-<TDVY9EB).6]ZU
M1W_\F*>4Y4[7RW#OEV_<T]/3W=#R9_@3\'94V2?#/P=M4!4"Z+9J% <. NU/
ME^8 \>F*J7/[/_P6NFB-U\,O!\_D@I$9-(@)13R=OKS^6>*]B0DYSGMU!'KZ
MBE^5O?'U'7_]52LRS&.L<?6B_*K4_P#DA_V5ECWRZ@[::T:>W;X3Q=/V=O@>
M"&'PN\(J0=RD::@.>#UW=.![<?6F2_L^_ ]IED;X:>$EG=BJ2+8F.8LJE@$>
M.0%6"@D>F#BO:"S*0/[QVKP#]/T'>FA0S?,L>Y?F#!?F#="02.#@GIZU?]K9
MK_T,\1_X.J?_ "1*R?*%_P RK#?^"*6W_@)\0?M!?LP_ 9?A-XFGB^&'AJ&:
M*[\)2PSA+MW1X?&GAZ:-QONB-P9<YY_F*[?]C*PLM,^"-A8Z?!%;65KXI\90
MV]O"FR*&-/$%X$1%Q\JCH.E>@_M#1*_P@\6HCM&S3>&5W*S93_BKM R5SD9S
MTXKC/V0T\OX.VJ<'/BKQDV00PYU^\/)!X;'4=?6L,1C,9BVGB\75Q3CM[2I.
M=O3F;ML;87 8' \_U+!4<)[2W-[*G"GS6VOR)7M=VO>Q]/M]T_Y[TW9\O3YO
MK[_7TJ2BN8ZR,+@9 ^;_ "/Y4 DMM;OU'Z]14E-^7=_M?CZ?X4 *  ,"E.,'
M/3'/THI#T/T- ##D_<Z=_KWZ^V*3#@'CCDD<?C0"RD#ID@XX[U(2.A[_ %[\
M4 0''8$=>N/PZ4]PJXP"?H<?SI2@'W1U))Y[\>II'(.,9.,] 3Z>@H "S#VS
M]#^&<4T,<G!Z]>!4I*X&>GT--^3T)^@8_P J )" >#2#'3T[>U+2<9]\?IG_
M !H 4C/!HZ444 -;=GY>F/;K^-*,X&>O?I_2EHH **** "F.S+C;CDXY!_I3
MZ0X[G'XXH 9^\_SBF[F'?]!_A4H([$'\<TQP ,XY)_QH /WA_P BG;@ ,YSW
MX/7\J52,#D=!43$Y/)ZF@!"<$D>IQQGK[4]2QP>W/;'^>:< H /3@<Y]129.
M[_9^G'3U^M 'XM_\%Q+B.']G;X"HRJ\D_P"U]\(8X%/5F71?&LC!?<*&/XU^
MN?PY"KX$\(*N1M\-Z*"I&-O_ !+X,#';BOQ=_P""]=W=6OP!_9K^REUG/[87
MPWG@\I%DD::S\(^.KA/D<X93M<'T!SS7[9^$8O)\+^'XR""FC:8IR "=ME"
M2%X!QV'K5M_NXJ^J;_2QC'^-4](G1$ XSVZ4<-@]<']:6C&/QYJ#8*0@'&>W
M2EHH :I)'/K_ (4W+DMCL?;^OTIX  XZ9]<T #)QU)YY_P ^]  V<?+US[=/
MQI@8Y(8]/H>?3CO0&^8@GCG&<=B!2,%Z@C)/K0 YGXRN#CU!_#M35=BP!]\X
M''MR:10N0I&XD9)ST]B!^-*25)4' &,# XH >2"=IS_D9HV+Z?J?\:%P<,>I
M[_I3J &Y4?+^G/>@;<''3OU_K2E0>HH  Z"@   '' HX(Z_D?ZBEZT@ ' H
M8<J<*<#'<Y]>[=*/WG^=M.(4GG'3UQ3B0.I ^M $>7/0@_\ ?-#*PQL ZY.2
M>HQC'/UIV%7VS[_XFER/4?F* $#+QSS^./UIA9LG!XR<=*;GELDD*>!Q\R\<
M ^@-.(7:"!C.,C/(R,X]J ) <@'VI"%')'4^_7\*5>@^@I2,\&@"/C^#KW^G
MX_A7Y/?\%8)!'\/?@2@DEBGN?CQX;M('A9D99;BWEC3+J1LC^8ACG&#SFOUD
M"@<@5^1'_!7R^.G?"OX*:F87N(=/^-WA^\N;>)2UQ+;V]K/)/';8^[<&-3M.
M>"*^DX/3?$^2QBN:4JUDENWRRLEY_-'S'&;@N%LZ=2*G!46VFTE92B[MNR5M
M[OL?:'[,-V=(_9E\"WL-E<ZB^EZ#XEGCTZQ\MKN^DLO$?B%Q:VN\HK7$CQ;4
MW$ LXR0":^*[[Q/\2/VT?B-HF@0>%=5\$>"/"=Q(/$-AJ*72C1?])*WLNISW
M%O$MQXAFM42&&*--L(RW W,_I/[*G[7GP/L_V=?ABVI^);C3[C^RM2DFM9M-
MNGE@>X\3ZQ((G9!AI%\U=Q''!-?26E?M3?L\W(N)K/QOI%D9)"]P\EC-9F:7
MY5W2-Y'[Z4@9R<G'>O0RS#9SDGURLN&:];,)>[1Q#IU7[#249N,%%PFY77+)
MZQ:T;4FCQL[KY'GSP6#J\68;#Y=3UQ&%C5H7Q'+*$H*51SYX1C*+4DKJ2E?1
MJ+/?+2UTKPUHEO:0"WTW1]#TZ.&/[D%K:6-E %W'^&.-8T)[#CIFORUU^_E_
M:Z_:*M?#>E7$\W@'PC.QU*XC+1PQ:%92JTDJ,KMBZO+A3&FX#Y3QP:]V_:)\
M5_"GXV^!'\->&OC_ *;X'UN'SKO3]0MKJX.G7AFA\O[#K4"1@SV+",94'(SQ
MUKE_V8M4_9__ &;?AZVC:G\6/#FO^-=6F.I^,?$%L96-]=,Y6*UL (MRZ;$F
M!&A.1N)/:M\GPM7+<#C<?'#8FOQ#B&Z5"C]6JWI<S]^LY.#4I-:*SNGHUJV<
M7$6*PF<8W 976Q^#PO"F&<:V(K/%T5[?V:3AAXQ4TXP4K<]]'&S3NDGY1^W%
MXPUKXD^.OA1^Q'\)=0O=%?Q3J6BOX\U#2?/-GI7A.V/E1:1=&T928(K:$W5Q
M$S*#':1H^5D-?J3X5\,:/X,\-:#X2\/6D=CHOAS2K'1]-MHEVB*UL;:."-S_
M ,])FV%W8Y+.S.S%B:_,?X<?$[]F3X6_&3XC_$^Y^(&J^*=4\;3R_P!C;_#U
MW<77AVVNY%N-2B:\D.7666&!(F7&(4V'CBOIN#]N+X W"QLFL:\!)*R R:#=
M8$0VK]I<A_E@RQY//RFNS/\ *\UK83*,ER?*<76P&7TO:5*CP]2$J^,KJ,Z]
M247%/]W948<U[1A=.TKN>'^(<CIXG-<VSC.L#A\QQM25.E2CB:,O88*C)PH0
MC.,FN6HKUG:VL]8IJR_,3_@NOX!LO%GA[]FK5YI+A;G0/'TB1QQ2I%$UMJ/B
M/P6D[R!HF:X=7ACPF=OS[R,J*_=OP9 L'A;PTA)*IX=T2,9SD[-,M5R<=\+Z
M"OY]O^"C'[1/@+XV>*_AQX?T#3=6NO#7A/5_#$NH:QJFGOI]I//JWCOPY'(U
MLTS?/$BV\8+=2P.!BOZ'-"$ T;24A(,*Z7IZPD-D>4MI"(\'N-F,>U>!GV6X
MG*\OR##8S#/#8JI2JU91:M+EG5:CSQ>JE9;:65M+W;^@X:SC#YQF/$M;!8I8
MO!4:]*G"47>%XT*?.X/9IRTNMVF:F6).#D9]NG;K3V4,,,#@$'\0<\8-(2%'
MRXY.#SGU]Z?7RY]>,P22&' /'OUYR#Z&G9#9'7U'/8TWY_,  'E[>3GY@V3V
M],8IP &<#K0!&Z@*V!@OV'<GI]#7P5X#('BSX2CY<']IC]J#U)R+7XDDXSWZ
MYK[VE_U;GN!D>Q'0U\%^ T+>*_A-QD+^TO\ M0,QV]%:W^)*8)![[A0!]Z_*
MPWD<$ \Y!_+\J:6(.%/';C_'WIX557;T4#')[4;4/3!_$_XT 1[FX&>O'0?X
M4[+@@'GOT'3/J*=M4<XZ<]3_ (TN1ZC\Q0 A+!AC&W').<]^GZ4H(/2D)&#R
M.A[BH@Q P#CGVY/X_2@"0$C.X_3I_3\*16Z[CZ8IQVGJ1^?_ ->DVI[?G_\
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MTH"@\8Z>N?2@!-V&()X_K@4,6'(Z<=A2D*2<]>_/],TC$!2 ?UST(X_SZ4
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M==(NM-BGMXI[1)I%\F2*[A;YYU@^MKC_ ()H^%I(98HOVO?V^+21T=([B/\
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M^U?MQNP!]I^,:*?GY),; \\?-QQBLFY)IO=6_#8)4XSIN&\9>=G]^Y^6:?\
M!%?]K*'Q19>,4_;MTUO$%IHUQHBW;?#?Q?&W]GW5U]MDA26'XII)$@N-QV"3
M8=Y)0M@U8UK_ ((P?M<^)-5T'6-8_;IT&]N?#>HSZEI7G_##QA-Y%U<6HM)'
M#3_%=BN8."5*L1P21Q7](Q7+D @#Z#N,\?D/RIP3:"3R<<9 XZ^G6J]I/^8Y
MOJ-"Z34N_P <K=.EU^1_-+XS_P""*?[6OC+2K'3-9_;4\%ZK;Z1J6GZII=M<
M_";Q:L5I<:=?6U_ (S+\4Y!&AGMH=Q0!OD&TJ0",7QM_P19_;%\5>'=8\*7'
M[7_@"ZT?7M+CT^^AF^''C"'(\^*8JBGXB2J )+=2=P8<Y(/.?Z<P,@MQWX_
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M@'US_.@!:*** "D)QV)^@S2TUEW8YQB@ 5MQQC'&>O\ ]:G4U6W'&,<9Z_\
MUJ5CM&<9YQ0 M% .0#ZC-0-U/U/\Z )B< GTIH&2']>WZ=:#]S\%_I2*W1<>
MO]3TH ?@Y!SQW'KZ4M%% #77> ,XP0?KCL:4CI@XQ^H_"EHH *9LYR#WSC_Z
M]/HH 1FVC/OBEIGW!ZY/TQQ_]:G,=HSC/.* %HIJMN.,8XSU_P#K4CD@<''/
M^- #Z3.21@\#KC@^PIJMGC'Z_P"-/H 0C((]:9Y?O^G_ ->I*;N^;;C\?PS0
M H&!C.::J[5*YSDDYQTS3Z:6PP&.O?/UH 51M&.M(RYYS@]/PIQ. 3Z#-,#Y
M(&.IQU_^M0 Y1@8SFEII;!Q[?3U]:=0 44UFQCCK[TZ@ HJ$,1[_ %S3V/RC
MWQG\C0 ^FA<$GUQVYXZ<YYI%;/'H,Y)I0V21CIGG\: '5\D_M(X'CK]GXE0Q
M'BKQV5)ZHP^'6M'(YZD8KZVKY7_:$@$WC;X$DX"Q>(?'LF-JGY1\/-:W=7&W
MOR Q]!1?5+JP.P_9U<R? WX8.W+-X5M"3[^=<#-=#XT\2:H;VV\$^$&B;Q9J
M\#37-\^)+?PEHI_=RZ]?(#S<$L4LX#@S3+GB)'8>1?"SQ?)H7P4^$7AWPU:P
MZSXT\0>%X8] T@L_V>WMH9Y5OO$.N21 FP\/68EC>>4X,KM':P![F>*-O>/"
M'A.V\*6-PK73ZMKFK7+:IXE\0W,:Q7>NZQ(B)+=O$';[)9)&D<5K;*S1VUM!
M'$"Q#,[6FZV)O?1/YGGB^#4^%:1>(_"<=U=Z>J>9X]LB/M.H>(3@>=XL>3 :
MXUN-0S3?\]85P #&,^QZ?J%GJMC:ZCIUQ'=V=["D]M<0L&CEB=<JP(Z'L1U!
MX(!%7,\]!R",$!A@\$8)Y&.H/6O(IWC^%FJ273,L7P\UZ_4W"K'*4\(:[?2[
M?M.(UVV_AVYE/[PD*EM*^]B(R30W??<>B\D9?CWQ!:7/Q%^&GAC2?%&AZ9XB
MM-5UR_U"TNGM+R_MK"Y\%^)H;69M-DNHWCCEF5PCGY3Y3 9(Q7B=S+=Q_M[_
M  ^&I:MI^J!?V4/B!':RV]K;6ACO9?BMX ^TQAEN9"YFCAMV5..+=B,X./E[
MX]_ [P?\;_VQM!T77M'CN'F\8^%#?:QI6NZUX1\0OI>D_!KXWZU9::GB[PLT
M>HVVEG5K:TE>VAF$-P8E$RE:\#^.'[.7@CX#?M8?"'Q'X6N/$VE3Z%IGPI\3
MZ;=W_P 6O'^N0_:M5_:/\$?#77;;5AXEOWC?1&\*>*Y42S+-"URK7#*) I(T
MDD0W+7E5]5]W4_H(5LY!/0XY[\GMZU\7_M;/._BK]ENVLKRVL[V3]H+PLT<]
MQ"MRL,:1RF21K<RIN!!P#D $UP?Q/_:C\3Q?M!?"70OAGX>N_&?P6TY?&D'Q
MO^(6A/#>Z'H%[%!I"Z1!83I,IUQK":0OJ4EC]I2S34 LV&CF$?Q7^U?IF@?&
M7]N+X*68\4>(-2TZSUSX7Z7H(\'>.=9TC1([/Q(;B_U35)/[%:6":](C58KC
M8SQ+D8S0ON-&?J-X@UZ#P_\ &?X:MXH\7Z EO>^&_&=A;"8VNE"34;J?1(+.
MWA,MXWGRR2.45,;BSC&>E<Y^VQ%;-^S_ *E)J$=TVEV7Q-^ NHZW)9M*DUGH
MMA\<OA[<ZQ?F2 [X+>WL4GFED!_=Q0LY("DC\Y?V@OV5OAI\'O'O@_4[;1=4
MUJ;6/"OBZ_6;Q?\ $GQ7\2I-/U[2]=\+:AI&L:!;>.E(T&_@OG9_.T\1R;"P
M*^6/E_53XMV$/Q=T_P 5? K3YF&F^)M#N]%^)^NVR03?\(UX7\06CP7&BV,D
MP:-/&M_IUPYM%97^P0.-1E7/V..X;22B[[[D-WYD]]O\CR?XN_ WP?\ M3^&
M];^$M[J.OV/PFV)8^*]7T/69([_Q)J-LZRQ^'K&YE$BMIEM=0V\EV[*XDEA\
MA2"KFE^!GP,T']G31K;X0:AJFN^(/#E[J>H:EX9\<ZSJ;QZC?WNHR)+<Z%KC
M6[*D5\@CC6V<*J2QH%&'&VKGP[O?B/\ L\:#I/PM\4?#GQ-\0O 7A:UM-%\%
M_$_X;:?9:W?WFA6T0AL8O'W@F+4%U2R\4)$BBYN["UO;&[?-SOMFD-O'#\4/
M&?Q(^+^C:E\,?A=\&/%EH=>QI^J_$KXM:9+X%\&^#;.3 DUS3-.N;V+7/$GB
M"#[]G#8VD<7GHIFO8$R2<TE:SLOU[_UZ!RI>^U>;_I+^O4S/V1+.VE\<?M?^
M(M*WOH>L?M$RZ?IUU(TTHNY_#?@7PIIVIO%-*/WT27<IB)0E0\+CJ#6)\)UD
M&H?"!FF\[?\ M0_M722NZLLN\ZC\8ECC'4,JQC;GCA5 %>O?L]>$[/X$^&]$
M^ NI72W6I:6FI:CHOBR:TEM&^)#7=S-JFMZW?223R[_&!O)[B6^@::1VBVSQ
M9B5UA\I^&<UQ+JOP;,D5Y%YO[3'[54F^2VA\N:&#4/B_ A::"(+$C,P,9;]X
MXA.6.#2>KT''9+JC[[(R",]<?Y^G% & !Z4HINX9Q@]A^=(H=1132V"!@\_3
M\* %)((&"<]_3]*6@G )]!FD4[AG&.<4 +1135;=GC&* !5VYYSFE P<]2>"
M?7\*9YGM^O\ ]:I/3W].: &LN2ISC:<_7M@T!<$G/7/ZG-.IH;)(QTS^AQ0
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M %J4G )]*4'(!]1F@!,_,5]!G/Y?XT9Y(QT[^_''ZT9YQ[9[?Y]*6@ HHHH
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M2/%5XN5V[5TZRP#C&X9'WN_7'M3!I&NC;_Q55T<!LE],LSN)*D'"NN, ,/\
M@1H"[[?E_F=25 &<8/U)Q[>_--&TCU)Z=>_3]:P(M-UH2HS^(7D12,PMIMNI
ME7Y=X=UFX. <$8P&YK?(VE?7 )],C\:!GQ3^TQ\,M"^*?QI_96T3Q!<:W91:
M)XM^(?BG3K_P]K4FB:K::G8?#'Q1:0/#<PHQ:)HK^=)%QM*R$'K7DWP^^#/A
M3X7?\%'=2UG2-8\2ZOKGBO\ 8\LX=5E\4ZY+KUZUGHOQ?U!=-BMKB6)/LEE&
M^H71$8!WO=.V1MKZ5^*]LUU\>/V;A:W[V6IQZA\2WB81F=39M\.=?BFD>V9U
M1PMQ);8).X%OEX+5YY#9ZI#_ ,% ;*2[O(M16W_9 $-Q.MO':RK/=?&?4'LF
M^S^>QVF.&X7Y2P/V7G:6&YIV4O[RM]XNNVY]$>*%7_A:OPT;RF9ET?QSME#?
M+%N30"P91]XG'KQM]Z^3_P!N'P!I7Q*\9?LB>%=<N]9TZTE^/$.H0ZCX=U)M
M)UFQO].T2>XLKJPU 1/]GF691T5N.*^NO$,FWXF?#[= \BG1_&'[\;=D#@:*
M%##;GY\D<$#Y>E?/G[4<5Q)\4_V0?)E$3CXU7!\PQF4)CP]<<E ZYYQW'UJ4
MN5)+H,YC0/@-X;^&7[6/PP\567B?X@>)]:U#X8_$S03/XV\4MXB2TTW[5X9O
MY(M/1K2+[,9+FW@9V&=WE*.*^^% 8!B.2 2,^O/XU\R:O!J]O^TA\*Q?ZI!J
M$<G@/XDF-%TR&R\C;+X=)9)VN78R%B,HN!C+$X!KZ8#-Z_I_B*8$FQ?3]3_C
M3"AR<#C/'(Z?G3MP_O#_ +Y/^-(I8L>1C!QP?7ZT -VG.,<_4?XTH0Y&1QWY
M_P #2L<9P1NX_A/^/I29?')_D/T- "L%&<=>..>*CR>F>/2G$$G.1V[K28/M
M^8_QH >J@CD=_?\ QI&7'0<8YY^OJ: 6 P".N>J_XT$L>I'YK_C0 RE"D]!_
M*C:3TP?Q'^-. <=/YB@!I!'7C-*NWG=_7^E*5<]1_*DV-Z?J* ',O]T?K_B:
M;\S>^/H.O_ZJ4%ST/\J ''0?RH  G/(_4?E3]B^GZG_&F$N.O]*7]X?\B@!2
MJ#K_ #/^-(V% *\9(Y]NN.?PI"'/7^E!#D8(X'TH :22<FL#Q5J=GHGACQ%K
M6HV,FIZ;I.AZMJ5_IT4$=W+?V=CI\]S=64=K("MP\L,;H$;ARX!X)KH-C>GZ
MC_&O&?VC-/BU;]G_ ..&D76KZ=X?M]2^$GQ%L;C7=7:Z72]&AN_".KPRZGJ3
M6-M-,+&".1I9O)BEE$<1*1NV%()[,_"_X(_!OQUXP^,/C/XN:)X_\ ?L7^&_
M&'QIC^(WAO3=#^)>G:OX_N_ EW8Z!I\'PVUCX:Z??OX?T.QO[K2[JZN &BNH
MI]>E6-.P_HR@7$<*F7S\11@S<#SCY8S+A3@;CSQQS7X8?#7]I7_@D3X8\$?#
MO1/$OAWX1W/B_P +> OAI_:>NQ_LN^,$ANY1I>FZ=IWB^RU&^^%,$DN@7&L6
MQ:WU*14C:21"\BRMMK]R;&>VN+.SN;'9]BGM;>:SV+LC-K+"CVY2/ ,:&%DP
M" 0.,<54O2WRM_PYG2M9VDI-ZZ.__#%QE_NC]?\ $T@5L\C/KS_]>@%R"0>!
M]*3>WK^@_P *DU,?Q+=:QIV@:U?^'=&'B#7++3+RYT?0C>V^G#6-2A@>2TTT
MW]XZQ67G3!(_-D81IOW,0 <?EA^T]^U!^V/X0^!?C;Q _P"RYXA^&#V'_"-"
M;QUI?Q.^'GB&Y\-PW7BW0K.ZOHM'L-5EGU!&MYYH62*-GVW)..,C]0O&;Z>/
M"/B=M8\23^#M)30=6DU3Q9:WUAI=QX:T^.RF>\UR'4M3@EM]/DM;</,)IXI(
M8O)#R(R @_A;X;^,GP7UC]KCQ]\)O$G_  47U/5O@9I?PX^''B7PE+K/Q?\
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MU_04@D). P)R1@8ZKC/\Q0!*2N>IS^/:E# G /Z&F?)U/ZYS^--) .5_S^=
M$AP3C)SZ9.#Q_+%)\HR"3GORV?S'^>:8I^8$G\?PH;[Q_P ]J 'Y3U/YM2$K
MR03GJ.6Z]JCQG_\ 6!_.EQ]/S'^- #U8'&2<]/KGZ#BE.T<'/KU;U^OK472E
M))ZT 3#'4$D>^?ZT;1SUY]STQBH0Q'0_RI2S<<C]/Z"@"4D#&>/2D) /)QG^
MF./\^M1$D]32DDXR0?R_I0!*2!UXZ_G_ $_^O0""3@\]^O\ 6FY4XSU^A[]:
M:2H^[USZ'ISZT 2$@#G@=./_ *U QP?R/^?K4;,"!Z]3^5*K8ZGC&!T_IS0
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M.?RH&1T(Y]Q_(]Z 'N!@G'/']!0I& ,\\_S--)8\$C\UIO(/7D?0T 2'@DD
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M9ZC'N/\ "D**F,9YZY/I_P#KKE_MWBK_ * &G_\ @[7_ .0Z/MWBO_H :?\
M^#M?_D.@#IJ<JY/.<8]NOY5RZWWBHQJ6\/Z>LASN0:XK* .X;[%S]*=)?>)U
M(V:!9.I R3K4:$,0"1AK3D>] '4[!ZG]/\*B*@$X'.3SG/'TQZUAB\U[8K?V
M+;ER!N4:K#@''(#>3S@^U5I-0\3C.SPU&YS\I_MFS"M\PYR5R 5SU&>E '2T
MJJI;H<^N?;TQ7/\ A/71XGT"PULV4^G-=HQDLIY(I)+>2.1HY$:2,E7 93@C
M@BNDV#U/Z?X4 1LJ@]#D8YS_ $I*EV#U/Z?X4;!ZG]/\* (N._3OVI-J=E.>
MWS?_ %JFV#U/Z?X4;!ZG]/\ "@#Y7^*>HP:?^T5^SPT\%S<^9IWQ5$$5I ]Q
M+YR>$W<N88QEQY(E7V+CVKC=/NXM0_;WU6X2VO()(_V2?#,!-U!-:[XV^,7C
MG;Y:RJ-ZY1OF']_%=;\5[.^NOVD_V;EL)WM6CL/BT\MVMN;E+>-_!EQ"C2+P
MNTSRQ@;V R1U) KT4?"!4^*-U\6AXHO3XDN/A]I?PZ6)M.M?L,>BZ9XGU?Q0
M+@1"3+WLEYK$L9.X(L4*83.30!V>IJ3XT\+'("+IFO@_WL[M/'KQV_.OFG]I
MRX%M\4?V22%E=#\9;OS!%$TS';X=N6 4(,YSGZU]'3>$];GU;3]6?Q9,9]-M
M[VWBC&DVXMV%ZT)E,BBYW,0(5"X/US7(^,?A /'>O_#WQ'K7B6X74?AIXGD\
M5:#]CTJ*W@FO9K%[!H;^)[QO/A\J0D;2A##(- & ^LVVI?M#>"HX(KR(I\)_
M'[G[7:36Q.SQ+X&4A1,H+?-*I^@-?0I1,9')/OCD\\CM7@$FGZI;?M!>!KC4
M-134?^+7^/[;S5LA9;!)K_@N4(J"XE\Q]T/7(P#CGBOH38#GU[XZ9ZD]/6AB
M5[*^Y&>_MV/IR3S_ )ZTW:AYVG_OK_ZU9M_8ZO/(6T_5X+"/8JB.73/MK!P3
MN?S#?1YR".,<8ZU4.F>)"H \168());^P>2"",?\A;U-.R_F2^__ ""[_E;^
M[_,W=J?W3V_B/^%* .@!]AU-<]_97B;<3_PDMIM(X7^P!@'!YS_:O/./RQ2C
M2_$H&/\ A)+,G!&[^P,'E0,@#5N#G)_'%.R_F7X_Y"N_Y7^'^9T! Z,..XZ?
M2C & !@>YZ?4FN9OH/$%C975[)KUD8[.WGNI2N@.\CQP1/*X"C5N6VJV .IP
M/>N3T3Q%XJU_2M.UFQM+M[/4[=+JWDET;2H62)P0OFP2^*U='.W)##(SCK2M
M_>3^_P#5 Y-;Q?X?YGJ.%)Y!)'0YP.,]L<]*6N$>\\9( 5LKIA@EP-)TMFX'
M1<>*^I;H!V&*JC4_&H8$6%\R_-A3H&G*P965<$GQ;TP^0<8PA[\$MYHGVB_E
M?W'HX7@YR#S@="?3ZTTJI^\#GZX_3%><MJOC,X/V'4$D#N#_ ,4[8."H8[0"
MGBS '7G/..E3'5O%^-QT_4#E<8&@60(R3U'_  E7)QCBGRO^OE_F'M/[K_#_
M #/1#&IZYX_#^GM3,$] 3^%>=+J_C+YO,TZ^?+$IM\/6:X0@<-_Q5?+ _P"%
M/BU?QAEE;3[U-[$1LV@V^U%+1JAD*^(VZ!I"><G;@9.!1RONA\_]U_U;_,]!
M"@9VJ1Z]3_3CG/Y4Y0&..>@.1P.<\'/>O/8-:\4NS%M/U"*,LRJS>'?GQ'(Z
MDLBZX3M*;<<<E@1WQ$=:\5N3MLKV, Y^?PO<-N'< )K.01QVP:.5]U_5O\PY
MU_*_N_KN>B%4R>">O.[KS]/K3EC1CC!'X_\ UJ\X?6O%<:HWV2Z?(^95\+7I
M;J1R%U4E/QQTI!KGBT*<6=UO +$GPK?!2F 0J_\ $SY?^M'*^_\ 6G^8<_\
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M5P> 2,<__KQQ0J@C//7'Z#VI1P60 XVYW>I/&.GM2H" <C'/^% $>#Z'\O\
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M ,"#').3S]/;FG@8&*0,2<;2/\_2G4 %%%% !112%@N,YYH ;O'H?T_QIXY
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M9(^"&_ZI'\1/_4F\"G^AKW7.>?7G\Z\+U63S/VC?!<81AGX2^/V$I'R\^)O
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MZ4N]?0_I_C368'&.WK^% #MX]#^G^-.+!<9SS3=X]#^G^-&]?0_D/\: 'CD
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M'\9:EXXU2^OM7N;>RO6$<K7+H&ADV(F]LO[.^W^8_MKIMKKM9:=C]DA^7M2
M@DCTI@D!'(/X8_QI P!8\\G_ !J#<EHIF\>A_3_&G9XSVQF@!:*9YB^_Z?XT
M\<@'UH *0'(S2%P#CG_/XTH.1F@!:*** "HY.WX_TJ2HF!&,DGKU_#WH D)
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M\L[6YLXO)MIHT9P2Z1#:,DY'7->C9.S.3GU[]::I)89)_,^E K+MN?._@?\
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M/U_IU_&@!A!'WL]\<Y_K3F^;&WG'7MU^OTH7YL[N<=.W7Z?2FKN_A]L]/ZT
M-I2"!DC@T $]!4IQM&[V]>N/:@"( GI0 <D#J.O.*D0J<E>Q*GKU'7K3@ "2
M!R: (B".2.I]NOX4@!)P*F(!ZT@"@X'7\?3_  H 9M?W_/\ ^O2$-CG./K_]
M>I3G!QU[?Y-(02N#U_\ KT 18.,]O7CUQTIR@\8)QG)Y/MGK1A\8QQ^'UI0=
MH(/!Y([]N/U% "/]X?0?S-)AF]\<?YS3@-P)/)Y [=N/U-( XZ?TH 0_+U4G
M/3D#^M)DCH2*5MW&[\.G]*0 GH* #)]3^=+AF]3CU/\ C2A0!EOPZ_TIZ@@M
MQQGCZ<T 1[&]/U'^-!4CDC]14HSDYZ9XZ=.?_K4I /!H @VG&<<?AWIR Y!Q
MQS_44Y@W( ^7C'3M^-.4$  _YYH C<')/;C_  IE3/\ =/\ GN*BVG&<<=?\
M_E0 F2>IS0.HQU[4]0"I)ZC./RI5 ()QR#Q]<#'ZT ,((//7ZYH"D]!_*G$,
M>2.@]NGX4Y.A^O\ 04 -4@9SW]OSIH!/04_]W_G-$??\/ZT (5<]<GZD?XTK
M?-C;SCKVZ_7Z4Y=W.[\.G]*8 XS@=?I_C0 ,1M [C&?P!%- )Z4\*23N'Z]_
MP-)M8$[1ZXZ=/QH 9WP:D)!4 $9&,YX[4,  #CDGGZX.?UI&0,HP,G@]?;ZT
M -P<X!Y[$']:""#SUI4&U@,8QG^1-._Y:?Y]* &9.,9./3M0 2>.M*RD9('%
M(,Y&.O:@ ((//7\Z!GH">>V:DVD@[A\W./Z=/>D4 8W?>SQU_#I[T  X!4\$
MYP/J,#]:0*P]0,Y//;OT-2$ G)'(H/(/T- $;D'&#TSZ^WK2N2,8)'7O]*%3
MKN'TY_P-/(!ZB@!< ?YY_.F#Y2Q/ )X_7TI](0#UH A/)..>2?UIRG!Y) QT
MY]NU*RK@X'IW([CWI0JX''8=S_C0 NX'/7 [X./_ *U#<J<>@/X=:CD VN$(
M#[3M)R0"1Q3ESG!8$8Z;2/3U[4 -0@D$>_\ (U-487#<#"C_  _QJ2@ HHHH
M *C9^FT_7C_$5)4;)TVCZ\_XF@!"5'W>OX]/Q_"GAQ@9/..>#U_*H]C>GZC_
M !HV-Z?J/\: %4@,23P<_P Z<"@)(/)^M,*L 3CH,]O\::H+*& X/^>] $K,
M"" ?T/K3 Q' /Z"C8WI^H_QI""#@T .#G(R>._'^ IQ+=5/&/;M]:8%)Y _4
M4N' QVP?3IWH <'&!D\\YX]_84BL .3CG_"F#J/J*9(LHE3:(_(*G?G=YF[(
MP4(; Q[T 6%)(Y]?\*8'.1D\9YX'3\J:&(& >/P_&@!F&=N.W7/\S0 ]V!'!
M[^_O3MZ^OZ'_  J/8WI^H_QI I.<#IUZ4 *S$YYXSQ2$DC!/ H*D=1_*EVL>
MWZC_ !H 56((R>/I[?2E)7D@_-]#_4>E($.1D<=^?\#0RD$D#CZ_Y[T  9B<
M _H*<6P,$X;Z?X#TJ,9R,=>W^33BK$Y(_44 )O;U_0?X4H<Y&3QGG@=/RII!
M!P:<%&TDCD9Q^0/]: '[U]?T/^%-+$D;3^G?\14?6E(*GT/6@!Q9QU/\J:"1
MT-+AFYZ]NP_SUHV-Z?J/\: %) ^Z?K_3K^-"D#.3UQV/O_\ 6II!'44NQO3]
M1_C0 I('W?QX_+K3MRD#<?KUZ_A3-C>GZC_&C8WI^H_QH 5"%+ '"DD]SR3U
MI26'.>#TZ=^13"I'4?RIV'('IVZ4 )O;U_0?X4F3G.>?\BD(QQ2@$]/\]?\
M T +O;U_0?X4H<Y&3QWX_P !32"#@TE $I<8.#SVX_Q%1DD]?3% !)QWI=C>
MGZC_ !H 56 4\\\X_*G*XQ\QYSZ=OP%,V-Z?J/\ &C8WI^H_QH >2AZG^=1@
MD=#2[&]/U'^-( 3T% #W8$8!YSZ'WINX_P!X'Z8S^([4;&]/U'^-!##J!CZ
M<\^E !O;U_0?X4]23U(^G&>W/TJ,J1U'\J 2.E $F[#$$\8XX[\?_7I2P/"G
MGM_DBHB23DT@.#D=10 XD\@L,]QD9_(4!B,#/'<>W?M2$D]<?D,_G1M.,XX_
M#M0!)E0" >H/KUQ[TU6 4C.#V_(>U,ZT[8WI^H_QH -S'O\ H/\ "D#$=#_*
M@@CK0%)Z#^5 "KMYW?AU_I2 D="!]2!_.@@CJ*"&7T&?4 __ *J %WMZ_H/\
M*-[>OZ#_  IM% $A?@8//&>/;GMZTFX_WE/L,$CZC%)M8]OU'^-&">,#CZ#I
MQUH 0L3P3^@IRMCJ>,<<?X"F=*>JY/(.,?G0 9&_.>/_ *V*=E,YSS^/TII0
MY.!QVY%-P<XQS_DT 2,P((!_0^M(I48)Z_C_ )Z4W8WI^H_QHV-Z?J/\: )"
MZX.#SVX-,!!!)/S#I_3I[TH3@Y'/..?;COZT!<*<CGG'/M[&@!N]O7]!_A1O
M;U_0?X4WK2D$'!')H >K]=Q^G'^ I-Q[LH^N!GZ<4T DE1U'449QZ?B ?YT
M/5^NX_3CZ^@I"QR<,"/08)'UH  ^\/I_7I^%-8_,5XSUQ@=.W(H 4L3P3^@I
M5;'4\8XX_P !2D*0=O7\?7WIA!!P: )"4)R?ZT@&"6Z+CC\<4W:Q[?J/\:D(
M.W'? _3%  7&#@\XXX/7\J53D GGK_.HMC>GZC_&I5!  /\ GF@!:*** "DR
M/4?F*6HF7'0 Y_O-C^7X4 /<D#CU_P :0M\HP1GC/3TH<$@<=^W/8TT*3U4
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M!^G/XF@ !;=S]W)ZC ]N:<<$<XQ]>/SI&(((!!/H.3UI@/\ "W _(^HSGWH
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MG\Q_A0 N%)[$]>O_ ->F@ /@=/\ ZU+C;RN2>GKQ^'TI!G=N(QZ]NQ'?_/-
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M4,N#P">/K_*D"G(R#U]* 'MM()R"<$#FA.A^O]!3"H! ['&?SJ0;0, C\Q0
M$!N^?H>E-<@XP0>O]*:"5SQU]?;_ /70H!SDX].E  H4YS^'.*5 #G(]/ZTW
M!]#^1J4 +WZ^I';_ /70 C-@#!'!QCV]*1#EB?4$_J*1U &1W/X<Y-*@.>AZ
M?X4 +A.^/S_^O2@*.F/SS3& Z@\YY&1[T@)7G'YC@T 34WY<YR,_7\/6F;MW
M!P >IZ>_>E*J 2"3^(^GI0 _(]1^8I:BV_+GG/I^.* S#@#IVP<^OK0!)D#J
M0/QHROJ/S%,QN!)R" <=NG/>F $^O7&<=* '' 9<8QQT^M/.TG)(R/?_ .O3
M"H# <\X_G2%0"!V.,_G0 XC!W)U/7'/^?_K5'4R@#.#G^G6HL'T/Y&@"8A3C
M./;)Q32J$EB1G&#SV_.E*ANN>/\ /I2;!ZG]/\* $488\''./S%*RC!..?Q_
MSTI"S GC@=R#2J6)Y&!CK@T +R%&.N!_2E!X!/H,YXI V6QM8#^\1@4UV(R"
M"1QR ?4=3V% $E%1@DX4D'C!/?IZ^M/ P,4 +1110 5')V_'^E25')V_'^E
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MPW?CD4 # [EX/;^9IK]1]/ZFG,6!X&1]#0!NY.00>.W3GO0 P$KVZ^H/;_\
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M?Y4 -9B#CC]:4,2I/'&?Y5#0.2!ZT 2#Y^O;T]_K]*>5#8SGBF?<]\_AT_\
MUT2=OQ_I0 YEW?@#^?&/PIH^;()!!.5QZ<C_ !_*FLV[''2I%7;GG.: &LH
M)!/'T]<>E/7H/H/Y4$X!/I3%.6)]1_A0 _ R3W/_ -;_  I ?F(],8_K_.D'
MWV^G^%/H **84R2<]?;_ .O3@,#'6@!:*** "BBFLP7J#^ S0 *NTYSGC'3_
M .O3JC\SV_7_ .M1Y@[ Y]^!^?>@"2D8;AC..<TSS/;]?_K5(#D ^HS0  8
M'H,5&Z]6SZ<?D*4O@D8Z''7_ .M3@<@'UH 8C=%QZ\_F:>W0_0_RHSR!ZC/^
M?R-+0! !D@>IQ3_+]_T_^O3R,D'T.:",D'T.: !1M&,YYS0HVC&<\YI:11M&
M,YYS0 M%(3@9]\4M #'Z#Z_T-.7H/H/Y4TO@D8Z''7_ZU*K;CC&.,]?_ *U
M#J;M^;=G\/PQ2DX!.,XIH?) QU]__K4 ,?[Q_#^0IX.$!]/\:5_NG\/YBFHW
M1<>O/YF@!X.Y?3((_I2!< C/7OZ4C-C(QVQG/J/I0G0_7^@H  F"#GH<]/\
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M@_(48'H/R% $0;!)QUS^IIS\J#ZX_D:<=H&2!^0I>"!P".W% $8?  QT]_\
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M56!XYR!S0 TH220 ,G.=S'/_  $C HVO_>_4TF[#'.2.>/QI5)+'DXYP/Q%
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M_.D4$#DY_$G^=*>A^AH 1@3T/;!&30H(&#CKFD7)4\\\X/X"G*"!R<\_7^=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g1078498.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078498.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" -6 I0# 2(  A$! Q$!_\0
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M_9_#T_QH^;=_L_AZ?XT;U]?T/^%&]?7]#_A0 N >3U'3_.::P)8$#@8S^?\
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M.+DXN278_;$$ $NH&,GA7(P._*\=*;NCZ@\# )PW5@648*<Y&,8%?RV>'_\
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M !S_ (B@!V1ZC\Q1D>H_,4S:G][]12@*""#S]0?7MCIB@!]&1ZCIG\/7Z4A
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M6S:I^T-\<-4-O(P9X!J>N6&H+$Y''F*+H*V.,BOWDW+QR/S'/4_R_E7X _\
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M3^]^HH >6 &002/<8_*F@EAA@ ,9R!CN.YZTFU/[WZBG?+C;NXX[CMTH 4$
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MNV0$!;J]M@<9P7Z<BOQ8^(_Q@@N/CM^SGXNBNF,FE_ [2I)7+XFAF\1^'/%
MOX!'&1Y+&X%LW[PLIV(XPK'/JW_!0_\ ;^\/_MJ^"_V?-$T?X>:UX$_X59:7
MT>JMKFL6.I)J<][X=TO2HTLOLMK'Y01K*>0,=WWE!]:_+_4=9?4)].N6D<3:
M%X?L_#\4K.!,;>QDO!''%)GY@L5X8P!QY: =!BO[I\*.'ZF5<)8'"YGA'1Q+
ME5J3ISLVO:27+JFU:4%%V77<_ >*\7#,LYE7PN(O1I*,;NW+\*O:[35FWT[]
M"X?$$Z^$]0\/(F^+4O$MIXD=2OEE;B.Q-G,["-S'N9%BSM'7/<FN/NP?[.U,
M$QH!:RE-K9QMA;]V W.><$]*L&6,JZ(R)&[9$>]!LR1P&SR,J>OK4$YCDLK_
M 'E54V=Q@LR#K$W0YY'3I7ZA7J4HT*BYDN6,OEM>_P#5O3KX5*#C"*YXSFDH
MN2:O*UE?SON?V!?\&TX8_P#!,C1][$X^.OQ?51M(P#=Z(0,D]*_?]BQ'(QSZ
M$?SK\"?^#;%0O_!,O1$'0?'#XMX/&<&YT0\D#YCSR?:OWV9\C&,>O/\ /_/:
MO\U,^:><YHTTX^WJ;6?VGV/Z5RUO^SL#=6:I0_\ 2(C?3'ZXZY_ETH/^ZP]R
M1C^5)4A?((QU_+Z_6O).XCHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** %P<9P<>N./SI*=N^7;C\?QS3?J<>YH **/H<^XHH **** "BBB@!RMMS
MQG-"L1G"EOICBFT4 %%/5]N>,Y&.2?7/\Z8>23Z__7_QH **** %!QZ?C03D
MD^M)10 I5L9 //0_Y%7;;[OY_P Q54/@ 8[>O_UJMVQR,XQG/&<\Y'>M8;/U
M)G\++-%%%68A67,N)6.>WI[UJ5F3'+ENF>QZC'7^=9U.A<-WZ$5%2>7[_I_]
M>D9-HSG],>]9FHRBG*-QQG'&:0C!(]"1^1H 2BBG;?EW9_#\<4 -HI0,D#UH
M(Q@=,#^IH 2BGA,@'/Z?_7H"9SST./\ Z] "*NX9SCG'2FTN2.A(_&DH ***
MD\OW_3_Z] $=*#CL#]1F@C!(]*2@ HHHH **=M^7=G\/QQ3: "BE R0/4@?F
M:5EVG'MGGB@!,C' /7J01^&*2C)/4YHX]\_3C\^U "YX ],_K245)Y?O^G_U
MZ (Z*<J[L\XQ0R[<<YS0 @. 1@?4CFDHHH **** "BG%< '/7V]LTV@ HI0-
MQ ]>.F?TI=OS;<_C^&: &U_.K_P<Z:LMA_P3DM[8O$LM_P#&WX:K 7D\N4M;
M:LEQB$?Q,%0D], $CFOZ+-OS;<_C^&:_G(_X.@([1O\ @G/:K+"TEV/C1\/6
ML)]KF.V<7Q,[RE<@AH=RC/0M6^%?+B:,K\KBT[]5;K\C#%O_ &>JG[L;/I?^
MOF?R=_\ !/[]C/P?^U1X9\5>.?V@OVD?&'P!^'+?%'X8_L\_"OQ)IEE#K0\7
M_'CXKZB\&CZ'=IJ5PB6F@VNG6SR7EPK8MQ<Q-)A2:^6?!O[-WQ3U#_@H!X:_
M80^)7C/Q#X)\3WO[1I_9\\5:W;,]U<Z2L.L7EC;>)].L[EU2ZBN]+BL;VWW$
M))#J,;9*X-?2R_M<?$G0OV-OV8?V;OA-^Q3#XH\,_##Q7XG^-/C?QA\5?AMX
MZ\1V7CWXS:O>M;^%?&G@B^\"^++"2ULK/PV&M"]PS%WB1X43:6KT3X]_M=S_
M !7_ ."E7[)G_!1-?V3?V@?"?BCP38_ _7OVK/!NG^ +OR/%_P 5_AA;W&BZ
MUX@^&*F9O.TN\\-1Z)%%_:;VD^=+02Y),E?94>(.(8SM#-<2HV:256=E:UNO
M7_(^9J9;E4X1O0ISDFG)N*NT[;W[>6NYYU^SM^P2/C+_ ,%)OCE^PSJOQW\>
M:'X2^"MU\;_MGQ'TO1XM4\1ZY8?!V_CMI/(\.O-Y:WEY"TK"-&)WJJIDL*]-
MUS_@GW\,_%7[.7[2GQX_9\_:,_:,G_X9ATF?7_%OA[]H;X+:I\+M-\6:6;I]
M/CL_!VLS*JW^IF4'"<_(0>]1_ O]LW6?@S_P4^_:5_;N@_9K_:8B\&?&>/X_
MMX.\/:)\/0/'/A74_BR\=SX;U+4+:YG6PW6=Y$DDYBN)N5!19>AY7XF_M]_M
M'?&7_@GEXY_90_:ET/\ :J\0^,-"^*4?Q(^%/Q9?0[VP\-S>%Y[Z6YU3P7\<
M))_LC:EHD$4R_8G2.X6%U_> @#$5>(>(Y/E>:8GEDDG^\GU2OYO3S,I9=D_)
M.$<)!U-6DH^:M9K;4_KN_P"#:1B__!+OPH^<E_C#\3VR226,A\/N6)8]?GYK
M]_:_G]_X-GE?_AUUX7?<"&^,WQ0(YSP1X=((/T_QK^@*OC\0W*O5DW>4G=^K
MW;^>[/JL*FL/235FDNW;I;2P444]DVC.?0\C'%8G0,HHHH ,CWS]./SHI<G&
M,G'IGC\J2@ HHHH **** "BBB@ HIS+MQSU]NWYT[R_?]/\ Z] $=%*1@D=>
M2!^?Z_\ UZ2@ HIQ7 !SUQQ]1FG!,@'/7V_3K0!'2@X[ _49H(P2/2DH 4G/
M8#Z#%)13MOR[L_A^.*  +D$YZ9X^@S3:7)]3^9I*  <D#U_^M_C2L,'&<TH7
M()SC'].:0DGK0 E%%.9=N.<YH ;13F7;CG.:;0 44Y5W''X],]*0C!(]* 'Q
MD@GZ']< _I37^\?P_D*7:0N[..!T]^V:79G!R>1GD?\ UZ &E2!GV!_[ZZ5<
MMON_G_,55*D \Y '3\1VJU;?=_/^8K6&S]29_"RU1115F(5FS_ZUO\^M:59<
MS RL!G_)K.IT+AN_07[O)).>/\\_7\Z-I;G<<'D ]L_C35;!R23^O\S2,QR>
M3U/>LS4 #D@'&,\].AI&ZGZG^=*I ))S_G\: -Q...I_7_Z] #:7)QC)QZ9X
M_*E!"MSU&>!^6>>U(QR2?\]* !3@@_YZ4K')S^5-HH 7)]3^9IRL ,8.>3[=
MORIR,,!><\_3U_E4"MO4,!C.< \="1_2@!U.5=PSG'..E-I<D="1^- "4N3Z
MG\S244 %%%% !1_D44JG!!_STH =N&W;SG].N:-_R8[\@Y].>:1CDYZCT/\
M]8TV@ HR3U.:** "ER<8R<>F>/RI** 'JFX$YQCV_K3<GU/YF@$CH:2@!<D=
M"1^-!)/4D_4DTE% !3V(*J.X SQ_GV_*F?UI>F1P??K^1% #F(*J.X SQ_GV
M_*F4O;I^/]!Z4XL"%&.F/Q]>: &\X[X[>E)3RP*@8Y&.?Y]Z:01[=OTZ?E0
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M HHHH **>K  @YYST^E,H ***>K 9S_GVH :23U)/U)-&3ZG\S24]"!G/>@
M5@&)/&<_X_TII.23ZFANI^I_G0!DXSB@ R?4_F:,GU/YFD/!(]/_ *_^%%
M3GDT444 %+DXQDX],\?E244 %%/5L CG)SC'N,4R@!<GU/YFA>H^H_G244 2
M2=OQ_I3"2>M!)/4D_4DTYF!QCM_7% #22<9S[9IRL #D=<8X]#G\^:1F#8QG
MC/6D].N./_KX_'- "@99B"1GG\,^WM_*D;@G)Z8Y/'84]G&.,Y/X8IA)/)H
M,G&,G'_U\T9/J?S-)10 N3ZG\S5VV^[^?\Q5&KUKRN?K_,5K#9^I,_A9:HHH
MJS$*SY2!,V?3^M:%9TP+2L!C\?K6=3H7#=^@ @YP<_AB@D#J:, = !^%)@Y.
M<$=@?T[>E9FHH8'H?YU&" S$^_\ .G-\HR  <XR .G/M36(*CINXSD=?7M0
MYV4@@'/X$=ZBJ0@;,X&<#G'/.,\U'0 NTXSV_P#KXI=AQNXQ@GWXR/YBER-F
M,\__ %\TJLH !/KV/J?:@!58  $X_ ^IIAVD@+CTP!@#G/\ 6E8C P/QQC^G
M-,H <RE<9QST_"FTI).,G..GM24 %/V'U'Z_X4RG;V]?T'^% #W((P."N,^_
MO^M*&7 [>WI_A46<G)Y_3^E)0 I.23ZTE*!D@>M!&"1D'!QD=* )%90 ,_H:
M8Q!.13:<I 8$].] #:*<2-V1TR#_ (TK8+?+SG\_Q_#% #0I()XX_.GH0 <G
MO_,?_6--R0".1GMC@^N<_A3: )MZ^OZ'_"F.P.,?RI I(R"/U_PIM #T(&<G
M&?;/K0[ XQ_*F4_8?4?K_A0 LF,KCKC\>WZ9KY4_;B_:0N_V1/V3/CG^TGI_
MAF#QG>_![P#K'C.#PO=7<FGV^M2Z5"95L9KV(%K='88+ 9%?5!)/7U)_.OST
M_P""L'PS\?\ QA_X)T?M;?#3X6^%-9\<?$#QC\'O$VC>%?"7AZTDO];U_5KF
MT9+;3]-LXQNN;J1CA5 R2>!32NTNY%1M0ER_%9V_4_+OP5_P6Y_::\-:U^R7
MXE_:>_8J\+_#CX$?M=?$/X<?#CP/X_\  7Q>TSQOXET_5/BM'!+X2O\ 4O!T
M,AN$L?)G$ERNWS(PA7A\ [-Y_P %A/VTO'G[1'[7/P:_9Q_8M^%/Q#\._LJ?
M'CQA\#M7\5>,_COI/@&_UG4/#-[/#;:A%I6L3QEUGM(TE8Q92-I=A.Y2*^%]
M#_X)4?$?]A/QQ_P32_;7^$?[/7Q2_:8LO#N@_#?1/VI?V9_%-YXC^(GC/X.^
M,M?T+29-1^-'PI\*W]^R:7K^@ZJ;^.6Q$#I;&WB6(("TUOX'XE_8VOM$_;6_
MX*->,_VD_P#@DW^W!^U-H_Q=_:Y^)?CSX,>/_@F^O>&O#,GPYU?5KZ>W=GM/
M%&FKJ374\[7,,VV?]W<A-T90J>A0IMW2YO\ AT</-6BTI75VK_<FM;'[8_$K
M_@M8/V=?VQ_V2?V4/VE/A#H_P[;]HCX2^$O%7C+QGIGBY-=TSX;?$3Q=<36-
MGX5%S"?(U30!J4!@^W!L,TZ$?*V:]0U7_@HY^TSXXU/]M#PW^R_^RSX9^,?B
MS]DKXZ>&_A<^F:M\01X5@\3^%=5\,2>(]6\7O=W0VPSVR($C@C)$H;<#7YG^
M._\ @G;X@_;B_;'^%<WC3]EOXO?!+]G?Q-_P31D^'>C7?Q&TJX?7?@/\6=*U
MB"[\$Z)K/B$75T;3QWILUO#(?])>=X@YW'=FOH'_ ((3_LK_ +87[.NC_P#!
M0?2_VM?"?B^V\:>+/B-I>G>&?&7B&VN88?BOIOAOPAJGAZP\5^'Y779JMK-9
M1::AF0EC(^QOFS3Y*=KI:Z:7\U_P?D4IUG+EYO==[/T7HCZ!_P""8'_!3#]L
M/_@H+KEOXJ\2_L;^%/A?^SI%K?Q&\$Z]\5M.^)2ZQJND>/OA_&8)]!_X1BX4
M2W$$FKM;VQG7Y1YN\?*#7TQ_P51_X*/:%_P31^ 7ASXJ3> [WXL^.O'?CRS\
M"^ ?AAI-Z++5O$MPFF:EK_B+4('VEOLNGZ+ILDLQ .&N8@<!J\7_ ."%'P.^
M+_[/O[%GBOP/\:_A[XF^&7B^^_:D_:$\7VOAWQ=IL^E:O/X9\2>*+>YT#6TL
M[A0WV"[MXWDA? #HNX9'-?(?_!0#]D_]O/\ ;L_X*@^!/^%/G3_@7\%/V+O@
MQ/JOPZ^,7Q@^'NH>,_A9\2/BY\9K&XTWQY;>&](#1QZ[?67@^XL+"27<R6<^
MFS_QRJ*S2BYZKEBOE^)K^]5&+3YISM\M4F?8'[2/_!771/A5^PM^S7^VE\(?
MA<_QBM_VE_%GPU\&^%? Z^(+31[BPUSXAPR1Q:?>ZE(?+2\M=606LRG[KYW?
M=-6_V<O^"H7Q%\4_M7^'?V.OVOOV5?$'[*OQ<^(WA+4O&/PAU&X\5Z7XO\'_
M !#L-$C,VK:=I^LZ<<)JL49!\L]6&P#<17\\_B+]C?\ X*(? _\ 9*U3]BO5
M_P!G7XN?'BQ_96_X*"?"WXW_  D\;_##P-JEUX=^)GPFN=6OO%OBH>"()AMB
M6TUHWG^CO*!;#4(87*X)K]*?%^D_MQ?MY_MU_ C]J/PM^Q5\4_V;O!O[$OPJ
M^).K>"(OVF;?2?!NN_%GXLZ[I#)X;\,V6E:=J5U-%X>-^B+/.,A5;<=IXK10
M@G=6;UUO]QDJE1M:M/2ZL]^O^?H?KI\<_P!NN#X,?MT?LG_L9R_#Z?76_:<\
M'?&3Q0GC>/5H[9/"S?"CPV/$/V23367=>B\!,89>8S@]*^1O!W_!86V\5_\
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M.? NH?'#]L#X\:W\&M8\7:+?Z*OC'3?%OPO73M#\5>%[N\A5=7T Z[.4M[J
MO&5MU7(92HGDAJK7VUN_(J-2K)QD[J][Z=O\S=^(7_!<#PKX9^ >A_&_P?\
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M\?TJ2QS+M[YS3:4DGJ:<Q4XQCOGC'I0 RGH0,Y/I_6F44 *>IQTY(XQQD\T
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MEM/45\0MM;_\#8\SL_\ @NMX*D^.7Q!^$4G[/6HWMGX(\=_&[X?KJ/A?XU^
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M?$/COXW:+XJ@;QSXOT_XM6&N:+XQ\):O;ZCI\VFMX;F\/ZV;!8H[%'2WTVW
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M!GC_ .M2*PW$YX.<'\:910!)P7[$?F.E/# ''&?3&1Z^E0@D'(HR<YSS_D4
M2#:@V#:%Z[0OKSU^M&4]OR_^M49)/6DH E++@\]CV/\ A45%% #P5VD'&><<
M>WKCUIH/(S^HSQ]#VY_6DHH <Q';!QGH,?UYIY9#UP?J,_TJ*B@"7*>WY?\
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MQ+$'.,>G?K0 H+#.,^_&?SIM.#%<XQSZ_P">*;0 4N#Z'\C24_>?0?K_ (T
M,HP3T&:#R2?7_P"O_C2A\9 4@^IS@D?RH E55.!P6XRN3G\1Z9J,CD@9./\
M/\S0&()/'/6@,02>.>M  N,_-^O]<T,.?E''L./PQ2$Y)/K2AB !P<>O7^=
M#:*4G))]:2@"15!'([^_3BG;%]/U/^-1AB!@8I=Y]!^O^-  R\C:#T_#_P#7
M2JH(Y'?WZ<4A=CGIR,=_\:0,0,#% #F48&T>W'I3,'T/Y&G;SZ#]?\:-Y]!^
MO^- #2".H(^H(I*<S%L9QQT_&FT +@^A_(T8/H?R-.WGT'Z_XT;SZ#]?\: '
M%5 )QT'6FH%)^;./;_/TI0V[(; &/IZ>IIN=I..1^?IZ4 ! W$=OP]/>KMN
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MINJW%]%'--/$5DDEC#LQ8 UMS0[?B8NC6>U3;\M+_D?B1\!/^"C7[1_[4_\
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M\8_#5[Y^IZOKFJ:K>_##28+_ %C6=?U*YU35M4OH],O((!<2WEU,Q$4,: $
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MU/ECL>.W';MWJ&K-J][&NY)32Q# <<XZ_6D"8(.<X/3'_P!>GGD$>O\ ]?\
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M* %P,9Y_+C/IG-.+Y4+CIWS].V/:F4\I@9S^&/\ Z] #0<$'TK0MSE.F.?\
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MC/3W]<TS)]3^9H F(R"/6H2,$CTHR?4_F:2@!ZJ."6 &>X[9^OI3V< \<^_
M_0$U%DD8YP,G'IZFDH ?G<P[?_6YIY4,?O$';P"!VR3W]/Y5#SU_(TI)ZYY[
M<\C\NG6@"9 5X'/.>GI[4T1CG<Q&3QP ,DGCV_\ K5'D^I_,T9/7)X[\\9_E
M0!,5W8YQC/7IZTSR_?\ 3_Z],R?4_F:<KXSG)]/U]_I0!-P?NG=] >/\YJ-^
M@^O]#48)'3O02>A)^AS0 ],DGV']0/\ /TI7Z#Z_T-19(Z'%9>MZ]HOANRBU
M'Q#K&FZ+8SW^G:7#=ZI>P65O+J6K7<5AI=A'+<.JO>7%[/%%%&"6D>0*H)-
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M+KYC9*(S+O/;*J3D@?-R!2N?+ ,DJ(&(52[B,,Y/"KN8;F/8#F@!WE^_Z?\
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M./3]: !A@XSGO^?_ .J@*2,\4A)/6@$@CD@ \CUH >,+PPSWX /'3O2. ,8
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MADEC@Y[]??O]:T*SV.TE6.#Z <?I]!6=3H:4^I&J8/.",?7^=!0Y.,8SZ_\
MUJF*D $XP?0@XJ([\G'3)Q]WIVK,T KD #&1C)_#IT^E!7( &,C&3^'3I]*4
M[L#'7C/3TY_6F_O/\[: (SP2/3_Z_P#A3@A(!XY^O^%2;1W'/?D]>_>E((&%
MZ]OS]_QH BV_-MSS_P#6S3L ?*0-Q!YQ]<<T -N!/T[>A]/\\TX@[P>P'^-
M#-A]1^O^%&P^H_7_  J0YXQZC/T[T-G'R]<\].GXT 1[#ZC]?\*-A]1^O^%+
M^\_SMIRDD<GO_A0 S8?4?K_A1L/J/U_PI?WG^=M.7=SN_#I_2@!'  X '/;\
M:8%+9QCCU_SS4F"2=W*]1T'\OQIFU@3M_#IT_&@ *$ GC ]Z A(SD<TXD$%0
M>??/;KDX]J0!QP!_*@!-A]1^O^%&P^H_7_"E_>?YVT N>0?Y4 -*D#)Q2 9(
M'K3B'/4?RH"L#D#I[C_&@!50Y'(ZCU]?I2/U'T_J:7]Y_G;2A2P.[KVY XH
MBHIVQO3]1_C2%2.HZT )3@I/3'XT;&]/U'^-2A0,X'UH C\MCTP?S_PI&0KG
M...O/2GG?GC@9XZ?G2\-P>2.O7KW_6@"(*3G':G*!N(/.,_H12[6!.T?RZ=N
MOX4F'SGN?I0 I0Y.,8_'_"@*1R<$#J._ZT?O/\[:"'/!'\J &L03D# ]*0$
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M.P<X(^7 QGCT_'UI3D#Y>".G^3[4 1[#ZC]?\*OVXQ&.F<G/YU0R^<=S]/\
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M$X)P/6DG;HF/E_O/[SY9^U?MG_\ 0-_9Q_\ ,A?_ "[H^U?MG_\ 0-_9Q_\
M,A?_ "[KZGVC<1SM'?CD8X/TIVQ?7WZCIZ].E/F_NK[@Y?[S^\^5?M/[9WWO
M[,_9RW>G_%P?I_T'/2G?:OVSMV/[-_9RQZ_\7!_^77]*^IBJ@9!R?J.G]?\
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M&.<?F/\  5F:B@ $GUJ-B22,=">@.>..:<S8'&"?3/UI@8@D\<]: &T\,P'
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M/'[./B3&/J/CQZBOII6*D \<@?-G/I_2ASSD'MV^I]*7KJ-1MU_K3_(^9?\
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M 'U.?<T444 .W';C ]/P_P :;11@]<<>O^10 <]R<^IZC]*.>Y.?4]1^E%%
M!SW)/UHHHH **** "CGN2?K_ /JHHH *.>A)(]#C'\J** "CGH22/0XQ_*BB
M@!VXXV\8_7KFFY;^^WYC_"BB@ I>>O/UY^G6DIV[Y=N/Q_'- #03U))_WL?T
MI6.[J!244 .#$ @'KGGOS]#2$DG)))]3244 %%%% #E8KG&.?49II.>3110
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M_"7P3V$UNIU.ZM]T'[VTWY3GJ"*\E\2?MN_MU^!8_$<.F_LUZE\1+.'0=/\
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M?=3^(_K4;':3P<GJPP0..._O6?/+N:2IQ5K1N?C/X>_X) >&+3Q[I/C3Q/\
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M27)$118@[([''ZLZ'\(OA3X9MM-M/#_PZ\%:1;Z.86TR.P\.Z9 UDUOJ":M
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MMW/\7=.&M7OA^#XE2N;^'X816]KH;_:M8/A4Q:B663>J2%/*.TO7V'>?LX_
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MGF>H?\-6?LY_]%>\(_\ @1>__(5'_#5O[.7_ $5_PAST_P!)O.W7_ERKR\?
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MU;]F/!Z?\6NN<_3_ (\:?(N[*YJCO[NWEZ>9ZA_PU=^SE_T5_P (?^!%Y_\
M(='_  U=^SE_T5_PA_X$7G_R'7E__"I?VE/^@K^S)_X:ZY_^0*/^%2_M*?\
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MX5G\'^"UUZX1K66_C*:6(/-8-9V]Q*OR_.D19<A2:?)'L)N26]WZFE=_$?\
M:HAN9([7X&?"N[MT*!+G_A><$(D!52Q\J7PGN0!B1R.V>E5_^%E?M8?]$#^%
M?_A^;7_YDZQ/'?P+_8#^%_AZ+Q7\0_A'^S;X2\/SZG%HL&K:MX)\)16<^KRO
M*J:9 \=@YFO289R8U!<")RP 1L=/IO[*?[%VNZ?9:MH?P&_9ZUC2]4L=-U/3
MM2TWP5X,O;*_T[6;6*]TB]MKB"U*SVMU9W$,MNZDK-'('CW*0:%&*Z7$G)MK
MFM;S_P" 54^)/[61.4^ 'PM8CKM^.]J<9X&2/"GUJ0_$7]K=B,_L^?# =O\
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M_P"M1YGM^O\ ]:LQ\B[L<Y...,GMQZTU%;.2S$$8P2,'O32Q(Q[Y_#TIP?
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M-7Q1NO!GBW3/$<>B75Y/;V6O:OXD\-W^A6][965E-#LBTZ&WU*]>623YF^Q
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M)^%=,U&XUWQ5IRMJ.HW5V/$=KH&B#P]I%K;EM7$LC7K7-LG^DVR1+*Z^6&-
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M'%NM+\&^&'L=?N9K>^N+;0+@Q/=-")0SMY;*IQ5_X6_\$8?AG\)/C9I/Q?\
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M_A#J/[7?QWUB+7OC!HOQ<L==NKVPDN='U;PQ8M;Z!<007-M(AUA+Q+.[GN
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M$+R;2M0036]CJ6DVNK^*_%,]M)%NCT?1H;R!9B0/-(;8<*:!VAY?>? ^B?\
M!#_]HC0KRRFT?_@H7X[\*VDVHZYJ>LVW@SPA8:$EM=:[!:6>HR>'(H+C;I]Q
M=0VL<]S)()6:[@BN$V,@KV;XX?\ !(?XS_'*+X5:1XI_;@\;WOA[P)X6^'^A
MZM#<^"?"R7U_/\.?$0U^S339+"RA0:1K$ZVB^((;U+M]573+=;B5XX@E?0'P
MO_X*O_ SXC^&M1\6XT_1]"L_CMI/P:M]4N?$5@=-N[/6-5_LZW\9K??ZN/2]
MA27:S!F60!<FN6C_ ."T7[+,'B?PMHNH1Z];Z+JFH^-M*\4^-+:!;SPSX/NO
M"FM6&G64EQ>QD#5;.ZT[5=-O9);;>+:'4H=^2] K4TEY>9Q/Q>_X)'_$#XI?
M'[Q?\>XOVS?B%X;\5:SX9T#3?#WB#1_!O@G2?%WAS7=+MO">C76J6^IZ)I%M
M!' WAOPK#;0K#;Q3(UU(SS.CR(_!WG_!(#]H+6/V?])^#FK?M]_$>]U;1/B?
MJ?C_ $[6)_#6EO96EIJ-M=V4FGV=V@75(998;AGN%_M VLLKN3;[6Q7UM\,/
M^"N/[&WQ6^(EO\,?#_BW7;7Q)_;MIX<U$ZIH%W;Z9HNI:QI.J:_X8AU/44#)
M;G4]%T?4KBV/.1;[3\Q%9$?_  57^#&E3>)]?\42Z#9> ;3Q'K'A;PQ/HGBK
M3=9\>:IJ6A:C=:?<3:GX*CD%QI=E,EE<31NX7RXTVR_.0* 2A_3?ZGSHG_!)
MC]I?5]2TNP\5?\%#OB9<^!_">CWUOX+T?1?"/A_2=2L=6GT#3M,L-1U.Y6)K
M>X6QU32[2>T1+=&A0L$82LTI\U\*?\$=_P!LOP/K7@SQ-X;_ ."CWBBTUOP/
M"9M*>Y\!V]]:W++K+^((/#6H07&H,+GP2-4CM;AK*3=F1Y0'5"JK]EZ1_P %
MFOV&M;N] MK+QSX@ \57]O#H-Q=>&=0M8-1TR6*\DN?$$+2 #^R+=[&ZBFD/
M21 O<5+K_P#P64_8>TO6?[#TGQKXE\8WL>GZ3J=TWA/PIJ.L6VGV^MZ!;>(=
M-%Y<PC;!,^GW/[Q3S%)!*CX*-0.T/+[SQ7XR_P#!)KXW_&.T^$.D>(OVY_'^
MJ:+X$^'G@7P5XD_MOP3X0O;W69O!=T]W<2Z:\&G1)'IVK33(VJ"^2\N;LZ18
M&>>0VZFO4/BG^P#^TYXL;XN:;X._;4U'1M ^+'A[P?I.I6^N?"CP+<ZA%/X1
MT33]!@)O=#TRS6&Q:RL8PJ0QPR JI>1VR34B_P""WO[!-S=ZY:Z7X]\3:U)H
M]E+K ?3/">ISVFH^'6UJR\-V/B*QN2@5M)NO$-[':6[G!=XG) 537TOX._;[
M^!7B_0?BMK=KXATQ'^&U@VMVFG+?!KWQ-HMYX1C\8Z-/9PA#Y%W-831121L?
MW,Y9&/% +DZ?J?E'X-_X(F?M.^$].UNRMO\ @H%K<=QJVISZA=RZ?\.M.L[7
MQ!<WY@675O%<)NW.KZ_IJ6MN=&N2RM:21!\-C!^C_'__  2N^.FJ?L^?#3X/
M^!_VX?'5CXK\!^(]3\17'CWQ7X)\(ZMJVH:IXCT_7M*\1ZU%K-AI]MJCZK=V
M&O7$5TEU?7%K>6TDUG<PR02[5]3^&O\ P6#_ &6?&=W\-?"FMZAK.B_$7XD7
M,=A8>';#2;S5+*UU!3'/J\=QJ42D16NFZ?=6<M[.X")YK;"0*Q/%O_!6_P"$
M^A_%?Q/\/M-TZQO=&\-Z5X[U[_A+I]0NGMM4TKX=)H\7B0V]I9V[-93K>ZA>
M+!Y^Q)ETJ38=TB9!+D6SW\V?*GC#_@BC\?==NI+;1_V[=;TS0+:;Q5=6%I/\
M-/#S/=7?B7XFZG\4437+;3_(MKZTC\2WD%XP6%"+M&:$PQ".-+2_\$7_ -H.
M]TN^M-4_;_\ ',NKKXIN_$.D>+;;P3HD?B:RCU*TL+:^:UU1\S6-\J:?##;^
M2\<,5O&L8BZD_5G@+_@L)^S;XK^#WB[XSZU>1>&?#7A+XHV7P[D@DOTU+4=4
MM[O2]-U-=>T^RM%+&-SJ4<4=NQ\UI!MQDBO3K_\ X*@_LT)I'PYU[3==,VG>
M/=8^(&@71UB:+P_<^$=6^'^GS7E_9:_;ZB!Y4LMU;S6\0#9+H3C% 6IZ?YO^
MOO/FCX,_\$POVF_AK\4?A_X_OOVZ/$]Q8^#='\3:)<Z1I'@'PRB&'7)4=-0T
MFWURVN[2'5[C;F_N9K>625W8Q&($BO4?V5O^";_Q&^!?[2UU^T/\2?VFM<^,
M,UAI?Q)T/PWX=U'PIHFF8M?B!JUIJEUKFLZE!"9'\3%8(H+F:V^SK-#IEE"$
M2"-HVP?#7_!:W]D_6-5T2SU-?%.@:)J6C75SJ?BB]TQSHNE:];ZQ::.NBQ7!
MP=2@>2]MB+J(&(&903WKW+X ?\%0/V4_VE?B-H?PJ^&7B+7[OQEKEYK6DK9:
MAX>O+&VL-?T71]>\13Z!?7CC9%J4GA[PUK%Y& 2ICMQSEUI2=DV5'D;5G:[[
MGZ)*S A1T+#D@<#/N>*5P5. 2!C. 01[Y].!4'F9!XQD'_.,>M-,VP*"C/N;
M;E>J9!.]_1,<5BW=M]S=0L[WN3<]B1]/_P!5%1^9[?K_ /6I=Y'52/\ /TI%
MBX9OOY..F3^?3\*=EO[S#V!''Z5'YGM^O_UJ/,]OU_\ K4":NFNY*#CL#]1Q
M1GC[JY[D#![9^G2HO,]OU_\ K4>9[?K_ /6H)4$FG>]AY4$Y(_4_XT[)QMR=
MOIV_*HO,]OU_^M1YGM^O_P!:@L4CYOXN?3C]2?:K< P.I.03SUZBJ>\X.!S[
MG Q[FKEN25R>G('Y_KTK6&S]29_"RQ1115F(5FS<.X]6W^^2 ,9].*TJS9"Y
MF?:H) YYS@$^P]16=3H7#=^@QE &1GKW_P#U4RGLTH&0BGU&YA^6U3_*E\P]
MUP>XST_2LS4:JY.#Z9X(I^P>I_3_  I-['[J@GT+,/\ T%#2_O3_  +^9./T
M'OV% #  6QVR?TS_ (4NT;MO./UZ9IW[[^X/S/\ A1^^_N#\S_A0 W:-^.W_
M -;_ !IVP>IH_??W!^9_PH_>XSL7'KDXH BIZJ",Y.>1[=OSIV)L A5.1ZG]
M>.*/WIYV*/;+G^:#B@",C!(]#BGHH/)!Z]LC@8/7\?UI6+@<H,DG SQC\B>F
M>U*KNIRZ;5!&,,Q.1T.&08[9.#32N[7L)NR;[&8='T"87D3:1H\XN97>_C:P
MLI/M$LT>R1[V-H3YLCQ#!,@+,HP211<:5H$J6*W>E:/-#H\L$NF+<65D\6ER
MQ#RX7T]9(2+&51A4,>TJ" IK\6-6_8._X*'1_$SQ9XZ\&_ME^"/"5G\8/$NK
M>._BE8Z=X;\<P7&D>(-)AN+7X>Z!X1DC\6;+WPI%8?98-0C8::6"NXCG(VMX
M+>_L5?\ !8:QTB&#QM^U;X"^*NC0>'_%&BW6B6$WC#4-4U*Z\2Z!J&G:$]QI
MFHR:59W%UIWC>ZTK5H-7^UV=YIUM9&.$7*0I:SW[/S.9R;?P']#LGASPY+>+
MJ,GA[0WU*.RNM,74'TC3WO4TZ]N&N[W3ENFM_,%C+=DR2Q!MCR'>ZE^:D?0-
M EU!M6FT'1I]5>V:R?4YM,L9-0>T*&/[*UZ]N9&MO+9EV%]NTD8Q7)?"W1O'
M7AWP)H6C_$+6]+\3^,K1M4.MZ_I<6I06&HRW.KW]U;S6]OJ5S<S6\?V.: ")
MIG6  6Z,R1*[=_\ OO\ GFN>N,D?7MT_#M4-6;78V@DUKW_R/-+'X*?"'3-:
M\0^(M/\ AGX&MM9\56%CI.OWJ>&=*+:EI>F1>38Z=<1/;&/[%'& /*5%1B-S
M*S<UTT/@GP; + 0>$?"\*Z4T[:4L?A_2(UTMKI ERU@J68^QF1%42&/9O" -
MD5T>Z7IY:D]QODS_ .B>.A[TC-.HR(ES]7;]#$/YT+6ROHPY8\R=UZ?UW.>E
M\'^#9;^TU27PCX7EU/3A_P 2_4Y- TB2_L?WMO/_ *)>-:>9;?O;2U;Y&7YK
M:-NJ+A7\(^$Y[2^TR7POX<ETS59X[C5--DT/2WL-1GA2*.&XO[-K4QWEPD=O
M JO(K,JP(%("J!T(,Q )C4G_ ($!Q]%..?:@-.6"^4@!')\P'G_=(!'Y4.ZT
MOHBO<\OP,6Z\)^$[W3H=)O/#'AV[TFVNDO;?2[G0],GTZWO$;>EW!92VICBN
M0_(=4#@\ALUS\'PH^%EIJ2ZS:?#3P!:ZPMP]TFJV_@WPW#J2W4BE9;E;Z/3!
M*MPR9!<-N(/)-=X3.,_(N.>H.?Q/K3 \N/\ 5H,>KL/T\O'ZTKNUKZ#M%[),
MYW2?!/@W0-.N]&T+PGX6T31K^![74-(TCP]I&F:9?VDIN/,M;S3[.U2*ZMV-
MW=[D=&4_:Y<C]XV9]/\ "'A'2=6O-?TKPIX:TS7-1FN+C4-9T[0M+LM5OY[H
M0"ZFO-1M[59KJ67[-;^8SN2_D(&)V+C;;SMR_(OH0>2.G?M_]:G[F'#* ?3)
M[]!G!H%[GE^!YEI_P3^$.F+JBVOPU\$NVLOJ1U62_P##FEZI->PZM=M?7]C-
M<:C;22-I;W3%Q:[OLZG[D:@ "^WPC^%,A._X8?#MLZ=<:2^_P5X;?=I5VBQW
M6FMNTS_CPEB55DA_U;J K*P %=Z3-WC7_ON0?^T*7,PX\M3Q_><>W:,\?E0'
MN>7X''7/PT^&UYHEQX:NOAYX&N/#MW<6-W=:!<^$]!GT2XN=+@M;;2[F?29+
M P2W%M:V-E%;NT9:*.SB2,JL: ,N_A?\-;]+1;OX?>"I6TX1G3)3X8T19]+>
M*2XGAETRX6Q#V$T=Q=W,L;PE&CEG>5"'8D]IF8 'RQG!_B<<^@VQGU[XZTF9
M<#"*Q[_,PQ_WS&<_I3N^[%:'E]YY;%\"?@HFBZ-X=N/A/\/]3T?P]"T&CVNM
M^%=%UU[%&4([13ZO932F9U $CER[X&YCBMR;X9?#63PC+X!?X>^"6\#3L7F\
M&_\ "+:(OA:60R"7S'T);'[,9?-56W>5NW*&SD9KM"\RD?N5.?\ ;D'IW\BG
M%I  60 'TWD GH,B,D_E3<F[>0HPC%;W1SL/@WP=::)/X>M/"/AFTT"\BMH+
MO0[?0=*BT>[M[2VAM+6"ZTU+00W$,5K;6\4:NC!([>-% 50!9OO#'AK4[F6^
MU'P]H-_?W TD7%[?:/I]W=SC0+R?4=#62XN+=GE6RU&YN;BSW,?LTUQ)+#LD
M=F.R#*<_NUQR1R_3/7#1+@<_K2[I.55!N[@AV7'N3&!W[$U)2Y7LE]QYSXJ^
M#_PQ\<:S/KOC'P7H7BB^OM"MO#>HQZ[80:GIVHZ/9:A/JEE;7VEWB/!<O#?7
M5S)%(R%T,[*K!3BJ]Q\%/@]=2:>;KX5?#JX.E3BYTMI_!7AV5M/N%@^SB>R+
MZ?\ Z-)]F CRF,KP>*].S,20(U!'7)8_^.^6 /SIC/."<Q*W?(:0<?00G^=-
M-K9A:-]E?Y'GOACX._";P4R-X0^&?@#PLT%W!?P2>'_".AZ3)%?6B7$=M>![
M*R0FZCCN[I8Y,[D6=E4@'C2G^'?@&[DNVN/!/A":74#XD:]ED\-:.[WC>,8;
M>#Q:UTQM,W$FJ06=K'J!<DWB6T:W!=44#L"TY7/EH#CCYG8=?0Q $=._>A3-
M@ JF>G!;/<]!'CK[TAVCKHM#Y0G_ &%/V3;GXCVGQ1N/@EX)D\0V/AJ]\*6N
MFMHNGKX3ATO46@:_<>%DM19O?S&UM]\[QLY*;LARS'V+6?@?\'O$,OAR;7/A
M=X!U:3PA9C3O"SWWA72)W\/:<KATT_2&:V_T&R!4'RH]J$C.W/->H?OO[@_,
M_P"%'[[^X/S/^%5SRM;KW(4(J6ZDSRS0O@;\%?"CSOX;^$GPYT)[JYCO;F32
M/!V@:?)/=PM(T-S.UM8*99D::78S$E=Y"D"JMG^S]\"+-=7%C\&_AG:#7=/G
MTC6!;>"_#\!U'2KI81<:?<F*P!-G(;>%F084R1"7!D&ZO7?WW&(UR3W9OY",
M^_>C<X^^HR<8VC'')_$]:5WW97)'L>0:_P#L\_ ?Q3IWA;2/$GP<^&>NZ5X'
MMOL7@_3-6\%Z#?Z?X:LCY+?9-&LY[(QV-N&MX"$10H:,, &&3K67P5^#VG>*
MK3QQ8_"_P%8^,=/CNHK+Q/9^%=&MM;MEOHTBNS%J$=H)%>2&.-&;=N**$SMX
MKTG]]_<'YG_"D!F/_+-?^^G/0X/WHQ2#ECV/$C^S3^SO->^)M0G^!WPLFOO%
M]S/=^);R3P3X?>YUBZN;2ZLKJXNYI+ DRR6EY=([+M+_ &ARQ+,323_LR_L\
MW/AF/P=<?!3X8S>%XO-\K0W\&Z(VGQO.-!^U3+$+3(NI3X8\.F67/FRG1X#(
M[% :]NS-_P \E_[ZD_\ C1_G2,)6'W%&#Z^F1CD#)IW?=B<4UHM78\7\)_LV
M?L^^!/$MSXQ\%_!7X9>%O$]XES'<:WH/@[1-,U&2.\D2:[B\^VM%V0R2IN9%
M"J6YQG.=A_@9\%Y;&ZTM_A3\/SIU_I-]H-Y9'PGH@M[G1=2NVO[_ $N6,68!
MLYKUVFD3HTI+D;N1Z=^_0;E1&SC&2V.OLC?RJ3,V ?+49"Y&YAG('<(>>G:J
M4VM]1<L5'E=CP^S_ &:OV=M-TJ'0-/\ @C\,;31[20S6^EQ^#-#^Q13$V3-.
M(3:;3,SZ?8LSD%F:V1F)89K(MOV2/V8+;2AH]O\  +X41:8=6TC77LT\&:-Y
M<NL:!/J<^C7\[FV+7$UL^LZHL6\LHBOI(,&%ME?0_P"^_N#\R?U*C^0IA>7=
MM$0/OOD].>!">_O2YW>ZV",(I)VW/!X?V7_@(WABQ\'ZO\,/"?BK1M.\5ZUX
MXMXO%>BZ=KMP/%?B'5[W7-9UII[FT&;F?4]0N9'  C(*KLVHH&WXC^ 7P6\5
MZ/X?\-:_\,O"%[H7A:5I/#>G1Z3'80:&SP^0QTPZ:T36@,/R$*0"O&,5[!^]
M[1C\V_JHI,S=/+0D?[4@_$XA/\STHE*[OM8?+'W6M$CS/1_@K\)- \$:W\-M
M+^'OAB'P%XD:^D\0^%)].BU#1]<?4X([;4'U6VU$R_;VE@AA1_-+96)1P *H
M^"O@%\$/A[I]]IG@?X3> _"UCJ.C2^'=1@T;PWIEHNHZ)/>ZGJ<VFW[)!NO;
M=[_6M4E?S69G>^D9B2>/6=LI(;:HQ@ ?,<CKP2H_EVIW[W_GF..I)8<]?[A!
M[]Q2N^['RQMHM#QO6_V<O@)XDOO FI:Y\(/A_JE[\,HX8? 5Q>>&M-D?PM!;
M"$6UOI>( ([6(V\#11N'2)X5D15<;A!%^SC\%$\;>-/'\_P_\.WWB#Q_IB:/
MXF?4-+TZ[M+O3QIRZ5=016\EG^X2YL$5+I0=LX&74GFO:BTHP-B$GD99NH/'
M C.:,S]XT_ R#_VC5^T\C/V<4]TOEZ'@G_#*W[-R^ =5^%MO\#_AG:_#O698
M9]4\(6OA33+71KNZM/+-I<M!;0(8KJ)HT,4J,KQE R,"*S[_ /9%_9>U"#PU
M:7WP"^%5Q:^$-1LM5\.6K^#])6UTR_T^RT[3K6:*WCMPEP%L=(TR-DF62.06
M$9D5R :^B5>9L_NE&/\ ;D_^,4N^8]4C/IAG'_M'FHN^['[)>7W'SQX&_9,_
M9I^&%Y)J/P_^!WPT\+:C<7^FZI-J&E^%K%+Z2_T>TU#3M(NGNYU>0R6VG:KJ
M,$&&Q%#=M&@"8 S]:_8U_90U[5O%>NZW^SU\)M4UCQQ+!<>*M1N/!VE-=:O<
M6UQ]JCN)I1!^XN#<9>22'RFF9B9B^3GZ8S-_SR7_ +[D_P#C%+^\(^6%5P><
M,YR.G.Z,=_YU?M/(M*&R2/GB\_9&_9>OUT07?[/WPI9?#S0/HBCP7HL2Z<+9
MGDAAMT@ME M0\LK&$@Q,7.]&-1>&OV/_ -EOP<-1'AGX _"G1CJDT]QJ,EGX
M/TE9;R:ZCNX)FN)W@9W0P7MW&%SM2.8H@"  ?10:9CCRE&,X.YN>QX,8X_$T
M[,Q./+7IU#,>G'0QC^=1=]V1[-+=I=CYK7]C3]E)+?Q':Q_L^?"F*#Q9;/8Z
M^L7A+38WN[![JVOC8PR1QAM/LA?V=M.D-LT,<<R&9$61F9M;PC^RS\!_!&M:
MQKWA_P"'VD6U[KEK=:;>0-#&-+71[FPATE=$M](AB2V73(M+MX;>%&B9HXH]
MH<DEC[YF<G!B0=<GS"Q/7^'RQC\S2@S= D>>_+L>#C^*,?SIN;:70%"*:O9_
MTCPO1?V7?V<O#OB]O'NA_!#X::9XP:..%?$-KX3TE-1@BBM?L82VE-N1;;K4
M!',:H9%1?,+E01<\/_LZ_!GPY>_$:\LO 6@2GXJS:FWC&WO-,TZ:UOK/6K#3
M]/UC1XHA9J8M#NETZ&:>V+.C7$LLHP9&%>T[I!RRJ/ZGIP/S_*@F4\JBG/U
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M][?I_P '[CZ2;X\?!.,+YGQE^%2ABR('^('A10S(=KJI;5OF96(! Y!(!Y-
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M9Q^%$FT2:=XQ(1%C7;\7/C#&=B_=R8_'B@GZ@GU)H]IY$\DN[_ Y8?&+]H@
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M_P"$P^!V/S_X6=2?\+Q^+P_YM"^,?X>,/@;^N/B=SUKU3_A5WA+_ )Z^-/\
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MK3:9XIT32[":RN=09M4O[!?#]Q)9:-<0V\%O:-EWEN2=RJA!KZZ_9?\ V_\
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MH4GH* #)/4D_C2444 +D^I_,T D="1]"13WVXX'/T(Q^G/&/SJ/J0._;\_\
MZ] "Y/J?S-)14IVE,KU)  QSZ]<>E $5*!D@>M/1><D<8]CZ'I]*1L[SCCTQ
MQVR>?QH :<J2,_EQ3MPVE>22",GW_&FG.>>OUS4JA=F3CN<8SW.?IP!0!%DC
MH2/QI/\ #'X<<?H*<Q!QC'O@8I%ZCZC^= #@5 P1D_Y[]J;DXQVSG\:<X /
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M(_XW2Y\9W.B6T[67A?1+5O"G^B^*8YK._DU!;LP6D-K9M+%<3# J^W_!6?\
M:(U'Q!X.\-^#OV(_&_BVZ\6WWAVQLM1M=*^)-AI-YI6IW$BZG\0]-NM1\!Q[
MO 4,MO<:=!).(;N?4X2B6WV5EN3S>N_\%"O^"DWC&]\%VW@O]@CXV?#Z[T1-
M)F^*]OJ'@JWU[2FN]1\<V-G/H>@ZAJ6L6HNYD\$!KD7=F]Q%;S:GFZ18K9B>
M(TO_ (*5_P#!2WQEI^A:EX,_83^+OB2U\(^(-4T3QM::!HOAVPN[KQ%X5U'6
MO#.M?#_7]>U_4&MKK5EU/P[]KO=1T:R@L[236)-(*QW5HD\Q9=D'/)V]]OY"
M1_\ !9W]I31->\4KJ7[%_C_Q;:7GBO1]+\*:!H?@WXD:9=Z5:7>CV-KJ%A/J
MFI>#T36+RR\2-<G47 B%O%(!$)E"NWIOBO\ X*^?M%>%+37K:]_8)^)TOBCP
M]I23S:'%IWC1H=398UENO$VFZL/"7V9/!5KOACGFN)(;L2OB.U<<U9^"G_!1
M'_@H9\4/B_\ #/POXV_81^*G@KPC+?:Y-XCE\,^#HR/'>AVT,JV>KVGB/XE>
M+=%TOX=0PWR^1)8ZC=R75VT1N+6X>!U6M3X3?\%'/VXU\=:!\-/B+^P_\1=:
MO/%GCW6?"/AK5KI?!?PP\02G3;[4=7U19/#_ (J^("6VO6.G^$+4,=8LKF+2
MKBX:./SXPX9RR[(%)Z6FU\O0[?XL?\%.?CWX+\/_  ONO#?[!/QW\2ZG\5/A
MAI_BVW2TTN81^%O$NJ)+HL.BZL[VP46P\::Y\/XEE)7.GZY=WDBHME(M</\
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M=+?PQXMN=(\,7W@:_GTF"XTN]7P^)/%%Q?:@UJ;>UBB60HLWF>64KYQ\=?\
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M[X<\+P:5X2\3VFEZ^EQ9>+M;U>RT/Q'K?A.*YOO%&L64'AJQT_1Y-)@@BO\
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M]: (<*1@<-^/7J?ZTX*. 0<]^N/SZ=#4A)QR$ ]01F@,2 ,@C&. .>>OUZT
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M@W6KQ=2\':K>NFK:A9W-K$IM]>@M(R/*9&C$L@!8 &@5_P"^U?R+WA;]LO\
MX*/:YI?[0MQXS_8\\2:/J7ACX/S7GPVT_P (_P!CV:W'CBSBUV:\UK2;C7KB
M]?4WD6[\.0QZ;+-+B33I9$RLK(M[P]^W7^WYXN_9R^*7C27]B#Q5X;^*_@WQ
MII>FZ)IMO';K#/X>7Q5X9^W6"Z-KVIO-XIUP>$[S5$N[^T^S6,=W<EK..5+5
MFD\NT;_@MK\0?$VFZGJ/AW]AGXU30Z+#<->27^F:E;QWMU'X=\1>+UBTO=;!
MI8QHOANZMW=@<7TZK]U2K>K_ !?_ ."NVK?#;X)>&O'</[+GQ?O?B-KES\5=
M&D\'WGAG6+321XG^&^J:EH-KH6DZND,AU#4=4U"WMIK5655%M%<[G9D5J!WB
MOMLHZ=^WC^WAXD_9_P!>^(D_[%?C+POXO\.^/_#5DMEIVB6]]<:UX8:*"?Q+
MIUMX,UK77NYKVVNI);(WT<\<,K6AN+>-$85X1X?_ ."F'_!3&[UCXF^(;O\
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M^#?A5IG@KQM-#-I_P[AL++6O$NDVZR>';ZSU'QEJMK<0I+N7?;>;(K.2J%P
M*XO1?^#@7X/ZGX6\9:_#^SM\88[KPG!IR/IR:=<,-7U22[EMM9NK:Y_LH+%H
M,.V)8[Z3*3RW"1)ECD=?\=_^"S=S\-IH7^'7P#\>^)],\0_!/0/&_A&UU3P1
MXKM=33XA:MKJI<>%-62UMO+33D\,F6=9$PQGBV9P: O_ '_P,7X8_P#!4O\
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MOH=AI^G7.E"Z\/:AHTEQ?_:9YIB2)"&+[%.5->G_ !Q_X*C>+/ WBKPEX(\
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MPUHFH:Y_PE$ZVUS=^#M*UC5(YDBDM4%K':RSQSNXB^QOC;^WI^RQ^SM\19O
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MHUK8SV\?ABUMM:OKN-FTZ."::VL+[4;B%$E^C/C]^V)^R#\ -;^'2:I^U?\
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M,("FFU>7]:'Z=O\ M2?#UW1C\./V@F,8*1,_[.7Q6;RD(VND9;PK^[7:<$#
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M7^+O$FO6*Z9K&N^(?!FAZIJ^HV<=O8VD45Q?W5FTC[;;3-.C5MVX)80@$"-
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M1IO#FD>!-%N-9MO!VH?#9)M'AB?XA>%+&#+Q3)IT,\DB01G3(-2.2/8.=_\
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M5?%3X6_$3XBV_P"S#XDM?%'@CX5R?$#2=4U#X1>*%T#QLS^*=>TOQ@(M3M_
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M$_Q%L+&Y\3Z)I\<NN0W.D^ [\:A<RE%BU.U2'%P();F%."L[+4%.5U>=[_\
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M"XBGM-KN00* O96YGY:>G]?UK],?M)_\%#?VG_!7Q!U#X2_"G]C3XQPZW=^
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M&?\ @J9\?/BC\1/AQX2U3]C'XB^!=(\5?$[2M/UJ;4OAG>WL5[X:2ZFCUO\
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MX'\,SZC]LAT_X>:M>7&N7BQ"^$TCZS PLOLL<VS4MFZ1GMF:!ANVU['\#_\
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M-RW1C55,@.XA0"<#%6Y-+TV2Y-_+IEC)?&-8C=R6EN]V8HVW1Q-<-&7,:DY
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M!P,#C!/?J>?K0LC G&3C(.X\?3WK^6?2O^"LO_!1O7KCX3PV7[.>N:5>>*O
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M-W]]-0$"XGB64NZCL\C$\UY2?V9]<(Q_PTK^T4/<>/+D'\Z&TMV'+/\ I/\
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M'  R="\'Y./^X52M#OM_7]6'>KW_  ./'[7WPD!8_P!C_&OD]/\ AGWXS?\
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M_P Q56[/]J_X47KG9IOQABVR11G[1\!OC%;@M*P0,I?P7\R _>/\(Y/%5/\
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M?YUKYGGTWQX^+HED6#XG?L:&$.PB:7QMXX$K)G"F14T A7V@9 )&> <=8?\
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MAS_Y74<UME_6@N62T4M#Q0>.OVIP?^0%^S 1WW?$_P 4GZ8QH5._X3K]J?\
MZ 7[+_\ X<[Q3_\ *&O:_P#A3/P=_P"B3_#;_P (GP[_ /*^D'P8^#H_YI/\
M-B?4^"?#F?S_ +.IN2;5^GEZ>8<LNLCQ0^.OVIC_ ,P+]E__ ,.?XJ'\M!H/
MCK]J8_\ ,"_9?_\ #G^*A_+0:]K7X,?!U<X^$_PVY]?!/AP_^XZD'P7^#@S_
M ,6G^&QSZ^"?#G;_ +AU*^EK?UI_D/E?\[_KYGBI\=?M3'_F!?LP?A\3_%0_
M]P--A\;?M1I*6DT/]F7RY'#R&/XH>*#(,+M.P/H0&>!^5>VGX+_!TX_XM/\
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M2_\ @C;^SW\1?#?B[PH/BO\ M(^&=,\9_$K6/B%J::;\5-3U9K*PU%I[K3_
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MX\G$/E+6#:?"7_@N/H6G^)+X?$?X-:U=WNK:S:V?AG0?$UAI<::1JD%G<_\
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MF_Z]3\:_C)_P2#_:DT'P):CX*_MD_$_XB>-=8FOM'\7Z5X^U.Q\+^%=7DO\
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MSKXFTZ7PK87\4^A#Q79Z7K1N?!>A:QIULFJM-;PW>NO>*;2:1KB.'0/V2?\
M@JKXU^#O[/'A[4?CW?\ PF\5VOQ$^.GB3XA1WOC;QOKTWP^\,:KXGM9?A;;R
MZSI?Q,O-2^).I6^E)<36.F:KK&J:5:)>2V=\]VL<.>.T70?^"Z7A6YT/P.OC
M;X9:#+XMT?P_\+] N[ZRD^(5AX:U33?!>IC6/BFNJ7%I$=-M[*TT>TE,-[YZ
M:AJ5X5>)F8E_9/'GPA_X*]^/_P!E_P"$_AB[\9?#G3OBOI'Q$DN/&5_I^O\
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M<='JH;)&[')^X<A0#RH/X_RZX(_!OQ&O_!<_4OB;\3SX0F^#FA>!;&YOM;\
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M/<8':@!F3ZG\Z2GE#DX'&3CD=,\=Z15^8*1]0/IVQ[4 ( 2<#K005[8].?\
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M&3Q7K=XMC)*-)U3[)HD"6L5N)+<K/,NR%I"XV5K*VQR\LDK\K2]31OOV%O\
M@I+<_LO^/O X_:&\ ZQ\7_'?QSL?B?XEUNVOM:M9]8BMM)\/^'[G31XC,@.G
MZ?#9Z2H>Q0)&QLW &Z;-8/BK]DK_ (+46":=X3\&_M3?#_6/">AV5M9:%?\
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M?":P72M3\"^";27Q1KUEKNK:DVHZ6(-!L;G6;.\UBRM]2MG)T&QLK"*S$-N
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MQ=)-JNKZQI=@+V[M[O5[CP]<6VN02%KG4YG.G6ZV;*(Q;*LI;.17@%[\=?\
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M_A2,XQ\IYSSQV_$5&01U%!4XR1P?IWK,T ,0<@X/K]:<I )+'J/U)%,IVQL
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M%9@K\>.7W[%__!:'4+_3M3U;]ICX:>(O$GC?P)H&E_$[4=6N=9;PMI]SX?\
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M+4?$MOIXN/LMKXN@MYH]'6%R+>UAL4D2/S@36\__  2__;'C\/\ A6T\2?\
M!0:]TCPKX:\/V-AXJO-,TBXMY+?1-&\0:MJ6M:1:ZE=WF)--U#2K]Y=1NKEA
M/]KL4"E8!BO0_ W_  2;^,/P_P#AK\6? F@?MQ_$2RO?BQH%Q;:[J46B07.G
M'Q;=^-]8\277BB+2M2O;@V4SZ7J:VSBWF2665#+-*^U6JAJ7_!+/]IC5?V7U
M^!-_^W1XSO\ 5AXIU?4KJXU'3]3N= US0-5T/5?#LUGXAOOMJZI?WS1:H]^Z
MB5;,W2B%K=XU$S'/'N#B_M0?W_\ !/0/!G["O[17@CQ+\8K3PA^VG!I'@CXE
M> X-"^&.@V?A;3S?:#%86L:J;&UENS%I>E0PR(#)8!I2MRTCMDK7._#G_@G+
M^U1X5^%GQZ\-^)?VR&\1>,/BGH%GHOA:UU#0IM:\'^#;&UM')TB :M<_:K:P
MEU-8+B26',S%W&<8%?.\W_!%7]I]-7U778/^"B?Q)FU4:1J_ASP_<W,.J1-;
M:)J2:>TBG[//MT.XE^Q"&86* "&"+8^2RUZ?X8_X(]?&VQTS2(?%/[??QG\0
MZK;W+W>J:FFK>(;4WC-K.F7D<$44.M(!;QZ/:7=HNY03YZN1RPJA<O\ <_$I
M?%W_ ()Z?M[?'3XD77Q4M_V]K+P];7VFZ!INM^!_"=EJ^G>#)+GPIJ034_#:
M6EM*/*T9KZSANY9,BX>Z22WD;R3BF>*_^">O[=E\NNZ8/^"C*>%M5U#XCZQ\
M6+C5++3I;#6+33+J=HK/6(DFN-MI8Z7:[+2UM-HL55W\PDX-5K'_ () _M/V
M7AO6;=_^"AOQ.E\3:HDEE)J%LVI:5I]WH,T&KW5]H=Y#:W)%M)>ZS=6+7-_!
M +Q8HG=6:0*'V/ W_!)#]HW0K?XH6_C']N?Q7XSN_&_P-E^$VF^(M2T:ZO\
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MLY+_ ,+:"VGS*6N$75M1)^>?%<WX6_84_;PNO@=\5?ASXL_;"\.^*V\5^*/
M7BGP+J+:!-?6E_IOAKQEHWC#9>:PLRSZ-I;:7IUA8P6]F3'-#8XES%)\W/W?
M_!,']L;7?A!\4/AQXJ_;A;6[SQ=XM\#>(O#ZW6A^(Y](BC\'^)W\0RSZK?3Z
MH+G2;NXBDAMFM+&)[%X])MPZ_O)<3?"3_@F%^VA\)OB3\*=3T/\ X*"^(O\
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MF75GIWB"_627$>D13M;I;6H @N#&[LS,%KU'X2_L?_M5ZK\/_BSX2\3?MF>
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MT:V,>JSM"]S/I&C>)M2L[%+S6M*U.YD9KS1/MJ7\4-B6*%M2$J_-D#3\8_\
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MW\H.4R$KAT_8>_X*\6NG0I??MH>$KFZL;;3+^VUW6Y+^6XTG[/%)NTB"%8Q
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M. >?4&G!\D@X'Z?AR?\ .*=W:U] %)(7/? _7'^-*IR ?\]::Y.6&...1TI
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M',2M:W*6UC:A6'G+NR@KED];;F;JPORWNS]@P&!! /'L:?N?^[^AIQ)PYQ@
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M*U_#WPA^)^E:YI>IZK^T;XS\0:;8W2SWFAW?ACPW:VNJPJK VEQ/;+YD<9+
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MISGU]OI]:7[F1][/X8V\Y%,9MV.,8H 554_WN,9Z?X5( !T%05)Y?O\ I_\
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MV< CTR1Z>@]J $\SV_7_ .M3LY4GU!_K1M^;.U0/09/\Z=@=,<>G^10!$'P
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M^#GP]L9Y[75[*1H?#6G&,6NO@C6[>*W>%HX(KI2XG"*OFACOR,T?N_ZN'O\
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M ."NGPW^'&L^%/#7Q$\!RZ1XD\1_$_X>?#_5;30_&.B^)-*\-:/XS^%WPO\
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M,?C_ (4X#  VKD?Q9.?UH 3.P;>N3GTQV_S]*/-8 @< ]1UIQ .?<8_"FA<
MC@GG!Q^76@!H?  QT]__ *U*7R",=??]>E.50!S@G/Z?B*7 ]!^0H @J3S/;
M]?\ ZU#@#& !U_I2LN<8P/T_I_G- #5<IG;QG'7GI_\ KII.3GI3MA]1^O\
MA2;>O(XZ]?\ "@!2^01C]?\ ZU!?*[<=@,Y/;^5&P^H_7_"C8?4?K_A0 H?
M QT&!S_]:G[B%W 8.![\9IJICK@GI[?7FG^G XQQVXH A+DMN/)]ZNV[;AGC
MN./J*J%"2<8 _P ^U6[="%'/0GZGZUK#9^I$VK-=66:***LR"L^M"LYPP;;G
M!').?ZBLZG0TI]0P!T 'X48'H/R%(&!.!FG5F:!146&9B ?7O@8%*I.X@DG
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MCU_QH 4$$<=!Q_G-!8#&<_Y[_P J7Z #&.G'3C/UJ#)/4D_C0!/Z^_\ ];_
M?E13/,!]>..W^--;</XB<^Y_QH EI<GU/?\ 7K4:$G.23TZDGUIQ( R>E "^
MWMC\,8Q^5"E68JQ8#G)!QR/QYYIIR0-I(Z').#T]O>E   X /<@<DGKD]^:
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M4$,!DM^IH F(0#(+9]^F/KFDI"0!DT$X ;!P?:@!:*9O'H?T_P :<&!Z?E0
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M5R YC!]S_.H6MR23@<^IJQ$I1-I&,$]\]:T@FD[JVI$VFTT[DE%%%60%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g1078499.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1078499.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@#/ *  P$1  (1 0,1 ?_$ +,  0 " @,! 0$
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M$W#U_C@!.(<1$?I_' KXOK-^WOP+ <3=@FX>O\< )Q#B(C]/XX%?%]9OV]^
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M]V! @)>.OT".  !-Z>SO$< !1'4.'# DQ@[ X#KQTX=FO=@5U$>T1P !KP#
MD2B'$=,"N!R%+Z1T$!# KIJ80#O'Z\"H\.& P& P&!(!KP# D"B(B'=@5'AP
MP& P&!R%+Z1T$!# "4P^GAKP#4<!^\'*':';W<.&!4"B(B'=@!*(<1TP E$
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MMFG$HPAI5["Q))^8:L'*\7"'D$8DDL_22.=M'FE'*2[>.*Z5 ""L<ARIZZB
MZ:8&C)+<+J#153"*Z;63]$Q2"JH\WMJD:=,XD3%0A$DJ]) H4BAC  B8NH%
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MTTAO3YIM::;1R,7TE'W"GIJF[CM;K7+5-T(\7+V:+W,92E">6VS0AZU_+][
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MV1E8]E)),WS&4:)/VC=XFUDXQRF]C)%N1PFH5%_'/$2+(+% %$52 <@@8 '
MS!.81'0QM.[4?OP*B(F  ,(CH.H:CKH.@AKQ]0X#4>S4=.[ C MJ'+IIQ[]
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M'FTVR(W8V[LESVMA%T=G;&$'8W<7,Q5A97G<=C-Q=,K$7N3 T^#JUALVU\+
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M[_@'W8 3"/ 1^K  80X /U8 3"/ 1^K C4=-/1@ '3B&!/.;O^ ?=@.<W?\
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MQCB9L4S%0,.T,W(ZE)F0:QL:W.\=(LF9%GCQ5%NF=V]<)HI )@%190I"ZF,
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M>@=?=I@1@,!@73_?+[<#-P&!@".HZCVCVC@1@,!@,!@,"1#3T@/L'7 C 8#
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M&OJ1LO*.*-MY9$9"I;;560V,GXY)@6.D&,DE'1\\E&/Y9RHV1,[6/R&(JYU
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M!WME(7&:@K63>JRN9AU/W:VM+U*S+Z*?_-TYJZ2M+!)TF2/BV2*BA ,X(L<
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M/?Y^PD[$_DODH/<R4C6,TR8,G\517UU9O$'[.<M-;9S,@951LDQC'(OE$19
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M '427F5=$["MSUFCM]JY:T8*$1G0BJFPGIN;G&SB*>S!&];8)1283#EJUCU
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M4>'# 8# 8# 8# 8# 8# 8# 8$Z<-=0]FO' C D./J]N!(AIZ2C[!P*X# 8#
MG3AKJ'LUX_1@3RCIS>C\=,"N P)TX:ZA[->/T8$8$AQ]7MP \/7[, ''U>W
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M@\<%E(J+666*D("9!N8QM2D'0,\#D/S"51,^A"JF$JA! J:A1.0YA VA2G*
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M^5[^_P"CLP*X$AIKQ[, .FO#LP)*&H@ _MPP!@T$0#]N& _+R_Y7O[_H[,"
MTUX]F '37AV8$8# 8# 8# N'+R\>WCW^[U8%,"X<O+Q[>/?[O5@4P+I_OE]N
M!FX# P3<W#F]W9]F! @(=N!&!;\QO7I[ [<"! 0[<",!@,"0 1[,","1*(=H
M8$8&._9_/1T@P,X<- ?LG3+YIH<I'3;YINJA\PV.8JA2.$?$YB")1 # ' <#
M\\-PO+.V0W'JU:KLW8;I\[5=N=JMLV%F#^'#S;ZO[/U2=K5<:S3LL(@Z?1DN
MZF_U"68$51:/7"!2@1,AC (9-S\N3;NYAM6T3W&O-:CMIMG:+L] GA8RE*V
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MZ:^C C 8$Z#IKZ,","0'3B& $=>(X  UX!@2)1#B(?5@5P& P)T'37T8$8#
M8$\HZ:Z<,",">4=-=.&!&!R)E'F*.G#7 S,!@81Q =-/7]F!41$>W C N(@'
M[GO^SMP*B(CVX$8# 8$@(AV8#B/^$ P B(\!'ZOLP(P)$PCVC@1@6#4.P0^D
MOWX#F-W_ %8%<"=/VU# C &,KR'!$4_%!,_@^-J"/B\@^%XHE_/X?/IS:<=.
MS _)* N'F ULK9>I5V^W"8?UA4N[#/?2H5Z0K<#O3"53<6V2C/9 M/L=#=N=
ML;7+UN.@6KPSM[%M"2L:J@"KPTD4H;8W$<]5>XW44UH],LTWMQ0H"3I,Q92Q
MH,63(:7);;RTG\VM.K5R5DEY.8W(+)1H)H'^7 (5#Q1)SF*L&M*)?^O]EM+O
MU9+%MW;9G<2$-M5);0T:>:P:",HNON?:C6^);R$49D]E&!:,C&_/E66!0J!N
M4ARJF..!N9\?K"W!A-E8*=55V^GD][;3';L6/;MK_!T3+[91.VUHEH*4;I3O
M\S)&!:/[BJP9$("RHNW+8!%1%)82%#Y>3?\ F;M8:SUN!0LCFZ;BKQ=IH%DM
MKNK+56D0U0N^Z%ELL3:9(=ND$Z'8[M7HJJ5E.!.VFFZD?*J2+223=INP9AOO
M>'=WK;3W"H5XV9V/FG^U4;LZDO=-N;&>OLK#+[K[HUV7DJ^W<,U4_P!77;;+
M3T/#-9;Y*29(G2F9(IBJG:MU$PT/MUU8]<XO=VJZKLS,;I3,9>I&%JD^YVOF
M*?'PIG-K@)B-;W"EHVE6:H$&39JQ!)M&CM[)2BJR:22JYW!_!4#T-3WS\SFQ
M3T0BMLY4JPPL%=H3J1<VW:>RJ0M5DUK['T"UJ1[*/W2AILQ7L1).K85J_=J.
MVL9&)(+(MCNC^$&7 ]27F7SDO*MGO2S2:PSCV24RF@]@+Q).7*4=5 EU*Z$M
M_%,/!&DKQ)\B3-RS5D#02BQVSYJHL@)E ]-9+UULLJULRJW;[DR>Y#C8N@2$
MU%57:^N-:'9=^PO\(SOT+N8YG(-TI1:L-3^:.)TY&**5KXBK-15P""9@TW#]
M5WF=R#N;L*W2NW90[F4@8*O0,]MU=HI)E'JGLTP]M4PQAINSV[]2</%8FL.$
MD3.&+0%#3)1,U0<E,'O*IU0=6$G'+?Q35C1\.:$VILE=N$73)%L63W-GM^ZI
M5+WL#)S<D="N*GCVTU*5ULFQ9+2#1E#*2+]TBL >,'WCTSW>V[A;/UBSW-<[
MV6=M4"(RBM:?UQ2>BBLVIX>T&,X%.-FAML:=*4%S'(MF*1G8M2IE4;J:AOW
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M$3,4#BH!3)D$ 4$1$5  2B *"(B.O;J.!/84I0  *4 *4I0 I2E*&@%*
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MZZCKWZCK].!/.;^D/M]/T]N! B(]HC@1@ #T & '@;E'][0#:>H1$ X]G:&
MP& P& P& P& P& P&!(!KP# " AVX$8# 8%T_P!\OMP,W 8& ("';@  1[,!
MII_A ?JP  (]F   ](Z>[7 GE$>SC[P^_ <HCV<?>'WX$"&G^$, )1#M# C
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M.!'ZIOU_Y#;.?Z5KS_J:P)"4WZ'@%%V<_P!*UX_U-8$_J>_A>/\  NS@:?\
MZUKQ_J:P'ZCOX<>8*+LX)A#EU_FM>.P!$=-/Y-AZ1' @9+?LO U&V;U#M_ZU
M[Q]7\FQP*_JF_?\ Y#;-Z?\ :K>1]O\ ZFPUP-O% -"\XAS<H<P%YA*!M Y@
M*82E$2@;L'0->[ " :\--/:'VCK@1RCIKZ/:&!&!(!KP# :#KIZ<"1*(<1#Z
ML" #7@& T'73TX 0TX#@ U#B&GTA]6 $1'MP(P+  :\=-/;]G;@#::_E[/?]
MN!*?[Y?;@9N P,(X@.FGK^S J B'9@1@2 B'9@1@2 B'9@ $0[,","1,(]HX
M !T] #[=?L$, )A'MP(P& P)$PCVC@1@3J(Z (\,#0<[=>HQC-RS2N[!T.=@
M6S]RA#S;[?P\$]EHU-00:OW4)_*:5")7<I@!C-_F7'A".GB&[<#J?X_ZI0'7
M^[=MSJ/_ /,D?_4M@!O_ %2CV]-VW/\ _4D?_4M@/X_ZI1#3^[=MSH'_ /,D
M?_4M@1_'W5)_LV[<_P#]22G^I? [!&\]1YA9^/T]4E,#\_Z@*/4 DN+;1403
M^3 ^UC<'W,CH8><6_*;\H:A^; [-C<]]CIB:1V*K;5;F. )L]Z6+]+E X@F;
MQ5J-&GYC$T$0Y! H\-1[<#,&Y;T!I_U)0Y@$Q0T#=N)_* F !..M7*(@0HZC
MQ$=.S4<#SDIN/O\ L5R)L>FA.92.D"AG#3>NE-4DCBHH44#$DHQFN90I2 ;4
M"F)H8..H" !UP;J=1G^RDL7U_P \]NA]W%N. '=/J,[?[J2YA_[<]N@]_P#\
M[X#^:?47_LI+>P=\]NN'O!M@3_-7J-$-/[J2N@?_ *]-N_\ BV #=3J,#LZ4
ME?\ 3IMW_P 6P(_FIU&?[**O^G3;O_BV _FIU&?[**H__MTV[^UO@/YI]1?^
MRDM[!WSVZX>\&V '=3J,T'3I15$=. ?STV[#7U?_ #M@?14:X=NXZ/=R$<>(
M?N635P^B5'+9ZI&.UD2*.(\[QF=1H[.S5,*8JI&%,XEU*.@A@9N!.@Z:\/I#
M7Z-=<",!@,!@,"Y1+P Q0T[-=3:AZ^W0=,#YT=[N[R(.W2#?I-W+?-T'3A!N
M^2W*V!12>H(K'31>)(N=TDG*23I,H*%*H0BA2F #%*8!  X WCWJ#LZ0]SO]
M)W3U_K5P [Q;UCQ'I"W/]O\ ,WI[_P!:N!'\XMZ?]D/<[_2=T]_ZU<!_.+>G
M_9#W._TG=/?^M7 ?SBWI_P!D/<[_ $G=/?\ K5P'\XMZ?]D/<[_2=T]_ZU<!
M_.+>K_9#W._TG=/?^M7 M_.+>SE_^%"W/Y?^TWI[T[>_^:O?@5_G%O3_ +(>
MYW^D[I[_ -:N!/\ ./>K33^Z'N=I_P!IW3U_K5P(_G%O3_LA[G?Z3NGO_6K@
M/YQ;T_[(>YW^D[I[_P!:N!(;Q;TAQ#I$W/U[OYF]/6GT_P U=<"1WDWK'@/2
M)N=_I.Z>O]:N!'\X]ZM-/[H>YVG_ &G=/7^M7 C^<6]/^R'N=_I.Z>_]:N _
MG%O3_LA[G=O^<[I[X>O_ -*OHP/H\IA,4AA(*8F(0QDS"4QDS"4!,03%$Q3"
M0PZ:@(@.G# G G4=-/1@1@2 Z<0P&HZZ^G D3"/ 1^K @!TXA@.8==>T?V#T
M:8 1U'70 ]FOVB.!& P& ]WO_;C@,"Z?[Y?;@9N P.OP& P& P& P& P& P&
M P)T$>P!' C D $>S MH Z '[WI[??ZNW TO,[G7:+EY..9]/F[=A:,7JS5K
M.0\GLZE%2R")A*G(,$YK=:*E4VKH/S$*X;(+ '[Q"CPP.M_F[?\ _9CWM_\
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M#]6XX8% WVE@$?\ ]WCJ)]]6I E]P!N-K@3_ #UE]>'3QU"A_P#FI20^/\R
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M_P!Z;9 OYC62Q:!V_P#5?NL/;P[/X([\"P=4^QYN(6.P\H__ *K]UP'_ -Y
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M!FX# Q#@(Z:>O[,"G(;N^(??@0("';@7-^;3EXZ=OH[?;@<>!;D-W?$/OP
M8>S7U\=,"! 0[?3@  1[,">0W=\0^_ <AN[XA]^ Y#=WQ#[\!R&[OB'WX$ 4
M1UT#L[<"P@<>W[,"HE$.T,"0*8>P.WV8'B76Y6W<<Z<,GVX=)8O&BZK9TR=V
M^!;.6CA(PE5;KMEI%-1NLD8-#$,4#%$-! ,#C3W3VT6-R([DT-4_]%.YUTYN
M&HC^4LF(]@8'=DMU74(51.U5XY# !BG)/19BF P:@)3%=B40$.[ O_%=;_\
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MN'LP @/:/I^WC@1@,"0 1[, (:<!P+%*?M#3CZR_4(X$& 0'4VG:':(:"/H
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MQBQ8:<?7@<I-K]MRB.FW-%* AI^6GUX-0#]T.$=KH 8')_++;?\ S>4?_HA
M?\W8$_RSVY#_ -7M(]U1@?LCL"O\LMM_\WE(_P"B$#_S=@5/MEMORC_U>4D
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M1X:>C QU.GK:5P*X*1%E,9R@@@X =S=T2"J@VY/ (H7^,BB)4O *!1'T%[L
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MH02B40]&!L=,HD(4@B8PE  YCFYCFT#3F.;AS'-VB.@:B/8&!? 8# 8# 8#
M8# 8# 8# 8%T_P!\OMP,W 8&";EX<OO[?MP*X%B\O'F]W;]F +R\>;W=OV8%
M<!@,!@,!@,!@,!@,!@,#QCFJ3#APNN3<B],DUU3JILVA*-\LT*8PB#=#YFD/
M'/@I .A1454.(!Q,(\1#KW%*L1TS$;[M;BME3<P%7*WVX7%/4AM!!-QMV9(=
M#" \0-V8'3%VZNX<3[^[HCKZ @]GM 'U:;7@.F!0-M[J(B/\_MT^.H\839X
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M4_&*)B%H=62,*0 ',GSB)M.8?\;01#NP,X*U=1,<1W-D0+S#R%"IU( *70O
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M;\O+_E>_O^CLP*X# 8# 8# NG^^7VX&;@,#". !IIZ_LP*8$@ CV8$8# 8#
M8# 8# D $>S C 8$B40[0P(P) -1[-?5V8'C74/=U'*ZC.[QS1N=50R+96FM
M71D$C&'PT1<#-MQ6%,H:"82AS=NF!UKR!W+.@)6.XT*V<"8G*LOMXV>(E+K^
M8#MR6MF<P&#T@H73 \Z:I[YB.I=Z*:0.P0'9<3:B':(?]96H . +4=]1'_TU
M4L?5_)8P?7N5@2%2WS 1YMZJ8/;P#9<Q=./?_,@=<"Q*MO<!AY]XZ@<.P--F
M^7CKVZ_S&-KPP.S;P&[Z0AX^YU,=!R%+H;:=XD/,43")Q%/<HOYCAPT[.X,#
MLBQ.YQ>)[U3#Z@ ?EVUE"" @&@B/_64(?F'CIZ,"?TK<T1X7>F?Z-I7L_P!)
M88$_I>Y8<!NU.U]/_5Q*=O\ I)' DL7N5KQNM-[/3MS*!_\ !(P+?IFY&NG\
M:4WV_P NI73_ /Z1@<8Q>YFHZ7>F::CI_P!6TJ/#V_S+#7 ZUU%;R\P?(7G;
M8">D'^V-C4-IJ;B M-TD@UTY>WU^K Z]2'W]YM4MP=H.40XE4VFN B41] &)
MO 41 .\0# !#[^_XVX&SX\/1M1< X^_=\1TP*&B.H#4>6_[.Z:\-=I[F(Z>L
M0W?T$?=@7_2=_  O-?MHC"/[W)M7;B^C41#FW;/H'H].GPP-K-"NBM&I7RJ"
MSXK=$KU9J@=LU6=@F4'"K9LHNZ4;MSJZB0AE5#$*( )C"&HAD8# G00#7T#@
M1@,!@,!^W[?L&!XIPWW+$%A:S-!3UY_ERN:S853$UU\('!D;80%-!TYQ(!=>
M.FF!AKM=V.0ORT]MQS^*7G^8JEG$G@?XP%!.W%,"P#V"(\OJ].!QIMMW0\3Q
MIW;0=3I>%X53M0 4FI?'!3GN!A4.(:\@@!0 > @.!E"UW3!7A.;=>!R_^2ME
M,OSZ\.(7$J?)IZM<#$<-=X!.'RL[M@"?.7F^8J=L,IX?-^;E\*Z%*!Q3TT]&
MNN!BKM=[?%U;3^TQ6_)Q*O4+D=;G\,/\=*[)D OBZ\.77E]?' P_E-_=#?\
MC'LSKJ;D_P#$F\!^74O+S!_'NNO+KKZ],"/D]_\ 37^(]E]?_<3>._N_C[7
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M^H.TF#Z0*TL46LA68*5I9=P(JRVET=VBWAX26JKALY9F,8R[TKM'Y=)4!.)
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MK=#^\%M(7;JNW NW\Y<S7>#+7HNZF*FH2M/)$SOP4I15JJ5R0@C^=F/S "*
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M'$/EU](_-MRM_+>2,]VI,8*5)K7Z^NY./:+SUML<C'NGKVQ.%I)G,2-XDP=
MN)U%4%RI<X)I) 0/9SW17TZ6BYV6]6"GS4G,V@UV5>,UK[>DJY'.=S*B_H^Y
M#RO5AM84(* >7ROR!BR:C9!,R[I--R'*X("N!HS;/RQM@J;+6&Q71];=TI]^
M\GH^JN9J=FH:.V^VYEJ',;:,=LZO$1DRHW2K\33Y]XBF)S"5-=<3MDFI")I%
M#=>QO1%TY].FX5DW3VKJ4U%7JUQLS#3,W,W>X6E1Q%3L^ULK]EX-AF9%$P?J
MK)(4UC@=RFBF5$JG@E*0H>?LWE\=)UPG-H[%8]LS24ML<PH\=MTZ6LEB!2)1
MVSNBVX&WRCA0LD"T@XJ5J>NG+4ZIQ$WSBI5O%*) ('O([I Z>XR/?Q;>CKJ,
M96GV.A2;9S9K,ND^JELI<'M[/13DII?\Y'M1KC-J"G!5/PO$(8JICG$/.Q?0
M_P!/431]RZ&2"MDC';Q3U0M>Y4S-[B728MEKM5'G&=D@+&[LLA,+R3263FV*
M;A8[4R!5SZ@<H@80P.*N="'2_5-YZ[O_  &WRD=NC6F,.P:3H3TTX2=I5RB-
M-MJVI)L7+M9L\<P%1;&0;*"4IN=PJJH*BA@,4-7/O*XZ0I:,K,/-5[<.:84J
M"LM4I?S^ZUZ%_4:A9B&,K4ZY-MIAK.Q<!$OSF=L44W(&;N3&$3&(82"'4'\I
M?HA5AWT&OM]9G#%XV:))D<W^TKA'/&\^\L;F7C459 S1M*23^1<D5.*1DTF[
ME9)N1$JRH'#?$UT4=.U@W49[Q2M3FG%RCJS7:E'&"YVI*$90U7;(,HI-. 2E
MB1CA=-DU22$ZY%="D,8H%457.J&M-L/+-Z0=GKQ!;B46DVMG:*Q(QDE .Y/<
MN^3J,>>&?+244U%"8GGI7[*/>.511(Z\<4TU/"*((E33(&9</+@Z6+Y&SD':
MH'<&3KMB"U,).L?S<W&:UPU2N,\UMTQMVSAVEB19QNWO\;,4)I&*;E302DD2
M'#\A03P/8?W%>FS^/R;E_P )SO\ %))QC9 4"ZVK]-_6HZZFO[9]^EC*?)BH
M%A, F#EY3(%!$0$@:8&J'WE6]&$FE&-Y"C6Y^TKZ\2-58/\ <N[OX^GL(Y>R
M.WT+5&3Z9<MH**L[VXRCB5*@4JKM=Z=3Q"F*F) W_P#W2]E_YWR?4&1A;F^X
M$[/P-GGTFE\M;:HS\[5*T6JU-]-4]"43@9+^%X\RRK%-5$R*+QTLXY!5/S &
MK*IY<O2M3[?MS?8^L7"3MVU,HW?TB:LVXURLSJ(CXP80];JQ!FI9Z7^$ZBM7
M&2D8R*!2-S(<1,518% X93RWNE*>LXVJ?K-WFWG\1/Y]*-E-T;\[@&B$C-W*
MRNZM'0YYX&D;3E;#?Y=V,>W!-(QGRB1A,@84A#MMGO+XZ8-A[-4[7MG5+'!O
MZ@K*/6S$]VLCNOSDW)U29H);-;*XL^&%LEFBZ!/.(-H]<HG62C!(D(F%-,Q0
M\87RO.D,5G2SFN[CR 2"\<,HA([R;EO6\M&UV"K=9I$!+)KV0P24!M[!5-BW
MA&RW,#$J0B F,838'8[O^7ALON%!VU2CR%FV@W0L6[LEOS%[O5J7F9"SU3=F
M94.G*VZ%;N)EFD@NK$N73-!%-5)%FDZ4%$"B8W,'K#=!73O(1VVC6S1%DLK[
M:[8.,Z=(237M4W$D>46/I%KH"CJ1AX1Y'PJEB>U^]S*9GA4 4(+\XDY1(D)
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MI:I=3L6X/3E-/U9F8A=J9W_Q/IM_DZK+;(.1AV+B1?05==1";Q1%8J,$8ZI
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M6<J#A:/=V"-KJ;0CI-7QGC8ITDW;IX\*X<'#=^ P/PLZVW'FA(]7\^ITPCO
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MW:G(2SV,@;!'V"2WRL;*C;F3BB[4[JFOVKD\>Q16=&>CXA4TP[ZJ[L>9-/\
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MV[Y,O@.DE% ^R=0T[./?K]F U#3LX]^OV8$8# 8# 8# 8# NG^^7VX&;@,#
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M:*"PJQBLVE #(-2S*D,@Z28K2R45XOSYXM%ZN1$S@$_"*J<I!,!A ,#LQ+P
M!*/H[ $?JXX$: '84=>':!N(#W<!UP(#3MY-=>_GT]O[H:8&*]>L(Y(CB1=L
MF""KA!HDL]=I-$5'3M4J#5LFJN=,AW#E<X$3( B8YA   1P,S7@' ---0$HB
M;4._N$/7@1R@(:@&OKU'3[<#&<N6;%(5WSALS0 Q2BLZ<)MT@,;7E**BQDR
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M3FT,0=#E'370Q1#00[0' &#N -?4(B/T:8%=!'@ #K@6_+P 0#4>':8./T8
M%D3 8H*(&Y#F2.!5BF,55,"F.F8 -J50A1 1+V@ X$_DUT#E_K#ZO=Z<"1*
M<1 /ZP_=@5_)J :DU,(E*'B:")BE$QB@ \1,!2B(AVZ!K@3H7A^[Q[-3B&N@
M:CH AJ.@=N!42CJ.@#IV\-1#Z<"Q= T$0+KZS"'PP B03:")-1$ T _'40U
M-/6 8 0)H(_ET* B(\_H#M'3U8  *;3EY1U[-#B.NOL# D0* B @ "&@B',(
MB #KH(AVZ"(8$!R:\.0?4)M!_J]N 'EU#4"@)NP.8P=G;PTP(_+J ?EU$0*
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M*'=S<<"#%*&FHE_[G[>W JGIQU ![.WWX%N4GHU'V@(:>S >&4/3S>X0T^.
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MM\WLO%FE=X[#?;G&UC>C;27VPKS%"_WBJQMV;764FI]-1D]7BV:8E6^6;"H
M%*<,,_1WUW.=Q*KN(GUM[<79WLHXF]OZ1*6'>*^E+&SKJ>81$7MU<*\A3YJ%
M<;@VFOJD83EG=K.[&LK)"T28G3(F=4/,VWI1Z]9>382-[\PC;$%[(XV0FMLF
M,IOE:XV+/O-M>_?1EL3HL?'TNO1B]=,]E_&69G8S#^:EFK0KH[-OSM<#Z[V#
MZ?\ K@IMPZFJA9-_MQYVA1FP]?I^P5PW/GFEC<374=?MO8A3=?<Y.2%[8;6?
M;ZD7>KL%ZXU>M6?Z<M.S35NT4:I-1 /FR[]$WFDQ3P\=4/,A1AH5+:/=Z&A$
M+A<[ M/H2,@[?OVUDFI-]37SVR S_7V:)IP3-9&H)M$!8*G35,@8-<6#HC\P
M#>56KW"B^8-3+;>JOL]8*=3MQ:UOW:4W367>0.QD-:XV/B:?ML^@"(L++39-
M2:M:8C8)I"Q-T%$XUP@DZ$/U^W IO4#=.EN[[)1FX>V=0ZEK-M>[I<?>V4E9
M9:+BVLNBWJ,GNNG%.FC6V$F21ZSQ^U;&%9!.7\%N=\H4#N<#\EJEY??7W4HX
MT!TO>8/M57I/:"!JNP\;-H(S]Z<26V.V-PWNW,H-/W6K4VK<7D!<H*9OD#75
ME!E7[U6K(R/BK*.%42B'J8WIO\TZ OC)6O=8CO<ZAWS>7:VM#8*M<BVIM1MD
M(^&O$)O?>K8QN98EK7[I-0246M HUT\HBA;V0&,W3;.'*F!N5AL?UI1/3UU!
M[5ONOVFUC?F3ZF8F?VJW,E;X[O,SMYM_?9.'11VQO1;%#5]L29E:X\E#5>(8
MPS%JD[)'B'S!BKKG#2LWY?77)O3LQN/6[GU[1>[>Y$A9/D%'L1=+!"T:CRL?
MM%NU6;A7J\C7*Z\E-OK&^W'NL(199 OSS*OLG*(<@N56JX;LVMV8ZS)79SJ7
MJCWKLI.[%ZW2WRB)O:![5MUI)@2K4*L7-C9-Q]H8K<&NU9[<-LYB<VW.G!*N
MHAK*JP9B!)HHIK.E0P-C0O2QUMQ73ENW7+CU<OK;OQ;I+9$D1>@N5LH53A]N
MMMX7;0NYM6B)"$KCB0VNL>Y[R+MB;NV1D<]E2IR;1X( J@""(?)>XG0)UV;S
M3M@"[]6>UTYMQ=$HN0V>K3S<C<^R#&2+?8K=NA.GL(YD*ZF5\K,L;TT?2"[!
M04I$D6>0%LBJH)0#?6^?2AU8PN_FZV^M ZO(79S9RZ[P;=;F336T[D6J":UQ
ME6MOMFMO1"3:.J^ZJK^O1BU*GRIU-5ZSAK$I:4G#YT@XC&Y50[G<7IFZQ[?O
M[:]R]J^ML(B/E9Q._P"WNTRVXUG7HS2@*J;314$C*4:(B%6CZN/XJ)NQ%5D5
M#(N'\PR7(MXS5-1L'PW3^B/S*V41<;8/F8[4?QIN#2W>U2\O&;C6R336?4&W
M;B7E611W#/7F=F<V?;VFRTC6@242<K1L>\=RZI_GXMF(A]4[L;6]9<RWV,G-
MN/,*VIA6-$Z.Y*L[JSMGW+78Q=YW'L4),5Z$W^18U.OQT([:FO 1J+6?D#J-
M4R%<^%&F>'+J'77WHL\SR_5F3F(;KK3V^W F;[7)MBVJ-[N[NB0>W9K+O#9Y
MZMPZBE"9$=RK)2U5!-B\<Q*J4C'UI1@Y31:.U@5#;N]>QO7WN/O;U"MML-\)
M^@;(_P +;)/=M(R7M+6F?QM>7TW3C;^5J O5+CKG?ML:<;;O;M)M&RB,6F_C
MK+;)A=J@J@5)0@=CM9T\>8W5HO=6*W%ZHJ-N O(=/UTIFU=B4?6F/=([U6BL
M;<LH.[6J'CJ;&# Q='L%8F#M74=(/GKE*8.L9!%4/# /G2&Z#_-/;;<4EC(>
M8>]+N77MQ]N5YE\VM%PD:_+;15-.XKS$0L^EZ:JYEKO*S$Q%K.W+^.63FFT9
M\J[4314,!@_=@R8?F$#<=1T* >O@&NNF!4":AW#ZQ#3]M,"?#  U,;CZ0*&O
MT#@3R%'TB'K$!U^C KX9>;_OFO\ D\@AZ._7 "4O8 CKW>[7NP %'L$  /Z6
MFHA\<"XE "Z!H8=!_-IH.OTX'&!##ZO:(8%N30..@CH/8/T>G3 J!1]/ /3V
M8$DT\0N@ZAK@9F P,;4.\/I# :AWA](8%A.!NT2\/7^.!0>4>T0^G\<"I! -
M=1T[/MP+ZAWA](8#4.\/I# :AWA](8#4.\/I# :AWA](8#4.\/I# :AWA](8
M#4.\/I# :AWA](8#4.\/I# :AWA](8'PQU<]&+OJILVW$LGO99ML*_5XUY6K
M[582 8S;3<RG/-T-G=UE:^X=/9-D%?.YF=FVK%RY*@\%>)D7C<"$\7GP/B>M
M^3#&5&OPD;7.I*4C92LU&%J,"X_E+7G=69-*]0]N:/%)JT9[:G$.\AC&VZ3D
MWD8<_P F]D'S@ZA=#:8'8UGR:X2%:[?@ZZC[:G([:U2C0=6=U"KO:PG$V.C2
MVVKM#<2*6EMP;C865UFXNA/$'KD\BX*=S8'JY2E()6^!YG97RG[^ITSV;9K?
MC<*CQ]G==4-+WUK$C5V,MN= M(K;S:6K[4,E)EK84MNRKWJ[)QLG,2L@V21*
M>8D1>*$65.LF8-F[ ^4="]/.\VQFYM1ZB[\M5-C8X8Z&VI_2WD55W*:FVT!1
M9)6/"+N:#"%&TS$:\F9I$S%VSD5WI">"FHW(X,'DY/R9H1=],V"'ZFMPX6UV
M&0FG=BE?TF5>QUOB[%<=UK?9*9=X8VX+?^(*3<27F"B)MJ1PU=OH2IMVJ;IO
M\P8Z(8]?\FM.$W%J5_>]4%AMI*D[Z=I=*KW7;M2T03V9Z>+U7KA7>3]7W&=.
MX*O),(Y]$QD?%J,OT]H\0.Z6DUF8'6#9NZWEEW2\6?>BW4_JGE=OY[=O<FR7
M@DX6@ST[88J$NVUVY&T=@I5AD$]WH6/M\/6:KN0H%0\-E%%KBC!N8Q'I@$V!
MJ^^>2["V;;>2JL#U/;DUNZR<95&;K<3Y6P/7SV1C-Y-Q-T[?.2#!#<2.<*R%
MTC;9"1!SHO&ZS0E.B5B*F!($2!LW;3RK6>VG4+MAU#CU 6[<"P4+<RZ[CS$9
MN)$R]A3M,A=0WXCE9 7JU[,,9;*]4=X(Z%CY$$E2%8UI(JJ"A5P(W#5Z_DS(
M,9([:E]35HI%*D$[",Q U^K3,5)J-[9NAN1N!;*C#R,-N5%1,50+NVW$3";:
M'CG,D\FZ_&2)'R*2)F(AZ^I>4LXH&Y<AN55>IJX.S2$];Y!U3+I&7&QTQ[ 6
MZ0WO.K5'[!ENS OS1T9!;DUEBV4;N&RB9:%&"7E(/AI!]#=<'0M-=95FV7L2
M&_UEV=#I\D97<C;%I5JE7)XR6_K>6K#^@[CV1>R"\!Y"TIC"/&@1T<2+D7"4
MLY LF@0YDSA\\])OE%P?2]NSMCO23>$+W<Z18K/)34>[HSF'IDE%6+9QCMB1
MU5:M_&TJUI]_A)%JNLA8"F=JJPTJ^BUDC@JBY0#!D?*IW!_EB3:V!ZEZQ6H6
MNS#-K3)*!V*<UFTRU+0)O,9J.]5VI.[%5O&Z5_J\WO$,Y!/4Y*)@&-B@FL@K
M#.%7+P% \8U\F6WMI=Q,J=;N\3QQ+RBRUO.HYW!15MT',3VYDK<(:2.VW@(F
MU6N#.UP39RZ;D341_AI$R )E4*FB&2]\GF])N*L%>ZWMX8.&KI9Y=2$^;W)7
M16FIRG0]66LS9X&\",DE,"G7FZ2B*BRS!6/<.6YD!YP/@>JD/*@N:0RS:F=4
ML[ 1B)*4YIC^9BMU+7;JX\JNU3>@'AW<F_WY0@WU0"=4E)UFFC&-9E%U/O2+
MR3G4IQ#)VV\IB3@^GG<S87=#J1L.Y1MT+YTX6>6N_P##\M$6B,KG3WNI&[@1
MM4BYB1NL_- X4@XQ*&C)%1T96)3125*FJ"94L#5['R;]WJRRGH6D=;-CK]:<
M[.3.S\'6F]/MS*",SF=T'M\E[5:HN'W;CHJ;N=L:R*ZTO((MVH+V%RXD$$44
M5A9%#;;/RL+6UZ?MM]HY7J 2O=THW4T3J3F=PKI5KPDI>Y@^R$KLX^C9I>J[
MLU^ZLY)Z64&35DF\X"RRQ!36(IXBAS!X6[>4UO-:=RMQ=QV75>C'N;%?['>M
MO8Q]6=TIQOM:XN/3[NALI/A67;[>X\BR!J:]L%(YJBJ1DT9Q(IE3Y5P31#QV
MW_DX;[46U;6VA+KGMQWE/W/V?OEY=143?HB6W-C]LH%.L$BK$\6W5E/G'496
M8IM%Q1UB*-",'\BFX;J)J()HA[WJ)\IG=S>3=/J+WSJG5]+[?[C]1C5Y1[0R
M84Z28UIELU5G5$D=DZ5%2U/NE4OS28HLQ13NW[I:3>1,H-AF4?TM))\KSAU\
MUY5W5"^F-R)!KU\6I-"^3FV4X+1Q%[M-P0FJGMA+;=2UR(YB=](^4C9B"DY-
M"QUF(:.R5QM.1J!Y!F]1'PD@X=S/*GZE;O5+I QG6Y+0TU8)S=55A>'$?O$Z
MMSR(W*NE$LR<K87I=]"1D=<H")JIHM U<90</\NW9F%B(E-RAAJ>4IO\V1LQ
M*SUCNJTZM%KD;),.8R*W68*R\G:)W<6SSEXEWT-O'#2[J_U6T[@HRL&(.@B%
MY""9J2;1WSJ@ ?</3KTP;X=.VZ<U/'WJ6W8V^W-"<?[GQVX,WN%*S\-9T[]O
M1<JW8=N&\Y:[)!0?SL!N%7ZY(L$$F3$&-7261(!SD33#XUZI_*%LW45O3N_N
MW#;Q4&C-=S;/5[([KSG;6UVPEG>,=MY+:9Q-;A*3>YSID>T[?5"87/45Z\W@
MF*+TC=60:.U&Z2I0[.F^3PTB=C-^-BK1O*9]!;T]1VSV[II>GUF0IDQ%5;9Z
M^0-RCG*CYI97;D^]]C&+$[ZT('12%\BT6!H)4!3.'BMS/)NOFX>V/2+M\[ZA
M:U*S'3O4-T:K;MP[)MW,FEK=+[C[T4+>,VXT57("Z0T %D92E)$%8Z1^:AW+
MAV*ID@(F5$0]>V\K3J*0L-%15ZXMR5]OXG:^G4C<>&-:-Z_XGW)L)=RZKN/N
MI9WMG5W;64C7%R5K[ME'&:$0/#1\HJT3YTB?V@=YM?Y7N\M8N]ALVY?52\W?
M1?=-6]6P-?E+E';@S=NB$-WJGM55&:2YI[<R5IHUNDH[8BY3%G$,IJ8<2BYY
M)\X.4AL#0NSWDH[N[1TU9"J]7I-M-QV=:DXRHW7:NF6.,-59Z2B.FJG2LNN>
M=O<E)VN+M=-V*?$?Q3Q4K%J[F&YV2:(1Z8JA]I[#=$6\>P'5;:]]&>[T'N?2
M[G'*;<*QFX3[=28W&K6T2<Y9KK LV=FLE]MM?>SM3F5XJ&;I,HV':/8I%5V\
M\5^(*"'SC&>5?U&4-'>%;93JKI6SLCN9N'99I M*VUND7%HU6W53?N F7\D5
M+=$UB"ZLY3>AO,1#5M)DK4'-0POF+!%9XJ! X*KY3._%(W$I]SJW6A.P3%GN
MGMKN'N&P@V6XD&\W!0I:#UC(1\H:-W+2AW7B,4&Y6:;EFL@/ZE*)N@7340*F
M'2=1'DI.M\.H#>[?&*WOK]/#=:Z0D['U9:A2L[&Q[*1JEEJU\L$THM<6SN3W
M*BS68TC49!)9%G!/VQ3E; 0YB$#Z.Z4_+EN'357NI/:P^[K"=VSZD('<**DK
M'7XZ:JNYU3D'L>A6*);&[Q26EXJ>W%DZ[8YMU9YY3Y99W*,(HZ"0$*L !\TC
MY/.\HU*60A^I;;K:^[)2T>[ITELGLT[VPA:S&0.QD-LJ:-8N*W<&EP9I[EL8
M1-6P@615,W;J*-V9^02Z![^Q>5KU#R56D(IIUPWV9E9N/5B[>2]3N],U6-PH
M9M$;.Q->KMGBH7>2NR$7'09Z=97:J\0Z8.Y1Q.D!Z9=(')%PU47R>.IXCAT5
M#KTD8B,@Z*TJ6UD=7JK>HI';-S&;(W39UK*5%)+= Z%5=2T596K624BRMA6C
MF0D(0ASI@@'VC*]%V^UPZ9MK=DMP-W=O+[=.G?=G;>_[;7;<NIVK<BL[OQ5"
MHZ+ (OJ'J4O;6,O-+JVZQ3!VZC26.=$D;$/3"=RFNF8.AVC\NO<;;+JQHW58
MXZ@JTX?UG;>%Z?);:JD[,PNW6U[GIXAMN63%K2:E"Q<[(R-)69[TL_XJ9-4'
M:T0R264:D;"H8SDP:6VI\GC^4U2:#$[A;56#<:O7;J'G*@\MFS[R?VSCZ=N_
MTQCTZ5_;V9V]EKJ^)8X!JO$1,[8!?NG+J=.W5:K+& WS!@U16_)'M,"E.OEM
MR]@YN4LNPTEME.Q=BV;M\O OKK8GK!*TVIB\:[F0L]5X:3!JO9F#**5:!7[L
M],\C_!9H(,RA^XVQ]'LVV&UE+VXM-C@K6YH5>A*;$S\%75:HG)5VKP\?!PKN
M3A32TNT;3KEHP\1W\H=%D"I]$$4TP N!MC4.\/I# :AWA](8#4.\/I# :AWA
M](8#4.\/I# KS?FTX:=_N[^S MJ'>'TA@1^7774-?;^. _+KKJ&OM_' G4.\
M/I# :AWA](8$<WY@#4-._P"G G4.\/I# J)@UTX:"'$?I]. +IXA=.SVZ]^!
MEX# Z_ 8# 8# 8# 8%BE$VNFG#O'3 J/#A@,!@2 "/9@3R&[OB'WX$"40[0P
M)Y3=WQ# <AN[XA]^!7 8$@ CV8$\AN[XA]^!/AFTUX>S4-<"HE$.T,",!@,!
M@2 "/9@1@?&_4OTILM_-RNG/<=%O26LULE9MPI9S,V2)5E),\?8=J;M T]M'
ML4T#,YQO6MVI" L8L7ZJ;7Q8@JQ!\=-,!#\O8SH \V1G$;?S3GKNKSC=:*-5
MJW>[BG-3II*PTB#OUUM:K!&7<[:*%<L$Y"QMY0&3IH<[I!,T(LX&/32U#O*3
MT7^9U=XNF;DWSJ84HNY].LMHM]-A[!N5+V-[%R4ZO7&$@PMW\-4%&MA1K3#0
M0E7J#<\M'1@ID5;OCJNW/A!L^!Z3O-+\&*7F.M*+C7]?LKV?9E;V:3LK6;F/
MUW9)!W*V(CO:F%1?4BU0L#>9%O35$5&=97FF4>W>O$D_FVP=3*]"?F [A])N
MS&VFY'5\W_O)[5[W;B;L-]Y&,U*2"'R2^T&Z53V]J4J+>FUUQ>*?(7VV-5)N
M,D&Y#IUUVX;(.CK-&HB&\^B_8+KTV)N*++>G=ZD;F[1Q]$I&WL95DKI,/"Q2
M5>BTD&EMK$>ZVJB74"]J41%-H%=BO*2)K8JZ6FW3QBNB1BL'R>ET ]2FZ>X4
MW+WB-9TNO.-J>L;;B=W A^H?=:G;RWO<?=?<W=Y[39^6;UB)>12.Q 5J?C7$
M3'1,K&2**C\5GWCC&M&0![^K]$O4SM_U)T+=$%85S#KR?2)5IN0J&Y=NF7+D
M=F*E:$-SMSK/%V2$@&-8C9VI.WU1-'-UIP\L#V,40_244GB"P:%NWE7];-DW
M<M=G#>VAR=/E^N)KU*-W$G?[Y'VJ4KG\3VM_')RR$-2V[-K"4NAS;&O)51-R
MLZ<C'&78V.):K?IY0VIO-Y8_4A-]&[G8#9;<7:K;IY;-X+7O+?J1%/=P:]&C
M:)[<:9L%6;43=H'5E&M4W;^GIP4:2"<4IZB^)$F5279.SI.4@V"MY5L18KL:
MSW&$H#@UIZJ-O=S[V]B;7N$1R7:';+:-NE^DUQJY5!5O=MV]^V2DE:UE71A?
M0LFY25<KG!,@!]G]$_3U.]+NVI=M'==IC!M/3U\W2MDK5+E9I:.9W^]7F4?)
M4RK5RQPI%6%&J=$3BF#)P#U,1^3Y!: 83N%0_.6N>7]US]/5 VCCNFW>2K!;
M9?>NU[K]4RLI=BU)2Y04A8&2T+MO6+*UV<L4A-1!:H^F$/U.;2<2C"0<H*)'
M5212*W#TF\O0_P"8CO/TD[2;=S75+"QO5'0+!O\ 3UOW<:6692J>X:-]VIW,
MH-,JSF"@:-6R1M.?-KHU8/FI6OC0XMQE&BKAXDD0X;@Z>]BO,4VMKFY]9W0W
M7KVZ4;,U&%I]!",W="KR%5>P2%^(PN-+E7'3I+*49,:T2HP+B,?)V8SF1:R$
M\=SXBOR*X>4ZKNE?J*WRZC7[ZI5MJ:L1NYG2I?FFX\UO1=MOW=7VTV^:7=2X
MUG9-K6*[9()#=)6YBL9\XFFAD48:9$S7E=.$W#,-+;L^7GU*U^L$<5*QRE\4
MI,CU^6MK-#OENI-;GVV$ZBC[[_RSVS4KLO'IQ\]-M5KS5I$)A2>C4HN5AS L
MB_;M&!DPSNLKR\^M3??<K<"X5#>"&7B+QTL;?[124>[W+LU-73F:[.0\SN#
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M"43A[ $!'L[M=<".8H'T*.O=J ]V !4%"ZE,0Q=1#F((&#4IA*8-0$0U*8!
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MK@-0'L'7 8# 8#7 8# 8# :AWX# 8# 8# 8# :Z=N P&H=^ P&H=^ U#OP&
MP& UT[<!@-0[\!@,!@,!KZ/3@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@-0[->
M/=@,!@,!@,!J'9KQ[L!J'9KQ[L"-0[P^G G 8# 8# 8# NG^^7VX&;@,# $>
M8PF'M'Z,"==/\4OQ'ZQP('O#L$> :\0]OIP(P)]VOT_8(8$8$^[3Z?M$<![M
M/I^T1P(P&!(#IZ 'VAK@!'7T 'LU^_ C 8# 8$^[Z_OP&O#30/;IQP(P& P&
M P)UX::![=..!'NU_;U8# GW?7]^!&!/N^O[\  Z>@/?J/VX$8# 8#W:_MZL
M!@3[OK^_ C 8# 8$^X/;Q^_3 @0UX#@,!@   '73C[_OP& P&!.O#30/M^G
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M>[[L"H]H^T<",!@,"PB70- $!](ZZZ^[3A@5P& P& P& P& P& P& P& P&
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MX$ARCH8>4/\ )]'T#QP($ $P &@!IZ/?[<"VA0#0=/:/;@5$0+P "F]8\1^
MA@7+RB #R%^@?OP'#F .0NG?H/K]>!8O+S!P* ^CO^O Y\!@89Q =-!U[?LP
M./ G01[ $<"2CIK^;3W:X'(!0#_&T]I /]G# X1P+"&G?] A]> , !IH.OO
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MXX# 8# 8#37LP)T'N' C 8#37LP& P& TU[,!@,!@,!@,"0'3B&! \>. P&
MP& P& P) 1#LP CKQ' C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MX\<"PF$> Z8 #"7L].  PAJ/#C@3SCZOC]^!0>/' 8# 8%A,(@ =V! #IQ#
M@>/' N!Q#AP_;WX$"81X#I@5P& P& P& P& P& P& P& P+<PZ:<-.'PP*X#
M 8# 8# 8# 8# D!T'7 ".HZX !T'7 ".HZX$8# 8# MS#IR^C\=<!S#IR^C\
M=<"N P& P& P& P&!8#B :<,"1.(\.'[>_ I@,!@,"W,.FG#3C\<"4_WR^W
MS<!@=?V#H/ >[TX# 8$Z"': A@1@,!@,!@/\/N[\!@3RZ% 3"43"(\"CJ %]
M'?Q[\",!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!IKV8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# D UX?6(!\1T# "&G=[A ?B&H8$8#
M 8$AH(\> 8$F  '@.N!7 8# NG^^7VX&;@,#"4#\W-Z3=O=P[OIP'AF[@_K%
M^_ GPSAVAI_W1?OP'AJ?XWNX@'UF' J8AB_O!IKZP'ZAP*X%_#-W!_6+]^!
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M!^<.(@8=>\!TXX#F4[S?1@.93TZC[0' K^?_ "OC@.4W:)3>W0<"0$P>@?>
MX$\RG>;Z,"-5 '7\VH^W @2F[1*;CZ=!XZX$:#W#] X$\AOZ)OH'[L!RF#M*
M;Z!P(T'N'Z!P&@]P_0. T'N'Z!P+:FT -!#3N <"N@]P_0.!81.(:#S:!Z-.
M[ @"G]!3>X!P <Y1U#F ?3P' :&$==#"/L' !S%']T>[B X 2F[>4W'CV#IQ
MP <P<0 ?H' MJ<W ==.[L#XZX$#S:<O+PX>OL]8<,"1Y^73E'3AQT' K^;_*
M^.!(B80TT'Z!UP&IQ#EXZ=VF!  8!UT'Z!P @8P_NCJ/< X#D/\ T3?U1^[
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MXB(?3^.!(*:!IJ7Z?QP)%37AJ7Z?QP*%-^<H!H(#^.!DX# PN<?5\?OP*8#
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MZ?=I]N!;D#N-])?OP'('<;Z2_?@08N@=@]OIT^S I@<@%#0.!OI+@5.'*&H
M(\?2(8 0_* Z" CIW:=GJP*X# 8'(!0T#@;Z2X%0#41#CPU[M>WZ,"O'40TT
M !'CJ'?ZL!@,"-1U[- []<#E H:!P-])<"@]H^W C 8$&#F$HC_B@(:?1]V!
M.!/-Z-!TT#CS#ZO1@5XZ]G#OU^S Y0*&@<#?27 CE_,(:#\-?1[L!R_F$-!^
M&OH]V!0=0,(::!WZ@/U8$@&HZ<?=^. -PUT ?8(A_@P(#UAIZL!@,"PA^74
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M@7$H 4!X\=/JP*8%Q*'+KQUT#XX%,!@,!@,!@,"_*'+S<=?QTP*8# 8# 8#
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MT^K D" ( /'L_;T8%!X"(>O L)0 H#QXZ?5@2! $ 'CV?MZ,"@\!$/7@6$H
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M?;@2(:  \>.G=IV?3@1H/<.!& P& P& P& P& P+%#4?3[M/MP('M'VX$8#
M8# 8# 8# 8%Q+^770?1W:??@!+^770?1W:??@5T'MT'3 C L4-1]/NT^W @0
MT'3C[_PP(P& P& P& P&!;3\NO'X:=OTX%<!@,!@6T_+KQ^&G;].!7 8# 8#
M 8# MI^77C\-.WZ<"N P& P& P& P&!.@]N@Z8%D_P!\OMP,W 8&"8W-IPTT
MP*X# 8# 8# 8# 8# 8# 8# 8# L(Z@ <>'K$?A@5P& P& P& P& P& P& P&
M P& P& P& P+<W#30?1Z1^KLP*X$ZCV:CI@1@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@-#:ZB <H_NCKQ'OU#T:8# 8# 8# 8%P-H733OXZ]^ 3_
M 'R^W S<!@=?@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@-->S
MG00[0' C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M@2'K#7U8 ?4&GJP(P& P)#CW^[C@!X=_OX8$8%@+KW_1P^G7 @0T'3 C 8#
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M0=.=O:FLE44YC9&MRM>.T7))I)6J?EBHI$2=LV;@164#]GQ#0=,",!@,"X%
M2\W, #_1].  NI==>_AIW8%,"0#4=,"_A^OX?C@5,'*.G;@2G^^7VX&;@,#!
M,7ETXZZX%<!@,!@,!@,!@,!@,#46Y [^@^B_Y.FV=+&?*./US^9I+L9_\_XY
M/E/TG^%#E;@S^6YO$\;\_/IR\-<#6PCUOCPY^E#WI[P_8J&!8/[\ ]A^E ?_
M /'O#_\ -,#TT<MU5$3*$NPZ=UU^0@*&CI;<QJD*H))@J8A',(],5,RX'$H"
M81 @@ B(@(B&UZD>ZGBU37U"J-IKYU4$4J<[F7L6,=X2(H'56FV,>[!Z*PJ
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MEG<3=^$L-&-U47Z$H]?KCF0K2[ZD,I1T9K(WRXO7,M&LBTJJF=QQI)5H*[M
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MHXRVW<V&RY;2UA+!'TR2J$M$D:[PN8B]2MR)=D&\=7J^[E+.J^9NVPQQ540
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M?P_' >'Z_A^. \/U_#\<!X?K^'XX#P_7\/QP'A^OX?C@/#]?P_' >'Z_A^.
M\/\ RC#ZA'4/<'HP'A^OX?C@/#]?P_' >'Z_A^. \/U_#\<!X?K^'XX$\G^4
M;V:_E^C CP_7\/QP'A_Y1O9K^7Z,!X?K^'XX#P_7\/QP'A^OX?C@/#]?P_'
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%,!@?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g107849ex10_37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g107849ex10_37.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 5@*  P$1  (1 0,1 ?_$ *@  0 " @(# 0
M       &!P@) 04#! H" 0$  04! 0$              0(#!08'! @)$
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M\9VI:P;\TOIE_<F1M.?'<L*.1PN\)+PDN/NYHRTS3C)# & , 8 P!@# & ,
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MUJV7")T#O6PU;7-_=4?9=E81D %>I)4Y$L5&RC^7-*G:N%YUX"@-F0"18"D
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MBNJ#<71\U5:/FC9[%ZWDV(9%K6W.*:]C)AGB+HP!@# & , 8 P!@# & , 8
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M7@M1QXE4[6T=JO=\?78O:=1:6]A4[(QM]?;/'DHS+&V*- Y64FF:+?,3JJ(
MH;H103ICU]2CF:V3N#>.W;MV]LM^5BY?M.U-I1=;<N,?J3HG3D>3*P<7-C&&
M3!2A&?4EK^)<RUN@?]\PO2O ]8Z '7_?UQ1< < 4 $1_U_WQ36H.>T!R%%(B
M@[0]/]LJ)'0,406G = _[?IE/2N7 '':&31!)+5'(  9)-:G."!@# & , 8
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M[%\S9'G+S.C & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M6LIR'NC>M*6"E;0<RDA#723?/J]:9R:M<&F^683!(IRLYD':O:B<Q?,*?D3
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M[7]HPM;?&*RG95G$LTU72J.Y)>$?Q2\9:<SG&T;;E;OG2GDNL%<ZKC?Q7O?
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MIJGOT.L;?FVMQQ(9=EKIDM?)\U[F6WF$/8, 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M;.S2CJ,B210IVI5@X>K%8KNS(*KH+%9(F6[1 2@:AJD%-R5'P^F7(GIEY?\
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MOX*MP,+*RHSLC$1$?%NYH[8K-6668-4FII%=J115)!P\\7D4*0>P%##V] Z
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MFWA2TU*HSJ;[S+MT%EG*R;1,AW9TD5*968R755-*G+Q#;5'1]+=*^9S6>=3
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@$5O?U/Z1<OOOL
MOHWU6P_<_DO)\=]3^(>?8_?^'^7V7P_F\O;^[Q]>GKDQZNI='XZZ>T&)\<'!
MOX-7XX=;_"?<.-'G\7O_ !_<OBJA_P"LOF[@\_O@A_B?C.O[/#_Y'IYLN/\
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=/^W[NOA_C[<L2KU1ZJUII[!R)]@# & , 8!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g107849ex10_39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g107849ex10_39.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P$< P$1  (1 0,1 ?_$ +T  0 !! (# 0
M       ( 0<)"@(& P0%"P$!  $% 0$!              4! @8'" 0#"1
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MD/ZA]^WNU8'$$@ B9G]F< =0F)RBO67?;?Q_0/[M73&K3^*4XH%).4.LOO\
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MZ*I ]!P/QCZ?$O*Q8YZKC"<<[-)!55]5%5A\$WQ^I1]$B8P]( [ !51*'_F
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MB D%LC62N7I3).!EG*,<WKN:VT?<>R[MJ&U?2FB2^$@XG6A6D2YS.7A..Z\
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M#8V)Q?;!*C8$!N3BOQ"=FE:_2827NB+QP_@H$Y!<>FH;U%5BE*<%! FLFO\
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M5724SH0R@DI2,52$@99 >&.,9&N4?9,H\OF/ /(W@,[Q]PYS-B*\L[!97<#
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MX?V7DE@'ONT!Q3;"RMK+.C?+N*%)2O2C!:2M6-K?F.RM4J\=XS0-(&G8<'+
MIVPGZOC2^8" &[!ON^[?:=P;/N5&\E5/]"*>H (P0KI)(/ $%)5CP$<GV[:E
M;>;1NBE?84BH%0EYF8Q*FR5&4OS)PPYXQU?BYBG.&>N$?=:YY9ZK]HE,IV3C
MG6^-..$I2K33.PN8.EUVFI6->%@WK490OQ,?#0K8QD2&]98CG;P$P#]=T7[;
MMHW9MO:%F?;%A8N!JW%@C25.+4L@RY$G/+"/C8[1N"[[7OVYKZRI5R71"G90
M0=8E(3$^$@/ME'RL[-LKPG _LYPF6H[D;#<$DZA;@Y+1>%&4U&6\+!^9-C.S
M96%BFBV50=A6SB>.3D2 W,)G(IAZP$'4A:JFQUN]=VW6@7;ZC=_7G1=<_L5I
M+2<)<<?29<?"+;VU<V-O;;:N::I.W$TLJ@-CU)6'%X\A),B)_?%FX&6XKX4Y
MW<)^3O%3BORSI/$K'V1FS*SY(R#4[E9[9EV] #LKE:OLI)T[;IEA&,PU131(
MX1%8#J'$H"3;7O6N]7?MQ>K/NZNLZMR5# Z5,RXVTED9!)T@3"2,)@F0QQB)
M8=L]#OJV7K;])<U61EP:W'$%161/U)(PD1(R)G/XX9ZNT=!S[#N;]X^8EJY/
MQ$9.YEBGD,_EH61CV4FW/=[^OZD:]>-D6LBF1-8AA,@=0H 8!WV$-])]T*ZB
M>[:[1HZ=Y#CM/3N!:4F>@@I&/R\Y3C</;FDJFM[[@K7VE-MO.)TE0S!4H_<8
MQ6VREW,^*_ZC]$M*MRAK'F;&RU=3+5YPYI]%//5J='6@DRQXJ3**;=4IS':@
MJ4I# ;?I'?6TZ2Z6T7;8#3M0STF+>L.DJ$D]1N<E<I9&?&->55MN#E'NUIEE
MP%VI0489AM9G+XC$>&<9-^9-:L;K^G I%>9UR>=6)+CMQ9;GKK.%DW$^#AK8
M<?F=-CPZ#0\B59L4AC'(*8&(!1Z@#8=:WV+74#7]0+MS=<:30]=\A<Y)EH<E
MB<,<A\8SG<U!6'LJU0@.?5)::FDC$_M!,&7S/@(@ OAXV0>X9V-82\XPD[/1
MF?";CVVML?8*=)R%9:R<# Y(F&;.RD<L#1C9:.FF358S=X)=E (!R#N #EU/
MN&EHMA;T;HZM+5R<N+I9*5":NJK#3(SEI!F1S$HPQ5F5<MX[6564Y71B@:2M
M*A@"UG/Y@_?$E^X;Q[R[VO>9M8[H'#"GRT]B[)$^C6^46$:?'O'<>Y<6!=$T
MT[)!Q;9?T(&]@B+A!=-,21%D135  2<"0(/85]H.Y.SW.W6[JD-76F1UJ%YT
MCTZ9@H)]Q,LN8SQC(][66LV+NQO>VVV9T+RNE4,-I,R%)G, >D8@'AB)"/GY
M)O#3D'WE,/\ (#'$#<WN-K[VU<FR47+/ZC8(X\<]?XKS>DM6YTKA@5.*L\;(
M*?!N&:A@5*Y#I*!NHHF^EI>IK3V8>L-2XW]=^O(3(*&77:7KS]LFR)^(\8MN
M =N/=%J\4[;@9_15D@@S!#:QI^,U@>1\(D%V)ZY8H7LZ9AC)RMST+,J6CDJ9
M*'F822BY=4JU$BD6ID8Y\V;O5 <G*)4Q @@H(;%W'PU$=Z;C25O=JCKVEH=I
M4FF5,&8 #JB1,83$3':NC?I^V;]*MLIJ)U4P1(J*T"4O#A\08PO8UXRYT5[5
M?"7E-0,76^VVKA?S*RED>Y8R)7Y=M:Y"@R5EH<\XF6E?<L2RSEK%R5-037,B
MW4.FV=G6 IB(GVVO<-T[?J>ZMXM#U4PW3WRR-M-. R;0XIJ6E9Y\Y3QPC6=+
MM^\T_;^W7IJG<4Y:KLIUQN7J4A+@Q2/C/.64YQ=CNS]R2K=R.L\9Z;Q\P#R&
M;0V-LR0-XR%:;EC249-HBQ2B"<-'4V/-#C-)N3$26=KKN5#H$,5 @)E,'4)8
MSM)L0=NC>+IN*NH6VZBA/22*A$W WK .DF8*OP@X@9\(DNX^[5[V5:F+;15(
M:8J@M;BDC2)@>G#&:>)XF-Y1CL+)G[A:M_/W"D3SUQ\N6LRRF8ZBIC.F;/\
M@3]PC3YQ[D'*782YC<FXW)>#<EY,X/<G+HMD"BY(Q?#'G5:J^+(2\C$M%O6%
M"-)*0["<6C)&.=N6BIR((.6YE"=1!Z@N%)9^]6S+=66^NIV-ZV]HH<0\=/4$
MI#3+Q$P9<Q'.=%4W3M+NJX,5M(\YM2L7K0IL3TD8S).& )!$=QR_R_Y#]Z3.
M_'_"G""G<C\!<:J!>6%VSQR EEIK&#A_%!Z:#J%^-KLJ9HHT)#@Y291X/%W+
MZ0<$4,BDD@)]1%OV9M;MCMZLNV]'Z.MOM53J#-,W):DN$$)421*<Y&8P2.9C
MW5NZK_W%N]'2[58?I[6T^"\ZY( HGC[>$O,F/>E<BV3LZ=TSEKF?-.(<I7OB
MOS.8,+#5\I8PK#BYO*W8FCHDP$!+ 99N0KQC(NGK=RW6<)+'04;.4O5+U@'J
M6W2]UNW=IL]MJZ=C<5F04!ATZ>N%+]10<DZ4^J:N1&<?$..]M-^5MVJJ=Y^R
M5Z$S6D34A2#J3.<IZE8'X\)1':0A<J<\<G=SWN9L\-9$QE@I+A#DO"6$(ZW0
M;R.N&2Y5>F1M=(\;P295',D"$:P=.''PP+H)KN6S=-150AQ+/M5MIV7;-K]N
M7JMEZZT]\15/.).IMM"BLF:L_25 '@9$C"(%;%WW;77[?C=*ZS;7+<ZTVA0&
MM9]  PF,0DG,QDQXDQ$E"_TY\I&S,9(Q$HUXC<D2/(Z6CW<7)-S'>9'52!TQ
M?HH.VYCI&*< .0!$A@'R'6NMVNT=P[]IJJ%X/TB[DPG6D^E4U(Q'P,XV+MMA
M^A[/+0\ V]]$\N1&4@3(^,8K."7>"J7'GMC)<3W_ !^S?:<W(57*-2PFM4:$
M\EJ#D=#(4G8QBI=S-H*"\35A9F?<-GB+9H[,N9H!4QZSF*39V_\ M:F\=V5W
MYNX4S=F;>:6^I:Y*9+*1Z=/'J >F1D"<<L=9;-[CKM/;U>WE4-0Y=76W4LZ4
M@I6'2KU9S]!EJP).$H]&U=MWE+Q6X&=N?DM'XRG;KE;BIG.V\@LP85C&BDE9
MX:GY M5.M<6FK$,TG+I20KS.AM4)9)!-=5D>0,<Q#%;J"%:/N!MS=.]K_M]]
M]+-MN5$*9AXD!.M 4 5*Y&<QQ,HK5[#W!MW:%GOU(PMRNHZDNO-C$A*BDB23
MQD)'# XQ>GG)RZ>=[UUQLX>\0\"YSB6R&7H+)^:\AY1H9JU!XRC(B/>PC@%Y
M%)V_:BTBFDZ\745.JB9VJDBB@0YU! L-L;;C/9EF\;QW'6TJJM%"[2TK:%A1
M=ZV(<D<"F7#W#CE$QO'<-7W4%%8-OT;Z%MNI<=4L !$QB"1/%.,SQB:O:YI\
MQ6N[KW<3OX"=:0:K^B1T+-2D+(LXV9;QTV]:@JPDW35)E)"*213G%!0X>T=M
M8;W*N%KK>UFV:*G<:6^D:W$C-)422%>,\O*,N[>VRKMW<&_!U+@; 2$*/M4
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#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g107849ex10_40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g107849ex10_40.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 2P$A P$1  (1 0,1 ?_$ +H  0 !! (# 0
M       (!@<)"@$% @0+ P$!  $% 0$!              4!! 8'" (#"1
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M(*D?RX05].2>5I7&=3C4ZZ)$9ZQO%V+-\HD5<L<V:)%5>NDTC[IF=?>$(GU
M8 $PFV';6)8A9)%[N0E59XR@-?/R609#<JBU41FTHC,*@_4.1&3*W.M).1LT
ME88P[A,92*EU =H.&9SE!R*(B4IVK@B0B9,R8E#J  $H@(AK9ETPJRU-$ZCD
MT[FU!V<-X](^(\E@]!D5=(JP9A)!W!4N^:LK4T^%O)^7MIVP5)7CIEAU)"^
MOH&9O<?S0-2G*<0 5%'2R12!Y^H( 'CK5F'2:\YM;)-!I5,NTEHAT(>!^"R[
M+)E),Q*X_5_RG6R:X_\ D<L&WZ8WE7.Y+XW9*XS6V36DWW'F:A)6B*/%CJNF
M^.<@!(*DA $XB)65>L\8[*@4/!-%T0@  % -;O\ [FL3I;+E%-D-" )-P'Q
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ME'81* B'D(@'A^[Y:JJ0$8PU0"E+OTE NX[CL !N(^8CMYCHJ-8QL2T 1,3
M;GQ*YT7I>)B$.4Q#%*8I@$#%,4!*8!\P, @(" Z#X3R;H[Q7ES&/:6/ +#T(
MB/V+Q3222(5-))--,O\ 533(4A"_[I"@!0UZ<YSSR>27>)U1C&2F\98#6^ $
M!^"\^DNVW2&P^8;!L/\ )Y:\JO%L(0$$Z2^ =(;!Y!L'AMY;?+;3K'J@:T"
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M"E#?8I0W\1V  W_?MYZ]'40.R\M8QFK !'P$%STE_LA\/@'P\OLUY#6@
M;>2];$N_,=UQT$W >DNY=^D>D-PW\]AVW#?7J) @-EY+6N<'N +QUZ_M7.P?
M(/L^7E]FJ  " V"]=8]4V#??8-_'QV\?'Q'[=5@(QZITAT3I+L(=(;#YAL&P
M_O#R'5  ! :!' .$':CS0"E#;8H!MY; 'A^[Y:JO(:T    #;R38/D&J0"])
ML'R#[-5ZQZJ@  @!HN=4@/!546.9G*C'_"WCKD7D+D5<IXRFQ9BP4$14B;^X
MW.2 6E4I\64Q@,=Y.2IB$,)0,*+<JBPATIFU/8IC%PRV^TE@M@+JB:^'L'5Q
M]@_&"@,ER"BQ6R5-[KS_ )4ML0/$] %\S6U6+D%W ^5CV;7:2&1L\\ALAI(,
M8=CZAT?Q"57!"*@X\H]2<34ZG$HD3 3""+-BV,H?8"F'7Z94]%CG;K">-,XT
M5HM[>4U[MR?S$^))7Y[U53=^X&31 +KM6S(,'MV \-%N]X3[9$#P&XWU.(J;
MHEIMCMJTD\^6LB/WLW=W*)1._CAZ062J,,"GL6:!O[I(A5C?6LH(<?#NW49U
ME-3+N9:VF=_* T^$#X8_Q$#EIXPZ+KFE[=R,0L5-)M_Q51(]0Z:N.^OA'12_
MXN9:&I6+\CS;OHKUG< $<LX-]U%V!7I31#J-X)MI4 !,V_@"W2/Q'6,]P; *
MNG^_T0#N(@?,>9\EDV*7)U+4_;ZO1IV'0>P+)N'D&M+K9":(FB)HB:(FB)HB
M:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FVFZ+C8/D&J!H:(-  1<ZJB:(FB)HB
M:(FB)HB:(FB)HB:(M []0_SJ<9_Y-$XQTF9.MB3C*[5CI0C%<RC.UYJ?M"%L
MDDL"745T6FL5 B6F_7T.1=F+MU[Z[G_MOP<63'7YA< /NM;\,J(U#1L1X<M_
M9!<8=],P?>\@;C- X_:J,1>0='.T)CT,- LT_80[6IN,..$>5V<*^1IR$RU7
MDBTR E6H ]Q'C&623=(-E4%B^HRN=S0Z%WX^"C5F*;;<!%<#:<[\=TVY5=/Z
M3LKR;'1.(F:_S'@P,?%K2#".YUV 6V>S/;K^F;=]^NK0;K5@>F# \&G4$::%
MPAM#1;(#QDTD&CAB^;HNF;M!5LZ;+$ Z*Z"Y!(JFH0? Q3D$0_EUSVTEAY,T
M/B-"MZEH.C@"L2><L2NL66HX,B+GJTPJJ\K;\#&$S51,XJ*Q*ZX[&*ZCQ'J2
M-XF.D!1\P'6^\2R*5?Z#TY@C=6  ,A\)@(1X[:K4]\LSK;6>J"8.,08^*G_Q
M\R0;)%!:.'ZP*3\"8L+.#O\ 4LL@F46K\2AY>_;;&'_J 8/AK4N5V.99[P99
MT:?B Z".X]W[EG]CN3;G1Q'S-T*OOK'E-)HB:(FB)HB:(FB)HB:(FB)HB:(F
MB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HBT-NU1VZI"V=V?,
MN.>6D<M8+!Q1--Y:G(:P)"NRR/=5[5'MZ+:7I5RF3F*P]4E FTQ#J2<G*D [
MEZBCVYW5[AR)?:2DK\2BQMQ?P;Q^$L #N0$/E/P\=-EQOVUP*HF=R)\C)QR-
M"WDX'4.VA&.A&L=5OCE*  'TE =@WV  \@V#[ UQ$/U$?$=UV/!H  ^4;>7L
M7EJJJL;!N2L)GC*%LXYR^-I",BS.[+&UJX*2(JR",_5FTVZ(_6CC,DO;E*:!
M7!P1%951D55 C@ !P7;/*6T5^,4=+DE/4,!+A\/7S\CO[S&&RP:9>:2^U]38
M:FG?$-(CU_Y>Y5KPP@I5N-YFU2JIPZQHZ(0,)3$2>2;!5VJ[40W "J%:E6 @
MF#</J /,!U?]RZRDJ?HY ,9Y;R)ZZP/MUZ*F$TQ;(?/'\L.+?V'_ )*>6M:+
M.DT1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1
M-$31$T1-$31$T18QY3\*_P#U+JG5_!;\=_RH63T?RC^<_P#,7^#_ )KA_=?Q
MB]/_ ..?X,>]]'\O>O\ ^=_&?4]O_A/<ZS.3R_\ SB9#ZOT?7'S<?IHP=_(_
MU/4A\T/AAOK!854\?ZWE1^G]3T_R\O6A#_6_T^/Z8Z[>2R;AY!^X/Z-86WY1
M[%FJYU5%$>.]+^,.3_\ Z]]?X!/^K^2?>_QUZ/0CO_9_^!MT[^[]'[SJ]O\
M';4Z8_12O_<[M^>'H]?E\O#WJ =Q^M?_ "-C\L?5]_\ BKVXB]'^'=9]O^5?
M;^R^Y_)GO_P#T_54Z?:_BG_DO<;?W_K_ 'GK=6_CJ)NG\_7U.G\SYO=#IX0Z
M*6H_Y/\ I?\ I_+_ -?'S5R]6XV5RFJHFB)HB:(FB)HB:(FB)HB:(FB)HB:(
BFB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g107849g85o46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g107849g85o46.jpg
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M 0$! 0$! 0$! ?_  !$( 5X!^P,!$0 "$0$#$0'_Q  >  $!  (# 0$! 0
M        " 8'!0D*! ," ?_$ %40   %!   "0H!"@0$! 0$!P,$!08'  $"
M"!<85E=8EYC7V D1$A,4%1:6U=8A(C$X4Y.4M]'2TR11=8<C,C-!&2<T0@HH
M-G$E-V%B-61R=H61M?_$ !<! 0$! 0                 ! @/_Q  S$0$
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MQ3Q ['PQ\0K%S=\@0!#86-C&19B[7F8UR9=\9;;]'^"^U"\O"W1#XRVWZ/\
M!?:A>7A;H'QEMOT?X+[4+R\+= ^,MM^C_!?:A>7A;H'QEMOT?X+[4+R\+= ^
M,MM^C_!?:A>7A;H'QEMOT?X+[4+R\+= ^,MM^C_!?:A>7A;H'QEMOT?X+[4+
MR\+= ^,MM^C_  7VH7EX6Z!\9;;]'^"^U"\O"W0/C+;?H_P7VH7EX6Z!\9;;
M]'^"^U"\O"W0/C+;?H_P7VH7EX6Z!\9;;]'^"^U"\O"W0/C+;?H_P7VH7EX6
MZ!\9;;]'^"^U"\O"W0/C+;?H_P %]J%Y>%N@?&6V_1_@OM0O+PMT#XRVWZ/\
M%]J%Y>%N@?&6V_1_@OM0O+PMT#XRVWZ/\%]J%Y>%N@?&6V_1_@OM0O+PMT#X
MRVWZ/\%]J%Y>%N@?&6V_1_@OM0O+PMT#XRVWZ/\ !?:A>7A;H'QEMOT?X+[4
M+R\+= ^,MM^C_!?:A>7A;H'QEMOT?X+[4+R\+= ^,MM^C_!?:A>7A;H'QEMO
MT?X+[4+R\+= ^,MM^C_!?:A>7A;H'QEMOT?X+[4+R\+= ^,MM^C_  7VH7EX
M6Z!\9;;]'^"^U"\O"W0/C+;?H_P7VH7EX6Z!\9;;]'^"^U"\O"W0/C+;?H_P
M7VH7EX6Z!\9;;]'^"^U"\O"W0/C+;?H_P7VH7EX6Z!\9;;]'^"^U"\O"W0/C
M+;?H_P %]J%Y>%N@?&6V_1_@OM0O+PMT#XRVWZ/\%]J%Y>%N@?&6V_1_@OM0
MO+PMT#XRVWZ/\%]J%Y>%N@?&6V_1_@OM0O+PMT#XRVWZ/\%]J%Y>%N@?&6V_
M1_@OM0O+PMT#XRVWZ/\ !?:A>7A;H)\V#W3D_65JG'%*,6Z_EEG-(6%%GQDB
M;4.58ER55%)(F#N+2B6.0]9@G&_W>JY%[DDI%0RHV0IL3"YL<F4P'-@B(K]L
M]<D?>3:\L/(GE)$%["L+6%@QL\V.LJ(9IAREL>JMARKK8LMJJ<1=+422<".
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M88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H' C#'-%&'R"U/I-
MX$88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H' C#'-%&'R"U/I
M- X$88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H' C#'-%&'R"U
M/I- X$88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H' C#'-%&'R
M"U/I- X$88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H' C#'-%&
M'R"U/I- X$88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H' C#'-
M%&'R"U/I- X$88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H' C#
M'-%&'R"U/I- X$88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H'
MC#'-%&'R"U/I- X$88YHHP^06I])H' C#'-%&'R"U/I- X$88YHHP^06I])H
M-$SV;UZ@QNHXMX(8C\D=]J]VE#\0M=BLJSRE1\"%!C@2&C>V)F!-)1TLD 87
M7L]5G,NV&$TB*FYW&=+$"7F&+$5TU8-">A<4))P[+6P<8PG*.P[O4$A>6%C"
M-VV=8D3AHH2G@V(Y@I)6D2XS::;* 7%<#)V9%23TD-=4EEXNP<N(HIC=;@KA
M%WOK/VQ5_ C#'-%&'R"U/I-$.!&&.:*,/D%J?2:!P(PQS11A\@M3Z30.!&&.
M:*,/D%J?2:!P(PQS11A\@M3Z30.!&&.:*,/D%J?2:!P(PQS11A\@M3Z30.!&
M&.:*,/D%J?2:#_,H0A;+&^.40Q?ECE:^.6.3 :E\<L;V\U[7M=)\U[7M^%[7
M_"]OPO01,K:!H,.JBB\=/&S$+=*'CIE7<&LLJM @JZ]NDX:&S-'LV&JE$-9>
M&MB\?&$$SL<CTBY(LP,#G%)6@Y<73XJX"6M?^6\7\3[ZM%_^(9Y.QI;&1?IU
M/43(.O>T\E*.*%A&#_BEF'$-$7% ,E9FX9RDVRRK'RRBRD;-YDHR5TA9''5C
MI?)'=*4S'**"@9%_":3U1;TQC'%_CP[3N!&&.:*,/D%J?2:,G C#'-%&'R"U
M/I-!X_\ RI##8Z5O;.9!+9C432('!EZ@D0;J03* ^MAV/AA?5%BY,,$/U@P@
M@HGH86],43,3+SY997N6LYSN]EI-WM)0][^P.ANGOA]:LVU[V-;33/N1Q7L4
MO9 5_4F<_=JU>Q\C>R4=]2>O8Z4_X'^(!],C[AEM%+BG@3"NE@#)A:YQ2"&/
ME A4\GB'@+D:/!YBXY%"V(0@8EQS%@PK!B89WR]'+&]PY+'+'/''/#+'/#/&
MV6&>-[98Y8Y6\^.6.5O/;+'*U[7M>U[VO:_GM^%!-D5_I!;4?ZK#G\,RE%FZ
M.WS*E:(4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@TC.\ZMF"&J05E)-5W>\G:L@M"*HL:>!8R^I7?YXJ9-IK/:1(V.
M6*XB>RDSBPXG"JF2#89#43%MYO!61FNA*JF5# 8$@ERH+B6)ZGE22'ALH^DB
MR.HG$;,R99$-,,0V"IE82AK%1 +'"[3('0"AYZ/(V23W-+[O)A.IREDM'3&.
MR&,]_OW5?;W^^-YFK*(4"@4"@4"@4"@4"@G5]ZD:U2=.<6[+/^&&.ZYVA8DI
MI\8R6K)?KW"UBJIE<3/ '+$7 DI")A@0R=;1A:**1AHJ!]44FL*CGU51,FBQ
M,Q$Q$V3?"BJ(4'C;\JO^GQ//^UW\&([H.U1!TKE\%H;5L57U];)EIR(Y&TFQ
MYEBZ(55)/:AO@@DIEN)X,E\.:,S"2\XZ233Q1FTR,IB3@9@;[=>4VNC,51>8
M:(FNLU6ZWWI?%F>VE,V=FM.IN#D!:=X[";J\"IKC&>DV))MPQZX4B?%9E21K
MTX&PC1NJ+S10G\W4EMLR.7V"*SY><_PX8<9>.$$VXW4EEKOIH"MGCTI-<<9G
MO?I#LGUO8*]%T&QJP7-@0*K+:;H9,RDI)FYU';( ILT<3F:BG/4%<32*RDTR
M4:2.8#*% 1DU%*B %"H.09<,REV.&YL^)/VT-DV8H(*"XK,47,YGM<'^H!BA
M9QV6R3\  P-IDS(N(6*7P ."""FL3QG'(T"$GA96)X%FZ.WS*A/A?;7GOUW[
M+DD>+VB'POMKSWZ[]ER2/%[0/A?;7GOUW[+DD>+V@?"^VO/?KOV7)(\7M ^%
M]M>>_7?LN21XO:!\+[:\]^N_9<DCQ>T#X7VUY[]=^RY)'B]H'POMKSWZ[]ER
M2/%[0/A?;7GOUW[+DD>+V@?"^VO/?KOV7)(\7M ^%]M>>_7?LN21XO:!\+[:
M\]^N_9<DCQ>T#X7VUY[]=^RY)'B]H'POMKSWZ[]ER2/%[0/A?;7GOUW[+DD>
M+V@?"^VO/?KOV7)(\7M ^%]M>>_7?LN21XO:!\+[:\]^N_9<DCQ>T#X7VUY[
M]=^RY)'B]H'POMKSWZ[]ER2/%[0/A?;7GOUW[+DD>+V@?"^VO/?KOV7)(\7M
M ^%]M>>_7?LN21XO:!\+[:\]^N_9<DCQ>T#X7VUY[]=^RY)'B]H'POMKSWZ[
M]ER2/%[0/A?;7GOUW[+DD>+V@?"^VO/?KOV7)(\7M ^%]M>>_7?LN21XO:!\
M+[:\]^N_9<DCQ>T#X7VUY[]=^RY)'B]H'POMKSWZ[]ER2/%[0/A?;7GOUW[+
MDD>+V@?"^VO/?KOV7)(\7M ^%]M>>_7?LN21XO:!\+[:\]^N_9<DCQ>T#X7V
MUY[]=^RY)'B]H'POMKSWZ[]ER2/%[0/A?;7GOUW[+DD>+V@?"^VO/?KOV7)(
M\7M ^%]M>>_7?LN21XO:!\+[:\]^N_9<DCQ>T&F9SDK8B!6<"YG%,T'N%<7E
M@HTHYCIIZIR$I/V5)!5@C(J$PF*C#;C% CZVI8%#9TX</&T]OM=O)ZT\7>L(
M#0;ZZN)P8/$&MNXV#P$V)F:9]=3^P;I:1)O9)..O\ANYEP0US.)$\L19#9[C
M+-/,-%55DD45WX\3R19UR.OD4X194;-1L,)K-(LS%T12/,SG/&&\S3WPOMKS
MWZ[]ER2/%[1#X7VUY[]=^RY)'B]H'POMKSWZ[]ER2/%[0/A?;7GOUW[+DD>+
MV@?"^VO/?KOV7)(\7M ^%]M>>_7?LN21XO:!\+[:\]^N_9<DCQ>T#X7VUY[]
M=^RY)'B]H'POMKSWZ[]ER2/%[0/A?;7GOUW[+DD>+V@?"^VO/?KOV7)(\7M
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MDPN4-\&OJ@EN%9D;*IA[/$+ *Y^U(CD8:4M$O2$!SR!]L(%_:2]PC9?UI0P
M,(6G;>.7L&XMNO/LCM3\X,B(=.?KL"?;U334=-(VG.EZ %/8074N)YI)&)J*
M\&6R&QP5# .9NPAL\8];[0H'13!*O[%UPUX'5'8N#0-# RV_BXY5]+ L7,<1
M4>A4TK)J^:+.Q0S0[FW&7,KJ.D+0X*P,<#&5DI-4A,<CA$J,$*SFVNDI*4@I
M::AH:8GHJ*C$"B6D(Z23+)R6E)B>7#*$$Y-3R88)0B0)%0@BQ0F5!"+EBX88
M((> >&.-@GJ*_P!(+:C_ %6'/X9E*+-T=OF5*T0H% H% H% H% H% H% H%
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M\_GL,&<56T:-!#XY?E8#ABXBX9?E8YVRM:]%K.<[L#X@>KI/\&HTG]%V-O\
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M/32(Z*W?RK?7+^K+L7>+1@H% H% H% H% H% H% H% H% H/&WY5?]/B>?\
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M>;_G/6/Q 4#AFE;HCS?\YZQ^("@<,TK=$>;_ )SUC\0% X9I6Z(\W_.>L?B
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MM2TPT'>UAR[B2C:4\]AO5YWQ*QBH-F-!P35I>6C#6+=2<<.>/U;>@000 00
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MKFKN_B/W[:S=?**BH[;1TIO-U)34% 0DXDCHB&BD2J6CHZ2FE@R:<EI2:1"
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M% H% H% H(XEZ<7NZ7RHZW:O9)1^8"I<B)*DJJY#WW'.L#=6BV!LDJ.DG@,
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M&62T"@4"@4$&;=^4XT;T/<K09^U\ZE(F<;\0SKD:B8.PI3>.:JB)Y_W6;/\
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MBX+BH,ONM>4$K5YS/9]N8R'@$:=4A/USZTK#S?KI- A EQG"[EQ85KDP"I'
MU@1*%2P)F9K]NQI#;/ C)G3"V,^6-2/"U0.!&3.F%L9\L:D>%J@<",F=,+8S
MY8U(\+5 X$9,Z86QGRQJ1X6J!P(R9TPMC/EC4CPM4#@1DSIA;&?+&I'A:H'
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M],KPFEX11JD5UIGGW:[ULA,$\(H@\%YG3NOL6+1%1S;=\B\WCI.)65)8^ &
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M,-32=?$H/ 7'$<L7>*6K.B?#A QC8TE.&;EQ&'O?!++XAEG++WQX]%L40H%
MH% H%!@$EQ3&DS-0VQY88;3D5HG1@#0S?>*$GKR;@>*97$(JA0!0 ']@6$T:
M]C*6L$;EU1+-XAFT\V6,AABXA+_ ;L3!O^)UHE^\C,LK^5AKYM2X7*ZB !;#
M\<4Z.]E "KEF-DWO:WFQX4DO89*!"P"345,:Y.V(P!;)OLUCBR-J,C:.Y#"S
M<B1',XMQUZO2PMG TI":$TAI::V7RK">E8(E$\PHBBKQ')QP]; 0T1:[?=]I
M(+)WJC3E8+:&$R)AB8QBV-,.\8>TX3*O*(4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@\;?E5_T^)Y_VN_@Q'=!Z5$#>^$UQCR%) Z=)*&R&"[$-H@.%08YU1)OH
MTXP0QDH\R+-4RXQC)8(/(09S)KB";;FCT@!FLR.@-%$$+*0Y:39&,X;\.;D;
M="'XG-.@N_2;[;@3> -#IB@KM09(3'N&F2;'<.+@K0.K)M."%(HDD2O'[=,K
M+A^'D)2#<(+@;JHMM<DI+9,1%?OK\3LI1I.0J\&NWG60*G21%R(R<N$BJC8G
M8\"44RH1PMB9]WG% C<6X V&5\B9XX6SM>V0!D8.^.>1&BXK_2"VH_U6'/X9
ME*+-T=OF5*T1J&?V=)<A0E*C&AN3,H:E5UL9PH3 E/%$*N+)B.E13QBZ2X[(
MQS+$ Y[ 9SPS_/ZXOY_:BWG,@ VN6*5BML.K3R?_ )-":&-K0SV!Y2/8N1=L
MWVD&E7U+"'EF1AX6;37,F\QDYGN0B6/M<?8,3'+,V?.J<UIKG3D\-0+-9OHQ
M9(;A ^>+U=43->F/QCS^O1V^LEA,:-&VGLV.&8TX_:"0'ZI*:K);J.U6VF!?
MA;U:>AH1,@F$@_PM^06*AX_A;\/PHRRR@4$0['?^2TSPEM84_P ,V<CR?K7L
M)EA^2#E&$J.4F!%3[4;8_P#5RB2<SJ$2]L,Y!)[9CN7I?<AX;  E>]BQ;$QZ
MQZ1;'K%OI2+UO40H% H% H% H% H% H% H% H% H%!%6YATX_$F/M2FZ:,EU
MW:E=4VN]32>.( ?;>MC1+$UC8MS8C@9!FB%EIJGDB$T5:)YV-(3\FEE*P>.0
M9,;+ L9Y6^N$?/:)662)$TTF43DXH6()Y J 2(D28 98H3)E0L "I0J6!QP!
M+EBX > (  6& 806&(>&...-K6(^J@4"@4"@4"@4"@QQW,]HO]MK#-?C6;KU
M:#A)B)R^U7:B)KC;BV0%\UQ2*NAK!8XF*1,2^-KYECA48'.]K7RPOYK4$A<5
MZ288_P ;J#,9YG(1;\O'7F;<UZ6($'!Q_&Z<RU,VJX2W"7I86L422[,>"W%S
M7!O84I"BIZO$OD6N<>MT^N>N,YOL(;EI3%/$VUMHP%G59Q&C0":2>3H52SLU
MM=*B8%P+E@VGL6E$DYK).:B;$#)H;?FA(AB05XU?+!'8YT+"QC,4RMTQV_M4
M#+D9@R."XC# >;9>A=HNI78KH';"T06P6^\D#$KFMM=7%3QQ\"*ZE8'B69],
M,98&RN)HOD*%C87"]R,TH% H% H% H% H% H% H% H% H%!XV_*K_I\3S_M=
M_!B.Z#T9LG0]K-;C19JLDO!SFMHAV6"Y5(5'9B"HIJ8PTXT21SAS- 0")-UO
MQ0R4CP;G?ZZ2S5'$FDFV5.%,3J.<55@M;M.:[:9S,XLI,ZEJ)IZRN_34WO)2
M7I*76PM)PZZS8O<-V(48CP1G:QV8W<UIGG,\8^;V:6<(X-BUR^1@XXW&^,%(
MK)RE=[A"MVE<\?7[V4!$,8HD-1LT8R;IM04$AHIMR "@JV3\#Y\8<T84#YX<
MLD$4M&(>UJ!PT8"2D-*2D))!$#3$1+3DHH4) $1Q'&LL,J,_;0AG&ZNB8%UF
M*!0;82+)0%\<S\=EC9J^61=WA9"6S'SRSPQ$OGB#C?U0%@PK6PL6ZEUL91G,
M*$XJ$%\F'#UG2I]ZT*SIM'!Q4(+Y,.'K.E3[UH5G3:.#BH07R8</6=*GWK0K
M.FT<'%0@ODPX>LZ5/O6A6=-HX.*A!?)AP]9TJ?>M"LZ;1P<5""^3#AZSI4^]
M:%9TVCAC;RTCUM?S2<S(=+*6U-MNY"56XN)YB29.&"-I2R2&('0<@S#P&!RO
MD /GZ%Q A,<<_1SOAEZ/FH5G3:.$]ZA0G'#NB\^QI03'&K37K^[E:"IB4AI)
MD\L9<CF9I1,.MJ212@+SP!* S/&2VPYD*$R^&("< _<4FUL!DX<(,LS,812;
M8LCC":QZ*HXJ$%\F'#UG2I]ZT2LZ;1P<5""^3#AZSI4^]:%9TVC@XJ$%\F'#
MUG2I]ZT*SIM'!Q4(+Y,.'K.E3[UH5G3:.#BH07R8</6=*GWK0K.FT<'%0@OD
MPX>LZ5/O6A6=-HX.*A!?)AP]9TJ?>M"LZ;1P<5""^3#AZSI4^]:%9TVC@XJ$
M%\F'#UG2I]ZT*SIM'!Q4(+Y,.'K.E3[UH5G3:.#BH07R8</6=*GWK0K.FT<'
M%0@ODPX>LZ5/O6A6=-HX.*A!?)AP]9TJ?>M"LZ;1P<5""^3#AZSI4^]:%9TV
MC@XJ$%\F'#UG2I]ZT*SIM'!Q4(+Y,.'K.E3[UH5G3:.#BH07R8</6=*GWK0K
M.FT<'%0@ODPX>LZ5/O6A6=-HX1EK-K-#4SOV9]F3K=73#-6W$<A?7L/*1))O
MZN(XG6#Z,[7T1-_%WMGH3', #M6"QH SFE.6,V;#:V7PRO;$;(LS,669S9%\
M^F$>L359O%0@ODPX>LZ5/O6B5G3:.#BH07R8</6=*GWK0K.FT<'%0@ODPX>L
MZ5/O6A6=-HX.*A!?)AP]9TJ?>M"LZ;1P<5""^3#AZSI4^]:%9TVC@XJ$%\F'
M#UG2I]ZT*SIM'!Q4(+Y,.'K.E3[UH5G3:.#BH07R8</6=*GWK0K.FT<'%0@O
MDPX>LZ5/O6A6=-HX.*A!?)AP]9TJ?>M"LZ;1P<5""^3#AZSI4^]:%9TVC@XJ
M$%\F'#UG2I]ZT*SIM'#B5[3N!EY#64,PUUBX"PE*"6+8Z_I(5B?JSY04KG[4
MEJ#Q&(*1>V(M[C$#H(I0V'Z1<R'F")GC<5G3:.'2CK=Y*E@>1_Q<+M4I+DO8
M'5&0U0H/-V2P<56,IZZ+0-K%4J>"*1&ZVE)ZU&HA<6S?FT84GBILQO$6L_\
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M(Y$@*JI3M&,Y%FR(UMG3+GM,+-^)]M^9'7/M2R9X/:(?$^V_,CKGVI9,\'M
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M"&NEBYTB:/)2F6 4 PC:>>'QO; S@5,EJC^1]?XB%;;E:95HV1$-V.%H.M6
M:JZYF>=!<3!;S&:;,5D!9:RRCK33--QN1JR$E,NU5!%P *H(-O0RS-J.9PM9
M]_-:^[/F:SFU'[70V6STL)%;3<(!)R2G!C&C60)<.^6>8ID\?'-**DH&Q\Q3
MBDJJ9LXJ*J@8,J*F<-GS1@P*2^V6C(K!!OL%M1YP@[__ (K#OY\,?^\9E+W_
M .W^=%FZ.WS*E/4 ?J0OV>'\J(>H _4A?L\/Y4#U 'ZD+]GA_*@>H _4A?L\
M/Y4#U 'ZD+]GA_*@>H _4A?L\/Y4#U 'ZD+]GA_*@>H _4A?L\/Y4#U 'ZD+
M]GA_*@>H _4A?L\/Y4#U 'ZD+]GA_*@>H _4A?L\/Y4$>;[ZD8;P:HRMJ]9]
MEHM!E0DAI9U]? :1()Q$3TQR)"Z?]UM]84T8G@IJ15,%22JS@? /H?MPBHEY
MA*18H,$7IG\9B:5I@F#4+R5@6KL L>&%#<+;%\+3# .)",^D67Y%9J6 U0S8
MF;8;2?$K@?,F1B@)[12L@$%, 0$%-3QDTB3]H3?:L3)@R7JZORF9I$5TQG&M
M^]?:E,<6&;$O\IL[Z[*6QP_ !,>["U#>:,':WYL11BVM#8>1K_\ =D9>@@N5
MO^43#+\JB5C_ %CS7WF/!P:[TI'X(VS^M[E+!_C8&0M/G@(KF;6_-ADO,+:Y
MDI)/++_WCXLHY;S_ (X%L;?DT/XY3O\ J?<]X^4!1/R;QOIC)=L?PN-C+TTP
MED);_OGB4R@R?\0\KV_'$#(_GCY[^A<S:W_$H6:[5^8.&C:]$_\ JC1HPO\
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MMH?LZ@401S!IO(@QP\;4L6PVS1LBEF33::81T-LMTR,E)(@Z*DD1<DE,OG[
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M4)O28:/GU.'P2)4E)(YE@99/=H&K])RNKVUTQP7D#'<^F 0C!?9P$< </ 8
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MFV7$FMN0ME6ZXE!"5R2 X,]Q-OU+!"6C:>8 2EG).,SM<L?Q3#P@!W(D8M<
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MQ%_JY!13W"698;<4SF+>,&38YL%0072E((KVG/\ C'%P:E;3TKEEZ.S.SRB
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ME<?-<<OAA<P+?,DW1/>++,N58T0H% H% H% H% H% H% H% H,:>?_T>[/\
M^VEW_P#Y9J@Z%(E\LAI61B.)4ARPW,JRLH,7L! .GQH\B=1Q%&1FJED!?9C1
M^3\#0A3UH(F1;UH0.?JLK7R!"ROEA9%MJS?/>?=K2*=X_)"0C(4ORI%VF;_:
M3\G==+.*3EXG&$5&<UQ1+ XX>B0(J$NFTULIYPWZ]:5$EKDT=,5W$=/.%4*F
MU@T*<N)ZIF(B9F8BYN5Q>5L\GXZ+,T!4@V<_=K'=*V\$A#)L*)B: ;5W%&SY
MB9:Q7$4"5<4Y;(*+(D5SI9H@? %+CY&"PPN.=R@6-B??E.#2W \DNS$4DE)>
MNNQAY00UIFK31>CC18]=$BL;)@/.TAM5,9K_ %^7E!U(B*1>HRLXCB<$J"!+
MIYR.:R_=4+KJ@ *6L_>U/9]_'K\GA8XAK-DS?/)TL\1K ,!YG%MA*SM83?9B
M<]DEO-1 65F45$8\CEB$ANPN</.S%RNE9LH 9K3C4!$M*S)"O;6R_P"Z4I@^
MC'=SR5&01P8]KWL4M.0:R(83'\XT&/')(S67D*0G1+I=WM!\+DO*#A;;O.RR
M]'3)2NOIAT$XK.U8&-GLAB9<B1*BLY_9BD^+'.,'RB7D_(UDML20V&_N]8)B
MMI99L?QPLGV$X8HC]KK@@HIE)9#)6I5.E6S<I<6Q%'5DLR OHC7 *1\EJQ2.
M2A=HABME*1WQ8KGNQY,A0]8"Z(VW&>R2$,YK(C>=0[%.-]KI;VEAJ36]$!!3
M"4M)P0:0Z7\QFF>5;*5U-0LG(H*.GJ!%.-* !LE?CP^-P;F>3'=Q3()WQYN0
M[E(8+$L=7W3:-7 JJA-//0XK-8@K!*DG&D92(,U;U_B%=1"9Q(&+GUAI&#KM
M#<V;O?=G06OWTI\RYU'WN\FRWTX%"16%N<E-C(9&55MI)9UE);8=CL0L,P$Y
MXN='39=*%E%6!)9X$<4<*Q1D@@)[=&+-, \SF8;;XK/Q=%UWW%RJ[O[Y,9SD
M7NEN"%=H55*D4XH''@FCE66$65K*K^G:2%(K?(I,Q8R4*''+L?*>8F!(P7%P
M(*B<2!&"P1R.08K/WTXAQO'W\G9\1 OW)L;M9RN67C3J+2Z(-&PC\ <YMJH$
M?BKN F<F7;-S5XV;27'8A7-M9I1IK^W6/)YM:4U!8,"L^F7GOCW3ZK;6Z?A&
M'FBL(_L(QXP/Q,\(NCB/<8L3%\&/C#\9L6L%>?9A54-P@\5]Z$4*-LE% 6D]
M,:A\F\%(F[39HZM@.XX_R_E=6VV)VKS]LI83G\IIY.AVM.*V0I0]LR7;,+IZ
M8E1\FIB0P" :0G(Z0G(2:4$S"F"^9P$JF)9(OA8QEE?S!7RO>^65[T2LUKBU
MNY]XO)BN\=?#78IVZ,-]Y*KQ6GVS01&64:CZ4WNYI;=*J9<R>6F$(R/[.=G*
M2RA(,@>3@;IJRE%U -0%9[,,-\?E/WM3XA_;-WJ\F>QE!D+*-&.W&*Y'3L.O
MAFJ>!2-4G!!=2N V$=PK">A-J44)K%33F9;12X[<5RR"#9491YVIP]O;W\^U
M-R"N%T9?>ZR?_'5U(YN]C/E&,^]VB-=OGRO?D_Y);SL:[U@>;5Q(>Z"LMESX
MC,*+2Y]21U],,(ZH7]\$Y<+JY08=.,C !GB1TN>*7O@*4,@#!!B8!(>H^QOD
M7=&@Y !UJU#GEFARAFULWIBX<$Z3K*63+LXK-VY7A1V$>-T7V.SJ7/761/=U
ME'VH&ZC[7<B0]F-=75U=7_*:TTB/92+]\J3Y.J2@L"CK@_8,PEAQI)<3!HZ:
MUXY1$P!H2PLL!PNW$F71Y?)9)RW[[C-I*R(X4T4FL-]3(B*20<*GQ?:<#-?O
MWNTFD[D>2=14)'2B&O.R!=:1<A0RTD%4IAILN"I8L8'85L@#RFDS"GO>R"6B
M@[\#)R:562P:4DD4HREY$UE)3U,N6L_>]?=R?'ZT!LX WOB%OR').9A5NIR<
M75HV)OE;3%9 ;C7$0%!2)2.7) )11#::&5(YHZ:E*P!DL,KY*@JV?/J1DE?O
M]U?@#N?Y)  @"3#U:FK,P54&X.27C3+C%0=9)!;,>(L0DV&7=:A+9MP\'Q^*
M$3&.UYI"J(J:OMI6<."M@:4EY343!:S\>:^[+HU\I)H;&KP=KT"3MZWTH/!D
M%(X,E)1662_B:&RT\,F 20FD86Y9%6FP#<L2!Q6S22KES[V/X@N)_FW4ZB*8
MND17[]^QA2&%*.[WDUG"4.%WBS-W'P;.D4=OC+CL6&<HN+)D(# F6,$9B"+@
M,NE% TB$F;L#+I"ZN>&-/DZ>=PJZHN\XNI2&I)@K/;['$/N.[Y^3J4A7B=/M
MO>09<E KD1F5R%E9CI"[,I$N4)IZ$1D XARPF!#IS73DXDD(B8W"[<3LF_@=
M:ZP55VPMN!'5172./O\ 3.0/*3>3;+QH'#@<*;(WBTL]KOM/8N2#'5VZE* J
MC=9/(J81M+ML2;345LPJ*QILAW]UX&%M4+$@2B:(6(%25F_%H]9VF\E(NH:2
MWE"(=O!R*6EG4H44Y=@+"DK^\VDP6BK+:LJK\KJR@*\E<O&C75E1^$S!)['E
M@1SYF'!FF/EZIB^6M\V;7=M,*749FY-W?)8.X(8-P05LZ?$,L$Y%ADY8FR2J
MB8CE8O,.#E9@JB3F0N>NWW87G1^@.)/L/8(\+\+*X=BZ^R6HKI K.]L_?9FD
M0>4D\GA""P57F-&VU)=2P0W4@*?M+>B,)+72CL5V\L&A3S<2)(26TGCIHK9(
M%DD-LI" 1!+&%/,X3/'5 P<R(PEJ[\^3_0TV.R"FVMP%(%@(,.-@TEII!A(+
M8D)+UP7[KD"'I!0 IE.8J;C8PQ9(,*RHC'4$H^#Z<$ Z4L^URZ4UDHM?GS?N
MSY8\IIH:X72D.9=0-VE8).<#$>*@UCYUBF6@Y'Q&"@058_>JTC"2U>X+@;2D
MCH1S'-OF4)-71D!%^*DU>P3P<+$9JQ?*_P"H;/>SV?9QN;/.5:=3:C-AE#BH
MT(SNH$F/%J:O"H1!6.VF/.R\O&WB^I(=2HX?9TVYK%T$TKW?CBB8G3PK93[:
MVL-Y<[4(R"*7,1KL.8+F A 1P!F=&(H(P(N%\!0A0LY<RP$"$PRRP$#SQRPS
MPROCE:]KWM01SMGNOY)W=F,R40[ :X;$KC$(NM,>>"8TR#3CDR96T<@K)Z?=
M056'-[?4U).!"638_N@\:'3,SX9%0S*Y'4XD. 6.J>F:Q-)^YMI0[Y3KR;$$
M1M'T41WKY.A1HQ>W4AJLRR\SHV=B^FHB %@ C%1G2Y9?5'$H9IA<($L2,'U(
MP.7+ERX 0F 0 6&!)FLS,WS;/JPIP>4!\F6YG^;DU6AG:,5W'USXD.' BK)!
M*&%L%UL-X)BD,F!S)9/%.H*FP@"K>-B%\C2(BNR0T=/&!(/A?"-EK/WM3[Z9
M0UVT-M?)5LI-<Z4CP_MGD6=\?*\7K60Y6-PQS+066FZ&.:!$%3Y2(7-K>;9=
MRJ4-NQ1L==2ZH>K<CF65MT#J*T?%9[?W7WXN;=&\I#Y. PLMA='B': <^T'F
M\'ZB^N3(_$+AN-\S*8GI?,F"V<O9!&0!)',B*10L+C<,D2M@F@6Q+X8VL*_'
MB*,63=\O)DI);,@1B/:\),P0U=JI27<)CB$&ZT51O2TTRS1;H&<P972FRVVQ
M-3U;S01@<[E&NAV;R,CX%DQM(Y0J2MM<6<1MY3KR?T5N\T\&LP-M\A<TU^)*
M6WU@K'RLUVX3E%[$9)D/%"23,M7N7%=S\)7<RF.<,GA@S!H5,3\R2 63$A/+
M6?ND4A@Z=O\ >3Q2"""GIS>WD+AL$JAIT-B9JS(.7@Y';AP VE(\:%3\L&DX
M$D&"5*HIP1WDG<H*K5*EF>K'3K6+@I& K]S[_;,*,35MV?)XYD6PWFBV]Q6(
MTDYQ.!?>":AE64,NOH-Q0*B:\*::>=IZ;AE0@&K,AN)0J\IVP/K:@M^VN0@I
M(SL&*N,@*_::U9ZB>4(\FT@.] >"?%NV-AV6Y7,ZH^0AB[!S;,>J+[>H,D2
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C + V*HXFQQPC.0Q8.UL,Q2S=$YS,^SL]HR4"@4"@4"@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6845106960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Feb. 22, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MNKD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MANNKIND CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000899460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428,850,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,461,620,053<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6845655376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 59,074<span></span>
</td>
<td class="nump">$ 120,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables from collaboration</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">50,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrent', window );">Deferred product costs from collaboration</a></td>
<td class="nump">13,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,018<span></span>
</td>
<td class="nump">20,206<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">76,654<span></span>
</td>
<td class="nump">201,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">48,749<span></span>
</td>
<td class="nump">192,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NontradeReceivablesNoncurrent', window );">State research and development credit exchange receivable - net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total</a></td>
<td class="nump">126,412<span></span>
</td>
<td class="nump">394,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">15,599<span></span>
</td>
<td class="nump">7,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">7,929<span></span>
</td>
<td class="nump">26,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtCurrent', window );">Facility financing obligation</a></td>
<td class="nump">74,582<span></span>
</td>
<td class="nump">72,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Senior convertible notes - current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDeferredCreditsCurrent', window );">Deferred product sales from collaboration</a></td>
<td class="nump">17,503<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PurchaseObligationCurrent', window );">Purchase commitment liabilities - current</a></td>
<td class="nump">12,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred payments from collaboration</a></td>
<td class="nump">140,231<span></span>
</td>
<td class="nump">196,967<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">268,319<span></span>
</td>
<td class="nump">403,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Note payable to principal stockholder</a></td>
<td class="nump">49,521<span></span>
</td>
<td class="nump">49,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Sanofi loan facility and loss share obligation</a></td>
<td class="nump">62,371<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Senior convertible notes - long term</a></td>
<td class="nump">27,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PurchaseObligationNoncurrent', window );">Purchase commitments - long term</a></td>
<td class="nump">53,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">15,225<span></span>
</td>
<td class="nump">12,301<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 476,741<span></span>
</td>
<td class="nump">$ 468,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Undesignated preferred stock, $0.01 par value - 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2015 and 2014</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value - 550,000,000 shares authorized at December 31, 2015 and 2014, respectively; 428,670,943 and 406,059,089 shares issued and outstanding at December 31, 2015 and 2014, respectively</a></td>
<td class="nump">$ 4,287<span></span>
</td>
<td class="nump">$ 4,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,508,633<span></span>
</td>
<td class="nump">2,416,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,863,229)<span></span>
</td>
<td class="num">(2,494,784)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(350,329)<span></span>
</td>
<td class="num">(73,770)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total</a></td>
<td class="nump">$ 126,412<span></span>
</td>
<td class="nump">$ 394,439<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PurchaseObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase Obligation Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PurchaseObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PurchaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase Obligation Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PurchaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3-4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3<br> -Subparagraph a(1)<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 4<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 12<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 13<br> -Section A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51655945&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.32)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 25<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of the receivable other than from customers, that is amounts expected to be collected after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCreditsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of unearned revenue or income not otherwise specified in the taxonomy which is expected to be taken into income within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCreditsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt not otherwise specified in the taxonomy that is scheduled to be repaid within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19, 20<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 8<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 8<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section E<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781929216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Undesignated preferred stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Undesignated preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Undesignated preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Undesignated preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">550,000,000<span></span>
</td>
<td class="nump">550,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">428,670,943<span></span>
</td>
<td class="nump">406,059,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">428,670,943<span></span>
</td>
<td class="nump">406,059,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6845394240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">29,674<span></span>
</td>
<td class="nump">100,244<span></span>
</td>
<td class="nump">109,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">40,960<span></span>
</td>
<td class="nump">79,383<span></span>
</td>
<td class="nump">59,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ManufacturingCosts', window );">Product manufacturing</a></td>
<td class="nump">67,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Property and equipment impairment</a></td>
<td class="nump">140,412<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_GainLossOnPurchaseCommitments', window );">Loss on purchase commitments</a></td>
<td class="nump">66,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">344,655<span></span>
</td>
<td class="nump">179,627<span></span>
</td>
<td class="nump">169,401<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(344,655)<span></span>
</td>
<td class="num">(179,627)<span></span>
</td>
<td class="num">(169,401)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">1,366<span></span>
</td>
<td class="nump">1,679<span></span>
</td>
<td class="num">(635)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="num">(1,049)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Interest expense on note payable to principal stockholder</a></td>
<td class="num">(2,894)<span></span>
</td>
<td class="num">(2,894)<span></span>
</td>
<td class="num">(6,309)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on notes</a></td>
<td class="num">(21,231)<span></span>
</td>
<td class="num">(17,549)<span></span>
</td>
<td class="num">(15,153)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before benefit for income taxes</a></td>
<td class="num">(368,445)<span></span>
</td>
<td class="num">(198,382)<span></span>
</td>
<td class="num">(191,490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (368,445)<span></span>
</td>
<td class="num">$ (198,382)<span></span>
</td>
<td class="num">$ (191,490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted</a></td>
<td class="num">$ (0.91)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (0.64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used to compute basic and diluted net loss per share</a></td>
<td class="nump">406,165<span></span>
</td>
<td class="nump">385,229<span></span>
</td>
<td class="nump">299,591<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_GainLossOnPurchaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Purchase Commitments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_GainLossOnPurchaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 225<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51659069&amp;loc=d3e92212-112881<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Impairment<br> -URI http://asc.fasb.org/extlink&amp;oid=6515133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51719941&amp;loc=d3e2921-110230<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51673353&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 10<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManufacturingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred in the production of goods for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManufacturingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Research and Development<br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6845140160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (368,445)<span></span>
</td>
<td class="num">$ (198,382)<span></span>
</td>
<td class="num">$ (191,490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other comprehensive (loss) income - cumulative translation (loss) gain</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) gain</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (368,451)<span></span>
</td>
<td class="num">$ (198,392)<span></span>
</td>
<td class="num">$ (191,488)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32022-110900<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32157-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=51821188&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6848628400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>TEL AVIV STOCK EXCHANGE</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>TEL AVIV STOCK EXCHANGE</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>TEL AVIV STOCK EXCHANGE</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Deficit Accumulated During the Development Stage</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2012</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,035,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2012</a></td>
<td class="num">$ (110,679)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,991,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
<td class="num">$ (2,104,912)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">880,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">2,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common shares from the release of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common shares from the release of restricted stock units</a></td>
<td class="num">(4,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesWarrantExercises', window );">Issuance of common shares pursuant to warrant exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,353,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueWarrantExercises', window );">Issuance of common shares pursuant to warrant exercises</a></td>
<td class="nump">172,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesForDebtExchange', window );">Issuance of common shares pursuant to debt conversions by Deerfield (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueForDebtExchange', window );">Issuance of common shares pursuant to debt conversions by Deerfield</a></td>
<td class="nump">5,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 48,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,824,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement', window );">Issuance of common shares pursuant to litigation settlement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,778,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement', window );">Issuance of common shares pursuant to litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common shares under Employee Stock Purchase Plan (in shares)</a></td>
<td class="nump">463,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common shares under Employee Stock Purchase Plan</a></td>
<td class="nump">$ 1,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">45,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized gain/(loss) on foreign currency translation</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Commitment to deliver common shares pursuant to Deerfield conversion to additional paid-in capital</a></td>
<td class="nump">998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(191,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(191,490)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2013</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369,392,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2013</a></td>
<td class="num">(30,713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,261,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(2,296,402)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">10,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common shares from the release of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,996,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common shares from the release of restricted stock units</a></td>
<td class="num">(26,908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesWarrantExercises', window );">Issuance of common shares pursuant to warrant exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueWarrantExercises', window );">Issuance of common shares pursuant to warrant exercises</a></td>
<td class="nump">27,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesForDebtExchange', window );">Issuance of common shares pursuant to debt conversions by Deerfield (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,521,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueForDebtExchange', window );">Issuance of common shares pursuant to debt conversions by Deerfield</a></td>
<td class="nump">$ 93,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common shares under Employee Stock Purchase Plan (in shares)</a></td>
<td class="nump">305,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common shares under Employee Stock Purchase Plan</a></td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Remeasurement of performance based grants pursuant to the modification of terms</a></td>
<td class="nump">22,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">25,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized gain/(loss) on foreign currency translation</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(198,382)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(198,382)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2014</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406,059,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2014</a></td>
<td class="num">$ (73,770)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,416,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(2,494,784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonStockLoanedUnderShareLendingAgreementShares', window );">Return of loaned common stock (in shares)</a></td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">1,700,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,701,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 3,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common shares from the release of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common shares from the release of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Restricted stock units taxes paid in cash</a></td>
<td class="num">(1,856)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,856)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesWarrantExercises', window );">Issuance of common shares pursuant to warrant exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueWarrantExercises', window );">Issuance of common shares pursuant to warrant exercises</a></td>
<td class="nump">10,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountContributions', window );">Capital contribution</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common shares pursuant to conversions of certain 2015 note holders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,874,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common shares pursuant to conversions of certain 2015 notes</a></td>
<td class="nump">7,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement', window );">Issuance of common stock for lender financing fees (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueShareLendingAgreement', window );">Issuance of common stock for lender financing fees</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion', window );">Discount on notes-for-stock exchange</a></td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonStockLoanedUnderShareLendingAgreementValue', window );">Return of loaned common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (90)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">$ 27,844<span></span>
</td>
<td class="nump">$ 34,710<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">27,754<span></span>
</td>
<td class="nump">$ 34,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,940,000<span></span>
</td>
<td class="nump">13,853,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common shares under Employee Stock Purchase Plan (in shares)</a></td>
<td class="nump">321,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common shares under Employee Stock Purchase Plan</a></td>
<td class="nump">$ 887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of warrant liability</a></td>
<td class="num">(202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity', window );">Reclassification of warrant liability to equity</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">8,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized gain/(loss) on foreign currency translation</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(368,445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(368,445)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428,671,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2015</a></td>
<td class="num">$ (350,329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,508,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(2,863,229)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonStockLoanedUnderShareLendingAgreementShares', window );">Return of loaned common stock (in shares)</a></td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (277,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428,671,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2015</a></td>
<td class="num">$ (350,329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,508,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="num">$ (2,863,229)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonStockLoanedUnderShareLendingAgreementShares', window );">Return of loaned common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital Reclassification Of Warrants From Liability To Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital Stock Option Issued Upon Debt Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AdjustmentsToAdditionalPaidInCapitalStockOptionIssuedUponDebtConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockLoanedUnderShareLendingAgreementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock loaned under share lending agreement, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockLoanedUnderShareLendingAgreementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockLoanedUnderShareLendingAgreementValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Loaned Under Share Lending Agreement Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockLoanedUnderShareLendingAgreementValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesForDebtExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, For Debt Exchange</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesForDebtExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares Issued Related To Legal Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesIssuedRelatedToLegalSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares share lending agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesShareLendingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares Warrant Exercises</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodValueForDebtExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during the period in exchange for the extinguishment debt obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodValueForDebtExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value Issued Related To Legal Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodValueShareLendingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value share lending agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodValueShareLendingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodValueWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value Warrant Exercises</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodValueWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=51663037&amp;loc=d3e34017-109320<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Beneficial Conversion Feature<br> -URI http://asc.fasb.org/extlink&amp;oid=6505963<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity-based compensation, related to restricted stock units or restricted stock awards, recognized as expense or an asset, if compensation is capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11149-113907<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11178-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28183637&amp;loc=d3e4724-112606<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Warrant<br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32022-110900<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32157-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total contributions made by each class of partners (i.e., general, limited and preferred partners).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187171-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28,29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30, 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30, 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section E<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XTAE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XTAE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mnkd_DeficitAccumulatedDuringDevelopmentStageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mnkd_DeficitAccumulatedDuringDevelopmentStageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6847498352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (368,445)<span></span>
</td>
<td class="num">$ (198,382)<span></span>
</td>
<td class="num">$ (191,490)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and accretion</a></td>
<td class="nump">13,276<span></span>
</td>
<td class="nump">18,575<span></span>
</td>
<td class="nump">14,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">8,725<span></span>
</td>
<td class="nump">48,622<span></span>
</td>
<td class="nump">45,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Loss on extinguishment of debt</a></td>
<td class="nump">1,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Loss on purchase commitments</a></td>
<td class="nump">66,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductionRelatedImpairmentsOrCharges', window );">Write-off of Inventory</a></td>
<td class="nump">36,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment', window );">Loss on sale, abandonment/disposal or impairment of property and equipment</a></td>
<td class="nump">140,582<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Interest incurred through borrowings under Sanofi Loan Facility</a></td>
<td class="nump">1,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_WriteOffOfDerivativeLiability', window );">Write-off of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange loss</a></td>
<td class="nump">2,697<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(26,434)<span></span>
</td>
<td class="num">(9,670)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Receivables from collaboration</a></td>
<td class="nump">50,413<span></span>
</td>
<td class="num">(50,436)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">13,485<span></span>
</td>
<td class="num">(14,734)<span></span>
</td>
<td class="num">(499)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCharges', window );">Deferred product costs from collaboration</a></td>
<td class="num">(13,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">150<span></span>
</td>
<td class="num">(615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">8,413<span></span>
</td>
<td class="nump">3,622<span></span>
</td>
<td class="num">(1,071)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(12,467)<span></span>
</td>
<td class="nump">2,276<span></span>
</td>
<td class="nump">3,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred product sales from collaboration</a></td>
<td class="nump">17,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits', window );">Deferred payments from collaboration</a></td>
<td class="nump">950<span></span>
</td>
<td class="nump">200,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">2,927<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
<td class="nump">591<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(57,232)<span></span>
</td>
<td class="nump">4,086<span></span>
</td>
<td class="num">(128,732)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(10,285)<span></span>
</td>
<td class="num">(24,097)<span></span>
</td>
<td class="num">(7,987)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities</a></td>
<td class="num">(10,203)<span></span>
</td>
<td class="num">(24,097)<span></span>
</td>
<td class="num">(7,987)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">4,146<span></span>
</td>
<td class="nump">12,341<span></span>
</td>
<td class="nump">3,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Exercise of warrants for common stock</a></td>
<td class="nump">10,123<span></span>
</td>
<td class="nump">27,779<span></span>
</td>
<td class="nump">94,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of facility financing obligation &amp; milestone rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">119,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Facility financing obligation &amp; milestone rights issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_MilestonePayments', window );">Milestone payment</a></td>
<td class="num">(4,219)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock pursuant to at-the-market issuance</a></td>
<td class="nump">28,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs associated with the Tel Aviv Stock Exchange</a></td>
<td class="num">(548)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment of employment taxes related to vested restricted stock units</a></td>
<td class="num">(1,858)<span></span>
</td>
<td class="num">(26,908)<span></span>
</td>
<td class="num">(4,801)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided by financing activities</a></td>
<td class="nump">5,668<span></span>
</td>
<td class="nump">70,062<span></span>
</td>
<td class="nump">145,669<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(61,767)<span></span>
</td>
<td class="nump">50,051<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD</a></td>
<td class="nump">120,841<span></span>
</td>
<td class="nump">70,790<span></span>
</td>
<td class="nump">61,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS, END OF PERIOD</a></td>
<td class="nump">59,074<span></span>
</td>
<td class="nump">120,841<span></span>
</td>
<td class="nump">70,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASH FLOWS DISCLOSURES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid in cash, net of amounts capitalized to Construction in progress</a></td>
<td class="nump">13,355<span></span>
</td>
<td class="nump">11,218<span></span>
</td>
<td class="nump">13,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Payment of 2015 notes and interest through issuance of common stock</a></td>
<td class="nump">8,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Issuance of common stock pursuant to debt conversion by Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,500<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid', window );">Non-cash construction in progress and property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,768<span></span>
</td>
<td class="nump">856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Capitalization of interest on note payable to principal stockholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty', window );">Reduction of principal on note payable to principal stockholder upon issuance of common stock and exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansAssumed1', window );">Reclassification of deferred payments from collaboration to Sanofi loan facility and loss share obligation</a></td>
<td class="nump">59,337<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XTAE', window );">TEL AVIV STOCK EXCHANGE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">36,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs associated with the Tel Aviv Stock Exchange</a></td>
<td class="num">(1,432)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandFifteenNotesMember', window );">2015 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payment of 2015 notes</a></td>
<td class="num">(64,287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandEighteenNotesMember', window );">2018 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Facility financing obligation &amp; milestone rights issuance costs</a></td>
<td class="num">$ (831)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandThirteenNotesMember', window );">2013 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payment of 2015 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (115,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_TrancheBMember', window );">Less portion of commitment asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_WriteOffOfCommitmentAsset', window );">Write-off Tranche B Commitment Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of facility financing obligation &amp; milestone rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cancellation of principal on note payable to related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CancellationOfPrincipalOnNotePayableToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>(Gain) loss on sale, abandonment/disposal or impairment of property and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone payments include payments to our partners related to alliance and collaboration agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity including any warrants issued. Proceeds are net of cash outflows for issuance costs related to the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ProceedsFromIssuanceOfCommonStockAndWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_WriteOffOfCommitmentAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write Off of Commitment Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_WriteOffOfCommitmentAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_WriteOffOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write Off of Derivative Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_WriteOffOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for construction in progress expenditures that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6401765&amp;loc=d3e13305-112630<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of accrued expenses and other operating obligations not separately disclosed in the statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of (a) prepayments by customers for goods or services to be provided at a later date, (b) the amount of customer money held in customer accounts, including security deposits, collateral for a current or future transactions, initial payment of the cost of acquisition or for the right to enter into a contract or agreement, or (c) a combination of (a) and (b).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCustomerAdvancesAndDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period for interest that is capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of loans assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow from other financing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3095-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionRelatedImpairmentsOrCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionRelatedImpairmentsOrCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XTAE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XTAE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandFifteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TwoThousandFifteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandEighteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TwoThousandEighteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandThirteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TwoThousandThirteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_TrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_TrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6609246336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business and basis of presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of business and basis of presentation</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>1. Description of
 business and basis of presentation</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Business</i>
 &#x2014;&#xA0;MannKind Corporation and subsidiaries (the
 &#x201C;Company&#x201D;) is a biopharmaceutical company focused on
 the discovery and development of therapeutic products for diseases
 such as diabetes. The Company&#x2019;s only approved product,
 AFREZZA, (insulin human [rDNA origin]) inhalation powder, is a
 rapid-acting inhaled insulin that was approved by the U.S. Food and
 Drug Administration (the &#x201C;FDA&#x201D;) on June&#xA0;27, 2014
 to improve glycemic control in adult patients with
 diabetes.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Basis of
 Presentation</i> &#x2014;&#xA0;The Company&#x2019;s primary
 activities since incorporation have been establishing its
 facilities, recruiting personnel, conducting research and
 development, business development, business and financial planning,
 raising capital, and commercial manufacturing. It is costly to
 develop therapeutic products and conduct clinical studies for these
 products. As of and for the year ended December&#xA0;31, 2015, the
 Company has reported an accumulated deficit of $2.9&#xA0;billion
 and has reported negative cash flow from operations for each year
 since inception, except for 2014, when the Company received the
 $150.0 million upfront payment from Sanofi.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">At
 December&#xA0;31, 2015, the Company&#x2019;s capital resources
 consisted of cash and cash equivalents of $59.1 million. The
 Company expects to continue to incur significant expenditures to
 support commercial manufacturing and sales and marketing of AFREZZA
 and the development of other product candidates. The facility
 agreement (the &#x201C;Facility Agreement&#x201D;) with Deerfield
 Private Design Fund II, L.P. (&#x201C;Deerfield Private Design
 Fund&#x201D;) and Deerfield Private Design International II, L.P.
 (collectively, &#x201C;Deerfield&#x201D;) and the First Amendment to
 Facility Agreement and Registration Rights Agreement (the
 &#x201C;First Amendment&#x201D;) that resulted in additional sales of
 an additional tranche of notes (the &#x201C;Tranche B notes&#x201D;)
 (see Note 17&#xA0;&#x2014;&#xA0;Facility Agreement) requires the
 Company to maintain at least $25.0 million in cash and cash
 equivalents or available borrowings under the loan arrangement,
 dated as of October&#xA0;2, 2007, between The Company and The Mann
 Group LLC (as amended, restated, or otherwise modified as of the
 date hereof, &#x201C;the Mann Group Loan Arrangement&#x201D;), as of
 the last day of each fiscal quarter. The Company will need to
 continue to incur expenses for the commercialization of AFREZZA and
 will need to raise additional capital to finance such activities.
 The Company cannot be certain that it will be able to raise
 additional capital on favorable terms, or at all, which raises
 substantial doubt about the Company&#x2019;s ability to continue as
 a going concern. The financial statements do not include any
 adjustments that might result from the outcome of this
 uncertainty.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On
 August&#xA0;11, 2014, we executed a license and collaboration
 agreement (the &#x201C;Sanofi License Agreement&#x201D;) with
 Sanofi-Aventis Deutschland GmbH (which subsequently assigned its
 rights and obligations under the agreement to Sanofi-Aventis U.S.
 LLC (&#x201C;Sanofi&#x201D;)), pursuant to which Sanofi is
 responsible for global commercial, regulatory and development
 activities for AFREZZA. The Sanofi License Agreement became
 effective on September&#xA0;23, 2014. The Company manufactured
 AFREZZA at its manufacturing facility in Danbury, Connecticut to
 supply Sanofi&#x2019;s demand for the product pursuant to a supply
 agreement dated August&#xA0;11, 2014 (the &#x201C;Sanofi Supply
 Agreement&#x201D;).</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On
 January&#xA0;4, 2016 the Company received notification from Sanofi
 of its election to terminate in its entirety the Sanofi License
 Agreement. Sanofi&#x2019;s notice indicated that the termination was
 pursuant to Sanofi&#x2019;s right to terminate the Sanofi License
 Agreement upon Sanofi&#x2019;s good faith determination that the
 commercialization of AFREZZA is no longer economically viable in
 the United States, in which case the effective date of termination
 (the &#x201C;Termination Date&#x201D;) will be April&#xA0;4, 2016. In
 the alternative, Sanofi indicated that the termination was also
 pursuant to its right to terminate the Sanofi License Agreement for
 any reason, in which case the Termination Date will be July&#xA0;4,
 2016. In the interest of an expedient transition, the Company is
 working with Sanofi to transfer and wind down the agreement
 activities by April&#xA0;4, 2016, or as soon as practicable
 thereafter.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Under the
 Sanofi License Agreement, worldwide profits and losses, which are
 determined based on the difference between the net sales of AFREZZA
 and the costs and expenses incurred by the Company and Sanofi that
 are specifically attributable or related to the development,
 regulatory filings, manufacturing, or commercialization of AFREZZA,
 are shared 65% by Sanofi and 35% by the us. As a result of the loss
 share provision, and because the Company does not have the ability
 to estimate the amount of costs that would potentially be incurred
 related to the Sanofi License Agreement, the amount of up-front
 cash payment or milestone payments that could be recognized as
 revenue is not fixed or determinable. In connection with the Sanofi
 License Agreement, an affiliate of Sanofi provided the Company with
 a secured loan facility (the &#x201C;Sanofi Loan Facility&#x201D;) of
 up to $175.0 million to fund the Company&#x2019;s share of net
 losses under the Sanofi License Agreement.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Additional
 funding sources that are, or in certain circumstances may be
 available to the Company, include approximately $30.1 million
 principal amount of available borrowings under The Mann Group Loan
 Arrangement. A portion of these available borrowings may be used to
 capitalize accrued interest into principal, upon mutual agreement
 of the parties, as it becomes due and payable under The Mann Group
 Loan Arrangement. (see note 7&#xA0;&#x2014;&#xA0;Related-party
 arrangements). The Company cannot provide assurances that its plans
 will not change or that changed circumstances will not result in
 the depletion of its capital resources more rapidly than it
 currently anticipates. The Company will need to raise additional
 capital, whether through a sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means, in order to continue the development
 and commercialization of AFREZZA and other product candidates and
 to support its other ongoing activities. However, the Company
 cannot provide assurances that such additional capital will be
 available on acceptable terms or at all.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Principles
 of Consolidation</i> &#x2014;&#xA0;The consolidated financial
 statements include the accounts of the Company and its wholly-owned
 subsidiaries. Intercompany balances and transactions have been
 eliminated.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Segment
 Information</i> &#x2014;&#xA0;In accordance with Accounting
 Standards Codification (&#x201C;ASC&#x201D;) 280-10-50 <i>Segment
 Reporting</i>, operating segments are identified as components of
 an enterprise about which separate discrete financial information
 is available for evaluation by the chief operating decision-maker
 in making decisions regarding resource allocation and assessing
 performance. To date, the Company has viewed its operations and
 manages its business as one segment operating in the United States
 of America.</font></p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6779121584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of significant accounting policies</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>2. Summary of
 significant accounting policies</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Financial
 Statement Estimates</i> &#x2014;&#xA0;The preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America (&#x201C;GAAP&#x201D;)
 requires management to make estimates and assumptions that affect
 the amounts reported in the financial statements and accompanying
 notes. Actual results could differ from those estimates. Management
 considers many factors in selecting appropriate financial
 accounting policies, and in developing the estimates and
 assumptions that are used in the preparation of the financial
 statements. Management must apply significant judgment in this
 process. The more significant estimates reflected in these
 accompanying financial statements involve assessing long-lived
 assets for impairment, accrued expenses, including clinical study
 expenses, inventory recoverability, valuation of the facility
 financing obligation, commitment asset, milestone rights, valuation
 of stock-based compensation and the determination of the provision
 for income taxes and corresponding deferred tax assets and
 liabilities and any valuation allowance recorded against net
 deferred tax assets.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>License and
 Collaboration and Supply Agreements</i> &#x2014;&#xA0;Pursuant to
 the Sanofi License Agreement and the Sanofi Supply Agreement, the
 Company granted to Sanofi exclusive, worldwide licenses to certain
 of the Company&#x2019;s patents, trademarks and know-how for the
 development and commercialization of AFREZZA and retained the right
 to be the exclusive manufacturer and supplier of AFREZZA until
 specified conditions are met upon which a portion of the
 manufacturing activities may be assumed by Sanofi. The terms of the
 Sanofi License Agreement provide for consideration to the Company
 in the form of a non-refundable up-front payment, product sales,
 manufacturing, regulatory and sales milestone payments and profit
 and loss sharing.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 analyzes consideration received under the provisions of ASC 605,
 Revenue Recognition, to determine whether the consideration, or a
 portion thereof, could be recognized as revenue. ASC 605 provides
 that revenue is recognized when there is persuasive evidence that
 an arrangement exists, delivery has occurred or services have been
 rendered, the price is fixed or determinable and collection is
 reasonably assured.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In arrangements
 involving the delivery of more than one element, each required
 deliverable is evaluated to determine whether it qualifies as a
 separate unit of accounting. This determination is generally based
 on whether the deliverable has &#x201C;stand-alone value&#x201D; to
 the customer. The arrangement&#x2019;s consideration that is fixed
 and determinable is then allocated to each separate unit of
 accounting based on the relative selling price of each deliverable.
 The estimated selling price of each deliverable is determined using
 the following hierarchy of values: (i)&#xA0;vendor-specific
 objective evidence of fair value, (ii)&#xA0;third-party evidence of
 selling price and (iii)&#xA0;best estimate of selling price (BESP).
 The BESP reflects the Company&#x2019;s best estimate of what the
 selling price would be if the deliverable was regularly sold by the
 Company on a stand-alone basis. In general, the consideration
 allocated to each unit of accounting is recognized as the related
 goods or services are delivered, limited to the consideration that
 is not contingent upon future deliverables.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The assessment
 of multiple element arrangements requires judgment in order to
 determine the appropriate units of accounting and the points in
 time that, or periods over which, revenue should be recognized.
 Given that, as of December&#xA0;31, 2015, the Company did not have
 the ability to estimate the amount of costs that would potentially
 be incurred under the loss share provision related to the Sanofi
 License Agreement and the Sanofi Supply Agreement, the Company
 believe the fixed and determinable fee requirement for revenue
 recognition was not met.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Cash and
 Cash Equivalents</i> &#x2014;&#xA0;The Company considers all highly
 liquid investments with original or remaining maturities of 90 days
 or less at the time of purchase, that are readily convertible into
 cash to be cash equivalents. As of December&#xA0;31, 2015 and 2014,
 cash equivalents were comprised of cash and money market accounts
 with maturities less than 90 days from the date of
 purchase.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Concentration of Credit Risk</i> &#x2014;&#xA0;Financial
 instruments which potentially subject the Company to concentration
 of credit risk consist of cash and cash equivalents. Cash and cash
 equivalents consist of interest-bearing accounts, which are
 regularly monitored by management and held in high credit quality
 institutions.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>State
 Research and Development Credit Exchange Receivable</i>
 &#x2014;&#xA0;The State of Connecticut provides certain companies
 with the opportunity to exchange certain research and development
 income tax credit carryforwards for cash in exchange for foregoing
 the carryforward of the research and development credits. The
 program provides for an exchange of research and development income
 tax credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Prepaid
 expenses and other current assets &#x2014;</i> Prepaid expenses and
 other current assets primarily consist of prepaid expenses for
 goods and services to be received. As of December&#xA0;31, 2015,
 prepaid and other current assets had a balance of $4.0 million,
 mainly comprised of prepaid insurance. As of December&#xA0;31, 2014
 prepaid and other current assets had a balance of $20.2 million,
 mainly comprised of a $15.0 million prepayment for 2015 quantities
 of insulin, and prepaid insurance.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Sale of
 intellectual property</i> &#x2014;&#xA0;On July&#xA0;18, 2014, the
 Company entered into an assignment agreement with a third party
 whereby the third party acquired all proprietary rights, technology
 and know-how that related to a small molecule inhibitor compound
 and all pre-clinical data and results related thereto. Under the
 terms of the assignment agreement, the Company received total
 consideration of $9.3 million and accrued $1.4 million in expense
 for a net amount of $7.9 million recorded as other income. In 2015,
 the Company recorded other income of $1.4 million related to the
 relief of the $1.4 million accrual for expenses associated with the
 sale of intellectual property related to oncology in 2014, which
 was subsequently resolved without payment.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Milestone
 Rights</i> &#x2014;&#xA0;On July&#xA0;1, 2013, in conjunction with
 the execution of the Facility Agreement, the Company issued
 Milestone Rights to Deerfield whereby the Company agreed to provide
 Deerfield with pre-specified Milestone Payments upon the
 achievement of 13 specific Milestone Events related to the
 commercial release and future cumulative net sales of AFREZZA. The
 Company analyzed the Milestone Rights under the provisions of ASC
 815 and determined that the agreement does not meet the definition
 of a freestanding derivative. Since the Company has not elected to
 apply the fair value option to the Milestone Rights Purchase
 Agreement, the Company recorded the Milestone Rights at their
 estimated fair value and accounted for the Milestone Rights as a
 liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones and
 discounted to present value using a selected market discount rate.
 The expected timing and probability of achieving the milestones was
 developed with consideration given to both internal data, such as
 progress made to date and assessment of criteria required for
 achievement, and external data, such as market research studies.
 The discount rate was selected based on an estimation of required
 rate of returns for similar investment opportunities using
 available market data. The Milestone Rights liability will be
 remeasured as the specified milestone events are achieved.
 Specifically, as each milestone event is achieved, the portion of
 the initially recorded Milestone Rights liability that pertains to
 the milestone event being achieved, will be remeasured to the
 amount of the specified related milestone payment. The resulting
 change in the balance of the Milestone Rights liability due to
 remeasurement will be recorded in the Company&#x2019;s Statement of
 Operations as interest expense. Furthermore, the Milestone Rights
 liability will be reduced upon the settlement of each milestone
 payment. As a result, each milestone payment would be effectively
 allocated between a reduction of the recorded Milestone Rights
 liability and an expense representing a return on a portion of the
 Milestone Rights liability paid to the investor for the achievement
 of the related milestone event (see Note
 17&#xA0;&#x2014;&#xA0;Facility Agreement). As of December&#xA0;31,
 2015, the remaining liability balance of $8.9 million was
 classified as long-term liability in other liabilities.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Deferred
 product costs from collaboration</i> &#x2014; Deferred product costs
 represent the costs of product manufactured and sold to Sanofi, as
 long as they are not greater than the amount of deferred product
 sales related to the collaboration, for which recognition of
 revenue has been deferred. Given that the costs of inventory
 delivered to a customer, but for which revenue may not yet be
 recognized, meet both the definition and characteristics of an
 &#x201C;asset&#x201D; and the Company believes that it is probable
 that the amount of future revenue will exceed the amount of
 deferred costs (i.e., the asset would be realizable through the
 recognition of probable future income), the Company has elected to
 account for the deferred costs related to the product sold to
 Sanofi as an asset and carry forward to future periods until the
 related revenue is recognized.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Fair Value
 of Financial Instruments</i> &#x2014;&#xA0;The Company utilizes fair
 value measurement guidance prescribed by GAAP to value its
 financial instruments. The guidance includes a definition of fair
 value, prescribes methods for measuring fair value, establishes a
 fair value hierarchy based on the inputs used to measure fair value
 and expands disclosures about the use of fair value measurements.
 The valuation techniques utilized are based upon observable and
 unobservable inputs. Observable inputs reflect market data obtained
 from independent sources, while unobservable inputs reflect
 internal market assumptions. These two types of inputs create the
 following fair value hierarchy:</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px">
 <font style="FONT-FAMILY: Times New Roman" size="2">Level
 1&#xA0;&#x2014;&#xA0;Quoted prices for identical instruments in
 active markets.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px">
 <font style="FONT-FAMILY: Times New Roman" size="2">Level
 2&#xA0;&#x2014;&#xA0;Quoted prices for similar instruments in active
 markets; quoted prices for identical or similar instruments in
 markets that are not active; and model-derived valuations whose
 inputs are observable or whose significant value drivers are
 observable.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px">
 <font style="FONT-FAMILY: Times New Roman" size="2">Level
 3&#xA0;&#x2014;&#xA0;Significant inputs to the valuation model are
 unobservable.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The carrying
 amounts reflected in the consolidated balance sheets for cash
 equivalents, other current assets, accounts payable, and accrued
 expenses and other current liabilities, approximate fair value due
 to their relatively short maturities.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Inventories</i> &#x2014;&#xA0;Inventories are stated at the
 lower of cost or market. The Company determines the cost of
 inventory using the first-in, first-out, or FIFO, method. The
 Company capitalizes inventory costs associated with the
 Company&#x2019;s products based on management&#x2019;s judgment that
 future economic benefit is expected to be realized; otherwise, such
 costs are expensed as product manufacturing. The Company
 periodically analyzes its inventory levels to identify inventory
 that may expire or has a cost basis in excess of its estimated
 realizable value, and writes-down such inventories as appropriate.
 In addition, the Company&#x2019;s products are subject to strict
 quality control and monitoring which the Company performs
 throughout the manufacturing process. If certain batches or units
 of product no longer meet quality specifications or become obsolete
 due to expiration, the Company will record a charge to write down
 such unmarketable inventory to its estimated realizable value.
 Inventory that is not expected to be used within one year is
 classified as a long term asset on the accompanying condensed
 consolidated balance sheet.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">We analyzed our
 inventory levels to identify inventory that may expire or has a
 cost basis in excess of its estimated realizable value. We
 performed an assessment of projected sales and to evaluate the
 lower of cost or market and the potential excess inventory on hand
 at December 31, 2015. As a result of this assessment, we recorded a
 charge of $39.3 million to record the inventory raw materials on
 hand at the lower of cost or market, inventory expiry, and
 write-off other inventory related assets.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In connection
 with the projected sales assessment, we also evaluated our
 inventory purchase commitments totalling $116.2 million for
 potential impairment. As a result of this assessment, we recorded a
 $66.2 million charge related to a loss on future purchase
 commitments both from a lower of cost or market excess inventory
 perspective. The purchase commitment obligation has been reduced to
 reflect our expectation that a portion will be recoverable from a
 third party.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Property and
 Equipment</i> &#x2014;&#xA0;Property and equipment are recorded at
 cost and depreciated using the straight-line method over the
 estimated useful lives of the related assets. Leasehold
 improvements are amortized over the term of the lease or the
 service lives of the improvements, whichever is shorter.
 Maintenance and repairs are expensed as incurred. Assets under
 construction are not depreciated until placed into
 service.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Impairment
 of Long-Lived Assets</i> &#x2014;&#xA0;The Company evaluates
 long-lived assets for impairment whenever events or changes in
 circumstances indicate that the carrying value of an asset may not
 be recoverable in accordance with ASC 360-10-35 <i>Property Plant
 and Equipment.</i> Assets are considered to be impaired if the
 carrying value may not be recoverable based upon management&#x2019;s
 assessment of the following events or changes in
 circumstances:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">significant changes in the Company&#x2019;s strategic business
 objectives and utilization of the assets;</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">a determination that the carrying value of such assets cannot
 be recovered through undiscounted cash flows;</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">loss of legal ownership or title to the assets;</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">a significant adverse change in legal factors or in the
 business climate that could affect the value of a long-lived asset
 (asset group), including an adverse action or assessment by a
 regulator; or</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the impact of significant negative industry or economic
 trends.</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">If the Company
 believes an asset to be impaired, the impairment recognized is the
 amount by which the carrying value of the assets exceeds the fair
 value of the assets. Any write-downs would be treated as permanent
 reductions in the carrying amount of the asset and an operating
 loss would be recognized.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 recorded an asset impairment of $140.4 million for the year ended
 December&#xA0;31, 2015 (see Note 5&#xA0;&#x2014;&#xA0;Property and
 Equipment). No asset impairment was recognized during the years
 ended December&#xA0;31, 2014, and 2013, respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Income
 Taxes</i> &#x2014;&#xA0;The provisions for federal, foreign, state,
 and local income taxes are calculated on pre-tax income based on
 current tax law and include the cumulative effect of any changes in
 tax rates from those used previously in determining deferred tax
 assets and liabilities. Deferred income tax assets and liabilities
 are measured using enacted tax rates expected to apply to taxable
 income in the year in which the temporary differences are expected
 to be recovered or settled. A valuation allowance is recorded to
 reduce net deferred income tax assets to amounts that are more
 likely than not to be realized.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Income tax
 positions are considered for uncertainty in accordance with ASC
 740-10-25 <i>Income Taxes,</i> The Company believes that its income
 tax filing positions and deductions will be sustained on audit and
 does not anticipate any adjustments that will result in a material
 change to its financial position. Therefore, no liabilities for
 uncertain income tax positions have been recorded. If a tax
 position does not meet the minimum statutory threshold to avoid
 payment of penalties, the Company recognizes an expense for the
 amount of the penalty in the period the tax position is claimed in
 the tax return of the Company. The Company recognizes interest
 accrued related to unrecognized tax benefits in income tax expense,
 if any. Penalties, if probable and reasonably estimable, are
 recognized as a component of income tax expense.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Significant
 management judgment is involved in determining the provision for
 income taxes, deferred tax assets, deferred tax liabilities, and
 any valuation allowance recorded against deferred tax assets. Due
 to uncertainties related to the realization of the Company&#x2019;s
 deferred tax assets as a result of its history of operating losses,
 a valuation allowance has been established against the total
 deferred tax asset balance. The valuation allowance is based on
 management&#x2019;s estimates of taxable income by jurisdiction in
 which the Company operates and the period over which deferred tax
 assets will be recoverable. In the event that actual results differ
 from these estimates or the Company adjusts these estimates in
 future periods, a change in the valuation allowance may be needed,
 which could materially impact the Company&#x2019;s financial
 position and results of operations.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Contingencies</i> &#x2014;&#xA0;Contingencies are recorded in
 accordance with ASC 450 <i>Contingencies.</i> Accordingly, the
 Company records a loss contingency for a liability when it is both
 probable that a liability has been incurred and the amount of the
 loss can be reasonably estimated. These accruals represent
 management&#x2019;s best estimate of probable loss. Disclosure also
 is provided when it is reasonably possible that a loss will be
 incurred or when it is reasonably possible that the amount of a
 loss will exceed the recorded provision. On a quarterly basis, the
 Company reviews the status of each significant matter and assesses
 its potential financial exposure. Significant judgment is required
 in both the determination of probability and the determination as
 to whether an exposure is reasonably estimable. Because of
 uncertainties related to these matters, accruals are based only on
 the best information available at the time. As additional
 information becomes available, the Company reassesses the potential
 liability related to pending claims and litigation and may revise
 its estimates. These revisions in the estimates of the potential
 liabilities could have a material impact on the Company&#x2019;s
 consolidated results of operations and financial
 position.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Stock-Based
 Compensation</i> &#x2014;&#xA0;As of December&#xA0;31, 2015, the
 Company had three active stock-based compensation plans, which are
 described more fully in Note 13. The Company accounts for all
 share-based payments to employees, including grants of stock awards
 and the compensatory elements of the employee stock purchase plan
 in accordance with ASC 718<i>.</i> ASC 718 <i>Compensation &#x2014;
 Stock Compensation</i> (&#x201C;ASC 718&#x201D;) requires all
 share-based payments to employees, including grants of stock
 options, restricted stock units, performance-based awards and the
 compensatory elements of employee stock purchase plans, to be
 recognized in the statement of operations based upon the fair value
 of the awards at the grant date. The Company uses the Black-Scholes
 option valuation model to estimate the grant date fair value of
 employee stock options and the compensatory elements of employee
 stock purchase plans. Option valuation models require the input of
 assumptions, including the expected life of the stock-based awards,
 the estimated stock price volatility, the risk-free interest rate,
 and the expected dividend yield. Beginning in the third quarter of
 2014, the Company began to assess both historical and implied
 volatility in order to determine its estimated volatility rate.
 Implied volatility was considered due to the change in the
 Company&#x2019;s business, which occurred with the approval for the
 sale of AFREZZA. The expected volatility assumption is based on an
 assessment of the historical volatility and the implied volatility
 of the Company&#x2019;s common stock, derived from an analysis of
 historical traded and quoted options on the Company&#x2019;s common
 stock. Restricted stock units are valued based on the market price
 on the grant date. The Company evaluates stock awards with
 performance conditions as to the probability that the performance
 conditions will be met and estimates the date at which the
 performance conditions will be met in order to properly recognize
 stock-based compensation expense over the requisite service
 period.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Warrants</i>
 &#x2014;&#xA0;The Company has issued warrants to purchase shares of
 its common stock. Warrants have been accounted for within equity in
 accordance with the provisions of ASC 815-40, Contracts in an
 Entity&#x2019;s Own Stock, previously EITF Issue No. 00-19:
 <i>Accounting for Derivative Financial Instruments Indexed to, and
 Potentially Settled in, a Company&#x2019;s Own Stock</i>.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Comprehensive Loss</i> &#x2014;&#xA0;Other comprehensive loss
 is recorded in accordance with ASC 220-10-45 <i>Comprehensive
 Income,</i> which requires that all components of comprehensive
 loss be reported in the financial statements in the period in which
 they are recognized. Other comprehensive loss includes certain
 changes in stockholders&#x2019; equity that are excluded from net
 income. Specifically, the Company includes unrealized gains and
 foreign exchange translation losses, if any, and cumulative
 translation gains and losses in other comprehensive
 loss.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Research and
 Development Expenses</i> &#x2014;&#xA0;Research and development
 expenses consist of costs associated with the clinical trials of
 the Company&#x2019;s product candidates, manufacturing supplies and
 other development materials, compensation and other expenses for
 research and development personnel, costs for consultants and
 related contract research, facility costs, and depreciation.
 Research and development costs, which are net of any tax credit
 exchange recognized for the Connecticut state research and
 development credit exchange program, are expensed as incurred
 consistent with ASC 730-10 <i>Research and Development.</i> The
 Company began commercial manufacturing in the latter part of the
 fourth quarter of 2014. As such, commercial manufacturing costs
 incurred in the fourth quarter of 2014 and included in research and
 development as expenses were immaterial for the year ended
 December&#xA0;31, 2014.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Clinical
 Trial Expenses</i> &#x2014;&#xA0;Clinical trial expenses, which are
 reflected in research and development expenses in the accompanying
 statements of operations, result from obligations under contracts
 with vendors, consultants, and clinical site agreements in
 connection with conducting clinical trials. The financial terms of
 these contracts are subject to negotiations which vary from
 contract to contract and may result in payment flows that do not
 match the periods over which materials or services are provided to
 the Company under such contracts. The appropriate level of trial
 expenses are reflected in the Company&#x2019;s financial statements
 by matching period expenses with period services and efforts
 expended. These expenses are recorded according to the progress of
 the trial as measured by patient progression and the timing of
 various aspects of the trial. Clinical trial accrual estimates are
 determined through discussions with internal clinical personnel and
 outside service providers as to the progress or state of completion
 of trials, or the services completed. Service provider status is
 then compared to the contractually obligated fee to be paid for
 such services. During the course of a clinical trial, the Company
 may adjust the rate of clinical expense recognized if actual
 results differ from management&#x2019;s estimates.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Interest
 Expense</i> &#x2014;&#xA0;Interest costs are expensed as incurred,
 except to the extent such interest is related to construction in
 progress, in which case interest is capitalized. Interest expense,
 net of interest capitalized, for the years ended December&#xA0;31,
 2015, 2014 and 2013 was $24.1 million, $20.4 million, and $21.5
 million, respectively. Interest costs capitalized for the years
 ended December&#xA0;31, 2015, 2014, and 2013 were $0.1 million,
 $0.8 million, and $0.4 million, respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Net Loss Per
 Share of Common Stock</i> &#x2014;&#xA0;Basic net loss per common
 share is computed by dividing net loss by the weighted-average
 number of common shares outstanding during the period. Diluted net
 loss per common share is computed by dividing the net loss by the
 sum of the weighted-average number of common shares outstanding
 during the period plus the potential dilutive effect of stock
 options, restricted stock units, warrants, and shares that could be
 issued upon conversion of the senior convertible notes outstanding
 during the period calculated in accordance with the treasury stock
 method, but are excluded if their effect is anti-dilutive. Because
 the impact of these items is anti-dilutive during periods of net
 loss, there was no difference between basic and diluted loss per
 common share for the years ended December&#xA0;31, 2015, 2014, and
 2013.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Recently
 Issued Accounting Standards</i> &#x2014;&#xA0;From time to time, new
 accounting pronouncements are issued by the Financial Accounting
 Standards Board (FASB) or other standard setting bodies that are
 adopted by the Company as of the specified effective date. Unless
 otherwise discussed, the Company believes that the impact of
 recently issued standards that are not yet effective will not have
 a material impact on the Company&#x2019;s financial position or
 results of operations upon adoption.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In May 2014,
 the FASB issued ASU 2014-09 related to revenue recognition, which
 requires an entity to recognize the amount of revenue to which it
 expects to be entitled for the transfer of promised goods or
 services to customers. The guidance requires a company to recognize
 revenue to depict the transfer of goods or services to customers in
 an amount that reflects the consideration it expects to be entitled
 to receive in exchange for those goods or services. In July 2015,
 the FASB issued ASU 2015-14, which delayed the effective date of
 the new revenue standard by one year. The FASB also agreed to allow
 entities to choose to adopt the standard as of the original
 effective date. The standard is effective beginning the first
 quarter of the Company&#x2019;s 2018 fiscal year and is required to
 be adopted using either a full retrospective or a modified
 retrospective approach. The Company is assessing the potential
 impact of the new standard on its consolidated financial statements
 and has not yet selected a transition method.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In August 2014,
 the FASB issued ASU 2014-15, which provides guidance on determining
 when and how reporting entities must disclose going-concern
 uncertainties in their financial statements. The new standard
 requires management to perform interim and annual assessments of an
 entity&#x2019;s ability to continue as a going concern within one
 year of the date of issuance of the entity&#x2019;s financial
 statements (or within one year after the date on which the
 financial statements are available to be issued, when applicable).
 Further, an entity must provide certain disclosures if there is
 &#x201C;substantial doubt about the entity&#x2019;s ability to
 continue as a going concern&#x201D;. The ASU is effective for annual
 periods ending after December&#xA0;15, 2016, and interim periods
 thereafter; early adoption is permitted. The Company is evaluating
 the impact the adoption of ASU 2014-15 will have on its
 consolidated financial statements.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In April 2015,
 the FASB issued ASU 2015-03, &#x201C;Simplifying the Presentation of
 Debt Issuance Costs.&#x201D; The guidance requires debt issuance
 costs to be presented in the balance sheet as a direct deduction
 from the carrying value of the associated debt, consistent with the
 presentation of a debt discount. The guidance is effective for
 annual reporting periods beginning after December&#xA0;15, 2015 and
 interim periods thereafter. As permitted by the standard, the
 Company adopted the new presentation prospectively and the adoption
 did not have an impact on its consolidated financial statements and
 disclosures.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In July 2015,
 the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the
 Measurement of Inventory. Topic 330, Inventory, currently requires
 an entity to measure inventory at the lower of cost or market.
 Market could be replacement cost, net realizable value, or net
 realizable value less an approximately normal profit margin. The
 amendments do not apply to inventory that is measured using
 last-in, first-out (LIFO) or the retail inventory method. The
 amendments apply to all other inventory, which includes inventory
 that is measured using first-in, first-out (FIFO) or average cost.
 The amendments are effective for fiscal years beginning after
 December&#xA0;15, 2016, including interim periods within those
 fiscal years. The amendments should be applied prospectively with
 earlier application permitted as of the beginning of an interim or
 annual reporting period. The Company is evaluating the impact the
 adoption of ASU 2015-11 will have on its consolidated financial
 statements.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In November
 2015, the FASB issued ASU No.&#xA0;2015-17, Income Taxes (Topic
 740): Balance Sheet Classification of Deferred Taxes. The new
 standard requires that deferred tax assets and liabilities be
 classified as noncurrent in a classified statement of financial
 position. For public business entities, the amendments in this
 Update are effective for financial statements issued for annual
 periods beginning after December&#xA0;15, 2016, and interim periods
 within those annual periods. As permitted by the standard, the
 Company adopted the new presentation and the adoption did not have
 an impact on its consolidated financial statements and
 disclosures.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In January
 2016, the FASB issued ASU 2016-01, Financial
 Instruments&#xA0;&#x2014;&#xA0;Overall (Subtopic 825-10):
 Recognition and Measurement of Financial Assets and Financial
 Liabilities. The update is intended to improve the recognition and
 measurement of financial instruments. The update are effective for
 fiscal years beginning after December&#xA0;15, 2017, including
 interim periods within those fiscal years. The Company is
 evaluating the impact the adoption of ASU 2016-01 will have on its
 consolidated financial statements.</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781300000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>State research and development credit exchange receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock', window );">State research and development credit exchange receivable</a></td>
<td class="text"><div>
 <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>3. State research and
 development credit exchange receivable</b></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The State of
 Connecticut provides certain companies with the opportunity to
 exchange certain research and development income tax credit
 carryforwards for cash in exchange for forgoing the carryforward of
 the research and development income tax credits. The program
 provides for an exchange of research and development income tax
 credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses. During the years ended December&#xA0;31, 2015, 2014 and
 2013, research and development expenses were offset by $743,000,
 $816,000, and $282,000, respectively.</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State research and development credit exchange receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StateResearchAndDevelopmentCreditExchangeReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6779792976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>4.
 Inventories</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Inventories
 consist of the following (in thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="79%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Raw materials</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,856</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Work-in-process</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,719</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Finished goods</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Inventory &#x2014;
 current</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,670</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total Inventory</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;9,670</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&#xA0;</p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a, b, c<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6612011808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and equipment</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>5. Property and
 equipment</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Property and
 equipment consist of the following (dollar amounts in
 thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="70%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" rowspan="2" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Estimated<br />
 Useful<br />
 Life<br />
 (Years)</b></font></td>
 <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap">
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center">
 <font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,273</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,273</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39-40</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">54,948</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">54,948</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Building
 improvements</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5-40</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">131,383</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">114,131</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Machinery and
 equipment</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3-15</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95,182</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,919</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Furniture, fixtures and
 office equipment</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5-10</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,137</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,015</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Computer equipment and
 software</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,707</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,465</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Leasehold
 improvements</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Construction in
 progress</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,044</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39,580</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">308,674</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">310,348</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Less impairment</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(140,412</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="bottom">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Less accumulated
 depreciation and amortization</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(119,513</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(118,221</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total property and
 equipment, net</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,749</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">192,127</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Leasehold
 improvements are amortized over four years which is the shorter of
 the term or the service lives of the improvements. Depreciation and
 amortization expense related to property and equipment for the
 years ended December&#xA0;31, 2015, 2014, and 2013, was $11.0
 million, $9.8 million, and $11.5 million, respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In connection
 with the Company&#x2019;s quarterly assessment of impairment
 indicators, the Company evaluated the continued lower than expected
 sales of AFREZZA as reported by Sanofi throughout the fourth
 quarter of 2015, revised forecasts for sales of AFREZZA provided by
 Sanofi in the fourth quarter of 2015 and level of commercial
 production in the fourth quarter of 2015, as well as the
 uncertainty associated with Sanofi&#x2019;s announcement during the
 fourth quarter of their intent to reorganize their diabetes
 business. These factors indicated potentially significant changes
 in the timing and extent of cash flows, and the Company therefore
 determined that an impairment indicator existed in the fourth
 quarter of 2015.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On
 January&#xA0;4, 2016, the Company received written notice from
 Sanofi of its election to terminate in its entirety the Sanofi
 License Agreement. Sanofi&#x2019;s notice indicated that the
 termination was pursuant to Sanofi&#x2019;s right to terminate the
 agreement upon Sanofi&#x2019;s good faith determination that the
 commercialization of AFREZZA is no longer economically viable in
 the United States, in which case the effective date of termination
 would be April&#xA0;4, 2016. In the alternative, Sanofi indicated
 that the termination was also pursuant to its right to terminate
 the License Agreement for any reason, in which case the Termination
 Date would be July&#xA0;4, 2016. In the interest of an expedient
 transition, the Company is currently working with Sanofi to
 transfer and wind down the agreement activities by April&#xA0;4,
 2016, or as soon as practicable thereafter.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 identified two primary asset groups to be evaluated for impairment:
 the Danbury manufacturing facility, which currently performs all
 the manufacturing of AFREZZA, and the Valencia facility, which was
 previously the Company&#x2019;s corporate headquarters. The Danbury
 manufacturing facility is the primary asset group that has been
 impacted by the impairment indicators noted above but the Company
 also evaluated the Valencia facility for potential impairment given
 the circumstances and identified an impairment charge of $1.8
 million based on a valuation utilizing a combination of market,
 income and cost approaches. Within the Danbury manufacturing
 facility, the Company identified the machinery and equipment as the
 primary assets within the asset group as they are associated with
 the production of AFREZZA. As such, the Company performed the fixed
 asset impairment test and performed the first step to test for
 recoverability of the Danbury manufacturing facility by utilizing
 two undiscounted cash flow projections and applying a probability
 weighted average to those cash flow projections. The first
 undiscounted cash flow projection was developed under a scenario
 assuming Sanofi would continue to sell and market AFREZZA as the
 termination of the arrangement by Sanofi was not known as of the
 balance sheet date. The second undiscounted cash flow projection
 assumed Sanofi would terminate the Sanofi License Agreement and
 that the Company would manufacture, sell and market AFREZZA
 independently.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Based on the
 evaluation performed, the probabilities assigned to the two
 undiscounted cash flows were not significant to the evaluation due
 to the projected negative cash flows over the estimation period,
 and it was determined that the probability weighted undiscounted
 cash flows were not sufficient to recover the carrying value of the
 Danbury manufacturing facility. As such, the Company was required
 to determine the fair value of the Danbury manufacturing facility
 to recognize an impairment loss if the carrying amount exceeds its
 fair value. The Company determined the fair value of the Danbury
 manufacturing facility by applying the highest and best use
 valuation concept and utilizing the market approach valuation
 technique to value the machinery and equipment and a combination of
 the market approach and cost approach in valuing the land,
 buildings, and building improvements. As a result of this
 assessment, the Company recorded an impairment charge of $138.6
 million for the Danbury manufacturing facility.</font></p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51717284&amp;loc=d3e1361-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51719941&amp;loc=d3e2921-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6610948768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued expenses and other current liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued expenses and other current liabilities</a></td>
<td class="text"><div>
 <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>6. Accrued expenses and
 other current liabilities</b></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Accrued expenses
 and other current liabilities are comprised of the following (in
 thousands):</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">
 <tr>
 <td width="85%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Salary and related
 expenses</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">5,662</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">14,928</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Accrued interest</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">615</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,396</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Construction in
 progress</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">238</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,343</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Other</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,414</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7,539</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Accrued expenses and other
 current liabilities</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7,929</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">26,206</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6639297824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-party arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related-party arrangements</a></td>
<td class="text"><div>
 <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>7. Related-party
 arrangements</b></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">In October 2007,
 the Company entered into a $350.0 million loan arrangement with its
 principal stockholder. The Loan Arrangement has been amended from
 time to time. On October&#xA0;31, 2013, the promissory note
 underlying The Mann Group Loan Arrangement was amended to, among
 other things, extend the maturity date of the loan to
 January&#xA0;5, 2020, extend the date through which the Company can
 borrow under The Mann Group Loan Arrangement to December&#xA0;31,
 2019, increase the aggregate borrowing amount under The Mann Group
 Loan Arrangement from $350.0 million to $370.0 million and provide
 that repayments or cancellations of principal under The Mann Group
 Loan Arrangement will not be available for reborrowing.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">As of
 December&#xA0;31, 2015, the total principal amount outstanding
 under The Mann Group Loan Arrangement was $49.5 million, and the
 amount available for future borrowings was $30.1 million. Interest,
 at a fixed rate of 5.84%, is due and payable quarterly in arrears
 on the first day of each calendar quarter for the preceding
 quarter, or at such other time as the Company and The Mann Group
 mutually agree. All or any portion of accrued and unpaid interest
 that becomes due and payable may be paid-in-kind and capitalized as
 additional borrowings at any time upon mutual agreement of the
 parties, and has been classified as non-current. The Mann Group can
 require the Company to prepay up to $200.0 million in advances that
 have been outstanding for at least 12 months (less approximately
 $105.0 million aggregate principal amount that has been cancelled
 in connection with two common stock purchase agreements). If The
 Mann Group exercises this right, the Company will have 90 days
 after The Mann Group provides written notice (or the number of days
 to maturity of the note if less than 90 days) to prepay such
 advances. However, pursuant to a letter agreement entered into in
 August 2010, The Mann Group has agreed to not require the Company
 to prepay amounts outstanding under the amended and restated
 promissory note if the prepayment would require the Company to use
 its working capital resources. In addition, The Mann Group entered
 into a subordination agreement with Deerfield pursuant to which The
 Mann Group agreed with Deerfield not to demand or accept any
 payment under The Mann Group Loan Arrangement until the
 Company&#x2019;s payment obligations to Deerfield under the Facility
 Agreement have been satisfied in full. Subject to the foregoing, in
 the event of a default under The Mann Group Loan Arrangement, all
 unpaid principal and interest either becomes immediately due and
 payable or may be accelerated at The Mann Group&#x2019;s option, and
 the interest rate will increase to the one-year LIBOR rate
 calculated on the date of the initial advance or in effect on the
 date of default, whichever is greater, plus 5%&#xA0;per annum. All
 borrowings under The Mann Group Loan Arrangement are unsecured. The
 Mann Group Loan Arrangement contains no financial
 covenants.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">As of
 December&#xA0;31, 2015 and 2014, the Company had accrued and unpaid
 interest of $6.4 million and $3.5 million, in long term other
 liabilities respectively, which related to the amount outstanding
 and had $30.1 million of available borrowings. Interest expense on
 the Company&#x2019;s note payable to the Company&#x2019;s principal
 stockholder for the years ended December&#xA0;31, 2015, 2014, and
 2013 was $2.9 million, $2.9 million, and $6.3 million,
 respectively.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">In May 2015, the
 Company entered into sublease agreement with the Alfred Mann
 Foundation for Scientific Research (the &#x201C;Mann
 Foundation&#x201D;), a California Not-For-Profit Corporation. The
 lease is for approximately 12,500 square feet of office space in
 Valencia, California and expires in April 2017. The office space
 contains the Company&#x2019;s principal executive offices. Lease
 payments to the Mann Foundation for the year ended
 December&#xA0;31, 2015 were $175,000. There were no lease payments
 to the Mann Foundation for the years ended December&#xA0;31, 2014
 and 2013.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">In connection
 with certain meetings of the Company&#x2019;s board of directors and
 on other occasions when the Company&#x2019;s business necessitated
 air travel for the Company&#x2019;s principal stockholder and other
 Company employees, the Company utilized the principal
 stockholder&#x2019;s private aircraft, and the Company paid the
 charter company that manages the aircraft on behalf of the
 Company&#x2019;s principal stockholder approximately $18,000,
 $79,000, and $82,000, respectively, for the years ended
 December&#xA0;31, 2015, 2014, and 2013 on the basis of the
 corresponding cost of commercial airfare.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The Company has
 entered into indemnification agreements with each of its directors
 and executive officers, in addition to the indemnification provided
 for in its amended and restated certificate of incorporation and
 amended and restated bylaws (see Note
 14&#xA0;&#x2014;&#xA0;Commitments and contingencies).</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph b<br> -Article 3A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6619038016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Senior convertible notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Senior convertible notes</a></td>
<td class="text"><div>
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>8. Senior convertible
 notes</b></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Senior
 convertible notes consist of the following (in
 thousands):</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">
 <tr>
 <td width="83%"></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2"><b>2015 notes</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Principal amount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">100,000</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Unaccreted debt issuance
 cost</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(645</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net carrying
 amount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">99,355</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2"><b>2018 notes</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Principal amount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">27,690</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Unamortized
 premium</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">660</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Unaccreted debt issuance
 costs</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(737</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net carrying
 amount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">27,613</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="margin-top:12px;margin-bottom:0px; margin-left:2%">
 <font style="font-family:Times New Roman" size="2"><i>Issuance of
 new 5.75% Convertible Senior Subordinated Exchange Notes due 2018
 in exchange for 2015 notes</i></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">On July&#xA0;28,
 2015, the Company entered into privately-negotiated exchange
 agreements (the &#x201C;Note Exchange Agreements&#x201D;) with a
 select holder of the Company&#x2019;s 5.75% Senior Convertible Notes
 due 2015 (the &#x201C;2015 notes&#x201D;), pursuant to which the
 Company agreed to issue $27.7 million aggregate principal amount of
 new 5.75% Convertible Senior Subordinated Exchange Notes due 2018
 (the &#x201C;2018 notes&#x201D;) to such holders in exchange for the
 delivery to the Company of the same principal amount of 2015 notes.
 The 2018 notes were issued at the closing of the exchange on
 August&#xA0;10, 2015. The Company analyzed this exchange under the
 provisions of ASC 470-50 and concluded that the exchange represents
 an extinguishment of the 2015 notes and a new issuance of 2018
 notes and recorded such notes at fair value which resulted in a
 premium of $0.7 million.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The 2018 notes
 are the Company&#x2019;s general, unsecured, senior obligations,
 except that the 2018 notes are subordinated in right of payment to
 the outstanding notes issued pursuant to the Facility Agreement and
 the Company&#x2019;s borrowings under the Sanofi Loan Facility with
 an affiliate of Sanofi-Aventis U.S. LLC. The 2018 notes rank
 equally in right of payment with the Company&#x2019;s other
 unsecured senior debt. The 2018 notes bear interest at the rate of
 5.75%&#xA0;per year on the principal amount, payable semiannually
 in arrears in cash on February&#xA0;15 and August&#xA0;15 of each
 year, beginning February&#xA0;15, 2016, with interest accruing from
 August&#xA0;15, 2015. The 2018 notes mature on August&#xA0;15,
 2018.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The 2018 notes
 are convertible, at the option of the holder, at any time on or
 prior to the close of business on the business day immediately
 preceding the stated maturity date, into shares of the
 Company&#x2019;s common stock at an initial conversion rate of
 147.0859 shares per $1,000 principal amount of 2018 notes, which is
 equal to a conversion price of approximately $6.80 per share, the
 same conversion price as that of the 2015 notes on the date of
 exchange. The conversion rate is subject to adjustment under
 certain circumstances described in an indenture governing the 2018
 notes dated August&#xA0;10, 2015 with Wells Fargo, National
 Association, including in connection with a make-whole fundamental
 change.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">If certain
 fundamental changes occur, the Company will be obligated to pay a
 fundamental change make-whole premium on any 2018 notes converted
 in connection with such fundamental change by increasing the
 conversion rate on such 2018 notes. In such instances, the amount
 of the fundamental change make-whole premium will be based on the
 Company&#x2019;s common stock price and the effective date of the
 applicable fundamental change.</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <p style="margin-top:0px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">If the Company
 undergoes certain fundamental changes, except in certain
 circumstances, each holder of 2018 notes will have the option to
 require the Company to repurchase all or any portion of that
 holder&#x2019;s 2018 notes. The fundamental change repurchase price
 will be 100% of the principal amount of the 2018 notes to be
 repurchased plus accrued and unpaid interest, if any.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">On or after the
 date that is one year following the original issue date of the 2018
 notes, the Company will have the right to redeem for cash all or
 part of the 2018 notes if the last reported sale price of its
 common stock exceeds 130% of the conversion price then in effect
 for 20 or more trading days during the 30 consecutive trading day
 period ending on the trading day immediately prior to the date of
 the redemption notice. The redemption price will equal the sum of
 100% of the principal amount of the 2018 notes to be redeemed, plus
 accrued and unpaid interest. Under the terms of the 2018 Note
 Indenture, the conversion option can be net-share settled and the
 maximum number of shares that could be required to be delivered
 under the indenture, including the make-whole shares, is fixed and
 less than the number of authorized and unissued shares less the
 maximum number of shares that could be required to be delivered
 during the term of the 2018 notes under existing commitments.
 Applying the Company&#x2019;s sequencing policy, the Company
 performed an analysis at the time of the offering of the 2018 notes
 and each reporting date since and has concluded that the number of
 available authorized shares at the time of the offering and each
 subsequent reporting date was sufficient to deliver the number of
 shares that could be required to be delivered during the term of
 the 2018 notes under existing commitments.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The 2018 notes
 provide that upon an acceleration of certain indebtedness,
 including the 9.75% Senior Convertible Notes due 2019 (the
 &#x201C;2019 notes&#x201D;) and the 8.75% Senior Convertible Notes
 due 2019 (the &#x201C;Tranche B notes&#x201D;) issued to Deerfield
 pursuant to the Facility Agreement (see Note
 17&#xA0;&#x2014;&#xA0;Facility Agreement), the holders may elect to
 accelerate the Company&#x2019;s repayment obligations under the
 notes if such acceleration is not cured, waived, rescinded or
 annulled. There can be no assurance that the holders would not
 choose to exercise these rights in the event such events were to
 occur.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The Company
 incurred approximately $0.8 million in issuance costs which are
 recorded as an offset to the 2018 notes in the accompanying
 condensed consolidated balance sheet. These costs are being
 accreted to interest expense using the effective interest method
 over the term of the 2018 notes.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Accretion of
 debt issuance expense in connection with the 2018 notes during the
 year ended December&#xA0;31, 2015 was $93,000. Amortization of 2018
 notes premium during the year ended December&#xA0;31, 2015 was
 $86,000.</font></p>
 <p style="margin-top:12px;margin-bottom:0px; margin-left:2%">
 <font style="font-family:Times New Roman" size="2"><i>Issuance of
 common stock in exchange for 2015 notes</i></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">On July&#xA0;28,
 2015, the Company entered into separate, privately-negotiated
 exchange agreements (the &#x201C;Stock-for-Note Exchange
 Agreements&#x201D;) with certain holders of the 2015 notes pursuant
 to which the Company agreed to issue shares of its common stock to
 such holders in exchange for the delivery to the Company of up to
 $56.9 million aggregate principal amount of 2015 notes.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Pursuant to the
 Stock-for-Note Exchange Agreements, the parties agreed to price the
 exchange transactions over a 10 trading day period spanning from
 July&#xA0;29, 2015 to and including August&#xA0;11, 2015. Between
 July&#xA0;28, 2015 and August&#xA0;10, 2015, the Company issued an
 aggregate of 1.9&#xA0;million shares of common stock to such
 holders in exchange for such holders&#x2019; delivery to the Company
 of $8.0 million aggregate principal amount of 2015 notes, resulting
 in a weighted-average exchange price of $4.40 per share.</font></p>
 <p style="margin-top:12px;margin-bottom:0px; margin-left:2%">
 <font style="font-family:Times New Roman" size="2"><i>Issuance of
 new 5.75% Convertible Senior Subordinated Exchange Notes due 2015
 in exchange for 2015 notes</i></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">On
 August&#xA0;14, 2015, the Company exchanged $32.1 million aggregate
 principal amount of newly issued, 5.75% Convertible Senior
 Subordinated Exchange Notes due 2015 (the &#x201C;Exchange
 Notes&#x201D;) for the same principal amount of the Company&#x2019;s
 previously outstanding 2015 notes. The Exchange Notes, payable at
 maturity on September&#xA0;30, 2015, were convertible, at the
 option of each holder thereof, at any time on or prior to the close
 of business on the business day immediately preceding the stated
 maturity date. The holders of the Exchange Notes did not elect to
 convert any of the outstanding principal amount of the Exchange
 Notes into shares of the Company&#x2019;s common stock. As a result,
 on September&#xA0;30, 2015, the Company paid $32.1 million to
 settle the Exchange Notes.</font></p>
 <p style="margin-top:12px;margin-bottom:0px; margin-left:2%">
 <font style="font-family:Times New Roman" size="2"><i>Settlement of
 2015 notes and Exchange Notes</i></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">On
 August&#xA0;17, 2015, the Company paid $32.2 million to settle the
 remaining 2015 notes. As of September&#xA0;30, 2015, all 2015
 notes, including the Exchange Notes, have been settled resulting in
 a total loss on extinguishment equal to $1.0 million. The loss on
 extinguishment resulted from write-off of debt discount and debt
 issuance costs associated with the 2015 notes and Exchange Notes
 and the difference between the principal amounts being exchanged
 for shares of the Company&#x2019;s common stock, pursuant to the
 various Stock-for-Note Exchange Agreements, and the fair market
 value of the Company&#x2019;s common stock issued in exchange for
 such reduction in principal.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Accretion of
 debt issuance expense in connection with the 2015 notes during the
 years ended December&#xA0;31, 2015, 2014, and 2013 was $0.6
 million, $0.9 million, and $0.9 million, respectively.</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6610929184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration arrangement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration arrangement</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>9. Collaboration
 arrangement</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 6px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Sanofi
 License Agreement and Sanofi Supply Agreement</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On
 August&#xA0;11, 2014, the Company and Sanofi entered into the
 Sanofi License Agreement, which became effective on
 September&#xA0;23, 2014. Under the terms of the Sanofi License
 Agreement, the Company granted to Sanofi exclusive, worldwide
 licenses to certain of the Company&#x2019;s patents, trademarks and
 know-how for the development and commercialization of AFREZZA.
 Under the terms of the Sanofi License Agreement, Sanofi has the
 exclusive right and responsibility to develop AFREZZA worldwide,
 subject to certain development activities that will be performed by
 the Company. Sanofi will also be obligated to use commercially
 reasonable efforts to file for, obtain and maintain marketing
 approvals for AFREZZA in certain major markets and countries. In
 addition, Sanofi will have exclusive, worldwide rights to
 commercialize AFREZZA and will be obligated to use commercially
 reasonable efforts to market, promote and commercialize AFREZZA in
 all countries in the world where regulatory approval for AFREZZA
 has been received. Pursuant to the terms of the Sanofi Supply
 Agreement, the Company is responsible for the manufacture and
 supply to Sanofi of its requirements of AFREZZA.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Under the
 Sanofi License Agreement, Sanofi paid the Company an up-front cash
 payment of $150.0 million in the third quarter of 2014. If certain
 manufacturing, regulatory and sales milestones are achieved, the
 Company will also be eligible to receive up to $775.0 million in
 milestone payments, of which $75.0 million relates to certain
 development and manufacturing milestone events, $50.0 million
 relates to the filing and completion of regulatory approvals and
 $650.0 million relates to the achievement of certain product sales
 milestones. As of December&#xA0;31, 2014, the Company earned and
 recorded a total of $50.0 million in milestone payments in
 connection with the satisfaction of manufacturing milestones
 specified in the Sanofi agreement, which were received subsequent
 to December&#xA0;31, 2014. In addition, worldwide profits and
 losses, which are determined based on the difference between the
 net sales of AFREZZA and the costs and expenses incurred by the
 Company and Sanofi that are specifically attributable or related to
 the development, improvement, regulatory filings, manufacturing,
 and commercialization of AFREZZA will be shared 65% by Sanofi and
 35% by the Company. In accordance with the terms of the Sanofi
 License Agreement, profit and loss sharing commenced in the fourth
 quarter of 2014.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to the
 terms of the Sanofi Supply Agreement, the Company will be the
 exclusive manufacturer and supplier of AFREZZA until the specified
 conditions are met, upon which a portion of the manufacturing
 activities may be assumed by Sanofi.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 analyzed the agreements entered into with Sanofi under the
 provisions of ASC 605, Revenue Recognition, to determine whether
 the consideration, or a portion thereof, could be recognized as
 revenue. ASC 605 provides that revenue is recognized when there is
 persuasive evidence that an arrangement exists, delivery has
 occurred or services have been rendered, the price is fixed or
 determinable and collection is reasonably assured. In addition,
 revenue arrangements with multiple elements are divided into
 separate units of accounting if certain criteria are met, including
 whether the delivered element has stand-alone value to the
 customer. When deliverables are separable, consideration received
 is allocated to the separate units of accounting based on the
 relative selling price of each deliverable and the appropriate
 revenue recognition principles are applied to each unit.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The assessment
 of multiple element arrangements requires judgment in order to
 determine the appropriate units of accounting and the points in
 time that, or periods over which, revenue should be recognized.
 Under the terms of the Sanofi License Agreement, Sanofi Supply
 Agreement and the Sanofi Loan Facility the Company determined that
 the arrangement contained significant deliverables including
 (i)&#xA0;licenses to develop and commercialize AFREZZA and to use
 the Company&#x2019;s trademarks, (ii)&#xA0;development activities,
 and (iii)&#xA0;manufacture and supply services for AFREZZA. Due to
 the proprietary nature of the manufacturing services being provided
 by the Company, the Company determined that all of the significant
 deliverables should be combined into a single unit of accounting.
 The Company believes that the manufacturing services are
 proprietary due to the fact that since the late 1990&#x2019;s, the
 Company has developed proprietary knowledge and patented equipment
 and tools that are used in the manufacturing process of AFREZZA.
 Due to the complexities of particle formulation and the specialized
 knowledge and equipment needed to handle the AFREZZA powder,
 neither Sanofi nor any third-party contract manufacturing
 organization currently possesses the capability of manufacturing
 AFREZZA.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In order for
 revenue to be recognized, the seller&#x2019;s price to the buyer
 must be fixed and determinable. Given that as of December&#xA0;31,
 2015, the Company did not have the ability to estimate the amount
 of costs that would potentially be incurred under the loss share
 provision related to the Sanofi License Agreement and the Sanofi
 Supply Agreement, the Company believes this requirement for revenue
 recognition has not been met.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As such, the
 Company did not recognize any revenue pursuant to the Sanofi
 License Agreement or the Sanofi Supply Agreement for the years
 ended December&#xA0;31, 2015 and 2014. The Company has recorded the
 $150.0 million up-front payment and $50.0 million from milestone
 payments as deferred payments from collaboration. In addition, as
 of December&#xA0;31, 2015 the Company has recorded $17.5 million in
 AFREZZA product shipments to Sanofi as deferred product sales from
 collaboration and recorded $13.5 million as deferred product costs
 from collaboration. Deferred product costs represent the costs of
 product manufactured and shipped to Sanofi, not to exceed the
 amount of deferred product sales, for which recognition of revenue
 has been deferred. During the year ended December&#xA0;31, 2015,
 the Company&#x2019;s portion of the loss sharing was
 $57.7&#xA0;million, which resulted in the reclassification from
 current deferred payments from collaboration to Sanofi loan
 facility and loss share obligation to reflect amounts owed to
 Sanofi.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Sanofi Loan
 Facility</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On
 September&#xA0;23, 2014, the Company entered into the Sanofi Loan
 Facility, consisting of a senior secured revolving promissory note
 and a guaranty and security agreement (the &#x201C;Security
 Agreement&#x201D;) with an affiliate of Sanofi which provides the
 Company with a secured loan facility of up to $175.0 million to
 fund the Company&#x2019;s share of net losses under the Sanofi
 License Agreement. In the event of certain future defaults under
 the Sanofi Loan facility agreement for which the Company is not
 able to obtain waivers, the lender under the Sanofi Loan Facility
 may accelerate all of the Company&#x2019;s repayment obligations,
 and take control of the Company&#x2019;s pledged assets, potentially
 requiring the Company to renegotiate the terms of its indebtedness
 on terms less favorable to the Company, or to immediately cease
 operations.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The obligations
 of the Company under the Sanofi Loan Facility are guaranteed by the
 Company&#x2019;s wholly-owned subsidiary, MannKind LLC, and are
 secured by a first priority security interest in certain insulin
 inventory located in the United States and any contractual rights
 and obligations pursuant to which the Company purchases or has
 purchased such insulin, and a second priority security interest in
 the Company&#x2019;s assets that secure the Company&#x2019;s
 obligations under the Facility Agreement, as amended. In addition,
 the Company granted to Sanofi, as additional security for the
 obligations under the Sanofi Loan Facility, a first priority
 mortgage on the Company&#x2019;s facility in Valencia, California,
 which has a carrying value of $17.9&#xA0;million as of
 December&#xA0;31, 2015.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Advances under
 the Sanofi Loan Facility bear interest at a rate of 8.5%&#xA0;per
 annum and are payable in-kind and compounded quarterly and added to
 the outstanding principal balance under the Sanofi Loan Facility.
 The Company is required to make mandatory prepayments on the
 outstanding loans under the Sanofi Loan Facility from its share of
 any Profits (as defined in the Sanofi License Agreement) under the
 Sanofi License Agreement within 30 days of receipt of its share of
 any such Profits. No advances may be made under the Sanofi Loan
 Agreement if Deerfield has commenced enforcement proceedings in
 connection with an event of default under the Facility
 Agreement.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The outstanding
 principal of all loans under the Sanofi Loan Facility, if not
 prepaid, will become due and payable on September&#xA0;23, 2024
 unless accelerated pursuant to the terms of the Sanofi Loan
 Facility. Additionally, if the Company sells its Valencia facility,
 the Company is required to prepay the loans under the Sanofi Loan
 Facility from the net cash proceeds of the sale within five
 business days of receipt.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The
 Company&#x2019;s total portion of the loss sharing was
 $57.7&#xA0;million for the year ended December&#xA0;31, 2015, of
 which $44.5&#xA0;million was borrowed under the Sanofi Loan
 Facility as of December&#xA0;31, 2015. Subsequent to
 December&#xA0;31, 2015, the Company borrowed $17.9&#xA0;million
 under the Sanofi Loan Facility to finance the portion of the
 Company&#x2019;s loss for the quarter ended December&#xA0;31, 2015.
 The total amount owed to Sanofi is $62.4 million, which includes
 $1.7&#xA0;million in paid-in-kind interest.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Sanofi Loan
 Facility includes customary representations, warranties and
 covenants by the Company, including restrictions on its ability to
 incur additional indebtedness, grant certain liens and make certain
 changes to its organizational documents. Events of default under
 the Sanofi Loan Facility include: the Company&#x2019;s failure to
 timely make payments due under the Sanofi Loan Facility;
 inaccuracies in the Company&#x2019;s representations and warranties
 to the noteholder; the Company&#x2019;s failure to comply with any
 of its covenants under any of the Sanofi Loan Facility or certain
 other related security agreements and documents entered into in
 connection with the Sanofi Loan Facility, subject to a cure period
 with respect to most covenants; the Company&#x2019;s insolvency or
 the occurrence of certain bankruptcy-related events; termination by
 Sanofi of the Sanofi License Agreement as a result of the
 Company&#x2019;s breach of the Sanofi License Agreement; and the
 failure of any material provision under any of the Sanofi Loan
 Facility or certain other related security agreements and documents
 entered into in connection with the Sanofi Loan Facility to remain
 in full force and effect. If one or more events of default occurs
 and is continuing, Sanofi may terminate its obligation to make
 advances under the Sanofi Loan Facility, and, if certain specified
 events of default (including the Company&#x2019;s failure to timely
 make payments due under the Sanofi Loan Facility; the
 Company&#x2019;s failure to comply with the negative covenants under
 the Sanofi Loan Facility limiting the Company&#x2019;s ability to
 incur additional indebtedness or grant certain liens; the
 Company&#x2019;s insolvency or the occurrence of certain
 bankruptcy-related events; termination by Sanofi of the Sanofi
 License Agreement as a result of the Company&#x2019;s breach of the
 non-compete provisions of the Sanofi License Agreement; or the
 failure of any material provision under any of the Sanofi Loan
 Facility or certain other related security agreements and documents
 entered into in connection with the Sanofi Loan Facility to remain
 in full force and effect) occur and are continuing, the noteholder
 may accelerate all of the Company&#x2019;s repayment obligations
 under the Sanofi Loan Facility and otherwise exercise any of its
 remedies as a secured creditor. There can be no assurance that the
 noteholder would not choose to exercise these rights in the event
 such events were to occur.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Subsequent to
 December&#xA0;31, 2015, the Company received written notice on
 January&#xA0;4, 2016 from Sanofi of its election to terminate in
 its entirety the Sanofi License Agreement. Pursuant to its terms,
 the Sanofi Supply Agreement will terminate concurrently with the
 Sanofi License Agreement. Sanofi&#x2019;s notice indicated that the
 termination was pursuant to Sanofi&#x2019;s right to terminate the
 Sanofi License Agreement upon Sanofi&#x2019;s good faith
 determination that the commercialization of AFREZZA is no longer
 economically viable in the United States, in which case the
 effective date of termination will be April&#xA0;4, 2016. In the
 alternative, Sanofi indicated that the termination was also
 pursuant to its right to terminate the Sanofi License Agreement for
 any reason, in which case the effective date of termination will be
 July&#xA0;4, 2016. In the interest of an expedient transition, the
 Company is currently working with Sanofi to transfer and wind down
 the agreement activities by April&#xA0;4, 2016, or as soon as
 practicable thereafter.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to the
 terms of the Sanofi License Agreement, the Company and Sanofi are
 required to use diligent efforts to facilitate the smooth and
 orderly transition of relevant obligations and rights to the
 Company with respect to development and commercialization
 activities related to AFREZZA, and are also required to negotiate
 in good faith a written transition agreement for this purpose. As a
 result of the foregoing termination, effective on the Termination
 Date and thereafter during any period which Sanofi is required to
 perform any wind-down activities pursuant to the terms of the
 Sanofi License Agreement, the rights granted to Sanofi under the
 Sanofi License Agreement to develop and commercialize AFREZZA will
 become non-exclusive and the Company will have the right to engage
 one or more other distributors and/or licensees of AFREZZA. Sanofi
 will continue to distribute AFREZZA during the wind-down period as
 required by the agreement until such time that the Company or its
 designee takes over responsibility for distribution. All profits
 and losses from AFREZZA product sales by Sanofi or its affiliates
 after the Termination Date, if any, will continue to be shared 65%
 by Sanofi and 35% by the Company pursuant to the terms of the
 License Agreement.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In addition to
 the Sanofi License Agreement and Sanofi Supply Agreement, as
 discussed above, the Company and Aventisub LLC, an affiliate of
 Sanofi, are parties to a Senior Secured Revolving Promissory Note,
 dated September&#xA0;23, 2014 and a Guaranty and Security
 Agreement. Both the Sanofi Loan Facility and the Security Agreement
 remain in effect. The original maturity date of September&#xA0;23,
 2024 for repayment of the outstanding principal amount of the loans
 under the Sanofi Loan Facility will not be affected by the
 termination of the Sanofi License Agreement.</font></p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6610562192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>10. Fair Value of
 Financial Instruments</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The carrying
 amounts of financial instruments, which include cash equivalents
 and accounts payable, approximate their fair values due to their
 relatively short maturities. The fair value of the note payable to
 the Company&#x2019;s principal stockholder cannot be reasonably
 estimated as the Company would not be able to obtain a similar
 credit arrangement in the current economic environment.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As of
 December&#xA0;31, 2015 and 2014, the Company held $59.1 million and
 $120.8 million, respectively of cash and cash equivalents,
 consisting of money market funds of $55.8 million and $118.5
 million, respectively, and the remaining funds in non-interest
 bearing checking accounts. The fair value of these money market
 funds was determined by using quoted prices for identical
 investments in an active market (Level 1 in the fair value
 hierarchy).</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>2018 notes,
 facility financing obligation and Sanofi Loan
 Facility</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The following
 is a summary of the carrying values and estimated fair values of
 the 2018 notes, the facility financing obligation (i.e., the 2019
 notes and Tranche B notes), and the Sanofi Loan Facility (in
 millions):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="67%"></td>
 <td valign="bottom" width="5%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="5%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="5%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="5%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,
 2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,
 2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Carrying<br />
 value</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Estimated<br />
 fair value</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Carrying<br />
 value</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Estimated<br />
 fair value</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015 notes</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">99.4</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">102.9</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018 notes</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">27.6</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21.3</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Facility financing
 obligation</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74.6</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">78.4</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">73.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75.1</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sanofi Loan
 Facility</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">44.5</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.5</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>2015
 notes</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The estimated
 fair value of the 2015 notes was calculated based on model-derived
 valuations whose inputs were observable, such as the
 Company&#x2019;s stock price, and non-observable, such as the
 Company&#x2019;s longer-term historical volatility (55%) (Level 3 in
 the fair value hierarchy). As there was no current active and
 observable market for the 2015 notes, the Company determined the
 estimated fair value using a convertible bond valuation model
 within a lattice framework. The convertible bond valuation model
 combined expected cash outflows with market-based assumptions
 regarding risk-adjusted yields, stock price volatility and recent
 price quotes and trading information regarding Company issued debt
 instruments and shares of common stock into which the notes are
 convertible. As of December&#xA0;31, 2015, all 2015 notes,
 including the Exchange Notes, have been extinguished through
 exchange for stock, exchange for 2018 notes or settlement in cash.
 (See Note 8&#xA0;&#x2014;Senior convertible notes).</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>2018
 notes</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The estimated
 fair value of the 2018 notes was calculated based on model-derived
 valuations whose inputs were observable, such as the
 Company&#x2019;s stock price and yields on U.S. Treasury notes and
 actively traded bonds, and non-observable, such as the
 Company&#x2019;s longer-term historical volatility, and estimated
 yields implied from any available market trades of the
 Company&#x2019;s issued debt instruments. As there is no current
 active and observable market for the 2018 notes, the Company
 determined the estimated fair value using a convertible bond
 valuation model within a lattice framework. The convertible bond
 valuation model combined expected cash flows based on terms of the
 notes with market-based assumptions regarding risk-free rate,
 risk-adjusted yields (20%), stock price volatility (90%) and recent
 price quotes and trading information regarding Company issued debt
 instruments and shares of common stock into which the notes are
 convertible (Level 3 in the fair value hierarchy).</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Facility
 financing agreement</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As discussed in
 Note 17 &#x2014;&#xA0;Facility Agreement, in connection with the
 Facility Agreement, the Company issued 2019 notes and subsequently
 issued Tranche B notes (the &#x201C;Facility Financing
 Obligation&#x201D;). As there is no current observable market for
 the 2019 notes or Tranche B notes, the Company determined the
 estimated fair value using a bond valuation model based on a
 discounted cash flow methodology. The bond valuation model combined
 expected cash flows associated with principal repayment and
 interest based on the contractual terms of the debt agreement
 discounted to present value using a selected market discount rate.
 On December&#xA0;31, 2015 the market discount rate was recalculated
 at 12.0% for the 2019 notes and the Tranche B notes (Level 3 in the
 fair value hierarchy).</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In addition to
 the 2019 notes and Tranche B notes, the Company also issued certain
 rights to receive payments of up to $90.0 million upon occurrence
 of specified strategic and sales milestones (the &#x201C;Milestone
 Rights&#x201D;). These rights are not reflected in the facility
 financing obligation. The estimated fair value of the Milestone
 Rights was calculated using the income approach in which the cash
 flows associated with the specified contractual payments were
 adjusted for both the expected timing and the probability of
 achieving the milestones discounted to present value using a
 selected market discount rate (Level 3 in the fair value
 hierarchy). The expected timing and probability of achieving the
 milestones, starting in 2014, was developed with consideration
 given to both internal data, such as progress made to date and
 assessment of criteria required for achievement, and external data,
 such as market research studies. The discount rate (15.0%)&#xA0;was
 selected based on an estimation of required rate of returns for
 similar investment opportunities using available market data. As of
 December&#xA0;31, 2015, the carrying value of the Milestone Rights
 is $8.9 million, classified as a long-term liability in other
 liabilities and the fair value is estimated at $14.4
 million.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Sanofi Loan
 Facility</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As discussed in
 Note 9 &#x2014;&#xA0;the Sanofi Loan Facility, consists of a senior
 secured revolving promissory note and a guaranty and security
 agreement with an affiliate of Sanofi which provides the Company
 with a secured loan facility of up to $175.0 million to fund the
 Company&#x2019;s share of net losses under the Sanofi License
 Agreement. The estimated fair value was determined using a
 discounted cash flow model in which time outstanding and discount
 rate were primary variables. This method considered the key
 elements of the contractual terms of the Sanofi Loan Facility,
 market-based estimated cost of capital, and time value of money,
 namely the amount of time to settlement and the estimated discount
 rate (11%)&#xA0;appropriate for the liability (Level 3 in the fair
 value hierarchy). As of December 31, 2015 the carrying value of the
 Sanofi Loan Facility is $44.5 million and the fair value is
 estimated at $36.5 million.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">There were no
 material re-measurements to fair value during the year ended
 December&#xA0;31, 2015 of financial assets and liabilities that are
 not measured at fair value on a recurring basis. There were no
 transfers of assets or liabilities between the fair value
 measurement levels during the twelve months ended December&#xA0;31,
 2015, 2014, and 2013.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Assets and
 Liabilities Measured at Fair Value on a Non-recurring
 Basis</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In accordance
 with ASC 360, <i>Property, Plant, and Equipment</i> (&#x201C;ASC
 360&#x201D;), land, buildings, and machinery and equipment, with a
 carrying amount of $189.2 million, were written down to a fair
 value of $48.8 million, resulting in an impairment charge of $140.4
 million, which is included in our Statements of Operations and
 Comprehensive Loss for the year ended December&#xA0;31,
 2015.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Our assessment
 of the real property includes Level 3 inputs, and was based on a
 combination of the income, market and cost approaches and the
 market approach was used for machinery and equipment which required
 Level 3 inputs.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Embedded
 Derivatives</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 identified and evaluated a number of embedded features in the notes
 issued under the Facility Agreement to determine if they
 represented embedded derivatives that are required to be separated
 from the notes and accounted for as freestanding instruments
 pursuant to ASC 815. In 2014, the Company analyzed the Tranche B
 notes and identified embedded derivatives which required separate
 accounting under ASC 815; however all of the embedded derivatives
 were determined to have a <i>de minimis</i> value.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">At
 December&#xA0;31, 2015, all of the embedded derivatives identified
 in the Tranche B notes were deemed to have a <i>de minimis</i>
 value.</font></p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13504-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6834858944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common and preferred stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonAndPreferredStockTextBlock', window );">Common and preferred stock</a></td>
<td class="text"><div>
 <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>11. Common and preferred
 stock</b></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The Company is
 authorized to issue 550,000,000 shares of common stock, par value
 $0.01 per share, and 10,000,000 shares of undesignated preferred
 stock, par value $0.01 per share, issuable in one or more series
 designated by the Company&#x2019;s board of directors. No other
 class of capital stock is authorized. As of December&#xA0;31, 2015
 and 2014, 428,670,943 and 406,059,089 shares of common stock,
 respectively, were issued and outstanding and no shares of
 preferred stock were outstanding.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">On
 November&#xA0;9, 2015, the Company entered into a series of stock
 purchase agreements to sell up to an aggregate of 50,000,000 shares
 its common stock in a registered direct offering to selected
 investment funds in Israel that hold securities included within
 certain stock indexes of the Tel Aviv Stock Exchange (the
 &#x201C;TASE&#x201D;). Pursuant to the agreements, the shares of
 common stock were sold at a price per share equal to 97% of the
 closing price of the Company&#x2019;s common stock on the TASE on
 November&#xA0;12, 2015. During November 2015, the Company sold
 13,852,435 shares of common stock for an aggregate price of
 approximately $34,710,000, or $2.61 per share, which is net of
 $1,433,000 of issuance costs.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The Company
 engaged Sunrise Securities Corporation as its exclusive placement
 agent in connection with the offering of 50,000,000 shares. In
 connection with the services provided the Company issued to Sunrise
 Securities Corporation, or its designee, restricted warrants to
 purchase a number of shares of the Company&#x2019;s common stock in
 an aggregate equal to 1.15% of the aggregate shares sold in the
 offering, which totaled 159,303 shares on November&#xA0;16, 2015.
 The warrants are exercisable for a five year period at an exercise
 price of $2.61, the price paid per share in connection with the
 offering. The Company had an obligation to register the common
 stock that may be issued pursuant to the exercise of the warrants,
 which resulted in their initial classification as liability and
 were deemed immaterial. On December&#xA0;15, 2015 the warrants were
 reclassified to equity as the Company registered the common stock
 pursuant to registration statement. As of December&#xA0;31, 2015
 the warrants were classified within equity.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Included in the
 common stock outstanding as of December&#xA0;31, 2014 is 9,000,000
 shares of common stock loaned to Bank of America under a share
 lending agreement in connection with the offering of the $100.0
 million aggregate principal amount of 2015 notes. Bank of America
 was obligated to return the borrowed shares (or, in certain
 circumstances, the cash value thereof) to the Company on or about
 the 45th business day following the date as of which the entire
 principal amount of the 2015 notes ceases to be outstanding,
 subject to extension or acceleration in certain circumstances or
 early termination at Bank of America&#x2019;s option. On
 October&#xA0;23, 2015, the 9,000,000 shares of common stock loaned
 to Bank of America were returned, as the Company settled all
 payments and deliveries in respect of such convertible notes on
 August&#xA0;17, 2015. The Company did not receive any proceeds from
 the sale of the borrowed shares by Bank of America, but the Company
 did receive a nominal lending fee of $0.01 per share from Bank of
 America for the use of borrowed shares.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">On
 February&#xA0;8, 2012, the Company sold 35,937,500 units in an
 underwritten public offering, including 4,687,500 units sold
 pursuant to the full exercise of an over-allotment option granted
 to the underwriters, with each unit consisting of one share of
 common stock and a warrant to purchase 0.6 of a share of common
 stock. All of the securities were offered by the Company at a
 combined price to the public of $2.40 per unit and the underwriters
 purchased the units at a price of $2.256 per unit. Net proceeds
 from this offering were approximately $80.6 million, excluding any
 warrant exercises. The 21,562,500 shares of common stock underlying
 the warrants are exercisable at $2.40 per share and expire four
 years from the date of the issuance.</font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">For the years
 ended December&#xA0;31, 2015, 2014, and 2013, the Company received
 $10.1 million, $27.8 million, and $94.2 million in proceeds,
 respectively, from the exercise of the February 2012 public
 offering warrants. Any unexercised February 2012 public offering
 warrants expired on February&#xA0;8, 2016.</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonAndPreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonAndPreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6614489024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per common share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net loss per common share</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>12. Net loss per common
 share</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Basic net loss
 per share excludes dilution for potentially dilutive securities and
 is computed by dividing net loss by the weighted average number of
 common shares outstanding during the period excluding the 9,000,000
 shares loaned to Bank of America under a share lending arrangement
 (see Note 11 &#x2014;&#xA0;Common and preferred stock). In the third
 quarter of 2015, the 9,000,000&#xA0;million shares loaned to Bank
 of America were returned. Prior to the return of those shares, the
 borrowed shares were not considered outstanding for the purpose of
 computing and reporting basic or diluted earnings (loss) per share
 because the share borrower had to return all borrowed shares to the
 Company (or, in certain circumstances, the cash value thereof).
 Diluted net loss per share reflects the potential dilution that
 could occur if securities or other contracts to issue common stock
 were exercised or converted into common stock. Potentially dilutive
 securities are excluded from the computation of diluted net loss
 per share for all of the periods presented in the accompanying
 condensed consolidated statements of operations because the
 reported net loss in each of these periods results in their
 inclusion being antidilutive. Antidilutive securities, which
 consist of stock options, restricted stock units, warrants, and
 shares that could be issued upon conversion of the senior
 convertible notes, that are not included in the diluted net loss
 per share calculation and excluded the 9,000,000 shares of the
 Company&#x2019;s common stock loaned under the share lending
 arrangement as of December&#xA0;31, 2014, and 2013.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Potentially
 dilutive securities outstanding are summarized as follows (in
 shares):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="67%"></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercise of common stock
 options</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,779,229</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,541,664</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">24,237,940</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Conversion of senior
 convertible notes into common stock</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,072,809</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17,323,080</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">25,415,366</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercise of common stock
 warrants</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,074,596</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,987,876</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,706,240</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vesting of restricted stock
 units</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,804,620</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,610,720</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,115,821</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29,731,254</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">51,463,340</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">78,475,367</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6630254080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock award plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock award plans</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>13. Stock award
 plans</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On May&#xA0;23,
 2013, the Company adopted the 2013 Equity Incentive Plan (the
 &#x201C;2013 Plan&#x201D;) as the successor to and continuation of
 the 2004 Equity Incentive Plan (the &#x201C;2004 Plan&#x201D;). The
 2013 Plan consists of 21.5&#xA0;million newly requested shares and
 the number of unallocated shares remaining available for grant for
 new awards under the 2004 Plan. The 2013 Plan provides for the
 granting of stock awards including stock options and restricted
 stock units, to employees, directors and consultants. The Plan also
 provides for the automatic, non-discretionary grant of options to
 the Company&#x2019;s non-employee directors. No additional awards
 will be granted under the 2004 Plan or under the 2004 Non-Employee
 Directors&#x2019; Stock Option Plan (the &#x201C;NED Plan&#x201D;) as
 all future awards will be made out of the 2013 Plan.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As of
 December&#xA0;31, 2015, the Company has two active stock-based
 compensation plans &#x2014;&#xA0;the 2013 Plan and the 2004 Employee
 Stock Purchase Plan (the &#x201C;ESPP&#x201D;). The following table
 summarizes information about the Company&#x2019;s stock-based award
 plans as of December&#xA0;31, 2015:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="65%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding<br />
 Options</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding<br />
 Restricted<br />
 Stock Units</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Shares&#xA0;Available<br />
 for<br />
 Future Issuance</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2004 Equity Incentive
 Plan</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,309,136</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">276,784</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2013 Equity Incentive
 Plan</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,026,762</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,527,836</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15,540,652</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2004 Non-Employee
 Directors&#x2019; Stock Option Plan</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">443,331</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,779,229</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,804,620</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15,540,652</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In March 2004,
 the Company&#x2019;s board of directors approved the ESPP, which
 became effective upon the closing of the Company&#x2019;s initial
 public offering. Initially, the aggregate number of shares that
 could be sold under the 2004 Plan was 2,000,000 shares of common
 stock. On January&#xA0;1 of each year, for a period of ten years
 beginning January&#xA0;1, 2005, the share reserve automatically
 increases by the lesser of: 700,000 shares, 1% of the total number
 of shares of common stock outstanding on that date, or an amount as
 may be determined by the board of directors. However, under no
 event can the annual increase cause the total number of shares
 reserved under the ESPP to exceed 10% of the total number of shares
 of capital stock outstanding on December&#xA0;31 of the prior year.
 On January&#xA0;1, 2013 and 2014 the ESPP share reserve was
 increased by 700,000 and 700,000 shares, respectively. There was no
 ESPP share reserve increase during 2015. As of December&#xA0;31,
 2015, 2,752,703 shares were available for issuance under the ESPP.
 For the years ended December&#xA0;31, 2015, 2014 and 2013 the
 Company sold 321,228, 305,076, and 463,290 shares, respectively, of
 its common stock to employees participating in the ESPP. The ESPP
 purchase for the period ending December&#xA0;31, 2015 was initiated
 prior to year-end but did not settle until January&#xA0;5, 2016. As
 a result, the shares sold are reflected in the ESPP share reserves
 but is excluded from common stock outstanding as of
 December&#xA0;31, 2015.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The
 Company&#x2019;s board of directors determines eligibility, vesting
 schedules and exercise prices for stock awards granted under the
 2013 Plan. Options and other stock awards under the 2013 Plan
 expire not more than ten years from the date of the grant and are
 exercisable upon vesting. Stock options generally vest over four
 years. Current stock option grants vest and become exercisable at
 the rate of 25% after one year and ratably on a monthly basis over
 a period of 36 months thereafter. Restricted stock units generally
 vest at a rate of 25%&#xA0;per year over four years with
 consideration satisfied by service to the Company. There are no
 outstanding performance-based awards as all milestones have been
 achieved as of December&#xA0;31, 2015. The 2013 Plan provides for
 full acceleration of vesting if an employee is terminated within
 three months of a change in control, as defined in the 2013
 Plan.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In accordance
 with ASC 718, share-based payment transactions are recognized as
 compensation cost based on the fair value of the instrument on the
 date of grant. The Company accounts for non-employee stock-based
 compensation expense based on the estimated fair value of the
 options, which is determined using the Black-Scholes option
 valuation model and amortizes such expense on a straight-line basis
 over the service period for time-based awards and over the expected
 dates of achievement for performance-based awards. These awards are
 subject to re-measurement until service is complete. As of
 December&#xA0;31, 2015, there were options to purchase 523,487
 shares of common stock outstanding to consultants.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">During the
 years ended December&#xA0;31, 2015, 2014 and 2013 the Company
 recorded stock-based compensation expense related to its stock
 award plans and the ESPP of $8.7 million, $48.6 million, and $45.2
 million, respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is as follows (in thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="77%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Year Ended
 December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Employee-related</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,407</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,622</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">45,181</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Consultant-related</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">318</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,725</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,622</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">45,186</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is included in the following categories
 (in thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="77%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Year Ended
 December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Research and
 development</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,029</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">22,357</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20,409</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">General and
 administrative</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,696</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26,265</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">24,777</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,725</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,622</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">45,186</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 uses the Black-Scholes option valuation model to estimate the grant
 date fair value of employee stock options. The expected term of an
 option granted is based on combining historical exercise data with
 expected weighted time outstanding. Expected weighted time
 outstanding is calculated by assuming the settlement of outstanding
 awards is at the midpoint between the remaining weighted average
 vesting date and the expiration date.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Beginning in
 the third quarter of 2014, the Company began to assess both
 historical and implied volatility in order to determine its
 estimated volatility rate. Implied volatility was considered due to
 the change in the Company&#x2019;s business, which occurred with the
 approval for the sale of AFREEZA. The Company has selected
 risk-free interest rates based on U.S. Treasury securities with an
 equivalent expected term in effect on the date the options were
 granted. Additionally, the Company uses historical data and
 management judgment to estimate stock option exercise behavior and
 employee turnover rates to estimate the number of stock option
 awards that will eventually vest. The Company calculated the fair
 value of employee stock options granted during the years ended
 December&#xA0;31, 2015, 2014 and 2013 using the following
 assumptions:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="46%"></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Year Ended
 December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Risk-free interest
 rate</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.61%&#xA0;&#x2014;&#xA0;1.86%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.64%&#xA0;&#x2014;&#xA0;2.11%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.94%
 &#x2014;&#xA0;1.82%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expected lives</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.79&#xA0;&#x2014;&#xA0;5.86&#xA0;years</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.77&#xA0;&#x2014;&#xA0;6.09&#xA0;years</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.64&#xA0;&#x2014;&#xA0;5.77&#xA0;years</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Volatility</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69.76%&#xA0;&#x2014;&#xA0;71.84%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">73.98%&#xA0;&#x2014;&#xA0;84.85%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75.83%&#xA0;&#x2014;&#xA0;86.26%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Dividends</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The following
 table summarizes information about stock options
 outstanding:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="70%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number<br />
 of<br />
 Shares</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br />
 Average<br />
 Exercise<br />
 Price<br />
 per&#xA0;Share</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Aggregate<br />
 Intrinsic<br />
 Value&#xA0;($000)</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding at
 January&#xA0;1, 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,541,664</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.53</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,495</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,541,100</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.11</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,700,964</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.91</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(706,387</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.78</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expired</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(896,184</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7.70</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding at
 December&#xA0;31, 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,779,229</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vested and expected to vest
 at December&#xA0;31, 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,597,097</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.53</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercisable at
 December&#xA0;31, 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17,217,332</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.47</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The weighted
 average grant date fair value of the stock options granted during
 the years ended December&#xA0;31, 2015, 2014 and 2013 was $2.56,
 $4.76 and $3.26 per option, respectively. The total intrinsic value
 of options exercised during the years ended December&#xA0;31, 2015,
 2014 and 2013 was $6.2 million, $14.9 million and $3.1 million,
 respectively. Intrinsic value is measured using the fair market
 value at the date of exercise (for options exercised) or at
 December&#xA0;31 (for outstanding options), less the applicable
 exercise price.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Cash received
 from the exercise of options during the years ended
 December&#xA0;31, 2015, 2014 and 2013 was approximately $3.3
 million, $11.0 million and $2.3 million, respectively. The
 weighted-average remaining contractual terms for options
 outstanding, vested and expected to vest, and exercisable at
 December&#xA0;31, 2015 was 6.34 years, 6.31 years and 5.97 years,
 respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">A summary of
 restricted stock unit activity for the year ended December&#xA0;31,
 2015 is presented below:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="80%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number<br />
 of<br />
 Shares</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br />
 Average<br />
 Grant&#xA0;Date<br />
 Fair Value<br />
 per Share</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding at January 1,
 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,610,720</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.20</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,133,404</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.14</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vested</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,111,134</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.93</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(828,370</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.88</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding at December 31,
 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,804,620</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.85</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The total
 restricted stock units expected to vest as of December&#xA0;31,
 2015 was 1,651,859 with a weighted average grant date fair value of
 $4.86. The total intrinsic value of restricted stock units expected
 to vest as of December&#xA0;31, 2015 was $2.4 million. Intrinsic
 value of restricted stock units expected to vest is measured using
 the closing share price at December&#xA0;31, 2015.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Total intrinsic
 value of restricted stock units vested during the years ended
 December&#xA0;31, 2015, 2014 and 2013 was $5.2 million, $62.7
 million and $13.9 million, respectively. Intrinsic value of
 restricted stock units vested is measured using the closing share
 price on the day prior to the vest date. The total grant date fair
 value of restricted stock units vested during the years ended
 December&#xA0;31, 2015, 2014 and 2013 was $5.5million, $36.4
 million and $14.9 million, respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As of
 December&#xA0;31, 2015, there was $4.9 million and $6.7 million of
 unrecognized compensation expense related to options and restricted
 stock units, respectively, which is expected to be recognized over
 the weighted average vesting period of 2.7 years. The Company
 evaluates stock awards with performance conditions as to the
 probability that the performance conditions will be met and
 estimates the date at which the performance conditions will be met
 in order to properly recognize stock-based compensation expense
 over the requisite service period. As of December&#xA0;31, 2015,
 all milestones have been achieved.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">During the year
 ended December&#xA0;31, 2015, there was $1.6 million of stock
 compensation expense related to certain Executives who entered into
 severance agreements which resulted in a modification to the terms
 of their awards. The severance agreements generally allowed for the
 separated Executives to continue to vest under their original award
 terms for a stated period of time without providing substantive
 services.</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51659978&amp;loc=d3e25284-112666<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6594586848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and contingencies</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>14. Commitments and
 contingencies</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Operating
 Leases</i> &#x2014;&#xA0;The Company leases certain facilities and
 equipment under various operating leases, which expire at various
 dates through 2016 and beyond. Future payments are deemed
 insignificant.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Rent expense
 under all operating leases, including office space and equipment,
 for the years ended December&#xA0;31, 2015, 2014, and 2013 was
 approximately $426,000, $737,000, and $645,000
 respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Leases</i>
 &#x2014;&#xA0;The Company&#x2019;s capital leases were not material
 for the years ended December&#xA0;31, 2015, 2014 and
 2013.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Guarantees
 and Indemnifications</i> &#x2014;&#xA0;In the ordinary course of its
 business, the Company makes certain indemnities, commitments and
 guarantees under which it may be required to make payments in
 relation to certain transactions. The Company, as permitted under
 Delaware law and in accordance with its Bylaws, indemnifies its
 officers and directors for certain events or occurrences, subject
 to certain limits, while the officer or director is or was serving
 at the Company&#x2019;s request in such capacity. The term of the
 indemnification period is for the officer&#x2019;s or
 director&#x2019;s lifetime. The maximum amount of potential future
 indemnification is unlimited; however, the Company has a director
 and officer insurance policy that may enable it to recover a
 portion of any future amounts paid. The Company believes the fair
 value of these indemnification agreements is minimal. The Company
 has not recorded any liability for these indemnities in the
 accompanying condensed consolidated balance sheets. However, the
 Company accrues for losses for any known contingent liability,
 including those that may arise from indemnification provisions,
 when future payment is probable and the amount can be reasonably
 estimated. No such losses have been recorded to date.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Litigation</i> &#x2014;&#xA0;The Company is subject to legal
 proceedings and claims which arise in the ordinary course of its
 business. As of December&#xA0;31, 2015, the Company believes that
 the final disposition of such matters will not have a material
 adverse effect on the financial position, results of operations or
 cash flows of the Company and no accrual has been recorded. The
 Company maintains liability insurance coverage to protect the
 Company&#x2019;s assets from losses arising out of or involving
 activities associated with ongoing and normal business operations.
 In accordance with ASC 450 <i>Contingencies</i>, the Company
 records a provision for a liability when it is both probable that a
 liability has been incurred and the amount of the loss can be
 reasonably estimated. The Company&#x2019;s policy is to accrue for
 legal expenses in connection with legal proceeding and claims as
 they are incurred.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In addition,
 several complaints were filed in the U.S. District Court for the
 Central District of California against the Company and certain of
 its officers and directors on behalf of certain purchasers of its
 common stock. The complaints include claims asserted under Sections
 10(b) and 20(a) of the Exchange Act and have been pled as putative
 shareholder class actions. In general, the complaints allege that
 the Company and certain of its officers and directors violated
 federal securities laws by making materially false and misleading
 statements regarding the prospects for AFREZZA, thereby
 artificially inflating the price of its common stock. The
 plaintiffs are seeking monetary damages and other relief. The
 Company expects the complaints to be transferred to a single court
 and consolidated for all purposes, following which the court would
 be expected to appoint a lead plaintiff and lead counsel and to
 order the lead plaintiff to file a consolidated complaint. The
 Company will vigorously defend against the claims
 advanced.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Following the
 receipt by the Company of the notice of termination from Sanofi
 regarding the Sanofi License Agreement and the subsequent decline
 of the price of its common stock, two motions were submitted to the
 District Court at Tel Aviv (Economic Department) for the
 certification of a class action against the Company and certain of
 its officers and directors. In general, the complaints allege that
 the Company and certain of its officers and directors violated
 Israeli and US securities laws by making materially false and
 misleading statements regarding the prospects for AFREZZA, thereby
 artificially inflating the price of its common stock. The
 plaintiffs are seeking monetary damages. The Company will
 vigorously defend against these claims.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Contingencies &#x2014;</i> In connection with the Facility
 Agreement, on July&#xA0;1, 2013 the Company also entered into a
 Milestone Rights Purchase Agreement (the &#x201C;Milestone
 Agreement&#x201D;) with Deerfield Private Design Fund and Horizon
 Sant&#xE9; FLML S&#xC1;RL (collectively, the &#x201C;Milestone
 Purchasers&#x201D;), pursuant to which the Company sold the
 Milestone Purchasers the Milestone Rights to receive payments up to
 $90.0 million upon the occurrence of specified strategic and sales
 milestones, including the first commercial sale of an AFREZZA
 product in the United States and the achievement of specified net
 sales figures (see Note 17&#xA0;&#x2014;&#xA0;Facility
 Agreement).</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Commitment
 &#x2014;</i> On July&#xA0;31, 2014, the Company entered into a
 supply agreement (the &#x201C;Insulin Supply Agreement&#x201D;) with
 Amphastar France Pharmaceuticals S.A.S., a French corporation
 (&#x201C;Amphastar&#x201D;), pursuant to which Amphastar will
 manufacture for and supply to the Company certain quantities of
 recombinant human insulin for use in AFREZZA. Under the terms of
 the Insulin Supply Agreement, Amphastar will be responsible for
 manufacturing the insulin in accordance with the Company&#x2019;s
 specifications and agreed-upon quality standards. The Company has
 agreed to purchase annual minimum quantities of insulin for
 calendar years 2015 through 2019 under the Insulin Supply Agreement
 of an aggregate total of approximately &#x20AC;120.1&#xA0;million,
 of which &#x20AC;98.5&#xA0;million is remaining at December&#xA0;31,
 2015. The Company has contracted for the purchase of
 &#x20AC;28.8&#xA0;million in 2016 and the remaining annual minimum
 quantities will be &#x20AC;23.3&#xA0;million for the years ending
 December&#xA0;31, 2017 through 2019. The Company may request to
 purchase additional quantities of insulin over such annual minimum
 quantities and will incur a cancellation fee of approximately $5.2
 million if not purchased (see Note 2&#xA0;&#x2014; Summary of
 Significant accounting policies).</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Unless earlier
 terminated, the term of the Insulin Supply Agreement expires on
 December&#xA0;31, 2019 and can be renewed for additional,
 successive two year terms upon 12 months&#x2019; written notice
 given prior to the end of the initial term or any additional two
 year term. The Company and Amphastar each have normal and customary
 termination rights, including termination for material breach that
 is not cured within a specific time frame or in the event of
 liquidation, bankruptcy or insolvency of the other party. In
 addition, the Company may terminate the Insulin Supply Agreement
 upon two years&#x2019; prior written notice to Amphastar without
 cause or upon 30 days&#x2019; prior written notice to Amphastar if a
 controlling regulatory authority withdraws approval for AFREZZA,
 provided, however, in the event of a termination pursuant to either
 of the latter two scenarios, the provisions of the Insulin Supply
 Agreement require the Company to pay the full amount of all unpaid
 purchase commitments due over the initial term within 60 calendar
 days of the effective date of such termination.</font></p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=51674963&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6835296800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee benefit plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee benefit plans</a></td>
<td class="text"><div>
 <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>15. Employee benefit
 plans</b></font></p>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The Company
 administers a 401(k) Savings Retirement Plan (the &#x201C;MannKind
 Retirement Plan&#x201D;) for its employees. For the years ended
 December&#xA0;31, 2015, 2014, and 2013, the Company contributed
 $593,000, $623,000, and $533,000 respectively, to the MannKind
 Retirement Plan.</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=49170332&amp;loc=SL14450702-114947<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=58740216&amp;loc=d3e2410-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39675-114964<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6414199&amp;loc=d3e39622-114963<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6630220464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>16. Income
 taxes</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">There is no
 provision for income taxes because the Company has incurred
 operating losses since inception. At December&#xA0;31, 2015, the
 Company has concluded that it is more likely than not that the
 Company may not realize the benefit of its deferred tax assets due
 to its history of losses. Accordingly, the net deferred tax assets
 have been fully reserved. The provision for income taxes consists
 of the following (in thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="73%"></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Year Ended
 December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Current</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">U.S. federal</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">U.S. state</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Non-U.S.</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total current</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deferred</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">U.S. federal</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">109,512</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">57,873</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">59,379</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">U.S. state</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(29,394</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,631</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,470</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Non-U.S.</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Valuation
 Allowance</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(80,118</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(65,504</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(66,849</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total deferred</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Deferred income
 taxes reflect the tax effects of temporary differences between the
 carrying amounts of assets and liabilities for financial reporting
 and income tax purposes. A valuation allowance is established when
 uncertainty exists as to whether all or a portion of the net
 deferred tax assets will be realized. Components of the net
 deferred tax asset as of December&#xA0;31, 2015 and 2014 are
 approximately as follows (in thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="80%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deferred tax
 assets:</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom" colspan="5"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net operating loss
 carryforwards</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">721,588</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">699,997</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Research and development
 credits</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">73,646</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">73,227</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalized
 research</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,872</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">28,516</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Payments from
 collaboration</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">52,484</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,217</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Milestone Rights</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,242</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,321</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued expenses</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">251</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">768</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Loss on purchase
 commitment</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">24,084</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Non-qualified stock option
 expense</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,941</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">43,691</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalized patent
 costs</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,574</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,624</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,186</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">131</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Depreciation</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,755</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,010</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total net deferred tax
 assets</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">962,623</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">882,502</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Valuation
 allowance</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(962,623</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(882,502</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net deferred tax
 assets</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As a result of
 certain realization requirements of ASC 718, the table of deferred
 tax assets and liabilities does not include certain deferred tax
 assets as of December&#xA0;31, 2015 that arose directly from tax
 deductions related to equity compensation which are greater than
 the compensation recognized for financial reporting. Equity would
 be increased by $10.0 million if and when such deferred tax assets
 are ultimately realized. The Company considered the requirements
 under ASC 740 <i>Income Taxes</i> (&#x201C;ASC 740&#x201D;) when
 determining when excess tax benefits have been realized.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The
 Company&#x2019;s effective income tax rate differs from the
 statutory federal income tax rate as follows for the years ended
 December&#xA0;31, 2015, 2014 and 2013:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="85%"></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Federal tax benefit
 rate</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">State tax benefit, net of
 federal benefit</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Permanent items</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.9</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intercompany transfer of
 intellectual property</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(4.1</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(4.3</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Valuation
 allowance</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(34</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(31.8</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(30.7</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Effective income tax
 rate</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As required by
 ASC 740, management of the Company has evaluated the positive and
 negative evidence bearing upon the realizability of its deferred
 tax assets. Management has concluded, in accordance with the
 applicable accounting standards, that it is more likely than not
 that the Company may not realize the benefit of its deferred tax
 assets. Accordingly, the net deferred tax assets have been fully
 reserved. Management reevaluates the positive and negative evidence
 on an annual basis. During the years ended December&#xA0;31, 2015,
 2014 and 2013, the change in the valuation allowance was $<a id="c84" name="diff"><strike><font color="#FF0000">62.6</font></strike></a> <font style="BACKGROUND-COLOR: #ffff00">80.1&#xA0;</font>million, $65.5
 million and $<strike><font color="#FF0000">80.1</font></strike> <font style="BACKGROUND-COLOR: #ffff00">66.8&#xA0;</font>million,
 respectively, for income taxes.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">At
 December&#xA0;31, 2015, the Company had federal and state net
 operating loss carryforwards of approximately $1.9 billion and $1.3
 billion available, respectively, to reduce future taxable income.
 The federal net operating loss carryforwards will expire at various
 dates beginning in 2018 and the state net operating loss
 carryforwards have started expiring, starting current year through
 various future dates. As a result of the Company&#x2019;s initial
 public offering, an ownership change within the meaning of Internal
 Revenue Code Section&#xA0;382 occurred in August 2004. As a result,
 federal net operating loss and credit carry forwards of
 approximately $216.0 million are subject to an annual use
 limitation of approximately $13.0 million. The annual limitation is
 cumulative and therefore, if not fully utilized in a year can be
 utilized in future years in addition to the Section&#xA0;382
 limitation for those years. The federal net operating losses
 generated subsequent to the Company&#x2019;s initial public offering
 in August 2004 are currently not subject to any such limitation as
 there have been no ownership changes since August 2004 within the
 meaning of Internal Revenue Code Section&#xA0;382. At
 December&#xA0;31, 2015, the Company had research and development
 credits of $49.1 million and $37.7 million for federal and state
 purposes, respectively. The federal credits begin to expire in
 2024, and the state credits may be carried forward
 indefinitely.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company has
 evaluated the impact of ASC 740, previously FIN 48 <i>Accounting
 for Uncertainty in Income Taxes</i> , on its financial statements,
 which was effective beginning January&#xA0;1, 2007. The evaluation
 of a tax position in accordance with this guidance is a two-step
 process. The first step is recognition: the enterprise determines
 whether it is more-likely-than-not that a tax position will be
 sustained upon examination, including resolution of any related
 appeals or litigation processes, based on the technical merits of
 the position. In evaluating whether a tax position has met the
 more-likely-than-not recognition threshold, the enterprise should
 presume that the position will be examined by the appropriate
 taxing authority that would have full knowledge of all relevant
 information. The second step is measurement: a tax position that
 meets the more-likely-than-not recognition threshold is measured to
 determine the amount of benefit to recognize in the financial
 statements. The tax position is measured at the largest amount of
 benefit that is greater than 50 percent likely of being realized
 upon ultimate settlement. Tax positions that previously failed to
 meet the more-likely-than-not recognition threshold should be
 recognized in the first subsequent financial reporting period in
 which that threshold is met. Previously recognized tax positions
 that no longer meet the more-likely-than-not recognition threshold
 should be derecognized in the first subsequent financial reporting
 period in which that threshold is no longer met. The Company
 believes that its income tax filing positions and deductions will
 be sustained on audit and does not anticipate any adjustments that
 will result in a material change to its financial position.
 Therefore, no liabilities for uncertain income tax positions have
 been recorded. Tax years since 2011 remain subject to examination
 by the major tax jurisdictions in which the Company is subject to
 tax.</font></p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6603316720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Facility Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Facility Agreement</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>17. Facility
 Agreement</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As of
 December&#xA0;31, 2015 and 2014, there were $60.0 million principal
 amount of 2019 notes and $20.0 million principal amount of Tranche
 B notes outstanding. The 2019 notes accrue interest at annual rate
 of 9.75% and the Tranche B notes accrue interest at an annual rate
 of 8.75% and is paid quarterly in arrears on the last day of each
 March, June, September, and December. The Facility Agreement
 principal repayment schedule is comprised of annual payments
 beginning on July&#xA0;1, 2016 and ending December&#xA0;9, 2019.
 Future principal payments for the years ended December&#xA0;31,
 2016, 2017, 2018, and 2019 are $5.0 million, $20.0 million, $20.0
 million, and $35.0 million, respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In conjunction
 with the Facility Agreement, the Company entered into a Milestone
 Rights Agreement with Deerfield which requires the Company to make
 contingent payments to Deerfield, totaling up to $90.0 million,
 upon the Company achieving specified commercialization milestones.
 The Milestone Rights were initially recorded as a short-term
 liability equal to $3.2 million included in accrued expenses and
 other current liabilities in the accompanying condensed
 consolidated balance sheet and a long-term liability equal to $13.1
 million included in other liabilities. During the first quarter of
 2015, a milestone triggering event was achieved following the
 Company&#x2019;s product launch on February&#xA0;3, 2015, which
 resulted in a $5.8 million incremental charge to interest expense
 due to the increase in carrying value of the liability to the
 required $10.0 million payment made in February of 2015. During the
 year ended December&#xA0;31, 2014, the first milestone triggering
 event was achieved following the Company&#x2019;s entry into the
 Sanofi License Agreement, which resulted in a $1.9 million
 incremental charge to interest expense due to the increase in
 carrying value of the liability to the required $5.0 million
 payment, which was paid to Deerfield pursuant to the terms of the
 Milestone Agreement. As of December&#xA0;31, 2015, the remaining
 liability balance of $8.9 million is classified as long-term
 liability in other liabilities.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As of December
 31, 2015, the uncreated debt discount and debt issuance costs were
 $5.3 million and $0.1 million, respectively.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Accretion of
 debt issuance cost and debt discount in connection with the
 Deerfield financing during the year ended December&#xA0;31, 2015
 and 2014 are as follows (in thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="86%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accretion expense- debt
 issuance cost</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">326</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accretion expense- debt
 discount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,553</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,550</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Facility
 Agreement includes customary representations, warranties and
 covenants, including, a restriction on the incurrence of additional
 indebtedness, and a financial covenant which requires the
 Company&#x2019;s cash and cash equivalents, which includes available
 borrowings on the principal stockholder note, on the last day of
 each fiscal quarter to not be less than $25.0 million. As discussed
 in Note 1 &#x2014;&#xA0;Basis of Presentation, the Company will need
 to raise additional capital to support its current operating plans.
 Due to the uncertainties related to maintaining sufficient
 resources to comply with the aforementioned covenant, the 2019
 notes have been classified as current liabilities in the
 accompanying balance sheet as of December&#xA0;31, 2015. In the
 event of non-compliance, Deerfield may declare all or any portion
 of the 2019 notes and/or Tranche B notes to be immediately due and
 payable.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Milestone
 Rights</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Milestone
 Agreement includes customary representations and warranties and
 covenants by the Company, including restrictions on transfers of
 intellectual property related to AFREZZA. The Milestone Rights are
 subject to acceleration in the event the Company transfers its
 intellectual property related to AFREZZA in violation of the terms
 of the Milestone Agreement.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 analyzed the Milestone Rights under the provisions of ASC 815
 <i>Derivatives and Hedging,</i> and determined that the instruments
 do not meet the definition of a freestanding derivative. Since the
 Company has not elected to apply the fair value option to the
 Milestone Rights, the Company has initially recorded the Milestone
 Rights at their estimated fair value and accounted for the
 Milestone Rights as a liability by applying the indexed debt
 guidance contained in paragraphs ASC 470-10-25-3 and
 35-4.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones discounted
 to present value using a selected market discount rate. In
 determining the fair value of the Milestone Rights, the 13
 individual milestone payments were adjusted for both (i)&#xA0;the
 expected timing and (ii)&#xA0;the probability of achieving the
 milestones, and then discounted to present value using a discount
 rate of 17.5%. Once the initial valuation of each specified
 milestone payment was determined, the individual milestone payments
 were then aggregated to arrive at a total fair value of $16.3
 million. The discount rate was based on the estimated cost of
 equity which was derived using the capital asset pricing model. In
 addition, a 5% risk premium was added to the computation of the
 cost of equity to adjust for non-systemic risk factors, such as the
 Company&#x2019;s lack of product diversification and history of
 financial losses, which were not captured in other model
 inputs.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Security
 Agreement</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In connection
 with the Facility Agreement, the Company and its subsidiary,
 MannKind LLC, entered into a Guaranty and Security Agreement (the
 &#x201C;Security Agreement&#x201D;) with Deerfield and HS
 (collectively, the &#x201C;Purchasers&#x201D;), pursuant to which the
 Company and MannKind LLC each granted the Purchasers a security
 interest in substantially all of their respective assets, including
 respective intellectual property, accounts, receivables, equipment,
 general intangibles, inventory and investment property, and all of
 the proceeds and products of the foregoing. The Security Agreement
 includes customary covenants by the Company and MannKind LLC,
 remedies of the Purchasers and representations and warranties by
 the Company and MannKind LLC. The security interests granted by the
 Company and MannKind LLC will terminate upon repayment of the 2019
 notes and tranche B notes, if applicable, in full. The
 Company&#x2019;s obligations under the Facility Agreement and the
 Milestone Agreement are also secured by the mortgage on the
 Company&#x2019;s facilities in Danbury, Connecticut, which has a
 carrying value of $23.0 million.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 12px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Embedded
 Derivatives</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 identified and evaluated a number of embedded features in the notes
 issued under the Facility Agreement to determine if they
 represented embedded derivatives that are required to be separated
 from the notes and accounted for as freestanding instruments
 pursuant to ASC 815. In 2014, the Company analyzed the
 Tranche&#xA0;B notes and identified embedded derivatives which
 required separate accounting under ASC&#xA0;815; however all of the
 embedded derivatives were determined to have a <i>de minimis</i>
 value.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">At
 December&#xA0;31, 2015, all of the embedded derivatives identified
 in the Tranche B notes were deemed to have a <i>de minimis</i>
 value.</font></p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6614263552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>18. Restructuring
 Charges</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On September
 2015, the Company initiated a restructuring of the organization as
 a result of its shift to commercial production of AFREZZA. In
 connection with the restructuring, the Company reduced its total
 workforce by approximately 26% to 198 employees. The Company
 recorded restructuring charges of $5.9 million, $1.9 million, and
 $0.4 million for the years ended December&#xA0;31, 2015, 2014, and
 2013, respectively. As of December&#xA0;31, 2015, the Company paid
 $2.8 million and the remaining balance is expected to be paid in
 the first quarter of 2016.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The $5.9
 million of costs associated with the restructuring are included in
 &#x201C;Research and development&#x201D; and &#x201C;General and
 administrative&#x201D; operating expenses in the condensed
 consolidated statements of operations as $3.0 million and $2.9
 million, respectively, for the year ended December&#xA0;31,
 2015.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">As of
 December&#xA0;31, 2015 and 2014, the Company had a restructuring
 accrual of $3.0 million and $0.3 million, respectively. The Company
 did not have a restructuring accrual as of December&#xA0;31,
 2013.</font></p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6617716240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected quarterly financial data (unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Selected quarterly financial data (unaudited)</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>19. Selected quarterly
 financial data (unaudited)</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Summarized
 quarterly financial data for the years ended December&#xA0;31, 2015
 and 2014 are set forth in the following tables:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="58%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March&#xA0;31</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June&#xA0;30</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>September&#xA0;30</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(In thousands, except
 per share data)</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>2015</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net loss</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(30,658</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(28,910</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(31,857</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(277,020</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net loss per share &#x2014;
 basic and diluted</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.08</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.07</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.08</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.66</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average common
 shares used to compute basic and diluted net loss per
 share</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">398,916</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">401,018</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">405,199</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">419,314</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="60%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March&#xA0;31</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June&#xA0;30</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>September&#xA0;30</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(In thousands, except
 per share data)</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>2014</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net loss</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(52,056</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(73,365</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(36,520</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(36,439</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net loss per share &#x2014;
 basic and diluted</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.14</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.19</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.09</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.09</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average common
 shares used to compute basic and diluted net loss per
 share</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">368,784</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">380,770</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">394,163</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">396,793</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Impairment
 charges recorded in 2015 for $242.7 million related to long-lived
 assets, inventory and loss on purchase commitments.</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the quarterly financial data in the annual financial statements.  The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=51655806&amp;loc=d3e765-108305<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)-(j)<br> -URI http://asc.fasb.org/extlink&amp;oid=51825399&amp;loc=d3e1280-108306<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=51655806&amp;loc=d3e725-108305<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section G<br> -Subsection 1<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 302<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6614263552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>20. Subsequent
 Events</b></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 6px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Sanofi
 Termination</i></font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On <font style="FONT-FAMILY: 'Times New Roman'" size="2">January&#xA0;4, 2016, the
 Company received written notice from Sanofi of its election to
 terminate in its entirety the Sanofi License Agreement.
 Sanofi&#x2019;s notice indicated that the termination was pursuant
 to Sanofi&#x2019;s right to terminate the agreement upon
 Sanofi&#x2019;s good faith determination that the commercialization
 of AFREZZA is no longer economically viable in the United States,
 in which case the effective date of termination would be
 April&#xA0;4, 2016. In the alternative, Sanofi indicated that the
 termination was also pursuant to its right to terminate the Sanofi
 License Agreement for any reason, in which case the Termination
 Date would be July&#xA0;4, 2016. In the interest of an expedient
 transition, the Company is currently working with Sanofi to
 transfer and wind down the agreement activities by April&#xA0;4,
 2016, or as soon as practicable thereafter.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Pursuant to the terms of
 the Sanofi License Agreement, the Company and Sanofi are required
 to use diligent efforts to facilitate the smooth and orderly
 transition of relevant obligations and rights to the Company with
 respect to development and commercialization activities related to
 AFREZZA, and are also required to negotiate in good faith a written
 transition agreement for this purpose. As a result of the foregoing
 termination, effective on the Termination Date and thereafter
 during any period which Sanofi is required to perform any wind-down
 activities pursuant to the terms of the Sanofi License Agreement,
 the rights granted to Sanofi under the Sanofi License Agreement to
 develop and commercialize AFREZZA will become non-exclusive and the
 Company will have the right to engage one or more other
 distributors and/or licensees of AFREZZA. Sanofi will continue to
 distribute AFREZZA during the wind-down period as required by the
 agreement until such time that the Company or its designee takes
 over responsibility for distribution. All profits and losses from
 AFREZZA product sales by Sanofi or its affiliates after the
 Termination Date, if any, will continue to be shared 65% by Sanofi
 and 35% by the Company pursuant to the terms of the Sanofi License
 Agreement.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">The Company and Sanofi
 are also parties to the Sanofi Supply Agreement, pursuant to which
 the Company is required to supply Sanofi or its affiliates or its
 sublicensees such quantities of AFREZZA as requested by Sanofi to
 cover its commercial requirements. As a result of the termination
 of the Sanofi License Agreement, the Sanofi Supply Agreement will
 terminate by its terms on the Termination Date.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-LEFT: 21px; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2"><i>Borrowings under
 Sanofi Loan Facility</i></font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">On February&#xA0;10,
 2016, the Company borrowed $17.9 million under the Sanofi Loan
 Facility to finance the portion of its losses for the quarter ended
 December&#xA0;31, 2015 (see Note 9 &#x2014;&#xA0;Collaboration
 arrangement).</font></font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6845109632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business and basis of presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_BusinessPolicyTextBlock', window );">Business</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Business</i>
 &#x2014;&#xA0;MannKind Corporation and subsidiaries (the
 &#x201C;Company&#x201D;) is a biopharmaceutical company focused on
 the discovery and development of therapeutic products for diseases
 such as diabetes. The Company&#x2019;s only approved product,
 AFREZZA, (insulin human [rDNA origin]) inhalation powder, is a
 rapid-acting inhaled insulin that was approved by the U.S. Food and
 Drug Administration (the &#x201C;FDA&#x201D;) on June&#xA0;27, 2014
 to improve glycemic control in adult patients with
 diabetes.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_BasisOfPresentationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Basis of
 Presentation</i> &#x2014;&#xA0;The Company&#x2019;s primary
 activities since incorporation have been establishing its
 facilities, recruiting personnel, conducting research and
 development, business development, business and financial planning,
 raising capital, and commercial manufacturing. It is costly to
 develop therapeutic products and conduct clinical studies for these
 products. As of and for the year ended December&#xA0;31, 2015, the
 Company has reported an accumulated deficit of $2.9&#xA0;billion
 and has reported negative cash flow from operations for each year
 since inception, except for 2014, when the Company received the
 $150.0 million upfront payment from Sanofi.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">At
 December&#xA0;31, 2015, the Company&#x2019;s capital resources
 consisted of cash and cash equivalents of $59.1 million. The
 Company expects to continue to incur significant expenditures to
 support commercial manufacturing and sales and marketing of AFREZZA
 and the development of other product candidates. The facility
 agreement (the &#x201C;Facility Agreement&#x201D;) with Deerfield
 Private Design Fund II, L.P. (&#x201C;Deerfield Private Design
 Fund&#x201D;) and Deerfield Private Design International II, L.P.
 (collectively, &#x201C;Deerfield&#x201D;) and the First Amendment to
 Facility Agreement and Registration Rights Agreement (the
 &#x201C;First Amendment&#x201D;) that resulted in additional sales of
 an additional tranche of notes (the &#x201C;Tranche B notes&#x201D;)
 (see Note 17&#xA0;&#x2014;&#xA0;Facility Agreement) requires the
 Company to maintain at least $25.0 million in cash and cash
 equivalents or available borrowings under the loan arrangement,
 dated as of October&#xA0;2, 2007, between The Company and The Mann
 Group LLC (as amended, restated, or otherwise modified as of the
 date hereof, &#x201C;the Mann Group Loan Arrangement&#x201D;), as of
 the last day of each fiscal quarter. The Company will need to
 continue to incur expenses for the commercialization of AFREZZA and
 will need to raise additional capital to finance such activities.
 The Company cannot be certain that it will be able to raise
 additional capital on favorable terms, or at all, which raises
 substantial doubt about the Company&#x2019;s ability to continue as
 a going concern. The financial statements do not include any
 adjustments that might result from the outcome of this
 uncertainty.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On
 August&#xA0;11, 2014, we executed a license and collaboration
 agreement (the &#x201C;Sanofi License Agreement&#x201D;) with
 Sanofi-Aventis Deutschland GmbH (which subsequently assigned its
 rights and obligations under the agreement to Sanofi-Aventis U.S.
 LLC (&#x201C;Sanofi&#x201D;)), pursuant to which Sanofi is
 responsible for global commercial, regulatory and development
 activities for AFREZZA. The Sanofi License Agreement became
 effective on September&#xA0;23, 2014. The Company manufactured
 AFREZZA at its manufacturing facility in Danbury, Connecticut to
 supply Sanofi&#x2019;s demand for the product pursuant to a supply
 agreement dated August&#xA0;11, 2014 (the &#x201C;Sanofi Supply
 Agreement&#x201D;).</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">On
 January&#xA0;4, 2016 the Company received notification from Sanofi
 of its election to terminate in its entirety the Sanofi License
 Agreement. Sanofi&#x2019;s notice indicated that the termination was
 pursuant to Sanofi&#x2019;s right to terminate the Sanofi License
 Agreement upon Sanofi&#x2019;s good faith determination that the
 commercialization of AFREZZA is no longer economically viable in
 the United States, in which case the effective date of termination
 (the &#x201C;Termination Date&#x201D;) will be April&#xA0;4, 2016. In
 the alternative, Sanofi indicated that the termination was also
 pursuant to its right to terminate the Sanofi License Agreement for
 any reason, in which case the Termination Date will be July&#xA0;4,
 2016. In the interest of an expedient transition, the Company is
 working with Sanofi to transfer and wind down the agreement
 activities by April&#xA0;4, 2016, or as soon as practicable
 thereafter.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Under the
 Sanofi License Agreement, worldwide profits and losses, which are
 determined based on the difference between the net sales of AFREZZA
 and the costs and expenses incurred by the Company and Sanofi that
 are specifically attributable or related to the development,
 regulatory filings, manufacturing, or commercialization of AFREZZA,
 are shared 65% by Sanofi and 35% by the us. As a result of the loss
 share provision, and because the Company does not have the ability
 to estimate the amount of costs that would potentially be incurred
 related to the Sanofi License Agreement, the amount of up-front
 cash payment or milestone payments that could be recognized as
 revenue is not fixed or determinable. In connection with the Sanofi
 License Agreement, an affiliate of Sanofi provided the Company with
 a secured loan facility (the &#x201C;Sanofi Loan Facility&#x201D;) of
 up to $175.0 million to fund the Company&#x2019;s share of net
 losses under the Sanofi License Agreement.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Additional
 funding sources that are, or in certain circumstances may be
 available to the Company, include approximately $30.1 million
 principal amount of available borrowings under The Mann Group Loan
 Arrangement. A portion of these available borrowings may be used to
 capitalize accrued interest into principal, upon mutual agreement
 of the parties, as it becomes due and payable under The Mann Group
 Loan Arrangement. (see note 7&#xA0;&#x2014;&#xA0;Related-party
 arrangements). The Company cannot provide assurances that its plans
 will not change or that changed circumstances will not result in
 the depletion of its capital resources more rapidly than it
 currently anticipates. The Company will need to raise additional
 capital, whether through a sale of equity or debt securities, a
 strategic business collaboration with a pharmaceutical company, the
 establishment of other funding facilities, licensing arrangements,
 asset sales or other means, in order to continue the development
 and commercialization of AFREZZA and other product candidates and
 to support its other ongoing activities. However, the Company
 cannot provide assurances that such additional capital will be
 available on acceptable terms or at all.</font></p>


 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Principles
 of Consolidation</i> &#x2014;&#xA0;The consolidated financial
 statements include the accounts of the Company and its wholly-owned
 subsidiaries. Intercompany balances and transactions have been
 eliminated.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Segment
 Information</i> &#x2014;&#xA0;In accordance with Accounting
 Standards Codification (&#x201C;ASC&#x201D;) 280-10-50 <i>Segment
 Reporting</i>, operating segments are identified as components of
 an enterprise about which separate discrete financial information
 is available for evaluation by the chief operating decision-maker
 in making decisions regarding resource allocation and assessing
 performance. To date, the Company has viewed its operations and
 manages its business as one segment operating in the United States
 of America.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Financial Statement Estimates</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Financial
 Statement Estimates</i> &#x2014;&#xA0;The preparation of financial
 statements in conformity with accounting principles generally
 accepted in the United States of America (&#x201C;GAAP&#x201D;)
 requires management to make estimates and assumptions that affect
 the amounts reported in the financial statements and accompanying
 notes. Actual results could differ from those estimates. Management
 considers many factors in selecting appropriate financial
 accounting policies, and in developing the estimates and
 assumptions that are used in the preparation of the financial
 statements. Management must apply significant judgment in this
 process. The more significant estimates reflected in these
 accompanying financial statements involve assessing long-lived
 assets for impairment, accrued expenses, including clinical study
 expenses, inventory recoverability, valuation of the facility
 financing obligation, commitment asset, milestone rights, valuation
 of stock-based compensation and the determination of the provision
 for income taxes and corresponding deferred tax assets and
 liabilities and any valuation allowance recorded against net
 deferred tax assets.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock', window );">License and Collaboration and Supply Agreements</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>License and
 Collaboration and Supply Agreements</i> &#x2014;&#xA0;Pursuant to
 the Sanofi License Agreement and the Sanofi Supply Agreement, the
 Company granted to Sanofi exclusive, worldwide licenses to certain
 of the Company&#x2019;s patents, trademarks and know-how for the
 development and commercialization of AFREZZA and retained the right
 to be the exclusive manufacturer and supplier of AFREZZA until
 specified conditions are met upon which a portion of the
 manufacturing activities may be assumed by Sanofi. The terms of the
 Sanofi License Agreement provide for consideration to the Company
 in the form of a non-refundable up-front payment, product sales,
 manufacturing, regulatory and sales milestone payments and profit
 and loss sharing.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 analyzes consideration received under the provisions of ASC 605,
 Revenue Recognition, to determine whether the consideration, or a
 portion thereof, could be recognized as revenue. ASC 605 provides
 that revenue is recognized when there is persuasive evidence that
 an arrangement exists, delivery has occurred or services have been
 rendered, the price is fixed or determinable and collection is
 reasonably assured.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In arrangements
 involving the delivery of more than one element, each required
 deliverable is evaluated to determine whether it qualifies as a
 separate unit of accounting. This determination is generally based
 on whether the deliverable has &#x201C;stand-alone value&#x201D; to
 the customer. The arrangement&#x2019;s consideration that is fixed
 and determinable is then allocated to each separate unit of
 accounting based on the relative selling price of each deliverable.
 The estimated selling price of each deliverable is determined using
 the following hierarchy of values: (i)&#xA0;vendor-specific
 objective evidence of fair value, (ii)&#xA0;third-party evidence of
 selling price and (iii)&#xA0;best estimate of selling price (BESP).
 The BESP reflects the Company&#x2019;s best estimate of what the
 selling price would be if the deliverable was regularly sold by the
 Company on a stand-alone basis. In general, the consideration
 allocated to each unit of accounting is recognized as the related
 goods or services are delivered, limited to the consideration that
 is not contingent upon future deliverables.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The assessment
 of multiple element arrangements requires judgment in order to
 determine the appropriate units of accounting and the points in
 time that, or periods over which, revenue should be recognized.
 Given that, as of December&#xA0;31, 2015, the Company did not have
 the ability to estimate the amount of costs that would potentially
 be incurred under the loss share provision related to the Sanofi
 License Agreement and the Sanofi Supply Agreement, the Company
 believe the fixed and determinable fee requirement for revenue
 recognition was not met.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Cash and
 Cash Equivalents</i> &#x2014;&#xA0;The Company considers all highly
 liquid investments with original or remaining maturities of 90 days
 or less at the time of purchase, that are readily convertible into
 cash to be cash equivalents. As of December&#xA0;31, 2015 and 2014,
 cash equivalents were comprised of cash and money market accounts
 with maturities less than 90 days from the date of
 purchase.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Concentration of Credit Risk</i> &#x2014;&#xA0;Financial
 instruments which potentially subject the Company to concentration
 of credit risk consist of cash and cash equivalents. Cash and cash
 equivalents consist of interest-bearing accounts, which are
 regularly monitored by management and held in high credit quality
 institutions.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">State Research and Development Credit Exchange Receivable</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>State
 Research and Development Credit Exchange Receivable</i>
 &#x2014;&#xA0;The State of Connecticut provides certain companies
 with the opportunity to exchange certain research and development
 income tax credit carryforwards for cash in exchange for foregoing
 the carryforward of the research and development credits. The
 program provides for an exchange of research and development income
 tax credits for cash equal to 65% of the value of corporation tax
 credit available for exchange. Estimated amounts receivable under
 the program are recorded as a reduction of research and development
 expenses.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock', window );">Prepaid expenses and other current assets</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Prepaid
 expenses and other current assets &#x2014;</i> Prepaid expenses and
 other current assets primarily consist of prepaid expenses for
 goods and services to be received. As of December&#xA0;31, 2015,
 prepaid and other current assets had a balance of $4.0 million,
 mainly comprised of prepaid insurance. As of December&#xA0;31, 2014
 prepaid and other current assets had a balance of $20.2 million,
 mainly comprised of a $15.0 million prepayment for 2015 quantities
 of insulin, and prepaid insurance.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_SaleOfIntellectualPropertyPolicyTextBlock', window );">Sale of intellectual property</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Sale of
 intellectual property</i> &#x2014;&#xA0;On July&#xA0;18, 2014, the
 Company entered into an assignment agreement with a third party
 whereby the third party acquired all proprietary rights, technology
 and know-how that related to a small molecule inhibitor compound
 and all pre-clinical data and results related thereto. Under the
 terms of the assignment agreement, the Company received total
 consideration of $9.3 million and accrued $1.4 million in expense
 for a net amount of $7.9 million recorded as other income. In 2015,
 the Company recorded other income of $1.4 million related to the
 relief of the $1.4 million accrual for expenses associated with the
 sale of intellectual property related to oncology in 2014, which
 was subsequently resolved without payment.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Milestone Rights</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Milestone
 Rights</i> &#x2014;&#xA0;On July&#xA0;1, 2013, in conjunction with
 the execution of the Facility Agreement, the Company issued
 Milestone Rights to Deerfield whereby the Company agreed to provide
 Deerfield with pre-specified Milestone Payments upon the
 achievement of 13 specific Milestone Events related to the
 commercial release and future cumulative net sales of AFREZZA. The
 Company analyzed the Milestone Rights under the provisions of ASC
 815 and determined that the agreement does not meet the definition
 of a freestanding derivative. Since the Company has not elected to
 apply the fair value option to the Milestone Rights Purchase
 Agreement, the Company recorded the Milestone Rights at their
 estimated fair value and accounted for the Milestone Rights as a
 liability by applying the indexed debt guidance contained in
 paragraphs ASC 470-10-25-3 and 35-4.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The initial
 fair value estimate of the Milestone Rights was calculated using
 the income approach in which the cash flows associated with the
 specified contractual payments were adjusted for both the expected
 timing and the probability of achieving the milestones and
 discounted to present value using a selected market discount rate.
 The expected timing and probability of achieving the milestones was
 developed with consideration given to both internal data, such as
 progress made to date and assessment of criteria required for
 achievement, and external data, such as market research studies.
 The discount rate was selected based on an estimation of required
 rate of returns for similar investment opportunities using
 available market data. The Milestone Rights liability will be
 remeasured as the specified milestone events are achieved.
 Specifically, as each milestone event is achieved, the portion of
 the initially recorded Milestone Rights liability that pertains to
 the milestone event being achieved, will be remeasured to the
 amount of the specified related milestone payment. The resulting
 change in the balance of the Milestone Rights liability due to
 remeasurement will be recorded in the Company&#x2019;s Statement of
 Operations as interest expense. Furthermore, the Milestone Rights
 liability will be reduced upon the settlement of each milestone
 payment. As a result, each milestone payment would be effectively
 allocated between a reduction of the recorded Milestone Rights
 liability and an expense representing a return on a portion of the
 Milestone Rights liability paid to the investor for the achievement
 of the related milestone event (see Note
 17&#xA0;&#x2014;&#xA0;Facility Agreement). As of December&#xA0;31,
 2015, the remaining liability balance of $8.9 million was
 classified as long-term liability in other liabilities.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock', window );">Deferred product costs from collaboration</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Deferred
 product costs from collaboration</i> &#x2014; Deferred product costs
 represent the costs of product manufactured and sold to Sanofi, as
 long as they are not greater than the amount of deferred product
 sales related to the collaboration, for which recognition of
 revenue has been deferred. Given that the costs of inventory
 delivered to a customer, but for which revenue may not yet be
 recognized, meet both the definition and characteristics of an
 &#x201C;asset&#x201D; and the Company believes that it is probable
 that the amount of future revenue will exceed the amount of
 deferred costs (i.e., the asset would be realizable through the
 recognition of probable future income), the Company has elected to
 account for the deferred costs related to the product sold to
 Sanofi as an asset and carry forward to future periods until the
 related revenue is recognized.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Fair Value
 of Financial Instruments</i> &#x2014;&#xA0;The Company utilizes fair
 value measurement guidance prescribed by GAAP to value its
 financial instruments. The guidance includes a definition of fair
 value, prescribes methods for measuring fair value, establishes a
 fair value hierarchy based on the inputs used to measure fair value
 and expands disclosures about the use of fair value measurements.
 The valuation techniques utilized are based upon observable and
 unobservable inputs. Observable inputs reflect market data obtained
 from independent sources, while unobservable inputs reflect
 internal market assumptions. These two types of inputs create the
 following fair value hierarchy:</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px">
 <font style="FONT-FAMILY: Times New Roman" size="2">Level
 1&#xA0;&#x2014;&#xA0;Quoted prices for identical instruments in
 active markets.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px">
 <font style="FONT-FAMILY: Times New Roman" size="2">Level
 2&#xA0;&#x2014;&#xA0;Quoted prices for similar instruments in active
 markets; quoted prices for identical or similar instruments in
 markets that are not active; and model-derived valuations whose
 inputs are observable or whose significant value drivers are
 observable.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%; MARGIN-TOP: 6px">
 <font style="FONT-FAMILY: Times New Roman" size="2">Level
 3&#xA0;&#x2014;&#xA0;Significant inputs to the valuation model are
 unobservable.</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The carrying
 amounts reflected in the consolidated balance sheets for cash
 equivalents, other current assets, accounts payable, and accrued
 expenses and other current liabilities, approximate fair value due
 to their relatively short maturities.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Inventories</i> &#x2014;&#xA0;Inventories are stated at the
 lower of cost or market. The Company determines the cost of
 inventory using the first-in, first-out, or FIFO, method. The
 Company capitalizes inventory costs associated with the
 Company&#x2019;s products based on management&#x2019;s judgment that
 future economic benefit is expected to be realized; otherwise, such
 costs are expensed as product manufacturing. The Company
 periodically analyzes its inventory levels to identify inventory
 that may expire or has a cost basis in excess of its estimated
 realizable value, and writes-down such inventories as appropriate.
 In addition, the Company&#x2019;s products are subject to strict
 quality control and monitoring which the Company performs
 throughout the manufacturing process. If certain batches or units
 of product no longer meet quality specifications or become obsolete
 due to expiration, the Company will record a charge to write down
 such unmarketable inventory to its estimated realizable value.
 Inventory that is not expected to be used within one year is
 classified as a long term asset on the accompanying condensed
 consolidated balance sheet.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">We analyzed our
 inventory levels to identify inventory that may expire or has a
 cost basis in excess of its estimated realizable value. We
 performed an assessment of projected sales and to evaluate the
 lower of cost or market and the potential excess inventory on hand
 at December 31, 2015. As a result of this assessment, we recorded a
 charge of $39.3 million to record the inventory raw materials on
 hand at the lower of cost or market, inventory expiry, and
 write-off other inventory related assets.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">In connection
 with the projected sales assessment, we also evaluated our
 inventory purchase commitments totalling $116.2 million for
 potential impairment. As a result of this assessment, we recorded a
 $66.2 million charge related to a loss on future purchase
 commitments both from a lower of cost or market excess inventory
 perspective. The purchase commitment obligation has been reduced to
 reflect our expectation that a portion will be recoverable from a
 third party.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Property and
 Equipment</i> &#x2014;&#xA0;Property and equipment are recorded at
 cost and depreciated using the straight-line method over the
 estimated useful lives of the related assets. Leasehold
 improvements are amortized over the term of the lease or the
 service lives of the improvements, whichever is shorter.
 Maintenance and repairs are expensed as incurred. Assets under
 construction are not depreciated until placed into
 service.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Impairment
 of Long-Lived Assets</i> &#x2014;&#xA0;The Company evaluates
 long-lived assets for impairment whenever events or changes in
 circumstances indicate that the carrying value of an asset may not
 be recoverable in accordance with ASC 360-10-35 <i>Property Plant
 and Equipment.</i> Assets are considered to be impaired if the
 carrying value may not be recoverable based upon management&#x2019;s
 assessment of the following events or changes in
 circumstances:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">significant changes in the Company&#x2019;s strategic business
 objectives and utilization of the assets;</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">a determination that the carrying value of such assets cannot
 be recovered through undiscounted cash flows;</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">loss of legal ownership or title to the assets;</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">a significant adverse change in legal factors or in the
 business climate that could affect the value of a long-lived asset
 (asset group), including an adverse action or assessment by a
 regulator; or</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr>
 <td width="2%"><font size="1">&#xA0;</font></td>
 <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td>
 <td valign="top" width="1%"><font size="1">&#xA0;</font></td>
 <td valign="top" align="left">
 <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">the impact of significant negative industry or economic
 trends.</font></p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">If the Company
 believes an asset to be impaired, the impairment recognized is the
 amount by which the carrying value of the assets exceeds the fair
 value of the assets. Any write-downs would be treated as permanent
 reductions in the carrying amount of the asset and an operating
 loss would be recognized.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 recorded an asset impairment of $140.4 million for the year ended
 December&#xA0;31, 2015 (see Note 5&#xA0;&#x2014;&#xA0;Property and
 Equipment). No asset impairment was recognized during the years
 ended December&#xA0;31, 2014, and 2013, respectively.</font></p>


 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Income
 Taxes</i> &#x2014;&#xA0;The provisions for federal, foreign, state,
 and local income taxes are calculated on pre-tax income based on
 current tax law and include the cumulative effect of any changes in
 tax rates from those used previously in determining deferred tax
 assets and liabilities. Deferred income tax assets and liabilities
 are measured using enacted tax rates expected to apply to taxable
 income in the year in which the temporary differences are expected
 to be recovered or settled. A valuation allowance is recorded to
 reduce net deferred income tax assets to amounts that are more
 likely than not to be realized.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Income tax
 positions are considered for uncertainty in accordance with ASC
 740-10-25 <i>Income Taxes,</i> The Company believes that its income
 tax filing positions and deductions will be sustained on audit and
 does not anticipate any adjustments that will result in a material
 change to its financial position. Therefore, no liabilities for
 uncertain income tax positions have been recorded. If a tax
 position does not meet the minimum statutory threshold to avoid
 payment of penalties, the Company recognizes an expense for the
 amount of the penalty in the period the tax position is claimed in
 the tax return of the Company. The Company recognizes interest
 accrued related to unrecognized tax benefits in income tax expense,
 if any. Penalties, if probable and reasonably estimable, are
 recognized as a component of income tax expense.</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Significant
 management judgment is involved in determining the provision for
 income taxes, deferred tax assets, deferred tax liabilities, and
 any valuation allowance recorded against deferred tax assets. Due
 to uncertainties related to the realization of the Company&#x2019;s
 deferred tax assets as a result of its history of operating losses,
 a valuation allowance has been established against the total
 deferred tax asset balance. The valuation allowance is based on
 management&#x2019;s estimates of taxable income by jurisdiction in
 which the Company operates and the period over which deferred tax
 assets will be recoverable. In the event that actual results differ
 from these estimates or the Company adjusts these estimates in
 future periods, a change in the valuation allowance may be needed,
 which could materially impact the Company&#x2019;s financial
 position and results of operations.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Contingencies</i> &#x2014;&#xA0;Contingencies are recorded in
 accordance with ASC 450 <i>Contingencies.</i> Accordingly, the
 Company records a loss contingency for a liability when it is both
 probable that a liability has been incurred and the amount of the
 loss can be reasonably estimated. These accruals represent
 management&#x2019;s best estimate of probable loss. Disclosure also
 is provided when it is reasonably possible that a loss will be
 incurred or when it is reasonably possible that the amount of a
 loss will exceed the recorded provision. On a quarterly basis, the
 Company reviews the status of each significant matter and assesses
 its potential financial exposure. Significant judgment is required
 in both the determination of probability and the determination as
 to whether an exposure is reasonably estimable. Because of
 uncertainties related to these matters, accruals are based only on
 the best information available at the time. As additional
 information becomes available, the Company reassesses the potential
 liability related to pending claims and litigation and may revise
 its estimates. These revisions in the estimates of the potential
 liabilities could have a material impact on the Company&#x2019;s
 consolidated results of operations and financial
 position.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Stock-Based
 Compensation</i> &#x2014;&#xA0;As of December&#xA0;31, 2015, the
 Company had three active stock-based compensation plans, which are
 described more fully in Note 13. The Company accounts for all
 share-based payments to employees, including grants of stock awards
 and the compensatory elements of the employee stock purchase plan
 in accordance with ASC 718<i>.</i> ASC 718 <i>Compensation &#x2014;
 Stock Compensation</i> (&#x201C;ASC 718&#x201D;) requires all
 share-based payments to employees, including grants of stock
 options, restricted stock units, performance-based awards and the
 compensatory elements of employee stock purchase plans, to be
 recognized in the statement of operations based upon the fair value
 of the awards at the grant date. The Company uses the Black-Scholes
 option valuation model to estimate the grant date fair value of
 employee stock options and the compensatory elements of employee
 stock purchase plans. Option valuation models require the input of
 assumptions, including the expected life of the stock-based awards,
 the estimated stock price volatility, the risk-free interest rate,
 and the expected dividend yield. Beginning in the third quarter of
 2014, the Company began to assess both historical and implied
 volatility in order to determine its estimated volatility rate.
 Implied volatility was considered due to the change in the
 Company&#x2019;s business, which occurred with the approval for the
 sale of AFREZZA. The expected volatility assumption is based on an
 assessment of the historical volatility and the implied volatility
 of the Company&#x2019;s common stock, derived from an analysis of
 historical traded and quoted options on the Company&#x2019;s common
 stock. Restricted stock units are valued based on the market price
 on the grant date. The Company evaluates stock awards with
 performance conditions as to the probability that the performance
 conditions will be met and estimates the date at which the
 performance conditions will be met in order to properly recognize
 stock-based compensation expense over the requisite service
 period.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Warrants</i>
 &#x2014;&#xA0;The Company has issued warrants to purchase shares of
 its common stock. Warrants have been accounted for within equity in
 accordance with the provisions of ASC 815-40, Contracts in an
 Entity&#x2019;s Own Stock, previously EITF Issue No. 00-19:
 <i>Accounting for Derivative Financial Instruments Indexed to, and
 Potentially Settled in, a Company&#x2019;s Own Stock</i>.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Comprehensive Loss</i> &#x2014;&#xA0;Other comprehensive loss
 is recorded in accordance with ASC 220-10-45 <i>Comprehensive
 Income,</i> which requires that all components of comprehensive
 loss be reported in the financial statements in the period in which
 they are recognized. Other comprehensive loss includes certain
 changes in stockholders&#x2019; equity that are excluded from net
 income. Specifically, the Company includes unrealized gains and
 foreign exchange translation losses, if any, and cumulative
 translation gains and losses in other comprehensive
 loss.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Research and
 Development Expenses</i> &#x2014;&#xA0;Research and development
 expenses consist of costs associated with the clinical trials of
 the Company&#x2019;s product candidates, manufacturing supplies and
 other development materials, compensation and other expenses for
 research and development personnel, costs for consultants and
 related contract research, facility costs, and depreciation.
 Research and development costs, which are net of any tax credit
 exchange recognized for the Connecticut state research and
 development credit exchange program, are expensed as incurred
 consistent with ASC 730-10 <i>Research and Development.</i> The
 Company began commercial manufacturing in the latter part of the
 fourth quarter of 2014. As such, commercial manufacturing costs
 incurred in the fourth quarter of 2014 and included in research and
 development as expenses were immaterial for the year ended
 December&#xA0;31, 2014.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ClinicalTrialExpensePolicyTextBlock', window );">Clinical Trial Expenses</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Clinical
 Trial Expenses</i> &#x2014;&#xA0;Clinical trial expenses, which are
 reflected in research and development expenses in the accompanying
 statements of operations, result from obligations under contracts
 with vendors, consultants, and clinical site agreements in
 connection with conducting clinical trials. The financial terms of
 these contracts are subject to negotiations which vary from
 contract to contract and may result in payment flows that do not
 match the periods over which materials or services are provided to
 the Company under such contracts. The appropriate level of trial
 expenses are reflected in the Company&#x2019;s financial statements
 by matching period expenses with period services and efforts
 expended. These expenses are recorded according to the progress of
 the trial as measured by patient progression and the timing of
 various aspects of the trial. Clinical trial accrual estimates are
 determined through discussions with internal clinical personnel and
 outside service providers as to the progress or state of completion
 of trials, or the services completed. Service provider status is
 then compared to the contractually obligated fee to be paid for
 such services. During the course of a clinical trial, the Company
 may adjust the rate of clinical expense recognized if actual
 results differ from management&#x2019;s estimates.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpensePolicyTextBlock', window );">Interest Expense</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Interest
 Expense</i> &#x2014;&#xA0;Interest costs are expensed as incurred,
 except to the extent such interest is related to construction in
 progress, in which case interest is capitalized. Interest expense,
 net of interest capitalized, for the years ended December&#xA0;31,
 2015, 2014 and 2013 was $24.1 million, $20.4 million, and $21.5
 million, respectively. Interest costs capitalized for the years
 ended December&#xA0;31, 2015, 2014, and 2013 were $0.1 million,
 $0.8 million, and $0.4 million, respectively.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share of Common Stock</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Net Loss Per
 Share of Common Stock</i> &#x2014;&#xA0;Basic net loss per common
 share is computed by dividing net loss by the weighted-average
 number of common shares outstanding during the period. Diluted net
 loss per common share is computed by dividing the net loss by the
 sum of the weighted-average number of common shares outstanding
 during the period plus the potential dilutive effect of stock
 options, restricted stock units, warrants, and shares that could be
 issued upon conversion of the senior convertible notes outstanding
 during the period calculated in accordance with the treasury stock
 method, but are excluded if their effect is anti-dilutive. Because
 the impact of these items is anti-dilutive during periods of net
 loss, there was no difference between basic and diluted loss per
 common share for the years ended December&#xA0;31, 2015, 2014, and
 2013.</font></p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2"><i>Recently
 Issued Accounting Standards</i> &#x2014;&#xA0;From time <font style="FONT-FAMILY: 'Times New Roman'" size="2">to time, new accounting
 pronouncements are issued by the Financial Accounting Standards
 Board (FASB) or other standard setting bodies that are adopted by
 the Company as of the specified effective date. Unless otherwise
 discussed, the Company believes that the impact of recently issued
 standards that are not yet effective will not have a material
 impact on the Company&#x2019;s financial position or results of
 operations upon adoption.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">In May 2014, the FASB
 issued ASU 2014-09 related to revenue recognition, which requires
 an entity to recognize the amount of revenue to which it expects to
 be entitled for the transfer of promised goods or services to
 customers. The guidance requires a company to recognize revenue to
 depict the transfer of goods or services to customers in an amount
 that reflects the consideration it expects to be entitled to
 receive in exchange for those goods or services. In July 2015, the
 FASB issued ASU 2015-14, which delayed the effective date of the
 new revenue standard by one year. The FASB also agreed to allow
 entities to choose to adopt the standard as of the original
 effective date. The standard is effective beginning the first
 quarter of the Company&#x2019;s 2018 fiscal year and is required to
 be adopted using either a full retrospective or a modified
 retrospective approach. The Company is assessing the potential
 impact of the new standard on its consolidated financial statements
 and has not yet selected a transition method.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">In August 2014, the FASB
 issued ASU 2014-15, which provides guidance on determining when and
 how reporting entities must disclose going-concern uncertainties in
 their financial statements. The new standard requires management to
 perform interim and annual assessments of an entity&#x2019;s ability
 to continue as a going concern within one year of the date of
 issuance of the entity&#x2019;s financial statements (or within one
 year after the date on which the financial statements are available
 to be issued, when applicable). Further, an entity must provide
 certain disclosures if there is &#x201C;substantial doubt about the
 entity&#x2019;s ability to continue as a going concern&#x201D;. The
 ASU is effective for annual periods ending after December&#xA0;15,
 2016, and interim periods thereafter; early adoption is permitted.
 The Company is evaluating the impact the adoption of ASU 2014-15
 will have on its consolidated financial
 statements.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">In April 2015, the FASB
 issued ASU 2015-03, &#x201C;Simplifying the Presentation of Debt
 Issuance Costs.&#x201D; The guidance requires debt issuance costs to
 be presented in the balance sheet as a direct deduction from the
 carrying value of the associated debt, consistent with the
 presentation of a debt discount. The guidance is effective for
 annual reporting periods beginning after December&#xA0;15, 2015 and
 interim periods thereafter. As permitted by the standard, the
 Company adopted the new presentation prospectively and the adoption
 did not have an impact on its consolidated financial statements and
 disclosures.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">In July 2015, the FASB
 issued ASU 2015-11, Inventory (Topic 330): Simplifying the
 Measurement of Inventory. Topic 330, Inventory, currently requires
 an entity to measure inventory at the lower of cost or market.
 Market could be replacement cost, net realizable value, or net
 realizable value less an approximately normal profit margin. The
 amendments do not apply to inventory that is measured using
 last-in, first-out (LIFO) or the retail inventory method. The
 amendments apply to all other inventory, which includes inventory
 that is measured using first-in, first-out (FIFO) or average cost.
 The amendments are effective for fiscal years beginning after
 December&#xA0;15, 2016, including interim periods within those
 fiscal years. The amendments should be applied prospectively with
 earlier application permitted as of the beginning of an interim or
 annual reporting period. The Company is evaluating the impact the
 adoption of ASU 2015-11 will have on its consolidated financial
 statements.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">In November 2015, the
 FASB issued ASU No.&#xA0;2015-17, Income Taxes (Topic 740): Balance
 Sheet Classification of Deferred Taxes. The new standard requires
 that deferred tax assets and liabilities be classified as
 noncurrent in a classified statement of financial position. For
 public business entities, the amendments in this Update are
 effective for financial statements issued for annual periods
 beginning after December&#xA0;15, 2016, and interim periods within
 those annual periods. As permitted by the standard, the Company
 adopted the new presentation and the adoption did not have an
 impact on its consolidated financial statements and
 disclosures.</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 2%; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2"><font style="FONT-FAMILY: 'Times New Roman'" size="2">In January 2016, the FASB
 issued ASU 2016-01, Financial Instruments&#xA0;&#x2014;&#xA0;Overall
 (Subtopic 825-10): Recognition and Measurement of Financial Assets
 and Financial Liabilities. The update is intended to improve the
 recognition and measurement of financial instruments. The update
 are effective for fiscal years beginning after December&#xA0;15,
 2017, including interim periods within those fiscal years. The
 Company is evaluating the impact the adoption of ASU 2016-01 will
 have on its consolidated financial statements.</font></font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BasisOfPresentationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BasisOfPresentationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ClinicalTrialExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Clinical Trial Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ClinicalTrialExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Product Costs From Collaboration [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredProductCostsFromCollaborationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Collaboration And Supply Agreements [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LicenseCollaborationAndSupplyAgreementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expenses And Other Current Assets Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recently issued accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SaleOfIntellectualPropertyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of intellectual property [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SaleOfIntellectualPropertyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Financial Reporting Release (FRR)<br> -Number 203<br> -Paragraph 02-03<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51674963&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph k<br> -Article 1<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02, 03<br> -Article 3A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred to obtain or issue debt, the effects of refinancings, method of amortizing deferred financing costs and original issue discount, and classifications of debt on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6423966&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 10<br> -Section 05<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28365394&amp;loc=d3e23770-108382<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28360613&amp;loc=d3e4492-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=28360613&amp;loc=d3e4556-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Financial Reporting Release (FRR)<br> -Number 206<br> -Paragraph b<br> -Subparagraph i, ii<br> -Chapter 2<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6378556&amp;loc=d3e10133-111534<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e4975-111524<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3-5<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Research and Development<br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6609106016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Components of Inventories</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Inventories
 consist of the following (in thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="79%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Raw materials</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,856</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Work-in-process</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,719</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Finished goods</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Inventory &#x2014;
 current</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,670</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total Inventory</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;9,670</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&#xA0;</p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 2<br> -Paragraph 6<br> -Subparagraph a,b,c<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6779808176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Property and
 equipment consist of the following (dollar amounts in
 thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="70%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" rowspan="2" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Estimated<br />
 Useful<br />
 Life<br />
 (Years)</b></font></td>
 <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap">
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center">
 <font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,273</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,273</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39-40</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">54,948</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">54,948</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Building
 improvements</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5-40</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">131,383</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">114,131</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Machinery and
 equipment</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3-15</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95,182</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,919</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Furniture, fixtures and
 office equipment</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5-10</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,137</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,015</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Computer equipment and
 software</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,707</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,465</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Leasehold
 improvements</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Construction in
 progress</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,044</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39,580</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">308,674</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">310,348</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Less impairment</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(140,412</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="bottom">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Less accumulated
 depreciation and amortization</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(119,513</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(118,221</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total property and
 equipment, net</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,749</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">192,127</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 &#xA0;</p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph b<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6779730048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued expenses and other current liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><div>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Accrued expenses
 and other current liabilities are comprised of the following (in
 thousands):</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">
 <tr>
 <td width="85%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="6" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Salary and related
 expenses</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">5,662</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">14,928</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Accrued interest</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">615</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,396</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Construction in
 progress</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">238</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,343</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Other</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,414</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7,539</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Accrued expenses and other
 current liabilities</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7,929</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">26,206</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6608833280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Senior convertible notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Senior Convertible Notes</a></td>
<td class="text"><div>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Senior
 convertible notes consist of the following (in
 thousands):</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">
 <tr>
 <td width="83%"></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2"><b>2015 notes</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Principal amount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">100,000</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Unaccreted debt issuance
 cost</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(645</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net carrying
 amount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">99,355</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2"><b>2018 notes</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Principal amount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">27,690</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Unamortized
 premium</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">660</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Unaccreted debt issuance
 costs</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(737</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net carrying
 amount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">27,613</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6610562192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Summary of Carrying Values Estimated Fair Values of Notes and Facility Financing Obligation</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The following
 <font style="FONT-FAMILY: 'Times New Roman'" size="2">is a summary
 of the carrying values and estimated fair values of the 2018 notes,
 the facility financing obligation (i.e., the 2019 notes and Tranche
 B notes), and the Sanofi Loan Facility (in
 millions):</font></font></p>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 6px 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 0px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></p>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 </p>
 <table style="FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="67%"></td>
 <td valign="bottom" width="5%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="5%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="5%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="5%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"><font style="FONT-FAMILY: 'Times New Roman'" size="1"><b>December&#xA0;31,
 2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" nowrap="nowrap" align="center"><font style="FONT-FAMILY: 'Times New Roman'" size="1"><b>December&#xA0;31,
 2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: 'Times New Roman'" size="1"><b>Carrying<br />
 value</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: 'Times New Roman'" size="1"><b>Estimated<br />
 fair value</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: 'Times New Roman'" size="1"><b>Carrying<br />
 value</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: 'Times New Roman'" size="1"><b>Estimated<br />
 fair value</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: 'Times New Roman'" size="2">2015 notes</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">99.4</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">102.9</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: 'Times New Roman'" size="2">2018 notes</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">27.6</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">21.3</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Facility financing
 obligation</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">74.6</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">78.4</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">73.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">75.1</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: 'Times New Roman'" size="2">Sanofi Loan
 Facility</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">44.5</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">36.5</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">3.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: 'Times New Roman'" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: 'Times New Roman'" size="2">3.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: 'Times New Roman'" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: medium 'Times New Roman'; MARGIN-LEFT: 30px; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px">
 <font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6613956256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per common share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Potential Dilutive Securities Outstanding</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Potentially
 dilutive securities outstanding are summarized as follows (in
 shares):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="67%"></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercise of common stock
 options</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,779,229</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,541,664</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">24,237,940</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Conversion of senior
 convertible notes into common stock</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,072,809</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17,323,080</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">25,415,366</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercise of common stock
 warrants</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,074,596</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,987,876</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,706,240</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vesting of restricted stock
 units</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,804,620</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,610,720</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,115,821</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top"></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29,731,254</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">51,463,340</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">78,475,367</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781455664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock award plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Stock Based Award Plans</a></td>
<td class="text"><div>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">The following
 table summarizes information about the Company&#x2019;s stock-based
 award plans as of December&#xA0;31, 2015:</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">
 <tr>
 <td width="65%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Outstanding<br />
 Options</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Outstanding<br />
 Restricted<br />
 Stock Units</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" nowrap="nowrap" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Shares&#xA0;Available<br />
 for<br />
 Future Issuance</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2004 Equity Incentive
 Plan</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">11,309,136</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">276,784</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2013 Equity Incentive
 Plan</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8,026,762</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,527,836</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15,540,652</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2004 Non-Employee
 Directors&#x2019; Stock Option Plan</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">443,331</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">19,779,229</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,804,620</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15,540,652</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Stock Based Compensation Expense Recognized in Accompanying Statements of Operations</a></td>
<td class="text"><div>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is as follows (in thousands):</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">
 <tr>
 <td width="77%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Year Ended
 December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Employee-related</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8,407</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">48,622</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">45,181</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Consultant-related</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">318</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">5</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8,725</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">48,622</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">45,186</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock', window );">Stock Based Compensation Expense Recognized in Accompanying Statements of Operations by Category</a></td>
<td class="text"><div>
 <p style="margin-top:12px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Total
 stock-based compensation expense recognized in the accompanying
 statements of operations is included in the following categories
 (in thousands):</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">
 <tr>
 <td width="77%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Year Ended
 December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Research and
 development</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,029</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">22,357</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">20,409</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">General and
 administrative</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">5,696</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">26,265</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">24,777</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:1px solid #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8,725</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">48,622</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">45,186</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="font-size:1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="border-top:3px double #000000">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Assumptions Used to Calculate Fair Value of Employee Stock Options</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The Company
 calculated the fair value of employee stock options granted during
 the years ended December&#xA0;31, 2015, 2014 and 2013 using the
 following assumptions:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="46%"></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Year Ended
 December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Risk-free interest
 rate</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.61%&#xA0;&#x2014;&#xA0;1.86%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.64%&#xA0;&#x2014;&#xA0;2.11%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.94%
 &#x2014;&#xA0;1.82%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expected lives</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.79&#xA0;&#x2014;&#xA0;5.86&#xA0;years</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.77&#xA0;&#x2014;&#xA0;6.09&#xA0;years</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.64&#xA0;&#x2014;&#xA0;5.77&#xA0;years</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Volatility</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69.76%&#xA0;&#x2014;&#xA0;71.84%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">73.98%&#xA0;&#x2014;&#xA0;84.85%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75.83%&#xA0;&#x2014;&#xA0;86.26%</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Dividends</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Options Outstanding</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The following
 table summarizes information about stock options
 outstanding:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="70%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number<br />
 of<br />
 Shares</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br />
 Average<br />
 Exercise<br />
 Price<br />
 per&#xA0;Share</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Aggregate<br />
 Intrinsic<br />
 Value&#xA0;($000)</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding at
 January&#xA0;1, 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,541,664</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.53</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,495</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,541,100</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.11</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,700,964</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.91</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(706,387</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.78</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Expired</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(896,184</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7.70</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding at
 December&#xA0;31, 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,779,229</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vested and expected to vest
 at December&#xA0;31, 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,597,097</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.53</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercisable at
 December&#xA0;31, 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17,217,332</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.47</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Unit Activity</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">A summary of
 restricted stock unit activity for the year ended December&#xA0;31,
 2015 is presented below:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="80%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number<br />
 of<br />
 Shares</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br />
 Average<br />
 Grant&#xA0;Date<br />
 Fair Value<br />
 per Share</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding at January 1,
 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,610,720</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.20</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Granted</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,133,404</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.14</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vested</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,111,134</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.93</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Forfeited</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(828,370</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.88</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding at December 31,
 2015</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,804,620</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.85</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share Based Compensation Activity by Category</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ScheduleOfShareBasedCompensationActivityByCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan.  Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6779276736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for Income Taxes</a></td>
<td class="text"><div>
 <p><font size="2">The provision for income taxes consists of the
 following (in thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="73%"></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Year Ended
 December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Current</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">U.S. federal</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">U.S. state</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Non-U.S.</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total current</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deferred</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">U.S. federal</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">109,512</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">57,873</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">59,379</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">U.S. state</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(29,394</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,631</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,470</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Non-U.S.</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Valuation
 Allowance</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(80,118</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(65,504</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(66,849</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total deferred</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of Net Deferred Tax Asset</a></td>
<td class="text"><div>
 <p><font size="2">Components of the net deferred tax asset as of
 December&#xA0;31, 2015 and 2014 are approximately as follows (in
 thousands):</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="80%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deferred tax
 assets:</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom" colspan="5"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net operating loss
 carryforwards</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">721,588</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">699,997</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Research and development
 credits</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">73,646</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">73,227</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalized
 research</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,872</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">28,516</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Payments from
 collaboration</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">52,484</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19,217</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Milestone Rights</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,242</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,321</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Accrued expenses</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">251</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">768</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Loss on purchase
 commitment</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">24,084</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Non-qualified stock option
 expense</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,941</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">43,691</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalized patent
 costs</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,574</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,624</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,186</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">131</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Depreciation</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">48,755</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,010</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total net deferred tax
 assets</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">962,623</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">882,502</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Valuation
 allowance</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(962,623</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(882,502</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net deferred tax
 assets</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 &#xA0;</p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Effective Income Tax Rate</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">The
 Company&#x2019;s effective income tax rate differs from the
 statutory federal income tax rate as follows for the years ended
 December&#xA0;31, 2015, 2014 and 2013:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="85%"></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="2%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Federal tax benefit
 rate</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">State tax benefit, net of
 federal benefit</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Permanent items</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.9</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intercompany transfer of
 intellectual property</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(4.1</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(4.3</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Valuation
 allowance</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(34</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(31.8</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(30.7</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Effective income tax
 rate</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.0</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 &#xA0;</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6835514832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Facility Agreement (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock', window );">Accretion of Debt Issuance Cost and Debt Discount</a></td>
<td class="text"><div>
 <p style="margin-top:6px;margin-bottom:0px; text-indent:2%">
 <font style="font-family:Times New Roman" size="2">Accretion of
 debt issuance cost and debt discount in connection with the
 Deerfield financing during the year ended December&#xA0;31, 2015
 and 2014 are as follows (in thousands):</font></p>
 <p style="font-size:6px;margin-top:0px;margin-bottom:0px">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center">
 <tr>
 <td width="86%"></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="3%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>December&#xA0;31,</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2015</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Accretion expense- debt
 issuance cost</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">35</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">326</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Accretion expense- debt
 discount</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,553</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7,550</font></td>
 <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other assets and other liabilities not separately disclosed on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6835347872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected quarterly financial data (unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Selected Quarterly Financial Data</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 <font style="FONT-FAMILY: Times New Roman" size="2">Summarized
 quarterly financial data for the years ended December&#xA0;31, 2015
 and 2014 are set forth in the following tables:</font></p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 6px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="58%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March&#xA0;31</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June&#xA0;30</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>September&#xA0;30</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(In thousands, except
 per share data)</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>2015</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net loss</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(30,658</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(28,910</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(31,857</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(277,020</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net loss per share &#x2014;
 basic and diluted</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.08</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.07</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.08</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.66</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average common
 shares used to compute basic and diluted net loss per
 share</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">398,916</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">401,018</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">405,199</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">419,314</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 12px; MARGIN-TOP: 0px">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0">
 <tr>
 <td width="60%"></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="4%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>March&#xA0;31</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>June&#xA0;30</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>September&#xA0;30</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(In thousands, except
 per share data)</b></font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>2014</b></font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net loss</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(52,056</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(73,365</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(36,520</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(36,439</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net loss per share &#x2014;
 basic and diluted</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.14</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.19</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.09</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(0.09</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr>
 <td valign="top">
 <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average common
 shares used to compute basic and diluted net loss per
 share</font></p>
 </td>
 <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">368,784</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">380,770</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">394,163</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 <td valign="bottom"><font size="1">&#xA0;</font></td>
 <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td>
 <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">396,793</font></td>
 <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: rgb(0,0,0) 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px; TEXT-INDENT: 2%">
 &#xA0;</p>


 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)-(j)<br> -URI http://asc.fasb.org/extlink&amp;oid=51825399&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782371088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2016</div></th>
<th class="th"><div>Aug. 11, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Sep. 23, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Dec. 31, 2012</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,863,229,000)<span></span>
</td>
<td class="num">$ (2,494,784,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,074,000<span></span>
</td>
<td class="nump">$ 120,841,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,790,000<span></span>
</td>
<td class="nump">$ 61,840,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount available for future borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UpfrontFee', window );">Up-front fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProfitLossSharingAgreementAllocationPercentage', window );">Profits and losses sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum secured loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UpfrontFee', window );">Up-front fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProfitLossSharingAgreementAllocationPercentage', window );">Profits and losses sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum secured loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember', window );">Senior convertible notes due December 31, 2019 | Deerfield | Minimum | Facility Agreement | Less portion of commitment asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity', window );">Available amount of credit facility under covenant restrictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | License and Collaboration Agreement with Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_TerminationDateOfLicenseAgreement', window );">Termination date</a></td>
<td class="text">Jul.  04,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility Restricted Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ProfitLossSharingAgreementAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Profit Loss Sharing Agreement Allocation Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ProfitLossSharingAgreementAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_TerminationDateOfLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination Date Of License Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_TerminationDateOfLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_UpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_UpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AgreementsAxis=mnkd_FacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AgreementsAxis=mnkd_FacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_TrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_TrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6845983088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Of Significant Accounting Policies - Additional Information (Detail)<br> $ in Thousands, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 18, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 01, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_MaturityPeriodOfCashEquivalents', window );">Maturity period of cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days or less at the time of  purchase<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PercentageOfCreditExchangeReceivable', window );">Percentage of credit exchange receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,018<span></span>
</td>
<td class="nump">$ 20,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepayment for 2015 quantities of insulin and prepaid insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
<td class="nump">1,679<span></span>
</td>
<td class="num">$ (635)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase commitment obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 98.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_GainLossOnPurchaseCommitments', window );">Loss on purchase commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Property and equipment impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,412<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net of interest capitalized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,100<span></span>
</td>
<td class="nump">20,400<span></span>
</td>
<td class="nump">21,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Interest cost capitalized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Milestone Rights Liability | Senior convertible notes due December 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Long term liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ConsiderationReceived', window );">Total consideration received</a></td>
<td class="nump">$ 9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Intellectual property sold, net</a></td>
<td class="nump">7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AccruedExpensesRelatedParty', window );">Accrued expense associated with intellectual property</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AccruedExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Expenses Related Party</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AccruedExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ConsiderationReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consideration Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ConsiderationReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_GainLossOnPurchaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Purchase Commitments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_GainLossOnPurchaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MaturityPeriodOfCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maturity period of cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MaturityPeriodOfCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:durationStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfCreditExchangeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of credit exchange receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfCreditExchangeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 225<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51659069&amp;loc=d3e92212-112881<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Impairment<br> -URI http://asc.fasb.org/extlink&amp;oid=6515133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51719941&amp;loc=d3e2921-110230<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Allowance for Funds Used during Construction<br> -URI http://asc.fasb.org/extlink&amp;oid=6504829<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Charge to cost of goods sold that represents the reduction of the carrying amount of inventory, generally attributable to obsolescence or market conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28360613&amp;loc=d3e4542-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of debt not otherwise defined (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 8<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6608833280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>State Research and Development Credit Exchange Receivable - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AccountsAndOtherReceivablesLineItems', window );"><strong>Accounts and Other Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PercentageOfCreditExchangeReceivable', window );">Percentage of credit exchange receivable</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_EstimatedAmountsCreditExchangeReceivable', window );">Estimated amounts receivable under program</a></td>
<td class="nump">$ 743,000<span></span>
</td>
<td class="nump">$ 816,000<span></span>
</td>
<td class="nump">$ 282,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AccountsAndOtherReceivablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts and Other Receivables [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AccountsAndOtherReceivablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_EstimatedAmountsCreditExchangeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated amounts credit exchange receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_EstimatedAmountsCreditExchangeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfCreditExchangeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of credit exchange receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfCreditExchangeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6618453792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Components of Inventories (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 4,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">4,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory - current</a></td>
<td class="nump">9,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_InventoryCurrentAndNoncurrent', window );">Total Inventory</a></td>
<td class="nump">$ 9,670<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_InventoryCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory Current And Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_InventoryCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section BB<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51655945&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section BB<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section BB<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6848351360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 308,674<span></span>
</td>
<td class="nump">$ 310,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Less impairment</a></td>
<td class="num">(140,412)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(119,513)<span></span>
</td>
<td class="num">(118,221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">48,749<span></span>
</td>
<td class="nump">192,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">5,273<span></span>
</td>
<td class="nump">5,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 54,948<span></span>
</td>
<td class="nump">54,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 131,383<span></span>
</td>
<td class="nump">114,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 95,182<span></span>
</td>
<td class="nump">80,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 4,137<span></span>
</td>
<td class="nump">5,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures and office equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures and office equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 9,707<span></span>
</td>
<td class="nump">10,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 8,044<span></span>
</td>
<td class="nump">$ 39,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 225<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51659069&amp;loc=d3e92212-112881<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Impairment<br> -URI http://asc.fasb.org/extlink&amp;oid=6515133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51719941&amp;loc=d3e2921-110230<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 8<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6845533520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2016</div></th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($) </div>
<div>asset_group</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DepreciationAndOtherAmortizationExpensesLineItems', window );"><strong>Depreciation and Other Amortization Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AmortizationPeriodOfLeaseHoldImprovements', window );">Amortization period of lease hold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 11,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_NumberOfAssetGroups', window );">Number of primary asset groups | asset_group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mnkd_DanburyFacilityMember', window );">Danbury Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DepreciationAndOtherAmortizationExpensesLineItems', window );"><strong>Depreciation and Other Amortization Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorPropertyClassAxis=mnkd_ValenciaMember', window );">Valencia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DepreciationAndOtherAmortizationExpensesLineItems', window );"><strong>Depreciation and Other Amortization Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | License and Collaboration Agreement with Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DepreciationAndOtherAmortizationExpensesLineItems', window );"><strong>Depreciation and Other Amortization Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_TerminationDateOfLicenseAgreement', window );">Termination date</a></td>
<td class="text">Jul.  04,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AmortizationPeriodOfLeaseHoldImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period of lease hold improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AmortizationPeriodOfLeaseHoldImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DepreciationAndOtherAmortizationExpensesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Depreciation and Other Amortization Expenses [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DepreciationAndOtherAmortizationExpensesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NumberOfAssetGroups">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Asset Groups</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NumberOfAssetGroups</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_TerminationDateOfLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination Date Of License Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_TerminationDateOfLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2420-110228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_DanburyFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_DanburyFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorPropertyClassAxis=mnkd_ValenciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorPropertyClassAxis=mnkd_ValenciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783331248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems', window );"><strong>Accrued Expenses and Other Current Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salary and related expenses</a></td>
<td class="nump">$ 5,662<span></span>
</td>
<td class="nump">$ 14,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">2,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionPayableCurrent', window );">Construction in progress</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">1,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">7,539<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 7,929<span></span>
</td>
<td class="nump">$ 26,206<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Expenses and Other Current Liabilities [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AccruedExpensesAndOtherCurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782244880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Arrangements - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2007 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May. 31, 2015 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount available for future borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AccruedInterestOfRelatedPartyDebt', window );">Accrued interest of related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AvailableBorrowingsUnderLoanAgreement', window );">Available borrowings under loan agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,100,000<span></span>
</td>
<td class="nump">30,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Interest expense on note payable principal stockholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,894,000<span></span>
</td>
<td class="nump">2,894,000<span></span>
</td>
<td class="nump">$ 6,309,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PaymentsForUseOfAircrafts', window );">Expenses related to charter service on behalf of principal shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">79,000<span></span>
</td>
<td class="nump">82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mnkd_AlfredMannFoundationMember', window );">Mann Foundation | Sublease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AreaOfOfficeSpaceLeased', window );">Area of office space leased | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LeaseExpirationMonthYear', window );">Lease expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2017-04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_OfficeLeaseExpense', window );">Lease payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember', window );">Principal stockholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LoanAgreementWithRelatedParty', window );">Loan agreement with related party</a></td>
<td class="nump">$ 370,000,000<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember', window );">Principal stockholder | Amended Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  05,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember', window );">Principal stockholder | Loan Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Principal amount outstanding under credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount available for future borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Fixed borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.84%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_RelatedPartyTransactionPrepaymentPeriod', window );">Related party transaction prepayment period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_AvailableLoanBalanceCancelled', window );">Aggregate principal amount cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember', window );">Principal stockholder | Loan Arrangement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_RelatedPartyTransactionDebtInstrumentPrepayment', window );">Amount prepaid for cancellation of indebtedness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember', window );">Principal stockholder | Loan Arrangement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_NumberOfMonthsAdvancesOutstanding', window );">Number of months advances outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_RelatedPartyDebtMember', window );">Related Party Debt | Letter Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Description of variable rate interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The interest rate will increase to the one-year LIBOR rate  calculated on the date of the initial advance or in effect on the date of  default, whichever is greater, plus 5% per annum.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_RelatedPartyDebtMember', window );">Related Party Debt | Letter Agreement | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AccruedInterestOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued interest of related party debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AccruedInterestOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AreaOfOfficeSpaceLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area Of Office Space Leased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AreaOfOfficeSpaceLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AvailableBorrowingsUnderLoanAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available borrowings under the loan agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AvailableBorrowingsUnderLoanAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AvailableLoanBalanceCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available Loan Balance Cancelled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AvailableLoanBalanceCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LeaseExpirationMonthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Expiration Month Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LeaseExpirationMonthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LoanAgreementWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loan agreement with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LoanAgreementWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NumberOfMonthsAdvancesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of months advances outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NumberOfMonthsAdvancesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_OfficeLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Office Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_OfficeLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PaymentsForUseOfAircrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Use of Aircrafts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PaymentsForUseOfAircrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RelatedPartyTransactionDebtInstrumentPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction Debt Instrument Prepayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RelatedPartyTransactionDebtInstrumentPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RelatedPartyTransactionPrepaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party transaction prepayment period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RelatedPartyTransactionPrepaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19, 20, 22<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_AlfredMannFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_AlfredMannFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LeaseAgreementTypeOfAgreementAxis=mnkd_SubleaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LeaseAgreementTypeOfAgreementAxis=mnkd_SubleaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_PrincipalOwnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_AmendedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_AmendedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_LoanArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_LoanArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_RelatedPartyDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_RelatedPartyDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_LetterOfAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_LetterOfAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783260128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Senior Convertible Notes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Aug. 14, 2015</div></th>
<th class="th"><div>Aug. 10, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember', window );">Senior convertible notes due August 15, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unaccreted debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(645)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember', window );">Senior convertible notes due August 15, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 27,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Unamortized premium</a></td>
<td class="nump">660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unaccreted debt issuance cost</a></td>
<td class="num">(737)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount</a></td>
<td class="nump">$ 27,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 16<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt premium that was originally recognized at the issuance of the instrument that has yet to be amortized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6847866000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Senior Convertible Notes - Additional Information (Detail)<br> $ / shares in Units, $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 17, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 10, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 10, 2015 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 28, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 18, 2010 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 14, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Aggregate principal amount for conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,500<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,049)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Premium of issuance of 2018 debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,553<span></span>
</td>
<td class="nump">7,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandEighteenNotesMember', window );">2018 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Accretion of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandFifteenNotesMember', window );">2015 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Accretion of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments on senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember', window );">Senior convertible notes due August 15, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="nump">$ 27,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Unamortized premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 15,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">No of convertible shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147.0859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PrincipalAmountPerShare', window );">Principal amount per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of shares | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.80<span></span>
</td>
<td class="nump">$ 6.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Percentage of repurchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionDescription', window );">Debt Instrument, redemption description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On or after the date that is one year following the original issue date of the 2018 notes, the Company will have the right to redeem for cash all or part of the 2018 notes if the last reported sale price of its common stock exceeds 130% of the conversion price then in effect for 20 or more trading days during the 30 consecutive trading day period ending on the trading day immediately prior to the date of the redemption notice. The redemption price will equal the sum of 100% of the principal amount of the 2018 notes to be redeemed, plus accrued and unpaid interest.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Percentage of conversion price equaling stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays', window );">Consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCosts', window );">Debt Issuance Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Premium of issuance of 2018 debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember', window );">Senior convertible notes due August 15, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of shares | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.40<span></span>
</td>
<td class="nump">$ 4.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Aggregate principal amount for conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Number of shares issued up on conversion of debt | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Principal amount of debt converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Payments on senior notes</a></td>
<td class="nump">$ 32,100<span></span>
</td>
<td class="nump">$ 32,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember', window );">Senior convertible notes due December 31, 2019 | Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember', window );">Senior convertible notes due December 31, 2019 | Deerfield | Less portion of commitment asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PrincipalAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PrincipalAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Conversion Rate<br> -URI http://asc.fasb.org/extlink&amp;oid=6509012<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instruments must exceed threshold percentage for a specified number of trading days to trigger conversion feature, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of debt redemption features under terms of the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt premium that was originally recognized at the issuance of the instrument that has yet to be amortized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandEighteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TwoThousandEighteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandFifteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TwoThousandFifteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_TrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_TrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6848274592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative Arrangement - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 10, 2016</div></th>
<th class="th"><div>Jan. 04, 2016</div></th>
<th class="th"><div>Aug. 11, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Sep. 23, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Paid-in-kind interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember', window );">Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,500,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember', window );">Sanofi-Aventis Deutschland GmbH | CALIFORNIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UpfrontFee', window );">Up-front fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PotentialMilestonePayments', window );">Potential milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 775,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProfitLossSharingAgreementAllocationPercentage', window );">Profits and losses sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum secured loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_TerminationDateOfLicenseAgreement', window );">Termination date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  04,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Manufacturing Milestone Events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Milestone payments earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Development Milestone Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PotentialMilestonePayments', window );">Potential milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Regulatory Approvals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PotentialMilestonePayments', window );">Potential milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Product Sales Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PotentialMilestonePayments', window );">Potential milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UpfrontFee', window );">Up-front fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProfitLossSharingAgreementAllocationPercentage', window );">Profits and losses sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue from collaboration product shipments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PotentialMilestonePaymentsToBeReceived', window );">Milestone receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LossSharingAgreementAmount', window );">Company's total portion of loss sharing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum secured loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Secured loan facility, amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Secured loan facility, amount owed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Paid-in-kind interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Secured loan facility, amount borrowed</a></td>
<td class="nump">$ 17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH | Operating loss Sharing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LossSharingAgreementAmount', window );">Company's total portion of loss sharing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH | AFREZZA product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue from collaboration product shipments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LossSharingAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Sharing Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LossSharingAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PotentialMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PotentialMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PotentialMilestonePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential Milestone Payments To Be Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PotentialMilestonePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ProfitLossSharingAgreementAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Profit Loss Sharing Agreement Allocation Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ProfitLossSharingAgreementAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_TerminationDateOfLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination Date Of License Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_TerminationDateOfLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_UpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_UpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 16<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of deferred costs that are expected to be recognized as a charge against earnings in periods after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 17<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 13<br> -Section A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration recognized during the period for the milestone or milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 28<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=51671726&amp;loc=SL6892177-166501<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneEventsAxis=mnkd_ManufacturingMilestoneEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneEventsAxis=mnkd_ManufacturingMilestoneEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneEventsAxis=mnkd_DevelopmentMilestoneEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneEventsAxis=mnkd_DevelopmentMilestoneEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneEventsAxis=mnkd_FilingAndCompletionOfRegulatoryApprovalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneEventsAxis=mnkd_FilingAndCompletionOfRegulatoryApprovalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneEventsAxis=mnkd_AchievementOfProductSalesMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneEventsAxis=mnkd_AchievementOfProductSalesMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis=mnkd_OperatingLossSharingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis=mnkd_OperatingLossSharingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6847922224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2013</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Sep. 23, 2014</div></th>
<th class="th"><div>Dec. 31, 2012</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,074,000<span></span>
</td>
<td class="nump">$ 120,841,000<span></span>
</td>
<td class="nump">$ 70,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,840,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Cash equivalents, money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,800,000<span></span>
</td>
<td class="nump">118,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers of assets between fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Transfers of liabilities between fair value measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,749,000<span></span>
</td>
<td class="nump">192,127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Property and equipment impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,412,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember', window );">Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,500,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,500,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember', window );">Senior convertible notes due August 15, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,355,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember', window );">Senior convertible notes due August 15, 2015 | Convertible Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember', window );">Senior convertible notes due August 15, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,613,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember', window );">Senior convertible notes due August 15, 2018 | Convertible Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum secured loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum secured loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Reported Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember', window );">Milestone Rights Liability | Deerfield | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ContingentLiability', window );">Contingent liability for milestone payments</a></td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember', window );">Milestone Rights Liability | Senior convertible notes due December 31, 2019 | Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Market discount rate</a></td>
<td class="nump">17.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Long term liability</a></td>
<td class="nump">$ 13,100,000<span></span>
</td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure', window );">Property, plant, and equipment, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | License and Collaboration Agreement with Sanofi | Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Market discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Milestone Rights Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value of Milestone Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Income Approach Valuation Technique | Senior convertible notes due December 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Market discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Income Approach Valuation Technique | Milestone Rights Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Market discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Market Approach Valuation Technique | Senior convertible notes due August 15, 2015 | Convertible Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Fair value assumption, stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Market Approach Valuation Technique | Senior convertible notes due August 15, 2018 | Convertible Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Fair value assumption, stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Fair value assumption, risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FairValueOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value of Financial Instruments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FairValueOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 16<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13476-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 225<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51659069&amp;loc=d3e92212-112881<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Impairment<br> -URI http://asc.fasb.org/extlink&amp;oid=6515133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51719941&amp;loc=d3e2921-110230<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of debt not otherwise defined (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 8<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782387472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Carrying Values Estimated Fair Values of Notes and Facility Financing Obligation and Sanofi Loan Facility (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember', window );">Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ConvertibleDebtLineItems', window );"><strong>Convertible Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="nump">$ 44,500<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">36,500<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember', window );">Senior convertible notes due August 15, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ConvertibleDebtLineItems', window );"><strong>Convertible Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="nump">27,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember', window );">Senior convertible notes due August 15, 2018 | Convertible Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ConvertibleDebtLineItems', window );"><strong>Convertible Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="nump">27,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">21,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_FacilityFinancingObligationMember', window );">Facility financing obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ConvertibleDebtLineItems', window );"><strong>Convertible Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="nump">74,600<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">$ 78,400<span></span>
</td>
<td class="nump">75,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember', window );">Senior convertible notes due August 15, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ConvertibleDebtLineItems', window );"><strong>Convertible Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember', window );">Senior convertible notes due August 15, 2015 | Convertible Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ConvertibleDebtLineItems', window );"><strong>Convertible Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ConvertibleDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Debt [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ConvertibleDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 16<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13476-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_FacilityFinancingObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_FacilityFinancingObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6847101152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common and Preferred Stock - Additional Information (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 16, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 09, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 08, 2012 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>$ / Right </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 01, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 23, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 14, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">550,000,000<span></span>
</td>
<td class="nump">550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Undesignated preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Undesignated preferred stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428,670,943<span></span>
</td>
<td class="nump">406,059,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428,670,943<span></span>
</td>
<td class="nump">406,059,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock shares sold aggregate price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs associated with the Tel Aviv Stock Exchange | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice', window );">Percentage of shares of common stock issued for offering</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Restricted warrants issued to purchase number of common stock for offering</a></td>
<td class="nump">159,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of restricted warrants per share in connection with the offering | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ClassOfWarrantExercisablePeriod', window );">Warrants exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonStockLoanedUnderShareLendingAgreementShares', window );">Common stock loaned under share lending agreement, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_NominalLendingFee', window );">Nominal lending fee | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_SharesReturnedUnderShareLendingAgreement', window );">Returned shares of common stock under share lending agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UnitsSoldUnderPublicOfferUnderwritten', window );">Number of Unit Sold in an Underwritten public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,937,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock', window );">Warrant to purchase of a share of common stock | $ / Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants', window );">Net proceeds from offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,123<span></span>
</td>
<td class="nump">$ 27,779<span></span>
</td>
<td class="nump">$ 94,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ClassOfWarrantsOrRightsExpirationDate', window );">Warrants expiration, date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb.  08,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mnkd_WarrantLiabilityMember', window );">Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of restricted warrants per share in connection with the offering | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants are exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_WarrantsExercisableExpirationPeriod', window );">Duration for Expiration of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonStockIssuedToByPartyAxis=mnkd_UnderwritersMember', window );">Underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UnitsSoldUnderPublicOfferUnderwritten', window );">Number of Unit Sold in an Underwritten public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,687,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UnitsSoldByUnderwritingPrice', window );">Purchased Price of the units by underwriters | $ / Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonStockIssuedToByPartyAxis=mnkd_PublicMember', window );">Public</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UnitsSoldByUnderwritingPrice', window );">Purchased Price of the units by underwriters | $ / Right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription', window );">Units sold composition description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each unit consisting of  one share of common stock and a warrant to purchase 0.6 of a share of common  stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XTAE', window );">TEL AVIV STOCK EXCHANGE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage', window );">Percentage of shares price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,852,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock shares sold aggregate price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,710<span></span>
</td>
<td class="nump">$ 34,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs associated with the Tel Aviv Stock Exchange | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,433<span></span>
</td>
<td class="nump">$ 1,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember', window );">Senior convertible notes due August 15, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ClassOfWarrantExercisablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant exercisable period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ClassOfWarrantExercisablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Exercise Price Of Warrants Stated As Percentage Of Offering Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ClassOfWarrantExercisePriceOfWarrantsStatedAsPercentageOfOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ClassOfWarrantsOrRightsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrants Or Rights Expiration Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ClassOfWarrantsOrRightsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockLoanedUnderShareLendingAgreementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock loaned under share lending agreement, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockLoanedUnderShareLendingAgreementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NominalLendingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal lending fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NominalLendingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ProceedsFromIssuanceOfCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SharesReturnedUnderShareLendingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares Returned Under Share Lending Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SharesReturnedUnderShareLendingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares New Issues Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesNewIssuesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_UnitsSoldByUnderwritingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Units sold by underwriting price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_UnitsSoldByUnderwritingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_UnitsSoldUnderPublicOfferUnderwritten">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Units sold under public offer underwritten.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_UnitsSoldUnderPublicOfferUnderwritten</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Units sold under public offer underwritten composition description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Units sold warrant portion convertible into common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_UnitsSoldWarrantPortionConvertibleIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_WarrantsExercisableExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable expiration period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_WarrantsExercisableExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30, 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mnkd_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mnkd_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockIssuedToByPartyAxis=mnkd_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockIssuedToByPartyAxis=mnkd_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockIssuedToByPartyAxis=mnkd_PublicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockIssuedToByPartyAxis=mnkd_PublicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XTAE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XTAE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_SeniorConvertibleNotesDueTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6638924304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net Loss per Common Share - Additional Information (Detail) - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_NetIncomeLossPerCommonShareLineItems', window );"><strong>Net Income Loss Per Common Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommonStockLoanedUnderShareLendingAgreementShares', window );">Return of loaned common stock (in shares)</a></td>
<td class="nump">9,000,000<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OwnshareLendingArrangementSharesIssued', window );">Shares loaned under the share lending arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockLoanedUnderShareLendingAgreementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock loaned under share lending agreement, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockLoanedUnderShareLendingAgreementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NetIncomeLossPerCommonShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income Loss Per Common Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NetIncomeLossPerCommonShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OwnshareLendingArrangementSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in connection with an own-share lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=7656903&amp;loc=SL6757479-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OwnshareLendingArrangementSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783428752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Potentially Dilutive Securities Outstanding (Detail) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding</a></td>
<td class="nump">29,731,254<span></span>
</td>
<td class="nump">51,463,340<span></span>
</td>
<td class="nump">78,475,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding</a></td>
<td class="nump">19,779,229<span></span>
</td>
<td class="nump">21,541,664<span></span>
</td>
<td class="nump">24,237,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding</a></td>
<td class="nump">4,072,809<span></span>
</td>
<td class="nump">17,323,080<span></span>
</td>
<td class="nump">25,415,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding</a></td>
<td class="nump">4,074,596<span></span>
</td>
<td class="nump">9,987,876<span></span>
</td>
<td class="nump">19,706,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities outstanding</a></td>
<td class="nump">1,804,620<span></span>
</td>
<td class="nump">2,610,720<span></span>
</td>
<td class="nump">9,115,821<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6846089456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2004</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>May. 23, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_SharesReservedForEmployeeStockPurchasePlan', window );">Share reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PercentageOfCommonStockSharesOutstanding', window );">Share of common stock outstanding</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares sold to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321,228<span></span>
</td>
<td class="nump">305,076<span></span>
</td>
<td class="nump">463,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockOptionsGrantedVestingRate', window );">Stock option grants vest exercisable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,779,229<span></span>
</td>
<td class="nump">21,541,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense related to stock award plans and the ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,725<span></span>
</td>
<td class="nump">$ 48,622<span></span>
</td>
<td class="nump">$ 45,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of the stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.56<span></span>
</td>
<td class="nump">$ 4.76<span></span>
</td>
<td class="nump">$ 3.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="nump">$ 14,900<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions', window );">Cash received from the exercise of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 11 months 19 days<span></span>
</td>
<td class="text">6 years 3 months 22 days<span></span>
</td>
<td class="text">6 years 4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest', window );">Restricted stock units expected to vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,651,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest', window );">Weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ValueOfRestrictedStockUnitsVested', window );">Total intrinsic value of restricted stock units expected to vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Total intrinsic value of restricted stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="nump">$ 62,700<span></span>
</td>
<td class="nump">$ 13,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of restricted stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="nump">36,400<span></span>
</td>
<td class="nump">14,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average vesting period for unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,725<span></span>
</td>
<td class="nump">$ 48,622<span></span>
</td>
<td class="nump">$ 45,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance | Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Restricted stock vesting rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PercentageOfShareReservedForShareBasedCompensation', window );">Shares reserved under ESPP</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Options granted expiry term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_StockAwardPlanTypeAxis=mnkd_ConsultantMember', window );">Consultant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non vested stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to non vested stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-based stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember', window );">2013 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Equity incentive plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,026,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_EmployeeStockPurchasePlansMember', window );">Employee Stock Purchase Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for issuance</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,752,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares', window );">Share reserve automatic increase each year</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan Annual Increase In Reserved Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_EmployeeStockPurchasePlanAnnualIncreaseInReservedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Common Stock Shares Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfShareReservedForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Share Reserved For Share Based Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfShareReservedForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement Restricted Stock Units Number Of Units Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SharesReservedForEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares Reserved For Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SharesReservedForEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockOptionsGrantedVestingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Options Granted Vesting Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockOptionsGrantedVestingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ValueOfRestrictedStockUnitsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of Restricted Stock Units Vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ValueOfRestrictedStockUnitsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant date fair value of restricted stock units expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br> -Section F<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received by the entity during the annual period from exercises of stock or unit options and conversion of similar instruments granted under equity-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of equity-based compensation awards vested. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockAwardPlanTypeAxis=mnkd_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockAwardPlanTypeAxis=mnkd_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_EmployeeStockPurchasePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_EmployeeStockPurchasePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783424560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock Based Award Plans (Detail) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Options</a></td>
<td class="nump">19,779,229<span></span>
</td>
<td class="nump">21,541,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding Restricted Stock Units</a></td>
<td class="nump">1,804,620<span></span>
</td>
<td class="nump">2,610,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Future Issuance</a></td>
<td class="nump">15,540,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_TwoThousandFourEquityIncentivePlanMember', window );">2004 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Options</a></td>
<td class="nump">11,309,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding Restricted Stock Units</a></td>
<td class="nump">276,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember', window );">2013 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Options</a></td>
<td class="nump">8,026,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding Restricted Stock Units</a></td>
<td class="nump">1,527,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Future Issuance</a></td>
<td class="nump">15,540,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember', window );">2004 Non Employee Directors Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Options</a></td>
<td class="nump">443,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_TwoThousandFourEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_TwoThousandFourEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_TwoThousandFourNonEmployeeDirectorsStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6846478320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation Expense Recognized in Accompanying Statements of Operation (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">$ 8,725<span></span>
</td>
<td class="nump">$ 48,622<span></span>
</td>
<td class="nump">$ 45,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=mnkd_EmployeeMember', window );">Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">8,407<span></span>
</td>
<td class="nump">$ 48,622<span></span>
</td>
<td class="nump">45,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=mnkd_ConsultantMember', window );">Consultant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">$ 318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br> -Section F<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=mnkd_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=mnkd_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=mnkd_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=mnkd_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6778868672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Based Compensation Expense Recognized in Accompanying Statements of Operations by Category (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">$ 8,725<span></span>
</td>
<td class="nump">$ 48,622<span></span>
</td>
<td class="nump">$ 45,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">3,029<span></span>
</td>
<td class="nump">22,357<span></span>
</td>
<td class="nump">20,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">$ 5,696<span></span>
</td>
<td class="nump">$ 26,265<span></span>
</td>
<td class="nump">$ 24,777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br> -Section F<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781423632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Employee Stock Options Assumptions (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">1.61%<span></span>
</td>
<td class="nump">1.64%<span></span>
</td>
<td class="nump">0.94%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">1.86%<span></span>
</td>
<td class="nump">2.11%<span></span>
</td>
<td class="nump">1.82%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, minimum</a></td>
<td class="nump">69.76%<span></span>
</td>
<td class="nump">73.98%<span></span>
</td>
<td class="nump">75.83%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, maximum</a></td>
<td class="nump">71.84%<span></span>
</td>
<td class="nump">84.85%<span></span>
</td>
<td class="nump">86.26%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected lives</a></td>
<td class="text">5 years 9 months 15 days<span></span>
</td>
<td class="text">5 years 9 months 7 days<span></span>
</td>
<td class="text">2 years 7 months 21 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems', window );"><strong>Fair Value Inputs, Liabilities, Quantitative Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected lives</a></td>
<td class="text">5 years 10 months 10 days<span></span>
</td>
<td class="text">6 years 1 month 2 days<span></span>
</td>
<td class="text">5 years 9 months 7 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsLiabilitiesQuantitativeInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br> -Section D<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6846594656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Stock Options Outstanding (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at January 1, 2015 | shares</a></td>
<td class="nump">21,541,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">1,541,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(1,700,964)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited | shares</a></td>
<td class="num">(706,387)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired | shares</a></td>
<td class="num">(896,184)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at December 31, 2015 | shares</a></td>
<td class="nump">19,779,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at December 31, 2015 | shares</a></td>
<td class="nump">19,597,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at December 31, 2015 | shares</a></td>
<td class="nump">17,217,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at January 1, 2015 | $ / shares</a></td>
<td class="nump">$ 4.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">4.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="nump">1.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited | $ / shares</a></td>
<td class="nump">5.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired | $ / shares</a></td>
<td class="nump">7.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at December 31, 2015 | $ / shares</a></td>
<td class="nump">4.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest at December 31, 2015 | $ / shares</a></td>
<td class="nump">4.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at December 31, 2015 | $ / shares</a></td>
<td class="nump">$ 4.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at January 1, 2015 | $</a></td>
<td class="nump">$ 33,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at December 31, 2015 | $</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at December 31, 2015 | $</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at December 31, 2015 | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28,29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6609039040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Restricted Stock Unit Activity (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at January 1, 2015 | shares</a></td>
<td class="nump">2,610,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">1,133,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(1,111,134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited | shares</a></td>
<td class="num">(828,370)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at December 31, 2015 | shares</a></td>
<td class="nump">1,804,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value Per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at January 1, 2015 | $ / shares</a></td>
<td class="nump">$ 5.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted | $ / shares</a></td>
<td class="nump">4.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested | $ / shares</a></td>
<td class="nump">4.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited | $ / shares</a></td>
<td class="nump">4.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at December 31, 2015 | $ / shares</a></td>
<td class="nump">$ 4.85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6838092976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2014 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jul. 01, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease rent expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 426,000<span></span>
</td>
<td class="nump">$ 737,000<span></span>
</td>
<td class="nump">$ 645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Purchase commitment amount under Insulin Supply Agreement</a></td>
<td class="nump">&#8364; 120.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase obligation remaining amount in 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 98.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Purchase obligation, due in 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Purchase obligation, due in 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Purchase obligation, due in 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">Purchase obligation, due in 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 23.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LongTermPurchaseCommitmentCancellationFees', window );">Purchase commitment cancellation fees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LongTermPurchaseCommitmentExpirationDate', window );">Supply Agreement expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LongtermPurchaseCommitmentRenewalTimePeriod', window );">Supply Agreement renewal period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Milestone Rights Liability | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ContingentLiability', window );">Contingent liability for milestone payments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LongTermPurchaseCommitmentCancellationFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long Term Purchase Commitment Cancellation Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LongTermPurchaseCommitmentCancellationFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LongTermPurchaseCommitmentExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long Term Purchase Commitment, Expiration Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LongTermPurchaseCommitmentExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LongtermPurchaseCommitmentRenewalTimePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term purchase commitment, renewal time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LongtermPurchaseCommitmentRenewalTimePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the fourth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the next fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the second fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the third fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6608769520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contribution savings retirement plan</a></td>
<td class="nump">$ 593,000<span></span>
</td>
<td class="nump">$ 623,000<span></span>
</td>
<td class="nump">$ 533,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in the fair value of plan assets from contributions made by the employer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=58740216&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6846163216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provision for Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">U.S. federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">U.S. state</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">U.S. federal</a></td>
<td class="nump">109,512<span></span>
</td>
<td class="nump">57,873<span></span>
</td>
<td class="nump">59,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">U.S. state</a></td>
<td class="num">(29,394)<span></span>
</td>
<td class="nump">7,631<span></span>
</td>
<td class="nump">7,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOtherTaxExpenseBenefit', window );">Valuation Allowance</a></td>
<td class="num">(80,118)<span></span>
</td>
<td class="num">(65,504)<span></span>
</td>
<td class="num">(66,849)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_IncomeTaxExpenseBenefitNet', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IncomeTaxExpenseBenefitNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense Benefit Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IncomeTaxExpenseBenefitNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Paragraph Question 1-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g),(h)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6510177<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 6<br> -Section I<br> -Subsection 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781685152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Components of Net Deferred Tax Asset (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 721,588<span></span>
</td>
<td class="nump">$ 699,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credits</a></td>
<td class="nump">73,646<span></span>
</td>
<td class="nump">73,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsCapitalizedResearchExpenses', window );">Capitalized research</a></td>
<td class="nump">5,872<span></span>
</td>
<td class="nump">28,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Payments from collaboration</a></td>
<td class="nump">52,484<span></span>
</td>
<td class="nump">19,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsMilestoneRights', window );">Milestone Rights</a></td>
<td class="nump">3,242<span></span>
</td>
<td class="nump">5,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Accrued expenses</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsLossOnPurchaseCommitment', window );">Loss on purchase commitment</a></td>
<td class="nump">24,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Non-qualified stock option expense</a></td>
<td class="nump">16,941<span></span>
</td>
<td class="nump">43,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsCapitalizedCosts', window );">Capitalized patent costs</a></td>
<td class="nump">8,574<span></span>
</td>
<td class="nump">8,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">7,186<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Depreciation</a></td>
<td class="nump">48,755<span></span>
</td>
<td class="nump">3,010<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total net deferred tax assets</a></td>
<td class="nump">962,623<span></span>
</td>
<td class="nump">882,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(962,623)<span></span>
</td>
<td class="num">(882,502)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsCapitalizedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Capitalized Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsCapitalizedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsCapitalizedResearchExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Capitalized Research Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsCapitalizedResearchExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsLossOnPurchaseCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Loss on Purchase Commitment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsLossOnPurchaseCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsMilestoneRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Milestone Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsMilestoneRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from other provisions, reserves, allowances, and accruals not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6834341120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes -Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2004</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DeferredTaxAssetIncreaseDecreaseInEquity', window );">Amount Equity would be increased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in the valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.1<span></span>
</td>
<td class="nump">$ 65.5<span></span>
</td>
<td class="nump">$ 66.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_OperatingLossCarryforwardsSubjectToLimitation', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 216.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_NetOperatingLossCarryforwardAnnualLimitation', window );">Net operating loss and credit carryforwards, annual use limitation</a></td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_NetOperatingLossCarryforwardsBeginsToExpire', window );">Net operating loss carryforwards, expiration year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Research and development credits subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ResearchAndDevelopmentCreditsBeginToExpire', window );">Federal research and development credits begin to expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Research and development credits not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetIncreaseDecreaseInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset Increase Decrease in Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetIncreaseDecreaseInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NetOperatingLossCarryforwardAnnualLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Operating Loss Carryforward Annual Limitation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NetOperatingLossCarryforwardAnnualLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NetOperatingLossCarryforwardsBeginsToExpire">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Operating Loss Carryforwards Begins To Expire</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NetOperatingLossCarryforwardsBeginsToExpire</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_OperatingLossCarryforwardsSubjectToLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards Subject To Limitation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_OperatingLossCarryforwardsSubjectToLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ResearchAndDevelopmentCreditsBeginToExpire">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Credits, Begin to Expire</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ResearchAndDevelopmentCreditsBeginToExpire</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6613877888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Effective Income Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ScheduleOfIncomeTaxesLineItems', window );"><strong>Schedule Of Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal tax benefit rate</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax benefit, net of federal benefit</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Intercompany transfer of intellectual property</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(4.10%)<span></span>
</td>
<td class="num">(4.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(33.80%)<span></span>
</td>
<td class="num">(31.80%)<span></span>
</td>
<td class="num">(30.70%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Permanent Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ScheduleOfIncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ScheduleOfIncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783821824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Facility Agreement - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2013</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Facility Agreement, total principle payment in 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Facility Agreement, total principle payment in 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Facility Agreement, total principle payment in 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Facility Agreement, total principle payment in 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtCurrent', window );">Short term liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,582,000<span></span>
</td>
<td class="nump">$ 72,995,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,231,000<span></span>
</td>
<td class="nump">17,549,000<span></span>
</td>
<td class="nump">$ 15,153,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember', window );">Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,500,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1', window );">Principal repayment schedule, start date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_DebtInstrumentDateOfLastRequiredPayment', window );">Principal repayment schedule, end date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  09,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Senior convertible notes due December 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt facility principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Senior convertible notes due December 31, 2019 | Facility Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Uncreated debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Uncreated debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Less portion of commitment asset | Senior convertible notes due December 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt facility principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Less portion of commitment asset | Minimum | Senior convertible notes due December 31, 2019 | Facility Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity', window );">Available amount of credit facility under covenant restrictions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Milestone Rights Liability | Senior convertible notes due December 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtCurrent', window );">Short term liability</a></td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Long term liability</a></td>
<td class="nump">$ 13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PaymentForContingentLiabilities', window );">Required payment pursuant to the terms of the Milestone Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate</a></td>
<td class="nump">17.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsEntityCreditRisk', window );">Risk premium</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Fair value of milestone rights</a></td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Milestone Rights Liability | Senior convertible notes due December 31, 2019 | Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_PaymentForContingentLiabilities', window );">Required payment pursuant to the terms of the Milestone Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Milestone Rights Liability | Senior convertible notes due December 31, 2019 | Danbury Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Milestone Rights Liability | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ContingentLiability', window );">Contingent liability for milestone payments</a></td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentDateOfLastRequiredPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Date Of Last Required Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentDateOfLastRequiredPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility Restricted Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LineOfCreditFacilityRestrictedBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PaymentForContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment For Contingent Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PaymentForContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 20<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 16<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt agreement requires the first payment to be made, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDateOfFirstRequiredPayment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsEntityCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk associated with risk of default, credit spread risk and downgrade risk, expressed as a percentage, used as an input to measure fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsEntityCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including both current and noncurrent portions, carrying amount as of the balance sheet date of other forms of debt not elsewhere specified in the taxonomy with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19, 20, 22<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt not otherwise specified in the taxonomy that is scheduled to be repaid within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19, 20<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of debt not otherwise defined (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_TwoThousandNineteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AgreementsAxis=mnkd_FacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AgreementsAxis=mnkd_FacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_TrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_TrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_DanburyFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_DanburyFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6617937488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accretion of Debt Issuance Cost and Debt Discount in Connection with Deerfield Financing (Detail) - Deerfield - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Accretion expense- debt issuance cost</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion expense- debt discount</a></td>
<td class="nump">$ 1,553<span></span>
</td>
<td class="nump">$ 7,550<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 8<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783427408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2015 </div>
<div>Employee</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent', window );">Percentage of workforce reduction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Number of employees eliminated | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payment to restructuring</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restucturing accrual</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section P<br> -Subsection 3, 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6834634208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data (Detail) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_InterimReportingLineItems', window );"><strong>Interim Reporting [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (277,020)<span></span>
</td>
<td class="num">$ (31,857)<span></span>
</td>
<td class="num">$ (28,910)<span></span>
</td>
<td class="num">$ (30,658)<span></span>
</td>
<td class="num">$ (36,439)<span></span>
</td>
<td class="num">$ (36,520)<span></span>
</td>
<td class="num">$ (73,365)<span></span>
</td>
<td class="num">$ (52,056)<span></span>
</td>
<td class="num">$ (368,445)<span></span>
</td>
<td class="num">$ (198,382)<span></span>
</td>
<td class="num">$ (191,490)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted</a></td>
<td class="num">$ (0.66)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.14)<span></span>
</td>
<td class="num">$ (0.91)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (0.64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding', window );">Weighted average common shares used to compute basic and diluted net loss per share</a></td>
<td class="nump">419,314<span></span>
</td>
<td class="nump">405,199<span></span>
</td>
<td class="nump">401,018<span></span>
</td>
<td class="nump">398,916<span></span>
</td>
<td class="nump">396,793<span></span>
</td>
<td class="nump">394,163<span></span>
</td>
<td class="nump">380,770<span></span>
</td>
<td class="nump">368,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares used to compute basic and diluted net loss per share applicable to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BasicAndDilutedWeightedAverageNumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_InterimReportingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interim Reporting [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_InterimReportingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6615474384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Selected Quarterly Financial Data - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_InterimReportingLineItems', window );"><strong>Interim Reporting [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="nump">$ 242.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_InterimReportingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interim Reporting [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_InterimReportingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2420-110228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6845720624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Detail) - License and Collaboration Agreement with Sanofi - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 10, 2016</div></th>
<th class="th"><div>Jan. 04, 2016</div></th>
<th class="th"><div>Aug. 11, 2014</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProfitLossSharingAgreementAllocationPercentage', window );">Profits and losses sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_ProfitLossSharingAgreementAllocationPercentage', window );">Profits and losses sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Secured loan facility, amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mnkd_TerminationDateOfLicenseAgreement', window );">Termination date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  04,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Sanofi-Aventis Deutschland GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Secured loan facility, amount borrowed</a></td>
<td class="nump">$ 17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ProfitLossSharingAgreementAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Profit Loss Sharing Agreement Allocation Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ProfitLossSharingAgreementAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_TerminationDateOfLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination Date Of License Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_TerminationDateOfLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_SanofiAventisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>102
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MX$G1H>)%]2-F Q+M*;V"^GH A3&^.R6:E((C-Z."N[_8_ )02P,$%     @
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M.J^4W?7S[C?R=>K/$/?7H=Z7'U!+ P04    " !8BF](U *'&9@$  "%$0
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M33,Y9^:\-X&@X_7VNEVAU7]02P,$%     @ 6(IO2!TIO?65 P  U0\  !@
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M'JOJ4/CTT'*QL+1_+WLZBQE>0PI>)D6"Z]L^12%Q*;"T02^+]P :2B#(@DI
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M/J3#\-PL'\X?ULUCU[_UZ?WN^%O@XX>N?3G]M/G\^^K;_P!02P,$%     @
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MN</;=M\-_R]NG[N^/5R:+!>'^L?XN3L.GR_C7X*8FO$-U-1 O3:0[I<-]-1
M_VQ@?MG 3 T,:; :IS(L1%7W]69]:E\6W5-]WA[R.LI/YTYBSXLX^V[X.:SO
M>/7[1IJP7GT_=P2:[:A1H^95L8J]LT,H'&*KDN:*&Z!,%9J55*G$A_>-T&2>
M>FBOIWD6[W=@2 =FZ, ,'106;3R.$QTE?I!<:1>,874EZ&01=%"<KB*Z:+9X
MWVY+[+;IQ&U&!XYTX)*)2RO9F8\:-VJT\HZ=-ZB"]>SJ5* RPOKW3?;$9 \F
MLXN[]<DPP2O^3J4B$YSB[Q.HK SN?8L#L3@D%H>"-3BDZR)RMG!!!BG20?@M
M7"2#."==QN)+09$B8/DU.] D&D?2+DXH8Z0W\)(PDN%'DF1#\=Y6@J[P[)T&
M39 YJZ.HS0ILYF_#))IL=LD6GA^($D]J&(AWR4GD+LS2&0-1,DH# [$KMYU$
MXT#*\>M;@NI*"OXF0%<9!E,D2F1B1C21%(H2J<A[K$Q1=J6<T>P.+5%7.)]!
M:4F9)U/HZ9EME9+*"B-9WRQ!=A5U.H-HDB)-IDS3@3<(H*8-3Z429%?2>'XA
M*]29(H.1DD)2II34,YNY 'NTU1DC*<I)E7+2\%%*I9A,PW>Z/""Z<M)F&$-1
MJE*4\GG+5@']YG8/J/1<S 15]'2?DUA2EJJ4I88EW%8I&$@9QZ,'=&HFA:E
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MG!0:G@VQ@U+<?*U!XKBB,[HOO(BV<Z' RH)-O%HHT%:@)@::%;V9+=?S@(B
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MB\Y?3+R3!M&!-Y&=+2CI_/.?$@F-"^&ECTUZ$2EQV!_>]_23E5]02P,$%
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M>.2F%MJ2/3H_F#B3"M&!-Y&<K2AI_/I/@83*A>NEOYMA(X; 87O<[^DGR[\
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M\/SG1$'M8W@58CN^B#'QV$WO>_[)BF]02P,$%     @ 6(IO2"E!,E"2 0
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M27?2('H()K*S"TJZ\/SG1$'C8W@58CN]B"GQV._?]_R3E=]02P,$%     @
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M+W-H965T,C N>&ULA5/;;N,@$/T5Q <4FVPOBAQ+3:K5[L-*51]VGXD]ME&
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MT/@87H;83N]A2CSVI]<]_V+E.U!+ P04    " !8BF](&>;V0)$!  !P P
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M$/T5P@=(E_6ZZ39Q-48?3(P/^LRVTY8(3 6ZU;\7:+?N&J,O968XY\P9H/F
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M\$^([7@CQL1C=[C?\T]6? -02P,$%     @ 6(IO2%HGVYC9 0  :04  !D
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M!8V/X5V([?0BIL1C/[_OY2<K/P%02P,$%     @ 6(IO2-6_FNCL @  OPP
M !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&ULG9=-<YLP$(;_"L.]01("
M0<;V3.,XB0^=R>30GHDMVTP N4B.TW]?(61'4D6-<PD??MYW=[6L I,C:]_X
MCE(1?-15PZ?A3HC];13QU8[6!;]A>]K(7S:LK0LA+]MMQ/<M+=9*5%<1 B"-
MZJ)LPME$W7MN9Q-V$%79T.<VX(>Z+MH_=[1BQVD(P].-EW*[$]V-:#:)SKIU
M6=.&EZP)6KJ9AM_A[1(I1!$_2WKDQGG0)?_*V%MWL5Q/0]#E0"NZ$IU%(0_O
M=$ZKJG.2D7]KT\^8G= \/[D_J')E^J\%IW-6_2K78B>S!6&PIIOB4(D7=GRB
MNH:D,URQBJN_P>K !:M/DC"HBX_^6#;J>.Q_R8"6^05("]!9<([C%\1:$'\*
M\'\%6 OP6$&B!<G8E%(M2,<*B!:0L2EE6I"-%>1:D#N"J.^?ZOY](8K9I&7'
M@.^+;B;@K<3;SD0Z![+E7%VJAZJ_^SZ+$9Q$[YV1Q=SU#-(,\C%SFXE]S+W-
M8!^S,!EOI ?;Q8<\VDCB8YY,AF0^9&G;I&<FDNOJ75SD+"Y2!K$V()<-8L<@
M5@98&:2IG633+UB/$(5\0UDJ&Y0# 'SL@\WB'),,F^Q@7MC)"QMYQ=B;5X^D
M"DER0/!04MA("B*083A /IDD :0KTPLN33"%JL81129.D8E9),J\529&I!AT
MF8^)E#J14BM2?MF . ;DV@<M<PPR,X/8NZKWF=FH!("1Q>9.J-P*Y=UQYC;C
M'?+%$#.8" 3NW@<LB]A7]:.&=-DD&5LV_&>GA58T/,+"W4_@U1L*='<4&%_N
M] +&7VLU=/<)B$<TVX&\V_5B$!I.QIUGF%QN]P(F7VRW.]/0&NIXQ'\/Z$XU
MO'JLH3O7T!YLXJ_9G&PTOF1WLJ$]DMEE"^2.) +7EHS<.4/VG.6^Q^G.AK!;
M;62\1.V++?U1M-NRX<$K$_)]3+V*;1@35%J!&_G$[.37Q/FBHAO1G1)YWO;O
MU_V%8/O3Y\+YFV7V%U!+ P04    " !8BF](*M.3PB$#  "?#0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T,"YX;6R5E]MRFS 0AE^%X;Y!)P1D;,_4AZ2]
MZ$RF%^TUL66;"2 7Y#A]^PHANY(BQ\J-.?C;_7=7\ .3$^]>^CUC(GIKZK:?
MQGLA#O=)TJ_WK"G[.WY@K?QGR[NF%/*PVR7]H6/E1@4U=8( H$E35FT\FZAS
M3]ULPH^BKEKVU$7]L6G*[N^<U?PTC6%\/O&SVNW%<"*939)+W*9J6-M7O(TZ
MMIW&7^'](T(#HHA?%3OUQGXT%/_,^<MP\'TSC<%0 ZO96@PI2KEY90M6UT,F
MJ?Q')_VO.02:^^?L#ZI=6?YSV;,%KW]7&[&7U8(XVK!M>:S%3W[ZQG0/Z9!P
MS>M>_4;K8R]X<PZ)HZ9\&[=5J[:G\9\<Z#!_ -(!Z!* X(<!6 ?@2P#Y.(#H
M !*JD.J -#2 Z@ :&I#I@,P)2,;IJK59EJ*<33I^BOI#.5RQ\%[BW9!$9H[D
M@O3J4"WY>/9UA@F<)*]#(HN9CPS2#/(Q"YO!/F9I,\3'K&PF]3$/-D-]S*/-
M9!<FD3/Q#@8Y@T$J =8)\ML)L), JP1$)RB\4[.8%-P6(8X(L1)XEV]A,3B]
M+9(Z(JF9(+<UVE%C1#*%$ "]T-*$$$" WBZ%.J50JU_DK65DJ&)@"D# 6#-'
M)C-D<G_'F:F"*?5V;$$T*WS0*C/&\H6&+%#NE)M;4\'>>G.C%$QQR%0*1Z:P
M9(A7IC [AA09.@;V,&*%PHK\+J!G"%SG N8BI=YJ-#.60ZE<@@"A=Q8)32%_
MVYK1?1- H/?:7%J<=S2K*\CU>EWG@LA:IRN3088*(M"_3DL; \2/K6QLN.D"
MZG8-$]INZ+VC%AK2@[Y6-39NJ?Q:S=CRK)"*7?>%MOV&7%RNM\+TL\\9Z'HB
MM$W1;U?0=,6\\,_D45.9=C48-!77/&%FU5,$I' -#>:?GHIK5M!R*^KM=ZZA
ML=\BR!21ZT,(6$+0*X1,(\J*("'7AQ"TA+P&,]=0=C:B$*%WKSZF@5QY_&GF
MJDYBO(8>RAW[47:[JNVC9R[D&ZUZF=UR+IC,!>[D/;"77TN7@YIMQ;";R?UN
M_'X8#P0_G#^'+M]DLW]02P,$%     @ 6(IO2.Y^GZ#D 0  #P4  !D   !X
M;"]W;W)K<VAE971S+W-H965T-#$N>&ULA53;CILP$/T5BP]8<T\4$:1-HJI]
MJ+3:A_;9@>&BM3&U3=C^?7TAA$1T\X(]P[G,6&-G(Q<?L@%0Z)/13NZ]1JE^
MA[$L&F!$OO >.OVGXH(1I4-18]D+(*4E,8I#WT\Q(VWGY9G-O8D\XX.B;0=O
M LF!,2+^'H#R<>\%WC7QWM:-,@F<9WCFE2V#3K:\0P*JO?<:[$Z)05C KQ9&
MN=@C4_N9\P\3_"CWGF]*  J%,@I$+Q<X J5&2!O_F31OEH:XW%_5O]EN=?5G
M(N'(Z>^V5(TNUO=0"149J'KGXW>86K 5%IQ*^T7%(!5G5XJ'&/ET:]O9=71_
MMOY$6R>$$R&<"4'Z)2&:"-&-$'])B"="_$# KA5[$">B2)X)/B+9$S,=P4[#
MA1'1RDAW+VUHS]=E+WF41AF^&*$[S,%A0HL)9@36ZJL6X;W%(5S0PS6#XQ(1
MK4).2\AF^[R(Z*'/R/*CJ<_XN4#\(!!;@=@)),'J0=UAHN2Y2?)@DBP%TN3>
MI',F#K-Q)Q%'ON^OP8Y+V#9(_P,[+6'A-ES"7-5X,4\,1&TOID0%'SKE!F?.
MSG?_-;3S>(/G64]J^$E$W782G;G24VT'NN)<@:[#?]&%-/IUF@,*E3+;C=X+
M=V%=H'A_?7[F-S#_!U!+ P04    " !8BF](7H,ZP\@!  #0!   &0   'AL
M+W=O<FMS:&5E=',O<VAE970T,BYX;6R%E,UNHS 4A5_%X@%J((";B"!-.AJU
MBY&J+CIK)UP"JHT9VPF=MZ]_" .(*IO8UYQ[ON-@G/="?J@:0*-/SEJU#VJM
MNQW&ZE0#I^I!=-":)Y60G&I3RC-6G01:NB;.<!R&&>:T:8,B=VNOLLC%1;.F
MA5>)U(5S*O\=@(E^'T3!;>&M.=?:+N BQV-?V7!H52-:)*':!S^BW8%8A1.\
M-]"KR1S9[$<A/FSQ4NZ#T$8 !B=M':@9KO $C%DC _X[>/Y'VL;I_.;^R^W6
MI#]2!4^"_6E*79NP88!*J.B%Z3?1/\.PA=0:G@13[A>=+DH+?FL)$*>??FQ:
M-_;^21H.;>L-\= 0CPVQ#^Y!+N9/JFF12]$CU5'[[J*=D4MK8IR1R:9<Z7;O
M5Z_%)LMR?+5&,\W!:V*O29)1@XW_*B1>0&)GL!D@Y+[!9F&P<0;)8/ X3]GZ
ME%Y#G"9Y3+/[E&1!26:4[2K%:S)/(='V/B5=4-(IA82KE'1"V:;W&=F"D<T8
MT2HCFS*R29!O*61!(3-*O$HAD[>R0L&3T]K1,_RF\MRT"AV%-@??G?E*" W&
M*GPP_TIMKI>Q8%!I.R5F+OT7YPLMNMO],5YBQ1=02P,$%     @ 6(IO2$GJ
M]+8\!   +A<  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULE9C;;N,V
M$(9?1?!]5SP,=0@< VL;17M18+$7[;5BTP>L)+J2$F_?OI+(..1868]N8DG^
M9_@/,Q]%<WDUS8_VI'47_:S*NGU>G+KN\A3'[>ZDJZ+]8BZZ[K\YF*8JNOZV
M.<;MI='%?@RJRE@PEL15<:X7J^7X[%NS6IK7KCS7^EL3M:]5533_K75IKL\+
MOGA_\/U\/'7#@WBUC&]Q^W.EZ_9LZJC1A^?%5_ZT5>D@&15_G_6U]:ZCP?R+
M,3^&FS_WSPLV>-"EWG5#BJ+_>-,;799#IG[D?UW2CS&'0/_Z/?OO8[F]_9>B
MU1M3_G/>=Z?>+5M$>WTH7LONN[G^H5T-:DBX,V4[_HUVKVUGJO>01505/^WG
MN1X_K_8;6]BG <(%B%L 3WX9(%V _ B 7P: "P 4$-M2QHG8%EVQ6C;F&K67
M8F@/_M3+FR%)GSGJJV_'VW%^[=.WE4SE,GX;$@6:M=6(4<-OBKC//CF$"(=8
M"R]<3 VP\15R4K+U)6GVV(1$=<HQ7KHZX7$"0 E@3  N@0I-UK92JTFMAF6)
M-XXGVP0RSB00ZE'(C@KL))-VK"89-;]Q8,#%I!]?QZ846^4Y9H_-)LAL$IA-
M)\TF@5F>*RXGS2)=)@2A)5-D* T,99.&4F\@R%+()^WX*IX++M+';C+D)@O<
MY(\3Y"A!/K>Y.</+ ".TMQ/98I7 JX6;D<]5G]NY6Y6X;R<CM!P7.(68/2EX
MS>"2,BG28T-!#I/=M'&R9$+VN2&\!O%@$<H(C<_QNL'5[&G!-/, YVQRO5XC
M$:4),*0\H#2C6,5D\6QVM9@MGE.J#47J\3@"$R@" K.$D )3(_C<:@6F1@A"
MRSN1;7DNN?_O]7O>Z=SBR*&7$BQA"D5 84987P7F1L#LB<'<"$5H R0B("XP
M7"+DAO R$)@;D<ZN%G,C,DJUV>RFQW")@)N<L,Y+S(UD<ZN5F!O)"4WO1+;I
M^]T)GA37\TYF>SYC.2?\!R6F4 84Y@1JY-U^=_:&5V)J)!":(!3E@C .1DL&
MU.2$5X7$U,AD=K68&IE2J@U$.64<C)8,J,D)U$A,C9R]WP-,#5#V>TYD6[Y?
MO2<W[AL(]GN,$RH"3" $!.:$EQ]@9F#V?@\P,R )+8!$A#4>[GY*ALP0WFB
MF8'9VSC S !E&Q>*<DJU&"P(F2&LAX"9@=G;.,#, &4;%XHHBYG"8"D*6,H'
M*T_9-%C*!XLS2 AD*4R6\LD"1GC#*DR6FDV6PF0I"EF!"!CAK:<P68IP2K-Q
M(C>O!/K4W>&+"IQ2^@33IV:_L10&2Z645DN]5LL83)](!:K^I73WBSOV3A4K
MW1S'X]DVVIG7NK/'<K>GMR/@KV(XE43/U_QI:P]R/]*LEI?BJ/\JFN.Y;J,7
MTW6F&H\[#\9TNO?'OO03?M+%_G93ZD,W7*;]=6./<^U-9R[OI].W(_+5_U!+
M P04    " !8BF](NA3='DT"  !]"   &0   'AL+W=O<FMS:&5E=',O<VAE
M970T-"YX;6R55MN2FR 8?A7'!U@!\9 =XTPW2:>]Z,S.7K37)"'1614K)&[?
MOH#&%4IWS4T0_ [_1SB8]:Q[Y06EPGNKJX:O_4*(]C$(^*&@->$/K*6-?'-B
M74V$[';G@+<=)4=-JJL  1 '-2D;/\_TV'.79^PBJK*ASYW'+W5-NC]/M&+]
MVH?^;>"E/!="#01Y%DR\8UG3AI>L\3IZ6OM?X.,.1@JB$3]+VO/9LZ>*WS/V
MJCK?CVL?J!IH10]"21#97.F&5I52DLZ_1]%W3T6</]_4O^JXLOP]X73#JE_E
M412R6N![1WHBETJ\L/X;'3/H"@^LXOK7.URX8/6-XGLU>1O:LM%M/[Q)T$AS
M$]!(0!-A\G$3PI$03H3P8P<\$O!$0/!#0C02(HL0#-GUS&V)('G6L=[C+5'K
M"3Y*>*=$I+(GIXOKKOY#AM%KCD&8!5<E9&">!@S2F! A%V8SQV" 79BMH8.=
MF)V)B29,(+,X R$K$-("X5C( H'0$@BU !X%8F=:$P,_-\&6"38$$M.D&4P&
M3*(Q$ ( 7*CM'+5*W:"=*17-4/^M.+(JCHR*4V?% R;6&/2Y16Q9Q(;%RFD1
MSY(@C)(E41++)YG[P 4"J260WKO&5I; :D'2U6PR89C&2Y)"8&]O8&1=L%+A
M/R<$O#<MM/<D1 ORCJ!QD::+XMI[%\XW9ABF"R3LG0GQW7'MK0(CHXJ5^U U
M0-A.&\R.\9:<Z0_2G<N&>WLFY(V@+X,38X)**? @I0KY+3!U*GH2ZC%1!0ZW
MX] 1K+U=]M,71_X74$L#!!0    ( %B*;T@X@8K3^@$  -P%   9    >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;(V4WY*;(!C%7\7Q 18%Q9@QSG3M=-J+
MSNSL17M-(D9G42R0N'W[ IHL.K3I3?CC.8??!X%BXN)-MI2JX+UG@SR$K5+C
M'@!Y:FE/Y!,?Z:"_-%ST1.FA. ,Y"DIJ:^H9@%&$04^Z(2P+._<BRH)?%.L&
M^B(">>E[(GX_4\:G0QB'MXG7[MPJ,P'* MQ]==?3079\" 1M#N&G>%]E1F$%
M/SHZ2:<?&/8CYV]F\*T^A)%!H(R>E$D@NKG2BC)F@O3"OY;,CR6-T>W?TK_8
M:C7]D4A:<?:SJU6K8:,PJ&E#+DR]\NDK74I(3>"),VE_@]-%*M[?+&'0D_>Y
M[0;;3O.77;38_ :X&.#=$"?_-*#%@#8&,)/9NCX31<I"\"F0(S&''>^U7)@0
MG1SH8J0=VNV:9Z]E$L,"7$W02O,\:Z#5>!65JT ?$J !O!1P0P&M'RT4Z'$
MV@0@&Y L <D:<IC+F#69U:080Y^H<D5QDL/=8Y9DPY*L6%(ORZS!5H/]FLK5
M0)3CQR3IAB1=D6 O2;I:9><E<34Q2O[C?/"&!#LD<8:\)-A=Y2^'6+FB+$7Y
M8Y1L@Y*YF^+?D\SY$V0YS+TDK@AB&&W/!S@7<21G^IV(<S?(X,B5OM/V.C><
M*ZJSHB>]PZU^:N\#1AMENIGNB_GUF0>*C[>W]/Z@EW\ 4$L#!!0    ( %B*
M;TB+R5!@S ,  +82   9    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;)58
MVW*C.!#]%<H?,*"6N+D<5XWM278?MFIJ'G:?B2W;U #R HYG_WZYR(RZ(Q(Y
M#P'DT]VG)9W69753]<_F+&7K_2J+JGE:G-OVLO3]9G^69=9\41=9=;\<55UF
M;?=9G_SF4LOL,!B5A0]!$/EEEE>+]6IH^UZO5^K:%GDEO]=><RW+K/YO(PMU
M>UJPQ;WA1WXZMWV#OU[YD]TA+V75Y*KR:GE\6GQERQ>>]) !\7<N;XWQ[O7D
M7Y7ZV7_\>7A:!#T'6<A]V[O(NL>;W,JBZ#UUD?_53G_'[ W-][OWYR'=COYK
MULBM*O[)#^VY8QLLO(,\9M>B_:%N?TB=0]@[W*NB&?Y[^VO3JO)NLO#*[-?X
MS*OA>1M_B9DVLQN -H#) #XVX-J NQH(;2 F@R3XT"#4!J%KA$@;1*X&L3:(
M)P,6#Z,U]NXP-KNLS=:K6MV\YI+U,Y8M.WC=.^D\>]V -,/G,.1CZ]M:L'CE
MO_6.$&8S8D!C$AMF9V+8A/ [!E8:@&EL (5(;2&V" .!E8:)X8+;,-\P1M@P
MSQ@3VC OF(]#TIST/1\<<.T /G<@B ,Q.! C2R #4XT],F+B$1.PH/_[/%)(
M(H5&) '<&FG$1 ,F$CB0@?L6FHQ"1T(1(10A0L)**#((O4O=9/0A<)923"C%
MB%)HI10;D2!)Q1PC1]QS;/1EQ(/4B7A"B">(>&0EGAB!6#)'.S%HQ^D<:1.5
M@!/EE%!.$>7X<P<LH(4O>%1][%WM9(B%57\O&C1FRR!TR98!C00HDK4^[C"(
MN\2A%8EQY()9IX(&Z;D0AW.3 >'L,V$&,D^85D F$&&74:2EC84/3P1:C!BJ
M1MQ:'C<:I.M>' 2S]6B+H2&%SA.C)8FAFL2%@PM:'%CR</=0L3*D5FY=37<$
M%'T>!ZBD(4 N'*H"4$D#>S1;H%H%+$/[JJQ!XPB+U'45!"I8, 4[MP4 4V7N
MZQM0L0$6F[T*89!PB4,5"6BW(9@]#@:YC!25+2#9TMWBO?-,+;(@=-4B4"T"
MTJ)PT")0+<+#6@2J14 RHSO;>\ZID3,$SO6'4T5RI$CA(&I.%<D?5B2GBN1(
MD<)ZR-D14.(0Y]U^'JV>(G5P027&Q</94O5P)(S0?DXB()?#"U4/1^H)7:A2
M2?#XX6RI)#C:O(;6$]^.@*CT?./(7,KZ-%R'--Y>7:MV9#>U3E<N7Z$_<I/V
M#5MNF:5]QY;/XX7*;_?KU24[R;^R^I17C?>JVNZ@/YSQCTJULF,=?.G&Z"RS
MP_11R&/;O\;=>SU>JXP?K;K<;XFFJZKU_U!+ P04    " !8BF](G:EN$CP"
M  #<!P  &0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6R554N3FR <_RJ.
M]ZZ*KY@QSC2/3GOHS,X>NF>2D.@LB@42M]^^O.(JM=5>1/#W^@-"WA'ZQDJ$
MN/->XX9MW)+S=NUY[%2B&K(GTJ)&?+D06D,NNO3JL98B>%:D&GO ]Q.OAE7C
M%KD:>Z9%3FX<5PUZI@Z[U36DO[8(DV[C!NYCX*6ZEEP.>$7N];QS5:.&5:1Q
M*+ILW,_!^A  "5&('Q7JV.#=D>&/A+S)SK?SQO5E!H31B4L)*)H[VB&,I9)P
M_FE$/SPE<?C^4/^BRA7QCY"A'<&OU9F7(JWO.F=T@3?,7TCW%9D:8BEX(IBI
MIW.Z,4[J!\5U:OBNVZI1;:>_I+ZA31. (8">$$3_)(2&$"XE1(80+27$AA!;
M!$_7KF9N#SDL<DHZA[50[J=@+>!4B@AE1TP74UVU('KT7D1QG'MW*33";#4&
M* R80NR&B"A.IC#[,2:=PAR&F/##RA.%3%8#K&J XD?&8S4O$%H"H1((C4 V
M+Q!9 M$P0>*/JVST;&E,:JH,_$G488@2&'\ ^VN:V$H3C]($DSX:DRC,IR2*
MYUT2RR49N8!)EV1039:%\0*;U+))1S;AO,#*$EC][^)FED VO[C;;% H2)-L
M$K4?H](E:QOX]J_KC^)$DW$,2"]O,IUY;T ZSK(P?YPCP?Q6VQJ0V6MIF"XP
MLG_Q ,SOMJT!]:L0V+O%&YR2+;RB[Y!>JX8Y1\+%@:O.V@LA' DQ_TDD*<55
MVW<PNG#YFLJ(^O+1'4[:QUW:7^C%;U!+ P04    " !8BF](.7RF094$  #U
M&   &0   'AL+W=O<FMS:&5E=',O<VAE970T."YX;6R=F=MRXC@0AE^%XGZQ
M=;!LIPA5FT#&F=163<W%[+431*#&QJSMA-FW7Q\41MUIJ&9OP#9?MUHM]2_)
MS(]5_;/96MM.?I7%OKF=;MOV<!,$S<O6EGDSJPYVW_VRJ>HR;[O;^C5H#K7-
MUX-1600R#$U0YKO]=#$?GGVK%_/JK2UV>_NMGC1O99G7_][9HCK>3L7TX\'W
MW>NV[1\$BWEPLEOO2KMO=M5^4MO-[?1/<?.DDQX9B!\[>VR\ZTD?_'-5_>QO
M'M>WT["/P1;VI>U=Y-W7N[VW1=%[ZEK^QSG]W69OZ%]_>'\8NMN%_YPW]KXJ
M_MZMVVT7;3B=K.TF?RO:[]4QLZX/4>_PI2J:X7/R\M:T5?EA,IV4^:_Q>[<?
MOH_C+TGHS&@#Z0SDR4"*BP;*&2BN@78&^F2@XHL&D3.(?AO(BP;&&1AN2+$S
MB+D&B3-(N&E-G4'*;:$?\W'D0K;):; %,@G&63+,L67>YHMY71TGS2'O*T_<
M]'S=^^F<3[J9U0RWP]P=G[XOM(GFP7OO"3!W(R,=8RCF'C(QQ2PADU#,"C(I
MQ3P )@XIY@MD!,5D/J.THIA'R&B*^0H9,H=/,!YY8H)ND.B1DFBDY.!!C1ZB
ME.%!(0]J\*!=#*B_^[&_(Q,/3*JB,*2HKSYE?.A\,!H%H[U@DI1J)=->*W^(
M4'/Z'*%F(M!GS?!@D =S==YCY"$&,41D7T?&#(R((GIP?"B.(D[:$Q1+XL4B
M$DYO4N0AO3H?(L2B$X*,&#(C#C)N*H:L628^Z9L '8XY/G#EB>M+3^#:$XK3
M9>5UV="U]PB@]$R!"E#'O-3A"A4:A!S3(6L_9"UY&<95*D"9&L7Q@>M47%^H
M E>J *5JR-PN'33F5L8Q/00K'I8)OZAE;%+66.&R%@D8*W)M72*(7%Q79Z$+
MT6")$"E(HZ;3F'KY.9M$!I0!R!A. B66) DD29&+> :AA-40%B0I@ ]!=MM!
M@W!VLJ7C69BP9K3\M&N0H#E)-R>]! J>TDJL<!(H7$*N8$L')>-0S1(ZG'/0
MA6BP>$D@7@FY<5LA*.(TA*5+ NE*R-UQAB".1DJL;]( '_3V&4&L*8-%4 (1
M3.G"E$"V6!,&:Y8$2I.2>_05@E@;9RQ'$LA12L[,+](7D815 @J+B(+[&GJG
MYR#7D.%5F\(RHH",1)P:45@;U/\X4GPZ4X"JIU?,1^5O67I]H87\2?F[%B4%
M+S6X]!7<MY"%\H0@5M]QZ:N(H7@.&L5,S\BU<'46NA -U@<%2I\^WCTX:,QP
M9'@[0X450D&%H-=W!XGQW8*8L5*,-4+!\B<K:NF@4^FR^H1%0@&1H'>[=RH]
M.T$][!YADG= QFJB?36AC\CWVA<3YLJML99HH"6IX?C 6J*OUQ*-M40SM"33
MX-W#.2EYU.@HQ<O,IY<4#"G)()1R%G>-I40#*4DY<JZQ .CK#T :5[9F'( R
M#4XVYX?@/'8A(JP FG&RR2"4XJX'WDO10_YJ_\KKU]V^F3Q7;5N5P\O5356U
MMG,5SKJ1V-I\?;HI[*;M+^/NNA[?RH\W;77X^)/A]$_'XC]02P,$%     @
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MDB"0O.Q (0=J;JHQ<A"#$2AOJI,F'C52]GLQPMMQ$GZ.G3D1$=2='5&"1I2
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M7YKN,FZOJ^';U'#3E*>/3VV?W_O6_P%02P,$%     @ 6(IO2&2[.CN0 @
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M5N8E>\N;'^7^WM@:9)?PN<SK_N_D^:UNRN(0,IT4V>_A>[/MO_?#?W1LP^@
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M2[A[!DATH&<)+&_AR3L=:<P>:+F=-5R&"$5@10I/;&G(>4U\.FZ)\SL8BTU
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MF09V9$P2Y<U_4E]GI:ZC<4')4>IIJN;<-FB[D*R[WC?CI5?\!U!+ P04
M" !8BF](%+Y 6#\"   J!P  &0   'AL+W=O<FMS:&5E=',O<VAE970U."YX
M;6R55=MNHS 4_!7$!Q1CP)"((#6)JN[#2E4?=I^=Q FH-J:V$[I_O[X0 @@U
MZ0NV#S/C.0=SG+=<?,B2$.5],5K+E5\JU2R#0.Y+PK!\X@VI]9LC%PPKO12G
M0#:"X(,E,1I  %# <%7[16YC;Z+(^5G1JB9OPI-GQK#XMR:4MRL_]*^!]^I4
M*A,(BCSH>8>*D5I6O/8$.:[\YW"Y#8&!6,2?BK1R,/>,^1WG'V;QZ[#R@?%
M*-DK(X'U<"$;0JE1TCM_=J*W/0UQ.+^JO]ATM?T=EF3#Z=_JH$KM%OC>@1SQ
MF:IWWKZ2+H?$".XYE?;I[<]2<7:E^![#7VZL:CNV[DT&.MH\ 78$V!-"]"TA
MZ@C1C1!_2X@[0CPA!"X56X@M5KC(!6\]V6!S/,*EA@LCHI4]G;VT2UM?%[T4
M"*$\N!BA$6;M,-!BPAX1:/79+>!XBS4<T.'<!ILA(IJ%;(>0-+MO(IKD&5E^
MY/(,D_L"\40@M@)Q5ZAX;+)VF3I,:C%9"I,YT&8(BC,$X1QJ.T(E88;N.TXF
MCI.!X^R![X8F?/33DJ43@?2!DCD,<I\>P,5LR88@"*,DG2W9" 5BL+CO.)LX
MSH8E@_?YBPE_\=.2A6#Z/X('BM:!W.E(T +-5FV$@@BBV?.X'</B-$TGMH-!
M1V%$G&QKEMZ>GVOE?LD^VK?_9V@ZTB2^-M>"[50WF2)O\(G\QN)4U=+;<:7[
MG6UU1\X5T?[ DS['I;ZX^@4E1V6FJ9X+U\K=0O'F>C/UUV/Q'U!+ P04
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MXYZ8H-($E54!9<")*@=462#P@BKS(56$5!A7]TF W/1"%@M[65IT@^45057
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M)_4G<LNY9"H>F*AX>W4'NS9JMI7]*U'OG;F5F(;DA\LEZWK36_P!4$L#!!0
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M=# D2F#@^S&DJ&Z\(C>Q-U[D["Q)W> W#L294L3_;3!AW=I;>-? >WVJI [
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MF7=#6#L@*4(JB%)7N-3UO[HZ() !RYF@_!;*L9/ZJT?AY*6A\P=H)P!GXK(
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M<;@/:GSBLIN)/M5'J1YPTMUN!O?K2?$/4$L#!!0    ( %B*;T@U#$'8#0,
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M971S+W-H965T-S(N>&ULA5/;;J,P$/T5BP^(P9 FB@A2TVK5?5BIZD/[[,
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MZ6NG?CMS.*,Z?!35X66'ZM#YY+F?,GH$'TR\WW)Y+I' &LQ$MC.Q@[PB+IK
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M4]2\H6B*SDQJF>\*N0SVN\T0I/T<.6>VNDK)I#"AVMAW7QR2]A4[GE3.VE9
M6>"-0+](8QK$?BBIF7QB7<<YN:*B$6%LZ^Q)TB4;Z>$TP#9_#$%%(1O"6]BR
M L"[2Y\A0Y R\-C(0M;C:#V%[-%#B1,G]*-RQQOKQ_354;"DXK[ =+)X1OPE
M_SPF7/C?[SQD'$?V]G!5I!JJ108F5*PJ15.D.5&EM(_>DA&&E4<X2PUD)7E!
MYG,&-N,:&?IA7ZI:0WJU+_1R\6\:]8H3Z;S]ZO4,Y4<NZ-YZ '[1)1=!1*ZG
MMO(CLM8>)$+YA,EL&FG)3"([QBX?2LZ+D8J/9Q@!NEJ9<C17*%RL,M*='"4*
MT31*I"#MGN#I88.?0R-LS<0,/UY)696+]1L6:L6^=:6\JW:3 A,RVAX&[]B3
MQ$& 8B,*^I;21KU-Q#'X+9/MJ5*PI%8*1GIH0>E"CDA*CD]++6QE.-VV\($@
M7$W]V"7Z/_V00J68[V]&-5%4UUJ$1M$HFP^,9A<=:<J)7$";:ZXH>-%S$@M)
M#?.F0](T0DT[ED.CLF#.':%D,*P\/55>U[JE[L26_L>__P\^722_Z+HC$^2C
M<YH$D0NN-VV1MT:07KF4PF,AP,G+.Z:(XOLDITP7NO&2:H667W& .].XN.+L
M\M'MH#/Y]RFCSU\:5A8IM8UOL'OV!O.EI'*09[AY?T0UI+<PC76Q>E)^8@O.
MD9F_PG1;#^KP$D,6/4P%:Q>.E)RK-.LDIX/H1V)&P0\>N;[Y&)<PQ@)-&+&8
MO;[;;;5KW!\_G"9:Z$XA/TD$V,4+PL_@)-6/4Q/S=7IQ<M4#)U+*";*CG7@(
M%][5:"<)M$/.24\L6ABBW"B-LJ94HBACC]:T"T)C_>2M$24I9W-Q\(JJF#A3
M)/AT!KFZ1&!G:0M@T7M4IN3R<PE*43(:]5]\E]1HSOT4PP?ZM^!L]"TS5IJ$
MA',E/!<ICA+Z-2[KTR[PGON)W;(FXW6WSA8\(WR6 5?JD09*I\)ZC?H/R9IQ
M'FHU$UO,:%Y+*15^&RB(018R+;KW%< 9Y2-1O744)P$"];%V3E/ LNXK-$%(
M?[E"OGGY[NV;#R_4,@2] GBY&4CD=_W+_I.@@M6=_BJ_I1C$NJ[;IR6SJ<WK
MC<XK0]OWGHN])%W.3&2?U[BV4;H:-\^UL.W@S*Q?0!&.I L[.ZPDLX99A%PX
M$G<4X+0WC>J#D/\7J-ZQ1.0+Z2]U4$[#G+E 4*?5S6%.B(\D%A^N17S@_6N(
MCX[;[FKBXWWYA?;3Q,CK-_Q]V9.OS-+(;R87';UJ<-&CUA')RP9$C>\^0^]Z
MG<QYQ=4@/V2MOJTZ,!QFWL0!^FVYU<@G>@ 3\VME4CY:?!6]Y VF2W)W*^]P
M5TU4*]\\O1!5@3[S\XYSI%J(N(6]RJ:VJ";/"9@.[<02N"JJ\ML_3.34A4R<
M\/F/$C)<%.YXJ1UR9GK5!SD3ZC*LZP9]UA^^4-Y[<GD+6B4)D^LA4"T0IS.5
M$K2@FA0*[J";0&GA0^],:@?1[9&/O>!T(?)N(_?>H!J<^UP;\T%70\T-&V,2
M):*Q&R3E3O'%!L',#%]L*"81V33YHBE;[N1#;6HLGL_O46.;,)N_LQM9?:!1
M+VF.Y<X;B^04OPV:L452\&:MK[&D_2KR*E2EAA1#LF#\^/I*Y^)"\$#FYD@=
MAO-_1&><SQII.'S@_[-EY%5H>4>]-.=_4LB TD&SC?/K9;X5/DONN6<'=3)H
MF'J.-2YX8;!L6F2FU_47Y7[G <O\V\9$Q6%T"CU?D;5,0A*.;TY'Z>/N$-9"
MMRJ$4:IZEES7<GR*3<_V..";V![<F@@J!A*<CW"U;Y5/WZ$\Y7*UHG#'4W(Q
M&X^H"Y:[N :NB/^B=R^&UT/^KRAHUH62VE((-XY3>>R_Q:K28PFU+Y?,,!C@
M%SAJ(\&.UNL^15DI%\27+Y)Q>CV9NK^4^U]!2;S:(3)FQ3Q[G,X&<ZRUXU 0
M.RSQA_G$!8L"'?TJV.E';.GEN(-.>$J_1K^>U\NG_M2D%T<^_8.N_<])]WXM
M,<UO[\F2ZF[#]GFZ[=K(=SA/7L\D'<Y&^K_NAV.Q7E)!]&A^->XGDW$Z'U_+
M__A?G0@CEHX3?'  'QA=CY+!8)S"O\$.6H 4R/?U)8W0&S&?I(/K87+=3^=X
M/L?]ED#>4,'_C='>\"4@5BP3"N^BN$UP^!G,%M9"*L81!51X!E^LRM7A$2_C
M"$YKUI]A\[GQ=.+>80L+1$N,YS^FG1C,7 WL,J2L7Z?]\1AV))U<]]VHCSW?
MX#]AU!%L"H$(FGCUY6 ,GQL,DQ=$6?1S%OJ8@(2H(T)O4%V7@.GE8 "?&8S@
M;?CG=3H<#I(70HR[5BIABQ*NP74Z&\_A'X/Y,!T,9UW+)9\<?S*7(.,*$WV8
MX8AQ)GGFF*1'=B[Q.4I.%5-0?/[)FG)HA$#M=Q"U,%ZHBQ8:DH!]7*<=>E-#
M+^X,CFB#_I@W<#$8]/I.<A72Y&+>NT[\?Q&[@P<FX4_U1('6=#3KR!<?/]=X
MFM3 0 ].@&C*?167-IEJ38[*D!MR*:X%*OWT!21UB!.NGD4M@+5O#UU"R47J
M\,1C!<O2Q"%XI_;Y%PI;8=L)D)DB/1O?,'"ZSH/JF(&3VL!L0:'L201+D\O/
M-4U9@/2Z!Z *A<=\O98Z!XL\UBC-,?A&F&:%CS)^E!>AKOD5=N.36GW@J!LH
M-IE&!N&G)2CC.99@JY5&VDJ5^\2I "MD\4Y:$M&<+-44W&#-BA2Y^(2OU)M
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M]-Z-1;//*%8L2R>OGGX[U+A*03U/I(A:?FH)!W?YP0;'QXQ.+,=7?0"E!LY
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M)UO36.0)^]UO@-*VI2^T<WV+A4 %71)<84PZR5TDE0 QI?R2FOM18%D3_+K
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M,8(@.\>2X&Y)RAWFDV*!-WJ?Y8SK:AY.7FR%KG2!9@5!=%\2OB_H4+FXMCB
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MPBVU(Y*9&>IF"'F=6 :U6H'1YKT9UHUWM*]L?;\^Q+4? A-@$;)=RILH0(:
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M6.A[+(ZQACYB#-S!.8LQ(K;!9:ZV#^OUCG0_Q!6QBH ?.\)X6UJK&9P0RFN
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MVCZ+R2/1RN'EB62L&YHUMG:V5%?%QA7D9Q.0"RIO4_G/633E[FZ6/JP)S.9
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M,!PM5-B&@'7+L6 E-HSK9[QN:$6ZO!Y3SNO)552JNE=?+WD80@Z$:@%#KCJ
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MKK.':1_27,2$5!?7EV;4;Y]WVN?=04""41NE>!K%M>7=Z'@\ (LT:I(QH&3
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MI'^DDT[[N^6**Z,/WM9I@X.R6PW  .E5@XF=H8E^XYDU)'H3W*7UT*JE(VM
MM//O_DD*$<R%*T0X&[?MF@"2U;.AU5;;??QK6(_[$^<)=;'(]$.2P6@.5("I
MJP.A%&]J?H:B<KF(*#-UE)F**;LKR$N(S-@CW&@OTG*3']#E%%;B4-Z.79-?
M,'WY234"<3T>V[^&$VM!3D8API*&,;U%A*6M/?CJ87\(_W2[(W/IL'DA7Y(?
MM<;CJ%O9C3KH#,T[ 0%"PK,0P770K?M6>%MI:L5B"F!A7]&WJ\J:QIW4:=H=
MV'4T')O7$8>J*O@%S:W-QA<L-H$\G 4GGWA^J\[0FO.=RII.0WOXJ"^K /L6
MA@"=>O:S1OT*E+\^.W='H/]!O,/.@_+D@_M], #ULR.QHGB-2&G09&CE9+=7
MC<==N[Z[:A?X<IPSN<DN?KZ/?9VY%AN6^Y4+67HY5KVWGY@1948;TS[6Z44:
MX011D=+6)XC!OM\3ZCH+B?@1M<@S--,Y2JQ \6QVZKSDE\+;;JR:?[=@=;('
MJ-U/PW\(Q57?2P$4NVVE\_Q[(%S>24EH94^F!]+QK#:*U[ ZQ.6E^Z3S/!:8
M/?-:<**=V7.0_K&3G%\#>"J>]:P.BO^V6U8E,E>9>:'/;>-GJO]/G<P)M513
MF,<!24,:8A6D(7)]COWY!:?R':6TZE9-FJ[(8D@E""+F>0H/;SP?E_<21U6J
MQS&8-S@,"M+7?P.+DG/LL@F_Q&K"Z&+M#HL/N&]\ FHRZI4C^V\[51%/X8HO
M.^&DE7]RK?@PPPO;2EXS_2MG_%\YX__*&9_CC#_ //E<,T]F&2.K\\I3/VB0
M\^KL!6:-/K-W?+Q^49T]27:SM;Q:59OI8A+AO?_4<@Q.J1QX;%60TUN\**15
MZ0?>MF13)_[CMYM/TQ5G,=0AK#N.0)S:GL%@W^)A0EEHU7]^#6BUK^"P_2_)
M]U%$U8,(8C86%3U[9HGCL=DU\:KC\8D?_\BT*(#3FC$88\9?6$*<3PK.?[LD
MXX= 'VDG9_2;J;4,]@]YSI+O_*3JUYAF+69UBU\PS/:QF(0 "(&Q^)_8M_KC
M^M?JS6*%'_AK!D_._HCY,@KL3BGXTYQIYF(T&@F8\&%=))D ?Z$.?S5%K!%R
MEN1"%->.SJZZ^LP]^KYUHTFH9AF]^Q_WRQ9P4?W-W^2VLKB'WMX%"&FJX%;8
M:X^0)D_@R/W@1?M?_OO_@E_><!@\V[/.F(1!00YIF3 XXIYCVND=\ZZKC^^K
M,_L!J62$7K>;6SIA5)ODT!N"8W/4\.N[A)$W?F32!OI.+ &E,@4N55T0[:,S
M;!,)X\2(6N"NP'33#(#\U>%)HQH;DF$O((BU6#$ +L(EXV](&U)*WOS*J%S)
MZQK1LHIE]ZP8BR7FDZ\\&]"L^##JVPTWAL(G\CJ\=LB2OU:GB;5$%J]!@PW0
M*G-=/H@-S?ZX+(G'40TB:CX.Y8'LNP3<^3B@ZV\%^?X>=>=",!=]MJ%ON'F3
M^F0=CPSIND0G R;R31^.3FDN2=3R;FGJ8)#$G*"(A%G,B44?I#*7WW\N#M[\
M:G,W'@<VEYFP R,A[=0$+!<UUS0ZA4SJ<X ^2\<C2L;-7E;)N%5C,FY^K!ZS
M'<KN-TBSCG]S&=;%"UY'*B_EC]OYW1[J(.[FU1G$#E)[O\?1SL;WD+(9W])O
M-S]:O5+YTT?=5/ZFP0FO*O<X2#<OHR(6;BOWKI?O74,[^?YU"I]9R'VOXMSW
M;WVN_&6GM%#XIL(J<5GY5SHKO[KFK/QT3W)6?N.JZI?>%:1D \H=IF0?*<=.
M59F/T7[12OFO",R8WAY)&SK)+G0!@,NK/V  ^R>\\KF$H:QP+!<-8YET(ZA
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M^_O_"U!+ 0(4 Q0    ( %B*;TB-%R[G+@(  &HK   3              "
M 0    !;0V]N=&5N=%]4>7!E<UTN>&UL4$L! A0#%     @ 6(IO2$AU!>[%
M    *P(   L              ( !7P(  %]R96QS+RYR96QS4$L! A0#%
M  @ 6(IO2$4G&KM; @  Z"L  !H              ( !30,  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 6(IO2-0"AQF8!   A1$
M !               ( !X 4  &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" !8BF](8VLH SX!  !I P  $0              @ &F"@  9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " !8BF](F5R<(Q &  "<)P  $P
M    @ $3#   >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( %B*;T@6
MOP))A@(  /0-   -              "  502  !X;"]S='EL97,N>&UL4$L!
M A0#%     @ 6(IO2(X[A+97!@  '!<   \              ( !!14  'AL
M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( %B*;TB;?5W&FP(  .@)   8
M          "  8D;  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !8BF](-T.*<$D$  !W%   &               @ %:'@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 6(IO2',"R= 9 @  3@<
M !@              ( !V2(  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+
M 0(4 Q0    ( %B*;T@=*;WUE0,  -4/   8              "  2@E  !X
M;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !8BF](Q[E.M"X"
M  #/!@  &               @ 'S*   >&PO=V]R:W-H965T<R]S:&5E=#4N
M>&UL4$L! A0#%     @ 6(IO2+U;Z$?J!P  :RT  !@              ( !
M5RL  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( %B*;TAI
M<J'XQ 8  .8D   8              "  7<S  !X;"]W;W)K<VAE971S+W-H
M965T-RYX;6Q02P$"% ,4    " !8BF](:UNM0)$!  !P P  &
M    @ %Q.@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M6(IO2(YJ?$F2 0  < ,  !@              ( !.#P  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( %B*;TA<U(/SD0$  ' #   9
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M970Q-"YX;6Q02P$"% ,4    " !8BF]((S>+.9 !  !P P  &0
M    @ 'I1@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M %B*;T@I03)0D@$  ' #   9              "  ;!(  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ 6(IO2#R<MZB0 0  < ,  !D
M             ( !>4H  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " !8BF](\_@M<)$!  !P P  &0              @ % 3   >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( %B*;TA9??_;D0$
M ' #   9              "  0A.  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ 6(IO2&0/'!&4 0  < ,  !D              ( !
MT$\  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !8BF](
MU2/K,Y,!  !N P  &0              @ &;40  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( %B*;T@9YO9 D0$  ' #   9
M      "  653  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ 6(IO2"N65T*/ 0  < ,  !D              ( !+54  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !8BF](IWQEL) !  !P P
M&0              @ 'S5@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( %B*;TB+3WMED0$  ' #   9              "  ;I8  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 6(IO2#N'U@>2
M 0  < ,  !D              ( !@EH  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " !8BF](L1"G-)$!  !P P  &0
M@ %+7   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( %B*
M;TC"%KJ]Z (  (4-   9              "  1->  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ 6(IO2!#E8T.8 0  < ,  !D
M         ( !,F$  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    " !8BF](:*ZJOY<!  !P P  &0              @ $!8P  >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( %B*;TA05O\BE $  ' #
M   9              "  <]D  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ 6(IO2-< V!Z7 0  < ,  !D              ( !FF8
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !8BF](!L$W
MU9,!  !P P  &0              @ %H:   >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( %B*;TB"SS==E@$  ' #   9
M  "  3)J  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M6(IO2%HGVYC9 0  :04  !D              ( !_VL  'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " !8BF](YOEXH[(!   Z!   &0
M            @ $/;@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( %B*;T@!"-P#E $  ' #   9              "  ?AO  !X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ 6(IO2 A)%>.7 0
M< ,  !D              ( !PW$  'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " !8BF](U;^:Z.P"  "_#   &0              @ &1
M<P  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( %B*;T@J
MTY/"(0,  )\-   9              "  ;1V  !X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ 6(IO2.Y^GZ#D 0  #P4  !D
M     ( !#'H  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %B*;TB+R5!@S ,  +82   9              "
M 4Z'  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ 6(IO
M2)VI;A(\ @  W <  !D              ( !48L  'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " !8BF](.7RF094$  #U&   &0
M        @ '$C0  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( %B*;TB\@;"U$@0  .D6   9              "  9"2  !X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ 6(IO2+![1F_%!   ^QL
M !D              ( !V98  'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " !8BF](9+LZ.Y "  "S"@  &0              @ '5FP
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( %B*;TA'G,;5
MP@0  %@9   9              "  9R>  !X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ 6(IO2$E\U&*] 0  G@0  !D
M ( !E:,  'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !8
MBF](0[A4Y;,"  #2"0  &0              @ &)I0  >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( %B*;T@=N+_7Z@0  & :   9
M          "  7.H  !X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#
M%     @ 6(IO2,P5W>%A @  Q0@  !D              ( !E*T  'AL+W=O
M<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !8BF](M@1B!RT"
M!P  &0              @ $LL   >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM
M;%!+ 0(4 Q0    ( %B*;T@4OD!8/P(  "H'   9              "  9"R
M  !X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 6(IO2)X'
M0U>  @  W D  !D              ( !!K4  'AL+W=O<FMS:&5E=',O<VAE
M970U.2YX;6Q02P$"% ,4    " !8BF](24$8A_P"  #N"P  &0
M    @ &]MP  >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M %B*;TA<M5!B50(  *T'   9              "  ?"Z  !X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ 6(IO2*>AF..5 @  ]0D  !D
M             ( !?+T  'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " !8BF](_LU##=T!  #"!   &0              @ %(P   >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( %B*;T@XS,+ALP(
M !,+   9              "  5S"  !X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ 6(IO2/#G.&W' @  Q@H  !D              ( !
M1L4  'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " !8BF](
M5TSP3JX"  #Q"0  &0              @ %$R   >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( %B*;T@TLUA+. (  -('   9
M      "  2G+  !X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ 6(IO2.CH/7L?!   Q!4  !D              ( !F,T  'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " !8BF]( 1D?[-\!  #+!
M&0              @ 'NT0  >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( %B*;TC;P2,140(  *H(   9              "  034  !X
M;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ 6(IO2#4,0=@-
M P  4@P  !D              ( !C-8  'AL+W=O<FMS:&5E=',O<VAE970W
M,2YX;6Q02P$"% ,4    " !8BF](H4(DBZH!  "V P  &0
M@ '0V0  >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( %B*
M;TB)D9:B*0(  *<'   9              "  ;';  !X;"]W;W)K<VAE971S
M+W-H965T-S,N>&UL4$L! A0#%     @ 6(IO2%I"44TGJP  @8P" !0
M         ( !$=X  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L%!@    !2 %(
*<!8  &J) 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.3.1.900</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>224</ContextCount>
  <ElementCount>434</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>78</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>101 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>103 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassified</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>104 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>105 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/StatementOfIncomeAlternative</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>106 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/StatementOfOtherComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>107 - Statement - Consolidated Statements of Stockholders' (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Stockholders' (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>108 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/StatementOfCashFlowsIndirect</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>109 - Disclosure - Description of business and basis of presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</Role>
      <ShortName>Description of business and basis of presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>110 - Disclosure - Summary of significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock</Role>
      <ShortName>Summary of significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>111 - Disclosure - State research and development credit exchange receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsStateResearchAndDevelopmentCreditExchangeReceivableTextBlock</Role>
      <ShortName>State research and development credit exchange receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>112 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>113 - Disclosure - Property and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock</Role>
      <ShortName>Property and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>114 - Disclosure - Accrued expenses and other current liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</Role>
      <ShortName>Accrued expenses and other current liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>115 - Disclosure - Related-party arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock</Role>
      <ShortName>Related-party arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>116 - Disclosure - Senior convertible notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock</Role>
      <ShortName>Senior convertible notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>117 - Disclosure - Collaboration arrangement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock</Role>
      <ShortName>Collaboration arrangement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>118 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>119 - Disclosure - Common and preferred stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommonAndPreferredStockTextBlock</Role>
      <ShortName>Common and preferred stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>120 - Disclosure - Net loss per common share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock</Role>
      <ShortName>Net loss per common share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>121 - Disclosure - Stock award plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</Role>
      <ShortName>Stock award plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>122 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>123 - Disclosure - Employee benefit plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPensionAndOtherPostretirementBenefitsDisclosureTextBlock</Role>
      <ShortName>Employee benefit plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>124 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>125 - Disclosure - Facility Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock</Role>
      <ShortName>Facility Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>126 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsRestructuringAndRelatedActivitiesDisclosureTextBlock</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>127 - Disclosure - Selected quarterly financial data (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock</Role>
      <ShortName>Selected quarterly financial data (unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>128 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>129 - Disclosure - Description of business and basis of presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies</Role>
      <ShortName>Description of business and basis of presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>130 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>131 - Disclosure - Property and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables</Role>
      <ShortName>Property and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>132 - Disclosure - Accrued expenses and other current liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables</Role>
      <ShortName>Accrued expenses and other current liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>133 - Disclosure - Senior convertible notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables</Role>
      <ShortName>Senior convertible notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>134 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>135 - Disclosure - Net loss per common share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables</Role>
      <ShortName>Net loss per common share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>136 - Disclosure - Stock award plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables</Role>
      <ShortName>Stock award plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>137 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>138 - Disclosure - Facility Agreement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables</Role>
      <ShortName>Facility Agreement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>139 - Disclosure - Selected quarterly financial data (unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables</Role>
      <ShortName>Selected quarterly financial data (unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>140 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformation</Role>
      <ShortName>Description of Business and Basis of Presentation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>141 - Disclosure - Summary Of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation</Role>
      <ShortName>Summary Of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>142 - Disclosure - State Research and Development Credit Exchange Receivable - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureStateResearchAndDevelopmentCreditExchangeReceivableAdditionalInformation</Role>
      <ShortName>State Research and Development Credit Exchange Receivable - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>143 - Disclosure - Components of Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfInventories</Role>
      <ShortName>Components of Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>144 - Disclosure - Property and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>145 - Disclosure - Property and Equipment - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation</Role>
      <ShortName>Property and Equipment - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>146 - Disclosure - Accrued Expenses and Other Current Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>147 - Disclosure - Related-Party Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureRelatedPartyArrangementsAdditionalInformation</Role>
      <ShortName>Related-Party Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>148 - Disclosure - Summary of Senior Convertible Notes (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfSeniorConvertibleNotes</Role>
      <ShortName>Summary of Senior Convertible Notes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>149 - Disclosure - Senior Convertible Notes - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSeniorConvertibleNotesAdditionalInformation</Role>
      <ShortName>Senior Convertible Notes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>150 - Disclosure - Collaborative Arrangement - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureCollaborativeArrangementAdditionalInformation</Role>
      <ShortName>Collaborative Arrangement - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>151 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation</Role>
      <ShortName>Fair Value of Financial Instruments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>152 - Disclosure - Summary of Carrying Values Estimated Fair Values of Notes and Facility Financing Obligation and Sanofi Loan Facility (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfCarryingValuesEstimatedFairValuesOfNotesAndFacilityFinancingObligationAndSanofiLoanFacility</Role>
      <ShortName>Summary of Carrying Values Estimated Fair Values of Notes and Facility Financing Obligation and Sanofi Loan Facility (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>153 - Disclosure - Common and Preferred Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformation</Role>
      <ShortName>Common and Preferred Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>154 - Disclosure - Net Loss per Common Share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation</Role>
      <ShortName>Net Loss per Common Share - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>155 - Disclosure - Potentially Dilutive Securities Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosurePotentiallyDilutiveSecuritiesOutstanding</Role>
      <ShortName>Potentially Dilutive Securities Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>156 - Disclosure - Stock Award Plans - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureStockAwardPlansAdditionalInformation</Role>
      <ShortName>Stock Award Plans - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>157 - Disclosure - Stock Based Award Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedAwardPlans</Role>
      <ShortName>Stock Based Award Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>158 - Disclosure - Stock Based Compensation Expense Recognized in Accompanying Statements of Operation (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperation</Role>
      <ShortName>Stock Based Compensation Expense Recognized in Accompanying Statements of Operation (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>159 - Disclosure - Stock Based Compensation Expense Recognized in Accompanying Statements of Operations by Category (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRecognizedInAccompanyingStatementsOfOperationsByCategory</Role>
      <ShortName>Stock Based Compensation Expense Recognized in Accompanying Statements of Operations by Category (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>160 - Disclosure - Fair Value of Employee Stock Options Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureFairValueOfEmployeeStockOptionsAssumptions</Role>
      <ShortName>Fair Value of Employee Stock Options Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>161 - Disclosure - Summary of Stock Options Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfStockOptionsOutstanding</Role>
      <ShortName>Summary of Stock Options Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>162 - Disclosure - Summary of Restricted Stock Unit Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitActivity</Role>
      <ShortName>Summary of Restricted Stock Unit Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>163 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>164 - Disclosure - Employee Benefit Plans - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformation</Role>
      <ShortName>Employee Benefit Plans - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>165 - Disclosure - Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureProvisionForIncomeTaxes</Role>
      <ShortName>Provision for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>166 - Disclosure - Components of Net Deferred Tax Asset (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAsset</Role>
      <ShortName>Components of Net Deferred Tax Asset (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>167 - Disclosure - Income Taxes -Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation</Role>
      <ShortName>Income Taxes -Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>168 - Disclosure - Effective Income Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureEffectiveIncomeTaxRate</Role>
      <ShortName>Effective Income Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>169 - Disclosure - Facility Agreement - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureFacilityAgreementAdditionalInformation</Role>
      <ShortName>Facility Agreement - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>170 - Disclosure - Accretion of Debt Issuance Cost and Debt Discount in Connection with Deerfield Financing (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureAccretionOfDebtIssuanceCostAndDebtDiscountInConnectionWithDeerfieldFinancing</Role>
      <ShortName>Accretion of Debt Issuance Cost and Debt Discount in Connection with Deerfield Financing (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>171 - Disclosure - Restructuring Charges - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureRestructuringChargesAdditionalInformation</Role>
      <ShortName>Restructuring Charges - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>172 - Disclosure - Selected Quarterly Financial Data (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialData</Role>
      <ShortName>Selected Quarterly Financial Data (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>173 - Disclosure - Selected Quarterly Financial Data - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataAdditionalInformation</Role>
      <ShortName>Selected Quarterly Financial Data - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mnkd-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>174 - Disclosure - Subsequent Events - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation</Role>
      <ShortName>Subsequent Events - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mnkd-20151231.xml</File>
    <File>mnkd-20151231.xsd</File>
    <File>mnkd-20151231_cal.xml</File>
    <File>mnkd-20151231_def.xml</File>
    <File>mnkd-20151231_lab.xml</File>
    <File>mnkd-20151231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>108
<FILENAME>0001193125-16-505366-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-16-505366-xbrl.zip
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M-OAT\>FB0/N_#3Y/)S/X]?U#-'D<../QX!->-1M\BF=Q^C4>7>0W_7Z=C@<
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M*1&<2,E;2'O?1?;.#+"/47J99@%V;2A\S$-N)^-TY(&K<@)JV<+@.C>!> %
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M"/+-ZJJJ]]YA8_8R+@G49'D55<;D%BV_3"?QXR]1^GL\#Q>346=^T?;A"%!
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M9 @&D8]&0),SP3H\67L0>L@E#VVJ#-/4!R!2&7C 8WC@9?B>%TCAAFCR65K
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M)\V/;RD1G,CB".4?&4\;-M5Y\&2()[8,5:"]B@. ?V X\7B9G@=.K@^6,9#
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MA@SN-[T9K& ;%'##7[_1/Q_\6W3_\-,_?T?V^"G_NV/^].4N'J#JB":/ W
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MA0?Q:C[Q"&G C;=^(12UT\48Y Q@^Y FXZUUOAB\RW@X&L-U>-77^/5:(N5
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MQ&.A(Y1AVY9G<.Y;AF,SU_"(9]G2#HBOR!6YXG!K4[[Z^</T/][L?*GR.WM
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MQUA&1.L:81S=T$HWKM-N-^R2T"M+Y6M2UM(P)GF"\U,:2)" !!(BBDMWE./
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M%:T;>CEG\SSEU]C"MHL7# &:Q"Z95\+.PA_)!IO392'H[-@+Z'7EAE*-T8E
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M^? P_:+>AI+8(I)9,&_R"F/T\]"G?,DXW)Q8@<4M6B90 ?Y/O@WC8!\G*AQ
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M""R[YE+-.3Q<X<$*CK0/<* BW^TYX//K]G[:FLV]EFUVSK&%@2['_=CLW<'
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MIQ LR0B/+N*(8=./Y#.<+.=YQ,OHO^UTRO%II+>VW6]TX/6-D_+^!+CVA"T
MIS@X'PRP%\61)7N2P "R*PEH0N^SVIYD"[&FK+)(&(&/C(7]?0;#+H*(]WO(
M4QSNKSQ& ERBD$ZI='^ C84#3W1OP=Y!L@,9+-MP:0\2!.]^Q#IOABW)KEP.
MO'P;@!Y(O-N']\^A.-6X;GU=1?-]*%I<"WR[??QGR7?J'P(TV^?M))"RYJY'
M':VD,$0*FX%1R%ON((5\<J-X'A@_QB[>*%R+YVE[P5D(?U[@GDM_;$>!342
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MY@N>=WV%::PW;H)Y/$82I)\MU_]/GN(H#P$+?=B_@E\5(8CIA'F\GPC_E3(
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MKZK5<E !=D2._P DY?L!D4A1,&=E\SN)VPW36'*E!Y+=);%!GIH448L*"(T
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M$1@!C'TW<TL3'A8!<BX%\@2;&A_V<6_B1 "*-4U)C*+-E 0P0N "V?V5!XE
M"E^UT(]DT7]1YT$HBID$$!'6"!G8$YRM97&L%=#:'9!N2G5LV*V*CU*_1)*<
MD2EAD<7::!SZ(LN3*!6J4)2X4NH/&?%R&2<9ULF#Q4CDKYXX<"_"AW"UJX24
MN:'\S!IO"<XB\\!XVV\,RFI.7@@PYVSA8ET;/$7Q,U082%(!$HA1_</[85FI
ML& "A:EA>*446&:\M9V&<U44FSD76_6LRQ5ML5$'6TS4;66"3%DPC#02&AOH
M]2&> !V$],[@0$72 SAZ 1HN%L=[7MO.N,E=+*K(/77T$M<3A97#90A6XIK/
M84K!/F(M7+##R'<!GKRK!U_^8K&2$-==E$\J]:?=ZR@*%+[! F([G1AX7,,!
ML&U/&*,P,N 5EE2**<$Y,4IQC,).WZ'F5JJ5E:)^LY%*1FBIUP#/Z$@%81SY
M4HC+%]&*(&L-[7(P1*D<U9T+\A+$" DYX$9N]1:"6G@*/C,JVL=]?X4-NM4X
MW4@>R-7J:;W</39WYM7HJ/.SJ$:%6RFD$Q5VPR$B=T$.()B%%U6D.?%90)?B
MGY2RIIQE%0SO;%N5WV0D %3P)VFSEA)MDR85[HPU/[[BQ#4JMO-&H0NC;"RZ
MA8(7XQ\JQ?76I&?E[(/R$R_4#R@]C^NA3 0Q1C$1!^EN/!E9"W+^"6I#/BSW
M[.>)M)8>0$L;#-C-WZGQJE4W>15\@J:JF[);-Q,>%;1;Q0((IJH-BMZN!*4(
M+0((.>#6064GP!11.F<)%X1\/J H=;H9R^[1+[]FE2D[-T*DN53=,;P4WE&9
MP^PVY5O?O/&K-T+9<U-,E(ULGXL^'19(@O&48L?&3PI>U'JQB)>?X\@J< /O
MC1 [9Z*#\=3H>7'BN_RH1@IK^&ELM+M-TRC@\A%$%!P)0==^#%UISD[!GEQ6
M?6+&._7H!N/ D#!2Y<1F&C"$;QJS/ A15PA'^@+-Y8@E7 TS.;8I="AZ'*48
M*P7P6[L_:+1*(Y%XX1[T=P8T[L?WI$S=JM3$UYS^2G72/)1G")"% 6C<("%6
M\$#1WO!W;*>IFHA%Z=Q45L^ELV:<)\:G#$1*H;%^68ISAZ0KU.@)NP7=C,?I
M'T%[%X*_E"P[V:O> O87 $%Y/N+G?UYY%8^Q@I(DT%*CU'!XI\.) 8V1BJ>,
MN[N*LTQYR#;E.82JR:)"EZ?NTO O+(#R1(X3Y*DXJ&TA/8%@>6Y"B5!9ZKD(
MM2F0D2^551+<42WF<Q%0OU7L:5XHEQ\"$57<*XJ?C"@GPP>(@XG]&G.&=:99
M*HTG<GJ5KN?28%YW:--Q7UK#1D 4]T Q ,(C@H:DG,<OH5KH\_*XC5X&!B;B
MTDWDG2A>WRGW*66%;>DY (D "RFL:>6V!B^ \B3-7;Y&%-5]$ C&!^G]J+CT
M(C=\^"];\7I>J259%8ANW$^5!XIMD >)EHSKXY 4:_G!N(WO@5$2"AL0S+II
M;%0W**]5KWK,8P?<4O7XZ)V*@H6J4KDDK[<4'&:/N$,>@8Z"&?+2;_1<"_@!
MR>X-.ZD'=T"/_T-?K?6'V-E'H-IR8 RGQ6'DX_]-RPK?'^,P\!X.WWI@TNWW
MKZ>CCC4<V=AZ8-RS!N/)Q!IUVI/A=-IM7?>NG]UZX#BD4N!K+,JBHY& ?RI@
M4XA_LWM$$93%*3HE(KL-;F[IRBT,8#R_4F&<C*LX"6X"]$N"Z"G+HY=%^I%,
M!TW#=Q^09_%$@5Y1D'-T-*"C_QRE$AA+*3-5$>CZ0?A0N2K&&V6RY6![7#*N
MEH!_/""IK$8O1U)>YSSAH8T5D &A5)NOU)*75=VEU:OLE_8'VXCDMDN1[7/O
M#Q?#M.%'Q- Z"^W%%U56FL[GO)+]!S)Z?G.__ KK&,<H?G- EF)C/K\?"FR,
MJ=U/VFN\-FJW1]?-J6--.X.QY8R& ZMOVP-KV&X[PWYW.FTZ8^"USC=_:S9@
MZG+K^^^CNO_B\6-)#\=NC2:MYL@:3KL#RYGVVM9@.)Y8DVZS.^HT)SUGU'VV
M]&@>5WIP(,%8 ">VG\ @MV5*=(-VQYSA'4EHX@<6W$1TN\)C5\AO$7O4/H0N
MMS*<A-A<N0(#ZQSL(PM^DX])*QXY55S&XZ^A>\_-#]%XA#?06.2\48C!B$[(
MC8'BC.("4Q'+"F^C!5+P),:#D2D/,]\%<9Z&=!$@K0H491L;$JZZ8AJ&['BD
M;''+LS@([+SPUG!O*8M<?I%5++&\VXKQ[($.Q!A_1L\G:76:1RAW.OQ5K@KA
M%+F,$W27^@% A.Y3.<SEP B0F'<Y\>([\IL6\9(^2%(E;J!HCXQ'5GP\\6EA
M9-7Z.7Q?Z0&_#@/<@^@G4XCX14RNJS#XS+VC;D1N++DF-P1"]>MMJ'TH-HI"
M/4X#<58G+5)XHY$]\DC<B_.KIM)Q4KA-8(2>T[1 \K0ZQ@IC<K8T%;Y45?:,
MA7A9*$ ;4/,/P<Z( KQWP N,<GGH8$>TB;#( !0]'C/R%!<H#LXYM:HA>\*/
M64JH<;'32+#D5YD/XAI9.#QQ:AJ)>T1HDX5_%#F8!^@"=G&!I6]3+DNX)%%Z
MF!A^HWH>^2UC 4*5OLI=E8'#DD#A9(.7.E7LE+M9,):)&VRP<_,%":P\PQN>
M[!9V@=V B'#OX@#!(&-?T& !=@UQ:=4S$TY\$P%]I'2%^@6;=!6>^:LWJO<?
M!2@-\B!9>$E=N3CO*AM#CO-"-UC(BR[Y +^"E8.))30JA*&L1^E1 [27Y'2W
MQ04O;#&/BD>Y")JQB,TY):G0%ENB*&Z2KPWC8PD*^(I?OH=,A!W*[DG"X<_;
M/Q'7*_/1E2P:76!A<>BLSUAO,? )]!V<MCR77%;PLRO:._TG]V]XZ#E"$J\2
MN:=/53"9JDL%J:MZTJRH("%05[Y4F,6440;1PT8!7DAO]\9%W\"FT4&=D6.?
M*$/*+61$A62D5R[X;\6SMNG*$47(^B0<[T):(-+A*Q[23->;,3?G $#\CI(,
MB8T[ND6''R4,I)@3Q?,%Y.Z(6^*,1-#Z(L#$"'$,SC9;])UBAI2HK=ZIROLL
M?IO(=71AQ3P &<!YP@]X,"0Q<:FG):_R_2H1!T(>H&86CV\V1:3X%EK<I;R,
M#URF@%9 HXDT+K_SY/!.A5&@.)12INXBJ?J"2-"G:X_15N8Y.LK$<I'\I*@7
M<FT35!<N:BTP&L!H],T"'AXU4I-* VTQF-_+MO=O*]2(*N"YZ.';+ D)5,23
M3UO;C@XKOHIXL0BX&L2C&1U(;L#< H8YUI'#[C6G/7O:M^SQJ&TYDW;7ZG?:
MCF4/'7BEVYWV6[W:.RQ40#UZXJ@\+3P$0I 1%6XPJ RGTS0V3]=0YAO2F_ 3
M=GJKQ$V(*7C$4,J/QWR(!^YJ52[;[V]!  4DZ#$N#.E1JD+.?LJSA< ""9$3
M0TN>KQ@(:!O3M&!+5'H1EM?G,H*15#H<N$L?\PYA-<.(73D$63-RI3@=R/["
M.T=QG>3TED$JOKI1947 ?&F@;A87+B03UV=\HW&RUP!56+@2$C0@^^(Q)OOQ
M"1(H]&<#PX%=XZ_<34"(P+ATW;V.U[N W?. &S+Z2% PO-Q)2U6.@BA#5W3D
MBSLI?@. O2SC#!VL($]+0Q8L%0):PU#,@8H%H-P&@6PLXBZE,5#H436"45)&
M]2&*VZ/T"H8Q:\+:Y#BKPK4PO!K&B'DN'':Y!VJ77L>FA+1UE.:2LI#EI";$
M1HS2%"5J4M-'RB@_Q<M'CCD98RQZ%9:OS!C*V;1\==6LEN#GBE$"_^J-PE3*
M%L!BI*L/,IOE^3M36_6A_D$BH @G1&BATXJ88":=&T*-557\EF4@++D2$^[T
M(D!$:#(1(K_%2L(S(_9YH(UL5&&T^DU:[^F>Q+VUUDI_YJ+)\UB:[.DO\T)3
M3KF]/N+GAVJCYX.IOVEG/.PU.VVK-VUU+6<PM*U1>]RWQDV[W>F,^F/G>GNK
MX&K>_LIU8<40K[JKU$A!$>DO^R5BMT'T)N4IH$<W&Z0/1;/!7OOIS09W]"<\
MU/>O<6K=-&Q#YQR[>:16.?]"G^QT5Z@?;6JV.8Y"=Y [41NEH]#"F;9U/'N@
MG[9)XRL%>KM6<JW^-:''_'+S$0N^%L6^3O7<,7A0[V7?YPY8X;1U# :BZBLB
M *'.7*0;"=2UMM[+<*O&O\:_QG\=\7]4H_%X.H]"[%Z/QCO@0C3IG[/HTX2@
M"4$3PADTM#B*ZL.D:51_6O%I,M?R3A.")@1-",<Y!:J3\J ,NYI>_TQ/Z[8E
M[O'NJMH5MT$4*++Q*F@#U3Q571Y[S@V//PV*-=F'AMUEP>[\O$._8<J#S)K4
M=K+6BMH\TH2@"4$3@K:37X&]HFT]#;LZV,G/L(J/$F@GBW34V2 ^]7/G%YUV
M27LYOY/FN<3>G<Z,/*#9:#<'9L=NG9_%>(KH^C/%<:=G]GMMC>)+1O' ;/<&
MYX?BN@<&G$=,W$60\+L6T/# .3$-O]?2Z?"H[9G=MGU^PDEC^ D8=GK-\\/P
M^1V.=*2:]K>?C6C3A* )01/">1!"W4]B?\BBCS#U4)9]K+,6O B[[EV_:=IV
M7Q_*+A"UW8[9:>KS]D6BMFOVG5.[ _='K8[^J/<MO(Y@T+"K0_1'_=TS/$K:
M/X.H$'TDJ_V13)_--2%H0M"$H WENLRIC3T-NSK"KNYATF06OQYK6-=1>]VV
MC\:_QK_&OS9YMY@!;3 #_#B?A>P%;8^OG[1FAIN&GH;>%NGP'74JVF'B'K@Q
MTGH/K&?TLEIIBG7K)FR$W=%P('B)8A^&28*-,+''UNBA?.0C[R,\O'<3G_[U
M!_86BVX^4@=-^W!-(IN3YJ@]&5E3YWIL.<-.UQI.VHYU/>UU6\U>:SKJ3O^T
M_W2^^=M'YU\*4 ZXERJ4?F4>"^X0C$=KC#D8]*_[UZ.)U1YV>Y9S;?<MV&7?
M&HQ;[>M1JS^>]H9U;XSY"1,88*A?6<K<Q+NEGF\3=L?">$FM!,<)P^;<TR^B
MT6H)5R+SH,H**XTTL<L9S8!]S,9Q%#$O"[P\DQT>4T-VV?:H21WO6$\]-;%S
M7;Q<QDF61]AR+XNQ&2-?@WPI41?MEXN^4IL:&Q[?@><FR<,\3I!PJ,LW?)/>
M8L>]8ES\$GN"W\1 55>\Y:#ZFNS&MVU>,17OZW=%73EO$G=1[I8:>2H3PGA;
MQZJT51<#E\MF?V&#70!*M_.M7!9(X9S&].($ ,<[$/+VO0(&9;M$'$@NHV%,
M98]/T0@3FS1*-!MYY%/S7M$[FG94Z8DJ>BN+'N^[-@6CB![;3^^/NYVAM_4,
M),DQ6Q4N0.E9$GBPV4\9O#R,_)5O?@=Z2X>PESN@NR,U%1SU)T/GNC^PQN.1
M8SECD!JCL=.TFKU!L^V,G&Y_4M>>ND,CS1<+EQIG7V%O=0D\& I!A.R*#: )
M?+(?O?& _<D8]B?;W)T,1D)P\>ZOU%06GIP!W=SK!H=D8HD!^LVG-SAT3M=E
M\.A3OX[&<O^G2?\Y::^MGW-B6OR8&-^)5<?SE2](YO(.V[-BDZ=VX1QDS/IB
MYI\,74$\ID1!Q?".)>X-6_GV[V!:9^6^)R)_57GBV@T2 V.J5W]8LH3C]Z3H
M/;^6:[_D69JYO$VTFQG_<*,<U6>A]!ZQA'2H^G/=G"VS:S?-7NL,TQ#/(;3Y
M*WS:!T1NIW&.>*U[3@VIB7J'*5Z$:+)-N]TVG9,G6VC1= 3D.@W[#/%Z?J'5
MZ ?6LNKHY/P.A)6- NO41'U9F6&GEE&#,ZS_57?SZ3I.YBS00ND%A%*_U3?;
M)Z\PHT72(452_]1IY:\X&FG=H[F!% \9#?+L"3<\?I0XFN,_=_:^37FW9[2U
M=_.EQ*5M]IN.V3U'+YC6A7OHP@T<5'>\7IHN?+G0R.?/>*G:<"V"<U>(Y>%#
M?ZI!1A_P_A;>%5&;QXHP['1:0^?:[EK-D=VVG.EP:O6'(]MJMEOM:V?:[0YZ
M=DW#A/!-"@Z4H(+1!+0(>?3;EK!!^0K ,<U2"C8386,4;!9$U&O.1PN#??'8
M,L- .(PR IACZ%R:>QC8)P8),)HMI.@V> Q0 R@7H6H!E@RCF#:6IB;& M[?
M!O"N!Y13&<!SET$&-/M?YC>,8GEB4;B.B&48^%:\H[Q@5H*@TCVBH$S\MT/!
M<_!'V[B'3;]M.0W;6 1A" LWX6.SX90?\=&W+;O1@1&*+V$A2PRXO&/A@[)J
M#E1E@=7U(5"WKU!9GZDL$$8VWC:5!<(H\+F_LL+*FBO+>\1*7&/UW0RX+2+P
M_\O=!-X+'ZZ#R(V\P T_1+#Y!4F'(X7ZC=M.N]\>-*UQSQE:SFC4M@;#H6--
M^M>VT^]T>N/KNO+P)PKT0Q*!8?Z2L#/F$GB&[V;N_M1-M ,C";)QB+%38!P8
M(:-(7!QF'F,)/SQ/D,!/=?R?&O_7Z>OX/SWUZXAZW)@>__+A=3]A)+LJR&@+
MLV(S]3K>'C2ZL288^$<>,04!38V %T; )["Q5_6YQL)+8V&34752)%R:&MJ*
M4=LY$DK??4"C-\Y3L(GA ,I/LU<\U#I%'P:9V.]KA>7Z7TH4X"WN'[; KGXW
M$:=Z[AA<J??R&O=2]X)3/[/,".,T/0=I<(XW5N_:3;/;.74 AX['.2!&6WUS
M8)_Z>EEC]) \:IO]3D]C]'(PVNKUS.;)8T!>=6.'"RN@=*A  0T]#3T-O=.5
M/CL'CXT\E"F.+S4T!!8T<]/ X_6$@C"_Z,R*$UL2S493G]XN"Y_:TK\L?&K^
MO"A\=KMG@T]];#OUI-ITUM#3T+M$Z-7]YDS6F3-<7ED.B_8NJ.LVG=A2(T]E
MC/UB"4>T]3,;A<G+<YY\[W(/<C5)$&P/\/[FU#;&A:8'U@3'3M,VFR?OQJYQ
M?%P<=TQ[<.K>W1K'1\6Q/3#;%U$U3!\,:V9>:N-<0T]#[QRA=Z!61G;K,G(@
MN[H'@IYZ3V_)^22?U#KU2.= GAH#.@=2YT!J+.@<2)T#60<LUS^BK@ O!M#M
M@EW]+EM.]=PQN%+OY37NI>XWN3H'\L@Q79V6V>R<^L951^D=$*.]MMGNGKH4
MJ\;H 3':[IJ=,TJ8TQC=!Z-.^]3WXSJ6]G(N7O2UE8:>AMXY0N_\'#8Z!;(^
MAD3S](T;M6%X6'R>CUFH\;E/"J3&I\:G/K:=W ZKI?&G36<-/0V]<X1>W2_.
M= KD>:;5M+M]L]<_]9E.ITX=%<?]IMD[>2-HC>.CXGC@F';W#!O6:QP_ <==
MLS<X0QSK@^&I)]7&N8:>AMXE0N\Y*9![-\K<O%S^#WVUH^/P$UJ+5KN33MTD
M"J*;]"-+J&OQX3N0CL:MP732&EFMX77/<L:=OC6\GK:MR:1[/>GWQZ..,WAV
M!U),+GVNR@U%R+K=:AB5Z]#J*9M0,2LTY=9S\XF[IX[HZ"^/^U=J0@/[XH6Y
M#Z^24P [$6,3U66,W8N!<L('\<,=]D?U\B3( GC8C; /*W8CYLX%WYCA@W<!
M9MB6?@7X$ONHWJ^Z*J(<$V>,> Z#<(!*IT6<9VD&H^,P/LR&O5=A!%AO$/MB
ML?++@0D4B/\K?1YA[$;<ZS%RH\_8!GFX@%<]U\@C'V9TQ:Y#QJ=PD\2-;M@"
M-@N#O$L9,WZ&K1NVO:4?])BO%KTHRX3-&39_!GP C[S'OL:TKNPV2)0VM;@*
MWJJXLNAR3-&&>/,>8!QE%]3=.&%9GD38_ODC0"61':?YU_AT=ANG3 Q'L\(@
MLSA)XGM<+)^%1HKBC+I0!P ;^$D%OFREN\R3)8XF<078)L ! !*VC!/ZQ%U+
M\(;T+#$A28QW2 ?O2WK#E3#/S5-&HW-LB+4EQJU+^Q8[ >I;6S;?*XR"S=3=
MZ,%X%R?4+=MC2>;B_P>)ER]P&Y[8/+;0OD5-DM.<"8OG[QLPPF2#%TPL"# ;
M,B]+.00D+Y0LDMVZ&8$C#P%J'K"%$<Q5_@!0Q#@7"<[$I:%BX)<T9P7!(]'
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MZH-B?<"B5> I3XEFKZE5X&NF +MI.MT+T('U/R3^R-R4W<:AK^\-Z\4"3GW
MHI6A#AK6.O'4A&"?H4E4_S,AY:Q[F*3.\Y]! ]XD+*VU_COU<UJ:?_6R^F;3
M>36:O3;;K!,%M =FIW^&SOYM18C4I.*Z5"$ZV7//6/.J\A.IF)1,O3$/<P.-
M/[<,T*'GW/#XTZ!8DWW4$7;/=36<7N&?^CEMQGR]$FOVS6Y/&S*OF@;LIMF^
MA-R.W7)RYZ&T=1R7;)JB+]8-DKH'YYSZN>/NZN79]8#L^<YVFJ9CGSK8\N2E
MZ%^C:#YOG_'76K8[C/.7N$<#H>UZ7K[(0RR)!BOPV3)A7D!%-#'4Q!!MAN@+
M+=6U5/\JJ6X/S,X^!<Q?E52_%-SVS5;KU+EA^^-6NP2U2U"[!.L#N[K?MOX6
M9VZ(-ZP;"U6;1L3T8??,_97UJK;E],V><X:Y9N=X%*X7YNU!R[1;%Q QHVVJ
MD]A491>4%S0,OG[2FEE5%P:]1QK6'*;QQ^;E\G_HJ[6V.(_W1:GV41ECTXQ9
MG+A9<,>4KBZ3(/7".,T3=OB&*NU>K]F>]-K6\+IS;3G3WM0:=(9=J]T>M5N#
MZ6@RMJ?/;JB"Q>R?*ZE#45MZT# 4.,48$NB6H")$S I9M=50W6?IX@;IVS4:
M48G^ZW<3X!^?W"B>!U?8?<%C4<J,X4W"F,Q],_C/QJ=\N0P?RM]H.\%A=GG$
MCC>_('*&^4V>9B7WV+9IH-_;I&8WF//G1@_J9JD2.?.-(,IB? ;&$+^LP<@T
M[F\#[]:8,<]=,(/-Y\Q#WC&(+#ZQ9;;2A:#5YI,WC-\CGR6T!)AMD<KF.]69
M</GE7.IZ;[ E$BP2EBB7_<4+\Q0FAT7%2>C?!SZ^'_*14GS2 V'@!I&<2XQ5
MW@4,?DB-I9MA=@?,EK@^6[C)9UD3X#-8/-9M?&_,8[YPG]VQ,"X2)4$D+!8L
M\0(0T-R%C1,-KW^=_OO?PP8,L->6U0V+7V[=5."AV*-!)B#-FK!TB0V,9D$8
MP)D1MBG6):<NP6'"$&D^^P\@205'91^(OR +$&"W;F;<!V$(Z#5 CL*V%P#Q
MV</5&Q5\#;E,>M0-TQB?CV>@I5R!H3QE"G!"'"!A;AI'U,((J"9.,D+0/ BQ
M_U)BPONT--S@ OZ@#X@,EHD.H$O,Q('9"!MRI_"0W-3"_0_\P%])!7KR*$M@
M9PWC TDMWP\02V9E [<N0'<3+7&0XS*OWE10S8KI<18)L*\# %^OB2Z 19RQ
M-;)BRE9Q"S!7L2W</>*%5@R,"4P,L]S@;4N,19\$Q%2 P1!(7#/&(GC48[!C
MOV%\S!-LATXTLHU:N43<SI]!6A(FQRG]#"(JGP.-@2J5N<5<M)9\#/,$&;X-
MRCKAJ58J']5:X!8<OE-FBE^6;N"OR& C7UKS!*?VW/06!EGR'G((@+=VI]EH
M&@N@+QZ+SW%S&R2^\5?N)IBX#8]QZ?IA+AD!!BF!#KQC5F@"R"MU0]@0#,O2
M+(ZP @KBQKL-0"KXIMB,7&*%QQE0.&$7D">H!S: G][V>IW*6G$5<@:Y*9"Q
ML%ZN0-Y6GD\8WA"J(ILN"ZO2MK(K971XC,9^JX*+&*X8E+J\@;B$]P2#+4,F
M!?8&EI$:X&VW@H*5$07,)+ZD(((A_!P$+L%9A0/(H2&1]L9F/1MT-'.3".0)
M7PL ')NSP4>8'[V&2"*K%+(.<XX+,%XCQG,Z[H/LEF;!7H8I E3 80M\<0OI
MDGG!/" ;014*[JI=<,]E$!<LJ'I2X&KX'35(O&/?**$5^5S*8 #F/,@D/L F
M!\TN)T.Z]1D*JP#!-,,>C&"(<%4=@&F2L,AC0+C9/<H[3M@1$YA19 P1!;[E
MQ:G0'>S+DEL10>3E24)J<(4U% N*-"<N1P#*0YEON!F(Z5G.^_:!/.3DXW.%
MLF)/F&JJ:85E.=W"IJM<C<K@$1.D4$W4(=,WNIUO<1<2=P31-O^NHMX1%1X2
MFXO@*^AE@U;89$:; F>T/$0838\D16N%(0LJFL=YDJ'46Q5GSY#YS^^SN+=*
M:1ZG:V55&2.I;%7'VY2Q1/RJ$:EHXX3K APFX)"75 /611!R"2'9GDL0SIU<
M7RS0:,F7*$\X+QI+C.2("UN[0JU(K*6=N7 ?<'%NFN;<OA2;JK>J_ZV$+_&>
M&S[\EW&Q48C!M'J6(M81",L52P$9/4@)E@CW3V.CV^R8QJ^HR7(&_^_%-Y$0
MA63>"QF'-AZVD17B@]J8PJ@N?Q(D3(D%?(S%<Q.M13 .9R25<51<LYN2/J'9
M&G)^OBI?G@/$S]RN*]Z$!8BQX0?<"4-B)=IB^#(*#"X,(]5) "08I*BC?3 A
M[K BZ2VM(?:$<(6UIRRY UF2<H-<6*@(-&&4P/JP0ANL9QY\H5?(1N"@(1'+
MY6$8"D5'*Q<V]P-16X+&KJIH2C"HJTTYXA9YF 5+--=#\34IG #WR1&,FI$M
M74  H_;$A$X4G<A"(/""TBCPD@!6&K@E\X!B"7-1GES@52@% A%,(>8EBSW-
M8'>6&Z)JOZ-&RH5X\."T'X,2:!C_1.R(]Q$B?,5\B?#1K%),H:=A#( 5J*S8
MD^<7XOY=6U.5K;2UD I2%I*9Q9$%[S"PDM0U%;J6;"UX#&90T)"4M(]C1!YB
M0)BH)*IH>30H+JO^(L-%BR5=<!L(K:P5JJH2GC@$I<9_<O^&?D;O14*B(U;H
MG:V"<".2)*B7<5!V,X8%$XN2P%A2]VEX#[##);E9H"*]71<=S_%JK)\@BP7*
M=V,0&]>N)QP;BD)3S#Q<NQ" JH1!]ZQ+#Z0!K!5M,/BVP@PJQ[T+E* >U64D
M?2G;#^*T:#KB5_TB5;=2Z4TR83)UMLW>%VG0P;/JPROG9WEZ+H2E<K9O&!,2
M"V)5G#18YH*TC5P:8)-J+H>:,<ZXI 50*%3M0G,70L@Q(897X$\4JV"@)"D
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M82F<8&F];3NTD!1D<&M$A=QN&J 3IN!LMN$.JXJY^UO0,@]6?!^)N[L P)8
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M!PY(2G3XMJ.^BAL>R%Z@Y^J-U#WH(L)6&"SY89_5\RM)Z<"A0"EA[I2HYKM
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M<J1*N.=0AB+1&$27*]1+M$M':W)$KL&LDDY[]:::4+LAG?8Q,ETW=FHMN)5
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MB#6@I=^M;'V/+O8 [_5%W/#X E18[/E7NJ$S[,\'MNR\]/M_8N:R.?K;-W"
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MO=OLG-9'@V&W/AT-X'][W>FH-?S2^M)Z_?/"#5.?O7^%K13=?79>R"=V_4Y
MBTN?*M]C<-KNC9N]=OUX"%OO]J?']7%O,JB/)\>3X7C<[G>/3_=TJ@:^23D=
ME#]3I[0:R2Q0$"1,VI7WL<,%;AS@5KK"I8MQU,3W>229SW,ZZARWFUM?=E:A
M&Z4UB??RH#K/3^=),$-G/D[TPBFTY A'+[[3ZG",2"=&<.B>PWLNS12C"53R
M+1T&QGEARU48W_@\#%)-?*899W0Z'B7B7KN)IV9HR31*WBU.1/)#&;DK40>U
MI+R\DEP%.M41S9S#_26<"T"^4@S[#UI#?2D-"_;R-T?_T;ZCPLU@D)"^N.46
MWYJ')S^I3^I?G?ST3@5*TT> &09A."NKAO&H+ DH2,L@P< J_%[FU2$<Y"L,
M:&M<^E9 [P(R+$UCQRC0-X\OHN _)JB76O$[V**.WO$&=,#-9#&8<)+:'6?"
M\/1K#(,7D2_'"6OXP''H GH#ZXU#&IXF.2VX*%_>,O;\D "J\B2*ZQ828M 7
M7SJT /AVK%3OX9UN %?#^;!Q:WJ^H(3<5KD$/7$.\E+=;G%0NLY6"(.%#LG:
MA,Y 5.-O3?:-; RG-SA7,69!\=AVGNZ7_E['/",38,5 ?LVB2/U=8+,!Z-V>
M<X-AAX9S[(-V3@$X08#L,D@\YX_<37"6'9T'R:>8/C3S+US*BN#L!DZ.N PP
MY(@A>!Y;#U#E\?%FOQ2;2RCQ*C:Y53PM6!_5>EPE>ISQ6O:?*#=&4C7P7#Q,
MC^[9#G\?;1FV/L.L!=BZ8J,R:MUDR7!J#5RYBJ$B=KBA7TXX,Z"U-F<P %,.
MK-0+Q@XK(02_9 '.7D.N+E@[NR&YC4?#)#KX&&%,C5/.,,\$AQKBL#O,BDN#
ME*_6^G26N)Y4Y/V1QW@@14#QCG@_?TQ13L/YM)&946"**-5*1*%,"<X4(;S&
M8T4[>8?/% @,Q!8\*G'2XI>(&3Q3D/(.!#'LM""=S6>]10Q5OZ>2#98^A_04
M@C+WXOR>S"1=;=^ O9"-_["=%4V'U5Q8@7&3T%?9 C3;DD/GP'S2(,/LA^2*
MX<=S->\=[+ZC9EB*'F],.+;&YAW?F$<D4W2,%S8%MOU/Q(6QX9.?@(5-@8.=
M"0/[!'OX)8B"9;Y\A/%XP,]]>RY>=TU7G0[&IY/CXW[]M-T9U;O'K6%]/!AV
MZL>MWDFWTYN.CH<#UE6;#5#)6Y;M\)W 4 3^)TD  R/EQ P#/F4<X6M[-#W^
MI-D^[;0FQ_7AR;@)>OR@"RI\?U!O3<:=:6?:''::XWW7XQ6\)/O0@IDC0+L]
MD=M>PQ[!C)J'K,$2B:=]HX=\8_ZE,P_A2IGE!H"/)OEL(X=5 VCGF$/L\6!V
M.&B^P*Q-2A5(<1)JH%,K99RO=41D6_2I6I&GX$'X:7T 3D=,MAP5&4R*F0QA
M3<Z'PA$/G8<9*;B\!959I+)+]8(U-2[[AM^OR1=6P ,#VA2*^VV05N]HRX?R
MP&FR.G!T]ZLS!PD>\(6(%F!IN"H7:B*I&'.:A8A\/"EB1^&+M*)9CQ(]W25/
MAQ6H>9S;Q@H$"Q%$ LZ=4_9+!].6G8T(::.C;=L4T]E9Y[(RY(M((.H;P!WU
M-IQ;:[+&%C&FV5E*':ETE*6%B:6U[:L2P,DJ$_5(/K-Y1=;[2.'E1W< %E,T
M%=)1OG&P5&BJ;\KDOQSMJ)Z\+?U[7=[=@7L^DJP[!1F=W9Q%H!3E9&^02^DS
MX)(4Y7 ?A+/H(T_$?KBL(ZLTM:7=V:_3-9X^'H\'K9-AJSZ=GA[7NZ>GT_JX
MT^QC:<YI_Z39:W=.,/>J\_KG%OZGTWT$@7=/6'RO&Z"A*NF^WD ;;Z#3Z3:_
MRPT487'/&TBW?586E^[=H(OI+ZB)AC+"4,U4H"&%CSL6^0M(KB_K-]->3[OL
MMT:=T^ZTWCR>3NO=3GM<'XV&HWI[<CKJGQZ/)NT15JEU7_^,?93O<2F/#)Y'
MOARU]@NX&F1:C=%]5/1'!<[M4ZX+)"F^)W)-JKJMCZ$;_5,YFRSSX(D2<4?]
M[NG)8'Q</^[V3^O=YDD?%/Q>J]X;CCJ=5J\]'8Z'>ZK@6]X!5+Q,K52Y8&[-
M):J<&Q<\4TO2;D411\4CO37SMF:4'BSHE+HEI7+)3&[;&_A(X[7[+V.Z=O<;
M\G#;SY>'^Y(__=(201\^X;?5?*(1O_^#-LWI+IN&3K0O^8H5)CS5K.>7GQ2\
MU[!_WK3@/S?L.WO%XO:_6>:GM0#O$==JW^+X>D%=AAYQ(X\[O:[?^N&V"ME6
M8]C_87_@MS<\ZD^*,-U;$:;=:+4JA*D0!M]L-D;='XQAO\Y:V@>(*?O?NE.G
M:5U)9+B2LL]' [W&8'0;S^R!D#4_D0-O?X!9<=#GQ9Y;FYCT&\U1A3W[<N!]
MPIXV*&RW\QX;PPX4>P[/+/ZGSHBM)/0S4TE_U!CT;[5K!J"N=@]07:U0Y@E0
M9M!IC(:WHLRPVQCV*I2I4(90!I3\SNTHTV^T#]'?MN]&\8F4#E7V\'/3P6:\
MO^5?>P/)BH56J%.A3H4Z^XDZCS*"XY$R/$NII+C &0UZ.*%D1<Y%I:^F]J /
ME8[Z_9+9)\/!>'#2[=2;@_:XWNU.N_71<#JM#[O][JC=/IXTQZ>2F3MH-D=]
M.YG]WJ<J0N743;!\.877%/R#.19V!&&>/0H(OB55>0H'GP[;HWJS.1S4NZ/^
MJ'[</A[4)YUF\V0R.>WWCJ?8NV/P^N=ZLY"L?,MY2BCA7RSM+K]<N_)4#3V.
M6]-6OS-LUZ>3WG&].^CUZN,Q7/6X>SSLM#K#<7/4W=,\87R3&WHPQ&"QLXB*
M=>_4R^-L0U,*;J+!.</G.."#:I$GL4=MZ*F^KMQ2POR([23:0YIDT;.JPLSN
M])6:O=54/P8L^>,'N; :M?),M\3&"K\XDMX&1Z^HTSAFC:R2 ,>IS.)<52VG
M/L[6R'AL0.)C1P7N0NR&3F"@<_2*^N;K[OY8G>6;7@@R3@8;C"^L'2)UX%"5
M^M+]W<>:PB!RX)_VG["!P@5 #7\'%!4#;_15GW55GLC5\@QEJ[ZZX7SF&0O%
MO@0X0>4J\*^Q^@S/;W6?IP(T>->] "S!/ZH.  @S['TN(+6.(+5NOP$C@ 6I
MLSTUJE@XXZ6/1?/W+CR[$[VN5?IF22[U>, 'I#Y;ACD%?GH"EQ?&V*W_\2E^
MW.OW^]UAOSX9M";U;F?8J@];$^#PTY/A<#)LM@?MZ8,IOM66]/6'D3>ED[6&
MTH) 00PV,P$V>B%1W"TY9WLT+>9#Y)S[JXS2@H_L5OEZU!--J*#AR=PZ1AU5
M-86(DPLW"OXC-$1]>63F 3Z!J)]>!HL,6Q!8=9]29BS3!G2'BS,D_PW-RXN?
M+@\7XO$, ?7#R6CLS76<_ [$"P3.0X"2^"MU4PAOG';_!]Q+:S0TK7,*?1^.
M7IG!"L43S_EJ:51 SXP*J#EO6O9/3/QOFHVN'B9@EYC>M=)#+<33NV G*S4?
M8N? @PUWB+,:<$?MQE#O2/7[,",1U""$("W,R)[Y/.N!IB-1G4N0I%FI%K>_
M_S.1\,:0)\OY=Y;,%Z^=A)XI,RYDQTRVUNG;TI?^9K_T=S\"MA_*#;O>$JX
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M:$RY-Q!ZR:RO0H0*$2I$.(!&\$\B^GZ-HSJ*OTKP56A>\;L*$2I$J!#A::Q
M^Z.<B-&R\BYVHLZ=4&S;%N_P;EGL2BB(DD/6XT ;4.:^LO))/[CA\?O!;Q\.
M44'M14#M\'Q!G[')L2H)J;3B2@96RE"%"!4B5(A0:<4O6E.I]+L*:L^E%3]
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M7-6!&L7 ]-/I__[OF!Y(?%% *=J(R(]0B5$Y)9ZF3H"L,T?."<I1PAXI!$=
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M5]'Y?W+^V &\K>N8!4R>#17MTO(_29H+: 1U\LOYGB%'3->(R8$F^(KO6F1
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MA2ZU=IM. UIK<P8#;$N5V^:L9S1;@+/7D*L+ULY^M'N&(U:BP,<(8VJ.:@C
MA2,15ZQA>1E=K?5IFOC(JKWT*% $M$,)D(\IRFG@@($-S(RT,:)4K]BA1"IM
M"*^/7JG?;N,=.O6^('A4NUF+7Q9F0>JR?EM/U6J[]19K-.H]9< O)>YH%"K2
M;\G;FAF/P?8-V O9^,_MC>TI]@J,FX2^<EOJ>A)B/BF6@4HUQI&J$3X0W>I?
M-+K)KKXP0;D=]1=HC7*38. !O )!4_%L$LN"WD%6)(>&HSYJ^:6+_5^EPA6!
M2_QJ@ZU>< WJ*8_#5J_>;=9P_@7U(>7^'_C^*7:<+]'-A^N(U9&:'>0Z/?L\
M=<[P<*"Y-9QFL]X:_2C0)@B94?"TV1/=A7=SDR3X-_>ES6+E@/QHC6TYYZ"2
M0_WO-].WWJ>YI0-!+SQ.XH/Q3@,LWX,]?JO*_H&,TWGA133DV:5@=XW<I**V
MVQ0FZO:<S7M .4:^1SM@I)JTB6;)[@C@%]KQGG)A8G$=\BZ0C^4.P\Z+@0P5
MC60-XT:[IB1KPMD& ]/2RDP2MJH5B+PP- -6N(U!BI!T>)'&_'I*(/'0:-69
MOMCZU%8X],<Q),(A2(=<R8+5$MTV(U> !*,T9-8IGFJ)C7#&@8E,(R"LA_6J
M\IIIPKCI$@Z$%NRQ/Y0K8N;/G$KKE%N)X]/MPUX*$YVVM>8PH]<SJ=56'6MW
M]8% KZ)'G@:XR&*_!ID.71RX8H_8T67AM?6!ZOQT:>3*UF$]6/Z+Y=1A376S
ME-G.>9BYD9ZAKGP[JB6U7K"F)\;S^[5BM2KZ18Y*0YH*<X?X'6WX4WA?,BK,
M^""Z$"$#R\!;Z.B!F<]$7*)PW*/B8&\9**37D\% M:WUI>(5 B30HT#(ENX@
M;W0V(J2-CK9I_[G@'F&3PVJK7T0"87(ANT"Q+-IXI1<Q]N:U;!JR:,C%AS4A
MM>VKJHZCVA^L!W5O6M%.?Z%'=P#630W249/R8*E];_?+[]KSGO%&%@K9PVJ?
MZ9AWYCR3 L/0<"L/=K.Z3VTE8 WS8+TG"6G?6FH6W!\U%1 EH67J^]7P!47H
M>JP9C]\EAJ.9@P@>=1A2W?4$!E6[JILUZ!;NE!!"WN$"VV3+R A\-92&>6GJ
MFSV5.^A$_D6<!;HY'(+P"A.2\&R\!69:/,"/_VV<T"J+1$]6HN;\)-Z]6 J2
ME]@MQU(Z[ &I=I..TIA;';/1[<>UTXB@3 5<^E@R&-J:X4H]5XCL);G%M 4C
M):?4GFQWZ-+"!5B)1@3"H2ACAQ4I0[XT6(1_:<Z#%N,"*)E>IV<]$_\J;4R%
M_E5DSS)8N1>_%I%, =@^7^6IS;!?=A:0=)+'E6R38 8N2 O +:.= :^O:-:R
M.!%HS893HC(UO,>8O<K3;,T1X7(Y+);+TU2,77NX@,99+3B5D,XS]-SHS@=R
M]4G)7)?3)R*H1!,.?3.6)!/!+BQ3PU^>0Y"?E[ZA0F@!=X+R92JAZ5UOCY+
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M(;H/B-9G,7Q+$SRQ$.32YED-?F W*&2],E>0VR/G!W,(VH7B$3:'V*K BO2
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M$&J8@>O5KQP]@,;6".P%[0:[+?3:2_HI97Q15N(^?J%72W9BV'>#P!UIEA6
M5G<<1^N-;$/KN:8UZ%OVT/++G);I-<2_??[[UK6)2S/':)Y-W.N>WKB$L).4
MQAUA>4F4;Z.T)W/0J^4S%E"<>;:0!U#B2%ND:YY4)/8L)45#W[3S!R1Y<X84
M;UQ=SEY6M13>+]Z<*-U!T8&JE'<F!<.KJSR^BI9XE2A/TB*94#Z0<X7'F#,%
M$20?>BUG^O3L.5!:NW$,7=0RM/7O/NF"#+S0\((^"'80#L#Y[P6:;YNZ9CI#
M#];)TH>^Q2Z2V[H@C\R+QZBE(^-V]'5T^B/4T:U1WAZWO" 7S=!;$VU[.6EH
MKD ;X_^@BO@*NAJ4 XMBTR,X1MMCTXU*PVLX,W<AJQG.T+U#+'%5#[5E;A8-
MFO+K N5/?>480QJ#SC*#9DCS(#JWGEL?+:P!!G?XF6V'U^M !JHS(XHI2K5]
MC'O"PJ,4';ZST25K4K&F I,TG@I]@0Y;K;2[=RL<X?PI#TA#:^ $A@U>4@#^
MDNT-P67O^Y;F.F&@]_7 '/3ZPFD*ZH3O34XC?)W/LPG*>[N)?X[D7=\V[7 4
M@IET,8$#:X[V<PB.8S\8AGW/Z3D6\V"]9'8O:NZ&6R,KTH^T>LRT,)5C[HIR
M-]+4FKD1Z;^7X1>TI6XV$5"G]C<5K_+I;\WOJ<]M<,@]VZZ'GNM3WR75_56Q
M!$\I#Z=?\4)/05F^FZQ(CO-&IPE6+-B)R;2%J+7\+<2$DE_/D*331Z[CFBZH
M<J,/FMUT#"TT@X$V,(>>KP<CR[=&?YB8F'6"1O35-O=][S9#,$9X=T>XPD8
M&GS_V\R"DO8XIG9+Y@4%-1Y6NP96PVN]"U5K3APBZ5(X2&YLE=DM+O,C1B'#
M2R.NH=M-9VXW-9N]6%E:-,IR,G\M-PV.D16VM0Y%=#>J]DED'27E+2[=/G5P
ME5A<SMYGZ-Y\C:=\E_\_XSG>Q?G]. ^@'0AA;-UN',+N1<Y>5XBXOO1%7B$R
M"911-_6Z?7@8H7M8S7P53Q7W6%:&O)AP@# -37OGL=?=2&V/$OB.VXLPM%9K
ME+"! *9VD?XYW5YTAJKI?9S2J?A5'L=/?G1UQZHZNK'$EN5^Q"F,J:JY\>0K
M'$?I-$OQF4%2@ ,>S2]S58_)@[%C/^4CK6/KCCCI.Q2I"N/VP4OX%,M> -ST
MX'(F<EGD 508>1D?>!VQS-DH<[I?,?,1R%>82V<?N 1Q 5^@EQ^KOPW\V=#[
M1D\;AIBJ R)!M(Q0LPP_,*R>90P'P;'WMR%V<8,9E64[>]U\V=QM! 2'$-ZC
MRL<N$FQ$ ?^5Y3=9+@'=O\:,Z YV&^*ZI+A&Q'MN"3*+)L+N=!&T/8=%IH8B
M<5X@"/^\2VTO,#* W^;BUI+H-S"M;BYU.V-LEH/8\^V_Q;X&,W:?HWGG9AZE
M"'/=163YB.KX9+L<[L^"T/282H9G&QUF+JC9!\+>SV\9FEY\$'L$Y-%-O%HF
M$Z45"PU&%'0F\R3%9C2PBJLI<FN6Y?@6(>W+-PC?/YOQA/GOW#<$]',\+=M$
M5 LD^T5TZTU\"$<_CQ$87S2WF$Q6BQ6C_D_!]$T2:A_PVCP/JL'&W"4 %Q6^
M7QLBQ<-T<$^!4<5U9S;/OC&R?E;YECC?.(+UP0ECEQ4I#?$-]VG!]@ W2WH.
MQ:S;^78=I[7N+;FX:2*(>6TX^KE>-B]8W< G81O<<&#$$_@<I=DL.>ZF$B&V
MW]FQ=NW;3(@ERGZVRB=Q(;J_)'3+ SLPX'*0F.$_XNIPD%;7"<X-R;YF@RCN
MHT =5R;L05.C'%BO50ZSOTI)*Z?<U@:\ VP.4;#,%ZL;%(N-^X0F5+5-X>X0
M^'N84SCZ-/SO_PZ%C"'ARI;%![A[B.P4!#.84J.;@MM'"(U!BJ?TQ-[@,!7C
M^C^/Q%.=TJ&I_CKX^2UW]1C$<3Y+(,XBI0A\6\;P.Z2\,UK!W"XNNIWWYQ_/
M.V_4H<NW&N_ (/A6_3M(XJ87.G10QZ XP$#Y-1CGS22;S[EGQORVVVG]^OIW
MD <C; _6"8'@*;?BPM5:9P8]_RF^$E>>86M]PD8 A?+$&]Z!-:;6!Z_/@#IQ
M<%L2$,RDZEB%"H\D@8Q/5/L#?#V=7%//FC2#)5Y?R"_BB1X_4/LF<JJ(X\X'
M^$O'\-;Z$S9,V3H;WL*$Z8IKT5">L VP$P(UL@*RYA!(+4%5.HHN@K_4MAZ\
M7=M\>2?Z&B5S2LF.LSS/OH'\%^"&3>-<]-=!7E07:] 8346;'&3(Y629U;2%
MB<I"]\"JQ<MO:$_5=G(X#?SY-[!L,-"O>;:ZZ;Q_W^^\P39)"[(>:&*Y5QTU
MCRM[K746V;1L1D4M96(QEPX\$6>SN@@NQ6?D1Y .Y8)0;8FZ/"1U7P&2D8W3
MZ!8_0H9BEA1H$/^UBL#&Y/4&>=3+)8UE!YAU%17+RCAI)RMM).N"*G4C>Q0I
M@Y+ICU5QE,H6_L;.0LR=PBH/!W>G.DG03MCX:QR7?<^X']BR;$5# B _AAM@
M_7/8>B?ZFG&[&NP"5M#Z8&>;^;PK^K+1^P7IWC$L(O<%PC:6\-18MF5K-2'"
MAZ[I^0A'BCI7F>@L!K-/A7XMO202%>[],\VHOQGP?;Z:8@\O4K^5?R_Z<Z$.
MD:V)R#;CG&!NW,*->Q7!BZM4,&MG(YYG-MN7N)7"U16066U#@XVV39V6XN_Q
M9$5[M@.Q!QV@L\LWAYTO/.#MEHK=E\Y[\?86>P7C\,-:B/4YX(8.P-LL)M=S
M_.2OB_%_=MZPK*"(@#*"A[#Q88'&!G4R>=PY*WI\I>JZI.JE:JX@,(T/_G[^
M&7< Z95U(FI3AJU_L\H14H &XHD)8DD*0$YNT)&A'DT@[E?S;(R;HMS$J*ZN
MT&/%_EDX7\5/J(<=^+K8YRS$FYB*[01!&:*NGLW8P.+N^PQ>:<,U,RU>Y;I.
MJIP<:L-7ZI8E=9NKNT#244%+,8C2\0H[I?5%:['):EEY4K!(30;BOIW&"S4*
MD Z1RM5(O%\3,38BF\1VHP1^EB.UB^ +V*G_!_@/(6E%LTTDN^T1!BBT,NV@
M1A)G/Y7= ^?<!0XYO10 AAC/\!]A0^0QJM4U>5-Y>-ZZM/AM"HVP.RGU8;L6
M7?>6"M[C-]+2ZGJWC44;NC[%[5.", IEOF6HJRP#>8O0-Y;M:94V:^P6;#6R
MU =3=O:4C5^I_>K71+39%*X 0H "W73N66!/0:$A)G@O$Q^H-B@Y(F@]J@FA
MY[?F*2KS'< K307*YCB\R9/YFH1 7"\G%LV%4_XU[I;Z:N<Z4?N_QF*AE.RU
M.,K2<.,_EM.HP)AYG3--0DO:_L]J7A-^&$D2)UH_BA);RB^0_S1-2-'CQ<CU
M]K*LI[]E^9_4'A;%0DP<"1(WCKF?;8+J&6M<:Q:DKJ7'MQNXS]Y.T2FR+.7F
MOOC6! 6&%P5X,4/_\*A5T._2@I9V>GU]N\C-^?1;,B5]/DN$)9Y3$RKIZD4Y
M^=^R0?2T:KU,T7(".P,QJN(R$,!?I_&RC+-:8FS11AE^*MUF\J)S'/ZVMNKX
MD%QG[N1,#85E:UYJIKSD^X:TIV'QE':2C8">4FR5&9\E""8-E-9L)0G -L72
ME9/ HXIIQW7^AI,6D\3Y6OP;_/BJ:.F1&1.+T=[B",C[KTE!\HYOHU>P$KNK
M[,^=Q=S4E_*7)-9CF7C -K"BLRS_A=$G13],X0U_RU80\I<]/(%KX[CD.7&E
MQK/-(E/_PNI&HR08JF*,/V4N#)MP)K#\2^PT+'XI9C*AF8BVF%<I5>Q&[()Q
M39]H7SQ+OJ.8Y97RA^4E[5%U1*WZH9;6LF7*&-G.9E2O0*I;$'<CSG(;#9O)
MM057!LL:XBD'QJ7WM-%AQJ=D2%_7]11O0F0*G'UM>&K0CH'=*JU]OVX!63PP
M'1$CAWE?*L[QIE4Z;M54';Y@RGU%)WT=D4\4+53SF#8A9C5$(#M)\LEJ@:$F
M/H6]E\<4OY99#2&X@H_=*CK$YN7?:7> T+^V]"H%28EN>"ZY 4^_DNDMF1*9
MTU"2#>C+5.D&V.QE^U?>ZAB#M0W()'!7;DXIE"7@F!W',_+*1,(_LFJN7?:9
M%BOLB%FS;T*[8%=9.L2(L,&\Z%I>4*]R5# WXFY>&TVX@QHIE'/.:V'&J[,S
MK24N3&G4V);T9#E.\?:\+5LAMB%&AJN<EU=D+0HZ&BG*1 D\/"$@V@X%(9'\
M<=J0CO)IH7-+-V\J04ZD3[V6S^XL,MAQ.?QZ.J<^W^A>X^+PP3T:&]"?N IE
M"K@M0[26S*G6EXX9**<LFMBCKHGFM,UC/E4EG3=>L@H2QU'8,IC2H_%5,JE.
MDFJA/6O#J',#:F,13>CPAV-8WA+L#93G7O4,M]R(ZAD8)Q$H@ZXL(YD_:@PO
M++Q(WG46,:P6^8C8[SFOI_+KAECX KMR9!NS[R*!!E^0R7]<3GX:_'U*)"EY
MLLY_9M_@XWG-H:0UV2J"G&Y;3Y$)%[>F?S(ZU(+0O<J;56FS+0J9_U/O\[SG
MD;)R_LP@B6$ZA<?E'4YXXO"GSP-GY/D#KX]0%XYFV]Y0"^W0T=R!-] =3W==
MW]MY^KR(\JLDU9;9S3O#!!LC?AYGRV6V> =FJ#PM5BT,_EN;1:"\;]_M/&8>
MXS\,X[S#G&&])WE#>PFX0EP?ETNRVV J$W?;YOUS!YFL0?P!2_9NL['<FY0O
MS?@G6BVOLYR<)@SJ\ Y-QW'T+BPE_A^[# 4[?T0X$=I%D]#!=O!TCJF?ZP:>
M:O/3['4:;6.@A<!\';F&:^Q31ET?$Z<F@NP..H'H$:)N+6)L)$0113ERW>6O
M^T#C+,KI:'&:@,,(;COLY@\9;W7<P7AA@T\>>6_2S-"'K#@E3[$W'WD*=<2)
M5-OTNZZG=P/;HM_:NMO5G:"K^\$F]HH$8G5(]@WL-J_.E/78:HG6:2I/(].L
M&HK<$,%:,7UZ77EG7X?NR>63,ET?LJ\-O@8M)\F8HXIS]FHH5TB"@*PDFCE=
M0<W0*I>&CH.+&+0M.]#HR<M*>GQS3?!A%*XKJ1:'3O\PZL-#:OP^"Q*\#BS'
M]>!/4']W?+ULC4(F$0/3SD611_&<;0)VRE LL_0SIV1\R=.0+JO\^C3^'LN3
MK,X7&"?\FGSM,#;O\+OP:%H..+^$GX?UI&?GHY+0J>4V"F:U*E,U'I! %3AU
M-$CH2D+ 7NY6=#SXH"GP_E:=N4T@X*#[+_2T(*#]7H#Z+9$9P.EWLG;Y,$P6
MD/,.W_\K'VD1&YPU#&)87=\QN[;E;-B$E)JN"8B<-^[N1A1@=SVA\% QO3;/
MW9KRXLP'!J+QD@=X;<"G+9(T]!T%.C%'V$>[.[_4G)TXO8K06?Z\2G/T3I4F
M)7WEAA3%# 7>CIFO$%4;G?!)F4"[PHV1M,?@Y8YJVYDBJ=GV7L&(+T5[1"ZT
M*.:;>>*8T6J=.L>,>$!(IB6.^8B96SUUOHFK?!QM5;JFDZY(\E 1E8*UGZ0G
MJ;A#4(I<N9&,<\.16TGYN_@"[40ZGHTI:F.^2;E;(D@%S-@ HV/I5CFMM&TG
MN6(GB:/@DDK:UER!',E#K:@SPP6E&UPW=.66U$$J'^2K7V*STZ;HBL,>4A?8
MQZ72&>U"H)!3#X^N([KX59WR49@DM')Y8$[Z@IG+A[@<)0L9N&FH/SEMR6=)
M/-IC<4ZM7 &!)Q+,*21T6%V_Z8E2/Y?W.^7I/.K,*>I7>'V!JB.'%\\[EVF+
M)X%:"]>A-@\:@GP#^3469!'G147C+*@T414[5.-8TIZK=V7*@_&]W)RUZ764
MJ;$)$],[6JUV(2UNN8'JYD=UM;8SQ$85'TA%)?.QZY8%<X"\<KTH_9-B5 A;
M071$"B7B%S%%%XL/EV<H>^A*_/FUH8,'#2/(Y&#-C*WEJ$C4Z [2>7-.*+E(
M-V\TD8Z(EZN<S3*GH-#39%K?9'E72;0A-]5D"BL RNVRH[_D2SAO&PDWU$ZH
M8?#RAQ SVP%:JYNPL)-G&388(I_K6IRD\0H)O8=;F@XR-V3F\(&*<I@R0K+C
M1,8U;[E+)]GC_T$O#W?;]R5F,<0$(4:?BSNBF_.+=.X%6A)S0,KY%BBD!K/K
MQB&CFZ6H(>#U]1M3ENH5!SM"-B%TG.1HBAUM7%Y4O#[54"1%O%RB_8CFF'<J
ML^]\:6$.%B!GQU7&+&3Z,-4QJ9IZ"19GK7=./.F]J0I^FDQ%THV.M.G8\$;4
M#]*)MA +F>QJ$T8(!!NDXJWIVFTBC!SA2^57.GBJB\D9N?5F,9NO>D#*9^IB
M<*1)<%+>9UBQ%6E,Z&AU($G8*![G]2L&/BV,N>Y =RRG&UA>UP%YP]H+6GY*
M7I,&^P;.%&P2,#*@-2:*0\+1#;+5[KJ^^KYPRYLF>;:"8$VURVCS0:@T$,:,
MPRK>)9TKM$%2P&D)Y$SB' \?45/2M3S\GKQE+#0F)A3DX4A3_Z.81]+&X=BE
MJZ>?NS2CZERE[G*  87)"]%40CR.QNF<<_UX<DFI61AH3(>C["H)BDIVHC-E
MZR2-1(T\!U5)5IQ2^4<ZD*WB-1['=-QRH/,.8HO)78;'*7S/C8HKA(&AV3?B
M'Q]9(2Q-EUU]D9JX)?/!O)/+*!+=IM%U7)-$8(/*(G+FMS!2T]-H>J/14F$)
M+X<X#4YPKV8K5,#HIQ;5U;WRYL5U7 9@1[M!1TJU1$'!UZZ""4X^B3245=_"
M\IH0!:+*"587N.B=^]6/^/KKP#XWU9O!4C[6TU0E;YN>M%0MI$Z$'"NN?;FP
ML&5@>JLT+IO[M;U9OE<)5R'6FBX2;%)D[H[E;63,=R7!E7PY8HCB<0X7(0JH
M!YC@9W0AHGQ:/%;UUM#U70?^HR'^MV;W;%<++2O0?'TP'+A LA7VC[UZ2S(/
M1A-]W2L&=DH.[BSF&I'PP1>WS^G_BFZRXN?&S/B7]?FATH6GNIT4GHK*&9$O
MF:49WO,5CE"5FQ7:?%1>,VZC!$;H41;ZS2C\W'M;'7@5X@GRN/"5<4:E5/(0
MNQ--P=C19X1"+,U&F640-UG@H?H=L_/.[^D<'>?R8CQY/L5D513H\ZFCC<&K
MB[_*#Y-^A#^P8Y>+Q1(4DZT3=%7S1+_M%BQ)-87R#)4NG$0=&?YBAE2,7:N5
MJCO"2G%;QE>Y^%X.!N,B/:E4:M%I-K$*O>?U+7^_BPS_^,^++T/M\\>P/WP'
ME.2+:"XVQ9=/X8?/H\M/O^'OTQ@>O?PTH"<O/OPJWNY?OK_\]*Z37XW?@)?>
MU=_^W$&I?-=9Q--DM=@FE3#>Q>#R'Y_?=8R6;?E^^.7+\%/UM=K,JNWZ<T?[
M%H__3)8:&2:(]K,_8^U;,EU>TPP/LYT?ONDNTLYOT:TP7K258(N@D C%\/EW
M^ANH._6*D;SJDU?]U<O* E$#PYDU# >Y6*"\+=2X@22'*F]U)TNEE@Q&&7-0
M21&1]/;+ZX(P "B'!5DNO&]*9[9E/I+O90BH)^$%7:V2*:5^RV*=2)ZPUZ=9
M38P.NVZ2R7+MVVV?K#[(/KJ@E10(%37-YDP<Y8C *YZ6X:Q*>8UNFH,,F3##
M(X\=F"$9&/ZUJ=!5*[S$62OHQ.5M+*ZC<?$D,A_BR^A6^*\M=V9I"%3/DCFE
M!AW?DE./[A+SF3Z$]U@YET)B@S'$-W*FENR9([>N,YP^_A4U".M4.6JE9K,\
MN4KX(D93SWY1WP#/N?K[.(9W4IFOF&'!&;POZH.VIHGA?WQ93T3I5G3,DD(*
MS;0436DA5G32$B=D5R(.HR# SS/IKE'RHJR-HN54_TH./D1+]9@<CT'QSE@A
M:2@O "IZ?"9N;'ZKN)"EXA@MA3 OX2O\;:4X9U5IKC0A\B@-)EM=Y 6M"5(V
M/>GVEZ;;.?6S6[VC@F -(,YPBDI1PO++*YP4.F"5-6?8K[-OHJ2;A%_NZ@5^
M$EV=.2LF^*,FJL*4:BW.8;%?E>2MXLF;H2;9I=8&FJ,K65F$/F*<@S)<\)V[
M9,%IA#2E&W:TA1:RC+DT2ZV%;9S/4$K;FH5M,LLNU9W<@$))"N8RYV9E3K3Y
MM=;"N#>@(ZK1103=H=OJRB=2)=W:.@QYKO)B$]-3GL&(*GE0-W.^$__VO#-:
MY:BVNHK!IB44HJ <B8M%I=+M9,:Y9%12ZK'WEHI"J?KW*BEL\ET]2I?%YRB_
M-8W/9\BTZGQ AJ4UG!HA+K8>_)S]) H'2,D+^9&O+\N"@9]%1EEZNOCE&]P6
M2U"7S5).G!4FW D0277IR?N1(V">M-J"9^*B)+GL6U4X1P%REYRT\DO3REBX
MHIPEM"IE1].M>JGT9Q"A>3*[E1*E7BWD<[+Q4L3TI'[Z?+E!V3<;/&"ZK5J_
M$U$Z.#?\D?*XKC..YES+?!V#NT#[5-S(F<8"=;',2Z'JB/*<9LS'3_)$O2@R
M[%Q(\"'C9;=$H4B7ZE'T38/"B*>*:@A]ZH9'W]0$Y-V0+JB,E-S6E6NX13'P
M817;NLUZ@<YM2T4@4Q+28C615*3#*'VV&HDWE4<XORVSS%)=B*.3*JI/E5A^
M+W]/8MU4:ORD/%Z:\JB'=)MT!Q;HEIT7.V^^9!"_=BQ+?_NNTU C\++2,01W
M6?D>["_YGC):5[E-ORG:7_"(=!N/IR 26Q  <NB%6H8NE1*:"YK/W^A?:GU1
M>7.)GN[2;2[8='C9' \A2*/0I2&NKVG^J3-GL*;&Z0F+@*B8Z_!1@G0H(@E'
M4J(41%1133 1DA0N;R@DD2+XP]L#48%G$%T.-37T>MZ\OQA=ONV(O 7$?."6
M*4.)N&K]Z^5G(SS2HJ@RJ19 9$KX(D51_44F&=8F)V;4F-M(S@VT20[>-+%9
M>C+J9/*XX6,IH?&:+CUK R<2VM15CR2;*E6XOI3/P+,PY1OGS2D5UU),R)6E
MDSM5=XHZ,/38$HS(V=]E)5NJZBJ]4)'  8*<VC8CLA:J;W3X<(QUEP\WZ<GA
M^TOH[/7KL2VIN _9N7+9A.3#0[5+>"=?(KR$+/2X9Z,>[[$C!B-])E>L7[\1
M1PZAN)5.;V^)IJ7>F,H7EM%WKA$2%<4*>.VX=N6,*C]!1(1)X,O:RM]+J<7Y
MK!\K0/!)6TR<,Y:WC60N0=:KEON>] -BA]SP]:.\#K_!NJG%\1%\7H\/R<O=
MTQ?<$"*6-\<Y$UL??P_O4+D:L]4[;/J#36^P=K9S\@?_(KI%X)0(^=SH$KJ:
M#BYA=5"J-#O<51-ZB=X!W45[\WDU7I(*\DU03ZB%/E5'0"2@#5]2.9DE=2(R
MSM6O%;!H5E KWME)0?N,KEV@][7 ;%0L5&?>^.BB_M%*U).*2G7TLY_NZ--L
M2QQY^_HTZQZ-$A?>-6&$ZTG> ^9A=_H/]_0>&A<T[GKK0KFP(6K<^VJ]:YA.
M&2:H+'Q_M&L;NCFPAKZI:X.1:6EV8.M:X#H]K>?IMNX&ACDTC_[:QOL*$HSD
M1JT<)I0-!G^JF+GS!H=2CB3N-VR$DI&VIP;OU,"54*197 ZL4(:J>A05M42@
MG/%!8'F!>=O!'!9N<[E4'B&D5?XG>RA_IMDW#<\CQ!'Q60W1=[]B98K.4F%]
M"6NG3)[S'2M94:, =_')(.%F)1S8RA%Q:Y#?7EX00>C>A*],H/:!V(^O3@B<
ME@;P +S:0$&MP&]$6076.R_8J1"XM:3C1/&R'&7CFLJRZ1GAI:@GT?6[X93]
MXN,&/&&A/!Q8;BV/L<*.H0@$CHB\K=PM:[ZIQKS;)&8-C8U+T5LP1[CP%T-U
M83H018.N'-ZAKK)MY](._'SQWT.Q<=6=K%KXRCC>&X=#?Q3%\*7N.:;1_/9_
MN;F$LI(E0%F%.E+"U3"XS^=^Q]7)ELFF[)_46QT@"B5VD )]T+B[P*!+Z,@+
M&5Y*K,]VN!AY@>!<?K\\=ZSN291H,LJ;$N*9CYT0V'L5T9:,\65, DN0H1H:
M*NS=I$"M(>[/,Z!U-A&01>H%CA)@G-P,9)J\K<67>).B'=FF1&H4E2("E1!A
MM^#/MXQ-$+<=H1\1M,M%C6M4C9M^S>9?RY(/R3X0'*H&)X0-W*_Q7-@!NO(M
MKTF0%J97N)2\]''8-*P+5K+$ZQESU)<%G2V@ HUO(@3.X*O7J'U*QP/U75(T
MX.7@%U=Q2B[K+8-=H4U):\*KS@I%H7: B=Z,%LV1+,HCUDY02E,IK_F(U%0;
M9"T7'-84J\C.D0@)A5:3HH1.%E*Z*C.1?"*>-MF ;U>7'6N@7G13"W<%EE[7
M*H!I)(5XF>R3 %33W:]T%(8KN4\V#[(^Z!J,(8+KDZ00$XMWG3?)VTJ;PNZ>
M9KDF@<!PB:CBI[:9T9>/DEQF>M\DZ@C@6.<"J$9]@R1&I0%Y#&^JKXX1E*<$
MW<+RF=H;;WK#SQ_?2M[@#_5K6^U !\TQOU4PA_7AOTF5F,S6A/$;Z48TC7C4
M3*4?G#)0G"OT]SJJE(X1:H3N>PG![ZYK:!27-9E:WU$-?2LJD\35/QAC_<9;
ME)<4H*:<)XM$ 2);%W^*3!D,B [[KTH0R=D*/2J5'7L7\#R/NOS")YGB<@E[
MKHO5?)G<S$N-6%.HU9'K_ZRF5[*^4*+MG"DP?1SVX;D%R(S<]45CK:13?I,E
MG!O#?8@7LI'/9))E&(HE/.QG=JN[>]?KIAEE_E?@?BJ&V%& V2CU5_-10B4H
M=SON 7+'1] EM* *=UY(>+72G6G'P#MK@93;*YI1?"MQ/UO<N/DN,$%J>ANK
MUL3B2NA-R>A&ON*;N&P'[O_=RB/N%T+?L8,055Q<4K*!H_S?86?BQ8(^U186
M3]T!\(Y=@W3L5!7<K6O0'B0K3)0Y]2_1=\IHK7=(>_3>2NM-8CVG/^PY9E\+
M1D&@V;U^H(6^%VC&R.KYPY'1-WV3TQN&KNM*)Z]]J:EU-H--]DDTSZ&^N668
MW8>1DJ7$1/E$H0?NCD<HP_%M;Z0/=2UP1B06?2UT1K[FZ,%PH)N6[H%$' N,
ME77.R,1;6@YU)L2ZZF)W7C+O98!<,8'D?:FHY.5MTK).FY0J5666I?0$ (=2
M+WH@E4R0+ZE\JW$MX<,Q/*UB!LH+1Z!^OU&)#.4VL/J]>6L>_H^O%Y*7HKS3
M*1M,[/]9D5P&:J_R:$$7EP3= M2F_#15/.P<%LG@@2L"2F@2MP(F*>]4J2VR
MU/<5@#OJIR2F<=X9E@X_6^)"D3BVLX()@B9R\]",Y5-V"Q&225[WVD(4+2=#
M!)=@04M95[EG5:78+EQ6N9%[)1*Q+/=%A$/PG5][-N'^8(;CM6^XC!I$A9:@
M%?DGM:KR;D;Y(=I0[3\G#CX?*__=[P5&KQ]:&A@#3[.MOJ[U0E_7C'#4#SRS
M[UB]WK'GOR6/JK1VE9YK)+81#_6_$$6\!HQ$B=HQA"-)1 @*+9A=:Y$=(@!C
M%49GG&3MN)RPL28K#K[%EJ'KB90F:<HH;]OUQFZX-^$MPL/ <)%P*R',3J)Q
MW 0J;4!6I)A;NJ'#L:D<$$5=8EU#Z)L6*X@^.]<KX&WG_\T''T)13O/_ 6WI
M=307]V*R;U.\!9YPVH5 5+6(F^718W0'E,=B=STJJD^+@VWLZ=$9(?(_;]I!
MOKKJA%.L'2@1;];[:PW"!N8R7G-+8^4Z!$-6V)R0EX>!5_-;T!S 2-PF>3;G
M1E$(&7L#7Z* 2]P#*CEYI\V]85<J^Y9:GE[./I4P5>1,8CN"XN\Q-55[2C?0
M<GNNZ1@#33=#0[.'?5L+;,/7!O" ;QGNL$^M)<U7OYBVZ@7NI$(]R,O2*XQ[
M/@JL RS:3LC#_A2G\;=HCIN9^\$>3'N% ]>V!D"(92%H:>!XFA_XMC8,AM;0
M&KB.[?A E_'JEX_F/V6TM/\\&]1]:7UKB.7N)+_4)>&)20/%C!M>,TS-,A0*
M]YEKLRLQASK%KWQ$]W?N?_WI0425LGJSRF-52,TU@@U]H/>L04\;VJ.^9H>.
MJX4#R]9&0\\U=<\<]MPA$ZR?FX[:<'CCO%4")]?@E<Q!F-O[OXLVW[>]VSY"
M,6?Y[9?'"5 LUW8'$*%HON="1&8Y?<T/!WW-#!UO-.HY=F"&#P]0#N_*(W3=
MF<!3T3BI/%'X)[TL-4<HS@8Q+T4&BO/!RB4C!'RIJL43!7.S/%:4>>,)KPHC
MS+[ABQ.K DQ)\?;=GN$/T8HTJ=$/LE#?&.)M/^9C1.A)/)\7-]$$9OD?KV"]
M\><;Q)86/]/=H/]X!?'UWUXA#!&84OJ]F%7O\M-@^$GK7[Y_'W[\/'PG__&J
M$\V3J_0_7DT(7E5=P&6N_C"57_"\OY5^T;\OI_5GOHK1F,!R5M;F5P[U^[_B
MI_^]OD3YUEG5<PFTYPS^95WT:A*^@])]QKS_Z'B<"2*?HE0WY53*-4NZW%#&
MS?<.W3[J_!NGF>Z;03'J&91_8AWD$(/%LPV=;[=E20[ Q.UC_F7DP'Q>,4![
M^ZP+_5?FO'WB_#-QWCHJY=897P%O,O!N_JW?'PY'HU?M$P"72_U+TZF=Q[/E
M.^-<U^-%W8O5^)</R[U_VIAIWY$ >%:A>Q#)K^\NX^)'NNKXL(];7=T,=D\@
MS;[ET<U_O.+_?750^A]A!4[K*S]NFEW+\4X+_.,NL-ZU]9>W@_?SO)_5%/W*
M5[*$)8J45/C7^(<U1@_QO XGU$[7#=P7)].GA;Z[]G*[INN<5OHOL-)VU_->
MGB.R%D2M):N->E'IYL7;:Y$WS7"/=YM&4H2Y= C1'N-N3IT_]_=:'C]Q[\2]
MH^#>B\RKT/G@#^NU/FL$YG<]\^3"_+CK:_M=US1/"_SC+K#3-?R7%V[^&*ZI
M!>8:T6;G\1/Y!P__X%&Y5R?^/3<Y1\>_NF+X=[H&I?ZB<1'^@3?OE$M\!&1V
M.?N'Z#1TF7]"Y5P\T@U,Q^N[IM4?::[N#32[KQM:KP<#F/K M0+#]09VP)=+
M&77'U'1?-BS:9Z(*8;]%B'ZQO.5KIY>S?E1<8WT5K#Q=E#L4279HNF[HFIIO
MCWJ:;9E#+32"D=;W_)[GCUS3]6V^?!CHV-B1"GH9+%/TN, BTFS6*3N:"8)W
M$*"0^C&/L=_L4!1EA.GT$F^^]QDFCK&@'JO8P0E]/?!L7?/[(UNSS:&G^:;M
M:L.1K;NVZYC^R#GV8@?!O[.J?(;[T!."@03;$PA]M1H(W)F,^2.&J T X[4.
M<9,G$#^">R&!F+FS2F, QE3F$G"JIE"ZGHSC$FMD=R-;+%"0HV\DBSH.EW#3
MV#S//M?+5FEGB"B3I#3CQ4U.'6"4.6.A0DX=YG9-QK[?7$R]:M*V:3)1Y[7A
M5'/FS]R6]<&$+OTO!& B5)\SJA\7%19= 7S3I&9'[%W7R??8A,H69N3)+]%W
M\7XO3N-9LOP0+Y^T MCJ#1QCI/N:9QFPFW4?U!IL8\UU7;MG>4X(&AOU,RAH
M6<^P>>;-N_!<\,MU::S4J!9":/2A;*!XQ"7/EHU%O?"YJISC+I0I#)%F[-'4
M\F#@ZL-0U_KF,-#LH>L!78ZGA7[?<'W/<VQO=\WN,ZMER:-*S>*XK35H*C@P
M0LP(.$:EC7W5V;3LQPFC,8A?U97SO",_6F$321 (@6A:Z_LMNMI/L%23M%59
M:+L._.1CS8G>Q9+=91Y-E+:RPY8^'9??T@[)%J)[Q5^3;%6 QAM>?!EQ'T%$
ML.V 7!C!.\%MXI#2D@\G.P!A_,KP-*UHE/#O:?R=8!RZPF1]K! A.I]%<V12
MD>TU<>4\JU6ZF][<L!-4]P:V#^*R7H&_NZG.\TG*:3S?\'JA,] "QX>U[(%V
M#(Q>J+F.K0\#;V"Y>E^6T[BRG&:?V=?\\23%BL<OV$!0J-3'4A)6/PAU'92$
M-1SZFNWV0U 28:!YPY[AZ: !^])U/5XE(?D%HQ'+.M( *\Y9N\Z0;W:6])YT
MO"3@.Z,="R@B+I_970Y]M_*<KNCRR"T\1!-Z[O)(X"L3J2G.?F+%PCA.!7?P
M@!<C0F<D,#1)3)$@4G,)4,(*:B)0 C)NJ$3@B"LN-IW4N""J7RLH4PEO>$;5
MMD5<S8F*U)7.\2G$F: V>/[,PJ\(E2NZF<OW9.,A^C?!R4:WD@W8?E>Z;//L
MFP"JX=X Y/4M12>F=:2=LN?F.EZ2@ >85FABTE(PEV4W=R9+((PI8$!S7&BJ
M)A8]/2L?G\KT%0'9B%>UH1_<^):)JG#NE<IZ7"CQRXJ>E%J?9CF]3L].8P;'
M+^+FQ"1^ %DGP@+(*I0!ZI8JP1=X!T1*(P.8F2CK+1]74;$A9F7\?A@ 5AFM
M$[S.[10%7 *->=YI[#*83([0"A*?J!#[3 $Y6U[GV>KJ6O9O97E"9A#<+W:O
M+V46,0E1M.6%KVRU1  LR2^Y]#G!VZU1G_-BB,[<-_-80'?)I2ZZLI5$R7_Q
M'++\<^,;--BJ8"Q"@I4C'9#7X+E(QE9D6\5V1Z\BCD501_$'!WXDE55[207-
M 0Q\+MK%-W9O$TH)MU9$H#P,L2&)E2^UU1<BYA7.D'0?MZ"=)MB1FI54U0FN
M+N#E>MZQ"_5N:Z=B*BT0\)+Q9&56Y#W6\?]G-I]><)WZXJ#)'3^PAX%I&YKE
MNJ9FCP9@\8.PK]EFV!^X@X%O.Z* ]J,MBZ'WGJ4:'T68S+N 21.F)?#_8XYV
M8GG[6+;?=OQ!H/NZIKL]5[-]?P24!0X$"&X(,5%_. A&QV[[D6O"CU<XASN2
M6+?3 [CD!C_5+PQ?MI:O@P!2+0JI>&P2DV*B(KE*&=VLQ#DC'15U""FQ0TB)
M:+81/E7 -2A_@4TF>IMBRQFV-?$2S26=C2'D<CRY3K-Y=L5XLPKHLD!L+>'7
MHDZQP%$6&3!@A9B1Z74R3I8$-+RX@7! @E_RMV*M5 #3:!D)-&;>ZN6P..UE
MAGVU!0H<*C4%ZKB5!76 NA(-=RGJG.OPA)C7"<ZM,E]#$T3K &^\-L[M\@])
M60@-8Q#$#_4FJD#M7GOG0?FT"ILC6_E@@H(0&V4ZK#%-?D%]FH95)U&'NR/E
M.$_BF>1&[5EIXQ@$2)KDJ@F;TG.M8 ENEU_UHUDZ(6% ;K"$DMN#$@:$(M(*
M!*2R3521S;^*[V#K(>%3W1%K9U^-M!>@0Q^#XSECGXSB1\WQK"-U!(%N]#U_
MJ+DF)K4"S]!ZPZ"G.1#.>:/>*!B $K?^<%_]XI@J4L?^Y-1R\=DDCJ?%"*RE
M; X(@1_E&"A.#M.I#'F?.KOGZJ,>!*D#K1<$(PTL6Z % \O4''T4NN% ]SP;
MXU<+E+YMV&[%B3L2I9["2)#QCQ)C_ @)1B1#&%&!,ER;MKK"XE>C+/^] #:$
M23[)H]ECDK9NOLTP\&S'&6E>.!QJMNU8FN][IA8.C5%_,+1Z9C\0((2^LHZ;
MIJZ0]V&%F7OX&V:L?P57_.80A%%J_X\K'$XE[.+#:(VT'I P](U0<ZT1^%S]
M@:6%7CC2K-#2/6O0\X9#2Z"T"+):IKSQA%,D8S'K<F#@G)X^]'LC$^2LIX.'
M.(#)^XYM:;V!ZSI>8-E>+_S#_,,"7]'Y9^NAYMK<6J P/S+J%+4;Q>U80RA]
M/&?1,T+?MK5^WP<-:AL]/.W4-3_L^X$S#$9A</2(9I*!= +%[1(8#9?BFHG*
MQ@V.8]7BJS8 .0.B=Y0(T H.@^5C2@L+/O8BJ.FR74>7&WO-,T09)@SH6XK@
M$;@67*N(.U)':0/+=]J8C7 GBH:O4B>MRSEL2IFH0+GD14NP8LR@4^9;?N)<
MP2FNDZAV0RR!J=DKE9CMW<YXM:Q]EK^"T2F2>(O0@0IP[_\BLO4"FZR-,Y%,
MAWDD2@<BL,881\,6@:AS(OJ,U\X&^C^3PJE^,?BYS%U(QT\ #8LL4T)0\<#*
ML6SD+6FM."XPLR4!U$XP_HZ6L?X@\4(L#G/J37(>GW>EXQPO*UARI8^F3'RL
MMUUB61HSM"1/@OW4MW67&Q<N%NDHRG:)HPO9J*4YK8:DE&U$6#S/RG8F42&B
MGEAT=T$(SX[$\(2WQ:1D7H[:L52.,GVCM<?$W7S2^^A 187^&B7I^PST;;KN
MT3VM7S*R77ODFX&FZ[X''JD;:#VSYVE]2]<'_?[0=7H8?(-'JKFNX7J5!=]*
M ].Z*K2K*+IYM^%J4(60WKNM'A&>08@+2O\E(+_8#AGWY<X?AJ';=J!_A_]U
M;#>X)T(9C$YV$W,LCT'><3/.<YUUD[P7XTQDG F,L]S?GH]S#^&!:U@&\,#0
M ]O%GP,_L) G@>'<,R0PPGZ_UP^U?HA\0W#6L-<WM8'M!7W#<8>C4 @<P9N+
M>' [@74FA++S0_O#(LOY<*:8KA$$YKV8, B![F!H:('9,S3; 7: + $3 @B1
M;&MD>Y93,L&W=:_&A/T(?":F0$QON(_'%-I1QJM?+!%6/80GHRC)Z9[(17JS
M6A8#1+(%R_D0=$ADA*<[L$5,&WF!/_N!Y^(6LAR7_AX$NDGZV'#,+<??ZPSJ
M]0;AP L@,#-\O+P9>%IH0PAJC8)1@/<W/=M'J3'Y!!QV:,6?+;1N8$J(_=88
MA1*YAS[-WS-,N6"+BP?S"&)GY(EIV:;"(]WQ=+/)HS]0_4#T!C^[@1[<[<J
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MRH)<G_$GU%L2NXAK\ (A>RY  R0YX1:"4KUZ4$J;X$B  6AS[X?&N!^\FV
MH2S4Z&\E2#UR^QHE<P1*PO. 'O>0$7"-#[IM +&62R7;EFU9BM=A.[9IW8L1
MX$TX_5[/U\"O0&^#_A4.-:OGZ8'K#N#+0A*P0E1W=-4%VTJFPHY/C+Z$=SG5
MY//'LCG.PT#P=C/FWD1C8BG0!X+>/>EHP3'\#2B[+L+I5^1.<0G.V3)BJ_!(
M-.^,4_?B@2ESBH;Y6P/F<"-%N]>]KD,K[CT!+T3PNFNCM"%"[L4P2_CE#.%:
M[90[<N(I[.0&CKFN;:^K"<MP=,?J>UK/,R&"'7D]K3> "-;O!5[?#(UASZ)
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M6Y.XM9.?$@I?=2W1#CTC&^Z9X"<V8"&R[33YL(7.>KN#6;)L/1!@1$1N@G.
M//7!LOSA:&B <]'7?-\UL&.QJ_5<\*^#P!BY[FCH#4WU2*AJY'<G4A4>_7XS
MRX'N4?P4].\O();CA3;RP0U\T"MZ&&A^@-$%^&*AZ?5'0\>O$C%./:JJ:'KL
MH[##$QZ.C!!4LJ79H$+AO_J(9C\8:)[7[SM^;VCJCA  V!F.=Z>C+WX(HXVJ
M,3G%Z__$@./!7+ PT -?VS1=RPZ0"XX7K!\)#US7!!&WM+YIZ9KM>+86C/HC
M,!GZT 2!!]5@\@$$=UKW--V6!&Z8NT+>Y6R63&+YX -Q6W<0=O?.&/O33NK?
MJ=9VG:['3J9*V@W+NQ^0KS<TO&#D#6']_!#VL.-KOAL,M5Y@#>R^B2&95Z$9
M6WX3SWAG.O63:'D9IM-!U?"2^Y@6O?@J2;]D)"T/E $G^,[0M>OI,M#-KC?"
M9/DH!'WMZT">K_<U"#K]GC$ H^8+"$N/$B!VF?C9=^IJUC!>7G)_SO0*]WH?
MD>X%T#V_5!P1P2:?E,C\X/YS?V)P9L,*.#, ?O#]!-URP2I;UD@S!B/J0.)J
M@1,,-#\<#ES#&1IZ6!DKQPT:M:7W0&>F K05-NT =AY@K]^1!>MF2Q]B)YD1
MZ.H^*&S;#W00"SO4AGU?'P1A__]O[UJ;$\>QZ%_9ZN],),O/KIZN@@1VLYMT
M4DEZ=O=3EQM$XEG'9HR=#O]^)?F!S2,8L.':5M5438?(#M(YDNZ].KK78#Y"
M-@2*M3+3-W7G7"Q@R)4Y,CF0!:FG3I!B@65!R2%8U_:58L%R"/9F0=UW8DYX
M!T;G8K_D#HRX G-LPI>X>-;=-'M8G+J)2BKG')!25<X$)?C->ZR28IZ#C_IU
M^L)VIQX1S@X=YQ-Q'53LKG /Z)OO^>E&'%]JJ6#Q9%/=$,%U8A[F]B@J&8RN
M\(!7?.4'22,V*(0M)-CD S3 UG"(8\.81XW5E97CXXY5I''[*.4XK\1XU.G%
MAV>R(X-YPH.!WALJQ.JI VPRA\$DO0'6KE2BC:R!:60VU[WV7^N6_:("0=O.
M'C=H9#?+DTN-K)**[K7_8G2+49.&=NDL'Z^E^' D2PDNEY=RT&JQI"HZ=Y;0
M7[VAOO36&OJ-'!/J6YI8L^6&2CW'#XX-#>LZYJ2P+&;%U+<=QOH)]=-7755,
M8\5JW-2ECU1W(\=CVR:W,;D5P3WP1*5VE*6TYT!L"GF.>""3^0]*?]A3+P<C
MYC^8XE#%)%?ZD/W)?A8N68N5E.SA-JM1G%17933&0\&K$*DU<D(<N?/4@";!
M6VS&M5Z=BQ9'C$4I36;J4UEK3M5AQ%B1>C"_E#\;S$.1NBK(EN&C=F9=U_G*
M:6##6M?6$%XJF/6NIQA<=4$(<Z2'NM7KJ]A";)9A1 99')R]5^\AYG;BK6J5
M[5TXH4"WV..#RH A?6B,>)4K?F[&"X(-!L-AKV]9PY%R.;@<\IK1V;'(2L;5
M??6Y'U"G(:/ PPQ:Z?E0J&B\SIX;>XT\ .BO"?I;;-?H\:/U?;Y]$>[5TW4N
M5QJ+)<*-PGWDR1;B/541V5Z"] =SU'ZL*PPVE(ABYI4Q&#&SDD';4W7SLM='
MUJ!W91C#?E\G5\1BK@]G>P_]AM4ESCMZ4TF^BA(=W<'DDMUC-&;K/5I)2K@A
M*X5 ?Z6K_Z;\/@V=]-^8<_Q,4Z%NG&?Y(,GQMGZ7RAU=LLL*#WWPU#3+V,>!
M_:J5Y5HE++]"E_I09P;."!.3N:$:F^@:&YBA.C QNC29.80REB/S'"S_L*.[
MUNMRW>,L)TC73$@L7^]W*9:7[#)GN65:^4H$E; \E0<E$;#]G+Q"QW_@M:*=
MA0O/!VSHZZ[/D!A]Z[)/>D0?L35A@$C/1)K:TT;FE67V-3+L#V(9.?GT55N]
M=K.AL_E(0+S7C?R 9P=G(\5^2-/B[94?%?*PQ.G9\EJ0'=VN:U'$\<Z@$W2:
MK5])MW[KQ(OB[HY6L0^*2[@]@S#K$<BBN*7?U6W]0OI"3!1+FV!N_3A>":I@
M>:F-(F4Y,L[!\@\[6L4^&+-<8?L@@L3R]7Y7M_4KL;P<(VR"9;D23W7K5&LY
M25E^ZK5\=T>K6-A(;.#JF@*%Y5OZ7=U:3F(#5\4ZJ8CE!VN6"YVM1*D[&@W[
MV!AH/:R:@YZJ\1 -ONKWKM (&^12'5Y9E\N;.3LDRC7-7JV2V5MJ12/G<D]W
M=[2*!3N9O=C4#$BS=[W?U>U1)-ZC-)X9!O8>%0=53[%'J>?=HS[J:!4+MIKL
M4>I*";)S[U%K_:YNCU+C/4HWK*KVJ+K6\DI87FKFIRS7];.LY4>PO&3WA+_!
M/$Q8IMAZQZM;S 7-56P17%5$/>F<^#9[=$X\S!ZG7IC6HQ _.Q/^R=2AP=_F
MXQ?Z2G__]!*&L\\7%[]^_?IM3L>_/?MO%Y?7__KTE8-F6I:JLWXL'TM??%%X
M\Y?94AHD?F:=",21&#\V8\8;$J?&RT^SAI2-R[*9PO9^_NI)KM&7B]S+OUPD
M W+0Z*@01T<M-SIJ[:.36CF@1D=+%0>[N(.L'D%U<F>+4U/W:/$!H<_B(/G+
M^\_ G3B?Z?O,=<9.>$OYTO&WB?/*ZPWXWN^?TB7V:3&C=].<N*__[LP_?4T*
M9KBN_=./)7UL6;IQQCR@G^G;XK=^N=CXQ[XR())O<Q#52X&IG@I,6%2',#J%
MD!RHT6$S7"VW$.CUCHX*<734<J.CUCDZ1YW<@5I&)]3Y?$.?;7<HODUN\;RB
M-&!O=2>WMF?'2VN27O5FMF/A++UXQ_=31_98U!3+_?%;QZ7ST/=HG/<V*SM6
MU1^^\;WGD :O_&R7[R"Y/_WTRW]Z\:,Y,TV_.1X-*?6^\92E-6X6FLAB5F;"
MD]KLHH(X =2$!S,Z*L314<N-CEKCZ.R0(K9_O3O)W*_/)]HA,@>%WV8U]N;E
M>RBB#X"6[]-#F%P?:2R$(V?:702E[]TB- N7'4&B^<!1C!%,/[JUWYW7Z+6C
M6,67IQN#E>-U$:M"I@"06(UX/F5ZX[Q1GF61 >?\=*G(134?+&[M/_W@DE?<
M+J+)-<BN2\=A9+MIW:K.09O/C $*6NY%Q [$C2/*\_ <HR_+.4G93Y__\]0?
M=@>L0JX?4& MIQ0_B7T,V5#P)V^2J^W%>;<YCUIR$Z!K$["0Q:NYF/Z=>C2P
M709I?_+*%F/F<M@\0W!'42VDXP.,ZI/]WH_"%S_(XC2%"SJ>[3ZP&>I%])$&
M;\R[N'YX[!Z4N92:(*'<4I D'W>SO9]1L$@/ ;H*X<:,L* @76;,S9SX) "0
MY8M9HOH8,2/7+N_O5TBHOCL-*(_B>B,_\B9Q9M].LFI+&FE0K"J/ZZ/M^5.G
M_\;_VJY@H QAU4&J?&$'D"0ZLO[#8+'Y!47KXU+4\PRY%\]#V,MF'>5#7#>E
MNWQ(TF-V%7U1A:B[Z ]?9ZZ_H%0D2[V;==+8R)?WZBX31+IIAR?<%%SH&@OV
MJI<'DB6[3= ;&H;\!L.IO)KY8)'_3>Z;K%8IJNJ+Y,L(%NE]XWL3WQ.AEY^V
M][^[Z90R-XNW$Y4E)=USA3TEO4]+[[:R:W/1W(:RJ\^>8;OM6<FU+/CF>&-G
M9KMWOSP:2'9]4,0:)ML.U:I4N5KZ=CZIN*0S<#JW4<XCZ=PM.@.EKR178\B%
M#)VY*9Q30+=VH8A+)6\Y99S@T1^V2QEZ=M=@BR\4*JJI6T#/[SZX41=7T<@=
MFP@Y_U5$-]S5Z!RPBJ4+4UN!>C#[!Q4*Q^(BNKFHH"BBP]=A]B7OO*X)JY!E
M(47$P9G%V<Q#^*R*U&"1_?,?[)U<$;FXX7K((@VR1M?>+ KGH@4YG<DJ%0'G
M9KRJ\=5+8[M30V4GL0[_T7<GW[T)#3(DYT_^ YU%C/=<Q+1D0*'F<%(O2Q*^
M,X0W+4-LUT33-R[Y^<0/, D/:HFO/@W#'@==;B18_43'+Y[S5[02?XDUR/W9
M+/#M\<MZZZXQW[ P9DNYIEJX(?<94Q_RWK79FL9<C+\B1]SF&"Q6N#:* L\)
MHX".G'?^/U[([&XZ96M=]DQE:[R\9/DQH0!':1M#J$[>!$T(A0VB6GK3"13+
MD6B0M6"M'_UIR!SLCNX\&*NZU9#3R5(XIXT'D>/R)*C7K\S4>(N=#[G;G(A$
M3=]MSD6B3N\PG#Y -5Y[D4;<Y7KQW<D>K&DMIDC5E1;N+K?,>67N<[#(-Y3;
MRXE8U);MY>0LZO3^@BRBJ"U<BU(C12X_)R).6Y:?4Q"GHRN.:G(YD$D0!IHE
M,LOMPAD2+GA@Q/>XH5I(W3KE+^F/Q]%K),[0KB)^,)?+X,->\]R]R(E %V-"
M=*#'KSO0S4YIE\C>A2\TX.T"^L+?]D;CDYJ.8HMX2?NV)TNKG$Z3B<,/\VSW
MWG8FU]ZE/7-"V^TRA6!11N)Y#)X:(G))V)-"[/-7W^OBQ>T";6#11&)8'D--
M2U/SY'1*2#.0LEVG!%E/GM,I"8W>AARYAR;B:9U6JD*!?67ZJ5L[^!\-I7[J
MN!F*=0M!RP,H9V@],S2I=2$GZ)DF:+&&VX=27Y@3\FS5U$#-0BGLW8_W.B9<
MAVEB P.5S3TYH4OOIM?>Q'ES)I'M%H1RWCQRP^[EWTMQT[%E 5V//L(M39O7
M3=3$U2E=["IF4C8!0[TP(M+:1>-0G*A<^G-^6L>K) 1O*PMKE@F1\G+OWG@7
MML?R*/N[[\RLY(GY8H5UUZ[T(U6U$/!$G.)>\-JQKDR=F6$'.'7F9NPZG.P2
M5OU7.,.CROJO!^!7NG[O:?&3Q4,;CF#NYCW[64/8XNE)";*@*<**$8KAVXJV
MA\W&:&HGYN=*L\H,3)@WX$$2"[XF]2RR4,A8 9:!GD6)"1(K63^QO9C*^HEM
M0E56;-M3;0^M8AM,5LGB6L<H!MK*!UE<J^[B6J#1!QS3/P7ZISTA ,T$P"<$
MIV#"Z<X;(+) WM/K +KRGEZ+L967K%J&I[PMTV ,BU+?0M;>C6FLNW6<#5]P
M?,:\P=4FZ6[KU&(32@<:MMA*VJ1PQ:!KD$DA<=-0@Z5 @S,\9%7!I.ALDP>Z
M#I51,#V].,$I)$RD'(3D#!!*$5IS$91:H<9A);5"#<!*:H7:BZG4"K4)5:D5
M:KA6"":KI%;H7%HAR'R06J&ZM4*@T9=:H1-JA4 S06J%3J05@L@"J17J +I2
M*]1B;*56J&5X2JU0<S&4Z=$:C9M4-30&-5BJ!@C#H\19AS!*_+LV)_0_+D44
M&[=2.9!B2.O "L=,1JDOC@U=Y'LF*@%Z1K<EUCX?+/*_*1H"]\P%&SLSV[W[
MY=6::8^4@U0TJVOZ<4B1(2&M!E)DE((T;E8KI"HRP>TW2.TAL\3HB&8UCPZ1
M^IU=4)%R4)%3084T2^%7&$R#0#T$X)4>O]FO=(.5*QS+^RA@%L.<\G8UGN"!
M0P_<,G3NT<%$F+W(Q"A>AN"7PCA)Y8<CDZ@:/<7:;2&SW06C>F#EJ.J(>2^)
M@VZ:(O6MJ<>7L/(9"V&B_!C]G-._(AXM>TOD,<6M9Z5!5:(8H.D)=>$AJ[LX
ME36KBU- T_(F<8'SI>6-!P=91"ZC%2ZC5H^@$LMHW*QF5*%1'LK@K%@.D,O<
MG::JVY&<CVV",YL.&C(44ZYDE1J$9@E4XV9UH:HB ][FK?)>[]Z\LV8U#@Y.
M**^:%J<\THD)="4;.9X3TAOGC4ZNO9"9JIS;HC#@?+"XM?]DG%\O$,A:4M>E
MXS"RW?O 9P.W,TG D3=YC1[>R?JL65W $F2@DKDH9.Z)UN>>./(4URAU3I(T
MJ\^Q5Q*C:\VQ7\NF M[1KS;'AXPO'!Q?4$H8GEFS^N(+C+/03!1QEHWU4D?>
MO%F-@X,LJ4[8"14J$7M-FM7I%QO2@:K4+3;*N<5&G3Z"B3?4_(&)*M"=1ARJ
MXS+^7MSL!%A*HTE2J@I**4A!20A!%R$$!1/# JID'CF>[8T=V]V85">YWEG6
MH3L&/87;E&AGG"!K=@+T8O&9HJDJ5/3V$9\)0/,?=P=,6'X$E,%A_<&F/+2I
MBO-(["L[8<V:U0 K*I8Z-H@J ID +]+$P'$-FBAVS 5H*ZC6=8W&8?L<>VE!
M"9!^5A\4S+C4+!&ALW1@GGHQU]"3_=Z/PA<_<%9%R^+>&K?H_+'M_C,*G/G$
M&5=_Y?_,^!A(:R@^_%PG\&SW@3)K/Z*/-'ACMO?UPV-+\)'.6<.<,P!,Z0(S
MFH%*_B)/#B554Y7&HG3CVUYNHE4U@Z'=*#H38Z1/TCRTL&5H4/-H?(!6*FE(
M@F'>\]U/UWFN(<_A><'9*'!A/VNZIJO"3P1W-G4>P4N<]3*UBN8;F%)Y%LZS
M2UP 4E-2L?/\0):%%)'/!VM <XJ,;"?XPW8C.EAD__P'>R=/L[VXX:G3BJ9:
MUNC:FT7A7+0@[<!*5T6.7$QTI9D^^WW@3Z)Q>!<DT9-5(UO\MF8[7P8(:J8I
M,W.X6)+YGE"OV.>6E%MJSZ- #/[ GCNK2<+L(%@P>_6!SOR <:G_ZD=>F#U^
MY<S'KL^?;P5PAH6Q.(^U,%#@4CT]/\\(V?SA*=Y$WLS!8M7EB +/"1DR(^>=
M_V_.6M]-IVR^9<^T"#-^% 7U#+T\9G&>7!ID+5CK1W\:_K);-<'81HV@9MLI
M!59F,S.+N%6XJ#K4XC-[X3*('/96[_GZ=1;X;[&/W2J<D*H#=5;VPNG6'K\P
MAS)8Y!NV"2AD$05HM/*@"=4J;$SF+K8 &ZYC"8-(N';7'GN4^5+SEBQWFB'R
MHF.D:5T\>=T_Y?/?*8/?GKTXXS3U[#R<!9\O^TUG@JQ_T$S(9%&#I@$F*Q4T
M 219?@ <,)J6UN]KAKHD%P06*3TVI/*X/+ :GU2X',(@F35$9@UI U'3 KF8
M&(HD;B>(6Z&#?&5[/Z-@D0Y+&V=, T0G9^.F5+NLD(8MKKHI[8$*J,O7&S8&
M [C+:#N(F9280(:!5*D&!JD&;O <*6]J;*@CXGC5UQ$YTRR,JX,HJL[^@S6+
M/JH.(F)"U]Z8O_]-U 5Y^L7^O7AZ<8+6>/*R< M<3! QFC-=\MG/_"CXYGLI
M2E=.0,>A'\P%7'<S[D3Q%[0)*U5A_E%3L=JPTK4"&U6UA+A9(U!/8D7"CW6=
MQ#TSX/S@E9DW]/'%#EIBBR=P,$L: 9TJ6^!XH/,P<,8AG8@5[+OGA/.'Q^^M
M L70H>[_6T IV #QIM)X0,Z>F^N4?59EFHK]45%/B(J\Q@X?')E"N4%@R7!X
M@Z+4)^2'O,S76,SD9;XF@24O\P'%15[F:P9.S(8!9K <-G^H/:<OOCMI+5#R
MUF4S@)*W+@%C(V]=@D=*WK5K)F3RKEW3 )-W[9H DKQK!PZ837?M(,?M6W#7
MKD5G!U):WSW9,'QB0A(JU-YG(OV-BFE*3@Z9]#>:!ICT-YH DO0W  $#:5>N
MO<^*W)4KIJER<LCDKMPTP.2NW 20Y*X,"!A(NW+M?=88^Q+1JZJ9*B>C2BQ@
M9.2!J3@F=>/,0[;%SH?OXY?E%6S*?OK\GZ?^L)ZK)+B':D4 *006ZUB?44\A
M-?89601!ZS.R>@35V6<=8)_U6ONL(HMSNQGUDT#6%E(Y+6N<BDA%)K!-#[$^
MF_5N>KR,DBS46M4&R=#"M2Z<*VA!/HP%?A!Z K"TXB51PB8TL7Y@1=&):O$=
M0#.@@1<7Q.8:XVQ!3S:#],<\C!&#SBZ_]E=X9;7O3@/*SV"]D1]YD[IK_"*M
MWJ-)9& S<3U,B\]K9B&90%?AD>,Y(;UQWNCDVF/#\<PGL)!;S >+6_M/-K'7
M91>L)75=.@XCVTT5H'5:"D8/FS4&K9&!MF1I3;*R89V-N-0X'*!QJ#OSY:9\
M9?9[K?G*".=CG8[S!WR4FAO@?(2DP:F;J,S%(C)[VUZ8<!>0U&I\Z$A1%%!N
M+]9[2.DI2JVQ7JS#ZK.(KF*]WOBV)>/;N^+;5KWNNRK=]PK==[5.G\S$>#U@
MRS,K(VQI7-?,/'E@5[^+%LOPC:XD.F:6B_?<]R;<?'(I=YKOI@_TF8L _&#1
MG_$KQ;;;[AKU(J:*:_7F=S '&Z9)@$W['<S)*7E6&DFNU,L5HIHJL$UZ!U?Z
MXQ>'QID)[J;W@3^)QN&CS5IGCTC.U, 96!SI-D0$:<EIKTP@OQ\TA,?:ZQ1<
M*$A!(M:N,%"(PF-ABJ$!R^J;IK9*E637\WE$)T_^8"'.1')(??<F-/@5.,Q4
MKR\NI'!_'-484%\'A?FF&*)Q70J4^^@G>T<+X& [C#B/XD7FH.:*2]*DVNZU
MR!6RLL?\V^9;3U@V; L?%$@QJP/Z''E.W&%G[JL*-GY\?[SZP9K_$.'UK',3
MYXU]L>4?Y8]]8]@&W%'-/F:_>*7V/ KHU^1UG]GKOERD'V:/7VQ^7KSVBGK^
M*^/0EA<+%HDOM^V]ZR_X<I'[_G&CE=[/16[\K+OIB^./BW]HX_.KH[?R/CC#
MMZE'QPU=KNMKX[>U&QO?-&._77L%_[#$L_._IN':LU$8?.:_V / X?>'K;U@
MOROQIO51X%^C3/_3TXRU%Q3..DJ\R.:G_S^> S^:;7Y7KL&6U\4K\M?_ U!+
M P04    " !8BF](W8#)@' <  #_10$ $0   &UN:V0M,C Q-3$R,S$N>'-D
M[3UK<^,VDM^W:O\#SQ_NLE4K/\=)9BJS6W[F7.6Q?)8FR=V7%$1"$C84J "D
M;>VO/S3X%D (I.0Q5,4O,S+1W>A&-UZ-1N.G?[XN0N\9,TXB^OG@Y/#XP,/4
MCP)"9Y\/OHX&%Z.KN[N#?_[CKW_YZ3\& ^_IR;N.*,5AB%?>;SX.,4,Q]L;H
M-:+18N6-_#E>H+][$\1QX$74^^WRZ=X[/3SQO'D<+S\=';V\O!PR%N1$#OUH
M<>0-!GD%OZ2L?/*^/SP]/?Q0*7F*$AI\\G[X87IV=GQ^/)@$:#KX@$Z"P<?I
MCVAP]F-P/IU^/#T_]8,*UA7#*!8$O4#P^<D[/3[Y?G!\-C@Y'Y^>?#H^^_3A
M_/^JT-%RQ<AL'GO?^7\3P,?G X%QYCT=/AU6!/]/;Q11+J 72T17WD48>D^
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M@?8L<.*W9B#'@1_;51XO6?O:<R3YJZ%^L5V5KFQ@X/-!_IQ!GK^D3.#%Q5H
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MA"[/>!I>A6V-Z5*WL^)=Z7]ML)SLB)#$@= B7\-PNOY:<45:"]C:4>Z[9GN
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MU,TP>S'J%.Q?BXJ?$6S"BQ%&*Z86SL69\*<C[L_Q HF?_P]02P,$%     @
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M] WI3#C0RT'[@+#>I1&2Q;$%K$K)E-S A*-8#$?7_\/A-14G5^DT!S%8NC%
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M[9%5L@WJQG2&D@L>V2O;<*'NJR7X$S_UFL:I8ST'H=R_WB)D50IAB=I/C=Z
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M6XN,1.-WW TZXS="/AJAYZO?HL=-E,8.X5?^>I,@E&4XQ (HQ#-T0W7EK]2
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MCOGRLH:!!'O42M?6A!%1<(I@AD$8" ^!> Y(2$OZ%*,_4B*H7#YW!?"RQQH
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M>)@[XB!M*+/7&^/N"%<;RN[I1)^Q[Y.0X'C^&?CJ>UK1E'#NVM#$J"O&J#(
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MIB]AZ(>O]S3=K'Z6^;DKT+?<.TX@K$GX,?9K&'JFFX2[(Y0K_"0BS4VNN:6
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M]1$&M9"86WD,Y4@G:PG!^SX*_0C7@C=NHP3%%REZ_!8];J(T=LCMI:P/H5
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M["O12+GO\2(,4R>X\;=^PGK@U>>/#G%\AM9^&!<,A'E(5:9K@5>"W8E)K+:
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MMV/"_S. CF#G*,Q=LVR.MN"<CRS;V-_>HQWU08=KGHFG8_ HL' ;L;('SLZ
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M'+[>S+IGUGURI^J@"S!S<_.X>>EDFW"Y) TY6/)EAH139HGC%4H<,W^>^3-
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M5O**V0E1R(?RE#"?NHL2(P4Y*^<_3=(R -U'?K#R]UO,-J%KQ('GOU9S;$R
M<JU 82J)#JPMSTUP'X4OQ")BUJ"43,X'FA88K YTS_C3(?D2)O^%DWO/%Z>O
M]J-F&(D]6%0U6W<TF8Y*D.8C(3] ^5BH.AC*1T//AP21\= [3A =$0ZZ@ZN'
MH9IUUO+B5S8S5O6TS_64UO@+]YB6\Z#_4>P?0,/^!,0T/4)?9=OC+%IN(DI>
M 8=]QPM]BYGKMF ;^JZB+BE=F93VP4]VF[%%)=! NO?>Z6'>)<5Y($XX$+X
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M4S C"I4$#+4J/ZWG$[*78(#&X439]):3^;P59]"'%=H$;<.8Q)L ($QBE@*
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M3A>N3 [=Y'G2S?M)D!>2-'P][@UG>[S%,9#$GJ&A QN\@!_]E:9C*7["_&E
M'Y"QH'Z9;301G=A18HA1J]R=L,,9])*2(>4J3OR=1^]/;ZAXPF0[*+0T#$X&
MEJH2X+&29P33F9S5]JELQ"M]52D!,$3)N%+VU-.9(]K)+A*IZ0!G:3FKZH&7
M#7C3IX-J@Q765(4L3#<;O&*GX'XUI]P>3*H8MABFK;J#1^ZMH)UNV]-@F+SM
MV)F53 #SD>CFTRU4SUFMLO$O0;7(!H.G(W,3@^<6O/%LG9]?O(2VZWSGE-57
M> $,+U4N.MSU&8OFK)P>0)%]W0(RW!3RV'4<P[,V,5:.=  /ER_>#DL;&PD?
M!X-*R8-ZJOUL+KH32*D!MSG2(QYO>E$0#P8WQV8G1DU#(?"8><!KO&.;HY5]
M4J5ORW\3#$E<=I2M;CH5GA*4A&LG!C; 2X/,?*1%!6&TEHL, SFIU8K1)]:7
M34!D^8,=-S/$;UL R 9+ZA'39+IH!66:F'MFV1:&)N$Y2;@1WA/>7[T8VY9O
MVVK!*L#DJ0L>G$^2;N>\)\% ]]2ET?=H-AEGYW&/6>(&M;#ZG?<*[&+T&Z-O
M16C90U)7CZ0PZ'H2-307J04>-;\&WBZ,$O^?>$T/=)1/MWGO@2&*PXQZ&Z.%
M\+YIA2S*Z=H JY/%35M&!*L(LY.%-15\+1$0!DT2TQ1C2Z0;JY!V'^&=?]AU
M_=CY:S;@+.-%_;1U+$PKJ<(L(VL9RGH)FX&LE&TOE@T<8 V+5,)752M@\,J*
M[5Z&<2(]JZH]9QI U<'5VR#/G5H61EY6F%(!Q$=_65QU68SB@6="1P X$AO*
MXN_#K;]Z5RG5VGS2L-4WAE>_+;-85AH=G*&4#OHM^]>*,JTGR9:>+_E;'"=A
M@-&#__*:@%_7$YA5$P<\P37=XLFJG__B!=X+3J_][?9>\'Z[E_3G:G_+_-V=
M-I94[W',G?ERF5_;R8BBDBK*R*+;/50C+\VB.N"BMMW3T2NO6Y,7\!:.*O0J
M%W"4- $S1VYP%.&U/"*L/F-T7JP,K!X]+9QBCSU]GP5.\1GZ0CZMN#NKB;FP
MMSQN39X5>"#(L9KZY->4%-RXLZ:9*I\F?Q3*U+/QU2UDN9SR+5[2C-BPN?>2
MJ6[U^RA<'U8)L_X848LD/V[)H&':=]@:1#1,30B,JDX@\7&-USCRMBV-X 5?
MM^5E  S).5*V0&<Q=1JHRBA+FZ##8DVG[&6KY$U*U0: J=DJ#W(*J@$%81AA
M_R7H"4+YRQ @E'*D;HBCLN%&#L*4LLT@U"A[5MN4/$. : 4 E>R4"\!VM4 "
ML!_R+(+<J?;F5O+5,ZR9QUA[@7V-PK(:^T]T2+3.Z-H L1[8^F"@N@R#Q \.
M?O!RM\=I]!ZW]AOL3]$>,,K85"^!.YDV)T494%FQOVQ45 YK09M#0ZJJ+2,M
M!K@**CJ OU6!D([A+GG%4=?)5O 2 +SYG*BG/"RGS:F64;0QFM4A*D,@O6O/
MK!!=;+?A5WI ; ,8Y9;(PYM$(YI.]])Q[M,-+[97=$UXOZSN=LE/MOO3,7\"
MV)U)1>,;$S;F;GXFF.$L&R?=(45T)%0;RMC1N>2@<&B-.'9JI.T\<6BUV+_=
M?+)[J)Q)]M0F9-#P@-]P(*DE5'\*("S(AE8.3^?NI'E6F9& G?-[R5&'3Y22
MX "G0%;\ZN_9W00;PH"&;?'F_:I6+("!VHEFXV$X4'0\ 726[M&I9D;)DG/-
M4^1J3#5I!59;9ADU>Y,@Q):#358NZ")8WY*A>AYO*I$  )4*7QT.VYTFU!A]
MY 5KQ$:P^+1%OR;*@\\X :]GTMV2><!45I+6!2P9XB*.<7+#+D_%^#-._[T)
MKOXX^,F[+,QO?1=JH=K&F*JMS9=39]98G%)X,>(HIXYR\L@/4#H S&I4K]B.
M)6*K+3GURL[<2UJE-1,-?0T/VS5ZIM*FE"'S6[MA]VA%J:2L0=Q,?.GM_<3;
MTNM6O(16Q9>@'<L11ZIYTLYBL1B+/$J,*F33O1Y81W*BF (/8DK,;H[C1%FS
M]O:E7'LRFP?9UI0UGD((/Z&+X*ME<-_P@&-,A'S-PI_.;N+H?9L\1I,YU;EI
MN23Z4W,>^1#Y2L B1W*:]$H^Q8ST_?W+:2HX<C511LY*-R-"LI+'X2H*<KNB
M8+)^L-^R_A6]!; I(6!%/>-Q.1$N#6):JZZ6[0*[[:!%UK0:EMV[?RU6R=MM
MD.G&"H#].0KCMNMNC8<AX<0X4-_#FHZ:ATI5%#%BL,F;IPA6R=D,<%+D;:*$
MB.@QHE:!IF9I4JR4NA@F +X5%*EO>QH\N+WM6-#=G8WF(^'.6CQ\P7KUR+6G
M:,(X%:X6OU;YW+[RP02D1\@2AY^W)]3C5P8Z\2-WP7U64_,RW.W\1-S35?5E
M>#<@X$PYQ\>9N)+=,4H>T>*K>2W2<@1H)Z%%<*'/,"UX5Q>B17KF47))BW*S
M*ZFD0,ZD!;T2WR+3U#"NIJC+DY;E4?J@S7? '4N#(=5P=#&:+R11ADK)(H-.
MY"0AA;[#B) ='<9)DEI3;:H3WL0^@:<,*U;@7W!;YDWM4<C5-QE?>8DZF1P5
MGZFNO0FIM"^STDT(@ 5Y9UG9<OS+!UB(5PQ.N@S/-6 %2K*+6\$+G=LOO2AZ
MWX315R]:*V]>22A 8DK,5H<JF8NY!&K%"&F 6QO#DIUC74IP<PR&A<Q;*O.J
M368P,+;;M12C+8JS'+J?PQV9D_W5Z6924+(3RCE[ZI?RY3O7,DB?H7PTZ\'=
M3RT,Y'D!HG\!H#=1T!/P-65:#OPO8?)X>/X'7B5/X=6WO1_QUJCZZ-KI%/C,
M=C@V=9NIZNHN@HR-LL%1$J)R>.M]A@ZM,0]29*_0U/XU?L/;D-W!0BO"B$^6
M] '145SJ"$MU9*%?D8.LIY>1J-]RGU-+_#_=#NOD[/0P-1X[M'J9CGH[EL9M
M&>O=R0DJ2EM.,7G_!:(0+CQZ.HECI=KN&X8(1CY.)'+:A'I41J&#M_B0(<C)
MZE*+/SYR[*$_\+ [ZJ!U<)0-BST,Z@DH!^J3W6@DW5ZDQ&S!;'?!L@R;?817
MOH4(JQJ6'#F%Z,,<<//:I,J>!#_,[M)$E,1SCB-)B1FR-ZKZR74/B<3Y<1#=
M7K6))4Z+@VOMJ@ ;\>DT=&O7(W:^7;(HI#8%YQ&+JC=NH0(Y \I94S_X'4\F
MDJF1_IP.TPQ\'R1WB0#F39WJ4 INK9IDU:Q=.OLJ*- 68.>_RRY[=3"1YIO
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MU"U*U+04YXT;)Y&_2O"Z#:B]2)A??'?B3S5O:C2;3T;YJCM@=UH:8$7E**;
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MO;EXJK]463C%N>5W5B3@?^5G6ID.K'A6QHNKCI0!"8U[\LU?/7II?K?S65/
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M\7QR]*!1E#1'5[X@.9XMESD^*D00HP*%BM.DR1H9A.O#*D&[*C%8'(A,J8X
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M8Y+/\95Q66V2<F26]U8=FQ[%%:.C<GCXW2KSRG,-*<_8$D8G&&M+'6W?1D\
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M/T+(9MBH1)%B78"!A_!1%"%(-V'X=3T57S(-(2$GZN7>%^,:BJH4BRW*C.A
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MJ 7/#ILNA1"D\FE$I_,FASZP5.H'070;IWZP\$8'^6[>!%V($TTC.9W=7OW
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MZ];VT;Q01NL['K9Z443/B;#B%#9B%GAONZS+S* VC9WCF]T=#OPPHMN!C7U
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M@<7).^;@454$'AE-)O,&F#")Z"<B,_Z;79@98JL0.Q5;+0*2N$>V $K@&6/
M.FZ28T0GA<$VW=NZW"3^"[LGL#/)"?J^;L!!E ('0M-2\;^2;!8-93N]A7@+
M$J!&<8"KR %:,2K3N6MX!?O02NS*I&CT$&43HH>D*[CEA9;NOFU9^L;8CA&
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MIJOSUI8-&F>9M0>USM5/6P?/<]?D_TK .%T!NDR2R'\X)BR*3D)TZT5C'>B
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M&@AFA\%6EIB!+[.@1RHQ1B_T]I5T)L-N7(H:C-7-#"W0$[%"DX?4,,+Q@6W
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MB5P 75>G&W0ON:N\K$63XV#?_E\>*7OYT"C8[_'F*?#_/+;=B-OPL G@5C0
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M/$3<Q\A[I_[$$Q$&9R]>N(A"NCFN<+*-$O)FB6\W6P_'Q88A,A1Y@>6E^:@
MN>7EE3(QK(U5.A2";\,RL"6IBA&2URHB@C-YP/&N6[TQQC7+\FVJ/;.JWVAF
M$V=H4=GDJ9*@1'ZO/VC\36>R.L.. XO++$FC#8IGBU>JE* D$]$D2G"J/G'1
M&..8Y56I5;Q<>_%*8TD/^XUK-H_H%85<786\WSAF<TL>3B'YFLY1:_89QRSV
M1[P*>!1K.#4&&,G\6GQLEB1(@T$P.X]Q7EW8_M@Y_$.,B"2UJ Y_KMY*4'4U
M::ZDTF!VYIVB&"4B=5^KB6T:RU.._\W-1LIK[>J*%?C0**2$[+AL@Q8\S5R[
MC9$7T6=,Q/(T"JF=)K=0L=XWQXTL55YC&<ENR LQ]%M&,OI^Q&%&?BL9&;\X
M5\]!SP\'R4UN:/ 1X4*%JR0UO#]4!ST_'+KM#]W!1X0+P\C>?W^H#GI^.'3;
M'[J#N\J>_#J4U.OZ/W"XJ"0J#JF,AG;H+42&0OU.PY:H4N4R2KABNJB'W1GL
M@]O4I\#H8G,.^^C/9^^-^NA39UIR F^BF)W(33(_[>%LSOTYFOE_9#A&E?Z=
MAAZF MU^AP&LS"^.?(06>6!6M=-HHIM]@@/>M*3]C+PPI)\A %:Q982]LMX?
MND.,9Q4H!]."/^]@F_YJPY-SG"M"&-*_PJ141K$]4VJOJPURR@Q!8P3;,Y24
M7%'J8FD.B\*7K;QD:@MJ,H_%E@^UOC9F]8BVM6B 0ERDQ.-,@]/86O5M5>E@
M1'?_&=>OWCO8JY>M/N[BJE4KU=GB*5Q;3:S0F&VW17X6+ZA6]S9<1O&F<+63
M; W%WD;D/.J#Y*_1156XY5B,.VAAYJM?H^=UE"4>N7/Q:ITBE$<=) (JQ#U,
M4W6#EWI$,3J8INEYC6,]HE@]C%#U:XQ3(C\M"W$>YU$RN=V-11"_L6%:KE",
M7\D9>47[3!=B>E@=IEF;KN(]0\97->/PA+[*T#,RGPIDGOC7*X/S663(.!7"
M:F[.W7(]GU,*RE/A+7%0[I8/V@%]#+3B.QYZ)NFAX3;GWMXM.[7;^HRMSS#5
M0<]7?9)]+A'4NZ6W=CN8B_+1TZQ;*FRWBP\YA%8@6+>$VN>TK?E1X:VRW<Q8
M;.C9G401Z/LC>ZB#@UX>C!\4WE81\$*QH6\:61!ZO7'$"DOH=26[X,14-T,O
M'-D%**:V&6JI1[4$ /L<:P<!^%#YD7ZQ>Z#5!O4C[9H7F23:L%L%D7,2$$W#
M)PQW[U9.9,IPJL7F=:LS,F5<C^*]N]4:F3*$[(#?;F5'IHSC4>H,Z 5(!@!0
M*UL']'HE0_'*?38)Z(5)3 ,H3*$"O?K(L-<.^V!WJ2XR8B@%(??MU.+0'[V2
MD,B.\=I[#8MV7 WTXBOF<5:+IX!>OV4X7'G1$-W*OIR36'Z:O7H8A]:K7,RD
M=ZHPBKF&%>HK<J KC)%\IL82JO?1J8]^*Q"XAA?F:_(4'("5!:#&%:K+T6FV
MK5+D<0TVS$?H\)M8/PW$'O,?H#H?#8=ZW\1E-?9='FY1Z@5315ZOB$R-<Y>'
MG,-96H2H!KAS.<^GU(M3![.X7E,#:+AU0<VFN6/=DBH)@VJD)_;V,X&S3B*6
M&FB8=L;A8.Z;%[-&OLN;\6ROQ8[Y$%4*??\ TQ(Y')##Q&/4ZS&I=Z2!]= Q
MD^Y1_G%2YCTS[*-7PMH:>9CO1GYR)W,H,O;Q]S#-I[W0U!93:C1A&DU[H:G]
M5*S1[/"P!H.F<K*L&BZ8=E"5+'+,6O;/!SZ=0#URV!GJ*N^D(^>E$HX?I@>'
M*#"WVB3?3Q<65OAI!<M$#X\H]JV"YN/TH!%=9/N#!/<DZ66Q;+\TFX6PZA<-
M4*FQ.U#M;*8U4$ %PNY R<O;-]#K(!^>15J['O@1[.B-EV<IH2%_T8J0G^2Q
M?D1&R,A_W(8^36BRN,C2^RC])SHZO#"3"!CB<JU2>C5F,*T>'3#+/0<OJ>]5
M$.2-J-D(D^?RU@OF>9*!,C:-:HIS-Y<'+VZEA?H1IN];C_UW4'RP1FIH0\7?
MOFL"182BWXN?#W]MX8?>4L)KZDJ31PANO##\'8<+/XJWW_K1YKO4>XO":+,K
M*+S"B1]$"6%55RCQ8[PM=M%%EA"A+*$!3Q=>@A.ZKQJ+N"#<+2>]@>DW)M(.
MSP@#S9<M892G9+4PDNRX'K.=D(']W;*-C13H,QIOL2JG'R[NR1+4OS0R9K$3
M67<=Q<9,%;UHF/-3ZVMDYUQ&A/&^1(42DGSS#OMYF'^U6?@)Q15[6L&>FWKL
M$.CCAO;I91YA85,C.^$*H7B)4;#X[(5><92HUZ@7[NZV_%V@T&OXHL#7K1#$
M%I%'?S:"U7['R(\)KZDKE5Q**^2:GB_;V_JS]X8WV>8BBN/H:V&&)G\Y2MO?
M:8BQS/$1T>U(*.LS2\$@1O8Y^YM$],0^$<5EE'<:PDZY[G!%)-T-U1L\DX\)
M;@QFTS'0++PU.(UMT/V9[%=R,(7R7;N-#2KG\<H+R\H35$<2!7A1"3K-A\1\
M69IWO6"O#9;5>#(SMI'SW8N4^N5U9,AM,@#CWQC3S%E5L<R/;ZITYQ*GU+N.
MA@51?X1*(ID%^3B$F@<4^Y2R%7-.FB-8*<EWF)SQX.S5?[=&G9#S-5O8*6E8
M*]D:#VD1HH(>(YJ!\'H4][$SBY1\&BVNO9B*=\G,][--EE-YA9:82$K<J4@[
M&N$F3UY(F,&,)JS$@JICK&9V2N^]).B/C)!Q_<I[KHG;CH!JB6C*:ST2RH4G
MD-_>3+F\NAS0E4?K(!PJJUA[5]X)1JG%>\(O] H(LGK8V&5TF\R7#6VPX'2P
MVQK!\LMV&4=A>H.84E/CKS8,2@*KQ-X =VP^@.HT*+26[/'@JO? %[;J9IZI
M+;F*U@3HF<%=[9.A:I\ J_W)LU[L@5"QRG2K;W@>X+CDDQN)\IG!6'BZX:GA
M(R]GPI1]>Q7"/0.8C"JW]ZB:U:A"W:J#JMW;Z3CE&B2H49"#@WST[(,: 7FR
M[:J;= A8;.1I=JRV.1]J;.5IX%;0.D*MQ7<:@'5-FE +^IV,2[,8"-]9"VI9
M0*MPB_S&H%:('<QCHYUP@&-L QL;?1)8V3H+L('5@V(J2F@ +Q#[)-OS\3BB
M_9,#4@-(IGVQ@A)<EHV3[$E1@HX?':(=$.4X"E2@_LF!VH5UBGP%*VC_[*#5
M9:;F7Q;PDY(<^?T>W?''M>H!(W'LGL$)OZA-7;#TJ1K^S HL;2KV4R7?Z3V?
M8KH UQ#!3,,K<<F5*!2FLI&D[K\"G(Y9$RQEK9+S:BM?MJY3WNEVE^6,'T_9
M9N/%N_GR":]"O,0^+310U#3'X>J!"$X^S1'>/]F'H>07QZ2)(P4%'<RD#2G*
ME^?IGA*4M#/LM"B2-C>4C"),\*+,B/N(?(1?ZVW2SCW!:F@_=8-+-:&TSB[5
MQ&#K2YZ$."5OOU>:>CHEMP0F3\Q9DJ TN=A]]OX5Q9>!E["2$W49860SK*F[
M]S;B@"/=46S,]&?R86K<GH?DRMM&"2Y>_8?T<F:HVMO(B:X_]I#%_MI+$*U4
MBM.R$.SQ819WL('V+6$E."X2;5.C5;XW"HS^09C.311_27@)F]3Z6IE5F*(@
M0'Z:>4%5D$D8_2CH8(M^FDPQ+\W:RJ;(I9[9W";MI< D(;EJ98=2^O**XMVO
M1-PG+.\KCVTR&KI$1BZ)3._[X[.79O2E653S+"H=-/Q 63>(K(L9NJJBYH]X
MM4Z3.^R]%$Y/7"E5TL-*,AM:?)FNWG.Y>O=1D=3W*.Y9I8>U&1 :HJK.3U$J
M3,Q8)9W,)%79>Q=6?EI5EOSB5<I+#Z/4SP;2#S$BHDSUQI^%BQS%0I2Y%.X9
ME9[V9Z0S!ZM4EU+Q_"7 JT)CQ2'YN*&9!!]*NK4[4>8GW2%.2#<W;Y-.]Y$G
M8K 1/R[5<-;6(YUU@FXO<?'B/>/%97):;4R"Y8IN.'X<ILVV@TZT>>RT%8[0
M3V1'#>QAC0R>6@JJX=>E,W#I#.RF,P 8%=3QF5(+#C+%$^@8^;[HJ:D_0 ?'
M]X!02^<".O+=.(@,V !&L/<]OAQ_&]!!Z0:VFK)='G2\>=_-)W0^ QTZ;F +
MR@PBH"/!3>'',XE!]6$W!1[+6P!J1D]CX@G#G@,UJ:61ZT'B4=8M1]]/!78A
M6M&[!B9ZFOYL4"/ S#&[ R<NJ-E630-V[+$'-7MV5[NSHI'AV$8!.R--1R2%
MR5' Z8A-[#E1G@F8V61Z B;.900S;TQ'R+K=)J=,5& [=I&F;'@DGR+K0#.?
M7J%7%$3;W$#/T:0/6+6\6)2DTCW7WQ1[>"GU,Q6JR/L2UY=+VN><P\4X.%TG
M*=[0Q\ULD\]=QRE5N>_YN_R/WYV75VLH)&W1BK V(E)SPH<%#>W5W-'@,,Z\
MV!,W=28 VJJH>F=(7P\@!3L==#2V(MQ<4\Y_J[E]A!>1RIXYN6NW98&?NMU&
M(=5>4U-Q84$AKY_NB4A&*X/N[4.E%T:1M(8=<:;0P6I ;$D1ZXTA;FN5ZGK7
M23+,B'I8G0'5AR9KM/@YBA;)/4KG2_I6CE\1+Z96I:?5&?$>TH*&5NDET,DH
MI4VLTOCH??U,;J$8>X'>)N%WM!M^'\6_WX8/<>2C1&]"@IZC?JU;<*L6\O;)
MO06441$Q-+A"O\;5R@2IC>9D-A%3-Z'#OJ$J=3HB);H8H.IP.D(EDARA>H-W
MA"H7\?IY>T>I%YPS)BH/5JANW"-6:%G6U50AJ60CT&"PW"IK*6-L7;25S-W'
M135!M U0OD%"JN*/T[):0$7V0^#EF[BFG?UZ,#:\C4?3148V-/5\WVSCZ+5(
MCRS,;"?H8)-^)9H[T<G-LKO99N0T[I>/+.53M$R_$D;!SSJBT,M*/MLH)%)X
MEB? S@6D%>$0XGT@[ +0)> FBT.<$JYV@]_H_^3*^.42^VB_EOQE5^_L<G8:
MR\KGA0OA#FXTL$(?\A*TCH*%,NL5]1BU>NJ$J'[VB(@6HK@E= A1%?6P,X.W
M9FT9#LW--E:H;%? 85/9:F,G:QU'UI(8=.3]1C6;BYTD5:I*SU'-Z.<X2K0G
M4W0:U3QDYBJ%CJ.:#]^<)>PRJCE(4_2J]!S5C(B(M<R".[SD26DJ/6W,Z*C@
MW '=]=^M42>\X9HM;%#XY*_1(@O0?,G?LP*?"^7N3J\V A6LLC#3*@NFO$,F
M"]^Q]-3.B*-PC4P6.Z&%1.F^ZA:"/EGH2L$8:KQY/]2T@_5U[)?GD/6@'WSF
M["3=8M3A(RQ^5_5*V5IDT'H]UW/-SLS)TN5"]S[H"-&A(0QJ^CE#,+&4[E ]
M%'I")E2I0TTQUQ$S75,AU QS?>!3L:Q#32[7]YX4V12A)I?KB9G8]P%J=CFN
M!K8)34L!"EW'P=#VMF[!ML$3:D)S533:1FKH?N:Z>G99_ NX)$=]@-)2T()-
MVF8"P08S!YNR;="==C?))%HL/^T!LV0U58AEO9!<;OW'@=S*<J14[VS#'#N+
M8WH"<P**Z >O_N69_"OQ<C%3[.:G.XJ5F5*E>JUNOUQ[\8H;7LMI;,@-.R!?
MBXKB"P2M._+*IN4_B!"/Q#ZYBCV-4'GEA2]9O*N21/*)8C<T0T-#I;^OCM(X
M3E4)@2,%=HL^[4%.2CLWB9W> #9.E(K%A7.^E+J>LTL^9'?E?T5Q=?\>U4\\
M\OIE-AX'W4*/.FYS(]SA/J-<<K[,[YF?XRC;,GD7J]FHW/C.TBFY67&F(9R(
MG/H$/48T ^&&%O>QX@J8O23HCXQLA^M76<@#N^T(J):XL?-:CX1RX8[AMS=3
M !W%&QP6(@#9F>15="#.LCBBO),-9"DTA$O7;Q[!CF"W-8+H+[1V)9&J^,+Z
M00N;VI".+\^&S4WM&0757MGOA50G:E37;4!5F?='4N]%!#5OBZ$=J7 O0'6H
M,H0@\W4!U;O*W.GE:0A[.5F]HO@E H&=EKGP1VA&G'Y021\/8(V$9G#C"-A@
M389F4..IZF#7>NH-FU _!+OH4V?LNM["<!.(NF#0@P>_V' @YEO3Q8CC<7RH
MZIFL=S&W H4F*X.^LQ2,'@IWX%3.H9*!I=YJ;%\)Z-[K$DN(Y-TSE:TDM;H(
M<)I*R)+0?M)2T>@:#2:3N7;F^W&&%M6M5MUX96+C.^R]4-ZD77>(7Y53[6M'
M"K>6:Z3^**9JBJI]5U1A5&<$*_Z.!8D-6BZ9A9CD[6VG=WWP=A1%,?F"#C;H
MO]YL@VB'4"E(**^"O!\4K[@^57,(8T9)JK0O.(V=-U\!3_$LTF05DDY6/-2*
MY:6<."?,"Q*9;YJ@A\W:G!WOU::4I,!\0-ORS:#(8S.@S?=FH!/=WJ!M]V;@
MDS%ET*9\,Q JH=<E9\IXZ][T>-I,KOA=3ZPZ;U1G[IJ,N4M!(M7?2E.KG=W4
MP[=T?\/%^A9+40E_M(A<3<(5>F%ZI<L[F=%;!4NRR)\)>#=1%B[R2?-]O06M
MS5"SR1=9(6Z5T](,%3'RYLLB5]73UO-1[KR\8)+!:6J&CE</!_1T7D1Q''W%
MX2KY0B8=WT5>*(QH4.MHED8Z]H47>*&/+NG_"P(.8L(.=F).7]+;_'&1I]GP
M$IP\$5[D+>;A+UZ,*:V/Y.1]X#SZE;O;G]L52OP8Y]QXOFP2EU.M-#_)$/;G
M^-E+,WK]4#]OI1FU.IRS)I1S0G..M#_UI5FL^D^&&E&QT_"T,3%2[F:./B)"
MX2(DZ',4INM_(H]Y(W';GK]>F(M.FN8Q ?+KFM?42LDQ\G::+R^)((-YBMQ6
M$]LT5CX@CXAN;'*9[V_U2X^('.0O"K-0&,3,GFB*&+_B=-T46YD[0]C!'$VU
MI"_8I<R&5M8_"A<T$2,Y-"]>^#L1,,DK8$'OV;O;B_FCN$">4E]+LUK14"QZ
M 3^@V*>OO16Z($R2[,,;_%8_=Q[YM[?F(*YXG:WB=9(\%?D%25[=KU3X3^99
MFJ1>2)-2LTZFO),1VHJ'7'634\4)BQA&*R-??_!VN2:BJ-! +DL<^[&W9.<
MXS>VD\T#AS[>>L'\:XABX99B-G5EMTY9=HNS_PXU3/R+DM/2=MX2Y60E%CU-
M;&:*45CWIF=RZYG\$*-MP7)D&T)EB!$A?V89;C@457K^FSC:-)U6)2*XJ5%'
MA,2=I-BHM-N09ZH^ D5B#(VS=-1U1)C+'*.DW<8TEXM=RT2DS9A9 ]@MBZE&
MJ%J-3)VQC)RDIXP,Y2DE,^4UM8%^4S<NV$-'S6S3*KP.&0VMN5HHZ[7W)G$E
M;3-4'P)=??L>->[YVR/U$9;7G7,[<=51S-8#^0C+(5H5#4ZMF(\PZ\KQ%1'M
MH@LL15F-#=!S(\1&J'RJH8$9I^J"Z(<+HN>YD]5["FC9*BV4..;1&B18$0$=
M0>+Y.M0PP<H%V_'$"=Q):Z1@YI-1U4>V#Q[?5P)J/%T7O%1\_: &T?7!ZZ[E
MZP0U3LX40BJ>5E #Y7IAJ.G7 [W$N/9-H&V!A9Z]1QM!!:\BJ%G[3>^Z8QLE
M]$R VLA)HEZ@9VGK+[F)HFS %QOOC9XLCJ=&T+T<5",P:\S<ZT$G^K#&S;TI
MC/EHU:"Z1X8X)+=&RCTE)"%K-53NS<#U]J]!<H\$65!"C=6DG@7,G!L]G>XF
M:K<3^%KR[M.I6#I[>6].KI22,=2Z;%BPA99.A2KPRDOF8:P=\L#673(.VK%#
M-MBZ2\:P4W6TKI#\P2'9C0/>32&?GRPT@G=:IR+R\<,P#HRM*JDA:F^;H?69
MEO/Y/66;C1?OYLLG%!)*+Z/P%<4I)CC>1ZEN;0IS&:D:933$L7&<QO8S:5UZ
M<;S#X6JVB3)NWG9A%_MSN/%\I$%_H[E]VH]T,D+2[SK&KPY!N2B2D-72/L5?
M0J^HXT:NYAAM<+91(I_1[9PSR(TQ]YBYS$-IZ:%$)5A!1":SZ1AH%D9F<AJ;
MB<!E7JQ7&7K^&CVOHRSQPL4U7JU3A 2Y8SN,<C+J;_"R/_'M06SLF 8[ROE4
MDF34*86=RDBQDTV!6"Q'\?TC)J)4EX@+?'R:4E$OKVER&EXBL#"QA +H+M0:
M8,FX33=/Z9\*J$(B-*1E6PA@B9]64.N'*#P/9*8JL(IM"29BR16\R4D1'>X)
MA*M%=>DI#K:*Z&TG.DE3Q8>7YT7_G50C!]-3VR!RA^_CTP5WVE;/,\$Q4&S'
MS)-Y5HBP7N%+7STXJ50FU@/*^UDIT-RBZ@:'1""GT8M1DM<VKTCDJ;Z4NULI
MW]P*T10H\!@-[=,K5-XQF]I2BA='-2%;H#RT-&ZBDK"*!XNH%(Y2]U'.[6E-
M+H2$/F/1HO,,VX/8G^<\QBMRC@/ZJ\[BL?K9FLWYFU(%W(K1T#Z]C>NZWA(/
M,?85JV")^H]T=H_TUNLQN[+_J&;W3+Z2K*-@08LG(S]+\2MZCCT:#GWE[=1V
MI,9PXYQ[G9!@OGQ*(__W?!\^$_ZVXJ;6[SOJ.)$PL?3C6N]S=N]HIL1X2G.G
MP/V>4IJ-< #[\SM2AY^-^XJM$H*FZ+_W-F)G 6YS^[0_H@7:;(OD)_L@=Z5I
ML'N.:4;Y%:%YR/F][<_,N7E9F$MI9<UU,B+B6^V,.-)<(10O,0IH>C^OR!5Y
M&6VV7KB[V_(]9Q1Z07&9Z[ZR/Y,/)W=1DJ!D'EZ_I43"RG"RIF 5RD7.2LO[
M.0= N9'(.0#*"M-52:L+X9E<0KF:BW7<>4WM%'@I\U@E57" X"AQ&CL'RO-P
MH.303D.L_#6ZX!-VT,+,5X\7))^N@ IQ#]-4E4BK$\7H8)JF>_("U".*U<.F
MN9AOH6JZ(;#M0M"=$$36L+TA_?"TGBZ&S?DWCQ0>M@V%#TU3]S$M?([T;;K^
MWQU\>&#[?XLUM-#3LP_D-@^7DW<"BY?"?O+1!1HF6^@IV150$S_3H>=;-[NM
M*C\'Z#G6.Z,FL&A S[%N +.670MZ9G43)U/5DP-ZUG6C6+9\0:!G7#>*',^7
M"GK2=5T0VX9*Z.G5-=!1=]*'GEN],VC,.(U>2=,A:C(D7N#04Z=W1DL>&P ]
ME;I)Z!C[;?)O YYE&GI&=0V(%%QBH%?-EGEUUG8SB;VY!FH*<H0:4"P3./02
M]2[EA/&4$Q-)7=XC@0O<U.2*&X;E%@(^];C+WR+*W\+R1]Y?4BI^UO5-!4O9
MY)+;N.0VHTO1\A&F5OP$>8$^PC3(*R(G<VZM81I:BV0Y!]!E% 3>2T0K$KZB
M61S3\C6Y\-P_"Q#'KWA&5@^]HD);\!!'B\Q/G[R 8(_)_TNC$/$]C)7[6LGP
M4Z-'C07W!+SZEV8]$N;\NHYB9:9)@M+D*0H6>=G9?<69Y#EZ1-LL]M>T+ T_
MC$>]_VAG)PWZT1VE?S18DFYC.LL/^;_H[#XT9D=_^^UR=D!M]:N1B($&+R'\
M/ES<89^FF]U/G7^N%7M:R17%89#EX?0Y?VZ>U"-EZF&.*9.?L!_)"Z$X"<0,
M$(4$(XY.;K:Q2>4CN>7#C ]UNY6A&.I7%$3;G-U4TL3U*SV&H@AJ29]SCI_F
MX'2# WI2PP75? 2HL/H_HE46T"%VL^TVCEZ]0(":Y@@N3KI\VA >/U^V59:?
MO3>\R38741Q'7ZFGBK<E?Z%UZID'1VL(6W'5S^3Y=A>1N^W!VPG26#";&MGA
MU+1)O0KH)MT74V1=9K+61JCY[(79DESS&?V",F=2Z&6&NO;0C./#;3;$]YE\
M4-#0" WS+:+"6;AJ; 7^R@A:VSAQ#QY>W(;_@<-%);)PSANCH9D,!E%*%@1[
MP7Z%JKKV+/0$K0>FYCFZ0(_(1T0(7^A1UNII98WCR$=HD=S$T:95L)V?<T'8
MQ=(<J+9'J#MIM[%(Y3Q^0O$K><0*E"#,IA9IIJ_-DA0V&Y6W-Y31)%KBE'FK
M!ODX-+B%]QCK,H*=_">":NM,U$4]1C0#X<X1]QG1+!))-F-I-SMSR5_#Y*:)
M5F&NO&]HQ=-UM&@W^/?1-=9C(#/9;+R0'-P9E<^P0+1E-;.!=UUXW( "3Y2P
M;X /6<$+K2@Q/Z-H%7O;-?:]0,@M^.VM4$^5>(?T"/@UO[T5ZK.7!/V1$7+R
MYX]0BF*W'0'5DN1PO-8CH5R\U[GMS>1R0O$&A[G@0[,9S)>'!A86GY5WLH$L
MA6:^;%JJ^3N"W=8(HE^VRS@*TQO$E$ ;?[7I#-'1(KWWDE UZ$&/N=&V=[?"
MXW3-R=#]PCK:U_>[4J1N@YZ6; AK]![8)D^#GD)I*"#[/,:@9V(:=/.*U,C0
M<S<-"ZRF/@YZRJ>A.<>1"P3T%%&6V$+;G@,]H]2I=NUA3A&@R:8&W;,B_P/H
M6:F&WJ=W6DXTT/-6#<\51(ZAT'-;G19=Q92X0%-@#8VUV(4">@JMP;DRT^T/
M>HZMP?<LP[4+?B:N044S!4,*U-Q=+OZ[!$+F][K?+!S?U"GAPE'AJ_@T0\U)
MI@&3/"0%:OHH#9!TXU&@1L!K0*8>@@T][9;(7_= _.?YR$)EY\KNP0R<CK</
M3&P4W'C;1D&ASRSTG:3D,EPG-V%Y@T+/PJGJC]S<54/XH4+?BL/Y[LIR[OW9
M0=H%4HG['_@,F*=!5WB?@<^D>1J,V2(G^(R<IP%7X*4//J_GL CSM5X5L#\X
M8/ML70TGXPKQ'QWBO9@%+[RDPO=/#M\^^)JUQ,!-.ZP<($?!W>=Q@YX#51IP
MUSK*?.C /V7%07(2AC=AE/A:3$ZT)-3,WDJA=2U113>N['2[RW(ZW1L/Q[]X
M08;VU>-H MW*12LQD%77Y:K5FVGE=$ADZ(A6ORJ<#_?K5"^=<*:ZH]B9:;*F
M9E#R/]=_9/C5"_)UV;M=YI1RYZ?2%V*66"Z5(0TQ1+3RA?>2NPFS23IN9B=+
M[3X'//5(?$(^+5V/D?C\RGI9F0FC) N;^..&]ND5!ODSF]K/=0LA7^^>$RN1
M7[<VE#E67A7FF'4H]#KG[+%F5GF_4H5V[#/RZ"6[F(>/E%=1[[$++\')ES B
M$GO\2C41M^$V2VE8;4C/67Y77.SR[I>!EXA3FPWV.=O8946!^^3Z;8M\(K_\
M$@6$5,J&:+B  AJ2 <8ROT><_'Y#Q(%F,(3&[)C=K<ZMN9<$ER&_O67J]__\
M!T8Q>8JN=W?4J5%M*J+.EN=5L@;*M7.6H#8A9B^K,ZE?+E3-6MSGBCQ2U'4D
M<Y+E\1-VL3J'_%I)JD+J*FR,T6,$,\@/["?A*T34P^H,&J<U.69%:H=$:8RQ
MS/)7G*Z/9)ND+=RT):'\LLDU/4L4)_=(>M ,?^U\D=OK"TZ&'ON+9FI"B-6>
M=YP".'I]3T$I*PVG>C\;N_&6/!EQ7+CRTS#*.YK/HGB^_(,\+F^B^$O"NSO4
M^EJ95>A'&Y3';GC^F@*?;^AGY*]#_$<F5M8J=G9U10JX*KZ 4<*0AS@82SJY
M^BC#U4?AU9P]G NKZ1AH%@I.G,8VZ/[LQ;^CM",/4NQL9U[YAI:0WVQCME++
M(RWF6TLC@AHVXAY6L"/4[(JUO<G"A:)U3=;+QDSFZ1K%5=X%>MJH1Q:1%A'7
M!"#J8:ENQ1;%Z>XA\,)T%BZHX7+;4N]+;S&M(48U1_YC0=C%2ET"ZA$@JFRQ
M_[LUZH2\L-EB1#4J7*V0OC?2R>I-\+ZO4+[]L/(]@SS]44Y&_4'Q^6[$MP<Q
MDP]?4O[]F%!)CREDPC=#];$H+"";TW@<= O9%[?YI.H! $NQ4>'(]U%JA3\P
M/8.@.UJ+_*&.X\@X;T&HL0T\EYM&QA^Y*Q%T-_2A?7[:(4H2OTGHI4VDCB9-
MM(9;&>A<4<\CAHFYFC5Z0D"*7'"8" I]728#G(+'3XM#ZL9/0$\9IN)F5">G
M4S(W3V;OZ7C4,(\PRZD(=*)(7<^*]M%5"@BJ=U\'87O4*8%[(R@U]T MD]4;
M.1WG<ZAUKP8!D>WA#K7"E3D(60ZUO4I5P>9\,J<@J$6I>@,GM*M#K3+5&35^
MK"W4"E(&3F:G"D; ZD7UAE&U-!&L%YEAV!IAMU"+.9F30$P'6D MZ302Q#D!
M&E!+/?5&7>RJUJN6$VQ16\^/L5<!)\C[3S$0!FIY)NWH)B;'E)BGP*;9[H4>
MSZ4);,+L7FBQG&? 9K\V=2K9MDZP*:U[P28I$0 N374OL-@!96 33)LZCX>^
M,F S1O<"3*F<!+B"*)T@$Y6,^? 7!U%S5]7Q1!5 /SF %#U.[J:04-V5JCUP
MP!&%C8ND@:GBP_'.EH4-02]WJ A3A\BP&CE8UKX!D#N,"*RA@V7AXX8/'\D"
MI\\R;Q&)X] L3EZ'>E_ ,E1HA$6[VJN#U%X%5FM<*9[V3,I?V$%.'-,K5I5/
MY0#*XH=;IBS%[&?0JR'K8*::K:GF8D.[X%DN1?.4;39>O)LO6R[KR762X@V]
M"O:*@F2^S,5,PLHJJTRI.0A7\Y< KZIP[^)6N(N\L&JG5[J&7VJC&8-Y9.1M
MIF'@MIUJT0TU3+EI+9GM[)=S<"4ISK/H S?I*I>M\#.NR#O9+CK@"E)TQ.Z\
MBQI83R\/+/VL2VEJ.Q&;2R77]X9SJ>3..97<J0V[LA=/AS@5B %EW6%BQ:5
MC",3/?-D7B4P_>!DB*CYO8'SB-#"1LEM"YRB5@LB!5= F+[,,H DC!NNS]&X
ML]<!B])WV>O&F_**S2&@0N1<#9VKX>@\P;HD\H(#G8*U 6K:KA,Z:@++U>6\
MRFQ[E77)P75._AB7T6:3NU$\5%-\2B/_]]EB@0LR;\-E%&]R,O3\*@QY,U")
M=K[,B3I2M1WZ,##;FO%<*(;^-7>I2Z_?4.SCA,J0#X@L\.* (*4NP]&%'F+L
MH_VOR5-*C\,L(1_VZ99:D;_-EV2UR2V4-U4F7W]D*QXP+=+G<9[.GS.#\J_)
M!_&>TAQK-+.^SR@_(V=B_PB_](( +2YVAT3KS%]CU-$@,<_2)"62 ]F9.E-M
M=AO@Q.Z!NG[;XJ*"R=5Q576-CH;\M.BED//1VR3)T.(YNMCEURG#)JO28V"J
MF'96M3ZF*:-^B&CQA5S.\=.:2"IW*-\[^V(T^8\R"!4'L>-=N*>2P#B/BQL@
M5\,\E-1R/0SE/2W/J,!UEJ5K(K/]&QU>ZRH]1C&#8JNK4E^V'@7E"EQ:U&4,
M_I4^TO /;30_9P_+[M3<X81F6277F+_F5.24-+:QYC09&KG:Q'YV!XU.@&@)
M"W^%VPVL^"L>1_^+?"TYK9V7HO-2["VUW4<;LKV"4KBZ04RI^[B1E8++WBZ/
MZRN5&_3&)N<"748)]^$F[&*G:'13P:0I/"IVMC\O11%2TLG(_GZ((Q^A17(3
M1YMJ^>?+AOPT"Q?5:Y*U];7Z6RI#OB?P0$_%/16B+F90SUX"[/,=0EM_M^VK
MK.R@;)+O-L?EX\1H91NM9A#UQ:[Y%WU7==8 -N;WY*_1(@M0>4U<['(U$RLR
M3Z4'"+_K4Z)/&3]+!<]H8 ;;_*9Y1&D6"S5,3$A5^UI!LE;Q766Y^2&WLA0T
MWZ.O^9]X9U2QLYD54/I6;5!AKH3N&"-:D5Q@Z[@@!WUMS&J?=I]&GJ/X%>>N
M'.Q,>(26A/TGX;UK]!-&]FQ^UK_&F!JV^2R7T<K0UW&:/$7!XF*W_X3(<BEL
M;Y:B?/Q"HLO-GOOOI8AICE#K>#H::17O*,DM_5<H\6.<^R9TIIPSG-GYE&+[
M0Q33P1LW_&V81HW7B7 6RH,8H;W\VE%!^6,".2U-4I$T7!%JXR'?CT&E6W]]
M''KSUR47)O\ZY+[TM]_^ZWEV?4!@_;M-?R.ACTK;,UY@:H+N_=<%);Z6"+K'
MGS):,O43U!J</8%2V5FP2MGTYU:561EZ_$YWA%KF:ZA1T,HP=7SO0HV-UMY>
MJCH-J-4T30%VJ'* 6D93'Z^&^A%JI4Q].4%H:X5:WE*/J9MR.X=:ME)?DI"Z
M+/<J50D>*KEW/]0*E08.;C..!6HA2DV8]!VZ:^ F*NW+_6%KB#H(]J.NMJNW
MNQB.9]!S9BN^%96MT]!KVJCAI6B'JL&:J&C?WR!60SAEL;^##0YZO1=-X)@F
M;.@E3-0PTG-7K3&;J#AO+.RW1G+*$K^2<?QT53I&"I6:YW6OLGF Y'S%4&^H
MI?(T0LE9#V].C#?4Y#5:(>X-P>+8,V^/T"=8LFHWA-KQ&#4VL,0&M8#:?>Z_
M@T!1J&=*'*[;LH2)PB"@PL./&:;0-'SNZE,#"P#%H.3F1C'K_PUY9[G\HR[_
MZ)A20WZ"J?SDAW/N46,%7-:PP-3+Z<=M\A)H3N4(*D2"3JYXAR8V8FX/MHQ'
MAQTD>JN K>71<3?IL#*P93XTL5/2/55@?9HX6-)G4 64X^]"]2_\,C)#1#\?
MFF".HB1K475H\ZCE7-SW*+V+$NHO6W(NZOMB(!.WRUIZ[<4A%32J*"]9YCY>
M\ZGE:!PZ"QXO,QM*;T-R4M#Q<3BRMK62M:GT&YI";E5[:1\;)V/^-4R:AY6R
MX%7CN I3R2IVMJKZEYS\VBE3NJ)0%0!.6=LT,.KP'B/^XEW"_4?M)-$)1EU^
M!#7^7^MVD>GC)G="V7H M;UXRM>;Y8?&0T1&2LFC+-A=X2!+\2NJ/06;46<6
M!)(9(6QQ1-3UFQ]D9.[4X8SZ:&<%1O/ET?TNRKUN9FP;8EI/RB]V[ $$>2N'
M_.(9(LA[=Q@??CS8W'L;<7)N:3<[)24DU8>94Y'UFJ;2H@?MFVT0[1#*1>)Y
M?OD)\>>W=RH7LRH7,^O[B,CFPGY:9E,2KBV[K=UDQSW9M5I^9",?L8%3J8D7
MKFJ[C4T5SPEDH^8+57Y90GU]#25*R='5%O^A)U-4E=B:T KN9*C:E#YP205)
MZ)D5NX!V<'- SZ78!2*.Z 0]J:**(68H.0WJA>PL-UP_'I,"ODS-/@%G.]-P
MGD1VGY##[4C79YKFE2);Q5<O7CP$7I@8\. RI.8-\L%1D4'VPDO0@JX>"I.<
MI.LW^D^>6D.QLQ7U-85:4OZRW<9RK>-+;XM3+ZC2724H?B6'*8IOLI1LGRKY
M"5=5K3N.H1KG89(%*4\MQ&YCI1[S_ASFV6/V.[1TEL_SN.:(O= ]7&5[E2C7
M>PYJ506?^^DB]K&]])+U(_(1?BVX>97%HW1N+K0$O#-E\@NC1>B>J@$2FLB6
M<I#D.2('KC4_LO3W4?I/E))91JM04/1SN.^!0J_(MD/86/D3;??AU)"RB;"+
M\RN**3]7,Z0=M)Z2$9!S@[6&?\AB?TTV"I709F&84>',CQ'YY3:L;E*^UWO7
MH8:=AZ VF[3/.9M9>3CE63_(6E!?I]=\ML]?R;]WSVL<BZN'JG:U<JK>R#N,
M4C5?+@G+B\5'BMW8F;$+>#Y[;WB3;800MMN8J1'=R(@OKB%SO#65^QJG-/]$
MXY7!OFQE-"N.8J6>.(KS]WE8"A)BER%>:RN4$P9%K0Z"!W"KB4T:A2YE!XVL
MN+8<9LTZ=&?9_]T:=6)WFT8+YQK4D>H\8>_CTQ<=Z@_Z6)M%YJ=Y\2/ZK)F%
MBY+7"DO4BWM9KDO/O" :@2')Q:YN4ZI>"G6?6A7[GN-;JQLONWHEC<=#=P-K
M'M3Y__L%Y>E"BJ<Y3R-@]!/6,'J13^!%-($BTRRWBORPWSHKU*JGWCX[P3Q=
MH_AY[86E:G*V6L7DJ9+2W/:$02;8S^O)_9)KE$SCVI.:LSK3TKD6D[HMTV_G
M:KL;#\?YA$V?_G[$G->.%Q?]-C_^6>W*.TF@CX&!SPJ/?2F!H\K29N'A?N>L
MSE;)+!I5!'Y%]'I$BQG5QZ_0(Z(/VUS.#G/;8.8%SRC>",69$U-R5ONS/4^4
MM#AT^Y(TO65U/GV.F/Z<ERVH9G6P??(_T@(&@UW)':DX1Z0;>MN"#PZ$Y?%W
MC&B)I62Q-"45P\__@[H/T3\_1U3.8NF0C7]CE/N$JVNH_9?"A9(F=9!/C0BS
MG$AJX5ZC>2C6B.J,8.X\-!VRN.97[DY7ZVV&VI:[(L>/3M1R("J8VUO<ULK^
M9!>=+U:1;W?G[=6.HYE;@^:UB_8ZGKQ2$6<E^#ULK,<S3JE:]Y;<<J]X081:
M@>:;W7845/^*TW7N74BA7>/M<R1PH.@ZBI69D@_,ERV;@WA.W/9&]GPN-);C
M'T@/3!6?8B<;R)8G3[#?FRTL4BA<[W8;(VLL?32PEU(NE)H9V&H$(\MWOA6+
M-XC("CT0S8P3.J="55^#*%3P73CDP2YDN06URGA.[%2R'\[[/('*#J/0Z\#*
M<)(Z()\N9;NEZD*LRHI,%RWH1XKAC];$XL#!ME=EX'- 0\W_JE50D/\<@KYW
MC/MXR0+U_^R0U$"2+45,**A^ "P/GEM3*G5E#DRAUGI*%;#,[\^&8#.EZECF
M@6SIXJ94/VN /2D3JBIX?W3P=H"78R^I0/V3 [4#J";<#^&7DS/GI&D$>[ZK
M(_1THL,L1(>,-] 3D9H%NE]: ^CY2P? 6L>Q!WKNTP'@58^+AYXM=6!P54/Y
M:YAA&CH&$D"Z>H35<'=0CX^Z)MR0/%GBM%:#^I/;PWI"M/DHU/UB?' OFA.\
M:)AAT_4:?'!K,/R!. ZWK!? O29/< CX,3;U0KC7IOI"J*81KM'M\+Z<H#1C
M+6RO7BCW4CW=,JE%K-9KXQZZZFMC-/=QO03N$7P">:E/"'V]5##]RX92:1J-
MW:T7P3VX%1?!4(!*[5[I7M>*R"N$?]6HNO?R*=[+/1-RU<OE7M<GD&9[9O&J
M5\L]P0W+M]TJ5]0+XJS"(U@03C&,>I7<D[TODVNB.=%'=H^T,[H5AC]-5#0U
M!+&L>NRGB?*#8> ]3 ->P^P811^8N946:H!AZ=H4$BT)(EN@!P0J)8#:XW-<
MB;#>-3!?Z,*41D)??ED6(:@[JF=:I990PZFW5&\ZF'H&:9XF]OOGH$A=C1+,
M]STCYQ(C#&PJQXV9WTE!S<1.YE@_RX8V)(RA8'2.2ETUVD:!:%BE<UUA0E?@
MSQ5&<R693H3.8 :4O=IXF-3@VM\_*W2/],&F8+L#4<[CU<,!/3(W49P['9A&
M2?:YL\(.1K+^YZ_1\SK*$C+R393%#(F"+WXH]QV"4L*'JF?F%8Z13X9)&I8&
M+<K5QW)91#EW.-2WK,LBZK*(]LF.J<Y?H4>(&T^W"C386V]#:5R#X,.W3YU
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M%3M;G5?!"CK.2]S9YKRZ3>B,9M*!H?09T28"16( S:7D=+(YCQ9[Z[9!E8:
MHL#ICO@>&67%L:B'D<"_AN2[%XC+!=O7,6VTX6G\^HUE8R;<= 2=QC$[@_;!
M.0Y>E+5VRLD#Y61O&;CE#2%[K4'5)0P*ITQ AQKJ,>P>Y;[#>P6$3!5.KG#4
M+SPD2KU@W&@:$/H/]+)*KU>HT2,#PZHFT$.-,1EZSTHT$U!#4 :&E?>8AAJ3
M,C"<\NW9*4YE,C>5]#W6+V!E_#@JJ"J.<=)Z>4/U,C"B5E$7/L4[&JK[N7&0
M>_&-T[GICA_E:;L8&4&LY^:&ZS?DG%D$29>W44C#V>9+(I]4W(QLC5F2$'G%
MDM=\1=(A/5(? Z6^AG+&'@Q_Z6TQ$<_PO\M2MBS=N[S3X+0]DGU%3LRZO*>T
MR3SJ;],$N2>P?0U+K(Z\7J.8R<]QE C\XEF-A]DS0I.=H/5 U)")SL/CG !J
MQ/$Z#T/K06RG$HF'?4:Q%_GI3YE-1T%SG5>.+/JE%\>[95%*0?E0"488QPRI
MRDMY,GGC8?8YUQ3.:3D*],@_B@#MULI6MYHJK))1QC+3ZK?RLM:8W6'/D<[H
M('RH?.@D["HN5,+J#H'^IT:*F1;_X'4?Q=QHM9QB/8(@^DKS4JE.B]'3N9G9
M=#.;@#.1SKN6I6)4$G' ^Q 90U$F"(!W'-)%LH-J ;RWD+'=>*C @)HXUO#N
M.WIJ0W?],<K_CIX'T'U[#.TZOC(*NA?/D-NOPUL.NI>/^3NZ-$U 33M[BGU:
MOI^AIIX=X+UR")A[FH@!*VU _=Q#QN\K9@XPEB*H6Y+(GPKT0K3R4C3R.N7F
M\#MP3805C*!HWFRYSJDA6R,&Z[&A8.Z9IH>6'!/I9H/K9=7%!9@'*-1=Y#S1
M>)YH#9]$ PE<%4W8Y*,Q+3]WA8K_O0VO_\@X%=Z5^X["-,:W$9"=A9(4^P=S
M[#/2R&=\'Z5/V<N_D)\^1W7]E?[SYXP[<C1:47[]06@/-_:Y#[$-S.X!<,;D
M69:N\YM'4*F6TW@<=#,QEC:?F@%?GEWEZ,7%R9YR-UA^%Y7<+?9<U6Y#(J\1
MH><1O:(P0T\H?L4^NGU\$A91EO4:M1M&GW6]1RF7)\_",/.".[S!*8O)Z_<?
MG.+D JUPF)27"'.3ZG0W0J_"E2>&6&\ (S17/@A$(KDB)R*(MGD%F=S1HP!)
M!+%&;QL<HB5K_;]9C),%]BEV0@XAZV5C)L<*VT.!ZW)-*Y[<AE7)9N;4M(<9
MA5Z$*1$UU8]\&02J7D15^FJC)+DOH1N<=,"2L@ZHL<@]$Q, UT=*972NII:O
M.H/J@JJ$5?<+#JJ_J19LG?284+U,AT+N0 ,(U=54G;=I/<R@>IBJPZ7Y+H3J
M5&IF?QVK*J#ZD [&SEA*?:B>H4.!R+.1074453^\.AHEJ#ZA0D6ZS!4(9NEX
M$1HRC<_>!VARR B.'5S'*.?TPW/ZN5XNR8V#7VOOGT?R-+&1=8I-"2M]'T<5
MK3& #84[F[Q'Y$>ACP-<'(.J-@%](&:$D%U[670FKC?R6!&I=#3=,P^8_LI8
MD<IC/&:+?V5)'@FG=THD0QDQ#*I\^0'%A'61;W+=%#J,,M858V=[/TH(9V1(
MYPXUH=P:?4[ID[]&BRQ ZL6C)#V&HXKK3"1H?2X&,-&$H9K"1BRE6WC$J1W$
MYF/7B(0)VG8X#*;\>QRT15$=S,[B'VB[XC";\?@9 -JZ. R(6J].T.9(4_BR
M]3C]#),C#WB6RZS3#.%5PT5I]YU28VU947OC4>Y$-L@J1HAR]N%B-/>?2!@/
M3U8+(T^\>DRF#H'=QLB7"]ZT(L/>8>\E1YGU<58S&XJ,PO"YWP_\F"Y&0_OT
M"F.YF$W-I,[VPI<LWE5#,]WU!0WM1%6^I,JZ*DYC6W3?AH2 +#?34Q\'<FR$
M403"+O;G<$4$F/GR!L=)^HC^R##9I0_>CO[E@]*$1/T-)88__MR==_0UYGY7
M[&I_%<B11!J[J-'</NUYI 0BJ!)\<W7!@CQU?2HVK/@9LY4'L#\_GH)8UMH^
MY2PELJBE?8J_A-XFBE.:2Y!R?.4#P>IGB/N@>(E1L/CLA60[YBP\VFR]<'>W
M%5RT\E[G;+3B8'4DQO,!XC6UL0-O/!Q3W0=YU&\S(GV7^T?@E"#J,8(9%"M;
MR)N/./E=;19'O:Q%J9.KH$R&20\YUX!YW!*LX9)>*O-E^P7Q2"8?8Y_<EA=1
M'$=?B5!YZ6W)']DO/-TA;*S^712NGE&\H8OYV4NS&*<8)8]H6\AIR7SY$./0
MQUNJ%[A';^GS5Q2\HL_D\;KFW<[]QAP]"O]$7GP39;SH[&YCG<6LG\G7>0RZ
MXV#G,>^OD;%9DZ%LS3DM"7TF'Q/H>9A-QT"S4-?#:6R#[L_>&]YD&V$.AW8;
M(S?60>F$O5:1+Q)*>EC!#H=R[%IM;%"96T6;9Y]#Z7&[45!;%I)7);IJ/@K:
M[Z/0UR._T</(.2M56#=1?*S"Q^SZN[(N-I!]I#9IP350_]T:=4(NT&QAA4(4
MY'HS+TYWS[$7)EZ>?D.$J*#'B&8@O&;%?<PX9WIAM,2S5W)&<,*_O%C-C'R?
M3LM?HPO^IP]:F/GJU^AY'66)%R[NR;LQ12B\CU(D $#2P\:.:NH$J;(P23+J
MU"*N5BKI9,VQ@&VWWCL3'!N80;M9\.SI>SRXJL@]+!]A.8S)#>BM"@1,LS74
M+:-BK-_OG$.&6V\86&ZN6J#(7G,U2+"2<*BY*[23(C ,<- /EL1>RL>G:?:N
M08*5W: W2&+[.M28AMZP"1U;H 8O:*"FYUP#-5JAPS;K::6"&K(P-))[VP?4
MF(23 %@8S: F33L%A(6U%6H:-=T+A.E?#C4]6H?MQ3=W],I]]HKBEP@R3$W+
M"M2\9QUP8OI'0<]$KLJ+I+8PZ%G(.[^5F&ZWW4K<@D1+9DKH5]P6!%3=_!2A
MUKCML,>$;L@U3I,7V*7.SC56DQ7-!:Y!-3J3E\W%P7RU36,*2GN]V'UP2505
M01%962ML)F+EX6+3<.6J( &7HUD3$K:_<X7.IXFBP_1KJ4#Y8:*@*#GT52#]
M.'&0N'<][&S?UXS SH9%3QZP6HLVL!1&+LGBP3D2!=J(+JBIXL/S"9.XP];G
M"::"^L@[_TC>.T("Z(9A1 (TL3@(&*KW!4SME@R-=NA9C09,O8Q"#(:"A#<5
MUJL4[U$GRV.%8=0;"J:!0@\B3A:P&J2A]7V6DPC.?#]&>9;89=-&<QDE:5Y<
MJ_#@I;J]V_ R"D.4@_DK3M=[D?D&AZ0+#E<V:L3,"@N35T^AHO<A1AN<;:J/
M'D2LR/O9"+YI4[4'EJX&+R)-V,4EJ7/IJ\RFKW()GX:EID>J'!?A,3911,.J
M)N;\+LI#X^*>6'"'LT$ZY?<)E=_ 0G]&K/RV_#+,/= RG_KVDWMH[<4KE!C(
M,#]>$:V[ /XS"FD!)?)@GBTV.,14#*+U+DI/1V$.%+6^]LKCY;&3.:^D7Q)G
M1Q'U&-$,A-E1Q'U&_0 X(;*ETWAR$\4M/L$!E=O<3LX<5O%XE;.JTM/2C&I,
M"7&E"G1&B^[D3OP2+8QZ_Q'-CCZ-[C.*^7SY$"7YO91<!Y@P4?IGO:G*!CN?
M>3\@(E=4L>Y&06B/;!V14B11F6+5U#[-A5J=\I'X%<ETC$I=K<^II$AE#E53
M&S37A:,$NY]90+;+"/:+R@KEMG9PG%!(@JZC4Y(1VQ9H!?$!>JBX-FJ*3R2H
M >(C5C/8LM)KBJS-S:3%RR>%I$3 ..!C_<5+Z*KVTX(+5\UJ%,^]Y \]O5)7
MM/C:&>AIE(SLK_V+!GK.I YO(IF!$6S06D>LE!YEX(VS/<%3.]43*OW\A )$
M<T/\9^;%A.Y@5SJ,>,&5EWI&2CY?> GVZ1L7!QGYTJ^(YK E OHK><:M4"7$
M/)&K&"7S+$U2+UP<&P!Z#65#373MQ2'Y=D(DW)R@ ]HYJB%9KW/V8N/LCSRG
M$MX\HBWUQPE7/&6FI/$@M+"T>(*&SJA7[.)[E!;7U%V4\'32[38VJ#SF>0U?
M!&7'8]U1K"7MEYZSYD5YL()07^?ZP$C9.M2'MSI4_6Y]J$]Q^?TB=;F$)M2K
M02+;>+#]+9VN?]/]KI7MHI,K]D?]VC/LD]DC>"U)B/BQV7HXSEV(A?X9G,;N
MH>0>2N-_*+DGB" ^A\,%)O46<0*B$Q"=@.@$Q%,)B-E+@O[(J!L:S?5A.DRG
MAT@8QS3939&I,%S<$Y+J7QK).=@E4KN.8D14NHP"0D84%^<@7-QAGSJJ'97&
M/):=%'N>LZ@+5[1[B",?H45R0QA4,Y.,H$*\L(N9<N5QM,0IU>E2S1LUG%9[
M:18$I26Y6=WN>$]JCC"B4M:N&'??W7.R8MR&'/7;EQGON2QM/@+:A;<:N^T(
MJ)9%BW&;CX!V8?P&J^D8:#Y(,2HANVH]$LJ%W(W?W@AGH_49J.<L99A%$<X#
M48O%Y^2=;"!+H9DO&Y*N8$>PV]I\P'64\QOU\-2$;:@.F4XCX+*"CB0K*-"
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MSA*GDS.=G.GD3"=G&I SG73II$LG72I)EV5,6_+@[2ABY!217^*,S!Q[+SC
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M,C Q-3$R,S$N>&UL4$L! A0#%     @ 6(IO2-V R8!P'   _T4! !$
M         ( !B[P! &UN:V0M,C Q-3$R,S$N>'-D4$L! A0#%     @ 6(IO
M2.Z$V)4B&   V6$! !4              ( !*MD! &UN:V0M,C Q-3$R,S%?
M8V%L+GAM;%!+ 0(4 Q0    ( %B*;TA_>@NLO&<  &@6"  5
M  "  7_Q 0!M;FMD+3(P,34Q,C,Q7V1E9BYX;6Q02P$"% ,4    " !8BF](
MV[@D99"X  !7A H %0              @ %N60( ;6YK9"TR,#$U,3(S,5]L
M86(N>&UL4$L! A0#%     @ 6(IO2(,P1ND$;0  (F,) !4
M ( !,1(# &UN:V0M,C Q-3$R,S%?<')E+GAM;%!+!08     !@ & (H!  !H
%?P,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
